PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ketroussi, F; Giuliani, M; Bahri, R; Azzarone, B; Charpentier, B; Durrbach, A				Ketroussi, Farah; Giuliani, Massimo; Bahri, Rajia; Azzarone, Bruno; Charpentier, Bernard; Durrbach, Antoine			Lymphocyte Cell-Cycle Inhibition by HLA-G Is Mediated by Phosphatase SHP-2 and Acts on the mTOR Pathway	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-CELLS; G EXPRESSION; G MOLECULE; PROLIFERATIVE RESPONSE; ALLOGRAFT ACCEPTANCE; DENDRITIC CELLS; RECEPTOR; ANTIGEN; CD4(+)	Human leukocyte antigen G (HLA-G) is involved in regulating T-cell responses through its interaction with inhibitory receptors belonging to the immunoglobulin-like transcript family (ILT). In this context, we investigated the pathways involved in the control of cell-cycle entry of T cells following HLA-G interaction with its inhibitory receptor. We show that HLA-G acts through its interaction with the LILRB1 receptor expressed on T lymphocytes. Both HLA-G and LILRB1 antibodies block the inhibitory effect of HLA-G and restore T-cell proliferation. The interaction of HLA-G with T lymphocytes is associated with phosphorylation of SHP-2 phosphatase, but not SHP-1. In addition, in activated T cells, their incubation with HLA-G is not associated with a decrease in the TCR or CD28 downstream pathways, but is associated with dephosphorylation of the mTOR molecule and p70S6K. In contrast, Akt, which acts upstream of mTOR, is not affected by HLA-G. The inhibition of SHP-2 by NSC-87877(5 mu M), a chemical inhibitor of SHP-2, or the use of siRNA, abrogates dephosphorylation of mTOR and impairs the overexpression of p27(kip) in the presence of HLA-G. Together, these results indicate that HLA-G is associated with activation of phosphatase SHP-2, which inhibits the mTOR pathway and favors the inhibition of the cell-cycle entry of human-activated T cells.	[Ketroussi, Farah; Giuliani, Massimo; Bahri, Rajia; Azzarone, Bruno; Charpentier, Bernard; Durrbach, Antoine] INSERM U1014, Villejuif, France; [Charpentier, Bernard; Durrbach, Antoine] Univ Paris 11, Dept Nephrol, Hop Kremlin Bicetre, IFRNT, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Ketroussi, F (corresponding author), INSERM U1014, Villejuif, France.	antoine.durrbach@vjf.inserm.fr	Azzarone, Bruno/AAH-9251-2019; Bahri, Rajia/ABE-1725-2021	Azzarone, Bruno/0000-0002-5962-3849; 	Association pour Utilisation du Rein Artificiel (AURA)	Association pour Utilisation du Rein Artificiel (AURA)	This work was supported by the Association pour Utilisation du Rein Artificiel (AURA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X; Bellon T, 2002, J IMMUNOL, V168, P3351, DOI 10.4049/jimmunol.168.7.3351; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chiang YJ, 2001, CELL TRANSPLANT, V10, P343, DOI 10.3727/000000001783986729; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Colonna M, 1997, IMMUNOL REV, V155, P127, DOI 10.1111/j.1600-065X.1997.tb00945.x; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Creput C, 2003, J HEPATOL, V39, P587, DOI 10.1016/S0168-8278(03)00354-4; Crisa L, 1997, J EXP MED, V186, P289, DOI 10.1084/jem.186.2.289; Dorling A, 2000, EUR J IMMUNOL, V30, P586, DOI 10.1002/1521-4141(200002)30:2<586::AID-IMMU586>3.0.CO;2-Y; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; Le Friec G, 2003, HUM IMMUNOL, V64, P752, DOI 10.1016/S0198-8859(03)00091-0; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Le Rond S, 2004, EUR J IMMUNOL, V34, P649, DOI 10.1002/eji.200324266; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Liang SY, 2003, HUM IMMUNOL, V64, P1025, DOI 10.1016/j.humimm.2003.08.348; Lila N, 2000, LANCET, V355, P2138, DOI 10.1016/S0140-6736(00)02386-2; Lila N, 2002, CIRCULATION, V105, P1949, DOI 10.1161/01.CIR.0000015075.89984.46; Lila N, 2001, P NATL ACAD SCI USA, V98, P12150, DOI 10.1073/pnas.201407398; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; NAJI A, 2007, BLOOD; Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X; Puppo Francesco, 2002, ScientificWorldJournal, V2, P421; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Riteau B, 1999, J REPROD IMMUNOL, V43, P203, DOI 10.1016/S0165-0378(99)00034-0; Riteau B, 2001, INT IMMUNOL, V13, P193, DOI 10.1093/intimm/13.2.193; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; Saverino D, 2000, J IMMUNOL, V165, P3742, DOI 10.4049/jimmunol.165.7.3742; SUMIMOTO R, 1990, TRANSPLANTATION, V50, P678, DOI 10.1097/00007890-199010000-00029	37	23	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22776	10.1371/journal.pone.0022776	http://dx.doi.org/10.1371/journal.pone.0022776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887223	Green Submitted, Green Published, gold			2022-12-27	WOS:000295832000005
J	Alhamidi, M; Buvang, EK; Fagerheim, T; Brox, V; Lindal, S; Van Ghelue, M; Nilssen, O				Alhamidi, Maisoon; Buvang, Elisabeth Kjeldsen; Fagerheim, Toril; Brox, Vigdis; Lindal, Sigurd; Van Ghelue, Marijke; Nilssen, Oivind			Fukutin-Related Protein Resides in the Golgi Cisternae of Skeletal Muscle Fibres and Forms Disulfide-Linked Homodimers via an N-Terminal Interaction	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; ALPHA-DYSTROGLYCAN; SUBCELLULAR-LOCALIZATION; ABNORMAL GLYCOSYLATION; MENTAL-RETARDATION; BETA-DYSTROGLYCAN; MUTATIONS; GENE; GLYCOSYLTRANSFERASES; ORGANIZATION	Limb-Girdle Muscular Dystrophy type 2I (LGMD2I) is an inheritable autosomal, recessive disorder caused by mutations in the FuKutin-Related Protein (FKRP) gene (FKRP) located on chromosome 19 (19q13.3). Mutations in FKRP are also associated with Congenital Muscular Dystrophy (MDC1C), Walker-Warburg Syndrome (WWS) and Muscle Eye Brain disease (MEB). These four disorders share in common an incomplete/aberrant O-glycosylation of the membrane/extracellular matrix (ECM) protein alpha-dystroglycan. However, further knowledge on the FKRP structure and biological function is lacking, and its intracellular location is controversial. Based on immunogold electron microscopy of human skeletal muscle sections we demonstrate that FKRP co-localises with the middle-to-trans-Golgi marker MG160, between the myofibrils in human rectus femoris muscle fibres. Chemical cross-linking experiments followed by pairwise yeast 2-hybrid experiments, and co-immune precipitation, demonstrate that FKRP can exist as homodimers as well as in large multimeric protein complexes when expressed in cell culture. The FKRP homodimer is kept together by a disulfide bridge provided by the most N-terminal cysteine, Cys6. FKRP contains N-glycan of high mannose and/or hybrid type; however, FKRP N-glycosylation is not required for FKRP homodimer or multimer formation. We propose a model for FKRP which is consistent with that of a Golgi resident type II transmembrane protein.	[Alhamidi, Maisoon; Fagerheim, Toril; Brox, Vigdis; Van Ghelue, Marijke; Nilssen, Oivind] Univ Hosp N Norway, Dept Med Genet, Div Child & Adolescent Hlth, Tromso, Norway; [Alhamidi, Maisoon; Buvang, Elisabeth Kjeldsen; Van Ghelue, Marijke; Nilssen, Oivind] Univ Tromso, Dept Clin Med Med Genet, Tromso, Norway; [Lindal, Sigurd] Univ Hosp N Norway, Dept Pathol, Tromso, Norway; [Lindal, Sigurd] Univ Tromso, Inst Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Alhamidi, M (corresponding author), Univ Hosp N Norway, Dept Med Genet, Div Child & Adolescent Hlth, Tromso, Norway.	oivind.nilssen@uit.no			Helse Nord RHF [1911 / SFP802-08]	Helse Nord RHF	This work was supported by Helse Nord RHF, http://www.helse-nord.no/, (AM, MVG, ON) Grant ID 1911 / SFP802-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartel P. L., 1993, CELLULAR INTERACTION, P153; Beedle AM, 2007, J BIOL CHEM, V282, P16713, DOI 10.1074/jbc.C700061200; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cullen MJ, 1998, J HISTOCHEM CYTOCHEM, V46, P945, DOI 10.1177/002215549804600808; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Dolatshad NF, 2005, EXP CELL RES, V309, P370, DOI 10.1016/j.yexcr.2005.06.017; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; Esapa CT, 2002, HUM MOL GENET, V11, P3319, DOI 10.1093/hmg/11.26.3319; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gleeson PA, 1998, HISTOCHEM CELL BIOL, V109, P517, DOI 10.1007/s004180050252; GRIFFITHS G, FINE STRUCTURE IMMUN; Harnett W, 2010, TRENDS PARASITOL, V26, P114, DOI 10.1016/j.pt.2009.12.003; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kellokumpu S, 1997, J BIOL CHEM, V272, P2770, DOI 10.1074/jbc.272.5.2770; Keramaris-Vrantsis E, 2007, MUSCLE NERVE, V36, P455, DOI 10.1002/mus.20833; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Louhichi N, 2004, NEUROGENETICS, V5, P27, DOI 10.1007/s10048-003-0165-9; Lu PJ, 2010, BBA-MOL BASIS DIS, V1802, P253, DOI 10.1016/j.bbadis.2009.10.016; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Martin-Rendon E, 2003, TRENDS PHARMACOL SCI, V24, P178, DOI 10.1016/S0165-6147(03)00050-6; Matsumoto H, 2004, J BIOCHEM, V135, P709, DOI 10.1093/jb/mvh086; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Ralston E, 1999, J NEUROSCI, V19, P10694, DOI 10.1523/JNEUROSCI.19-24-10694.1999; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Torelli S, 2005, NEUROMUSCULAR DISORD, V15, P836, DOI 10.1016/j.nmd.2005.09.004; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wakayama Y, 2001, MICROSC RES TECHNIQ, V55, P154, DOI 10.1002/jemt.1166; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22968	10.1371/journal.pone.0022968	http://dx.doi.org/10.1371/journal.pone.0022968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886772	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500005
J	Cermelli, S; Ruggieri, A; Marrero, JA; Ioannou, GN; Beretta, L				Cermelli, Silvia; Ruggieri, Anna; Marrero, Jorge A.; Ioannou, George N.; Beretta, Laura			Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							IN-VIVO; VIRUS; EXPRESSION; MIR-122; TRANSLATION; BIOMARKERS; STEATOSIS; INFECTION	MicroRNAs miR-122, miR-34a, miR-16 and miR-21 are commonly deregulated in liver fibrosis and hepatocellular carcinoma. This study examined whether circulating levels of these miRNAs correlate with hepatic histological disease severity in patients with chronic hepatitis C infection (CHC) or non-alcoholic fatty-liver disease (NAFLD) and can potentially serve as circulating markers for disease stage assessment. We first used an in vitro model of hepatitis C virus (HCV) infection to measure the extracellular levels of these four miRNAs. Whereas miR-21 extracellular levels were unchanged, extracellular levels of miR-122, miR-34a and to a lesser extent miR-16, steadily increased during the course of HCV infection, independently of viral replication and production. Similarly, in CHC patients, serum levels of miR-122, miR-34a and miR-16 were significantly higher than in control individuals, while miR-21 levels were unchanged. There was no correlation between the serum levels of any of these microRNAs and HCV viral loads. In contrast, miR-122 and miR-34a levels positively correlated with disease severity. Identical results were obtained in an independent cohort of CHC patients. We extended the study to patients with NAFLD. As observed in CHC patients, serum levels of miR-122, miR-34a and miR-16 were significantly higher in NAFLD patients than in controls, while miR-21 levels were unchanged. Again, miR-122 and miR-34a levels positively correlated with disease severity from simple steatosis to steatohepatitis. In both CHC and NAFLD patient groups, serum levels of miR-122 and miR-34a correlated with liver enzymes levels, fibrosis stage and inflammation activity. miR-122 levels also correlated with serum lipids in NAFLD patients. Conclusion: Serum levels of miR-34a and miR-122 may represent novel, noninvasive biomarkers of diagnosis and histological disease severity in patients with CHC or NAFLD.	[Cermelli, Silvia; Ruggieri, Anna; Beretta, Laura] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Ruggieri, Anna] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Marrero, Jorge A.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Ioannou, George N.] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Div Gastroenterol, Seattle, WA USA; [Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Cermelli, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	lberetta@fhcrc.org	ruggieri, anna/C-9950-2015	Ruggieri, Anna/0000-0003-2987-3844; Laura, Beretta/0000-0002-2054-684X	National Institutes of Health [DK066840]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK066840 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BIHRER V, 2011, AM J GASTROENTEROL; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Morita K, 2011, LIVER INT, V31, P474, DOI 10.1111/j.1478-3231.2010.02433.x; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; QU KZ, 2011, J CLIN GAST IN PRESS; Ramcharran D, 2011, J VIRAL HEPATITIS, V18, pe144, DOI 10.1111/j.1365-2893.2010.01394.x; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Sanyal AJ., 2011, HEPATOLOGY, DOI 10.1002/hep.24376; Sanyal AJ, 2011, LIVER INT, V31, P23, DOI 10.1111/j.1478-3231.2010.02397.x; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	37	410	433	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23937	10.1371/journal.pone.0023937	http://dx.doi.org/10.1371/journal.pone.0023937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886843	gold, Green Submitted, Green Published			2022-12-27	WOS:000294253500040
J	Miyajima, F; Roberts, P; Swale, A; Price, V; Jones, M; Horan, M; Beeching, N; Brazier, J; Parry, C; Pendleton, N; Pirmohamed, M				Miyajima, Fabio; Roberts, Paul; Swale, Andrew; Price, Valerie; Jones, Maureen; Horan, Michael; Beeching, Nicholas; Brazier, Jonathan; Parry, Christopher; Pendleton, Neil; Pirmohamed, Munir			Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom	PLOS ONE			English	Article							TERM-CARE FACILITIES; INCREASED SPORULATION; TOXIN PRODUCTION; COLONIZATION; DIARRHEA; INFECTION; RESIDENTS; RISK; TRANSMISSION; EPIDEMIC	Background: Community-associated Clostridium difficile infection (CDI) appears to be an increasing problem. Reported carriage rates by C.difficile are debatable with suggestions that primary asymptomatic carriage is associated with decreased risk of subsequent diarrhoea. However, knowledge of potential reservoirs and intestinal carriage rates in the community, particularly in the elderly, the most susceptible group, is limited. We have determined the presence of C.difficile in the faeces of a healthy elderly cohort living outside of long-term care facilities (LCFs) in the United Kingdom. Methods: Faecal samples from 149 community-based healthy elderly volunteers (median age 81 years) were screened for C.difficile using direct (Brazier's CCEY) and enrichment (Cooked Meat broth) culture methods and a glutamate dehydrogenase (GDH) immunoassay. Isolates were PCR-ribotyped and analysed for toxin production and the presence of toxin genes. Results: Of 149 faecal samples submitted, six (4%) were found to contain C.difficile. One particular sample was positive by both the GDH immunoassay and direct culture, and concurrently produced two distinct strain types: one toxigenic and the other non-toxigenic. The other five samples were only positive by enrichment culture method. Overall, four C.difficile isolates were non-toxigenic (PCR-ribotypes 009, 026 (n = 2) and 039), while three were toxigenic (PCR-ribotypes 003, 005 and 106). All individuals who had a positive culture were symptom-free and none of them had a history of CDI and/or antibiotics use in the 3 month period preceding recruitment. Conclusions: To our knowledge, this is the first study of the presence of C.difficile in healthy elderly community-dwelling individuals residing outside of LCFs. The observed carriage rate is lower than that reported for individuals in LCFs and interestingly no individual carried the common epidemic strain PCR-ribotype 027 (NAP1/BI). Further follow-up of asymptomatic carriers in the community, is required to evaluate host susceptibility to CDI and identify dynamic changes in the host and microbial environment that are associated with pathogenicity.	[Miyajima, Fabio; Roberts, Paul; Swale, Andrew; Price, Valerie; Beeching, Nicholas; Parry, Christopher; Pirmohamed, Munir] Royal Liverpool & Broadgreen Univ Hosp Natl Hlth, NIHR, Biomed Res Ctr, Liverpool, Merseyside, England; [Miyajima, Fabio; Swale, Andrew; Pirmohamed, Munir] Univ Liverpool, Dept Pharmacol, Wolfson Ctr Personalised Med, Liverpool L69 3BX, Merseyside, England; [Roberts, Paul; Price, Valerie] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Directorate Infect & Immun, Liverpool, Merseyside, England; [Jones, Maureen; Horan, Michael; Pendleton, Neil] Univ Manchester, Sch Community Based Med, Neurodegenerat Res Grp, Manchester, Lancs, England; [Beeching, Nicholas] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [Brazier, Jonathan] Univ Wales Hosp, Publ Hlth Lab, Anaerobe Reference Unit, Cardiff CF4 4XW, S Glam, Wales; [Parry, Christopher] Univ Liverpool, Inst Global Hlth, Div Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Parry, Christopher] Mahidol Oxford Trop Med Res Unit, Wellcome Trust Major Overseas Programme, Bangkok, Thailand	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Manchester; Liverpool School of Tropical Medicine; University of Liverpool; Cardiff University; University of Liverpool; Mahidol Oxford Tropical Medicine Research Unit (MORU)	Miyajima, F (corresponding author), Royal Liverpool & Broadgreen Univ Hosp Natl Hlth, NIHR, Biomed Res Ctr, Liverpool, Merseyside, England.	munirp@liv.ac.uk	Miyajima, Fabio/K-6587-2012; Pirmohamed, Munir/H-6004-2011; Pendleton, Neil/F-2333-2015; Beeching, Nicholas J/L-5363-2017	Miyajima, Fabio/0000-0002-1347-4825; Pirmohamed, Munir/0000-0002-7534-7266; Pendleton, Neil/0000-0003-0794-2386; Beeching, Nicholas/0000-0002-7019-8791	Liverpool Biomedical Research Centre (Royal Liverpool University Hospital/NHS Trust and the Wolfson Centre for Personalised Medicine/University of Liverpool); National Institute for Health Research; Northwest Development Agency	Liverpool Biomedical Research Centre (Royal Liverpool University Hospital/NHS Trust and the Wolfson Centre for Personalised Medicine/University of Liverpool); National Institute for Health Research(National Institute for Health Research (NIHR)); Northwest Development Agency	This work was supported by the Liverpool Biomedical Research Centre (Royal Liverpool University Hospital/NHS Trust and the Wolfson Centre for Personalised Medicine/University of Liverpool), the National Institute for Health Research and The Northwest Development Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Brazier JS, 1999, J HOSP INFECT, V43, P317, DOI 10.1016/S0195-6701(99)90431-0; BRAZIER JS, 1993, CLIN INFECT DIS, V16, pS228, DOI 10.1093/clinids/16.Supplement_4.S228; CAMPBELL RR, 1988, AGE AGEING, V17, P333, DOI 10.1093/ageing/17.5.333; DENEVE C, 2009, INT J ANTIMICROBIAL, V33; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; DONTA ST, 1982, J PEDIATR-US, V100, P431, DOI 10.1016/S0022-3476(82)80454-X; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; GERDING DN, 1986, ARCH INTERN MED, V146, P95, DOI 10.1001/archinte.146.1.95; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Kato H, 2001, J MED MICROBIOL, V50, P720, DOI 10.1099/0022-1317-50-8-720; Kaur S, 2007, MICROBIOL IMMUNOL, V51, P1209, DOI 10.1111/j.1348-0421.2007.tb04016.x; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Martinsen TC, 2005, BASIC CLIN PHARMACOL, V96, P94, DOI 10.1111/j.1742-7843.2005.pto960202.x; Matsuki S, 2005, INT MICROBIOL, V8, P43; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; SIMOR AE, 1993, CLIN INFECT DIS, V17, P672, DOI 10.1093/clinids/17.4.672; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; TATAROWICZ W, 2010, 3 INT CLOSTR DIFF S, V44; US Department of Health and Human Services, 2009, COMMON TERMINOLOGY C; WALKER KJ, 1993, J AM GERIATR SOC, V41, P940, DOI 10.1111/j.1532-5415.1993.tb06759.x; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	33	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22804	10.1371/journal.pone.0022804	http://dx.doi.org/10.1371/journal.pone.0022804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886769	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000294253500003
J	Oballah, P; Flach, B; Eller, LA; Eller, MA; Ouma, B; de Souza, M; Kibuuka, HN; Wabwire-Mangen, F; Brown, BK; Michael, NL; Robb, ML; Montefiori, D; Polonis, VR				Oballah, Peter; Flach, Britta; Eller, Leigh A.; Eller, Michael A.; Ouma, Benson; de Souza, Mark; Kibuuka, Hannah N.; Wabwire-Mangen, Fred; Brown, Bruce K.; Michael, Nelson L.; Robb, Merlin L.; Montefiori, David; Polonis, Victoria R.			B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODY-RESPONSES; MEDIATED CYTOTOXICITY; DISEASE PROGRESSION; EFFECTOR FUNCTION; RHESUS MACAQUES; DIFFERENT RATES; MEMORY; PANEL; NAIVE	To better understand the nature of B cell dysfunctions in subjects infected with HIV-1 subtype A, a rural cohort of 50 treatment-naive Ugandan patients chronically infected with HIV-1 subtype A was studied, and the relationship between B cell depletion and HIV disease was assessed. B cell absolute counts were found to be significantly lower in HIV-1+ patients, when compared to community matched negative controls (p<0.0001). HIV-1-infected patients displayed variable functional and binding antibody titers that showed no correlation with viral load or CD4+ T cell count. However, B cell absolute counts were found to correlate inversely with neutralizing antibody (NAb) titers against subtype A (p = 0.05) and subtype CRF02_AG (p = 0.02) viruses. A positive correlation was observed between subtype A gp120 binding antibody titers and NAb breadth (p = 0.02) and mean titer against the 10 viruses (p = 0.0002). In addition, HIV-1 subtype A sera showed preferential neutralization of the 5 subtype A or CRF02_AG pseudoviruses, as compared with 5 pseudoviruses from subtypes B, C or D (p<0.001). These data demonstrate that in patients with chronic HIV-1 subtype A infection, significant B cell depletion can be observed, the degree of which does not appear to be associated with a decrease in functional antibodies. These findings also highlight the potential importance of subtype in the specificity of cross-clade neutralization in HIV-1 infection.	[Oballah, Peter; Flach, Britta; Ouma, Benson; Kibuuka, Hannah N.; Wabwire-Mangen, Fred] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Flach, Britta; Eller, Leigh A.; Eller, Michael A.; de Souza, Mark; Brown, Bruce K.; Michael, Nelson L.; Robb, Merlin L.; Polonis, Victoria R.] Mil HIV Res Program, Rockville, MD USA; [Flach, Britta; Eller, Leigh A.; Eller, Michael A.; de Souza, Mark; Brown, Bruce K.; Robb, Merlin L.] Henry M Jackson Fdn, Rockville, MD USA; [de Souza, Mark] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Michael, Nelson L.; Polonis, Victoria R.] Walter Reed Army Inst Res, Rockville, MD USA; [Montefiori, David] Duke Univ, Durham, NC USA	Makerere University; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Duke University	Oballah, P (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	vpolonis@hivresearch.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877	Bill and Melinda Gates Foundation through Duke University [210810/2]	Bill and Melinda Gates Foundation through Duke University	The funding for this study was provided by the Bill and Melinda Gates Foundation through Duke University to Makere University (contract number 210810/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD A, 1994, J ACQ IMMUN DEF SYND, V7, P428; Ahmad R, 2001, J CLIN IMMUNOL, V21, P227, DOI 10.1023/A:1011087132180; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Banks ND, 2002, AIDS RES HUM RETROV, V18, P1197, DOI 10.1089/08892220260387940; Beniguel Lydie, 2004, Clin Dev Immunol, V11, P121, DOI 10.1080/10446670410001722104; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Blish CA, 2009, J VIROL, V83, P7783, DOI 10.1128/JVI.00673-09; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Cecilia D, 1999, J INFECT DIS, V179, P1365, DOI 10.1086/314773; CHIRMULE N, 1992, BLOOD, V79, P1245; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Chuenchitra T, 2003, AIDS RES HUM RETROV, V19, P293, DOI 10.1089/088922203764969492; Chung A, 2008, CURR HIV RES, V6, P515, DOI 10.2174/157016208786501472; Conge AM, 1998, AIDS, V12, P1437, DOI 10.1097/00002030-199812000-00005; Cox JH, 1999, METH MOLEC MED, V17, P373, DOI 10.1385/0-89603-369-4:373; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Eller MA, 2009, JAIDS-J ACQ IMM DEF, V51, P380, DOI 10.1097/QAI.0b013e3181aa256e; Epeldegui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011448; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Forthal DN, 2001, AIDS RES HUM RETROV, V17, P553, DOI 10.1089/08892220151126661; Gaidano G, 2000, SEMIN ONCOL, V27, P431; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guwatudde D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004145; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; KATZ IR, 1986, CLIN IMMUNOL IMMUNOP, V39, P359, DOI 10.1016/0090-1229(86)90164-9; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; KOUP RA, 1991, AIDS, V5, P1309, DOI 10.1097/00002030-199111000-00004; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Letvin NL, 2002, ANNU REV IMMUNOL, V20, P73, DOI 10.1146/annurev.immunol.20.081501.094854; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; LJUNGGREN K, 1988, CLIN EXP IMMUNOL, V73, P343; Malaspina A, 2003, J IMMUNOL, V170, P5965, DOI 10.4049/jimmunol.170.12.5965; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROOK AH, 1987, J IMMUNOL, V138, P1064; SAWYER LA, 1990, AIDS RES HUM RETROV, V6, P341, DOI 10.1089/aid.1990.6.341; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; SHEN X, CURR HIV AIDS REP, V8, P23; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2003, CLIN EXP IMMUNOL, V132, P297, DOI 10.1046/j.1365-2249.2003.02145.x; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; TYLER DS, 1990, J IMMUNOL, V144, P3375; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Widney D, 1999, CLIN IMMUNOL, V93, P114, DOI 10.1006/clim.1999.4782; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10; Yates A, 2007, PLOS MED, V4, P948, DOI 10.1371/journal.pmed.0040177; Zhang YJ, 1997, J INFECT DIS, V176, P1180, DOI 10.1086/514111	83	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22653	10.1371/journal.pone.0022653	http://dx.doi.org/10.1371/journal.pone.0022653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886768	gold, Green Published, Green Submitted			2022-12-27	WOS:000294253500002
J	Wang, W; Hale, C; Goulding, D; Haslam, SM; Tissot, B; Lindsay, C; Michell, S; Titball, R; Yu, J; Toribio, AL; Rossi, R; Dell, A; Bradley, A; Dougan, G				Wang, Wei; Hale, Christine; Goulding, Dave; Haslam, Stuart M.; Tissot, Berangere; Lindsay, Christopher; Michell, Stephen; Titball, Rick; Yu, Jun; Toribio, Ana Luisa; Rossi, Raffaella; Dell, Anne; Bradley, Allan; Dougan, Gordon			Mannosidase 2, alpha 1 Deficiency Is Associated with Ricin Resistance in Embryonic Stem (ES) Cells	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; GLYCANS; GLYCOPROTEINS; TRANSPORT; PIGGYBAC; LIBRARY	Host gene products required for mediating the action of toxins are potential targets for reversing or controlling their pathogenic impact following exposure. To identify such targets libraries of insertional gene-trap mutations generated with a PiggyBac transposon in Blm-deficient embryonic stem cells were exposed to the plant toxin, ricin. Resistant clones were isolated and genetically characterised and one was found to be a homozygous mutant of the mannosidase 2, alpha 1 (Man2 alpha 1) locus with a matching defect in the homologous allele. The causality of the molecular lesion was confirmed by removal of the transposon following expression of PB-transposase. Comparative glycomic and lectin binding analysis of the Man2 alpha 1 (-/-) ricin resistant cells revealed an increase in the levels of hybrid glycan structures and a reduction in terminal beta-galactose moieties, potential target receptors for ricin. Furthermore, naive ES cells treated with inhibitors of the N-linked glycosylation pathway at the mannosidase 2, alpha 1 step exhibited either full or partial resistance to ricin. Therefore, we conclusively identified mannosidase 2, alpha 1 deficiency to be associated with ricin resistance.	[Wang, Wei; Hale, Christine; Goulding, Dave; Toribio, Ana Luisa; Rossi, Raffaella; Bradley, Allan; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Haslam, Stuart M.; Tissot, Berangere; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England; [Lindsay, Christopher] Dept Biomed Sci, Cellular Tox Team, Salisbury, Wilts, England; [Michell, Stephen; Titball, Rick] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Yu, Jun] Univ Strathclyde, Royal Coll, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	Wellcome Trust Sanger Institute; Imperial College London; University of Exeter; University of Strathclyde	Wang, W (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	cbh@sanger.ac.uk		Toribio, Ana/0000-0002-0101-4258; Bradley, Allan/0000-0002-2349-8839	Biotechnology and Biological Sciences Research Council (BBSRC) [BBF0083091]; Wellcome Trust [077187, 076962]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, www.bbsrc.ac.uk) grant number BBF0083091 (awarded to AD, SMH) and the Wellcome Trust (www.wellcome.ac.uk) grant numbers 077187 and 076962 (awarded to AB and GD respectively). Ricin was supplied by the Biomedical Sciences Department, Dstl Porton Down, Salisbury, Wiltshire SP4 0JQ. The funding providers had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Crispin M, 2009, J BIOL CHEM, V284, P21684, DOI 10.1074/jbc.M109.006254; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; FONG WP, 1991, LIFE SCI, V49, P1859, DOI 10.1016/0024-3205(91)90286-K; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Hato M, 2006, MOL CELL PROTEOMICS, V5, P2146, DOI 10.1074/mcp.M600213-MCP200; Hughes R C, 1979, Nature, V281, P526, DOI 10.1038/281526a0; HUGHES RC, 1986, J CELL PHYSIOL, V128, P402, DOI 10.1002/jcp.1041280309; HUGHES RC, 1985, BIOCHEM J, V226, P487, DOI 10.1042/bj2260487; HUGHES RC, 1983, BIOCHEM J, V211, P575, DOI 10.1042/bj2110575; MEAGER A, 1975, NATURE, V257, P137, DOI 10.1038/257137a0; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Parry S, 2007, GLYCOBIOLOGY, V17, P646, DOI 10.1093/glycob/cwm024; POWELL LD, 2001, CURR PROTOC IMMUNOL, pCH8; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Ripper D, 2008, BIOL CELL, V100, P109, DOI 10.1042/BC20070106; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Sandvig K, 1999, FEBS LETT, V452, P67, DOI 10.1016/S0014-5793(99)00529-3; SORIANO P, 1991, J VIROL, V65, P2314, DOI 10.1128/JVI.65.5.2314-2319.1991; SUTTONSMITH M, 2006, CELL BIOL LAB HDB, P425; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; TOKUYASU, 1997, CELLS LAB MANUAL; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; Wang W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r48; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wu JH, 2006, BIOCHIMIE, V88, P201, DOI 10.1016/j.biochi.2005.07.007; WU JH, 1993, MOL IMMUNOL, V30, P333, DOI 10.1016/0161-5890(93)90062-G; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646	33	49	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22993	10.1371/journal.pone.0022993	http://dx.doi.org/10.1371/journal.pone.0022993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886775	gold, Green Accepted, Green Published			2022-12-27	WOS:000294253500007
J	Wang, Q; Byrnes, LJ; Shui, B; Rohrig, UF; Singh, A; Chudakov, DM; Lukyanov, S; Zipfel, WR; Kotlikoff, MI; Sondermann, H				Wang, Qi; Byrnes, Laura J.; Shui, Bo; Roehrig, Ute F.; Singh, Avtar; Chudakov, Dmitriy M.; Lukyanov, Sergey; Zipfel, Warren R.; Kotlikoff, Michael I.; Sondermann, Holger			Molecular Mechanism of a Green-Shifted, pH-Dependent Red Fluorescent Protein mKate Variant	PLOS ONE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURES; PROTON PATHWAYS; CHROMOPHORE; SENSORS; GFP; PHOTOCONVERSION; APPROXIMATION; EXCITATION; CONVERSION	Fluorescent proteins that can switch between distinct colors have contributed significantly to modern biomedical imaging technologies and molecular cell biology. Here we report the identification and biochemical analysis of a green-shifted red fluorescent protein variant GmKate, produced by the introduction of two mutations into mKate. Although the mutations decrease the overall brightness of the protein, GmKate is subject to pH-dependent, reversible green-to-red color conversion. At physiological pH, GmKate absorbs blue light (445 nm) and emits green fluorescence (525 nm). At pH above 9.0, GmKate absorbs 598 nm light and emits 646 nm, far-red fluorescence, similar to its sequence homolog mNeptune. Based on optical spectra and crystal structures of GmKate in its green and red states, the reversible color transition is attributed to the different protonation states of the cis-chromophore, an interpretation that was confirmed by quantum chemical calculations. Crystal structures reveal potential hydrogen bond networks around the chromophore that may facilitate the protonation switch, and indicate a molecular basis for the unusual bathochromic shift observed at high pH. This study provides mechanistic insights into the color tuning of mKate variants, which may aid the development of green-to-red color-convertible fluorescent sensors, and suggests GmKate as a prototype of genetically encoded pH sensors for biological studies.	[Wang, Qi; Byrnes, Laura J.; Sondermann, Holger] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Shui, Bo; Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Roehrig, Ute F.] Ludwig Inst Canc Res, Mol Modeling Grp, Lausanne, Switzerland; [Roehrig, Ute F.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Singh, Avtar; Zipfel, Warren R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Chudakov, Dmitriy M.; Lukyanov, Sergey] Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Chudakov, Dmitriy M.; Lukyanov, Sergey] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia	Cornell University; Cornell University; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; Cornell University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Privolzhsky Research Medical University	Wang, Q (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	qwang@berkeley.edy; mik7@cornell.edu; hs293@cornell.edu	Lukyanov, Sergey/F-9140-2014; Chudakov, Dmitriy M/G-7741-2014; Wang, Qi/H-9399-2012; Zipfel, Warren/B-4059-2016	Chudakov, Dmitriy M/0000-0003-0430-790X; Wang, Qi/0000-0002-9703-1676; Singh, Avtar/0000-0001-5509-8330; Roehrig, Ute/0000-0002-4676-4087; Zipfel, Warren/0000-0003-2640-329X	National Science Foundation [DMR-0225180]; National Institutes of Health (NIH)/National Institute of General Medical Sciences [RR-01646]; Ministry of Education and Science of the Russian Federation [11.G34.31.0017, 16.512.11.2139]; National Institutes of Health [R01GM086736]; PEW Scholar award in Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086736] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PEW Scholar award in Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is based upon research conducted at CHESS/MacCHESS, which is supported by the National Science Foundation (award DMR-0225180) and the National Institutes of Health (NIH)/National Institute of General Medical Sciences (award RR-01646). This work was supported by grants 11.G34.31.0017 and 16.512.11.2139 from the Ministry of Education and Science of the Russian Federation (D. M. C. and S. L.), grant R01GM086736 from the National Institutes of Health (M. I. K.), and a PEW Scholar award in Biomedical Sciences (H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Chudakov DM, 2003, J BIOL CHEM, V278, P7215, DOI 10.1074/jbc.M211988200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filippi C, 2009, J CHEM THEORY COMPUT, V5, P2074, DOI 10.1021/ct900227j; Frisch G. W., 2013, GAUSSIAN 09; Goedecker S, 1996, PHYS REV B, V54, P1703, DOI 10.1103/PhysRevB.54.1703; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Hasegawa J, 2010, J PHYS CHEM B, V114, P2971, DOI 10.1021/jp9099573; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Henderson JN, 2009, J AM CHEM SOC, V131, P13212, DOI 10.1021/ja904665x; Henderson JN, 2009, J AM CHEM SOC, V131, P4176, DOI 10.1021/ja808851n; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Laino T, 2005, J CHEM THEORY COMPUT, V1, P1176, DOI 10.1021/ct050123f; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McAnaney TB, 2002, BIOCHEMISTRY-US, V41, P15489, DOI 10.1021/bi026610o; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P8701, DOI 10.1021/bi050132a; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakatsuji H., 1997, COMPUTATIONAL CHEM R, V2, P62, DOI DOI 10.1016/J.CPLETT.2005.12.040; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Piatkevich KD, 2010, J AM CHEM SOC, V132, P10762, DOI 10.1021/ja101974k; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; RIDLEY J, 1973, THEOR CHIM ACTA, V32, P111, DOI 10.1007/BF00528484; Sanchez-Garcia E, 2010, J COMPUT CHEM, V31, P1603, DOI 10.1002/jcc.21443; Sanchez-Garcia E, 2009, J PHYS CHEM B, V113, P16622, DOI 10.1021/jp9069042; Schafer LV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000034; Schafer LV, 2007, ANGEW CHEM INT EDIT, V46, P530, DOI 10.1002/anie.200602315; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shinobu A, 2010, J AM CHEM SOC, V132, P11093, DOI 10.1021/ja1010652; Silva-Junior MR, 2010, J CHEM THEORY COMPUT, V6, P1546, DOI 10.1021/ct100030j; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Subach FV, 2009, P NATL ACAD SCI USA, V106, P21097, DOI 10.1073/pnas.0909204106; Sun Q, 2010, PHYS CHEM CHEM PHYS, V12, P2450, DOI 10.1039/b918523b; Taguchi N, 2009, J PHYS CHEM B, V113, P1153, DOI 10.1021/jp808151c; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tretyakova YA, 2007, J AM CHEM SOC, V129, P7748, DOI 10.1021/ja071992c; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2009, CHEM BIOL, V16, P1140, DOI 10.1016/j.chembiol.2009.10.010; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Zhang L, 2010, Bioorg Khim, V36, P187; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	64	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23513	10.1371/journal.pone.0023513	http://dx.doi.org/10.1371/journal.pone.0023513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887263	Green Published, Green Submitted, gold			2022-12-27	WOS:000294251800015
J	Haywood-Watson, RJ; Holcomb, JB; Gonzalez, EA; Peng, ZL; Pati, S; Park, PW; Wang, WW; Zaske, AM; Menge, T; Kozar, RA				Haywood-Watson, Ricky J.; Holcomb, John B.; Gonzalez, Ernest A.; Peng, Zhanglong; Pati, Shibani; Park, Pyong Woo; Wang, WeiWei; Zaske, Ana Maria; Menge, Tyler; Kozar, Rosemary A.			Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; HEPARAN-SULFATE PROTEOGLYCAN; ENDOTHELIAL GLYCOCALYX; INFLAMMATORY RESPONSE; BLOOD; TRAUMA; MODEL; TRANSFUSIONS; COAGULATION; FRACTALKINE	The early use of fresh frozen plasma as a resuscitative agent after hemorrhagic shock has been associated with improved survival, but the mechanism of protection is unknown. Hemorrhagic shock causes endothelial cell dysfunction and we hypothesized that fresh frozen plasma would restore endothelial integrity and reduce syndecan-1 shedding after hemorrhagic shock. A prospective, observational study in severely injured patients in hemorrhagic shock demonstrated significantly elevated levels of syndecan-1 (554+/-93 ng/ml) after injury, which decreased with resuscitation (187+/-36 ng/ml) but was elevated compared to normal donors (27+/-1 ng/ml). Three pro-inflammatory cytokines, interferon-gamma, fractalkine, and interleukin-1 beta, negatively correlated while one anti-inflammatory cytokine, IL-10, positively correlated with shed syndecan-1. These cytokines all play an important role in maintaining endothelial integrity. An in vitro model of endothelial injury then specifically examined endothelial permeability after treatment with fresh frozen plasma orlactated Ringers. Shock or endothelial injury disrupted junctional integrity and increased permeability, which was improved with fresh frozen plasma, but not lactated Ringers. Changes in endothelial cell permeability correlated with syndecan-1 shedding. These data suggest that plasma based resuscitation preserved endothelial syndecan-1 and maintained endothelial integrity, and may help to explain the protective effects of fresh frozen plasma after hemorrhagic shock.	[Haywood-Watson, Ricky J.; Holcomb, John B.; Peng, Zhanglong; Pati, Shibani; Menge, Tyler; Kozar, Rosemary A.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA; [Holcomb, John B.; Pati, Shibani; Zaske, Ana Maria] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury & Res CeTIR, Houston, TX USA; [Gonzalez, Ernest A.] Univ Texas SW Austin, Dept Surg, Austin, TX USA; [Park, Pyong Woo] Harvard Univ, Childrens Hosp, Sch Med, Div Resp Dis, Boston, MA 02115 USA; [Wang, WeiWei] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston	Haywood-Watson, RJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA.	Rosemary.A.Kozar@uth.tmc.edu		Park, Pyong Woo/0000-0002-7979-4979; holcomb, john/0000-0001-8312-9157	National Institutes of Health [T-32 GM008792, P-50 GM38529]; Department of Defense [W81XWH-08-C-0712]; NIH CTSA [UL1 RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107482, P50GM038529, T32GM008792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the National Institutes of Health T-32 GM008792 and P-50 GM38529 and the Department of Defense W81XWH-08-C-0712. Statistical support was provided by the Biostatistics/Epidemiology/Research Design (BERD) component of the Center for Clinical and Translational Sciences (CCTS) for this project. CCTS is mainly funded by NIH CTSA grant (UL1 RR024148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Childs EW, 2010, SHOCK, V34, P229, DOI 10.1097/SHK.0b013e3181d75b50; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; GONZALEZ EA, 2009, SHOCK, V31, P56; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jastrow KM, 2009, J AM COLL SURGEONS, V209, P320, DOI 10.1016/j.jamcollsurg.2009.05.002; Kadl A, 2005, ANTIOXID REDOX SIGN, V7, P1744, DOI 10.1089/ars.2005.7.1744; KELLUM JA, 2009, ARCH INTERN MED, V167, P1655; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; London NR, 2009, ANGIOGENESIS, V12, P149, DOI 10.1007/s10456-009-9130-z; Lozano FS, 2005, WORLD J SURG, V29, P1248, DOI 10.1007/s00268-005-7877-y; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Maroszynska I, 2000, Ann Transplant, V5, P5; Matheson PJ, 2009, ARCH SURG-CHICAGO, V144, P625, DOI 10.1001/archsurg.2009.125; Matsuo Mitsunori, 2008, Kurume Medical Journal, V55, P19, DOI 10.2739/kurumemedj.55.19; Mees ST, 2007, LANGENBECK ARCH SURG, V392, P629, DOI 10.1007/s00423-007-0152-y; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Peng Z, 2010, SHOCK, V33, P61; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Robinson EK, 2008, JPEN-PARENTER ENTER, V32, P433, DOI 10.1177/0148607108319806; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Takahashi T, 2001, CIRC RES, V88, P422; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tharakan B, 2010, CLIN EXP PHARMACOL P, V37, P939, DOI 10.1111/j.1440-1681.2010.05414.x; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F	46	128	135	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23530	10.1371/journal.pone.0023530	http://dx.doi.org/10.1371/journal.pone.0023530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886795	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100017
J	Asmal, M; Hellmann, I; Liu, WM; Keele, BF; Perelson, AS; Bhattacharya, T; Gnanakaran, S; Daniels, M; Haynes, BF; Korber, BT; Hahn, BH; Shaw, GM; Letvin, NL				Asmal, Mohammed; Hellmann, Ina; Liu, Weimin; Keele, Brandon F.; Perelson, Alan S.; Bhattacharya, Tanmoy; Gnanakaran, S.; Daniels, Marcus; Haynes, Barton F.; Korber, Bette T.; Hahn, Beatrice H.; Shaw, George M.; Letvin, Norman L.			A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DYNAMICS IN-VIVO; QUALITY-CONTROL; SELECTIVE TRANSMISSION; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN; SEQUENCE; PROTEIN; GP120; POPULATION	Mucosal transmission of the human immunodeficiency virus (HIV) results in a bottleneck in viral genetic diversity. Gnanakaran and colleagues used a computational strategy to identify signature amino acids at particular positions in Envelope that were associated either with transmitted sequences sampled very early in infection, or sequences sampled during chronic infection. Among the strongest signatures observed was an enrichment for the stable presence of histidine at position 12 at transmission and in early infection, and a recurrent loss of histidine at position 12 in chronic infection. This amino acid lies within the leader peptide of Envelope, a region of the protein that has been shown to influence envelope glycoprotein expression and virion infectivity. We show a strong association between a positively charged amino acid like histidine at position 12 in transmitted/founder viruses with more efficient trafficking of the nascent envelope polypeptide to the endoplasmic reticulum and higher steady-state glycoprotein expression compared to viruses that have a non-basic position 12 residue, a substitution that was enriched among viruses sampled from chronically infected individuals. When expressed in the context of other viral proteins, transmitted envelopes with a basic amino acid position 12 were incorporated at higher density into the virus and exhibited higher infectious titers than did non-signature envelopes. These results support the potential utility of using a computational approach to examine large viral sequence data sets for functional signatures and indicate the importance of Envelope expression levels for efficient HIV transmission.	[Asmal, Mohammed; Hellmann, Ina; Letvin, Norman L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Sch Med, Boston, MA 02215 USA; [Liu, Weimin; Keele, Brandon F.; Hahn, Beatrice H.; Shaw, George M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Perelson, Alan S.; Bhattacharya, Tanmoy; Gnanakaran, S.; Daniels, Marcus; Korber, Bette T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Bhattacharya, Tanmoy; Korber, Bette T.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Duke University	Asmal, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Sch Med, Boston, MA 02215 USA.	masmal@bidmc.harvard.edu	Perelson, Alan S/Z-1959-2019; Bhattacharya, Tanmoy/J-8956-2013	Perelson, Alan S/0000-0002-2455-0002; Bhattacharya, Tanmoy/0000-0002-1060-652X; Korber, Bette/0000-0002-2026-5757; Hahn, Beatrice/0000-0002-9400-9887; Gnanakaran, S/0000-0002-9368-3044	NIH [AI28433-19, RR06555-18, AI-067854]; Center for HIV/AIDS Vaccine Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094604, U19AI067854, U01AI067854, R01AI028433, R37AI028433, P30AI060354, T32AI007387] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for HIV/AIDS Vaccine Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the NIH AI28433-19, RR06555-18 and AI-067854, and the Center for HIV/AIDS Vaccine Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Bachrach E, 2005, VIROLOGY, V332, P418, DOI 10.1016/j.virol.2004.11.031; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; CRISE B, 1992, J VIROL, V66, P2296, DOI 10.1128/JVI.66.4.2296-2301.1992; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28; Enose Y, 1997, ARCH VIROL, V142, P37, DOI 10.1007/s007050050057; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frater AJ, 2006, J VIROL, V80, P7226, DOI 10.1128/JVI.02014-05; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; JABBAR MA, 1990, J VIROL, V64, P6297, DOI 10.1128/JVI.64.12.6297-6304.1990; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; LI Y, 1994, VIROLOGY, V204, P266, DOI 10.1006/viro.1994.1531; Li Y, 2000, VIROLOGY, V272, P417, DOI 10.1006/viro.2000.0357; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; MAC ARTHUR ROBERT H., 1967; Maggioni C, 2005, CURR TOP MICROBIOL, V285, P175; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; MCNEARNEY T, 1992, P NATL ACAD SCI USA, V89, P10247, DOI 10.1073/pnas.89.21.10247; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pfeiffer T, 2006, FEBS LETT, V580, P3775, DOI 10.1016/j.febslet.2006.05.070; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rizzotto L, 2006, MOL MED, V12, P137, DOI 10.2119/2005-00040.Rizzotto; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Stepanyuk GA, 2008, PROTEIN EXPRES PURIF, V61, P142, DOI 10.1016/j.pep.2008.05.013; Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	49	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23673	10.1371/journal.pone.0023673	http://dx.doi.org/10.1371/journal.pone.0023673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876761	Green Submitted, Green Published, gold			2022-12-27	WOS:000294126900033
J	Evans, CL; Abu-Yousif, AO; Park, YJ; Klein, OJ; Celli, JP; Rizvi, I; Zheng, X; Hasan, T				Evans, Conor L.; Abu-Yousif, Adnan O.; Park, Yong Jin; Klein, Oliver J.; Celli, Jonathan P.; Rizvi, Imran; Zheng, Xiang; Hasan, Tayyaba			Killing Hypoxic Cell Populations in a 3D Tumor Model with EtNBS-PDT	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; OVARIAN-CANCER; IN-VITRO; 3-DIMENSIONAL MODEL; OXYGEN-CONSUMPTION; DRUG-RESISTANCE; MURINE SARCOMAS; SOLID TUMORS; BENZOPHENOTHIAZINE; EFFICACY	An outstanding problem in cancer therapy is the battle against treatment-resistant disease. This is especially true for ovarian cancer, where the majority of patients eventually succumb to treatment-resistant metastatic carcinomatosis. Limited perfusion and diffusion, acidosis, and hypoxia play major roles in the development of resistance to the majority of front-line therapeutic regimens. To overcome these limitations and eliminate otherwise spared cancer cells, we utilized the cationic photosensitizer EtNBS to treat hypoxic regions deep inside in vitro 3D models of metastatic ovarian cancer. Unlike standard regimens that fail to penetrate beyond similar to 150 mu m, EtNBS was found to not only penetrate throughout the entirety of large (>200 mu m) avascular nodules, but also concentrate into the nodules' acidic and hypoxic cores. Photodynamic therapy with EtNBS was observed to be highly effective against these hypoxic regions even at low therapeutic doses, and was capable of destroying both normoxic and hypoxic regions at higher treatment levels. Imaging studies utilizing multiphoton and confocal microscopies, as well as time-lapse optical coherence tomography (TL-OCT), revealed an inside-out pattern of cell death, with apoptosis being the primary mechanism of cell killing. Critically, EtNBS-based photodynamic therapy was found to be effective against the model tumor nodules even under severe hypoxia. The inherent ability of EtNBS photodynamic therapy to impart cytotoxicity across a wide range of tumoral oxygenation levels indicates its potential to eliminate treatment-resistant cell populations.	[Evans, Conor L.; Abu-Yousif, Adnan O.; Klein, Oliver J.; Celli, Jonathan P.; Rizvi, Imran; Zheng, Xiang; Hasan, Tayyaba] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA; [Park, Yong Jin] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea	Harvard University; Harvard Medical School; Massachusetts General Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Evans, CL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	thasan@partners.org	Rizvi, Imran/A-3889-2019; Rizvi, Imran/E-5049-2013	Rizvi, Imran/0000-0001-9673-4700; Rizvi, Imran/0000-0001-9673-4700; Hasan, Tayyaba/0000-0003-0871-6057	F32 fellowship [F32 CA138153]; Wellman graduate fellowship; HST-KAIST; National Institutes of Health [NIH RC1 CA146337, DP2 OD007096]; NATIONAL CANCER INSTITUTE [F32CA138153, RC1CA146337] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007096] Funding Source: NIH RePORTER	F32 fellowship; Wellman graduate fellowship; HST-KAIST; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CLE was supported by a F32 fellowship (F32 CA138153). IR was supported by the Wellman graduate fellowship. YJP was supported by the HST-KAIST summer internship program. Funding for this work came from National Institutes of Health grant NIH RC1 CA146337 to TH and an NIH New Innovator Award DP2 OD007096 to CLE. Information on the New Innovator Award Program is at http://nihroadmap.nih.gov/newinnovator/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, CLIN EXP METASTAS, V22, P391, DOI 10.1007/s10585-005-1262-y; Alderden RA, 2007, J AM CHEM SOC, V129, P13400, DOI 10.1021/ja076281t; Berek J. S., 2003, CANC MED, P1831; BREDELGEISSLER A, 1992, J CELL PHYSIOL, V153, P44, DOI 10.1002/jcp.1041530108; Busch TM, 2004, CLIN CANCER RES, V10, P4630, DOI 10.1158/1078-0432.CCR-04-0359; Celli JP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3483903; Celli JP, 2010, CHEM REV, V110, P2795, DOI 10.1021/cr900300p; CINCOTTA L, 1993, CANCER RES, V53, P2571; CINCOTTA L, 1994, CANCER RES, V54, P1249; Cincotta L, 1996, PHOTOCHEM PHOTOBIOL, V63, P229, DOI 10.1111/j.1751-1097.1996.tb03019.x; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; del Carmen MG, 2005, JNCI-J NATL CANCER I, V97, P1516, DOI 10.1093/jnci/dji314; Duska LR, 1999, J NATL CANCER I, V91, P1557, DOI 10.1093/jnci/91.18.1557; Ebbesen P, 2009, J ENZYM INHIB MED CH, V24, P1, DOI 10.1080/14756360902784425; Evans C. L., 2010, P SPIE, V7551; Evans CL, 2009, OPT EXPRESS, V17, P8892, DOI 10.1364/OE.17.008892; Frimberger AE, 1998, CLIN CANCER RES, V4, P2207; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Georgakoudi I, 1998, PHOTOCHEM PHOTOBIOL, V68, P115, DOI 10.1111/j.1751-1097.1998.tb03261.x; Gillies Robert J., 1999, Neoplasia (New York), V1, P197, DOI 10.1038/sj.neo.7900037; Greijer AE, 2005, CELL ONCOL, V27, P43; Hendren SK, 2001, ANN SURG ONCOL, V8, P65, DOI 10.1245/aso.2001.8.1.65; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Jain RK, 1998, J CONTROL RELEASE, V53, P49, DOI 10.1016/S0168-3659(97)00237-X; Koch S, 2003, BRIT J CANCER, V89, P2133, DOI 10.1038/sj.bjc.6601375; Molpus KL, 1996, CANCER RES, V56, P1075; PASS HI, 1993, JNCI-J NATL CANCER I, V85, P443, DOI 10.1093/jnci/85.6.443; Rahmanzadeh R, 2010, CANCER RES, V70, P9234, DOI 10.1158/0008-5472.CAN-10-1190; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Rizvi I, 2010, CANCER RES, V70, P9319, DOI 10.1158/0008-5472.CAN-10-1783; Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Tannock IF, 2002, CLIN CANCER RES, V8, P878; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Verma S, 2009, PHOTOCHEM PHOTOBIOL, V85, P111, DOI 10.1111/j.1751-1097.2008.00403.x; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Zhong H, 1999, CANCER RES, V59, P5830	38	68	69	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23434	10.1371/journal.pone.0023434	http://dx.doi.org/10.1371/journal.pone.0023434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876751	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900023
J	Feist, BE; Buhle, ER; Arnold, P; Davis, JW; Scholz, NL				Feist, Blake E.; Buhle, Eric R.; Arnold, Paul; Davis, Jay W.; Scholz, Nathaniel L.			Landscape Ecotoxicology of Coho Salmon Spawner Mortality in Urban Streams	PLOS ONE			English	Article							LAND-USE; PETROLEUM-HYDROCARBONS; PARVICAPSULA-MINIBICORNIS; ONCORHYNCHUS-KISUTCH; SOCKEYE-SALMON; CHINOOK SALMON; STORM WATER; RUNOFF; RIVER; URBANIZATION	In the Pacific Northwest of the United States, adult coho salmon (Oncorhynchus kisutch) returning from the ocean to spawn in urban basins of the Puget Sound region have been prematurely dying at high rates (up to 90% of the total runs) for more than a decade. The current weight of evidence indicates that coho deaths are caused by toxic chemical contaminants in land-based runoff to urban streams during the fall spawning season. Non-point source pollution in urban landscapes typically originates from discrete urban and residential land use activities. In the present study we conducted a series of spatial analyses to identify correlations between land use and land cover (roadways, impervious surfaces, forests, etc.) and the magnitude of coho mortality in six streams with different drainage basin characteristics. We found that spawner mortality was most closely and positively correlated with the relative proportion of local roads, impervious surfaces, and commercial property within a basin. These and other correlated variables were used to identify unmonitored basins in the greater Seattle metropolitan area where recurrent coho spawner die-offs may be likely. This predictive map indicates a substantial geographic area of vulnerability for the Puget Sound coho population segment, a species of concern under the U. S. Endangered Species Act. Our spatial risk representation has numerous applications for urban growth management, coho conservation, and basin restoration (e. g., avoiding the unintentional creation of ecological traps). Moreover, the approach and tools are transferable to areas supporting coho throughout western North America.	[Feist, Blake E.; Buhle, Eric R.; Scholz, Nathaniel L.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Arnold, Paul; Davis, Jay W.] US Fish & Wildlife Serv, Washington Fish & Wildlife Off, Lacey, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service	Feist, BE (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	blake.feist@noaa.gov	Feist, Blake E/H-2669-2012; Scholz, Nathaniel L/L-1642-2013	Feist, Blake E/0000-0001-5215-4878; Scholz, Nathaniel L/0000-0001-6207-0272	National Oceanic and Atmospheric Administration; U.S. Fish and Wildlife Service; City of Seattle (Seattle Public Utilities); U.S. Environmental Protection Agency - Region 10	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); City of Seattle (Seattle Public Utilities); U.S. Environmental Protection Agency - Region 10(United States Environmental Protection Agency)	This work was supported by the National Oceanic and Atmospheric Administration - Coastal Storms Program; U.S. Fish and Wildlife Service - National Contaminants Program; City of Seattle (Seattle Public Utilities); and the U.S. Environmental Protection Agency - Region 10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2004, PHOTOGRAMM ENG REM S, V70, P1043, DOI 10.14358/PERS.70.9.1043; Alberti M, 2007, LANDSCAPE URBAN PLAN, V80, P345, DOI 10.1016/j.landurbplan.2006.08.001; [Anonymous], 2010, R LANG ENV STAT COMP; Bilby RE, 2008, CAN J FISH AQUAT SCI, V65, P2138, DOI 10.1139/F08-113; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; BOURCIER DR, 1979, SCI TOTAL ENVIRON, V12, P205, DOI 10.1016/0048-9697(79)90086-X; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Claireaux G, 2010, AQUAT TOXICOL, V98, P113, DOI 10.1016/j.aquatox.2010.02.006; Conko KM, 2004, ATMOS ENVIRON, V38, P4025, DOI 10.1016/j.atmosenv.2004.03.062; Cuffney TF, 2010, ECOL APPL, V20, P1384, DOI 10.1890/08-1311.1; Davis AP, 2001, CHEMOSPHERE, V44, P997, DOI 10.1016/S0045-6535(00)00561-0; Feist BE, 2010, LANDSCAPE ECOL, V25, P727, DOI 10.1007/s10980-010-9458-1; Gelman A., 2007, DATA ANAL USING REGR; HOFFMAN EJ, 1982, J WATER POLLUT CON F, V54, P1517; Hoffman RS, 2000, ENVIRON TOXICOL CHEM, V19, P2249, DOI [10.1002/etc.5620190915, 10.1897/1551-5028(2000)019&lt;2249:COPIEU&gt;2.3.CO;2]; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; KARR JR, 1991, ECOL APPL, V1, P66, DOI 10.2307/1941848; Katz SL, 2007, RESTOR ECOL, V15, P494, DOI 10.1111/j.1526-100X.2007.00245.x; Keefer ML, 2010, ECOL FRESHW FISH, V19, P361, DOI 10.1111/j.1600-0633.2010.00418.x; Kocan R, 2004, J AQUAT ANIM HEALTH, V16, P58, DOI 10.1577/H03-068.1; McCarthy SG, 2008, AM FISH S S, V64, P7; Morley SA, 2002, CONSERV BIOL, V16, P1498, DOI 10.1046/j.1523-1739.2002.01067.x; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Pess GR, 2002, CAN J FISH AQUAT SCI, V59, P613, DOI 10.1139/F02-035; *PEW OC COMM, 2003, AM LIV OC CHART COUR; PINHEIRO JC, 2001, MIXED EFFECTS MODELS; Raverty S, 2000, CAN VET J, V41, P317; Spromberg JA, 2006, ECOL MODEL, V199, P240, DOI 10.1016/j.ecolmodel.2006.05.007; St-Hilaire S, 2002, J FISH DIS, V25, P107, DOI 10.1046/j.1365-2761.2002.00344.x; Stein ED, 2006, ENVIRON TOXICOL CHEM, V25, P373, DOI 10.1897/05-285R.1; Tiefenthaler LL, 2008, ENVIRON TOXICOL CHEM, V27, P277, DOI 10.1897/07-126R.1; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI; Weinstein MP, 2007, FRONT ECOL ENVIRON, V5, P43, DOI 10.1890/1540-9295(2007)5[43:MCRITS]2.0.CO;2; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; WHIPPLE W, 1979, WATER RESOUR BULL, V15, P1096; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1007/S10980-010-9458-1; [No title captured]; [No title captured], DOI DOI 10.1016/J.AQUATOX.2010.02.006; [No title captured]; [No title captured], DOI DOI 10.1002/IEAM.219	50	31	31	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23424	10.1371/journal.pone.0023424	http://dx.doi.org/10.1371/journal.pone.0023424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858112	Green Published, gold			2022-12-27	WOS:000294121300045
J	Lok, GTM; Chan, DW; Liu, VWS; Hui, WWY; Leung, THY; Yao, KM; Ngan, HYS				Lok, Gabriel T. M.; Chan, David W.; Liu, Vincent W. S.; Hui, Winnie W. Y.; Leung, Thomas H. Y.; Yao, K. M.; Ngan, Hextan Y. S.			Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells	PLOS ONE			English	Article							M1 TRANSCRIPTION FACTOR; INDUCE APOPTOSIS; OVER-EXPRESSION; GLIOMA-CELLS; ERK ACTIVITY; FOXM1; TARGET; REPRESSION; TUMORIGENICITY; PROLIFERATION	Forkhead box M1 (FOXM1) is a proliferation-associated transcription factor essential for cell cycle progression. Numerous studies have documented that FOXM1 has multiple functions in tumorigenesis and its elevated levels are frequently associated with cancer progression. Here, we characterized the role of ERK/FOXM1 signaling in mediating the metastatic potential of ovarian cancer cells. Immunohistochemical (IHC), immunoblotting and semi-quantitative RT-PCR analyses found that both phospho-ERK and FOXM1 were frequently upregulated in ovarian cancers. Intriguingly, the overexpressed phospho-ERK (p<0.001) and FOXM1 (p<0.001) were significantly correlated to high-grade ovarian tumors with aggressive behavior such as metastasized lymph node (5 out of 6). Moreover, the expressions of phospho-ERK and FOXM1 had significantly positive correlation (p<0.001). Functionally, ectopic expression of FOXM1B remarkably enhanced cell migration/invasion, while FOXM1C not only increased cell proliferation but also promoted cell migration/invasion. Conversely, inhibition of FOXM1 expression by either thiostrepton or U0126 could significantly impair FOXM1 mediated oncogenic capacities. However, the down-regulation of FOXM1 by either thiostrepton or U0126 required the presence of p53 in ovarian cancer cells. Collectively, our data suggest that over-expression of FOXM1 might stem from the constitutively active ERK which confers the metastatic capabilities to ovarian cancer cells. The impairment of metastatic potential of cancer cells by FOXM1 inhibitors underscores its therapeutic value in advanced ovarian tumors.	[Lok, Gabriel T. M.; Chan, David W.; Liu, Vincent W. S.; Hui, Winnie W. Y.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Yao, K. M.] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lok, GTM (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hkucc.hku.hk	Chan, David/O-9896-2018	Chan, David/0000-0002-6951-3467; Ngan, Hextan Y S/0000-0003-3945-159X	Wong Cheuk She Charitable Foundation	Wong Cheuk She Charitable Foundation	This study was supported by the Wong Cheuk She Charitable Foundation. This support is from private donations, and no funder's website is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Frau M, 2010, MOL ASPECTS MED, V31, P179, DOI 10.1016/j.mam.2010.02.007; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Liao YC, 2009, J AGR FOOD CHEM, V57, P8933, DOI 10.1021/jf902630w; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Neill GW, 2008, CARCINOGENESIS, V29, P738, DOI 10.1093/carcin/bgn037; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Teh MT, 2002, CANCER RES, V62, P4773; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	38	64	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23790	10.1371/journal.pone.0023790	http://dx.doi.org/10.1371/journal.pone.0023790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858223	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300095
J	Poiroux, G; Pitie, M; Culerrier, R; Lafont, E; Segui, B; Van Damme, EJM; Peumans, WJ; Bernadou, J; Levade, T; Rouge, P; Barre, A; Benoist, H				Poiroux, Guillaume; Pitie, Marguerite; Culerrier, Raphael; Lafont, Elodie; Segui, Bruno; Van Damme, Els J. M.; Peumans, Willy J.; Bernadou, Jean; Levade, Thierry; Rouge, Pierre; Barre, Annick; Benoist, Herve			Targeting of T/Tn Antigens with a Plant Lectin to Kill Human Leukemia Cells by Photochemotherapy	PLOS ONE			English	Article							JACALIN-RELATED LECTINS; GROWTH-FACTOR RECEPTOR; HUMAN-COLON-CANCER; PHOTODYNAMIC THERAPY; OXIDATIVE STRESS; LYMPHOCYTIC-LEUKEMIA; FLUORESCENT-PROBES; ANTIOXIDANT STATUS; INDUCED APOPTOSIS; SIALOSYL-TN	Photochemotherapy is used both for solid tumors and in extracorporeal treatment of various hematologic disorders. Nevertheless, its development in oncology remains limited, because of the low selectivity of photosensitizers (PS) towards human tumor cells. To enhance PS efficiency, we recently covalently linked a porphyrin (TrMPyP) to a plant lectin (Morniga G), known to recognize with high affinity tumor-associated T and Tn antigens. The conjugation allowed a quick uptake of PS by Tn-positive Jurkat leukemia cells and efficient PS-induced phototoxicity. The present study was performed: (i) to evaluate the targeting potential of the conjugate towards tumor and normal cells and its phototoxicity on various leukemia cells, (ii) to investigate the mechanism of conjugate-mediated cell death. The conjugate: (i) strongly increased (x1000) the PS phototoxicity towards leukemic Jurkat T cells through an O-glycan-dependent process; (ii) specifically purged tumor cells from a 1:1 mixture of Jurkat leukemia (Tn-positive) and healthy (Tn-negative) lymphocytes, preserving the activation potential of healthy lymphocytes; (iii) was effective against various leukemic cell lines with distinct phenotypes, as well as fresh human primary acute and chronic lymphoid leukemia cells; (iv) induced mostly a caspase-independent cell death, which might be an advantage as tumor cells often resist caspase-dependent cell death. Altogether, the present observations suggest that conjugation with plant lectins can allow targeting of photosensitizers towards aberrant glycosylation of tumor cells, e. g. to purge leukemia cells from blood and to preserve the normal leukocytes in extracorporeal photochemotherapy.	[Poiroux, Guillaume; Lafont, Elodie; Segui, Bruno; Levade, Thierry; Benoist, Herve] CHU Rangueil, Ctr Rech Cancerol Toulouse, INSERM, UMR 1037,Equipe 4, F-31432 Toulouse, France; [Lafont, Elodie; Segui, Bruno; Bernadou, Jean; Barre, Annick; Benoist, Herve] Univ Toulouse, Fac Pharmaceut Sci, F-31062 Toulouse, France; [Poiroux, Guillaume; Culerrier, Raphael; Rouge, Pierre; Barre, Annick] Univ Toulouse, UMR UPS CNRS 5546, F-31326 Castanet Tolosan, France; [Pitie, Marguerite; Bernadou, Jean] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France; [Van Damme, Els J. M.; Peumans, Willy J.] Univ Ghent, Dept Mol Biotechnol, Lab Biochem & Glycobiol, B-9000 Ghent, Belgium	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Ghent University	Poiroux, G (corresponding author), CHU Rangueil, Ctr Rech Cancerol Toulouse, INSERM, UMR 1037,Equipe 4, BP84225, F-31432 Toulouse, France.	herve.benoist@inserm.fr	Benoist, Hervé/P-2927-2014; Van Damme, Els J/B-4410-2015; Van Damme, Els/U-3904-2019; Lafont, Elodie/L-3288-2019; Lafont, Elodie/GPS-9642-2022; Levade, Thierry/O-8948-2014; Ségui, Bruno/O-8957-2014; Guillaume, Poiroux/M-2854-2015; Rouge, Pierre/T-2059-2019	Van Damme, Els/0000-0001-9848-766X; Lafont, Elodie/0000-0003-1978-7491; Lafont, Elodie/0000-0003-1978-7491; Ségui, Bruno/0000-0002-6119-1889; Guillaume, Poiroux/0000-0002-6769-3716; Barre, annick/0000-0002-1360-8491	Universite Paul Sabatier; Institut National de la Sante et de la Recherche Medicale [U858, I2MR]; Centre National de la Recherhce Scientifique [UMR5546]; Scientific Research Flanders	Universite Paul Sabatier; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherhce Scientifique; Scientific Research Flanders(FWO)	Funding provided by: Universite Paul Sabatier; Institut National de la Sante et de la Recherche Medicale U858, I2MR; Centre National de la Recherhce Scientifique UMR5546; and Scientific Research Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcouffe J, 2004, FASEB J, V18, P122, DOI 10.1096/fj.02-0808fje; Battisti V, 2008, CLIN BIOCHEM, V41, P511, DOI 10.1016/j.clinbiochem.2008.01.027; Benoist H, 2009, J LEUKOCYTE BIOL, V86, P103, DOI [10.1189/JLB.0708434, 10.1189/jlb.0708434]; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Brooks CL, 2010, P NATL ACAD SCI USA, V107, P10056, DOI 10.1073/pnas.0915176107; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Cao Y, 2008, INT J CANCER, V123, P89, DOI 10.1002/ijc.23493; CASAS C, 1993, J ORG CHEM, V58, P2913, DOI 10.1021/jo00062a045; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chen BJ, 2002, BLOOD, V99, P3083, DOI 10.1182/blood.V99.9.3083; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Copley L, 2008, INT J BIOCHEM CELL B, V40, P227, DOI 10.1016/j.biocel.2007.07.014; del Carmen MG, 2005, JNCI-J NATL CANCER I, V97, P1516, DOI 10.1093/jnci/dji314; Del Governatore M, 2000, BRIT J CANCER, V82, P56; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Giusti C, 2009, EXP CELL RES, V315, P26, DOI 10.1016/j.yexcr.2008.09.028; Hamblin MR, 2000, BRIT J CANCER, V83, P1544, DOI 10.1054/bjoc.2000.1486; Heimburg-Molinaro J, 2009, NEOPLASIA, V11, P780, DOI 10.1593/neo.09504; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; ITZKOWITZ SH, 1989, CANCER RES, V49, P197; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; Kessel D, 1999, CELL DEATH DIFFER, V6, P28, DOI 10.1038/sj.cdd.4400446; Korbelik M, 2007, BRIT J CANCER, V97, P1381, DOI 10.1038/sj.bjc.6604059; Lafont E, 2010, CELL DEATH DIFFER, V17, P642, DOI 10.1038/cdd.2009.130; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Marchal S, 2005, BIOCHEM PHARMACOL, V69, P1167, DOI 10.1016/j.bcp.2005.01.021; Mazor D, 2008, PEDIATR BLOOD CANCER, V51, P613, DOI 10.1002/pbc.21665; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; Moran EC, 2002, BRIT J HAEMATOL, V116, P316, DOI 10.1046/j.1365-2141.2002.03280.x; Negre-Salvayre A, 2002, METHOD ENZYMOL, V352, P62; Nyman ES, 2004, J PHOTOCH PHOTOBIO B, V73, P1, DOI 10.1016/j.jphotobiol.2003.10.002; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oliven A, 2001, BLOOD REV, V15, P103, DOI 10.1054/blre.2001.0155; PILLER V, 1990, J BIOL CHEM, V265, P9264; Poiroux G, 2011, PHOTOCHEM PHOTOBIOL, V87, P370, DOI 10.1111/j.1751-1097.2010.00858.x; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Savellano MD, 2005, CANCER RES, V65, P6371, DOI 10.1158/0008-5472.CAN-05-0426; Savellano MD, 2005, CLIN CANCER RES, V11, P1658, DOI 10.1158/1078-0432.CCR-04-1902; Separovic D, 2009, BRIT J CANCER, V100, P626, DOI 10.1038/sj.bjc.6604896; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Shan L, 2004, MOL IMAGING CONTRAST; Shanafelt TD, 2005, BLOOD, V105, P2099, DOI 10.1182/blood-2004-06-2205; Singh T, 2007, MOL IMMUNOL, V44, P451, DOI 10.1016/j.molimm.2006.02.017; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Sze KL, 2011, APPL MICROBIOL BIOT, V89, P45, DOI 10.1007/s00253-010-2892-9; Thurston G, 1998, AM J PATHOL, V153, P1099, DOI 10.1016/S0002-9440(10)65654-4; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Van Damme EJM, 2002, PLANT PHYSIOL, V130, P757, DOI 10.1104/pp.005892; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; Vittar NBR, 2010, INT J BIOCHEM CELL B, V42, P1123, DOI 10.1016/j.biocel.2010.03.019; Wu AM, 2009, GLYCOCONJUGATE J, V26, P899, DOI 10.1007/s10719-008-9119-7; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003	54	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23315	10.1371/journal.pone.0023315	http://dx.doi.org/10.1371/journal.pone.0023315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858067	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300033
J	Saber, T; Veale, DJ; Balogh, E; McCormick, J; NicAnUltaigh, S; Connolly, M; Fearon, U				Saber, Tajvur; Veale, Douglas J.; Balogh, Emese; McCormick, Jennifer; NicAnUltaigh, Sinead; Connolly, Mary; Fearon, Ursula			Toll-Like Receptor 2 Induced Angiogenesis and Invasion Is Mediated through the Tie2 Signalling Pathway in Rheumatoid Arthritis	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; SYNOVIAL TISSUE; GENE-THERAPY; EXPRESSION; ANGIOPOIETIN-1; PATHOGENESIS; INHIBITION; CYTOKINES; CELLS	Background: Angiogenesis is a critical early event in inflammatory arthritis, facilitating leukocyte migration into the synovium resulting in invasion and destruction of articular cartilage and bone. This study investigates the effect of TLR2 on angiogenesis, EC adhesion and invasion using microvascular endothelial cells and RA whole tissue synovial explants ex-vivo. Methods: Microvascular endothelial cells (HMVEC) and RA synovial explants ex vivo were cultured with the TLR2 ligand, Pam3CSK4 (1 mu g/ml). Angiopoietin 2 (Ang2), Tie2 and TLR2 expression in RA synovial tissue was assessed by immunohistology. HMVEC tube formation was assessed using Matrigel matrix assays. Ang2 was measured by ELISA. ICAM-1 cell surface expression was assessed by flow cytometry. Cell migration was assessed by wound repair scratch assays. ECM invasion, MMP-2 and -9 expression were assessed using transwell invasion chambers and zymography. To examine if the angiopoietin/Tie2 signalling pathway mediates TLR2 induced EC tube formation, invasion and migration assays were performed in the presence of a specific neutralising anti-Tie2mAb (10 ug/ml) and matched IgG isotype control Ab (10 ug/ml). Results: Ang2 and Tie2 were localised to RA synovial blood vessels, and TLR2 was localised to RA synovial blood vessels, sub-lining infiltrates and the lining layer. Pam3CSK4 significantly increased angiogenenic tube formation (p<0.05), and upregulated Ang2 production in HMVEC (p<0.05) and RA synovial explants (p<0.05). Pam3CSK4 induced cell surface expression of ICAM-1, from basal level of 149+/-54 (MFI) to 617+/-103 (p<0.01). TLR-2 activation induced an 8.8+/-2.8 fold increase in cell invasion compared to control (p<0.05). Pam3CSK4 also induced HMVEC cell migration and induced MMP-2 and -9 from RA synovial explants. Neutralisation of the Ang2 receptor, Tie2 significantly inhibited Pam3CSK4-induced EC tube formation and invasion (p<0.05). Conclusion: TLR2 activation promotes angiogenesis, cell adhesion and invasion, effects that are in part mediated through the Tie2 signalling pathway, key mechanisms involved in the pathogenesis of RA.	[Saber, Tajvur] Univ Coll Dublin, Dublin Acad Med Ctr, Dept Rheumatol, Dublin 2, Ireland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Saber, T (corresponding author), Univ Coll Dublin, Dublin Acad Med Ctr, Dept Rheumatol, Dublin 2, Ireland.	ursula.fearon@ucd.ie		Fearon, Ursula/0000-0001-8084-0429; Saber, Tajvur/0000-0002-2599-2400; Veale, Douglas/0000-0003-2802-4971	Centrocor Newman fellowship; EU	Centrocor Newman fellowship; EU(European Commission)	This study was sponsored by a Centrocor Newman fellowship and EU FP6 Autocure. The anti-TLR2 antibody was a kind gift from Opsona Therapeutics Ltd, The Trinity Centre for Health Sciences, Institute of Molecular Medicine, St James' Hospital, Dublin, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; BUCALA R, 1991, J EXP MED, V173, P569, DOI 10.1084/jem.173.3.569; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Chen Y, 2005, ARTHRITIS RHEUM-US, V52, P1585, DOI 10.1002/art.21016; Cho ML, 2007, IMMUNOL LETT, V108, P121, DOI 10.1016/j.imlet.2006.11.005; CHU CQ, 1992, BRIT J RHEUMATOL, V31, P653; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; DeBusk LM, 2003, ARTHRITIS RHEUM-US, V48, P2461, DOI 10.1002/art.11213; Donnini S, 2004, LIFE SCI, V74, P2975, DOI 10.1016/j.lfs.2003.09.075; Faveeuw C, 2001, BLOOD, V98, P688, DOI 10.1182/blood.V98.3.688; Fearon U, 2003, J RHEUMATOL, V30, P260; Fearon U, 2006, ARTHRITIS RHEUM-US, V54, P3152, DOI 10.1002/art.22161; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gravallese EM, 2003, ANN RHEUM DIS, V62, P100, DOI 10.1136/ard.62.2.100; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Haas CS, 2007, ARTHRITIS RHEUM-US, V56, P2535, DOI 10.1002/art.22823; Hayashi K, 2009, ARCH VIROL, V154, P219, DOI 10.1007/s00705-008-0303-7; Hitchon CA, 2002, J RHEUMATOL, V29, P107; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Kasama T, 2007, TRANSL RES, V149, P265, DOI 10.1016/j.trsl.2006.12.007; Koch AE, 2003, ANN RHEUM DIS, V62, P60, DOI 10.1136/ard.62.suppl_2.ii60; KOCH AE, 1994, J IMMUNOL, V152, P4149; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; LI Y, 2009, AM J PHYSIOL-REG I; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; Nijhuis MMO, 2007, J VASC RES, V44, P214, DOI 10.1159/000100420; Przybysz M, 2007, RHEUMATOLOGY, V46, P1071, DOI 10.1093/rheumatology/kem067; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Reece RJ, 1999, ARTHRITIS RHEUM, V42, P1481, DOI 10.1002/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Sawa Y, 2008, CELL TISSUE RES, V333, P237, DOI 10.1007/s00441-008-0625-5; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472.CAN-07-1034; Schrijver IA, 2000, ARTHRITIS RHEUM-US, V43, P2160, DOI 10.1002/1529-0131(200010)43:10<2160::AID-ANR3>3.0.CO;2-T; Scott BB, 2002, J RHEUMATOL, V29, P230; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Shahrara S, 2002, ARTHRITIS RES, V4, P201, DOI 10.1186/ar407; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Szekanecz Z, 2004, CURR OPIN PHARMACOL, V4, P423, DOI 10.1016/j.coph.2004.03.013; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Takahara K, 2004, HUM PATHOL, V35, P150, DOI 10.1016/j.humpath.2003.11.010; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Ultaigh SNA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3261; Varoga D, 2006, J PATHOL, V210, P315, DOI 10.1002/path.2059; Yu D, 1997, ARTHRITIS RHEUM-US, V40, P648, DOI 10.1002/art.1780400409; ZHANG J, 2009, FASEB J, P23153	53	51	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23540	10.1371/journal.pone.0023540	http://dx.doi.org/10.1371/journal.pone.0023540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858161	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300059
J	Sutherland, KP; Shaban, S; Joyner, JL; Porter, JW; Lipp, EK				Sutherland, Kathryn Patterson; Shaban, Sameera; Joyner, Jessica L.; Porter, James W.; Lipp, Erin K.			Human Pathogen Shown to Cause Disease in the Threatened Eklhorn Coral Acropora palmata	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; INTENSIVE-CARE-UNIT; CARIBBEAN ELKHORN CORAL; WHITE-BAND DISEASE; SERRATIA-MARCESCENS; FLORIDA-KEYS; HUMAN SEWAGE; OUTBREAK; WATERS; REEFS	Coral reefs are in severe decline. Infections by the human pathogen Serratia marcescens have contributed to precipitous losses in the common Caribbean elkhorn coral, Acropora palmata, culminating in its listing under the United States Endangered Species Act. During a 2003 outbreak of this coral disease, called acroporid serratiosis (APS), a unique strain of the pathogen, Serratia marcescens strain PDR60, was identified from diseased A. palmata, human wastewater, the non-host coral Siderastrea siderea and the corallivorous snail Coralliophila abbreviata. In order to examine humans as a source and other marine invertebrates as vectors and/or reservoirs of the APS pathogen, challenge experiments were conducted with A. palmata maintained in closed aquaria to determine infectivity of strain PDR60 from reef and wastewater sources. Strain PDR60 from wastewater and diseased A. palmata caused disease signs in elkhorn coral in as little as four and five days, respectively, demonstrating that wastewater is a definitive source of APS and identifying human strain PDR60 as a coral pathogen through fulfillment of Koch's postulates. A. palmata inoculated with strain PDR60 from C. abbreviata showed limited virulence, with one of three inoculated fragments developing APS signs within 13 days. Strain PDR60 from non-host coral S. siderea showed a delayed pathogenic effect, with disease signs developing within an average of 20 days. These results suggest that C. abbreviata and non-host corals may function as reservoirs or vectors of the APS pathogen. Our results provide the first example of a marine "reverse zoonosis" involving the transmission of a human pathogen (S. marcescens) to a marine invertebrate (A. palmata). These findings underscore the interaction between public health practices and environmental health indices such as coral reef survival.	[Sutherland, Kathryn Patterson; Shaban, Sameera] Rollins Coll, Dept Biol, Winter Pk, FL 32789 USA; [Joyner, Jessica L.; Porter, James W.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Joyner, Jessica L.; Lipp, Erin K.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	Rollins College; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sutherland, KP (corresponding author), Rollins Coll, Dept Biol, Winter Pk, FL 32789 USA.	kpsutherland@rollins.edu		Patterson Sutherland, Kathryn/0000-0002-8192-1500; Lipp, Erin/0000-0002-8066-0636				Alaidan A, 2009, J MICROBIOL METH, V78, P238, DOI 10.1016/j.mimet.2009.05.007; Alfizah H., 2004, SMJ Singapore Medical Journal, V45, P214; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Bayramoglu G, 2011, J MICROBIOL IMMUNOL, V44, P111, DOI 10.1016/j.jmii.2010.02.002; Bonkosky M, 2009, MAR POLLUT BULL, V58, P45, DOI 10.1016/j.marpolbul.2008.09.008; CABRERA HA, 1969, ARCH INTERN MED, V123, P650, DOI 10.1001/archinte.123.6.650; CH2MHILL, 2000, MONR COUNT SAN WAST; FARMER JJ, 1973, APPL MICROBIOL, V25, P151, DOI 10.1128/AEM.25.1.151-152.1973; Futch JC, 2010, ENVIRON MICROBIOL, V12, P964, DOI 10.1111/j.1462-2920.2010.02141.x; GLADFELTER WB, 1982, B MAR SCI, V32, P639; GRABER CD, 1965, J AMER MED ASSOC, V192, P956, DOI 10.1001/jama.1965.03080240026005; GRASSO GM, 1988, EPIDEMIOL INFECT, V101, P315, DOI 10.1017/S0950268800054248; Griffin DW, 1999, APPL ENVIRON MICROB, V65, P4118; GRIMONT F, 2006, PROKARYOTES, V6, P219; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HAZEN TC, 1988, TOXIC ASSESS, V3, P461, DOI 10.1002/tox.2540030504; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hogarth W.T., 2006, FED REGISTER, V71, P26852; Krediet CJ, 2009, APPL ENVIRON MICROB, V75, P3851, DOI 10.1128/AEM.00457-09; LAPOINTE BE, 1990, BIOGEOCHEMISTRY, V10, P289; Ligozzi M, 2010, J CLIN MICROBIOL, V48, P1690, DOI 10.1128/JCM.01528-09; Looney EE, 2010, ENVIRON MICROBIOL, V12, P2479, DOI 10.1111/j.1462-2920.2010.02221.x; MAGNUSON CW, 1966, ANN INTERN MED, V65, P409, DOI 10.7326/0003-4819-65-3-409; Maragakis LL, 2008, INFECT CONT HOSP EP, V29, P418, DOI 10.1086/587969; Milisavljevic V, 2004, INFECT CONT HOSP EP, V25, P719, DOI 10.1086/502466; Miller MW, 2001, CORAL REEFS, V19, P293, DOI 10.1007/PL00006963; Miranda G, 1996, J CLIN MICROBIOL, V34, P3138, DOI 10.1128/JCM.34.12.3138-3141.1996; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Nobles R., 2000, FLORIDA J ENV HLTH, V169, P15; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Paul JH, 1997, WATER RES, V31, P1448, DOI 10.1016/S0043-1354(96)00374-0; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; RINGROSE RE, 1968, ANN INTERN MED, V69, P719, DOI 10.7326/0003-4819-69-4-719; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez-Martinez RE, 2001, DIS AQUAT ORGAN, V47, P229, DOI 10.3354/dao047229; Shi ZY, 1997, J CLIN MICROBIOL, V35, P325, DOI 10.1128/JCM.35.1.325-327.1997; Steppberger K, 2002, INFECTION, V30, P277, DOI 10.1007/s15010-002-2141-y; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; TILLOTSON JR, 1969, J INFECT DIS, V119, P597, DOI 10.1093/infdis/119.6.597; van der Vorm ER, 2002, J HOSP INFECT, V52, P263, DOI 10.1053/jhin.2002.1313; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Wilson VL, 1999, J MICROBIOL METH, V39, P59, DOI 10.1016/S0167-7012(99)00098-6; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	44	99	104	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23468	10.1371/journal.pone.0023468	http://dx.doi.org/10.1371/journal.pone.0023468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858132	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300049
J	Sathish, V; Delmotte, PF; Thompson, MA; Pabelick, CM; Sieck, GC; Prakash, YS				Sathish, Venkatachalem; Delmotte, Philippe F.; Thompson, Michael A.; Pabelick, Christina M.; Sieck, Gary C.; Prakash, Y. S.			Sodium-Calcium Exchange in Intracellular Calcium Handling of Human Airway Smooth Muscle	PLOS ONE			English	Article							RETICULUM CA2+ REUPTAKE; NECROSIS-FACTOR-ALPHA; NA+/CA2+ EXCHANGER; SARCOPLASMIC-RETICULUM; NA+-CA2+ EXCHANGE; REVERSE-MODE; VOLATILE ANESTHETICS; CELLS; INFLUX; CHANNELS	Enhanced airway contractility following inflammation by cytokines such as tumor necrosis factor alpha (TNF alpha) or interleukin-13 (IL-13) involves increased intracellular Ca2+ ([Ca2+](i)) levels in airway smooth muscle (ASM). In ASM, plasma membrane Ca2+ fluxes form a key component of [Ca2+](i) regulation. There is now growing evidence that the bidirectional plasma membrane Na+/Ca2+ exchanger (NCX) contributes to ASM [Ca2+](i) regulation. In the present study, we examined NCX expression and function in human ASM cells under normal conditions, and following exposure to TNFa or IL-13. Western blot analysis showed significant expression of the NCX1 isoform, with increased NCX1 levels by both cytokines, effects blunted by inhibitors of nuclear factor NF-kappa B or mitogen-activated protein kinase. Cytokine-mediated increase in NCX1 involved enhanced transcription followed by protein synthesis. NCX2 and NCX3 remained undetectable even in cytokine-stimulated ASM. In fura-2 loaded human ASM cells, NCX-mediated inward Ca2+ exchange as well as outward exchange (measured as rates of change in [Ca2+](i)) was elicited by altering extracellular Na+ and Ca2+ levels. Contribution of NCX was verified by measuring [Na+](i) using the fluorescent Na+ indicator SBFI. NCX-mediated inward exchange was verified by demonstrating prevention of rising [Ca2+](i) or falling [Na+](i) in the presence of the NCX inhibitor KBR7943. Inward exchange-mode NCX was increased by both TNF beta and IL-13 to a greater extent than outward exchange. NCX siRNA transfection substantially blunted outward exchange and inward exchange modes. Finally, inhibition of NCX expression or function blunted peak [Ca2+](i) and rate of fall of [Ca2+](i) following histamine stimulation. These data suggest that NCX-mediated Ca2+ fluxes normally exist in human ASM (potentially contributing to rapid Ca2+ fluxes), and contribute to enhanced [Ca2+](i) regulation in airway inflammation.	[Sathish, Venkatachalem; Delmotte, Philippe F.; Pabelick, Christina M.; Sieck, Gary C.; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sathish, Venkatachalem; Thompson, Michael A.; Pabelick, Christina M.; Sieck, Gary C.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Sathish, V (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	prakash.ys@mayo.edu		sieck, gary/0000-0003-3040-9424; venkatachalem, sathish/0000-0001-9770-8299; Prakash, Y S/0000-0002-2968-224X	NIH [HL74309, HL090595, HL090595-S2, HL088029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090595, R01HL074309, R01HL088029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grants HL74309 (GCS), HL090595 (CMP), HL090595-S2 (CMP, VS), and HL088029 (YSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICKIN CC, 1994, J PHYSIOL-LONDON, V479, P301, DOI 10.1113/jphysiol.1994.sp020297; Algara-Suarez P, 2007, AM J PHYSIOL-LUNG C, V293, pL191, DOI 10.1152/ajplung.00485.2006; AMRANI Y, 1993, CR ACAD SCI III-VIE, V316, P1489; Ay B, 2006, AM J PHYSIOL-LUNG C, V290, pL278, DOI 10.1152/ajplung.00188.2005; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BEAUVAIS F, 1994, CLIN EXP IMMUNOL, V95, P191; Bers DM, 1996, ANN NY ACAD SCI, V779, P430, DOI 10.1111/j.1749-6632.1996.tb44818.x; Bers DM, 2007, ANN NY ACAD SCI, V1099, P326, DOI 10.1196/annals.1387.060; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bradley E, 2006, J PHYSIOL-LONDON, V574, P651, DOI 10.1113/jphysiol.2006.110932; Chalmers S, 2007, CELL CALCIUM, V42, P447, DOI 10.1016/j.ceca.2007.05.010; Chen H, 2003, J APPL PHYSIOL, V95, P864, DOI 10.1152/japplphysiol.00140.2003; COBURN RF, 1990, AM J PHYSIOL, V258, pL119, DOI 10.1152/ajplung.1990.258.4.L119; Dai JM, 2007, AM J RESP CELL MOL, V36, P600, DOI 10.1165/rcmb.2006-0096OC; Davis KA, 2009, J CELL MOL MED, V13, P1775, DOI 10.1111/j.1582-4934.2008.00480.x; Despa S, 2002, J PHYSIOL-LONDON, V539, P133, DOI 10.1113/jphysiol.2001.012940; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirota S, 2007, EUR RESPIR J, V30, P269, DOI 10.1183/09031936.00008507; Hirota S, 2007, AM J PHYSIOL-LUNG C, V292, pL438, DOI 10.1152/ajplung.00222.2006; Iwamoto T, 2004, MOL CELL BIOCHEM, V259, P157, DOI 10.1023/B:MCBI.0000021367.42752.54; Iwamoto Takahiro, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P188, DOI 10.2174/187152907781745288; Janssen LJ, 1997, AM J PHYSIOL-LUNG C, V273, pL322, DOI 10.1152/ajplung.1997.273.2.L322; Janssen LJ, 1996, J PHARMACOL EXP THER, V279, P813; Jeffs GJ, 2007, J CLIN NEUROSCI, V14, P507, DOI 10.1016/j.jocn.2006.07.013; Kannan MS, 1997, AM J PHYSIOL-LUNG C, V272, pL659, DOI 10.1152/ajplung.1997.272.4.L659; KAWANISHI M, 1984, JPN J PHYSIOL, V34, P127, DOI 10.2170/jjphysiol.34.127; KHOYI MA, 1993, AM J PHYSIOL, V265, pC1325; KNOX AJ, 1995, THORAX, V50, P894, DOI 10.1136/thx.50.8.894; KNOX AJ, 1994, PULM PHARMACOL, V7, P99, DOI 10.1006/pulp.1994.1011; Lamont C, 1998, PFLUG ARCH EUR J PHY, V435, P523, DOI 10.1007/s004240050548; Liu B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-168; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; McCarron JG, 2006, CELL CALCIUM, V40, P461, DOI 10.1016/j.ceca.2006.08.010; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; MURRAY RK, 1991, J PHYSIOL-LONDON, V435, P123, DOI 10.1113/jphysiol.1991.sp018501; Nagano T, 2004, J NEUROCHEM, V90, P784, DOI 10.1111/j.1471-4159.2004.02511.x; Pabelick CM, 2004, ANESTHESIOLOGY, V101, P373, DOI 10.1097/00000542-200408000-00018; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Prakash YS, 2006, ANESTHESIOLOGY, V105, P976, DOI 10.1097/00000542-200611000-00019; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash YS, 2009, AM J PHYSIOL-LUNG C, V297, pL794, DOI 10.1152/ajplung.00237.2009; Prakash YS, 2002, ANN NY ACAD SCI, V976, P530; Prakash YS, 1997, AM J PHYSIOL-CELL PH, V272, pC966, DOI 10.1152/ajpcell.1997.272.3.C966; Raina H, 2008, J PHYSIOL-LONDON, V586, P1669, DOI 10.1113/jphysiol.2007.150268; Rebolledo A, 2006, BIOCHEM BIOPH RES CO, V339, P840, DOI 10.1016/j.bbrc.2005.11.084; Reuter H, 2005, CARDIOVASC RES, V67, P198, DOI 10.1016/j.cardiores.2005.04.031; REUTER H, 1973, PHILOS T R SOC B, V265, P87, DOI 10.1098/rstb.1973.0011; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Sakai Y, 2005, CAN J PHYSIOL PHARM, V83, P791, DOI 10.1139/Y05-079; Sathish V, 2009, AM J PHYSIOL-LUNG C, V297, pL26, DOI 10.1152/ajplung.00026.2009; Sathish V, 2008, AM J PHYSIOL-LUNG C, V294, pL787, DOI 10.1152/ajplung.00461.2007; Schneider JC, 2002, AM J PHYSIOL-HEART C, V283, pH837, DOI 10.1152/ajpheart.00789.2001; Schuster A, 2004, J CARDIOVASC PHARM, V43, P539, DOI 10.1097/00005344-200404000-00009; Shore SA, 2004, CURR OPIN PHARMACOL, V4, P235, DOI 10.1016/j.coph.2004.01.008; Sieck GC, 2008, AM J PHYSIOL-LUNG C, V294, pL378, DOI 10.1152/ajplung.00394.2007; Sieck GC, 1997, CAN J PHYSIOL PHARM, V75, P878, DOI 10.1139/cjpp-75-7-878; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Wang XH, 2000, CHINESE MED J-PEKING, V113, P18; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; WORLEY JF, 1990, AM J PHYSIOL, V259, pL468, DOI 10.1152/ajplung.1990.259.6.L468; Zhang S, 2005, AM J PHYSIOL-CELL PH, V288, pC245, DOI 10.1152/ajpcell.00411.2004	64	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23662	10.1371/journal.pone.0023662	http://dx.doi.org/10.1371/journal.pone.0023662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858195	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700037
J	Liu, J; Zhang, CY				Liu, Jun; Zhang, Chiyu			Phylogeographic Analyses Reveal a Crucial Role of Xinjiang in HIV-1 CRF07_BC and HCV 3a Transmissions in Asia	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INJECTION-DRUG USERS; CIRCULATING RECOMBINANT; GENETIC DIVERSITY; TYPE-1 GENOME; INFECTION; FORMS; EPIDEMIOLOGY; CRF08-BC; DYNAMICS	Background: China faces an increasing prevalence of two HIV-1 circulating recombinant forms (CRFs) 07_BC and 08_BC. Both CRFs_BC were previously demonstrated to originate in Yunnan and spread to Liaoning from Yunnan via injection drug use (IDU) in China. Supposing it is true, we are unable to answer why only CRF07_BC, rather than both CRFs_BC together, was transmitted to Xinjiang. Methodology/Principal Findings: We investigated the phylogeography of CRF07_BC and CRF08_BC using multiple HIV-1 genomic regions with Bayesian phylogeography method. Phylogenetic reconstructions showed that all CRF07_BC sequences were divided into two clades, Yunnan and Xinjiang, and all strains from other regions of mainland China clustered within the Xinjiang clade. Significant geographic diffusion links of Xinjiang with other regions (including Liaoning, Beijing, Jiangsu and Guangdong) were supported by Bayes factor tests. The temporal dynamics analyses showed that CRF07_BC spread from Xinjiang to Liaoning in 1996.10, and to Jiangsu in 2000.9. The analyses of CRF08_BC not only confirmed the previous conclusion on temporal and spatial dynamics of CRF08_BC, but also indicated that the CRF08_BC strains from Guangdong and Shanghai originated from Yunnan. The analyses of HCV 3a showed that it was introduced into Xinjiang in the early 1980s, and spread from Xinjiang to Yunnan in 1990.10 and to Jiangsu in 1999.2, and further from Yunnan to Guangxi in 1995.3. The temporal and spatial dynamics of HCV 3a were similar to some extent to that of HIV-1 CRF07_BC and/or CRF08_BC, suggesting a possible association in migration patterns between HCV and HIV-1 through IDU. In addition, HCV 3a spread from Xinjiang to Pakistan, implying a drug trafficking route linking them. Conclusions/Significance: Xinjiang, as the most important transfer station for drug trafficking from Golden Crescent to other regions of China, plays a very crucial role in the transmission of viruses (e. g., HIV-1 and HCV) through IDU in Asia.	[Liu, Jun; Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Liu, J (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	zhangcy1999@hotmail.com		Zhang, Chiyu/0000-0001-8735-9857	Jiangsu University; National Natural Science Foundation of China [81071391]	Jiangsu University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the "Top-notch personnel" Project of Jiangsu University (to C. Zhang) and the National Natural Science Foundation of China (No. 81071391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Guo HX, 2009, AIDS RES HUM RETROV, V25, P463, DOI 10.1089/aid.2008.0250; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Lam TTY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000130; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey Philippe, 2009, PLoS Curr, V1, pRRN1031; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu SY, 2008, ARCH VIROL, V153, P1233, DOI 10.1007/s00705-008-0107-9; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Takebe Y, 2010, VACCINE, V28, pB39, DOI 10.1016/j.vaccine.2009.07.101; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tebit DM, 2007, AIDS REV, V9, P75; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2008, AIDS, V22, P156, DOI 10.1097/QAD.0b013e3282f2d77a; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Xin RL, 2009, J GEN VIROL, V90, P1757, DOI 10.1099/vir.0.009290-0; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016817; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017	46	33	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23347	10.1371/journal.pone.0023347	http://dx.doi.org/10.1371/journal.pone.0023347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858079	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500032
J	Thompson, PA; Brewster, AM; Do, KA; Baladandayuthapani, V; Broom, BM; Edgerton, ME; Hahn, KM; Murray, JL; Sahin, A; Tsavachidis, S; Wang, YK; Zhang, L; Hortobagyi, GN; Mills, GB; Bondy, ML				Thompson, Patricia A.; Brewster, Abenaa M.; Do, Kim-Anh; Baladandayuthapani, Veerabhadran; Broom, Bradley M.; Edgerton, Mary E.; Hahn, Karin M.; Murray, James L.; Sahin, Aysegul; Tsavachidis, Spyros; Wang, Yuker; Zhang, Li; Hortobagyi, Gabriel N.; Mills, Gordon B.; Bondy, Melissa L.			Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; GENE-EXPRESSION SIGNATURES; ALLELIC LOSS; ARRAY-CGH; SURVIVAL; SUBTYPES; PATTERNS; BASAL; RISK; 8P22	A number of studies of copy number imbalances (CNIs) in breast tumors support associations between individual CNIs and patient outcomes. However, no pattern or signature of CNIs has emerged for clinical use. We determined copy number (CN) gains and losses using high-density molecular inversion probe (MIP) arrays for 971 stage I/II breast tumors and applied a boosting strategy to fit hazards models for CN and recurrence, treating chromosomal segments in a dose-specific fashion (-1 [loss], 0 [no change] and +1 [gain]). The concordance index (C-Index) was used to compare prognostic accuracy between a training (n = 728) and test (n = 243) set and across models. Twelve novel prognostic CNIs were identified: losses at 1p12, 12q13.13, 13q12.3, 22q11, and Xp21, and gains at 2p11.1, 3q13.12, 10p11.21, 10q23.1, 11p15, 14q13.2-q13.3, and 17q21.33. In addition, seven CNIs previously implicated as prognostic markers were selected: losses at 8p22 and 16p11.2 and gains at 10p13, 11q13.5, 12p13, 20q13, and Xq28. For all breast cancers combined, the final full model including 19 CNIs, clinical covariates, and tumor marker-approximated subtypes (estrogen receptor [ER], progesterone receptor, ERBB2 amplification, and Ki67) significantly outperformed a model containing only clinical covariates and tumor subtypes (C-Index full model, train[test] = 0.72[0.71] +/- 0.02 vs. C-Index (clinical + subtype model), train[test] = 0.62[0.62] +/- 0.02; p < 10(-6)). In addition, the full model containing 19 CNIs significantly improved prognostication separately for ER-, HER2+, luminal B, and triple negative tumors over clinical variables alone. In summary, we show that a set of 19 CNIs discriminates risk of recurrence among early-stage breast tumors, independent of ER status. Further, our data suggest the presence of specific CNIs that promote and, in some cases, limit tumor spread.	[Thompson, Patricia A.] Univ Arizona, Arizona Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Brewster, Abenaa M.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Do, Kim-Anh; Baladandayuthapani, Veerabhadran; Zhang, Li] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Broom, Bradley M.; Sahin, Aysegul] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Edgerton, Mary E.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hahn, Karin M.; Murray, James L.; Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Tsavachidis, Spyros; Bondy, Melissa L.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wang, Yuker] Affymetrix Inc, Santa Clara, CA USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Arizona Center Cancer Care; University of Arizona; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Affymetrix; University of Texas System; UTMD Anderson Cancer Center	Thompson, PA (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.	PThompson@azcc.arizona.edu		Zhang, Li/0000-0003-0517-7860	National Institute of Health; Cancer Institute; Susan G. Komen for the Cure; National Breast Cancer Foundation; SPORE [P50CA116199]; CCSG [CA023074];  [R01CA089608]; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA023074, R01CA089608, P50CA098258, P50CA116199] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Institute; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Breast Cancer Foundation; SPORE; CCSG; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding sources for the study included the National Institute of Health, Cancer Institute, and Susan G. Komen for the Cure, National Breast Cancer Foundation, SPORE P50CA116199, R01CA089608, and CCSG CA023074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Binder H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-14; Binder H, 2009, BIOINFORMATICS, V25, P890, DOI 10.1093/bioinformatics/btp088; Brewster AM, 2007, J CLIN ONCOL, V25, P4438, DOI 10.1200/JCO.2007.10.6815; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Du J, 2010, J BIOCHEM, V147, P265, DOI 10.1093/jb/mvp161; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heagerty PJ., **DATA OBJECT**; Hirano A, 2001, CLIN CANCER RES, V7, P876; Hirano Akira, 2001, International Journal of Clinical Oncology, V6, P6, DOI 10.1007/PL00012082; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Horlings HM, 2010, CLIN CANCER RES, V16, P651, DOI 10.1158/1078-0432.CCR-09-0709; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Mollerstrom E, 2010, CANCER GENET CYTOGEN, V198, P79, DOI 10.1016/j.cancergencyto.2009.12.012; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Raftery AE, 2011, BMA BAYESIAN MODEL A; Rennstam K, 2003, CANCER RES, V63, P8861; Rodriguez C, 2004, CLIN CANCER RES, V10, P5785, DOI 10.1158/1078-0432.CCR-03-0410; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; SAHIN AA, 1991, CANCER-AM CANCER SOC, V68, P549, DOI 10.1002/1097-0142(19910801)68:3<549::AID-CNCR2820680318>3.0.CO;2-J; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Therneau T.M., 2000, MODELING SURVIVAL DA; Tsuneizumi M, 2002, CANCER LETT, V180, P75, DOI 10.1016/S0304-3835(02)00010-1; Utada Y, 2000, CANCER, V88, P1410, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1410::AID-CNCR19>3.3.CO;2-O; van Beers EH, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1510; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Venkatraman ES, 2009, DNACOPY PACKAGE ANAL; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Volinsky CT, 1997, J R STAT SOC C-APPL, V46, P433, DOI 10.1111/1467-9876.00082; Wang Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r246; Wang Y, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-8; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	52	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23543	10.1371/journal.pone.0023543	http://dx.doi.org/10.1371/journal.pone.0023543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858162	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500053
J	George, J; Singh, M; Srivastava, AK; Bhui, K; Roy, P; Chaturvedi, PK; Shukla, Y				George, Jasmine; Singh, Madhulika; Srivastava, Amit Kumar; Bhui, Kulpreet; Roy, Preeti; Chaturvedi, Pranav Kumar; Shukla, Yogeshwer			Resveratrol and Black Tea Polyphenol Combination Synergistically Suppress Mouse Skin Tumors Growth by Inhibition of Activated MAPKs and p53	PLOS ONE			English	Article							FACTOR-KAPPA-B; PROTEIN-KINASES; GREEN TEA; GENE-EXPRESSION; INDUCTION; APOPTOSIS; ADENOCARCINOMA; MECHANISMS; PATHWAYS; SULFIDE	Cancer chemoprevention by natural dietary agents has received considerable importance because of their cost-effectiveness and wide safety margin. However, single agent intervention has failed to bring the expected outcome in clinical trials; therefore, combinations of chemopreventive agents are gaining increasing popularity. The present study aims to evaluate the combinatorial chemopreventive effects of resveratrol and black tea polyphenol (BTP) in suppressing two-stage mouse skin carcinogenesis induced by DMBA and TPA. Resveratrol/BTP alone treatment decreased tumor incidence by similar to 67% and similar to 75%, while combination of both at low doses synergistically decreased tumor incidence even more significantly by similar to 89% (p<0.01). This combination also significantly regressed tumor volume and number (p<0.01). Mechanistic studies revealed that this combinatorial inhibition was associated with decreased expression of phosphorylated mitogen-activated protein kinase family proteins: extracellular signal-regulated kinase 1/2, c-Jun N-terminal kinase 1/2, p38 and increased in total p53 and phospho p53 (Ser 15) in skin tissue/tumor. Treatment with combinations of resveratrol and BTP also decreased expression of proliferating cell nuclear antigen in mouse skin tissues/tumors than their solitary treatments as determined by immunohistochemistry. In addition, histological and cell death analysis also confirmed that resveratrol and BTP treatment together inhibits cellular proliferation and markedly induces apoptosis. Taken together, our results for the first time lucidly illustrate that resveratrol and BTP in combination impart better suppressive activity than either of these agents alone and accentuate that development of novel combination therapies/chemoprevention using dietary agents will be more beneficial against cancer. This promising combination should be examined in therapeutic trials of skin and possibly other cancers.	[George, Jasmine; Singh, Madhulika; Srivastava, Amit Kumar; Bhui, Kulpreet; Roy, Preeti; Chaturvedi, Pranav Kumar; Shukla, Yogeshwer] Indian Inst Toxicol Res, CSIR, Prote Lab, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	George, J (corresponding author), Indian Inst Toxicol Res, CSIR, Prote Lab, Lucknow, Uttar Pradesh, India.	yogeshwer_shukla@hotmail.com	Singh, Madhulika/AAC-6647-2021; Shukla, Yogeshwer/B-4144-2012		Council of Scientific & Industrial Research (CSIR), New Delhi, India [NWP-017]	Council of Scientific & Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant from Network Project (NWP-017), Council of Scientific & Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2003, ONCOGENE, V22, P9254, DOI 10.1038/sj.onc.1207035; Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Akesson B, 2008, EUR J NUTR, V47, P1, DOI 10.1007/s00394-008-2002-2; Arora A, 2004, MOL CANCER THER, V3, P1459; Baker JA, 2007, INT J GYNECOL CANCER, V17, P50, DOI 10.1111/j.1525-1438.2006.00773.x; Bishayee A, 2010, CANCER TREAT REV, V36, P43, DOI 10.1016/j.ctrv.2009.10.002; Bogovski P, 1979, IARC Sci Publ, V23, P1; Chen WX, 1998, J BIOL CHEM, V273, P32176, DOI 10.1074/jbc.273.48.32176; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; de Kok TMCM, 2010, MOL NUTR FOOD RES, V54, P208, DOI 10.1002/mnfr.200900288; George J, 2011, FOOD CHEM TOXICOL, V49, P1511, DOI 10.1016/j.fct.2011.03.040; Gromadzinska J., 2007, Dietary vitamins, polyphenols, selenium and probiotics: biomarkers of exposure and mechanisms of anticarcinogenic action, P91; Hsieh TC, 2010, BIOFACTORS, V36, P360, DOI 10.1002/biof.105; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kalra N, 2007, LIFE SCI, V80, P2137, DOI 10.1016/j.lfs.2007.04.009; Kalra N, 2008, LIFE SCI, V82, P348, DOI 10.1016/j.lfs.2007.11.006; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Kim YS, 1999, ARCH PHARM RES, V22, P1, DOI 10.1007/BF02976427; Kumi-Diaka J, 2010, J MED FOOD, V13, P842, DOI 10.1089/jmf.2009.0199; Kundu JK, 2004, BIOFACTORS, V21, P33, DOI 10.1002/biof.552210108; Kundu JK, 2006, BIOCHEM PHARMACOL, V72, P1506, DOI 10.1016/j.bcp.2006.08.005; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JB, 2000, CANCER RES, V60, P6465; MANCINI R, 1994, LIVER, V14, P57; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mowat MRA, 1998, ADV CANCER RES, V74, P25, DOI 10.1016/S0065-230X(08)60764-2; Ndiaye M, 2011, ARCH BIOCHEM BIOPHYS, V508, P164, DOI 10.1016/j.abb.2010.12.030; Nigam N, 2007, MOL NUTR FOOD RES, V51, P1324, DOI 10.1002/mnfr.200700140; Parshad R, 1998, ANTICANCER RES, V18, P3263; Roy P, 2009, CANCER BIOL THER, V8, P1281, DOI 10.4161/cbt.8.13.8728; Roy P, 2009, PHARM RES-DORDR, V26, P211, DOI 10.1007/s11095-008-9723-z; Seeni A, 2008, ASIAN PAC J CANCER P, V9, P7; Sengottuvelan M, 2009, CHEM-BIOL INTERACT, V181, P193, DOI 10.1016/j.cbi.2009.06.004; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Sil H, 2010, J ENVIRON PATHOL TOX, V29, P55, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i1.80; Singh RP, 2002, CARCINOGENESIS, V23, P499, DOI 10.1093/carcin/23.3.499; Sun CL, 2006, CARCINOGENESIS, V27, P1310, DOI 10.1093/carcin/bgi276; Weisburger JH, 1998, CARCINOGENESIS, V19, P229, DOI 10.1093/carcin/19.1.229; Weisburger JH, 1999, FOOD CHEM TOXICOL, V37, P943, DOI 10.1016/S0278-6915(99)00086-1; Xu G, 2010, FOOD CHEM TOXICOL, V48, P390, DOI 10.1016/j.fct.2009.10.027; Zhou JR, 2003, J NUTR, V133, P516, DOI 10.1093/jn/133.2.516; Zhu WH, 2002, AM J PATHOL, V161, P823, DOI 10.1016/S0002-9440(10)64242-3	46	63	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23395	10.1371/journal.pone.0023395	http://dx.doi.org/10.1371/journal.pone.0023395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887248	Green Published, Green Submitted, gold			2022-12-27	WOS:000294298800007
J	Jones, RW; Ospina-Giraldo, M				Jones, Richard W.; Ospina-Giraldo, Manuel			Novel Cellulose-Binding-Domain Protein in Phytophthora Is Cell Wall Localized	PLOS ONE			English	Article							ENDOGLUCANASE-ENCODING GENE; PARASITICA VAR.-NICOTIANAE; TRICHODERMA; EXPRESSION; IDENTIFICATION; SWOLLENIN; ELICITOR; MODULES; CLONING	Cellulose binding domains (CBD) in the carbohydrate binding module family 1 (CBM1) are structurally conserved regions generally linked to catalytic regions of cellulolytic enzymes. While widespread amongst saprophytic fungi that subsist on plant cell wall polysaccharides, they are absent amongst most plant pathogenic fungal cellulases. A genome wide survey for CBM1 was performed on the highly destructive plant pathogen Phytophthora infestans, a fungal-like Stramenopile, to determine if it harbored cellulolytic enzymes with CBM1. Only five genes were found to encode CBM1, and none were associated with catalytic domains. Surveys of other genomes indicated that the CBM1-containing proteins, lacking other domains, represent a unique group of proteins largely confined to the Stramenopiles. Immunolocalization of one of these proteins, CBD1, indicated that it is embedded in the hyphal cell wall. Proteins with CBM1 domains can have plant host elicitor activity, but tests with Agrobacterium-mediated in planta expression and synthetic peptide infiltration failed to identify plant hypersensitive elicitation with CBD1. A structural basis for differential elicitor activity is proposed.	[Jones, Richard W.] ARS, Genet Improvement Fruit & Vegetables Lab, USDA, Beltsville, MD USA; [Ospina-Giraldo, Manuel] Lafayette Coll, Dept Biol, Easton, PA 18042 USA	United States Department of Agriculture (USDA); Lafayette College	Jones, RW (corresponding author), ARS, Genet Improvement Fruit & Vegetables Lab, USDA, Beltsville, MD USA.	Richard.Jones@ars.usda.gov			United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding for this study was obtained from ongoing budgeted federal funding of the United States Department of Agriculture Agriculture Research Service program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; Costanzo S, 2006, FUNGAL GENET BIOL, V43, P707, DOI 10.1016/j.fgb.2006.04.006; FARKAS V, 1979, MICROBIOL REV, V43, P117, DOI 10.1128/MMBR.43.2.117-144.1979; Gaulin E, 2002, J CELL SCI, V115, P4565, DOI 10.1242/jcs.00138; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; HOFFREN AM, 1995, PROTEIN ENG, V8, P443, DOI 10.1093/protein/8.5.443; JONES RW, 1988, J GEN MICROBIOL, V134, P2067; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; Liu QY, 1996, J PHYCOL, V32, P995, DOI 10.1111/j.0022-3646.1996.00995.x; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; Mattinen ML, 1997, PROTEIN SCI, V6, P294; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1348, DOI 10.1094/MPMI-19-1348; Metcalf T, 2003, MICROBIOL-SGM, V149, P305, DOI 10.1099/mic.0.25984-0; Picard K, 2000, APPL ENVIRON MICROB, V66, P4305, DOI 10.1128/AEM.66.10.4305-4314.2000; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Wang Haiyin, 1996, Phytopathology, V86, pS91; WANG HY, 1995, GENE, V158, P125, DOI 10.1016/0378-1119(95)00094-M; WANG HY, 1995, APPL ENVIRON MICROB, V61, P2004, DOI 10.1128/AEM.61.5.2004-2006.1995; Wang YZ, 2001, EUR J BIOCHEM, V268, P4334, DOI 10.1046/j.1432-1327.2001.02354.x; Wei YD, 2002, MICROBIOL-SGM, V148, P2149, DOI 10.1099/00221287-148-7-2149; Westerink N, 2002, MOL PLANT MICROBE IN, V15, P1219, DOI 10.1094/MPMI.2002.15.12.1219	32	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23555	10.1371/journal.pone.0023555	http://dx.doi.org/10.1371/journal.pone.0023555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887271	Green Published, gold			2022-12-27	WOS:000295832000027
J	Kraev, I; Henneberger, C; Rossetti, C; Conboy, L; Kohler, LB; Fantin, M; Jennings, A; Venero, C; Popov, V; Rusakov, D; Stewart, MG; Bock, E; Berezin, V; Sandi, C				Kraev, Igor; Henneberger, Christian; Rossetti, Clara; Conboy, Lisa; Kohler, Lene B.; Fantin, Martina; Jennings, Alistair; Venero, Cesar; Popov, Victor; Rusakov, Dmitri; Stewart, Michael G.; Bock, Elisabeth; Berezin, Vladimir; Sandi, Carmen			A Peptide Mimetic Targeting Trans-Homophilic NCAM Binding Sites Promotes Spatial Learning and Neural Plasticity in the Hippocampus	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; POLYSIALIC ACID; DENTATE GYRUS; DENDRITIC SPINES; UP-REGULATION; COGNITIVE IMPAIRMENT; RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY	The key roles played by the neural cell adhesion molecule ( NCAM) in plasticity and cognition underscore this membrane protein as a relevant target to develop cognitive-enhancing drugs. However, NCAM is a structurally and functionally complex molecule with multiple domains engaged in a variety of actions, which raise the question as to which NCAM fragment should be targeted. Synthetic NCAM mimetic peptides that mimic NCAM sequences relevant to specific interactions allow identification of the most promising targets within NCAM. Recently, a decapeptide ligand of NCAM-plannexin, which mimics a homophilic trans-binding site in Ig2 and binds to Ig3-was developed as a tool for studying NCAM's trans-interactions. In this study, we investigated plannexin's ability to affect neural plasticity and memory formation. We found that plannexin facilitates neurite outgrowth in primary hippocampal neuronal cultures and improves spatial learning in rats, both under basal conditions and under conditions involving a deficit in a key plasticity-promoting posttranslational modification of NCAM, its polysialylation. We also found that plannexin enhances excitatory synaptic transmission in hippocampal area CA1, where it also increases the number of mushroom spines and the synaptic expression of the AMPAR subunits GluA1 and GluA2. Altogether, these findings provide compelling evidence that plannexin is an important facilitator of synaptic functional, structural and molecular plasticity in the hippocampal CA1 region, highlighting the fragment in NCAM's Ig3 module where plannexin binds as a novel target for the development of cognition-enhancing drugs.	[Kraev, Igor; Popov, Victor; Stewart, Michael G.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Henneberger, Christian; Jennings, Alistair; Rusakov, Dmitri] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Rossetti, Clara; Conboy, Lisa; Fantin, Martina; Sandi, Carmen] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland; [Kohler, Lene B.; Bock, Elisabeth; Berezin, Vladimir] Univ Copenhagen, Panum Inst, Prot Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Venero, Cesar] UNED, Dept Psychobiol, Madrid, Spain	Open University - UK; University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Copenhagen; Universidad Nacional de Educacion a Distancia (UNED)	Kraev, I (corresponding author), Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England.	m.g.stewart@open.ac.uk; carmen.sandi@epfl.ch	Henneberger, Christian/C-1557-2008; Venero, César/G-2789-2011; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021; Venero, César/AAP-7263-2021; Kraev, Igor V/J-2528-2015	Henneberger, Christian/0000-0002-5391-7387; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Venero, César/0000-0003-4879-3495; Kraev, Igor V/0000-0003-1822-278X; Sandi, Carmen/0000-0001-7713-8321	EU; Swiss Society for Neuroscience [310000-120791, CRSIK0-122697, CRSIK0-122691]; Swiss Federal Institute for Technology; MRC [G0802216, G0900613] Funding Source: UKRI; Medical Research Council [G0802216, G0900613] Funding Source: researchfish	EU(European Commission); Swiss Society for Neuroscience; Swiss Federal Institute for Technology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the EU 7th Framework Program (MemStick), the Swiss Society for Neuroscience (310000-120791; Sinergia CRSIK0-122697 and CRSIK0-122691) and by the Swiss Federal Institute for Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonurm-Helm A, 2008, EUR J NEUROSCI, V28, P1618, DOI 10.1111/j.1460-9568.2008.06471.x; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Belluardo N, 1997, J COMP NEUROL, V379, P226; Berezin V, 2004, J MOL NEUROSCI, V22, P33, DOI 10.1385/JMN:22:1-2:33; Bisaz R, 2011, HIPPOCAMPUS, V21, P56, DOI 10.1002/hipo.20723; Bisaz R, 2009, NEUROBIOL LEARN MEM, V91, P333, DOI 10.1016/j.nlm.2008.11.003; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; CHENG B, 1995, J NEUROCHEM, V65, P2525; Chernyshova Y, 2011, J NEUROSCI, V31, P3522, DOI 10.1523/JNEUROSCI.3109-10.2011; Conboy L, 2010, ADV EXP MED BIOL, V663, P271, DOI 10.1007/978-1-4419-1170-4_18; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; El Maarouf A, 2010, ADV EXP MED BIOL, V663, P137, DOI 10.1007/978-1-4419-1170-4_9; Fiala JC, 1998, J NEUROSCI, V18, P8900; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kohler LB, 2010, EUR J CELL BIOL, V89, P817, DOI 10.1016/j.ejcb.2010.07.007; Kohler LB, 2010, J NEUROSCI RES, V88, P2165, DOI 10.1002/jnr.22380; Liu Y, 2010, NAT NEUROSCI, V13, P223, DOI 10.1038/nn.2474; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Markram K, 2007, NEUROSCIENCE, V144, P788, DOI 10.1016/j.neuroscience.2006.10.024; Markram K, 2007, NEUROBIOL LEARN MEM, V87, P573, DOI 10.1016/j.nlm.2006.11.007; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Medvedev NI, 2010, NEUROSCIENCE, V165, P1170, DOI 10.1016/j.neuroscience.2009.11.047; Medvedev NI, 2008, EUR J NEUROSCI, V27, P315, DOI 10.1111/j.1460-9568.2007.06005.x; Merino JJ, 2000, EUR J NEUROSCI, V12, P3283, DOI 10.1046/j.1460-9568.2000.00191.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Murphy KJ, 1999, NEUROBIOL LEARN MEM, V72, P28, DOI 10.1006/nlme.1998.3894; Murphy KJ, 2001, J NEUROCHEM, V78, P704, DOI 10.1046/j.1471-4159.2001.00411.x; Narisawa-Saito M, 1999, P NATL ACAD SCI USA, V96, P2461, DOI 10.1073/pnas.96.5.2461; Ni Dhuill CM, 1999, J NEUROSCI RES, V55, P99, DOI 10.1002/(SICI)1097-4547(19990101)55:1<99::AID-JNR11>3.0.CO;2-S; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Popov VI, 2004, NEUROSCIENCE, V128, P251, DOI 10.1016/j.neuroscience.2004.06.029; Popov VI, 2008, EUR J NEUROSCI, V27, P301, DOI 10.1111/j.1460-9568.2007.06004.x; Potschka H, 2008, NEUROSCIENCE, V152, P1093, DOI 10.1016/j.neuroscience.2007.09.027; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rizhova L, 2007, NEUROSCIENCE, V149, P931, DOI 10.1016/j.neuroscience.2007.08.008; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Savtchouk I, 2011, J NEUROSCI, V31, P501, DOI 10.1523/JNEUROSCI.2608-10.2011; Schousboe A., 1989, DISSECTION TISSUE CU, P203; Scott R, 2006, J NEUROSCI, V26, P7071, DOI 10.1523/JNEUROSCI.0946-06.2006; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Sorra KE, 1998, J NEUROSCI, V18, P658; Stewart MG, 2005, EUR J NEUROSCI, V21, P3368, DOI 10.1111/j.1460-9568.2005.04174.x; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Vaithianathan T, 2004, J BIOL CHEM, V279, P47975, DOI 10.1074/jbc.M407138200; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Zhou M, 2009, EUR J NEUROSCI, V30, P1559, DOI 10.1111/j.1460-9568.2009.06951.x	73	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23433	10.1371/journal.pone.0023433	http://dx.doi.org/10.1371/journal.pone.0023433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887252	Green Published, Green Accepted, gold			2022-12-27	WOS:000295832000019
J	Krakauer, DC; Page, K; Flack, J				Krakauer, David C.; Page, Karen; Flack, Jessica			The Immuno-Dynamics of Conflict Intervention in Social Systems	PLOS ONE			English	Article							COOPERATION; PRIMATES; ROBUSTNESS; PUNISHMENT; RESOLUTION; SOCIETIES; EVOLUTION; COST	We present statistical evidence and dynamical models for the management of conflict and a division of labor (task specialization) in a primate society. Two broad intervention strategy classes are observed- a dyadic strategy - pacifying interventions, and a triadic strategy - policing interventions. These strategies, their respective degrees of specialization, and their consequences for conflict dynamics can be captured through empirically-grounded mathematical models inspired by immuno-dynamics. The spread of aggression, analogous to the proliferation of pathogens, is an epidemiological problem. We show analytically and computationally that policing is an efficient strategy as it requires only a small proportion of a population to police to reduce conflict contagion. Policing, but not pacifying, is capable of effectively eliminating conflict. These results suggest that despite implementation differences there might be universal features of conflict management mechanisms for reducing contagion-like dynamics that apply across biological and social levels. Our analyses further suggest that it can be profitable to conceive of conflict management strategies at the behavioral level as mechanisms of social immunity.	[Krakauer, David C.; Flack, Jessica] Santa Fe Inst, Santa Fe, NM 87501 USA; [Page, Karen] UCL, Dept Math, London, England; [Flack, Jessica] Yerkes Natl Primate Res Ctr, Atlanta, GA USA	The Santa Fe Institute; University of London; University College London	Krakauer, DC (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	krakauer@santafe.edu		Page, Karen/0000-0003-4189-4664	National Science Foundation [0904863]; National Institute for Mathematical and Biological Synthesis	National Science Foundation(National Science Foundation (NSF)); National Institute for Mathematical and Biological Synthesis	DK and JF acknowledge support from National Science Foundation grant 0904863 on network conflict theory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KP thanks the National Institute for Mathematical and Biological Synthesis for a sabbatical fellowship during which part of the work was completed.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F., 2000, NATURAL CONFLICT RES; Bergstrom CT, 2006, TRENDS ECOL EVOL, V21, P22, DOI 10.1016/j.tree.2005.11.008; Boehm C., 2010, SOCIAL PSYCHOL POWER; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Buss L., 1987, EVOLUTION INDIVIDUAL; Caldecott J., 1986, CONTRIBUTIONS PRIMAT, V21; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DeDeo S, 2011, J R SOC INTERFACE, V8, P1260, DOI 10.1098/rsif.2010.0687; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; Durkheim E, 1893, DIVISION LABOR SOC F; El Mouden C, 2010, EVOLUTION, V64, P2139, DOI 10.1111/j.1558-5646.2010.00963.x; Flack JC, 2006, AM NAT, V168, pE87, DOI 10.1086/506526; Flack J.C., 2004, MACAQUE SOC, P157; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Flack JC, 2007, P NATL ACAD SCI USA, V104, P1581, DOI 10.1073/pnas.0603565104; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Frank S, 2009, EVOLUTIONAR IN PRESS; Frank SA, 2003, EVOLUTION, V57, P693; Karzem AJN, 2005, ANIMAL COMMUNICATION; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Levin S, 2009, SPRINGER SER GAME TH, P143, DOI 10.1007/978-3-540-85436-4_8; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Michod RE, 2003, PNAS, V103, P9113; Nowak MA., 2000, VIRUS DYNAMICS MATH; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Snolnoki A, 2011, PHYS REV E, V83; Thierry Bernard, 2000, P106; Thiery B, 2004, MACAQUE SOC MODEL ST; Wahl LW, 2002, J THEOR BIOL, V250, P135; Wodarz D, 2000, VIROLOGY, V274, P94, DOI 10.1006/viro.2000.0399; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	41	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22709	10.1371/journal.pone.0022709	http://dx.doi.org/10.1371/journal.pone.0022709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887221	Green Submitted, Green Published, gold			2022-12-27	WOS:000295832000004
J	Dhurandhar, EJ; Dubuisson, O; Mashtalir, N; Krishnapuram, R; Hegde, V; Dhurandhar, NV				Dhurandhar, Emily J.; Dubuisson, Olga; Mashtalir, Nazar; Krishnapuram, Rashmi; Hegde, Vijay; Dhurandhar, Nikhil V.			E4orf1: A Novel Ligand That Improves Glucose Disposal in Cell Culture	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HUMAN ADENOVIRUS TYPE-36; INSULIN-RESISTANCE; PHOSPHATIDYLINOSITOL 3-KINASE; GLYCOGEN-SYNTHESIS; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; PI 3-KINASE; RAS; ADIPONECTIN	Reducing dietary fat intake and excess adiposity, the cornerstones of behavioral treatment of insulin resistance(IR), are marginally successful over the long term. Ad36, a human adenovirus, offers a template to improve IR, independent of dietary fat intake or adiposity. Ad36 increases cellular glucose uptake via a Ras-mediated activation of phosphatidyl inositol 3-kinase(PI3K), and improves hyperglycemia in mice, despite a high-fat diet and without reducing adiposity. Ex-vivo studies suggest that Ad36 improves hyperglycemia in mice by increasing glucose uptake by adipose tissue and skeletal muscle, and by reducing hepatic glucose output. It is impractical to use Ad36 for therapeutic action. Instead, we investigated if the E4orf1 protein of Ad36, mediates its anti-hyperglycemic action. Such a candidate protein may offer an attractive template for therapeutic development. Experiment-1 determined that Ad36 'requires' E4orf1 protein to up-regulate cellular glucose uptake. Ad36 significantly increased glucose uptake in 3T3-L1 preadipocytes, which was abrogated by knocking down E4orf1 with siRNA. Experiment-2 identified E4orf1 as 'sufficient' to up-regulate glucose uptake. 3T3-L1 cells that inducibly express E4orf1, increased glucose uptake in an induction-dependent manner, compared to null vector control cells. E4orf1 up-regulated PI3K pathway and increased abundance of Ras-the obligatory molecule in Ad36-induced glucose uptake. Experiment-3: Signaling studies of cells transiently transfected with E4orf1 or a null vector, revealed that E4orf1 may activate Ras/PI3K pathway by binding to Drosophila discs-large(Dlg1) protein. E4orf1 activated total Ras and, particularly the H-Ras isoform. By mutating the PDZ domain binding motif(PBM) of E4orf1, Experiment-4 showed that E4orf1 requires its PBM to increase Ras activation or glucose uptake. Experiment-5: In-vitro, a transient transfection by E4orf1 significantly increased glucose uptake in preadipocytes, adipocytes, or myoblasts, and reduced glucose output by hepatocytes. Thus, the highly attractive anti-hyperglycemic effect of Ad36 is mirrored by E4orf1 protein, which may offer a novel ligand to develop anti-hyperglycemic drugs.	[Dhurandhar, Emily J.; Dubuisson, Olga; Mashtalir, Nazar; Krishnapuram, Rashmi; Hegde, Vijay; Dhurandhar, Nikhil V.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dhurandhar, EJ (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA.	Nikhil.Dhurandhar@PBRC.edu			National Institutes of Health [R-01 DK066164]; Mathile Institute for the Advancement of Human Nutrition; COBRE (NIH) [P20-RR021945]; NORC (NIH) [1P30-DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066164, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathile Institute for the Advancement of Human Nutrition; COBRE (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded in part by grants by the National Institutes of Health (R-01 DK066164) and by The Mathile Institute for the Advancement of Human Nutrition, awarded to NVD. This work used Genomics core facilities at the Pennington Biomedical Research Center, which are supported in part by COBRE (NIH P20-RR021945) and NORC (NIH 1P30-DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson R. L, 2009, INT J PEDIATR OBES, P1, DOI DOI 10.1080/17477160903111789; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Crompton AM, 2007, CURR CANCER DRUG TAR, V7, P133; Dhurandhar NV, 2001, INT J OBESITY, V25, P990, DOI 10.1038/sj.ijo.0801668; Dhurandhar NV, 2002, J NUTR, V132, P3155, DOI 10.1093/jn/131.10.3155; Dhurandhar NV, 2000, INT J OBESITY, V24, P989, DOI 10.1038/sj.ijo.0801319; Dorrestijn J, 1996, DIABETOLOGIA, V39, P558, DOI 10.1007/s001250050478; Dorrestijn J, 1997, EXP CLIN ENDOCR DIAB, V105, P254, DOI 10.1055/s-0029-1211762; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Frese KK, 2003, ONCOGENE, V22, P710, DOI 10.1038/sj.onc.1206151; Gabbert C, 2010, PEDIATRICS, V126, P721, DOI 10.1542/peds.2009-3362; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; Heiker JT, 2010, BIOL CHEM, V391, P1005, DOI 10.1515/BC.2010.104; Home PD, 2008, DIABETES OBES METAB, V10, P699, DOI 10.1111/j.1463-1326.2007.00761.x; Houseknecht KL, 1996, J BIOL CHEM, V271, P11347, DOI 10.1074/jbc.271.19.11347; Katagiri H, 1997, AM J PHYSIOL-ENDOC M, V272, pE326, DOI 10.1152/ajpendo.1997.272.2.E326; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; KRISHNAPURAM R, AM J PHYSL ENDOCRINO; Libertini S, 2007, ENDOCRINOLOGY, V148, P5186, DOI 10.1210/en.2007-0752; Lin E, 2007, DIABETES, V56, P735, DOI 10.2337/db06-1161; Na HN, 2010, INT J OBESITY, V34, P89, DOI 10.1038/ijo.2009.207; Pagliassotti MJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE170, DOI 10.1152/ajpendo.2002.282.1.E170; Pan Q, 2007, MOL CELL BIOCHEM, V304, P315, DOI 10.1007/s11010-007-9514-6; Pasarica M, 2008, ARCH VIROL, V153, P2097, DOI 10.1007/s00705-008-0219-2; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Rogers PM, 2008, INT J OBESITY, V32, P397, DOI 10.1038/sj.ijo.0803748; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Semple RK, 2008, DIABETES CARE, V31, P977, DOI 10.2337/dc07-2194; Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Sesti G, 2001, DIABETES-METAB RES, V17, P363, DOI 10.1002/dmrr.225; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; Trovato GM, 2010, LIVER INT, V30, P184, DOI 10.1111/j.1478-3231.2009.02127.x; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313	46	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23394	10.1371/journal.pone.0023394	http://dx.doi.org/10.1371/journal.pone.0023394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886789	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500014
J	Park, JH; Magan, N				Park, Jeong Hyeon; Magan, Natisha			Reverse Transcriptase-Coupled Quantitative Real Time PCR Analysis of Cell-Free Transcription on the Chromatin-Assembled p21 Promoter	PLOS ONE			English	Article							RNA-POLYMERASE-II; IN-VITRO; P53; ACTIVATION; DROSOPHILA; INITIATION; BINDING; SYSTEM	Background: Cell-free eukaryotic transcription assays have contributed tremendously to the current understanding of the molecular mechanisms that govern transcription at eukaryotic promoters. Currently, the conventional G-less cassette transcription assay is one of the simplest and fastest methods for measuring transcription in vitro. This method requires several components, including the radioisotope labelling of RNA product during the transcription reaction followed by visualization of transcripts using autoradiography. Methodology/Principal Findings: To further simplify and expedite the conventional G-less cassette transcription assay, we have developed a method to incorporate a reverse transcriptase-coupled quantitative real time PCR (RT-qPCR). By using DNA template depletion steps that include DNA template immobilization, Trizol extraction and DNase I treatment, we have successfully enriched p21 promoter-driven transcripts over DNA templates. The quantification results of RNA transcripts using the RT-qPCR assay were comparable to the results of the conventional G-less cassette transcription assay both in naked DNA and chromatin-assembled templates. Conclusions: We first report a proof-of-concept demonstration that incorporating RT-qPCR in cell-free transcription assays can be a simpler and faster alternative method to the conventional radioisotope-mediated transcription assays. This method will be useful for developing high throughput in vitro transcription assays and provide quantitative data for RNA transcripts generated in a defined cell-free transcription reaction.	[Park, Jeong Hyeon; Magan, Natisha] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Park, JH (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	J.Park@massey.ac.nz		Park, Jeong Hyeon/0000-0003-2294-6342	Massey University	Massey University	This work was supported by 2011 Massey University Research Fund to JHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2004, METHOD ENZYMOL, V377, P460; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; BULGER M, 1995, P NATL ACAD SCI USA, V92, P11726, DOI 10.1073/pnas.92.25.11726; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; CAREY MF, 2010, COLD SPRING HARB PRO; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Guermah M, 2009, METHODS, V48, P353, DOI 10.1016/j.ymeth.2009.02.022; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; WEIL PA, 1979, CELL, V18, P469	16	5	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23617	10.1371/journal.pone.0023617	http://dx.doi.org/10.1371/journal.pone.0023617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886803	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500019
J	Ramos-Sevillano, E; Moscoso, M; Garcia, P; Garcia, E; Yuste, J				Ramos-Sevillano, Elisa; Moscoso, Miriam; Garcia, Pedro; Garcia, Ernesto; Yuste, Jose			Nasopharyngeal Colonization and Invasive Disease Are Enhanced by the Cell Wall Hydrolases LytB and LytC of Streptococcus pneumoniae	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; IMPAIRED OPSONIZATION; VIRULENCE FACTORS; GENOME SEQUENCE; COMPLEMENT; PEPTIDOGLYCAN; CHOLINE; PHAGOCYTOSIS; AUTOLYSIN; BINDING	Background\ Streptococcus pneumoniae is a common colonizer of the human nasopharynx and one of the major pathogens causing invasive disease worldwide. Dissection of the molecular pathways responsible for colonization, invasion, and evasion of the immune system will provide new targets for antimicrobial or vaccine therapies for this common pathogen. Methodology/Principal Findings: We have constructed mutants lacking the pneumococcal cell wall hydrolases (CWHs) LytB and LytC to investigate the role of these proteins in different phases of the pneumococcal pathogenesis. Our results show that LytB and LytC are involved in the attachment of S. pneumoniae to human nasopharyngeal cells both in vitro and in vivo. The interaction of both proteins with phagocytic cells demonstrated that LytB and LytC act in concert avoiding pneumococcal phagocytosis mediated by neutrophils and alveolar macrophages. Furthermore, C3b deposition was increased on the lytC mutant confirming that LytC is involved in complement evasion. As a result, the lytC mutant showed a reduced ability to successfully cause pneumococcal pneumonia and sepsis. Bacterial mutants lacking both LytB and LytC showed a dramatically impaired attachment to nasopharyngeal cells as well as a marked degree of attenuation in a mouse model of colonization. In addition, C3b deposition and phagocytosis was more efficient for the double lytB lytC mutant and its virulence was greatly impaired in both systemic and pulmonary models of infection. Conclusions/Significance: This study confirms that the CWHs LytB and LytC of S. pneumoniae are essential virulence factors involved in the colonization of the nasopharynx and in the progress of invasive disease by avoiding host immunity.	[Ramos-Sevillano, Elisa] CSIC, Ctr Invest Biol, Madrid, Spain; CIBER Enfermed Respiratorias CIBERES, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ramos-Sevillano, E (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	jyuste@isciii.es	Sevillano, Elisa Ramos/J-4824-2016; YUSTE, JOSE/ABG-9851-2020; García, Pedro/L-2808-2017	Sevillano, Elisa Ramos/0000-0003-0803-2755; García, Pedro/0000-0001-6717-8717; Moscoso, Miriam/0000-0001-8977-3269; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; YUSTE, JOSE/0000-0001-7996-0837	Direccion General de Investigacion Cientifica y Tecnica [SAF2009-10824]; Ministerio de Ciencia e Innovacion	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Partial support for these investigations was provided by grant SAF2009-10824 from Direccion General de Investigacion Cientifica y Tecnica. Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) is an initiative of the ISCIII. E.R-S. was supported by an FPU fellowship from the Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; AUSTRIAN R, 1953, J EXP MED, V98, P21, DOI 10.1084/jem.98.1.21; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Eldholm V, 2009, MICROBIOL-SGM, V155, P2223, DOI 10.1099/mic.0.026328-0; Fleck RA, 2005, CLIN DIAGN LAB IMMUN, V12, P19, DOI 10.1128/CDLI.12.1.19-27.2005; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kharat AS, 2006, MOL MICROBIOL, V60, P93, DOI 10.1111/j.1365-2958.2006.05082.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Moscoso M, 2005, APPL ENVIRON MICROB, V71, P8706, DOI 10.1128/AEM.71.12.8706-8713.2005; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2009, INT MICROBIOL, V12, P77, DOI 10.2436/20.1501.01.84; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Quin LR, 2007, INFECT IMMUN, V75, P4082, DOI 10.1128/IAI.00474-07; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Stegenga ME, 2009, CRIT CARE MED, V37, P614, DOI 10.1097/CCM.0b013e31819599b6; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Yuste J, 2010, MICROBES INFECT, V12, P626, DOI 10.1016/j.micinf.2010.04.004; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	50	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23626	10.1371/journal.pone.0023626	http://dx.doi.org/10.1371/journal.pone.0023626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886805	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500021
J	Wu, D; Li, GX; Qin, CF; Ren, XF				Wu, Dan; Li, Guangxing; Qin, Chengfeng; Ren, Xiaofeng			Phage Displayed Peptides to Avian H5N1 Virus Distinguished the Virus from Other Viruses	PLOS ONE			English	Article							INFLUENZA-VIRUS; LIBRARY; ANTIBODY; ASSAY	The purpose of the current study was to identify potential ligands and develop a novel diagnostic test to highly pathogenic avian influenza A virus (HPAI), subtype H5N1 viruses using phage display technology. The H5N1 viruses were used as an immobilized target in a biopanning process using a 12-mer phage display random peptide library. After five rounds of panning, three phages expressing peptides HAWDPIPARDPF, AAWHLIVALAPN or ATSHLHVRLPSK had a specific binding activity to H5N1 viruses were isolated. Putative binding motifs to H5N1 viruses were identified by DNA sequencing. In terms of the minimum quantity of viruses, the phage-based ELISA was better than antiserum-based ELISA and a manual, semi-quantitative endpoint RT-PCR for detecting H5N1 viruses. More importantly, the selected phages bearing the specific peptides to H5N1 viruses were capable of differentiating this virus from other avian viruses in enzyme-linked immunosorbent assays.	[Wu, Dan; Ren, Xiaofeng] NE Agr Univ, Dept Vet Prevent Med, Coll Vet Med, Harbin, Peoples R China; [Li, Guangxing] NE Agr Univ, Dept Basic Vet Med, Coll Vet Med, Harbin, Peoples R China; [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China; Beijing Institute of Microbiology & Epidemiology	Wu, D (corresponding author), NE Agr Univ, Dept Vet Prevent Med, Coll Vet Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807	National 973 Plan of China [2010CB534002]; National Natural Science Foundation of China [30972195]; Heilongjiang Provincial University [1155-NCET-005]; Heilongjiang Provincial Science and Technology Department, China [ZJN0702-01]	National 973 Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial University; Heilongjiang Provincial Science and Technology Department, China	This work was supported, in part, by the National 973 Plan of China (2010CB534002). We also acknowledge National Natural Science Foundation of China (30972195), the Program for New Century Excellent Talents in Heilongjiang Provincial University (1155-NCET-005) and Heilongjiang Provincial Science and Technology Department, China (ZJN0702-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN H, 2008, CHIN ANIMAL HUSBANDR, V35, P120; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Fouchier R, 2005, NATURE, V435, P419, DOI 10.1038/435419a; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Guo JianShun, 2004, Chinese Journal of Veterinary Science, V24, P534; Hayden MS, 1997, CURR OPIN IMMUNOL, V9, P201, DOI 10.1016/S0952-7915(97)80136-7; Kang SK, 2008, J BIOTECHNOL, V135, P210, DOI 10.1016/j.jbiotec.2008.01.021; Kang XP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-113; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Latzka J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019383; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YinJu, 2008, Chinese Journal of Veterinary Science, V28, P511; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019848; Matsubara T, 2009, J MED CHEM, V52, P4247, DOI 10.1021/jm801570y; Ren XF, 2011, VIROLOGY, V410, P299, DOI 10.1016/j.virol.2010.11.014; Ren XF, 2010, J CLIN MICROBIOL, V48, P1875, DOI 10.1128/JCM.01707-09; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; WANG J, 2011, CHIN ANIMAL HUSBANDR, V38, P178; WANG Q, 2011, HUNAN ANIMAL SCI VET, V1, P20; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, EP PAND AL RESP EPR; Yingst SL, 2006, EMERG INFECT DIS, V12, P1295, DOI 10.3201/eid1708.060264; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; ZENG Q, 2010, HUNAN ANIMAL SCI VET, V1, P3; Zhao JQ, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-74	28	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23058	10.1371/journal.pone.0023058	http://dx.doi.org/10.1371/journal.pone.0023058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887228	Green Published, gold, Green Submitted			2022-12-27	WOS:000294251800007
J	Hamer, GL; Chaves, LF; Anderson, TK; Kitron, UD; Brawn, JD; Ruiz, MO; Loss, SR; Walker, ED; Goldberg, TL				Hamer, Gabriel L.; Chaves, Luis F.; Anderson, Tavis K.; Kitron, Uriel D.; Brawn, Jeffrey D.; Ruiz, Marilyn O.; Loss, Scott R.; Walker, Edward D.; Goldberg, Tony L.			Fine-Scale Variation in Vector Host Use and Force of Infection Drive Localized Patterns of West Nile Virus Transmission	PLOS ONE			English	Article							POPULATION-DYNAMICS; ECOLOGICAL TRAPS; MOSQUITO; DISEASE; BIODIVERSITY; DIVERSITY; DESIGN; PREVALENCE; RESERVOIRS; CULICIDAE	The influence of host diversity on multi-host pathogen transmission and persistence can be confounded by the large number of species and biological interactions that can characterize many transmission systems. For vector-borne pathogens, the composition of host communities has been hypothesized to affect transmission; however, the specific characteristics of host communities that affect transmission remain largely unknown. We tested the hypothesis that vector host use and force of infection (i.e., the summed number of infectious mosquitoes resulting from feeding upon each vertebrate host within a community of hosts), and not simply host diversity or richness, determine local infection rates of West Nile virus (WNV) in mosquito vectors. In suburban Chicago, Illinois, USA, we estimated community force of infection for West Nile virus using data on Culex pipiens mosquito host selection and WNV vertebrate reservoir competence for each host species in multiple residential and semi-natural study sites. We found host community force of infection interacted with avian diversity to influence WNV infection in Culex mosquitoes across the study area. Two avian species, the American robin (Turdus migratorius) and the house sparrow (Passer domesticus), produced 95.8% of the infectious Cx. pipiens mosquitoes and showed a significant positive association with WNV infection in Culex spp. mosquitoes. Therefore, indices of community structure, such as species diversity or richness, may not be reliable indicators of transmission risk at fine spatial scales in vector-borne disease systems. Rather, robust assessment of local transmission risk should incorporate heterogeneity in vector host feeding and variation in vertebrate reservoir competence at the spatial scale of vector-host interaction.	[Hamer, Gabriel L.; Anderson, Tavis K.; Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Chaves, Luis F.; Kitron, Uriel D.] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Chaves, Luis F.] Univ Nacl, Programa Invest Enfermedades Trop, Escuela Med Vet, Heredia, Costa Rica; [Chaves, Luis F.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Chaves, Luis F.] Hokkaido Univ, Global Ctr Excellence Program Integrated Field &, Sapporo, Hokkaido, Japan; [Brawn, Jeffrey D.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Ruiz, Marilyn O.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Loss, Scott R.] Univ Minnesota, St Paul, MN 55108 USA; [Hamer, Gabriel L.; Walker, Edward D.] Michigan State Univ, Dept Microbiol & Mol Genet, Lansing, MI USA	University of Wisconsin System; University of Wisconsin Madison; Emory University; Universidad Nacional Costa Rica; Hokkaido University; Hokkaido University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University	Hamer, GL (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	ghamer@msu.edu	Loss, Scott R/B-1504-2014; Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764; Kitron, Uriel/0000-0003-0493-2043; Loss, Scott/0000-0002-8753-2995; Anderson, Tavis/0000-0002-3138-5535	National Science Foundation [EF-0840403]; Michigan Agricultural Experiment Station; Agricultural Research Service [NE-507]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [10F00392] Funding Source: KAKEN	National Science Foundation(National Science Foundation (NSF)); Michigan Agricultural Experiment Station; Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by the National Science Foundation Ecology of Infectious Diseases Program, award no. EF-0840403, and the Michigan Agricultural Experiment Station and the Agricultural Research Service, multi-state project NE-507. LFC is funded by Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; ANDERSON R M, 1991; Anderson RA, 1999, ECOL LETT, V2, P98, DOI 10.1046/j.1461-0248.1999.22055.x; Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Begon Michael, 2008, P12; Biggerstaff B.J., 2006, POOLEDINFRATE VERSIO; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Celli A, 1933, HIST MALARIA ROMAN C; Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003; Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; CORBET PS, 1966, ARCTIC, V19, P153; Darbro JM, 2007, AM J TROP MED HYG, V77, P488, DOI 10.4269/ajtmh.2007.77.488; Darbro JM, 2007, BEHAV ECOL, V18, P750, DOI 10.1093/beheco/arm043; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; Ezenwa VO, 2007, VECTOR-BORNE ZOONOT, V7, P173, DOI 10.1089/vbz.2006.0584; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250; Griffing SM, 2007, VECTOR-BORNE ZOONOT, V7, P437, DOI 10.1089/vbz.2006.0560; Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Koenig WD, 2010, OECOLOGIA, V163, P903, DOI 10.1007/s00442-010-1627-z; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Loss SR, 2009, OECOLOGIA, V159, P415, DOI 10.1007/s00442-008-1224-6; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manly B.F.J., 2002, RESOURCE SELECTION A; McKenzie VJ, 2010, ECOHEALTH, V7, P439, DOI 10.1007/s10393-010-0360-8; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Platt KB, 2008, VECTOR-BORNE ZOONOT, V8, P225, DOI 10.1089/vbz.2007.0182; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; R Core Team, 2018, R LANG ENV STAT COMP; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	57	97	100	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23767	10.1371/journal.pone.0023767	http://dx.doi.org/10.1371/journal.pone.0023767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886821	Green Published, gold, Green Submitted			2022-12-27	WOS:000294128100030
J	Santini, V; Girelli, D; Sanna, A; Martinelli, N; Duca, L; Campostrini, N; Cortelezzi, A; Corbella, M; Bosi, A; Reda, G; Olivieri, O; Cappellini, MD				Santini, Valeria; Girelli, Domenico; Sanna, Alessandro; Martinelli, Nicola; Duca, Lorena; Campostrini, Natascia; Cortelezzi, Agostino; Corbella, Michela; Bosi, Alberto; Reda, Gianluigi; Olivieri, Oliviero; Cappellini, Maria Domenica			Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes	PLOS ONE			English	Article							IRON OVERLOAD; URINARY; QUANTIFICATION; CLASSIFICATION; INFLAMMATION; EXPRESSION; EXCRETION; CRITERIA; ANEMIA; HEART	Iron overload may represent an additional clinical problem in patients with Myelodysplastic Syndromes (MDS), with recent data suggesting prognostic implications. Beyond red blood cells transfusions, dysregulation of hepcidin, the key iron hormone, may play a role, but studies until now have been hampered by technical problems. Using a recently validated assay, we measured serum hepcidin in 113 patients with different MDS subtypes. Mean hepcidin levels were consistently heterogeneous across different MDS subtypes, with the lowest levels in refractory anemia with ringed sideroblasts (RARS, 1.43 nM) and the highest in refractory anemia with excess blasts (RAEB, 11.3 nM) or in chronic myelomonocytic leukemia (CMML, 10.04 nM) (P = 0.003 by ANOVA). MDS subtypes remained significant predictors of hepcidin in multivariate analyses adjusted for ferritin and transfusion history. Consistently with current knowledge on hepcidin action/regulation, RARS patients had the highest levels of toxic non-transferrin-bound-iron, while RAEB and CMML patients had substantial elevation of C-Reactive Protein as compared to other MDS subtypes, and showed lost of homeostatic regulation by iron. Growth differentiation factor 15 did not appear as a primary hepcidin regulator in this series. If confirmed, these results may help to calibrate future treatments with chelating agents and/or hepcidin modulators in MDS patients.	[Santini, Valeria; Sanna, Alessandro; Bosi, Alberto] Univ Florence, Hematol Unit, AOU Careggi, Florence, Italy; [Girelli, Domenico; Martinelli, Nicola; Campostrini, Natascia; Corbella, Michela; Olivieri, Oliviero] Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy; [Duca, Lorena; Cappellini, Maria Domenica] Univ Milan, Dept Internal Med, Ca Granda Fdn IRCCS, Milan, Italy; [Cortelezzi, Agostino; Reda, Gianluigi] Univ Milan, Hematol Unit 1, Ca Granda Fdn IRCCS, Milan, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Santini, V (corresponding author), Univ Florence, Hematol Unit, AOU Careggi, Florence, Italy.	domenico.girelli@univr.it	Nava, Isabella/AAA-7747-2020; Duca, Lorena/AAV-5773-2021; SANTINI, VALERIA/AAL-3135-2020; Martinelli, Nicola/J-5622-2016; CAPPELLINI, MARIA DOMENICA/B-4475-2017; Reda, Gianluigi/J-8127-2015	Nava, Isabella/0000-0003-4106-0088; SANTINI, VALERIA/0000-0002-5439-2172; GIRELLI, Domenico/0000-0001-9684-1899; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; Martinelli, Nicola/0000-0001-6465-5119; olivieri, oliviero/0000-0001-8209-9056; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864; Duca, Lorena/0000-0002-2008-3187; BOSI, ALBERTO/0000-0002-5486-4838; Reda, Gianluigi/0000-0003-4687-7089	Telethon Foundation (Rome, Italy) [GGP06213]; Cariverona Foundation (Verona, Italy)	Telethon Foundation (Rome, Italy)(Fondazione Telethon); Cariverona Foundation (Verona, Italy)(Fondazione Cariverona)	This work was supported by Telethon Foundation (Rome, Italy) Grants GGP06213 and the Cariverona Foundation (Verona, Italy) to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand P, 2011, BIOL BLOOD MARROW TR, V17, P852, DOI 10.1016/j.bbmt.2010.09.006; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bennett JM, 2008, AM J HEMATOL, V83, P858, DOI 10.1002/ajh.21269; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bozzini C, 2008, BLOOD CELL MOL DIS, V40, P347, DOI 10.1016/j.bcmd.2007.10.001; Breda L, 2007, BLOOD, V110, p225B, DOI 10.1182/blood.V110.11.4612.4612; BUJA LM, 1971, AM J MED, V51, P209, DOI 10.1016/0002-9343(71)90240-3; Campostrini N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/329646; Castagna A, 2010, J PROTEOMICS, V73, P527, DOI 10.1016/j.jprot.2009.08.003; Cazzola Mario, 2008, Hematology Am Soc Hematol Educ Program, P166, DOI 10.1182/asheducation-2008.1.166; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cortelezzi A, 2000, Hematol J, V1, P153, DOI 10.1038/sj.thj.6200028; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fenaux P, 2009, BLOOD REV, V23, pS15, DOI 10.1016/S0268-960X(09)70005-0; FINCH CA, 1982, NEW ENGL J MED, V306, P1520, DOI 10.1056/NEJM198206243062504; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gattermann N, 2007, LEUKEMIA RES, V31, pS10, DOI 10.1016/S0145-2126(07)70461-7; Girelli D, 2010, HAEMATOLOGICA, V96, P500, DOI DOI 10.3324/HAEMAT0L.2010.033449.EPUB; Gosriwatana I, 1999, ANAL BIOCHEM, V273, P212, DOI 10.1006/abio.1999.4216; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kempf T, 2009, CIRC-CARDIOVASC GENE, V2, P286, DOI 10.1161/CIRCGENETICS.108.824870; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Malcovati L, 2006, HAEMATOLOGICA, V91, P1588; Mariani R, 2008, BRIT J HAEMATOL, V143, DOI 10.1111/j.1365-2141.2008.07397.x; Murphy PT, 2009, BRIT J HAEMATOL, V144, P451, DOI 10.1111/j.1365-2141.2008.07455.x; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, HAEMATOLOGICA, V91, P727; Piperno A, 1998, HAEMATOLOGICA, V83, P447; Poli M, 2011, BLOOD, V117, P997, DOI 10.1182/blood-2010-06-289082; Porter JB, 2005, ANN NY ACAD SCI, V1054, P155, DOI 10.1196/annals.1345.018; Pullarkat V, 2009, BLOOD, V114, P5251, DOI 10.1182/blood-2009-07-234062; Ramirez JM, 2009, BRIT J HAEMATOL, V144, P251, DOI 10.1111/j.1365-2141.2008.07441.x; Rose C, 2010, LEUKEMIA RES, V34, P864, DOI 10.1016/j.leukres.2009.12.004; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; TRAGLIA M, 2011, J MED GENET IN PRESS; Valenti L, 2009, CLIN J AM SOC NEPHRO, V4, P1331, DOI 10.2215/CJN.01370209; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Winder A, 2008, BRIT J HAEMATOL, V142, P669, DOI 10.1111/j.1365-2141.2008.07225.x; Zaidi SHE, 2010, J AM COLL CARDIOL, V55, P135, DOI 10.1016/j.jacc.2009.08.041	49	82	115	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23109	10.1371/journal.pone.0023109	http://dx.doi.org/10.1371/journal.pone.0023109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886780	Green Published, gold, Green Submitted			2022-12-27	WOS:000294128100007
J	Villarreal-Silva, M; Centeno-Cruz, F; Suarez-Sanchez, R; Garrido, E; Cisneros, B				Villarreal-Silva, Marcela; Centeno-Cruz, Federico; Suarez-Sanchez, Rocio; Garrido, Efrain; Cisneros, Bulmaro			Knockdown of Dystrophin Dp71 Impairs PC12 Cells Cycle: Localization in the Spindle and Cytokinesis Structures Implies a Role for Dp71 in Cell Division	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; DEPENDENT TRANSCRIPTION; PHEOCHROMOCYTOMA CELLS; NONMUSCLE TISSUES; SKELETAL-MUSCLE; MAJOR PRODUCT; LAMIN-A; GENE; DUCHENNE	The function of dystrophin Dp71 in neuronal cells remains to be established. Previously, we revealed the involvement of this protein in both nerve growth factor (NGF)-induced neuronal differentiation and cell adhesion by isolation and characterization of PC12 neuronal cells with depleted levels of Dp71. In this work, a novel phenotype of Dp71-knockdown cells was characterized, which is their delayed growth rate. Cell cycle analyses revealed an altered behavior of Dp71-depleted cells, which consists of a delay in G0/G1 transition and an increase in apoptosis during nocodazole-induced mitotic arrest. Dp71 associates with lamin B1 and beta-dystroglycan, proteins involved in aspects of the cell division cycle; therefore, we compared the distribution of Dp71 with that of lamin B1 and beta-dystroglycan in PC12 cells at mitosis and cytokinesis by means of immunofluorescence and confocal microscopy analysis. All of these three proteins exhibited a similar immunostaining pattern, localized at mitotic spindle, cleavage furrow, and midbody. It is noteworthy that a drastic decreased staining in mitotic spindle, cleavage furrow, and midbody was observed for both lamin B1 and beta-dystroglycan in Dp71-depleted cells. Furthermore, we demonstrated the interaction of Dp71 with lamin B1 in PC12 cells by immunoprecipitation and pull-down assays, and importantly, we revealed that knockdown of Dp71 expression caused a marked reduction in lamin B1 levels and altered localization of the nuclear envelope protein emerin. Our data indicate that Dp71 is a component of the mitotic spindle and cytokinesis multi-protein apparatuses that might modulate the cell division cycle by affecting lamin B1 and beta-dystroglycan levels.	[Villarreal-Silva, Marcela; Centeno-Cruz, Federico; Suarez-Sanchez, Rocio; Garrido, Efrain; Cisneros, Bulmaro] Ctr Invest & Estudios Avanzados IPN CINVESTAV IPN, Dept Genet & Mol Biol, Mexico City, DF, Mexico; [Centeno-Cruz, Federico] Inst Nacl Med Genom, Lab Enfermedades Complejas, Mexico City, DF, Mexico; [Suarez-Sanchez, Rocio] Inst Nacl Rehabil, Dept Genet, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Nacional de Medicina Genomica	Villarreal-Silva, M (corresponding author), Ctr Invest & Estudios Avanzados IPN CINVESTAV IPN, Dept Genet & Mol Biol, Mexico City, DF, Mexico.	bcisnero@cinvestav.mx		Centeno Cruz, Federico/0000-0002-3512-4519	CONACYT-Mexico [54858, 183964]	CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACYT-Mexico, grant 54858 (to Dr. Cisneros) and grant 183964 for PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta R, 2004, EXP CELL RES, V296, P265, DOI 10.1016/j.yexcr.2004.01.015; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Cerna J, 2006, J MOL BIOL, V362, P954, DOI 10.1016/j.jmb.2006.07.075; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; DIAZBARRIGA F, 1989, TOXICOL IN VITRO, V3, P277, DOI 10.1016/0887-2333(89)90034-9; Eaton MJ, 2004, MOL CELL ENDOCRINOL, V228, P39, DOI 10.1016/j.mce.2003.02.001; Endo K, 2010, FEBS LETT, V584, P2387, DOI 10.1016/j.febslet.2010.04.029; Enriquez-Aragon JA, 2005, NEUROREPORT, V16, P235; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; FUJITA K, 1989, ENVIRON HEALTH PERSP, V80, P127, DOI 10.2307/3430738; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Gojo I, 2002, CLIN CANCER RES, V8, P3527; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Higginson JR, 2008, INT J BIOCHEM CELL B, V40, P892, DOI 10.1016/j.biocel.2007.10.019; Holder E, 1996, HUM GENET, V97, P232, DOI 10.1007/BF02265272; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kutay U, 2008, CURR OPIN CELL BIOL, V20, P669, DOI 10.1016/j.ceb.2008.09.010; LEDERFEIN D, 1993, HUM MOL GENET, V2, P1883, DOI 10.1093/hmg/2.11.1883; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; Long BH, 1998, CANCER RES, V58, P1111; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; Martin C, 2010, CHROMOSOME RES, V18, P525, DOI 10.1007/s10577-010-9137-8; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Rivier F, 1999, HISTOCHEM J, V31, P425, DOI 10.1023/A:1003805905456; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; SUNADA Y, 1995, CURR OPIN NEUROL, V8, P379, DOI 10.1097/00019052-199510000-00010; Tanaka K, 2009, CANCER SCI, V100, P1158, DOI 10.1111/j.1349-7006.2009.01178.x; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Villarreal-Silva M, 2010, NEUROCHEM RES, V35, P366, DOI 10.1007/s11064-009-0064-z	45	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23504	10.1371/journal.pone.0023504	http://dx.doi.org/10.1371/journal.pone.0023504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886794	gold, Green Submitted, Green Published			2022-12-27	WOS:000294128100016
J	Gao, W; Xu, LJ; Guan, R; Liu, XX; Han, YX; Wu, Q; Xiao, Y; Qi, F; Zhu, ZY; Lin, S; Zhang, B				Gao, Wei; Xu, Linjie; Guan, Rui; Liu, Xinxing; Han, Yuxiang; Wu, Qian; Xiao, Yi; Qi, Fei; Zhu, Zuoyan; Lin, Shuo; Zhang, Bo			Wdr18 Is Required for Kupffer's Vesicle Formation and Regulation of Body Asymmetry in Zebrafish	PLOS ONE			English	Article							PROTEIN-KINASE-C; LATERALITY ORGAN; BETA-SUBUNIT; NO TAIL; GENE; CELLS; EMBRYO; BRAIN; IDENTIFICATION; SPECIFICATION	Correct specification of the left-right (L-R) axis is important for organ morphogenesis. Conserved mechanisms involving cilia rotation inside node-like structures and asymmetric Nodal signaling in the lateral plate mesoderm (LPM), which are important symmetry-breaking events, have been intensively studied. In zebrafish, the clustering and migration of dorsal forerunner cells (DFCs) is critical for the formation of the Kuppfer's vesicle (KV). However, molecular events underlying DFC clustering and migration are less understood. The WD-repeat proteins function in a variety of biological processes, including cytoskeleton assembly, intracellular trafficking, mRNA splicing, transcriptional regulation and cell migration. However, little is known about the function of WD-repeat proteins in L-R asymmetry determination. Here, we report the identification and functional analyses of zebrafish wdr18, a novel gene that encodes a WD-repeat protein that is highly conserved among vertebrate species. wdr18 was identified from a Tol2 transposon-mediated enhancer trap screen. Follow-up analysis of wdr18 mRNA expression showed that it was detected in DFCs or the KV progenitor cells and later in the KV at early somitogenesis stages. Morpholino knockdown of wdr18 resulted in laterality defects in the visceral organs, which were preceded by the mis-expression of Nodal-related genes, including spaw and pitx2. Examination of morphants at earlier stages revealed that the KV had fewer and shorter cilia which are immotile and a smaller cavity. We further investigated the organization of DFCs in wdr18 morphant embryos using ntl and sox17 as specific markers and found that the clustering and migration of DFC was altered, leading to a disorganized KV. Finally, through a combination of wdr18 and itgb1b morpholino injections, we provided evidence that wdr18 and itgb1b genetically interact in the laterality determination process. Thus, we reveal a new and essential role for WD-repeat proteins in the determination and regulation of L-R asymmetry and propose a potential mechanism for wdr18 in the regulation of DFC clustering and migration and KV formation.	[Gao, Wei; Xu, Linjie; Guan, Rui; Liu, Xinxing; Han, Yuxiang; Wu, Qian; Xiao, Yi; Qi, Fei; Zhu, Zuoyan; Lin, Shuo; Zhang, Bo] Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University of California System; University of California Los Angeles	Gao, W (corresponding author), Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China.	shuolin@ucla.edu; bzhang@pku.edu.cn	Zhang, Bo/K-7162-2012		NSFC [30730056]; 973 program [2007CB914502]	NSFC(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This work was partially supported by grants from NSFC (30730056) and 973 program (2007CB914502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aamar E, 2010, DEV DYNAM, V239, P2980, DOI 10.1002/dvdy.22431; Ablooglu AJ, 2010, DEVELOPMENT, V137, P3449, DOI 10.1242/dev.045310; Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Cooper MS, 1996, DEV BIOL, V180, P184, DOI 10.1006/dbio.1996.0294; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Furtado MB, 2008, GENE DEV, V22, P3037, DOI 10.1101/gad.1682108; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Monsoro-Burq AH, 2001, MOL CELL, V7, P789, DOI 10.1016/S1097-2765(01)00223-4; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Oteiza P, 2010, DEVELOPMENT, V137, P3459, DOI 10.1242/dev.049981; Rietzler M, 1998, J BIOL CHEM, V273, P27459, DOI 10.1074/jbc.273.42.27459; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; THISSE C, 1993, DEVELOPMENT, V119, P1203; Yamauchi H, 2009, DEV BIOL, V332, P177, DOI 10.1016/j.ydbio.2009.05.568; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016	37	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23386	10.1371/journal.pone.0023386	http://dx.doi.org/10.1371/journal.pone.0023386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876750	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900022
J	Iguchi, A; Shirai, H; Seto, K; Ooka, T; Ogura, Y; Hayashi, T; Osawa, K; Osawa, R				Iguchi, Atsushi; Shirai, Hiroki; Seto, Kazuko; Ooka, Tadasuke; Ogura, Yoshitoshi; Hayashi, Tetsuya; Osawa, Kayo; Osawa, Ro			Wide Distribution of O157-Antigen Biosynthesis Gene Clusters in Escherichia coli	PLOS ONE			English	Article							PCR-BASED DETECTION; SALMONELLA-TYPHIMURIUM; CHAIN-LENGTH; SEQUENCE; STRAINS; O157; IDENTIFICATION; PREVALENCE; VIRULENCE; DNA	Most Escherichia coli O157-serogroup strains are classified as enterohemorrhagic E. coli (EHEC), which is known as an important food-borne pathogen for humans. They usually produce Shiga toxin (Stx) 1 and/or Stx2, and express H7-flagella antigen (or nonmotile). However, O157 strains that do not produce Stxs and express H antigens different from H7 are sometimes isolated from clinical and other sources. Multilocus sequence analysis revealed that these 21 O157:non-H7 strains tested in this study belong to multiple evolutionary lineages different from that of EHEC O157:H7 strains, suggesting a wide distribution of the gene set encoding the O157-antigen biosynthesis in multiple lineages. To gain insight into the gene organization and the sequence similarity of the O157-antigen biosynthesis gene clusters, we conducted genomic comparisons of the chromosomal regions (about 59 kb in each strain) covering the O-antigen gene cluster and its flanking regions between six O157:H7/non-H7 strains. Gene organization of the O157-antigen gene cluster was identical among O157:H7/non-H7 strains, but was divided into two distinct types at the nucleotide sequence level. Interestingly, distribution of the two types did not clearly follow the evolutionary lineages of the strains, suggesting that horizontal gene transfer of both types of O157-antigen gene clusters has occurred independently among E. coli strains. Additionally, detailed sequence comparison revealed that some positions of the repetitive extragenic palindromic (REP) sequences in the regions flanking the O-antigen gene clusters were coincident with possible recombination points. From these results, we conclude that the horizontal transfer of the O157-antigen gene clusters induced the emergence of multiple O157 lineages within E. coli and speculate that REP sequences may involve one of the driving forces for exchange and evolution of O-antigen loci.	[Iguchi, Atsushi] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Shirai, Hiroki; Osawa, Kayo] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo 657, Japan; [Seto, Kazuko] Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Osaka 537, Japan; [Ooka, Tadasuke; Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Microbiol, Miyazaki, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioenvironm Sci, Miyazaki, Japan; [Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Kobe, Hyogo, Japan	University of Miyazaki; Kobe University; Osaka Prefectural Institute of Public Health; University of Miyazaki; University of Miyazaki; Kobe University	Iguchi, A (corresponding author), Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan.	iguchi@med.miyazaki-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020	, Atsushi/0000-0003-3826-7520	Japanese Ministry of Education, Culture, Sports, Science and Technology [21790424]; University of Miyazaki, Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Miyazaki, Japan	This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 21790424), the Special Coordination Fund for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and a Grant-in-Aid for Scientific Research on Priority Areas from the University of Miyazaki, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellier S, 1997, GENETICS, V145, P551; Bertrand R, 2007, WATER RES, V41, P1280, DOI 10.1016/j.watres.2006.11.027; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; CHART H, 1993, J INFECTION, V27, P237, DOI 10.1016/0163-4453(93)91952-L; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; ENGELHORN N, 1995, NUCLEIC ACIDS RES, V23, P2959, DOI 10.1093/nar/23.15.2959; Feng PCH, 2010, FEMS MICROBIOL LETT, V308, P62, DOI 10.1111/j.1574-6968.2010.01990.x; FRANKE J, 1994, J CLIN MICROBIOL, V32, P2460, DOI 10.1128/JCM.32.10.2460-2463.1994; GILSON E, 1990, NUCLEIC ACIDS RES, V18, P3941, DOI 10.1093/nar/18.13.3941; GUNZBURG ST, 1995, J CLIN MICROBIOL, V33, P1375, DOI 10.1128/JCM.33.5.1375-1377.1995; Guo HJ, 2005, APPL ENVIRON MICROB, V71, P7995, DOI 10.1128/AEM.71.12.7995-8001.2005; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HIGGINS CF, 1982, NATURE, V298, P760, DOI 10.1038/298760a0; Iguchi A, 2007, CURR MICROBIOL, V54, P14, DOI 10.1007/s00284-006-0139-x; KARCH H, 1993, J CLIN MICROBIOL, V31, P1200, DOI 10.1128/JCM.31.5.1200-1205.1993; Kobayashi H, 2001, APPL ENVIRON MICROB, V67, P484, DOI 10.1128/AEM.67.1.484-489.2001; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Makino S, 1999, MICROBIOL IMMUNOL, V43, P381, DOI 10.1111/j.1348-0421.1999.tb02419.x; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEWBURY SF, 1987, CELL, V48, P297, DOI 10.1016/0092-8674(87)90433-8; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Samuel G, 2004, J BACTERIOL, V186, P6536, DOI 10.1128/JB.186.19.6536-6543.2004; Scheutz F, 2004, APMIS, V112, P569, DOI 10.1111/j.1600-0463.2004.apm1120903.x; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Shimizu T, 1999, MICROB PATHOGENESIS, V26, P235, DOI 10.1006/mpat.1998.0253; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054, DOI 10.1128/JCM.33.5.1054-1059.1995; Stephan R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-10; STERN MJ, 1988, MOL MICROBIOL, V2, P141, DOI 10.1111/j.1365-2958.1988.tb00015.x; STERN MJ, 1984, CELL, V37, P1015, DOI 10.1016/0092-8674(84)90436-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; WILLSHAW GA, 1994, J CLIN MICROBIOL, V32, P897, DOI 10.1128/JCM.32.4.897-902.1994; YANG Y, 1988, P NATL ACAD SCI USA, V85, P8850, DOI 10.1073/pnas.85.23.8850; Yatsuyanagi J, 2002, J CLIN MICROBIOL, V40, P294, DOI 10.1128/JCM.40.1.294-297.2002; Zhang WL, 2002, J CLIN MICROBIOL, V40, P4486, DOI 10.1128/JCM.40.12.4486-4492.2002	40	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23250	10.1371/journal.pone.0023250	http://dx.doi.org/10.1371/journal.pone.0023250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876740	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900012
J	Forment, JV; Blasius, M; Guerini, I; Jackson, SP				Forment, Josep V.; Blasius, Melanie; Guerini, Ilaria; Jackson, Stephen P.			Structure-Specific DNA Endonuclease Mus81/Eme1 Generates DNA Damage Caused by Chk1 Inactivation	PLOS ONE			English	Article							REPLICATION FORK PROGRESSION; VERTEBRATE S-PHASE; CHECKPOINT FUNCTION; GENOME INTEGRITY; ATR; KINASE; ROLES; CONTRIBUTES; INITIATION; RESTART	The DNA-damage checkpoint kinase Chk1 is essential in higher eukaryotes due to its role in maintaining genome stability in proliferating cells. CHK1 gene deletion is embryonically lethal, and Chk1 inhibition in replicating cells causes cell-cycle defects that eventually lead to perturbed replication and replication-fork collapse, thus generating endogenous DNA damage. What is the cause of replication-fork collapse when Chk1 is inactivated, however, remains poorly understood. Here, we show that generation of DNA double-strand breaks at replication forks when Chk1 activity is compromised relies on the DNA endonuclease complex Mus81/Eme1. Importantly, we show that Mus81/Eme1-dependent DNA damage-rather than a global increase in replication-fork stalling-is the cause of incomplete replication in Chk1-deficient cells. Consequently, Mus81/Eme1 depletion alleviates the S-phase progression defects associated with Chk1 deficiency, thereby increasing cell survival. Chk1-mediated protection of replication forks from Mus81/Eme1 even under otherwise unchallenged conditions is therefore vital to prevent uncontrolled fork collapse and ensure proper S-phase progression in human cells.	[Forment, Josep V.; Blasius, Melanie; Guerini, Ilaria; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Gurdon Inst, Cambridge CB2 1QW, England	University of Cambridge	Forment, JV (corresponding author), Univ Cambridge, Dept Biochem, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QW, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Forment, Josep/J-3678-2015	Jackson, Stephen Philip/0000-0001-9317-7937; Forment, Josep/0000-0002-7797-2583; Blasius, Melanie/0000-0001-5032-2209	Cancer Research UK [C6/A11226]; European Community; Wellcome Trust; University of Cambridge; Swiss National Foundation; Cancer Research UK [11224] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Community(European Commission); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Cancer Research UK(Cancer Research UK)	Research in the Jackson Lab is supported by grants from Cancer Research UK (C6/A11226) and the European Community's Seventh Framework Program (GENICA and DDResponse) and by core infrastructure funding provided by Cancer Research UK and the Wellcome Trust. SPJ receives his salary from the University of Cambridge, supplemented by Cancer Research UK. MB is funded by a Swiss National Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Froget B, 2008, MOL BIOL CELL, V19, P445, DOI 10.1091/mbc.E07-07-0728; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Scorah J, 2009, CELL CYCLE, V8, P1036, DOI 10.4161/cc.8.7.8040; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	29	80	81	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23517	10.1371/journal.pone.0023517	http://dx.doi.org/10.1371/journal.pone.0023517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858151	gold, Green Submitted, Green Published			2022-12-27	WOS:000294121300056
J	Hadjidimitrakis, K; Breveglieri, R; Placenti, G; Bosco, A; Sabatini, SP; Fattori, P				Hadjidimitrakis, Kostas; Breveglieri, Rossella; Placenti, Giacomo; Bosco, Annalisa; Sabatini, Silvio P.; Fattori, Patrizia			Fix Your Eyes in the Space You Could Reach: Neurons in the Macaque Medial Parietal Cortex Prefer Gaze Positions in Peripersonal Space	PLOS ONE			English	Article							VISUAL AREA V6; PARIETOOCCIPITAL CORTEX; DISTANCE PERCEPTION; 3-DIMENSIONAL SPACE; FIXATION-DISTANCE; BRAIN LOCATION; FMRI REVEALS; MONKEY; MOVEMENTS; REPRESENTATION	Interacting in the peripersonal space requires coordinated arm and eye movements to visual targets in depth. In primates, the medial posterior parietal cortex (PPC) represents a crucial node in the process of visual-to-motor signal transformations. The medial PPC area V6A is a key region engaged in the control of these processes because it jointly processes visual information, eye position and arm movement related signals. However, to date, there is no evidence in the medial PPC of spatial encoding in three dimensions. Here, using single neuron recordings in behaving macaques, we studied the neural signals related to binocular eye position in a task that required the monkeys to perform saccades and fixate targets at different locations in peripersonal and extrapersonal space. A significant proportion of neurons were modulated by both gaze direction and depth, i. e., by the location of the foveated target in 3D space. The population activity of these neurons displayed a strong preference for peripersonal space in a time interval around the saccade that preceded fixation and during fixation as well. This preference for targets within reaching distance during both target capturing and fixation suggests that binocular eye position signals are implemented functionally in V6A to support its role in reaching and grasping.	[Hadjidimitrakis, Kostas; Breveglieri, Rossella; Placenti, Giacomo; Bosco, Annalisa; Fattori, Patrizia] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Sabatini, Silvio P.] Univ Genoa, Dept Biophys & Elect Engn, Genoa, Italy	University of Bologna; University of Genoa	Hadjidimitrakis, K (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy.	patrizia.fattori@unibo.it	Sabatini, Silvio P/A-5500-2012; Fattori, Patrizia/Q-8947-2017; breveglieri, rossella/C-2014-2014	Sabatini, Silvio P/0000-0002-0557-7306; Fattori, Patrizia/0000-0002-0079-3755; breveglieri, rossella/0000-0001-5059-1441; BOSCO, ANNALISA/0000-0003-3032-9571	European Union [FP7-ICT-217077-'EYESHOTS']; Italian Ministry of Education; University and Research (MIUR); Fondazione del Monte di Bologna e Ravenna, Italy	European Union(European Commission); Italian Ministry of Education; University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna e Ravenna, Italy(Fondazione del Monte di Bologna e Ravenna)	This work was supported by the European Union (FP7-ICT-217077-'EYESHOTS', www.eyeshots.it), Italian Ministry of Education, University and Research (MIUR,www.miur.it), Fondazione del Monte di Bologna e Ravenna, Italy (www.fondazionedelmonte.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2005, J NEUROPHYSIOL, V93, P2415, DOI 10.1152/jn.01028.2004; Baylis GC, 2001, NEUROPSYCHOLOGIA, V39, P865, DOI 10.1016/S0028-3932(01)00009-4; BHATTACHARYYA R, 2009, J NEUROPHYSIOL; Breveglieri R, 2002, NEUROREPORT, V13, P2113, DOI 10.1097/00001756-200211150-00024; Brozzoli C, 2010, NEUROPSYCHOLOGIA, V48, P796, DOI 10.1016/j.neuropsychologia.2009.10.009; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; CRITCHLEY M, 1953, BRAIN, V76, P19, DOI 10.1093/brain/76.1.19; Culham J. C., 2008, EMBODIMENT EGO SPACE, P247; Danckert J, 2009, EXP BRAIN RES, V195, P183, DOI 10.1007/s00221-009-1766-9; Dounskaia N, 2011, EXP BRAIN RES, V209, P299, DOI 10.1007/s00221-011-2547-9; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Fattori P, 2009, J NEUROSCI, V29, P1928, DOI 10.1523/JNEUROSCI.4998-08.2009; FOLEY JM, 1980, PSYCHOL REV, V87, P411, DOI 10.1037/0033-295X.87.5.411; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; Gamberini M, 2011, J NEUROSCI, V31, P5145, DOI 10.1523/JNEUROSCI.5489-10.2011; Gamberini M, 2009, J COMP NEUROL, V513, P622, DOI 10.1002/cne.21980; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Henriques DYP, 2003, EXP BRAIN RES, V152, P70, DOI 10.1007/s00221-003-1523-4; Karnath HO, 1997, PHILOS T ROY SOC B, V352, P1411, DOI 10.1098/rstb.1997.0127; Kutz DF, 2005, J NEUROPHYSIOL, V93, P3674, DOI 10.1152/jn.01292.2004; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; Mon-Williams M, 1999, EXP BRAIN RES, V128, P578, DOI 10.1007/s002210050885; Moody SL, 1998, J COGNITIVE NEUROSCI, V10, P35, DOI 10.1162/089892998563761; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; PELISSON D, 1986, EXP BRAIN RES, V62, P303; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; POUGET A, 1994, CEREB CORTEX, V4, P314, DOI 10.1093/cercor/4.3.314; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Trotter Y, 1996, J NEUROPHYSIOL, V76, P2872, DOI 10.1152/jn.1996.76.5.2872; Vernet M, 2008, INVEST OPHTH VIS SCI, V49, P230, DOI 10.1167/iovs.07-0854; Viguier A, 2001, PERCEPTION, V30, P115, DOI 10.1068/p3119; Williams AL, 2010, J NEUROPHYSIOL, V104, P2169, DOI 10.1152/jn.00713.2009; YGGE J, 1995, VISION RES, V35, P3169, DOI 10.1016/0042-6989(95)00125-J	54	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23335	10.1371/journal.pone.0023335	http://dx.doi.org/10.1371/journal.pone.0023335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858075	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300036
J	Kakazu, E; Ueno, Y; Kondo, Y; Inoue, J; Ninomiya, M; Kimura, O; Wakui, Y; Fukushima, K; Tamai, K; Shimosegawa, T				Kakazu, Eiji; Ueno, Yoshiyuki; Kondo, Yasuteru; Inoue, Jun; Ninomiya, Masashi; Kimura, Osamu; Wakui, Yuta; Fukushima, Koji; Tamai, Keiichi; Shimosegawa, Tooru			Plasma L-Cystine/L-Glutamate Imbalance Increases Tumor Necrosis Factor-Alpha from CD14+Circulating Monocytes in Patients with Advanced Cirrhosis	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; DENDRITIC CELLS; LIVER-DISEASE; EX-VIVO; INTERLEUKIN-6; EXPRESSION; MATURATION; CYSTEINE	Background and Aims: The innate immune cells can not normally respond to the pathogen in patients with decompensated cirrhosis. Previous studies reported that antigen-presenting cells take up L-Cystine (L-Cys) and secrete substantial amounts of L-Glutamate (L-Glu) via the transport system Xc-(4F2hc+xCT), and that this exchange influences the immune responses. The aim of this study is to investigate the influence of the plasma L-Cys/L-Glu imbalance observed in patients with advanced cirrhosis on the function of circulating monocytes. Methods: We used a serum-free culture medium consistent with the average concentrations of plasma amino acids from patients with advanced cirrhosis (ACM), and examined the function of CD14+ monocytes or THP-1 under ACM that contained 0-300 nmol/mL L-Cys with LPS. In patients with advanced cirrhosis, we actually determined the TNF-alpha and xCT mRNA of monocytes, and evaluated the correlation between the plasma L-Cys/L-Glu ratio and TNF-alpha. Results: The addition of L-Cys significantly increased the production of TNF alpha from monocytes under ACM. Monocytes with LPS and THP-1 expressed xCT and a high level of extracellular L-Cys enhanced L-Cys/L-Glu antiport, and the intracellular GSH/GSSG ratio was decreased. The L-Cys transport was inhibited by excess L-Glu. In patients with advanced cirrhosis (n = 19), the TNF-alpha and xCT mRNA of monocytes were increased according to the Child-Pugh grade. The TNF-alpha mRNA of monocytes was significantly higher in the high L-Cys/L-Glu ratio group than in the low ratio group, and the plasma TNF-alpha was significantly correlated with the L-Cys/L-Glu ratio. Conclusions: A plasma L-Cys/L-Glu imbalance, which appears in patients with advanced cirrhosis, increased the TNF-alpha from circulating monocytes via increasing the intracellular oxidative stress. These results may reflect the immune abnormality that appears in patients with decompensated cirrhosis.	[Kakazu, Eiji; Ueno, Yoshiyuki; Kondo, Yasuteru; Inoue, Jun; Ninomiya, Masashi; Kimura, Osamu; Wakui, Yuta; Fukushima, Koji; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 980, Japan; [Tamai, Keiichi] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan	Tohoku University; Miyagi Cancer Center	Kakazu, E (corresponding author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 980, Japan.	yueno@med.tohoku.ac.jp	Tamai, Keiichi/AAW-8261-2021; Ueno, Yoshiyuki/R-9242-2019; Kondo, Yasuteru/A-6893-2010; Inoue, Jun/S-9282-2019	Ueno, Yoshiyuki/0000-0001-5623-4250; Kondo, Yasuteru/0000-0001-5935-4346; Inoue, Jun/0000-0003-1171-7835; Tamai, Keiichi/0000-0003-0813-5885	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23790762]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to EK (23790762), and by Health and Labour Sciences Research Grants for the Research on Measures for Intractable Diseases (from the Ministry of Health, Labour and Welfare of Japan) to YU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNAI S, 1980, J BIOL CHEM, V255, P2372; BYL B, 1993, GASTROENTEROLOGY, V104, P1492, DOI 10.1016/0016-5085(93)90361-F; D'Angelo JA, 2010, J IMMUNOL, V185, P3217, DOI 10.4049/jimmunol.1001199; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; ECK HP, 1989, BIOL CHEM H-S, V370, P109, DOI 10.1515/bchm3.1989.370.1.109; Galbois A, 2009, HEPATOLOGY, V49, P175, DOI 10.1002/hep.22582; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Gustot T, 2009, HEPATOLOGY, V50, P2022, DOI 10.1002/hep.23264; Iyer SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005017; Kakazu E, 2007, J IMMUNOL, V179, P7137, DOI 10.4049/jimmunol.179.10.7137; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MORGAN MY, 1982, GUT, V23, P362, DOI 10.1136/gut.23.5.362; Navasa M, 1998, HEPATOLOGY, V27, P1227, DOI 10.1002/hep.510270507; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Riordan SM, 2003, HEPATOLOGY, V37, P1154, DOI 10.1053/jhep.2003.50180; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Ubeda M, 2010, HEPATOLOGY, V52, P2086, DOI 10.1002/hep.23961; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; WALSHE JM, 1955, J CLIN INVEST, V34, P302, DOI 10.1172/JCI103083	26	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23402	10.1371/journal.pone.0023402	http://dx.doi.org/10.1371/journal.pone.0023402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858100	Green Submitted, gold, Green Published			2022-12-27	WOS:000294121300043
J	Lee, JY; Lee, YM; Chang, GC; Yu, SL; Hsieh, WY; Chen, JJW; Chen, HW; Yang, PC				Lee, Jen-Yi; Lee, Yee-Ming; Chang, Gee-Chen; Yu, Sung-Liang; Hsieh, Wan-Yu; Chen, Jeremy J. W.; Chen, Huei-Wen; Yang, Pan-Chyr			Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; PREVIOUSLY TREATED PATIENTS; TYROSINE KINASE-ACTIVITY; FACTOR-KAPPA-B; GENE-EXPRESSION; PROSTATE-CANCER; IN-VITRO; MUTATIONS; INHIBITION; RESISTANCE	Background: Non-small cell lung cancer (NSCLC) patients with L858R or exon 19 deletion mutations in epidermal growth factor receptor (EGFR) have good responses to the tyrosine kinase inhibitor (TKI), gefitinib. However, patients with wild-type EGFR and acquired mutation in EGFR T790M are resistant to gefitinib treatment. Here, we showed that curcumin can improve the efficiency of gefitinib in the resistant NSCLC cells both in vitro and in vivo models. Methods/Principal Findings: After screening 598 herbal and natural compounds, we found curcumin could inhibit cell proliferation in different gefitinib-resistant NSCLC cell lines; concentration-dependently down-regulate EGFR phosphorylation through promoting EGFR degradation in NSCLC cell lines with wild-type EGFR or T790M EGFR. In addition, the antitumor activity of gefitinib was potentiated via curcumin through blocking EGFR activation and inducing apoptosis in gefitinib-resistant NSCLC cell lines; also the combined treatment with curcumin and gefitinib exhibited significant inhibition in the CL1-5, A549 and H1975 xenografts tumor growth in SCID mice through reducing EGFR, c-MET, cyclin D1 expression, and inducing apoptosis activation through caspases-8, 9 and PARP. Interestingly, we observed that the combined treatment group represented better survival rate and less intestinal mucosal damage compare to gefitinib-alone therapy. We showed that curcumin attenuated the gefitinib-induced cell proliferation inhibition and apoptosis through altering p38 mitogen-activated protein kinase (MAPK) activation in intestinal epithelia cell. Conclusions/Significance: Curcumin potentiates antitumor activity of gefitinib in cell lines and xenograft mice model of NSCLC through inhibition of proliferation, EGFR phosphorylation, and induction EGFR ubiquitination and apoptosis. In addition, curcumin attenuates gefitinib-induced gastrointestinal adverse effects via altering p38 activation. These findings provide a novel treatment strategy that curcumin as an adjuvant to increase the spectrum of the usage of gefitinib and overcome the gefitinib inefficiency in NSCLC patients.	[Lee, Jen-Yi; Lee, Yee-Ming; Hsieh, Wan-Yu] Natl Yang Ming Univ, Sch Med, Dept Pharmacol, Taipei 112, Taiwan; [Lee, Jen-Yi; Lee, Yee-Ming; Hsieh, Wan-Yu] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lee, Jen-Yi; Lee, Yee-Ming; Hsieh, Wan-Yu; Chen, Huei-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chang, Gee-Chen; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Coll Life Sci, Inst Biomed Sci, Taichung 40227, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; Taichung Veterans General Hospital; National Chung Hsing University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, JY (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Pharmacol, Taipei 112, Taiwan.	shwchen@ntu.edu.tw		CHEN, HUEI-WEN/0000-0001-5051-9896; YU, SUNG-LIANG/0000-0003-4535-9036; YANG, PAN-CHYR/0000-0001-6330-6048; Chen, Jeremy J.W./0000-0003-1049-3825	National Science Council [NSC95-2314-B-002-340-MY3]; Department of Health, Taiwan [DOH100-TD-B-111-001]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	This work was supported by grants from the National Science Council (NSC95-2314-B-002-340-MY3) and the Department of Health, Taiwan (DOH100-TD-B-111-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Arteaga CL, 2007, NAT MED, V13, P675, DOI 10.1038/nm0607-675; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914; Chen HW, 2004, MOL PHARMACOL, V65, P99, DOI 10.1124/mol.65.1.99; Cheng AL, 2001, ANTICANCER RES, V21, P2895; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Dorai T, 2000, MOL UROL, V4, P1; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Epstein J, 2010, BRIT J NUTR, V103, P824, DOI 10.1017/S0007114509992510; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Giommarelli C, 2010, CELL MOL LIFE SCI, V67, P995, DOI 10.1007/s00018-009-0233-x; Hong RL, 1999, CLIN CANCER RES, V5, P1884; Howells LM, 2007, INT J CANCER, V121, P175, DOI 10.1002/ijc.22645; HUANG MT, 1991, CANCER RES, V51, P813; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Judde JG, 2007, INT J CANCER, V120, P1579, DOI 10.1002/ijc.22364; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kari C, 2003, CANCER RES, V63, P1; Kim SY, 2005, BIOCHEM BIOPH RES CO, V337, P510, DOI 10.1016/j.bbrc.2005.09.079; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kokubo Y, 2005, BRIT J CANCER, V92, P1711, DOI 10.1038/sj.bjc.6602559; KORUTLA L, 1995, CARCINOGENESIS, V16, P1741, DOI 10.1093/carcin/16.8.1741; KORUTLA L, 1994, BBA-MOL CELL RES, V1224, P597, DOI 10.1016/0167-4889(94)90299-2; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Levitzki A, 2003, LUNG CANCER, V41, pS9, DOI 10.1016/S0169-5002(03)00134-X; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Patel BB, 2008, INT J CANCER, V122, P267, DOI 10.1002/ijc.23097; Perez-Soler R, 2004, ONCOLOGIST, V9, P58, DOI 10.1634/theoncologist.9-1-58; Reck M, 2005, RESP MED, V99, P298, DOI 10.1016/j.rmed.2004.08.009; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; Sheng G, 2007, AM J PHYSIOL-GASTR L, V293, pG599, DOI 10.1152/ajpgi.00182.2007; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Song WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012969; Sung B, 2009, MOL CANCER THER, V8, P959, DOI 10.1158/1535-7163.MCT-08-0905; Thangapazham RL, 2008, INT J ONCOL, V32, P1119; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Vansteenkiste Johan, 2004, Expert Rev Anticancer Ther, V4, P5, DOI 10.1586/14737140.4.1.5; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wu SG, 2008, ONCOLOGIST, V13, P1276, DOI 10.1634/theoncologist.2008-0093	62	75	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23756	10.1371/journal.pone.0023756	http://dx.doi.org/10.1371/journal.pone.0023756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858220	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300093
J	Scharadin, TM; Jiang, HB; Jans, R; Rorke, EA; Eckert, RL				Scharadin, Tiffany M.; Jiang, Haibing; Jans, Ralph; Rorke, Ellen A.; Eckert, Richard L.			TIG3 Tumor Suppressor-Dependent Organelle Redistribution and Apoptosis in Skin Cancer Cells	PLOS ONE			English	Article							TRANSGLUTAMINASE CROSS-LINKING; MITOGEN-ACTIVATED-KINASE; KERATINOCYTE TRANSGLUTAMINASE; DOWN-REGULATION; RETINOIC ACID; IN-VIVO; GENE; RIG1; DIFFERENTIATION; EXPRESSION	TIG3 is a tumor suppressor protein that limits keratinocyte survival during normal differentiation. It is also important in cancer, as TIG3 level is reduced in tumors and in skin cancer cell lines, suggesting that loss of expression may be required for cancer cell survival. An important goal is identifying how TIG3 limits cell survival. In the present study we show that TIG3 expression in epidermal squamous cell carcinoma SCC-13 cells reduces cell proliferation and promotes morphological and biochemical apoptosis. To identify the mechanism that drives these changes, we demonstrate that TIG3 localizes near the centrosome and that pericentrosomal accumulation of TIG3 alters microtubule and microfilament organization and organelle distribution. Organelle accumulation at the centrosome is a hallmark of apoptosis and we demonstrate that TIG3 promotes pericentrosomal organelle accumulation. These changes are associated with reduced cyclin D1, cyclin E and cyclin A, and increased p21 level. In addition, Bax level is increased and Bcl-XL level is reduced, and cleavage of procaspase 3, procaspase 9 and PARP is enhanced. We propose that pericentrosomal localization of TIG3 is a key event that results in microtubule and microfilament redistribution and pericentrosomal organelle clustering and that leads to cancer cell apoptosis.	[Scharadin, Tiffany M.; Jiang, Haibing; Jans, Ralph; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Rorke, Ellen A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Jans, Ralph/F-2150-2013		National Institutes of Health [NIH R01 AR094713, NIH R01 AR04694]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants to RE (NIH R01 AR094713 and NIH R01 AR04694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aslan JE, 2009, TRAFFIC, V10, P1390, DOI 10.1111/j.1600-0854.2009.00951.x; BROWN WJ, 1984, CELL, V36, P295, DOI 10.1016/0092-8674(84)90223-X; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; CHAKRAVARTY R, 1989, J BIOL CHEM, V264, P625; Cheong JW, 2010, CANCER LETT, V297, P171, DOI 10.1016/j.canlet.2010.05.009; DEGLI EM, 2008, METHOD ENZYMOL, V442, P421; Degli Esposti M, 2009, MOL BIOL CELL, V20, P600, DOI 10.1091/mbc.E08-09-0925; Deucher A, 2000, INT J ONCOL, V17, P1195; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Duvic M, 2003, J INVEST DERMATOL, V121, P902, DOI 10.1046/j.1523-1747.2003.12488.x; Duvic M, 2000, CLIN CANCER RES, V6, P3249; Duvic M, 1997, J AM ACAD DERMATOL, V37, pS18; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; HAJNAL A, 1994, ONCOGENE, V9, P479; Han BG, 2010, PROTEIN EXPRES PURIF, V71, P103, DOI 10.1016/j.pep.2010.01.018; Higuchi E, 2003, ONCOGENE, V22, P4627, DOI 10.1038/sj.onc.1206235; Huang SL, 2002, ANTICANCER RES, V22, P799; Huang SL, 2000, MOL CELL ENDOCRINOL, V159, P15, DOI 10.1016/S0303-7207(99)00207-5; Husmann K, 1998, ONCOGENE, V17, P1305, DOI 10.1038/sj.onc.1202060; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; Jiang SY, 2005, BIOCHEM BIOPH RES CO, V331, P630, DOI 10.1016/j.bbrc.2005.03.214; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; KIM SY, 1995, J INVEST DERMATOL, V104, P211, DOI 10.1111/1523-1747.ep12612769; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Lim HH, 2009, TRENDS CELL BIOL, V19, P325, DOI 10.1016/j.tcb.2009.03.008; Lotz K, 2005, INT J CANCER, V116, P894, DOI 10.1002/ijc.21127; Matarrese P, 2008, BIOCHEM J, V413, P467, DOI 10.1042/BJ20071704; Nozawa K, 2009, CELL BIOL INT, V33, P148, DOI 10.1016/j.cellbi.2008.10.016; OGAWA H, 1976, J BIOL CHEM, V251, P7281; Ou CC, 2008, CARCINOGENESIS, V29, P299, DOI 10.1093/carcin/bgm263; Ouasti S, 2007, CELL DEATH DIFFER, V14, P453, DOI 10.1038/sj.cdd.4402043; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Rice R H, 1988, Adv Exp Med Biol, V231, P51; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1990, BIOCHEM J, V265, P351, DOI 10.1042/bj2650351; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Sesso A, 1999, TISSUE CELL, V31, P357, DOI 10.1054/tice.1999.0042; Shyu RY, 2005, ANTICANCER RES, V25, P2453; Simmons DP, 2006, CARCINOGENESIS, V27, P693, DOI 10.1093/carcin/bgi235; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Steinert PM, 1999, CELL DEATH DIFFER, V6, P916, DOI 10.1038/sj.cdd.4400568; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; TA BM, 1990, J CELL SCI, V95, P631; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Tsai FM, 2006, CELL SIGNAL, V18, P349, DOI 10.1016/j.cellsig.2005.05.005; Tsai FM, 2007, CELL SIGNAL, V19, P989, DOI 10.1016/j.cellsig.2006.11.005; Tsai FM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-15; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200	55	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23230	10.1371/journal.pone.0023230	http://dx.doi.org/10.1371/journal.pone.0023230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858038	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300021
J	Van Hoeck, V; Sturmey, RG; Bermejo-Alvarez, P; Rizos, D; Gutierrez-Adan, A; Leese, HJ; Bols, PEJ; Leroy, JLMR				Van Hoeck, Veerle; Sturmey, Roger G.; Bermejo-Alvarez, Pablo; Rizos, Dimitrios; Gutierrez-Adan, Alfonso; Leese, Henry J.; Bols, Peter E. J.; Leroy, Jo L. M. R.			Elevated Non-Esterified Fatty Acid Concentrations during Bovine Oocyte Maturation Compromise Early Embryo Physiology	PLOS ONE			English	Article							BODY-MASS INDEX; IN-VITRO; PREIMPLANTATION DEVELOPMENT; GLUCOSE-TRANSPORTER; INDUCE APOPTOSIS; INFERTILE WOMEN; PALMITIC ACID; STEARIC-ACID; METABOLISM; OBESITY	Elevated concentrations of serum non-esterified fatty acids (NEFA), associated with maternal disorders such as obesity and type II diabetes, alter the ovarian follicular micro-environment and have been associated with subfertility arising from reduced oocyte developmental competence. We have asked whether elevated NEFA concentrations during oocyte maturation affect the development and physiology of zygotes formed from such oocytes, using the cow as a model. The zygotes were grown to blastocysts, which were evaluated for their quality in terms of cell number, apoptosis, expression of key genes, amino acid turnover and oxidative metabolism. Oocyte maturation under elevated NEFA concentrations resulted in blastocysts with significantly lower cell number, increased apoptotic cell ratio and altered mRNA abundance of DNMT3A, IGF2R and SLC2A1. In addition, the blastocysts displayed reduced oxygen, pyruvate and glucose consumption, up-regulated lactate consumption and higher amino acid metabolism. These data indicate that exposure of maturing oocytes to elevated NEFA concentrations has a negative impact on fertility not only through a reduction in oocyte developmental capacity but through compromised early embryo quality, viability and metabolism.	[Van Hoeck, Veerle; Bols, Peter E. J.; Leroy, Jo L. M. R.] Univ Antwerp, Lab Vet Physiol & Biochem, Dept Vet Sci, Fac Biomed Pharmaceut & Vet Sci, Antwerp, Belgium; [Sturmey, Roger G.; Leese, Henry J.] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Bermejo-Alvarez, Pablo; Rizos, Dimitrios; Gutierrez-Adan, Alfonso] INIA, Dept Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain	University of Antwerp; University of Hull; University of York - UK	Van Hoeck, V (corresponding author), Univ Antwerp, Lab Vet Physiol & Biochem, Dept Vet Sci, Fac Biomed Pharmaceut & Vet Sci, Antwerp, Belgium.	veerle.vanhoeck@ua.ac.be	Leroy, Jo/AAC-1791-2020; Gutierrez-Adan, Alfonso/A-1485-2014; Rizos, Dimitrios/E-7058-2012	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; Rizos, Dimitrios/0000-0001-6813-3940; Sturmey, Roger/0000-0003-4423-5058; Bermejo-Alvarez, Pablo/0000-0001-9907-2626; Bols, Peter/0000-0003-0432-8719	Flemish Research Fund (FWO) [1106910N]; GEMINI COST ACTION [FA0702]; Spanish Ministry of Science and Innovation (AGA) [AGL2009-11358, AGL2009-11810]; Special Research Fund (BOF-UA: JLMRL); MRC [G0802556] Funding Source: UKRI; Medical Research Council [G0802556] Funding Source: researchfish	Flemish Research Fund (FWO)(FWO); GEMINI COST ACTION; Spanish Ministry of Science and Innovation (AGA)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Special Research Fund (BOF-UA: JLMRL); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded by the Flemish Research Fund (FWO grant 1106910N: VVH), GEMINI COST ACTION FA0702 (short mission scientific stay in HJL's lab), the Spanish Ministry of Science and Innovation (AGA by Grant AGL2009-11358; DR by Grant AGL2009-11810) and the Special Research Fund (BOF-UA: JLMRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDEMA H, 2011, BIOL REPROD IN PRESS; Anderiesz C, 2000, HUM REPROD, V15, P1140, DOI 10.1093/humrep/15.5.1140; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Campbell BK, 2003, REPRODUCTION, P429; Clark AM, 1998, HUM REPROD, V13, P1502, DOI 10.1093/humrep/13.6.1502; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; Fedorcsak P, 2000, ACTA OBSTET GYN SCAN, V79, P43, DOI 10.1034/j.1600-0412.2000.079001043.x; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Harding EA, 1999, PFLUG ARCH EUR J PHY, V438, P397, DOI 10.1007/s004240050927; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Humpherson PG, 2005, THERIOGENOLOGY, V64, P1852, DOI 10.1016/j.theriogenology.2005.04.019; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jorritsma R, 2004, ANIM REPROD SCI, V81, P225, DOI 10.1016/j.anireprosci.2003.10.005; KAKINUMA K, 1978, BIOCHIM BIOPHYS ACTA, V538, P50, DOI 10.1016/0304-4165(78)90251-9; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; Lane M, 2000, BIOL REPROD, V62, P16, DOI 10.1095/biolreprod62.1.16; LASH NM, 2009, FERTIL STERIL, V91, P12; Latham KE, 1998, DEVELOPMENT, V125, P929; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; Leroy JLMR, 2010, HUM REPROD, V25, P768, DOI 10.1093/humrep/dep420; Leroy JLMR, 2005, REPRODUCTION, V130, P485, DOI 10.1530/rep.1.00735; LEVESQUE JT, 1995, MOL REPROD DEV, V42, P114, DOI 10.1002/mrd.1080420115; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lopes AS, 2007, HUM REPROD, V22, P558, DOI 10.1093/humrep/del404; Lopes AS, 2005, REPRODUCTION, V130, P669, DOI 10.1530/rep.1.00703; Lu ZH, 2003, BIOCHEM BIOPH RES CO, V303, P1002, DOI 10.1016/S0006-291X(03)00449-2; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Menezo YJR, 2000, THERIOGENOLOGY, V53, P599, DOI 10.1016/S0093-691X(99)00260-5; Metwally M, 2007, REPROD BIOMED ONLINE, V15, P532, DOI 10.1016/S1472-6483(10)60385-9; Minge CE, 2008, ENDOCRINOLOGY, V149, P2646, DOI 10.1210/en.2007-1570; Mooradian AD, 2008, OBESITY, V16, P1152, DOI 10.1038/oby.2008.202; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; NAVARA CS, 1995, THERIOGENOLOGY, V44, P1099, DOI 10.1016/0093-691X(95)00323-Z; Pantaleon M, 1997, P NATL ACAD SCI USA, V94, P3795, DOI 10.1073/pnas.94.8.3795; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; SIRARD MA, 1989, BIOL REPROD, V40, P1257, DOI 10.1095/biolreprod40.6.1257; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; STOLBA P, 1993, ANN NY ACAD SCI, V683, P373, DOI 10.1111/j.1749-6632.1993.tb35738.x; Sturmey RG, 2010, MOL REPROD DEV, V77, P285, DOI 10.1002/mrd.21145; Sturmey RG, 2009, HUM REPROD, V24, P81, DOI 10.1093/humrep/den346; Sviderskaya EV, 1996, J MEMBRANE BIOL, V149, P133, DOI 10.1007/s002329900014; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.1471-4159.2003.01571.x; van der Steeg JW, 2008, HUM REPROD, V23, P324, DOI 10.1093/humrep/dem371; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; VanBlerkom J, 1995, HUM REPROD UPDATE, V1, P429, DOI 10.1093/humupd/1.5.429; Vandaele L, 2008, ANIM REPROD SCI, V106, P168, DOI 10.1016/j.anireprosci.2007.12.016; Vandaele L, 2006, THERIOGENOLOGY, V65, P1691, DOI 10.1016/j.theriogenology.2005.09.014; Vanholder T, 2005, ANIM REPROD SCI, V87, P33, DOI 10.1016/j.anireprosci.2004.09.006; Watson AJ, 1999, THERIOGENOLOGY, V51, P117, DOI 10.1016/S0093-691X(98)00236-2; WENGER RH, 1999, ENV STRESS GENE REGU, P25; Wilding M, 2009, REPRODUCTION, V137, P619, DOI 10.1530/REP-08-0444; Wittemer C, 2000, J ASSIST REPROD GEN, V17, P547, DOI 10.1023/A:1026477628723; Wrenzycki C, 2007, THERIOGENOLOGY, V68, pS77, DOI 10.1016/j.theriogenology.2007.04.028; Wu DF, 2000, MOL CELL BIOCHEM, V204, P157, DOI 10.1023/A:1007064706101; Wutz A, 2001, DEVELOPMENT, V128, P1881; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	63	183	185	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23183	10.1371/journal.pone.0023183	http://dx.doi.org/10.1371/journal.pone.0023183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858021	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300017
J	McLaren, JR; Turkington, R				McLaren, Jennie R.; Turkington, Roy			Plant Identity Influences Decomposition through More Than One Mechanism	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; LEAF-LITTER DECOMPOSITION; FUNCTIONAL-GROUP IDENTITY; BOREAL FOREST; TERRESTRIAL ECOSYSTEMS; NITROGEN DEPOSITION; NUTRIENT RELEASE; SPECIES IDENTITY; ELEVATED CO2; DIVERSITY	Plant litter decomposition is a critical ecosystem process representing a major pathway for carbon flux, but little is known about how it is affected by changes in plant composition and diversity. Single plant functional groups (graminoids, legumes, non-leguminous forbs) were removed from a grassland in northern Canada to examine the impacts of functional group identity on decomposition. Removals were conducted within two different environmental contexts (fertilization and fungicide application) to examine the context-dependency of these identity effects. We examined two different mechanisms by which the loss of plant functional groups may impact decomposition: effects of the living plant community on the decomposition microenvironment, and changes in the species composition of the decomposing litter, as well as the interaction between these mechanisms. We show that the identity of the plant functional group removed affects decomposition through both mechanisms. Removal of both graminoids and forbs slowed decomposition through changes in the decomposition microenvironment. We found non-additive effects of litter mixing, with both the direction and identity of the functional group responsible depending on year; in 2004 graminoids positively influenced decomposition whereas in 2006 forbs negatively influenced decomposition rate. Although these two mechanisms act independently, their effects may be additive if both mechanisms are considered simultaneously. It is essential to understand the variety of mechanisms through which even a single ecosystem property is affected if we are to predict the future consequences of biodiversity loss.	Univ British Columbia, Dept Bot, Vancouver, BC, Canada; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	McLaren, JR (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	jennie.mclaren@gmail.com	McLaren, Jennie/U-9130-2019	McLaren, Jennie/0000-0003-2004-4783	Natural Science and Engineering Research Council of Canada; Killam Foundation; Northern Scientific Training Program	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Foundation; Northern Scientific Training Program	This research was supported by the Natural Science and Engineering Research Council of Canada (Discovery grant to R. T. and scholarship to J.R.M.), the Killam Foundation (fellowship to J.R.M.), and the Northern Scientific Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Ayres E, 2009, J ECOL, V97, P901, DOI 10.1111/j.1365-2745.2009.01539.x; Bryant DM, 1998, CAN J BOT, V76, P1295, DOI 10.1139/cjb-76-7-1295; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; CHRISTENSEN H, 1993, BIOL FERT SOILS, V15, P253, DOI 10.1007/BF00337209; Cody W. J., 2000, FLORA YUKON TERRITOR; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Duffy J. Emmett, 2009, P60; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hector A, 2000, OIKOS, V90, P357, DOI 10.1034/j.1600-0706.2000.900217.x; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; Hobbie SE, 1999, OIKOS, V84, P417, DOI 10.2307/3546421; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hobbie SE, 2000, ECOSYSTEMS, V3, P484, DOI 10.1007/s100210000042; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; John E, 1997, J ECOL, V85, P419, DOI 10.2307/2960566; JOHNSON NC, 1993, ECOL APPL, V3, P749, DOI 10.2307/1942106; Jonsson M, 2008, OIKOS, V117, P1674, DOI 10.1111/j.1600-0706.2008.16810.x; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; Knops JMH, 2001, OECOLOGIA, V126, P429, DOI 10.1007/s004420000537; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Madritch MD, 2004, OIKOS, V105, P125, DOI 10.1111/j.0030-1299.2004.12760.x; Marshall CB, 2011, SOIL BIOL BIOCHEM, V43, P78, DOI 10.1016/j.soilbio.2010.09.016; McLaren JR, 2011, J VEG SCI, V22, P503, DOI 10.1111/j.1654-1103.2011.01263.x; McLaren JR, 2010, GLOBAL CHANGE BIOL, V16, P3075, DOI 10.1111/j.1365-2486.2009.02151.x; McLaren JR, 2010, J ECOL, V98, P459, DOI 10.1111/j.1365-2745.2009.01630.x; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Moore TN, 2006, OIKOS, V114, P329, DOI 10.1111/j.2006.0030-1299.14576.x; Moorhead DL, 1998, OECOLOGIA, V113, P530, DOI 10.1007/s004420050406; Pfister JA, 2001, J RANGE MANAGE, V54, P447, DOI 10.2307/4003116; Prescott CE, 1999, CAN J FOREST RES, V29, P393, DOI 10.1139/cjfr-29-3-393; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Scherer-Lorenzen M, 2008, FUNCT ECOL, V22, P547, DOI 10.1111/j.1365-2435.2008.01389.x; SEASTEDT TR, 1984, ANNU REV ENTOMOL, V29, P25, DOI 10.1146/annurev.en.29.010184.000325; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Shevtsova A, 1997, OIKOS, V78, P440, DOI 10.2307/3545606; Smith MD, 2000, SOIL BIOL BIOCHEM, V32, P935, DOI 10.1016/S0038-0717(99)00223-0; Smith VC, 2003, OIKOS, V102, P235, DOI 10.1034/j.1600-0706.2003.12503.x; Talley SM, 2002, J CHEM ECOL, V28, P2141, DOI 10.1023/A:1021037029684; Turkington R, 2002, J ECOL, V90, P325, DOI 10.1046/j.1365-2745.2001.00666.x; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Wardle DA, 2008, J ECOL, V96, P1174, DOI 10.1111/j.1365-2745.2008.01437.x; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053	60	25	25	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23702	10.1371/journal.pone.0023702	http://dx.doi.org/10.1371/journal.pone.0023702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858210	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500042
J	Mulcahy, H; Lewenza, S				Mulcahy, Heidi; Lewenza, Shawn			Magnesium Limitation Is an Environmental Trigger of the Pseudomonas aeruginosa Biofilm Lifestyle	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEMS; RECOMBINANT HUMAN DNASE; CYSTIC-FIBROSIS; BACTERIAL BIOFILMS; POLYMYXIN-B; ANTIBIOTIC-RESISTANCE; SIGNAL-TRANSDUCTION; EXTRACELLULAR DNA; GENE-EXPRESSION; SMALL RNAS	Biofilm formation is a conserved strategy for long-term bacterial survival in nature and during infections. Biofilms are multicellular aggregates of cells enmeshed in an extracellular matrix. The RetS, GacS and LadS sensors control the switch from a planktonic to a biofilm mode of growth in Pseudomonas aeruginosa. Here we detail our approach to identify environmental triggers of biofilm formation by investigating environmental conditions that repress expression of the biofilm repressor RetS. Mg2+ limitation repressed the expression of retS leading to increased aggregation, exopolysaccharide (EPS) production and biofilm formation. Repression of retS expression under Mg2+ limitation corresponded with induced expression of the GacA-controlled small regulatory RNAs rsmZ and rsmY and the EPS biosynthesis operons pel and psl. We recently demonstrated that extracellular DNA sequesters Mg2+ cations and activates the cation-sensing PhoPQ two-component system, which leads to increased antimicrobial peptide resistance in biofilms. Here we show that exogenous DNA and EDTA, through their ability to chelate Mg2+, promoted biofilm formation. The repression of retS in low Mg2+ was directly controlled by PhoPQ. PhoP also directly controlled expression of rsmZ but not rsmY suggesting that PhoPQ controls the equilibrium of the small regulatory RNAs and thus fine-tunes the expression of genes in the RetS pathway. In summary, Mg2+ limitation is a biologically relevant environmental condition and the first bonafide environmental signal identified that results in transcriptional repression of retS and promotes P. aeruginosa biofilm formation.	[Mulcahy, Heidi; Lewenza, Shawn] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Calgary	Mulcahy, H (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	slewenza@ucalgary.ca			Westaim Corporation; Alberta Science and Research Authority; Cystic Fibrosis Canada; Canadian Foundation for Innovation	Westaim Corporation; Alberta Science and Research Authority; Cystic Fibrosis Canada; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This research was supported by the Westaim Corporation and the Alberta Science and Research Authority. HM is the recipient of a Cystic Fibrosis Canada fellowship. SL holds the Westaim-Alberta Science and Research Authority Chair in Biofilm Research. This work was supported by an equipment and infrastructure grant from the Canadian Foundation for Innovation and the Alberta Science and Research Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Banin E, 2006, APPL ENVIRON MICROB, V72, P2064, DOI 10.1128/AEM.72.3.2064-2069.2006; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; BRANDT T, 1995, THORAX, V50, P880, DOI 10.1136/thx.50.8.880; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hardalo C, 1997, CRIT REV MICROBIOL, V23, P47, DOI 10.3109/10408419709115130; HOSKINS LC, 1978, J INFECT DIS, V137, P694, DOI 10.1093/infdis/137.5.694; Hyland RM, 2006, J MED MICROBIOL, V55, P669, DOI 10.1099/jmm.0.46344-0; Irie Y, 2010, MOL MICROBIOL; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; Kuchma SL, 2005, J BACTERIOL, V187, P1441, DOI 10.1128/JB.187.4.1441-1454.2005; Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; Lesley JA, 2001, J BIOL CHEM, V276, P30827, DOI 10.1074/jbc.M104262200; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Lewenza S, 2008, J BACTERIOL, V190, P6119, DOI 10.1128/JB.00603-08; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; NICAS TI, 1980, J BACTERIOL, V143, P872, DOI 10.1128/JB.143.2.872-878.1980; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Prost LR, 2008, MOL MICROBIOL, V69, P503, DOI 10.1111/j.1365-2958.2008.06303.x; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Ramsey MM, 2004, MOL MICROBIOL, V53, P1075, DOI 10.1111/j.1365-2958.2004.04181.x; RANASINHA C, 1993, LANCET, V342, P199, DOI 10.1016/0140-6736(93)92297-7; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Shih PC, 2002, J ANTIMICROB CHEMOTH, V49, P309, DOI 10.1093/jac/49.2.309; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Workentine ML, 2010, ENV MICROBIOL; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	67	52	52	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23307	10.1371/journal.pone.0023307	http://dx.doi.org/10.1371/journal.pone.0023307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858064	Green Submitted, gold, Green Published			2022-12-27	WOS:000294125500026
J	Lingappa, JR; Dumitrescu, L; Zimmer, SM; Lynfield, R; McNicholl, JM; Messonnier, NE; Whitney, CG; Crawford, DC				Lingappa, Jairam R.; Dumitrescu, Logan; Zimmer, Shanta M.; Lynfield, Ruth; McNicholl, Janet M.; Messonnier, Nancy E.; Whitney, Cynthia G.; Crawford, Dana C.			Identifying Host Genetic Risk Factors in the Context of Public Health Surveillance for Invasive Pneumococcal Disease	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; C-REACTIVE PROTEIN; PROMOTER POLYMORPHISM; SURFACTANT PROTEINS; PLASMINOGEN-ACTIVATOR-INHIBITOR-1 GENE; ALVEOLAR MACROPHAGES; SEPTIC SHOCK; IN-VIVO; ASSOCIATION; ALPHA	Host genetic factors that modify risk of pneumococcal disease may help target future public health interventions to individuals at highest risk of disease. We linked data from population-based surveillance for invasive pneumococcal disease (IPD) with state-based newborn dried bloodspot repositories to identify biological samples from individuals who developed invasive pneumococcal disease. Genomic DNA was extracted from 366 case and 732 anonymous control samples. TagSNPs were selected in 34 candidate genes thought to be associated with host response to invasive pneumococcal disease, and a total of 326 variants were successfully genotyped. Among 543 European Americans (EA) (182 cases and 361 controls), and 166 African Americans (AA) (53 cases and 113 controls), common variants in surfactant protein D (SFTPD) are consistently underrepresented in IPD. SFTPD variants with the strongest association for IPD are intronic rs17886286 (allelic OR 0.45, 95% confidence interval (CI) [0.25, 0.82], with p = 0.007) in EA and 59 flanking rs12219080 (allelic OR 0.32, 95% CI [0.13, 0.78], with p = 0.009) in AA. Variants in CD46 and IL1R1 are also associated with IPD in both EA and AA, but with effects in different directions; FAS, IL1B, IL4, IL10, IL12B, SFTPA1, SFTPB, and PTAFR variants are associated (p <= 0.05) with IPD in EA or AA. We conclude that variants in SFTPD may protect against IPD in EA and AA and genetic variation in other host response pathways may also contribute to risk of IPD. While our associations are not corrected for multiple comparisons and therefore must be replicated in additional cohorts, this pilot study underscores the feasibility of integrating public health surveillance with existing, prospectively collected, newborn dried blood spot repositories to identify host genetic factors associated with infectious diseases.	[Lingappa, Jairam R.] Univ Washington, Dept Global Hlth, Dept Med, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dumitrescu, Logan; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Zimmer, Shanta M.] Emory Univ, Atlanta, GA 30322 USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [McNicholl, Janet M.; Messonnier, Nancy E.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Atlanta, GA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University; Emory University; Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Dept Med, Seattle, WA 98195 USA.	lingappa@u.washington.edu	Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012; Lingappa, Jairam/N-7760-2017	Crawford, Dana/0000-0002-6437-6248; 	U.S. Federal Government, National Heart, Lung, and Blood Institute [N01-HV-48195]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	U.S. Federal Government, National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Genotyping services were provided by the Johns Hopkins University under U.S. Federal Government contract number N01-HV-48195 from the National Heart, Lung, and Blood Institute. Intramural support was also provided through the Centers for Disease Control and Prevention (CDC) Genetics Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bernard GR, 2003, CRIT CARE MED, V31, pS85, DOI 10.1097/00003246-200301001-00012; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BOUDEWIJNS M, 2005, J LEUKOC BIOL; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; Chen QY, 2006, J IMMUNOL, V177, P6044, DOI 10.4049/jimmunol.177.9.6044; Crawford DC, 2008, EMERG INFECT DIS, V14, P1138, DOI 10.3201/eid1407.071287; Crawford DC, 2005, ANNU REV GENOM HUM G, V6, P287, DOI 10.1146/annurev.genom.6.080604.162309; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dumitrescu L, 2010, GENET MED, V12, P648, DOI 10.1097/GIM.0b013e3181efe2df; Echchannaoui H, 2005, IMMUNOBIOLOGY, V210, P229, DOI 10.1016/j.imbio.2005.05.017; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Falush D, 2003, GENETICS, V164, P1567; Fang XM, 1999, CRIT CARE MED, V27, P1330, DOI 10.1097/00003246-199907000-00024; Forbes LR, 2010, CLIN EXP ALLERGY, V40, P547, DOI 10.1111/j.1365-2222.2010.03483.x; Gallagher PM, 2003, THORAX, V58, P154, DOI 10.1136/thorax.58.2.154; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Geishofer G, 2005, EUR J PEDIATR, V164, P486, DOI 10.1007/s00431-005-1673-4; Gordon SB, 2005, AIDS, V19, P1197, DOI 10.1097/01.aids.0000176220.25614.5e; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; IOM (Institute of Medicine), 2010, CHALL OPP US RES NEW; Jeurissen A, 2004, EUR J IMMUNOL, V34, P850, DOI 10.1002/eji.200324381; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Jounblat R, 2004, INFECT IMMUN, V72, P709, DOI 10.1128/IAI.72.2.709-716.2004; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Letiembre M, 2005, J NEUROIMMUNOL, V168, P21, DOI 10.1016/j.jneuroim.2005.06.016; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x; Ling E, 2003, J INFECT DIS, V188, P1752, DOI 10.1086/379371; Liu CF, 2010, CLIN EXP ALLERGY, V40, P111, DOI [10.1111/j.1365-2222.2009.03367.x, 10.1111/j.1365-2222.2010.03549.x]; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Lynch JM, 2003, INFECT IMMUN, V71, P4780, DOI 10.1128/IAI.71.8.4780-4788.2003; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matute-Bello G, 2005, J INFECT DIS, V191, P596, DOI 10.1086/427261; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Mold C, 2002, J IMMUNOL, V168, P6375, DOI 10.4049/jimmunol.168.12.6375; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; Paterson GK, 2005, J MED MICROBIOL, V54, P323, DOI 10.1099/JMM.0.45873-0; Paul R, 2004, J NEUROIMMUNOL, V152, P78, DOI 10.1016/j.jneuroim.2004.04.004; Pendergrass SA, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-10; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Read RC, 2003, ANN INTERN MED, V138, P534, DOI 10.7326/0003-4819-138-7-200304010-00009; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Schaaf BM, 2003, AM J RESP CRIT CARE, V168, P476, DOI 10.1164/rccm.200210-1164OC; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Seya T, 1999, INT J BIOCHEM CELL B, V31, P1255, DOI 10.1016/S1357-2725(99)00092-8; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Stuber F, 1996, CRIT CARE MED, V24, P381, DOI 10.1097/00003246-199603000-00004; van der Pol WL, 2001, J INFECT DIS, V184, P1548, DOI 10.1086/324662; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Waterer GW, 2005, CLIN CHEST MED, V26, P29, DOI 10.1016/j.ccm.2004.10.002; Westendorp RGJ, 1999, LANCET, V354, P561, DOI 10.1016/S0140-6736(98)09376-3; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yamamoto N, 2004, MICROBES INFECT, V6, P1241, DOI 10.1016/j.micinf.2004.08.007; Yee AMF, 1997, ARTHRITIS RHEUM, V40, P1180, DOI 10.1002/art.1780400626; YOTHER J, 1982, J IMMUNOL, V128, P2374; Zwijnenburg PJG, 2003, J NEUROIMMUNOL, V138, P31, DOI 10.1016/S0165-5728(03)00088-2	77	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23413	10.1371/journal.pone.0023413	http://dx.doi.org/10.1371/journal.pone.0023413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858107	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953700021
J	Ozato-Sakurai, N; Fujita, A; Fujimoto, T				Ozato-Sakurai, Nami; Fujita, Akikazu; Fujimoto, Toyoshi			The Distribution of Phosphatidylinositol 4,5-Bisphosphate in Acinar Cells of Rat Pancreas Revealed with the Freeze-Fracture Replica Labeling Method	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; GOLGI-APPARATUS; PLASMA-MEMBRANE; PHOSPHOINOSITIDES; POLARITY; PTDINS(4,5)P-2; LOCALIZATION; 3-PHOSPHATE; EXOCYTOSIS; ENDOCRINE	Phosphatidylinositol 4,5-bisphosphate [PI(4,5)P-2] is a phospholipid that has been implicated in multiple cellular activities. The distribution of PI(4,5)P-2 has been analyzed extensively using live imaging of the GFP-coupled phospholipase C-delta 1 pleckstrin homology domain in cultured cell lines. However, technical difficulties have prevented the study of PI(4,5)P-2 in cells of in vivo tissues. We recently developed a method to analyze the nanoscale distribution of PI(4,5)P-2 in cultured cells by using the quick-freezing and freeze-fracture replica labeling method. In principle, this method can be applied to any cell because it does not require the expression of artificial probes. In the present study, we modified the method to study cells of in vivo tissues and applied it to pancreatic exocrine acinar cells of the rat. We found that PI(4,5)P-2 in the plasma membrane is distributed in an equivalent density in the apical and basolateral domains, but exists in a significantly higher concentration in the gap junction. The intracellular organelles did not show labeling for PI(4,5)P-2. The results are novel or different from the reported distribution patterns in cell lines and highlight the importance of studying cells differentiated in vivo.	[Ozato-Sakurai, Nami; Fujita, Akikazu; Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan	Nagoya University	Ozato-Sakurai, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan.	afujita@agri.kagoshima-u.ac.jp; tfujimot@med.nagoya-u.ac.jp	Fujimoto, Toyoshi/ABH-9058-2020	Fujimoto, Toyoshi/0000-0002-3601-7977	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [21890095, 50115929, 21390053]	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-Aid for Scientific Research 21890095 to NS, 50115929 to AF, 21390053 to TF (http://www.jsps.go.jp/english/e-grants/grants.html), and the Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders'' from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government to NS, TF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Balla T, 2007, J PHYSIOL-LONDON, V582, P927, DOI 10.1113/jphysiol.2007.132795; CHANDLER DE, 1984, J CELL SCI, V72, P23; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; FUJITA A, 2009, BIOCH BIOPHYS ACTA; Akikazu F, 2007, HISTOCHEM CELL BIOL, V128, P385, DOI 10.1007/s00418-007-0341-3; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujita A, 2010, NAT PROTOC, V5, P661, DOI 10.1038/nprot.2010.20; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; GILKEY JC, 1986, J ELECTRON MICR TECH, V3, P177, DOI 10.1002/jemt.1060030206; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Hofgaard JP, 2008, PFLUG ARCH EUR J PHY, V457, P303, DOI 10.1007/s00424-008-0538-x; ICHIKAWA A, 1965, J CELL BIOL, V24, P369, DOI 10.1083/jcb.24.3.369; Irvine R, 2004, CURR BIOL, V14, pR308, DOI 10.1016/j.cub.2004.03.051; JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; JOST P, 1973, J MOL BIOL, V76, P313, DOI 10.1016/0022-2836(73)90394-X; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MEDA P, 1993, ENDOCRINOLOGY, V133, P2371, DOI 10.1210/en.133.5.2371; MOOR H, 1980, CELL TISSUE RES, V209, P201; SCHEELE GA, 1975, J BIOL CHEM, V250, P2660; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Sweeney DA, 2002, J BIOL CHEM, V277, P3030, DOI 10.1074/jbc.M104639200; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; VANDEURS B, 1979, J ULTRA MOL STRUCT R, V68, P160, DOI 10.1016/S0022-5320(79)90151-5; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657	41	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23567	10.1371/journal.pone.0023567	http://dx.doi.org/10.1371/journal.pone.0023567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858170	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700034
J	Sun, YW; Dai, MH; Hao, HH; Wang, YL; Huang, LL; Almofti, YA; Liu, ZL; Yuan, ZH				Sun, Yawei; Dai, Menghong; Hao, Haihong; Wang, Yulian; Huang, Lingli; Almofti, Yassir A.; Liu, Zhenli; Yuan, Zonghui			The Role of RamA on the Development of Ciprofloxacin Resistance in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							MUTANT PREVENTION CONCENTRATION; MEDIATED MULTIDRUG-RESISTANCE; EFFLUX SYSTEMS; ACTIVE EFFLUX; QUINOLONE RESISTANCE; EMERGING MECHANISMS; ESCHERICHIA-COLI; SELECTION WINDOW; ACRB; MUTATIONS	Active efflux pump is a primary fluoroquinolone resistant mechanism of clinical isolates of Salmonella enterica serovar Typhimurium. RamA is an essential element in producing multidrug resistant (MDR) S. enterica serovar Typhimurium. The aim of the present study was to elucidate the roles of RamA on the development of ciprofloxacin, the first choice for the treatment of salmonellosis, resistance in S. enterica serovar Typhimurium. Spontaneous mutants were selected via several passages of S. enterica serovar Typhimurium CVCC541 susceptible strain (ST) on M-H agar with increasing concentrations of ciprofloxacin (CIP). Accumulation of ciprofloxacin was tested by the modified fluorometric method. The expression levels of MDR efflux pumps were determined by real time RT-PCR. In ST and its spontaneous mutants, the ramA gene was inactivated by insertion of the kan gene and compensated on a recombinant plasmid pGEX Phi(gst-ramA). The mutant prevention concentration (MPC) and mutant frequencies of ciprofloxacin against ST and a spontaneous mutant in the presence, absence and overexpression of RamA were tested. Four spontaneous mutants (SI1-SI4) were obtained. The SI1 (CIP MICs, 0.1 mg/L) without any target site mutation in its quinolone resistant determining regions (QRDRs) and SI3 (CIP MICs, 16 mg/L) harboring the Ser83 -> Phe mutation in its QRDR of GyrA strains exhibited reduced susceptibility and resistance to multidrugs, respectively. In SI1, RamA was the main factor that controlled the susceptibility to ciprofloxacin by activating MdtK as well as increasing the expression level of acrAB. In SI3, RamA played predominant role in ciprofloxacin resistance via increasing the expression level of acrAB. Likewise, the deficiency of RamA decreased the MPCs and mutant frequencies of ST and SI2 to ciprofloxacin. In conclusion, the expression of RamA promoted the development of ciprofloxacin resistant mutants of S. enterica serovar Typhimurium. The inhibition of RamA could decrease the appearance of the ciprofloxacin resistant mutants.	[Sun, Yawei; Dai, Menghong; Hao, Haihong; Wang, Yulian; Huang, Lingli; Almofti, Yassir A.; Liu, Zhenli; Yuan, Zonghui] Huazhong Agr Univ, MOA Key Lab Food Safety Evaluat, Natl Reference Lab Vet Drug Residues HZAU, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Sun, YW (corresponding author), Huazhong Agr Univ, MOA Key Lab Food Safety Evaluat, Natl Reference Lab Vet Drug Residues HZAU, Wuhan, Hubei, Peoples R China.	yuan5802@mail.hzau.edu.cn	yuan, zonghui/A-1158-2017; DAI, M/GPS-8291-2022; Hao, Haihong/E-2789-2019	Hao, Haihong/0000-0003-0199-5700	China Ministry of Agriculture	China Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This work was financially supported by China Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; Baucheron S, 2004, ANTIMICROB AGENTS CH, V48, P3729, DOI 10.1128/AAC.48.10.3729-3735.2004; Chen Feng-Jui, 2003, Journal of Microbiology Immunology and Infection, V36, P1; Chinni SV, 2010, NUCLEIC ACIDS RES, V38, P5893, DOI 10.1093/nar/gkq281; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Coldham NG, 2010, J ANTIMICROB CHEMOTH, V65, P1655, DOI 10.1093/jac/dkq169; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Cristobal RE, 2006, J ANTIMICROB CHEMOTH, V58, P31, DOI 10.1093/jac/dkl172; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; Escribano I, 2004, INT J ANTIMICROB AG, V24, P428, DOI 10.1016/j.ijantimicag.2004.05.004; Ferrari R, 2011, CURR MICROBIOL, V62, P628, DOI 10.1007/s00284-010-9754-7; Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131, DOI 10.1128/AAC.43.9.2131; Giraud E, 2000, ANTIMICROB AGENTS CH, V44, P1223, DOI 10.1128/AAC.44.5.1223-1228.2000; Giraud E, 2006, MICROBES INFECT, V8, P1937, DOI 10.1016/j.micinf.2005.12.025; Hansen GT, 2006, INT J ANTIMICROB AG, V27, P120, DOI 10.1016/j.ijantimicag.2005.10.005; Hansen GT, 2003, ANTIMICROB AGENTS CH, V47, P440, DOI 10.1128/AAC.47.1.440-441.2003; Hawkey PM, 2003, J ANTIMICROB CHEMOTH, V51, P29, DOI 10.1093/jac/dkg207; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Horiyama T, 2010, J ANTIMICROB CHEMOTH, V65, P1372, DOI 10.1093/jac/dkq160; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V59, P886, DOI 10.1093/jac/dkm072; Kehrenberg C, 2009, J ANTIMICROB CHEMOTH, V64, P1175, DOI 10.1093/jac/dkp347; Koutsolioutsou A, 2001, ANTIMICROB AGENTS CH, V45, P38, DOI 10.1128/AAC.45.1.38-43.2001; Lee A, 2000, J BACTERIOL, V182, P3142, DOI 10.1128/JB.182.11.3142-3150.2000; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Linde HJ, 2004, J ANTIMICROB CHEMOTH, V53, P252, DOI 10.1093/jac/dkh036; Mann PA, 1997, GENETICS, V146, P447; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Randall LP, 2004, J ANTIMICROB CHEMOTH, V54, P688, DOI 10.1093/jac/dkh360; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; Ricci V, 2009, J ANTIMICROB CHEMOTH, V64, P654, DOI 10.1093/jac/dkp234; Rodriguez JC, 2004, J ANTIMICROB CHEMOTH, V53, P441, DOI 10.1093/jac/dkh119; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sulavik MC, 1997, J BACTERIOL, V179, P1857, DOI 10.1128/jb.179.6.1857-1866.1997; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; van der Straaten T, 2004, INFECT IMMUN, V72, P996, DOI 10.1128/IAI.72.2.996-1003.2004; van der Straaten T, 2004, ANTIMICROB AGENTS CH, V48, P2292, DOI 10.1128/AAC.48.6.2292-2294.2004; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Yang S, 2003, J ANTIMICROB CHEMOTH, V51, P545, DOI 10.1093/jac/dkg126; Zheng J, 2009, J ANTIMICROB CHEMOTH, V63, P95, DOI 10.1093/jac/dkn448	50	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23471	10.1371/journal.pone.0023471	http://dx.doi.org/10.1371/journal.pone.0023471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858134	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500045
J	Enders, J; Zimmermann, E; Rief, M; Martus, P; Klingebiel, R; Asbach, P; Klessen, C; Diederichs, G; Wagner, M; Teichgraber, U; Bengner, T; Hamm, B; Dewey, M				Enders, Judith; Zimmermann, Elke; Rief, Matthias; Martus, Peter; Klingebiel, Randolf; Asbach, Patrick; Klessen, Christian; Diederichs, Gerd; Wagner, Moritz; Teichgraeber, Ulf; Bengner, Thomas; Hamm, Bernd; Dewey, Marc			Reduction of Claustrophobia with Short-Bore versus Open Magnetic Resonance Imaging: A Randomized Controlled Trial	PLOS ONE			English	Article							MEDICAL PROCEDURES; MOTION ARTIFACTS; BACK-PAIN; ANXIETY; SEDATION; MRI; ANALGESIA; PATIENT; BREAST; SAFETY	Background: Claustrophobia is a common problem precluding MR imaging. The purpose of the present study was to assess whether a short-bore or an open magnetic resonance (MR) scanner is superior in alleviating claustrophobia. Methods: Institutional review board approval and patient informed consent were obtained to compare short-bore versus open MR. From June 2008 to August 2009, 174 patients (139 women; mean age = 53.1 [SD 12.8]) with an overall mean score of 2.4 (SD 0.7, range 0 to 4) on the Claustrophobia Questionnaire (CLQ) and a clinical indication for imaging, were randomly assigned to receive evaluation by open or by short-bore MR. The primary outcomes were incomplete MR examinations due to a claustrophobic event. Follow-up was conducted 7 months after MR imaging. The primary analysis was performed according to the intention-to-treat strategy. Results: With 33 claustrophobic events in the short-bore group (39% [95% confidence interval [CI] 28% to 50%) versus 23 in the open scanner group (26% [95% CI 18% to 37%]; P = 0.08) the difference was not significant. Patients with an event were in the examination room for 3.8 min (SD 4.4) in the short-bore and for 8.5 min (SD 7) in the open group (P = 0.004). This was due to an earlier occurrence of events in the short-bore group. The CLQ suffocation subscale was significantly associated with the occurrence of claustrophobic events (P = 0.003). New findings that explained symptoms were found in 69% of MR examinations and led to changes in medical treatment in 47% and surgery in 10% of patients. After 7 months, perceived claustrophobia increased in 32% of patients with events versus in only 11% of patients without events (P = 0.004). Conclusions: Even recent MR cannot prevent claustrophobia suggesting that further developments to create a more patient-centered MR scanner environment are needed.	[Enders, Judith; Klingebiel, Randolf] Humboldt Univ, Dept Radiol, Charite, Div Neuroradiol,Med Sch, Berlin, Germany; [Enders, Judith; Zimmermann, Elke; Rief, Matthias; Martus, Peter; Klingebiel, Randolf; Asbach, Patrick; Klessen, Christian; Diederichs, Gerd; Wagner, Moritz; Teichgraeber, Ulf; Bengner, Thomas; Hamm, Bernd; Dewey, Marc] Free Univ Berlin, D-1000 Berlin, Germany; [Martus, Peter] Humboldt Univ, Dept Biostat & Clin Epidemiol, Charite, Sch Med, Berlin, Germany; [Bengner, Thomas] Humboldt Univ, Dept Clin Psychol, Charite, Sch Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Enders, J (corresponding author), Humboldt Univ, Dept Radiol, Charite, Div Neuroradiol,Med Sch, Berlin, Germany.	marc.dewey@charite.de	Teichgräber, med. Ulf/H-8562-2019	Teichgräber, med. Ulf/0000-0002-4048-3938; Dewey, Marc/0000-0002-4402-2733; Bengner, Thomas/0000-0003-0992-2098; Asbach, Patrick/0000-0002-6885-3283	GE Healthcare; Toshiba Medical Systems; Philips Medical Systems; Siemens Medical Solutions	GE Healthcare(General ElectricGE Healthcare); Toshiba Medical Systems; Philips Medical Systems; Siemens Medical Solutions(Siemens AG)	The following conflicts apply to this study: Dr. Dewey has received grant support from GE Healthcare and Toshiba Medical Systems and lecture fees from Toshiba Medical Systems. Dr. Teichgraber has received grant support from Philips Medical Systems. Prof. Hamm has received grant support from GE Healthcare, Siemens Medical Solutions, and Toshiba Medical Systems, and lecture fees from Siemens Medical Solutions. Furthermore, there are institutional master research agreements with Philips Medical Systems, Siemens Medical Solutions, and Toshiba Medical Systems. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adamietz B, 2007, ROFO-FORTSCHR RONTG, V179, P826, DOI 10.1055/s-2007-963168; Altman D, 2000, STAT CONFIDENCE, P108; Altman DG., 2000, STAT CONFIDENCE, V2, P48; *AM COLL RAD, ACR APPR CRIT VERT H; *AM COLL RAD, ACR APPR CRIT ACUT S; American College of Radiology, ACR APPR CRIT HEAD; American College of Radiology, ACR APPR CRIT LOW BA; Bangard C, 2007, EUR J RADIOL, V64, P152, DOI 10.1016/j.ejrad.2007.02.012; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Berg WA, 2010, RADIOLOGY, V254, P79, DOI 10.1148/radiol.2541090953; Berlin L, 2001, AM J ROENTGENOL, V177, P293, DOI 10.2214/ajr.177.2.1770293; Bluemke DA, 2000, RADIOLOGY, V216, P645, DOI 10.1148/radiology.216.3.r00se45645; Blumich B, 1998, MAGN RESON IMAGING, V16, P479, DOI 10.1016/S0730-725X(98)00069-1; BOOTH R, 1992, BEHAV RES THER, V30, P207, DOI 10.1016/0005-7967(92)90067-Q; BRENNAN SC, 1988, LANCET, V2, P512; CARTER MM, 1995, J ABNORM PSYCHOL, V104, P156, DOI 10.1037/0021-843X.104.1.156; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; DANTENDORFER K, 1991, LANCET, V338, P761, DOI 10.1016/0140-6736(91)91486-E; Dantendorfer K, 1997, MAGN RESON IMAGING, V15, P301, DOI 10.1016/S0730-725X(96)00385-2; Dewey M, 2007, EUR J RADIOL, V63, P124, DOI 10.1016/j.ejrad.2007.01.025; Dewey M, 2007, J MAGN RESON IMAGING, V26, P1322, DOI 10.1002/jmri.21147; Dewey M, 2010, RADIOLOGY, V256, P328, DOI 10.1148/radiol.100113; Enders J, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-4; FISHBAIN D, 1989, AM J ROENTGENOL, V152, P653, DOI 10.2214/ajr.152.3.653-b; FISHBAIN DA, 1988, AM J PSYCHIAT, V145, P1038; Fuchs VR, 2001, HEALTH AFFAIR, V20, P30, DOI 10.1377/hlthaff.20.5.30; Ghoshhajra BB., 2022, J AM COLL RADIOL, V19, pS1, DOI [10.1016/j.jacr.2022.02.021, DOI 10.1016/J.JACR.2022.02.021]; Granet R B, 1990, N J Med, V87, P479; Harris LM, 1999, BEHAV RES THER, V37, P155, DOI 10.1016/S0005-7967(98)00110-7; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008; KATZ RC, 1994, J BEHAV THER EXP PSY, V25, P131, DOI 10.1016/0005-7916(94)90005-1; KILBORN LC, 1990, J BEHAV MED, V13, P391, DOI 10.1007/BF00844886; KORTEPETER MG, 1991, ANN INTERN MED, V115, P749, DOI 10.7326/0003-4819-115-9-749; Lang EV, 2006, PAIN, V126, P155, DOI 10.1016/j.pain.2006.06.035; Lang EV, 2010, ACAD RADIOL, V17, P18, DOI 10.1016/j.acra.2009.07.002; Lang EV, 2000, LANCET, V355, P1486, DOI 10.1016/S0140-6736(00)02162-0; Lukins R, 1997, J BEHAV THER EXP PSY, V28, P97, DOI 10.1016/S0005-7916(97)00006-2; MACKENZIE R, 1995, CLIN RADIOL, V50, P137, DOI 10.1016/S0009-9260(05)83042-9; Malviya S, 2000, BRIT J ANAESTH, V84, P743, DOI 10.1093/oxfordjournals.bja.a013586; MARKS I, 1991, BRIT MED J, V302, P1037, DOI 10.1136/bmj.302.6784.1037; McGlynn FD, 2007, J ANXIETY DISORD, V21, P367, DOI 10.1016/j.janxdis.2006.06.003; McIsaac HK, 1998, J BEHAV MED, V21, P255, DOI 10.1023/A:1018717016680; MELENDEZ JC, 1993, JAMA-J AM MED ASSOC, V270, P745, DOI 10.1001/jama.270.6.745; Meriles CA, 2001, SCIENCE, V293, P82, DOI 10.1126/science.1061498; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; QUIRK ME, 1989, RADIOLOGY, V170, P463, DOI 10.1148/radiology.170.2.2911670; QUIRK ME, 1989, RADIOLOGY, V173, P759, DOI 10.1148/radiology.173.3.2682775; Radomsky AS, 2001, J ANXIETY DISORD, V15, P287, DOI 10.1016/S0887-6185(01)00064-0; Sarji S A, 1998, Australas Radiol, V42, P293, DOI 10.1111/j.1440-1673.1998.tb00525.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spouse E, 2000, BRIT J RADIOL, V73, P146, DOI 10.1259/bjr.73.866.10884726; Tornqvist E, 2006, J CLIN NURS, V15, P954, DOI 10.1111/j.1365-2702.2006.01499.x; VITALIANO PP, 1990, J PERS SOC PSYCHOL, V59, P582, DOI 10.1037/0022-3514.59.3.582; Wolpe J., 1977, MANUAL FEAR SURVEY S; 1990, HLTH POLICY, V16, P199; 1996, ANESTHESIOLOGY, V84, P459	58	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23494	10.1371/journal.pone.0023494	http://dx.doi.org/10.1371/journal.pone.0023494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887259	Green Published, Green Submitted, gold			2022-12-27	WOS:000294251800012
J	Grami, B; Rasconi, S; Niquil, N; Jobard, M; Saint-Beat, B; Sime-Ngando, T				Grami, Boutheina; Rasconi, Serena; Niquil, Nathalie; Jobard, Marlene; Saint-Beat, Blanche; Sime-Ngando, Telesphore			Functional Effects of Parasites on Food Web Properties during the Spring Diatom Bloom in Lake Pavin: A Linear Inverse Modeling Analysis	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ASTERIONELLA-FORMOSA; BACTERIAL PRODUCTION; CONVERSION FACTORS; SEASONAL DYNAMICS; CELL-VOLUME; ENERGY-FLOW; ECOSYSTEM; WATER; STABILITY	This study is the first assessment of the quantitative impact of parasitic chytrids on a planktonic food web. We used a carbon-based food web model of Lake Pavin (Massif Central, France) to investigate the effects of chytrids during the spring diatom bloom by developing models with and without chytrids. Linear inverse modelling procedures were employed to estimate undetermined flows in the lake. The Monte Carlo Markov chain linear inverse modelling procedure provided estimates of the ranges of model-derived fluxes. Model results support recent theories on the probable impact of parasites on food web function. In the lake, during spring, when 'inedible' algae (unexploited by planktonic herbivores) were the dominant primary producers, the epidemic growth of chytrids significantly reduced the sedimentation loss of algal carbon to the detritus pool through the production of grazer-exploitable zoospores. We also review some theories about the potential influence of parasites on ecological network properties and argue that parasitism contributes to longer carbon path lengths, higher levels of activity and specialization, and lower recycling. Considering the "structural asymmetry" hypothesis as a stabilizing pattern, chytrids should contribute to the stability of aquatic food webs.	[Grami, Boutheina; Rasconi, Serena; Niquil, Nathalie; Saint-Beat, Blanche] Univ La Rochelle, CNRS, UMR Littoral Environm & Soc LIENSs 6250, La Rochelle, France; [Rasconi, Serena; Jobard, Marlene; Sime-Ngando, Telesphore] Clermont Univ, LMGE, Lab Microorganismes Genome & Environm, UMR CNRS 6023, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Grami, B (corresponding author), Univ La Rochelle, CNRS, UMR Littoral Environm & Soc LIENSs 6250, La Rochelle, France.	nniquil@univ-lr.fr	Niquil, Nathalie/N-2561-2013; Sime-Ngando, Télesphore/M-4134-2019; Niquil, Nathalie/C-8233-2009	Sime-Ngando, Télesphore/0000-0002-7240-5803; Niquil, Nathalie/0000-0002-0772-754X; Saint-Beat, Blanche/0000-0002-2401-2052; GRAMI, Boutheina/0000-0001-5537-4817; Rasconi, Serena/0000-0001-6667-8904	French ANR (Agence Nationale de la Recherche); DREP; CNRS; Region Poitou-Charentes	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); DREP; CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This study was supported by a grant from the French ANR (Agence Nationale de la Recherche) Programme Blanc 'DREP: Diversite et Roles des Eumycetes dans le Pelagos'; Coordinator TSN. B. G. and S. R. were supported by grants from DREP (T.S.-N., N.N.). B. S. B. was supported by a PhD fellowship from the CNRS and Region Poitou-Charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD C, 1992, MICROBIAL ECOL, V24, P109, DOI 10.1007/BF00174449; AMBLARD C, 1990, J PLANKTON RES, V12, P645, DOI 10.1093/plankt/12.3.645; AMBLARD C, 1978, THESIS U CLERMONT FD; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P43, DOI 10.3354/meps320043; Arnous MB, 2010, AQUAT SCI, V72, P245, DOI 10.1007/s00027-010-0127-x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; Baird D, 1996, WATER SA, V22, P307; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Baird D, 1998, ESTUAR COAST SHELF S, V47, P329, DOI 10.1006/ecss.1998.0360; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Bettarel Y, 2003, MICROB ECOL, V45, P119, DOI 10.1007/s00248-002-1016-1; Bettarel Y, 2002, ANN LIMNOL-INT J LIM, V38, P263, DOI 10.1051/limn/2002021; BJORNSEN PK, 1986, APPL ENVIRON MICROB, V51, P1199; BORSHEIM KY, 1987, MAR ECOL PROG SER, V36, P171, DOI 10.3354/meps036171; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; CANTER HM, 1979, NEW PHYTOL, V82, P187, DOI 10.1111/j.1469-8137.1979.tb07574.x; CANTER HM, 1969, OSTERR BOT Z, V116, P351, DOI 10.1007/BF01379634; CANTER HM, 1950, ANN BOT-LONDON, V14, P263, DOI 10.1093/oxfordjournals.aob.a083246; CANTER HM, 1951, ANN BOT-LONDON, V15, P359; CARON DA, 1983, APPL ENVIRON MICROB, V46, P491, DOI 10.1128/AEM.46.2.491-498.1983; Carrias JF, 1998, FRESHWATER BIOL, V39, P91, DOI 10.1046/j.1365-2427.1998.00263.x; De Bruin A, 2008, J EUKARYOT MICROBIOL, V55, P69, DOI 10.1111/j.1550-7408.2008.00306.x; DEANGELIS DL, 1980, ECOLOGY, V61, P764, DOI 10.2307/1936746; DEVAUX J, 1980, HYDROBIOLOGIA, V62, P67; DEVAUX J, 1976, ANN STN BIOL BESSE E, V10, P1; Dobson AR, 2006, SFI S SCI C, P119; DUSSART B., 1967, COPEPODES EAUX CONTI, P500; Elton C. S., 1958, ECOLOGY INVASIONS AN; Feller R.J., 1988, P181; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; GLEASON FH, 2009, NEWSLETTER MYCOL SOC, V59, P1; Gradinger R, 1999, DEEP-SEA RES PT II, V46, P1457, DOI 10.1016/S0967-0645(99)00030-2; Grami B, 2008, ESTUAR COAST SHELF S, V79, P101, DOI 10.1016/j.ecss.2008.03.009; Hosack GR, 2009, ECOL MODEL, V220, P1054, DOI 10.1016/j.ecolmodel.2009.01.033; HUBERPESTALOZZI G, 1946, NEW PHYTOL, V47, P238; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; HUXHAM M, 1995, J ANIM ECOL, V64, P168, DOI 10.2307/5752; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Jobard M, 2010, J MICROBIOL METH, V83, P236, DOI 10.1016/j.mimet.2010.09.006; Johnson GA, 2009, ECOL MODEL, V220, P3448, DOI 10.1016/j.ecolmodel.2009.08.003; Jordan F, 2003, ECOL MODEL, V161, P117, DOI 10.1016/S0304-3800(02)00296-X; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Kagami M, 2006, LIMNOL OCEANOGR, V51, P2775, DOI 10.4319/lo.2006.51.6.2775; Kagami M, 2011, HYDROBIOLOGIA, V659, P49, DOI 10.1007/s10750-010-0274-z; KANKAALA P, 1986, J PLANKTON RES, V8, P1027, DOI 10.1093/plankt/8.6.1027; Kay J. J, 1989, NETWORK ANAL MARINE; Kones JK, 2006, J MARINE SYST, V60, P153, DOI 10.1016/j.jmarsys.2005.12.002; Kones JK, 2009, ECOL MODEL, V220, P370, DOI 10.1016/j.ecolmodel.2008.10.012; KUDOH S, 1990, J PHYCOL, V26, P239, DOI 10.1111/j.0022-3646.1990.00239.x; KURIS AM, 2008, NATURE, V24, P15; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty Kevin D., 2006, P119; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Legendre L., 1991, PARTICLE ANAL OCEANO, P261, DOI [DOI 10.1007/978-3-642-75121-9_11, 10.1007/978-3-642-75121-9_11]; Lepere C, 2010, ISME J, V4, P1509, DOI 10.1038/ismej.2010.83; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Marquis E, 2007, ESTUAR COAST SHELF S, V73, P223, DOI 10.1016/j.ecss.2007.01.003; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCauley E., 1984, IBP HDB, P228; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MULLIN MM, 1966, LIMNOL OCEANOGR, V11, P307, DOI 10.4319/lo.1966.11.2.0307; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Niquil N, 1998, MAR ECOL PROG SER, V165, P17, DOI 10.3354/meps165017; NIQUIL N, 2012, TREATISE COASTAL EST, V9, pCH9; Niquil N, 2006, FRESHWATER BIOL, V51, P1570, DOI 10.1111/j.1365-2427.2006.01595.x; Niquil N, 2011, HYDROBIOLOGIA, V659, P65, DOI 10.1007/s10750-010-0308-6; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; PACE ML, 1981, LIMNOL OCEANOGR, V26, P822, DOI 10.4319/lo.1981.26.5.0822; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Petit M, 1999, FRESHWATER BIOL, V42, P513, DOI 10.1046/j.1365-2427.1999.00500.x; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pimm SL, 1991, BALANCE NATURE ECOLO; PREPAS E, 1978, LIMNOL OCEANOGR, V23, P557, DOI 10.4319/lo.1978.23.3.0557; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; RASCONI S, 2010, THESIS BLAISE PASCAL; Rasconi S, 2009, APPL ENVIRON MICROB, V75, P2545, DOI 10.1128/AEM.02211-08; RIEMANN F, 1990, MAR BIOL, V104, P453, DOI 10.1007/BF01314349; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; RUTLEDGE RW, 1976, J THEOR BIOL, V57, P355, DOI 10.1016/0022-5193(76)90007-2; Sigee D. C., 2005, FRESHWATER MICROBIOL; SIMENGANDO T, 1991, EUR J PROTISTOL, V27, P249, DOI 10.1016/S0932-4739(11)80062-3; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SONDERGAARD M, 1991, MAR ECOL PROG SER, V79, P139, DOI 10.3354/meps079139; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; SUBERKROPP KF, 1973, ARCH MIKROBIOL, V89, P205, DOI 10.1007/BF00422201; Thompson RM, 2005, J ANIM ECOL, V74, P77, DOI 10.1111/j.1365-2656.2004.00899.x; Tsui C.K.M., 2003, FUNGAL DIVERSITY RES, V10; Tukey JW, 1977, EXPLORATORY DATA ANA; Ulanowicz R. E., 1991, Environmental Software, V6, P131, DOI 10.1016/0266-9838(91)90024-K; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; ULANOWICZ RE, 1979, AM NAT, V114, P871, DOI 10.1086/283534; ULANOWICZ RE, 1980, J THEOR BIOL, V85, P223, DOI 10.1016/0022-5193(80)90019-3; Ulanowicz RE, 2003, COMPUT BIOL CHEM, V27, P523, DOI 10.1016/S1476-9271(03)00050-1; ULANOWICZ RE, 1988, ECOL MODEL, V43, P45, DOI 10.1016/0304-3800(88)90072-5; ULANOWICZ RE, 1991, COMPARATIVE ANALYSES OF ECOSYSTEMS, P140; ULANOWICZ RE, 1990, INT J SYST SCI, V21, P429, DOI 10.1080/00207729008910372; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Donk E., 1989, P171; VANDONK E, 1983, FRESHWATER BIOL, V13, P241; VEZINA AF, 1988, MAR ECOL PROG SER, V42, P269, DOI 10.3354/meps042269; Weinbauer MG, 2002, AQUAT MICROB ECOL, V27, P103, DOI 10.3354/ame027103; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Yoshimizu Chikage, 2001, Limnology, V2, P37, DOI 10.1007/s102010170014	118	52	53	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23273	10.1371/journal.pone.0023273	http://dx.doi.org/10.1371/journal.pone.0023273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887240	Green Published, gold			2022-12-27	WOS:000294251800009
J	Kuete, V; Wabo, HK; Eyong, KO; Feussi, MT; Wiench, B; Krusche, B; Tane, P; Folefoc, GN; Efferth, T				Kuete, Victor; Wabo, Hippolyte K.; Eyong, Kenneth O.; Feussi, Michel T.; Wiench, Benjamin; Krusche, Benjamin; Tane, Pierre; Folefoc, Gabriel N.; Efferth, Thomas			Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants	PLOS ONE			English	Article							ANTHRAQUINONE COUPLED PIGMENT; ANTIMICROBIAL ACTIVITY; CONSTITUENTS; NEWBOULDIAQUINONE; EXTRACTS	Background: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V-1 (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (6) against MiaPaCa-2 pancreatic and CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000. Compounds 1 and 2 were then tested in several other cancer cells and their possible mode of action were investigated. Methodology/Findings: The tested compounds were previously isolated from the Cameroonian medicinal plants Vismia laurentii (1, 3, 4, 5 and 6) and Newbouldia laevis (2). The preliminary cytotoxicity results allowed the selection of xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone, which were then tested on a panel of cancer cell lines. The study was also extended to the analysis of cell cycle distribution, apoptosis induction, caspase 3/7 activation and the anti-angiogenic properties of xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone. IC50 values around or below 4 mu g/ml were obtained on 64.29% and 78.57% of the tested cancer cell lines for xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone, respectively. The most sensitive cell lines (IC50 <1 mu g/ml) were breast MCF-7 (to xanthone V-1), cervix HeLa and Caski (to xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone), leukemia PF-382 and melanoma colo-38 (to 2-acetylfuro-1,4-naphthoquinone). The two compounds showed respectively, 65.8% and 59.6% inhibition of the growth of blood capillaries on the chorioallantoic membrane of quail eggs in the anti-angiogenic assay. Upon treatment with two fold IC50 and after 72 h, the two compounds induced cell cycle arrest in S-phase, and also significant apoptosis in CCRF-CEM leukemia cells. Caspase 3/7 was activated by xanthone V-1. Conclusions/Significance: The overall results of the present study provided evidence for the cytotoxicity of compounds xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone, and bring supportive data for future investigations that will lead to their use in cancer therapy.	[Kuete, Victor] Univ Dschang, Fac Sci, Dept Biochem, Dschang, Cameroon; [Kuete, Victor; Wiench, Benjamin; Krusche, Benjamin; Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharm & Biochem, Mainz, Germany; [Wabo, Hippolyte K.; Feussi, Michel T.; Tane, Pierre] Univ Dschang, Fac Sci, Dept Chem, Dschang, Cameroon; [Eyong, Kenneth O.; Folefoc, Gabriel N.] Univ Yaounde I, Dept Organ Chem, Fac Sci, Yaounde, Cameroon	Johannes Gutenberg University of Mainz; University of Yaounde I	Kuete, V (corresponding author), Univ Dschang, Fac Sci, Dept Biochem, Dschang, Cameroon.	efferth@uni-mainz.de	Victor, Kuete/O-2742-2018	Victor, Kuete/0000-0002-1070-1236; Efferth, Thomas/0000-0002-3096-3292	University of Mainz	University of Mainz	VK received a six-month funding stay at the University of Mainz paid by the University of Mainz, and a three-month stay as DAAD fellow at the University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu G, 2010, NAT PROD COMMUN, V5, P747; Boik J, 2001, NATURAL COMPOUNDS CA; Boonsri S, 2006, PHYTOCHEMISTRY, V67, P723, DOI 10.1016/j.phytochem.2006.01.007; Brahemi G, 2010, J MED CHEM, V53, P2757, DOI 10.1021/jm901757t; CORDELL GA, 1991, J ETHNOPHARMACOL, V32, P117, DOI 10.1016/0378-8741(91)90110-Y; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; DARCY PF, 1967, BRIT J PHARM CHEMOTH, V29, P378, DOI 10.1111/j.1476-5381.1967.tb01969.x; Eyong KO, 2006, PHYTOCHEMISTRY, V67, P605, DOI 10.1016/j.phytochem.2005.12.019; Eyong KO, 2005, CHEM PHARM BULL, V53, P616, DOI 10.1248/cpb.53.616; Guo SY, 2011, MOLECULES, V16, P1201, DOI 10.3390/molecules16021201; Hussein AA, 2003, J NAT PROD, V66, P858, DOI 10.1021/np020566w; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joshi SC, 2010, FOOD CHEM TOXICOL, V48, P37, DOI 10.1016/j.fct.2009.09.011; Kuete V, 2007, PHARMAZIE, V62, P552, DOI 10.1691/ph.2007.7.6757; Kuete V, 2007, J ETHNOPHARMACOL, V109, P372, DOI 10.1016/j.jep.2006.07.044; Kuete V, 2011, J ETHNOPHARMACOL, V134, P803, DOI 10.1016/j.jep.2011.01.035; Kuo YC, 1997, LIFE SCI, V61, P2335, DOI 10.1016/S0024-3205(97)00937-5; Lenta BN, 2007, MOLECULES, V12, P1548, DOI 10.3390/12081548; Ma XX, 2010, PEST MANAG SCI, V66, P718, DOI 10.1002/ps.1933; Marchesan M, 1998, PHYTOTHER RES, V12, pS33, DOI 10.1002/(SICI)1099-1573(1998)12:1+&lt;S33::AID-PTR242&gt;3.0.CO;2-B; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Popoca J, 1998, J ETHNOPHARMACOL, V59, P173, DOI 10.1016/S0378-8741(97)00110-4; Shao Li-Jun, 2010, Zhong Yao Cai, V33, P1091; Tsaffack M, 2009, CHEM PHARM BULL, V57, P1113, DOI 10.1248/cpb.57.1113; Wabo HK, 2007, CHEM PHARM BULL, V55, P1640, DOI 10.1248/cpb.55.1640; Wang Junxian, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1435; WITTMANN J, 1987, J EXP ZOOL, P325	27	76	76	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e21762	10.1371/journal.pone.0021762	http://dx.doi.org/10.1371/journal.pone.0021762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886765	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100001
J	Lagarde, M; Paintain, LS; Antwi, G; Jones, C; Greenwood, B; Chandramohan, D; Tagbor, H; Webster, J				Lagarde, Mylene; Paintain, Lucy Smith; Antwi, Gifti; Jones, Caroline; Greenwood, Brian; Chandramohan, Daniel; Tagbor, Harry; Webster, Jayne			Evaluating Health Workers' Potential Resistance to New Interventions: A Role for Discrete Choice Experiments	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; PREGNANCY; MALARIA; IMPLEMENTATION; DELIVERY; GAP	Background: The currently recommended approach for preventing malaria in pregnancy (MiP), intermittent preventive treatment with sulphadoxine-pyrimethamine (SP-IPT), has been questioned due to the spread of resistance to SP. Whilst trials are underway to test the efficacy of future alternative approaches, it is important to start exploring the feasibility of their implementation. Methods and Findings: This study uses a discrete choice experiment (DCE) method to assess the potential resistance of health workers to changing strategies for control of MiP. In Ashanti region in Ghana, 133 antenatal clinic health workers were presented with 16 choice sets of two alternative policy options, each consisting of a bundle of six attributes representing certain clinical guidelines for controlling MiP (type of approach and drug used), possible associated maternal and neo-natal outcomes, workload and financial incentives. The data were analysed using a random effects logit model. Overall, staff showed a preference for a curative approach with pregnant women tested for malaria parasites and treated only if positive, compared to a preventive approach (OR 1.6; p = 0.001). Increasing the incidence of low birth weight or severe anaemia by 1% would reduce the odds of preferring an approach by 18% and 10% respectively. Midwives were more resistant to potential changes to current guidelines than lower-level cadres. Conclusions: In Ashanti Region, resistance to change by antenatal clinic workers from a policy of SP-IPT to IST would generally be low, and it would disappear amongst midwives if health outcomes for the mother and baby were improved by the new strategy. DCEs are a promising approach to identifying factors that will increase the likelihood of effective implementation of new interventions immediately after their efficacy has been proven.	[Lagarde, Mylene] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Paintain, Lucy Smith; Jones, Caroline; Greenwood, Brian; Chandramohan, Daniel; Tagbor, Harry; Webster, Jayne] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Antwi, Gifti; Tagbor, Harry] KNUST, Sch Med Sci, Kumasi, Ghana	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Kwame Nkrumah University Science & Technology	Lagarde, M (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Mylene.Lagarde@lshtm.ac.uk	Tagbor, Harry/B-9312-2018; Lagarde, Mylene/GVS-9289-2022	Tagbor, Harry/0000-0002-9300-665X; Webster, Jayne/0000-0002-0498-8883	DFiD; Bill and Melinda Gates Foundation	DFiD; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this study was provided by the DFiD-funded TARGETS Research Consortium and by Gates Malaria Partnership at the London School of Hygiene & Tropical Medicine which received support from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; BRABIN B, 1991, APPL FIELD RES MALAR, V1; Chico RM, 2011, TROP MED INT HEALTH, V16, P774, DOI 10.1111/j.1365-3156.2011.02765.x; de Bekker-Grob EW, 2010, HLTH EC; *GHAN HLTH SERV, 2009, GUID MAL PREGN; Guindon GE, 2010, CAN MED ASSOC J, V182, pE362, DOI 10.1503/cmaj.081165; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Kuhfeld W., 2009, MARKETING RES METHOD; Kweku M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007256; Landry CE, 2007, AM J AGR ECON, V89, P420, DOI 10.1111/j.1467-8276.2007.01017.x; Lomas J, 1997, IMPROVING RES DISSEM; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Newman RD, 2003, TROP MED INT HEALTH, V8, P488, DOI 10.1046/j.1365-3156.2003.01066.x; PAINTAIN LS, PLOS ONE UNPUB; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Siddiqi K, 2005, B WORLD HEALTH ORGAN, V83, P882; Street D. J., 2007, CONSTRUCTION OPTIMAL; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; Webster J, 2010, AM J TROP MED HYG, V82, P672, DOI 10.4269/ajtmh.2010.09-0473; *WHO REG OFF AFR, 2004, AFRMAL0401 WHO REG O	25	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23588	10.1371/journal.pone.0023588	http://dx.doi.org/10.1371/journal.pone.0023588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810LZ	21886800	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000294128100020
J	Liot, C; Seguin, L; Siret, A; Crouin, C; Schmidt, S; Bertoglio, J				Liot, Caroline; Seguin, Laetitia; Siret, Aurelie; Crouin, Catherine; Schmidt, Susanne; Bertoglio, Jacques			APC(cdh1) Mediates Degradation of the Oncogenic Rho-GEF Ect2 after Mitosis	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; CYTOKINESIS REGULATOR ECT2; AURORA-B; SIGNALING PATHWAYS; DESTRUCTION BOX; ACTIVATION; EXPRESSION; MGCRACGAP; GTPASE; PHOSPHORYLATION	Background: Besides regulation of actin cytoskeleton-dependent functions, Rho GTPase pathways are essential to cell cycle progression and cell division. Rho, Rac and Cdc42 regulate G1 to S phase progression and are involved in cytokinesis. RhoA GDP/GTP cycling is required for normal cytokinesis and recent reports have shown that the exchange factor Ect2 and the GTPase activating protein MgcRacGAP regulate RhoA activity during mitosis. We previously showed that the transcription factors E2F1 and CUX1 regulate expression of MgcRacGAP and Ect2 as cells enter S-phase. Methodology/Principal Findings: We now report that Ect2 is subject to proteasomal degradation after mitosis, following ubiquitination by the APC/C complex and its co-activator Cdh1. A proper nuclear localization of Ect2 is necessary for its degradation. APC-Cdh1 assembles K11-linked poly-ubiquitin chains on Ect2, depending upon a stretch of similar to 25 amino acid residues that contain a bi-partite NLS, a conventional D-box and two TEK-like boxes. Site-directed mutagenesis of target sequences generated stabilized Ect2 proteins. Furthermore, such degradation-resistant mutants of Ect2 were found to activate RhoA and subsequent signalling pathways and are able to transform NIH3T3 cells. Conclusions/Significance: Our results identify Ect2 as a bona fide cell cycle-regulated protein and suggest that its ubiquitination-dependent degradation may play an important role in RhoA regulation at the time of mitosis. Our findings raise the possibility that the overexpression of Ect2 that has been reported in some human tumors might result not only from deregulated transcription, but also from impaired degradation.	[Liot, Caroline; Seguin, Laetitia; Siret, Aurelie; Crouin, Catherine; Bertoglio, Jacques] Inst Gustave Roussy, Inserm U749, Villejuif, France; [Schmidt, Susanne] CNRS UMR 5237, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Liot, C (corresponding author), Inst Gustave Roussy, Inserm U749, Villejuif, France.	jacques.bertoglio@igr.fr		Seguin, Laetitia/0000-0002-9610-7093; SEGUIN, Laetitia/0000-0003-2950-4766	Inserm; Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche [BLAN06 2_135169]; Ministry of Research and Education; Association pour la Recherche contre le Cancer	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministry of Research and Education; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was funded in part by Inserm, and grants from Ligue Nationale Contre le Cancer (equipe labellisee) and Agence Nationale de la Recherche grant BLAN06 2_135169. CL was supported by Ministry of Research and Education and by Association pour la Recherche contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Bouquier N, 2009, CHEM BIOL, V16, P391, DOI 10.1016/j.chembiol.2009.02.006; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Eguchi T, 2007, ONCOGENE, V26, P509, DOI 10.1038/sj.onc.1209810; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hahn MA, 2005, ONCOGENE, V24, P6241, DOI 10.1038/sj.onc.1208778; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; HORI T, 1987, BLOOD, V70, P1069; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Manchinelly SAS, 2010, J BIOL CHEM, V285, P26923, DOI 10.1074/jbc.M110.103804; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mzali R, 2005, FASEB J, V19, P1911, DOI 10.1096/fj.05-4030fje; Naoe H, 2010, MOL CELL BIOL, V30, P3994, DOI 10.1128/MCB.01358-09; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Seguin L, 2009, MOL CELL BIOL, V29, P570, DOI 10.1128/MCB.01275-08; Solski PA, 2004, J BIOL CHEM, V279, P25226, DOI 10.1074/jbc.M313792200; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Su L, 2009, EXP CELL RES, V315, P1347, DOI 10.1016/j.yexcr.2009.02.014; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Toure A, 2008, FEBS LETT, V582, P1182, DOI 10.1016/j.febslet.2007.12.036; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200	50	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23676	10.1371/journal.pone.0023676	http://dx.doi.org/10.1371/journal.pone.0023676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886810	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100024
J	Howard, MK; Sabarth, N; Savidis-Dacho, H; Portsmouth, D; Kistner, O; Kreil, TR; Ehrlich, HJ; Barrett, PN				Howard, M. Keith; Sabarth, Nicolas; Savidis-Dacho, Helga; Portsmouth, Daniel; Kistner, Otfried; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel			H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model	PLOS ONE			English	Article							PANDEMIC INFLUENZA VACCINE; CELL-CULTURE; MONOCLONAL-ANTIBODIES; THERAPEUTIC-EFFICACY; EGG-ADAPTATION; H1N1 VACCINE; WILD-TYPE; INFECTION; MICE; HEMAGGLUTININ	Background: Vero cell culture-derived whole-virus H5N1 vaccines have been extensively tested in clinical trials and consistently demonstrated to be safe and immunogenic; however, clinical efficacy is difficult to evaluate in the absence of wide-spread human disease. A lethal mouse model has been utilized which allows investigation of the protective efficacy of active vaccination or passive transfer of vaccine induced sera following lethal H5N1 challenge. Methods: We used passive transfer of immune sera to investigate antibody-mediated protection elicited by a Vero cell-derived, non-adjuvanted inactivated whole-virus H5N1 vaccine. Mice were injected intravenously with H5N1 vaccine-induced rodent or human immune sera and subsequently challenged with a lethal dose of wild-type H5N1 virus. Results: Passive transfer of H5N1 vaccine-induced mouse, guinea pig and human immune sera provided dose-dependent protection of recipient mice against lethal challenge with wild-type H5N1 virus. Protective dose fifty values for serum H5N1 neutralizing antibody titers were calculated to be <= 1:11 for all immune sera, independently of source species. Conclusions: These data underpin the confidence that the Vero cell culture-derived, whole-virus H5N1 vaccine will be effective in a pandemic situation and support the use of neutralizing serum antibody titers as a correlate of protection for H5N1 vaccines.	[Howard, M. Keith; Sabarth, Nicolas; Savidis-Dacho, Helga; Portsmouth, Daniel; Kistner, Otfried; Kreil, Thomas R.; Barrett, P. Noel] Baxter BioSci, Vaccine Res & Dev, Orth, Austria; [Ehrlich, Hartmut J.] Baxter BioSci, Global Res & Dev, Vienna, Austria		Howard, MK (corresponding author), Baxter BioSci, Vaccine Res & Dev, Orth, Austria.	keith_howard@baxter.com	Sabarth, Nicolas/GQQ-0093-2022; Sabarth, Nicolas/GQP-7376-2022	Sabarth, Nicolas/0000-0003-3844-6297; 	Baxter Bioscience	Baxter Bioscience	This study was funded by Baxter Bioscience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Ascione A, 2009, ANTIVIR RES, V83, P238, DOI 10.1016/j.antiviral.2009.05.005; Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Barrett PN, 2010, CURR OPIN MOL THER, V12, P21; Beasley DWC, 2004, VACCINE, V22, P3722, DOI 10.1016/j.vaccine.2004.03.027; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ehrlich HJ, 2009, J INFECT DIS, V200, P1113, DOI 10.1086/605608; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; FDA, 2007, GUID IND CLIN DAT NE; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Govorkova E A, 1999, Dev Biol Stand, V98, P39; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; HARDY CT, 1995, VIROLOGY, V211, P302, DOI 10.1006/viro.1995.1405; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; Howard MK, 2008, BIOL CHEM, V389, P569, DOI 10.1515/BC.2008.060; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Keitel W, 2010, VACCINE, V28, P840, DOI 10.1016/j.vaccine.2009.10.019; Kistner O, 1999, Dev Biol Stand, V98, P101; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Koudstaal W, 2009, J INFECT DIS, V200, P1870, DOI 10.1086/648378; Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X; Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Leroux-Roels I, 2009, EXPERT REV VACCINES, V8, P401, DOI 10.1586/ERV.09.15; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Nicholson KG, 2011, LANCET INFECT DIS, V11, P91, DOI 10.1016/S1473-3099(10)70296-6; *NIH, 2010, GUID SURV BLEED MIC; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Planitzer CB, 2007, J INFECT DIS, V196, P435, DOI 10.1086/519392; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005672; Prabhu N, 2009, ANTIVIR THER, V14, P911, DOI 10.3851/IMP1413; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROBERTSON JS, 1993, J GEN VIROL, V74, P2047, DOI 10.1099/0022-1317-74-10-2047; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Stephenson I, 2006, LANCET, V368, P965, DOI 10.1016/S0140-6736(06)69340-9; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Takada A, 2007, VACCINE, V25, P993, DOI 10.1016/j.vaccine.2006.09.076; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	49	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23791	10.1371/journal.pone.0023791	http://dx.doi.org/10.1371/journal.pone.0023791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876771	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900043
J	Benedetti, G; Morais, KLP; Guerreiro, JR; de Oliveira, EF; Hoshida, MS; Oliveira, L; Sass, N; Lebrun, I; Ulrich, H; Lameu, C; de Camargo, ACM				Benedetti, Gabriel; Morais, Katia L. P.; Guerreiro, Juliano R.; de Oliveira, Eduardo Fontana; Hoshida, Mara Sandra; Oliveira, Leandro; Sass, Nelson; Lebrun, Ivo; Ulrich, Henning; Lameu, Claudiana; Martins de Camargo, Antonio Carlos			Bothrops jararaca Peptide with Anti-Hypertensive Action Normalizes Endothelium Dysfunction Involved in Physiopathology of Preeclampsia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; L-ARGININE; CALMODULIN; PREGNANCIES; INHIBITION; SYNTHETASE; MECHANISMS; THERAPY; TISSUES	Preeclampsia, a pregnancy-specific syndrome characterized by hypertension, proteinuria and edema, is a major cause of fetal and maternal morbidity and mortality especially in developing countries. Bj-PRO-10c, a proline-rich peptide isolated from Bothrops jararaca venom, has been attributed with potent anti-hypertensive effects. Recently, we have shown that Bj-PRO-10c-induced anti-hypertensive actions involved NO production in spontaneous hypertensive rats. Using in vitro studies we now show that Bj-PRO-10c was able to increase NO production in human umbilical vein endothelial cells from hypertensive pregnant women (HUVEC-PE) to levels observed in HUVEC of normotensive women. Moreover, in the presence of the peptide, eNOS expression as well as argininosuccinate synthase activity, the key rate-limiting enzyme of the citrulline-NO cycle, were enhanced. In addition, excessive superoxide production due to NO deficiency, one of the major deleterious effects of the disease, was inhibited by Bj-PRO-10c. Bj-PRO-10c induced intracellular calcium fluxes in both, HUVEC-PE and HUVEC, which, however, led to activation of eNOS expression only in HUVEC-PE. Since Bj-PRO-10c promoted biological effects in HUVEC from patients suffering from the disorder and not in normotensive pregnant women, we hypothesize that Bj-PRO-10c induces its anti-hypertensive effect in mothers with preeclampsia. Such properties may initiate the development of novel therapeutics for treating preeclampsia.	[Benedetti, Gabriel; Morais, Katia L. P.; de Oliveira, Eduardo Fontana; Martins de Camargo, Antonio Carlos] Inst Butantan, Ctr Pesquisa Inovacio & Difusao, Ctr Appl Toxinol, Sao Paulo, Brazil; [Benedetti, Gabriel; Morais, Katia L. P.; de Oliveira, Eduardo Fontana] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Guerreiro, Juliano R.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Ciencias Biol, Ctr Biotecnol Agr,Lab Bioquim Prot, Sao Paulo, Brazil; [Hoshida, Mara Sandra] Univ Sao Paulo, Fac Med, Lab Fisiol Obstet, Sao Paulo, Brazil; [Oliveira, Leandro; Sass, Nelson] Hosp Maternidade Vila Nova Cachoeirinha, Sao Paulo, Brazil; [Lebrun, Ivo] Inst Butantan, Lab Bioquim & Biofis, Sao Paulo, Brazil; [Ulrich, Henning; Lameu, Claudiana] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Martins de Camargo, Antonio Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Benedetti, G (corresponding author), Inst Butantan, Ctr Pesquisa Inovacio & Difusao, Ctr Appl Toxinol, Sao Paulo, Brazil.	claulameu@usp.br	Ulrich, Henning/C-5245-2013; Lameu, Claudiana/B-9089-2012; De Oliveira, Leandro/G-3476-2012; Hoshida, Mara S/D-3900-2012; Ulrich, Henning/AAX-8586-2021; Sass, Nelson/AAD-8259-2020; Sass, Nelson/E-3252-2013	Ulrich, Henning/0000-0002-2114-3815; Lameu, Claudiana/0000-0002-6874-5864; De Oliveira, Leandro/0000-0002-8422-9907; Hoshida, Mara S/0000-0003-2232-4631; Ulrich, Henning/0000-0002-2114-3815; Morais, Katia/0000-0001-8877-5887	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Pesquisa, Brazil through the Center for Applied Toxinology-Centros de Pesquisa, Inovacio e Difusao	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa, Brazil through the Center for Applied Toxinology-Centros de Pesquisa, Inovacio e Difusao	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Pesquisa, Brazil through the Center for Applied Toxinology-Centros de Pesquisa, Inovacio e Difusao supported this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Atherton E., 1990, SOLID PHASE PEPTIDE; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Cawley SM, 2007, CELL SIGNAL, V19, P1023, DOI 10.1016/j.cellsig.2006.11.012; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; Duley L, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001449.pub2, 10.1002/14651858.CD001449.pub3]; Escudero C, 2008, PLACENTA, V29, P469, DOI 10.1016/j.placenta.2008.02.008; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Gu Y, 2006, HYPERTENS PREGNANCY, V25, P169, DOI 10.1080/10641950600912950; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Ianzer D, 2007, J PHARMACOL EXP THER, V322, P795, DOI 10.1124/jpet.107.120873; Khalil A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002766; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; LAMEU C, 2010, HYP RES IN PRESS; Lameu C, 2010, CYTOM PART A, V77A, P220, DOI 10.1002/cyto.a.20860; Lindheimer MD, 2010, J AM SOC HYPERTENS, V4, P68, DOI 10.1016/j.jash.2010.03.002; Lopez-Jaramillo Patricio, 2008, Ther Adv Cardiovasc Dis, V2, P261, DOI 10.1177/1753944708092277; LOWE D, 2000, BIOL CHEM, V4, P441; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NEGRAES PD, 2010, CYTOMETRY A IN PRESS; Noris M, 2004, HYPERTENSION, V43, P614, DOI 10.1161/01.HYP.0000116220.39793.c9; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; RUGGENENTI MDP, 2005, L ARGININE PREECLAMP; Rytlewski K, 2005, EUR J CLIN INVEST, V35, P32, DOI 10.1111/j.1365-2362.2005.01445.x; Sachdeva P, 2009, INDIAN J PHARM SCI, V71, P1, DOI 10.4103/0250-474X.51941; Sankaralingam S, 2010, CARDIOVASC RES, V85, P194, DOI 10.1093/cvr/cvp277; Santana LF, 2009, J MOL CELL CARDIOL, V47, P436, DOI 10.1016/j.yjmcc.2009.07.008; SCHMIDT HHHW, 1991, P NATL ACAD SCI USA, V88, P365, DOI 10.1073/pnas.88.2.365; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Thadhani R, 2010, HYPERTENSION, V55, P238, DOI 10.1161/HYPERTENSIONAHA.109.143933; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Zhang G, 2006, AM J PHYSIOL-HEART C, V290, pH1172, DOI 10.1152/ajpheart.00441.2005	39	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23680	10.1371/journal.pone.0023680	http://dx.doi.org/10.1371/journal.pone.0023680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858206	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300082
J	Botti, V; Bianchi, A; Foung, SKH; Merola, M				Botti, Valentina; Bianchi, Alessia; Foung, Steven K. H.; Merola, Marcello			The Hepatitis C Virus E1 Glycoprotein Undergoes Productive Folding but Accelerated Degradation When Expressed as an Individual Subunit in CHO Cells	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; DISULFIDE BOND FORMATION; NEUTRALIZING ANTIBODIES; MISFOLDED GLYCOPROTEINS; PROTEIN; BINDING; DIMERIZATION; RECOGNITION; VACCINATION; SIGNAL	Hepatitis C Virus E1E2 heterodimers are components of the viral spike. Although there is a general agreement on the necessity of the co-expression of both E1 and E2 on a single coding unit for their productive folding and assembly, in a previous study using an in vitro system we obtained strong indications that E1 can achieve folding in absence of E2. Here, we have studied the folding pathway of unescorted E1 from stably expressing CHO cells, compared to the folding observed in presence of the E2 protein. A DTT-resistant conformation is achieved by E1 in both situations, consistent with the presence of an E2-independent oxidative pathway. However, while the E1E2 heterodimer is stable inside cells, E1 expressed alone is degraded within a few hours. On the other hand, the oxidation and stability of individually expressed E2 subunits is dependent on E1 co-expression. These data are consistent with E1 and E2 assisting each other for correct folding via different mechanisms: E2 assists E1 by stabilizing a semi-native conformation meanwhile E1 drives E2 towards a productive folding pathway.	[Botti, Valentina; Bianchi, Alessia; Merola, Marcello] Novartis Vaccines & Diagnost, Siena, Italy; [Foung, Steven K. H.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Merola, Marcello] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy	Novartis; Stanford University; University of Naples Federico II	Botti, V (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	marcello.merola@novartis.com		Foung, Steven/0000-0001-7149-6160	PHS [AI081903]; EU [LSH-CT-2007-037435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081903] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); EU(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by PHS grant AI081903 to SKHF and by the EU FP6 contract LSH-CT-2007-037435 HEPACIVAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI LS, 2009, J VIROL; Andersson H, 1997, J VIROL, V71, P9654, DOI 10.1128/JVI.71.12.9654-9663.1997; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Brazzoli M, 2005, VIROLOGY, V332, P438, DOI 10.1016/j.virol.2004.11.034; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2003, J VIROL, V77, P1604, DOI 10.1128/JVI.77.2.1604-1609.2003; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Lin YL, 2008, J VIROL, V82, P7492, DOI 10.1128/JVI.02743-07; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; Merola M, 2001, J VIROL, V75, P11205, DOI 10.1128/JVI.75.22.11205-11217.2001; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SPAETE RR, 1992, VIROLOGY, V188, P819, DOI 10.1016/0042-6822(92)90537-Y; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Zeisel MB, 2007, WORLD J GASTROENTERO, V13, P4824, DOI 10.3748/wjg.v13.i36.4824	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23838	10.1371/journal.pone.0023838	http://dx.doi.org/10.1371/journal.pone.0023838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858229	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300100
J	Finley, LWS; Haas, W; Desquiret-Dumas, V; Wallace, DC; Procaccio, V; Gygi, SP; Haigis, MC				Finley, Lydia W. S.; Haas, Wilhelm; Desquiret-Dumas, Valerie; Wallace, Douglas C.; Procaccio, Vincent; Gygi, Steven P.; Haigis, Marcia C.			Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LYSINE ACETYLATION; COMPLEX-II; CALORIE RESTRICTION; RESPIRATORY-CHAIN; SIRT3-MEDIATED DEACETYLATION; MITOCHONDRIA; METABOLISM; PROTEOMICS; STRESS	Background: Sirtuins (SIRT1-7) are a family of NAD-dependent deacetylases and/or ADP-ribosyltransferases that are involved in metabolism, stress responses and longevity. SIRT3 is localized to mitochondria, where it deacetylates and activates a number of enzymes involved in fuel oxidation and energy production. Methodology/Principal Findings: In this study, we performed a proteomic screen to identify SIRT3 interacting proteins and identified several subunits of complex II and V of the electron transport chain. Two subunits of complex II (also known as succinate dehydrogenase, or SDH), SDHA and SDHB, interacted specifically with SIRT3. Using mass spectrometry, we identified 13 acetylation sites on SDHA, including six novel acetylated residues. SDHA is hyperacetylated in SIRT3 KO mice and SIRT3 directly deacetylates SDHA in a NAD-dependent manner. Finally, we found that SIRT3 regulates SDH activity both in cells and in murine brown adipose tissue. Conclusions/Significance: Our study identifies SDHA as a binding partner and substrate for SIRT3 deacetylase activity. SIRT3 loss results in decreased SDH enzyme activity, suggesting that SIRT3 may be an important physiological regulator of SDH activity.	[Finley, Lydia W. S.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; [Finley, Lydia W. S.; Haas, Wilhelm; Gygi, Steven P.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Desquiret-Dumas, Valerie; Procaccio, Vincent] Angers Univ Hosp, Sch Med, Dept Biochem & Genet, Angers, France; [Desquiret-Dumas, Valerie; Procaccio, Vincent] U771 CNRS6214, UMR INSERM, Angers, France; [Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Finley, LWS (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu	Desquiret-Dumas, Valérie/K-2695-2015	procaccio, Vincent/0000-0002-1537-4684; Desquiret-Dumas, Valerie/0000-0001-9551-9400	National Science Foundation; National Institutes of Health [AG032375]; Muscular Dystrophy Association; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	LWSF is supported by a National Science Foundation graduate research fellowship. MH is supported in part by National Institutes of Health grant AG032375 and funding from the Muscular Dystrophy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackrell BAC, 2000, FEBS LETT, V466, P1, DOI 10.1016/S0014-5793(99)01749-4; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	249	259	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23295	10.1371/journal.pone.0023295	http://dx.doi.org/10.1371/journal.pone.0023295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858060	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300029
J	Li, J; Hand, LE; Meng, QJ; Loudon, ASI; Bechtold, DA				Li, Jian; Hand, Laura E.; Meng, Qing-Jun; Loudon, Andrew S. I.; Bechtold, David A.			GPR50 Interacts with TIP60 to Modulate Glucocorticoid Receptor Signalling	PLOS ONE			English	Article							MELATONIN-RELATED RECEPTOR; PROTEIN TIP60; IDENTIFICATION; ACTIVATION; BINDING	GPR50 is an orphan G-protein coupled receptor most closely related to the melatonin receptors. The physiological function of GPR50 remains unclear, although our previous studies implicate the receptor in energy homeostasis. Here, we reveal a role for GPR50 as a signalling partner and modulator of the transcriptional co-activator TIP60. This interaction was identified in a yeast-two-hybrid screen, and confirmed by co-immunoprecipitation and co-localisation of TIP60 and GPR50 in HEK293 cells. Co-expression with TIP60 increased perinuclear localisation of full length GPR50, and resulted in nuclear translocation of the cytoplasmic tail of the receptor, suggesting a functional interaction of the two proteins. We further demonstrate that GPR50 can enhance TIP60-coactiavtion of glucocorticoid receptor (GR) signalling. In line with in vitro results, repression of pituitary Pomc expression, and induction of gluconeogenic genes in liver in response to the GR agonist, dexamethasone was attenuated in Gpr50(-/-) mice. These results identify a novel role for GPR50 in glucocorticoid receptor signalling through interaction with TIP60.	[Li, Jian; Hand, Laura E.; Meng, Qing-Jun; Loudon, Andrew S. I.; Bechtold, David A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Li, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	andrew.loudon@manchester.ac.uk; david.bechtold@manchester.ac.uk		Meng, Qing Jun/0000-0002-9426-8336; Loudon, Andrew/0000-0003-3648-445X; Bechtold, David/0000-0001-8676-8704	Biotechnology and Biological Sciences Research Council (BBSRC) [BBE0104901]; MRC [G0900414] Funding Source: UKRI; Medical Research Council [G0900414] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC #BBE0104901, www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Bhattacharyya S, 2006, J LIPID RES, V47, P761, DOI 10.1194/jlr.M500338-JLR200; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Conway S, 2000, J BIOL CHEM, V275, P20602, DOI 10.1074/jbc.M002358200; Dufourny L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-105; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Giles A, 2011, J CELL SCI, V124, P540, DOI 10.1242/jcs.078642; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kim MS, 2006, J BIOL CHEM, V281, P15082, DOI 10.1074/jbc.M513593200; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; MacIntyre DJ, 2010, NEUROSCI LETT, V475, P169, DOI 10.1016/j.neulet.2010.03.072; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Ran QT, 2000, GENE, V258, P141, DOI 10.1016/S0378-1119(00)00410-8; Reppert SM, 1996, FEBS LETT, V386, P219, DOI 10.1016/0014-5793(96)00437-1; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sliva D, 1999, BIOCHEM BIOPH RES CO, V263, P149, DOI 10.1006/bbrc.1999.1083; Thomson PA, 2005, MOL PSYCHIATR, V10, P470, DOI 10.1038/sj.mp.4001593; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595	32	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23725	10.1371/journal.pone.0023725	http://dx.doi.org/10.1371/journal.pone.0023725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858214	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300087
J	Mueller, C; Edmiston, KH; Carpenter, C; Gaffney, E; Ryan, C; Ward, R; White, S; Memeo, L; Colarossi, C; Petricoin, EF; Liotta, LA; Espina, V				Mueller, Claudius; Edmiston, Kirsten H.; Carpenter, Calvin; Gaffney, Eoin; Ryan, Ciara; Ward, Ronan; White, Susan; Memeo, Lorenzo; Colarossi, Cristina; Petricoin, Emanuel F., III; Liotta, Lance A.; Espina, Virginia			One-Step Preservation of Phosphoproteins and Tissue Morphology at Room Temperature for Diagnostic and Research Specimens	PLOS ONE			English	Article							PHASE PROTEIN MICROARRAYS; IMMUNOHISTOCHEMICAL DETECTION; WOUND AGE; DECALCIFICATION; RECOMMENDATIONS; EXPRESSION; RECEPTORS; PATHWAYS; FIXATION; VITALITY	Background: There is an urgent need to measure phosphorylated cell signaling proteins in cancer tissue for the individualization of molecular targeted kinase inhibitor therapy. However, phosphoproteins fluctuate rapidly following tissue procurement. Snap-freezing preserves phosphoproteins, but is unavailable in most clinics and compromises diagnostic morphology. Formalin fixation preserves tissue histomorphology, but penetrates tissue slowly, and is unsuitable for stabilizing phosphoproteins. We originated and evaluated a novel one-step biomarker and histology preservative (BHP) chemistry that stabilizes signaling protein phosphorylation and retains formalin-like tissue histomorphology with equivalent immunohistochemistry in a single paraffin block. Results: Total protein yield extracted from BHP-fixed, routine paraffin-embedded mouse liver was 100% compared to snap-frozen tissue. The abundance of 14 phosphorylated proteins was found to be stable over extended fixation times in BHP fixed paraffin embedded human colon mucosa. Compared to matched snap-frozen tissue, 8 phosphoproteins were equally preserved in mouse liver, while AMPK beta 1 Ser108 was slightly elevated after BHP fixation. More than 25 tissues from mouse, cat and human specimens were evaluated for preservation of histomorphology. Selected tissues were evaluated in a multi-site, independent pathology review. Tissue fixed with BHP showed equivalent preservation of cytoplasmic and membrane cytomorphology, with significantly better nuclear chromatin preservation by BHP compared to formalin. Immunohistochemical staining of 13 non-phosphorylated proteins, including estrogen receptor alpha, progesterone receptor, Ki-67 and Her2, was equal to or stronger in BHP compared to formalin. BHP demonstrated significantly improved immunohistochemical detection of phosphorylated proteins ERK Thr202/Tyr204, GSK3-alpha/beta Ser21/Ser9, p38-MAPK Thr180/Tyr182, eIF4G Ser1108 and Acetyl-CoA Carboxylase Ser79. Conclusion: In a single paraffin block BHP preserved the phosphorylation state of several signaling proteins at a level comparable to snap-freezing, while maintaining the full diagnostic immunohistochemical and histomorphologic detail of formalin fixation. This new tissue fixative has the potential to greatly facilitate personalized medicine, biobanking, and phospho-proteomic research.	[Mueller, Claudius; Petricoin, Emanuel F., III; Liotta, Lance A.; Espina, Virginia] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA; [Edmiston, Kirsten H.] Inova Fairfax Hosp, Inova Hlth Syst, Canc Translat Res Ctr, Falls Church, VA USA; [Carpenter, Calvin] George Mason Univ, Ctr Biodefense & Infect Dis, Manassas, VA USA; [Gaffney, Eoin; Ryan, Ciara; Ward, Ronan; White, Susan] St James Hosp, Dublin, Ireland; [Memeo, Lorenzo; Colarossi, Cristina] Mediterranean Inst Oncol, Pathol Unit, Catania, Italy	George Mason University; Inova Fairfax Hospital; Inova Health System; George Mason University; Trinity College Dublin; Mediterranean Institute of Oncology	Mueller, C (corresponding author), George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA.	cmuelle1@gmu.edu	Mueller, Claudius/A-4459-2012	Mueller, Claudius/0000-0003-4499-4724; Memeo, Lorenzo/0000-0003-4251-7203; Espina, Virginia/0000-0001-5080-5972; Colarossi, Cristina/0000-0001-5395-8608	George Mason University; Inova Fairfax Hospital; Istituto Superiore di Sanita, Italy; National Institutes of Health, National Cancer Institute [R21CA125698-01A1]; NATIONAL CANCER INSTITUTE [R33CA157403, R21CA125698] Funding Source: NIH RePORTER	George Mason University; Inova Fairfax Hospital; Istituto Superiore di Sanita, Italy; National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by George Mason University, Inova Fairfax Hospital, the Istituto Superiore di Sanita, Italy, and a National Institutes of Health grant to LAL (R21CA125698-01A1) from the National Cancer Institute program "Innovations in cancer sample preparation". The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funding agencies.	Adegboyega PA, 2003, APPL IMMUNOHISTO M M, V11, P194, DOI 10.1097/00129039-200306000-00019; Alers JC, 1999, J HISTOCHEM CYTOCHEM, V47, P703, DOI 10.1177/002215549904700512; Arber DA, 2002, APPL IMMUNOHISTO M M, V10, P183, DOI 10.1097/00022744-200206000-00015; ATHANASOU NA, 1987, J CLIN PATHOL, V40, P874, DOI 10.1136/jcp.40.8.874; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Bell WC, 2008, BIOTECH HISTOCHEM, V83, P71, DOI 10.1080/10520290802127610; Bignold LP, 2002, BRIT J BIOMED SCI, V59, P105; BIRNER P, 2010, J NEUROONCOL; Boenisch T, 2005, APPL IMMUNOHISTO M M, V13, P283, DOI 10.1097/01.0000146524.74402.a4; Broxterman HJ, 2004, DRUG RESIST UPDATE, V7, P79, DOI 10.1016/j.drup.2004.02.004; Burns JA, 2009, J HISTOCHEM CYTOCHEM, V57, P257, DOI 10.1369/jhc.2008.952911; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; *CLSI, 1999, QUAL ASS IMM APPR GU; Davenport A, 2003, J CLIN PATHOL, V56, P200, DOI 10.1136/jcp.56.3.200; Delfour C, 2006, J MOL DIAGN, V8, P157, DOI 10.2353/jmoldx.2006.050105; ESPINA VA, 2008, MOL CELL PROTEOMICS; Espina V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010240; Espina V, 2009, PROTEOM CLIN APPL, V3, P874, DOI 10.1002/prca.200800001; Feng W, 2008, ANN CLIN LAB SCI, V38, P195; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Goldstein NS, 2007, APPL IMMUNOHISTO M M, V15, P124, DOI 10.1097/PAI.0b013e31804c7283; Grellner W, 2005, FORENSIC SCI INT, V153, P174, DOI 10.1016/j.forsciint.2004.08.021; Grellner W, 2002, FORENSIC SCI INT, V130, P90, DOI 10.1016/S0379-0738(02)00342-0; Grellner W, 2007, FORENSIC SCI INT, V165, P150, DOI 10.1016/j.forsciint.2006.05.029; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; KIERNAN, 2000, MICROSCOPY TODAY, V8, P8; Lee P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002007; LIM MD, 2010, ANAL CHEM; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; MARWITZ S, 2011, J HISTOCHEM CYTOCHEM; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Mueller C, 2010, MOL ONCOL, V4, P461, DOI 10.1016/j.molonc.2010.09.003; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Ostasiewicz P, 2010, J PROTEOME RES, V9, P3688, DOI 10.1021/pr100234w; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Robinson AA, 2009, PROTEOMICS, V9, P4433, DOI 10.1002/pmic.200900287; Rountree CB, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-61; Sarsfield P, 2000, J CLIN PATHOL-MOL PA, V53, P336; START RD, 1992, J CLIN PATHOL, V45, P1120, DOI 10.1136/jcp.45.12.1120; van Essen HF, 2010, J CLIN PATHOL, V63, P1090, DOI 10.1136/jcp.2010.079905; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	47	60	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23780	10.1371/journal.pone.0023780	http://dx.doi.org/10.1371/journal.pone.0023780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858221	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300094
J	Kondrak, M; Marincs, F; Kalapos, B; Juhasz, Z; Banfalvi, Z				Kondrak, Mihaly; Marincs, Ferenc; Kalapos, Balazs; Juhasz, Zsofia; Banfalvi, Zsofia			Transcriptome Analysis of Potato Leaves Expressing the Trehalose-6-Phosphate Synthase 1 Gene of Yeast	PLOS ONE			English	Article							MADS-BOX GENE; MEDIATED REGULATION; METABOLIC PATHWAYS; TREHALOSE; PLANTS; GROWTH; PHOSPHORYLATION; BIOSYNTHESIS; EVOLUTION; RESPONSES	Transgenic lines of the potato cultivar White Lady expressing the trehalose-6-phosphate synthase (TPS1) gene of yeast exhibit improved drought tolerance, but grow slower and have a lower carbon fixation rate and stomatal density than the wild-type. To understand the molecular basis of this phenomenon, we have compared the transcriptomes of wild-type and TPS1-transgenic plants using the POCI microarray containing 42,034 potato unigene probes. We show that 74 and 25 genes were up-, and down-regulated, respectively, in the mature source leaves of TPS1-transgenic plants when compared with the wild-type. The differentially regulated genes were assigned into 16 functional groups. All of the seven genes, which were assigned into carbon fixation and metabolism group, were up-regulated, while about 42% of the assigned genes are involved in transcriptional and post-transcriptional regulation. Expression of genes encoding a 14-3-3 regulatory protein, and four transcription factors were down-regulated in the TPS1-transgenic leaves. To verify the microarray results, we used RNA gel blot analysis to examine the expression of eight genes and found that the RNA gel blot and microarray data correlated in each case. Using the putative Arabidopsis orthologs of the assigned potato sequences we have identified putative transcription binding sites in the promoter region of the differentially regulated genes, and putative protein-protein interactions involving some of the up-and down-regulated genes. We have also demonstrated that starch content is lower, while malate, inositol and maltose contents are higher in the TPS1-transgenic than in the wild-type leaves. Our results suggest that a complex regulatory network, involving transcription factors and other regulatory proteins, underpins the phenotypic alterations we have observed previously in potato when expressing the TPS1 gene of yeast.	[Kondrak, Mihaly; Marincs, Ferenc; Juhasz, Zsofia; Banfalvi, Zsofia] Agr Biotechnol Ctr, H-2101 Godollo, Hungary; [Kalapos, Balazs] Szent Istvan Univ, Inst Genet & Biotechnol, Godollo, Hungary	Hungarian University of Agriculture & Life Sciences	Kondrak, M (corresponding author), Agr Biotechnol Ctr, H-2101 Godollo, Hungary.	banfalvi@abc.hu	Juhász, Zsófia/D-3740-2012; Bánfalvi, Zsófia/D-3494-2012; Kondrák, Mihály/D-3748-2012; Marincs, Ferenc/A-8562-2011	Marincs, Ferenc/0000-0002-5388-8344; Kalapos, Balazs/0000-0003-2340-4270	Hungarian grant OTKA [F68318]; Janos Bolyai Research Fellowship	Hungarian grant OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was supported by the Hungarian grant OTKA F68318. MK was a recipient of the Janos Bolyai Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; BANFALVI Z, 1994, MOL GEN GENET, V245, P517, DOI 10.1007/BF00302265; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Bulow L, 2009, NUCLEIC ACIDS RES, V37, pD983, DOI 10.1093/nar/gkn709; Carmona MJ, 1998, PLANTA, V207, P181, DOI 10.1007/s004250050471; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Doczi R, 2002, PLANT CELL ENVIRON, V25, P1197, DOI 10.1046/j.1365-3040.2002.00904.x; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; FU HY, 1995, PLANT CELL, V7, P1369, DOI 10.1105/tpc.7.9.1369; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kutter C, 2007, PLANT CELL, V19, P2417, DOI 10.1105/tpc.107.050377; Lozano-Juste J, 2010, PLANT PHYSIOL, V152, P891, DOI 10.1104/pp.109.148023; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Mitra A, 1998, FUNDAMENTALS QUALITY; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Rosin FM, 2003, PLANT PHYSIOL, V131, P1613, DOI 10.1104/pp.102.012500; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Rutschow H, 2008, PLANT PHYSIOL, V148, P156, DOI 10.1104/pp.108.124545; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sawchuk MG, 2008, PLANT PHYSIOL, V148, P1908, DOI 10.1104/pp.108.126946; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spooner DM, 2007, P NATL ACAD SCI USA, V104, P19398, DOI 10.1073/pnas.0709796104; STIEKEMA WJ, 1988, PLANT MOL BIOL, V11, P255, DOI 10.1007/BF00027383; Stiller I, 2008, PLANTA, V227, P299, DOI 10.1007/s00425-007-0617-9; Sun YJ, 2007, J INTEGR PLANT BIOL, V49, P940, DOI 10.1111/j.1744-7909.2007.00498.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Wei W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007209; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	56	24	27	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23466	10.1371/journal.pone.0023466	http://dx.doi.org/10.1371/journal.pone.0023466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858131	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500035
J	Chen, YL; Amantana, A; Tyavanagimatt, SR; Zima, D; Yan, XS; Kasi, G; Weeks, M; Stone, MA; Weimers, WC; Samuel, P; Tan, Y; Jones, KF; Lee, DR; Kickner, SS; Saville, BM; Lauzon, M; McIntyre, A; Honeychurch, KM; Jordan, R; Hruby, DE; Leeds, JM				Chen, Yali; Amantana, Adams; Tyavanagimatt, Shanthakumar R.; Zima, Daniela; Yan, X. Steven; Kasi, Gopi; Weeks, Morgan; Stone, Melialani A.; Weimers, William C.; Samuel, Peter; Tan, Ying; Jones, Kevin F.; Lee, Daniel R.; Kickner, Shirley S.; Saville, Bradley M.; Lauzon, Martin; McIntyre, Alan; Honeychurch, Kady M.; Jordan, Robert; Hruby, Dennis E.; Leeds, Janet M.			Comparison of the Safety and Pharmacokinetics of ST-246 (R) after IV Infusion or Oral Administration in Mice, Rabbits and Monkeys	PLOS ONE			English	Article							ANTIPOXVIRUS COMPOUND ST-246; CYTOMEGALOVIRUS RETINITIS; INTRAVENOUS CIDOFOVIR; SMALLPOX; VIRUS; EFFICACY; COWPOX; INFECTIONS; VACCINIA; PATIENT	Background: ST-246 (R) is an antiviral, orally bioavailable small molecule in clinical development for treatment of orthopoxvirus infections. An intravenous (IV) formulation may be required for some hospitalized patients who are unable to take oral medication. An IV formulation has been evaluated in three species previously used in evaluation of both efficacy and toxicology of the oral formulation. Methodology/Principal Findings: The pharmacokinetics of ST-246 after IV infusions in mice, rabbits and nonhuman primates (NHP) were compared to those obtained after oral administration. Ten minute IV infusions of ST-246 at doses of 3, 10, 30, and 75 mg/kg in mice produced peak plasma concentrations ranging from 16.9 to 238 mu g/mL. Elimination appeared predominately first-order and exposure dose-proportional up to 30 mg/kg. Short IV infusions (5 to 15 minutes) in rabbits resulted in rapid distribution followed by slower elimination. Intravenous infusions in NHP were conducted at doses of 1 to 30 mg/kg. The length of single infusions in NHP ranged from 4 to 6 hours. The pharmacokinetics and tolerability for the two highest doses were evaluated when administered as two equivalent 4 hour infusions initiated 12 hours apart. Terminal elimination half-lives in all species for oral and IV infusions were similar. Dose-limiting central nervous system effects were identified in all three species and appeared related to high C-max plasma concentrations. These effects were eliminated using slower IV infusions. Conclusions/Significance: Pharmacokinetic profiles after IV infusion compared to those observed after oral administration demonstrated the necessity of longer IV infusions to (1) mimic the plasma exposure observed after oral administration and (2) avoid Cmax associated toxicity. Shorter infusions at higher doses in NHP resulted in decreased clearance, suggesting saturated distribution or elimination. Elimination half-lives in all species were similar between oral and IV administration. The administration of ST-246 was well tolerated as a slow IV infusion.	[Saville, Bradley M.; Lauzon, Martin] Charles River Labs, Reno, NV USA; [McIntyre, Alan] Charles River Labs, Quebec City, PQ, Canada; [Chen, Yali; Amantana, Adams; Tyavanagimatt, Shanthakumar R.; Zima, Daniela; Yan, X. Steven; Kasi, Gopi; Weeks, Morgan; Stone, Melialani A.; Weimers, William C.; Samuel, Peter; Tan, Ying; Jones, Kevin F.; Lee, Daniel R.; Kickner, Shirley S.; Honeychurch, Kady M.; Jordan, Robert; Hruby, Dennis E.; Leeds, Janet M.] SIGA Technol, Corvallis, OR 97333 USA		Chen, YL (corresponding author), SIGA Technol, Corvallis, OR 97333 USA.	jleeds@siga.com			Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800041C, HHSN266200600014C]	Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services, and the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract nos. HHSN272200800041C and HHSN266200600014C. http://www.niaid.nih.gov/Pages/default.aspx. These funders reviewed and made suggestions regarding the study designs for studies in nonhuman primates. The funders had no input into the data collection or analysis, the decision to publish, or the preparation of the manuscript. They did review the manuscript. Yali Chen, Adams Amantana, Shanthakumar R. Tyavanagimatt, Daniela Zima, X. Steven Yan, Gopi Kasi, Morgan Weeks, Melialani A. Stone, William C. Weimers, Peter Samuel, Ying Tan, Kevin F. Jones, Daniel R. Lee, Shirley S. Kickner, Kady M. Honeychurch, Robert Jordan, Dennis E. Hruby and Janet M. Leeds are employees of SIGA Technologies. Bradley M. Saville, Martin Lauzon and Alan McIntyre are employees of Charles River Laboratories. These authors contributed to all aspects of the study. No additional external funding was received for this study.	Bailey TR, 2007, J MED CHEM, V50, P1442, DOI 10.1021/jm061484y; Baker R, 2003, ANTIVIR RES, V57, P13, DOI 10.1016/S0166-3542(02)00196-1; Bolken TC, 2010, DRUG TODAY, V46, P109, DOI 10.1358/dot.2010.46.2.1437244; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P532; Chen YL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-44; Ciesla SL, 2003, ANTIVIR RES, V59, P163, DOI 10.1016/S0166-3542(03)00110-4; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; Duclos P, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S2; Duraffour S, 2007, ANTIVIR THER, V12, P1205; Eriksson U, 2008, MOL PHARMACEUT, V5, P598, DOI 10.1021/mp8000099; Geerinck K, 2001, J MED VIROL, V64, P543, DOI 10.1002/jmv.1084; Goff A, 2007, VIRUS RES, V128, P88, DOI 10.1016/j.virusres.2007.04.014; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Jordan R, 2008, ANTIMICROB AGENTS CH, V52, P1721, DOI 10.1128/AAC.01303-07; Jordan R, 2010, VIRUSES-BASEL, V2, P2409, DOI 10.3390/v2112409; Jordan R, 2010, ANTIMICROB AGENTS CH, V54, P2560, DOI 10.1128/AAC.01689-09; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; Kaiser J, 2007, SCIENCE, V316, P1418, DOI 10.1126/science.316.5830.1418; Lalezari JP, 1998, J ACQ IMMUN DEF SYND, V17, P339, DOI 10.1097/00042560-199804010-00008; Lalezari JP, 1997, ANN INTERN MED, V126, P257, DOI 10.7326/0003-4819-126-4-199702150-00001; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; McCabe D, 2003, PEDIATR INFECT DIS J, V22, P1027, DOI 10.1097/01.inf.0000095433.88772.7e; Nafziger SD, 2005, CRIT CARE CLIN, V21, P739, DOI 10.1016/j.ccc.2005.06.004; Nalca A, 2008, ANTIVIR RES, V79, P121, DOI 10.1016/j.antiviral.2008.03.005; Neyts J, 2003, ANTIVIR RES, V57, P25, DOI 10.1016/S0166-3542(02)00197-3; Nitsche A, 2007, J CLIN VIROL, V40, P160, DOI 10.1016/j.jcv.2007.07.014; Papastamopoulos V, 2000, J CHEMOTHERAPY, V12, P258, DOI 10.1179/joc.2000.12.3.258; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Quenelle DC, 2003, ANTIMICROB AGENTS CH, V47, P3275, DOI 10.1128/AAC.47.10.3275-3280.2003; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P689, DOI 10.1128/AAC.00879-06; Rosenthal SR, 2001, EMERG INFECT DIS, V7, P920, DOI 10.3201/eid0706.010602; Sbrana E, 2007, AM J TROP MED HYG, V76, P768, DOI 10.4269/ajtmh.2007.76.768; Smee Donald F., 2008, Antiviral Chemistry & Chemotherapy, V19, P115; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005	37	14	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23237	10.1371/journal.pone.0023237	http://dx.doi.org/10.1371/journal.pone.0023237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858040	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700009
J	Klein, JD; Ossowski, S; Schneeberger, K; Weigel, D; Huson, DH				Klein, Juliane D.; Ossowski, Stephan; Schneeberger, Korbinian; Weigel, Detlef; Huson, Daniel H.			LOCAS - A Low Coverage Assembly Tool for Resequencing Projects	PLOS ONE			English	Article							DE-NOVO; SHORT READS; ARABIDOPSIS-THALIANA; HUMAN GENOME; ALIGNMENT; ALGORITHMS; DISCOVERY; EFFICIENT; ABYSS	Motivation: Next Generation Sequencing (NGS) is a frequently applied approach to detect sequence variations between highly related genomes. Recent large-scale re-sequencing studies as the Human 1000 Genomes Project utilize NGS data of low coverage to afford sequencing of hundreds of individuals. Here, SNPs and micro-indels can be detected by applying an alignment-consensus approach. However, computational methods capable of discovering other variations such as novel insertions or highly diverged sequence from low coverage NGS data are still lacking. Results: We present LOCAS, a new NGS assembler particularly designed for low coverage assembly of eukaryotic genomes using a mismatch sensitive overlap-layout-consensus approach. LOCAS assembles homologous regions in a homology-guided manner while it performs de novo assemblies of insertions and highly polymorphic target regions subsequently to an alignment-consensus approach. LOCAS has been evaluated in homology-guided assembly scenarios with low sequence coverage of Arabidopsis thaliana strains sequenced as part of the Arabidopsis 1001 Genomes Project. While assembling the same amount of long insertions as state-of-the-art NGS assemblers, LOCAS showed best results regarding contig size, error rate and runtime. Conclusion: LOCAS produces excellent results for homology-guided assembly of eukaryotic genomes with short reads and low sequencing depth, and therefore appears to be the assembly tool of choice for the detection of novel sequence variations in this scenario.	[Klein, Juliane D.; Huson, Daniel H.] Univ Tubingen, Chair Algorithms Bioinformat, Tubingen, Germany; [Ossowski, Stephan] Univ Pompeu Fabra, Barcelona, Spain; [Ossowski, Stephan] Ctr Genom Regulat, Genes & Dis Program, Barcelona, Spain; [Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Max Planck Society; Max Planck Society	Klein, JD (corresponding author), Univ Tubingen, Chair Algorithms Bioinformat, Tubingen, Germany.	kleinj@informatik.uni-tuebingen.de	Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Huson, Daniel H./AAC-5494-2019; Weigel, Detlef/GSJ-0799-2022; Schneeberger, Korbinian/U-6329-2019; Ossowski, Stephan/E-2139-2011	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Schneeberger, Korbinian/0000-0002-5512-0443; Ossowski, Stephan/0000-0002-7416-9568	BMBF [German Plant Genome Initiative GABI-GNADE]	BMBF [German Plant Genome Initiative GABI-GNADE]	The study was supported by the BMBF [German Plant Genome Initiative GABI-GNADE]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arslan AN, 2001, BIOINFORMATICS, V17, P327, DOI 10.1093/bioinformatics/17.4.327; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; KECECIOGLU JD, 1995, ALGORITHMICA, V13, P7, DOI 10.1007/BF01188580; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Palmer LE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-33; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Pop M, 2004, GENOME RES, V14, P149; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Rausch T, 2009, BIOINFORMATICS, V25, P1118, DOI 10.1093/bioinformatics/btp131; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wendl MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-485; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	31	15	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23455	10.1371/journal.pone.0023455	http://dx.doi.org/10.1371/journal.pone.0023455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858125	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953700024
J	Wu, MC; Lin, TL; Hsieh, PF; Yang, HC; Wang, JT				Wu, Meng-Chuan; Lin, Tzu-Lung; Hsieh, Pei-Fang; Yang, Hui-Ching; Wang, Jin-Town			Isolation of Genes Involved in Biofilm Formation of a Klebsiella pneumoniae Strain Causing Pyogenic Liver Abscess	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL BIOFILMS; RESISTANCE; DISEASE; MECHANISMS; EXPRESSION; VIRULENCE; SURFACES; TAIWAN; TRACT	Background: Community-acquired pyogenic liver abscess (PLA) complicated with meningitis and endophthalmitis caused by Klebsiella pneumoniae is an emerging infectious disease. To investigate the mechanisms and effects of biofilm formation of K. pneumoniae causing PLA, microtiter plate assays were used to determine the levels of biofilm formed by K. pneumoniae clinical isolates and to screen for biofilm-altered mutants from a transposon mutant library of a K. pneumoniae PLA-associated strain. Methodology/Principal Findings: The biofilm formation of K. pneumoniae was examined by microtiter plate assay. Higher levels of biofilm formation were demonstrated by K. pneumoniae strains associated with PLA. A total of 23 biofilm-decreased mutants and 4 biofilm-increased mutants were identified. Among these mutants, a biofilm-decreased treC mutant displayed less mucoviscosity and produced less capsular polysaccharide (CPS), whereas a biofilm-increased sugE mutant displayed higher mucoviscosity and produced more CPS. The biofilm phenotypes of treC and sugE mutants also were confirmed by glass slide culture. Deletion of treC, which encodes trehalose-6-phosphate hydrolase, impaired bacterial trehalose utilization. Addition of glucose to the culture medium restored the capsule production and biofilm formation in the treC mutant. Transcriptional profile analysis suggested that the increase of CPS production in Delta sugE may reflect elevated cps gene expression (upregulated through rmpA) in combination with increased treC expression. In vivo competition assays demonstrated that the treC mutant strain was attenuated in competitiveness during intragastric infection in mice. Conclusions/Significance: Genes important for biofilm formation by K. pneumoniae PLA strain were identified using an in vitro assay. Among the identified genes, treC and sugE affect biofilm formation by modulating CPS production. The importance of treC in gastrointestinal tract colonization suggests that biofilm formation contributes to the establishment and persistence of K. pneumoniae infection.	[Wu, Meng-Chuan; Lin, Tzu-Lung; Hsieh, Pei-Fang; Yang, Hui-Ching; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wu, MC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	wangjt@ntu.edu.tw			National Science Council; National Taiwan University; Liver Disease Prevention and Treatment Research Foundation in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Liver Disease Prevention and Treatment Research Foundation in Taiwan	The work was supported by National Science Council (http://web1.nsc.gov.tw/), the Excellent Research Projects of National Taiwan University (http://www.ntu.edu.tw), and the Liver Disease Prevention and Treatment Research Foundation in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Boddicker JD, 2006, INFECT IMMUN, V74, P4590, DOI 10.1128/IAI.00129-06; Chang SC, 2000, DIAGN MICR INFEC DIS, V37, P279, DOI 10.1016/S0732-8893(00)00157-7; Chen W, 2008, CRIT CARE MED, V36, P1184, DOI 10.1097/CCM.0b013e31816a0a06; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Chou FF, 1997, WORLD J SURG, V21, P384, DOI 10.1007/PL00012258; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsieh PF, 2010, J INFECT DIS, V202, P52, DOI 10.1086/653079; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; KLEIN W, 1995, J BACTERIOL, V177, P4043, DOI 10.1128/jb.177.14.4043-4052.1995; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Ramphal R, 2006, CLIN INFECT DIS, V42, pS164, DOI 10.1086/500663; RIMMELE M, 1994, J BACTERIOL, V176, P5654, DOI 10.1128/JB.176.18.5654-5664.1994; Rosen DA, 2008, INFECT IMMUN, V76, P3346, DOI 10.1128/IAI.00340-08; Sikora CW, 2005, BIOCHEM BIOPH RES CO, V335, P105, DOI 10.1016/j.bbrc.2005.07.051; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wellman N, 1996, ANTIMICROB AGENTS CH, V40, P2012, DOI 10.1128/AAC.40.9.2012; Yeoh KG, 1997, POSTGRAD MED J, V73, P89, DOI 10.1136/pgmj.73.856.89; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07	43	84	93	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23500	10.1371/journal.pone.0023500	http://dx.doi.org/10.1371/journal.pone.0023500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858144	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953500049
J	Wlodarski, T; Kutner, J; Towpik, J; Knizewski, L; Rychlewski, L; Kudlicki, A; Rowicka, M; Dziembowski, A; Ginalski, K				Wlodarski, Tomasz; Kutner, Jan; Towpik, Joanna; Knizewski, Lukasz; Rychlewski, Leszek; Kudlicki, Andrzej; Rowicka, Maga; Dziembowski, Andrzej; Ginalski, Krzysztof			Comprehensive Structural and Substrate Specificity Classification of the Saccharomyces cerevisiae Methyltransferome	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; MESSENGER-RNA; TRANSMEMBRANE TOPOLOGY; LOCALIZATION PREDICTOR; CONSENSUS PREDICTION; RIBOSOMAL-RNA; YEAST; METHYLATION; DATABASE; IDENTIFICATION	Methylation is one of the most common chemical modifications of biologically active molecules and it occurs in all life forms. Its functional role is very diverse and involves many essential cellular processes, such as signal transduction, transcriptional control, biosynthesis, and metabolism. Here, we provide further insight into the enzymatic methylation in S. cerevisiae by conducting a comprehensive structural and functional survey of all the methyltransferases encoded in its genome. Using distant homology detection and fold recognition, we found that the S. cerevisiae methyltransferome comprises 86 MTases (53 well-known and 33 putative with unknown substrate specificity). Structural classification of their catalytic domains shows that these enzymes may adopt nine different folds, the most common being the Rossmann-like. We also analyzed the domain architecture of these proteins and identified several new domain contexts. Interestingly, we found that the majority of MTase genes are periodically expressed during yeast metabolic cycle. This finding, together with calculated isoelectric point, fold assignment and cellular localization, was used to develop a novel approach for predicting substrate specificity. Using this approach, we predicted the general substrates for 24 of 33 putative MTases and confirmed these predictions experimentally in both cases tested. Finally, we show that, in S. cerevisiae, methylation is carried out by 34 RNA MTases, 32 protein MTases, eight small molecule MTases, three lipid MTases, and nine MTases with still unknown substrate specificity.	[Wlodarski, Tomasz; Kutner, Jan; Towpik, Joanna; Knizewski, Lukasz; Ginalski, Krzysztof] Univ Warsaw, Lab Bioinformat & Syst Biol, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Rychlewski, Leszek] BioInfoBank Inst, Poznan, Poland; [Kudlicki, Andrzej; Rowicka, Maga] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Rowicka, Maga] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA; [Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Wlodarski, T (corresponding author), Univ Warsaw, Lab Bioinformat & Syst Biol, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland.	kginal@icm.edu.pl	Włodarski, Tomasz/G-3343-2013; Kudlicki, Andrzej/AAG-8537-2019; Rowicka, Maga/E-2496-2012; Kudlicki, Andrzej/C-7612-2012; Kutner, Jan/R-6653-2016	Kudlicki, Andrzej/0000-0001-8158-9600; Rowicka, Maga/0000-0002-4011-071X; Wlodarski, Tomasz/0000-0001-6498-334X; Kutner, Jan/0000-0002-3647-5556; Knizewski, Lukasz/0000-0003-1882-4051; Dziembowski, Andrzej/0000-0001-8492-7572	European Molecular Biology Organization; Foundation for Polish Science; Ministry of Science and Higher Education; Innovative Economy 2007-2013 Programme; European Social Fund; March of Dimes [5-FY10-136]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Innovative Economy 2007-2013 Programme; European Social Fund(European Social Fund (ESF)); March of Dimes(March of Dimes)	This work was supported by the European Molecular Biology Organization, the Foundation for Polish Science, the Ministry of Science and Higher Education, the Innovative Economy 2007-2013 Programme, the European Social Fund and March of Dimes grant 5-FY10-136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Cheng X, 1999, S ADENOSYLMETHIONINE; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franke J, 2008, J CELL SCI, V121, P3553, DOI 10.1242/jcs.033308; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Ginalski K, 2004, NUCLEIC ACIDS RES, V32, pW576, DOI 10.1093/nar/gkh370; Ginalski K, 2003, NUCLEIC ACIDS RES, V31, P3291, DOI 10.1093/nar/gkg503; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hansen J, 1997, FEBS LETT, V401, P20, DOI 10.1016/S0014-5793(96)01423-8; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MCCAMMON MT, 1984, J BACTERIOL, V157, P475, DOI 10.1128/JB.157.2.475-483.1984; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; ROSE MD, 1999, METHODS YEAST GENETI; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 1998, NAT STRUCT BIOL, V5, P585, DOI 10.1038/846; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SUBBARAMAIAH K, 1992, J BIOL CHEM, V267, P8636; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wade CH, 2006, YEAST, V23, P293, DOI 10.1002/yea.1353; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Yang CK, 2006, MOL ENDOCRINOL, V20, P3251, DOI 10.1210/me.2006-0200	65	41	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23168	10.1371/journal.pone.0023168	http://dx.doi.org/10.1371/journal.pone.0023168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858014	gold, Green Published			2022-12-27	WOS:000293774300024
J	Quaranta, MG; Vincentini, O; Felli, C; Spadaro, F; Silano, M; Moricoli, D; Giordani, L; Viora, M				Quaranta, Maria Giovanna; Vincentini, Olimpia; Felli, Cristina; Spadaro, Francesca; Silano, Marco; Moricoli, Diego; Giordani, Luciana; Viora, Marina			Exogenous HIV-1 Nef Upsets the IFN-gamma-Induced Impairment of Human Intestinal Epithelial Integrity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-DIFFERENTIATION; BARRIER FUNCTION; T-CELLS; POSSIBLE MECHANISM; DENDRITIC CELLS; LYMPHOID-TISSUE; CACO-2 CELLS; TAT PROTEIN; INFECTION	Background: The mucosal tissues play a central role in the transmission of HIV-1 infection as well as in the pathogenesis of AIDS. Despite several clinical studies reported intestinal dysfunction during HIV infection, the mechanisms underlying HIV-induced impairments of mucosal epithelial barrier are still unclear. It has been postulated that HIV-1 alters enterocytic function and HIV-1 proteins have been detected in several cell types of the intestinal mucosa. In the present study, we analyzed the effect of the accessory HIV-1 Nef protein on human epithelial cell line. Methodology/Principal Findings: We used unstimulated or IFN-gamma-stimulated Caco-2 cells, as a model for homeostatic and inflamed gastrointestinal tracts, respectively. We investigated the effect of exogenous recombinant Nef on monolayer integrity analyzing its uptake, transepithelial electrical resistance, permeability to FITC-dextran and the expression of tight junction proteins. Moreover, we measured the induction of proinflammatory mediators. Exogenous Nef was taken up by Caco-2 cells, increased intestinal epithelial permeability and upset the IFN-gamma-induced reduction of transepitelial resistance, interfering with tight junction protein expression. Moreover, Nef inhibited IFN-gamma-induced apoptosis and up-regulated TNF-alpha, IL-6 and MIP-3 alpha production by Caco-2 cells while down-regulated IL-10 production. The simultaneous exposure of Caco-2 cells to Nef and IFN-gamma did not affect cytokine secretion respect to untreated cells. Finally, we found that Nef counteracted the IFN-gamma induced arachidonic acid cascade. Conclusion/Significance: Our findings suggest that exogenous Nef, perturbing the IFN-gamma-induced impairment of intestinal epithelial cells, could prolong cell survival, thus allowing for accumulation of viral particles. Our results may improve the understanding of AIDS pathogenesis, supporting the discovery of new therapeutic interventions.	[Quaranta, Maria Giovanna; Felli, Cristina; Giordani, Luciana; Viora, Marina] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Vincentini, Olimpia; Silano, Marco] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Spadaro, Francesca] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Moricoli, Diego] Diatheva Srl, Fano, PU, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Quaranta, MG (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	mariagiovanna.quaranta@iss.it	Spadaro, Francesca/M-7512-2017; Felli, Cristina/I-9795-2014; VINCENTINI, OLIMPIA/B-3837-2015; Silano, Marco/AAC-9792-2022; vincentini, olimpia/N-3332-2019; Silano, Marco/B-3835-2015	Spadaro, Francesca/0000-0002-6610-350X; Felli, Cristina/0000-0002-5253-0367; VINCENTINI, OLIMPIA/0000-0002-4137-4135; vincentini, olimpia/0000-0002-4137-4135; Silano, Marco/0000-0002-7051-3405; Quaranta, Maria Giovanna/0000-0002-1077-1488	National Research Project on AIDS	National Research Project on AIDS	This work was funded by a grant to M. Viora from the National Research Project on AIDS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Diatheva s.r.l. had a role in the study as employer of author D. Moricoli who contributed to the recombinant HIV-1 Nef protein manufacturing process and analysis tools for this manuscript.	Alessandrini L, 2000, J GEN VIROL, V81, P2905, DOI 10.1099/0022-1317-81-12-2905; Belyakov IM, 2004, IMMUNITY, V20, P247, DOI 10.1016/S1074-7613(04)00053-6; BISWAS P, 1992, J EXP MED, V176, P739, DOI 10.1084/jem.176.3.739; Boirivant M, 1998, J CLIN IMMUNOL, V18, P39, DOI 10.1023/A:1023235803948; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Campbell TD, 2008, ETHN DIS, V18; Canani RB, 2006, AIDS, V20, P5, DOI 10.1097/01.aids.0000198088.85572.68; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; De Angelis I, 1998, TOXICOL APPL PHARM, V152, P119, DOI 10.1006/taap.1998.8445; Delezay O, 1997, VIROLOGY, V238, P231, DOI 10.1006/viro.1997.8829; Dhawan S, 1995, J LEUKOCYTE BIOL, V58, P713, DOI 10.1002/jlb.58.6.713; Fackler OT, 2001, J VIROL, V75, P6601, DOI 10.1128/JVI.75.14.6601-6608.2001; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Giordani L, 2000, CLIN EXP IMMUNOL, V122, P358, DOI 10.1046/j.1365-2249.2000.01388.x; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Hariharan D, 1999, BLOOD, V93, P1137, DOI 10.1182/blood.V93.4.1137.404a35_1137_1144; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Husain M, 2005, AIDS, V19, P1975, DOI 10.1097/01.aids.0000191918.42110.27; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Janoff EN, 2001, GASTROENTEROLOGY, V120, P607, DOI 10.1053/gast.2001.22427; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kaiserlian D, 2005, J LEUKOCYTE BIOL, V78, P311, DOI 10.1189/jlb.0105053; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; Kuster H, 2000, AM J PATHOL, V156, P1973, DOI 10.1016/S0002-9440(10)65070-5; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Martin-Venegas R, 2006, J LIPID RES, V47, P1416, DOI 10.1194/jlr.M500564-JLR200; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Ndolo T, 2005, VIROLOGY, V343, P1, DOI 10.1016/j.virol.2005.08.013; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Olivetta E, 2000, J VIROL, V74, P483, DOI 10.1128/JVI.74.1.483-492.2000; Paiardini M, 2008, AIDS REV, V10, P36; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Peretti S, 2005, MOL THER, V12, P1185, DOI 10.1016/j.ymthe.2005.06.474; POLI G, 1992, AIDS RES HUM RETROV, V8, P191, DOI 10.1089/aid.1992.8.191; Quaranta MG, 2007, FASEB J, V21, P2323, DOI 10.1096/fj.06-7883com; Quaranta MG, 2011, VIRAL IMMUNOL, V24, P245, DOI 10.1089/vim.2010.0112; Quaranta MG, 2009, BIOFACTORS, V35, P169, DOI 10.1002/biof.28; Quaranta MG, 1999, EXP CELL RES, V250, P112, DOI 10.1006/excr.1999.4494; Quaranta MG, 2004, FASEB J, V18, P1459, DOI 10.1096/fj.04-1633fje; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Quaranta MG, 2002, EXP CELL RES, V275, P243, DOI 10.1006/excr.2002.5497; ROSENBERG ZF, 1990, IMMUNOL TODAY, V11, P176, DOI 10.1016/0167-5699(90)90070-P; Sharpstone D, 1996, LANCET, V348, P379, DOI 10.1016/S0140-6736(96)01034-3; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Sunamoto M, 2003, KIDNEY INT, V64, P1695, DOI 10.1046/j.1523-1755.2003.00283.x; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08	54	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23442	10.1371/journal.pone.0023442	http://dx.doi.org/10.1371/journal.pone.0023442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858117	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300029
J	Wang, YJ; Jung, TP				Wang, Yijun; Jung, Tzyy-Ping			A Collaborative Brain-Computer Interface for Improving Human Performance	PLOS ONE			English	Article							SINGLE-TRIAL EEG; EVOKED-POTENTIALS; BCI; CLASSIFICATION; COMMUNICATION	Electroencephalogram (EEG) based brain-computer interfaces (BCI) have been studied since the 1970s. Currently, the main focus of BCI research lies on the clinical use, which aims to provide a new communication channel to patients with motor disabilities to improve their quality of life. However, the BCI technology can also be used to improve human performance for normal healthy users. Although this application has been proposed for a long time, little progress has been made in real-world practices due to technical limits of EEG. To overcome the bottleneck of low single-user BCI performance, this study proposes a collaborative paradigm to improve overall BCI performance by integrating information from multiple users. To test the feasibility of a collaborative BCI, this study quantitatively compares the classification accuracies of collaborative and single-user BCI applied to the EEG data collected from 20 subjects in a movement-planning experiment. This study also explores three different methods for fusing and analyzing EEG data from multiple subjects: (1) Event-related potentials (ERP) averaging, (2) Feature concatenating, and (3) Voting. In a demonstration system using the Voting method, the classification accuracy of predicting movement directions (reaching left vs. reaching right) was enhanced substantially from 66% to 80%, 88%, 93%, and 95% as the numbers of subjects increased from 1 to 5, 10, 15, and 20, respectively. Furthermore, the decision of reaching direction could be made around 100-250 ms earlier than the subject's actual motor response by decoding the ERP activities arising mainly from the posterior parietal cortex (PPC), which are related to the processing of visuomotor transmission. Taken together, these results suggest that a collaborative BCI can effectively fuse brain activities of a group of people to improve the overall performance of natural human behavior.	[Wang, Yijun; Jung, Tzyy-Ping] Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, San Diego, CA 92103 USA	University of California System; University of California San Diego	Wang, YJ (corresponding author), Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, San Diego, CA 92103 USA.	yijun@sccn.ucsd.edu; jung@sccn.ucsd.edu	Kheir, Michael/ABA-5760-2021; Wang, Yijun/F-3547-2012; Wang, Yijun/GXW-1763-2022	Kheir, Michael/0000-0001-6469-6746	Abraxis Bioscience Inc.; Army Research Laboratory [W911NF-10-2-0022]	Abraxis Bioscience Inc.; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	This work is supported by a gift fund from Abraxis Bioscience Inc. Research is also sponsored in part by the Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-10-2-0022. The views and the conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigdely-Shamlo N, 2008, IEEE T NEUR SYS REH, V16, P432, DOI 10.1109/TNSRE.2008.2003381; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Blankertz B, 2002, ADV NEUR IN, V14, P157; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; DAVILA CE, 1992, IEEE T BIO-MED ENG, V39, P338, DOI 10.1109/10.126606; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Duda R.O., 2000, PATTERN CLASSIFICATI; Fabiani M., 1987, ADV PSYCHOPHYSIOL, V2, P1, DOI DOI 10.1016/0013-4694(88)90149-6; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; Jung TP, 1997, IEEE T BIO-MED ENG, V44, P60, DOI 10.1109/10.553713; Katzenbach JR, 1993, WISDOM TEAMS CREATIN; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lin CT, 2010, NEUROIMAGE, V52, P633, DOI 10.1016/j.neuroimage.2010.04.250; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Luck S.J., 2005, INTRO EVENT RELATED; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; NIJHOLT A, 2009, LECT NOTES COMPUTER, P225; Parra LC, 2003, IEEE T NEUR SYS REH, V11, P173, DOI 10.1109/TNSRE.2003.814446; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Roco M. C., 2003, CONVERGING TECHNOLOG; SANTAMARIA J, 1987, J CLIN NEUROPHYSIOL, V4, P327, DOI 10.1097/00004691-198710000-00002; Schalk G, 2000, CLIN NEUROPHYSIOL, V111, P2138, DOI 10.1016/S1388-2457(00)00457-0; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; SUMMERER L, 2009, INT REV NEUROBIOL, P213; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Vidaurre C, 2007, IEEE T BIO-MED ENG, V54, P550, DOI 10.1109/TBME.2006.888836; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437, DOI 10.1007/978-3-642-02812-0_52; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	39	365	379	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20422	10.1371/journal.pone.0020422	http://dx.doi.org/10.1371/journal.pone.0020422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21887260	Green Published, gold			2022-12-27	WOS:000291097600065
J	Adachi, I; Hampton, RR				Adachi, Ikuma; Hampton, Robert R.			Rhesus Monkeys See Who They Hear: Spontaneous Cross-Modal Memory for Familiar Conspecifics	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; MACACA-MULATTA; FACE RECOGNITION; SOCIAL RELATIONSHIPS; VOCAL RECOGNITION; CONTACT CALLS; DISCRIMINATION; INDIVIDUALS; CATEGORIZATION; ORIENTATION	Rhesus monkeys gather much of their knowledge of the social world through visual input and may preferentially represent this knowledge in the visual modality. Recognition of familiar faces is clearly advantageous, and the flexibility and utility of primate social memory would be greatly enhanced if visual memories could be accessed cross-modally either by visual or auditory stimulation. Such cross-modal access to visual memory would facilitate flexible retrieval of the knowledge necessary for adaptive social behavior. We tested whether rhesus monkeys have cross-modal access to visual memory for familiar conspecifics using a delayed matching-to-sample procedure. Monkeys learned visual matching of video clips of familiar individuals to photographs of those individuals, and generalized performance to novel videos. In crossmodal probe trials, coo-calls were played during the memory interval. The calls were either from the monkey just seen in the sample video clip or from a different familiar monkey. Even though the monkeys were trained exclusively in visual matching, the calls influenced choice by causing an increase in the proportion of errors to the picture of the monkey whose voice was heard on incongruent trials. This result demonstrates spontaneous cross-modal recognition. It also shows that viewing videos of familiar monkeys activates naturally formed memories of real monkeys, validating the use of video stimuli in studies of social cognition in monkeys.	[Adachi, Ikuma; Hampton, Robert R.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA		Adachi, I (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA USA.	adachi@pri.kyoto-u.ac.jp		Hampton, Robert/0000-0002-6686-2290; Adachi, Ikuma/0000-0003-2856-8792	Japan Society for the Promotion of Science; MEXT [22700270]; James S. McDonnell Foundation; Center for Behavioral Neuroscience under National Science Foundation [IBN-9876754]; National Institutes of Health [RR-00165, R01MH082819]; National Science Foundation [0000017475]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082819] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); James S. McDonnell Foundation; Center for Behavioral Neuroscience under National Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Postdoctoral Fellowship for Research Abroad awarded to IA by the Japan Society for the Promotion of Science and by a Grant-in-Aid for Young Scientists (B) # 22700270 from MEXT to IA. This study was also supported by a grant from the James S. McDonnell Foundation, by the Center for Behavioral Neuroscience under the STC Program of the National Science Foundation under Agreement No. IBN-9876754, and by Yerkes Center base grant No. RR-00165 awarded by the Animal Resources Program of the National Institutes of Health. Additional support was provided by grant R01MH082819 from the National Institutes of Health and grant 0000017475 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Adachi I, 2006, PRIMATES, V47, P350, DOI 10.1007/s10329-006-0182-z; Adachi I, 2009, DEVELOPMENTAL SCI, V12, P446, DOI 10.1111/j.1467-7687.2008.00780.x; Adachi I, 2009, CURR BIOL, V19, P1270, DOI 10.1016/j.cub.2009.05.067; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bovet D, 2003, J COMP PSYCHOL, V117, P400, DOI 10.1037/0735-7036.117.4.400; Bovet D, 2009, FOLIA PRIMATOL, V80, P220, DOI 10.1159/000235688; BRUCE C, 1982, NEUROPSYCHOLOGIA, V20, P515, DOI 10.1016/0028-3932(82)90025-2; Byrne R., 1988, MACHIAVELLIAN INTELL; CHENEY D, 1986, SCIENCE, V234, P1361, DOI 10.1126/science.3538419; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Dahl CD, 2010, P ROY SOC B-BIOL SCI, V277, P2973, DOI 10.1098/rspb.2010.0438; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; DASSER V, 1988, ANIM BEHAV, V36, P225, DOI 10.1016/S0003-3472(88)80265-3; GOUZOULES S, 1984, ANIM BEHAV, V32, P182, DOI 10.1016/S0003-3472(84)80336-X; Humphrey NK., 1976, GROWING POINTS ETHOL, P303; ITAKURA S, 1992, PSYCHOL REC, V42, P157, DOI 10.1007/BF03399594; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; Koba R, 2006, ANIM COGN, V9, P183, DOI 10.1007/s10071-006-0020-0; Kummer H., 1982, Life Sciences Research Report, P113; Martin-Malivel J, 2001, ANIM LEARN BEHAV, V29, P10, DOI 10.3758/BF03192812; Martin-Malivel J, 2001, BEHAV BRAIN RES, V122, P209, DOI 10.1016/S0166-4328(01)00179-6; Martin-Malivel J, 2007, BEHAV NEUROSCI, V121, P1145, DOI 10.1037/0735-7044.121.6.1145; Matsuzawa T, 1991, CHIMPANZEE KARA MITA; MITANI JC, 1985, ANIM BEHAV, V33, P272, DOI 10.1016/S0003-3472(85)80141-X; Morrongiello BA, 2003, J EXP CHILD PSYCHOL, V84, P1, DOI 10.1016/S0022-0965(02)00162-5; Owren MJ, 2003, J COMP PSYCHOL, V117, P380, DOI 10.1037/0735-7036.117.4.380; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 2008, ANIM COGN, V11, P467, DOI 10.1007/s10071-008-0137-4; Parr LA, 2006, PERCEPTION, V35, P1473, DOI 10.1068/p5455; Paxton R, 2010, J COMP PSYCHOL, V124, P395, DOI 10.1037/a0019751; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; ROSENFELD SA, 1979, NEUROPSYCHOLOGIA, V17, P503, DOI 10.1016/0028-3932(79)90057-5; Schell A, 2011, ANIM COGN, V14, P503, DOI 10.1007/s10071-011-0383-8; Seyfarth RM, 2009, P NATL ACAD SCI USA, V106, P669, DOI 10.1073/pnas.0811894106; Sliwa J, 2011, P NATL ACAD SCI USA, V108, P1735, DOI 10.1073/pnas.1008169108; SNOWDON CT, 1980, ANIM BEHAV, V28, P717, DOI 10.1016/S0003-3472(80)80131-X; Tomasello Michael, 1994, Yearbook of Physical Anthropology, V37, P273; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; WASSERMAN EA, 1988, J EXP PSYCHOL ANIM B, V14, P235, DOI 10.1037/0097-7403.14.3.235; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004	48	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23345	10.1371/journal.pone.0023345	http://dx.doi.org/10.1371/journal.pone.0023345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887244	Green Published, gold, Green Submitted			2022-12-27	WOS:000295832000014
J	Douce, RW; Aleman, W; Chicaiza-Ayala, W; Madrid, C; Sovero, M; Delgado, F; Rodas, M; Ampuero, J; Chauca, G; Perez, J; Garcia, J; Kochel, T; Halsey, ES; Laguna-Torres, VA				Douce, Richard W.; Aleman, Washington; Chicaiza-Ayala, Wilson; Madrid, Cesar; Sovero, Merly; Delgado, Franklin; Rodas, Mireya; Ampuero, Julia; Chauca, Gloria; Perez, Juan; Garcia, Josefina; Kochel, Tadeusz; Halsey, Eric S.; Alberto Laguna-Torres, V.			Sentinel Surveillance of Influenza-Like-Illness in Two Cities of the Tropical Country of Ecuador: 2006-2010	PLOS ONE			English	Article							SOUTH-AMERICA; TRANSMISSION; SEASONALITY; VIRUSES	Background: Tropical countries are thought to play an important role in the global behavior of respiratory infections such as influenza. The tropical country of Ecuador has almost no documentation of the causes of acute respiratory infections. The objectives of this study were to identify the viral agents associated with influenza like illness (ILI) in Ecuador, describe what strains of influenza were circulating in the region along with their epidemiologic characteristics, and perform molecular characterization of those strains. Methodology/Findings: This is a prospective surveillance study of the causes of ILI based on viral culture of oropharyngeal specimens and case report forms obtained in hospitals from two cities of Ecuador over 4 years. Out of 1,702 cases of ILI, nine viral agents were detected in 597 patients. During the time of the study, seven genetic variants of influenza circulated in Ecuador, causing six periods of increased activity. There appeared to be more heterogeneity in the cause of ILI in the tropical city of Guayaquil when compared with the Andean city of Quito. Conclusions/Significance: This was the most extensive documentation of the viral causes of ILI in Ecuador to date. Influenza was a common cause of ILI in Ecuador, causing more than one outbreak per year. There was no well defined influenza season although there were periods of time when no influenza was detected alternating with epidemics of different variant strains.	[Douce, Richard W.; Chicaiza-Ayala, Wilson] Hosp Vozandes, Quito, Ecuador; [Aleman, Washington; Rodas, Mireya] Hosp Alcivar & Vernaza, Guayaquil, Ecuador; [Madrid, Cesar; Delgado, Franklin] Hosp Naval, Guayaquil, Ecuador; [Sovero, Merly; Ampuero, Julia; Chauca, Gloria; Perez, Juan; Garcia, Josefina; Kochel, Tadeusz; Halsey, Eric S.; Alberto Laguna-Torres, V.] US Naval Med Res Unit Six, Lima, Peru		Douce, RW (corresponding author), Hosp Vozandes, Quito, Ecuador.	rdouce@hcjb.org.ec	Halsey, Eric/AAC-8110-2022	Halsey, Eric/0000-0001-6291-8923; , Merly Sovero/0000-0002-4373-0295; Douce, Richard/0000-0002-8675-7658; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; Ampuero, Julia/0000-0001-5486-1656; Chicaiza-Ayala, Wilson/0000-0001-8639-698X	United States Department of Defense [847705.82000.25GB.B0016]; sentinel centers in Ecuador	United States Department of Defense(United States Department of Defense); sentinel centers in Ecuador	This study was funded by the United States Department of Defense Global Emerging Infections Systems Research Program, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to all personnel working at sentinel centers in Ecuador for supporting this surveillance study. We thank Dr. Brett Forshey who provided the map and the professional staff of the Virology Department of NAMRU-6 for invaluable laboratory and technical support in the execution of the study. We would also like to thank Dr. Juan Martin Moreira and members of the department of epidemiology as well as Dr. Nancy Vasconez and the members of the department of the national program of immunization of the Ecuadorian Ministry of Health for their comments and insight as to the behavior of acute respiratory infections in Ecuador.	Aguilera JF, EUROFLU CASE DEFINIT; Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Estrella B, 2005, ENVIRON HEALTH PERSP, V113, P607, DOI 10.1289/ehp.7494; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Forshey BM, 2010, INFLUENZA OTHER RESP, V4, P235, DOI 10.1111/j.1750-2659.2010.00139.x; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P327, DOI 10.1111/j.1750-2659.2009.00107.x; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P69, DOI 10.1111/j.1750-2659.2009.00072.x; Gonzalez V, 2001, INCIDENCIA ENFERMEDA; Gordon A, 2009, EMERG INFECT DIS, V15, P2005; Hall CB, 2010, MANDELL DOUGLAS BENN, P2207; Hanley BP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-98; Laguna-Torres VA, 2011, INFLUENZA OTHER RESP, V5, P123, DOI 10.1111/j.1750-2659.2010.00182.x; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lee VJ, 2009, PLOS ONE, V4, P8; Lieberman D, 2006, J CLIN MICROBIOL, V44, P525, DOI 10.1128/JCM.44.2.525-528.2006; Lieberman D, 2009, J CLIN MICROBIOL, V47, P3439, DOI 10.1128/JCM.00886-09; Little P, 2008, NICE CLIN GUIDEL, P1; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Naumova EN, 2007, ENV HLTH, V6, P1; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Paredes G, 2010, MED INTENSIVA, V34, P310, DOI 10.1016/j.medin.2010.03.011; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Schiffer JT, 2010, MANDELL DOUGLAS BENN; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Tamerius J, 2010, ENVIRON HEALTH PERSP; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002768; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; World Health Organization, 2008, PRIM HLTH CAR MOR NE, P1	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22206	10.1371/journal.pone.0022206	http://dx.doi.org/10.1371/journal.pone.0022206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887216	gold, Green Published, Green Submitted			2022-12-27	WOS:000295832000001
J	Karmali, PP; Brunquell, C; Tram, H; Ireland, SK; Ruoslahti, E; Biliran, H				Karmali, Priya Prakash; Brunquell, Chris; Tram, Hau; Ireland, Shubha Kale; Ruoslahti, Erkki; Biliran, Hector			Metastasis of Tumor Cells Is Enhanced by Downregulation of Bit1	PLOS ONE			English	Article							CANCER METASTASIS; KINASE; INVASION; ACTIVATION; INTEGRINS; SURVIVAL; ADHESION; PROTEIN; PHOSPHATASES; PREDICTION	Background: Resistance to anoikis, which is defined as apoptosis induced by loss of integrin-mediated cell attachment to the extracellular matrix, is a determinant of tumor progression and metastasis. We have previously identified the mitochondrial Bit1 (Bcl-2 inhibitor of transcription) protein as a novel anoikis effector whose apoptotic function is independent from caspases and is uniquely controlled by integrins. In this report, we examined the possibility that Bit1 is suppressed during tumor progression and that Bit1 downregulation may play a role in tumor metastasis. Methodology/Principal Findings: Using a human breast tumor tissue array, we found that Bit1 expression is suppressed in a significant fraction of advanced stages of breast cancer. Targeted disruption of Bit1 via shRNA technology in lowly aggressive MCF7 cells conferred enhanced anoikis resistance, adhesive and migratory potential, which correlated with an increase in active Extracellular kinase regulated (Erk) levels and a decrease in Erk-directed phosphatase activity. These pro-metastasis phenotypes were also observed following downregulation of endogenous Bit1 in Hela and B16F1 cancer cell lines. The enhanced migratory and adhesive potential of Bit1 knockdown cells is in part dependent on their high level of Erk activation since down-regulating Erk in these cells attenuated their enhanced motility and adhesive properties. The Bit1 knockdown pools also showed a statistically highly significant increase in experimental lung metastasis, with no differences in tumor growth relative to control clones in vivo using a BALB/c nude mouse model system. Importantly, the pulmonary metastases of Bit1 knockdown cells exhibited increased phospho-Erk staining. Conclusions/Significance: These findings indicate that downregulation of Bit1 conferred cancer cells with enhanced anoikis resistance, adhesive and migratory properties in vitro and specifically potentiated tumor metastasis in vivo. These results underscore the therapeutic importance of restoring Bit1 expression in cancer cells to circumvent metastasis at least in part through inhibition of the Erk pathway.	[Karmali, Priya Prakash] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Brunquell, Chris; Ruoslahti, Erkki] Sanford Burnham Med Res Inst, Santa Barbara, CA USA; [Tram, Hau; Ireland, Shubha Kale; Biliran, Hector] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Xavier University of Louisiana	Karmali, PP (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	hbiliran@xula.edu			National Institute of Health-National Institute of General Medical Sciences SCORE2 (NIH-NIGMS SC2); Louisiana Cancer Research Consortium (LCRC)	National Institute of Health-National Institute of General Medical Sciences SCORE2 (NIH-NIGMS SC2); Louisiana Cancer Research Consortium (LCRC)	Funding was provided by the National Institute of Health-National Institute of General Medical Sciences SCORE2 (NIH-NIGMS SC2 grant) and Louisiana Cancer Research Consortium (LCRC) start up funds to H. Biliran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Blaschke F, 2002, BIOCHEM BIOPH RES CO, V296, P890, DOI 10.1016/S0006-291X(02)02033-8; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; FIDLER IJ, 1990, CANCER RES, V50, P6130; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Griffiths GS, 2011, J BIOL CHEM, V286, P14713, DOI 10.1074/jbc.M111.228387; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Laakko T, 2003, J BIOL CHEM, V278, P31621, DOI 10.1074/jbc.M304700200; LESTER BR, 1992, CANCER METAST REV, V11, P31, DOI 10.1007/BF00047601; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Mitsushima M, 2007, EXP CELL RES, V313, P1830, DOI 10.1016/j.yexcr.2007.03.001; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Ward Y, 2001, MOL CELL BIOL, V21, P5958, DOI 10.1128/MCB.21.17.5958-5969.2001; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004	27	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23840	10.1371/journal.pone.0023840	http://dx.doi.org/10.1371/journal.pone.0023840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886829	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500033
J	Barrett, S; Mohr, PG; Schmidt, PM; McKimm-Breschkin, JL				Barrett, Susan; Mohr, Peter G.; Schmidt, Peter M.; McKimm-Breschkin, Jennifer L.			Real Time Enzyme Inhibition Assays Provide Insights into Differences in Binding of Neuraminidase Inhibitors to Wild Type and Mutant Influenza Viruses	PLOS ONE			English	Article							SLOW-BINDING; ACTIVE-SITE; B VIRUSES; OSELTAMIVIR; SENSITIVITY; RESISTANCE; PERAMIVIR; SIALIDASE; SUSCEPTIBILITY; MUTATIONS	The influenza neuraminidase (NA) inhibitors zanamivir, oseltamivir and peramivir were all designed based on the knowledge that the transition state analogue of the cleaved sialic acid, 2-deoxy, 2,3-dehydro N-acetyl neuraminic acid (DANA) was a weak inhibitor of NA. While DANA bound rapidly to the NA, modifications leading to the improved potency of these new inhibitors also conferred a time dependent or slow binding phenotype. Many mutations in the NA leading to decreased susceptibility result in loss of slow binding, hence this is a phenotypic marker of many but not all resistant NAs. We present here a simplified approach to determine whether an inhibitor is fast or slow binding by extending the endpoint fluorescent enzyme inhibition assay to a real time assay and monitoring the changes in IC(50)s with time. We carried out two reactions, one with a 30 min preincubation with inhibitor and the second without. The enzymatic reaction was started via addition of substrate and IC(50)s were calculated after each 10 min interval up to 60 min. Results showed that without preincubation IC(50)s for the wild type viruses started high and although they decreased continuously over the 60 min reaction time the final IC(50)s remained higher than for pre-incubated samples. These results indicate a slow equilibrium of association and dissociation and are consistent with slow binding of the inhibitors. In contrast, for viruses with decreased susceptibility, preincubation had minimal effect on the IC(50)s, consistent with fast binding. Therefore this modified assay provides additional phenotypic information about the rate of inhibitor binding in addition to the IC(50), and critically demonstrates the differential effect of incubation times on the IC(50) and K(i) values of wild type and mutant viruses for each of the inhibitors.	[Barrett, Susan; Schmidt, Peter M.; McKimm-Breschkin, Jennifer L.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia; [Mohr, Peter G.] CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Barrett, S (corresponding author), CSIRO Mat Sci & Engn, Parkville, Vic, Australia.	mck245@csiro.au	McKimm-Breschkin, Jennifer L/D-1880-2013; Schmidt, Peter/V-3882-2019	Schmidt, Peter/0000-0003-1340-9086; McKimm-Breschkin, Jennifer/0000-0002-2345-6786; Barrett, Susan/0000-0003-1132-5268	NIAID [RO1A1062721]; NHMRC Australia [595625]; MRC UK [77869]; Medical Research Council [G0600514] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062721] Funding Source: NIH RePORTER; MRC [G0600514] Funding Source: UKRI	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Parts of this work were supported by Grant RO1A1062721 from the NIAID http://www.niaid.nih.gov/Pages/default.aspx, a Pandemic influenza grant 595625 from the NHMRC Australia http://www.nhmrc.gov.au/and Grant ID 77869 from the MRC UK http://www.mrc.ac.uk/index. htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantia S, 2006, ANTIVIR RES, V69, P39, DOI 10.1016/j.antiviral.2005.10.002; BANTIA S, 2011, ANTIVIRAL RES; Baum EZ, 2003, ANTIVIR RES, V59, P13, DOI 10.1016/S0166-3542(03)00011-1; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Blick TJ, 1995, VIROLOGY, V214, P475, DOI 10.1006/viro.1995.0058; Buxton RC, 2000, ANAL BIOCHEM, V280, P291, DOI 10.1006/abio.2000.4517; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Hurt AC, 2006, ANTIMICROB AGENTS CH, V50, P1872, DOI 10.1128/AAC.50.5.1872-1874.2006; Kati WM, 1998, BIOCHEM BIOPH RES CO, V244, P408, DOI 10.1006/bbrc.1998.8282; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000786; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; PEGG MS, 1994, BIOCHEM MOL BIOL INT, V32, P851; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Tashiro M, 2009, ANTIVIR THER, V14, P751, DOI 10.3851/IMP1194; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003	28	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23627	10.1371/journal.pone.0023627	http://dx.doi.org/10.1371/journal.pone.0023627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858186	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300071
J	Bedard, JEJ; Haaning, AM; Ware, SM				Bedard, James E. J.; Haaning, Allison M.; Ware, Stephanie M.			Identification of a Novel ZIC3 Isoform and Mutation Screening in Patients with Heterotaxy and Congenital Heart Disease	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; ZINC-FINGER PROTEIN; GLI PROTEINS; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; GREAT-ARTERIES; SUPPRESSOR; DEFECTS; TRANSPOSITION; ABNORMALITIES	Patients with heterotaxy have characteristic cardiovascular malformations, abnormal arrangement of their visceral organs, and midline patterning defects that result from abnormal left-right patterning during embryogenesis. Loss of function of the transcription factor ZIC3 causes X-linked heterotaxy and isolated congenital heart malformations and represents one of the few known monogenic causes of congenital heart disease. The birth incidence of heterotaxy-spectrum malformations is significantly higher in males, but our previous work indicated that mutations within ZIC3 did not account for the male over-representation. Therefore, cross species comparative sequence alignment was used to identify a putative novel fourth exon, and the existence of a novel alternatively spliced transcript was confirmed by amplification from murine embryonic RNA and subsequent sequencing. This transcript, termed Zic3-B, encompasses exons 1, 2, and 4 whereas Zic3-A encompasses exons 1, 2, and 3. The resulting protein isoforms are 466 and 456 amino acid residues respectively, sharing the first 407 residues. Importantly, the last two amino acids in the fifth zinc finger DNA binding domain are altered in the Zic3-B isoform, indicating a potential functional difference that was further evaluated by expression, subcellular localization, and transactivation analyses. The temporo-spatial expression pattern of Zic3-B overlaps with Zic3-A in vivo, and both isoforms are localized to the nucleus in vitro. Both isoforms can transcriptionally activate a Gli binding site reporter, but only ZIC3-A synergistically activates upon co-transfection with Gli3, suggesting that the isoforms are functionally distinct. Screening 109 familial and sporadic male heterotaxy cases did not identify pathogenic mutations in the newly identified fourth exon and larger studies are necessary to establish the importance of the novel isoform in human disease.	Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati	Bedard, JEJ (corresponding author), Adams State Coll, Alamosa, CO 81102 USA.	stephanie.ware@cchmc.org	Ware, Stephanie M./AAF-5577-2020		NIH [HL088639]; American Heart Association [0725539B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (HL088639) to SMW and an American Heart Association Postdoctoral Fellowship Research Award, Great Rivers Affiliate (0725539B) to JEJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUGA J, 1994, J NEUROCHEM, V63, P1880; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Bedard JEJ, 2007, HUM MOL GENET, V16, P187, DOI 10.1093/hmg/ddl461; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; Czosek RJ, 2010, PEDIATR RES, V68, P275, DOI 10.1203/00006450-201011001-00539; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; De Luca A, 2010, HEART, V96, P673, DOI 10.1136/hrt.2009.181685; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kitaguchi T, 2000, DEVELOPMENT, V127, P4787; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Kuiper RP, 2004, NUCLEIC ACIDS RES, V32, P2315, DOI 10.1093/nar/gkh571; Lim LS, 2010, STEM CELLS, V28, P1961, DOI 10.1002/stem.527; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Megarbane A, 2000, EUR J HUM GENET, V8, P704, DOI 10.1038/sj.ejhg.5200526; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nakata K, 1997, P NATL ACAD SCI USA, V94, P11980, DOI 10.1073/pnas.94.22.11980; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Purandare SM, 2002, DEVELOPMENT, V129, P2293; Sakai-Kato K, 2008, BBA-PROTEINS PROTEOM, V1784, P1011, DOI 10.1016/j.bbapap.2008.01.013; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Stone DM, 1999, J CELL SCI, V112, P4437; Tzschach A, 2006, EUR J HUM GENET, V14, P1317, DOI 10.1038/sj.ejhg.5201707; Ware SM, 2006, DEV DYNAM, V235, P776, DOI 10.1002/dvdy.20668; Ware SM, 2004, AM J HUM GENET, V74, P93, DOI 10.1086/380998; Ware SM, 2006, DEV DYNAM, V235, P1631, DOI 10.1002/dvdy.20719; ZHU L, 2007, HUM MUTAT, P1; Zhu L, 2007, HUM MOL GENET, V16, P1649, DOI 10.1093/hmg/ddm106	37	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23755	10.1371/journal.pone.0023755	http://dx.doi.org/10.1371/journal.pone.0023755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858219	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300092
J	Everaert, BR; Boulet, GA; Timmermans, JP; Vrints, CJ				Everaert, Bert R.; Boulet, Gaelle A.; Timmermans, Jean-Pierre; Vrints, Christiaan J.			Importance of Suitable Reference Gene Selection for Quantitative Real-Time PCR: Special Reference to Mouse Myocardial Infarction Studies	PLOS ONE			English	Article							EXPRESSION	Background: Quantitative real-time PCR (qPCR) is a widely used technique for gene expression analysis. Its reliability is highly dependent upon selection of the appropriate reference genes for accurate gene expression normalization. In this study, we investigated the expression stability of 10 commonly used reference genes in a mouse myocardial infarction model. Methods & Results: The expression stability of the 10 reference genes (Actb, B2m, Eef1a1, Gapdh, Hprt, Polr2a, Ppia, Rpl13a, Tbp, Tpt1) was analyzed using the geNorm software. Overall, the combination of Hprt, Rpl13a and Tpt1 was the most stable reference gene set in our experiments. Gapdh, Polr2a and Actb consistently showed the highest gene expression variability and the expression levels of Gapdh, Polr2a, Actb, B2m and Eef1a1 were found to be selectively up-or downregulated after myocardial infarction. We normalized the expression of Nppb and Vcam1, using different reference gene strategies and demonstrated that their induction after myocardial infarction was most clearly revealed with the optimal reference gene combination. However, the use of suboptimal reference gene combinations resulted in detrimental effects on gene expression levels and variability with a gradual loss of the expression differences and a significant reduction in statistical power. Conclusions: Hprt, Rpl13a and Tpt1 are a set of stably expressed reference genes for accurate gene expression normalization in myocardial infarction studies in mice. We found that Gapdh, Polr2a and Actb display high expression variability in mouse myocardial infarction tissues and that loss of statistical power and increase in sample size are the evident consequences of choosing suboptimal combinations of reference genes. We furthermore caution against the use of Gapdh, Polr2a, Actb, B2m and Eef1a1 for gene expression normalization in myocardial infarction studies because of selective up-or downregulation after myocardial infarction, which could potentially lead to biased study outcomes.	[Everaert, Bert R.; Boulet, Gaelle A.; Timmermans, Jean-Pierre] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium; [Everaert, Bert R.; Vrints, Christiaan J.] Univ Antwerp Hosp, Lab Cellular & Mol Cardiol, Antwerp, Belgium	University of Antwerp; University of Antwerp	Everaert, BR (corresponding author), Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium.	bert.everaert@ua.ac.be		Timmermans, Jean-Pierre/0000-0003-2506-6252	Research Foundation - Flanders (FWO) [G014906]	Research Foundation - Flanders (FWO)(FWO)	This work was supported by the Research Foundation - Flanders (FWO), grant No. G014906. B. Everaert is supported by a Ph.D. fellowship of the Reseach Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bommer UA, 2010, ONCOGENE, V29, P763, DOI 10.1038/onc.2009.380; Brattelid T, 2007, BASIC RES CARDIOL, V102, P198, DOI 10.1007/s00395-007-0648-1; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Lenth RV, JAVA APPLETS POWER S; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Perez S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-114; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Thiele H, 2000, EUR J BIOCHEM, V267, P5473, DOI 10.1046/j.1432-1327.2000.01609.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	21	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23793	10.1371/journal.pone.0023793	http://dx.doi.org/10.1371/journal.pone.0023793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858224	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300096
J	Friberg, U; Stewart, AD; Rice, WR				Friberg, Urban; Stewart, Andrew D.; Rice, William R.			Empirical Evidence for Son-Killing X Chromosomes and the Operation of SA-Zygotic Drive	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; Y-CHROMOSOME; CONFLICT; SIMULANS; SYSTEM; GENES	Background: Diploid organisms have two copies of all genes, but only one is carried by each haploid gamete and diploid offspring. This causes a fundamental genetic conflict over transmission rate between alternative alleles. Single genes, or gene clusters, only rarely code for the complex phenotypes needed to give them a transmission advantage (drive phenotype). However, all genes on a male's X and Y chromosomes co-segregate, allowing different sex-linked genes to code for different parts of the drive phenotype. Correspondingly, the well-characterized phenomenon of male gametic drive, occurring during haploid gametogenesis, is especially common on sex chromosomes. The new theory of sexually antagonistic zygotic drive of the sex chromosomes (SA-zygotic drive) extends the logic of gametic drive into the diploid phase of the lifecycle, whenever there is competition among siblings or harmful sib-sib mating. The X and Y are predicted to gain a transmission advantage by harming offspring of the sex that does not carry them. Results: Here we analyzed a mutant X-chromosome in Drosophila simulans that produced an excess of daughters when transmitted from males. We developed a series of tests to differentiate between gametic and SA-zygotic drive, and provide multiple lines of evidence that SA-zygotic drive is responsible for the sex ratio bias. Driving sires produce about 50% more surviving daughters than sons. Conclusion: Sex-ratio distortion due to genetic conflict has evolved via gametic drive and maternally transmitted endosymbionts. Our data indicate that sex chromosomes can also drive by harming the non-carrier sex of offspring.	[Friberg, Urban; Stewart, Andrew D.; Rice, William R.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Friberg, Urban] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden	University of California System; University of California Santa Barbara; Uppsala University	Friberg, U (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	Urban.Friberg@ebc.uu.se	Friberg, Urban/C-9412-2015; Friberg, Urban/H-4569-2011	Friberg, Urban/0000-0001-6112-9586; 	National Science Foundation [DEB-0128780, DEB-0111613]; National Institutes of Health [1R01HD057974-01]; Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057974] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Science Foundation (DEB-0128780 and DEB-0111613), the National Institutes of Health (1R01HD057974-01), and the Wenner-Gren Foundations (http://www.swgc.org/index.aspx?languageID = 5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Burt A, 2006, GENES CONFLICT BIOL; Dawkins Richard, 1976, SELFISH GENE; Fox M, 2010, P ROY SOC B-BIOL SCI, V277, P567, DOI 10.1098/rspb.2009.1660; Golic KG, 1998, CURR BIOL, V8, P1273, DOI 10.1016/S0960-9822(07)00537-4; HOFFMANN AA, 1985, AM NAT, V125, P421, DOI 10.1086/284351; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; HURST LD, 1992, P ROY SOC B-BIOL SCI, V248, P135, DOI 10.1098/rspb.1992.0053; Jaenike J, 2003, EVOL ECOL RES, V5, P1023; Koerich LB, 2008, NATURE, V456, P949, DOI 10.1038/nature07463; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lloyd V, 2000, GENETICA, V109, P35, DOI 10.1023/A:1026592318341; Maggert KA, 2002, GENETICS, V162, P1245; Menon DU, 2009, GENETICS, V183, P811, DOI 10.1534/genetics.109.107219; Miller PM, 2006, SCIENCE, V312, P73, DOI 10.1126/science.1123727; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; NEELEY JC, 1971, J HERED, V62, P334, DOI 10.1093/oxfordjournals.jhered.a108187; NOOR MAF, 1995, RES NOTE DROSOPHILA, V76, P151; Rice WR, 2010, P ROY SOC B-BIOL SCI, V277, P2727, DOI 10.1098/rspb.2010.0409; Rice WR, 2009, BIOL LETTERS, V5, P686, DOI 10.1098/rsbl.2009.0061; Rice WR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000313; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Tao Y, 2007, PLOS BIOL, V5, P2560, DOI 10.1371/journal.pbio.0050292; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; Williamson DL., 1979, MYCOPLASMAS, P175, DOI [10.1016/B978-0-12-078403-5.50012-8, DOI 10.1016/B978-0-12-078403-5.50012-8]	27	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23508	10.1371/journal.pone.0023508	http://dx.doi.org/10.1371/journal.pone.0023508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858149	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300054
J	Nagoor, NH; Muttiah, NSJ; Lim, CS; In, LLA; Mohammad, K; Awang, K				Nagoor, Noor Hasima; Muttiah, Norliza Shah Jehan; Lim, Chong Soon; In, Lionel L. A.; Mohammad, Khalit; Awang, Khalijah			Regulation of Apoptotic Effects by Erythrocarpine E, a Cytotoxic Limonoid from Chisocheton erythrocarpus in HSC-4 Human Oral Cancer Cells	PLOS ONE			English	Article							PRODUCTS; BAX	The aim of this study was to determine the cytotoxic and apoptotic effects of erythrocarpine E (CEB4), a limonoid extracted from Chisocheton erythrocarpus on human oral squamous cell carcinoma. Based on preliminary dimethyl-2-thiazolyl-2,5-diphenyl-2H-tetrazolium bromide (MTT) assays, CEB4 treated HSC-4 cells demonstrated a cytotoxic effect and inhibited cell proliferation in a time and dose dependent manner with an IC50 value of 4.0+/-1.9 mu M within 24 h of treatment. CEB4 was also found to have minimal cytotoxic effects on the normal cell line, NHBE with cell viability levels maintained above 80% upon treatment. Annexin V-fluorescein isothiocyanate (FITC), poly-ADP ribose polymerase (PARP) cleavage and DNA fragmentation assay results showed that CEB4 induces apoptosis mediated cell death. Western blotting results demonstrated that the induction of apoptosis by CEB4 appeared to be mediated through regulation of the p53 signalling pathway as there was an increase in p53 phosphorylation levels. CEB4 was also found to up-regulate the pro-apoptotic protein, Bax, while down-regulating the anti-apoptotic protein, Bcl-2, suggesting the involvement of the intrinsic mitochondrial pathway. Reduced levels of initiator procaspase-9 and executioner caspase-3 zymogen were also observed following CEB4 exposure, hence indicating the involvement of cytochrome c mediated apoptosis. These results demonstrate the cytotoxic and apoptotic ability of erythrocarpine E, and suggest its potential development as a cancer chemopreventive agent.	[Nagoor, Noor Hasima; Muttiah, Norliza Shah Jehan; In, Lionel L. A.] Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia; [Lim, Chong Soon; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod Res & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia; [Mohammad, Khalit] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Nagoor, NH (corresponding author), Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia.	hasima@um.edu.my; lionelin@um.edu.my	IN, LIONEL/AAI-9847-2020; In, Lionel/D-1338-2013; PITCHAI, NOOR HASIMA A K NAGOOR/B-9270-2010; AWANG, KHALIJAH/B-8781-2010	IN, LIONEL/0000-0001-7182-112X; In, Lionel/0000-0001-7182-112X; AWANG, KHALIJAH/0000-0001-5971-6570	University of Malaya [PS166-2008B, RG0008/09BIO]; Ministry of Science, Technology and Innovation (MOSTI) [12-02-03-2022]; Centre for Natural Product Research and Drug Discovery (CENAR) [4911274]	University of Malaya(Universiti Malaya); Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Centre for Natural Product Research and Drug Discovery (CENAR)	This study was supported by the University of Malaya Postgraduate Research Grant (PPP) (PS166-2008B), the Ministry of Science, Technology and Innovation (MOSTI) eScience Fund (12-02-03-2022), the University of Malaya Research Grant (UMRG) (RG0008/09BIO), and the Centre for Natural Product Research and Drug Discovery (CENAR) Grant (4911274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awang K, 2007, BIOORGAN MED CHEM, V15, P5997, DOI 10.1016/j.bmc.2007.05.049; Bursztajn S, 2000, MOL BRAIN RES, V76, P363; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Gewies A, 2003, APOREVIEW, V1002, P1; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Guthrie N., 2000, CITRUS LIMONOIDS FUN, V758, P164, DOI DOI 10.1021/BK-2000-0758.CH012; Hasima N, 2010, PHYTOMEDICINE, V17, P935, DOI 10.1016/j.phymed.2010.03.011; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; JESSIE L, 1999, AAPS PHARMSCI, V1, P1; Kumar S, 2006, J ETHNOPHARMACOL, V105, P246, DOI 10.1016/j.jep.2005.11.006; LAM LKT, 1994, FOOD TECHNOL-CHICAGO, V48, P104; Matsumoto H, 2004, JPN J CLIN ONCOL, V34, P124, DOI 10.1093/jjco/hyh026; OZAKI Y, 1995, J FOOD SCI, V60, P186, DOI 10.1111/j.1365-2621.1995.tb05634.x; Patil JR, 2010, MICROCHEM J, V94, P108, DOI 10.1016/j.microc.2009.09.008; Patil JR, 2009, FOOD CHEM, V114, P1351, DOI 10.1016/j.foodchem.2008.11.033; Tanaka T., 2000, CITRUS LIMONOIDS FUN, P145, DOI DOI 10.1021/BK-2000-0758.CH011; Tolis C, 1999, EUR J CANCER, V35, P796, DOI 10.1016/S0959-8049(98)00425-0; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Zhao JF, 2009, MICROB PATHOGENESIS, V46, P194, DOI 10.1016/j.micpath.2008.12.005	22	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23661	10.1371/journal.pone.0023661	http://dx.doi.org/10.1371/journal.pone.0023661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858194	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300075
J	Scott, D; Shields, A; Straker, M; Dalrymple, H; Dhillon, PK; Harbinder, S				Scott, David; Shields, Alicia; Straker, Michaela; Dalrymple, Heidi; Dhillon, Priya K.; Harbinder, Singh			Variation in the Male Pheromones and Mating Success of Wild Caught Drosophila melanogaster	PLOS ONE			English	Article							CIS-VACCENYL ACETATE; CUTICULAR HYDROCARBONS; INCIPIENT SPECIATION; BEHAVIORAL-RESPONSES; GENETIC-ANALYSIS; MALE COURTSHIP; SEX-PHEROMONE; FEMALES; SONG; ATTRACTIVENESS	Drosophila melanogaster males express two primary cuticular hydrocarbons (male-predominant hydrocarbons). These act as sex pheromones by influencing female receptivity to mating. The relative quantities of these hydrocarbons vary widely among natural populations and can contribute to variation in mating success. We tested four isofemale lines collected from a wild population to assess the effect of intrapopulation variation in male-predominant hydrocarbons on mating success. The receptivity of laboratory females to males of the four wild-caught lines varied significantly, but not consistently in the direction predicted by variation in male-predominant hydrocarbons. Receptivity of the wild-caught females to laboratory males also varied significantly, but females from lines with male-predominant hydrocarbon profiles closer to a more cosmopolitan one did not show a correspondingly strong mating bias toward a cosmopolitan male. Among wild-caught lines, the male-specific ejaculatory bulb lipid, cis-vaccenyl acetate, varied more than two-fold, but was not associated with variation in male mating success. We observed a strong inverse relationship between the receptivity of wild-caught females and the mating success of males from their own lines, when tested with laboratory flies of the opposite sex.	[Scott, David; Straker, Michaela] S Carolina State Univ, Dept Biol & Phys Sci, Orangeburg, SC 29117 USA; [Shields, Alicia] Stanford Univ, Beckman Ctr, Sch Med, Stanford, CA 94305 USA; [Dalrymple, Heidi] St Georges Univ Grenagde, Univ Ctr, Sch Med, St Georges, Grenada; [Dhillon, Priya K.; Harbinder, Singh] Delaware State Univ, Dept Biol, Dover, DE USA	South Carolina State University; Stanford University; Delaware State University	Scott, D (corresponding author), S Carolina State Univ, Dept Biol & Phys Sci, Orangeburg, SC 29117 USA.	dscott@physics.scsu.edu	Dhillon, Harbinder Singh/J-1981-2019	Dhillon, Harbinder Singh/0000-0002-9760-6724; Shields, Alicia/0000-0002-0280-7188	United States Department of Agriculture, Cooperative State Research Service [CRS SCX-420-18-04]	United States Department of Agriculture, Cooperative State Research Service(United States Department of Agriculture (USDA))	This research was funded by the United States Department of Agriculture, Cooperative State Research Service, Grant # CRS SCX-420-18-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Blows MW, 1999, P ROY SOC B-BIOL SCI, V266, P2169, DOI 10.1098/rspb.1999.0904; Box GE., 1978, STAT EXPT; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Carson HL, 2002, GENETICA, V116, P383, DOI 10.1023/A:1021280325474; Casares P, 2007, BEHAV GENET, V37, P498, DOI 10.1007/s10519-006-9141-0; Coyne JA, 1999, GENET RES, V73, P189, DOI 10.1017/S0016672398003723; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Etges WJ, 2008, J EVOLUTION BIOL, V21, P1641, DOI 10.1111/j.1420-9101.2008.01601.x; Etges WJ, 2007, EVOLUTION, V61, P1106, DOI 10.1111/j.1558-5646.2007.00104.x; Etges WJ, 2010, EVOLUTION, V64, P3549, DOI 10.1111/j.1558-5646.2010.01096.x; Etges WJ, 2009, EVOLUTION, V63, P1712, DOI 10.1111/j.1558-5646.2009.00661.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 1996, GENET RES, V67, P211, DOI 10.1017/S0016672300033693; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Ferveur JF, 1996, GENETICA, V97, P73, DOI 10.1007/BF00132583; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Hoikkala A, 2005, CURR TOP DEV BIOL, V67, P225, DOI 10.1016/S0070-2153(05)67007-X; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; MARKOW TA, 1981, P NATL ACAD SCI-BIOL, V78, P430, DOI 10.1073/pnas.78.1.430; Petfield D, 2005, P NATL ACAD SCI USA, V102, P6045, DOI 10.1073/pnas.0409378102; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; SCOTT D, 1986, P NATL ACAD SCI USA, V83, P8429, DOI 10.1073/pnas.83.21.8429; SCOTT D, 1987, J INSECT PHYSIOL, V33, P363, DOI 10.1016/0022-1910(87)90125-9; SCOTT D, 1988, GENETICS, V119, P639; SCOTT D, 1988, J INSECT PHYSIOL, V34, P863, DOI 10.1016/0022-1910(88)90120-5; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; SCOTT D, 1994, EVOLUTION, V48, P112, DOI [10.2307/2410007, 10.1111/j.1558-5646.1994.tb01298.x]; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P383; Svetec N, 2005, GENET RES, V85, P183, DOI 10.1017/S0016672305007536; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; VANDENBERG MJ, 1984, BEHAV GENET, V14, P45, DOI 10.1007/BF01066068; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x; Yew JY, 2008, P NATL ACAD SCI USA, V105, P7135, DOI 10.1073/pnas.0802692105; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	41	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23645	10.1371/journal.pone.0023645	http://dx.doi.org/10.1371/journal.pone.0023645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858189	gold, Green Submitted, Green Published			2022-12-27	WOS:000294121300073
J	Igari, S; Ohtaki, A; Yamanaka, Y; Sato, Y; Yohda, M; Odaka, M; Noguchi, K; Yamada, K				Igari, Sayaka; Ohtaki, Akashi; Yamanaka, Yasuaki; Sato, Yuichi; Yohda, Masafumi; Odaka, Masafumi; Noguchi, Keiichi; Yamada, Kazuhiro			Properties and Crystal Structure of Methylenetetrahydrofolate Reductase from Thermus thermophilus HB8	PLOS ONE			English	Article							DEPENDENT 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; ESCHERICHIA-COLI; VASCULAR-DISEASE; RISK-FACTOR; PURIFICATION; ASPARTATE-120; CATALYSIS; BINDING; ROLES	Background: Methylenetetrahydrofolate reductase ( MTHFR) is one of the enzymes involved in homocysteine metabolism. Despite considerable genetic and clinical attention, the reaction mechanism and regulation of this enzyme are not fully understood because of difficult production and poor stability. While recombinant enzymes from thermophilic organisms are often stable and easy to prepare, properties of thermostable MTHFRs have not yet been reported. Methodology/Principal Findings: MTHFR from Thermus thermophilus HB8, a homologue of Escherichia coli MetF, has been expressed in E. coli and purified. The purified MTHFR was chiefly obtained as a heterodimer of apo- and holo-subunits, that is, one flavin adenine dinucleotide ( FAD) prosthetic group bound per dimer. The crystal structure of the holo-subunit was quite similar to the beta(8)alpha(8) barrel of E. coli MTHFR, while that of the apo-subunit was a previously unobserved closed form. In addition, the intersubunit interface of the dimer in the crystals was different from any of the subunit interfaces of the tetramer of E. coli MTHFR. Free FAD could be incorporated into the apo-subunit of the purified Thermus enzyme after purification, forming a homodimer of holo-subunits. Comparison of the crystal structures of the heterodimer and the homodimer revealed different intersubunit interfaces, indicating a large conformational change upon FAD binding. Most of the biochemical properties of the heterodimer and the homodimer were the same, except that the homodimer showed approximate to 50% activity per FAD-bound subunit in folate-dependent reactions. Conclusions/Significance: The different intersubunit interfaces and rearrangement of subunits of Thermus MTHFR may be related to human enzyme properties, such as the allosteric regulation by S-adenosylmethionine and the enhanced instability of the Ala222Val mutant upon loss of FAD. Whereas E. coli MTHFR was the only structural model for human MTHFR to date, our findings suggest that Thermus MTHFR will be another useful model for this important enzyme.	[Igari, Sayaka; Ohtaki, Akashi; Yamanaka, Yasuaki; Sato, Yuichi; Yohda, Masafumi; Odaka, Masafumi; Noguchi, Keiichi; Yamada, Kazuhiro] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan	Tokyo University of Agriculture & Technology	Igari, S (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan.	yamadak@cc.tuat.ac.jp	Yohda, Masafumi/A-5149-2013; Noguchi, Keiichi/B-9978-2013; Odaka, Masafumi/C-2378-2013	Yohda, Masafumi/0000-0001-8307-9671; Noguchi, Keiichi/0000-0003-0833-0808; 	Ministry of Education, Culture, Sports, Science and Technology through the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21570132] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology through the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology through the Japan Science and Technology Agency (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLARK JE, 1984, J BIOL CHEM, V259, P845; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DRUMMOND JT, 1995, ANAL BIOCHEM, V228, P323, DOI 10.1006/abio.1995.1358; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MN, 2009, BIOCHEMISTRY-US, V48, P7673, DOI 10.1021/bi9007325; MATTHEWS RG, 1984, J BIOL CHEM, V259, P1647; MATTHEWS RG, 1986, METHOD ENZYMOL, V122, P372; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2006, BIOCHEMISTRY-US, V45, P4808, DOI 10.1021/bi052294c; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Roje S, 1999, J BIOL CHEM, V274, P36089, DOI 10.1074/jbc.274.51.36089; Segel I.H., 1975, ENZYME KINETICS; Sheppard CA, 1999, J BACTERIOL, V181, P718, DOI 10.1128/JB.181.3.718-725.1999; Trimmer EE, 2005, BIOCHEMISTRY-US, V44, P6809, DOI 10.1021/bi0477236; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6205, DOI 10.1021/bi002789w; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6216, DOI 10.1021/bi002790v; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Williams C H Jr, 1979, Methods Enzymol, V62, P185; WOHLFARTH G, 1990, EUR J BIOCHEM, V192, P411, DOI 10.1111/j.1432-1033.1990.tb19242.x; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	29	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23716	10.1371/journal.pone.0023716	http://dx.doi.org/10.1371/journal.pone.0023716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858212	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700040
J	Singh, NP; Singh, UP; Singh, B; Price, RL; Nagarkatti, M; Nagarkatti, PS				Singh, Narendra P.; Singh, Udai P.; Singh, Balwan; Price, Robert L.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.			Activation of Aryl Hydrocarbon Receptor (AhR) Leads to Reciprocal Epigenetic Regulation of FoxP3 and IL-17 Expression and Amelioration of Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HELPER-CELL DIFFERENTIATION; NF-KAPPA-B; T-CELLS; FAS LIGAND; IN-VIVO; CHEMOKINE RECEPTORS; ULCERATIVE-COLITIS; DNA METHYLATION; IL-10(-/-) MICE	Background: Aryl hydrocarbon receptor (AhR), a transcription factor of the bHLH/PAS family, is well characterized to regulate the biochemical and toxic effects of environmental chemicals. More recently, AhR activation has been shown to regulate the differentiation of Foxp3(+) Tregs as well as Th17 cells. However, the precise mechanisms are unclear. In the current study, we investigated the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent AhR ligand, on epigenetic regulation leading to altered Treg/Th17 differentiation, and consequent suppression of colitis. Methodology/Principal Findings: Dextran sodium sulphate (DSS) administration induced acute colitis in C57BL/6 mice, as shown by significant weight loss, shortening of colon, mucosal ulceration, and increased presence of CXCR3(+) T cells as well as inflammatory cytokines. Interestingly, a single dose of TCDD (25 mg/kg body weight) was able to attenuate all of the clinical and inflammatory markers of colitis. Analysis of T cells in the lamina propria (LP) and mesenteric lymph nodes (MLN), during colitis, revealed decreased presence of Tregs and increased induction of Th17 cells, which was reversed following TCDD treatment. Activation of T cells from AhR(+/+) but not AhR(-/-) mice, in the presence of TCDD, promoted increased differentiation of Tregs while inhibiting Th17 cells. Analysis of MLN or LP cells during colitis revealed increased methylation of CpG islands of Foxp3 and demethylation of IL-17 promoters, which was reversed following TCDD treatment. Conclusions/Significance: These studies demonstrate for the first time that AhR activation promotes epigenetic regulation thereby influencing reciprocal differentiation of Tregs and Th17 cells, and amelioration of inflammation.	[Singh, Narendra P.; Singh, Udai P.; Price, Robert L.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Singh, Balwan] Emory Univ, Primate Res Ctr, Atlanta, GA 30322 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Emory University	Singh, NP (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	pnagark@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Singh, Udai/0000-0002-7048-4325	National Institutes of Health [R01-DA016545, R01-ES09098, P01-AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was funded by National Institutes of Health (R01-DA016545, R01-ES09098, and P01-AT003961 to MN and PSN). The funding agency had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Beedanagari SR, 2010, MOL PHARMACOL, V78, P608, DOI 10.1124/mol.110.064899; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Camacho IA, 2005, J IMMUNOL, V175, P90, DOI 10.4049/jimmunol.175.1.90; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; CLARK DA, 1981, P SOC EXP BIOL MED, V168, P290; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Desaulniers D, 2005, TOXICOL SCI, V86, P175, DOI 10.1093/toxsci/kfi178; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Kamath AB, 1999, TOXICOL APPL PHARM, V160, P141, DOI 10.1006/taap.1999.8753; Kamath AB, 1997, TOXICOL APPL PHARM, V142, P367, DOI 10.1006/taap.1996.8049; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon JH, 2005, AM J PHYSIOL-GASTR L, V289, pG1075, DOI 10.1152/ajpgi.00073.2005; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Luster MI, 2010, METHODS MOL BIOL, V598, P3, DOI 10.1007/978-1-60761-401-2_1; Marshall NB, 2010, ANN NY ACAD SCI, V1183, P25, DOI 10.1111/j.1749-6632.2009.05125.x; Mir A, 2002, AM J GASTROENTEROL, V97, P1452, DOI 10.1016/S0002-9270(02)04043-1; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NAGARKATTI PS, 1984, TOXICOL APPL PHARM, V72, P169, DOI 10.1016/0041-008X(84)90261-8; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Scheerens H, 2001, EUR J IMMUNOL, V31, P1465, DOI 10.1002/1521-4141(200105)31:5<1465::AID-IMMU1465>3.0.CO;2-E; Singh NP, 2008, MOL PHARMACOL, V73, P1722, DOI 10.1124/mol.107.043406; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Singh NP, 2007, MOL PHARMACOL, V71, P145, DOI 10.1124/mol.106.028365; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Singh UP, 2003, J IMMUNOL, V171, P1401, DOI 10.4049/jimmunol.171.3.1401; Singh UP, 2003, J INTERFERON CYTOKIN, V23, P2000; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; TAKAMURA T, 2010, IMMUNOL CELL BIOL; Tian YA, 2009, BIOCHEM PHARMACOL, V77, P670, DOI 10.1016/j.bcp.2008.10.023; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	58	189	204	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23522	10.1371/journal.pone.0023522	http://dx.doi.org/10.1371/journal.pone.0023522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858153	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700028
J	Aburto-Oropeza, O; Erisman, B; Galland, GR; Mascarenas-Osorio, I; Sala, E; Ezcurra, E				Aburto-Oropeza, Octavio; Erisman, Brad; Galland, Grantly R.; Mascarenas-Osorio, Ismael; Sala, Enric; Ezcurra, Exequiel			Large Recovery of Fish Biomass in a No-Take Marine Reserve	PLOS ONE			English	Article							CORAL-REEFS; PROTECTION; COMMUNITIES; ASSEMBLAGES; FISHERIES; ISLANDS; TRENDS; RATES; SIZE	No-take marine reserves are effective management tools used to restore fish biomass and community structure in areas depleted by overfishing. Cabo Pulmo National Park (CPNP) was created in 1995 and is the only well enforced no-take area in the Gulf of California, Mexico, mostly because of widespread support from the local community. In 1999, four years after the establishment of the reserve, there were no significant differences in fish biomass between CPNP (0.75 t ha(-1) on average) and other marine protected areas or open access areas in the Gulf of California. By 2009, total fish biomass at CPNP had increased to 4.24 t ha(-1) (absolute biomass increase of 3.49 t ha(-1), or 463%), and the biomass of top predators and carnivores increased by 11 and 4 times, respectively. However, fish biomass did not change significantly in other marine protected areas or open access areas over the same time period. The absolute increase in fish biomass at CPNP within a decade is the largest measured in a marine reserve worldwide, and it is likely due to a combination of social (strong community leadership, social cohesion, effective enforcement) and ecological factors. The recovery of fish biomass inside CPNP has resulted in significant economic benefits, indicating that community-managed marine reserves are a viable solution to unsustainable coastal development and fisheries collapse in the Gulf of California and elsewhere.	[Aburto-Oropeza, Octavio; Erisman, Brad; Galland, Grantly R.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Mascarenas-Osorio, Ismael] Ctr Biodiversidad Marina & Conservac, La Paz, Bcs, Mexico; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Sala, Enric] Ctr Estudis Avancats Blanes CSIC, Blanes, Spain; [Ezcurra, Exequiel] Univ Calif Riverside, UC MEXUS, Riverside, CA 92521 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Riverside	Aburto-Oropeza, O (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	maburto@ucsd.edu	Erisman, Brad/R-8827-2019; Erisman, Brad/P-1640-2019	Erisman, Brad/0000-0002-9336-7957; Erisman, Brad/0000-0002-9336-7957; Aburto-Oropeza, Octavio/0000-0002-8173-1432	Kathryn Fuller Fellowship - WWF Scientific Program; David and Lucile Packard Foundation; Tinker Foundation; Robins Family Foundation; Pew Fellowship Program on Marine Conservation; Walton Family Foundation	Kathryn Fuller Fellowship - WWF Scientific Program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Tinker Foundation; Robins Family Foundation; Pew Fellowship Program on Marine Conservation; Walton Family Foundation	OA-O was supported by a Kathryn Fuller Fellowship - WWF Scientific Program. Additional funding for this research was provided by the David and Lucile Packard Foundation, The Tinker Foundation, the Robins Family Foundation, the Pew Fellowship Program on Marine Conservation, and the Walton Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O., 2006, RED RESERVAS MARINAS; Aburto-Oropeza O, 2007, ECOLOGY, V88, P2220, DOI 10.1890/06-0857.1; Aburto-Oropeza O, 2009, MAR BIOL, V156, P2461, DOI 10.1007/s00227-009-1271-5; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bonilla HR, 1997, CONSERV BIOL, V11, P838; Cudney-Bueno R, 2009, OCEAN COAST MANAGE, V52, P207, DOI 10.1016/j.ocecoaman.2008.12.005; DELATORRE JAM, 2008, TURISMO SUSTENTABILI, P133; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2005, MAR ECOL PROG SER, V297, P259, DOI 10.3354/meps297259; Erisman BE, 2011, ICES J MAR SCI, V68, P564, DOI 10.1093/icesjms/fsq179; Ezcurra E., 2009, ECOSYSTEM BASED MANA, P227; FRAGA J, 2008, COASTAL MARINE PROTE, P16976; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Froese R., 2011, FISHBASE WORLD WIDE; Gamez A. E., 2008, TURISMO SUSTENTABILI; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harmelin-Vivien Mireille L., 2002, P265, DOI 10.1016/B978-012615185-5/50016-5; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Leisher C., 2007, NATURES INVESTMENT B; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; LOPEZSAGASTEGUI C, 2005, MARINE BIODIVERSITY, P16976; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Montes HML, 2008, FRONT ECOL ENVIRON, V6, P75, DOI 10.1890/070056; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; PESENTI C, 2003, SUSTAINABLE COASTAL, P16976; Roberts CM, 1997, CORAL REEFS, V16, P150, DOI 10.1007/BF03257480; ROBERTS CM, 1995, CONSERV BIOL, V9, P815, DOI 10.1046/j.1523-1739.1995.09040815.x; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 1999, CORAL REEFS, V18, P307, DOI 10.1007/s003380050203; SAENZARROYO A, 2005, DESIGN EVALUATION MA, P16976; Sagarin AD, 2008, FRONT ECOL ENVIRON, V6, P374, DOI 10.1890/070067; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Sala E, 2003, B MAR SCI, V72, P103; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; SQUIRES DONALD F., 1959, BULL AMER MUS NAT HIST, V118, P367; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	54	147	153	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23601	10.1371/journal.pone.0023601	http://dx.doi.org/10.1371/journal.pone.0023601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858183	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500058
J	Le Lay, S; Rodriguez, M; Jessup, W; Rentero, C; Li, Q; Cartland, S; Grewal, T; Gaus, K				Le Lay, Soazig; Rodriguez, Macarena; Jessup, Wendy; Rentero, Carles; Li, Qiong; Cartland, Sian; Grewal, Thomas; Gaus, Katharina			Caveolin-1-Mediated Apolipoprotein A-I Membrane Binding Sites Are Not Required for Cholesterol Efflux	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR-BI; AORTIC ENDOTHELIAL-CELLS; CASSETTE TRANSPORTER A1; MACROPHAGE FOAM CELLS; CELLULAR CHOLESTEROL; PLASMA-MEMBRANE; SR-BI; LIPID RAFTS; APOA-I	Caveolin-1 (Cav1), a structural protein required for the formation of invaginated membrane domains known as caveolae, has been implicated in cholesterol trafficking and homeostasis. Here we investigated the contribution of Cav1 to apolipoprotein A-I (apoA-I) cell surface binding and intracellular processing using mouse embryonic fibroblasts (MEFs) derived from wild type (WT) or Cav1-deficient (Cav1(-/-)) animals. We found that cells expressing Cav1 have 2.6-fold more apoA-I binding sites than Cav1(-/-) cells although these additional binding sites are not associated with detergent-free lipid rafts. Further, Cav1-mediated binding targets apoA-I for internalization and degradation and these processes are not correlated to cholesterol efflux. Despite lower apoA-I binding, cholesterol efflux from Cav1(-/-) MEFs is 1.7-fold higher than from WT MEFs. Stimulation of ABCA1 expression with an LXR agonist enhances cholesterol efflux from both WT and Cav1(-/-) cells without increasing apoA-I surface binding or affecting apoA-I processing. Our results indicate that there are at least two independent lipid binding sites for apoA-I; Cav1-mediated apoA-I surface binding and uptake is not linked to cholesterol efflux, indicating that membrane domains other than caveolae regulate ABCA1-mediated cholesterol efflux.	[Le Lay, Soazig] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Rodriguez, Macarena; Jessup, Wendy; Rentero, Carles; Li, Qiong; Cartland, Sian; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of New South Wales Sydney; University of Sydney	Le Lay, S (corresponding author), Ctr Rech Cordeliers, INSERM, U872, Paris, France.	k.gaus@unsw.edu.au	Le Lay, Soazig/AAI-2442-2021; Le Lay, Soazig/N-6862-2018; Rentero Alfonso, Carles/L-4430-2017	Le Lay, Soazig/0000-0003-2456-2422; Rentero Alfonso, Carles/0000-0003-4684-0278; Gaus, Katharina/0000-0002-8009-9658; Grewal, Thomas/0000-0002-7937-8887; Cartland, Sian/0000-0003-1723-2679	Australian Research Council; National Heart Foundation of Australia; National Health and Medical Research Council [455301, 510293, 510294]; University of Sydney [2010-02681]; Beatriu de Pinos fellowship	Australian Research Council(Australian Research Council); National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Beatriu de Pinos fellowship	KG would like to acknowledge funding from the Australian Research Council and the National Heart Foundation of Australia. KG and WJ are recipients of funding by the National Health and Medical Research Council (Project Grant 455301). TG is supported by the NHMRC (510293, 510294) and the University of Sydney (2010-02681). CR holds a Beatriu de Pinos fellowship (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa R, 2000, J LIPID RES, V41, P1952; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Boucrot E, 2011, J CELL SCI, V124, P1965, DOI 10.1242/jcs.076570; Bultel S, 2008, ARTERIOSCL THROM VAS, V28, P2288, DOI 10.1161/ATVBAHA.108.175042; Cao H, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-3; Cavelier C, 2006, CIRC RES, V99, P1060, DOI 10.1161/01.RES.0000250567.17569.b3; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Denis M, 2008, J BIOL CHEM; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; Faulkner LE, 2008, J LIPID RES, V49, P1322, DOI 10.1194/jlr.M800048-JLR200; Fielding CJ, 1999, BIOCHEMISTRY-US, V38, P2506, DOI 10.1021/bi981012o; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Frank PG, 2001, AM J PHYSIOL-CELL PH, V280, pC1204, DOI 10.1152/ajpcell.2001.280.5.C1204; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Gargalovic P, 2001, J BIOL CHEM, V276, P26164, DOI 10.1074/jbc.M011291200; Gaus K, 2005, J LIPID RES, V46, P1526, DOI 10.1194/jlr.M500103-JLR200; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gaus K, 2001, BIOCHEMISTRY-US, V40, P9363, DOI 10.1021/bi010323n; Gaus K, 2001, BIOCHEMISTRY-US, V40, P13002, DOI 10.1021/bi010833h; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gelissen IC, 1999, J LIPID RES, V40, P1636; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ikonen E, 2000, TRAFFIC, V1, P212, DOI 10.1034/j.1600-0854.2000.010303.x; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lin GR, 2000, ATHEROSCLEROSIS, V149, P359, DOI 10.1016/S0021-9150(99)00503-1; Lin YC, 2007, CARDIOVASC RES, V75, P575, DOI 10.1016/j.cardiores.2007.04.012; Lin YC, 2009, BIOCHEM BIOPH RES CO, V382, P189, DOI 10.1016/j.bbrc.2009.03.005; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Matveev S, 1999, J LIPID RES, V40, P1647; Matveev S, 2001, EUR J BIOCHEM, V268, P5609, DOI 10.1046/j.1432-1033.2001.02496.x; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Razani B, 2001, J BIOL CHEM, V276, P38121; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Skretting G, 1999, J CELL SCI, V112, P3899; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Sviridov D, 2001, BIOCHEM J, V358, P79, DOI 10.1042/0264-6021:3580079; Takahashi Y, 1999, P NATL ACAD SCI USA, V96, P11358, DOI 10.1073/pnas.96.20.11358; Truong TQ, 2006, BBA-MOL CELL BIOL L, V1761, P24, DOI 10.1016/j.bbalip.2005.12.004; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200	74	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23353	10.1371/journal.pone.0023353	http://dx.doi.org/10.1371/journal.pone.0023353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858084	Green Published, gold			2022-12-27	WOS:000293953500033
J	Luo, HB; Ma, L; Xi, HF; Duan, W; Li, SH; Loescher, W; Wang, JF; Wang, LJ				Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Duan, Wei; Li, Shao-Hua; Loescher, Wayne; Wang, Jun-Fang; Wang, Li-Jun			Photosynthetic Responses to Heat Treatments at Different Temperatures and following Recovery in Grapevine (Vitis amurensis L.) Leaves	PLOS ONE			English	Article							PHOTOSYSTEM-II; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; FLUORESCENCE TRANSIENT; ELECTRON-TRANSPORT; ACTIVATION STATE; LEAF TEMPERATURE; CO2 FIXATION; RUBISCO; STRESS; INHIBITION	Background: The electron transport chain, Rubisco and stomatal conductance are important in photosynthesis. Little is known about their combined responses to heat treatment at different temperatures and following recovery in grapevines (Vitis spp.) which are often grown in climates with high temperatures. Methodology/Findings: The electron transport function of photosystem II, the activation state of Rubisco and the influence of stomatal behavior were investigated in grapevine leaves during heat treatments and following recovery. High temperature treatments included 35, 40 and 45 degrees C, with 25 degrees C as the control and recovery temperature. Heat treatment at 35 degrees C did not significantly (P>0.05) inhibit net photosynthetic rate (P-n). However, with treatments at 40 and 45 degrees C, P-n was decreased, accompanied by an increase in substomatal CO2 concentration (C-i), decreases in stomatal conductance (g(s)) and the activation state of Rubisco, and inhibition of the donor side and the reaction center of PSII. The acceptor side of PSII was inhibited at 45 degrees C but not at 40 degrees C. When grape leaves recovered following heat treatment, P-n, g(s) and the activation state of Rubisco also increased, and the donor side and the reaction center of PSII recovered. The increase in P-n during the recovery period following the second 45 degrees C stress was slower than that following the 40 degrees C stress, and these increases corresponded to the donor side of PSII and the activation state of Rubisco. Conclusions: Heat treatment at 35 degrees C did not significantly (P>0.05) influence photosynthesis. The decrease of P-n in grape leaves exposed to more severe heat stress (40 or 45 degrees C) was mainly attributed to three factors: the activation state of Rubisco, the donor side and the reaction center of PSII. However, the increase of P-n in grape leaves following heat stress was also associated with a stomatal response. The acceptor side of PSII in grape leaves was responsive but less sensitive to heat stress.	[Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Duan, Wei; Wang, Jun-Fang; Wang, Li-Jun] Chinese Acad Sci, Inst Bot, Beijing Key Lab Viticulture & Enol, Beijing, Peoples R China; [Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Duan, Wei; Wang, Jun-Fang; Wang, Li-Jun] Chinese Acad Sci, Inst Bot, Key Lab Plant Resource Sci, Beijing, Peoples R China; [Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Wang, Jun-Fang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Li, Shao-Hua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Loescher, Wayne] Michigan State Univ, Coll Agr & Nat Resources, E Lansing, MI 48824 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Michigan State University	Luo, HB (corresponding author), Chinese Acad Sci, Inst Bot, Beijing Key Lab Viticulture & Enol, Beijing, Peoples R China.	ljwang@ibcas.ac.cn			National Natural Science Foundation of China [30771758]; Chinese Academy of Sciences [KSCX2-EW-J-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (No. 30771758) and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-1). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BUKHOV NG, 1990, PHOTOSYNTH RES, V23, P81, DOI 10.1007/BF00030066; Bukhov NG, 2002, RUSS J PLANT PHYSL+, V49, P332, DOI 10.1023/A:1015536817680; Cen YP, 2005, PLANT PHYSIOL, V139, P979, DOI 10.1104/pp.105.066233; Chen LS, 2003, J AM SOC HORTIC SCI, V128, P754, DOI 10.21273/JASHS.128.5.0754; Cheng LL, 2000, J EXP BOT, V51, P1687, DOI 10.1093/jexbot/51.351.1687; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Crafts-Brandner SJ, 2000, PLANTA, V212, P67, DOI 10.1007/s004250000364; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; ENAMI I, 1994, BBA-BIOENERGETICS, V1185, P75, DOI 10.1016/0005-2728(94)90195-3; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; FERRINI F, 1995, AM J ENOL VITICULT, V46, P375; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; HAVAUX M, 1993, PLANT CELL ENVIRON, V16, P461, DOI 10.1111/j.1365-3040.1993.tb00893.x; Hendrickson L, 2003, FUNCT PLANT BIOL, V30, P631, DOI 10.1071/FP02114; Hendrickson L, 2004, PLANT CELL ENVIRON, V27, P795, DOI 10.1111/j.1365-3040.2004.01184.x; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kadir S, 2007, J AM SOC HORTIC SCI, V132, P764, DOI 10.21273/JASHS.132.6.764; Kadir S, 2006, J AM SOC HORTIC SCI, V131, P476, DOI 10.21273/JASHS.131.4.476; KOBZA J, 1987, PLANT PHYSIOL, V83, P69, DOI 10.1104/pp.83.1.69; Kouril R, 2004, PHOTOSYNTH RES, V81, P49, DOI 10.1023/B:PRES.0000028391.70533.eb; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; LAKSO AN, 1978, AM J ENOL VITICULT, V29, P145; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Lin ZH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-43; Makino A, 2007, PLANT CELL PHYSIOL, V48, P1472, DOI 10.1093/pcp/pcm118; MATSUI S, 1986, AM J ENOL VITICULT, V37, P67; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; NASH D, 1985, BIOCHIM BIOPHYS ACTA, V807, P127, DOI 10.1016/0005-2728(85)90115-X; Pospisil P, 1999, PHOTOSYNTH RES, V62, P55, DOI 10.1023/A:1006369009170; Quinn P. J., 1985, Photosynthetic mechanisms and the environment, P1; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Schrader SM, 2004, PLANT CELL ENVIRON, V27, P725, DOI 10.1111/j.1365-3040.2004.01172.x; Schultz H. R., 2000, Australian Journal of Grape and Wine Research, V6, P2, DOI 10.1111/j.1755-0238.2000.tb00156.x; SCHULTZ HR, 2007, COST ACT 858 WORKSH; SEPULVEDA G, 1986, AM J ENOL VITICULT, V37, P44; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Strasser RJ., 1999, CROP IMPROVEMENT FOO, P72; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; Wang LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-34; WEIS E, 1981, PLANTA, V151, P33, DOI 10.1007/BF00384234; Wise RR, 2004, PLANT CELL ENVIRON, V27, P717, DOI 10.1111/j.1365-3040.2004.01171.x	50	67	83	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23033	10.1371/journal.pone.0023033	http://dx.doi.org/10.1371/journal.pone.0023033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887227	Green Published, Green Submitted, gold			2022-12-27	WOS:000294298800003
J	Owen, KA; Abshire, MY; Tilghman, RW; Casanova, JE; Bouton, AH				Owen, Katherine A.; Abshire, Michelle Y.; Tilghman, Robert W.; Casanova, James E.; Bouton, Amy H.			FAK Regulates Intestinal Epithelial Cell Survival and Proliferation during Mucosal Wound Healing	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CYCLIN D1; CANCER-CELLS; SRC; APOPTOSIS; P53; PROGRESSION; EXPRESSION; ACTIVATION; MEDIATORS	Background: Following damage to the intestinal epithelium, restoration of epithelial barrier integrity is triggered by a robust proliferative response. In other tissues, focal adhesion kinase (FAK) regulates many of the cellular processes that are critical for epithelial homeostasis and restitution, including cell migration, proliferation and survival. However, few studies to date have determined how FAK contributes to mucosal wound healing in vivo. Methodology and Principal Findings: To examine the role of FAK in intestinal epithelial homeostasis and during injury, we generated intestinal epithelium (IE)-specific conditional FAK knockout mice. Colitis was induced with dextran-sulfate-sodium (DSS) and intestinal tissues were analyzed by immunohistochemistry and immunoblotting. While intestinal development occurred normally in mice lacking FAK, FAK-deficient animals were profoundly susceptible to colitis. The loss of epithelial FAK resulted in elevated p53 expression and an increased sensitivity to apoptosis, coincident with a failure to upregulate epithelial cell proliferation. FAK has been reported to function as a mechanosensor, inducing cyclin D1 expression and promoting cell cycle progression under conditions in which tissue/matrix stiffness is increased. Collagen deposition, a hallmark of inflammatory injury resulting in increased tissue rigidity, was observed in control and FAK knockout mice during colitis. Despite this fibrotic response, the colonic epithelium in FAK-deficient mice exhibited significantly reduced cyclin D1 expression, suggesting that proliferation is uncoupled from fibrosis in the absence of FAK. In support of this hypothesis, proliferation of Caco-2 cells increased proportionally with matrix stiffness in vitro only under conditions of normal FAK expression; FAK depleted cells exhibited reduced proliferation concomitant with attenuated cyclin D1 expression. Conclusions: In the colon, FAK functions as a regulator of epithelial cell survival and proliferation under conditions of mucosal injury and a mechanosensor of tissue compliance, inducing repair-driven proliferation in the colonic epithelium through upregulation of cyclin D1.	[Owen, Katherine A.; Casanova, James E.] Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA USA; [Abshire, Michelle Y.; Tilghman, Robert W.; Casanova, James E.; Bouton, Amy H.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA	University of Virginia; University of Virginia	Owen, KA (corresponding author), Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA USA.	jec9e@virginia.edu; ahb8y@virginia.edu			National Institutes of Health [AI050733, DK58536, 5F32DK839022, NCI-CA40042]; University of Virginia Digestive Health Research Center; Coulter Foundation; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050733, T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Digestive Health Research Center; Coulter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health (AI050733 to AHB, DK58536 to JEC, 5F32DK839022 to KAO and NCI-CA40042 to J. Thomas Parsons, University of Virginia), the University of Virginia Digestive Health Research Center pilot grant program (to AHB and JEC) and the Coulter Foundation Translational Partners Award (to RWT). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bhattacharya S, 2006, BIOCHEM J, V397, P437, DOI 10.1042/BJ20060256; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; Hao HF, 2009, WORLD J GASTROENTERO, V15, P5916, DOI 10.3748/wjg.15.5916; HARPER J, 1987, BIOCHEM BIOPH RES CO, V147, P550, DOI 10.1016/0006-291X(87)90966-1; HARPER PH, 1987, DIS COLON RECTUM, V30, P174, DOI 10.1007/BF02554332; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; KANNER SB, 1989, ONCOGENE, V4, P295; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MATTHES H, 1992, GASTROENTEROLOGY, V102, P431, DOI 10.1016/0016-5085(92)90087-F; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Sanders MA, 2008, BIOL CHEM, V389, P47, DOI 10.1515/BC.2008.008; Sasaki Makoto, 2005, J Inflamm (Lond), V2, P13, DOI 10.1186/1476-9255-2-13; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	50	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23123	10.1371/journal.pone.0023123	http://dx.doi.org/10.1371/journal.pone.0023123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887232	Green Published, Green Submitted, gold			2022-12-27	WOS:000295832000007
J	Zhao, XB; Valen, E; Parker, BJ; Sandelin, A				Zhao, Xiaobei; Valen, Eivind; Parker, Brian J.; Sandelin, Albin			Systematic Clustering of Transcription Start Site Landscapes	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DNA METHYLATION; PROMOTERS; IDENTIFICATION; ELEMENTS; DIFFERENTIATION; ARCHITECTURE; PLURIPOTENT; VERTEBRATE; INITIATION	Genome-wide, high-throughput methods for transcription start site (TSS) detection have shown that most promoters have an array of neighboring TSSs where some are used more than others, forming a distribution of initiation propensities. TSS distributions (TSSDs) vary widely between promoters and earlier studies have shown that the TSSDs have biological implications in both regulation and function. However, no systematic study has been made to explore how many types of TSSDs and by extension core promoters exist and to understand which biological features distinguish them. In this study, we developed a new non-parametric dissimilarity measure and clustering approach to explore the similarities and stabilities of clusters of TSSDs. Previous studies have used arbitrary thresholds to arrive at two general classes: broad and sharp. We demonstrated that in addition to the previous broad/sharp dichotomy an additional category of promoters exists. Unlike typical TATA-driven sharp TSSDs where the TSS position can vary a few nucleotides, in this category virtually all TSSs originate from the same genomic position. These promoters lack epigenetic signatures of typical mRNA promoters and a substantial subset of them are mapping upstream of ribosomal protein pseudogenes. We present evidence that these are likely mapping errors, which have confounded earlier analyses, due to the high similarity of ribosomal gene promoters in combination with known G addition bias in the CAGE libraries. Thus, previous two-class separations of promoter based on TSS distributions are motivated, but the ultra-sharp TSS distributions will confound downstream analyses if not removed.	[Zhao, Xiaobei] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; Univ Copenhagen, Biotech Res & Innovat Ctr, Bioinformat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Zhao, XB (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	albin@binf.ku.dk	Sandelin, Albin/G-2881-2011; Valen, Eivind/A-8617-2011; Zhao, Xiaobei/G-3567-2014	Sandelin, Albin/0000-0002-7109-7378; Zhao, Xiaobei/0000-0002-5277-0846; Parker, Brian/0000-0002-5193-6867; Valen, Eivind/0000-0003-1840-6108	Novo Nordisk Foundation; European Research Council under the EU [204135]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council under the EU(European Research Council (ERC))	This work was supported by a grant from the Novo Nordisk Foundation, http://www.novonordiskfonden.dk/. The European Research Council (http://erc.europa.eu/) has provided financial support to Dr. Sandelin under the EU 7th Framework Programme (FP7/2007-2013)/ERC grant agreement 204135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumann M, 2010, MOL BIOTECHNOL, V45, P241, DOI 10.1007/s12033-010-9265-6; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, CAP ANAL GENE EXPRES; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cha SH, 2002, PATTERN RECOGN, V35, P1355, DOI 10.1016/S0031-3203(01)00118-2; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Frith MC, 2006, GENOME RES, V16, P713, DOI 10.1101/gr.5031006; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Islam S, 2011, GENOME RES; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kobor MS, 2009, TRENDS BIOCHEM SCI, V34, P158, DOI 10.1016/j.tibs.2008.12.006; Kratz A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-257; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Mark S.A., 1984, CLUSTER ANAL QUANTIT; MARUYAMA K, 1994, GENE, V138, P171; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Perry RP, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-15; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	65	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23409	10.1371/journal.pone.0023409	http://dx.doi.org/10.1371/journal.pone.0023409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887249	Green Published, Green Submitted, gold			2022-12-27	WOS:000295832000017
J	Wang, SC; Chang, Y; Guo, JJ; Zeng, QN; Ellis, BE; Chen, JG				Wang, Shucai; Chang, Ying; Guo, Jianjun; Zeng, Qingning; Ellis, Brian E.; Chen, Jin-Gui			Arabidopsis Ovate Family Proteins, a Novel Transcriptional Repressor Family, Control Multiple Aspects of Plant Growth and Development	PLOS ONE			English	Article							AUX/IAA PROTEINS; CELL-DIVISION; BETA-SUBUNIT; GENES; ROLES; LEAF; SUPPRESSES; EXPRESSION	Background: The Arabidopsis genome contains 18 genes that are predicted to encode Ovate Family Proteins (AtOFPs), a protein family characterized by a conserved OVATE domain, an approximately 70-amino acid domain that was originally found in tomato OVATE protein. Among AtOFP family members, AtOFP1 has been shown to suppress cell elongation, in part, by suppressing the expression of AtGA20ox1, AtOFP4 has been shown to regulate secondary cell wall formation by interact with KNOTTED1-LIKE HOMEODOMAIN PROTEIN 7 (KNAT7), and AtOFP5 has been shown to regulate the activity of a BEL1-LIKEHOMEODOMAIN 1(BLH1)-KNAT3 complex during early embryo sac development, but little is known about the function of other AtOFPs. Methodology/Principal Findings: We demonstrated here that AtOFP proteins could function as effective transcriptional repressors in the Arabidopsis protoplast transient expression system. The analysis of loss-of-function alleles of AtOFPs suggested AtOFP genes may have overlapping function in regulating plant growth and development, because none of the single mutants identified, including T-DNA insertion mutants in AtOFP1, AtOFP4, AtOFP8, AtOFP10, AtOFP15 and AtOFP16, displayed any apparent morphological defects. Further, Atofp1 Atofp4 and Atofp15 Atofp16 double mutants still did not differ significantly from wild-type. On the other hand, plants overexpressing AtOFP genes displayed a number of abnormal phenotypes, which could be categorized into three distinct classes, suggesting that AtOFP genes may also have diverse functions in regulating plant growth and development. Further analysis suggested that AtOFP1 regulates cotyledon development in a postembryonic manner, and global transcript profiling revealed that it suppress the expression of many other genes. Conclusions/Significance: Our results showed that AtOFPs function as transcriptional repressors and they regulate multiple aspects of plant growth and development. These results provided the first overview of a previously unknown transcriptional repressor family, and revealed their possible roles in plant growth and development.	[Wang, Shucai] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China; [Wang, Shucai] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Chang, Ying] NE Agr Univ, Dept Bot, Haerbin, Peoples R China; [Wang, Shucai; Chang, Ying; Guo, Jianjun; Zeng, Qingning; Chen, Jin-Gui] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Zeng, Qingning; Ellis, Brian E.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Chen, Jin-Gui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Northeast Normal University - China; Northeast Normal University - China; Northeast Agricultural University - China; University of British Columbia; University of British Columbia; United States Department of Energy (DOE); Oak Ridge National Laboratory	Wang, SC (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China.	wangshucai@yahoo.com	guo, jianjun/G-6852-2013; Zeng, Qingning/M-2245-2013; Chen, Jin-Gui/A-4773-2011; Chen, Jin-Gui/AFV-6337-2022	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Wang, Shucai/0000-0001-7619-2385	Northeast Normal University; National Natural Science Foundation of China [30870144]; Oak Ridge National Laboratory; U.S. Department of Energy [DE-AC05-00OR22725]	Northeast Normal University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oak Ridge National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by a startup grant from Northeast Normal University (www.nenu.edu.cn) (S. W.), grant from the National Natural Science Foundation of China (www.nsfc.gov.cn, grant No 30870144) (Y.C.), and the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (www.ornl.gov/ornlhome/ldrd) (J.-G.C.). Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; TSUKAYA H, 1994, PLANTA, V195, P309, DOI 10.1007/BF00199692; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Wang SC, 2005, PLANT CELL, V17, P1979, DOI 10.1105/tpc.105.031096; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x	22	78	109	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23896	10.1371/journal.pone.0023896	http://dx.doi.org/10.1371/journal.pone.0023896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886836	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500036
J	Tummala, H; Fleming, S; Hocking, PM; Wehner, D; Naseem, Z; Ali, M; Inglehearn, CF; Zhelev, N; Lester, DH				Tummala, Hemanth; Fleming, Stewart; Hocking, Paul M.; Wehner, Daniel; Naseem, Zahid; Ali, Manir; Inglehearn, Christopher F.; Zhelev, Nikolai; Lester, Douglas H.			The D153del Mutation in GNB3 Gene Causes Tissue Specific Signalling Patterns and an Abnormal Renal Morphology in Rge Chickens	PLOS ONE			English	Article							PROTEIN BETA-3 SUBUNIT; HETEROTRIMERIC G-PROTEINS; GAMMA-SUBUNITS; SPLICE VARIANT; RETINAL DEGENERATION; COUPLED RECEPTORS; GOLGI MEMBRANES; 825T ALLELE; CYCLIC-GMP; KINASE	Background: The GNB3 gene is expressed in cone but not rod photoreceptors of vertebrates, where it acts as the beta transducin subunit in the colour visual transduction process. A naturally occurring mutation 'D153del' in the GNB3 gene causes the recessively inherited blinding phenotype retinopathy globe enlarged (rge) disease in chickens. GNB3 is however also expressed in most other vertebrate tissues suggesting that the D153del mutation may exert pathological effects that outlie from eye. Principal Findings: Recombinant studies in COS-7 cells that were transfected with normal and mutant recombinant GNB3 constructs and subjected to cycloheximide chase showed that the mutant GNB3d protein had a much shorter half life compared to normal GNB3. GNB3 codes for the G beta 3 protein subunit that, together with different G gamma and G alpha subunits, activates and regulates phosphorylation cascades in different tissues. As expected, the relative levels of cGMP and cAMP secondary messengers and their activated kinases such as MAPK, AKT and GRK2 were also found to be altered significantly in a tissue specific manner in rge chickens. Histochemical analysis on kidney tissue sections, from rge homozygous affected chickens, showed the chickens had enlargement of the glomerular capsule, causing glomerulomegaly and tubulointerstitial inflammation whereas other tissues (brain, heart, liver, pancreas) were unaffected. Significance: These findings confirm that the D153del mutation in GNB3 gene targets GNB3 protein to early degradation. Lack of GNB3 signalling causes reduced phosphorylation activity of ERK2 and AKT leading to severe pathological phenotypes such as blindness and renal abnormalities in rge chickens.	[Tummala, Hemanth; Wehner, Daniel; Naseem, Zahid; Zhelev, Nikolai; Lester, Douglas H.] Univ Abertay Dundee, Sch Contemporary Sci, Dundee, Scotland; [Hocking, Paul M.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Hocking, Paul M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Ali, Manir; Inglehearn, Christopher F.] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Fleming, Stewart] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Ctr Oncol & Mol Med,Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland	University of Abertay Dundee; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Saint James's University Hospital; University of Leeds; University of Dundee	Tummala, H (corresponding author), Univ Abertay Dundee, Sch Contemporary Sci, Dundee, Scotland.	D.Lester@abertay.ac.uk	Zhelev, Nikolai Z/A-8589-2012; Tummala, Hemanth/ABC-8367-2020; Ali, Manir/ABE-5251-2020	Zhelev, Nikolai Z/0000-0002-5189-3975; Tummala, Hemanth/0000-0002-1413-745X; Ali, Manir/0000-0003-3204-3788; Wehner, Daniel/0000-0003-2880-4759	MRC [G0501050]; Medical Research Council [G0501050] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by MRC research grant no. G0501050 between September 2006 and August 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Baltrons MA, 2008, NEUROCHEM RES, V33, P2427, DOI 10.1007/s11064-008-9681-1; Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; Boote C, 2008, J STRUCT BIOL, V161, P1, DOI 10.1016/j.jsb.2007.08.015; Boote C, 2009, J STRUCT BIOL, V166, P195, DOI 10.1016/j.jsb.2009.01.009; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Bullido MJ, 2004, NEUROBIOL AGING, V25, P853, DOI 10.1016/j.neurobiolaging.2003.10.006; Davis RJ, 2008, INVEST OPHTH VIS SCI, V49, P5067, DOI 10.1167/iovs.07-1422; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Downs MA, 2006, VISION RES, V46, P4442, DOI 10.1016/j.visres.2006.07.021; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; Gao JX, 2005, FEBS LETT, V579, P122, DOI 10.1016/j.febslet.2004.11.057; Gao Y Q, 1998, Mol Vis, V4, P16; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Inglehearn C, 2003, MOL VIS, V9, P295; Ionita MA, 2007, EXP EYE RES, V84, P1, DOI 10.1016/j.exer.2005.12.012; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kleppisch Thomas, 2009, V191, P549, DOI 10.1007/978-3-540-68964-5_24; Larhammar D, 2009, PHILOS T R SOC B, V364, P2867, DOI 10.1098/rstb.2009.0077; Lee HJ, 2004, PHARMACOGENOMICS J, V4, P29, DOI 10.1038/sj.tpj.6500217; Montiani-Ferreira F, 2005, MOL VIS, V11, P11; Mustafa SB, 2008, J CELL PHYSIOL, V215, P101, DOI 10.1002/jcp.21291; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Poon LSW, 2009, CELL SIGNAL, V21, P737, DOI 10.1016/j.cellsig.2009.01.018; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; RITCHEY ER, 2010, NEUROSCIENCE; Rosskopf D, 2003, BBA-GENE STRUCT EXPR, V1626, P33, DOI 10.1016/S0167-4781(03)00035-6; Rosskopf D, 2003, CELL SIGNAL, V15, P479, DOI 10.1016/S0898-6568(02)00140-7; Rosskopf D, 2003, BIOCHEM J, V371, P223, DOI 10.1042/BJ20021208; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; SANGHERA JS, 1992, MOL BIOL CELL, V3, P775, DOI 10.1091/mbc.3.7.775; Schrader EK, 2009, NAT CHEM BIOL, V5, P954, DOI 10.1038/nchembio1209-954c; Siffert W, 2000, NEPHROL DIAL TRANSPL, V15, P1298, DOI 10.1093/ndt/15.9.1298; Siffert W, 1998, KIDNEY INT, V53, P1466, DOI 10.1046/j.1523-1755.1998.00934.x; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Thompson Miles D., 2008, V448, P77, DOI 10.1007/978-1-59745-205-2_6; Traverso V, 2002, INVEST OPHTH VIS SCI, V43, P1655; Tummala H, 2006, INVEST OPHTH VIS SCI, V47, P4714, DOI 10.1167/iovs.06-0292; Vanhoutte P M, 2006, Bull Mem Acad R Med Belg, V161, P529; Vanhoutte P. M., 2006, B MEM ACAD R MED BEL, V161, P536; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e21156	10.1371/journal.pone.0021156	http://dx.doi.org/10.1371/journal.pone.0021156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887213	Green Published, Green Submitted, gold			2022-12-27	WOS:000294251800001
J	Golob, JL; Kumar, RM; Guenther, MG; Pabon, LM; Pratt, GA; Loring, JF; Laurent, LC; Young, RA; Murry, CE				Golob, Jonathan L.; Kumar, Roshan M.; Guenther, Matthew G.; Pabon, Lil M.; Pratt, Gabriel A.; Loring, Jeanne F.; Laurent, Louise C.; Young, Richard A.; Murry, Charles E.			Evidence That Gene Activation and Silencing during Stem Cell Differentiation Requires a Transcriptionally Paused Intermediate State	PLOS ONE			English	Article							RNA-POLYMERASE-II; CHROMATIN IMMUNOPRECIPITATION; INITIATION; PROMOTERS; TRANSPLANTATION; ELONGATION; EXPRESSION; RELEASE; EMBRYO; HEART	A surprising portion of both mammalian and Drosophila genomes are transcriptionally paused, undergoing initiation without elongation. We tested the hypothesis that transcriptional pausing is an obligate transition state between definitive activation and silencing as human embryonic stem cells (hESCs) change state from pluripotency to mesoderm. Chromatin immunoprecipitation for trimethyl lysine 4 on histone H3 (ChIP-Chip) was used to analyze transcriptional initiation, and 3' transcript arrays were used to determine transcript elongation. Pluripotent and mesodermal cells had equivalent fractions of the genome in active and paused transcriptional states (similar to 48% each), with similar to 4% definitively silenced (neither initiation nor elongation). Differentiation to mesoderm changed the transcriptional state of 12% of the genome, with roughly equal numbers of genes moving toward activation or silencing. Interestingly, almost all loci (98-99%) changing transcriptional state do so either by entering or exiting the paused state. A majority of these transitions involve either loss of initiation, as genes specifying alternate lineages are archived, or gain of initiation, in anticipation of future full-length expression. The addition of chromatin dynamics permitted much earlier predictions of final cell fate compared to sole use of conventional transcript arrays. These findings indicate that the paused state may be the major transition state for genes changing expression during differentiation, and implicate control of transcriptional elongation as a key checkpoint in lineage specification.	[Golob, Jonathan L.; Pabon, Lil M.; Pratt, Gabriel A.; Murry, Charles E.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Golob, Jonathan L.; Pabon, Lil M.; Pratt, Gabriel A.; Murry, Charles E.] Univ Washington, Dept Bioengn, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Kumar, Roshan M.; Guenther, Matthew G.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Loring, Jeanne F.; Laurent, Louise C.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92103 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute; University of California System; University of California San Diego	Golob, JL (corresponding author), Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	murry@u.washington.edu	Young, Richard A/F-6495-2012; Loring, Jeanne F/A-1620-2011	Young, Richard A/0000-0001-8855-8647; Loring, Jeanne F/0000-0001-6226-9767; Laurent, Louise/0000-0002-2095-7534	NIGMS [P01GM081619]; NHLBI [P01 HL 094374, U01 HL100405, R01 HL084642]; Experimental Pathology of Cardiovascular Disease Training Grant [T32 HL07312-31]; ARCS Foundation; Poncin Foundation; NIH/NICHD WRHR [K12 HD001259]; CIRM [RT1-01108, TR1-01250]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, R01HL084642, T32HL007312, P01HL094374] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Experimental Pathology of Cardiovascular Disease Training Grant; ARCS Foundation; Poncin Foundation; NIH/NICHD WRHR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants NIGMS P01GM081619, NHLBI P01 HL 094374, U01 HL100405 and R01 HL084642. JLG was supported by the Experimental Pathology of Cardiovascular Disease Training Grant (T32 HL07312-31), the ARCS Foundation and the Poncin Foundation. LCL is supported by an NIH/NICHD WRHR Career Development Award (K12 HD001259). JFL is supported by CIRM (RT1-01108, TR1-01250). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chiba K, 2010, EXP CELL RES, V316, P2723, DOI 10.1016/j.yexcr.2010.05.036; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Morkin E, 2000, MICROSC RES TECHNIQ, V50, P522, DOI 10.1002/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Tulloch NL, 2011, CIRC RES; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e22416	10.1371/journal.pone.0022416	http://dx.doi.org/10.1371/journal.pone.0022416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886766	Green Submitted, gold, Green Published			2022-12-27	WOS:000294128100002
J	von Leupoldt, A; Brassen, S; Baumann, HJ; Klose, H; Buchel, C				von Leupoldt, Andreas; Brassen, Stefanie; Baumann, Hans Joerg; Klose, Hans; Buechel, Christian			Structural Brain Changes Related to Disease Duration in Patients with Asthma	PLOS ONE			English	Article							GRAY-MATTER; SYMPTOM PERCEPTION; CHRONIC PAIN; DYSPNEA; CHILDREN; INTENSITY; CIRCUITRY; IMPACT; LOADS	Dyspnea is the impairing, cardinal symptom patients with asthma repeatedly experience over the course of the disease. However, its accurate perception is also crucial for timely initiation of treatment. Reduced perception of dyspnea is associated with negative treatment outcome, but the underlying brain mechanisms of perceived dyspnea in patients with asthma remain poorly understood. We examined whether increasing disease duration in fourteen patients with mild-to-moderate asthma is related to structural brain changes in the insular cortex and brainstem periaqueductal grey (PAG). In addition, the association between structural brain changes and perceived dyspnea were studied. By using magnetic resonance imaging in combination with voxel-based morphometry, gray matter volumes of the insular cortex and the PAG were analysed and correlated with asthma duration and perceived affective unpleasantness of resistive load induced dyspnea. Whereas no associations were observed for the insular cortex, longer duration of asthma was associated with increased gray matter volume in the PAG. Moreover, increased PAG gray matter volume was related to reduced ratings of dyspnea unpleasantness. Our results demonstrate that increasing disease duration is associated with increased gray matter volume in the brainstem PAG in patients with mild-to-moderate asthma. This structural brain change might contribute to the reduced perception of dyspnea in some patients with asthma and negatively impact the treatment outcome.	[von Leupoldt, Andreas] Univ Hamburg, Dept Psychol, Hamburg, Germany; [von Leupoldt, Andreas; Brassen, Stefanie; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Baumann, Hans Joerg; Klose, Hans] Univ Med Ctr Hamburg Eppendorf, Dept Pneumol, Hamburg, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	von Leupoldt, A (corresponding author), Univ Hamburg, Dept Psychol, Hamburg, Germany.	andreas.vonleupoldt@uni-hamburg.de	Brassen, Stefanie/H-5386-2012	Brassen, Stefanie/0000-0002-8884-7593	Deutsche Forschungsgemeinschaft (DFG) [LE 1843/5-1, LE 1843/9-1, BR 2877/2-1]; Federal Ministry of Education and Research Germany (BMBF) [01GO0510]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG LE 1843/5-1 and LE 1843/9-1) to AvL and SB (BR 2877/2-1) and a grant from the Federal Ministry of Education and Research Germany (BMBF, 01GO0510) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Banzett RB, 2000, AM J RESP CRIT CARE, V162, P1178, DOI 10.1164/ajrccm.162.3.9909112; BARNES PJ, 1994, NEW ENGL J MED, V330, P1383, DOI 10.1056/NEJM199405123301910; Barnes SJ, 2010, NEUROSCIENTIST, V16, P186, DOI 10.1177/1073858409343961; BERNHARDT V, 2010, FASEB J, V24; Carrieri-Kohlman V, 2001, NURS RES, V50, P136, DOI 10.1097/00006199-200105000-00002; Chen CY, 2001, J ALLERGY CLIN IMMUN, V108, P557; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Davenport PW, 2000, AM J RESP CRIT CARE, V161, P1830, DOI 10.1164/ajrccm.161.6.9903077; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Fauroux B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-61; Feldman JM, 2007, PEDIATR PULM, V42, P339, DOI 10.1002/ppul.20584; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gaser C., 2009, NEUROIMAGE, V1, pS121, DOI [10.1016/S1053-8119(09)71151-6, DOI 10.1016/S1053-8119(09)71151-6]; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; *GINA, 2009, NIH PUBL; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; KENDRICK AH, 1993, BRIT MED J, V307, P422, DOI 10.1136/bmj.307.6901.422; Kifle Y, 1997, AM J RESP CRIT CARE, V156, P1530, DOI 10.1164/ajrccm.156.5.9703011; KIKUCHI Y, 1994, NEW ENGL J MED, V330, P1329, DOI 10.1056/NEJM199405123301901; Lansing RW, 2009, RESP PHYSIOL NEUROBI, V167, P53, DOI 10.1016/j.resp.2008.07.012; Magadle R, 2002, CHEST, V121, P329, DOI 10.1378/chest.121.2.329; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; PATE KM, 2010, FASEB J, V24; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rosenkranz MA, 2009, NEUROIMAGE, V47, P972, DOI 10.1016/j.neuroimage.2009.05.042; Rosi E, 2006, LUNG, V184, P251, DOI 10.1007/s00408-005-2590-z; RUBINFELD AR, 1976, LANCET, V1, P882; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Serrano J, 2006, EUR RESPIR J, V28, P296, DOI 10.1183/09031936.06.00008105; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; von Leupoldt A, 2007, RESP MED, V101, P1079, DOI 10.1016/j.rmed.2006.10.026; Von Leupoldt A, 2006, PSYCHOPHYSIOLOGY, V43, P641, DOI 10.1111/j.1469-8986.2006.00453.x; von Leupoldt A, 2011, PSYCHOPHYSIOLOGY, V48, P808, DOI 10.1111/j.1469-8986.2010.01141.x; von Leupoldt A, 2010, PSYCHOPHYSIOLOGY, V47, P579, DOI 10.1111/j.1469-8986.2009.00956.x; Wan L, 2009, CHEST, V135, P455, DOI 10.1378/chest.08-1226; Webster KE, 2002, AM J RESP CRIT CARE, V166, P47, DOI 10.1164/rccm.2012006; Yorke J, 2010, THORAX, V65, P21, DOI 10.1136/thx.2009.118521	55	26	27	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23739	10.1371/journal.pone.0023739	http://dx.doi.org/10.1371/journal.pone.0023739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886820	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100029
J	Demattei, MV; Hedhili, S; Sinzelle, L; Bressac, C; Casteret, S; Moire, N; Cambefort, J; Thomas, X; Pollet, N; Gantet, P; Bigot, Y				Demattei, Marie-Veronique; Hedhili, Sabah; Sinzelle, Ludivine; Bressac, Christophe; Casteret, Sophie; Moire, Nathalie; Cambefort, Jeanne; Thomas, Xavier; Pollet, Nicolas; Gantet, Pascal; Bigot, Yves			Nuclear Importation of Mariner Transposases among Eukaryotes: Motif Requirements and Homo-Protein Interactions	PLOS ONE			English	Article							INVERTED TERMINAL REPEATS; LOCALIZATION SIGNALS; N-TERMINUS; IN-VITRO; TRANSPOSITION; ELEMENT; EVOLUTION; IDENTIFICATION; AGGRESOMES; ORIGIN	Mariner-like elements (MLEs) are widespread transposable elements in animal genomes. They have been divided into at least five sub-families with differing host ranges. We investigated whether the ability of transposases encoded by Mos1, Himar1 and Mcmar1 to be actively imported into nuclei varies between host belonging to different eukaryotic taxa. Our findings demonstrate that nuclear importation could restrict the host range of some MLEs in certain eukaryotic lineages, depending on their expression level. We then focused on the nuclear localization signal (NLS) in these proteins, and showed that the first 175 N-terminal residues in the three transposases were required for nuclear importation. We found that two components are involved in the nuclear importation of the Mos1 transposase: an SV40 NLS-like motif (position: aa 168 to 174), and a dimerization sub-domain located within the first 80 residues. Sequence analyses revealed that the dimerization moiety is conserved among MLE transposases, but the Himar1 and Mcmar1 transposases do not contain any conserved NLS motif. This suggests that other NLS-like motifs must intervene in these proteins. Finally, we showed that the over-expression of the Mos1 transposase prevents its nuclear importation in HeLa cells, due to the assembly of transposase aggregates in the cytoplasm.	[Demattei, Marie-Veronique; Casteret, Sophie; Cambefort, Jeanne; Thomas, Xavier] UFR Sci & Tech, CNRS, GICC, UMR 6239, Tours, France; [Casteret, Sophie; Bigot, Yves] UMR INRA CNRS 6175, PRC, Nouzilly, France; [Bressac, Christophe] UFR Sci & Tech, CNRS, IRBI, UMR 6035, Tours, France; [Moire, Nathalie] UFR Pharm, INRA, UMR 0483, Tours, France; [Sinzelle, Ludivine; Pollet, Nicolas] Univ Evry Val dEssonne, CNRS, UPS3201, Evry, France; [Hedhili, Sabah; Gantet, Pascal] CIRAD, UMR Dev & Ameliorat Plantes 1098, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CIRAD	Demattei, MV (corresponding author), UFR Sci & Tech, CNRS, GICC, UMR 6239, Tours, France.	bigot@univ-tours.fr	Bressac, Christophe/AAF-9183-2021; Pollet, Nicolas/A-4746-2013	Pollet, Nicolas/0000-0002-9975-9644; bressac, christophe/0000-0001-7609-8970	C.N.R.S.; Groupement de Recherche CNRS [2157]; European Project SyntheGeneDelivery [18716]; Ministere de l'Education Nationale, de la Recherche et de la Technologie; University of Tours; Region Centre and Ludivine Sinzelle; Genopole	C.N.R.S.(Centre National de la Recherche Scientifique (CNRS)); Groupement de Recherche CNRS; European Project SyntheGeneDelivery; Ministere de l'Education Nationale, de la Recherche et de la Technologie; University of Tours; Region Centre and Ludivine Sinzelle(Region Centre-Val de Loire); Genopole	This work was funded by grants from the C.N.R.S., the Groupement de Recherche CNRS 2157, the European Project SyntheGeneDelivery (N<SUP>o</SUP> 18716), the Ministere de l'Education Nationale, de la Recherche et de la Technologie and the University of Tours. Sabah Hedhili holds a doctoral fellowship from the Region Centre and Ludivine Sinzelle a doctoral fellowship from the Genopole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge-Gouillou C, 2005, J MOL BIOL, V351, P117, DOI 10.1016/j.jmb.2005.05.019; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P51, DOI 10.1007/s004380000385; Beall EL, 2002, GENETICS, V162, P217; Benjamin B, 2007, GENETICA, V130, P105, DOI 10.1007/s10709-006-0025-2; Bigot Y, 2005, J MOL BIOL, V351, P108, DOI 10.1016/j.jmb.2005.05.006; BOEHM U, 1995, PLANT J, V7, P441, DOI 10.1046/j.1365-313X.1995.7030441.x; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Butler MG, 2006, GENETICA, V127, P351, DOI 10.1007/s10709-006-6250-x; Carpentier G, 2011, J MOL BIOL, V405, P892, DOI 10.1016/j.jmb.2010.11.032; Casse N, 2006, MOL PHYLOGENET EVOL, V40, P609, DOI 10.1016/j.ympev.2006.02.005; Ceru S, 2010, BIOL CELL, V102, P319, DOI 10.1042/BC20090163; Chatterjee S, 1997, EXP CELL RES, V236, P346, DOI 10.1006/excr.1997.3746; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Clark KJ, 2009, NUCLEIC ACIDS RES, V37, P1239, DOI 10.1093/nar/gkn1025; Claudianos C, 2002, MOL BIOL EVOL, V19, P2101, DOI 10.1093/oxfordjournals.molbev.a004035; Coy MR, 2005, INSECT MOL BIOL, V14, P537, DOI 10.1111/j.1365-2583.2005.00584.x; Feng WQ, 1999, J CELL SCI, V112, P339; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Germon S, 2009, GENETICA, V137, P265, DOI 10.1007/s10709-009-9375-x; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; Halaimia-Toumi N, 2004, J MOL EVOL, V59, P747, DOI 10.1007/s00239-004-2665-0; Hedhili Sabah, 2010, BMC Res Notes, V3, P301, DOI 10.1186/1756-0500-3-301; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; Jarvik T, 1998, GENETICS, V149, P1569; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Keravala A, 2006, HUM GENE THER, V17, P1006, DOI 10.1089/hum.2006.17.1006; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; Lohe AR, 1996, MOL BIOL EVOL, V13, P549, DOI 10.1093/oxfordjournals.molbev.a025615; MCBRIDE KM, 2003, SCI STKE, V195, pRE13; Michel K, 2003, J CELL BIOCHEM, V89, P778, DOI 10.1002/jcb.10554; Mikitani K, 2000, J BIOL CHEM, V275, P37725, DOI 10.1074/jbc.M005271200; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Mortada H, 2010, J MOL EVOL, V71, P180, DOI 10.1007/s00239-010-9376-5; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; Ono A, 2002, PLANT MOL BIOL, V50, P599, DOI 10.1023/A:1019970206057; Renault S, 2010, BIOCHEMISTRY-US, V49, P3534, DOI 10.1021/bi901957p; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; ROBERTSON HM, 1995, J INSECT PHYSIOL, V41, P99, DOI 10.1016/0022-1910(94)00082-R; SCHENBORN E, 1997, PROMEGA NOTES, V63, P13; Silva JC, 2005, MOL BIOL EVOL, V22, P126, DOI 10.1093/molbev/msh260; Sinzelle L, 2006, J MOL EVOL, V62, P53, DOI 10.1007/s00239-005-0013-7; Sinzelle L, 2008, P NATL ACAD SCI USA, V105, P4715, DOI 10.1073/pnas.0707746105; Thomas X, 2010, GENETICA, V138, P519, DOI 10.1007/s10709-009-9414-7; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566	55	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23693	10.1371/journal.pone.0023693	http://dx.doi.org/10.1371/journal.pone.0023693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876763	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900035
J	Johnell, K; Fischer, H				Johnell, Kristina; Fischer, Hakan			Dopaminergic and Serotonergic Drug Use: A Nationwide Register-Based Study of Over 1 300 000 Older People	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; AGE-DEPENDENT DECLINE; HUMAN BRAIN; F-18 SETOPERONE; RECEPTORS; ANTIDEPRESSANTS; DISEASE; PET; ACTIVATION; MANAGEMENT	Objective: To investigate the use of dopaminergic and serotonergic drugs in elderly people. Methods: We analyzed data on age, sex and dispensed drugs for individuals aged >= 65 years registered in the Swedish Prescribed Drug Register from July to September 2008 (n = 1 347 564; 81% of the total population aged >= 65 years in Sweden). Main outcome measures were dopaminergic (enhancing and/or lowering) and serotonergic (enhancing and/or lowering) drugs and combinations of these. Results: Dopaminergic and serotonergic drugs were used by 5.6% and 13.2% the participants, respectively. Female gender was related to use of both dopaminergic and, particularly, serotonergic drugs. Higher age was associated with use of dopamine lowering drugs and serotonergic drugs, whereas the association with use of dopamine enhancing drugs declined in the oldest old. The occurrence of combinations of dopaminergic and serotonergic drugs was generally low, with dopamine lowering + serotonin lowering drug the most common combination (1.6%). Female gender was associated with all of the combinations of dopaminergic and serotonergic drugs, whereas age showed a mixed pattern. Conclusion: Approximately one out of ten older patients uses serotonergic drugs and one out of twenty dopaminergic drugs. The frequent use of dopaminergic and serotonergic drugs in the elderly patients is a potential problem due to the fact that aging is associated with a down-regulation of both these monoaminergic systems. Future studies are needed for evaluation of the impact of these drugs on different cognitive and emotional functions in old age.	[Johnell, Kristina; Fischer, Hakan] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Fischer, Hakan] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Johnell, K (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	kristina.johnell@ki.se		Fischer, Hakan/0000-0001-6710-1744	Swedish Research Council [dnr 2007-5870]; Konung Gustav V:s och Drottning Victorias Frimurarstiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Konung Gustav V:s och Drottning Victorias Frimurarstiftelse	This study was supported financially by a grant from the Swedish Research Council (dnr 2007-5870) and from Konung Gustav V:s och Drottning Victorias Frimurarstiftelse (HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI A, 1993, ARCH NEUROL-CHICAGO, V50, P474, DOI 10.1001/archneur.1993.00540050026010; Arbouw MEL, 2011, OSTEOPOROSIS INT, V22, P2197, DOI 10.1007/s00198-010-1455-3; ARBOUW ME, 2010, OSTEOPOROS INT; Backman L, 1997, BRAIN, V120, P2207, DOI 10.1093/brain/120.12.2207; Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; Bannon MJ, 1997, NEUROLOGY, V48, P969, DOI 10.1212/WNL.48.4.969; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; BLIN J, 1993, BRAIN, V116, P497, DOI 10.1093/brain/116.3.497; Chan DKY, 2008, GERIATRICS-US, V63, P22; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; DESPLENTER F, INT PSYCHOG IN PRESS; Fischer H, 2010, BIOL PSYCHIAT, V67, P575, DOI 10.1016/j.biopsych.2009.12.013; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Ginzburg R, 2009, ANN PHARMACOTHER, V43, P98, DOI 10.1345/aph.1L264; Giron MST, 2005, INT J GERIATR PSYCH, V20, P201, DOI 10.1002/gps.1273; Glickstein SB, 2005, CEREB CORTEX, V15, P1016, DOI 10.1093/cercor/bhh202; Haider SI, 2008, CLIN THER, V30, P419, DOI 10.1016/j.clinthera.2008.02.010; Hasnain M, 2009, AM J MED, V122, P614, DOI 10.1016/j.amjmed.2009.01.025; Haukka J, 2007, EUR J CLIN PHARMACOL, V63, P1069, DOI 10.1007/s00228-007-0349-6; Hovstadius Bo, 2009, BMC Clin Pharmacol, V9, P11, DOI 10.1186/1472-6904-9-11; JEDENIUS E, SCAND J PRI IN PRESS; JOHNELL K, EUR J CLIN IN PRESS; Johnell K, 2007, ANN PHARMACOTHER, V41, P1243, DOI 10.1345/aph.1K154; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Lotrich FE, 2005, J CLIN PHARMACOL, V45, P1106, DOI 10.1177/0091270005280297; Lovheim H, 2008, PHARMACOEPIDEM DR S, V17, P912, DOI 10.1002/pds.1600; Luciana M, 1998, CEREB CORTEX, V8, P218, DOI 10.1093/cercor/8.3.218; Meltzer HY, 2011, PSYCHOPHARMACOLOGY, V213, P289, DOI 10.1007/s00213-010-2137-8; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Mozley LH, 2001, AM J PSYCHIAT, V158, P1492, DOI 10.1176/appi.ajp.158.9.1492; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; PARABIAGHI A, EUR J CLIN IN PRESS; Rajji TK, 2008, DRUG AGING, V25, P841, DOI 10.2165/00002512-200825100-00003; RINNE JO, 1990, BRAIN RES, V508, P349, DOI 10.1016/0006-8993(90)90423-9; Stein M, 2010, CURR TOP BEHAV NEURO, V2, P469, DOI 10.1007/7854_2009_35; Treit D, 2010, CURR TOP BEHAV NEURO, V2, P121, DOI 10.1007/7854_2009_17; Verdel BM, 2011, CLIN PHARMACOL THER, V89, P89, DOI 10.1038/clpt.2010.240; Verhoeff NPLG, 2000, PSYCHIAT RES-NEUROIM, V99, P123, DOI 10.1016/S0165-1781(00)00198-0; Wang Y, 1998, SYNAPSE, V30, P56, DOI 10.1002/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23750	10.1371/journal.pone.0023750	http://dx.doi.org/10.1371/journal.pone.0023750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858217	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700041
J	Miron, RJ; Hedbom, E; Ruggiero, S; Bosshardt, DD; Zhang, YF; Mauth, C; Gemperli, AC; Iizuka, T; Buser, D; Sculean, A				Miron, Richard J.; Hedbom, Erik; Ruggiero, Sabrina; Bosshardt, Dieter D.; Zhang, Yufeng; Mauth, Corinna; Gemperli, Anja C.; Iizuka, Tateyuki; Buser, Daniel; Sculean, Anton			Premature Osteoblast Clustering by Enamel Matrix Proteins Induces Osteoblast Differentiation through Up-Regulation of Connexin 43 and N-Cadherin	PLOS ONE			English	Article							GAP-JUNCTIONAL COMMUNICATION; INTRABONY PERIODONTAL DEFECTS; TO-CELL COMMUNICATION; GENE-EXPRESSION; INCREASES PROLIFERATION; SIGNAL-TRANSDUCTION; PARATHYROID-HORMONE; BONE; AMELOGENIN; EMDOGAIN	In recent years, enamel matrix derivative (EMD) has garnered much interest in the dental field for its apparent bioactivity that stimulates regeneration of periodontal tissues including periodontal ligament, cementum and alveolar bone. Despite its widespread use, the underlying cellular mechanisms remain unclear and an understanding of its biological interactions could identify new strategies for tissue engineering. Previous in vitro research has demonstrated that EMD promotes premature osteoblast clustering at early time points. The aim of the present study was to evaluate the influence of cell clustering on vital osteoblast cell-cell communication and adhesion molecules, connexin 43 (cx43) and N-cadherin (N-cad) as assessed by immunofluorescence imaging, real-time PCR and Western blot analysis. In addition, differentiation markers of osteoblasts were quantified using alkaline phosphatase, osteocalcin and von Kossa staining. EMD significantly increased the expression of connexin 43 and N-cadherin at early time points ranging from 2 to 5 days. Protein expression was localized to cell membranes when compared to control groups. Alkaline phosphatase activity was also significantly increased on EMD-coated samples at 3, 5 and 7 days post seeding. Interestingly, higher activity was localized to cell cluster regions. There was a 3 fold increase in osteocalcin and bone sialoprotein mRNA levels for osteoblasts cultured on EMD-coated culture dishes. Moreover, EMD significantly increased extracellular mineral deposition in cell clusters as assessed through von Kossa staining at 5, 7, 10 and 14 days post seeding. We conclude that EMD up-regulates the expression of vital osteoblast cell-cell communication and adhesion molecules, which enhances the differentiation and mineralization activity of osteoblasts. These findings provide further support for the clinical evidence that EMD increases the speed and quality of new bone formation in vivo.	[Miron, Richard J.; Ruggiero, Sabrina; Bosshardt, Dieter D.; Sculean, Anton] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Miron, Richard J.; Hedbom, Erik; Ruggiero, Sabrina; Bosshardt, Dieter D.; Zhang, Yufeng; Buser, Daniel] Univ Bern, Sch Dent Med, Dept Oral Surg & Stomatol, Bern, Switzerland; [Hedbom, Erik; Iizuka, Tateyuki] Univ Hosp Bern, Inselspital, Dept Craniomaxillofacial Surg, CH-3010 Bern, Switzerland; [Mauth, Corinna; Gemperli, Anja C.] Inst Straumann AG, Basel, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern; Institut Straumann AG	Miron, RJ (corresponding author), Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland.	richard.miron@zmk.unibe.ch	Miron, Richard/J-4995-2012; Zhang, Yufeng/GZL-1973-2022; Buser, Daniel/D-3971-2011; Bosshardt, Dieter D/C-9442-2012		Institute Straumann	Institute Straumann	This study was funded by Institute Straumann (www.straumann.com). Corinna Mauth and Anja Graf are employed by Straumann's research department and assisted in the study design, data collection and analysis of the data.	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Bartold PM, 2010, PERIODONTOL 2000, V53, P55, DOI 10.1111/j.1600-0757.2010.00347.x; Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; Carinci F, 2006, ORAL DIS, V12, P329, DOI 10.1111/j.1601-0825.2005.01204.x; Cho SW, 2009, BONE, V44, P1069, DOI 10.1016/j.bone.2009.02.012; CHRIST GJ, 1993, J PHARMACOL EXP THER, V266, P1054; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; Du C, 2005, J DENT RES, V84, P1070, DOI 10.1177/154405910508401120; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub3; Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P678, DOI 10.1111/j.1600-051X.1997.tb00249.x; Gramsch B, 2001, EXP CELL RES, V264, P397, DOI 10.1006/excr.2000.5145; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hagewald S, 2004, ORAL SURG ORAL MED O, V98, P243, DOI 10.1016/j.tripleo.2004.02.063; HAYASHI M, 2011, DENT MAT J; He JN, 2004, ORAL SURG ORAL MED O, V97, P239, DOI 10.1016/j.tripleo.2003.10.005; Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713; Huang YC, 2010, CELL TISSUE RES, V342, P205, DOI 10.1007/s00441-010-1064-7; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jepsen S, 2004, J PERIODONTOL, V75, P1150, DOI 10.1902/jop.2004.75.8.1150; Jiang J, 2001, ORAL SURG ORAL MED O, V91, P95, DOI 10.1067/moe.2001.111304; Johnson DL, 2009, J PERIODONTOL, V80, P648, DOI 10.1902/jop.2009.070420; Kawana F, 2001, ANAT RECORD, V264, P438, DOI 10.1002/ar.10016; Kawase T, 2002, J PERIODONTAL RES, V37, P255, DOI 10.1034/j.1600-0765.2002.01615.x; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Laird DW, 2008, J BIOL CHEM, V283, P2997, DOI 10.1074/jbc.R700041200; Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li ZY, 2006, AM J PHYSIOL-CELL PH, V290, pC1248, DOI 10.1152/ajpcell.00428.2005; Lin WL, 1999, J PERIODONTOL, V70, P1039, DOI 10.1902/jop.1999.70.9.1039; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; Matsuzawa M, 2009, J PERIODONTAL RES, V44, P289, DOI 10.1111/j.1600-0765.2008.01091.x; Megson E, 2010, INT J EVID-BASED HEA, V8, P129, DOI 10.1111/j.1744-1609.2010.00171.x; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; Mumulidu A, 2007, J CHROMATOGR B, V857, P210, DOI 10.1016/j.jchromb.2007.07.017; MUNARISILEM Y, 1995, J CLIN INVEST, V95, P1429, DOI 10.1172/JCI117813; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Olkku A, 2010, BONE, V47, P320, DOI 10.1016/j.bone.2010.04.604; PALUMBO C, 1990, BONE, V11, P401, DOI 10.1016/8756-3282(90)90134-K; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Reseland JE, 2006, EUR J ORAL SCI, V114, P205, DOI 10.1111/j.1600-0722.2006.00333.x; SAEZ JC, 1993, ADV SEC MESS PHOSPH, V27, P163; Saito K, 2008, BONE, V43, P371, DOI 10.1016/j.bone.2008.03.029; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0; Schwartz Z, 2000, J PERIODONTOL, V71, P1287, DOI 10.1902/jop.2000.71.8.1287; Schwarz Frank, 2004, Clin Oral Investig, V8, P165; Sculean A, 1999, INT J PERIODONT REST, V19, P157; Sculean A, 2008, J CLIN PERIODONTOL, V35, P817, DOI 10.1111/j.1600-051X.2008.01295.x; Sculean A, 2007, INT J PERIODONT REST, V27, P221; Sculean A, 2007, MED PRIN PRACT, V16, P167, DOI 10.1159/000100386; Shimizu E, 2005, J PERIODONTOL, V76, P1482, DOI 10.1902/jop.2005.76.9.1482; Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012; Statuto M, 1997, J BIOL CHEM, V272, P24710, DOI 10.1074/jbc.272.39.24710; Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605; Takayama T, 2005, J PERIODONTOL, V76, P244, DOI 10.1902/jop.2005.76.2.244; Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007; van Haasteren G, 1999, J RECEPT SIGNAL TR R, V19, P481, DOI 10.3109/10799899909036666; Weishaupt P, 2008, ORAL SURG ORAL MED O, V106, P304, DOI 10.1016/j.tripleo.2008.02.033; Wu Chun-lan, 2002, Shanghai Kou Qiang Yi Xue, V11, P135; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Yang RJ, 1996, J BIOL CHEM, V271, P29839, DOI 10.1074/jbc.271.47.29839; Yoneda Satoshi, 2002, Kokubyo Gakkai Zasshi, V69, P207; Zeichner-David M, 2006, EUR J ORAL SCI, V114, P244, DOI 10.1111/j.1600-0722.2006.00322.x; Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218	74	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23375	10.1371/journal.pone.0023375	http://dx.doi.org/10.1371/journal.pone.0023375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858092	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700019
J	Quinlan, AMT; Sierad, LN; Capulli, AK; Firstenberg, LE; Billiar, KL				Quinlan, Angela M. Throm; Sierad, Leslie N.; Capulli, Andrew K.; Firstenberg, Laura E.; Billiar, Kristen L.			Combining Dynamic Stretch and Tunable Stiffness to Probe Cell Mechanobiology In Vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMOOTH MUSCLE ACTIN; SUBSTRATE STIFFNESS; ENDOTHELIAL-CELLS; SILICONE-RUBBER; EXPRESSION; LOCOMOTION; STRESSES; STRAIN; GROWTH	Cells have the ability to actively sense their mechanical environment and respond to both substrate stiffness and stretch by altering their adhesion, proliferation, locomotion, morphology, and synthetic profile. In order to elucidate the interrelated effects of different mechanical stimuli on cell phenotype in vitro, we have developed a method for culturing mammalian cells in a two-dimensional environment at a wide range of combined levels of substrate stiffness and dynamic stretch. Polyacrylamide gels were covalently bonded to flexible silicone culture plates and coated with monomeric collagen for cell adhesion. Substrate stiffness was adjusted from relatively soft (G' = 0.3 kPa) to stiff (G' = 50 kPa) by altering the ratio of acrylamide to bis-acrylamide, and the silicone membranes were stretched over circular loading posts by applying vacuum pressure to impart near-uniform stretch, as confirmed by strain field analysis. As a demonstration of the system, porcine aortic valve interstitial cells (VIC) and human mesenchymal stem cells (hMSC) were plated on soft and stiff substrates either statically cultured or exposed to 10% equibiaxial or pure uniaxial stretch at 1Hz for 6 hours. In all cases, cell attachment and cell viability were high. On soft substrates, VICs cultured statically exhibit a small rounded morphology, significantly smaller than on stiff substrates (p < 0.05). Following equibiaxial cyclic stretch, VICs spread to the extent of cells cultured on stiff substrates, but did not reorient in response to uniaxial stretch to the extent of cells stretched on stiff substrates. hMSCs exhibited a less pronounced response than VICs, likely due to a lower stiffness threshold for spreading on static gels. These preliminary data demonstrate that inhibition of spreading due to a lack of matrix stiffness surrounding a cell may be overcome by externally applied stretch suggesting similar mechanotransduction mechanisms for sensing stiffness and stretch.	[Quinlan, Angela M. Throm; Sierad, Leslie N.; Capulli, Andrew K.; Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Quinlan, Angela M. Throm] UMass Med Sch, Grad Sch Biomed Sci, Worcester, MA USA; [Firstenberg, Laura E.] Franklin W Olin Coll Engn, Needham, MA USA; [Billiar, Kristen L.] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA	Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Worcester; Franklin W. Olin College of Engineering; University of Massachusetts System; University of Massachusetts Worcester	Quinlan, AMT (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.	kbilliar@wpi.edu			American Heart Association [SDG 0535265N]	American Heart Association(American Heart Association)	This project was supported by the American Heart Association (www.heart.org) to KLB (SDG 0535265N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; BALESTRINI JL, 2005, J BIOMECH, V28, P28; Banes AJ, 1995, BIOCHEM CELL BIOL, V73, P349, DOI 10.1139/o95-043; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Chen YJ, 2008, CONNECT TISSUE RES, V49, P7, DOI 10.1080/03008200701818561; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Humphrey JD, 2003, BIOMECH MODEL MECHAN, V2, P109, DOI [10.1007/s10237-003-0033-4, 10.1007/S10237-003-0033-4]; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kelly DJ, 2007, MED ENG PHYS, V29, P154, DOI 10.1016/j.medengphy.2006.01.001; KLOXIN AM, IN SITU ELASTICITY M; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; LEUNG DYM, 1976, SCIENCE, V191, P475; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331; Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Wang D, 2010, INTEGR BIOL-UK, V2, P288, DOI 10.1039/b920644b; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang JHC, 2000, J THEOR BIOL, V202, P33, DOI 10.1006/jtbi.1999.1035; Wang JHC, 2000, ANN BIOMED ENG, V28, P1165, DOI 10.1114/1.1317528; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046	50	73	75	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23272	10.1371/journal.pone.0023272	http://dx.doi.org/10.1371/journal.pone.0023272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858051	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700013
J	Dezzutti, CS; Hendrix, CW; Marrazzo, JM; Pan, ZY; Wang, L; Louissaint, N; Kalyoussef, S; Torres, NM; Hladik, F; Parikh, U; Mellors, J; Hillier, SL; Herold, BC				Dezzutti, Charlene S.; Hendrix, Craig W.; Marrazzo, Jeanne M.; Pan, Zhenyu; Wang, Lei; Louissaint, Nicolette; Kalyoussef, Sabah; Torres, N. Merna; Hladik, Florian; Parikh, Urvi; Mellors, John; Hillier, Sharon L.; Herold, Betsy C.			Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; BACTERIAL VAGINOSIS; DOUBLE-BLIND; REPRODUCTIVE-TRACT; EPITHELIAL-CELLS; HIV-1 INFECTION; CHLAMYDIA-TRACHOMATIS; IMMUNE MEDIATORS; TRIAL; ACQUISITION	Background: Measurement of immune mediators and antimicrobial activity in female genital tract secretions may provide biomarkers predictive of risk for HIV-1 acquisition and surrogate markers of microbicide safety. However, optimal methods for sample collection do not exist. This study compared collection methods. Methods: Secretions were collected from 48 women (24 with bacterial vaginosis [BV]) using vaginal and endocervical Dacron and flocked swabs. Cervicovaginal lavage (CVL) was collected with 10 mL of Normosol-R (n = 20), saline (n = 14), or water (n = 14). The concentration of gluconate in Normosol-R CVL was determined to estimate the dilution factor. Cytokine and antimicrobial mediators were measured by Luminex or ELISA and corrected for protein content. Endogenous anti-HIV-1 and anti-E. coli activity were measured by TZM-bl assay or E. coli growth. Results: Higher concentrations of protein were recovered by CVL, despite a 10-fold dilution of secretions, as compared to swab eluents. After protein correction, endocervical swabs recovered the highest mediator levels regardless of BV status. Endocervical and vaginal flocked swabs recovered significantly higher levels of anti-HIV-1 and anti-E. coli activity than Dacron swabs (P < 0.001). BV had a significant effect on CVL mediator recovery. Normosol-R tended to recover higher levels of most mediators among women with BV, whereas saline or water tended to recover higher levels among women without BV. Saline recovered the highest levels of anti-HIV-1 activity regardless of BV status. Conclusions: Endocervical swabs and CVL collected with saline provide the best recovery of most mediators and would be the optimal sampling method(s) for clinical trials.	[Dezzutti, Charlene S.; Hillier, Sharon L.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Parikh, Urvi; Mellors, John] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Hendrix, Craig W.; Louissaint, Nicolette] Johns Hopkins Univ, Dept Clin Pharmacol, Baltimore, MD USA; [Marrazzo, Jeanne M.] Univ Washington, Dept Med, Seattle, WA USA; [Hladik, Florian] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Pan, Zhenyu; Wang, Lei] SCHARP Stat Ctr, Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Kalyoussef, Sabah; Torres, N. Merna; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Dezzutti, CS (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	cdezzutti@mwri.magee.edu	Hendrix, Craig W/G-4182-2014; Hladik, Florian/G-1041-2012; Hladik, Florian/AAR-8852-2021	Hendrix, Craig W/0000-0002-5696-8665; Hladik, Florian/0000-0002-0375-2764; Hladik, Florian/0000-0002-0375-2764; Herold, Betsy/0000-0001-9974-0786; Dezzutti, Charlene/0000-0001-5902-5841; Marrazzo, Jeanne/0000-0002-9277-7364	National Institute of Allergy and Infectious Diseases [U01 AI068633]; National Institute of Child Health and Development; National Center for Research Resources [UL1 RR 025005]; National Institute of Mental Health; United States National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was performed by the Microbicide Trials Network's Biomedical Sciences Working Group, which is funded by the National Institute of Allergy and Infectious Diseases (U01 AI068633), the National Institute of Child Health and Development, the National Center for Research Resources (UL1 RR 025005), and the National Institute of Mental Health, all of the United States National Institutes of Health (NIH). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance for Microbicide Development, 2006, MICR DEV STRAT; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Berneman A, 1998, INFECT IMMUN, V66, P4163; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; Chomont N, 2001, AIDS, V15, P801, DOI 10.1097/00002030-200104130-00018; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Draper DL, 2000, AM J OBSTET GYNECOL, V183, P1243, DOI 10.1067/mob.2000.107383; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Ghanem KG, 2005, J CLIN MICROBIOL, V43, P5295, DOI 10.1128/JCM.43.10.5295-5297.2005; Ghanem Khalil G, 2006, J Pediatr Adolesc Gynecol, V19, P23, DOI 10.1016/j.jpag.2005.11.002; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Jespers V, 2010, EXPERT REV VACCINES, V9, P381, DOI [10.1586/erv.10.21, 10.1586/ERV.10.21]; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Krech T, 2009, J VIROL METHODS, V162, P291, DOI 10.1016/j.jviromet.2009.08.011; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Mitchell C, 2011, AIDS RES HUM RETROV, V27, P35, DOI 10.1089/aid.2010.0129; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Shust GF, 2010, AM J REPROD IMMUNOL, V63, P110, DOI 10.1111/j.1600-0897.2009.00768.x; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; *UNAIDS WHO, 2010, REP GLOB AIDS EP; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yudin MH, 2003, OBSTET GYNECOL, V102, P527, DOI 10.1016/S0029-7844(03)00566-0	46	67	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23136	10.1371/journal.pone.0023136	http://dx.doi.org/10.1371/journal.pone.0023136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858008	Green Published, gold			2022-12-27	WOS:000293953500022
J	Sharma, S; Vander Zanden, MJ; Magnuson, JJ; Lyons, J				Sharma, Sapna; Vander Zanden, M. Jake; Magnuson, John J.; Lyons, John			Comparing Climate Change and Species Invasions as Drivers of Coldwater Fish Population Extirpations	PLOS ONE			English	Article							CISCO COREGONUS-ARTEDI; LAURENTIAN GREAT-LAKES; SMELT OSMERUS-MORDAX; RAINBOW SMELT; HYPOLIMNETIC OXYGENATION; VERTICAL-DISTRIBUTION; THERMAL HABITAT; SMALLMOUTH BASS; AMISK LAKE; WATER	Species are influenced by multiple environmental stressors acting simultaneously. Our objective was to compare the expected effects of climate change and invasion of non-indigenous rainbow smelt (Osmerus mordax) on cisco (Coregonus artedii) population extirpations at a regional level. We assembled a database of over 13,000 lakes in Wisconsin, USA, summarising fish occurrence, lake morphology, water chemistry, and climate. We used A1, A2, and B1 scenarios from the Intergovernmental Panel on Climate Change (IPCC) of future temperature conditions for 15 general circulation models in 2046-2065 and 2081-2100 totalling 78 projections. Logistic regression indicated that cisco tended to occur in cooler, larger, and deeper lakes. Depending upon the amount of warming, 25-70% of cisco populations are predicted to be extirpated by 2100. In addition, cisco are influenced by the invasion of rainbow smelt, which prey on young cisco. Projecting current estimates of rainbow smelt spread and impact into the future will result in the extirpation of about 1% of cisco populations by 2100 in Wisconsin. Overall, the effect of climate change is expected to overshadow that of species invasion as a driver of coldwater fish population extirpations. Our results highlight the potentially dominant role of climate change as a driver of biotic change.	[Sharma, Sapna; Vander Zanden, M. Jake; Magnuson, John J.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Lyons, John] Wisconsin Dept Nat Resources, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Sharma, S (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	sapna.sharma23@gmail.com		Vander Zanden, Jake/0000-0002-8122-1416; Sharma, Sapna/0000-0003-4571-2768	Natural Sciences and Engineering Research Council of Canada; North Temperate Lakes Long-Term Ecological Research program; Wisconsin Department of Natural Resources	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); North Temperate Lakes Long-Term Ecological Research program; Wisconsin Department of Natural Resources	Financial support was provided by a Natural Sciences and Engineering Research Council of Canada post-doctoral fellowship to Sapna Sharma (www.nserc.ca). Additional support was provided by the North Temperate Lakes Long-Term Ecological Research program (http://lter.limnology.wisc.edu/), and the Wisconsin Department of Natural Resources (http://dnr.wi.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aku PMK, 1997, CAN J FISH AQUAT SCI, V54, P2182, DOI 10.1139/f97-124; Aku PMK, 1997, CAN J FISH AQUAT SCI, V54, P2196, DOI 10.1139/cjfas-54-9-2196; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Becker G. C., 1983, FISHES WISCONSIN; Beisner BE, 2003, J ANIM ECOL, V72, P331, DOI 10.1046/j.1365-2656.2003.00699.x; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Casselman JM, 2002, AM FISH S S, V32, P39; COLBY PJ, 1969, LIMNOL OCEANOGR, V14, P958, DOI 10.4319/lo.1969.14.6.0958; CROWDER LB, 1982, CAN J FISH AQUAT SCI, V39, P1046, DOI 10.1139/f82-139; D'Amen M, 2009, BIOL CONSERV, V142, P3060, DOI 10.1016/j.biocon.2009.08.004; DeStasio BT, 1996, LIMNOL OCEANOGR, V41, P1136, DOI 10.4319/lo.1996.41.5.1136; Dextrase AJ, 2006, BIOL INVASIONS, V8, P13, DOI 10.1007/s10530-005-0232-2; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; EVANS DO, 1987, CAN J FISH AQUAT SCI, V44, P249, DOI 10.1139/f87-327; Fang X, 2004, ECOL MODEL, V172, P55, DOI 10.1016/S0304-3800(03)00286-2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; FREY DAVID G., 1955, INVEST INDIANA LAKES AND STREAMS, V4, P177; HASLER AD, 1947, ECOLOGY, V28, P383, DOI 10.2307/1931228; HONDZO M, 1993, CLIMATIC CHANGE, V24, P187, DOI 10.1007/BF01091829; Hrabik TR, 1999, CAN J FISH AQUAT SCI, V56, P35, DOI 10.1139/cjfas-56-S1-35; Hrabik TR, 1998, CAN J FISH AQUAT SCI, V55, P1364, DOI 10.1139/cjfas-55-6-1364; Jacobson PC, 2008, T AM FISH SOC, V137, P1464, DOI 10.1577/T07-148.1; King JR, 1999, T AM FISH SOC, V128, P656, DOI 10.1577/1548-8659(1999)128&lt;0656:ELBTHF&gt;2.0.CO;2; Latta W. C, 1995, 2014 MICH DEP NAT RE; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Livingstone DM, 1998, J PALEOLIMNOL, V19, P181, DOI 10.1023/A:1007904817619; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; LODGE DM, 1993, BIOTIC INTERACTIONS, P559; Lyons J., 2000, WISCONSIN FISHES 200; Mackenzie-Grieve JL, 2006, CAN J FISH AQUAT SCI, V63, P788, DOI 10.1139/F05-257; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Magnuson JJ, 2002, AM FISH S S, V32, P273; McKinney ML, 2007, GLOBAL ECOL BIOGEOGR, V16, P394, DOI 10.1111/j.1466-8238.2007.00296.x; MCLAIN A S, 1988, Finnish Fisheries Research, V9, P155; Mercado-Silva N, 2007, CAN J FISH AQUAT SCI, V64, P1543, DOI 10.1139/F07-112; Mercado-Silva N, 2006, CONSERV BIOL, V20, P1740, DOI 10.1111/j.1523-1739.2006.00508.x; Notaro M, 2011, INT J CLIMATOL, V31, P1615, DOI 10.1002/joc.2179; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rennie MD, 2010, ECOGRAPHY, V33, P471, DOI 10.1111/j.1600-0587.2009.06160.x; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Rouse WR, 1997, HYDROL PROCESS, V11, P873, DOI 10.1002/(SICI)1099-1085(19970630)11:8<873::AID-HYP510>3.0.CO;2-6; RUDSTAM LG, 1985, CAN J FISH AQUAT SCI, V42, P1178, DOI 10.1139/f85-146; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schindler DW, 1996, LIMNOL OCEANOGR, V41, P1004, DOI 10.4319/lo.1996.41.5.1004; Sharma S, 2008, CAN J FISH AQUAT SCI, V65, P471, DOI 10.1139/F07-178; Sharma S, 2007, GLOBAL CHANGE BIOL, V13, P2052, DOI 10.1111/j.1365-2486.2007.01426.x; Sharma S, 2009, ECOGRAPHY, V32, P517, DOI 10.1111/j.1600-0587.2008.05544.x; Shuter BJ, 2004, IN ST WA MA, P281; Simon KS, 2003, FRESHWATER BIOL, V48, P982, DOI 10.1046/j.1365-2427.2003.01069.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stefan HG, 1996, LIMNOL OCEANOGR, V41, P1124, DOI 10.4319/lo.1996.41.5.1124; STEFAN HG, 1994, ENVIRON MANAGE, V18, P73, DOI 10.1007/BF02393751; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Vander Zanden MJ, 2004, IN ST WA MA, P239; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson Karen A., 2006, P151; [No title captured]	65	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22906	10.1371/journal.pone.0022906	http://dx.doi.org/10.1371/journal.pone.0022906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860661	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200025
J	Wang, LL; Li, CZ; Guo, H; Kern, TS; Huang, K; Zheng, L				Wang, Leilei; Li, Chuanzhou; Guo, Hao; Kern, Timothy S.; Huang, Kun; Zheng, Ling			Curcumin Inhibits Neuronal and Vascular Degeneration in Retina after Ischemia and Reperfusion Injury	PLOS ONE			English	Article							NF-KAPPA-B; DIABETIC-RETINOPATHY; GANGLION-CELLS; EXPRESSION; STAT3; REGENERATION; INFLAMMATION; DAMAGE	Background: Neuron loss, glial activation and vascular degeneration are common sequelae of ischemia-reperfusion (I/R) injury in ocular diseases. The present study was conducted to explore the ability of curcumin to inhibit retinal I/R injury, and to investigate underlying mechanisms of the drug effects. Methodology/Principal Findings: Different dosages of curcumin were administered. I/R injury was induced by elevating the intraocular pressure for 60 min followed by reperfusion. Cell bodies, brn3a stained cells and TUNEL positive apoptotic cells in the ganglion cell layer (GCL) were quantitated, and the number of degenerate capillaries was assessed. The activation of glial cells was measured by the expression level of GFAP. Signaling pathways including IKK-IkB alpha, JAK-STAT1/3, ERK/MAPK and the expression levels of beta-tubulin III and MCP-1 were measured by western blot analysis. Pre-treatment using 0.01%-0.25% curcumin in diets significantly inhibited I/R-induced cell loss in GCL. 0.05% curcumin pre-treatment inhibited I/R-induced degeneration of retinal capillaries, TUNEL-positive apoptotic cell death in the GCL, brn3a stained cell loss, the I/R-induced up-regulation of MCP-1, IKK alpha, p-IkB alpha and p-STAT3 (Tyr), and down-regulation of beta-tubulin III. This dose showed no effect on injury-induced GFAP overexpression. Moreover, 0.05% curcumin administered 2 days after the injury also showed a vaso-protective effect. Conclusions/Significance: Curcumin protects retinal neurons and microvessels against I/R injury. The beneficial effects of curcumin on neurovascular degeneration may occur through its inhibitory effects on injury-induced activation of NF-kappa B and STAT3, and on over-expression of MCP-1. Curcumin may therefore serve as a promising candidate for retinal ischemic diseases.	[Wang, Leilei; Li, Chuanzhou; Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Guo, Hao; Huang, Kun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH USA	Wuhan University; Huazhong University of Science & Technology; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Wang, LL (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	kunhuang2008@hotmail.com; lzheng217@hotmail.com	Huang, Kun/H-4427-2012	Zheng, Ling/0000-0002-6545-4180; Li, Chuanzhou/0000-0003-0174-4215	Natural Science Foundation of China [30801445, 30970607, 30870949]; National Basic Research Program of China [2009CB918304]; Program for New Century Excellent Talents in University [NECT-10-0623]; Chinese Ministry of Education [109103]; Important National Science and Technology Specific Projects [2009ZX09301-014]; NATIONAL EYE INSTITUTE [R01EY000300] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Ministry of Education(Ministry of Education, China); Important National Science and Technology Specific Projects; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Natural Science Foundation of China (Nos. 30801445, 30970607 and 30870949; www.nsfc.gov.cn), the National Basic Research Program of China (2009CB918304; http://www.973.gov.cn/AreaAppl.aspx), the Program for New Century Excellent Talents in University (NECT-10-0623; www.dost.moe.gov.cn), the Key Project of Chinese Ministry of Education (No. 109103; www.dost.moe.gov.cn), and the Important National Science and Technology Specific Projects (2009ZX09301-014; www.cncbd.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Broadbelt NV, 2009, AM J PHYSIOL-RENAL, V297, pF114, DOI 10.1152/ajprenal.90752.2008; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Ghoneim AI, 2002, PHARMACOL RES, V46, P273, DOI 10.1016/S1043-6618(02)00123-8; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Jo N, 2003, INVEST OPHTH VIS SCI, V44, P4054, DOI 10.1167/iovs.02-1308; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; LIN MS, 2009, J SURG RES; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; MIDDELDORP J, 2011, PROG NEUROBIOL; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pari Leelavinothan, 2008, Archives of Physiology and Biochemistry, V114, P127, DOI [10.1080/13813450802033958, 10.1080/13813450802033958 ]; Pimentel B, 2000, J NEUROSCI, V20, P3254, DOI 10.1523/JNEUROSCI.20-09-03254.2000; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Ramudo L, 2009, J CELL MOL MED, V13, P1314, DOI 10.1111/j.1582-4934.2008.00529.x; Rathore P, 2008, NEUROCHEM RES, V33, P1672, DOI 10.1007/s11064-007-9515-6; Raymond ID, 2008, MOL VIS, V14, P1559; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yin YQ, 2003, J NEUROSCI, V23, P2284; YU S, 2011, REJUV RES, V13, P55; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2004, DIABETES, V53, P2960, DOI 10.2337/diabetes.53.11.2960; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, PROTEOMICS, V9, P1869, DOI 10.1002/pmic.200701071	41	73	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23194	10.1371/journal.pone.0023194	http://dx.doi.org/10.1371/journal.pone.0023194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858029	Green Submitted, Green Published, gold			2022-12-27	WOS:000293774300026
J	Kou, XJ; Li, Q; Liu, SR				Kou, Xiaojun; Li, Qin; Liu, Shirong			Quantifying Species' Range Shifts in Relation to Climate Change: A Case Study of Abies spp. in China	PLOS ONE			English	Article							GLOBAL LAND AREAS; DISTRIBUTION MODELS; EXTINCTION RISK; DISTRIBUTIONS; TRANSFERABILITY; CLASSIFICATION; UNCERTAINTIES; PERFORMANCE; PROJECTIONS; PREVALENCE	Predicting species range shifts in response to climatic change is a central aspect of global change studies. An ever growing number of species have been modeled using a variety of species distribution models (SDMs). However, quantitative studies of the characteristics of range shifts are rare, predictions of range changes are hard to interpret, analyze and summarize, and comparisons between the various models are difficult to make when the number of species modeled is large. Maxent was used to model the distribution of 12 Abies spp. in China under current and possible future climate conditions. Two fuzzy set defined indices, range increment index (I) and range overlapping index (O), were used to quantify range shifts of the chosen species. Correlation analyses were used to test the relationships between these indices and species distribution characteristics. Our results show that Abies spp. range increments (I) were highly correlated with longitude, latitude, and mean roughness of their current distributions. Species overlapping (O) was moderately, or not, correlated with these parameters. Neither range increments nor overlapping showed any correlation with species prevalence. These fuzzy sets defined indices provide ideal measures of species range shifts because they are stable and threshold-free. They are reliable indices that allow large numbers of species to be described, modeled, and compared on a variety of taxonomic levels.	[Kou, Xiaojun] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Li, Qin] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Shirong] Chinese Acad Forestry, Inst Forest Environm & Ecol, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Forestry	Kou, XJ (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	xj_kou@bnu.edu.cn			Special Research Program for Public-Welfare Forestry [200804001]; NSFC [30590383]	Special Research Program for Public-Welfare Forestry; NSFC(National Natural Science Foundation of China (NSFC))	This research was carried out with the support of the Special Research Program for Public-Welfare Forestry (Grant No. 200804001) and NSFC's Major Project (Grant No. 30590383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dunn AM, 2008, EMU, V108, P42, DOI 10.1071/MU07034; *ED COMM FLOR CHIN, 1978, FLOR CHIN, V7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Harrison JA, 1997, ATLAS SO AFRICAN BIR; Harrison SP, 2010, J VEG SCI, V21, P300, DOI 10.1111/j.1654-1103.2009.01144.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hou X., 2001, VEGETATION ATLAS CHI; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kou XJ, 2011, ECOL INFORM, V6, P196, DOI 10.1016/j.ecoinf.2011.01.004; Kurtto Arto, 1999, Acta Botanica Fennica, V162, P67; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Patterson BD, 2003, DIGITAL DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Platts PJ, 2010, DIVERS DISTRIB, V16, P628, DOI 10.1111/j.1472-4642.2010.00668.x; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Robertson MP, 2010, DIVERS DISTRIB, V16, P363, DOI 10.1111/j.1472-4642.2010.00639.x; Robertson MP, 2004, DIVERS DISTRIB, V10, P461, DOI 10.1111/j.1366-9516.2004.00108.x; Svenning JC, 2009, ECOGRAPHY, V32, P3, DOI 10.1111/j.1600-0587.2009.06024.x; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wu, 1980, VEGETATION CHINA; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	45	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23115	10.1371/journal.pone.0023115	http://dx.doi.org/10.1371/journal.pone.0023115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887231	gold, Green Published, Green Submitted			2022-12-27	WOS:000295832000006
J	Lanyi, A; Barath, M; Peterfi, Z; Bogel, G; Orient, A; Simon, T; Petrovszki, E; Kis-Toth, K; Sirokmany, G; Rajnavolgyi, E; Terhorst, C; Buday, L; Geiszt, M				Lanyi, Arpad; Barath, Monika; Peterfi, Zalan; Bogel, Gabor; Orient, Anna; Simon, Tuende; Petrovszki, Eniko; Kis-Toth, Katalin; Sirokmany, Gabor; Rajnavoelgyi, Eva; Terhorst, Cox; Buday, Laszlo; Geiszt, Miklos			The Homolog of the Five SH3-Domain Protein (HOFI/SH3PXD2B) Regulates Lamellipodia Formation and Cell Spreading	PLOS ONE			English	Article							CANCER-CELLS; PX DOMAIN; ACTIN CYTOSKELETON; PODOSOME FORMATION; CONTACT SITES; SRC SUBSTRATE; CORTACTIN; PHOSPHORYLATION; MIGRATION; INVASION	Motility of normal and transformed cells within and across tissues requires specialized subcellular structures, e. g. membrane ruffles, lamellipodia and podosomes, which are generated by dynamic rearrangements of the actin cytoskeleton. Because the formation of these sub-cellular structures is complex and relatively poorly understood, we evaluated the role of the adapter protein SH3PXD2B [HOFI, fad49, Tks4], which plays a role in the development of the eye, skeleton and adipose tissue. Surprisingly, we find that SH3PXD2B is requisite for the development of EGF-induced membrane ruffles and lamellipodia, as well as for efficient cellular attachment and spreading of HeLa cells. Furthermore, SH3PXD2B is present in a complex with the non-receptor protein tyrosine kinase Src, phosphorylated by Src, which is consistent with SH3PXD2B accumulating in Src-induced podosomes. Furthermore, SH3PXD2B closely follows the subcellular relocalization of cortactin to Src-induced podosomes, EGF-induced membrane ruffles and lamellipodia. Because SH3PXD2B also forms a complex with the C-terminal region of cortactin, we propose that SH3PXD2B is a scaffold protein that plays a key role in regulating the actin cytoskeleton via Src and cortactin.	[Lanyi, Arpad; Barath, Monika; Simon, Tuende; Petrovszki, Eniko; Kis-Toth, Katalin; Rajnavoelgyi, Eva] Univ Debrecen Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary; [Lanyi, Arpad; Barath, Monika; Simon, Tuende; Petrovszki, Eniko; Kis-Toth, Katalin; Rajnavoelgyi, Eva] Univ Debrecen Med & Hlth Sci Ctr, Res Ctr Mol Med, Debrecen, Hungary; [Peterfi, Zalan; Orient, Anna; Sirokmany, Gabor; Geiszt, Miklos] Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary; [Bogel, Gabor; Buday, Laszlo] Semmelweis Univ, Fac Med, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Immunol, Boston, MA 02215 USA; [Buday, Laszlo] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Budapest, Hungary; [Peterfi, Zalan; Geiszt, Miklos] Semmelweis Univ, Peroxidase Enzyme Res Grp, Budapest, Hungary	University of Debrecen; University of Debrecen; Semmelweis University; Semmelweis University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Semmelweis University	Lanyi, A (corresponding author), Univ Debrecen Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary.	alanyi@dote.hu; geiszt@eok.sote.hu	Rajnavölgyi, Éva/D-4384-2013	Peterfi, Zalan/0000-0002-7432-2438	Hungarian Research Fund [OTKA 042573, NF72669, OTKA 63700, OTKA 81676, OTKA 61555, 83867]; Jedlik Anyos program [1/010/2005, A1-0069/2006]; National Office for Research and Technology [OMFB-01680/2009]; Wellcome Trust; Mihaly Polanyi grant [KFKT-1-2006-0006]; Hungarian Academy of Sciences; TAMOP [4.2.1./B-09/1/KONV-2010-0007]; European Social Fund	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Jedlik Anyos program; National Office for Research and Technology(National Office for Research and Technology); Wellcome Trust(Wellcome TrustEuropean Commission); Mihaly Polanyi grant; Hungarian Academy of Sciences(Hungarian Academy of Sciences); TAMOP; European Social Fund(European Social Fund (ESF))	This work was supported by grants from the Hungarian Research Fund OTKA 042573 and NF72669 (MG), OTKA 63700 (AL), OTKA 81676 (AL), and OTKA 61555 and 83867 (LB); by grants from the Jedlik Anyos program 1/010/2005 (MG) and A1-0069/2006 (AL); and by grants from the National Office for Research and Technology OMFB-01680/2009 (MG), the Wellcome Trust (MG), the Mihaly Polanyi grant KFKT-1-2006-0006, and the "Lendulet" grant from the Hungarian Academy of Sciences (LB). The work was also supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 project (AL). The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Adam Z, 2000, CLIN EXP METASTAS, V18, P295, DOI 10.1023/A:1011043412634; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; BUSCHMAN MD, 2009, MOL BIOL CELL; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Campbell DH, 1999, CANCER RES, V59, P5376; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Illes A, 2006, IMMUNOL LETT, V104, P124, DOI 10.1016/j.imlet.2005.11.011; Illes A, 2006, CELL SIGNAL, V18, P830, DOI 10.1016/j.cellsig.2005.07.012; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Li YS, 2001, CANCER RES, V61, P6906; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Rethi B, 2006, BLOOD, V107, P2821, DOI 10.1182/blood-2005-06-2265; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tsai WC, 2007, J HISTOCHEM CYTOCHEM, V55, P955, DOI 10.1369/jhc.7A7235.2007; Turner CE, 2000, J CELL SCI, V113, P4139; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; vanDamme H, 1997, J BIOL CHEM, V272, P7374, DOI 10.1074/jbc.272.11.7374; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; WHITE MK, 1988, MOL CELL BIOL, V8, P138, DOI 10.1128/MCB.8.1.138; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wunderlich L, 1999, CELL SIGNAL, V11, P253, DOI 10.1016/S0898-6568(98)00054-0; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200	56	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23653	10.1371/journal.pone.0023653	http://dx.doi.org/10.1371/journal.pone.0023653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886807	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500023
J	Sun, J; Steindler, L; Thrash, JC; Halsey, KH; Smith, DP; Carter, AE; Landry, ZC; Giovannoni, SJ				Sun, Jing; Steindler, Laura; Thrash, J. Cameron; Halsey, Kimberly H.; Smith, Daniel P.; Carter, Amy E.; Landry, Zachary C.; Giovannoni, Stephen J.			One Carbon Metabolism in SAR11 Pelagic Marine Bacteria	PLOS ONE			English	Article							METHYLOBACTERIUM-EXTORQUENS AM1; MULTIPLE SEQUENCE ALIGNMENT; GLYCINE BETAINE; PARACOCCUS-DENITRIFICANS; ESCHERICHIA-COLI; FORMALDEHYDE DEHYDROGENASE; METHYLOTROPHIC BACTERIA; METHANOL DEHYDROGENASE; UTILIZATION PATHWAY; CRYSTAL-STRUCTURE	The SAR11 Alphaproteobacteria are the most abundant heterotrophs in the oceans and are believed to play a major role in mineralizing marine dissolved organic carbon. Their genomes are among the smallest known for free-living heterotrophic cells, raising questions about how they successfully utilize complex organic matter with a limited metabolic repertoire. Here we show that conserved genes in SAR11 subgroup Ia (Candidatus Pelagibacter ubique) genomes encode pathways for the oxidation of a variety of one-carbon compounds and methyl functional groups from methylated compounds. These pathways were predicted to produce energy by tetrahydrofolate (THF)-mediated oxidation, but not to support the net assimilation of biomass from C1 compounds. Measurements of cellular ATP content and the oxidation of C-14-labeled compounds to (CO2)-C-14 indicated that methanol, formaldehyde, methylamine, and methyl groups from glycine betaine (GBT), trimethylamine (TMA), trimethylamine N-oxide (TMAO), and dimethylsulfoniopropionate (DMSP) were oxidized by axenic cultures of the SAR11 strain Ca. P. ubique HTCC1062. Analyses of metagenomic data showed that genes for C1 metabolism occur at a high frequency in natural SAR11 populations. In short term incubations, natural communities of Sargasso Sea microbial plankton expressed a potential for the oxidation of C-14-labeled formate, formaldehyde, methanol and TMAO that was similar to cultured SAR11 cells and, like cultured SAR11 cells, incorporated a much larger percentage of pyruvate and glucose (27-35%) than of C1 compounds (2-6%) into biomass. Collectively, these genomic, cellular and environmental data show a surprising capacity for demethylation and C1 oxidation in SAR11 cultures and in natural microbial communities dominated by SAR11, and support the conclusion that C1 oxidation might be a significant conduit by which dissolved organic carbon is recycled to CO2 in the upper ocean.	[Sun, Jing; Steindler, Laura; Thrash, J. Cameron; Smith, Daniel P.; Carter, Amy E.; Landry, Zachary C.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Halsey, Kimberly H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Sun, J (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Smith, Daniel/L-6827-2019	Smith, Daniel/0000-0002-2479-2044; Halsey, Kimberly/0000-0002-1407-0777; Thrash, Cameron/0000-0003-0896-9986	Marine Microbiology Initiative of the Gordon and Betty Moore Foundation; National Science Foundation [MCB-0237728, DBI-1003269]; Division Of Ocean Sciences [0802004] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1003269] Funding Source: National Science Foundation	Marine Microbiology Initiative of the Gordon and Betty Moore Foundation; National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by a grant from the Marine Microbiology Initiative of the Gordon and Betty Moore Foundation to SJG, National Science Foundation Microbial Observatory grant MCB-0237728 to SJG, and is based upon work supported by the National Science Foundation award no. DBI-1003269 to JCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Antoine E, 1999, EUR J BIOCHEM, V264, P880, DOI 10.1046/j.1432-1327.1999.00685.x; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Arfman N, 1997, EUR J BIOCHEM, V244, P426, DOI 10.1111/j.1432-1033.1997.00426.x; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Barra L, 2006, J BACTERIOL, V188, P7195, DOI 10.1128/JB.00208-06; BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023; BENBASSAT A, 1980, J GEN MICROBIOL, V116, P213; BICKNELL B, 1980, J GEN MICROBIOL, V117, P89; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Bystrykh Leonid V., 1993, P245; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Chen Y, 2010, APPL ENVIRON MICROB, V76, P4102, DOI 10.1128/AEM.00469-10; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; CHLUMSKY LJ, 1995, J BIOL CHEM, V270, P18252, DOI 10.1074/jbc.270.31.18252; CRAFT TR, 1987, MUTAT RES, V176, P147, DOI 10.1016/0027-5107(87)90262-4; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; DEVRIES GE, 1992, J BACTERIOL, V174, P5346, DOI 10.1128/JB.174.16.5346-5353.1992; DIAZ MR, 1992, FEMS MICROBIOL LETT, V96, P61, DOI 10.1016/0378-1097(92)90457-Y; Dixon JL, 2011, ISME J, V5, P704, DOI 10.1038/ismej.2010.169; Dworkin M, 2006, CAPNOPHILIC BIRD PAT, V3rd; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gabaldon T, 2007, PLOS COMPUT BIOL, V3, P2209, DOI 10.1371/journal.pcbi.0030219; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giovannoni SJ, 2008, ENVIRON MICROBIOL, V10, P1771, DOI 10.1111/j.1462-2920.2008.01598.x; Goenrich M, 2002, J BIOL CHEM, V277, P3069, DOI 10.1074/jbc.C100579200; Goode JG, 2000, J GEOPHYS RES-ATMOS, V105, P22147, DOI 10.1029/2000JD900287; GRAFSTROM RC, 1983, SCIENCE, V220, P216, DOI 10.1126/science.6828890; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hasona A, 1998, J BACTERIOL, V180, P1466, DOI 10.1128/JB.180.6.1466-1472.1998; Heikes BG, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001895; HENDERSON JF, 1979, BIOCHEM EDUC, V7, P51; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; JONES DP, 1978, J BIOL CHEM, V253, P6031; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Kiene RP, 1998, APPL ENVIRON MICROB, V64, P1045; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Latypova E, 2010, MOL MICROBIOL, V75, P426, DOI 10.1111/j.1365-2958.2009.06989.x; Lin CN, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-84; Liu XQ, 2009, MICROBIOL-SGM, V155, P2078, DOI 10.1099/mic.0.027201-0; MANIAN SS, 1984, APPL ENVIRON MICROB, V48, P276, DOI 10.1128/AEM.48.2.276-279.1984; Mcdowell L. R., 2000, VITAMINS ANIMAL HUMA, DOI DOI 10.1002/9780470376911; Meskys R, 2001, EUR J BIOCHEM, V268, P3390, DOI 10.1046/j.1432-1327.2001.02239.x; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; RAS J, 1995, J BACTERIOL, V177, P247, DOI 10.1128/jb.177.1.247-251.1995; Reisch CR, 2008, J BACTERIOL, V190, P8018, DOI 10.1128/JB.00770-08; Robbertse B, 2006, FUNGAL GENET BIOL, V43, P715, DOI 10.1016/j.fgb.2006.05.001; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Scott DA, 2008, J BIOL CHEM, V283, P155, DOI 10.1074/jbc.M708014200; Scrutton NS, 2005, BIOCHEM SOC T, V33, P776, DOI 10.1042/BST0330776; Serra AL, 2002, J BACTERIOL, V184, P4301, DOI 10.1128/JB.184.15.4301-4303.2002; Singh HB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017933; SINGH RK, 1984, J BIOSCIENCE, V6, P181, DOI 10.1007/BF02702639; Sorokin DY, 2010, MICROBIOL-SGM, V156, P819, DOI 10.1099/mic.0.033712-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Studer A, 2002, J BACTERIOL, V184, P3476, DOI 10.1128/JB.184.13.3476-3484.2002; Teplyakov A, 2004, J BACTERIOL, V186, P7134, DOI 10.1128/JB.186.21.7134-7140.2004; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Vandecasteele J.-P, 2008, PETROLEUM MICROBIOLO; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Wang W, 2002, APPL MICROBIOL BIOT, V60, P139, DOI 10.1007/s00253-002-1093-6; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27; Wilson SM, 2008, MICROBIOL-SGM, V154, P296, DOI 10.1099/mic.0.2007/011346-0; ZIMMERMAN PR, 1978, GEOPHYS RES LETT, V5, P679, DOI 10.1029/GL005i008p00679	82	110	110	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23973	10.1371/journal.pone.0023973	http://dx.doi.org/10.1371/journal.pone.0023973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886845	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500041
J	Schauble, S; Heiland, I; Voytsekh, O; Mittag, M; Schuster, S				Schaeuble, Sascha; Heiland, Ines; Voytsekh, Olga; Mittag, Maria; Schuster, Stefan			Predicting the Physiological Role of Circadian Metabolic Regulation in the Green Alga Chlamydomonas reinhardtii	PLOS ONE			English	Article							RNA-BINDING PROTEIN; CONSTRAINT-BASED ANALYSIS; ELEMENTARY MODE ANALYSIS; FLUX BALANCE MODELS; ESCHERICHIA-COLI; PATHWAY ANALYSIS; MESSENGER-RNAS; RECONSTRUCTION; ASSIMILATION; NETWORKS	Although the number of reconstructed metabolic networks is steadily growing, experimental data integration into these networks is still challenging. Based on elementary flux mode analysis, we combine sequence information with metabolic pathway analysis and include, as a novel aspect, circadian regulation. While minimizing the need of assumptions, we are able to predict changes in the metabolic state and can hypothesise on the physiological role of circadian control in nitrogen metabolism of the green alga Chlamydomonas reinhardtii.	[Schaeuble, Sascha; Heiland, Ines; Schuster, Stefan] Univ Jena, Dept Bioinformat, Jena, Germany; [Voytsekh, Olga; Mittag, Maria] Univ Jena, Inst Gen Bot & Plant Physiol, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schauble, S (corresponding author), Univ Jena, Dept Bioinformat, Jena, Germany.	heiland.ines@uni-jena.de	Heiland, Ines/B-9212-2014; Schäuble, Sascha/AAF-7809-2021	Heiland, Ines/0000-0002-9124-5112; 	German Federal Ministry of Education and Research (BMBF) [0315260A]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (BMBF project 0315260A; http://www.bmbf.de/; http://www.forsys.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACUA V, 2010, BIOSYSTEMS, V99, P210; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Behre J, 2008, J THEOR BIOL, V252, P433, DOI 10.1016/j.jtbi.2007.09.043; Carlson R, 2002, BIOTECHNOL BIOENG, V79, P121, DOI 10.1002/bit.10305; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Daniel-Vedele F, 1998, CURR OPIN PLANT BIOL, V1, P235, DOI 10.1016/S1369-5266(98)80110-6; Diniz SC, 2006, BIOTECHNOL BIOENG, V93, P698, DOI 10.1002/bit.20760; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Feist AM, 2010, CURR OPIN MICROBIOL; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; Gonzalez-Ballester D, 2004, PLANT MOL BIOL, V56, P863, DOI 10.1007/s11103-004-5292-7; Gonzalez-Ballester D, 2005, PLANT PHYSIOL, V137, P522, DOI 10.1104/pp.104.050914; Hadicke O, 2010, J BIOTECHNOL, V147, P88, DOI 10.1016/j.jbiotec.2010.03.006; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Iliev D, 2006, PLANT PHYSIOL, V142, P797, DOI 10.1104/pp.106.085944; Kaleta C, 2009, GENOME RES, V19, P1872, DOI 10.1101/gr.090639.108; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kenanov D, 2010, FEBS J, V277, P1023, DOI 10.1111/j.1742-4658.2009.07546.x; Kiaulehn S, 2007, J BIOL RHYTHM, V22, P275, DOI 10.1177/0748730407301053; Kromer JO, 2006, METAB ENG, V8, P353, DOI 10.1016/j.ymben.2006.02.001; Kucho K, 2005, PLANT MOL BIOL, V57, P889, DOI 10.1007/s11103-005-3248-1; May P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-209; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michal G, 1999, BIOCH PATHWAYS ATLAS; Mittag M, 1996, P NATL ACAD SCI USA, V93, P14401, DOI 10.1073/pnas.93.25.14401; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; QUESADA A, 1993, MOL GEN GENET, V240, P387, DOI 10.1007/BF00280390; Ruppin E, 2010, CURR OPIN BIOTECH, V21, P502, DOI 10.1016/j.copbio.2010.07.002; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 2005, FEBS J, V272, P5278, DOI 10.1111/j.1742-4658.2005.04924.x; Schuster S, 2008, J THEOR BIOL, V252, P497, DOI 10.1016/j.jtbi.2007.12.008; Schwartz JM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r123; Schwarz R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-313; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Trinh CT, 2009, APPL ENVIRON MICROB, V75, P6696, DOI 10.1128/AEM.00670-09; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Waltenberger H, 2001, MOL GENET GENOMICS, V265, P180; Wlaschin AP, 2006, METAB ENG, V8, P338, DOI 10.1016/j.ymben.2006.01.007; Zhao B, 2004, EUKARYOT CELL, V3, P815, DOI 10.1128/EC.3.3.815-825.2004; [No title captured], DOI DOI 10.1142/S0218339094000131	47	2	3	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23026	10.1371/journal.pone.0023026	http://dx.doi.org/10.1371/journal.pone.0023026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887226	gold, Green Published, Green Submitted			2022-12-27	WOS:000294251800006
J	Caputi, AA; Aguilera, PA; Pereira, AC				Caputi, Angel A.; Aguilera, Pedro A.; Pereira, Ana Carolina			Active Electric Imaging: Body-Object Interplay and Object's "Electric Texture"	PLOS ONE			English	Article							ORGAN DISCHARGES; SENSORY ACQUISITION; GYMNOTIFORM FISHES; GYMNOTUS-CARAPO; WAVE-FORM; IMAGES; ELECTROLOCATION; SIGNAL; ELECTRORECEPTION; RESPONSES	This article deals with the role of fish's body and object's geometry on determining the image spatial shape in pulse Gymnotiforms. This problem was explored by measuring local electric fields along a line on the skin in the presence and absence of objects. We depicted object's electric images at different regions of the electrosensory mosaic, paying particular attention to the perioral region where a fovea has been described. When sensory surface curvature increases relative to the object's curvature, the image details depending on object's shape are blurred and finally disappear. The remaining effect of the object on the stimulus profile depends on the strength of its global polarization. This depends on the length of the object's axis aligned with the field, in turn depending on fish body geometry. Thus, fish's body and self-generated electric field geometries are embodied in this "global effect'' of the object. The presence of edges or local changes in impedance at the nearest surface of closely located objects adds peaks to the image profiles ("local effect" or "object's electric texture"). It is concluded that two cues for object recognition may be used by active electroreceptive animals: global effects (informing on object's dimension along the field lines, conductance, and position) and local effects (informing on object's surface). Since the field has fish's centered coordinates, and electrosensory fovea is used for exploration of surfaces, fish fine movements are essential to perform electric perception. We conclude that fish may explore adjacent objects combining active movements and electrogenesis to represent them using electrosensory information.	[Caputi, Angel A.; Aguilera, Pedro A.; Pereira, Ana Carolina] Inst Invest Biol Clemente Estable, Dept Integrat & Computat Neurosci, Montevideo, Uruguay	Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Caputi, AA (corresponding author), Inst Invest Biol Clemente Estable, Dept Integrat & Computat Neurosci, Montevideo, Uruguay.	caputiangel@gmail.com			European Commission Information, Society and Media, Future and Emerging Technologies (FET) [231845]; Agencia Nacional de Investigacion e Innovacion (ANII Uruguay); Fondo Clemente Estable [655]; PEDECIBA (Uruguay)	European Commission Information, Society and Media, Future and Emerging Technologies (FET)(European CommissionEuropean Commission Joint Research Centre); Agencia Nacional de Investigacion e Innovacion (ANII Uruguay); Fondo Clemente Estable; PEDECIBA (Uruguay)	This work was partially funded by the European Commission Information, Society and Media, Future and Emerging Technologies (FET) Grant # 231845; Agencia Nacional de Investigacion e Innovacion (ANII Uruguay), Fondo Clemente Estable # 655 and PEDECIBA (Uruguay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera PA, 2003, J EXP BIOL, V206, P989, DOI 10.1242/jeb.00198; Aguilera PA, 2001, J EXP BIOL, V204, P185; Assad C, 1999, J EXP BIOL, V202, P1185; ASSAD C, 1997, ELECT FIELD MAPS BOU; Babineau D, 2006, J EXP BIOL, V209, P3636, DOI 10.1242/jeb.02403; Bacelo J, 2008, J COMP NEUROL, V511, P342, DOI 10.1002/cne.21843; BASTIAN J, 1993, J COMP PHYSIOL A, V173, P257, DOI 10.1007/BF00212690; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Bullock T.H., 1986, ELECTRORECEPTION; Bullock TH, 2005, ELECTRORECEPTION; CAPUTI A, 1995, J COMPUT NEUROSCI, V2, P131, DOI 10.1007/BF00961884; Caputi AA, 1998, J EXP BIOL, V201, P2115; Caputi AA, 2003, J EXP BIOL, V206, P999, DOI 10.1242/jeb.00199; Caputi AA, 2002, J PHYSIOLOGY-PARIS, V96, P493, DOI 10.1016/S0928-4257(03)00005-6; Caputi AA, 2008, J PHYSIOL-PARIS, V102, P256, DOI 10.1016/j.jphysparis.2008.10.005; Pereira AC, 2010, INTERDISCIP SCI, V2, P291, DOI 10.1007/s12539-010-0049-2; Castello ME, 2000, J EXP BIOL, V203, P3279; Chen L, 2005, J COMP PHYSIOL A, V191, P331, DOI 10.1007/s00359-004-0587-3; Engelmann J, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-21; Gibson J.J., 1966, SENSES CONSIDERED PE; Gomez L, 2004, J EXP BIOL, V207, P2443, DOI 10.1242/jeb.01053; HEILIGENBERG W, 1973, J COMP PHYSIOL, V87, P137, DOI 10.1007/BF01352158; Hollmann M, 2008, J ZOOL, V276, P149, DOI 10.1111/j.1469-7998.2008.00465.x; Kalmijn A.J., 1974, P147; LISSMANN HW, 1958, J EXP BIOL, V35, P156; LISSMANN HW, 1958, J EXP BIOL, V35, P451; Migliaro A, 2005, PLOS COMPUT BIOL, V1, P123, DOI 10.1371/journal.pcbi.0010016; Nelson ME, 2006, J COMP PHYSIOL A, V192, P573, DOI 10.1007/s00359-006-0099-4; Nelson ME, 2002, BRAIN BEHAV EVOLUT, V59, P199, DOI 10.1159/000064907; Nelson ME, 1999, J EXP BIOL, V202, P1195; Nunez P.L, 1981, ELECT FIELDS BRAIN N; Pereira A.C., 2009, THESIS UDELAR MONTEV; Pereira AC, 2005, J EXP BIOL, V208, P961, DOI 10.1242/jeb.01481; Pusch R, 2008, J EXP BIOL, V211, P921, DOI 10.1242/jeb.014175; Rasnow B, 1996, J COMP PHYSIOL A, V178, P383; Rasnow B, 1996, J COMP PHYSIOL A, V178, P397; Rother D, 2003, BIOSYSTEMS, V71, P169, DOI 10.1016/S0303-2647(03)00124-2; Sicardi EA, 2000, PHYSICA A, V283, P86, DOI 10.1016/S0378-4371(00)00132-1; Snyder JB, 2007, PLOS BIOL, V5, P2671, DOI 10.1371/journal.pbio.0050301; Stoddard PK, 1999, J COMP PHYSIOL A, V184, P609, DOI 10.1007/s003590050359; von der Emde G, 2002, J PHYSIOLOGY-PARIS, V96, P431, DOI 10.1016/S0928-4257(03)00021-4; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; VONDEREMDE G, 1990, J COMP PHYSIOL A, V167, P413, DOI 10.1007/BF00192576; VONDEREMDE G, 2010, FRONT BEHAV NEUROSCI, V28, P4	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22793	10.1371/journal.pone.0022793	http://dx.doi.org/10.1371/journal.pone.0022793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876730	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900002
J	Neel, NF; Sai, J; Ham, AJL; Sobolik-Delmaire, T; Mernaugh, RL; Richmond, A				Neel, Nicole F.; Sai, Jiqing; Ham, Amy-Joan L.; Sobolik-Delmaire, Tammy; Mernaugh, Raymond L.; Richmond, Ann			IQGAP1 Is a Novel CXCR2-Interacting Protein and Essential Component of the "Chemosynapse"	PLOS ONE			English	Article							INFLUENCES ZYXIN LOCALIZATION; ACTIN-FILAMENT; CELL-MIGRATION; INTERLEUKIN-8 RECEPTOR; ENA/VASP PROTEINS; BINDING PROTEIN; SIGNALING RGS; CANCER CELLS; CDC42; REGULATORS	Background: Chemotaxis is essential for a number of physiological processes including leukocyte recruitment. Chemokines initiate intracellular signaling pathways necessary for chemotaxis through binding seven transmembrane G protein-couple receptors. Little is known about the proteins that interact with the intracellular domains of chemokine receptors to initiate cellular signaling upon ligand binding. CXCR2 is a major chemokine receptor expressed on several cell types, including endothelial cells and neutrophils. We hypothesize that multiple proteins interact with the intracellular domains of CXCR2 upon ligand stimulation and these interactions comprise a "chemosynapse", and play important roles in transducing CXCR2 mediated signaling processes. Methodology/Principal Findings: In an effort to define the complex of proteins that assemble upon CXCR2 activation to relay signals from activated chemokine receptors, a proteomics approach was employed to identify proteins that co-associate with CXCR2 with or without ligand stimulation. The components of the CXCR2 "chemosynapse" are involved in processes ranging from intracellular trafficking to cytoskeletal modification. IQ motif containing GTPase activating protein 1 (IQGAP1) was among the novel proteins identified to interact directly with CXCR2. Herein, we demonstrate that CXCR2 co-localizes with IQGAP1 at the leading edge of polarized human neutrophils and CXCR2 expressing differentiated HL-60 cells. Moreover, amino acids 1-160 of IQGAP1 directly interact with the carboxyl-terminal domain of CXCR2 and stimulation with CXCL8 enhances IQGAP1 association with Cdc42. Conclusions: Our studies indicate that IQGAP1 is a novel essential component of the CXCR2 "chemosynapse".	[Neel, Nicole F.; Sai, Jiqing; Sobolik-Delmaire, Tammy; Richmond, Ann] Dept Vet Affairs, Nashville, TN USA; [Neel, Nicole F.; Sai, Jiqing; Sobolik-Delmaire, Tammy; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Ham, Amy-Joan L.; Mernaugh, Raymond L.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Neel, NF (corresponding author), Dept Vet Affairs, Nashville, TN USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health (NIH) [R01CA34590, P50CA64845]; Vanderbilt-Ingram Cancer Center; Department of Veterans Affairs; Vanderbilt Multidisciplinary Basic Research Training in Cancer [T32CA09592]; Vanderbilt Vascular Biology Training [T32HL07751]; NIH [DK-20593, DK-58404, HD-15052, DK-59637, EY-08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA163069, P30CA068485, R01CA034590, T32CA009592] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, U2CDK059637, P60DK020593, P30DK020593, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center; Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Multidisciplinary Basic Research Training in Cancer; Vanderbilt Vascular Biology Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole or in part by National Institutes of Health (NIH) Grants - R01CA34590 (A. R.) and P50CA64845 in support of the Vanderbilt-Ingram Cancer Center. This work was also supported by a Senior Research Career Scientist Award from the Department of Veterans Affairs (A. R.), Ingram Professorship (A.R.), the Vanderbilt Multidisciplinary Basic Research Training in Cancer Grant T32CA09592 (N.F.N.), and the Vanderbilt Vascular Biology Training Grant T32HL07751 (T.S.). The authors acknowledge the VUMC cell imaging shared resource used in confocal studies (supported by NIH grants DK-20593, DK-58404, HD-15052, DK-59637 and EY-08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Benzing T, 2000, J BIOL CHEM, V275, P28167; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Chen TY, 2003, BIOCHEM BIOPH RES CO, V303, P1114, DOI 10.1016/S0006-291X(03)00482-0; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Ichimura T, 2002, BIOCHEMISTRY-US, V41, P5566, DOI 10.1021/bi015946f; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V262, P1, DOI 10.1006/bbrc.1999.1122; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lee AH, 2002, CELL MICROBIOL, V4, P739, DOI 10.1046/j.1462-5822.2002.00225.x; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sai JQ, 2004, J CELL SCI, V117, P5489, DOI 10.1242/jcs.01398; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Seroussi E, 1998, GENE, V212, P13, DOI 10.1016/S0378-1119(98)00098-5; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Takahashi K, 2006, J CELL PHYSIOL, V208, P213, DOI 10.1002/jcp.20657; Vroon A, 2007, EUR J PHARMACOL, V560, P9, DOI 10.1016/j.ejphar.2007.01.007; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	49	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23813	10.1371/journal.pone.0023813	http://dx.doi.org/10.1371/journal.pone.0023813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876773	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900045
J	Garcia-Serrano, L; Gomez-Ferreria, MA; Contreras-Jurado, C; Segrelles, C; Paramio, JM; Aranda, A				Garcia-Serrano, Laura; Ana Gomez-Ferreria, Maria; Contreras-Jurado, Constanza; Segrelles, Carmen; Paramio, Jesus M.; Aranda, Ana			The Thyroid Hormone Receptors Modulate the Skin Response to Retinoids	PLOS ONE			English	Article							KERATIN GENE-EXPRESSION; UNION-OF-PHARMACOLOGY; NUCLEAR RECEPTORS; EPIDERMAL TRANSGLUTAMINASE; TERMINAL DIFFERENTIATION; ACID TREATMENT; MICE; PROLIFERATION; TRANSCRIPTION; LORICRIN	Background: Retinoids play an important role in skin homeostasis and when administered topically cause skin hyperplasia, abnormal epidermal differentiation and inflammation. Thyroidal status in humans also influences skin morphology and function and we have recently shown that the thyroid hormone receptors (TRs) are required for a normal proliferative response to 12-O-tetradecanolyphorbol-13-acetate (TPA) in mice. Methodology/Principal findings: We have compared the epidermal response of mice lacking the thyroid hormone receptor binding isoforms TR alpha 1 and TR beta to retinoids and TPA. Reduced hyperplasia and a decreased number of proliferating cells in the basal layer in response to 9-cis-RA and TPA were found in the epidermis of TR-deficient mice. Nuclear levels of proteins important for cell proliferation were altered, and expression of keratins 5 and 6 was also reduced, concomitantly with the decreased number of epidermal cell layers. In control mice the retinoid (but not TPA) induced parakeratosis and diminished expression of keratin 10 and loricrin, markers of early and terminal epidermal differentiation, respectively. This reduction was more accentuated in the TR deficient animals, whereas they did not present parakeratosis. Therefore, TRs modulate both the proliferative response to retinoids and their inhibitory effects on skin differentiation. Reduced proliferation, which was reversed upon thyroxine treatment, was also found in hypothyroid mice, demonstrating that thyroid hormone binding to TRs is required for the normal response to retinoids. In addition, the mRNA levels of the pro-inflammatory cytokines TNF alpha and IL-6 and the chemotactic proteins S1008A and S1008B were significantly elevated in the skin of TR knock-out mice after TPA or 9-cis-RA treatment and immune cell infiltration was also enhanced. Conclusions/significance: Since retinoids are commonly used for the treatment of skin disorders, these results demonstrating that TRs regulate skin proliferation, differentiation and inflammation in response to these compounds could have not only physiological but also therapeutic implications.	[Garcia-Serrano, Laura; Ana Gomez-Ferreria, Maria; Contreras-Jurado, Constanza; Aranda, Ana] CSIC, Inst Invest Biomed, Madrid, Spain; [Garcia-Serrano, Laura; Ana Gomez-Ferreria, Maria; Contreras-Jurado, Constanza; Aranda, Ana] Univ Autonoma Madrid, Madrid, Spain; [Segrelles, Carmen; Paramio, Jesus M.] Ctr Invest Energt Medioambientales & Tecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Garcia-Serrano, L (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	aaranda@iib.uam.es	Paramio, Jesus M/M-8482-2014; Aranda, Ana/ABG-8820-2020; Segrelles, Carmen/E-3655-2016; Contreras-Jurado, Constanza/K-9028-2014	Paramio, Jesus M/0000-0001-7520-3177; Aranda, Ana/0000-0002-8338-9589; Segrelles, Carmen/0000-0001-9340-2102; Contreras-Jurado, Constanza/0000-0002-4578-801X	Ministerio de Ciencia e Innovacion [BFU2007-62402, SAF2008-00121]; Fondo de Investigaciones Sanitarias [RD06/0020/0036, RD06/0020/0029]; European Grant CRESCENDO [FP-018652]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European Grant CRESCENDO	This work was supported by grants BFU2007-62402 and SAF2008-00121 from Ministerio de Ciencia e Innovacion, RD06/0020/0036 and RD06/0020/0029 from the Fondo de Investigaciones Sanitarias and by the European Grant CRESCENDO (FP-018652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan Mohammad Kamrul, 1998, Journal of Medical Investigation, V44, P179; ANESKIEVICH BJ, 1992, MOL CELL BIOL, V12, P4862, DOI 10.1128/MCB.12.11.4862; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ASSELINEAU D, 1989, DEV BIOL, V133, P322, DOI 10.1016/0012-1606(89)90037-7; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; BLUMENBERG M, 1992, J INVEST DERMATOL, V98, pS42, DOI 10.1111/1523-1747.ep12462194; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Contreras-Jurado C, 2011, J BIOL CHEM, V286, P24079, DOI 10.1074/jbc.M111.218487; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Ghyselinck NB, 2002, ANN DERMATOL VENER, V129, P793; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Goyette P, 2000, J BIOL CHEM, V275, P16497, DOI 10.1074/jbc.M909382199; GRIFFITHS CEM, 1992, J INVEST DERMATOL, V99, P283, DOI 10.1111/1523-1747.ep12616626; GRIFFITHS RJ, 1988, AGENTS ACTIONS, V25, P344, DOI 10.1007/BF01965041; GSCHWENDT M, 1984, CANCER LETT, V25, P177, DOI 10.1016/S0304-3835(84)80043-9; HOHL D, 1991, J INVEST DERMATOL, V96, P414, DOI 10.1111/1523-1747.ep12469779; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; Jho SH, 2005, J INVEST DERMATOL, V124, P1034, DOI 10.1111/j.0022-202X.2005.23691.x; Jho SH, 2001, J BIOL CHEM, V276, P45914, DOI 10.1074/jbc.M103144200; Lee DD, 2009, J CELL PHYSIOL, V220, P427, DOI 10.1002/jcp.21784; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; MAGNALDO T, 1992, DIFFERENTIATION, V49, P39, DOI 10.1111/j.1432-0436.1992.tb00767.x; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; MOLLOY CJ, 1987, CANCER RES, V47, P4674; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; O'Shea PJ, 2002, J ENDOCRINOL, V175, P553, DOI 10.1677/joe.0.1750553; PARAMIO JM, 1994, EXP CELL RES, V215, P319, DOI 10.1006/excr.1994.1348; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Radoja N, 2004, MOL CELL BIOL, V24, P3168, DOI 10.1128/MCB.24.8.3168-3179.2004; Radoja N, 1997, J INVEST DERMATOL, V109, P566, DOI 10.1111/1523-1747.ep12337483; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; RAO TS, 1993, INFLAMMATION, V17, P723, DOI 10.1007/BF00920477; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; ROOP DR, 1987, DIFFERENTIATION, V35, P143, DOI 10.1111/j.1432-0436.1987.tb00162.x; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; ROSENTHAL DS, 1992, J INVEST DERMATOL, V98, P343, DOI 10.1111/1523-1747.ep12499802; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; THIBOUTOT DM, 1995, J CLIN ENDOCR METAB, V80, P3082, DOI 10.1210/jc.80.10.3082; TOMIC M, 1990, CELL REGUL, V1, P965, DOI 10.1091/mbc.1.12.965; TomicCanic M, 1996, J BIOL CHEM, V271, P1416, DOI 10.1074/jbc.271.3.1416; Varani J, 2003, ARCH DERMATOL RES, V295, P255, DOI 10.1007/s00403-003-0416-5; Varani J, 2008, ARCH DERMATOL RES, V300, P27, DOI 10.1007/s00403-007-0797-y; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011	63	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23825	10.1371/journal.pone.0023825	http://dx.doi.org/10.1371/journal.pone.0023825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858227	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300098
J	Lee, TS; Kantarjian, H; Ma, WL; Yeh, CH; Giles, F; Albitar, M				Lee, Tai-Sung; Kantarjian, Hagop; Ma, Wanlong; Yeh, Chen-Hsiung; Giles, Francis; Albitar, Maher			Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; RECEPTOR TYROSINE KINASES; MOLECULAR-DYNAMICS; THROMBOPOIETIN RECEPTOR; ERYTHROPOIETIN RECEPTOR; ACTIVE CONFORMATION; LIPID-MEMBRANES; ACTIVATION; JUXTAMEMBRANE; JAK2	Background: Mutations in the thrombopoietin receptor (MPL) may activate relevant pathways and lead to chronic myeloproliferative neoplasms (MPNs). The mechanisms of MPL activation remain elusive because of a lack of experimental structures. Modern computational biology techniques were utilized to explore the mechanisms of MPL protein activation due to various mutations. Results: Transmembrane (TM) domain predictions, homology modeling, ab initio protein structure prediction, and molecular dynamics (MD) simulations were used to build structural dynamic models of wild-type and four clinically observed mutants of MPL. The simulation results suggest that S505 and W515 are important in keeping the TM domain in its correct position within the membrane. Mutations at either of these two positions cause movement of the TM domain, altering the conformation of the nearby intracellular domain in unexpected ways, and may cause the unwanted constitutive activation of MPL's kinase partner, JAK2. Conclusions: Our findings represent the first full-scale molecular dynamics simulations of the wild-type and clinically observed mutants of the MPL protein, a critical element of the MPL-JAK2-STAT signaling pathway. In contrast to usual explanations for the activation mechanism that are based on the relative translational movement between rigid domains of MPL, our results suggest that mutations within the TM region could result in conformational changes including tilt and rotation (azimuthal) angles along the membrane axis. Such changes may significantly alter the conformation of the adjacent and intrinsically flexible intracellular domain. Hence, caution should be exercised when interpreting experimental evidence based on rigid models of cytokine receptors or similar systems.	[Lee, Tai-Sung] Rutgers State Univ, Dept Chem & Chem Biol, BioMaPS Inst, Piscataway, NJ 08854 USA; [Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ma, Wanlong; Yeh, Chen-Hsiung; Albitar, Maher] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA; [Giles, Francis] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA; [Giles, Francis] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Rutgers State University New Brunswick; University of Texas System; UTMD Anderson Cancer Center; Nichols Institute; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Lee, TS (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, BioMaPS Inst, Piscataway, NJ 08854 USA.	cancersimulation@gmail.com	Lee, Tai-Sung/HCH-7775-2022	Lee, Tai-Sung/0000-0003-2110-2279	National Science Foundation (NSF) through Ranger and the Kraken systems [TG-MCB100054]	National Science Foundation (NSF) through Ranger and the Kraken systems(National Science Foundation (NSF))	This research was supported by the National Science Foundation (NSF) through TeraGrid resources (the Ranger and the Kraken systems) under grant number TG-MCB100054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett M, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-41; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chaligne R, 2008, LEUKEMIA, V22, P1557, DOI 10.1038/leu.2008.137; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; DING J, 2009, BLOOD; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Drexler HG, 1996, LEUKEMIA, V10, P1405; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grotzinger J, 2002, BBA-MOL CELL RES, V1592, P215, DOI 10.1016/S0167-4889(02)00316-6; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Hubbard SR, 2009, CELL, V137, P1181, DOI 10.1016/j.cell.2009.06.008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kilpivaara O, 2008, LEUKEMIA, V22, P1813, DOI 10.1038/leu.2008.229; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018103; Lee TS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-58; Lee TS, 2009, J MOL BIOL, V388, P195, DOI 10.1016/j.jmb.2009.02.054; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Norman KE, 2006, BIOPHYS J, V91, P2046, DOI 10.1529/biophysj.105.080275; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pezet A, 1997, MOL CELL ENDOCRINOL, V129, P199, DOI 10.1016/S0303-7207(97)00063-4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schnittger S, 2009, HAEMATOL-HEMATOL J, V94, P141, DOI 10.3324/haematol.13224; Sebald W, 2010, FEBS J, V277, P106, DOI 10.1111/j.1742-4658.2009.07480.x; Shi L, 2009, BIOPHYS J, V96, P3648, DOI 10.1016/j.bpj.2009.02.025; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Tefferi A, 2008, LEUKEMIA LYMPHOMA, V49, P388, DOI 10.1080/10428190801895360; Tong W, 2007, EXP HEMATOL, V35, P1447, DOI 10.1016/j.exphem.2007.05.010; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ulmschneider MB, 2006, BIOPHYS J, V90, P1650, DOI 10.1529/biophysj.105.065367; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; Wendling F, 1998, EUR CYTOKINE NETW, V9, P221; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018	41	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23396	10.1371/journal.pone.0023396	http://dx.doi.org/10.1371/journal.pone.0023396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858098	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300042
J	Pierer, M; Wagner, U; Rossol, M; Ibrahim, S				Pierer, Matthias; Wagner, Ulf; Rossol, Manuela; Ibrahim, Saleh			Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced Arthritis in DBA1J Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; TLR4; RESPONSES; DISEASE; PATHOGENESIS; PROTEINS; DECTIN-1; CELLS	In rheumatoid arthritis, a significant proportion of cytokine and chemokine synthesis is attributed to innate immune mechanisms. TLR4 is a prominent innate receptor since several endogenous ligands known to activate the innate immune system bind to it and may thereby promote joint inflammation. We generated TLR4 deficient DBA1J mice by backcrossing the TLR4 mutation present in C3H/HeJ strain onto the DBA1J strain and investigated the course of collagen-induced arthritis in TLR4 deficient mice in comparison to wild type littermates. The incidence of collagen-induced arthritis was significantly lower in TLR4 deficient compared to wild type mice (59 percent vs. 100 percent). The severity of arthritis was reduced in the TLR4 deficient mice compared to wild type littermates (mean maximum score 2,54 vs. 6,25). Mice deficient for TLR4 were virtually protected from cartilage destruction, and infiltration of inflammatory cells was reduced compared to wt mice. In parallel to the decreased clinical severity, lower anti-CCP antibody concentrations and lower IL-17 concentrations were found in the TLR4 deficient mice. The study further supports the role of TLR4 in the propagation of joint inflammation and destruction. Moreover, since deficiency in TLR4 led to decreased IL-17 and anti-CCP antibody production, the results indicate a link between TLR4 stimulation and the adaptive autoimmune response. This mechanism might be relevant in human rheumatoid arthritis, possibly in response to activating endogenous ligands in the affected joints.	[Pierer, Matthias; Wagner, Ulf; Rossol, Manuela] Univ Leipzig, Dept Med 2, Rheumatol Sect, Leipzig, Germany; [Ibrahim, Saleh] Univ Lubeck, Dept Dermatol, Lubeck, Germany	Leipzig University; University of Lubeck	Pierer, M (corresponding author), Univ Leipzig, Dept Med 2, Rheumatol Sect, Leipzig, Germany.	matthias.pierer@medizin.uni-leipzig.de	Wagner, Ulf/F-4351-2016; Ibrahim, Saleh/AAO-9541-2020	Ibrahim, Saleh/0000-0001-7827-2290	Deutsche Forschungsgemeinschaft [Pi 624/1-2, IB 24/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft, grant number Pi 624/1-2 and IB 24/5-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Choe JY, 2003, J EXP MED, V197, P537, DOI 10.1084/jem.20021850; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; van de Veerdonk FLV, 2010, J LEUKOCYTE BIOL, V88, P227, DOI 10.1189/jlb.0809550; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	20	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23539	10.1371/journal.pone.0023539	http://dx.doi.org/10.1371/journal.pone.0023539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858160	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300058
J	Chaves, I; Nijman, RM; Biernat, MA; Bajek, MI; Brand, K; da Silva, AC; Saito, S; Yagita, K; Eker, APM; van der Horst, GTJ				Chaves, Ines; Nijman, Romana M.; Biernat, Magdalena A.; Bajek, Monika I.; Brand, Karl; da Silva, Antonio Carvalho; Saito, Shoko; Yagita, Kazuhiro; Eker, Andre P. M.; van der Horst, Gijsbertus T. J.			The Potorous CPD Photolyase Rescues a Cryptochrome-Deficient Mammalian Circadian Clock	PLOS ONE			English	Article							GENE-EXPRESSION; DNA PHOTOLYASE; TRANSCRIPTION; EVOLUTION; FAMILY; REPAIR; OSCILLATIONS; MECHANISMS; SIMILARITY; COMPONENTS	Despite the sequence and structural conservation between cryptochromes and photolyases, members of the cryptochrome/photolyase (flavo) protein family, their functions are divergent. Whereas photolyases are DNA repair enzymes that use visible light to lesion-specifically remove UV-induced DNA damage, cryptochromes act as photoreceptors and circadian clock proteins. To address the functional diversity of cryptochromes and photolyases, we investigated the effect of ectopically expressed Arabidopsis thaliana (6-4) PP photolyase and Potorous tridactylus CPD-photolyase (close and distant relatives of mammalian cryptochromes, respectively), on the performance of the mammalian cryptochromes in the mammalian circadian clock. Using photolyase transgenic mice, we show that Potorous CPD-photolyase affects the clock by shortening the period of behavioral rhythms. Furthermore, constitutively expressed CPD-photolyase is shown to reduce the amplitude of circadian oscillations in cultured cells and to inhibit CLOCK/BMAL1 driven transcription by interacting with CLOCK. Importantly, we show that Potorous CPD-photolyase can restore the molecular oscillator in the liver of (clock-deficient) Cry1/Cry2 double knockout mice. These data demonstrate that a photolyase can act as a true cryptochrome. These findings shed new light on the importance of the core structure of mammalian cryptochromes in relation to its function in the circadian clock and contribute to our further understanding of the evolution of the cryptochrome/photolyase protein family.	[Chaves, Ines; Nijman, Romana M.; Bajek, Monika I.; Brand, Karl; da Silva, Antonio Carvalho; Saito, Shoko; Eker, Andre P. M.; van der Horst, Gijsbertus T. J.] Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands; [Biernat, Magdalena A.] Wageningen Univ, Virol Lab, Wageningen, Netherlands; [Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Neurosci & Cell Biol, Kyoto, Japan	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Kyoto Prefectural University of Medicine	Chaves, I (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands.	i.chaves@erasmusmc.nl; g.vanderhorst@erasmusmc.nl	Chaves, Ines/L-3074-2015; van der Horst, Gijsbertus TJ/E-3661-2015	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Carvalho da Silva, Antonio Manuel/0000-0002-8017-104X	Netherlands Organization for Scientific Research [ZonMW Vici 918.36.619, NWO-CW 700.51.304, NWO-CW ECHO 700.57.012]; SenterNovem [Neuro-Bsik BSIK03053]; European Community [EUCLOCK LSHG-CT-2006-018741]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); SenterNovem; European Community(European Commission)	This work was supported in part by grants from the Netherlands Organization for Scientific Research (ZonMW Vici 918.36.619, NWO-CW 700.51.304, NWO-CW ECHO 700.57.012), SenterNovem (Neuro-Bsik BSIK03053) and the European Community (EUCLOCK LSHG-CT-2006-018741) to GTJvdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Eker APM, 2009, CELL MOL LIFE SCI, V66, P968, DOI 10.1007/s00018-009-8735-0; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; HOGAN B, 1994, MANIPULATING MOUSE E, P217; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jans J, 2006, MOL CELL BIOL, V26, P8515, DOI 10.1128/MCB.00807-06; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; RUSAK B, 1989, BRAIN RES, V493, P283, DOI 10.1016/0006-8993(89)91163-3; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schul W, 2002, EMBO J, V21, P4719, DOI 10.1093/emboj/cdf456; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Schalie EA, 2007, MOL CELL BIOL, V27, P2120, DOI 10.1128/MCB.01638-06; vanderSpek PJ, 1996, GENOMICS, V37, P177, DOI 10.1006/geno.1996.0539; Vanselow K, 2007, COLD SPRING HARB SYM, V72, P167, DOI 10.1101/sqb.2007.72.036; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	42	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23447	10.1371/journal.pone.0023447	http://dx.doi.org/10.1371/journal.pone.0023447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858120	gold, Green Published			2022-12-27	WOS:000294125500034
J	Jobke, B; Burghardt, AJ; Muche, B; Hahn, M; Semler, J; Amling, M; Majumdar, S; Busse, B				Jobke, Bjoern; Burghardt, Andrew J.; Muche, Burkhard; Hahn, Michael; Semler, Jutta; Amling, Michael; Majumdar, Sharmila; Busse, Bjoern			Trabecular Reorganization in Consecutive Iliac Crest Biopsies when Switching from Bisphosphonate to Strontium Ranelate Treatment	PLOS ONE			English	Article							BONE-MINERAL DENSITY; MICRO-COMPUTED-TOMOGRAPHY; POSTMENOPAUSAL WOMEN; CANCELLOUS BONE; NONVERTEBRAL FRACTURES; ALKALINE-PHOSPHATASE; PARATHYROID-HORMONE; VERTEBRAL FRACTURE; OSTEOPOROSIS; HISTOMORPHOMETRY	Background: Several agents are available to treat osteoporosis while addressing patient-specific medical needs. Individuals' residual risk to severe fracture may require changes in treatment strategy. Data at osseous cellular and microstructural levels due to a therapy switch between agents with different modes of action are rare. Our study on a series of five consecutively taken bone biopsies from an osteoporotic individual over a six-year period analyzes changes in cellular characteristics, bone microstructure and mineralization caused by a therapy switch from an antiresorptive (bisphosphonate) to a dual action bone agent (strontium ranelate). Methodology/Principal Findings: Biopsies were progressively taken from the iliac crest of a female patient. Four biopsies were taken during bisphosphonate therapy and one biopsy was taken after one year of strontium ranelate (SR) treatment. Furthermore, serum bone markers and dual x-ray absorptiometry measurements were acquired. Undecalcified histology was used to assess osteoid parameters and bone turnover. Structural indices and degree of mineralization were determined using microcomputed tomography, quantitative backscattered electron imaging, and combined energy dispersive x-ray/mu-x-ray-fluorescence microanalysis. Conclusions/Significance: Microstructural data revealed a notable increase in bone volume fraction after one year of SR treatment compared to the bisphosphonate treatment period. Indices of connectivity density, structure model index and trabecular bone pattern factor were predominantly enhanced indicating that the architectural transformation from trabecular rods to plates was responsible for the bone volume increase and less due to changes in trabecular thickness and number. Administration of SR following bisphosphonates led to a maintained mineralization profile with an uptake of strontium on the bone surface level. Reactivated osteoclasts designed tunneling, hook-like intratrabecular resorption sites. The appearance of tunneling resorption lacunae and the formation of both mini-modeling units and osteon-like structures within increased plate-like cancellous bone mass provides additional information on the mechanisms of strontium ranelate following bisphosphonate treatment, which may deserve special attention when monitoring a treatment switch.	[Jobke, Bjoern; Burghardt, Andrew J.; Majumdar, Sharmila] Univ Calif San Francisco, Dept Radiol, Musculoskeletal Quantitat Imaging Res Grp, San Francisco, CA 94143 USA; [Jobke, Bjoern] Helios Klinikum Berlin Buch, Inst Radiol, Berlin, Germany; [Muche, Burkhard; Semler, Jutta] Immanuel Hosp Berlin Wannsee, Dept Bone Metab & Osteol, Berlin, Germany; [Hahn, Michael; Amling, Michael; Busse, Bjoern] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Busse, Bjoern] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Helios Kliniken; University of Hamburg; University Medical Center Hamburg-Eppendorf; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jobke, B (corresponding author), Univ Calif San Francisco, Dept Radiol, Musculoskeletal Quantitat Imaging Res Grp, San Francisco, CA 94143 USA.	b.busse@uke.uni-hamburg.de	Busse, Björn/O-8462-2016; Busse, Björn/AAC-4033-2020; Burghardt, Andrew J/ABF-2691-2020	Busse, Björn/0000-0002-3099-8073; Busse, Björn/0000-0002-3099-8073; Burghardt, Andrew J/0000-0002-6343-4944; Muche, Burkhard/0000-0003-4104-5080				AMLING M, 1994, KIDNEY INT, V46, P733, DOI 10.1038/ki.1994.328; Amling M, 1996, J BONE MINER RES, V11, P36, DOI 10.1002/jbmr.5650110107; Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003; Bjeoumikhov A, 2005, X-RAY SPECTROM, V34, P493, DOI 10.1002/xrs.872; Blake GM, 2007, J CLIN DENSITOM, V10, P34, DOI 10.1016/j.jocd.2006.10.004; Blake GM, 2005, J BONE MINER RES, V20, P1901, DOI 10.1359/JBMR.050810; Boivin G, 2010, OSTEOPOROSIS INT, V21, P667, DOI 10.1007/s00198-009-1005-z; Bromage Timothy G., 2003, Anatomical Record, V274B, P157, DOI 10.1002/ar.b.10031; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Burghardt AJ, 2007, ANN BIOMED ENG, V35, P1678, DOI 10.1007/s10439-007-9344-4; Busse B, 2010, ACTA BIOMATER, V6, P4513, DOI 10.1016/j.actbio.2010.07.019; Busse B, 2010, AGING CELL, V9, P1065, DOI 10.1111/j.1474-9726.2010.00633.x; Busse B, 2010, J BIOMED MATER RES A, V92A, P1440, DOI 10.1002/jbm.a.32432; Chavassieux PM, 1997, J CLIN INVEST, V100, P1475, DOI 10.1172/JCI119668; Ding M, 2000, BONE, V26, P291, DOI 10.1016/S8756-3282(99)00281-1; Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4; Doube M, 2011, P ROYAL SCI B; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; DVO, 2011, OSTEOLOGIE, V20, P55; Ensrud KE, 2008, J BONE MINER RES, V23, P112, DOI 10.1359/JBMR.070904; Eriksen EF, 2002, BONE, V31, P620, DOI 10.1016/S8756-3282(02)00869-4; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Frost H M, 1983, Henry Ford Hosp Med J, V31, P3; Garnero P, 2001, CLIN CHEM, V47, P694; Garnero P, 1999, BONE, V24, P603, DOI 10.1016/S8756-3282(99)00087-3; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; GOMEZ B, 1995, CLIN CHEM, V41, P1560; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; HAHN M, 1991, VIRCHOWS ARCH A, V418, P1, DOI 10.1007/BF01600238; Hauge EM, 2001, BONE, V28, P556, DOI 10.1016/S8756-3282(01)00424-0; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Iki M, 2004, OSTEOPOROSIS INT, V15, P981, DOI 10.1007/s00198-004-1634-1; Jee W. S. S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P232; Jobke B, 2006, THESIS U MED CTR HAM; Jobke B, 2011, TERIPARATIDE BISPHOS, P1; KUFAHL RH, 1990, J BIOMECH, V23, P171, DOI 10.1016/0021-9290(90)90350-C; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Li CH, 2010, J BONE MINER RES, V25, P968, DOI 10.1359/jbmr.091038; Liao J, 2010, BONE, V47, P882, DOI 10.1016/j.bone.2010.08.005; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Liu XWS, 2006, J BONE MINER RES, V21, P1608, DOI 10.1359/JBMR.060716; Ma YFL, 2006, J BONE MINER RES, V21, P855, DOI 10.1359/JBMR.060314; Marx RE, 2007, J ORAL MAXIL SURG, V65, P2397, DOI 10.1016/j.joms.2007.08.003; Meunier PJ, 2009, OSTEOPOROSIS INT, V20, P1663, DOI 10.1007/s00198-008-0825-6; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Middleton ET, 2010, J BONE MINER RES, V25, P455, DOI 10.1359/jbmr.090821; Mulder L, 2004, ACTA RADIOL, V45, P769, DOI 10.1080/02841850410008171; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nielsen SP, 1999, J CLIN DENSITOM, V2, P371, DOI 10.1016/S1094-6950(06)60402-2; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; PARFITT AM, 1988, CALCIFIED TISSUE INT, V42, P284, DOI 10.1007/BF02556360; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patel V, 2003, J ORTHOP RES, V21, P6, DOI 10.1016/S0736-0266(02)00093-1; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; SATO K, 1981, CALCIFIED TISSUE INT, V33, P459, DOI 10.1007/BF02409474; Schafer AL, 2010, OSTEOPOROSIS INT, V21, P439, DOI 10.1007/s00198-009-0974-2; SCHNITZLER CM, 1990, BONE MINER, V10, P183, DOI 10.1016/0169-6009(90)90261-D; Sebba AI, 2004, CURR MED RES OPIN, V20, P2031, DOI 10.1185/030079904X16768; Seitz S, 2010, OSTEOPOROSIS INT, V21, P119, DOI 10.1007/s00198-009-0933-y; SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108; Stauber M, 2006, BONE, V38, P475, DOI 10.1016/j.bone.2005.09.019; Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; VEDI S, 1982, METAB BONE DIS RELAT, V4, P231, DOI 10.1016/0221-8747(82)90032-7; Watts NB, 2001, OSTEOPOROSIS INT, V12, P279, DOI 10.1007/s001980170117; Won YY, 2003, YONSEI MED J, V44, P811, DOI 10.3349/ymj.2003.44.5.811; WOODS CG, 1972, J PATHOL, V107, P137, DOI 10.1002/path.1711070210; Zikan V, 2009, BONE, V44, P634, DOI 10.1016/j.bone.2008.12.013	73	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23638	10.1371/journal.pone.0023638	http://dx.doi.org/10.1371/journal.pone.0023638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858188	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500038
J	Tavares, FN; Campos, RD; Burlandy, FM; Fontella, R; de Melo, MMM; da Costa, EV; da Silva, EE				Tavares, Fernando Neto; Campos, Renata de Mendonca; Burlandy, Fernanda Marcicano; Fontella, Rachel; Monte de Melo, Maria Mabel; da Costa, Eliane Veiga; da Silva, Edson Elias			Molecular Characterization and Phylogenetic Study of Coxsackievirus A24v Causing Outbreaks of Acute Hemorrhagic Conjunctivitis (AHC) in Brazil	PLOS ONE			English	Article							VARIANT; EPIDEMIC	Background: Coxsackievirus A24 variant (CA24v) is the most prevalent viral pathogen associated with acute hemorrhagic conjunctivitis (AHC) outbreaks. Sixteen years after its first outbreak in Brazil, this agent reemerged in 2003 in Brazil, spread to nearly all states and caused outbreaks until 2005. In 2009, a new outbreak occurred in the northeast region of the country. In this study, we performed a viral isolation in cell culture and characterized clinical samples collected from patients presenting symptoms during the outbreak of 2005 in Vitoria, Espirito Santo State (ES) and the outbreak of 2009 in Recife, Pernambuco State (PE). We also performed a phylogenetic analysis of worldwide strains and all meaningful Brazilian isolates since 2003. Methods and Findings: Sterile cotton swabs were used to collect eye discharges, and all 210 clinical samples were used to inoculate cell cultures. Cytopathic effects in HEp-2 cells were seen in 58 of 180 (32%) samples from Vitoria and 3 of 30 (10%) samples from Recife. Phylogenetic analysis based on a fragment of the VP1 and 3C gene revealed that the CA24v causing outbreaks in Brazil during the years 2003, 2004 and 2005 evolved from Asian isolates that had caused the South Korean outbreak of AHC during the summer of 2002. However, the 2009 outbreak of AHC in Pernambuco was originated from the reintroduction of a new CA24v strain that was circulating during 2007 in Asia, where CA24v outbreaks has been continuously reported since 1970. Conclusions: This study is the first phylogenetic analysis of AHC outbreaks caused by CA24v in Brazil. The results showed that Asian strains of CA24v were responsible for the outbreaks since 1987 and were independently introduced to Brazil in 2003 and 2009. Phylogenetic analysis of complete VP1 gene is a useful tool for studying the epidemiology of enteroviruses associated with outbreaks.	[Tavares, Fernando Neto; Campos, Renata de Mendonca; Burlandy, Fernanda Marcicano; da Costa, Eliane Veiga; da Silva, Edson Elias] Fiocruz MS, Inst Oswaldo Cruz, Lab Enterovirus, BR-21045900 Rio De Janeiro, Brazil; [Fontella, Rachel] Univ Fed Rio de Janeiro, Dept Genet, Lab Biol Evolut Teor & Aplicada, Rio De Janeiro, Brazil; [Monte de Melo, Maria Mabel] Lab Cent Saude Publ LACEN, Virol Lab, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Tavares, FN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Enterovirus, BR-21045900 Rio De Janeiro, Brazil.	edson@ioc.fiocruz.br	Azevedo, Renata/V-3130-2019		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministry of Health of Brazil (CGLAB/SVS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health of Brazil (CGLAB/SVS)	This work was partially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Ministry of Health of Brazil (CGLAB/SVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BRANDFUL JAM, 1990, E AFR MED J, V67, P878; Cabrerizo M, 2008, J CLIN VIROL, V43, P323, DOI 10.1016/j.jcv.2008.07.017; *CDCP, 1987, MMWR-MORBID MORTAL W, V36, P245; *CDCP, 1989, MMWR-MORBID MORTAL W, V38, P327; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P632; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P899; Dussart P, 2005, J MED VIROL, V75, P559, DOI 10.1002/jmv.20304; Finger C, 2003, LANCET, V361, P1714, DOI 10.1016/S0140-6736(03)13391-0; GHENDON Y, 1989, ACUTE HEMORRHAGIC CO, P3; Gopalkrishna V, 2007, J MED VIROL, V79, P748, DOI 10.1002/jmv.20886; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Ishiguru K., 1989, Annual Report of the Society of Plant Protection of North Japan, P11; Khan A, 2008, VIRUS RES, V137, P150, DOI 10.1016/j.virusres.2008.06.011; Kurokawa Manabu, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P904; Leveque N, 2007, EUR J CLIN MICROBIOL, V26, P199, DOI 10.1007/s10096-007-0265-9; LINHARES AC, 1989, ACUTE HEMORRHAGIC CO, P201; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; MIRKOVIC RR, 1974, INTERVIROLOGY, V4, P119, DOI 10.1159/000149850; Moura FEA, 2006, BRIT J OPHTHALMOL, V90, P1091, DOI 10.1136/bjo.2006.098822; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oh MD, 2003, EMERG INFECT DIS, V9, P1010; SANTOS ED, 1989, REV I MED TROP, V31, P183; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares FN, 2006, EMERG INFECT DIS, V12, P495, DOI 10.3201/eid1203.051173; Wu D, 2008, J MED VIROL, V80, P1762, DOI 10.1002/jmv.21288	27	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23206	10.1371/journal.pone.0023206	http://dx.doi.org/10.1371/journal.pone.0023206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858030	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500021
J	Cuadros, DF; Branscum, AJ; Garcia-Ramos, G				Cuadros, Diego F.; Branscum, Adam J.; Garcia-Ramos, Gisela			No Evidence of Association between HIV-1 and Malaria in Populations with Low HIV-1 Prevalence	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM MALARIA; CLINICAL EPISODES; RISK-FACTORS; 4 CITIES; INFECTION; TRANSMISSION; ADULTS; EPIDEMICS; SPREAD	Background: The geographic overlap between HIV-1 and malaria has generated much interest in their potential interactions. A variety of studies have evidenced a complex HIV-malaria interaction within individuals and populations that may have dramatic effects, but the causes and implications of this co-infection at the population level are still unclear. In a previous publication, we showed that the prevalence of malaria caused by the parasite Plasmodium falciparum is associated with HIV infection in eastern sub-Saharan Africa. To complement our knowledge of the HIV-malaria co-infection, the objective of this work was to assess the relationship between malaria and HIV prevalence in the western region of sub-Saharan Africa. Methodology/Principal Findings: Population-based cross-sectional data were obtained from the HIV/AIDS Demographic and Health Surveys conducted in Burkina Faso, Ghana, Guinea, Mali, Liberia and Cameroon, and the malaria atlas project. Using generalized linear mixed models, we assessed the relationship between HIV-1 and Plasmodium falciparum parasite rate (PfPR) adjusting for important socio-economic and biological cofactors. We found no evidence that individuals living in areas with stable malaria transmission (PfPR>0.46) have higher odds of being HIV-positive than individuals who live in areas with PfPR <= 0.46 in western sub-Saharan Africa (estimated odds ratio 1.14, 95% confidence interval 0.86-1.50). In contrast, the results suggested that PfPR was associated with being infected with HIV in Cameroon (estimated odds ratio 1.56, 95% confidence interval 1.23-2.00). Conclusion/Significance: Contrary to our previous research on eastern sub-Saharan Africa, this study did not identify an association between PfPR and infection with HIV in western sub-Saharan Africa, which suggests that malaria might not play an important role in the spread of HIV in populations where the HIV prevalence is low. Our work highlights the importance of understanding the epidemiologic effect of co-infection and the relevant factors involved in this relationship for the implementation of effective control strategies.	[Cuadros, Diego F.; Garcia-Ramos, Gisela] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Branscum, Adam J.] Oregon State Univ, Dept Publ Hlth, Corvallis, OR 97331 USA	University of Kentucky; Oregon State University	Cuadros, DF (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	dfcuad2@uky.edu						Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; [Anonymous], 2010, R LANG ENV STAT COMP; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Herrero MD, 2007, AIDS REV, V9, P88; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Idemyor V, 2007, HIV CLIN TRIALS, V8, P246, DOI 10.1310/hct0804-246; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2006, J INFECT DIS, V193, P1, DOI 10.1086/498581; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Renia L, 2006, PARASITE IMMUNOL, V28, P589, DOI 10.1111/j.1365-3024.2006.00903.x; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1093/IJE/DYQ1256; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23458	10.1371/journal.pone.0023458	http://dx.doi.org/10.1371/journal.pone.0023458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858127	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953500042
J	Lecours, PB; Duchaine, C; Taillefer, M; Tremblay, C; Veillette, M; Cormier, Y; Marsolais, D				Lecours, Pascale Blais; Duchaine, Caroline; Taillefer, Michel; Tremblay, Claudine; Veillette, Marc; Cormier, Yvon; Marsolais, David			Immunogenic Properties of Archaeal Species Found in Bioaerosols	PLOS ONE			English	Article							HYPERSENSITIVITY PNEUMONITIS; DENDRITIC CELLS; CONVENTIONAL LIPOSOMES; METHANOGENIC ARCHAEA; RESPIRATORY VIRUSES; IN-VIVO; INFLAMMATION; RESPONSES; ADJUVANT; ACTIVATION	The etiology of bioaerosol-related pulmonary diseases remains poorly understood. Recently, archaea emerged as prominent airborne components of agricultural environments, but the consequences of airway exposure to archaea remain unknown. Since subcomponents of archaea can be immunogenic, we used a murine model to study the pulmonary immune responses to two archaeal species found in agricultural facilities: Methanobrevibacter smithii (MBS) and Methanosphaera stadtmanae (MSS). Mice were administered intranasally with 6.25, 25 or 100 mu g of MBS or MSS, once daily, 3 days a week, for 3 weeks. MSS induced more severe histopathological alterations than MBS with perivascular accumulation of granulocytes, pronounced thickening of the alveolar septa, alveolar macrophages accumulation and increased perivascular mononucleated cell accumulation. Analyses of bronchoalveolar lavage fluids revealed up to 3 times greater leukocyte accumulation with MSS compared to MBS. Instillation of 100 mu g of MBS or MSS caused predominant accumulation of monocyte/macrophages (4.5 x 10(5) and 4.8 x 10(5) cells/ml respectively) followed by CD4(+) T cells (1.38 x 10(5) and 1.94 x 10(5) cells/ml respectively), B cells (0.73 x 10(5) and 1.28 x 10(5) cells/ml respectively), and CD8(+) T cells (0.20 x 10(5) and 0.31 x 10(5) cells/ml respectively) in the airways. Both archaeal species induced similar titers of antigen-specific IgGs in plasma. MSS but not MBS caused an accumulation of eosinophils and neutrophils in the lungs, which surprisingly, correlated inversely with the size of the inoculum. Stronger immunogenicity of MSS was confirmed by a 3 fold higher accumulation of myeloid dendritic cells in the airways, compared to MBS. Thus, the dose and species of archaea determine the magnitude and nature of the pulmonary immune response. This is the first report of an immunomodulatory role of archaeal species found in bioaerosols.	[Lecours, Pascale Blais; Duchaine, Caroline; Taillefer, Michel; Veillette, Marc; Cormier, Yvon; Marsolais, David] Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Duchaine, Caroline] Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Tremblay, Claudine] Serv Preclin, Labs Charles River, Montreal, PQ, Canada; [Cormier, Yvon; Marsolais, David] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Lecours, PB (corresponding author), Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	David.Marsolais@criucpq.ulaval.ca			Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST)/Canadian Centre for Health and Safety in Agriculture (CCHSA) [099-8640]; Respiratory Health Network of the Fonds de Recherche en Sante du Quebec; La chaire de pneumologie de la Fondation J-D Begin de l'Universite Laval; la Fondation de l'IUCPQ; department de medicine at Laval University	Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST)/Canadian Centre for Health and Safety in Agriculture (CCHSA); Respiratory Health Network of the Fonds de Recherche en Sante du Quebec; La chaire de pneumologie de la Fondation J-D Begin de l'Universite Laval; la Fondation de l'IUCPQ; department de medicine at Laval University	This study was funded by the Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST)/Canadian Centre for Health and Safety in Agriculture (CCHSA) (099-8640; www.irsst.qc.ca; www.cchsa-ccssma.usask.ca) (CD); Respiratory Health Network of the Fonds de Recherche en Sante du Quebec (http://rsr.chus.qc.ca) (DM, CD); and by La chaire de pneumologie de la Fondation J-D Begin de l'Universite Laval and la Fondation de l'IUCPQ (DM). PBL is a Canadian Institutes of Health Research Strategic Training Fellow in Public Health and the Agricultural Rural Ecosystem Training program (PHARE), and received research internship grant from Respiratory Health Network of the Fonds de Recherche en Sante du Quebec. MT has a scholarship from the department de medicine at Laval University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; *ATS, 1998, RESP HLTH HAZ AGR AM, pS1; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cayer MP, 2007, CAN J MICROBIOL, V53, P92, DOI 10.1139/W06-105; CHEN W, 2010, HUM VACCIN, V6; Cormier Y, 2000, EUR RESPIR J, V15, P560, DOI 10.1034/j.1399-3003.2000.15.22.x; Cormier Y, 2000, ARCH ENVIRON HEALTH, V55, P424, DOI 10.1080/00039890009604041; Dakhama A, 1999, AM J RESP CRIT CARE, V159, P1316, DOI 10.1164/ajrccm.159.4.9807085; *DEP HLTH HUM SERV, 2007, PUBL DHHS; DONHAM KJ, 1995, AM J IND MED, V27, P405, DOI 10.1002/ajim.4700270309; Dutil S, 2009, J OCCUP ENVIRON HYG, V6, P121, DOI 10.1080/15459620802633957; Gilbert Y, 2010, J OCCUP ENVIRON HYG, V7, P280, DOI 10.1080/15459621003680227; Girard M, 2009, ALLERGY, V64, P322, DOI 10.1111/j.1398-9995.2009.01949.x; Girard M, 2010, CURR OPIN ALLERGY CL, V10, P99, DOI 10.1097/ACI.0b013e3283373bb8; Gudmundsson G, 1997, J CLIN INVEST, V99, P2386, DOI 10.1172/JCI119420; HUET J, 1983, EMBO J, V2, P1291, DOI 10.1002/j.1460-2075.1983.tb01583.x; Israel-Assayag E, 1999, J IMMUNOL, V163, P6794; Kates M, 1992, Biochem Soc Symp, V58, P51; Krishnan L, 2000, INFECT IMMUN, V68, P54, DOI 10.1128/IAI.68.1.54-63.2000; Krishnan L, 2001, J IMMUNOL, V166, P1885, DOI 10.4049/jimmunol.166.3.1885; Krishnan L, 2008, VACCINE, V26, P2043, DOI 10.1016/j.vaccine.2008.02.026; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2000, J IMMUNOL, V164, P2937, DOI 10.4049/jimmunol.164.6.2937; LECOURS R, 1986, THORAX, V41, P924, DOI 10.1136/thx.41.12.924; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Nance S, 2004, EUR J IMMUNOL, V34, P677, DOI 10.1002/eji.200324634; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Patel GB, 2007, VACCINE, V25, P8622, DOI 10.1016/j.vaccine.2007.09.042; Patel GB, 2010, EXPERT REV VACCINES, V9, P431, DOI 10.1586/ERV.10.34; Poole JA, 2007, J ALLERGY CLIN IMMUN, V120, P366, DOI 10.1016/j.jaci.2007.04.033; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Sprott GD, 2003, METHOD ENZYMOL, V373, P155; Sprott GD, 1999, BBA-MOL CELL BIOL L, V1440, P275, DOI 10.1016/S1388-1981(99)00130-4; Tolson Douglas L., 1996, Journal of Liposome Research, V6, P755, DOI 10.3109/08982109609039925; Wang ZP, 1996, AM J RESP CRIT CARE, V154, P1261, DOI 10.1164/ajrccm.154.5.8912733; Whitehead TR, 1999, FEMS MICROBIOL LETT, V179, P223, DOI 10.1111/j.1574-6968.1999.tb08731.x; Wiley JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007142; Yamabe K, 2010, MOL ORAL MICROBIOL, V25, P112, DOI 10.1111/j.2041-1014.2009.00548.x; Yamabe K, 2008, FEMS MICROBIOL LETT, V287, P69, DOI 10.1111/j.1574-6968.2008.01304.x	42	39	39	9	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23326	10.1371/journal.pone.0023326	http://dx.doi.org/10.1371/journal.pone.0023326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858070	gold, Green Published			2022-12-27	WOS:000293953500030
J	Lim, CH; Hamazaki, T; Braun, EL; Wade, J; Terada, N				Lim, Chae Ho; Hamazaki, Takashi; Braun, Edward L.; Wade, Juli; Terada, Naohiro			Evolutionary Genomics Implies a Specific Function of Ant4 in Mammalian and Anole Lizard Male Germ Cells	PLOS ONE			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; MITOCHONDRIAL ADP/ATP CARRIER; ADP ATP TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; TISSUE DISTRIBUTION; MAXIMUM-LIKELIHOOD; DNA METHYLATION; GENE; SPERM; EXPRESSION	Most vertebrates have three paralogous genes with identical intron-exon structures and a high degree of sequence identity that encode mitochondrial adenine nucleotide translocase (Ant) proteins, Ant1 (Slc25a4), Ant2 (Slc25a5) and Ant3 (Slc25a6). Recently, we and others identified a fourth mammalian Ant paralog, Ant4 (Slc25a31), with a distinct intron-exon structure and a lower degree of sequence identity. Ant4 was expressed selectively in testis and sperm in adult mammals and was indeed essential for mouse spermatogenesis, but it was absent in birds, fish and frogs. Since Ant2 is X-linked in mammalian genomes, we hypothesized that the autosomal Ant4 gene may compensate for the loss of Ant2 gene expression during male meiosis in mammals. Here we report that the Ant4 ortholog is conserved in green anole lizard (Anolis carolinensis) and demonstrate that it is expressed in the anole testis. Further, a degenerate DNA fragment of putative Ant4 gene was identified in syntenic regions of avian genomes, indicating that Ant4 was present in the common amniote ancestor. Phylogenetic analyses suggest an even more ancient origin of the Ant4 gene. Although anole lizards are presumed male (XY) heterogametic, like mammals, copy numbers of the Ant2 as well as its neighboring gene were similar between male and female anole genomes, indicating that the anole Ant2 gene is either autosomal or located in the pseudoautosomal region of the sex chromosomes, in contrast to the case to mammals. These results imply the conservation of Ant4 is not likely simply driven by the sex chromosomal localization of the Ant2 gene and its subsequent inactivation during male meiosis. Taken together with the fact that Ant4 protein has a uniquely conserved structure when compared to other somatic Ant1, 2 and 3, there may be a specific advantage for mammals and lizards to express Ant4 in their male germ cells.	[Lim, Chae Ho; Hamazaki, Takashi; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32611 USA; [Braun, Edward L.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA; [Wade, Juli] Michigan State Univ, Neurosci Program, Dept Psychol, Dept Zool, E Lansing, MI 48824 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Michigan State University	Lim, CH (corresponding author), Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32611 USA.	terada@pathology.ufl.edu	wade, juli/F-4993-2012	Braun, Edward/0000-0003-1643-5212	University of Florida; NIH [HD060474]; NSF [IOS0742833]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060474] Funding Source: NIH RePORTER	University of Florida(University of Florida); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	C.H.L. is a recipient of University of Florida Alumni Fellowship. This work was supported in part by NIH grants HD060474 to N.T. and NSF grant IOS0742833 to J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, INFORM THEORY EXTENS, P267; Amiri H, 2003, J MOL EVOL, V56, P137, DOI 10.1007/s00239-002-2387-0; Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; Braun Edward L, 2003, Appl Bioinformatics, V2, P13; Braun EL, 2001, MOL BIOL EVOL, V18, P1401, DOI 10.1093/oxfordjournals.molbev.a003924; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; Brower JV, 2009, BBA-GENE REGUL MECH, V1789, P198, DOI 10.1016/j.bbagrm.2008.12.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cai XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003569; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; CECI JD, 1994, MAMM GENOME, V5, pS124; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Cueto MA, 2011, B MATH BIOL, V73, P1202, DOI 10.1007/s11538-010-9556-x; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Ellison JW, 1996, GENOMICS, V36, P369, DOI 10.1006/geno.1996.0478; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gorman G.C., 1973, P349; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Holland BR, 2003, SYST BIOL, V52, P229, DOI 10.1080/10635150390192771; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katsu Y, 2009, CYTOGENET GENOME RES, V127, P79, DOI 10.1159/000297715; KIERSZENBAUM AL, 2002, SPERMATOGENESIS HIST, P541; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Kimura M., 1983, NEUTRAL THEORY MOL E; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lin YH, 2002, MOL BIOL EVOL, V19, P2060, DOI 10.1093/oxfordjournals.molbev.a004031; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; LUNARDI J, 1992, J BIOL CHEM, V267, P15267; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MEISEL RP, 2011, MOL BIOL EV IN PRESS; Mentel M, 2005, MOL GENET GENOMICS, V273, P84, DOI 10.1007/s00438-005-1107-z; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Miura I, 1998, MOL BIOL EVOL, V15, P1612, DOI 10.1093/oxfordjournals.molbev.a025889; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rodic N, 2005, STEM CELLS, V23, P1314, DOI 10.1634/stemcells.2005-0119; Rolland AD, 2011, BIOL REPROD, V84, P790, DOI 10.1095/biolreprod.110.088443; SABOVA L, 1993, EUR J BIOCHEM, V213, P547, DOI 10.1111/j.1432-1033.1993.tb17793.x; Sassi SO, 2007, MOL BIOL EVOL, V24, P1012, DOI 10.1093/molbev/msm020; Smith CP, 2008, GENETICS, V179, P1285, DOI 10.1534/genetics.108.087700; Spinks PQ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-56; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suarez SS, 2003, CELL MOL BIOL, V49, P351; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Varriale A, 2006, GENE, V385, P122, DOI 10.1016/j.gene.2006.05.034; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	68	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23122	10.1371/journal.pone.0023122	http://dx.doi.org/10.1371/journal.pone.0023122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858006	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500021
J	Bridle, A; Nosworthy, E; Polinski, M; Nowak, B				Bridle, Andrew; Nosworthy, Elizabeth; Polinski, Mark; Nowak, Barbara			Evidence of an Antimicrobial-Immunomodulatory Role of Atlantic Salmon Cathelicidins during Infection with Yersinia ruckeri	PLOS ONE			English	Article							RAINBOW-TROUT; ANTIBACTERIAL PEPTIDES; KERATINOCYTE MIGRATION; GENE-EXPRESSION; SKIN; IDENTIFICATION; LL-37; RECEPTOR; FAMILY; LIPOPOLYSACCHARIDE	Cathelicidins are a family of antimicrobial peptides that act as effector molecules of the innate immune system with broad-spectrum antimicrobial properties. These evolutionary conserved cationic host-defence peptides are integral components of the immune response of fish, which are generally believed to rely heavily on innate immune defences to invading pathogens. In this study we showed that Atlantic salmon cathelicidin 1 and 2 (asCATH1 and asCATH2) stimulated peripheral blood leukocytes increasing the transcription of the chemokine interleukin-8. Further, functional differences were identified between the two cathelicidins. In the presence of serum, asCATH1 displayed greatly diminished host haemolytic activity, while the constitutively expressed asCATH2 had no haemolytic activity with or without serum. These findings support our hypothesis that fish cathelicidins exert their primary antimicrobial action at the site of pathogen invasion such as epithelial surfaces. Further, we hypothesise that like their mammalian counterparts in the presence of serum they act as mediators of the innate and adaptive immune response via the release of cytokines thus indirectly protecting against a variety of pathogens. We highlight the importance of this immunomodulatory role from the involvement of asCATHs during an infection with the fish pathogen Yersinia ruckeri. While we were able to demonstrate in vitro that asCATH1 and 2, possessed direct microbicidal activity against the fish pathogen, Vibrio anguillarum, and a common gram negative bacterium, Escherichia coli, little or no bactericidal activity was found against Y. ruckeri. The contribution of either asCATH in the immune response or as a potential virulence factor during yersiniosis is highlighted from the increased expression of asCATH1 and 2 mRNA during an in vivo challenge with Y. ruckeri. We propose that Atlantic salmon cathelicidins participate in the interplay between the innate and adaptive immune systems via the release of cytokines enabling a more effective response to invading pathogens.	[Bridle, Andrew; Nosworthy, Elizabeth; Polinski, Mark; Nowak, Barbara] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Hobart, Tas 7001, Australia	University of Tasmania	Bridle, A (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Hobart, Tas 7001, Australia.	Andrew.Bridle@utas.edu.au	Bridle, Andrew/B-4117-2013; Nowak, Barbara/J-7261-2014	Nowak, Barbara/0000-0002-0347-643X; Polinski, Mark/0000-0001-7237-3808; Bridle, Andrew/0000-0002-5788-1297	Australian Research Council [LP0883880]	Australian Research Council(Australian Research Council)	This research was supported under Australian Research Council's Linkage Projects funding scheme (project number LP0883880). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 1999, J CLIN INVEST, V103, P1113, DOI 10.1172/JCI6570; Basanez G, 2002, FEBS LETT, V532, P115, DOI 10.1016/S0014-5793(02)03651-7; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bowdish DME, 2004, J IMMUNOL, V172, P3758, DOI 10.4049/jimmunol.172.6.3758; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Caipang CMA, 2010, COMP BIOCHEM PHYS B, V156, P319, DOI 10.1016/j.cbpb.2010.04.009; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Carson J., 2009, YERSINIOSIS FISH, P1; Casadei E, 2009, MOL IMMUNOL, V46, P3358, DOI 10.1016/j.molimm.2009.07.018; Castaneda-Delgado J, 2010, CLIN EXP IMMUNOL, V161, P542, DOI 10.1111/j.1365-2249.2010.04199.x; Chang CI, 2006, ANTIMICROB AGENTS CH, V50, P185, DOI 10.1128/AAC.50.1.185-195.2006; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Dawson RM, 2009, DRUG DEVELOP RES, V70, P481, DOI 10.1002/ddr.20329; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Feng CY, 2009, PHYSIOL GENOMICS, V37, P149, DOI 10.1152/physiolgenomics.90373.2008; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Maier VH, 2008, MOL IMMUNOL, V45, P2352, DOI 10.1016/j.molimm.2007.11.008; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; OTVOS L, 2007, BROTH MICRODILUTION, P309; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Rajanbabu V, 2011, PEPTIDES, V32, P415, DOI 10.1016/j.peptides.2010.11.005; Ramanathan B, 2002, MICROBES INFECT, V4, P361, DOI 10.1016/S1286-4579(02)01549-6; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Ruckner R. R., 1966, Bulletin Office International des Epizooties, V65, P825; Scocchi M, 2009, COMP BIOCHEM PHYS B, V152, P376, DOI 10.1016/j.cbpb.2009.01.003; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2009, DIS AQUAT ORGAN, V84, P219, DOI 10.3354/dao02057; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wu H, 2000, INFECT IMMUN, V68, P5552, DOI 10.1128/IAI.68.10.5552-5558.2000; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yahata Y, 2006, J BIOL CHEM, V281, P13209, DOI 10.1074/jbc.M509771200; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yu K, 2002, J PEPT RES, V60, P1, DOI 10.1034/j.1399-3011.2002.01968.x; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; ZANETTI M, 1993, J BIOL CHEM, V268, P522; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008	61	68	72	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23417	10.1371/journal.pone.0023417	http://dx.doi.org/10.1371/journal.pone.0023417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858109	Green Submitted, Green Published, gold			2022-12-27	WOS:000293774300035
J	Raberto, M; Rapallo, F; Scalas, E				Raberto, Marco; Rapallo, Fabio; Scalas, Enrico			Semi-Markov Graph Dynamics	PLOS ONE			English	Article							WAITING-TIMES; NETWORKS	In this paper, we outline a model of graph (or network) dynamics based on two ingredients. The first ingredient is a Markov chain on the space of possible graphs. The second ingredient is a semi-Markov counting process of renewal type. The model consists in subordinating the Markov chain to the semi-Markov counting process. In simple words, this means that the chain transitions occur at random time instants called epochs. The model is quite rich and its possible connections with algebraic geometry are briefly discussed. Moreover, for the sake of simplicity, we focus on the space of undirected graphs with a fixed number of nodes. However, in an example, we present an interbank market model where it is meaningful to use directed graphs or even weighted graphs.	[Raberto, Marco] Univ Genoa, Dipartimento Ingn Biofis & Elettron, Genoa, Italy; [Rapallo, Fabio; Scalas, Enrico] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate, Alessandria, Italy; [Scalas, Enrico] Basque Ctr Appl Math, Bizkaia Technology Pk, Derio, Spain	University of Genoa; University of Eastern Piedmont Amedeo Avogadro; Basque Center for Applied Mathematics (BCAM)	Raberto, M (corresponding author), Univ Genoa, Dipartimento Ingn Biofis & Elettron, Genoa, Italy.	enrico.scalas@mfn.unipmn.it	Raberto, Marco/F-7990-2012; Rapallo, Fabio/AAD-8204-2021	Rapallo, Fabio/0000-0001-6451-5140; Scalas, Enrico/0000-0002-1516-9285	INdAM (Istituto Italiano di Alta Matematica); Erasmus Teaching Staff program; Universitat Jaume I, Castellon de La Plana, Spain	INdAM (Istituto Italiano di Alta Matematica); Erasmus Teaching Staff program; Universitat Jaume I, Castellon de La Plana, Spain	This study was funded in part by the INdAM (Istituto Italiano di Alta Matematica http://www.altamatematica.it/en), by the Erasmus Teaching Staff program, and the Research Promotion Plan 2010 of Universitat Jaume I, Castellon de La Plana, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi A.-L., 2010, BURSTS HIDDEN PATTER; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2003, LINKED EVERHTHING CO; Beghin L, 2009, ELECTRON J PROBAB, V14, P1790, DOI 10.1214/EJP.v14-675; Biggs N., 1993, ALGEBRAIC GRAPH THEO; Billingsley P., 1995, PROBABILITY MEASURE; Chung FRK, 1997, CBMS REGIONAL C S MA; Cinlar E., 1975, INTRO STOCHASTIC PRO; Drton M., 2009, LECT ALGEBRAIC STAT; Durrett Richard, 2007, RANDOM GRAPH DYNAMIC; Flomenbom O, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041101; Flomenbom O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098105; Fulger D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021122; Garibaldi U., 2010, FINITARY PROBABILIST, DOI DOI 10.1017/CBO9780511777585; Gentleman R, 2010, GRAPH PACKAGE; Germano G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066102; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Howard R.A, 1971, DYNAMIC PROBABILISTI, V2; Janssen J., 2007, SEMIMARKOV RISK MODE; Laskin N, 2003, COMMUN NONLINEAR SCI, V8, P201, DOI 10.1016/S1007-5704(03)00037-6; Mainardi F, 2004, VIETN J MATH, V32, P53; Meerschaert MM, 2010, ELECT J PRO IN PRESS; MILGRAM S, 1967, PSYCHOL TODAY, V2, P60, DOI DOI 10.1145/335305.335325; Rapallo F, 2006, J SYMB COMPUT, V41, P164, DOI 10.1016/j.jsc.2005.04.002; Rapallo F, 2010, ANN I STAT MATH, V62, P785, DOI 10.1007/s10463-010-0289-2; Saa A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031110; Scalas E, 2004, QUANT FINANC, V4, P695, DOI 10.1080/14697680500040413; Scalas E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011107; Scalas E, 2006, PHYSICA A, V366, P463, DOI 10.1016/j.physa.2005.09.047; Schrijver A, 2003, LECT NOTES COMPUT SC, V2880, P13; SIMON HA, 1955, BIOMETRIKA, V42, P425; Team RDC, 2010, R LANG ENV STAT COMP; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	34	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23370	10.1371/journal.pone.0023370	http://dx.doi.org/10.1371/journal.pone.0023370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887245	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000295832000015
J	Tsuge, M; Fujimoto, Y; Hiraga, N; Zhang, YZ; Ohnishi, M; Kohno, T; Abe, H; Miki, D; Imamura, M; Takahashi, S; Ochi, H; Hayes, CN; Miya, F; Tsunoda, T; Chayama, K				Tsuge, Masataka; Fujimoto, Yoshifumi; Hiraga, Nobuhiko; Zhang, Yizhou; Ohnishi, Mayu; Kohno, Tomohiko; Abe, Hiromi; Miki, Daiki; Imamura, Michio; Takahashi, Shoichi; Ochi, Hidenori; Hayes, C. Nelson; Miya, Fuyuki; Tsunoda, Tatsuhiko; Chayama, Kazuaki			Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; CORE PROTEIN; PEGYLATED-INTERFERON; B-VIRUS; HEPATOCELLULAR-CARCINOMA; PLUS RIBAVIRIN; COMBINATION THERAPY; CYTIDINE DEAMINASE; GENETIC-VARIATION; TRANSGENIC MICE	Background and Aims: Recent studies indicate that hepatitis C virus (HCV) can modulate the expression of various genes including those involved in interferon signaling, and up-regulation of interferon-stimulated genes by HCV was reported to be strongly associated with treatment outcome. To expand our understanding of the molecular mechanism underlying treatment resistance, we analyzed the direct effects of interferon and/or HCV infection under immunodeficient conditions using cDNA microarray analysis of human hepatocyte chimeric mice. Methods: Human serum containing HCV genotype 1b was injected into human hepatocyte chimeric mice. IFN-alpha was administered 8 weeks after inoculation, and 6 hours later human hepatocytes in the mouse livers were collected for microarray analysis. Results: HCV infection induced a more than 3-fold change in the expression of 181 genes, especially genes related to Organismal Injury and Abnormalities, such as fibrosis or injury of the liver (P = 5.90E-16 similar to 3.66E-03). IFN administration induced more than 3-fold up-regulation in the expression of 152 genes. Marked induction was observed in the anti-fibrotic chemokines such as CXCL9, suggesting that IFN treatment might lead not only to HCV eradication but also prevention and repair of liver fibrosis. HCV infection appeared to suppress interferon signaling via significant reduction in interferon-induced gene expression in several genes of the IFN signaling pathway, including Mx1, STAT1, and several members of the CXCL and IFI families (P = 6.0E-12). Genes associated with Antimicrobial Response and Inflammatory Response were also significantly repressed (P = 5.22x10(-10) similar to 1.95x10(-2)). Conclusions: These results provide molecular insights into possible mechanisms used by HCV to evade innate immune responses, as well as novel therapeutic targets and a potential new indication for interferon therapy.	[Tsuge, Masataka; Fujimoto, Yoshifumi; Hiraga, Nobuhiko; Zhang, Yizhou; Ohnishi, Mayu; Kohno, Tomohiko; Abe, Hiromi; Miki, Daiki; Imamura, Michio; Takahashi, Shoichi; Ochi, Hidenori; Hayes, C. Nelson; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Programs Biomed Res,Div Frontier Med Sci, Hiroshima, Japan; [Tsuge, Masataka] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Tsuge, Masataka; Hiraga, Nobuhiko; Zhang, Yizhou; Ohnishi, Mayu; Kohno, Tomohiko; Abe, Hiromi; Miki, Daiki; Imamura, Michio; Takahashi, Shoichi; Ochi, Hidenori; Hayes, C. Nelson; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Fujimoto, Yoshifumi] Hiroshima Gen Hosp, Dept Internal Med 4, Hatsukaichi, Japan; [Miki, Daiki; Ochi, Hidenori; Chayama, Kazuaki] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Liver Dis, Hiroshima, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Yokohama, Kanagawa, Japan	Hiroshima University; Hiroshima University; Hiroshima University; RIKEN; RIKEN	Tsuge, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Programs Biomed Res,Div Frontier Med Sci, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; Hayes, C. Nelson N/G-4596-2019; Tsuge, Masataka/G-5246-2019; Chayama, Kazuaki/B-2493-2016; Abe-Chayama, Hiromi/M-8256-2019; Miki, Daiki/L-5069-2018	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tsuge, Masataka/0000-0001-7591-8287; Miki, Daiki/0000-0002-6505-9826; Miya, Fuyuki/0000-0001-6758-2015; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Sports, Culture and Technology; Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [22659147] Funding Source: KAKEN	Ministry of Education, Sports, Culture and Technology; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Ministry of Education, Sports, Culture and Technology and Ministry of Health, Labor and Welfare (Grants-in-Aid for scientific research and development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2004, J HEPATOL, V40, P831, DOI 10.1016/j.jhep.2004.01.019; Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2007, INTERVIROLOGY, V50, P361, DOI 10.1159/000107707; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Caillot F, 2009, WORLD J GASTROENTERO, V15, P300, DOI 10.3748/wjg.15.300; Caillot F, 2009, AM J PATHOL, V175, P46, DOI 10.2353/ajpath.2009.080850; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hiraga N, 2007, FEBS LETT, V581, P1983, DOI 10.1016/j.febslet.2007.04.021; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hoofnagle JH, 2003, HEPATOLOGY, V38, P66, DOI 10.1053/jhep.2003.50258; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kimura T, 2008, J GEN VIROL, V89, P2108, DOI 10.1099/vir.0.83658-0; Kitamura S, 2010, ANTIVIR THER, V15, P1087, DOI 10.3851/IMP1674; Komohara Y, 2006, J MOL HISTOL, V37, P327, DOI 10.1007/s10735-006-9059-0; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lee SH, 2005, J IMMUNOL, V175, P8226, DOI 10.4049/jimmunol.175.12.8226; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 2001, CANCER RES, V61, P4365; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Noguchi C, 2007, J GEN VIROL, V88, P432, DOI 10.1099/vir.0.82319-0; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SEZAKI H, 2008, DIG DIS SCI; Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Toh PPC, 2010, EXP DERMATOL, V19, P987, DOI 10.1111/j.1600-0625.2010.01124.x; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	62	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23856	10.1371/journal.pone.0023856	http://dx.doi.org/10.1371/journal.pone.0023856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886832	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500034
J	You, XJ; Xu, C; Lu, JQ; Zhu, XY; Gao, L; Cui, XR; Li, Y; Gu, H; Ni, X				You, Xing-Ji; Xu, Chen; Lu, Jian-Qiang; Zhu, Xiao-Yan; Gao, Lu; Cui, Xiao-Rui; Li, Yuan; Gu, Hang; Ni, Xin			Expression of Cystathionine beta-synthase and Cystathionine gamma-lyase in Human Pregnant Myometrium and Their Roles in the Control of Uterine Contractility	PLOS ONE			English	Article							SMOOTH-MUSCLE RELAXANT; HYDROGEN-SULFIDE; L-CYSTEINE; IN-VITRO; H2S; MEDIATOR; PRETERM; TISSUES; CELLS; LABOR	Background: Human uterus undergoes distinct molecular and functional changes during pregnancy and parturition. Hydrogen sulfide (H2S) has recently been shown to play a key role in the control of smooth muscle tension. The role of endogenous H2S produced locally in the control of uterine contractility during labour is unknown. Methodology/Principal Findings: Human myometrium biopsies were obtained from pregnant women undergoing cesarean section at term. Immunohistochemistry analysis showed that cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthetase (CBS), the principle enzymes responsible for H2S generation, were mainly localized to smooth muscle cells of human pregnant myometrium. The mRNA and protein expression of CBS as well as H2S production rate were down-regulated in labouring tissues compared to nonlabouring tissues. Cumulative administration of L-cysteine (10(-7) - 10(-2) mol/L), a precursor of H2S, caused a dose-dependent decrease in the amplitude of spontaneous contractions in nonlabouring and labouring myometrium strips. L-cysteine at high concentration (10(-3) mol/L) increased the frequency of spontaneous contractions and induced tonic contraction. These effects of L-cysteine were blocked by the inhibitors of CBS and CSE. Pre-treatment of myometrium strips with glibenclamide, an inhibitor of ATP-sensitive potassium (K-ATP) channels, abolished the inhibitory effect of L-cysteine on spontaneous contraction amplitude. The effects of L-cysteine on the amplitude of spontaneous contractions and baseline muscle tone were less potent in labouring tissues than that in nonlabouring strips. Conclusion/Significance: H2S generated by CSE and CBS locally exerts dual effects on the contractility of pregnant myometrium. Expression of H2S synthetic enzymes is down-regulated during labour, suggesting that H2S is one of the factors involved in the transition of pregnant uterus from quiescence to contractile state after onset of parturition.	[You, Xing-Ji; Xu, Chen; Zhu, Xiao-Yan; Gao, Lu; Ni, Xin] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Cui, Xiao-Rui; Li, Yuan; Gu, Hang] Second Mil Med Univ, Changhai Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Lu, Jian-Qiang] Shanghai Univ Sports, Dept Biomech, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Shanghai University of Sport	You, XJ (corresponding author), Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China.	nxljq2003@yahoo.com.cn	Xingji, You/GQY-5030-2022		National Natural Science Foundation of China [30811120433, 30971090]; Science and Technology Commission of Shanghai Municipals [09XD1405600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipals	This work is supported by National Natural Science Foundation of China No. 30811120433 and No. 30971090 and Science and Technology Commission of Shanghai Municipals (09XD1405600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle S, 2007, MOL HUM REPROD, V13, P69, DOI 10.1093/molehr/gal093; AWATA S, 1995, BIOCHEM MOL BIOL INT, V35, P1331; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bhatia M, 2005, IUBMB LIFE, V57, P603, DOI 10.1080/15216540500217875; Bianca RDD, 2009, P NATL ACAD SCI USA, V106, P4513, DOI 10.1073/pnas.0807974105; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Havelock OC, 2005, BIOL REPROD, V72, P707, DOI 10.1095/biolreprod.104.032979; Hay A, 2010, MOL HUM REPROD, V16, P752, DOI 10.1093/molehr/gaq046; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Kubo S, 2007, J PHARMACOL SCI, V104, P392, DOI 10.1254/jphs.SC0070199; Lim JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1261, DOI 10.1152/ajpcell.00195.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowicka E, 2007, PHARMACOL REP, V59, P4; Mazloum-Ardakani M, 2010, J IRAN CHEM SOC, V7, P251, DOI 10.1007/BF03245886; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Raoof JB, 2007, ELECTROANAL, V19, P1822, DOI 10.1002/elan.200703932; Sidhu R, 2001, PHARMACOL TOXICOL, V88, P198, DOI 10.1034/j.1600-0773.2001.d01-104.x; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Tapley DW, 1999, BIOL BULL, V196, P52, DOI 10.2307/1543166; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu XY, 2010, CELL MOL LIFE SCI, V67, P1119, DOI 10.1007/s00018-009-0250-9	33	42	47	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23788	10.1371/journal.pone.0023788	http://dx.doi.org/10.1371/journal.pone.0023788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886822	Green Submitted, Green Published, gold			2022-12-27	WOS:000294253500030
J	Elhaik-Goldman, S; Kafka, D; Yossef, R; Hadad, U; Elkabets, M; Vallon-Eberhard, A; Hulihel, L; Jung, S; Ghadially, H; Braiman, A; Apte, RN; Mandelboim, O; Dagan, R; Mizrachi-Nebenzahl, Y; Porgador, A				Elhaik-Goldman, Shirin; Kafka, Daniel; Yossef, Rami; Hadad, Uzi; Elkabets, Moshe; Vallon-Eberhard, Alexandra; Hulihel, Luai; Jung, Steffen; Ghadially, Hormas; Braiman, Alex; Apte, Ron N.; Mandelboim, Ofer; Dagan, Ron; Mizrachi-Nebenzahl, Yaffa; Porgador, Angel			The Natural Cytotoxicity Receptor 1 Contribution to Early Clearance of Streptococcus pneumoniae and to Natural Killer-Macrophage Cross Talk	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INNATE IMMUNE-RESPONSE; HUMAN NK CELLS; PNEUMOCOCCAL PNEUMONIA; INTERFERON-GAMMA; DENDRITIC CELLS; INFLUENZA INFECTION; T-CELLS; NKP46; DEFENSE	Natural killer (NK) cells serve as a crucial first line of defense against tumors, viral and bacterial infections. We studied the involvement of a principal activating natural killer cell receptor, natural cytotoxicity receptor 1 (NCR1), in the innate immune response to S. pneumoniae infection. Our results demonstrate that the presence of the NCR1 receptor is imperative for the early clearance of S. pneumoniae. We tied the ends in vivo by showing that deficiency in NCR1 resulted in reduced lung NK cell activation and lung IFN gamma production at the early stages of S. pneumoniae infection. NCR1 did not mediate direct recognition of S. pneumoniae. Therefore, we studied the involvement of lung macrophages and dendritic cells (DC) as the mediators of NK-expressed NCR1 involvement in response to S. pneumoniae. In vitro, wild type BM-derived macrophages and DC expressed ligands to NCR1 and co-incubation of S. pneumoniae-infected macrophages/DC with NCR1-deficient NK cells resulted in significantly lesser IFN gamma levels compared to NCR1-expressing NK cells. In vivo, ablation of lung macrophages and DC was detrimental to the early clearance of S. pneumoniae. NCR1-expressing mice had more potent alveolar macrophages as compared to NCR1-deficient mice. This result correlated with the higher fraction of NCR1-ligand(high) lung macrophages, in NCR1-expressing mice, that had better phagocytic activity compared to NCR1-ligand(dull) macrophages. Overall, our results point to the essential contribution of NK-expressed NCR1 in early response to S. pneumoniae infection and to NCR1-mediated interaction of NK and S. pneumoniae infected-macrophages and -DC.	[Elhaik-Goldman, Shirin; Kafka, Daniel; Yossef, Rami; Hadad, Uzi; Elkabets, Moshe; Hulihel, Luai; Braiman, Alex; Apte, Ron N.; Mizrachi-Nebenzahl, Yaffa; Porgador, Angel] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Elhaik-Goldman, Shirin; Kafka, Daniel; Yossef, Rami; Hadad, Uzi; Elkabets, Moshe; Hulihel, Luai; Braiman, Alex; Apte, Ron N.; Mizrachi-Nebenzahl, Yaffa; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Elhaik-Goldman, Shirin; Kafka, Daniel; Dagan, Ron; Mizrachi-Nebenzahl, Yaffa] Ben Gurion Univ Negev, Pediat Infect Dis Unit, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Vallon-Eberhard, Alexandra; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ghadially, Hormas; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Weizmann Institute of Science; Hebrew University of Jerusalem	Elhaik-Goldman, S (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	angel@bgu.ac.il	Braiman, Alex/F-2179-2012; Yossef, Rami/K-5740-2019; Jung, Steffen/K-1409-2012; Yoseph, Rami/L-6823-2019; Mizrachi Nebenzahl, Yaffa/F-1657-2012; elkabets, moshe/R-6822-2019; Braiman, Alex/ABC-3482-2021	Braiman, Alex/0000-0003-2802-1148; Jung, Steffen/0000-0003-4290-5716; Braiman, Alex/0000-0003-2802-1148; Mandelboim, Ofer/0000-0002-9354-1855; Porgador, Angel/0000-0003-1540-4449	Croatia-Israel research grant; Israeli Ministry of Health [4476, 5540, 3000003867]	Croatia-Israel research grant; Israeli Ministry of Health	This work was supported by a joint Croatia-Israel research grant (AP). This work was also supported by the Israeli Ministry of Health, 4476, 5540 and 3000003867 (YMN). The Israel Academy of Science, 613/04 (YMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Blue CE, 2003, INFECT IMMUN, V71, P4925, DOI 10.1128/IAI.71.9.4925-4935.2003; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Cundell D, 1995, CLIN INFECT DIS, V21, pS204, DOI 10.1093/clind/21.Supplement_3.S204; DAGAN RGD, 2004, PNEUMOCOCCAL INFECT, P1204; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Gaforio JJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1282, DOI 10.1128/CDLI.9.6.1282-1294.2002; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kerr AR, 2005, MICROBES INFECT, V7, P845, DOI 10.1016/j.micinf.2005.02.011; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Le-Barillec K, 2005, J IMMUNOL, V175, P1735, DOI 10.4049/jimmunol.175.3.1735; Mandelboim O, 2001, INT J BIOCHEM CELL B, V33, P1147, DOI 10.1016/S1357-2725(01)00078-4; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Rijneveld AW, 2002, J INFECT DIS, V185, P91, DOI 10.1086/338122; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Schultz MJ, 2001, EUR CYTOKINE NETW, V12, P39; Scott MJ, 2003, AM SURGEON, V69, P679; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; vanderPoll T, 1997, AM J RESP CRIT CARE, V155, P603, DOI 10.1164/ajrccm.155.2.9032201; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Weiss L, 2004, BONE MARROW TRANSPL, V33, P1137, DOI 10.1038/sj.bmt.1704475; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	39	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23472	10.1371/journal.pone.0023472	http://dx.doi.org/10.1371/journal.pone.0023472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887255	gold, Green Published, Green Submitted			2022-12-27	WOS:000294251800011
J	Charytan, DM; Helfand, AM; MacDonald, BA; Cinelli, A; Kalluri, R; Zeisberg, EM				Charytan, David M.; Helfand, Alexander M.; MacDonald, Brian A.; Cinelli, Angeles; Kalluri, Raghu; Zeisberg, Elisabeth M.			Circulating Endoglin Concentration Is Not Elevated in Chronic Kidney Disease	PLOS ONE			English	Article							BETA-BINDING-PROTEIN; GLOMERULAR-FILTRATION-RATE; EXPERIMENTAL RENAL-FAILURE; GROWTH-FACTOR VEGF; SOLUBLE ENDOGLIN; HEART DEVELOPMENT; MASS REDUCTION; UP-REGULATION; EXPRESSION; FIBROSIS	Background: Soluble endoglin, a TGF-beta receptor, plays a key role in cardiovascular physiology. Whether circulating concentrations of soluble endoglin are elevated in CKD or underlie the high risk of cardiovascular death associated with chronic kidney disease (CKD) is unknown. Methods: Individuals with and without CKD were recruited at a single center. Estimated glomerular filtration rate (eGFR) was estimated using the modified MDRD study equation and the serum creatinine at the time of recruitment, and patients were assigned to specific CKD stage according to usual guidelines. Serum endoglin concentration was measured by ELISA and univariate and multivariable regression was used to analyze the association between eGFR or CKD stage and the concentration of soluble endoglin. Results: Serum endoglin was measured in 216 patients including 118 with stage 3 or higher CKD and 9 individuals with end stage renal disease (ESRD). Serum endoglin concentration did not vary significantly with CKD stage (increase of 0.16 ng/mL per 1 stage increase in CKD, P = 0.09) or eGFR (decrease -0.06 ng/mL per 10 mL/min/1.73 m(2) increase in GFR, P = 0.12), and was not higher in individuals with ESRD than in individuals with preserved renal function (4.2 +/- 1.1 and 4.3 +/- 1.2 ng/mL, respectively). Endoglin concentration was also not significantly associated with urinary albumin excretion. Conclusions: Renal function is not associated with the circulating concentration of soluble endoglin. Elevations in soluble endoglin concentration are unlikely to contribute to the progression of CKD or the predisposition of individuals with CKD to develop cardiovascular disease.	[Charytan, David M.; Helfand, Alexander M.; Cinelli, Angeles] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [MacDonald, Brian A.; Kalluri, Raghu; Zeisberg, Elisabeth M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Charytan, DM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA.	dcharytan@partners.org	Zeisberg, Elisabeth/ABG-4970-2021; Kalluri, Raghu/E-2677-2015	charytan, david/0000-0002-7695-3583; Kalluri, Raghu/0000-0002-2190-547X	American Heart Association Scientist Development [SDG0735602T]; Satellite Health Care; Paul Teschan Research Fund; National Institutes of Health [KO8CA129204, DK 55001]; NATIONAL CANCER INSTITUTE [K08CA129204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055001] Funding Source: NIH RePORTER	American Heart Association Scientist Development(American Heart Association); Satellite Health Care; Paul Teschan Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Charytan was funded by an American Heart Association Scientist Development Grant, a Norman S. Coplon Grant from Satellite Health Care, and the Paul Teschan Research Fund. Dr. Zeisberg was funded by an American Heart Association Scientist Development Grant (SDG0735602T) and a Mentored Clinical Scientist Development Award (KO8CA129204) from the National Institutes of Health. Dr. Kalluri was funded by NIH DK 55001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Amann K, 2003, KIDNEY INT, V63, P1708, DOI 10.1046/j.1523-1755.2003.00927.x; Amann K, 1998, NEPHROL DIAL TRANSPL, V13, P1958, DOI 10.1093/ndt/13.8.1958; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Cui SY, 2005, J AM SOC NEPHROL, V16, P3247, DOI 10.1681/ASN.2005030278; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Finn AV, 2010, JACC-CARDIOVASC IMAG, V3, P41, DOI 10.1016/j.jcmg.2009.11.001; Ikemoto T, 2011, HEART VESSELS; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kappers MHW, 2009, J HYPERTENS, V27, P2297, DOI 10.1097/HJH.0b013e3283309b59; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li DY, 2001, HYPERTENSION, V38, P1062, DOI 10.1161/hy1101.092971; Ly J, 2004, CURR OPIN NEPHROL HY, V13, P299, DOI 10.1097/00041552-200405000-00006; Matsumoto Y, 2007, J AM SOC NEPHROL, V18, P1525, DOI 10.1681/ASN.2006070696; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mohsenin V, 2011, RESP MED, V105, P801, DOI 10.1016/j.rmed.2011.01.001; Onoue K, 2009, CIRCULATION, V120, P2470, DOI 10.1161/CIRCULATIONAHA.109.867929; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Prieto M, 2005, J PHYSIOL BIOCHEM, V61, P457, DOI 10.1007/BF03168452; Prieto M, 2005, KIDNEY BLOOD PRESS R, V28, P32, DOI 10.1159/000081439; Rodriguez-Pena A, 2001, NEPHROL DIAL TRANSPL, V16, P34, DOI 10.1093/ndt/16.suppl_1.34; Rodriguez-Pena A, 2002, HYPERTENSION, V40, P713, DOI 10.1161/01.HYP.0000037429.73954.27; RoyChaudhury P, 1997, EXP NEPHROL, V5, P55; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sun XF, 2009, NEPHROLOGY, V14, P506, DOI 10.1111/j.1440-1797.2009.01098.x; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vincent EB, 1998, DEV DYNAM, V213, P237, DOI 10.1002/(SICI)1097-0177(199811)213:3<237::AID-AJA1>3.0.CO;2-M	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23718	10.1371/journal.pone.0023718	http://dx.doi.org/10.1371/journal.pone.0023718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886815	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100027
J	Hartung, JS; Shao, J; Kuykendall, LD				Hartung, John S.; Shao, Jonathan; Kuykendall, L. David			Comparison of the 'Ca. Liberibacter asiaticus' Genome Adapted for an Intracellular Lifestyle with Other Members of the Rhizobiales	PLOS ONE			English	Article							GREENING DISEASE; L. AMERICANUS; PCR DETECTION; CITRUS; SEQUENCE; LIBEROBACTER; BACTERIUM; PROTEOBACTERIA; MICROSCOPY; REDUCTION	An intracellular plant pathogen 'Candidatus Liberibacter asiaticus,' a member of the Rhizobiales, is related to Sinorhizobium meliloti, Bradyrhizobium japonicum, nitrogen fixing endosymbionts, Agrobacterium tumefaciens, a plant pathogen, and Bartonella henselae, an intracellular mammalian pathogen. Whole chromosome comparisons identified at least 50 clusters of conserved orthologous genes found on the chromosomes of all five metabolically diverse species. The intracellular pathogens 'Ca. Liberibacter asiaticus' and Bartonella henselae have genomes drastically reduced in gene content and size as well as a relatively low content of guanine and cytosine. Codon and amino acid preferences that emphasize low guanosine and cytosine usage are globally employed in these genomes, including within regions of microsynteny and within signature sequences of orthologous proteins. The length of orthologous proteins is generally conserved, but not their isoelectric points, consistent with extensive amino acid substitutions to accommodate selection for low GC content. The 'Ca. Liberibacter asiaticus' genome apparently has all of the genes required for DNA replication present in Sinorhizobium meliloti except it has only two, rather than three RNaseH genes. The gene set required for DNA repair has only one rather than ten DNA ligases found in Sinorhizobium meliloti, and the DNA Poll of 'Ca. Liberibacter asiaticus' lacks domains needed for excision repair. Thus the ability of 'Ca. Liberibacter asiaticus' to repair mutations in its genome may be impaired. Both 'Ca. Liberibacter asiaticus and Bartonella henselae lack enzymes needed for the metabolism of purines and pyrimidines, which must therefore be obtained from the host. The 'Ca. Liberibacter asiaticus' genome also has a greatly reduced set of sigma factors used to control transcription, and lacks sigma factors 24, 28 and 38. The 'Ca. Liberibacter asiaticus' genome has all of the hallmarks of a reduced genome of a pathogen adapted to an intracellular lifestyle.	[Hartung, John S.; Shao, Jonathan; Kuykendall, L. David] USDA, Agr Res Serv, Mol Plant Pathol Lab, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA)	Hartung, JS (corresponding author), USDA, Agr Res Serv, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	hartungj@ba.ars.usda.gov			United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture, Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Bove JM, 2006, J PLANT PATHOL, V88, P7; Carbajal D, 2004, CURR MICROBIOL, V49, P372, DOI 10.1007/s00284-004-4369-5; Cordwell SJ, 1997, GENE, V195, P113, DOI 10.1016/S0378-1119(97)00063-2; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; Davis MJ, 2008, PLANT DIS, V92, P1547, DOI 10.1094/PDIS-92-11-1547; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769; GARNETT HM, 1984, S CITR GREEN NELSPR, P4; GHOSH SK, 1971, CURR SCI INDIA, V40, P299; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Guerrero G, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-55; Hartung JS, 2010, PHYTOPATHOLOGY, V100, P756, DOI 10.1094/PHYTO-100-8-0756; Itoh T, 2002, P NATL ACAD SCI USA, V99, P12944, DOI 10.1073/pnas.192449699; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Jagoueix S, 1997, INT J SYST BACTERIOL, V47, P224, DOI 10.1099/00207713-47-1-224; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Kuykendall L., 2006, INT J SYST EVOL MICR, V56, P1; Kuykendall L. D., 2005, BERGEYS MANUAL SYSTE, V2, P324; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; LIN K. -H., 1956, Acta Phytopathologica Sinica, V2, P1; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; MOLL J N, 1973, Phytophylactica, V5, P41; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; NATH D, 1927, MEMOIRS DEP AGR INDI, V10, P1; PLANET P, 1995, CURR MICROBIOL, V30, P137, DOI 10.1007/BF00296198; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Sallstrom B, 2005, CURR OPIN MICROBIOL, V8, P579, DOI 10.1016/j.mib.2005.08.002; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Subandiyah S, 2000, PLANT DIS, V84, P15, DOI 10.1094/PDIS.2000.84.1.15; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07	43	37	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23289	10.1371/journal.pone.0023289	http://dx.doi.org/10.1371/journal.pone.0023289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876745	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900017
J	Graziano, F; Elia, C; Laudanna, C; Poli, G; Alfano, M				Graziano, Francesca; Elia, Chiara; Laudanna, Carlo; Poli, Guido; Alfano, Massimo			Urokinase Plasminogen Activator Inhibits HIV Virion Release from Macrophage-Differentiated Chronically Infected Cells via Activation of RhoA and PKC epsilon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-KINASE-C; PHORBOL-MYRISTATE ACETATE; GTP-BINDING PROTEIN; CYTOCHALASIN-D; ANTIRETROVIRAL THERAPY; PROMONOCYTIC CELLS; ACTIN CYTOSKELETON; INDUCED MIGRATION; LFA-1 ACTIVATION	Background: HIV replication in mononuclear phagocytes is a multi-step process regulated by viral and cellular proteins with the peculiar feature of virion budding and accumulation in intra-cytoplasmic vesicles. Interaction of urokinase-type plasminogen activator (uPA) with its cell surface receptor (uPAR) has been shown to favor virion accumulation in such subcellular compartment in primary monocyte-derived macrophages and chronically infected promonocytic U1 cells differentiated into macrophage-like cells by stimulation with phorbol myristate acetate (PMA). By adopting this latter model system, we have here investigated which intracellular signaling pathways were triggered by uPA/uPAR interaction leading the redirection of virion accumulation in intra-cytoplasmic vesicles. Results: uPA induced activation of RhoA, PKC delta and PKC epsilon in PMA-differentiated U1 cells. In the same conditions, RhoA, PKC delta and PKC epsilon modulated uPA-induced cell adhesion and polarization, whereas only RhoA and PKC epsilon were also responsible for the redirection of virions in intracellular vesicles. Distribution of G and F actin revealed that uPA reorganized the cytoskeleton in both adherent and polarized cells. The role of G and F actin isoforms was unveiled by the use of cytochalasin D, a cell-permeable fungal toxin that prevents F actin polymerization. Receptor-independent cytoskeleton remodeling by Cytochalasin D resulted in cell adhesion, polarization and intracellular accumulation of HIV virions similar to the effects gained with uPA. Conclusions: These findings illustrate the potential contribution of the uPA/uPAR system in the generation and/or maintenance of intra-cytoplasmic vesicles that actively accumulate virions, thus sustaining the presence of HIV reservoirs of macrophage origin. In addition, our observations also provide evidences that pathways controlling cytoskeleton remodeling and activation of PKC epsilon bear relevance for the design of new antiviral strategies aimed at interfering with the partitioning of virion budding between intra-cytoplasmic vesicles and plasma membrane in infected human macrophages.	[Graziano, Francesca; Elia, Chiara; Poli, Guido; Alfano, Massimo] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunophatogenesis Unit, I-20132 Milan, Italy; [Poli, Guido] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy; [Laudanna, Carlo] Fac Med & Surg, Dept Pathol & Diagnost, Verona, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Graziano, F (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunophatogenesis Unit, I-20132 Milan, Italy.	massimo.alfano@hsr.it	ALESSANDRIA, CARLO/AAH-1448-2019; Alfano, Massimo/AAC-1950-2019	Alfano, Massimo/0000-0002-6904-9158; Poli, Guido/0000-0001-7241-4526; Graziano, Francesca/0000-0001-5294-8459	VI National Program of Research against HIV/AIDS of the ISS; Italian Minister of Health [40H11]; NIH [1R21 MH075670-01A1]; Fondation Dormeur; Italian Association for Cancer Research (AIRC); MIUR; Fondazione Cariverona, Verona, Italy; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH075670] Funding Source: NIH RePORTER	VI National Program of Research against HIV/AIDS of the ISS; Italian Minister of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Dormeur; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by grants of the VI National Program of Research against HIV/AIDS of the ISS (to MA and GP), by grant of Italian Minister of Health (#40H11 to MA), by the NIH grant n. 1R21 MH075670-01A1 to MA and GP, the Fondation Dormeur to GP, and the Italian Association for Cancer Research (AIRC) 2009-2011, MIUR and Fondazione Cariverona, Verona, Italy, to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aepfelbacher M, 1996, J IMMUNOL, V157, P5070; Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; Alfano M, 2002, P NATL ACAD SCI USA, V99, P8862, DOI 10.1073/pnas.142078099; ALFANO M, 2007, HIV MACROPHAGE, P89; Alfano M, 2006, LETT DRUG DES DISCOV, V3, P598, DOI 10.2174/157018006778341183; Alfano M, 2009, BLOOD, V113, P1699, DOI 10.1182/blood-2008-02-138412; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Audoly G, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-48; Azab AK, 2009, BLOOD, V114, P619, DOI 10.1182/blood-2009-01-199281; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; BISWAS P, 1992, J EXP MED, V176, P739, DOI 10.1084/jem.176.3.739; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blasi F, 1997, IMMUNOL TODAY, V18, P415, DOI 10.1016/S0167-5699(97)01121-3; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; CAVNAR PJ, J CELL BIOL, V193, P465; Cinque P, 2004, ANN NEUROL, V55, P687, DOI 10.1002/ana.20076; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Elia C, 2007, J LEUKOCYTE BIOL, V82, P1212, DOI 10.1189/jlb.0407251; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; FANTUZZI L, 2003, BLOOD; FERNIE BF, 1991, J VIROL, V65, P3968, DOI 10.1128/JVI.65.7.3968-3971.1991; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Kamiya K, 2007, J SURG RES, V141, P91, DOI 10.1016/j.jss.2007.02.025; Karczewski MK, 1996, J VIROL, V70, P494, DOI 10.1128/JVI.70.1.494-507.1996; Kiian I, 2003, THROMB HAEMOSTASIS, V89, P904; Kindzelskii AL, 1996, J IMMUNOL, V156, P297; KINTER AL, 1990, J VIROL, V64, P4306, DOI 10.1128/JVI.64.9.4306-4312.1990; Konecny G, 2001, CLIN CANCER RES, V7, P1743; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LAURENCE J, 1990, BIOCHEM BIOPH RES CO, V166, P349, DOI 10.1016/0006-291X(90)91952-O; LUCKENBILLEDDS L, 1990, CELL TISSUE RES, V260, P485, DOI 10.1007/BF00297228; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Madsen CD, 2008, EUR J CELL BIOL, V87, P617, DOI 10.1016/j.ejcb.2008.02.003; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; MULLOY JC, BLOOD, V115, P936; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Ostrowski SR, 2006, SCAND J IMMUNOL, V63, P478, DOI 10.1111/j.1365-3083.2006.001768.x; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Petzinger J, 2007, CELL COMMUN ADHES, V14, P137, DOI 10.1080/15419060701557487; PICONE R, 1989, J CELL BIOL, V108, P693, DOI 10.1083/jcb.108.2.693; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Rabbi MF, 1998, VIROLOGY, V245, P257, DOI 10.1006/viro.1998.9158; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Shoeman RL, 2001, MOL BIOL CELL, V12, P143, DOI 10.1091/mbc.12.1.143; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Sidenius N, 2004, J NEUROIMMUNOL, V157, P133, DOI 10.1016/j.jneuroim.2004.08.038; Sidenius N, 2000, BLOOD, V96, P4091; Sidenius N, 2002, J BIOL CHEM, V277, P27982, DOI 10.1074/jbc.M111736200; Sier CFM, 2004, THROMB HAEMOSTASIS, V91, P403, DOI 10.1160/TH03-06-0351; Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Sporer B, 2005, J NEUROIMMUNOL, V163, P190, DOI 10.1016/j.jneuroim.2005.02.013; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Surin B, 2002, INT J MOL MED, V10, P25; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wada M, 2001, BIOCHEM BIOPH RES CO, V284, P346, DOI 10.1006/bbrc.2001.4965; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang LP, 2000, J IMMUNOL, V164, P5369, DOI 10.4049/jimmunol.164.10.5369; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015	77	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23674	10.1371/journal.pone.0023674	http://dx.doi.org/10.1371/journal.pone.0023674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858203	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300079
J	Kok, J; Thomas, LC; Olma, T; Chen, SCA; Iredell, JR				Kok, Jen; Thomas, Lee C.; Olma, Thomas; Chen, Sharon C. A.; Iredell, Jonathan R.			Identification of Bacteria in Blood Culture Broths Using Matrix-Assisted Laser Desorption-Ionization Sepsityper (TM) and Time of Flight Mass Spectrometry	PLOS ONE			English	Article							STREAM INFECTIONS; PSEUDOMONAS; MICROORGANISMS; PHYLOGENY; DIAGNOSIS; BOTTLES	Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) is a novel method for the direct identification of bacteria from blood culture broths. We evaluate for the first time, the performance of the MALDI Sepsityper (TM) Kit and MS for the identification of bacteria compared to standard phenotypic methods using the manufacturer's specified bacterial identification criteria (spectral scores >= 1.700-1.999 and >= 2.000 indicated identification to genus and species level, respectively). Five hundred and seven positive blood culture broths were prospectively examined, of which 379 (74.8%; 358 monomicrobial, 21 polymicrobial) were identified by MALDI-TOF MS; 195 (100%) and 132 (67.7%) of 195 gram-positive; and 163 (100%) and 149 (91.4%) of 163 gram-negative organisms from monomicrobial blood cultures were correctly identified to genus and species level, respectively. Spectral scores <1.700 (no identification) were obtained in 128/507 (25.2%) positive blood culture broths, including 31.6% and 32.3% of gram-positive and polymicrobial blood cultures, respectively. Significantly more gram-negative organisms were identified compared to gram-positive organisms at species level (p < 0.0001). Five blood cultures were misidentified, but at species level only; including four monomicrobial blood cultures with Streptococcus oralis/mitis that were misidentified as Streptococcus pneumoniae. Positive predictive values for the direct identification of both gram-positive and gram-negative bacteria from monomicrobial blood culture broths to genus level were 100%. A diagnostic algorithm for positive blood culture broths that incorporates gram staining and MALDI-TOF MS should identify the majority of pathogens, particularly to genus level.	[Kok, Jen; Thomas, Lee C.; Olma, Thomas; Chen, Sharon C. A.; Iredell, Jonathan R.] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis, Westmead, NSW 2145, Australia; [Kok, Jen; Thomas, Lee C.; Olma, Thomas; Chen, Sharon C. A.; Iredell, Jonathan R.] Westmead Hosp, Inst Clin Pathol & Med Res, Microbiol Lab Serv, Westmead, NSW 2145, Australia; [Kok, Jen; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Res Excellence Crit & Emerging Infect Dis, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney	Kok, J (corresponding author), Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis, Westmead, NSW 2145, Australia.	jen.kok@swahs.health.nsw.gov.au						Almuzara MN, 2010, J CLIN MICROBIOL, V48, P660, DOI 10.1128/JCM.01849-09; Arise Committee AAM, 2007, CRIT CARE RESUSC, V9, P8; Beekmann SE, 2003, J CLIN MICROBIOL, V41, P3119, DOI 10.1128/JCM.41.7.3119-3125.2003; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Kochanek KD, 2011, NATL VITAL STAT REPO; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Mehta MS, 2009, J CLIN MICROBIOL, V47, P1082, DOI 10.1128/JCM.01850-08; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Petti CA, 2005, J CLIN MICROBIOL, V43, P2510, DOI 10.1128/JCM.43.5.2510-2512.2005; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Romero-Gomez MP, 2011, J INFECTION, V62, P251, DOI 10.1016/j.jinf.2010.12.008; Saavedra MJ, 2006, INT J SYST EVOL MICR, V56, P2481, DOI 10.1099/ijs.0.64351-0; Seok Y, 2010, J CLIN MICROBIOL, V48, P2656, DOI 10.1128/JCM.01609-09; Stender H, 2003, EXPERT REV MOL DIAGN, V3, P649, DOI 10.1586/14737159.3.5.649; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Szabados F, 2011, CLIN MICROBIOL INFEC, V17, P192, DOI 10.1111/j.1469-0691.2010.03229.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	23	119	131	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23285	10.1371/journal.pone.0023285	http://dx.doi.org/10.1371/journal.pone.0023285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858058	Green Submitted, Green Published, gold			2022-12-27	WOS:000294125500025
J	Matsumoto, M; Kurihara, S; Kibe, R; Ashida, H; Benno, Y				Matsumoto, Mitsuharu; Kurihara, Shin; Kibe, Ryoko; Ashida, Hisashi; Benno, Yoshimi			Longevity in Mice Is Promoted by Probiotic-Induced Suppression of Colonic Senescence Dependent on Upregulation of Gut Bacterial Polyamine Production	PLOS ONE			English	Article							INTESTINAL ENVIRONMENT; LKM512 YOGURT; LIFE-SPAN; MICROBIOTA; CONSUMPTION; AUTOPHAGY; CYTOKINE; SURVIVAL; IMPROVES; HEALTH	Background: Chronic low-grade inflammation is recognized as an important factor contributing to senescence and age-related diseases. In mammals, levels of polyamines (PAs) decrease during the ageing process; PAs are known to decrease systemic inflammation by inhibiting inflammatory cytokine synthesis in macrophages. Reductions in intestinal luminal PAs levels have been associated with intestinal barrier dysfunction. The probiotic strain Bifidobacterium animalis subsp. lactis LKM512 is known to increase intestinal luminal PA concentrations. Methodology/Principal Findings: We supplemented the diet of 10-month-old Crj:CD-1 female mice with LKM512 for 11 months, while the controls received no supplementation. Survival rates were compared using Kaplan-Meier survival curves. LKM512-treated mice survived significantly longer than controls (P<0.001); moreover, skin ulcers and tumors were more common in the control mice. We then analyzed inflammatory and intestinal conditions by measuring several markers using HPLC, ELISA, reverse transcription-quantitative PCR, and histological slices. LKM512 mice showed altered 16S rRNA gene expression of several predominant intestinal bacterial groups. The fecal concentrations of PAs, but not of short-chain fatty acids, were significantly higher in LKM512-treated mice (P<0.05). Colonic mucosal function was also better in LKM512 mice, with increased mucus secretion and better maintenance of tight junctions. Changes in gene expression levels were evaluated using the NimbleGen mouse DNA microarray. LKM512 administration also downregulated the expression of ageing-associated and inflammation-associated genes and gene expression levels in 21-month-old LKM512-treated mice resembled those in 10-month-old untreated (younger) mice. Conclusion/Significance: Our study demonstrated increased longevity in mice following probiotic treatment with LKM512, possibly due to the suppression of chronic low-grade inflammation in the colon induced by higher PA levels. This indicates that ingestion of specific probiotics may be an easy approach for improving intestinal health and increasing lifespan. Further studies are required to clarify its effectiveness in humans.	[Matsumoto, Mitsuharu] Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan; [Matsumoto, Mitsuharu; Kibe, Ryoko; Benno, Yoshimi] RIKEN, Innovat Ctr, Benno Lab, Wako, Saitama, Japan; [Kurihara, Shin] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Appl Biol, Kyoto 606, Japan; [Kurihara, Shin; Ashida, Hisashi] Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Kyoto, Japan	RIKEN; Kyoto Institute of Technology; Kyoto University	Matsumoto, M (corresponding author), Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan.	m-matumoto@meito.co.jp	Ashida, Hisashi/HCI-0293-2022; Matsumoto, Mitsuharu/AHB-4023-2022	Ashida, Hisashi/0000-0001-5844-4075; Matsumoto, Mitsuharu/0000-0002-0378-3077	Bio-oriented Technology Research Advancement Institution (BRAIN), Japan; Kyodo Milk Industry Co. Ltd	Bio-oriented Technology Research Advancement Institution (BRAIN), Japan; Kyodo Milk Industry Co. Ltd	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also funded by Kyodo Milk Industry Co. Ltd. M. Matsumoto is an employee of Kyodo Milk Industry Co. Ltd. and had a role in study design, data analysis, preparation of the manuscript, and the decision to publish the manuscript.	Anderson Rozalyn M., 2007, V35, P18; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Cipolla BG, 2007, AMINO ACIDS, V33, P203, DOI 10.1007/s00726-007-0524-1; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Deloyer P, 2001, EUR J GASTROEN HEPAT, V13, P1027, DOI 10.1097/00042737-200109000-00005; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GORDON HA, 1966, J GERONTOL, V21, P380, DOI 10.1093/geronj/21.3.380; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; KATNIK I, 1990, J IMMUNOASSAY, V11, P503; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koltun WA, 1996, GUT, V39, P291, DOI 10.1136/gut.39.2.291; Lee HM, 2001, MECH AGEING DEV, V122, P355, DOI 10.1016/S0047-6374(00)00254-2; Li L, 2001, AM J PHYSIOL-GASTR L, V280, pG992, DOI 10.1152/ajpgi.2001.280.5.G992; Loft S, 1998, FREE RADICAL RES, V29, P525, DOI 10.1080/10715769800300571; LUK GD, 1980, SCIENCE, V210, P195, DOI 10.1126/science.6774420; MA TY, 1992, EXP GERONTOL, V27, P321, DOI 10.1016/0531-5565(92)90059-9; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsumoto M, 2007, CLIN EXP ALLERGY, V37, P358, DOI 10.1111/j.1365-2222.2007.02642.x; Matsumoto M, 2001, FEMS IMMUNOL MED MIC, V31, P181, DOI 10.1111/j.1574-695X.2001.tb00518.x; Matsumoto M, 2011, MED HYPOTHE IN PRESS; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; Matsumoto M, 2007, FEMS IMMUNOL MED MIC, V49, P387, DOI 10.1111/j.1574-695X.2007.00215.x; Matsumoto M, 2006, BIOSCI BIOTECH BIOCH, V70, P1287, DOI 10.1271/bbb.50464; Matsumoto M, 2009, MICROBIOL IMMUNOL, V53, P421, DOI 10.1111/j.1348-0421.2009.00140.x; Matsuzaki T, 2007, J NUTR, V137, p798S, DOI 10.1093/jn/137.3.798S; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Metchnikoff E., 1907, PROLONGATION LIFE OP; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Noack J, 1998, J NUTR, V128, P1385, DOI 10.1093/jn/128.8.1385; ODA Y, 1985, MUTAT RES, V147, P219, DOI 10.1016/0165-1161(85)90062-7; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pillai SP, 1997, MUTAT RES-FUND MOL M, V377, P217, DOI 10.1016/S0027-5107(97)00075-4; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; RUSSELL DH, 1971, CANCER RES, V31, P1555; SARHAN S, 1992, ANTICANCER RES, V12, P457; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Sreekumar O, 1998, J DAIRY SCI, V81, P1508, DOI 10.3168/jds.S0022-0302(98)75716-9; Takahashi T, 2010, ANN BOT-LONDON, V105, P1, DOI 10.1093/aob/mcp259; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tosato M, 2007, CLIN INTERV AGING, V2, P401; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Weindruch R., 1988, RETARDATION AGING DI; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759	58	153	156	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23652	10.1371/journal.pone.0023652	http://dx.doi.org/10.1371/journal.pone.0023652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858192	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500039
J	Chi, W; Tong, CB; Gan, XN; He, SP				Chi, Wei; Tong, Chaobo; Gan, Xiaoni; He, Shunping			Characterization and Comparative Profiling of MiRNA Transcriptomes in Bighead Carp and Silver Carp	PLOS ONE			English	Article							MICRORNA GENES; EVOLUTION; EXPRESSION; RNAS; SET; RETROTRANSPOSONS; IDENTIFICATION; DUPLICATION; SIRNAS; ROLES	MicroRNAs (miRNAs) are small non-coding RNA molecules that are processed from large 'hairpin' precursors and function as post-transcriptional regulators of target genes. Although many individual miRNAs have recently been extensively studied, there has been very little research on miRNA transcriptomes in teleost fishes. By using high throughput sequencing technology, we have identified 167 and 166 conserved miRNAs (belonging to 108 families) in bighead carp (Hypophthalmichthys nobilis) and silver carp (Hypophthalmichthys molitrix), respectively. We compared the expression patterns of conserved miRNAs by means of hierarchical clustering analysis and log2 ratio. Results indicated that there is not a strong correlation between sequence conservation and expression conservation, most of these miRNAs have similar expression patterns. However, high expression differences were also identified for several individual miRNAs. Several miRNA* sequences were also found in our dataset and some of them may have regulatory functions. Two computational strategies were used to identify novel miRNAs from un-annotated data in the two carps. A first strategy based on zebrafish genome, identified 8 and 22 novel miRNAs in bighead carp and silver carp, respectively. We postulate that these miRNAs should also exist in the zebrafish, but the methodologies used have not allowed for their detection. In the second strategy we obtained several carp-specific miRNAs, 31 in bighead carp and 32 in silver carp, which showed low expression. Gain and loss of family members were observed in several miRNA families, which suggests that duplication of animal miRNA genes may occur through evolutionary processes which are similar to the protein-coding genes.	[Chi, Wei; Tong, Chaobo; Gan, Xiaoni; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Lab Fish Phylogenet & Biogeog, Wuhan, Hubei, Peoples R China; [Chi, Wei; Tong, Chaobo; Gan, Xiaoni] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chi, W (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Lab Fish Phylogenet & Biogeog, Wuhan, Hubei, Peoples R China.	clad@ihb.ac.cn			National Basic Research Program of China [2007CB411601]	National Basic Research Program of China(National Basic Research Program of China)	The research is supported by the National Basic Research Program of China (No. 2007CB411601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; CINDY K, 2005, ASIAN CARPS GENUS HY; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Force A, 1999, GENETICS, V151, P1531; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; JOHANSEN SD, 2009, ATLANTIC, V25, P263; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PING X, 2000, AQUACULTURE, V195, P149; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Walsh B, 2003, GENETICA, V118, P279, DOI 10.1023/A:1024194802441; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Xie P, 1999, AQUACULTURE, V180, P295, DOI 10.1016/S0044-8486(99)00205-7; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997	37	56	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23549	10.1371/journal.pone.0023549	http://dx.doi.org/10.1371/journal.pone.0023549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858165	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700032
J	Steinacker, P; Fang, LB; Kuhle, J; Petzold, A; Tumani, H; Ludolph, AC; Otto, M; Brettschneider, J				Steinacker, Petra; Fang, Lubin; Kuhle, Jens; Petzold, Axel; Tumani, Hayrettin; Ludolph, Albert C.; Otto, Markus; Brettschneider, Johannes			Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MARKERS; DEGENERATION; BIOMARKERS; DIAGNOSIS; CRITERIA; CLEAVAGE	Background: Biomarkers of disease progression in amyotrophic lateral sclerosis (ALS) could support the identification of beneficial drugs in clinical trials. We aimed to test whether soluble fragments of beta-amyloid precursor protein (sAPPa and sAPP beta) correlated with clinical subtypes of ALS and were of prognostic value. Methodology/Principal Findings: In a cross-sectional study including patients with ALS (N = 68) with clinical follow-up data over 6 months, Parkinson's disease (PD, N = 20), and age-matched controls (N = 40), cerebrospinal fluid (CSF) levels of sAPP alpha a, sAPP beta and neurofilaments (NfH(SMI35)) were measured by multiplex assay, Progranulin by ELISA. CSF sAPP alpha and sAPP beta levels were lower in ALS with a rapidly-progressive disease course (p = 0.03, and p = 0.02) and with longer disease duration (p = 0.01 and p = 0.01, respectively). CSF NfH(SMI35) was elevated in ALS compared to PD and controls, with highest concentrations found in patients with rapid disease progression (p, 0.01). High CSF NfH(SMI35) was linked to low CSF sAPP alpha and sAPP beta (p = 0.001, and p = 0.007, respectively). The ratios CSF NfH(SMI35)/CSF sAPP alpha,-beta were elevated in patients with fast progression of disease (p = 0.002 each). CSF Progranulin decreased with ongoing disease (p = 0.04). Conclusions: This study provides new CSF candidate markers associated with progression of disease in ALS. The data suggest that a deficiency of cellular neuroprotective mechanisms (decrease of sAPP) is linked to progressive neuro-axonal damage (increase of NfH(SMI35)) and to progression of disease.	[Steinacker, Petra; Fang, Lubin; Tumani, Hayrettin; Ludolph, Albert C.; Otto, Markus; Brettschneider, Johannes] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Kuhle, Jens] Univ Basel, Dept Neurol, Basel, Switzerland; [Petzold, Axel] Natl Hosp Neurol & Neurosurg, Dept Neuroimmunol, UCL Inst Neurol, London WC1N 3BG, England	Ulm University; University of Basel; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Steinacker, P (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	Johannes.brettschneider@uni-ulm.de	Kuhle, Jens/AGE-3474-2022; Petzold, Axel/C-1090-2009; Otto, Markus/F-4304-2015	Petzold, Axel/0000-0002-0344-9749; Otto, Markus/0000-0003-4273-4267				[Anonymous], 1996, Arch Neurol, V53, P141; Beghi E, 2006, BBA-MOL BASIS DIS, V1762, P1150, DOI 10.1016/j.bbadis.2006.09.008; Bodansky A, 2010, AMYOTROPH LATERAL SC, V11, P321, DOI 10.3109/17482961003602363; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Ehehalt R, 2002, BIOCHEM BIOPH RES CO, V293, P30, DOI 10.1016/S0006-291X(02)00169-9; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Kogel D, 2003, J NEUROCHEM, V87, P248, DOI 10.1046/j.1471-4159.2003.02000.x; Kuhle J, 2010, J NEUROIMMUNOL, V220, P114, DOI 10.1016/j.jneuroim.2010.01.004; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; Steinacker P, 2009, J NEURAL TRANSM, V116, P1169, DOI 10.1007/s00702-009-0271-4; Strong M, 2003, AMYOTROPH LATERAL SC, V4, P136, DOI 10.1080/14660820310011250; Sussmuth SD, 2010, NEUROLOGY, V74, P982, DOI 10.1212/WNL.0b013e3181d5dc3b; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Tumani H, 2008, EXPERT REV MOL DIAGN, V8, P479, DOI 10.1586/14737159.8.4.479; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Winhammar JMC, 2005, LANCET NEUROL, V4, P229, DOI 10.1016/S1474-4422(05)70042-9; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	32	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23600	10.1371/journal.pone.0023600	http://dx.doi.org/10.1371/journal.pone.0023600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858182	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700036
J	Ahrens, I; Domeij, H; Topcic, D; Haviv, I; Merivirta, RM; Agrotis, A; Leitner, E; Jowett, JB; Bode, C; Lappas, M; Peter, K				Ahrens, Ingo; Domeij, Helena; Topcic, Denijal; Haviv, Izhak; Merivirta, Ruusu-Maaria; Agrotis, Alexander; Leitner, Ephraem; Jowett, Jeremy B.; Bode, Christoph; Lappas, Martha; Peter, Karlheinz			Successful In Vitro Expansion and Differentiation of Cord Blood Derived CD34+Cells into Early Endothelial Progenitor Cells Reveals Highly Differential Gene Expression	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; BONE-MARROW; NEOVASCULARIZATION; TRANSPLANTATION; FACTOR-15; MOBILIZATION; RECRUITMENT; ACTIVATION; GALECTIN-3	Endothelial progenitor cells (EPCs) can be purified from peripheral blood, bone marrow or cord blood and are typically defined by a limited number of cell surface markers and a few functional tests. A detailed in vitro characterization is often restricted by the low cell numbers of circulating EPCs. Therefore in vitro culturing and expansion methods are applied, which allow at least distinguishing two different types of EPCs, early and late EPCs. Herein, we describe an in vitro culture technique with the aim to generate high numbers of phenotypically, functionally and genetically defined early EPCs from human cord blood. Characterization of EPCs was done by flow cytometry, immunofluorescence microscopy, colony forming unit (CFU) assay and endothelial tube formation assay. There was an average 48-fold increase in EPC numbers. EPCs expressed VEGFR-2, CD144, CD18, and CD61, and were positive for acetylated LDL uptake and ulex lectin binding. The cells stimulated endothelial tube formation only in co-cultures with mature endothelial cells and formed CFUs. Microarray analysis revealed highly up-regulated genes, including LL-37 (CAMP), PDK4, and alpha-2-macroglobulin. In addition, genes known to be associated with cardioprotective (GDF15) or pro-angiogenic (galectin-3) properties were also significantly up-regulated after a 72 h differentiation period on fibronectin. We present a novel method that allows to generate high numbers of phenotypically, functionally and genetically characterized early EPCs. Furthermore, we identified several genes newly linked to EPC differentiation, among them LL-37 (CAMP) was the most up-regulated gene.	[Ahrens, Ingo; Bode, Christoph] Univ Hosp Med Ctr, Dept Cardiol & Angiol, Freiburg, Germany; [Haviv, Izhak; Jowett, Jeremy B.] Baker IDI Heart & Diabet Inst, Blood & DNA Profiling Facil, Melbourne, Vic, Australia; [Agrotis, Alexander] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Lappas, Martha] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Melbourne, Vic, Australia	University of Freiburg; Baker Heart and Diabetes Institute; Monash University; University of Melbourne	Ahrens, I (corresponding author), Univ Hosp Med Ctr, Dept Cardiol & Angiol, Freiburg, Germany.	ingo.ahrens@uniklinik-freiburg.de	/S-2765-2019; Peter, Karlheinz/E-8772-2010; Haviv, Izhak/E-3782-2015	/0000-0002-8040-2258; Peter, Karlheinz/0000-0002-8040-2258; Haviv, Izhak/0000-0002-0837-5005	National Health and Medical Research Council (NHMRC) of Australia; German Research Foundation [185/1-1]; Australian Research Council; Henning and Johan Throne-Holst's foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Research Foundation(German Research Foundation (DFG)); Australian Research Council(Australian Research Council); Henning and Johan Throne-Holst's foundation	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, the German Research Foundation (AH 185/1-1, Ahrens I), the Australian Research Council (Peter K), and the Henning and Johan Throne-Holst's foundation (Domeij H). Dr. Martha Lappas is a recipient of a NHMRC RD Wright Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bowman Teresa V., 2007, V134, P1; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Eggers KM, 2008, EUR HEART J, V29, P2327, DOI 10.1093/eurheartj/ehn339; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erbs S, 2005, CIRC RES, V97, P756, DOI 10.1161/01.RES.0000185811.71306.8b; Eunju O, 2011, FASEB J, V25, P159, DOI 10.1096/fj.10-162040; Furuhata S, 2007, MOL CELL BIOCHEM, V298, P125, DOI 10.1007/s11010-006-9359-4; Hahne F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-3; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2009, J THROMB HAEMOST, V7, P31, DOI 10.1111/j.1538-7836.2009.03406.x; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Iacobini C, 2009, ARTERIOSCL THROM VAS, V29, P831, DOI 10.1161/ATVBAHA.109.186791; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Leone AM, 2009, EUR HEART J, V30, P890, DOI 10.1093/eurheartj/ehp078; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Neidhart M, 2005, ANN RHEUM DIS, V64, P419, DOI 10.1136/ard.2004.023135; Ott HC, 2005, NEW ENGL J MED, V353, P2614; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pfosser A, 2010, STEM CELLS, V28, P376, DOI 10.1002/stem.280; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Raponi M, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-56; Redondo S, 2008, J IMMUNOL METHODS, V335, P21, DOI 10.1016/j.jim.2008.02.011; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Renault MA, 2007, MICROVASC RES, V74, P159, DOI 10.1016/j.mvr.2007.08.005; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Taddei S, 2010, EUR HEART J, V31, P1168, DOI 10.1093/eurheartj/ehq077; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Umemoto T, 2008, BIOCHEM BIOPH RES CO, V365, P176, DOI 10.1016/j.bbrc.2007.10.168; Wang XG, 2007, J AM COLL CARDIOL, V49, P1566, DOI 10.1016/j.jacc.2006.12.037; Wu YJ, 2006, CIRC RES, V99, P315, DOI 10.1161/01.RES.0000235986.35957.a3; Yamagishi SI, 2009, CURR PHARM DESIGN, V15, P1027, DOI 10.2174/138161209787581940; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Zhang Y, 2006, J BIOL CHEM, V281, P39096, DOI 10.1074/jbc.M601362200; Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985	51	38	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23210	10.1371/journal.pone.0023210	http://dx.doi.org/10.1371/journal.pone.0023210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858032	Green Published, gold			2022-12-27	WOS:000293953500025
J	Zhang, YJ; Klein, K; Sugathan, A; Nassery, N; Dombkowski, A; Zanger, UM; Waxman, DJ				Zhang, Yijing; Klein, Kathrin; Sugathan, Aarathi; Nassery, Najlla; Dombkowski, Alan; Zanger, Ulrich M.; Waxman, David J.			Transcriptional Profiling of Human Liver Identifies Sex-Biased Genes Associated with Polygenic Dyslipidemia and Coronary Artery Disease	PLOS ONE			English	Article							SEXUALLY DIMORPHIC GENE; LIPID-LEVELS; EPIGENETIC REGULATION; DOSAGE COMPENSATION; GENDER-DIFFERENCES; NUCLEAR RECEPTORS; IMPRINTED GENE; HEART-DISEASE; PPAR-ALPHA; EXPRESSION	Sex-differences in human liver gene expression were characterized on a genome-wide scale using a large liver sample collection, allowing for detection of small expression differences with high statistical power. 1,249 sex-biased genes were identified, 70% showing higher expression in females. Chromosomal bias was apparent, with female-biased genes enriched on chrX and male-biased genes enriched on chrY and chr19, where 11 male-biased zinc-finger KRAB-repressor domain genes are distributed in six clusters. Top biological functions and diseases significantly enriched in sex-biased genes include transcription, chromatin organization and modification, sexual reproduction, lipid metabolism and cardiovascular disease. Notably, sex-biased genes are enriched at loci associated with polygenic dyslipidemia and coronary artery disease in genome-wide association studies. Moreover, of the 8 sex-biased genes at these loci, 4 have been directly linked to monogenic disorders of lipid metabolism and show an expression profile in females (elevated expression of ABCA1, APOA5 and LDLR; reduced expression of LIPC) that is consistent with the lower female risk of coronary artery disease. Female-biased expression was also observed for CYP7A1, which is activated by drugs used to treat hypercholesterolemia. Several sex-biased drug-metabolizing enzyme genes were identified, including members of the CYP, UGT, GPX and ALDH families. Half of 879 mouse orthologs, including many genes of lipid metabolism and homeostasis, show growth hormone-regulated sex-biased expression in mouse liver, suggesting growth hormone might play a similar regulatory role in human liver. Finally, the evolutionary rate of protein coding regions for human-mouse orthologs, revealed by dN/dS ratio, is significantly higher for genes showing the same sex-bias in both species than for non-sex-biased genes. These findings establish that human hepatic sex differences are widespread and affect diverse cell metabolic processes, and may help explain sex differences in lipid profiles associated with sex differential risk of coronary artery disease.	[Zhang, Yijing; Sugathan, Aarathi; Nassery, Najlla; Waxman, David J.] Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA; [Klein, Kathrin; Zanger, Ulrich M.] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Dombkowski, Alan] Wayne State Univ, Dept Pediat, Div Clin Pharmacol & Toxicol, Detroit, MI 48202 USA	Boston University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Wayne State University	Zhang, YJ (corresponding author), Boston Univ, Dept Biol, Div Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA.	djw@bu.edu	Zanger, Ulrich M./A-9364-2012	Zanger, Ulrich M./0000-0002-5276-2002; Waxman, David/0000-0001-7982-9206; Zhang, Yijing/0000-0001-9568-9389; Dombkowski, Alan/0000-0002-0312-8750	National Institutes of Health [DK33765]; German Federal Ministry of Education and Research [0315755]; Robert Bosch Foundation, Stuttgart, Germany; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Bosch Foundation, Stuttgart, Germany; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by National Institutes of Health grant DK33765 (to D.J.W.), the German Federal Ministry of Education and Research grant "Virtual Liver" 0315755 and the Robert Bosch Foundation, Stuttgart, Germany (to U.M.Z.). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Arnold AP, 2009, TRENDS ENDOCRIN MET, V20, P471, DOI 10.1016/j.tem.2009.06.007; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Balci H, 2005, MATURITAS, V50, P289, DOI 10.1016/j.maturitas.2004.07.002; Bittner V, 2006, CURR OPIN CARDIOL, V21, P602, DOI 10.1097/01.hco.0000245739.47712.0a; Blum A, 2009, GENDER MED, V6, P410, DOI 10.1016/j.genm.2009.09.005; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cheung C, 2006, J PHARMACOL EXP THER, V316, P1328, DOI 10.1124/jpet.105.094367; Chu MC, 2003, HUM REPROD, V18, P1570, DOI 10.1093/humrep/deg330; Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Delongchamp RR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S13; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030; Hayes FJ, 1999, METABOLISM, V48, P308, DOI 10.1016/S0026-0495(99)90077-X; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hemelaar M, 2003, MENOPAUSE, V10, P550, DOI 10.1097/01.GME.0000064866.58809.E5; Hofmann MH, 2008, J PHARMACOL EXP THER, V325, P284, DOI 10.1124/jpet.107.133306; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Hovingh GK, 2005, CURR OPIN LIPIDOL, V16, P139, DOI 10.1097/01.mol.0000162318.47172.ef; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaffe CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE1008, DOI 10.1152/ajpendo.00513.2001; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Johansson A. G., 1999, Journal of Endocrinological Investigation, V22, P58; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Klein K, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00129; Kurian JR, 2010, ENDOCRINOLOGY, V151, P2297, DOI 10.1210/en.2009-0649; Lamba V, 2010, J PHARMACOL EXP THER, V332, P1088, DOI 10.1124/jpet.109.160804; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Lofgren S, 2008, DRUG METAB DISPOS, V36, P955, DOI 10.1124/dmd.107.019349; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; Mosammaparast N, 2010, ANN REV BIOCH; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oliva CP, 2005, ARTERIOSCL THROM VAS, V25, P411, DOI 10.1161/01.ATV.0000153087.36428.dd; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; Paquette A, 2008, MENOPAUSE, V15, P1169, DOI 10.1097/gme.0b013e31817b8159; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Reinius B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000100; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scandlyn MJ, 2008, EXPERT OPIN DRUG MET, V4, P413, DOI 10.1517/17425255.4.4.413; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010; Staels B, 2009, POSTGRAD MED, V121, P25, DOI 10.3810/pgm.2009.05.suppl53.290; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Tsai HW, 2009, EPIGENETICS-US, V4, P47, DOI 10.4161/epi.4.1.7288; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Wauthier V, 2008, MOL ENDOCRINOL, V22, P1962, DOI 10.1210/me.2007-0549; Wauthier Valerie, 2010, Mol Endocrinol, V24, P667, DOI 10.1210/me.2009-0454; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Westberry JM, 2010, ENDOCRINOLOGY, V151, P731, DOI 10.1210/en.2009-0955; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Williams CM, 2004, P NUTR SOC, V63, P153, DOI 10.1079/PNS2003314; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Wranicz JK, 2005, INT J CARDIOL, V101, P105, DOI 10.1016/j.ijcard.2004.07.010; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhang Z, 2004, MOL BIOL EVOL, V21, P2130, DOI 10.1093/molbev/msh223; Zhao SP, 2007, CLIN CHIM ACTA, V376, P68, DOI 10.1016/j.cca.2006.07.014	93	105	107	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23506	10.1371/journal.pone.0023506	http://dx.doi.org/10.1371/journal.pone.0023506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858147	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953500051
J	Liu, HJ; Tan, YR; Li, ML; Liu, C; Xiang, Y; Qin, XQ				Liu, Hui Jun; Tan, Yu Rong; Li, Meng Lan; Liu, Chi; Xiang, Yang; Qin, Xiao Qun			Cloning of a Novel Protein Interacting with BRS-3 and Its Effects in Wound Repair of Bronchial Epithelial Cells	PLOS ONE			English	Article							LUNG; EXPRESSION; RECEPTORS	Bombesin receptor subtype 3 (BRS-3), the orphan bombesin receptor, may play a role in the regulation of stress responses in lung and airway epithelia. Bombesin receptor activated protein (BRAP) is a novel protein we found in our previous study which interacts with BRS-3. This study was designed to observe the subcellular location and wound repair function of BRAP in human bronchial epithelial cells (HBECs). BRAP ORF was amplified by RT-PCR and ligated to pEGFP-C1 vector, and then the recombinant plasmid pEGFP-C1-BRAP was transfected into Hela cells. The location of BRAP protein was observed by laser confocal microscope, and the expression of it was analyzed by Western-blot. At the same time, we built the recombinant plasmid pcDNA3.1(+)-BRAP, transfected it into HBECs and observed its impact on cell cycle and wound repair of HBECs. The results showed that BRAP locates in membrane and cytoplasm and increases significantly in transfected cells. Flow cytometry results demonstrated that the recombinant plasmid increases S phase plus G2 phase of cell cycle by 25%. Microscopic video analysis system showed that the repair index of wounded HBECs increases by 20% through stable expression of BRAP. The present study demonstrated that BRAP locates in the membrane and cytoplasm, suggesting that this protein is a cytoplasm protein, which promotes cell cycle and wound repair of HBECs.	[Liu, Hui Jun; Tan, Yu Rong; Li, Meng Lan; Liu, Chi; Xiang, Yang; Qin, Xiao Qun] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha 410083, Peoples R China	Central South University	Liu, HJ (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha 410083, Peoples R China.	xiaoqun1988@xysm.net			National Natural Science Foundation of China [30870917]; hunan college innovation platform [10K079]; construct program of the key discipline in Hunan province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); hunan college innovation platform; construct program of the key discipline in Hunan province	This work was supported by grant #30870917 from National Natural Science Foundation of China, grant #10K079 from the open fund of hunan college innovation platform and the construct program of the key discipline in Hunan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Fathi Z, 1996, J CELL BIOCHEM, P237; Gomperts BN, 2007, AM J RESP CELL MOL, V37, P48, DOI 10.1165/rcmb.2006-0384OC; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; KIM JS, 1995, AM J PHYSIOL-LUNG C, V269, pL119, DOI 10.1152/ajplung.1995.269.1.L119; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; Liu Hui-jun, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P178; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Renz H, 2004, PROG BRAIN RES, V146, P325; Shan L, 2004, AM J PHYSIOL-LUNG C, V286, pL165, DOI 10.1152/ajplung.00436.2002; SPINDEL ER, 1993, RECENT PROG HORM RES, V48, P365; TAN Y, 2006, PEPTIDES, V387, P283; Tesfaigzi Y, 2003, ARCH IMMUNOL THER EX, V51, P283; TOISCOTT M, 1996, LUNG CANCER, V17, P111; Wada K, 2006, BIOCHEM BIOPH RES CO, V340, P872, DOI 10.1016/j.bbrc.2005.12.084	15	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23072	10.1371/journal.pone.0023072	http://dx.doi.org/10.1371/journal.pone.0023072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857995	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300019
J	Wang, Y; Wang, JY; Luo, F				Wang, Yan; Wang, Jin-Yan; Luo, Fei			Why Self-Induced Pain Feels Less Painful than Externally Generated Pain: Distinct Brain Activation Patterns in Self- and Externally Generated Pain	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; COROLLARY DISCHARGE INHIBITION; PARAMETRIC FMRI; ELECTRICAL-STIMULATION; STRIDULATING CRICKET; CINGULATE CORTEX; NEURAL ACTIVITY; PASSIVE TOUCH; RESPONSES; TRANSMISSION	Voluntary movement generally inhibits sensory systems. However, it is not clear how such movement influences pain. In the present study, subjects actively or passively experienced mechanical pain or pressure during functional MRI scanning. Pain and pressure were induced using two modified grip strengthener rings, each twined with four crystal bead strings, with polyhedral beads to induce pain, or spherical beads to induce pressure. Subjects held one ring in the left hand and were either asked to squeeze their left hand with their right hand (i.e., active pain or pressure), or to have their left hand squeezed by the experimenter (i.e., passive pain or pressure). Subjects rated the intensity and unpleasantness of the pain sensation lower in the active procedure than in the passive one. Correspondingly, pain-related brain areas were inhibited in the case of self-generated pain, including the primary somatosensory cortex (SI), anterior cingulate cortex (ACC), and the thalamus. These results suggest that active movement behaviorally inhibits concomitant mechanical pain, accompanied by an inhibition of pain response in pain-related brain areas such as the SI cortex. This might be part of the mechanisms underlying the kinesitherapy for pain treatment.	[Wang, Yan; Wang, Jin-Yan; Luo, Fei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Wang, Yan] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, Y (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangjy@psych.ac.cn; luof@psych.ac.cn			NNSF [30700223, 30770688, 30970959]; Beijing NNSF [5082008]; 100 Talented Plan, two Knowledge Innovation Projects [KKCX1-YW-05, KSCX2-YW-R-254]; Chinese Academy of Sciences [YZ200944]; National Hi-Tech Research and Development Program of China [2008AA022604]; NIH Fogarty International Center [R03TW008038]; FOGARTY INTERNATIONAL CENTER [R03TW008038] Funding Source: NIH RePORTER	NNSF(National Natural Science Foundation of China (NSFC)); Beijing NNSF; 100 Talented Plan, two Knowledge Innovation Projects; Chinese Academy of Sciences(Chinese Academy of Sciences); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by a NNSF grant (30700223) to JYW, NNSF grants (30770688 and 30970959), a Beijing NNSF grant (5082008), the 100 Talented Plan, two Knowledge Innovation Projects (KKCX1-YW-05, KSCX2-YW-R-254), and a Scientific Apparatus Development Project of the Chinese Academy of Sciences (YZ200944), the National Hi-Tech Research and Development Program of China (Grant No. 2008AA022604), and a grant from NIH Fogarty International Center (R03TW008038) to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Chen Li-Min, 2008, Shengli Xuebao, V60, P664; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Creac'h C, 2000, AM J NEURORADIOL, V21, P1402; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Freund W, 2009, SOMATOSENS MOT RES, V26, P1, DOI 10.1080/08990220902738243; Freund W, 2007, SOMATOSENS MOT RES, V24, P203, DOI 10.1080/08990220701723636; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; Helmchen C, 2004, NEUROSCI LETT, V361, P237, DOI 10.1016/j.neulet.2003.12.017; Helmchen C, 2006, HUM BRAIN MAPP, V27, P755, DOI 10.1002/hbm.20217; Hsu MC, 2009, PAIN, V143, P262, DOI 10.1016/j.pain.2009.03.017; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; KAKIGI R, 1992, J NEUROL NEUROSUR PS, V55, P282, DOI 10.1136/jnnp.55.4.282; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kieras JE, 2005, PSYCHOL SCI, V16, P391, DOI 10.1111/j.0956-7976.2005.01546.x; Kwiatek R, 2000, ARTHRITIS RHEUM-US, V43, P2823, DOI 10.1002/1529-0131(200012)43:12<2823::AID-ANR24>3.0.CO;2-E; LICHTMAN AH, 1991, BEHAV NEUROSCI, V105, P687, DOI 10.1037/0735-7044.105.5.687; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Luo WH, 2007, BRAIN RES, V1133, P67, DOI 10.1016/j.brainres.2006.09.111; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; Mohr C, 2008, EUR J NEUROSCI, V27, P739, DOI 10.1111/j.1460-9568.2008.06036.x; Mohr C, 2005, PAIN, V114, P347, DOI 10.1016/j.pain.2004.12.036; Monconduit L, 2006, J NEUROSCI, V26, P8441, DOI 10.1523/JNEUROSCI.1293-06.2006; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; Nakata H, 2004, PAIN, V107, P91, DOI 10.1016/j.pain.2003.10.001; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; Poulet JFA, 2005, J COMP PHYSIOL A, V191, P979, DOI 10.1007/s00359-005-0027-z; Poulet JFA, 2003, J NEUROSCI, V23, P4717; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Pruimboom L, 2007, MED HYPOTHESES, V68, P506, DOI 10.1016/j.mehy.2006.08.036; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schmeichel BJ, 2007, J PERS, V75, P743, DOI 10.1111/j.1467-6494.2007.00455.x; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Senapati AK, 2005, BRAIN RES, V1057, P134, DOI 10.1016/j.brainres.2005.07.044; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; Smith AM, 2009, J NEUROPHYSIOL, V102, P3519, DOI 10.1152/jn.00043.2009; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SUGA N, 1972, SCIENCE, V177, P82, DOI 10.1126/science.177.4043.82; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; VOLKMANN FC, 1962, J OPT SOC AM, V52, P571, DOI 10.1364/JOSA.52.000571; Wang JY, 2007, SYNAPSE, V61, P335, DOI 10.1002/syn.20375; Wang JY, 2003, BRAIN RES, V992, P263, DOI 10.1016/j.brainres.2003.08.059; Wang N, 2009, PAIN, V142, P108, DOI 10.1016/j.pain.2008.12.016; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	57	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23536	10.1371/journal.pone.0023536	http://dx.doi.org/10.1371/journal.pone.0023536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812MY	21887267	gold, Green Submitted, Green Published			2022-12-27	WOS:000294298800013
J	Fujii, T; Tsunesumi, S; Yamaguchi, K; Watanabe, S; Furukawa, Y				Fujii, Tomoaki; Tsunesumi, Shin-ichiro; Yamaguchi, Kiyoshi; Watanabe, Sumiko; Furukawa, Yoichi			Smyd3 Is Required for the Development of Cardiac and Skeletal Muscle in Zebrafish	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; EXPRESSION; GENES; HEART; ORGANIZATION; CHROMATIN; GENETICS; ENCODES; PROTEIN; CANCER	Modifications of histone tails are involved in the regulation of a wide range of biological processes including cell cycle, cell survival, cell division, and cell differentiation. Among the modifications, histone methylation plays a critical role in cardiac and skeletal muscle differentiation. In our earlier studies, we found that SMYD3 has methyltransferase activity to histone H3 lysine 4, and that its up-regulation is involved in the tumorigenesis of human colon, liver, and breast. To clarify the role of Smyd3 in development, we have studied its expression patterns in zebrafish embryos and the effect of its suppression on development using Smyd3-specific antisense morpholino-oligonucleotides. We here show that transcripts of smyd3 were expressed in zebrafish embryos at all developmental stages examined and that knockdown of smyd3 in embryos resulted in pericardial edema and defects in the trunk structure. In addition, these phenotypes were associated with abnormal expression of three heart-chamber markers including cmlc2, amhc and vmhc, and abnormal expression of myogenic regulatory factors including myod and myog. These data suggest that Smyd3 plays an important role in the development of heart and skeletal muscle.	[Fujii, Tomoaki; Tsunesumi, Shin-ichiro; Yamaguchi, Kiyoshi; Furukawa, Yoichi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Genome Res, Tokyo, Japan; [Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol Dev Biol, Tokyo, Japan	University of Tokyo; University of Tokyo	Fujii, T (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Genome Res, Tokyo, Japan.	furukawa@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology Japan [17015009]; Grants-in-Aid for Scientific Research [23790126] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid (#17015009) for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Liew HP, 2008, DEV BIOL, V324, P226, DOI 10.1016/j.ydbio.2008.09.020; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Peng YB, 2009, ANIM GENET, V40, P242, DOI 10.1111/j.1365-2052.2008.01818.x; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Roy S, 2004, CURR BIOL, V14, P1772, DOI 10.1016/j.cub.2004.09.046; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Schoenebeck JJ, 2007, SEMIN CELL DEV BIOL, V18, P27, DOI 10.1016/j.semcdb.2006.12.010; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2004, NAT CELL BIOL, V6, P685, DOI 10.1038/ncb0804-685; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Xu YF, 2000, DEV DYNAM, V219, P201, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1043>3.3.CO;2-9; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593; Zhou ZM, 2005, ANN CLIN LAB SCI, V35, P270	33	48	54	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23491	10.1371/journal.pone.0023491	http://dx.doi.org/10.1371/journal.pone.0023491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887258	Green Submitted, Green Published, gold			2022-12-27	WOS:000295832000022
J	Babiychuk, EB; Atanassoff, AP; Monastyrskaya, K; Brandenberger, C; Studer, D; Allemann, C; Draeger, A				Babiychuk, Eduard B.; Atanassoff, Alexander P.; Monastyrskaya, Katia; Brandenberger, Christina; Studer, Daniel; Allemann, Catherine; Draeger, Annette			The Targeting of Plasmalemmal Ceramide to Mitochondria during Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SIMPLE SPHINGOLIPIDS; MOLECULAR MACHINERY; OUTER-MEMBRANE; CELL-DEATH; CALCIUM; ER; TRAFFICKING; DYNAMICS; SPHINGOMYELIN	Ceramide is a key lipid mediator of cellular processes such as differentiation, proliferation, growth arrest and apoptosis. During apoptosis, ceramide is produced within the plasma membrane. Although recent data suggest that the generation of intracellular ceramide increases mitochondrial permeability, the source of mitochondrial ceramide remains unknown. Here, we determine whether a stress-mediated plasmalemmal pool of ceramide might become available to the mitochondria of apoptotic cells. We have previously established annexin A1-a member of a family of Ca(2+) and membrane-binding proteins-to be a marker of ceramide platforms. Using fluorescently tagged annexin A1, we show that, upon its generation within the plasma membrane, ceramide self-associates into platforms that subsequently invaginate and fuse with mitochondria. An accumulation of ceramide within the mitochondria of apoptotic cells was also confirmed using a ceramide-specific antibody. Electron microscopic tomography confirmed that upon the formation of ceramide platforms, the invaginated regions of the plasma membrane extend deep into the cytoplasm forming direct physical contacts with mitochondrial outer membranes. Ceramide might thus be directly transferred from the plasma membrane to the mitochondrial outer membrane. It is conceivable that this "kiss-of-death'' increases the permeability of the mitochondrial outer membrane thereby triggering apoptosis.	[Babiychuk, Eduard B.; Atanassoff, Alexander P.; Monastyrskaya, Katia; Brandenberger, Christina; Studer, Daniel; Allemann, Catherine; Draeger, Annette] Univ Bern, Inst Anat, Bern, Switzerland	University of Bern	Babiychuk, EB (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	draeger@ana.unibe.ch	Studer, Daniel/F-8581-2012; Babiychuk, Eduard/AAV-7223-2021	Monastyrskaya, Katia/0000-0003-2042-1139; Babiychuk, Eduard/0000-0003-1786-0085	Swiss National Science Foundation [320030_128064/1, 3100A0-121980/1, 320000-111778]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by grants from the Swiss National Science Foundation http://www.snf.ch/D/Seiten/default.aspx to AD (320030_128064/1), EB (3100A0-121980/1) and KM (320000-111778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Cowart LA, 2002, J LIPID RES, V43, P2042, DOI 10.1194/jlr.M200241-JLR200; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dolman NJ, 2005, J BIOL CHEM, V280, P15794, DOI 10.1074/jbc.M412694200; Fine M, 2011, J GEN PHYSIOL, V137, P137, DOI 10.1085/jgp.201010469; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; George NM, 2010, J BIOL CHEM, V285, P1384, DOI 10.1074/jbc.M109.049924; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hilgemann DW, 2011, J GEN PHYSIOL, V137, P155, DOI 10.1085/jgp.201010470; Jayadev S, 2000, AM J PHYSIOL-CELL PH, V279, pC1640; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Morales A, 2004, GLYCOCONJUGATE J, V20, P579; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rensing KH, 2002, PROTOPLASMA, V220, P39, DOI 10.1007/s00709-002-0033-8; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; VANCE JE, 1991, J BIOL CHEM, V266, P89; VERDURMEN WP, 2010, J CONTROL RELEASE; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	54	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23706	10.1371/journal.pone.0023706	http://dx.doi.org/10.1371/journal.pone.0023706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886813	gold, Green Submitted, Green Published			2022-12-27	WOS:000294128100026
J	Han, J; Seaman, WE; Di, XM; Wang, W; Willingham, M; Torti, FM; Torti, SV				Han, Jian; Seaman, William E.; Di, Xiumin; Wang, Wei; Willingham, Mark; Torti, Frank M.; Torti, Suzy V.			Iron Uptake Mediated by Binding of H-Ferritin to the TIM-2 Receptor in Mouse Cells	PLOS ONE			English	Article							HUMAN ERYTHROID PRECURSORS; SERUM FERRITIN; HEAVY-CHAIN; IN-VIVO; T-CELL; PROTEIN; METABOLISM; EXPRESSION; MECHANISM; SITES	Ferritin binds specifically and saturably to a variety of cell types, and recently several ferritin receptors have been cloned. TIM-2 is a specific receptor for H ferritin (HFt) in the mouse. TIM-2 is a member of the T cell immunoglobulin and mucin domain containing (TIM) protein family and plays an important role in immunity. The expression of TIM-2 outside of the immune system indicates that this receptor may have broader roles. We tested whether ferritin binding to TIM-2 can serve as an iron delivery mechanism. TIM-2 was transfected into normal (TCMK-1) mouse kidney cells, where it was appropriately expressed on the cell surface. HFt was labeled with Fe-55 and Fe-55-HFt was incubated with TIM-2 positive cells or controls. Fe-55-HFt uptake was observed only in TIM-2 positive cells. HFt uptake was also seen in A20 B cells, which express endogenous TIM-2. TIM-2 levels were not increased by iron chelation. Uptake of Fe-55-HFt was specific and temperature-dependent. HFt taken up by TIM-2 positive cells transited through the endosome and eventually entered a lysosomal compartment, distinguishing the HFt pathway from that of transferrin, the classical vehicle for cellular iron delivery. Iron delivered following binding of HFt to TIM-2 entered the cytosol and became metabolically available, resulting in increased levels of endogenous intracellular ferritin. We conclude that TIM-2 can function as an iron uptake pathway.	[Han, Jian] N Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC USA; [Seaman, William E.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Seaman, William E.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Di, Xiumin; Wang, Wei; Torti, Frank M.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Willingham, Mark] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA; [Willingham, Mark; Torti, Frank M.; Torti, Suzy V.] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Torti, Suzy V.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA	University of North Carolina; North Carolina A&T State University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Han, J (corresponding author), N Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC USA.	storti@wfubmc.edu			National Institutes of Health [R01 AI061164, R01 DK071892, R37 DK42412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042412, R01DK071892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health (R01 AI061164 [WES], R01 DK071892 [SVT], and R37 DK42412 [FMT]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PC, 1988, HEPATOLOGY, V8, P719, DOI 10.1002/hep.1840080402; Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; ANDERSON GJ, 1989, BRIT J HAEMATOL, V73, P260, DOI 10.1111/j.1365-2141.1989.tb00262.x; ARAD I, 1988, AM J PERINAT, V5, P40, DOI 10.1055/s-2007-999651; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Barabanova YA, 2004, IMMUNOLOGY, V111, P165, DOI 10.1111/j.0019-2805.2003.01772.x; Bresgen N, 2007, J CELL PHYSIOL, V212, P157, DOI 10.1002/jcp.21009; BROXMEYER HE, 1989, BLOOD, V73, P74; CAZZOLA M, 1985, TUMORI, V71, P547, DOI 10.1177/030089168507100606; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; CLEGG GA, 1980, PROG BIOPHYS MOL BIO, V36, P53; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; COHEN LA, 2010, BLOOD; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; dos Santos CO, 2008, J BIOL CHEM, V283, P26956, DOI 10.1074/jbc.M802421200; FARGION S, 1988, BLOOD, V71, P753; FARGION S, 1991, CURR STUD HEMATOL BL, V58, P164; FISH WW, 1980, METHOD ENZYMOL, V158, P357; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Hulet SW, 2002, DEV NEUROSCI-BASEL, V24, P208, DOI 10.1159/000065704; Hulet SW, 1999, J NEUROCHEM, V72, P868, DOI 10.1046/j.1471-4159.1999.720868.x; Jiang Y, 2006, J BIOL CHEM, V281, P9058, DOI 10.1074/jbc.M507874200; Knickelbein JE, 2006, J IMMUNOL, V177, P4966, DOI 10.4049/jimmunol.177.8.4966; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; KONIJN AM, 1981, BRIT J HAEMATOL, V49, P361, DOI 10.1111/j.1365-2141.1981.tb07238.x; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Leimberg MJ, 2008, J CELL BIOCHEM, V103, P1211, DOI 10.1002/jcb.21499; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; MACK U, 1983, J BIOL CHEM, V258, P4672; MATZNER Y, 1979, BRIT J HAEMATOL, V42, P345, DOI 10.1111/j.1365-2141.1979.tb01142.x; Meyron-Holtz EG, 1999, BLOOD, V94, P3205, DOI 10.1182/blood.V94.9.3205.421k25_3205_3211; MOSS D, 1992, J LAB CLIN MED, V120, P239; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; RAMM GA, 1994, J CLIN INVEST, V94, P9, DOI 10.1172/JCI117353; Recalcati S, 2008, J AUTOIMMUN, V30, P84, DOI 10.1016/j.jaut.2007.11.003; Rennert PD, 2006, J IMMUNOL, V177, P4311, DOI 10.4049/jimmunol.177.7.4311; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; SANTAMBROGIO P, 1987, BRIT J HAEMATOL, V65, P235, DOI 10.1111/j.1365-2141.1987.tb02271.x; SIBILLE JC, 1988, HEPATOLOGY, V8, P296, DOI 10.1002/hep.1840080218; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; TAKAMI M, 1986, BIOCHIM BIOPHYS ACTA, V884, P31, DOI 10.1016/0304-4165(86)90223-0; Todorich B, 2008, J NEUROCHEM, V107, P1495, DOI 10.1111/j.1471-4159.2008.05678.x; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Torti S V, 1994, Adv Inorg Biochem, V10, P119; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Watanabe N, 2007, HEPATOLOGY, V45, P1240, DOI 10.1002/hep.21539; Yuan XM, 2004, FREE RADICAL RES, V38, P1133, DOI 10.1080/10715760400011692	57	50	51	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23800	10.1371/journal.pone.0023800	http://dx.doi.org/10.1371/journal.pone.0023800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886823	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100032
J	Brachtl, G; Sahakyan, K; Denk, U; Girbl, T; Alinger, B; Hofbauer, SW; Neureiter, D; Hofbauer, JP; Egle, A; Greil, R; Hartmann, TN				Brachtl, Gabriele; Sahakyan, Karine; Denk, Ursula; Girbl, Tamara; Alinger, Beate; Hofbauer, Sebastian W.; Neureiter, Daniel; Hofbauer, Josefina Pinon; Egle, Alexander; Greil, Richard; Hartmann, Tanja Nicole			Differential Bone Marrow Homing Capacity of VLA-4 and CD38 High Expressing Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							B-CELLS; PROGNOSTIC PARAMETER; ADHESION MOLECULE-1; CXCR4 EXPRESSION; SURVIVAL; ACTIVATION; SIGNALS; RELEVANCE; MIGRATION; NETWORK	Background: VLA-4 and CD38 predict a poor clinical outcome in chronic lymphocytic leukemia (CLL). We used CLL samples with discordant VLA-4/CD38 risk to address their individual roles in human bone marrow infiltration (BM), CLL cell homing to murine BM, and in supportive CLL cell-stromal cell interactions. Methods: VLA-4, CD38, and Ki-67 expression was measured in CLL cells from peripheral blood (PB) and bone marrow (BM) aspirates. CLL BM infiltration rates, routinely determined by Pathology, were correlated to VLA-4 and CD38 expression. Short-term homing capacity of CLL cells was evaluated by adoptive transfer experiments. CLL cell viability and adhesion in stromal cell co-culture was determined. Results: About 20% of CLL samples in our cohort displayed discordant VLA-4 and CD38 risk, with either high VLA-4 and low CD38 risk or vice versa. Using particularly such samples, we observed that VLA-4, and not CD38, was responsible for recirculation of CLL cells to murine BM. Human BM infiltration was also significantly higher in patients with high VLA-4 risk but not high CD38 risk. However, both molecules acted as independent prognostic markers. While both VLA-4 and CD38 expression were increased in BM-derived CLL cells, and VLA-4+ and CD38+ subpopulations showed enriched Ki-67 expression, VLA-4 did not contribute to CLL cell protection by stromal cells in vitro. Conclusions: Our data argue for a prominent role of VLA-4 but not CD38 expression in the homing of CLL cells to BM niches and in human BM infiltration, but only a limited role in their protection by stromal cells.	[Brachtl, Gabriele; Sahakyan, Karine; Denk, Ursula; Girbl, Tamara; Hofbauer, Sebastian W.; Hofbauer, Josefina Pinon; Egle, Alexander; Greil, Richard; Hartmann, Tanja Nicole] Private Med Univ Hosp, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Alinger, Beate; Neureiter, Daniel] Paracelsus Med Univ, Inst Pathol, Salzburg, Austria	Paracelsus Private Medical University	Brachtl, G (corresponding author), Private Med Univ Hosp, Lab Immunol & Mol Canc Res, Salzburg, Austria.	t.hartmann@salk.at	Hofbauer, Josefina Pinon/S-6826-2019; Egle, Alexander/AAC-3787-2020; Greil, Richard F/C-7673-2017; Hartmann, Tanja Nicole/C-9345-2017; Hartmann, Tanja Nicole/AAA-6735-2020; Hartmann, Tanja Nicole/C-9345-2017	Egle, Alexander/0000-0003-0648-4416; Greil, Richard F/0000-0002-4462-3694; Hartmann, Tanja Nicole/0000-0002-0377-7179; Hartmann, Tanja Nicole/0000-0002-0377-7179; Brachtl, Gabriele/0000-0002-2688-2940; Girbl, Tamara/0000-0001-7632-478X; Pinon Hofbauer, Josefina/0000-0002-8558-9031; Hartmann, Tanja Nicole/0000-0002-2633-7301	Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH [P021]; Austrian National Bank [13420]; Austrian Science Foundation [P021, P19481-B12, L488-B13]; province of Salzburg; Austrian Academy of Sciences	Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH; Austrian National Bank; Austrian Science Foundation(Austrian Science Fund (FWF)); province of Salzburg; Austrian Academy of Sciences	This work was supported by the Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH, SFB program P021 to RG, grants from the Austrian National Bank (no. 13420 to TNH), the Austrian Science Foundation (FWF no. P19481-B12, L488-B13 to AE, SFB program P021 to RG), and the province of Salzburg. GB was a recipient of a DOC-FFORTE-fellowship of the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Coscia M, 2011, LEUKEMIA, V25, P828, DOI 10.1038/leu.2011.12; Dal-Bo M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-76; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Deaglio S, 2003, BLOOD, V102, P2146, DOI 10.1182/blood-2003-03-0989; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Deaglio S, 2007, BLOOD, V109, P5390, DOI 10.1182/blood-2006-12-061812; Deaglio S, 2006, BLOOD, V108, P1135, DOI 10.1182/blood-2006-01-013003; Gallay N, 2007, CANCER RES, V67, P8624, DOI 10.1158/0008-5472.CAN-07-0402; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Goichberg P, 2006, BLOOD, V107, P870, DOI 10.1182/blood-2005-03-0941; Hartmann TN, 2009, CANCER RES, V69, P3121, DOI 10.1158/0008-5472.CAN-08-4136; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; ROZMAN C, 1984, BLOOD, V64, P642; Schweighofer Carmen Diana, 2008, Curr Hematol Malig Rep, V3, P54, DOI 10.1007/s11899-008-0009-7; Shanafelt TD, 2008, BRIT J HAEMATOL, V140, P537, DOI 10.1111/j.1365-2141.2007.06965.x; Shiozawa Y, 2008, LEUKEMIA, V22, P941, DOI 10.1038/leu.2008.48; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Vaisitti T, 2010, LEUKEMIA, V24, P958, DOI 10.1038/leu.2010.36; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	27	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23758	10.1371/journal.pone.0023758	http://dx.doi.org/10.1371/journal.pone.0023758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876768	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900040
J	Kavanagh, DH; Savage, DA; Patterson, CC; McKnight, AJ; Crean, JK; Maxwell, AP; McKay, GJ				Kavanagh, David H.; Savage, David A.; Patterson, Christopher C.; McKnight, Amy Jayne; Crean, John K.; Maxwell, Alexander P.; McKay, Gareth J.		Warren 3 Uk GoKinD Study Grp	Association Analysis of Canonical Wnt Signalling Genes in Diabetic Nephropathy	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; EXPRESSION; FIBROSIS; MATRIX	Aims/Hypothesis: Several studies have provided compelling evidence implicating the Wnt signalling pathway in the pathogenesis of diabetic nephropathy. Gene expression profiles associated with renal fibrosis have been attenuated through Wnt pathway modulation in model systems implicating Wnt pathway members as potential therapeutic targets for the treatment of diabetic nephropathy. We assessed tag and potentially functional single nucleotide polymorphisms (SNPs; n = 31) in four key Wnt pathway genes (CTNNB1, AXIN2, LRP5 and LRP6) for association with diabetic nephropathy using a case-control design. Methods: SNPs were genotyped using Sequenom or Taqman technologies in 1351 individuals with type 1 diabetes (651 cases with nephropathy and 700 controls without nephropathy). Cases and controls were white and recruited from the UK and Ireland. Association analyses were performed using PLINK, to compare allele and haplotype frequencies in cases and controls. Adjustment for multiple testing was performed by permutation testing. Results: Following logistic regression analysis adjusted by collection centre, duration of T1D, and average HbA1c as covariates, a single SNP in LRP6 (rs1337791) was significantly associated with DN (OR = 0.74; CI: 0.57-0.97; P = 0.028), although this was not maintained following correction for multiple testing. Three additional SNPs (rs2075241 in LRP6; rs3736228 and rs491347 both in LRP5) were marginally associated with diabetic nephropathy, but none of the associations were replicated in an independent dataset. Haplotype and subgroup analysis (according to duration of diabetes, and end-stage renal disease) also failed to reveal an association with diabetic nephropathy. Conclusions/Interpretation: Our results suggest that analysed common variants in CTNNB1, AXIN2, LRP5 and LRP6 are not strongly associated with diabetic nephropathy in type 1 diabetes among white individuals. Our findings, however, cannot entirely exclude these genes or other members of the Wnt pathway, from involvement in the pathogenesis of diabetic nephropathy as our study had limited power to detect variants with small effect size.	[Kavanagh, David H.; McKnight, Amy Jayne; Maxwell, Alexander P.; McKay, Gareth J.] Queens Univ Belfast, Nephrol Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Savage, David A.] Belfast City Hosp, Histocompatibil & Immunogenet Lab, Blood Transfus Serv, Belfast BT9 7AD, Antrim, North Ireland; [Patterson, Christopher C.] Queens Univ Belfast, Epidemiol Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Crean, John K.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	Queens University Belfast; Belfast City Hospital; Queens University Belfast; University College Dublin	Kavanagh, DH (corresponding author), Queens Univ Belfast, Nephrol Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	g.j.mckay@qub.ac.uk	McKay, Gareth/AAZ-2601-2020; McKnight, Amy Jayne/ABF-4492-2020; Savage, David A./AAP-6101-2020; McKnight, AJ/B-2450-2009	McKay, Gareth/0000-0001-8197-6280; McKnight, Amy Jayne/0000-0002-7482-709X; Maxwell, Alexander P./0000-0002-6110-7253; /0000-0002-4337-6177	Northern Ireland Kidney Research Fund (NIKRF); Northern Ireland Research and Development Office; Diabetes UK; Juvenile Diabetes Research Foundation; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Public Health Agency [STL/3714/07] Funding Source: researchfish	Northern Ireland Kidney Research Fund (NIKRF); Northern Ireland Research and Development Office; Diabetes UK(Diabetes UK); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Public Health Agency	David H. Kavanagh is supported by a Northern Ireland Kidney Research Fund (NIKRF) PhD studentship. We thank the NIKRF and Northern Ireland Research and Development Office for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Warren 3/UK GoKinD Study Group was jointly funded by Diabetes UK and the Juvenile Diabetes Research Foundation and includes the following individuals: Belfast: Professor A. P. Maxwell, Dr A. J. McKnight, Dr D. A. Savage; Edinburgh: Dr J. Walker; London: Dr S. Thomas, Professor G. C. Viberti; Manchester: Professor A. J. M. Boulton; Newcastle: Professor S. Marshall; Plymouth: Professor A. G. Demaine and Dr B. A. Millward; Swansea: Professor S. C. Bain.	Gradl D, 1999, MOL CELL BIOL, V19, P5576; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hughes TA, 2005, J BIOL CHEM, V280, P8581, DOI 10.1074/jbc.M410806200; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Kavanagh D, 2011, DIABETOLOGIA, V54, P334, DOI 10.1007/s00125-010-1978-3; Lin CL, 2010, J AM SOC NEPHROL, V21, P124, DOI 10.1681/ASN.2008101059; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Ullmann U, 2008, MOL HUM REPROD, V14, P169, DOI 10.1093/molehr/gan001; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031	13	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23904	10.1371/journal.pone.0023904	http://dx.doi.org/10.1371/journal.pone.0023904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876774	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900046
J	Kerschgens, J; Renaud, S; Schutz, F; Grasso, L; Egener-Kuhn, T; Delaloye, JF; Lehr, HA; Vogel, H; Mermod, N				Kerschgens, Jan; Renaud, Stephanie; Schuetz, Frederic; Grasso, Luigino; Egener-Kuhn, Tanja; Delaloye, Jean-Francois; Lehr, Hans-Anton; Vogel, Horst; Mermod, Nicolas			Protein-Binding Microarray Analysis of Tumor Suppressor AP2 alpha Target Gene Specificity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; CELL-CYCLE ARREST; DNA-BINDING; CANCER-CELLS; HUMAN TISSUE; HUMAN GENOME; APOPTOSIS INDUCTION; KALLIKREIN GENE-5; CARCINOMA-CELLS; E-CADHERIN	Cheap and massively parallel methods to assess the DNA-binding specificity of transcription factors are actively sought, given their prominent regulatory role in cellular processes and diseases. Here we evaluated the use of protein-binding microarrays (PBM) to probe the association of the tumor suppressor AP2 alpha with 6000 human genomic DNA regulatory sequences. We show that the PBM provides accurate relative binding affinities when compared to quantitative surface plasmon resonance assays. A PBM-based study of human healthy and breast tumor tissue extracts allowed the identification of previously unknown AP2 alpha target genes and it revealed genes whose direct or indirect interactions with AP2 alpha are affected in the diseased tissues. AP2 alpha binding and regulation was confirmed experimentally in human carcinoma cells for novel target genes involved in tumor progression and resistance to chemotherapeutics, providing a molecular interpretation of AP2 alpha role in cancer chemoresistance. Overall, we conclude that this approach provides quantitative and accurate assays of the specificity and activity of tumor suppressor and oncogenic proteins in clinical samples, interfacing genomic and proteomic assays.	[Kerschgens, Jan; Renaud, Stephanie; Egener-Kuhn, Tanja; Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland; [Schuetz, Frederic] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Grasso, Luigino; Vogel, Horst] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, Lausanne, Switzerland; [Egener-Kuhn, Tanja] Ecole Polytech Fed Lausanne, Natl Competence Ctr Biomed Imaging, Lausanne, Switzerland; [Delaloye, Jean-Francois; Lehr, Hans-Anton] CHU Vaudois, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kerschgens, J (corresponding author), Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland.	nicolas.mermod@unil.ch	Vogel, Horst/AAJ-5490-2021		University of Lausanne; Cancer Swiss Research Foundation	University of Lausanne; Cancer Swiss Research Foundation	Work in Dr. Mermod's lab is supported by a priority grant from the University of Lausanne and by an OncoSuisse grant of the Cancer Swiss Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babini E, 2004, BIOCHEMISTRY-US, V43, P16076, DOI 10.1021/bi048388o; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; BAUER R, 1994, NUCLEIC ACIDS RES, V22, P1413, DOI 10.1093/nar/22.8.1413; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Berger Michael F., 2006, V338, P245; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Collavin L, 1998, GENOMICS, V48, P265, DOI 10.1006/geno.1997.5172; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dong Y, 2003, CLIN CANCER RES, V9, P1710; Dong Y, 2008, BIOL CHEM, V389, P99, DOI 10.1515/BC.2008.013; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Egener T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni079; Esnault G, 2009, MOL CELL BIOL, V29, P2409, DOI 10.1128/MCB.00779-08; FOHR UG, 1993, EUR J BIOCHEM, V215, P719, DOI 10.1111/j.1432-1033.1993.tb18084.x; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Johnson W, 1997, J BIOL CHEM, V272, P15405, DOI 10.1074/jbc.272.24.15405; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerschgens J, 2009, TRENDS MOL MED, V15, P352, DOI 10.1016/j.molmed.2009.06.004; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Marreiros A, 2005, ONCOGENE, V24, P637, DOI 10.1038/sj.onc.1208216; Masternak K, 2000, GENE DEV, V14, P1156; McPherson LA, 2002, J BIOL CHEM, V277, P45028, DOI 10.1074/jbc.M208924200; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; NYBORG JK, 1990, J BIOL CHEM, V265, P8230; Obiezu CV, 2005, CANCER LETT, V224, P1, DOI 10.1016/j.canlet.2004.09.024; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Orso F, 2008, FASEB J, V22, P2702, DOI 10.1096/fj.08-106492; Pellikainen JM, 2007, INT J CANCER, V120, P2061, DOI 10.1002/ijc.22648; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; Planque C, 2005, BIOCHEM BIOPH RES CO, V329, P1260, DOI 10.1016/j.bbrc.2005.02.100; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; *R DEV COR TEAM T, 2004, R LANG ENV STAT COMP; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Sgorbissa A, 1999, J CELL SCI, V112, P4475; Shinoda Y, 2007, CANCER SCI, V98, P1078, DOI 10.1111/j.1349-7006.2007.00495.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Thomadaki H, 2009, THROMB HAEMOSTASIS, V101, P373, DOI 10.1160/TH08-01-0025; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vrba L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-486; Wajapeyee N, 2005, CANCER RES, V65, P8628, DOI 10.1158/0008-5472.CAN-05-1059; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; Yousef GM, 2003, CLIN BIOCHEM, V36, P443, DOI 10.1016/S0009-9120(03)00055-9; Yousef GM, 2002, UROLOGY, V60, P714, DOI 10.1016/S0090-4295(02)01811-3; Yousef GM, 2002, PROSTATE, V51, P126, DOI 10.1002/pros.10067	73	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22895	10.1371/journal.pone.0022895	http://dx.doi.org/10.1371/journal.pone.0022895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876733	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900005
J	Ludwig, K; Habbach, S; Krieglstein, J; Klumpp, S; Konig, S				Ludwig, Katrin; Habbach, Schaehdi; Krieglstein, Josef; Klumpp, Susanne; Koenig, Simone			MALDI-TOF High Mass Calibration up to 200 kDa Using Human Recombinant 16 kDa Protein Histidine Phosphatase Aggregates	PLOS ONE			English	Article							SUBSTRATE	Background: Protein histidine phosphatase (PHP) is an enzyme which removes phosphate groups from histidine residues. It was described for vertebrates in the year 2002. The recombinant human 16 kDa protein forms multimeric complexes in physiological buffer and in the gas phase. High-mass calibration in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has remained a problem due to the lack of suitable standards. Large proteins can hardly be freed of their substructural microheterogeneity by classical purification procedures so that their use as calibrants is limited. A small adduct-forming protein of validated quality is a valuable alternative for that purpose. Methodology/Principal Findings: Three major PHP clusters of similar to 113, 209 and similar to 600 kDa were observed in gel filtration analysis. Re-chromatography of the monomer peak showed the same cluster distribution. The tendency to associate was detected also in MALDI-TOF MS measuring regular adducts up to 200 kDa. Conclusions/Significance: PHP forms multimers consisting of up to more than 35 protein molecules. In MALDI-TOF MS it generates adduct ions every 16 kDa. The protein can be produced with high quality so that its use as calibration compound for high mass ranges above 100 kDa, where standards are difficult to obtain, is feasible.	[Koenig, Simone] Univ Munster, Core Unit, Interdisciplinary Ctr Clin Res, Fac Med, Munster, Germany; [Ludwig, Katrin; Habbach, Schaehdi; Krieglstein, Josef; Klumpp, Susanne] Univ Munster, Inst Pharmaceut & Med Chem, Munster, Germany	University of Munster; University of Munster	Ludwig, K (corresponding author), Univ Munster, Inst Pharmaceut & Med Chem, Munster, Germany.	koenigs@uni-muenster.de	König, Simone/B-6504-2008	König, Simone/0000-0003-0672-7246	Interdisciplinary Center for Clinical Research of the Medical Faculty of the University of Muenster; Institute of Pharmaceutical and Medical Chemistry, Muenster, Germany	Interdisciplinary Center for Clinical Research of the Medical Faculty of the University of Muenster; Institute of Pharmaceutical and Medical Chemistry, Muenster, Germany	This work was supported by the Interdisciplinary Center for Clinical Research of the Medical Faculty of the University of Muenster and the Institute of Pharmaceutical and Medical Chemistry, Muenster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumer Nicole, 2007, V365, P247; Ek P, 2002, EUR J BIOCHEM, V269, P5016, DOI 10.1046/j.1432-1033.2002.03206.x; Klumpp S, 2002, J CEREBR BLOOD F MET, V22, P1420, DOI 10.1097/01.wcb.0000045041.03034.99; Klumpp S, 2003, BIOCHEM BIOPH RES CO, V306, P110, DOI 10.1016/S0006-291X(03)00920-3; Konig S, 1998, ANAL CHEM, V70, P4453, DOI 10.1021/ac980169j; LUDWIG K, 2008, THESIS MUNSTER; LUDWIG K, 2010, BIOMACROMOL MASS SPE, V2, P89; MA NT, 2009, THESIS MUNSTER; Maurer A, 2005, BIOCHEM BIOPH RES CO, V334, P1115, DOI 10.1016/j.bbrc.2005.06.200; MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P1158, DOI 10.1002/rcm.1290091215; Srivastava S, 2008, P NATL ACAD SCI USA, V105, P14442, DOI 10.1073/pnas.0803678105	11	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23612	10.1371/journal.pone.0023612	http://dx.doi.org/10.1371/journal.pone.0023612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876758	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900030
J	Xiao, TZ; Bhatia, N; Urrutia, R; Lomberk, GA; Simpson, A; Longley, BJ				Xiao, Tony Z.; Bhatia, Neehar; Urrutia, Raul; Lomberk, Gwen A.; Simpson, Andrew; Longley, B. Jack			MAGE I Transcription Factors Regulate KAP1 and KRAB Domain Zinc Finger Transcription Factor Mediated Gene Repression	PLOS ONE			English	Article							TUMOR-ANTIGENS; CELL-LINES; PROTEIN; CANCER; FAMILY; RESISTANCE; COMPLEXES; MELANOMA; KS1	Class I MAGE proteins (MAGE I) are normally expressed only in developing germ cells but are aberrantly expressed in many cancers. They have been shown to promote tumor survival, aggressive growth, and chemoresistance but the underlying mechanisms and MAGE I functions have not been fully elucidated. KRAB domain zinc finger transcription factors (KZNFs) are the largest group of vertebrate transcription factors and regulate neoplastic transformation, tumor suppression, cellular proliferation, and apoptosis. KZNFs bind the KAP1 protein and direct KAP1 to specific DNA sequences where it suppresses gene expression by inducing localized heterochromatin characterized by histone 3 lysine 9 trimethylation (H3me3K9). Discovery that MAGE I proteins also bind to KAP1 prompted us to investigate whether MAGE I can affect KZNF and KAP1 mediated gene regulation. We found that expression of MAGE I proteins, MAGE-A3 or MAGE-C2, relieved repression of a reporter gene by ZNF382, a KZNF with tumor suppressor activity. ChIP of MAGE I (-) HEK293T cells showed KAP1 and H3me3K9 are normally bound to the ID1 gene, a target of ZNF382, but that binding is greatly reduced in the presence of MAGE I proteins. MAGE I expression relieved KAP1 mediated ID1 repression, causing increased expression of ID1 mRNA and ID1 chromatin relaxation characterized by loss of H3me3K9. MAGE I binding to KAP1 also induced ZNF382 poly-ubiquitination and degradation, consistent with loss of ZNF382 leading to decreased KAP1 binding to ID1. In contrast, MAGE I expression caused increased KAP1 binding to Ki67, another KAP1 target gene, with increased H3me3K9 and decreased Ki67 mRNA expression. Since KZNFs are required to direct KAP1 to specific genes, these results show that MAGE I proteins can differentially regulate members of the KZNF family and KAP1 mediated gene repression.	[Xiao, Tony Z.; Bhatia, Neehar; Longley, B. Jack] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Urrutia, Raul; Lomberk, Gwen A.] Mayo Clin, Dept Mol Neurosci, Dept Biochem & Mol Biol, Rochester, MN USA; [Urrutia, Raul; Lomberk, Gwen A.] Mayo Clin, Gastroenterol Res Unit, Rochester, MN USA; [Simpson, Andrew] Ludwig Inst Canc Res, New York, NY USA; [Longley, B. Jack] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Mayo Clinic; Ludwig Institute for Cancer Research; University of Wisconsin System; University of Wisconsin Madison	Xiao, TZ (corresponding author), Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	Txiao@dermatology.wisc.edu; bjlongley@dermatology.wisc.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X	University of Wisconsin Department of Dermatology; Ludwig Institute for Cancer Research; Paul P. Carbone Comprehensive Cancer Center; National Institutes of Health [1T32AR055893-01A1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR055893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	University of Wisconsin Department of Dermatology; Ludwig Institute for Cancer Research; Paul P. Carbone Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the University of Wisconsin Department of Dermatology and the Ludwig Institute for Cancer Research. This work was partially supported by the Paul P. Carbone Comprehensive Cancer Center. TZX is a recipient of a National Institutes of Health T32 training award (1T32AR055893-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATIA BYN, 2011, ARCH BIOCH BIOPHYSIC; Brichard VG, 2007, VACCINE, V25, pB61, DOI 10.1016/j.vaccine.2007.06.038; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Chomez P, 2001, CANCER RES, V61, P5544; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Park JH, 2002, MOL CELLS, V14, P122; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548	23	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23747	10.1371/journal.pone.0023747	http://dx.doi.org/10.1371/journal.pone.0023747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876767	Green Submitted, gold, Green Published			2022-12-27	WOS:000294126900039
J	Goldfeder, RL; Parker, SCJ; Ajay, SS; Abaan, HO; Margulies, EH				Goldfeder, Rachel L.; Parker, Stephen C. J.; Ajay, Subramanian S.; Abaan, Hatice Ozel; Margulies, Elliott H.			A Bioinformatics Approach for Determining Sample Identity from Different Lanes of High-Throughput Sequencing Data	PLOS ONE			English	Article							MAP	The ability to generate whole genome data is rapidly becoming commoditized. For example, a mammalian sized genome (similar to 3Gb) can now be sequenced using approximately ten lanes on an Illumina HiSeq 2000. Since lanes from different runs are often combined, verifying that each lane in a genome's build is from the same sample is an important quality control. We sought to address this issue in a post hoc bioinformatic manner, instead of using upstream sample or "barcode" modifications. We rely on the inherent small differences between any two individuals to show that genotype concordance rates can be effectively used to test if any two lanes of HiSeq 2000 data are from the same sample. As proof of principle, we use recent data from three different human samples generated on this platform. We show that the distributions of concordance rates are non-overlapping when comparing lanes from the same sample versus lanes from different samples. Our method proves to be robust even when different numbers of reads are analyzed. Finally, we provide a straightforward method for determining the gender of any given sample. Our results suggest that examining the concordance of detected genotypes from lanes purported to be from the same sample is a relatively simple approach for confirming that combined lanes of data are of the same identity and quality.	[Goldfeder, Rachel L.; Parker, Stephen C. J.; Ajay, Subramanian S.; Abaan, Hatice Ozel; Margulies, Elliott H.] NHGRI, Genome Informat Sect, Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Goldfeder, RL (corresponding author), NHGRI, Genome Informat Sect, Technol Branch, NIH, Bethesda, MD 20892 USA.	emargulies@illumina.com	Parker, Stephen/ABF-1063-2021		National Human Genome Research Institute at the National Institutes of Health, USA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200341] Funding Source: NIH RePORTER	National Human Genome Research Institute at the National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the intramural research program of the National Human Genome Research Institute at the National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAY SS, 2011, GENOME RES IN PRESS; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; LANDER E S, 1988, Genomics, V2, P231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; 2001, NATURE, V409, P928, DOI DOI 10.1038/35057149	11	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23683	10.1371/journal.pone.0023683	http://dx.doi.org/10.1371/journal.pone.0023683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858207	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300083
J	Das, A; Bhadra, K; Kumar, GS				Das, Abhi; Bhadra, Kakali; Kumar, Gopinatha Suresh			Targeting RNA by Small Molecules: Comparative Structural and Thermodynamic Aspects of Aristololactam-beta-D-glucoside and Daunomycin Binding to tRNA(phe)	PLOS ONE			English	Article							PLANT ALKALOID PALMATINE; SELF-STRUCTURE INDUCTION; INDIAN MEDICINAL-PLANTS; PHENANTHRENE DERIVATIVES; STRANDED POLY(A); RIBOSOMAL-RNA; A-FORM; DNA; AMINOGLYCOSIDE; RECOGNITION	Background: Interaction of aristololactam-beta-D-glucoside and daunomycin with tRNA(phe) was investigated using various biophysical techniques. Methodology/Principal Findings: Absorption and fluorescence studies revealed that both the compounds bind tRNA(phe) non-cooperatively. The binding of daunomycin was about one order of magnitude higher than that of aristololactam-beta-Dglucoside. Stronger binding of the former was also inferred from fluorescence quenching data, quantum efficiency values and circular dichroic results. Results from isothermal titration calorimetry experiments suggested that the binding of both compounds was predominantly entropy driven with a smaller but favorable enthalpy term that increased with temperature. A large favorable electrostatic contribution to the binding of daunomycin to tRNA(phe) was revealed from salt dependence data and the dissection of the free energy values. The electrostatic component to the free energy change for aristololactam-beta-D-glucoside-tRNA(phe) interaction was smaller than that of daunomycin. This was also inferred from the slope of log K versus [Na+] plots. Both compounds enhanced the thermal stability of tRNA(phe). The small heat capacity changes of -47 and -99 cal/mol K, respectively, observed for aristololactam-b-D-glucoside and daunomycin, and the observed enthalpy-entropy compensation phenomenon confirmed the involvement of multiple weak noncovalent interactions. Molecular aspects of the interaction have been revealed. Conclusions/Significance: This study presents the structural and eneregetic aspects of the binding of aristololactam-b-Dglucoside and daunomycin to tRNA(phe).	[Das, Abhi; Bhadra, Kakali; Kumar, Gopinatha Suresh] Indian Inst Chem Biol, Council Sci & Ind Res, Biophys Chem Lab, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, A (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Biophys Chem Lab, Kolkata, W Bengal, India.	gskumar@csiriicb.in	Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020; Kumar, Gopinatha Suresh/W-1461-2019	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604; 	CSIR, Government of India [NWP0036]; CSIR	CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Network Project NWP0036 of CSIR, Government of India, CSIR Senior Research Fellowship (to AD) and CSIR Research Associateship (to KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARI B, 1984, ORG MAGN RESONANCE, V22, P741, DOI 10.1002/mrc.1270221202; Balachandran P, 2005, KIDNEY INT, V67, P1797, DOI 10.1111/j.1523-1755.2005.00277.x; Bhadra K, 2007, BBA-GEN SUBJECTS, V1770, P1071, DOI 10.1016/j.bbagen.2007.03.001; Buchmueller KL, 2006, BIOCHEMISTRY-US, V45, P13551, DOI 10.1021/bi061245c; Buurma NJ, 2007, METHODS, V42, P162, DOI 10.1016/j.ymeth.2007.01.010; CASSADY JM, 1990, J NAT PROD, V53, P23, DOI 10.1021/np50067a003; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; CHAIRES JB, 1987, BIOCHEMISTRY-US, V26, P8227, DOI 10.1021/bi00399a031; Chaires JB, 1996, ANTI-CANCER DRUG DES, V11, P569; CHAIRES JB, 1990, BIOPHYS CHEM, V35, P191, DOI 10.1016/0301-4622(90)80008-U; CHAIRES JB, 1982, BIOCHEMISTRY-US, V21, P3933, DOI 10.1021/bi00260a005; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; CHAKRABORTY S, 1990, BIOCHEM PHARMACOL, V39, P1181, DOI 10.1016/0006-2952(90)90260-R; CHAMBERS HF, 1996, GOODMAN GILMANS PHAR; Chao PW, 2007, BIOORGAN MED CHEM, V15, P3825, DOI 10.1016/j.bmc.2007.03.025; Chen Z., 1988, ALKALOIDS CHEM PHARM, V31; Cheong HK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh081; Das A, 2011, BIOPHYS CHEM, V155, P10, DOI 10.1016/j.bpc.2011.01.011; Esau CC, 2007, ADV DRUG DELIVER REV, V59, P101, DOI 10.1016/j.addr.2007.03.007; Feig AL, 2007, BIOPOLYMERS, V87, P293, DOI 10.1002/bip.20816; Foloppe N, 2006, DRUG DISCOV TODAY, V11, P1019, DOI 10.1016/j.drudis.2006.09.001; Fulle S, 2010, J MOL RECOGNIT, V23, P220, DOI 10.1002/jmr.1000; Gallego J, 2001, ACCOUNTS CHEM RES, V34, P836, DOI 10.1021/ar000118k; Garbett NC, 2004, BIOPHYS J, V87, P3974, DOI 10.1529/biophysj.104.047415; Giri P, 2006, BIOORG MED CHEM LETT, V16, P2364, DOI 10.1016/j.bmcl.2006.01.124; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Giri P, 2007, BBA-GEN SUBJECTS, V1770, P1419, DOI 10.1016/j.bbagen.2007.05.005; Giri P, 2006, INT J BIOL MACROMOL, V39, P210, DOI 10.1016/j.ijbiomac.2006.03.026; Giri P, 2009, CURR MED CHEM, V16, P965, DOI 10.2174/092986709787581932; Guthrie KM, 2007, BIOPHYS CHEM, V126, P117, DOI 10.1016/j.bpc.2006.05.006; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3; HARFORD JB, 1995, GENE EXPRESSION, V4, P357; Hermann T, 2002, BIOCHIMIE, V84, P869, DOI 10.1016/S0300-9084(02)01460-8; Hossain M, 2008, DNA CELL BIOL, V27, P81, DOI 10.1089/dna.2007.0652; Hossain M, 2009, MOL BIOSYST, V5, P1311, DOI 10.1039/b909563b; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Islam MM, 2008, J MOL STRUCT, V891, P498, DOI 10.1016/j.molstruc.2008.04.043; Islam MM, 2009, MOL BIOSYST, V5, P244, DOI 10.1039/b816480k; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; Job P, 1928, ANN CHIM FRANCE, V9, P113; Kanakis CD, 2009, SPECTROSC-INT J, V23, P29, DOI 10.1155/2009/154321; Kaul M, 2002, BIOCHEMISTRY-US, V41, P7695, DOI 10.1021/bi020130f; KUMAR CV, 1992, J CHEM SOC CHEM COMM, P470, DOI 10.1039/c39920000470; Lakowicz J.R., 1983, PRINCIPLE FLUORESCEN; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Murphy FV, 2000, STRUCT FOLD DES, V8, pR83, DOI 10.1016/S0969-2126(00)00126-X; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; N'soukpoe-Kossi CN, 2009, BIOCHEM CELL BIOL, V87, P621, DOI [10.1139/O09-036, 10.1139/o09-036]; NANDI R, 1991, BIOCHEMISTRY-US, V30, P3715, DOI 10.1021/bi00229a018; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Nguyen B, 2006, BIOPHYS J, V90, P1319, DOI 10.1529/biophysj.105.071381; Ouameur AA, 2010, RNA, V16, P1968, DOI 10.1261/rna.1994310; PAKRASHI SC, 1977, PHYTOCHEMISTRY, V16, P1103, DOI 10.1016/S0031-9422(00)86755-2; Ray A, 1999, BIOCHEMISTRY-US, V38, P6239, DOI 10.1021/bi982128n; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Ren JS, 2000, BIOCHEMISTRY-US, V39, P8439, DOI 10.1021/bi000474a; RIESNER D, 1973, EUR J BIOCHEM, V36, P76, DOI 10.1111/j.1432-1033.1973.tb02887.x; SHAFER RH, 1977, BIOCHEM PHARMACOL, V26, P1729, DOI 10.1016/0006-2952(77)90154-X; Sinha R, 2006, BIOORGAN MED CHEM, V14, P800, DOI 10.1016/j.bmc.2005.09.007; Suh D, 2002, NUCLEOS NUCLEOT NUCL, V21, P637, DOI 10.1081/NCN-120015722; Sun T, 2008, NUCLEIC ACIDS RES, V36, P1654, DOI 10.1093/nar/gkm1180; Tor Y, 1998, CHEM BIOL, V5, pR277, DOI 10.1016/S1074-5521(98)90286-1; Tor Y, 1999, ANGEW CHEM INT EDIT, V38, P1579, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1579::AID-ANIE1579>3.0.CO;2-H; Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684; Walter F, 1999, CURR OPIN CHEM BIOL, V3, P694, DOI 10.1016/S1367-5931(99)00028-9; Wang H, 1997, J AM CHEM SOC, V119, P8734, DOI 10.1021/ja9715105; Yadav RC, 2005, BIOORGAN MED CHEM, V13, P165, DOI 10.1016/j.bmc.2004.09.045	70	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23186	10.1371/journal.pone.0023186	http://dx.doi.org/10.1371/journal.pone.0023186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858023	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500020
J	Du Pasquier, D; Dupre, A; Jessus, C				Du Pasquier, David; Dupre, Aude; Jessus, Catherine			Unfertilized Xenopus Eggs Die by Bad-Dependent Apoptosis under the Control of Cdk1 and JNK	PLOS ONE			English	Article							BCL-X-L; CELL-DEATH; OOCYTE APOPTOSIS; PROTEIN PHOSPHATASE-1; MEIOTIC MATURATION; SIGNALING PATHWAY; STARFISH EGGS; MOUSE OOCYTES; OKADAIC ACID; PHOSPHORYLATION	Ovulated eggs possess maternal apoptotic execution machinery that is inhibited for a limited time. The fertilized eggs switch off this time bomb whereas aged unfertilized eggs and parthenogenetically activated eggs fail to stop the timer and die. To investigate the nature of the molecular clock that triggers the egg decision of committing suicide, we introduce here Xenopus eggs as an in vivo system for studying the death of unfertilized eggs. We report that after ovulation, a number of eggs remains in the female body where they die by apoptosis. Similarly, ovulated unfertilized eggs recovered in the external medium die within 72 h. We showed that the death process depends on both cytochrome c release and caspase activation. The apoptotic machinery is turned on during meiotic maturation, before fertilization. The death pathway is independent of ERK but relies on activating Bad phosphorylation through the control of both kinases Cdk1 and JNK. In conclusion, the default fate of an unfertilized Xenopus egg is to die by a mitochondrial dependent apoptosis activated during meiotic maturation.	[Du Pasquier, David; Dupre, Aude; Jessus, Catherine] CNRS, UMR Biol Dev 7622, Paris, France; [Du Pasquier, David; Dupre, Aude; Jessus, Catherine] Univ Paris 06, UMR Biol Dev 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Du Pasquier, D (corresponding author), WatchFrog, Evry, France.	catherine.jessus@upmc.fr		Du Pasquier, David/0000-0002-1890-4564	CNRS (Centre National de la Recherche Scientifique); UPMC (Universite Pierre et Marie Curie); ARC (Association pour la Recherche contre le Cancer) [3969]; ANR (Agence Nationale pour la Recherche) [BLAN07-3_185404]	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); UPMC (Universite Pierre et Marie Curie); ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR))	This work was supported by grants from CNRS (Centre National de la Recherche Scientifique), UPMC (Universite Pierre et Marie Curie), ARC (Association pour la Recherche contre le Cancer, N<SUP>o</SUP>3969 to C.J.) and ANR (Agence Nationale pour la Recherche, BLAN07-3_185404 to C.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Austin C R, 1970, J Reprod Fertil Suppl, V12, P39; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhakar AL, 2003, J NEUROSCI, V23, P11373; BRUN G, 1981, EUR J BIOCHEM, V118, P407; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Coen L, 2001, P NATL ACAD SCI USA, V98, P7869, DOI 10.1073/pnas.141226798; De Smedt V, 2002, J BIOL CHEM, V277, P28592, DOI 10.1074/jbc.M202742200; Deming Paula, 2006, V322, P379; Domingos PM, 2007, CURR OPIN GENET DEV, V17, P294, DOI 10.1016/j.gde.2007.05.009; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frank-Vaillant M, 1999, MOL BIOL CELL, V10, P3279, DOI 10.1091/mbc.10.10.3279; Fujino Y, 1996, HUM REPROD, V11, P1480; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; GORIS J, 1989, FEBS LETT, V245, P91, DOI 10.1016/0014-5793(89)80198-X; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Haccard O, 2006, CELL CYCLE, V5, P1152, DOI 10.4161/cc.5.11.2800; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Huchon D, 1981, NATURE, V294, P358, DOI 10.1038/294358a0; JESSUS C, 1991, DEVELOPMENT, V111, P813; Jessus C, 2007, NATURE, V449, P297, DOI 10.1038/449297a; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Klumpp S, 2003, NEUROCHEM INT, V42, P555, DOI 10.1016/S0197-0186(02)00174-2; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane JD, 2001, J CELL BIOL, V153, P1415, DOI 10.1083/jcb.153.7.1415; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Mood K, 2004, CELL SIGNAL, V16, P631, DOI 10.1016/j.cellsig.2003.10.005; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Perez GI, 1997, HUM REPROD, V12, P2781, DOI 10.1093/humrep/12.12.2781; Perez GI, 2000, NATURE, V403, P500, DOI 10.1038/35000651; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rowe I, 2005, DEV DYNAM, V233, P76, DOI 10.1002/dvdy.20312; Sadler KC, 2004, MOL REPROD DEV, V67, P366, DOI 10.1002/mrd.20023; Saitoh T, 2009, BIOCHEM BIOPH RES CO, V384, P491, DOI 10.1016/j.bbrc.2009.05.004; Sasaki K, 2001, DEV BIOL, V237, P18, DOI 10.1006/dbio.2001.0337; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; Tsuchiya Y, 2005, FEBS J, V272, P2237, DOI 10.1111/j.1742-4658.2005.04648.x; Tsuchiya Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175927; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; WALKER DH, 1992, MOL BIOL CELL, V3, P687, DOI 10.1091/mbc.3.6.687; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Yuce O, 2001, DEV BIOL, V237, P29, DOI 10.1006/dbio.2001.0361; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576; Zhou Y, 2009, MOL CELL BIOL, V29, P1786, DOI 10.1128/MCB.01815-08	67	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23672	10.1371/journal.pone.0023672	http://dx.doi.org/10.1371/journal.pone.0023672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858202	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500040
J	Griffin, M; Iqbal, SA; Sebastian, A; Colthurst, J; Bayat, A				Griffin, Michelle; Iqbal, Syed Amir; Sebastian, Anil; Colthurst, James; Bayat, Ardeshir			Degenerate Wave and Capacitive Coupling Increase Human MSC Invasion and Proliferation While Reducing Cytotoxicity in an In Vitro Wound Healing Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PULSED ELECTROMAGNETIC-FIELD; BONE-MARROW; ELECTRICAL-STIMULATION; MYOCARDIAL-INFARCTION; CLINICAL-IMPLICATIONS; TISSUE INHIBITOR; COLLAGEN I; MIGRATION; REPAIR	Non-unions pose complications in fracture management that can be treated using electrical stimulation (ES). Bone marrow mesenchymal stem cells (BMMSCs) are essential in fracture healing; however, the effect of different clinical ES waveforms on BMMSCs cellular activities remains unknown. We compared the effects of direct current (DC), capacitive coupling (CC), pulsed electromagnetic field (PEMF) and degenerate wave (DW) on cellular activities including cytotoxicity, proliferation, cell-kinetics and apoptosis by stimulating human-BMMSCs 3 hours a day, up to 5 days. In addition, migration and invasion were assessed using fluorescence microscopy and by quantifying gene and protein expression. We found that DW had the greatest proliferative and least apoptotic and cytotoxic effects compared to other waveforms. DC, DW and CC stimulations resulted in a higher number of cells in S phase and G(2)/M phase as shown by cell cycle analysis. CC and DW caused more cells to invade collagen and showed increased MMP-2 and MT1-MMP expression. DC increased cellular migration in a scratch-wound assay and all ES waveforms enhanced expression of migratory genes with DC having the greatest effect. All ES treated cells showed similar progenitor potential as determined by MSC differentiation assay. All above findings were shown to be statistically significant (p<0.05). We conclude that ES can influence BMMSCs activities, especially DW and CC, which show greater invasion and higher cell proliferation compared to other types of ES. Application of DW or CC to the fracture site may help in the recruitment of BMMSCs to the wound that may enhance rate of bone healing at the fracture site.	[Griffin, Michelle; Iqbal, Syed Amir; Sebastian, Anil; Bayat, Ardeshir] Univ Manchester, Sch Translat Med, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Colthurst, James] Fenzian Ltd, Hungerford, Berks, England; [Bayat, Ardeshir] S Manchester Univ Hosp Fdn Trust, Wythenshawe Hosp, Dept Plast & Reconstruct Surg, Manchester, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Manchester Acad Hlth Sci Ctr, S Manchester Univ Hosp Fdn Trust, Wythenshawe Hosp, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Griffin, M (corresponding author), Univ Manchester, Sch Translat Med, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	ardeshir.bayat@manchester.ac.uk		BAYAT, ARDESHIR/0000-0002-4116-6491	National Institute of Health and Research (NIHR), United Kingdom; GATT Family Foundation (USA); Fenzian Ltd	National Institute of Health and Research (NIHR), United Kingdom(National Institute for Health Research (NIHR)); GATT Family Foundation (USA); Fenzian Ltd	Senior author (AB) would like to acknowledge personal funding from National Institute of Health and Research (NIHR), United Kingdom, GATT Family Foundation (USA), and partial funding from Fenzian Ltd for their work in bone repair and regeneration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; BRASHEAR HR, 1965, J BONE JOINT SURG AM, VA 47, P174, DOI 10.2106/00004623-196547010-00015; Callaghan MJ, 2008, PLAST RECONSTR SURG, V121, P130, DOI 10.1097/01.prs.0000293761.27219.84; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Cho MR, 2000, ANN BIOMED ENG, V28, P234, DOI 10.1114/1.263; Chung R, 2009, BONE, V44, P878, DOI 10.1016/j.bone.2009.01.377; Cypher T J, 1996, J Foot Ankle Surg, V35, P413; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; Dezawa M, 2005, EXPERT OPIN BIOL TH, V5, P427, DOI 10.1517/14712598.5.4.427; EBERHARDT A, 1986, Acta Physiologica Polonica, V37, P41; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Fiedler J, 2006, BIOCHEM BIOPH RES CO, V345, P1177, DOI 10.1016/j.bbrc.2006.05.034; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; FITZSIMMONS RJ, 1992, J CELL PHYSIOL, V150, P84, DOI 10.1002/jcp.1041500112; Fujii H, 1999, HISTOCHEM CELL BIOL, V112, P131, DOI 10.1007/s004180050399; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Hartig M, 2000, EUR BIOPHYS J BIOPHY, V29, P499, DOI 10.1007/s002490000100; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Iqbal SA, 2010, BR J DERMATOL; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Kim HK, 2010, JPN J OPHTHALMOL, V54, P221, DOI 10.1007/s10384-009-0793-1; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Li XF, 2002, J VASC RES, V39, P391, DOI 10.1159/000064517; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; MACKLIS RM, 1993, ANN INTERN MED, V118, P376, DOI 10.7326/0003-4819-118-5-199303010-00009; Neuss S, 2010, CELLS TISSUES ORGANS, V191, P36, DOI 10.1159/000215579; NIEDZWIEDZKI T, 1993, BIOMATERIALS, V14, P115, DOI 10.1016/0142-9612(93)90221-M; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Sato T, 2008, JPN J OPHTHALMOL, V52, P217, DOI 10.1007/s10384-008-0533-y; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Sebastian A, EXP DERMATOL; Sebastian A, 2011, EXP DERMATOL, V20, P64, DOI 10.1111/j.1600-0625.2010.01150.x; Shumakov VI, 2003, B EXP BIOL MED+, V136, P192, DOI 10.1023/A:1026387411627; Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tsai MT, 2009, J ORTHOP RES, V27, P1169, DOI 10.1002/jor.20862; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Zhang XJ, 2007, ELECTROMAGN BIOL MED, V26, P167, DOI 10.1080/15368370701580756	50	36	37	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23404	10.1371/journal.pone.0023404	http://dx.doi.org/10.1371/journal.pone.0023404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858102	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500031
J	Kim, HS; Choi, HC; Cho, B; Lee, JY; Kwon, MJ				Kim, Hyun Su; Choi, Ho Chun; Cho, Belong; Lee, Joon Yong; Kwon, Min Jeong			Effect of the H1N1 Influenza Pandemic on the Incidence of Epidemic Keratoconjunctivitis and on Hygiene Behavior: A Cross-Sectional Study	PLOS ONE			English	Article							RESPONSES; OUTBREAK	Background: EKC is transmitted chiefly by direct hand contact. It is suspected that the 2009/2010 influenza pandemic influenced hand washing. This study aims to examine the relationship between the 2009/2010 H1N1 influenza pandemic and hygiene behavior. Methods: We compared the EKC prevalence trends before, during and after the 2009/2010 influenza pandemic by using a t-test comparison of EKC sentinel surveillance. Results: During the pre-pandemic period, the incidence of EKC increased from the 21st to the 44th week each year. However, during the pandemic period in 2009, there was no epidemic peak. In the post-pandemic period, the epidemic curve was similar to that in the pre-pandemic period. Compared to the pre-pandemic period, the total number of EKC patients during the pandemic period showed a decrease of 44.9% (t value = -7.23, p = 0.002). Comparing the pre-pandemic and pandemic periods by age group, we found there to be a significant decrease in the number of EKC patients for all age groups (-4.12 <= t value <=-27.23, all P<0.05). This finding was most evident in the teenage group (62%) compared to the other age groups (decreases of 29 to 44%). Conclusions: A continuing effort should be made to educate the public on basic infection prevention behaviors in the aftermath of the pandemic, particularly to teenagers.	[Kim, Hyun Su; Choi, Ho Chun; Cho, Belong] Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea; [Lee, Joon Yong] Korea Univ, Guro Hosp, Dept Family Med, Seoul, South Korea; [Kwon, Min Jeong] Korea Ctr Dis Control & Prevent, Div Infect Dis Surveillance, Chungcheongbuk Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control	Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea.	Belong@snu.ac.kr	Cho, Belong/GLU-3443-2022	Cho, Belong/0000-0001-9558-689X; Lee, Junyong/0000-0001-9467-9277				Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413; Aoki Koki, 2002, International Ophthalmology Clinics, V42, P49; Azar MJ, 1996, AM J OPHTHALMOL, V121, P711, DOI 10.1016/S0002-9394(14)70640-3; Chaberny IF, 2003, INFECT CONT HOSP EP, V24, P514, DOI 10.1086/502247; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Gottsch J D, 1999, Ophthalmic Epidemiol, V6, P29; Jung SH, 2010, PERSONAL HYGIENE BEH; Kang S, 2010, J CLIN MICROBIOL, V48, P2177, DOI 10.1128/JCM.00209-10; Kim JH, 2010, J KOREAN MED SCI, V25, P709; Korea Centers for Disease Control and Prevention, 2010, PAND AL STAT DOWNGR; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lee Dong Han, 2010, J Prev Med Public Health, V43, P99, DOI 10.3961/jpmph.2010.43.2.99; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; Manning S, 2010, EURO SURVEILL; Park JO, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-14; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Schmidt WP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-390; Stefkovicova M., 2005, Central European Journal of Public Health, V13, P29; WHO, 2010, H1N1 POSTP PER; Wong LP, 2010, PREV MED, V51, P92, DOI 10.1016/j.ypmed.2010.04.010; Yuan J, 2009, EPIDEMIOL INFECT, V137, P988, DOI 10.1017/S0950268809002726	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23444	10.1371/journal.pone.0023444	http://dx.doi.org/10.1371/journal.pone.0023444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858118	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500033
J	Shen, SK; Yang, WJ; Wang, ZG; Lei, X; Xu, LQ; Wang, Y; Wang, LZ; Huang, L; Yu, ZW; Zhang, XH; Li, J; Chen, Y; Zhao, XP; Yin, XL; Zhang, CP				Shen, Shukun; Yang, Wenjun; Wang, Zhugang; Lei, Xia; Xu, Liqun; Wang, Yang; Wang, Lizhen; Huang, Lei; Yu, Zhiwei; Zhang, Xinhong; Li, Jiang; Chen, Yan; Zhao, Xiaoping; Yin, Xuelai; Zhang, Chenping			Tumor-Initiating Cells Are Enriched in CD44(hi) Population in Murine Salivary Gland Tumor	PLOS ONE			English	Article							CANCER STEM-CELL; PLEOMORPHIC ADENOMAS; IDENTIFICATION; SUBPOPULATION; INDUCTION; CARCINOMA; PLAG1; MICE	Tumor-initiating cells (T-ICs) discovered in various tumors have been widely reported. However, T-IC populations in salivary gland tumors have yet to be elucidated. Using the established Pleomorphic Adenoma Gene-1 (Plag1) transgenic mouse model of a salivary gland tumor, we identified CD44(high) (CD44(hi)) tumor cells, characterized by high levels of CD44 cell surface expression, as the T-ICs for pleomorphic adenomas. These CD44(hi) tumor cells incorporated 5-bromo-2-deoxyuridine (BrdU), at a lower rate than their CD44(negative) (CD44(neg)) counterparts, and also retained BrdU for a long period of time. Cell surface maker analysis revealed that 25% of the CD44(hi) tumor cells co-express other cancer stem cell markers such as CD133 and CD117. As few as 500 CD44(hi) tumor cells were sufficient to initiate pleomorphic adenomas in one third of the wildtype mice, whereas more than 1 x 10(4) CD44(neg) cells were needed for the same purpose. In NIH 3T3 cells, Plag1 was capable of activating the gene transcription of Egr1, a known upregulator for CD44. Furthermore, deletion of sequence 81-96 in the Egr1 promoter region abolished the effect of Plag1 on Egr1 upregulation. Our results establish the existence of T-ICs in murine salivary gland tumors, and suggest a potential molecular mechanism for CD44 upregulation.	[Shen, Shukun; Yang, Wenjun; Xu, Liqun; Wang, Yang; Yu, Zhiwei; Yin, Xuelai; Zhang, Chenping] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Dept Oral & Maxillofacial Surg,Sch Med, Shanghai 200030, Peoples R China; [Shen, Shukun; Yang, Wenjun; Xu, Liqun; Wang, Yang; Yu, Zhiwei; Yin, Xuelai; Zhang, Chenping] Shanghai Key Lab Stomatol, Lab Oral Tumor & Oral Biol, Shanghai, Peoples R China; [Shen, Shukun; Yang, Wenjun; Xu, Liqun; Wang, Yang; Yu, Zhiwei; Yin, Xuelai; Zhang, Chenping] Shanghai Res Inst Stomatol, Shanghai, Peoples R China; [Wang, Zhugang; Lei, Xia; Huang, Lei; Zhang, Xinhong; Chen, Yan; Zhao, Xiaoping] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Model Organism Div, Shanghai 200030, Peoples R China; [Wang, Lizhen; Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Dept Oral Pathol,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, WJ (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Dept Oral & Maxillofacial Surg,Sch Med, Shanghai 200030, Peoples R China.	wenjun_yang2009@163.com; chenping_zhang2009@163.com		Chen, Yan/0000-0001-5325-1151	National Natural Science Foundation of China [30772432, 30772430]; Ministry of Education of China [20070248062]; Shanghai Jiao Tong University School of Medicine; Shanghai Municipal Education Commission; Science and Technology Commission of Shanghai Municipality [10dz1951300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Shanghai Jiao Tong University School of Medicine; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China 30772432 and 30772430, as well as the Doctoral Fund from the Ministry of Education of China 20070248062 and Doctoral Construction Fund of Shanghai Jiao Tong University School of Medicine. It was also partially supported by the Program for Innovative Research Team of Shanghai Municipal Education Commission and by the Research Grants (10dz1951300) from the Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Declercq J, 2005, CANCER RES, V65, P4544, DOI 10.1158/0008-5472.CAN-04-4041; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; GILLIS AJ, 2011, INT J ANDRO IN PRESS; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Laskawi R, 1998, BRIT J ORAL MAX SURG, V36, P48, DOI 10.1016/S0266-4356(98)90748-3; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sabesan T, 2007, BRIT J ORAL MAX SURG, V45, P65, DOI 10.1016/j.bjoms.2005.04.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith BH, 2011, CANCER RES, V71, P716, DOI 10.1158/0008-5472.CAN-10-2254; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XD, 2006, INT J CANCER, V118, P643, DOI 10.1002/ijc.21400; Zhao Xu-dong, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P390; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	38	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23282	10.1371/journal.pone.0023282	http://dx.doi.org/10.1371/journal.pone.0023282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858056	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500024
J	Amunugama, R; Fishel, R				Amunugama, Ravindra; Fishel, Richard			Subunit Interface Residues F129 and H294 of Human RAD51 Are Essential for Recombinase Function	PLOS ONE			English	Article							DNA STRAND-EXCHANGE; REPLICATION PROTEIN-A; COLI RECA PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; METHANOCOCCUS-VOLTAE; ATP BINDING; HYDROLYSIS; OVEREXPRESSION; FILAMENT	RAD51 mediated homologous recombinational repair (HRR) of DNA double-strand breaks (DSBs) is essential to maintain genomic integrity. RAD51 forms a nucleoprotein filament (NPF) that catalyzes the fundamental homologous pairing and strand exchange reaction (recombinase) required for HRR. Based on structural and functional homology with archaeal and yeast RAD51, we have identified the human RAD51 (HsRAD51) subunit interface residues HsRad51(F129) in the Walker A box and HsRad51(H294) in the L2 ssDNA binding region as potentially important participants in salt-induced conformational transitions essential for recombinase activity. We demonstrate that the HsRad51(F129V) and HsRad51(H294V) substitution mutations reduce DNA dependent ATPase activity and are largely defective in the formation of a functional NPF, which ultimately eliminates recombinase catalytic functions. Our data are consistent with the conclusion that the HsRAD51(F129) and HsRAD51(H294) residues are important participants in the cation-induced allosteric activation of HsRAD51.	[Amunugama, Ravindra] Ohio State Univ, Med Ctr, Biophys Grad Program, Columbus, OH 43210 USA; [Amunugama, Ravindra; Fishel, Richard] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Amunugama, Ravindra; Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Amunugama, R (corresponding author), Ohio State Univ, Med Ctr, Biophys Grad Program, Columbus, OH 43210 USA.	rfishel@osu.edu			National Institutes of Health [GM080176]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant GM080176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Grigorescu AA, 2009, NUCLEIC ACIDS RES, V37, P557, DOI 10.1093/nar/gkn973; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu YL, 2004, J MOL BIOL, V337, P817, DOI 10.1016/j.jmb.2004.02.022; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renodon-Corniere A, 2008, J MOL BIOL, V383, P575, DOI 10.1016/j.jmb.2008.08.030; Reymer A, 2009, P NATL ACAD SCI USA, V106, P13248, DOI 10.1073/pnas.0902723106; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Schild D, 2010, NUCLEIC ACIDS RES, V38, P1061, DOI 10.1093/nar/gkp1063; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shim KS, 2006, DNA REPAIR, V5, P718, DOI 10.1016/j.dnarep.2006.03.006; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8845; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8829; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	43	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23071	10.1371/journal.pone.0023071	http://dx.doi.org/10.1371/journal.pone.0023071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857994	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953500017
J	Dicko, A; Barry, A; Dicko, M; Diallo, AI; Tembine, I; Dicko, Y; Dara, N; Sidibe, Y; Santara, G; Conare, T; Chandramohan, D; Cousens, S; Milligan, PJ; Diallo, DA; Doumbo, OK; Greenwood, B				Dicko, Alassane; Barry, Amadou; Dicko, Mohamed; Diallo, Abdoulbaki I.; Tembine, Intimbeye; Dicko, Yahia; Dara, Niawanlou; Sidibe, Youssoufa; Santara, Gaoussou; Conare, Toumani; Chandramohan, Daniel; Cousens, Simon; Milligan, Paul J.; Diallo, Diadier A.; Doumbo, Ogobara K.; Greenwood, Brian			Malaria Morbidity in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria in Mali: A Randomized Control Trial	PLOS ONE			English	Article							ANEMIA	Background: Intermittent preventive treatment of malaria in children (IPTc) is a promising strategy for malaria control. A study conducted in Mali in 2008 showed that administration of three courses of IPTc with sulphadoxine-pyrimethamine (SP) and amodiaquine (AQ) at monthly intervals reduced clinical malaria, severe malaria and malaria infection by >80% in children under 5 years of age. Here we report the results of a follow-on study undertaken to establish whether children who had received IPTc would be at increased risk of malaria during the subsequent malaria transmission season. Methods: Morbidity from malaria and the prevalence of malaria parasitaemia and anaemia were measured in children who had previously received IPTc with SP and AQ using similar surveillance methods to those employed during the previous intervention period. Results: 1396 of 1508 children (93%) who had previously received IPTc and 1406 of 1508 children (93%) who had previously received placebos were followed up during the high malaria transmission season of the year following the intervention. Incidence rates of clinical malaria during the post-intervention transmission season (July -November 2009) were 1.87 (95% CI 1.76-1.99) and 1.73 (95% CI; 1.62-1.85) episodes per child year in the previous intervention and placebo groups respectively; incidence rate ratio (IRR) 1.09 (95% CI 0.99-1.21) (P = 0.08). The prevalence of malaria infection was similar in the two groups, 7.4% versus 7.5%, prevalence ratio (PR) of 0.99 (95% CI 0.73-1.33) (P = 0.95). At the end of post-intervention malaria transmission season, the prevalence of anaemia, defined as a haemoglobin concentration <11g/dL, was similar in the two groups (56.2% versus 55.6%; PR = 1.01 [95% CI 0.91-1.12]) (P = 0.84). Conclusion: IPTc with SP+AQ was not associated with an increase in incidence of malaria episodes, prevalence of malaria infection or anaemia in the subsequent malaria transmission season.	[Dicko, Alassane; Barry, Amadou; Dicko, Mohamed; Diallo, Abdoulbaki I.; Tembine, Intimbeye; Dicko, Yahia; Dara, Niawanlou; Sidibe, Youssoufa; Santara, Gaoussou; Doumbo, Ogobara K.] Univ Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali; [Conare, Toumani] Ctr Sante Reference Kati, Kati, Mali; [Chandramohan, Daniel; Cousens, Simon; Milligan, Paul J.; Diallo, Diadier A.; Greenwood, Brian] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Bamako; University of London; London School of Hygiene & Tropical Medicine	Dicko, A (corresponding author), Univ Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali.	adicko@icermali.org	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395	Bill & Melinda Gates Foundation [41783]; Malian Ministry of the Health; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Malian Ministry of the Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant to the London School of Hygiene & Tropical Medicine from the Bill & Melinda Gates Foundation (Grant number: 41783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are very grateful to the study participants, the study populations, the members of community health associations and the staff of the health centres of Djoliba, Siby and Ouelessebougou for their cooperation throughout the study. Special thanks to Dr Amit Bhasin, Manuela Claite, the Mali Service Center for proving administrative and financial services support to the project. The authors' special thanks goes also to the members of the Data and Safety Monitoring Board, (Prof Geoffrey Targett (chair), Dr Jim Todd, Dr Daniel Ansong, Dr Fousseni Dao and Dr Tatiana Keita and Dr Helena Gatakaa) to the local Medical Monitor Dr Aminata Diallo and to the Malian Ministry of the Health for their support and advice. The authors are grateful to the Malaria Diagnosis Centre of Excellence of Kisumu for the external quality control of slides reading, Prof Sekou F Traore and his team for the determination of the entomological data collection and analysis, to Dr Harparkash Kaur for performing analysis for the quality control of the study drugs and for determination of insecticide concentration on the samples of bednets. The authors thank KINAPHARMA Limited who manufactured the trial drugs and the World Swim against Malaria for help in obtaining and distributing LLINs.	Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Boulanger D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-363; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012223; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; *WHO, 2009, SOFTW ASS GROWTH DEV; *WHO, 2009, WORLD MAL REP; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976	16	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23390	10.1371/journal.pone.0023390	http://dx.doi.org/10.1371/journal.pone.0023390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858096	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000293953500035
J	Guillaume, S; Jaussent, I; Olie, E; Genty, C; Bringer, J; Courtet, P; Schmidt, U				Guillaume, Sebastien; Jaussent, Isabelle; Olie, Emilie; Genty, Catherine; Bringer, Jacques; Courtet, Philippe; Schmidt, Ulrike			Characteristics of Suicide Attempts in Anorexia and Bulimia Nervosa: A Case-Control Study	PLOS ONE			English	Article							EATING-DISORDERS; EXCESS MORTALITY; BEHAVIOR; NEUROBIOLOGY; COMORBIDITY; IMPULSIVITY; DEPRESSION; VALIDATION; PREDICTOR; SCALE	Objective: Compared to other eating disorders, anorexia nervosa (AN) has the highest rates of completed suicide whereas suicide attempt rates are similar or lower than in bulimia nervosa (BN). Attempted suicide is a key predictor of suicide, thus this mismatch is intriguing. We sought to explore whether the clinical characteristics of suicidal acts differ between suicide attempters with AN, BN or without an eating disorders (ED). Method: Case-control study in a cohort of suicide attempters (n = 1563). Forty-four patients with AN and 71 with BN were compared with 235 non-ED attempters matched for sex, age and education, using interview measures of suicidal intent and severity. Results: AN patients were more likely to have made a serious attempt (OR = 3.4, 95% CI 1.4-7.9), with a higher expectation of dying (OR = 3.7, 95% CI 1.1-13.5), and an increased risk of severity (OR = 3.4, 95% CI 1.2-9.6). BN patients did not differ from the control group. Clinical markers of the severity of ED were associated with the seriousness of the attempt. Conclusion: There are distinct features of suicide attempts in AN. This may explain the higher suicide rates in AN. Higher completed suicide rates in AN may be partially explained by AN patients' higher desire to die and their more severe and lethal attempts.	[Guillaume, Sebastien; Jaussent, Isabelle; Olie, Emilie; Genty, Catherine; Courtet, Philippe] INSERM, U1061, Montpellier, France; [Guillaume, Sebastien; Courtet, Philippe] Univ Montpellier I, Montpellier, France; [Guillaume, Sebastien; Olie, Emilie; Courtet, Philippe] CHU Montpellier, Hop Lapeyronie, Psychiat Emergency & Post Emergency Dept, Montpellier, France; [Guillaume, Sebastien; Schmidt, Ulrike] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Bringer, Jacques] CHU Montpellier, Dept Endocrinol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of London; King's College London; Universite de Montpellier; CHU de Montpellier	Guillaume, S (corresponding author), INSERM, U1061, Montpellier, France.	guillaumesebastien@ymail.com		Jaussent, Isabelle/0000-0002-8205-7590; guillaume, sebastien/0000-0002-6769-9982	CHU Montpellier [PHRC UF 7653]; Agence Nationale de la Recherche; l'Institut Servier; NIHR Biomedical Research Centre for Mental Health, South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institute of Health (NIHR) [RP-PG-0606-1043]	CHU Montpellier; Agence Nationale de la Recherche(French National Research Agency (ANR)); l'Institut Servier; NIHR Biomedical Research Centre for Mental Health, South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London(General Electric); National Institute of Health (NIHR)(National Institute for Health Research (NIHR))	This study received financial support from CHU Montpellier (PHRC UF 7653, Ph Courtet PI) and Agence Nationale de la Recherche (ANR NEURO 2007 "GENESIS", Ph Courtet PI). S. Guillaume received a grant from l'Institut Servier. Ulrike Schmidt is supported by the NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London and by a National Institute of Health (NIHR) Programme Grant for Applied Research (Reference number RP-PG-0606-1043). The views expressed herein are not necessarily those of the NHS, the NIHR or Department of Health. All authors report no financial relationships with commercial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445; Blasco-Fontecilla H, 2009, J CLIN PSYCHIAT, V70, P1583, DOI 10.4088/JCP.08m04899; Bulik CM, 1999, ACTA PSYCHIAT SCAND, V100, P27, DOI 10.1111/j.1600-0447.1999.tb10910.x; Bulik CM, 2008, PSYCHOSOM MED, V70, P378, DOI 10.1097/PSY.0b013e3181646765; Corcos M, 2002, ACTA PSYCHIAT SCAND, V106, P381, DOI 10.1034/j.1600-0447.2002.02318.x; Crow SJ, 2009, AM J PSYCHIAT, V166, P1342, DOI 10.1176/appi.ajp.2009.09020247; Favaro A, 1996, INT J EAT DISORDER, V20, P99; Favaro A, 2008, J AFFECT DISORDERS, V105, P285, DOI 10.1016/j.jad.2007.05.010; Franko DL, 2006, CLIN PSYCHOL REV, V26, P769, DOI 10.1016/j.cpr.2006.04.001; Guillaume S, 2010, J AFFECT DISORDERS, V122, P53, DOI 10.1016/j.jad.2009.06.006; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Holm-Denoma JM, 2008, J AFFECT DISORDERS, V107, P231, DOI 10.1016/j.jad.2007.07.029; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Keel PK, 2003, ARCH GEN PSYCHIAT, V60, P179, DOI 10.1001/archpsyc.60.2.179; Keel PK, 1997, AM J PSYCHIAT, V154, P313; Klump KL, 2009, INT J EAT DISORDER, V42, P97, DOI 10.1002/eat.20589; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Nagata T, 2000, PSYCHIAT RES, V94, P239, DOI 10.1016/S0165-1781(00)00157-8; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Preti A, 2010, ACTA PSYCHIAT SCAND; Rihmer Z, 2005, CLIN NEUROPSYCHIATR, V2, P48; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Selby EA, 2010, BEHAV RES THER, V48, P634, DOI 10.1016/j.brat.2010.03.016; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simon J, 2005, PSYCHOL MED, V35, P1543, DOI 10.1017/S0033291705004708; Tiller JM, 1997, INT J EAT DISORDER, V21, P31; Tondo L, 2007, ACTA PSYCHIAT SCAND, V116, P419, DOI 10.1111/j.1600-0447.2007.01066.x; WEISMAN AD, 1972, ARCH GEN PSYCHIAT, V26, P553; Welch SL, 1996, BRIT J PSYCHIAT, V169, P451, DOI 10.1192/bjp.169.4.451; Youssef G, 2004, EUR PSYCHIAT, V19, P131, DOI 10.1016/j.eurpsy.2003.11.005	32	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23578	10.1371/journal.pone.0023578	http://dx.doi.org/10.1371/journal.pone.0023578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808CT	21858173	Green Published, gold			2022-12-27	WOS:000293953500056
J	Kikkawa, Y; Miwa, T; Tohara, Y; Hamakubo, T; Nomizu, M				Kikkawa, Yamato; Miwa, Takahiro; Tohara, Yukiko; Hamakubo, Takayuki; Nomizu, Motoyoshi			An Antibody to the Lutheran Glycoprotein (Lu) Recognizing the LU4 Blood Type Variant Inhibits Cell Adhesion to Laminin alpha 5	PLOS ONE			English	Article							BINDING-SITES; IMMUNOGLOBULIN SUPERFAMILY; MOLECULE GLYCOPROTEIN; DYSTROGLYCAN-BINDING; IN-VIVO; RECEPTOR; EXPRESSION; INTEGRINS; PROTEIN; CAM	Background: The Lutheran blood group glycoprotein (Lu), an Ig superfamily (IgSF) transmembrane receptor, is also known as basal cell adhesion molecule (B-CAM). Lu/B-CAM is a specific receptor for laminin alpha 5, a major component of basement membranes in various tissues. Previous reports have shown that Lu/B-CAM binding to laminin alpha 5 contributes to sickle cell vaso-occlusion. However, as there are no useful tools such as function-blocking antibodies or drugs, it is unclear how epithelial and sickled red blood cells adhere to laminin alpha 5 via Lu/B-CAM. Methodology/Principal Findings: In this study, we discovered a function-blocking antibody that inhibits Lu binding to laminin alpha 5 using a unique binding assay on tissue sections. To characterize the function-blocking antibody, we identified the site on Lu/B-CAM recognized by this antibody. The extracellular domain of Lu/B-CAM contains five IgSF domains, D1-D2-D3-D4-D5. The antibody epitope was localized to D2, but not to the D3 domain containing the major part of the laminin alpha 5 binding site. Furthermore, mutagenesis studies showed that Arg(175), the LU4 blood group antigenic site, was crucial for forming the epitope and the antibody bound sufficiently close to sterically hinder the interaction with alpha 5. Cell adhesion assay using the antibody also showed that Lu/B-CAM serves as a secondary receptor for the adhesion of carcinoma cells to laminin alpha 5. Conclusion/Significance: This function-blocking antibody against Lu/B-CAM should be useful for not only investigating cell adhesion to laminin alpha 5 but also for developing drugs to inhibit sickle cell vaso-occlusion.	[Kikkawa, Yamato; Miwa, Takahiro; Tohara, Yukiko; Hamakubo, Takayuki; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Kikkawa, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Tokyo, Japan.	kikkawa@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010		Ministry of Education, Sciences, Sports and Culture, Japan	Ministry of Education, Sciences, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the Ministry of Education, Sciences, Sports and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2008, BLOOD, V112, P5212, DOI 10.1182/blood-2008-03-146068; Bartolucci P, 2010, BLOOD, V116, P2152, DOI 10.1182/blood-2009-12-257444; Burton NM, 2008, BLOOD CELL MOL DIS, V40, P446, DOI 10.1016/j.bcmd.2008.01.004; CAMPBELL IG, 1994, CANCER RES, V54, P5761; El Nemer W, 1998, J BIOL CHEM, V273, P16686; El Nemer W, 2001, J BIOL CHEM, V276, P23757, DOI 10.1074/jbc.M102978200; El Nemer W, 1999, J BIOL CHEM, V274, P31903, DOI 10.1074/jbc.274.45.31903; Eyler CE, 2006, TRANSFUSION, V46, P668, DOI 10.1111/j.1537-2995.2006.00779.x; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; Hebbel RP, 1997, J CLIN INVEST, V99, P2561, DOI 10.1172/JCI119442; Hines PC, 2003, BLOOD, V101, P3281, DOI 10.1182/blood-2001-12-0289; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kroviarski Y, 2004, BRIT J HAEMATOL, V126, P255, DOI 10.1111/j.1365-2141.2004.05010.x; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Moulson CL, 2001, DEV DYNAM, V222, P101, DOI 10.1002/dvdy.1169; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Murphy MM, 2005, BLOOD, V105, P3322, DOI 10.1182/blood-2004-07-2881; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Parsons SF, 2001, BLOOD, V97, P312, DOI 10.1182/blood.V97.1.312; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Wick T M, 1996, Curr Opin Hematol, V3, P118; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500; Zen Q, 1999, J BIOL CHEM, V274, P728, DOI 10.1074/jbc.274.2.728; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23329	10.1371/journal.pone.0023329	http://dx.doi.org/10.1371/journal.pone.0023329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858073	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953500031
J	Souza, RT; Lima, FM; Barros, RM; Cortez, DR; Santos, MF; Cordero, EM; Ruiz, JC; Goldenberg, S; Teixeira, MMG; da Silveira, JF				Souza, Renata T.; Lima, Fabio M.; Barros, Roberto Moraes; Cortez, Danielle R.; Santos, Michele F.; Cordero, Esteban M.; Ruiz, Jeronimo Conceicao; Goldenberg, Samuel; Teixeira, Marta M. G.; da Silveira, Jose Franco			Genome Size, Karyotype Polymorphism and Chromosomal Evolution in Trypanosoma cruzi	PLOS ONE			English	Article							CLONE CL-BRENER; FLOW CYTOMETRIC ANALYSIS; CHAGAS-DISEASE; MOLECULAR KARYOTYPE; PARASITIC PROTOZOA; GENETIC EXCHANGE; UNITED-STATES; LINEAGE-I; TOTAL DNA; SEQUENCE	Background: The Trypanosoma cruzi genome was sequenced from a hybrid strain (CL Brener). However, high allelic variation and the repetitive nature of the genome have prevented the complete linear sequence of chromosomes being determined. Determining the full complement of chromosomes and establishing syntenic groups will be important in defining the structure of T. cruzi chromosomes. A large amount of information is now available for T. cruzi and Trypanosoma brucei, providing the opportunity to compare and describe the overall patterns of chromosomal evolution in these parasites. Methodology/Principal Findings: The genome sizes, repetitive DNA contents, and the numbers and sizes of chromosomes of nine strains of T. cruzi from four lineages (TcI, TcII, TcV and TcVI) were determined. The genome of the TcI group was statistically smaller than other lineages, with the exception of the TcI isolate Tc1161 (Jose-IMT). Satellite DNA content was correlated with genome size for all isolates, but this was not accompanied by simultaneous amplification of retrotransposons. Regardless of chromosomal polymorphism, large syntenic groups are conserved among T. cruzi lineages. Duplicated chromosome-sized regions were identified and could be retained as paralogous loci, increasing the dosage of several genes. By comparing T. cruzi and T. brucei chromosomes, homologous chromosomal regions in T. brucei were identified. Chromosomes Tb9 and Tb11 of T. brucei share regions of syntenic homology with three and six T. cruzi chromosomal bands, respectively. Conclusions: Despite genome size variation and karyotype polymorphism, T. cruzi lineages exhibit conservation of chromosome structure. Several syntenic groups are conserved among all isolates analyzed in this study. The syntenic regions are larger than expected if rearrangements occur randomly, suggesting that they are conserved owing to positive selection. Mapping of the syntenic regions on T. cruzi chromosomal bands provides evidence for the occurrence of fusion and split events involving T. brucei and T. cruzi chromosomes.	[Souza, Renata T.; Lima, Fabio M.; Barros, Roberto Moraes; Cortez, Danielle R.; Santos, Michele F.; Cordero, Esteban M.; da Silveira, Jose Franco] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Ruiz, Jeronimo Conceicao] Ctr Pesquisas Rene Rachou Fiocruz, Fiocruz, MG, Brazil; [Goldenberg, Samuel] Inst Carlos Chagas, Curitiba, Parana, Brazil; [Teixeira, Marta M. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Souza, RT (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	jose.franco@unifesp.br	Teixeira, Marta M G/B-1115-2009; Cordero, Esteban M/F-2511-2012; Lima, Fabio Mitsuo/GQH-9488-2022; Ruiz, Jeronimo/D-2511-2011; Lima, Fabio M/C-9018-2013; GOLDENBERG, SAMUEL/B-4116-2009; Goldenberg, Samuel/ABD-8908-2022; de Moraes Barros, Roberto Rudge/F-4973-2018; P, CM/B-1358-2013; Lima, Fabio Mitsuo/AHD-6582-2022; Cordero, Esteban M./Q-6513-2019; Publica, Inct Saude/J-9544-2013; da Silveira, Jose Franco/F-5390-2012	Cordero, Esteban M/0000-0002-6099-5113; Lima, Fabio Mitsuo/0000-0002-1953-2950; Lima, Fabio M/0000-0002-1953-2950; GOLDENBERG, SAMUEL/0000-0002-4892-163X; de Moraes Barros, Roberto Rudge/0000-0002-0155-8431; Lima, Fabio Mitsuo/0000-0002-1953-2950; Cordero, Esteban M./0000-0002-6099-5113; /0000-0002-1361-9721	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (Brazil); FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP (www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (www.cnpq.br) (Brazil) to JFS. RTS and DRC were awarded postdoctoral and master fellowships by FAPESP, respectively. FML and RMB were awarded doctoral fellowships by FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araya J, 1997, PARASITOLOGY, V115, P563, DOI 10.1017/S0031182097001674; Barnabe C, 2001, EXP PARASITOL, V99, P73, DOI 10.1006/expr.2001.4651; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Branche C, 2006, MOL BIOCHEM PARASIT, V147, P30, DOI 10.1016/j.molbiopara.2006.01.005; Briones MRS, 1999, MOL BIOCHEM PARASIT, V104, P219, DOI 10.1016/S0166-6851(99)00155-3; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; Carolina M, 2002, EUKARYOT CELL, V1, P944, DOI 10.1128/EC.1.6.944-953.2002; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CASTRO C, 1981, MOL BIOCHEM PARASIT, V4, P273, DOI 10.1016/0166-6851(81)90060-8; Cornillot E, 2002, GENE, V293, P87, DOI 10.1016/S0378-1119(02)00604-2; Cura CI, 2010, INT J PARASITOL, V40, P1599, DOI 10.1016/j.ijpara.2010.06.006; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4; DVORAK JA, 1982, J PROTOZOOL, V29, P430, DOI 10.1111/j.1550-7408.1982.tb05427.x; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Ghedin E, 2004, MOL BIOCHEM PARASIT, V134, P183, DOI 10.1016/j.molbiopara.2003.11.012; GIBSON WC, 1986, EMBO J, V5, P1299, DOI 10.1002/j.1460-2075.1986.tb04359.x; HENRIKSSON J, 1990, MOL BIOCHEM PARASIT, V42, P213, DOI 10.1016/0166-6851(90)90164-H; HENRIKSSON J, 1995, MOL BIOCHEM PARASIT, V73, P63, DOI 10.1016/0166-6851(95)00096-J; Henriksson J, 1996, PARASITOL TODAY, V12, P108, DOI 10.1016/0169-4758(96)80670-3; Henriksson J, 2002, PARASITOLOGY, V124, P277, DOI 10.1017/S0031182001001093; HENRIKSSON J, 1993, EXP PARASITOL, V77, P334, DOI 10.1006/expr.1993.1091; KOOY RF, 1989, MOL BIOCHEM PARASIT, V36, P73, DOI 10.1016/0166-6851(89)90202-8; LANAR DE, 1981, MOL BIOCHEM PARASIT, V3, P327, DOI 10.1016/0166-6851(81)90006-2; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Martins C, 2008, MOL BIOCHEM PARASIT, V160, P60, DOI 10.1016/j.molbiopara.2008.03.004; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; NOZAKI T, 1991, J PROTOZOOL, V38, P234, DOI 10.1111/j.1550-7408.1991.tb04435.x; Ocana-Mayorga S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000915; PEARSON WR, 1992, METHOD ENZYMOL, V210, P575; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pedroso A, 2003, MOL BIOCHEM PARASIT, V129, P79, DOI 10.1016/S0166-6851(03)00096-3; Porcile PE, 2003, GENE, V308, P53, DOI 10.1016/S0378-1119(03)00489-X; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Santos MRM, 1999, GENOME RES, V9, P1268, DOI 10.1101/gr.9.12.1268; Santos MRM, 1997, MEM I OSWALDO CRUZ, V92, P821, DOI 10.1590/S0074-02761997000600018; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Souza RT, 2007, EUKARYOT CELL, V6, P1228, DOI 10.1128/EC.00036-07; Sterkers Y, 2011, CELL MICROBIOL, V13, P274, DOI 10.1111/j.1462-5822.2010.01534.x; Teixeira MMG, 2006, TROP MED INT HEALTH, V11, P294, DOI 10.1111/j.1365-3156.2006.01575.x; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; THOMPSON CT, 1989, ANAL BIOCHEM, V177, P353, DOI 10.1016/0003-2697(89)90065-1; Tibayrenc M, 1998, INT J PARASITOL, V28, P85, DOI 10.1016/S0020-7519(97)00180-X; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; Tibayrenc Michel, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-12; Tomazi L, 2009, GENET MOL RES, V8, P458, DOI 10.4238/vol8-2gmr591; Vargas N, 2004, MOL BIOCHEM PARASIT, V138, P131, DOI 10.1016/j.molbiopara.2004.08.005; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; Westenberger SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-60; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	61	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23042	10.1371/journal.pone.0023042	http://dx.doi.org/10.1371/journal.pone.0023042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857989	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500015
J	Rodriguez-Cruz, TG; Liu, SJ; Khalili, JS; Whittington, M; Zhang, MY; Overwijk, W; Lizee, G				Rodriguez-Cruz, Tania G.; Liu, Shujuan; Khalili, Jahan S.; Whittington, Mayra; Zhang, Minying; Overwijk, Willem; Lizee, Gregory			Natural Splice Variant of MHC Class I Cytoplasmic Tail Enhances Dendritic Cell-Induced CD8(+) T-Cell Responses and Boosts Anti-Tumor Immunity	PLOS ONE			English	Article							COMPLEX CLASS-I; CROSS-PRESENTATION; CANCER-IMMUNOTHERAPY; ANTIGEN PRESENTATION; PHOSPHORYLATION; MOLECULES; DOMAIN; VACCINATION; VACCINES; PEPTIDE	Dendritic cell (DC)-mediated presentation of MHC class I (MHC-I)/peptide complexes is a crucial first step in the priming of CTL responses, and the cytoplasmic tail of MHC-I plays an important role in modulating this process. Several species express a splice variant of the MHC-I tail that deletes exon 7-encoding amino acids (Delta 7), including a conserved serine phosphorylation site. Previously, it has been shown that Delta 7 MHC-I molecules demonstrate extended DC surface half-lives, and that mice expressing Delta 7-K-b generate significantly augmented CTL responses to viral challenge. Herein, we show that Delta 7-D-b-expressing DCs stimulated significantly more proliferation and much higher cytokine secretion by melanoma antigen-specific (Pmel-1) T cells. Moreover, in combination with adoptive Pmel-1 T-cell transfer, Delta 7-D-b DCs were superior to WT-D-b DCs at stimulating anti-tumor responses against established B16 melanoma tumors, significantly extending mouse survival. Human DCs engineered to express Delta 7-HLA-A*0201 showed similarly enhanced CTL stimulatory capacity. Further studies demonstrated impaired lateral membrane movement and clustering of human Delta 7-MHC-I/peptide complexes, resulting in significantly increased bioavailability of MHC-I/peptide complexes for specific CD8(+) T cells. Collectively, these data suggest that targeting exon 7-encoded MHC-I cytoplasmic determinants in DC vaccines has the potential to increase CD8(+) T-cell stimulatory capacity and substantially improve their clinical efficacy.	[Rodriguez-Cruz, Tania G.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Rodriguez-Cruz, TG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.	glizee@mdanderson.org		Lizee, Gregory/0000-0003-4449-7461	National Institutes of Health (NIH) [R01-AI85371, R01-CA111999-S1]; NATIONAL CANCER INSTITUTE [R01CA111999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085371] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (NIH), R01-AI85371. In addition, TR-C was supported by a NIH minority supplement, R01-CA111999-S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Andrews DM, 2008, IMMUNOL REV, V222, P242, DOI 10.1111/j.1600-065X.2008.00612.x; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Capps GG, 2000, MOL IMMUNOL, V37, P59, DOI 10.1016/S0161-5890(00)00019-5; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dalgaard TS, 2005, SCAND J IMMUNOL, V62, P259, DOI 10.1111/j.1365-3083.2005.01652.x; ELLIS SA, 1992, IMMUNOGENETICS, V37, P49, DOI 10.1007/BF00223544; Engell-Noerregaard L, 2009, CANCER IMMUNOL IMMUN, V58, P1, DOI 10.1007/s00262-008-0568-4; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; GUILD BC, 1984, J BIOL CHEM, V259, P9235; Ide F, 2006, J MED VIROL, V78, P711, DOI 10.1002/jmv.20612; Lizee G, 2005, TRENDS IMMUNOL, V26, P141, DOI 10.1016/j.it.2005.01.005; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lou YY, 2004, CANCER RES, V64, P6783, DOI 10.1158/0008-5472.CAN-04-1621; Luo J, 2010, VACCINE, V28, P2497, DOI 10.1016/j.vaccine.2010.01.038; MCCLUSKEY J, 1986, EMBO J, V5, P2477, DOI 10.1002/j.1460-2075.1986.tb04524.x; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; MOTAL UMA, 1995, EUR J IMMUNOL, V25, P1121, DOI 10.1002/eji.1830250441; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Palucka K, 2009, ANN NY ACAD SCI, V1174, P88, DOI 10.1111/j.1749-6632.2009.05000.x; POBER JS, 1978, P NATL ACAD SCI USA, V75, P6002, DOI 10.1073/pnas.75.12.6002; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688	30	15	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22939	10.1371/journal.pone.0022939	http://dx.doi.org/10.1371/journal.pone.0022939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860662	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200027
J	Dykes, J; Lenshof, A; Astrand-Grundstrom, IB; Laurell, T; Scheding, S				Dykes, Josefina; Lenshof, Andreas; Astrand-Grundstrom, Ing-Britt; Laurell, Thomas; Scheding, Stefan			Efficient Removal of Platelets from Peripheral Blood Progenitor Cell Products Using a Novel Micro-Chip Based Acoustophoretic Platform	PLOS ONE			English	Article							P-SELECTIN; FLOW-CYTOMETRY; TRANSPLANTATION; COLLECTION; ACTIVATION; PARTICLE; MOBILIZATION; EXPRESSION; SEPARATION; ULTRASOUND	Background: Excessive collection of platelets is an unwanted side effect in current centrifugation-based peripheral blood progenitor cell (PBPC) apheresis. We investigated a novel microchip-based acoustophoresis technique, utilizing ultrasonic standing wave forces for the removal of platelets from PBPC products. By applying an acoustic standing wave field onto a continuously flowing cell suspension in a micro channel, cells can be separated from the surrounding media depending on their physical properties. Study Design and Methods: PBPC samples were obtained from patients (n = 15) and healthy donors (n = 6) and sorted on an acoustophoresis-chip. The acoustic force was set to separate leukocytes from platelets into a target fraction and a waste fraction, respectively. The PBPC samples, the target and the waste fractions were analysed for cell recovery, purity and functionality. Results: The median separation efficiency of leukocytes to the target fraction was 98% whereas platelets were effectively depleted by 89%. PBPC samples and corresponding target fractions were similar in the percentage of CD34+ hematopoetic progenitor/stem cells as well as leukocyte/lymphocyte subset distributions. Median viability was 98%, 98% and 97% in the PBPC samples, the target and the waste fractions, respectively. Results from hematopoietic progenitor cell assays indicated a preserved colony-forming ability post-sorting. Evaluation of platelet activation by P-selectin (CD62P) expression revealed a significant increase of CD62P+ platelets in the target (19%) and waste fractions (20%), respectively, compared to the PBPC input samples (9%). However, activation was lower when compared to stored blood bank platelet concentrates (48%). Conclusion: Acoustophoresis can be utilized to efficiently deplete PBPC samples of platelets, whilst preserving the target stem/progenitor cell and leukocyte cell populations, cell viability and progenitor cell colony-forming ability. Acoustophoresis is, thus, an interesting technology to improve current cell processing methods.	[Dykes, Josefina] Univ Labs, Lund, Sweden; [Dykes, Josefina; Astrand-Grundstrom, Ing-Britt; Scheding, Stefan] Lund Univ, Inst Lab Med, Stem Cell Ctr, Lund, Sweden; [Scheding, Stefan] Univ Hosp Skane, Dept Hematol, Lund, Sweden; [Laurell, Thomas] Dongguk Univ, Seoul, South Korea	Lund University; Dongguk University	Dykes, J (corresponding author), Univ Labs, Lund, Sweden.	josefina.dykes@med.lu.se	; Lenshof, Andreas/D-8566-2013	Scheding, Stefan/0000-0002-8005-9568; Lenshof, Andreas/0000-0003-2887-6365; Laurell, Thomas/0000-0002-2486-3607	Vinnova (Swedish Innovation Agency)	Vinnova (Swedish Innovation Agency)(Vinnova)	This work was supported by funds from Vinnova (Swedish Innovation Agency) under the program Innovations for Future Health - CellCARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JD, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3467259; Arslan O, 2007, TRANSFUS APHER SCI, V37, P179, DOI 10.1016/j.transci.2007.08.002; Augustsson P, 2009, LAB CHIP, V9, P810, DOI 10.1039/b811027a; *COUNC EUR PUBL, 2006, GUID PREP US QUAL AS; Cutler C, 2001, STEM CELLS, V19, P108, DOI 10.1634/stemcells.19-2-108; DAILEY JF, 1998, BLOOD; Del Fante C, 2005, STEM CELLS DEV, V14, P734; Dykes JH, 2007, TRANSFUSION, V47, P2134, DOI 10.1111/j.1537-2995.2007.01438.x; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; Goodall Alison H, 2004, Methods Mol Biol, V272, P225; Gutensohn K, 1997, J HEMATOTHER, V6, P315, DOI 10.1089/scd.1.1997.6.315; Hagberg IA, 2000, PLATELETS, V11, P137; Hagberg IA, 2000, TRANSFUSION, V40, P182, DOI 10.1046/j.1537-2995.2000.40020182.x; Hawkes JJ, 2004, LAB CHIP, V4, P446, DOI 10.1039/b408045a; HILL L, 2008, J CLIN APHERESIS, V23, P25; Holme S, 1997, TRANSFUSION, V37, P12, DOI 10.1046/j.1537-2995.1997.37197176945.x; Ikeda K, 2003, TRANSFUSION, V43, P814, DOI 10.1046/j.1537-2995.2003.00422.x; Jonsson H, 2004, ANN THORAC SURG, V78, P1572, DOI 10.1016/j.athoracsur.2004.04.071; KIM S, 2011, TRANSFUSION; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Krailadsiri P, 2000, VOX SANG, V78, P171, DOI 10.1046/j.1423-0410.2000.7830171.x; Kronenwett R, 2000, STEM CELLS, V18, P320, DOI 10.1634/stemcells.18-5-320; Laurell T, 2007, CHEM SOC REV, V36, P492, DOI 10.1039/b601326k; Lenshof A, 2010, CHEM SOC REV, V39, P1203, DOI 10.1039/b915999c; MCLEOD BC, 2003, APHERESIS PRINCIPLES; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Metcalfe P, 1997, BRIT J HAEMATOL, V98, P86, DOI 10.1046/j.1365-2141.1997.1572983.x; Michelson AD, 1996, BLOOD, V87, P4925, DOI 10.1182/blood.V87.12.4925.bloodjournal87124925; Nilsson A, 2004, LAB CHIP, V4, P131, DOI 10.1039/b313493h; Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017; Petersson F, 2005, ANAL CHEM, V77, P1216, DOI 10.1021/ac048394q; Petersson F, 2004, ANALYST, V129, P938, DOI 10.1039/b409139f; Petersson F, 2007, ANAL CHEM, V79, P5117, DOI 10.1021/ac070444e; Ravagnani F, 1999, TRANSFUSION, V39, P48, DOI 10.1046/j.1537-2995.1999.39199116894.x; Reddy RL, 2005, TRANSFUS APHER SCI, V32, P63, DOI 10.1016/j.transci.2004.10.007; Reiser M, 2000, TRANSFUSION, V40, P178, DOI 10.1046/j.1537-2995.2000.40020178.x; Scheding S, 1999, TEXTBOOK OF MALIGNANT HAEMATOLOGY, P383; Scheding S, 1999, CYTOKINES IN THE TREATMENT OF HEMATOPOIETIC FAILURE, P51; Skripchenko A, 2008, TRANSFUSION, V48, P1469, DOI 10.1111/j.1537-2995.2008.01733.x; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; *SYSM CORP, 2004, OP MAN SYSM KX 21N; Tassi C, 2005, BONE MARROW TRANSPL, V36, P289, DOI 10.1038/sj.bmt.1705066; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; Zinno F, 2010, CYTOTHERAPY, V12, P60, DOI 10.3109/14653240903348301	44	83	88	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23074	10.1371/journal.pone.0023074	http://dx.doi.org/10.1371/journal.pone.0023074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857996	Green Published, gold, Green Submitted			2022-12-27	WOS:000293774300020
J	Leonhardt, SD; Schmitt, T; Bluthgen, N				Leonhardt, Sara D.; Schmitt, Thomas; Bluethgen, Nico			Tree Resin Composition, Collection Behavior and Selective Filters Shape Chemical Profiles of Tropical Bees (Apidae: Meliponini)	PLOS ONE			English	Article							CUTICULAR HYDROCARBON PROFILES; STINGLESS BEE; POLLINATION; RECOGNITION; ECOLOGY; CUES; HYMENOPTERA; ATTRACTION; EVOLUTION; INSECT	The diversity of species is striking, but can be far exceeded by the chemical diversity of compounds collected, produced or used by them. Here, we relate the specificity of plant-consumer interactions to chemical diversity applying a comparative network analysis to both levels. Chemical diversity was explored for interactions between tropical stingless bees and plant resins, which bees collect for nest construction and to deter predators and microbes. Resins also function as an environmental source for terpenes that serve as appeasement allomones and protection against predators when accumulated on the bees' body surfaces. To unravel the origin of the bees' complex chemical profiles, we investigated resin collection and the processing of resin-derived terpenes. We therefore analyzed chemical networks of tree resins, foraging networks of resin collecting bees, and their acquired chemical networks. We revealed that 113 terpenes in nests of six bee species and 83 on their body surfaces comprised a subset of the 1,117 compounds found in resins from seven tree species. Sesquiterpenes were the most variable class of terpenes. Albeit widely present in tree resins, they were only found on the body surface of some species, but entirely lacking in others. Moreover, whereas the nest profile of Tetragonula melanocephala contained sesquiterpenes, its surface profile did not. Stingless bees showed a generalized collecting behavior among resin sources, and only a hitherto undescribed species-specific "filtering" of resin-derived terpenes can explain the variation in chemical profiles of nests and body surfaces from different species. The tight relationship between bees and tree resins of a large variety of species elucidates why the bees' surfaces contain a much higher chemodiversity than other hymenopterans.	[Leonhardt, Sara D.; Bluethgen, Nico] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Schmitt, Thomas] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, Freiburg, Germany	University of Wurzburg; University of Freiburg	Leonhardt, SD (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany.	bluethgen@bio.tu-darmstadt.de	Leonhardt, Sara/AAI-6901-2020; Schmitt, Thomas/H-3033-2013; Blüthgen, Nico/F-5983-2010	Leonhardt, Sara/0000-0002-8154-9569; 	Deutsche Forschungsgemeinschaft (DFG): Sonderforschungsbereich SFB [554]; German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg; DFG; University of Wurzburg	Deutsche Forschungsgemeinschaft (DFG): Sonderforschungsbereich SFB(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg; DFG(German Research Foundation (DFG)); University of Wurzburg	The study was funded by the following: Deutsche Forschungsgemeinschaft (DFG): Sonderforschungsbereich SFB 554 (Mechanisms and Evolution of Arthropod Behaviour), www.dfg.de; German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg, http://www.graduateschools.uniwuerzburg.de/life_sciences/home/. Publication fees were kindly funded in the programme Open Access Publishing by the DFG and the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; BLUM MS, 1972, AM ZOOL, V12, P553; BREED MD, 1988, BEHAV GENET, V18, P439, DOI 10.1007/BF01065513; Bruschini C, 2008, J EXP BIOL, V211, P2442, DOI 10.1242/jeb.017749; Buchwald R, 2005, ANIM BEHAV, V70, P1331, DOI 10.1016/j.anbehav.2005.03.017; Chen C, 2009, FUNCT ECOL, V23, P941, DOI 10.1111/j.1365-2435.2009.01622.x; Corlett RT, 2004, BIOL REV, V79, P497, DOI 10.1017/S1464793103006341; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dotterl S, 2006, NEW PHYTOL, V169, P707, DOI 10.1111/j.1469-8137.2005.01509.x; Downs SG, 2000, APIDOLOGIE, V31, P357, DOI 10.1051/apido:2000127; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Dudareva N, 2006, BIOL FLORAL SCENT; EDGAR JA, 1974, NATURE, V248, P614, DOI 10.1038/248614a0; EISNER T, 1974, SCIENCE, V184, P996, DOI 10.1126/science.184.4140.996; Eltz T, 2005, BEHAV ECOL SOCIOBIOL, V59, P149, DOI 10.1007/s00265-005-0021-z; Eltz T, 2004, J TROP ECOL, V20, P317, DOI 10.1017/S0266467403001196; Fox J.E.D., 1973, HDB KABILI SEPILOK F; Gleason JM, 2009, HEREDITY, V103, P416, DOI 10.1038/hdy.2009.79; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Gotelli N. J., 2009, ECOSIM NULL MODELS S; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; HOWARD RW, 1982, J CHEM ECOL, V8, P1227, DOI 10.1007/BF00990755; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kainulainen P, 1998, J AGR FOOD CHEM, V46, P3780, DOI 10.1021/jf980108m; Langenheim J.H., 2003, PLANT RESINS CHEM EV; LANGENHEIM JH, 1978, BIOCHEM SYST ECOL, V6, P299, DOI 10.1016/0305-1978(78)90050-9; Legendre A, 2008, INSECT BIOCHEM MOLEC, V38, P244, DOI 10.1016/j.ibmb.2007.11.005; Lehmberg L, 2008, J APICULT RES, V47, P17, DOI 10.1080/00218839.2008.11101418; Leonhardt SD, 2009, INSECT SOC, V56, P157, DOI 10.1007/s00040-009-0007-3; Leonhardt SD, 2010, BEHAV ECOL SOCIOBIOL, V64, P1415, DOI 10.1007/s00265-010-0956-6; Leonhardt SD, 2009, BIOTROPICA, V41, P730, DOI 10.1111/j.1744-7429.2009.00535.x; LEONHARDT SD, 2010, J CHEM ECOL IN PRESS; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Menzel F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-16; MESSER AC, 1985, BIOTROPICA, V17, P175, DOI 10.2307/2388512; MICHENER C D, 1974, P404; Moure J. S., 1961, Studia Entomologica Petropolis (NS), V4, P181; Nielsen J, 1999, INSECT SOC, V46, P58, DOI 10.1007/s000400050113; Nunes TM, 2009, J CHEM ECOL, V35, P1172, DOI 10.1007/s10886-009-9691-8; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Roubik DW, 2006, APIDOLOGIE, V37, P124, DOI 10.1051/apido:2006026; ROUBIK DW, 1983, J KANSAS ENTOMOL SOC, V56, P327; Said I, 2005, J INSECT PHYSIOL, V51, P995, DOI 10.1016/j.jinsphys.2005.04.017; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; Soepadmo E, 2004, TREE FLORA SABAH SAR; Terzo M, 2005, APIDOLOGIE, V36, P85, DOI 10.1051/apido:2004072; Thomas ML, 2008, J EVOLUTION BIOL, V21, P801, DOI 10.1111/j.1420-9101.2008.01514.x; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; VOGEL S, 1966, OSTERR BOT Z, V113, P302, DOI DOI 10.1007/BF01373435; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	59	30	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23445	10.1371/journal.pone.0023445	http://dx.doi.org/10.1371/journal.pone.0023445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858119	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300030
J	Gront, D; Kulp, DW; Vernon, RM; Strauss, CEM; Baker, D				Gront, Dominik; Kulp, Daniel W.; Vernon, Robert M.; Strauss, Charlie E. M.; Baker, David			Generalized Fragment Picking in Rosetta: Design, Protocols and Applications	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION	The Rosetta de novo structure prediction and loop modeling protocols begin with coarse grained Monte Carlo searches in which the moves are based on short fragments extracted from a database of known structures. Here we describe a new object oriented program for picking fragments that greatly extends the functionality of the previous program (nnmake) and opens the door for new approaches to structure modeling. We provide a detailed description of the code design and architecture, highlighting its modularity, and new features such as extensibility, total control over the fragment picking workflow and scoring system customization. We demonstrate that the program provides at least as good building blocks for ab-initio structure prediction as the previous program, and provide examples of the wide range of applications that are now accessible.	[Gront, Dominik] Univ Warsaw, Fac Chem, Warsaw, Poland; [Kulp, Daniel W.; Strauss, Charlie E. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Vernon, Robert M.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Baker, David] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA	University of Warsaw; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Gront, D (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	dgront@chem.uw.edu.pl		Strauss, Charlie/0000-0003-3639-4673; Gront, Dominik/0000-0002-2260-2083	Marie Curie fellowship [221081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	Marie Curie fellowship(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DG was supported by a Marie Curie fellowship (FP7-people-IOF), project no. 221081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Doreleijers JF, 2009, J BIOMOL NMR, V45, P389, DOI 10.1007/s10858-009-9378-z; Gamma E, 2005, DESIGN PATTERNS ELEM, VXV; Gront D, 2006, BIOINFORMATICS, V22, P621, DOI 10.1093/bioinformatics/btk037; Gront D, 2008, BIOINFORMATICS, V24, P584, DOI 10.1093/bioinformatics/btm627; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Nieuwkoop AJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3211103; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223	11	121	125	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23294	10.1371/journal.pone.0023294	http://dx.doi.org/10.1371/journal.pone.0023294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887241	gold, Green Submitted, Green Published			2022-12-27	WOS:000295832000011
J	Ratzka, A; Baron, O; Grothe, C				Ratzka, Andreas; Baron, Olga; Grothe, Claudia			FGF-2 Deficiency Does Not Influence FGF Ligand and Receptor Expression during Development of the Nigrostriatal System	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR HOMOLOGOUS FACTORS; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; FACTOR-2 ISOFORMS; GENE-EXPRESSION; CEREBRAL-CORTEX; FACTOR (FGF)-2; FACTOR FAMILY	Secreted proteins of the fibroblast growth factor (FGF) family play important roles during development of various organ systems. A detailed knowledge of their temporal and spatial expression profiles, especially of closely related FGF family members, are essential to further identification of specific functions in distinct tissues. In the central nervous system dopaminergic neurons of the substantia nigra and their axonal projections into the striatum progressively degenerate in Parkinson's disease. In contrast, FGF-2 deficient mice display increased numbers of dopaminergic neurons. In this study, we determined the expression profiles of all 22 FGF-ligands and 10 FGF-receptor isoforms, in order to clarify, if FGF-2 deficiency leads to compensatory up-regulation of other FGFs in the nigrostriatal system. Three tissues, ventral mesencephalon (VM), striatum (STR) and as reference tissue spinal cord (SC) of wild-type and FGF-2 deficient mice at four developmental stages E14.5, P0, P28, and adult were comparatively analyzed by quantitative RT-PCR. As no differences between the genotypes were observed, a compensatory up-regulation can be excluded. Moreover, this analysis revealed that the majority of FGFligands (18/22) and FGF-receptors (9/10) are expressed during normal development of the nigrostriatal system and identified dynamic changes for some family members. By comparing relative expression level changes to SC reference tissue, general alterations in all 3 tissues, such as increased expression of FGF-1, -2, -22, FgfR-2c, -3c and decreased expression of FGF-13 during postnatal development were identified. Further, specific changes affecting only one tissue, such as increased FGF-16 (STR) or decreased FGF-17 (VM) expression, or two tissues, such as decreased expression of FGF-8 (VM, STR) and FGF-15 (SC, VM) were found. Moreover, 3 developmentally down-regulated FGFs (FGF-8b, FGF-15, FGF-17a) were functionally characterized by plasmid-based over-expression in dissociated E11.5 VM cell cultures, however, such a continuous exposure had no influence on the yield of dopaminergic neurons in vitro.	[Ratzka, Andreas; Baron, Olga; Grothe, Claudia] Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany; [Baron, Olga; Grothe, Claudia] Ctr Syst Neurosci ZSN, Hannover, Germany	Hannover Medical School	Ratzka, A (corresponding author), Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany.	grothe.claudia@mh-hannover.de	Ratzka, Andreas/H-7917-2012; Baron, Olga/HII-8390-2022	Baron, Olga/0000-0002-0536-8678	Deutsche Forschungsgemeinschaft (DFG) [GR 857/23-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp) to C. G. (GR 857/23-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; BEAN AJ, 1992, NEUROREPORT, V3, P993, DOI 10.1097/00001756-199211000-00012; BEAN AJ, 1991, P NATL ACAD SCI USA, V88, P10237, DOI 10.1073/pnas.88.22.10237; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; BOUVIER MM, 1995, J NEUROSCI, V15, P7141; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Fischer T, 2011, DEV BIOL, V350, P496, DOI 10.1016/j.ydbio.2010.12.017; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Gimeno L, 2003, GENE EXPR PATTERNS, V3, P473, DOI 10.1016/S1567-133X(03)00059-0; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Grothe C, 2004, NEUROBIOL DIS, V17, P163, DOI 10.1016/j.nbd.2004.07.007; Grothe C, 2000, NEUROSCIENCE, V100, P73, DOI 10.1016/S0306-4522(00)00247-5; Grothe C, 2007, BRAIN RES REV, V54, P80, DOI 10.1016/j.brainresrev.2006.12.001; Guo QX, 2010, DEV BIOL, V338, P183, DOI 10.1016/j.ydbio.2009.11.034; Haastert-Talini K, 2011, J NEUROTRAUM, V28, P661, DOI 10.1089/neu.2010.1637; Irmady K, 2011, GLIA, V59, P708, DOI 10.1002/glia.21141; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Miller DL, 2000, MOL CELL BIOL, V20, P2260, DOI 10.1128/MCB.20.6.2260-2268.2000; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohmachi S, 2000, BIOCHEM BIOPH RES CO, V277, P355, DOI 10.1006/bbrc.2000.3675; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Powles N, 2004, DEV DYNAM, V230, P44, DOI 10.1002/dvdy.20028; Quarto N, 2005, GENE, V356, P49, DOI 10.1016/j.gene.2005.05.014; Raballo R, 2000, J NEUROSCI, V20, P5012; RATZKA A, 2011, CELL TRANSP IN PRESS; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Reuss B, 2003, J NEUROSCI, V23, P6404; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Theil T, 2008, DEV DYNAM, V237, P3417, DOI 10.1002/dvdy.21765; Timmer M, 2006, NEUROBIOL DIS, V21, P587, DOI 10.1016/j.nbd.2005.09.003; Timmer M, 2007, J NEUROSCI, V27, P459, DOI 10.1523/JNEUROSCI.4493-06.2007; TOOYAMA I, 1993, NEUROLOGY, V43, P372, DOI 10.1212/WNL.43.2.372; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Umemori H, 2009, DEV GROWTH DIFFER, V51, P263, DOI 10.1111/j.1440-169X.2008.01079.x; van der Walt JM, 2004, AM J HUM GENET, V74, P1121, DOI 10.1086/421052; Yamauchi K, 2009, J NEUROSCI, V29, P4044, DOI 10.1523/JNEUROSCI.4794-08.2009; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	58	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23564	10.1371/journal.pone.0023564	http://dx.doi.org/10.1371/journal.pone.0023564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876757	Green Submitted, gold, Green Published			2022-12-27	WOS:000294126900029
J	Ryan, KS				Ryan, Katherine S.			Biosynthetic Gene Cluster for the Cladoniamides, Bis-Indoles with a Rearranged Scaffold	PLOS ONE			English	Article							LECHEVALIERIA-AEROCOLONIGENES ATCC-39243; ALPHA/BETA-HYDROLASE FOLD; PSEUDOMONAS-FLUORESCENS; HETEROLOGOUS EXPRESSION; CHROMOPYRROLIC ACID; BIOLOGICAL-ACTIVITY; TANDEM ACTION; REBECCAMYCIN; INDOLOCARBAZOLE; ENZYMES	The cladoniamides are bis-indole alkaloids isolated from Streptomyces uncialis, a lichen-associated actinomycete strain. The cladoniamides have an unusual, indenotryptoline structure rarely observed among bis-indole alkaloids. I report here the isolation, sequencing, and annotation of the cladoniamide biosynthetic gene cluster and compare it to the recently published gene cluster for BE-54017, a closely related indenotryptoline natural product. The cladoniamide gene cluster differs from the BE-54017 gene cluster in gene organization and in the absence of one N-methyltransferase gene but otherwise contains close homologs to all genes in the BE-54017 cluster. Both gene clusters encode enzymes needed for the construction of an indolocarbazole core, as well as flavin-dependent enzymes putatively involved in generating the indenotryptoline scaffold from an indolocarbazole. These two bis-indolic gene clusters exemplify the diversity of biosynthetic routes that begin from the oxidative dimerization of two molecules of L-tryptophan, highlight enzymes for further study, and provide new opportunities for combinatorial engineering.	Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia	Ryan, KS (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	ksryan@chem.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfattah MS, 2006, ANGEW CHEM INT EDIT, V45, P5685, DOI 10.1002/anie.200600511; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BUSH JA, 1987, J ANTIBIOT, V40, P668, DOI 10.7164/antibiotics.40.668; Chang FY, 2011, J AM CHEM SOC, V133, P9996, DOI 10.1021/ja2022653; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Daum M, 2009, CHEMBIOCHEM, V10, P1073, DOI 10.1002/cbic.200800823; Davies J, 2005, ORG LETT, V7, P5233, DOI 10.1021/ol052081f; De Schrijver A, 1999, MICROBIOL-UK, V145, P1287, DOI 10.1099/13500872-145-6-1287; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; Ishida K, 2006, J AM CHEM SOC, V128, P14619, DOI 10.1021/ja064550u; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim SY, 2007, APPL MICROBIOL BIOT, V75, P1119, DOI 10.1007/s00253-007-0924-x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Medema MH, 2010, GENOME BIOL EVOL, V2, P212, DOI 10.1093/gbe/evq013; Nicolaou KC, 2007, ANGEW CHEM INT EDIT, V46, P4704, DOI 10.1002/anie.200700917; Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; OMURA S, 1977, J ANTIBIOT, V30, P275, DOI 10.7164/antibiotics.30.275; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127, DOI 10.1271/bbb.67.127; Palfey BA, 2003, J BIOL CHEM, V278, P22210, DOI 10.1074/jbc.M301830200; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Pickens LB, 2009, J AM CHEM SOC, V131, P17677, DOI 10.1021/ja907852c; Prudhomme M, 2003, EUR J MED CHEM, V38, P123, DOI 10.1016/S0223-5234(03)00011-4; Rafanan ER, 2000, ORG LETT, V2, P3225; Ramos A, 2008, MICROBIOL-SGM, V154, P781, DOI 10.1099/mic.0.2007/014035-0; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102; Sanchez C, 2006, NAT PROD REP, V23, P1007, DOI 10.1039/b601930g; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Williams DE, 2008, ORG LETT, V10, P3501, DOI 10.1021/ol801274c; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zehner S, 2005, CHEM BIOL, V12, P445, DOI 10.1016/j.chembiol.2005.02.005; Zhang C, 2006, CHEMBIOCHEM, V7, P795, DOI 10.1002/cbic.200500504; Zhang W, 2008, J AM CHEM SOC, V130, P6068, DOI 10.1021/ja800951e	46	28	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23694	10.1371/journal.pone.0023694	http://dx.doi.org/10.1371/journal.pone.0023694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876764	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900036
J	Duncan, WC; Shaw, JLV; Burgess, S; McDonald, SE; Critchley, HOD; Horne, AW				Duncan, W. Colin; Shaw, Julie L. V.; Burgess, Stewart; McDonald, Sarah E.; Critchley, Hilary O. D.; Horne, Andrew W.			Ectopic Pregnancy as a Model to Identify Endometrial Genes and Signaling Pathways Important in Decidualization and Regulated by Local Trophoblast	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-4; RICH SECRETORY PROTEIN-3; STROMAL CELLS; DIFFERENTIAL EXPRESSION; CHORIONIC-GONADOTROPIN; IMPLANTATION; INVASION; DECIDUA; IDENTIFICATION; PROGESTERONE	The endometrium in early pregnancy undergoes decidualization and functional changes induced by local trophoblast, which are not fully understood. We hypothesized that endometrium from tubal ectopic pregnancy (EP) could be interrogated to identify novel genes and pathways involved in these processes. Gestation-matched endometrium was collected from women with EP (n = 11) and intrauterine pregnancies (IUP) (n = 13). RNA was extracted from the tissue. In addition, tissues were prepared for histological analysis for degree of decidualization. We compared a) the samples from EP that were decidualized (n = 6) with non-decidualized samples (n = 5), and b) the decidualized EP (n = 6) with decidualization-matched IUP (n = 6) samples using an Affymetrix gene array platform, with Ingenuity Pathway Analysis, combined with quantitative RT-PCR. Expression of PRL and IGFBP1 was used to confirm the degree of decidualization in each group. There were no differences in PRL or IGFBP1 expression in the decidualization-matched samples but a marked reduction (P<0.001) in the non-decidualized samples. Decidualization was associated with increased expression of 428 genes including SCARA5 (181-fold), DKK1 (71-fold) and PROK1 (32-fold), and decreased expression of 230 genes including MMP-7 (35-fold) and SFRP4 (21-fold). The top canonical pathways associated with these differentially expressed genes were Natural Killer Cell and Wnt/beta-Catenin signaling. Local trophoblast was associated with much less alteration of endometrial gene expression with an increase in 56 genes, including CSH1 (8-fold), and a reduction in 29 genes including CRISP3 (8-fold). The top associated canonical pathway was Antigen Presentation. The study of endometrium from tubal EP may promote novel insights into genes involved in decidualization and those influenced by factors from neighboring trophoblast. This has afforded unique information not highlighted by previous studies and adds to our understanding of the endometrium in early pregnancy.	[Duncan, W. Colin; Shaw, Julie L. V.; McDonald, Sarah E.; Critchley, Hilary O. D.; Horne, Andrew W.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Burgess, Stewart] Moredun Res Inst, Penicuik, Midlothian, Scotland	University of Edinburgh; Moredun Research Institute	Duncan, WC (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk	CRITCHLEY, HILARY OD/C-7575-2013	Horne, Andrew/0000-0002-9656-493X; McDonald, Sarah/0000-0003-2776-7415; CRITCHLEY, HILARY/0000-0003-1913-4044; burgess, stewart/0000-0002-9268-7641	Wellbeing of Women Project Grant [R40608]; Cunningham Trust; Medical Research Council; Scottish Senior Clinical Fellowship; MRC [G0600048, G1002033, G0802808] Funding Source: UKRI; Medical Research Council [G0802808, G0600048, G1002033] Funding Source: researchfish; Chief Scientist Office [SCD/02] Funding Source: researchfish	Wellbeing of Women Project Grant(Wellbeing of Women (WoW)); Cunningham Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Senior Clinical Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by a Wellbeing of Women Project Grant (R40608) to AWH and HODC and a grant from The Cunningham Trust to WCD. AWH is supported by a Clinician Scientist Fellowship from the Medical Research Council. WCD is a supported by a Scottish Senior Clinical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; Battersby S, 2004, J CLIN ENDOCR METAB, V89, P2463, DOI 10.1210/jc.2003-032012; Bulmer JN, 2010, INT J DEV BIOL, V54, P281, DOI 10.1387/ijdb.082763jb; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chao C, 2010, CURR OPIN ENDOCRINOL, V17, P33, DOI 10.1097/MED.0b013e328333faf8; Chen HW, 2002, MOL HUM REPROD, V8, P475, DOI 10.1093/molehr/8.5.475; Corpa JM, 2006, REPRODUCTION, V131, P631, DOI 10.1530/rep.1.00606; EARL U, 1987, J CLIN PATHOL, V40, P901, DOI 10.1136/jcp.40.8.901; Evans J, 2008, ENDOCRINOLOGY, V149, P2877, DOI 10.1210/en.2007-1633; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; Finn CA, 1996, EUR J OBSTET GYN R B, V70, P3, DOI 10.1016/S0301-2115(96)02565-1; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Fujita M, 2002, J MOL ENDOCRINOL, V28, P213, DOI 10.1677/jme.0.0280213; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; GRAHAM CH, 1992, BIOCHEM CELL BIOL, V70, P867, DOI 10.1139/o92-135; Guzeloglu-Kayisli O, 2007, REPROD BIOMED ONLINE, V15, P728, DOI 10.1016/S1472-6483(10)60541-X; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; Hombach-Klonisch S, 2005, J MOL ENDOCRINOL, V34, P517, DOI 10.1677/jme.1.01550; Horne AW, 2008, J CLIN ENDOCR METAB, V93, P2375, DOI 10.1210/jc.2008-0136; Horne AW, 2009, MOL HUM REPROD, V15, P287, DOI 10.1093/molehr/gap019; Hrzenjak A, 2004, J PATHOL, V204, P19, DOI 10.1002/path.1616; Huang J, 2010, J CLIN INVEST, V120, P223, DOI 10.1172/JCI38012; Ibiza S, 2009, AM J PHYSIOL-CELL PH, V297, pC1588, DOI 10.1152/ajpcell.00082.2009; Jiang Y, 2006, J BIOL CHEM, V281, P9058, DOI 10.1074/jbc.M507874200; Kalma Y, 2009, FERTIL STERIL, V91, P1042, DOI 10.1016/j.fertnstert.2008.01.043; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; KING A, 1990, AM J OBSTET GYNECOL, V162, P308, DOI 10.1016/0002-9378(90)90375-H; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Knoeller S, 2003, AM J REPROD IMMUNOL, V50, P41, DOI 10.1034/j.1600-0897.2003.00046.x; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Liu YA, 2010, HUM REPROD, V25, P479, DOI 10.1093/humrep/dep429; Loke YW, 1995, HUM REPROD, V10, P14, DOI 10.1093/humrep/10.suppl_2.14; Mannik J, 2010, J CLIN ENDOCR METAB, V95, P2433, DOI 10.1210/jc.2010-0023; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Marx L, 1999, AM J REPROD IMMUNOL, V41, P34; MENZIES FM, 2010, HUM REPROD UPDATE; PAIDAS MJ, 2010, AM J OBSTET GYNECOL, V459, pE1; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sarno J, 2009, MOL HUM REPROD, V15, P451, DOI 10.1093/molehr/gap030; Savaris RF, 2008, REPROD SCI, V15, P797, DOI 10.1177/1933719108317585; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sherwin JRA, 2007, ENDOCRINOLOGY, V148, P618, DOI 10.1210/en.2006-0832; SMITH NL, 2010, BLOOD; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; SONG C, 2011, REPROD DOMEST ANIM; STRICKLAND S, 1992, CELL, V71, P355, DOI 10.1016/0092-8674(92)90503-5; Troadec MB, 2009, DEV CELL, V16, P3, DOI 10.1016/j.devcel.2008.12.013; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; von Rango U, 2001, FERTIL STERIL, V76, P116, DOI 10.1016/S0015-0282(01)01859-3	53	30	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23595	10.1371/journal.pone.0023595	http://dx.doi.org/10.1371/journal.pone.0023595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858178	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300067
J	Hoffmann, LS; Schmidt, PM; Keim, Y; Hoffmann, C; Schmidt, HHHW; Stasch, JP				Hoffmann, Linda S.; Schmidt, Peter M.; Keim, Yvonne; Hoffmann, Carsten; Schmidt, Harald H. H. W.; Stasch, Johannes-Peter			Fluorescence Dequenching Makes Haem-Free Soluble Guanylate Cyclase Detectable in Living Cells	PLOS ONE			English	Article							NITRIC-OXIDE; DOWN-REGULATION; PROTEIN; NO; ACTIVATION; IDENTIFICATION; CGMP; STABILIZATION; STIMULATORS; DYSFUNCTION	In cardiovascular disease, the protective NO/sGC/cGMP signalling-pathway is impaired due to a decreased pool of NO-sensitive haem-containing sGC accompanied by a reciprocal increase in NO-insensitive haem-free sGC. However, no direct method to detect cellular haem-free sGC other than its activation by the new therapeutic class of haem mimetics, such as BAY 58-2667, is available. Here we show that fluorescence dequenching, based on the interaction of the optical active prosthetic haem group and the attached biarsenical fluorophor FlAsH can be used to detect changes in cellular sGC haem status. The partly overlap of the emission spectrum of haem and FlAsH allows energy transfer from the fluorophore to the haem which reduces the intensity of FlAsH fluorescence. Loss of the prosthetic group, e. g. by oxidative stress or by replacement with the haem mimetic BAY 58-2667, prevented the energy transfer resulting in increased fluorescence. Haem loss was corroborated by an observed decrease in NO-induced sGC activity, reduced sGC protein levels, and an increased effect of BAY 58-2667. The use of a haem-free sGC mutant and a biarsenical dye that was not quenched by haem as controls further validated that the increase in fluorescence was due to the loss of the prosthetic haem group. The present approach is based on the cellular expression of an engineered sGC variant limiting is applicability to recombinant expression systems. Nevertheless, it allows to monitor sGC's redox regulation in living cells and future enhancements might be able to extend this approach to in vivo conditions.	[Hoffmann, Linda S.; Keim, Yvonne; Stasch, Johannes-Peter] Bayer HealthCare, Pharma Res Ctr, Wuppertal, Germany; [Schmidt, Peter M.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia; [Hoffmann, Carsten] Univ Wurzburg, Sch Pharmacol & Toxicol, Wurzburg, Germany; [Schmidt, Harald H. H. W.] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Sch Pharm, Halle, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Wurzburg; Maastricht University; Martin Luther University Halle Wittenberg	Hoffmann, LS (corresponding author), Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia.	johannes-peter.stasch@bayer.com	Schmidt, Harald HHW/B-1549-2008; Schmidt, Peter/V-3882-2019	Schmidt, Harald HHW/0000-0003-0419-5549; Schmidt, Peter/0000-0003-1340-9086				Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; Chirkov YY, 2007, PHARMACOL THERAPEUT, V116, P287, DOI 10.1016/j.pharmthera.2007.06.012; Davydov DR, 2008, BIOCHEMISTRY-US, V47, P11348, DOI 10.1021/bi8011803; Estevez JM, 2006, BIOTECHNIQUES, V41, P569, DOI 10.2144/000112264; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; FRITZ BG, 2011, BIOCHEMISTRY; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HOBBS AJ, 2009, NITRIC OXIDE BIOL PA, P301; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Kagota S, 2001, BRIT J PHARMACOL, V134, P737, DOI 10.1038/sj.bjp.0704300; Kosarikov DN, 2001, J INORG BIOCHEM, V87, P267, DOI 10.1016/S0162-0134(01)00387-7; Kuznetsova S, 2006, ANAL BIOCHEM, V350, P52, DOI 10.1016/j.ab.2005.11.036; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu RC, 2006, J AM CHEM SOC, V128, P10034, DOI 10.1021/ja057005m; Lucas KA, 2000, PHARMACOL REV, V52, P375; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Nikolaev Viacheslav O., 2009, V191, P229, DOI 10.1007/978-3-540-68964-5_11; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Straub A, 2002, BIOORGAN MED CHEM, V10, P1711, DOI 10.1016/S0968-0896(02)00034-2; Takeda S, 2001, BIOCHEM BIOPH RES CO, V289, P299, DOI 10.1006/bbrc.2001.5966; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Wunder F, 2005, ANAL BIOCHEM, V339, P104, DOI 10.1016/j.ab.2004.12.025; Yantsevich AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P77, DOI 10.1134/S0006297907010099; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	48	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23596	10.1371/journal.pone.0023596	http://dx.doi.org/10.1371/journal.pone.0023596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858179	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300068
J	Krobath, H; Rozycki, B; Lipowsky, R; Weikl, TR				Krobath, Heinrich; Rozycki, Bartosz; Lipowsky, Reinhard; Weikl, Thomas R.			Line Tension and Stability of Domains in Cell-Adhesion Zones Mediated by Long and Short Receptor-Ligand Complexes	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; PATTERN-FORMATION; TCR-CD28 MICROCLUSTERS; MEMBRANE ADHESION; HYBRID LIPIDS; T-CELLS; ACTIVATION; COSTIMULATION; TRANSLOCATION; RECOGNITION	Submicron scale domains of membrane-anchored receptors play an important role in cell signaling. Central questions concern the stability of these microdomains, and the mechanisms leading to the domain formation. In immune-cell adhesion zones, microdomains of short receptor-ligand complexes form next to domains of significantly longer receptor-ligand complexes. The length mismatch between the receptor-ligand complexes leads to membrane deformations and has been suggested as a possible cause of the domain formation. The domain formation is a nucleation and growth process that depends on the line tension and free energy of the domains. Using a combination of analytical calculations and Monte Carlo simulations, we derive here general expressions for the line tension between domains of long and short receptor-ligand complexes and for the adhesion free energy of the domains. We argue that the length mismatch of receptor-ligand complexes alone is sufficient to drive the domain formation, and obtain submicron-scale minimum sizes for stable domains that are consistent with the domain sizes observed during immune-cell adhesion.	[Krobath, Heinrich; Rozycki, Bartosz; Lipowsky, Reinhard; Weikl, Thomas R.] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society	Krobath, H (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	thomas.weikl@mpikg.mpg.de	Weikl, Thomas/G-8572-2016; Rozycki, Bartosz/B-7005-2009	Weikl, Thomas/0000-0002-0911-5328; Rozycki, Bartosz/0000-0001-5938-7308; Lipowsky, Reinhard/0000-0001-8417-8567; Krobath, Heinrich/0000-0001-6473-8109	interdisciplinary network of excellence "Synthetic Bioactive Surfaces" of the Fraunhofer Society; Max Planck Society	interdisciplinary network of excellence "Synthetic Bioactive Surfaces" of the Fraunhofer Society; Max Planck Society(Max Planck Society)	This work was supported by the interdisciplinary network of excellence "Synthetic Bioactive Surfaces" of the Fraunhofer Society and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann A, 1996, J PHYS II, V6, P255, DOI 10.1051/jp2:1996108; Asfaw M, 2006, EUROPHYS LETT, V76, P703, DOI 10.1209/epl/i2006-10317-0; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Binder K, 2002, MONTE CARLO SIMULATI; Brewster R, 2009, BIOPHYS J, V97, P1087, DOI 10.1016/j.bpj.2009.05.051; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Choudhuri K, 2010, FEBS LETT, V584, P4823, DOI 10.1016/j.febslet.2010.10.015; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Figge MT, 2006, PLOS COMPUT BIOL, V2, P1377, DOI 10.1371/journal.pcbi.0020171; Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gutlederer E, 2009, SOFT MATTER, V5, P3303, DOI 10.1039/b902388g; Heinrich MC, 2008, J PHYS CHEM B, V112, P8063, DOI 10.1021/jp7116246; Hu JL, 2011, SOFT MATTER, V7, P6092, DOI 10.1039/c0sm01500h; JULICHER L, 1993, PHYS REV LETT, V70, P2964; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Krobath H, 2009, SOFT MATTER, V5, P3354, DOI 10.1039/b902036e; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; LIPOWSKY R, 1992, J PHYS II, V2, P1825, DOI 10.1051/jp2:1992238; Lipowsky R, 1996, PHYS REV LETT, V77, P1652, DOI 10.1103/PhysRevLett.77.1652; LIPOWSKY R, 1994, J PHYS II, V4, P1755, DOI 10.1051/jp2:1994230; Milstein O, 2008, J BIOL CHEM, V283, P34414, DOI 10.1074/jbc.M804756200; Molnar E, 2010, FEBS LETT, V584, P4832, DOI 10.1016/j.febslet.2010.09.004; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Raychaudhuri S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208101; Rozycki B, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/095003; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Semrau S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.088101; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Weikl TR, 2006, ADV PLANAR LIP BILAY, V5, P63, DOI 10.1016/S1554-4516(06)05004-6; Weikl TR, 2009, SOFT MATTER, V5, P3213, DOI 10.1039/b902017a; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Weikl TR, 2002, EUROPHYS LETT, V59, P916, DOI 10.1209/epl/i2002-00130-3; Weikl TR, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011903; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yamamoto T, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/28002; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	51	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23284	10.1371/journal.pone.0023284	http://dx.doi.org/10.1371/journal.pone.0023284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858057	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300028
J	Hirakawa, Y; Howe, A; James, ER; Keeling, PJ				Hirakawa, Yoshihisa; Howe, Alexis; James, Erick R.; Keeling, Patrick J.			Morphological Diversity between Culture Strains of a Chlorarachniophyte, Lotharella globosa	PLOS ONE			English	Article							SP-NOV CHLORARACHNIOPHYTA; NUCLEOMORPH; GEN.; CHLOROPLAST	Chlorarachniophytes are marine unicellular algae that possess secondary plastids of green algal origin. Although chlorarachniophytes are a small group (the phylum of Chlorarachniophyta contains 14 species in 8 genera), they have variable and complex life cycles that include amoeboid, coccoid, and/or flagellate cells. The majority of chlorarachniophytes possess two or more cell types in their life cycles, and which cell types are found is one of the principle morphological criteria used for species descriptions. Here we describe an unidentified chlorarachniophyte that was isolated from an artificial coral reef that calls this criterion into question. The life cycle of the new strain includes all three major cell types, but DNA barcoding based on the established nucleomorph ITS sequences showed it to share 100% sequence identity with Lotharella globosa. The type strain of L. globosa was also isolated from a coral reef, but is defined as completely lacking an amoeboid stage throughout its life cycle. We conclude that L. globosa possesses morphological diversity between culture strains, and that the new strain is a variety of L. globosa, which we describe as Lotharella globosa var. fortis var. nov. to include the amoeboid stage in the formal description of L. globosa. This intraspecies variation suggest that gross morphological stages maybe lost rather rapidly, and specifically that the type strain of L. globosa has lost the ability to form the amoeboid stage, perhaps recently. This in turn suggests that even major morphological characters used for taxonomy of this group may be variable in natural populations, and therefore misleading.	[Hirakawa, Yoshihisa] Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada; Univ British Columbia, Dept Bot, Vancouver, BC, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of British Columbia	Hirakawa, Y (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada.	pkeeling@mail.ubc.ca	Hirakawa, Yoshihisa/A-6119-2012; James, Erick R/D-4725-2012	Hirakawa, Yoshihisa/0000-0002-3780-354X; Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council of Canada [227301]; Tula Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tula Foundation	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (227301), and by a grant to the Centre for Microbial Diversity and Evolution from the Tula Foundation. PJK is a Fellow of the Canadian Institute for Advanced Research and a Senior Scholar of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dietz C, 2003, PHYCOLOGIA, V42, P582, DOI 10.2216/i0031-8884-42-6-582.1; Gile GH, 2010, J PHYCOL, V46, P743, DOI 10.1111/j.1529-8817.2010.00851.x; Gilson PR, 2006, P NATL ACAD SCI USA, V103, P9566, DOI 10.1073/pnas.0600707103; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; Ishida K, 1999, MOL BIOL EVOL, V16, P321, DOI 10.1093/oxfordjournals.molbev.a026113; ISHIDA K, 1994, PHYCOLOGIA, V33, P351, DOI 10.2216/i0031-8884-33-5-351.1; Ishida K, 2011, PHYCOL RES, V59, P52, DOI 10.1111/j.1440-1835.2010.00597.x; Ishida Ken-Ichiro, 1996, Phycological Research, V44, P37, DOI 10.1111/j.1440-1835.1996.tb00036.x; Ishida Ken-ichiro, 2000, Phycological Research, V48, P221, DOI 10.1111/j.1440-1835.2000.tb00218.x; Kasai K, 2009, JPN J PHYCOL SOSUI, V57, P220; MCFADDEN GI, 1994, P NATL ACAD SCI USA, V91, P3690, DOI 10.1073/pnas.91.9.3690; Ota S, 2005, PHYCOL RES, V53, P275, DOI 10.1111/j.1440-183.2005.00395.x; OTA S, 2011, PROTIST IN PRESS; Ota S, 2007, J PLANT RES, V120, P661, DOI 10.1007/s10265-007-0115-y; Ota S, 2007, J PHYCOL, V43, P333, DOI 10.1111/j.1529-8817.2007.00316.x; Ota S, 2009, PHYCOLOGIA, V48, P315, DOI 10.2216/09-02.1; Ota S, 2009, PROTIST, V160, P137, DOI 10.1016/j.protis.2008.09.003; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129	18	5	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23193	10.1371/journal.pone.0023193	http://dx.doi.org/10.1371/journal.pone.0023193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858028	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953700007
J	Fahim, AT; Bowne, SJ; Sullivan, LS; Webb, KD; Williams, JT; Wheaton, DK; Birch, DG; Daiger, SP				Fahim, Abigail T.; Bowne, Sara J.; Sullivan, Lori S.; Webb, Kaylie D.; Williams, Jessica T.; Wheaton, Dianna K.; Birch, David G.; Daiger, Stephen P.			Allelic Heterogeneity and Genetic Modifier Loci Contribute to Clinical Variation in Males with X-Linked Retinitis Pigmentosa Due to RPGR Mutations	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; LEBER CONGENITAL AMAUROSIS; JOUBERT-SYNDROME; CENTROSOMAL PROTEIN; RETINAL DEGENERATION; MISSENSE MUTATION; VISUAL FUNCTION; MECKEL-SYNDROME; EXON ORF15; FAMILIES	Mutations in RPGR account for over 70% of X-linked retinitis pigmentosa (XlRP), characterized by retinal degeneration and eventual blindness. The clinical consequences of RPGR mutations are highly varied, even among individuals with the same mutation: males demonstrate a wide range of clinical severity, and female carriers may or may not be affected. This study describes the phenotypic diversity in a cohort of 98 affected males from 56 families with RPGR mutations, and demonstrates the contribution of genetic factors (i.e., allelic heterogeneity and genetic modifiers) to this diversity. Patients were categorized as grade 1 (mild), 2 (moderate) or 3 (severe) according to specific clinical criteria. Patient DNAs were genotyped for coding SNPs in 4 candidate modifier genes with products known to interact with RPGR protein: RPGRIP1, RPGRIP1L, CEP290, and IQCB1. Family-based association testing was performed using PLINK. A wide range of clinical severity was observed both between and within families. Patients with mutations in exons 1-14 were more severely affected than those with ORF15 mutations, and patients with predicted null alleles were more severely affected than those predicted to make RPGR protein. Two SNPs showed association with severe disease: the minor allele (N) of I393N in IQCB1 (p = 0.044) and the common allele (R) of R744Q in RPGRIP1L (p = 0.049). These data demonstrate that allelic heterogeneity contributes to phenotypic diversity in XlRP and suggest that this may depend on the presence or absence of RPGR protein. In addition, common variants in 2 proteins known to interact with RPGR are associated with severe disease in this cohort.	[Fahim, Abigail T.; Bowne, Sara J.; Sullivan, Lori S.; Williams, Jessica T.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Webb, Kaylie D.; Wheaton, Dianna K.; Birch, David G.] Retina Fdn SW, Dallas, TX USA; [Wheaton, Dianna K.; Birch, David G.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Retina Foundation of the Southwest; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fahim, AT (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA.	stephen.p.daiger@uth.tmc.edu		Fahim, Abigail/0000-0001-9737-054X; Jones, Kaylie/0000-0003-2818-5097; Birch, David/0000-0002-6594-2897	Foundation Fighting Blindness; Nuclear Energy Institute/National Institutes of Health [EY007142]; NATIONAL EYE INSTITUTE [R01EY007142] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); Nuclear Energy Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the Foundation Fighting Blindness (www.blindness.org) and grant EY007142 from the Nuclear Energy Institute/National Institutes of Health (www.nei.org) to SPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Bader I, 2003, INVEST OPHTH VIS SCI, V44, P1458, DOI 10.1167/iovs.02-0605; Banin E, 2007, AM J MED GENET A, V143A, P1150, DOI 10.1002/ajmg.a.31642; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Berson EL, 2007, EXP EYE RES, V85, P7, DOI 10.1016/j.exer.2007.03.001; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; Brancati F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Demirci FYK, 2004, AM J OPHTHALMOL, V138, P504, DOI 10.1016/j.ajo.2004.04.019; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Ebenezer ND, 2005, INVEST OPHTH VIS SCI, V46, P1891, DOI 10.1167/iovs.04-1482; Ferreira PA, 2005, HUM MOL GENET, V14, pR259, DOI 10.1093/hmg/ddi272; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Grover S, 2000, OPHTHALMOLOGY, V107, P386, DOI 10.1016/S0161-6420(99)00045-7; Guevara-Fujita M, 2001, Hum Mutat, V17, P151, DOI 10.1002/1098-1004(200102)17:2<151::AID-HUMU7>3.3.CO;2-N; Guo DC, 2003, BIOTECHNOL LETT, V25, P2079, DOI 10.1023/B:BILE.0000007075.24434.5e; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; He S, 2008, VISION RES, V48, P366, DOI 10.1016/j.visres.2007.08.005; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2004, INVEST OPHTH VIS SCI, V45, P36, DOI 10.1167/iovs.03-0787; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; KEITH CG, 1991, OPHTHALMIC PAED GEN, V12, P91, DOI 10.3109/13816819109023680; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kirschner R, 1999, HUM MOL GENET, V8, P1571, DOI 10.1093/hmg/8.8.1571; Koenekoop RK, 2003, AM J OPHTHALMOL, V136, P678, DOI 10.1016/S0002-9394(03)00331-3; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Mavlyutov TA, 2002, HUM MOL GENET, V11, P1899, DOI 10.1093/hmg/11.16.1899; Neidhardt J, 2007, HUM MUTAT, V28, P797, DOI 10.1002/humu.20521; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schmid F, 2010, INVEST OPHTH VIS SCI, V51, P1628, DOI 10.1167/iovs.09-4031; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Shimmin LC, 2007, DNA SEQUENCE, V18, P432, DOI 10.1080/10425170701388719; Souied E, 1997, J MED GENET, V34, P793, DOI 10.1136/jmg.34.10.793; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Walia S, 2008, ARCH OPHTHALMOL-CHIC, V126, P379, DOI 10.1001/archophthalmol.2007.72; Wheaton DK, 2007, INVEST OPHTHALMOL VI, V48; Yang ZL, 2002, HUM MOL GENET, V11, P605, DOI 10.1093/hmg/11.5.605; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zito I, 1999, HUM GENET, V105, P57, DOI 10.1007/s004390051064	59	69	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23021	10.1371/journal.pone.0023021	http://dx.doi.org/10.1371/journal.pone.0023021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857984	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500014
J	Groleau, J; Dussault, S; Turgeon, J; Haddad, P; Rivard, A				Groleau, Jessika; Dussault, Sylvie; Turgeon, Julie; Haddad, Paola; Rivard, Alain			Accelerated Vascular Aging in CuZnSOD-Deficient Mice: Impact on EPC Function and Reparative Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CIGARETTE-SMOKE EXPOSURE; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; SOD1-DEFICIENT MICE; SKELETAL-MUSCLE; ANGIOGENESIS; DYSFUNCTION; VASCULOGENESIS; IMPAIRMENT	Objective: Aging is associated with increased oxidative stress levels and impaired neovascularization following ischemia. CuZnSOD has an important role to limit oxidative stress in the vasculature. Here we investigated the role of CuZnSOD for the modulation of ischemia-induced neovascularisation during aging. Methods and Results: Hindlimb ischemia was surgically induced in young (2-month-old) or older (8-month-old) wild type (WT) and CuZnSOD-/- mice. We found that blood flow recovery after ischemia and vascular density in ischemic muscles were significantly reduced in older compared to young WT mice. Both in young and older mice, CuZnSOD deficiency led to a further reduction of neovascularization. Accordingly, the resulting neovascularisation potential in a young CuZnSOD-/- mouse was similar to that of an older WT mouse. Oxidative stress levels were also increased to similar levels in the ischemic muscles of young CuZnSOD-/- and older WT mice. To identify potential mechanisms involved, we investigated the effect of aging and CuZnSOD deficiency on the number and the function of endothelial progenitor cells (EPCs). Both aging and CuZnSOD deficiency were associated with reduced number of bone marrow and peripheral EPCs. The effect of moderate aging alone on specific functional activities of EPCs (migration, integration into tubules) was modest. However, CuZnSOD deficiency was associated with severe age-dependent defects in EPC functional activities. Conclusions: CuZnSOD deficiency is associated with accelerated vascular aging and impaired ischemia-induced neovascularization. Our results suggest that in the context of aging, CuZnSOD has an essential role to protect against excessive oxidative stress in ischemic tissues and preserve the function of EPCs.	[Groleau, Jessika; Dussault, Sylvie; Turgeon, Julie; Haddad, Paola; Rivard, Alain] Ctr Hosp Univ Montreal, Dept Cardiovasc Res, Montreal, PQ, Canada	Universite de Montreal	Groleau, J (corresponding author), Ctr Hosp Univ Montreal, Dept Cardiovasc Res, Montreal, PQ, Canada.	rivardal@total.net			Canadian Institute of Health Research (CIHR) [74687]; Heart and Stroke Foundation of Canada	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was supported by grants from the Canadian Institute of Health Research (CIHR#74687) and The Heart and Stroke Foundation of Canada to Alain Rivard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AR is a scholar from the Fonds de Recherche en Sante du Quebec (FRSQ). JG is a doctoral research awardee from the CIHR. PH is a doctoral research awardee from the Heart and Stroke Foundation of Canada. JT is a doctoral research awardee from the FRSQ.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asimakis GK, 2002, CIRCULATION, V105, P981, DOI 10.1161/hc0802.104502; Colak E, 2005, ANN MED, V37, P613, DOI 10.1080/07853890500330193; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Didion SP, 2006, HYPERTENSION, V48, P1072, DOI 10.1161/01.HYP.0000247302.20559.3a; Didion SP, 2002, CIRC RES, V91, P938, DOI 10.1161/01.RES.0000043280.65241.04; Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Edelberg JM, 2002, CIRCULATION, V105, P608, DOI 10.1161/hc0502.103672; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Groleau J, 2010, ARTERIOSCL THROM VAS, V30, P2173, DOI 10.1161/ATVBAHA.110.212530; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hodgkinson AD, 2003, DIABETES, V52, P846, DOI 10.2337/diabetes.52.3.846; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; McFadden SL, 1999, J COMP NEUROL, V413, P101; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Michaud SE, 2006, J MOL CELL CARDIOL, V41, P275, DOI 10.1016/j.yjmcc.2006.05.004; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023	32	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23308	10.1371/journal.pone.0023308	http://dx.doi.org/10.1371/journal.pone.0023308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858065	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500029
J	Kong, XD; Stephens, J; Ball, AR; Heale, JT; Newkirk, DA; Berns, MW; Yokomori, K				Kong, Xiangduo; Stephens, Jared; Ball, Alexander R., Jr.; Heale, Jason T.; Newkirk, Daniel A.; Berns, Michael W.; Yokomori, Kyoko			Condensin I Recruitment to Base Damage-Enriched DNA Lesions Is Modulated by PARP1	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; STRAND BREAK REPAIR; MAMMALIAN-CELLS; CHROMOSOME CONDENSATION; VERTEBRATE CELLS; COMPLEX; ACTIVATION; RESPONSES; SITES	Condensin I is important for chromosome organization and segregation in mitosis. We previously showed that condensin I also interacts with PARP1 in response to DNA damage and plays a role in single-strand break repair. However, whether condensin I physically associates with DNA damage sites and how PARP1 may contribute to this process were unclear. We found that condensin I is preferentially recruited to DNA damage sites enriched for base damage. This process is dictated by PARP1 through its interaction with the chromosome-targeting domain of the hCAP-D2 subunit of condensin I.	[Kong, Xiangduo; Ball, Alexander R., Jr.; Heale, Jason T.; Newkirk, Daniel A.; Yokomori, Kyoko] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92717 USA; [Stephens, Jared; Berns, Michael W.] Univ Calif Irvine, Dept Dev & Cell Biol, Beckman Laser Inst, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Kong, XD (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92717 USA.	kyokomor@uci.edu		Berns, Michael/0000-0002-9640-2885	NIH [RR01192, ES013511]; Air Force Office of Scientific Research [FA9550-04-1-0101]; Beckman Laser Institute Inc. Foundation; CA100710; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203, R01CA100710] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013511] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Beckman Laser Institute Inc. Foundation; CA100710; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the NIH Laser Microbeam and Medical Program (RR01192), the Air Force Office of Scientific Research (FA9550-04-1-0101) and Beckman Laser Institute Inc. Foundation to M.W.B., and NIH ES013511 and CA100710 to K.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ball AR, 2011, CURR OPIN CELL BIOL, V23, P277, DOI 10.1016/j.ceb.2011.03.012; Ball AR, 2002, MOL CELL BIOL, V22, P5769, DOI 10.1128/MCB.22.16.5769-5781.2002; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009	26	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23548	10.1371/journal.pone.0023548	http://dx.doi.org/10.1371/journal.pone.0023548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858164	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953500054
J	Taymans, JM; Vancraenenbroeck, R; Ollikainen, P; Beilina, A; Lobbestael, E; De Maeyer, M; Baekelandt, V; Cookson, MR				Taymans, Jean-Marc; Vancraenenbroeck, Renee; Ollikainen, Petri; Beilina, Alexandra; Lobbestael, Evy; De Maeyer, Marc; Baekelandt, Veerle; Cookson, Mark R.			LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; DOMINANT PARKINSONISM; ROC DOMAIN; PHOSPHORYLATES; PROTEIN; LEUCINE-RICH-REPEAT-KINASE-2; INHIBITION; DIMER; GENE	Leucine rich repeat kinase 2 (LRRK2) is a Parkinson's disease (PD) gene that encodes a large multidomain protein including both a GTPase and a kinase domain. GTPases often regulate kinases within signal transduction cascades, where GTPases act as molecular switches cycling between a GTP bound "on'' state and a GDP bound "off'' state. It has been proposed that LRRK2 kinase activity may be increased upon GTP binding at the LRRK2 Ras of complex proteins (ROC) GTPase domain. Here we extensively test this hypothesis by measuring LRRK2 phosphorylation activity under influence of GDP, GTP or nonhydrolyzable GTP analogues GTP gamma S or GMPPCP. We show that autophosphorylation and lrrktide phosphorylation activity of recombinant LRRK2 protein is unaltered by guanine nucleotides, when co-incubated with LRRK2 during phosphorylation reactions. Also phosphorylation activity of LRRK2 is unchanged when the LRRK2 guanine nucleotide binding pocket is previously saturated with various nucleotides, in contrast to the greatly reduced activity measured for the guanine nucleotide binding site mutant T1348N. Interestingly, when nucleotides were incubated with cell lysates prior to purification of LRRK2, kinase activity was slightly enhanced by GTP gamma S or GMPPCP compared to GDP, pointing to an upstream guanine nucleotide binding protein that may activate LRRK2 in a GTP-dependent manner. Using metabolic labeling, we also found that cellular phosphorylation of LRRK2 was not significantly modulated by nucleotides, although labeling is significantly reduced by guanine nucleotide binding site mutants. We conclude that while kinase activity of LRRK2 requires an intact ROC-GTPase domain, it is independent of GDP or GTP binding to ROC.	[Taymans, Jean-Marc; Ollikainen, Petri; Lobbestael, Evy; Baekelandt, Veerle] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Louvain, Belgium; [Vancraenenbroeck, Renee; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modeling, B-3001 Heverlee, Belgium; [Beilina, Alexandra; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	KU Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Taymans, JM (corresponding author), Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Louvain, Belgium.	Jean-Marc.Taymans@med.kuleuven.be	Lobbestael, Evy/H-7537-2018; Baekelandt, Veerle/ABB-9736-2020; Taymans, Jean-Marc/M-9175-2018; Cookson, Mark/AAW-2516-2021	Lobbestael, Evy/0000-0002-6417-4670; Baekelandt, Veerle/0000-0001-8966-2921; Taymans, Jean-Marc/0000-0001-5503-5524; Cookson, Mark/0000-0002-1058-3831; Vancraenenbroeck, Renee/0000-0003-2685-2749	NIH, National Institute on Aging; Research Foundation-Flanders (FWO) [G.0406.06, G.0666.09]; agency for Innovation by Science and Technology [SBO 80020]; K.U.Leuven [OT/08/052A, IOF-KP/07/001]; Michael J. Fox Foundation; NATIONAL INSTITUTE ON AGING [ZIAAG000937, ZIAAG000948] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Foundation-Flanders (FWO)(FWO); agency for Innovation by Science and Technology; K.U.Leuven(KU Leuven); Michael J. Fox Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. This work was supported by the Research Foundation-Flanders (FWO Vlaanderen projects G.0406.06, G.0666.09, postdoctoral fellowship to J-MT and doctoral fellowships to RV and EL), the agency for Innovation by Science and Technology (IWT project SBO 80020), the K.U.Leuven OT/08/052A and IOF-KP/07/001 and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Asensio CJA, 2003, ANAL BIOCHEM, V319, P21, DOI 10.1016/S0003-2697(03)00282-3; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Daniels V, 2011, NEUROSIGNALS, V19, P1, DOI 10.1159/000324488; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	37	76	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23207	10.1371/journal.pone.0023207	http://dx.doi.org/10.1371/journal.pone.0023207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858031	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500024
J	Balseiro, P; Falco, A; Romero, A; Dios, S; Martinez-Lopez, A; Figueras, A; Estepa, A; Novoa, B				Balseiro, Pablo; Falco, Alberto; Romero, Alejandro; Dios, Sonia; Martinez-Lopez, Alicia; Figueras, Antonio; Estepa, Amparo; Novoa, Beatriz			Mytilus galloprovincialis Myticin C: A Chemotactic Molecule with Antiviral Activity and Immunoregulatory Properties	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; 2 ANTIMICROBIAL PEPTIDES; TIME RT-PCR; RAINBOW-TROUT; C1Q-DOMAIN-CONTAINING PROTEIN; HUMAN ALPHA-DEFENSIN-1; CRASSOSTREA-VIRGINICA; ESCHERICHIA-COLI; RHABDOVIRUS VHSV; IMMUNE-RESPONSE	Previous research has shown that an antimicrobial peptide (AMP) of the myticin class C (Myt C) is the most abundantly expressed gene in cDNA and suppressive subtractive hybridization (SSH) libraries after immune stimulation of mussel Mytilus galloprovincialis. However, to date, the expression pattern, the antimicrobial activities and the immunomodulatory properties of the Myt C peptide have not been determined. In contrast, it is known that Myt C mRNA presents an unusual and high level of polymorphism of unidentified biological significance. Therefore, to provide a better understanding of the features of this interesting molecule, we have investigated its function using four different cloned and expressed variants of Myt C cDNA and polyclonal anti-Myt C sera. The in vivo results suggest that this AMP, mainly present in hemocytes, could be acting as an immune system modulator molecule because its overexpression was able to alter the expression of mussel immune-related genes (as the antimicrobial peptides Myticin B and Mytilin B, the C1q domain-containing protein MgC1q, and lysozyme). Moreover, the in vitro results indicate that Myt C peptides have antimicrobial and chemotactic properties. Their recombinant expression in a fish cell line conferred protection against two different fish viruses (enveloped and non-enveloped). Cell extracts from Myt C expressing fish cells were also able to attract hemocytes. All together, these results suggest that Myt C should be considered not only as an AMP but also as the first chemokine/cytokine-like molecule identified in bivalves and one of the few examples in all of the invertebrates.	[Balseiro, Pablo; Romero, Alejandro; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz] CSIC, IIM, Vigo, Spain; [Falco, Alberto; Martinez-Lopez, Alicia; Estepa, Amparo] Miguel Hernandez Univ, IBMC, Elche, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Universidad Miguel Hernandez de Elche	Balseiro, P (corresponding author), CSIC, IIM, Vigo, Spain.	virus@iim.csic.es	Falco, Alberto/A-3250-2012; Dios, Sonia/M-4201-2018; Romero, Alejandro/R-4565-2019; Figueras, Antonio/B-5133-2015; Figueras, Antonio/AAB-8921-2019; Novoa, Beatriz/K-3785-2014; Balseiro, Pablo/I-7406-2013	Falco, Alberto/0000-0001-7726-6577; Dios, Sonia/0000-0002-2126-991X; Romero, Alejandro/0000-0002-9343-3352; Figueras, Antonio/0000-0002-0617-0030; Figueras, Antonio/0000-0002-0617-0030; Martinez Lopez, Alicia/0000-0003-3347-0394; Novoa, Beatriz/0000-0003-4888-8419; Balseiro, Pablo/0000-0002-9365-6775	Spanish Ministerio de Ciencia e Innovation [AGL2008-05111/ACU]; Ministerio de Asuntos Exteriores y de Cooperacion [A/026000/09]	Spanish Ministerio de Ciencia e Innovation(Spanish Government); Ministerio de Asuntos Exteriores y de Cooperacion	This work was funded by the project AGL2008-05111/ACU from the Spanish Ministerio de Ciencia e Innovation and project A/026000/09 from the Ministerio de Asuntos Exteriores y de Cooperacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battison AL, 2008, FISH SHELLFISH IMMUN, V25, P181, DOI 10.1016/j.fsi.2008.04.005; BIRKBECK TH, 1982, MAR BIOL, V72, P7, DOI 10.1007/BF00393942; Brocal I, 2006, APPL MICROBIOL BIOT, V72, P1217, DOI 10.1007/s00253-006-0393-7; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chen Y, 2007, FISH SHELLFISH IMMUN, V23, P589, DOI 10.1016/j.fsi.2007.01.006; Chico V, 2006, J VIROL METHODS, V132, P154, DOI 10.1016/j.jviromet.2005.10.005; Chico V, 2009, VACCINE, V27, P1938, DOI 10.1016/j.vaccine.2009.01.103; CHU FLE, 1989, J INVERTEBR PATHOL, V54, P224, DOI 10.1016/0022-2011(89)90032-3; COLL J, 1989, MED VET, V6, P425; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; DEKINKELIN P, 1977, CR ACAD SCI D NAT, V284, P101; Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256; Falco A, 2008, FISH SHELLFISH IMMUN, V24, P102, DOI 10.1016/j.fsi.2007.09.007; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Falco A, 2007, ANTIVIR RES, V76, P111, DOI 10.1016/j.antiviral.2007.06.006; Falco A, 2009, MINI-REV MED CHEM, V9, P1159, DOI 10.2174/138955709789055171; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Govorin I., 2000, RUSS J MAR BIOL, V26, P81; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hong XT, 2006, FISH SHELLFISH IMMUN, V21, P357, DOI 10.1016/j.fsi.2005.12.013; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; KUMAZAWA NH, 1991, J VET MED SCI, V53, P883; Li H, 2010, FISH SHELLFISH IMMUN, V28, P640, DOI 10.1016/j.fsi.2009.12.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Cortes L, 1999, FISH SHELLFISH IMMUN, V9, P543, DOI 10.1006/fsim.1999.0211; Lorenzo G, 1996, J VIROL METHODS, V58, P1, DOI 10.1016/0166-0934(95)01972-3; Marroqui L, 2008, ANTIVIR RES, V80, P332, DOI 10.1016/j.antiviral.2008.07.007; Mas V, 2002, J GEN VIROL, V83, P2671, DOI 10.1099/0022-1317-83-11-2671; MCDADE JE, 1967, J INVERTEBR PATHOL, V9, P531, DOI 10.1016/0022-2011(67)90134-6; Mitta G, 2000, J BIOL CHEM, V275, P12954, DOI 10.1074/jbc.275.17.12954; Mitta G, 2000, J CELL SCI, V113, P2759; Mitta G, 1999, J CELL SCI, V112, P4233; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Murray HM, 2003, J FISH BIOL, V62, P816, DOI 10.1046/j.1095-8649.2003.00067.x; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; Ottaviani E, 2001, COMP BIOCHEM PHYS C, V129, P295, DOI 10.1016/S1532-0456(01)00211-3; Padhi A, 2008, PEPTIDES, V29, P1094, DOI 10.1016/j.peptides.2008.03.007; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Patrzykat A, 2005, PROTEIN PEPTIDE LETT, V12, P19, DOI 10.2174/0929866053406057; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roch P, 2008, DEV COMP IMMUNOL, V32, P227, DOI 10.1016/j.dci.2007.05.006; Roch P, 2004, EVID-BASED COMPL ALT, V1, P167, DOI 10.1093/ecam/neh033; Saint-Jean SR, 2006, VET IMMUNOL IMMUNOP, V110, P1, DOI 10.1016/j.vetimm.2005.08.023; STEFANO GB, 1989, P NATL ACAD SCI USA, V86, P626, DOI 10.1073/pnas.86.2.626; Tafalla C, 2007, FISH SHELLFISH IMMUN, V23, P210, DOI 10.1016/j.fsi.2006.10.009; Ulvatne H, 2002, J ANTIMICROB CHEMOTH, V50, P461, DOI 10.1093/jac/dkf156; VALERIO PF, 1992, J EXP BIOL, V164, P135; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003	56	60	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23140	10.1371/journal.pone.0023140	http://dx.doi.org/10.1371/journal.pone.0023140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858010	gold, Green Published, Green Submitted			2022-12-27	WOS:000293773300022
J	Hu, XB; Whaley, MA; Stein, MM; Mitchell, BE; O'Tousa, JE				Hu, Xiaobang; Whaley, Michelle A.; Stein, Michelle M.; Mitchell, Bronwen E.; O'Tousa, Joseph E.			Coexpression of Spectrally Distinct Rhodopsins in Aedes aegypti R7 Photoreceptors	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; DROSOPHILA; GENE; EYE; BEHAVIOR; OPSINS; CELLS	The retina of the mosquito Aedes aegypti can be divided into four regions based on the non-overlapping expression of a UV sensitive Aaop8 rhodopsin and a long wavelength sensitive Aaop2 type rhodopsin in the R7 photoreceptors. We show here that another rhodopsin, Aaop9, is expressed in all R7 photoreceptors and a subset of R8 photoreceptors. In the dorsal region, Aaop9 is expressed in both the cell body and rhabdomere of R7 and R8 cells. In other retinal regions Aaop9 is expressed only in R7 cells, being localized to the R7 rhabdomere in the central and ventral regions and in both the cell body and rhabdomere within the ventral stripe. Within the dorsal-central transition area ommatidia do not show a strict pairing of R7-R8 cell types. Thus, Aaop9 is coexpressed in the two classes of R7 photoreceptors previously distinguished by the non-overlapping expression of Aaop8 and Aaop2 rhodopsins. Electroretinogram analysis of transgenic Drosophila shows that Aaop9 is a short wavelength rhodopsin with an optimal response to 400-450 nm light. The coexpressed Aaop2 rhodopsin has dual wavelength sensitivity of 500-550 nm and near 350 nm in the UV region. As predicted by the spectral properties of each rhodopsin, Drosophila photoreceptors expressing both Aaop9 and Aaop2 rhodopsins exhibit a uniform sensitivity across the broad 350-550 nm light range. We propose that rhodopsin coexpression is an adaptation within the R7 cells to improve visual function in the low-light environments in which Ae. aegypti is active.	[Hu, Xiaobang; Whaley, Michelle A.; Stein, Michelle M.; Mitchell, Bronwen E.; O'Tousa, Joseph E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Hu, XB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	jotousa@nd.edu		Hu, Xiaobang/0000-0001-9964-1067; O'Tousa, Joseph/0000-0001-9754-6816; Stein, Michelle/0000-0002-7680-9012	National Institutes of Health [EY06808]; NATIONAL EYE INSTITUTE [R01EY006808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded by National Institutes of Health grant EY06808 awarded to J. O'Tousa. The web site is http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ST, 2006, INVEST OPHTH VIS SCI, V47, P3722, DOI 10.1167/iovs.06-0281; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Arikawa K, 2003, J NEUROSCI, V23, P4527; Bell ML, 2007, J COMP NEUROL, V502, P75, DOI 10.1002/cne.21298; Blackiston D, 2011, J EXP BIOL, V214, P509, DOI 10.1242/jeb.048728; BRAMMER JD, 1970, J EXP ZOOL, V175, P181, DOI 10.1002/jez.1401750207; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dabdoub A, 2003, VISUAL NEUROSCI, V20, P241, DOI 10.1017/S0952523803203035; Day JF, 2005, J AM MOSQUITO CONTR, V21, P17, DOI 10.2987/8756-971X(2005)21[17:HSOMDV]2.0.CO;2; DESPLAN C, 2003, COLOR POLARIZED LIGH; Earl JB, 2006, GENE EXPR PATTERNS, V6, P687, DOI 10.1016/j.modgep.2006.01.003; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; Greenspan R.J., 2004, FLY PUSHING THEORY P; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Hu XB, 2009, J COMP NEUROL, V516, P334, DOI 10.1002/cne.22114; Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2; Knox BE, 2003, J BIOL CHEM, V278, P40493, DOI 10.1074/jbc.M304567200; Land MF, 1999, J COMP PHYSIOL A, V185, P91, DOI 10.1007/s003590050369; Mazzoni EO, 2004, DEV NEUROSCI-BASEL, V26, P388, DOI 10.1159/000082281; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Morante J, 2007, CURR OPIN GENET DEV, V17, P314, DOI 10.1016/j.gde.2007.05.003; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Spaethe J, 2004, MOL BIOL EVOL, V21, P1583, DOI 10.1093/molbev/msh162; Stavenga DG, 2008, PLOS BIOL, V6, P675, DOI 10.1371/journal.pbio.0060115; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Townson SM, 1998, J NEUROSCI, V18, P2412; VOGT K, 1983, BIOPHYS STRUCT MECH, V9, P319, DOI 10.1007/BF00535667; WASHBURN T, 1992, GENETICS, V130, P585	29	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23121	10.1371/journal.pone.0023121	http://dx.doi.org/10.1371/journal.pone.0023121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858005	gold, Green Published, Green Submitted			2022-12-27	WOS:000293773300021
J	Ncaca, LN; Kranzer, K; Orrell, C				Ncaca, Lisa-Noelle; Kranzer, Katharina; Orrell, Catherine			Treatment Interruption and Variation in Tablet Taking Behaviour Result in Viral Failure: A Case-Control Study from Cape Town, South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; HIV-INFECTION; ADHERENCE; DISCONTINUATION; RESISTANCE; COHORT; SUPPRESSION; OUTCOMES; IMPACT	Background: Understanding of the impact of non-structured treatment interruption (TI) and variation in tablet-taking on failure of first-line antiretroviral therapy (ART) is limited in a resource-poor setting. Methods: A retrospective matched case-control analysis. Individuals failing ART were matched by time on ART with 4 controls. Viral load (VL) and CD4 count were completed 4-monthly. Adherence percentages, from tablet returns, were calculated 4-monthly (interval) and from ART start (cumulative). Variation between intervals and TI (>27 days off ART) were recorded. Conditional multivariate logistic regression analysis was performed to estimate the effect of cumulative adherence <90%, at least one episode of adherence variation >10% and TI on virological failure. Age, gender, baseline log VL and CD4 were included as possible confounders in the multivariate model. Results: 244 patients (44 cases, 200 controls) were included. Median age was 32 years (IQR28-37), baseline CD4 108 cells/mm3 (IQR56-151), VL 4.82 log (IQR4.48-5.23). 94% (96% controls, 86% failures) had cumulative adherence >90%. The odds of failure increased 3 times (aOR 3.01, 95% CI 0.81-11.21) in individuals with cumulative adherence <90%, 2.2 times (aOR 2.20, 95% CI 1.04-4.64) in individuals with at least one episode of fluctuating adherence of >10% and 4.01 times (aOR 4.01, 95% CI 1.45-11.10) in individuals with TIs. For individuals with TI and cumulative adherence >95%, the odds of failing were 5.65 (CI 1.40-22.85). Conclusion: It is well known that poor cumulative adherence increases risk of virological failure, but less well understood that TI and variations in tablet-taking also play a key role, despite otherwise excellent adherence.	[Ncaca, Lisa-Noelle; Kranzer, Katharina; Orrell, Catherine] Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Ncaca, LN (corresponding author), Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa.	catherine.orrell@hiv-reseaarch.org.za	Kranzer, Katharina/O-8845-2014; Orrell, Catherine/AAF-3405-2019	Kranzer, Katharina/0000-0001-5691-7270; Orrell, Catherine/0000-0003-1134-7475	USAID; Welltrust Trust	USAID(United States Agency for International Development (USAID)); Welltrust Trust	Lisa-Noelle Ncaca and Catherine Orrell receive funding through the USAID funded Anova Program. Katharina Kranzer receives funding through the Welltrust Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2008, AIDS, V22, P349, DOI 10.1097/QAD.0b013e3282f4709a; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Bisson GP, 2008, JAIDS-J ACQ IMM DEF, V49, P107, DOI 10.1097/QAI.0b013e3181820141; DARMINIO MA, 2005, J ACQ IMMUN DEF SYND, V38, P407; Datay MI, 2010, JAIDS-J ACQ IMM DEF, V54, P489, DOI 10.1097/QAI.0b013e3181d91788; *DEP HLTH, 2010, STAT SO AFR MID POP; Hirschel B, 2009, AIDS, V23, P757, DOI 10.1097/QAD.0b013e328321b791; Kiguba R, 2007, JAIDS-J ACQ IMM DEF, V45, P218, DOI 10.1097/QAI.0b013e31805d8ae3; Knobel H, 2009, HIV MED, V10, P364, DOI 10.1111/j.1468-1293.2009.00696.x; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; National Department of Health, 2004, S AFR NAT ANT TREAT; Olsen CH, 2007, HIV MED, V8, P96, DOI 10.1111/j.1468-1293.2007.00436.x; Orrell C, 2007, ANTIVIR THER, V12, P83; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pogany K, 2007, JAIDS-J ACQ IMM DEF, V44, P395, DOI 10.1097/QAI.0b013e31802f83bc; Taffe P, 2002, AIDS, V16, P747, DOI 10.1097/00002030-200203290-00010; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760	26	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23088	10.1371/journal.pone.0023088	http://dx.doi.org/10.1371/journal.pone.0023088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858001	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300019
J	Milenkovic, T; Memisevic, V; Bonato, A; Przulj, N				Milenkovic, Tijana; Memisevic, Vesna; Bonato, Anthony; Przulj, Natasa			Dominating Biological Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; INTERACTION DATABASE; SUBGRAPH CENTRALITY; CANCER PROTEINS; YEAST; INTERACTOME; RESOURCE; STRATEGY; GENES; ALGORITHMS	Proteins are essential macromolecules of life that carry out most cellular processes. Since proteins aggregate to perform function, and since protein-protein interaction (PPI) networks model these aggregations, one would expect to uncover new biology from PPI network topology. Hence, using PPI networks to predict protein function and role of protein pathways in disease has received attention. A debate remains open about whether network properties of "biologically central (BC)" genes (i.e., their protein products), such as those involved in aging, cancer, infectious diseases, or signaling and drug-targeted pathways, exhibit some topological centrality compared to the rest of the proteins in the human PPI network. To help resolve this debate, we design new network-based approaches and apply them to get new insight into biological function and disease. We hypothesize that BC genes have a topologically central (TC) role in the human PPI network. We propose two different concepts of topological centrality. We design a new centrality measure to capture complex wirings of proteins in the network that identifies as TC those proteins that reside in dense extended network neighborhoods. Also, we use the notion of domination and find dominating sets (DSs) in the PPI network, i.e., sets of proteins such that every protein is either in the DS or is a neighbor of the DS. Clearly, a DS has a TC role, as it enables efficient communication between different network parts. We find statistically significant enrichment in BC genes of TC nodes and outperform the existing methods indicating that genes involved in key biological processes occupy topologically complex and dense regions of the network and correspond to its "spine" that connects all other network parts and can thus pass cellular signals efficiently throughout the network. To our knowledge, this is the first study that explores domination in the context of PPI networks.	[Milenkovic, Tijana] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Memisevic, Vesna] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Bonato, Anthony] Ryerson Univ, Dept Math, Toronto, ON, Canada; [Przulj, Natasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	University of Notre Dame; University of California System; University of California Irvine; Toronto Metropolitan University; Imperial College London	Milenkovic, T (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	natasha@imperial.ac.uk	Przulj, Natasa/AAO-2850-2020	Przulj, Natasa/0000-0002-1290-853X	National Science Foundation Faculty [IIS-0644424]; National Science Foundation Cyber-Enabled Discovery and Innovation [OIA-1028394]; Serbian Ministry of Education and Science [III44006]; Natural Sciences and Engineering Research Council; Mathematics of Information Technology and Complex Systems	National Science Foundation Faculty; National Science Foundation Cyber-Enabled Discovery and Innovation(National Science Foundation (NSF)); Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics of Information Technology and Complex Systems	This work was supported by the National Science Foundation Faculty Early Career Development (CAREER) Program IIS-0644424, the National Science Foundation Cyber-Enabled Discovery and Innovation OIA-1028394, and the Serbian Ministry of Education and Science Project III44006 grants, as well as grants from Natural Sciences and Engineering Research Council and Mathematics of Information Technology and Complex Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANAL BIOL NETWORKS; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cooper C, 2005, INTERNET MATH, V2, P275, DOI 10.1080/15427951.2005.10129105; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Duckworth W, 2006, COMB PROBAB COMPUT, V15, P513, DOI 10.1017/S0963548305007431; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2007, CHEM PHYS LETT, V439, P247, DOI 10.1016/j.cplett.2007.03.098; Ferrarini L, 2005, BIOINFORMATICS, V21, P338, DOI 10.1093/bioinformatics/bti004; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao B, 2005, INT J COMMUN SYST, V18, P743, DOI 10.1002/dac.726; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Ho HA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-84; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Houmaidi M, 2003, J OPTICAL NETWORKING, V2; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Memisevic V, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-135; Milenkovic T, 2010, J ROYAL SOC INTERFAC, V44, P353; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Promislow DEL, 2004, P ROY SOC B-BIOL SCI, V271, P1225, DOI 10.1098/rspb.2004.2732; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Rai M, 2009, J NETWORKS, V4; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ratmann O, 2009, HFSP J, V3, P290, DOI 10.2976/1.3167215; Reguly T, 2006, J BIOL, V5, P10; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Safran M, 2002, BIOINFORMATICS, V18, P1542, DOI 10.1093/bioinformatics/18.11.1542; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R., 2007, MOL SYSTEMS BIOL, V3; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stojmenovic I, 2002, IEEE T PARALL DISTR, V13, P14, DOI 10.1109/71.980024; Sun JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S5; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wu J, 1999, P 3 ACM INT WORKSH D, V18, P7; Yidirim MA, 2007, NATURE BIOTECHNOLOGY, V25; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	71	71	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23016	10.1371/journal.pone.0023016	http://dx.doi.org/10.1371/journal.pone.0023016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887225	Green Published, gold			2022-12-27	WOS:000294298800002
J	Daneshvar, K; Khan, A; Goodliffe, JM				Daneshvar, Kaveh; Khan, Abid; Goodliffe, Julie M.			Myc Localizes to Histone Locus Bodies during Replication in Drosophila	PLOS ONE			English	Article							CAJAL BODY; RIBOSOME BIOGENESIS; PROTEIN; GROWTH; COILIN; TRANSACTIVATION; MELANOGASTER; ACTIVATION; POLYCOMB; DMYC	Myc is an important protein at the center of multiple pathways required for growth and proliferation in animals. The absence of Myc is lethal in flies and mice, and its over-production is a potent inducer of over-proliferation and cancer. Myc protein is localized to the nucleus where it executes its many functions, however the specific sub-nuclear localization of Myc has rarely been reported. The work we describe here began with an observation of unexpected, punctate spots of Myc protein in certain regions of Drosophila embryos. We investigated the identity of these puncta and demonstrate that Myc is co-localized with coilin, a marker for sub-nuclear organelles known as Cajal Bodies (CBs), in embryos, larvae and ovaries. Using antibodies specific for U7 snRNP component Lsm11, we show that the majority of Myc and coilin co-localization occurs in Histone Locus Bodies (HLBs), the sites of histone mRNA transcription and processing. Furthermore, Myc localizes to HLBs only during replication in mitotic and endocycling cells, suggesting that its role there relates to replication-dependent canonical histone gene transcription. These results provide evidence that sub-nuclear localization of Myc is cell-cycle dependent and potentially important for histone mRNA production and processing.	[Daneshvar, Kaveh; Khan, Abid; Goodliffe, Julie M.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Daneshvar, K (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	jmgoodli@uncc.edu	Khan, Abid/Y-8454-2019; Daneshvar, Kaveh/M-9443-2014	Daneshvar, Kaveh/0000-0002-7863-0489; Khan, Abid/0000-0003-0968-8705	NIH (NCI) [1R15CA135481-01]; NSF; NATIONAL CANCER INSTITUTE [R15CA135481] Funding Source: NIH RePORTER	NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded by the NIH (NCI, www.cancer.gov) to JMG, under grant number 1R15CA135481-01, and also by an NSF ADVANCE grant to UNC Charlotte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADING H, 1989, ONCOGENE, V4, P33; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Campos-Ortega JA, 1997, EMBRYONIC DEV DROSOP, Vxvii; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; CRANNA NJ, FLY AUSTIN, V5; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edgar BA, 2001, NOVART FDN SYMP, V237, P3, DOI 10.1002/0470846666.ch2; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Goodliffe JM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-40; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Khan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005076; Kim H, 2007, BIOCHEM BIOPH RES CO, V362, P842, DOI 10.1016/j.bbrc.2007.08.064; Kupsco JM, 2006, RNA, V12, P2103, DOI 10.1261/rna.186706; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Marinho J, 2011, DEVELOPMENT, V138, P349, DOI 10.1242/dev.054411; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nizami Z, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000653; Quinn LM, 2004, DEVELOPMENT, V131, P1411, DOI 10.1242/dev.01019; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; White AE, 2011, J CELL BIOL, V193, P677, DOI 10.1083/jcb.201012077; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23928	10.1371/journal.pone.0023928	http://dx.doi.org/10.1371/journal.pone.0023928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886841	gold, Green Published, Green Submitted			2022-12-27	WOS:000294253500039
J	Islam, AMMK; Richter, WF; Jacobs, LA; Lopez-Bigas, N; Benevolenskaya, EV				Islam, Abul B. M. M. K.; Richter, William F.; Jacobs, Laura A.; Lopez-Bigas, Nuria; Benevolenskaya, Elizaveta V.			Co-Regulation of Histone-Modifying Enzymes in Cancer	PLOS ONE			English	Article							METASTATIC PROSTATE-CANCER; POLYCOMB GROUP; BINDING; GENOME; GENE; DIFFERENTIATION; EZH2; METHYLTRANSFERASE; METHYLATION; LEUKEMIA	Cancer is characterized by aberrant patterns of expression of multiple genes. These major shifts in gene expression are believed to be due to not only genetic but also epigenetic changes. The epigenetic changes are communicated through chemical modifications, including histone modifications. However, it is unclear whether the binding of histone-modifying proteins to genomic regions and the placing of histone modifications efficiently discriminates corresponding genes from the rest of the genes in the human genome. We performed gene expression analysis of histone demethylases (HDMs) and histone methyltransferases (HMTs), their target genes and genes with relevant histone modifications in normal and tumor tissues. Surprisingly, this analysis revealed the existence of correlations in the expression levels of different HDMs and HMTs. The observed HDM/HMT gene expression signature was specific to particular normal and cancer cell types and highly correlated with target gene expression and the expression of genes with histone modifications. Notably, we observed that trimethylation at lysine 4 and lysine 27 separated preferentially expressed and underexpressed genes, which was strikingly different in cancer cells compared to normal cells. We conclude that changes in coordinated regulation of enzymes executing histone modifications may underlie global epigenetic changes occurring in cancer.	[Islam, Abul B. M. M. K.; Richter, William F.; Jacobs, Laura A.; Benevolenskaya, Elizaveta V.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60680 USA; [Islam, Abul B. M. M. K.; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt Hlth & Sci, Res Unit Biomed Informat, PRBB, Barcelona, Spain	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pompeu Fabra University	Islam, AMMK (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60680 USA.	evb@uic.edu	Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011	Lopez-Bigas, Nuria/0000-0003-4925-8988; Islam, Abul/0000-0002-7274-0855; Richter, William/0000-0003-4469-6428	American Cancer Society [115347-RSG-08-271-01-GMC]; Spanish Ministry of Science and Education [SAF2009-06954]; AGAUR of the Catalonian Government, Spain;  [R01CA138631]; NATIONAL CANCER INSTITUTE [R01CA138631] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Spanish Ministry of Science and Education(Spanish Government); AGAUR of the Catalonian Government, Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by R01CA138631 (E.V.B.) and grant number 115347-RSG-08-271-01-GMC from the American Cancer Society (E.V.B.). N.L.-B. acknowledges funding from the Spanish Ministry of Science and Education, grant number SAF2009-06954. A. B. M. M. K. I. is supported by a fellowship from AGAUR of the Catalonian Government, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benevolenskaya EV, 2007, BIOCHEM CELL BIOL, V85, P435, DOI 10.1139/O07-057; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Berezovska OP, 2006, CELL CYCLE, V5, P1886; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chik CL, 2007, ENDOCRINOLOGY, V148, P1465, DOI 10.1210/en.2006-1454; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Gildea JJ, 2000, GENETICS, V156, P645; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Islam ABMMK, 2011, CELL CYCLE, V10, P413, DOI 10.4161/cc.10.3.14705; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	41	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e24023	10.1371/journal.pone.0024023	http://dx.doi.org/10.1371/journal.pone.0024023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886846	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500043
J	Ma, MJ; Wang, HB; Li, H; Yang, JH; Yan, Y; Xie, LP; Qi, YC; Li, JL; Chen, MJ; Liu, W; Cao, WC				Ma, Mai-Juan; Wang, Hai-Bing; Li, Hao; Yang, Jun-Hai; Yan, Yan; Xie, Lan-Pin; Qi, Ying-Cheng; Li, Jun-Lian; Chen, Mei-Juan; Liu, Wei; Cao, Wu-Chun			Genetic Variants in MARCO Are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Han Population	PLOS ONE			English	Article							SCAVENGER RECEPTOR MARCO; GENOME-WIDE ASSOCIATION; HOST-DEFENSE; IDENTIFIES VARIANTS; IN-VITRO; MACROPHAGES; INVOLVEMENT; CLEARANCE; REGION; ROLES	Background: Susceptibility to tuberculosis is not only determined by Mycobacterium tuberculosis infection, but also by the genetic component of the host. Macrophage receptor with a collagenous structure (MARCO) is essential components required for toll like receptor-signaling in macrophage response to Mycobacterium tuberculosis, which may contribute to tuberculosis risk. Principal Findings: To specifically investigated whether single nucleotide polymorphisms (SNPs) in MARCO gene are associated with pulmonary tuberculosis in Chinese Han population. By selecting tagging SNPs in MARCO gene, 17 tag SNPs were identified and genotyped in 923 pulmonary tuberculosis patients and 1033 healthy control subjects using a hospital based case-control association study. Single-point and haplotype analysis revealed an association in intron and exon region of MARCO gene. One SNP (rs17009726) was associated with susceptibility to pulmonary tuberculosis, where the carriers of the G allele had a 1.65 fold (95% CI = 1.32-2.05, p(corrected) = 9.27E-5) increased risk of pulmonary tuberculosis. Haplotype analysis revealed that haplotype GC containing G allele of 17009726 and haplotype TGCC (rs17795618T/A, rs1371562G/T, rs6761637T/C, rs2011839C/T) were also associated with susceptibility to pulmonary tuberculosis (p(corrected) = 0.0001 and 0.029, respectively). Conclusions: Our study suggested that genetic variants in MARCO gene were associated with pulmonary tuberculosis susceptibility in Chinese Han population, and the findings emphasize the importance of MARCO mediated immune responses in the pathogenesis of tuberculosis.	[Ma, Mai-Juan; Li, Hao; Liu, Wei; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Hai-Bing] Shijiazhuang Fifth Hosp, Dept TB, Shijiazhuang, Hebei, Peoples R China; [Yang, Jun-Hai; Yan, Yan] Beijing Elect Hosp, Phys Examinat Dept, Beijing, Peoples R China; [Qi, Ying-Cheng; Li, Jun-Lian; Chen, Mei-Juan] Xinjiang Uygur Autonomous Reg Chest Hosp, Urumqi, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Ma, MJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	liu_weis@sohu.com; caowc@nic.bmi.ac.cn		Ma, Mai-Juan/0000-0002-8105-462X	National Science Fund for Distinguished Young Scholars [30725032]; Academy of Military Medical Sciences [2008ZD006]; China Special Grant for the Prevention and Control of Infection Diseases [2008ZX10003-010]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Academy of Military Medical Sciences; China Special Grant for the Prevention and Control of Infection Diseases	This study was supported by the grants of National Science Fund for Distinguished Young Scholars (30725032), Innovation Research Funds of Academy of Military Medical Sciences (2008ZD006) and China Special Grant for the Prevention and Control of Infection Diseases (2008ZX10003-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ito S, 1999, ARCH HISTOL CYTOL, V62, P83, DOI 10.1679/aohc.62.83; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Mukhopadhyay S, 2004, J LEUKOCYTE BIOL, V76, P577, DOI 10.1189/jlb.0104014; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; Rieder H L, 2003, Pneumologie, V57, P402; Seta N, 2001, ARTHRITIS RHEUM, V44, P931, DOI 10.1002/1529-0131(200104)44:4<931::AID-ANR150>3.3.CO;2-K; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; van der Laan LJW, 1999, J IMMUNOL, V162, P939; vanderLaan LJW, 1997, IMMUNOL LETT, V57, P203, DOI 10.1016/S0165-2478(97)00077-1; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	23	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e24069	10.1371/journal.pone.0024069	http://dx.doi.org/10.1371/journal.pone.0024069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886847	gold, Green Published, Green Submitted			2022-12-27	WOS:000294253500044
J	Zuo, WL; Li, S; Huang, JH; Yang, DL; Zhang, G; Chen, SL; Ruan, YC; Ye, KN; Cheng, CHK; Zhou, WL				Zuo, Wu-Lin; Li, Sheng; Huang, Jie-Hong; Yang, Deng-Liang; Zhang, Geng; Chen, Si-Liang; Ruan, Ye-Chun; Ye, Ke-Nan; Cheng, Christopher H. K.; Zhou, Wen-Liang			Sodium Coupled Bicarbonate Influx Regulates Intracellular and Apical pH in Cultured Rat Caput Epididymal Epithelium	PLOS ONE			English	Article							MALE REPRODUCTIVE-TRACT; SEMINIFEROUS TUBULES; ANION-EXCHANGER; CELLS; COTRANSPORTER; ACIDIFICATION; IMMUNOLOCALIZATION; TRANSPORT; FLUID; INHIBITION	Background: The epithelium lining the epididymis provides an optimal acidic fluid microenvironment in the epididymal tract that enable spermatozoa to complete the maturation process. The present study aims to investigate the functional role of Na+/HCO3- cotransporter in the pH regulation in rat epididymis. Method/Principal Findings: Immunofluorescence staining of pan cytokeratin in the primary culture of rat caput epididymal epithelium showed that the system was a suitable model for investigating the function of epididymal epithelium. Intracellular and apical pH were measured using the fluorescent pH sensitive probe carboxy-seminaphthorhodafluor-4F acetoxymethyl ester (SNARF-4F) and sparklet pH electrode respectively to explore the functional role of rat epididymal epithelium. In the HEPES buffered Krebs-Henseleit(KH) solution, the intracellular pH (pHi) recovery from NH4Cl induced acidification in the cultured caput epididymal epithelium was completely inhibited by amiloride, the inhibitor of Na+/H+ exchanger (NHE). Immediately changing of the KH solution from HEPES buffered to HCO3- buffered would cause another pHi recovery. The pHi recovery in HCO3- buffered KH solution was inhibited by 4, 4diisothiocyanatostilbene-2, 2-disulfonic acid (DIDS), the inhibitor of HCO3- transporter or by removal of extracellular Na+. The extracellular pH measurement showed that the apical pH would increase when adding DIDS to the apical side of epididymal epithelial monolayer, however adding DIDS to the basolateral side had no effect on apical pH. Conclusions: The present study shows that sodium coupled bicarbonate influx regulates intracellular and apical pH in cultured caput epididymal epithelium.	[Zuo, Wu-Lin; Li, Sheng; Huang, Jie-Hong; Yang, Deng-Liang; Zhang, Geng; Chen, Si-Liang; Ruan, Ye-Chun; Ye, Ke-Nan; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Cheng, Christopher H. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong	Zuo, WL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	chkcheng@cuhk.edu.hk; lsszwl@yahoo.com.cn	Ruan, Ye Chun/T-7531-2019; Li, Sheng/A-1964-2014; RUAN, Ye Chun/T-5919-2017; CHENG, Ki Christopher/R-9641-2018	Ruan, Ye Chun/0000-0002-4266-6789; RUAN, Ye Chun/0000-0002-4266-6789; CHENG, Ki Christopher/0000-0001-8970-9048	National Natural Science Foundation of China [30770817, 31071019]; National 973 project foundation of China [2010CB945401, 2009CB522102]; Research Grants Council of Hong Kong [CUHK 462810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 project foundation of China(National Basic Research Program of China); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	Supported by the National Natural Science Foundation of China (No. 30770817 and 31071019), National 973 project foundation (No. 2010CB945401 and 2009CB522102) of China and the Research Grants Council of Hong Kong for the provision of a General Research Fund (CUHK 462810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2004, ACTA PHYSIOL SCAND, V181, P505, DOI 10.1111/j.1365-201X.2004.01324.x; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF426, DOI 10.1152/ajprenal.2001.280.3.F426; Bernardo AA, 2006, SEMIN NEPHROL, V26, P352, DOI 10.1016/j.semnephrol.2006.07.008; BORON WF, 1986, ANNU REV PHYSIOL, V48, P377; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Brown D, 1997, J EXP BIOL, V200, P257; CHAN HC, 1995, BIOL REPROD, V52, P645, DOI 10.1095/biolreprod52.3.645; Chew SBC, 2000, BIOL REPROD, V62, P755, DOI 10.1095/biolreprod62.3.755; Da Silva N, 2007, ASIAN J ANDROL, V9, P476, DOI 10.1111/j.1745-7262.2007.00299.x; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Du JY, 2006, BIOL REPROD, V75, P407, DOI 10.1095/biolreprod.106.052316; Du JY, 2009, BIOL REPROD, V80, P13, DOI 10.1095/biolreprod.108.068346; Erdogan S, 2005, DEV BIOL, V286, P352, DOI 10.1016/j.ydbio.2005.08.009; Hansen LA, 1999, EXP PHYSIOL, V84, P521, DOI 10.1111/j.1469-445X.1999.01788.x; Herak-Kramberger CM, 2001, BIOL REPROD, V64, P1699, DOI 10.1095/biolreprod64.6.1699; Hilvo M, 2007, CURR TOP MED CHEM, V7, P893, DOI 10.2174/156802607780636672; Huang Y, 1999, BIOL REPROD, V60, P1509, DOI 10.1095/biolreprod60.6.1509; Jensen LJ, 1999, BIOL REPROD, V60, P573, DOI 10.1095/biolreprod60.3.573; Jensen LJ, 1999, BIOL REPROD, V61, P973, DOI 10.1095/biolreprod61.4.973; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; Kaunisto K, 2001, PFLUG ARCH EUR J PHY, V442, P230, DOI 10.1007/s004240100530; KIERSZENBAUM AL, 1981, P NATL ACAD SCI-BIOL, V78, P1675, DOI 10.1073/pnas.78.3.1675; Kim YB, 2003, BIOCHEM BIOPH RES CO, V304, P593, DOI 10.1016/S0006-291X(03)00632-6; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; LEUNG AYH, 1994, PFLUG ARCH EUR J PHY, V426, P396, DOI 10.1007/BF00388302; Leung GPH, 2001, BIOL REPROD, V64, P482, DOI 10.1095/biolreprod64.2.482; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; Liu CJ, 2008, MOL CELL BIOCHEM, V308, P117, DOI 10.1007/s11010-007-9619-y; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pushkin A, 2000, J ANDROL, V21, P708; ROBAIRE B, 2002, EPIDIDYMIS MOL CLIN, P81; Romero M F, 2001, JOP, V2, P182; Schwab A, 2005, J PHYSIOL-LONDON, V568, P445, DOI 10.1113/jphysiol.2005.092957; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Wang XF, 2002, BIOL REPROD, V66, P1846, DOI 10.1095/biolreprod66.6.1846; Wong P.Y.D., 2002, EPIDIDYMIS MOL CLIN, P119, DOI [10.1007/978-1-4615-0679-9_7, DOI 10.1007/978-1-4615-0679-9_7, DOI 10.1007/978-1-46150679-9_7]; WONG PYD, 1976, JPN J PHYSIOL, V26, P321; WONG PYD, 1976, BRIT J PHARMACOL, V58, P529, DOI 10.1111/j.1476-5381.1976.tb08620.x; WONG PYD, 1990, EPITHELIAL SECRETION, P333; Zhang WK, 2010, NAT CELL BIOL, V12, P507, DOI 10.1038/ncb2053; Zuo WL, 2010, FERTIL STERIL, V93, P2744, DOI 10.1016/j.fertnstert.2010.02.042	43	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e22283	10.1371/journal.pone.0022283	http://dx.doi.org/10.1371/journal.pone.0022283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887217	Green Published, gold, Green Submitted			2022-12-27	WOS:000294251800004
J	Lee, BR; Kamitani, T				Lee, Byung Rho; Kamitani, Tetsu			Improved Immunodetection of Endogenous alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; MUTATION; PHOSPHORYLATION; MEMBRANE	alpha-Synuclein is a key molecule in understanding the pathogenesis of neurodegenerative alpha-synucleinopathies such as Parkinson's disease. Despite extensive research, however, its precise function remains unclear partly because of a difficulty in immunoblotting detection of endogenous alpha-synuclein. This difficulty has largely restricted the progress for alpha-synucleinopathy research. Here, we report that alpha-synuclein monomers tend to easily detach from blotted membranes, resulting in no or very poor detection. To prevent this detachment, a mild fixation of blotted membranes with paraformaldehyde was applied to the immunoblotting method. Amazingly, this fixation led to clear and strong detection of endogenous alpha-synuclein, which has been undetectable by a conventional immunoblotting method. Specifically, we were able to detect endogenous alpha-synuclein in various human cell lines, including SH-SY5Y, HEK293, HL60, HeLa, K562, A375, and Daoy, and a mouse cell line B16 as well as in several mouse tissues such as the spleen and kidney. Moreover, it should be noted that we could clearly detect endogenous alpha-synuclein phosphorylated at Ser-129 in several human cell lines. Thus, in some tissues and cultured cells, endogenous alpha-synuclein becomes easily detectable by simply fixing the blotted membranes. This improved immunoblotting method will allow us to detect previously undetectable endogenous alpha-synuclein, thereby facilitating alpha-synuclein research.	[Lee, Byung Rho; Kamitani, Tetsu] Georgia Hlth Sci Univ, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA	University System of Georgia; Augusta University	Lee, BR (corresponding author), Georgia Hlth Sci Univ, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA.	tkamitani@georgiahealth.edu	Kamitani, Tetsu/GSI-7613-2022	Kamitani, Tetsu/0000-0002-3257-9630; Lee, Byung Rho/0000-0002-2729-1616	National Institutes of Health [R01AG024497]; NATIONAL INSTITUTE ON AGING [R01AG024497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health Grant R01AG024497 (to Tetsu Kamitani). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Jakes R, 1999, NEUROSCI LETT, V269, P13, DOI 10.1016/S0304-3940(99)00411-5; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LAURITZEN E, 1988, J ACQ IMMUN DEF SYND, V1, P333; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	16	97	100	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23939	10.1371/journal.pone.0023939	http://dx.doi.org/10.1371/journal.pone.0023939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886844	gold, Green Published, Green Submitted			2022-12-27	WOS:000294128100043
J	Schnepf, N; Resche-Rigon, M; Chaillon, A; Scemla, A; Gras, G; Semoun, O; Taboulet, P; Molina, JM; Simon, F; Goudeau, A; LeGoff, J				Schnepf, Nathalie; Resche-Rigon, Matthieu; Chaillon, Antoine; Scemla, Anne; Gras, Guillaume; Semoun, Oren; Taboulet, Pierre; Molina, Jean-Michel; Simon, Francois; Goudeau, Alain; LeGoff, Jerome			High Burden of Non-Influenza Viruses in Influenza-Like Illness in the Early Weeks of H1N1v Epidemic in France	PLOS ONE			English	Article							RESPIRATORY VIRUSES; VIRAL-INFECTIONS; SURVEILLANCE; PCR; DIAGNOSIS	Background: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observations are of little help to recognise myxovirus infection and implement appropriate prevention measures. The limited use of molecular tools underestimates the role of other common pathogens. Objectives: During the early weeks of the 2009-2010 flu pandemic, a clinical and virological survey was conducted in adult and paediatric patients with ILI referred to two French University hospitals in Paris and Tours. Aims were to investigate the different pathogens involved in ILI and describe the associated symptoms. Methods: H1N1v pandemic influenza diagnosis was performed with real time RT-PCR assay. Other viral aetiologies were investigated by the molecular multiplex assay RespiFinder19 (R). Clinical data were collected prospectively by physicians using a standard questionnaire. Results: From week 35 to 44, endonasal swabs were collected in 413 patients. Overall, 68 samples (16.5%) were positive for H1N1v. In 13 of them, other respiratory pathogens were also detected. Among H1N1v negative samples, 213 (61.9%) were positive for various respiratory agents, 190 in single infections and 23 in mixed infections. The most prevalent viruses in H1N1v negative single infections were rhinovirus (62.6%), followed by parainfluenza viruses (24.2%) and adenovirus (5.3%). 70.6% of H1N1v cases were identified in patients under 40 years and none after 65 years. There was no difference between clinical symptoms observed in patients infected with H1N1v or with other pathogens. Conclusion: Our results highlight the high frequency of non-influenza viruses involved in ILI during the pre-epidemic period of a flu alert and the lack of specific clinical signs associated with influenza infections. Rapid diagnostic screening of a large panel of respiratory pathogens may be critical to define and survey the epidemic situation and to provide critical information for patient management.	[Schnepf, Nathalie; Simon, Francois; LeGoff, Jerome] Univ Paris Diderot, St Louis Hosp, APHP, Dept Microbiol, Paris, France; [Schnepf, Nathalie; Chaillon, Antoine; Goudeau, Alain] Univ Tours, CHRU Tours, Bretonneau Hosp, Dept Microbiol, F-37041 Tours, France; [Resche-Rigon, Matthieu; Semoun, Oren] Univ Paris Diderot, St Louis Hosp, APHP, Dept Biostat, Paris, France; [Scemla, Anne; Molina, Jean-Michel] Univ Paris Diderot, St Louis Hosp, APHP, Dept Infect Dis, Paris, France; [Gras, Guillaume] CHRU Tours, Bretonneau Hosp, Internal Med & Infect Dis Dept, Tours, France; [Taboulet, Pierre] St Louis Hosp, APHP, Emergency Dept, Paris, France; [Simon, Francois; LeGoff, Jerome] Inst Univ Hematol, INSERM, U941, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Schnepf, N (corresponding author), Univ Paris Diderot, St Louis Hosp, APHP, Dept Microbiol, Paris, France.	jerome.le-goff@sls.aphp.fr	Resche-Rigon, Matthieu/ABA-5374-2021; LeGoff, jerome/AAP-7880-2021; chaillon, antoine/GNH-1623-2022; le goff, jerome/B-3447-2016; Chaillon, Antoine/GNH-6121-2022	le goff, jerome/0000-0001-7111-1865; resche-rigon, matthieu/0000-0003-2220-5085				Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beck ET, 2010, FUTURE MICROBIOL, V5, P901, DOI [10.2217/fmb.10.48, 10.2217/FMB.10.48]; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Brittain-Long R, 2010, J CLIN VIROL, V47, P263, DOI 10.1016/j.jcv.2009.12.010; Butler D, 2010, NATURE, V464, P1112, DOI 10.1038/4641112a; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Casalegno JS, 2010, EURO SURVEILL, V15; CASALEGNO JS, 2009, EUR SURVEILL, V14; Dumoulin A, 2009, TRANSPL INFECT DIS, V11, P287, DOI 10.1111/j.1399-3062.2009.00425.x; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Follin P, 2009, EUROSURVEILLANCE, V14; FUHRMAN C, 2010, EUR SURVEILL, V15; *GROUP REG OBS GRI, 2009, SURV GRIPP FRANC B H; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; Heddini A, 2009, EUROSURVEILLANCE, V14; *I VEILL SAN, 2009, B EP GRIPP A H1N1; *I VEILL SAN, 2009, SURV GRIPP FRANC; *I VEILL SAN, 2009, SIT EP BRONCH; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; LEVYBRUHL D, 2009, EUR SURVEILL, V14; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; Nisii C, 2010, J CLIN MICROBIOL, V48, P3383, DOI 10.1128/JCM.01179-10; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Reijans M, 2008, J CLIN MICROBIOL, V46, P1232, DOI 10.1128/JCM.02294-07; Renois F, 2010, J CLIN MICROBIOL, V48, P3836, DOI 10.1128/JCM.00733-10; *RES SENT, 2009, B HEBD; *RES SENT, 2010, RAPP ANN 2009 UPMC; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; World Health Organization, 2009, CDC PROT REAL TIM RT	34	47	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23514	10.1371/journal.pone.0023514	http://dx.doi.org/10.1371/journal.pone.0023514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858150	gold, Green Submitted, Green Published			2022-12-27	WOS:000294121300055
J	Swali, A; McMullen, S; Hayes, H; Gambling, L; McArdle, HJ; Langley-Evans, SC				Swali, Angelina; McMullen, Sarah; Hayes, Helen; Gambling, Lorraine; McArdle, Harry J.; Langley-Evans, Simon C.			Cell Cycle Regulation and Cytoskeletal Remodelling Are Critical Processes in the Nutritional Programming of Embryonic Development	PLOS ONE			English	Article							LOW-PROTEIN DIETS; SYSTOLIC BLOOD-PRESSURE; GENE-EXPRESSION; MATERNAL UNDERNUTRITION; EPIGENETIC MODIFICATION; FETAL EXPOSURE; WEANLING RATS; LATER LIFE; HYPERTENSION; PREGNANCY	Many mechanisms purport to explain how nutritional signals during early development are manifested as disease in the adult offspring. While these describe processes leading from nutritional insult to development of the actual pathology, the initial underlying cause of the programming effect remains elusive. To establish the primary drivers of programming, this study aimed to capture embryonic gene and protein changes in the whole embryo at the time of nutritional insult rather than downstream phenotypic effects. By using a cross-over design of two well established models of maternal protein and iron restriction we aimed to identify putative common "gatekeepers'' which may drive nutritional programming. Both protein and iron deficiency in utero reduced the nephron complement in adult male Wistar and Rowett Hooded Lister rats (P < 0.05). This occurred in the absence of damage to the glomerular ultrastructure. Microarray, proteomic and pathway analyses identified diet-specific and strain-specific gatekeeper genes, proteins and processes which shared a common association with the regulation of the cell cycle, especially the G1/S and G2/M checkpoints, and cytoskeletal remodelling. A cell cycle-specific PCR array confirmed the down-regulation of cyclins with protein restriction and the up-regulation of apoptotic genes with iron deficiency. The timing and experimental design of this study have been carefully controlled to isolate the common molecular mechanisms which may initiate the sequelae of events involved in nutritional programming of embryonic development. We propose that despite differences in the individual genes and proteins affected in each strain and with each diet, the general response to nutrient deficiency in utero is perturbation of the cell cycle, at the level of interaction with the cytoskeleton and the mitotic checkpoints, thereby diminishing control over the integrity of DNA which is allowed to replicate. These findings offer novel insight into the primary causes and mechanisms leading to the pathologies which have been identified by previous programming studies.	[Swali, Angelina; McMullen, Sarah; Langley-Evans, Simon C.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Hayes, Helen; Gambling, Lorraine; McArdle, Harry J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Nottingham; University of Aberdeen	Swali, A (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	angelina.swali@nottingham.ac.uk	Langley-Evans, Simon/AAR-4181-2020; Langley-Evans, Simon C/F-3564-2012; McMullen, Sarah/H-8652-2012	Langley-Evans, Simon C/0000-0002-1969-8416; Swali, Angelina/0000-0002-6428-6373; Hayes, Helen/0000-0001-5186-2696	Biotechnology and Biological Sciences Research Council; Scottish Government (RERAD); European Union (Nutrigenomics Organisation NoE); BBSRC [BB/F005245/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005245/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government (RERAD); European Union (Nutrigenomics Organisation NoE)(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for the study was provided by a Biotechnology and Biological Sciences Research Council project grant to SLE and SM. HH, HJM and LG were supported by the Scottish Government (RERAD) and the European Union (Nutrigenomics Organisation NoE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Barker DJP, 1997, BRIT MED BULL, V53, P96; Bennis-Taleb N, 1999, J NUTR, V129, P1613, DOI 10.1093/jn/129.8.1613; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Chechi Kanta, 2006, Exp Clin Cardiol, V11, P129; CROWE C, 1995, J PHYSIOL-LONDON, V488, P515, DOI 10.1113/jphysiol.1995.sp020986; Dwyer CM, 1995, REPROD FERT DEVELOP, V7, P1285, DOI 10.1071/RD9951285; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Gaj S, 2008, GENES NUTR, V3, P153, DOI 10.1007/s12263-008-0094-1; Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; LAI AC, 1984, J NUTR SCI VITAMINOL, V30, P285, DOI 10.3177/jnsv.30.285; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans S. C., 2004, FETAL NUTR ADULT DIS; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; LANGLEYEVANS SC, 1994, CLIN NUTR, V13, P319, DOI 10.1016/0261-5614(94)90056-6; LangleyEvans SC, 1996, J REPROD FERTIL, V106, P307, DOI 10.1530/jrf.0.1060307; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Marin ECS, 2008, RENAL FAILURE, V30, P547, DOI 10.1080/08860220802060448; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Watanabe D, 2009, HYPERTENS RES, V32, P807, DOI 10.1038/hr.2009.106; Welham SJM, 2005, PHYSIOL GENOMICS, V22, P48, DOI 10.1152/physiolgenomics.00167.2004; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x; Woodall SM, 1996, PEDIATR RES, V40, P438, DOI 10.1203/00006450-199609000-00012; Woods L. L., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P235, DOI 10.1079/9780851998213.0235; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595	34	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23189	10.1371/journal.pone.0023189	http://dx.doi.org/10.1371/journal.pone.0023189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858025	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300019
J	Lezin, G; Kosaka, Y; Yost, HJ; Kuehn, MR; Brunelli, L				Lezin, George; Kosaka, Yasuhiro; Yost, H. Joseph; Kuehn, Michael R.; Brunelli, Luca			A One-Step Miniprep for the Isolation of Plasmid DNA and Lambda Phage Particles	PLOS ONE			English	Article							ESCHERICHIA-COLI; RAPID PREPARATION; LYSIS; DETERGENTS	Plasmid DNA minipreps are fundamental techniques in molecular biology. Current plasmid DNA minipreps use alkali and the anionic detergent SDS in a three-solution format. In addition, alkali minipreps usually require additional column-based purification steps and cannot isolate other extra-chromosomal elements, such as bacteriophages. Non-ionic detergents (NIDs) have been used occasionally as components of multiple-solution plasmid DNA minipreps, but a one-step approach has not been developed. Here, we have established a one-tube, one-solution NID plasmid DNA miniprep, and we show that this approach also isolates bacteriophage lambda particles. NID minipreps are more time-efficient than alkali minipreps, and NID plasmid DNA performs better than alkali DNA in many downstream applications. In fact, NID crude lysate DNA is sufficiently pure to be used in digestion and sequencing reactions. Microscopic analysis showed that the NID procedure fragments E. coli cells into small protoplast-like components, which may, at least in part, explain the effectiveness of this approach. This work demonstrates that one-step NID minipreps are a robust method to generate high quality plasmid DNA, and NID approaches can also isolate bacteriophage lambda particles, outperforming current standard alkali-based minipreps.	[Lezin, George; Kosaka, Yasuhiro; Brunelli, Luca] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA; [Yost, H. Joseph] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Kuehn, Michael R.] NCI, Lab Prot Dynam & Signaling, NIH, Frederick, MD 21701 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lezin, G (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA.	mkuehn@mail.nih.gov; luca.brunelli@genetics.utah.edu	Kuehn, Michael R/A-4573-2014	Kuehn, Michael R/0000-0002-7703-9160	Division of Neonatology, the Children's Health Research Center; Primary Children's Medical Center Foundation; Department of Pediatrics, The University of Utah School of Medicine; American Heart Association; Western States Affiliate [09BGIA2251076]; National Institutes of Health, National Cancer Institute, and Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010256] Funding Source: NIH RePORTER	Division of Neonatology, the Children's Health Research Center; Primary Children's Medical Center Foundation; Department of Pediatrics, The University of Utah School of Medicine; American Heart Association(American Heart Association); Western States Affiliate; National Institutes of Health, National Cancer Institute, and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds to L.B. from the Division of Neonatology, the Children's Health Research Center, and the Primary Children's Medical Center Foundation Innovative Grant, Department of Pediatrics, The University of Utah School of Medicine, and the American Heart Association, Beginning Grant-In-Aid, Western States Affiliate (09BGIA2251076); and by funds to M.R.K. from the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services and nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHULER M, 1994, BIOTECHNIQUES, V17, P434; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Cheng L, 2004, J BIOCHEM MOL BIOL, V37, P351; Chowdhury EH, 2005, J BIOTECHNOL, V119, P343, DOI 10.1016/j.jbiotec.2005.05.013; CHOWDHURY K, 1991, NUCLEIC ACIDS RES, V19, P2792, DOI 10.1093/nar/19.10.2792; CLEWELL DB, 1970, BIOCHEMISTRY-US, V9, P4428; CURRIER TC, 1976, ANAL BIOCHEM, V76, P431, DOI 10.1016/0003-2697(76)90338-9; Ferrus M A, 1999, Int Microbiol, V2, P115; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; GODSON GN, 1967, BIOCHIM BIOPHYS ACTA, V149, P476, DOI 10.1016/0005-2787(67)90175-X; GRIFFIN WC, 1954, J SOC COSMET CHEM, V5, P259; GUERRY P, 1973, J BACTERIOL, V116, P1064, DOI 10.1128/JB.116.2.1064-1066.1973; HE M, 1990, NUCLEIC ACIDS RES, V18, P1660, DOI 10.1093/nar/18.6.1660; HELINSKI DR, 1971, ANNU REV BIOCHEM, V40, P899, DOI 10.1146/annurev.bi.40.070171.004343; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KLEIN RD, 1980, PLASMID, V3, P88, DOI 10.1016/S0147-619X(80)90037-2; KOVALENKO SA, 1994, NUCLEIC ACIDS RES, V22, P5771, DOI 10.1093/nar/22.25.5771; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; LEZIN G, 2011, BIOTECHNOL IN PRESS; Marra MA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e37; MORIYON I, 1982, J BACTERIOL, V152, P822; NEUGEBAUER JM, 1990, METHOD ENZYMOL, V182, P239; Paul B, 2008, ANAL BIOCHEM, V377, P218, DOI 10.1016/j.ab.2008.03.005; READER RW, 1971, VIROLOGY, V43, P607, DOI 10.1016/0042-6822(71)90286-8; Reshes G, 2008, BIOPHYS J, V94, P251, DOI 10.1529/biophysj.107.104398; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sayers JR, 1996, ANAL BIOCHEM, V241, P186, DOI 10.1006/abio.1996.0397; SERGHINI MA, 1989, NUCLEIC ACIDS RES, V17, P3604, DOI 10.1093/nar/17.9.3604; Song J, 1999, ANAL BIOCHEM, V271, P89, DOI 10.1006/abio.1999.4106; SUMMERTON J, 1983, ANAL BIOCHEM, V133, P79, DOI 10.1016/0003-2697(83)90224-5; WEISS RL, 1976, J BACTERIOL, V128, P668, DOI 10.1128/JB.128.2.668-670.1976; WOODFORD K, 1991, NUCLEIC ACIDS RES, V19, P6652, DOI 10.1093/nar/19.23.6652; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	36	11	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23457	10.1371/journal.pone.0023457	http://dx.doi.org/10.1371/journal.pone.0023457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858126	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953700025
J	Wanner, N; Noutsou, F; Baumeister, R; Walz, G; Huber, TB; Neumann-Haefelin, E				Wanner, Nicola; Noutsou, Foteini; Baumeister, Ralf; Walz, Gerd; Huber, Tobias B.; Neumann-Haefelin, Elke			Functional and Spatial Analysis of C. elegans SYG-1 and SYG-2, Orthologs of the Neph/Nephrin Cell Adhesion Module Directing Selective Synaptogenesis	PLOS ONE			English	Article							GLOMERULAR PODOCYTE; NEPHRIN; PROTEIN; GENE; DROSOPHILA; REGULATORS; MYOBLASTS; SYNAPSES; POLARITY; KINASE	The assembly of specific synaptic connections represents a prime example of cellular recognition. Members of the Ig superfamily are among the most ancient proteins represented in the genomes of both mammalian and invertebrate organisms, where they constitute a trans-synaptic adhesion system. The correct connectivity patterns of the highly conserved immunoglobulin superfamily proteins nephrin and Neph1 are crucial for the assembly of functional neuronal circuits and the formation of the kidney slit diaphragm, a synapse-like structure forming the filtration barrier. Here, we utilize the nematode C. elegans model for studying the requirements of synaptic specificity mediated by nephrin-Neph proteins. In C. elegans, the nephrin/Neph1 orthologs SYG-2 and SYG-1 form intercellular contacts strictly in trans between epithelial guidepost cells and neurons specifying the localization of synapses. We demonstrate a functional conservation between mammalian nephrin and SYG-2. Expression of nephrin effectively compensated loss of syg-2 function in C. elegans and restored defective synaptic connectivity further establishing the C. elegans system as a valuable model for slit diaphragm proteins. Next, we investigated the effect of SYG-1 and SYG-2 trans homodimerization respectively. Strikingly, synapse assembly could be induced by homophilic SYG-1 but not SYG-2 binding indicating a critical role of SYG-1 intracellular signalling for morphogenetic events and pointing toward the dynamic and stochastic nature of extra-and intracellular nephrin-Neph interactions to generate reproducible patterns of synaptic connectivity.	[Wanner, Nicola; Noutsou, Foteini; Walz, Gerd; Huber, Tobias B.; Neumann-Haefelin, Elke] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Bioinformat & Mol Genet Fac Biol, Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ Ctr Biochem & Mol Med, Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, FRIAS Sch Life Sci LIFENET, Freiburg, Germany; [Baumeister, Ralf; Walz, Gerd; Huber, Tobias B.] Univ Freiburg, Ctr Biol Signalling Studies Bioss, Freiburg, Germany; [Wanner, Nicola; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Wanner, N (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de; elke.neumann-haefelin@uniklinik-freiburg.de	Neumann-Haefelin, Elke/ABC-3089-2021	Huber, Tobias B./0000-0001-7175-5062	DFG (German Research Foundation) [KFO 201, HU 1016/5-1, SFB 592]; Excellence Initiative of the German Federal and State Governments [EXC 294]	DFG (German Research Foundation)(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This study was supported by DFG (German Research Foundation) grants to ENH (KFO 201) and TBH (HU 1016/5-1, Else-Kroner-Stiftung, SFB 592 and KFO 201) and by the Excellence Initiative of the German Federal and State Governments (EXC 294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Chao DL, 2008, MOL CELL NEUROSCI, V39, P248, DOI 10.1016/j.mcn.2008.07.001; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; LI M, J PATHOL; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; NEUMANNHAEFELIN E, 2010, HUM MOL GENET; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Simons M, 2009, CURR OPIN NEPHROL HY, V18, P324, DOI 10.1097/MNH.0b013e32832e316d; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229	31	18	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23598	10.1371/journal.pone.0023598	http://dx.doi.org/10.1371/journal.pone.0023598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858180	gold, Green Submitted, Green Published			2022-12-27	WOS:000293953700035
J	Sannasiddappa, TH; Costabile, A; Gibson, GR; Clarke, SR				Sannasiddappa, Thippeswamy H.; Costabile, Adele; Gibson, Glenn R.; Clarke, Simon R.			The Influence of Staphylococcus aureus on Gut Microbial Ecology in an In Vitro Continuous Culture Human Colonic Model System	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INTESTINAL MICROBIOTA; SITU HYBRIDIZATION; NASAL CARRIAGE; MOUSE MODEL; BACTERIA; BUTYRATE; GROWTH; BIFIDOBACTERIA; COLONIZATION	An anaerobic three-stage continuous culture model of the human colon (gut model), which represent different anatomical areas of the large intestine, was used to study the effect of S. aureus infection of the gut on the resident faecal microbiota. Studies on the development of the microbiota in the three vessels were performed and bacteria identified by culture independent fluorescence in situ hybridization (FISH). Furtheremore, short chain fatty acids (SCFA), as principal end products of gut bacterial metabolism, were measured along with a quantitative assessment of the predominant microbiota. During steady state conditions, numbers of S. aureus cells stabilised until they were washed out, but populations of indigenous bacteria were transiently altered; thus S. aureus was able to compromise colonisation resistance by the colonic microbiota. Furthermore, the concentration of butyric acid in the vessel representing the proximal colon was significantly decreased by infection. Thus infection by S. aureus appears to be able to alter the overall structure of the human colonic microbiota and the microbial metabolic profiles. This work provides an initial in vitro model to analyse interactions with pathogens.	[Sannasiddappa, Thippeswamy H.; Clarke, Simon R.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Costabile, Adele; Gibson, Glenn R.] Univ Reading, Sch Food & Nutr Sci, Food Microbial Sci Uni, Reading, Berks, England	University of Reading; University of Reading	Sannasiddappa, TH (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	s.r.clarke@reading.ac.uk	Gibson, Glenn R/A-9595-2009	Costabile, Adele/0000-0003-3185-030X				Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Bhalla A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-105; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Faden H, 2010, PEDIATRICS, V125, pE618, DOI 10.1542/peds.2009-1523; FONS M, 2000, MICROB ECOL HEALTH D, V2, P240; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Froberg MK, 2004, CLIN INFECT DIS, V39, P747, DOI 10.1086/423273; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; GIBSON GR, 1988, APPL ENVIRON MICROB, V54, P2750, DOI 10.1128/AEM.54.11.2750-2755.1988; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hess DJ, 2005, SHOCK, V24, P376, DOI 10.1097/01.shk.0000180615.75822.fe; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lemmens N, 2011, MICROB PATHOGENESIS, V50, P192, DOI 10.1016/j.micpath.2010.12.006; Lindberg E, 2004, J CLIN MICROBIOL, V42, P530, DOI 10.1128/JCM.42.2.530-534.2004; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Lundell AC, 2007, CLIN EXP ALLERGY, V37, P62, DOI 10.1111/j.1365-2222.2006.02625.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; Masaki H, 2003, INTERNAL MED, V42, P281, DOI 10.2169/internalmedicine.42.281; Nakamura Y, 2001, J SURG RES, V96, P35, DOI 10.1006/jsre.2000.6043; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Ochoa-Zarzosa A, 2009, MICROB PATHOGENESIS, V47, P1, DOI 10.1016/j.micpath.2009.04.006; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Ray AJ, 2003, CLIN INFECT DIS, V37, P875, DOI 10.1086/377451; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Rosignoli P, 2001, CARCINOGENESIS, V22, P1675, DOI 10.1093/carcin/22.10.1675; SAKATA T, 1983, COMP BIOCHEM PHYS A, V74, P459, DOI 10.1016/0300-9629(83)90631-X; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Siavoshian S, 1997, CELL BIOL INT, V21, P281, DOI 10.1006/cbir.1997.0153; Squier C, 2002, INFECT CONT HOSP EP, V23, P495, DOI 10.1086/502095; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; VONEIFF C, 2001, NEW ENGL J MED, V344, P505; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	49	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23227	10.1371/journal.pone.0023227	http://dx.doi.org/10.1371/journal.pone.0023227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858036	Green Submitted, Green Published, gold			2022-12-27	WOS:000293774300028
J	Griffiths, KL; Pathan, AA; Minassian, AM; Sander, CR; Beveridge, NER; Hill, AVS; Fletcher, HA; McShane, H				Griffiths, Kristin L.; Pathan, Ansar A.; Minassian, Angela M.; Sander, Clare R.; Beveridge, Natalie E. R.; Hill, Adrian V. S.; Fletcher, Helen A.; McShane, Helen			Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE SUPPRESSION; P2X(7) RECEPTOR; BCG VACCINATION; BOOSTING BCG; CD39; INTERLEUKIN-1-BETA; DIFFERENTIATION; IMMUNOGENICITY; EXPRESSION	Vaccination with Bacille Calmette-Guerin (BCG) has traditionally been used for protection against disease caused by the bacterium Mycobacterium tuberculosis (M.tb). The efficacy of BCG, especially against pulmonary tuberculosis (TB) is variable. The best protection is conferred in temperate climates and there is close to zero protection in many tropical areas with a high prevalence of both tuberculous and non-tuberculous mycobacterial species. Although interferon (IFN)-gamma is known to be important in protection against TB disease, data is emerging on a possible role for interleukin (IL)-17 as a key cytokine in both murine and bovine TB vaccine studies, as well as in humans. Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) is a novel TB vaccine designed to enhance responses induced by BCG. Antigen-specific IFN-gamma production has already been shown to peak one week post-MVA85A vaccination, and an inverse relationship between IL-17-producing cells and regulatory T cells expressing the ectonucleosidease CD39, which metabolises pro-inflammatory extracellular ATP has previously been described. This paper explores this relationship and finds that consumption of extracellular ATP by peripheral blood mononuclear cells from MVA85A-vaccinated subjects drops two weeks post-vaccination, corresponding to a drop in the percentage of a regulatory T cell subset expressing the ectonucleosidase CD39. Also at this time point, we report a peak in co-production of IL-17 and IFN-gamma by CD4(+) T cells. These results suggest a relationship between extracellular ATP and effector responses and unveil a possible pathway that could be targeted during vaccine design.	[Griffiths, Kristin L.; Pathan, Ansar A.; Minassian, Angela M.; Sander, Clare R.; Beveridge, Natalie E. R.; Hill, Adrian V. S.; Fletcher, Helen A.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Griffiths, KL (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	Helen.Mcshane@ndm.ox.ac.uk	Fletcher, Helen/D-1470-2011	Beveridge, Natalie/0000-0002-1160-2600; McShane, Helen/0000-0002-2126-5142; Minassian, Angela/0000-0001-7832-9824; /0000-0002-6008-2955; Fletcher, Helen/0000-0002-0435-1006	KLG's Wellcome Trust [WT086338RP]; HM's Wellcome Trust [WT076943MA]	KLG's Wellcome Trust; HM's Wellcome Trust	Funding was provided by KLG's Wellcome Trust studentship (www.wellcome.ac.uk; WT086338RP) and HM's Wellcome Trust Senior Fellowship (www.wellcome.ac.uk; WT076943MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Babu S, 2010, J INFECT DIS, V201, P20, DOI 10.1086/648735; Beveridge NER, 2008, TUBERCULOSIS, V88, P631, DOI 10.1016/j.tube.2008.06.005; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Churchyard CJ, 1999, INT J TUBERC LUNG D, V3, P791; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fletcher HA, 2008, VACCINE, V26, P5269, DOI 10.1016/j.vaccine.2008.07.040; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Freches D, 2011, CLIN VACCINE IMMUNOL, V18, P95, DOI 10.1128/CVI.00352-10; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Minassian A, MVA85A CANDIDA UNPUB; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; World Health Organization, 2010, GLOB TUB CONTR; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	35	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23463	10.1371/journal.pone.0023463	http://dx.doi.org/10.1371/journal.pone.0023463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887254	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000294298800010
J	Thrall, PH; Laine, AL; Broadhurst, LM; Bagnall, DJ; Brockwell, J				Thrall, Peter H.; Laine, Anna-Liisa; Broadhurst, Linda M.; Bagnall, David J.; Brockwell, John			Symbiotic Effectiveness of Rhizobial Mutualists Varies in Interactions with Native Australian Legume Genera	PLOS ONE			English	Article							ROOT-NODULE BACTERIA; MICROBIAL COMMUNITIES; MOLECULAR DIVERSITY; MYCORRHIZAL FUNGI; NITROGEN-FIXATION; SHRUBBY LEGUMES; RIBOSOMAL-RNA; TRADE-OFFS; SOIL; ACACIA	Background and Objectives: Interactions between plants and beneficial soil organisms (e.g. rhizobial bacteria, mycorrhizal fungi) are models for investigating the ecological impacts of such associations in plant communities, and the evolution and maintenance of variation in mutualisms (e.g. host specificity and the level of benefits provided). With relatively few exceptions, variation in symbiotic effectiveness across wild host species is largely unexplored. Methods: We evaluated these associations using representatives of several legume genera which commonly co-occur in natural ecosystems in south-eastern Australia and an extensive set of rhizobial strains isolated from these hosts. These strains had been previously assigned to specific phylotypes on the basis of molecular analyses. In the first of two inoculation experiments, the growth responses of each host species was evaluated with rhizobial strains isolated from that species. The second experiment assessed performance across genera and the extent of host specificity using a subset of these strains. Results: While host growth responses to their own (sympatric) isolates varied considerably, rhizobial phylotype was a significant predictor of symbiotic performance, indicating that bacterial species designations on the basis of molecular markers have ecological importance. Hosts responded in qualitatively different ways to sympatric and allopatric strains of rhizobia, ranging from species with a clear preference for their own strains, to those that were broad generalists, through to species that grew significantly better with allopatric strains. Conclusion: Theory has focused on trade-offs between the provision of benefits and symbiont competitive ability that might explain the persistence of less beneficial strains. However, differences in performance among co-occurring host species could also drive such patterns. Our results thus highlight the likely importance of plant community structure in maintaining variation in symbiotic effectiveness.	[Thrall, Peter H.; Laine, Anna-Liisa; Broadhurst, Linda M.; Bagnall, David J.; Brockwell, John] Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Canberra, ACT, Australia; [Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Helsinki, Finland	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Helsinki	Thrall, PH (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Canberra, ACT, Australia.	Peter.Thrall@csiro.au	Broadhurst, Linda/J-6907-2012; Laine, Anna-Liisa/B-1398-2016; Thrall, Peter/J-6672-2013	Broadhurst, Linda/0000-0002-9853-3328; Laine, Anna-Liisa/0000-0002-0703-5850; 	National Action Plan for Salinity and Water Quality [202749]	National Action Plan for Salinity and Water Quality	The work described in this study was funded by the National Action Plan for Salinity and Water Quality (project #202749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett AE, 2009, OECOLOGIA, V160, P807, DOI 10.1007/s00442-009-1345-6; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Bever JD, 2011, P NATL ACAD IN PRESS; Bissett A, 2010, MOL ECOL, V19, P4315, DOI 10.1111/j.1365-294X.2010.04804.x; Brockwell J, 2010, RANGELAND J, V32, P395, DOI 10.1071/RJ09080; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI [10.1111/j.1574-6968.2004.tb09695.x, 10.1016/j.femsle.2004.07.013]; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Elliott GN, 2009, ENVIRON MICROBIOL, V11, P762, DOI 10.1111/j.1462-2920.2008.01799.x; Finan TM, 2002, J BACTERIOL, V184, P2855, DOI 10.1128/JB.184.11.2855-2856.2002; Foster KR, 2006, P ROY SOC B-BIOL SCI, V273, P2233, DOI 10.1098/rspb.2006.3571; Han TX, 2008, SYST APPL MICROBIOL, V31, P287, DOI 10.1016/j.syapm.2008.04.004; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Heath KD, 2010, EVOLUTION, V64, P1446, DOI 10.1111/j.1558-5646.2009.00913.x; HERRERA MA, 1993, APPL ENVIRON MICROB, V59, P129, DOI 10.1128/AEM.59.1.129-133.1993; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Lafay B, 1998, APPL ENVIRON MICROB, V64, P3989; Lafay B, 2001, APPL ENVIRON MICROB, V67, P396, DOI 10.1128/AEM.67.1.396-402.2001; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; LAWRIE AC, 1983, APPL ENVIRON MICROB, V45, P1822, DOI 10.1128/AEM.45.6.1822-1828.1983; Littell R. C., 1996, SAS SYSTEM MIXED MOD; MacLean AM, 2007, PLANT PHYSIOL, V144, P615, DOI 10.1104/pp.107.101634; Marco DE, 2009, J THEOR BIOL, V259, P423, DOI 10.1016/j.jtbi.2009.03.033; Marsudi NDS, 1999, SOIL BIOL BIOCHEM, V31, P1229, DOI 10.1016/S0038-0717(99)00032-2; McKNIGHT T., 1949, QUEENSLAND JOUR AGRIC SCI, V6, P61; Murray B. R., 2001, Ecological Management & Restoration, V2, P213, DOI 10.1046/j.1442-8903.2001.00086.x; Ngom A, 2004, J GEN APPL MICROBIOL, V50, P17, DOI 10.2323/jgam.50.17; Palys T, 2000, INT J SYST EVOL MICR, V50, P1021, DOI 10.1099/00207713-50-3-1021; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Parker MA, 1999, APPL ENVIRON MICROB, V65, P4914; Parker MA, 2004, J BIOGEOGR, V31, P425, DOI 10.1046/j.0305-0270.2003.01030.x; Parker MA, 2002, MICROBIOL-SGM, V148, P2557, DOI 10.1099/00221287-148-8-2557; Portier P, 2006, APPL ENVIRON MICROB, V72, P7123, DOI 10.1128/AEM.00018-06; Rangin C, 2008, APPL ENVIRON MICROB, V74, P5653, DOI 10.1128/AEM.01107-08; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Rodriguez-Echeverria S, 2005, APPL SOIL ECOL, V29, P203, DOI 10.1016/j.apsoil.2004.11.004; SAS Institute, 1999, SAS STAT SOFTW US GU; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; Somasegaran P., 1994, HDB RHIZOBIA METHODS; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sprent J.I., 2009, LEGUME NODULATION; Sprent J.I., 2001, NODULATION LEGUMES; Thompson JN, 2002, INTEGR COMP BIOL, V42, P381, DOI 10.1093/icb/42.2.381; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2007, J ECOL, V95, P1110, DOI 10.1111/j.1365-2745.2007.01278.x; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Thrall PH, 2009, AUSTRAL ECOL, V34, P950, DOI 10.1111/j.1442-9993.2009.01998.x; Thrall PH, 2005, J APPL ECOL, V42, P740, DOI 10.1111/j.1365-2664.2005.01058.x; Thrall PH, 2000, J APPL ECOL, V37, P52, DOI 10.1046/j.1365-2664.2000.00470.x; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vincent JM, 1970, IBP HDB; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wall DH, 2010, NAT GEOSCI, V3, P297, DOI 10.1038/ngeo860; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Yates RJ, 2004, SOIL BIOL BIOCHEM, V36, P1319, DOI 10.1016/j.soilbio.2004.04.013	66	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23545	10.1371/journal.pone.0023545	http://dx.doi.org/10.1371/journal.pone.0023545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887270	Green Published, Green Submitted, gold			2022-12-27	WOS:000294298800014
J	Jain, M; Venkatraman, G; Moniaux, N; Kaur, S; Kumar, S; Chakraborty, S; Varshney, GC; Batra, SK				Jain, Maneesh; Venkatraman, Ganesh; Moniaux, Nicolas; Kaur, Sukhwinder; Kumar, Sushil; Chakraborty, Subhankar; Varshney, Grish C.; Batra, Surinder K.			Monoclonal Antibodies Recognizing the Non-Tandem Repeat Regions of the Human Mucin MUC4 in Pancreatic Cancer	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; MOLECULAR-CLONING; GENE-EXPRESSION; CARCINOMA; CELLS; ADENOCARCINOMA; GLYCOPROTEIN; DIAGNOSIS; COMPLEX; GROWTH	The MUC4 mucin is a high molecular weight, membrane-bound, and highly glycosylated protein. It is a multi-domain protein that is putatively cleaved into a large mucin-like subunit (MUC4 alpha) and a C-terminal growth-factor like subunit (MUC4 beta). MUC4 plays critical roles in physiological and pathological conditions and is aberrantly overexpressed in several cancers, including those of the pancreas, cervix, breast and lung. It is also a potential biomarker for the diagnosis, prognosis and progression of several malignancies. Further, MUC4 plays diverse functional roles in cancer initiation and progression as evident from its involvement in oncogenic transformation, proliferation, inhibition of apoptosis, motility and invasion, and resistance to chemotherapy in human cancer cells. We have previously generated a monoclonal antibody 8G7, which is directed against the TR region of MUC4, and has been extensively used to study the expression of MUC4 in several malignancies. Here, we describe the generation of anti-MUC4 antibodies directed against the non-TR regions of MUC4. Recombinant glutathione-S-transferase (GST)-fused MUC4 alpha fragments, both upstream (MUC4 alpha-N-Ter) and downstream (MUC4 alpha-C-Ter) of the TR domain, were used as immunogens to immunize BALB/c mice. Following cell fusion, hybridomas were screened using the aforementioned recombinant proteins ad lysates from human pancreatic cell lines. Three anti MUC4 alpha-N-Ter and one anti-MUC4 alpha-C-Ter antibodies were characterized by several inmmunoassays including enzyme-linked immunosorbent assay (ELISA), immunoblotting, immunofluorescene, flow cytometry and immunoprecipitation using MUC4 expressing human pancreatic cancer cell lines. The antibodies also reacted with the MUC4 in human pancreatic tumor sections in immunohistochemical analysis. The new domain-specific anti-MUC4 antibodies will serve as important reagents to study the structure-function relationship of MUC4 domains and for the development of MUC4-based diagnostics and therapeutics.	[Jain, Maneesh; Venkatraman, Ganesh; Moniaux, Nicolas; Kaur, Sukhwinder; Kumar, Sushil; Chakraborty, Subhankar; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Varshney, Grish C.] Inst Microbial Technol, Chandigarh, India	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Jain, M (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.	mjan@unmc.edu; sbatra@unmc.edu	Venkatraman, Ganesh/AAB-1467-2020; Moniaux, Nicolas/Y-3243-2018	Venkatraman, Ganesh/0000-0003-0179-9785; Moniaux, Nicolas/0000-0001-9718-1386	United States Department of Defense [BC074639, BC083295, BC09742, PC074289]; National Institutes of Health [R21 CA156037, RO1 CA78590, UO1 CA111294, RO1 CA131944, RO1 CA133774, RO1 CA138791, RO3 CA 139285, P50 CA127297]; NATIONAL CANCER INSTITUTE [R01CA133774, R01CA078590, P50CA127297, R01CA138791, U01CA111294, R21CA156037, R01CA131944, R03CA139285] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors on this work are supported, in part, by grants from the United States Department of Defense (BC074639, BC083295, BC09742, and PC074289) and the National Institutes of Health (R21 CA156037, RO1 CA78590, UO1 CA111294, RO1 CA131944, RO1 CA133774, RO1 CA138791, RO3 CA 139285 and P50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafna S, 2009, BRIT J CANCER, V101, P1155, DOI 10.1038/sj.bjc.6605285; Bafna S, 2008, CANCER RES, V68, P9231, DOI 10.1158/0008-5472.CAN-08-3135; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chauhan SC, 2006, MODERN PATHOL, V19, P1386, DOI 10.1038/modpathol.3800646; Choudhury A, 2000, J BIOCHEM-TOKYO, V128, P233, DOI 10.1093/oxfordjournals.jbchem.a022746; Copin MC, 2000, INT J CANCER, V86, P162, DOI 10.1002/(SICI)1097-0215(20000415)86:2<162::AID-IJC3>3.3.CO;2-I; Corrales RM, 2003, CURR EYE RES, V27, P323, DOI 10.1076/ceyr.27.5.323.17221; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Inatomi T, 1996, INVEST OPHTH VIS SCI, V37, P1684; Jhala N, 2006, AM J CLIN PATHOL, V126, P572, DOI 10.1309/CEV30BE088CBDQD9; Lin JZ, 2001, AM J PHYSIOL-LUNG C, V280, pL1157, DOI 10.1152/ajplung.2001.280.6.L1157; Liu B, 2002, J HISTOCHEM CYTOCHEM, V50, P811, DOI 10.1177/002215540205000607; Moniaux N, 2000, EUR J BIOCHEM, V267, P4536, DOI 10.1046/j.1432-1327.2000.01504.x; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; MUNRO EG, 2009, INT J GYNECOL PATHOL; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; OGATA S, 1992, CANCER RES, V52, P5971; Ponnusamy MP, 2008, BRIT J CANCER, V99, P520, DOI 10.1038/sj.bjc.6604517; PONNUSAMY MP, 2010, ONCOGENE; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Senapati S, 2008, BRIT J CANCER, V99, P949, DOI 10.1038/sj.bjc.6604632; SHENG ZQ, 1992, J BIOL CHEM, V267, P16341; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; TSUTSUMIDA H, 2006, LUNG CANC; WU K, 1994, J BIOL CHEM, V269, P11950	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23344	10.1371/journal.pone.0023344	http://dx.doi.org/10.1371/journal.pone.0023344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886786	Green Submitted, Green Published, gold			2022-12-27	WOS:000294253500012
J	Malhotra, S; Bustamante, MF; Miralles, F; Rio, J; de Villa, MCR; Vegas, E; Nonell, L; Deisenhammer, F; Fissolo, N; Nurtdinov, RN; Montalban, X; Comabella, M				Malhotra, Sunny; Bustamante, Marta F.; Miralles, Francisco; Rio, Jordi; Carmen Ruiz de Villa, Mari; Vegas, Esteban; Nonell, Lara; Deisenhammer, Florian; Fissolo, Nicolas; Nurtdinov, Ramil N.; Montalban, Xavier; Comabella, Manuel			Search for Specific Biomarkers of IFN beta Bioactivity in Patients with Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-INDUCIBLE GENE; NEUTRALIZING ANTIBODIES; DISEASE-ACTIVITY; EXPRESSION; THERAPY; PROTEIN; MONOCYTES; ISG15; MXA; BIOAVAILABILITY	Myxovirus A (MxA), a protein encoded by the MX1 gene with antiviral activity, has proven to be a sensitive measure of IFN beta bioactivity in multiple sclerosis (MS). However, the use of MxA as a biomarker of IFN beta bioactivity has been criticized for the lack of evidence of its role on disease pathogenesis and the clinical response to IFN beta. Here, we aimed to identify specific biomarkers of IFN beta bioactivity in order to compare their gene expression induction by type I IFNs with the MxA, and to investigate their potential role in MS pathogenesis. Gene expression microarrays were performed in PBMC from MS patients who developed neutralizing antibodies (NAB) to IFN beta at 12 and/or 24 months of treatment and patients who remained NAB negative. Nine genes followed patterns in gene expression over time similar to the MX1, which was considered the gold standard gene, and were selected for further experiments: IFI6, IFI27, IFI44L, IFIT1, HERC5, LY6E, RSAD2, SIGLEC1, and USP18. In vitro experiments in PBMC from healthy controls revealed specific induction of selected biomarkers by IFN beta but not IFN gamma, and several markers, in particular USP18 and HERC5, were shown to be significantly induced at lower IFN beta concentrations and more selective than the MX1 as biomarkers of IFN beta bioactivity. In addition, USP18 expression was deficient in MS patients compared with healthy controls (p = 0.0004). We propose specific biomarkers that may be considered in addition to the MxA to evaluate IFN beta bioactivity, and to further explore their implication in MS pathogenesis.	[Malhotra, Sunny; Bustamante, Marta F.; Miralles, Francisco; Rio, Jordi; Nonell, Lara; Fissolo, Nicolas; Nurtdinov, Ramil N.; Montalban, Xavier; Comabella, Manuel] Hosp Univ Vall Hebron HUVH, Unitat Neuroimmunol Clin, CEM Cat, Ctr Esclerosi Multiple Catalunya, Barcelona, Spain; [Carmen Ruiz de Villa, Mari; Vegas, Esteban] Univ Barcelona, Fac Biol, Dept Estadist, Barcelona, Spain; [Deisenhammer, Florian] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria	Hospital Universitari Vall d'Hebron; University of Barcelona; Medical University of Innsbruck	Malhotra, S (corresponding author), Hosp Univ Vall Hebron HUVH, Unitat Neuroimmunol Clin, CEM Cat, Ctr Esclerosi Multiple Catalunya, Barcelona, Spain.	mcomabel@ir.vhebron.net	Vegas, Esteban/G-4231-2015; Pérez-Miralles, Francisco Carlos/G-5067-2017; Nurtdinov, Ramil N/H-4713-2015; Fissolo, Nicolas/J-3067-2012; Malhotra, Sunny/ABI-1270-2020; Montalban, Xavier/J-5938-2016	Vegas, Esteban/0000-0002-6869-4075; Pérez-Miralles, Francisco Carlos/0000-0003-3767-3738; Nurtdinov, Ramil N/0000-0002-9753-6287; Fissolo, Nicolas/0000-0002-7701-9346; Montalban, Xavier/0000-0002-0098-9918; Malhotra Sareen, Sunny/0000-0003-1112-7739; Comabella Lopez, Manuel/0000-0002-2373-6657; Rio, Jordi/0000-0003-4546-7627	"Fondo de Investigacion Sanitaria" (FIS); Ministry of Science and Innovation, Spain; Ajuts per donar Suport als Grups de Recerca de Catalunya [SGR 2005-1081]; "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR); Generalitat de Catalunya, Spain; Merck-Serono (Ayudas a la Investigacion - Fundacion Salud 2000); European Community [212877]; INSERM [U563]	"Fondo de Investigacion Sanitaria" (FIS)(Instituto de Salud Carlos III); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ajuts per donar Suport als Grups de Recerca de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Generalitat de Catalunya, Spain(Generalitat de Catalunya); Merck-Serono (Ayudas a la Investigacion - Fundacion Salud 2000); European Community(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The authors thank the "Red Espanola de Esclerosis Multiple (REEM)" sponsored by the "Fondo de Investigacion Sanitaria" (FIS), Ministry of Science and Innovation, Spain, and the "Ajuts per donar Suport als Grups de Recerca de Catalunya (SGR 2005-1081)", sponsored by the "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR), Generalitat de Catalunya, Spain. This work was supported by a grant from Merck-Serono (Ayudas a la Investigacion - Fundacion Salud 2000). SM is early stage researcher funded by the European Community's Seventh Framework Programme ([FP7/2007-2013] under grant agreement n<SUP>o</SUP> 212877 (UEPHA*MS). RN is an experienced researcher also funded by the European Community's Seventh Framework Programme ([FP7/2007-2013] under grant agreement n<SUP>o</SUP> 212877 (UEPHA*MS), and has a contract with INSERM U563, University of Toulouse, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotto A, 2003, NEUROLOGY, V60, P634, DOI 10.1212/01.WNL.0000046662.03894.C5; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Cheriyath V, 2007, J CLIN INVEST, V117, P3107, DOI 10.1172/JCI31122; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Deisenhammer F, 1999, NEUROLOGY, V52, P1239, DOI 10.1212/WNL.52.6.1239; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gilli F, 2006, MULT SCLER J, V12, P47, DOI 10.1191/135248506ms1245oa; Gneiss C, 2006, MULT SCLER J, V12, P731, DOI 10.1177/1352458506070941; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kosugi A, 1998, J BIOL CHEM, V273, P12301, DOI 10.1074/jbc.273.20.12301; Li HT, 2010, MOL CELL BIOCHEM, V337, P101, DOI 10.1007/s11010-009-0289-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pachner Andrew, 2003, Mol Diagn, V7, P17, DOI 10.2165/00066982-200307010-00004; Pachner AR, 2009, NEUROLOGY, V73, P1493, DOI 10.1212/WNL.0b013e3181bf98db; Pachner AR, 2003, NEUROLOGY, V61, pS24, DOI 10.1212/01.WNL.0000092361.04511.D0; Pflugh DL, 2002, J IMMUNOL, V169, P5130, DOI 10.4049/jimmunol.169.9.5130; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rosebeck S, 2008, APOPTOSIS, V13, P562, DOI 10.1007/s10495-008-0190-0; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Serrano-Fernandez P, 2010, AUTOIMMUNITY, V43, P172, DOI 10.3109/08916930903219040; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; WATHELET MG, 1987, EUR J BIOCHEM, V169, P313, DOI 10.1111/j.1432-1033.1987.tb13614.x; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382	38	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23634	10.1371/journal.pone.0023634	http://dx.doi.org/10.1371/journal.pone.0023634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886806	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500022
J	Hagglund, AC; Dahl, L; Carlsson, L				Hagglund, Anna-Carin; Dahl, Lina; Carlsson, Leif			Lhx2 Is Required for Patterning and Expansion of a Distinct Progenitor Cell Population Committed to Eye Development	PLOS ONE			English	Article							LENS INDUCTION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; VERTEBRATE EYE; OPTIC VESICLE; HOMEOBOX GENE; RETINA; FOREBRAIN; MOUSE; FIELD	Progenitor cells committed to eye development become specified in the prospective forebrain and develop subsequently into the optic vesicle and the optic cup. The optic vesicle induces formation of the lens placode in surface ectoderm from which the lens develops. Numerous transcription factors are involved in this process, including the eye-field transcription factors. However, many of these transcription factors also regulate the patterning of the anterior neural plate and their specific role in eye development is difficult to discern since eye-committed progenitor cells are poorly defined. By using a specific part of the Lhx2 promoter to regulate Cre recombinase expression in transgenic mice we have been able to define a distinct progenitor cell population in the forebrain solely committed to eye development. Conditional inactivation of Lhx2 in these progenitor cells causes an arrest in eye development at the stage when the optic vesicle induces lens placode formation in the surface ectoderm. The eye-committed progenitor cell population is present in the Lhx2(-/-) embryonic forebrain suggesting that commitment to eye development is Lhx2-independent. However, re-expression of Lhx2 in Lhx2(-/-) progenitor cells only promotes development of retinal pigment epithelium cells, indicating that Lhx2 promotes the acquisition of the oligopotent fate of these progenitor cells. This approach also allowed us to identify genes that distinguish Lhx2 function in eye development from that in the forebrain. Thus, we have defined a distinct progenitor cell population in the forebrain committed to eye development and identified genes linked to Lhx2's function in the expansion and patterning of these progenitor cells.	[Hagglund, Anna-Carin; Dahl, Lina; Carlsson, Leif] Umea Univ, Umea Ctr Mol Med, Umea, Sweden	Umea University	Hagglund, AC (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	leif.carlsson@ucmm.umu.se			Swedish Research council; Swedish Cancer Society	Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work has been supported by the Swedish Research council and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Harlow E., 1999, USING ANTIBODIES LAB; Hernandez MC, 1997, J NEUROSCI, V17, P3038; Hill Robert E., 1992, Current Opinion in Cell Biology, V4, P967, DOI 10.1016/0955-0674(92)90126-W; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; KAUFMAN M, 1994, ADAS MOUSE DEV; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Lavado A, 2008, DEVELOPMENT, V135, P441, DOI 10.1242/dev.010082; Li HS, 1997, DEVELOPMENT, V124, P603; Li X, 2002, SCIENCE, V297, P1180; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Nagy A., 2003, MANIPULATING MOUSE E; NORNES HO, 1990, DEVELOPMENT, V109, P797; Ogino H, 2000, DEV GROWTH DIFFER, V42, P437; Porter FD, 1997, DEVELOPMENT, V124, P2935; Richter K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-75; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Tetreault N, 2009, DEV BIOL, V327, P541, DOI 10.1016/j.ydbio.2008.12.022; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Torres MA, 1996, DEVELOPMENT, V122, P3381; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Yun S, 2009, DEVELOPMENT, V136, P3895, DOI 10.1242/dev.041202; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	50	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23387	10.1371/journal.pone.0023387	http://dx.doi.org/10.1371/journal.pone.0023387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886788	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100012
J	Gehring, AJ; Koh, S; Chia, A; Paramasivam, K; Chew, VSP; Ho, ZZ; Lee, KH; Maini, MK; Madhavan, K; Lim, SG; Bertoletti, A				Gehring, Adam J.; Koh, Sarene; Chia, Adeline; Paramasivam, Komathi; Chew, Valerie Suk Peng; Ho, Zi Zong; Lee, Kang Hoe; Maini, Mala K.; Madhavan, Krishnakumar; Lim, Seng Gee; Bertoletti, Antonio			Licensing Virus-Specific T Cells to Secrete the Neutrophil Attracting Chemokine CXCL-8 during Hepatitis B Virus Infection	PLOS ONE			English	Article							VIRAL CLEARANCE; HBV INFECTION; KILLER-CELLS; IN-VIVO; LYMPHOCYTES; IL-15; LIVER; DISEASE; RECRUITMENT; EXPRESSION	T cell functional plasticity helps tailor antiviral immunity during different phases of infections. We tested whether, during different phases of HBV infection, virus-specific T cells can acquire specific proinflammatory functions that could drive granulocyte/mononuclear cell liver infiltration. Multifunctional analysis of HBV-specific T cells during acute and chronic HBV infection revealed that HBV-specific T cells had the capacity to produce the neutrophil chemokine CXCL-8 but not IL-17. CXCL-8 producing T cells were detectable in the liver of chronic HBV patients with active hepatitis; while in acute HBV patients CXCL-8 production by T cells was temporally limited to the acute phase of disease, concomitant with the peak of liver inflammation. Characterization of the conditions necessary for the development of CXCL-8 producing T cells showed a requirement for IL-7 and IL-15 during T cell expansion. These data show that functional plasticity of virus-specific T cells spontaneously occurs during HBV infection and that an environment rich IL-7 and IL-15 can license T cells with the ability to produce CXCL-8 and potentially influence liver pathology.	[Gehring, Adam J.; Koh, Sarene; Chia, Adeline; Paramasivam, Komathi; Ho, Zi Zong; Bertoletti, Antonio] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Koh, Sarene] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Chew, Valerie Suk Peng] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Lee, Kang Hoe] Gleneagles Hosp, Asian Ctr Liver Dis & Transplantat, Singapore, Singapore; [Maini, Mala K.] UCL, Div Infect & Immun, London, England; [Madhavan, Krishnakumar] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Lim, Seng Gee] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of London; University College London; National University of Singapore; National University of Singapore	Gehring, AJ (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	adam_gehring@sics.a-star.edu.sg	Madhavan, Krishnakumar/B-4633-2011; Bertoletti, Antonio/AAD-4830-2022	Madhavan, Krishnakumar/0000-0002-6267-9368; Bertoletti, Antonio/0000-0002-2942-0485; Maini, Mala/0000-0001-6384-1462; Gehring, Adam/0000-0003-1150-5840	Agency for Science Technology and Research (A*STAR); Medical Research Council [G0901374, G0801213] Funding Source: researchfish; MRC [G0901374, G0801213] Funding Source: UKRI	Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work was funded by the Agency for Science Technology and Research (A*STAR; http://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Badolato R, 1997, BLOOD, V90, P2804, DOI 10.1182/blood.V90.7.2804.2804_2804_2809; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Britschgi M, 2001, J CLIN INVEST, V107, P1433, DOI 10.1172/JCI12118; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Curtis MM, 2010, CELL HOST MICROBE, V8, P163, DOI 10.1016/j.chom.2010.07.006; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Golden-Mason L, 2004, CLIN EXP IMMUNOL, V138, P94, DOI 10.1111/j.1365-2249.2004.02586.x; GUIDOTTI LG, 1994, P NATL ACAD SCI USA, V91, P3764, DOI 10.1073/pnas.91.9.3764; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; JIYUAN Z, 2010, HEPATOLOGY, V51, P81; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Keller M, 2005, J IMMUNOL, V175, P7678, DOI 10.4049/jimmunol.175.11.7678; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Penna A, 1996, J CLIN INVEST, V98, P1185, DOI 10.1172/JCI118902; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schaerli P, 2004, J IMMUNOL, V173, P2151, DOI 10.4049/jimmunol.173.3.2151; Sitia G, 2002, P NATL ACAD SCI USA, V99, P13717, DOI 10.1073/pnas.172521999; Suzuki A, 2006, J HEPATOL, V45, P410, DOI 10.1016/j.jhep.2006.04.008; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	35	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23330	10.1371/journal.pone.0023330	http://dx.doi.org/10.1371/journal.pone.0023330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876747	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900019
J	Swithers, KS; Fournier, GP; Green, AG; Gogarten, JP; Lapierre, P				Swithers, Kristen S.; Fournier, Gregory P.; Green, Anna G.; Gogarten, J. Peter; Lapierre, Pascal			Reassessment of the Lineage Fusion Hypothesis for the Origin of Double Membrane Bacteria	PLOS ONE			English	Article							GENE; PROTEIN; PHOTOSYNTHESIS; PROKARYOTES; LIFE; TREE; ROOT	In 2009, James Lake introduced a new hypothesis in which reticulate phylogeny reconstruction is used to elucidate the origin of Gram-negative bacteria (Nature 460: 967-971). The presented data supported the Gram-negative bacteria originating from an ancient endosymbiosis between the Actinobacteria and Clostridia. His conclusion was based on a presence-absence analysis of protein families that divided all prokaryotes into five groups: Actinobacteria, Double Membrane bacteria (DM), Clostridia, Archaea and Bacilli. Of these five groups, the DM are by far the largest and most diverse group compared to the other groupings. While the fusion hypothesis for the origin of double membrane bacteria is enticing, we show that the signal supporting an ancient symbiosis is lost when the DM group is broken down into smaller subgroups. We conclude that the signal detected in James Lake's analysis in part results from a systematic artifact due to group size and diversity combined with low levels of horizontal gene transfer.	[Swithers, Kristen S.; Green, Anna G.; Gogarten, J. Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Lapierre, Pascal] Univ Connecticut, Univ Connecticut Biotechnol Ctr, Storrs, CT USA; [Fournier, Gregory P.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Connecticut; University of Connecticut; Massachusetts Institute of Technology (MIT)	Swithers, KS (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	pascal.lap@gmail.com	Green, Anna/AAE-7645-2019	Green, Anna/0000-0001-7548-3682; Gogarten, Johann Peter/0000-0001-6459-6518	National Aeronautic and Space Administration [NNX08AQ10G]; National Science Foundation [DEB 0830024]; Direct For Biological Sciences [0830024] Funding Source: National Science Foundation	National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported through grants from the National Aeronautic and Space Administration Exobiology Programs (NNX08AQ10G) and the National Science Foundation Assembling the Tree of Life Programs (DEB 0830024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Boussau B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-272; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GOGARTEN JP, 1994, J MOL EVOL, V39, P541; Gribaldo S, 1999, J BACTERIOL, V181, P434, DOI 10.1128/JB.181.2.434-443.1999; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Lake JA, 2008, MOL BIOL EVOL, V25, P1677, DOI 10.1093/molbev/msn117; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Margulis L., 1995, SYMBIOSIS CELL EVOLU; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Servin JA, 2008, MOL BIOL EVOL, V25, P1, DOI 10.1093/molbev/msm249; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; SUTCLIFFE IC, 2010, ENV MICROBIOL; Valas RE, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-30; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106; PATHOGENS GENES GENO	18	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23774	10.1371/journal.pone.0023774	http://dx.doi.org/10.1371/journal.pone.0023774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876769	Green Published, Green Submitted, gold			2022-12-27	WOS:000294126900041
J	Meslin, B; Beavogui, AH; Fasel, N; Picot, S				Meslin, Benoit; Beavogui, Abdoul H.; Fasel, Nicolas; Picot, Stephane			Plasmodium falciparum Metacaspase PfMCA-1 Triggers a z-VAD-fmk Inhibitable Protease to Promote Cell Death	PLOS ONE			English	Article							INTRACELLULAR LEISHMANIA-DONOVANI; BCL-X-L; TRYPANOSOMA-BRUCEI; ARABIDOPSIS-THALIANA; YEAST METACASPASE; MAJOR METACASPASE; PUTATIVE ROLE; APOPTOSIS; PROTOZOAN; MALARIA	Activation of proteolytic cell death pathways may circumvent drug resistance in deadly protozoan parasites such as Plasmodium falciparum and Leishmania. To this end, it is important to define the cell death pathway(s) in parasites and thus characterize proteases such as metacaspases (MCA), which have been reported to induce cell death in plants and Leishmania parasites. We, therefore, investigated whether the cell death function of MCA is conserved in different protozoan parasite species such as Plasmodium falciparum and Leishmania major, focusing on the substrate specificity and functional role in cell survival as compared to Saccharomyces cerevisae. Our results show that, similarly to Leishmania, Plasmodium MCA exhibits a calcium-dependent, arginine-specific protease activity and its expression in yeast induced growth inhibition as well as an 82% increase in cell death under oxidative stress, a situation encountered by parasites during the host or when exposed to drugs such as artemisins. Furthermore, we show that MCA cell death pathways in both Plasmodium and Leishmania, involve a z-VAD-fmk inhibitable protease. Our data provide evidence that MCA from both Leishmania and Plasmodium falciparum is able to induce cell death in stress conditions, where it specifically activates a downstream enzyme as part of a cell death pathway. This enzymatic activity is also induced by the antimalarial drug chloroquine in erythrocytic stages of Plasmodium falciparum. Interestingly, we found that blocking parasite cell death influences their drug sensitivity, a result which could be used to create therapeutic strategies that by-pass drug resistance mechanisms by acting directly on the innate pathways of protozoan cell death.	[Meslin, Benoit; Beavogui, Abdoul H.; Picot, Stephane] ICBMS UMR 5246 CNRS UCBL1 INSA, Malaria Res Unit, Lyon, France; [Fasel, Nicolas] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University of Lausanne	Meslin, B (corresponding author), ICBMS UMR 5246 CNRS UCBL1 INSA, Malaria Res Unit, Lyon, France.	Nicolas.Fasel@unil.ch	Fasel, Nicolas/O-4253-2016; picot, stephane/F-5973-2014	Fasel, Nicolas/0000-0003-0136-7245; picot, stephane/0000-0002-5735-6759	FNRS [3100A0-116665/1]; Novartis Foundation; Dr Rub Foundation; Swiss Secretariat for Education and Research	FNRS(Fonds de la Recherche Scientifique - FNRS); Novartis Foundation(Novartis); Dr Rub Foundation; Swiss Secretariat for Education and Research	This work was conducted in part with support from the FNRS No 3100A0-116665/1, the Novartis Foundation, the Dr Rub Foundation, and the Swiss Secretariat for Education and Research to NF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; Alzate JF, 2006, APOPTOSIS, V11, P161, DOI 10.1007/s10495-006-4570-z; Alzate JF, 2008, ANTIMICROB AGENTS CH, V52, P3779, DOI 10.1128/AAC.01665-07; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Arambage SC, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-32; Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Gonzalez IJ, 2007, INT J PARASITOL, V37, P161, DOI 10.1016/j.ijpara.2006.10.004; Guaragnella N, 2010, FEBS LETT, V584, P224, DOI 10.1016/j.febslet.2009.11.072; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Jiang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-198; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; Kosec G, 2006, BIOCELL, V30, P479; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lee REC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002956; Liang QL, 2008, BBA-MOL CELL RES, V1783, P1311, DOI 10.1016/j.bbamcr.2008.02.018; Lim HW, 2007, CAN J MICROBIOL, V53, P1016, DOI 10.1139/W07-067; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Madeo F, 2002, CURR GENET, V41, P208, DOI 10.1007/s00294-002-0310-2; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mazzoni C, 2008, BBA-MOL CELL RES, V1783, P1320, DOI 10.1016/j.bbamcr.2008.02.015; Meslin B, 2007, J INFECT DIS, V195, P1852, DOI 10.1086/518253; Meslin B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-26; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1981, J EXP MED, V153, P1690, DOI 10.1084/jem.153.6.1690; MURRAY HW, 1983, J CLIN INVEST, V72, P32, DOI 10.1172/JCI110972; Nedelcu AM, 2009, J MOL EVOL, V68, P256, DOI 10.1007/s00239-009-9201-1; Nogueira F, 2010, ACTA TROP, V114, P109, DOI 10.1016/j.actatropica.2010.01.013; Ojha M, 2010, GENE, V457, P25, DOI 10.1016/j.gene.2010.02.014; Olie RA, 1998, CURR BIOL, V8, P955, DOI 10.1016/S0960-9822(98)70395-1; PEARSON RD, 1983, J IMMUNOL, V131, P1994; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-169; Pino P, 2004, CELL MICROBIOL, V6, P839, DOI 10.1111/j.1462-5822.2004.00406.x; Rico E, 2009, MOL BIOCHEM PARASIT, V163, P28, DOI 10.1016/j.molbiopara.2008.09.007; Totino PRR, 2008, EXP PARASITOL, V118, P478, DOI 10.1016/j.exppara.2007.10.017; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Watanabe N, 2011, J BIOL CHEM, V286, P10027, DOI 10.1074/jbc.M110.194340; Withers-Martinez C, 1999, PROTEIN ENG, V12, P1113, DOI 10.1093/protein/12.12.1113; Woltering EJ, 2010, TRENDS PLANT SCI, V15, P185, DOI 10.1016/j.tplants.2010.02.001; Zalila H, 2011, MOL MICROBIOL, V79, P222, DOI 10.1111/j.1365-2958.2010.07443.x	62	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23867	10.1371/journal.pone.0023867	http://dx.doi.org/10.1371/journal.pone.0023867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858231	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300102
J	Puk, O; Moller, G; Geerlof, A; Krowiorz, K; Ahmad, N; Wagner, S; Adamski, J; de Angelis, MH; Graw, J				Puk, Oliver; Moeller, Gabriele; Geerlof, Arie; Krowiorz, Kathrin; Ahmad, Nafees; Wagner, Sibylle; Adamski, Jerzy; de Angelis, Martin Hrabe; Graw, Jochen			The Pathologic Effect of a Novel Neomorphic Fgf9(Y162C) Allele Is Restricted to Decreased Vision and Retarded Lens Growth	PLOS ONE			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; TRANSGENIC MICE; PTS2 RECEPTOR; FIBER DIFFERENTIATION; EXTRACELLULAR-MATRIX; MISSENSE MUTATION; MUTANT MICE; HUMAN PEX7; GENE; PROTEIN	Fibroblast growth factor (Fgf) signalling plays a crucial role in many developmental processes. Among the Fgf pathway ligands, Fgf9 (UniProt: P54130) has been demonstrated to participate in maturation of various organs and tissues including skeleton, testes, lung, heart, and eye. Here we establish a novel Fgf9 allele, discovered in a dominant N-ethyl-N-nitrosourea (ENU) screen for eye-size abnormalities using the optical low coherence interferometry technique. The underlying mouse mutant line Aca12 was originally identified because of its significantly reduced lens thickness. Linkage studies located Aca12 to chromosome 14 within a 3.6 Mb spanning interval containing the positional candidate genes Fgf9 (MGI: 104723), Gja3 (MGI: 95714), and Ift88 (MGI: 98715). While no sequence differences were found in Gja3 and Ift88, we identified an A -> G missense mutation at cDNA position 770 of the Fgf9 gene leading to an Y162C amino acid exchange. In contrast to previously described Fgf9 mutants, Fgf9(Y162C) carriers were fully viable and did not reveal reduced body-size, male-to-female sexual reversal or skeletal malformations. The histological analysis of the retina as well as its basic functional characterization by electroretinography (ERG) did not show any abnormality. However, the analysis of head-tracking response of the Fgf9(Y162C) mutants in a virtual drum indicated a gene-dosage dependent vision loss of almost 50%. The smaller lenses in Fgf9(Y162C) suggested a role of Fgf9 during lens development. Histological investigations showed that lens growth retardation starts during embryogenesis and continues after birth. Young Fgf9(Y162C) lenses remained transparent but developed age-related cataracts. Taken together, Fgf9(Y162C) is a novel neomorphic allele that initiates microphakia and reduced vision without effects on organs and tissues outside the eye. Our data point to a role of Fgf9 signalling in primary and secondary lens fiber cell growth. The results underline the importance of allelic series to fully understand multiple functions of a gene.	[Puk, Oliver; Krowiorz, Kathrin; Ahmad, Nafees; Graw, Jochen] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany; [Moeller, Gabriele; Wagner, Sibylle; Adamski, Jerzy; de Angelis, Martin Hrabe] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Expt Genet, Neuherberg, Germany; [Geerlof, Arie] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Biol Struct, Neuherberg, Germany; [Adamski, Jerzy; de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci, Inst Expt Genet, D-8050 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Puk, O (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany.	oliver.puk@helmholtz-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012; Graw, Jochen/D-9336-2013; Puk, Oliver/E-1443-2013	de Angelis, Martin Hrabe/0000-0002-7898-2353; Graw, Jochen/0000-0003-0298-9660; Ahmad, Nafees/0000-0002-7436-7644; Adamski, Jerzy/0000-0001-9259-0199; Moller, Gabriele/0000-0002-2730-1351	European Community (European Mouse Disease Clinic); National Genome Network (National Genome Research Network, National Genome Research Network plus) [LSHG-2006-037188, BMBF 01KW9923, BMBF 01GS0850]	European Community (European Mouse Disease Clinic)(European Commission); National Genome Network (National Genome Research Network, National Genome Research Network plus)	This work has been supported by the European Community (European Mouse Disease Clinic) and by National Genome Network Grants (National Genome Research Network, National Genome Research Network plus). Grant Identifications: LSHG-2006-037188, BMBF 01KW9923, and BMBF 01GS0850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Bates PA, 2001, PROTEINS, P39; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CHAMBERLAIN CG, 1987, CURR EYE RES, V6, P1165, DOI 10.3109/02713688709034890; Chamberlain CG, 1989, GROWTH FACTORS, V1, P125, DOI 10.3109/08977198909029122; Cinaroglu A, 2005, J NEUROSCI RES, V79, P329, DOI 10.1002/jnr.20363; Colvin JS, 1999, DEV DYNAM, V216, P72; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Cotton LM, 2008, ENDOCR REV, V29, P193, DOI 10.1210/er.2007-0028; Dalke C, 2004, INVEST OPHTH VIS SCI, V45, P601, DOI 10.1167/iovs.03-0561; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dunia I, 2006, EUR J CELL BIOL, V85, P729, DOI 10.1016/j.ejcb.2006.03.006; EHLING UH, 1985, MUTAT RES, V150, P393, DOI 10.1016/0027-5107(85)90136-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gao Y, 1998, INVEST OPHTH VIS SCI, V39, P1198; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; Koyama N, 2001, BIOTECHNOL APPL BIOC, V33, P117, DOI 10.1042/BA20000075; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Lovicu FJ, 1998, DEVELOPMENT, V125, P3365; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; Menez B, 1981, Med Trop (Mars), V41, P569; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Murakami H, 2002, MAMM GENOME, V13, P341, DOI 10.1007/s00335-001-2143-6; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puk O, 2008, INVEST OPHTH VIS SCI, V49, P1525, DOI 10.1167/iovs.07-1033; Puk O, 2006, MAMM GENOME, V17, P851, DOI 10.1007/s00335-006-0019-5; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; ROBINSON ML, 1995, DEVELOPMENT, V121, P505; Robinson ML, 1998, DEV BIOL, V198, P13, DOI 10.1016/S0012-1606(98)80026-2; Rong P, 2002, DEVELOPMENT, V129, P167; Sanchez E, 1997, KLIN MONATSBL AUGENH, V210, P329, DOI 10.1055/s-2008-1035067; Schmucker C, 2004, VISION RES, V44, P2445, DOI 10.1016/j.visres.2004.05.018; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu XL, 2009, AM J HUM GENET, V85, P53, DOI 10.1016/j.ajhg.2009.06.007; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028; Zhao SL, 2001, DEVELOPMENT, V128, P5051	48	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23678	10.1371/journal.pone.0023678	http://dx.doi.org/10.1371/journal.pone.0023678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858205	Green Submitted, gold, Green Published			2022-12-27	WOS:000294121300081
J	Tong, YG; Zhao, WJ; Zhou, CQ; Wawrowsky, K; Melmed, S				Tong, Yunguang; Zhao, Weijiang; Zhou, Cuiqi; Wawrowsky, Kolja; Melmed, Shlomo			PTTG1 Attenuates Drug-Induced Cellular Senescence	PLOS ONE			English	Article							TUMOR-TRANSFORMING GENE; BREAST-CANCER; DNA-DAMAGE; HISTONE DEACETYLATION; PITUITARY HYPOPLASIA; PROGNOSTIC MARKER; POOR-PROGNOSIS; EXPRESSION; SECURIN; CELLS	As PTTG1 (pituitary tumor transforming gene) abundance correlates with adverse outcomes in cancer treatment, we determined mechanisms underlying this observation by assessing the role of PTTG1 in regulating cell response to antineoplastic drugs. HCT116 cells devoid of PTTG1 (PTTG1(-/-)) exhibited enhanced drug sensitivity as assessed by measuring BrdU incorporation in vitro. Apoptosis, mitosis catastrophe or DNA damage were not detected, but features of senescence were observed using low doses of doxorubicin and TSA. The number of drug-induced PTTG1(-/-) senescent cells increased similar to 4 fold as compared to WT PTTG1-replete cells (p<0.001). p21, an important regulator of cell senescence, was induced similar to 3 fold in HCT116 PTTG1(-/-) cells upon doxorubicin or Trichostatin A treatment. Binding of Sp1, p53 and p300 to the p21 promoter was enhanced in PTTG1(-/-) cells after treatment, suggesting transcriptional regulation of p21. p21 knock down abrogated the observed senescent effects of these drugs, indicating that PTTG1 likely suppresses p21 to regulate drug-induced senescence. PTTG1 also regulated SW620 colon cancer cells response to doxorubicin and TSA mediated by p21. Subcutaneously xenografted PTTG1(-/-) HCT116 cells developed smaller tumors and exhibited enhanced responses to doxorubicin. PTTG1(-/-) tumor tissue derived from excised tumors exhibited increased doxorubicin-induced senescence. As senescence is a determinant of cell responses to anti-neoplastic treatments, these findings suggest PTTG1 as a tumor cell marker to predict anti-neoplastic treatment outcomes.	[Tong, Yunguang; Zhao, Weijiang; Zhou, Cuiqi; Wawrowsky, Kolja; Melmed, Shlomo] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Tong, YG (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	Melmed@csmc.edu		Zhao, Wei-jiang/0000-0002-6556-2827	NIH [CA 75979, K99CA138914]; Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE [K99CA138914, R01CA075979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The manuscript is supported by NIH Grant CA 75979 (SM), K99CA138914 (YT), and The Doris Factor Molecular Endocrinology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbud RA, 2005, MOL ENDOCRINOL, V19, P1383, DOI 10.1210/me.2004-0403; Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; Fujii T, 2006, HEPATOLOGY, V43, P1267, DOI 10.1002/hep.21181; Genkai N, 2006, ONCOL REP, V15, P1569; Ghayad SE, 2009, J MOL ENDOCRINOL, V42, P87, DOI 10.1677/JME-08-0076; GUNVEN P, 1986, CANCER CHEMOTH PHARM, V17, P153, DOI 10.1007/BF00306745; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hlubek F, 2006, BRIT J CANCER, V94, P1672, DOI 10.1038/sj.bjc.6603155; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kim DS, 2007, CARCINOGENESIS, V28, P749, DOI 10.1093/carcin/bgl202; Lehmann BD, 2007, CELL CYCLE, V6, P595, DOI 10.4161/cc.6.5.3901; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Ogbagabriel S, 2005, MODERN PATHOL, V18, P985, DOI 10.1038/modpathol.3800382; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Place RF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-37; Rebbaa A, 2006, CELL DEATH DIFFER, V13, P1960, DOI 10.1038/sj.cdd.4401895; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Saez C, 2006, J CLIN ENDOCR METAB, V91, P1404, DOI 10.1210/jc.2005-2532; Sanchez-Puig N, 2005, PROTEIN SCI, V14, P1410, DOI 10.1110/ps.051368005; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shibata Y, 2002, JPN J CLIN ONCOL, V32, P233, DOI 10.1093/jjco/hyf058; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Solbach C, 2004, BREAST, V13, P80, DOI 10.1016/j.breast.2003.09.008; Solbach C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-242; Thompson AD, 2005, FEBS LETT, V579, P3195, DOI 10.1016/j.febslet.2005.05.008; Tong Y, 2008, ONCOGENE, V27, P6385, DOI 10.1038/onc.2008.234; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; TRAIL PA, 1992, CANCER RES, V52, P5693; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Yu R, 2000, J BIOL CHEM, V275, P36502, DOI 10.1074/jbc.C000546200; Yu R, 2000, MOL ENDOCRINOL, V14, P1137, DOI 10.1210/me.14.8.1137; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	47	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23754	10.1371/journal.pone.0023754	http://dx.doi.org/10.1371/journal.pone.0023754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858218	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300091
J	Tung, JY; Do, CB; Hinds, DA; Kiefer, AK; Macpherson, JM; Chowdry, AB; Francke, U; Naughton, BT; Mountain, JL; Wojcicki, A; Eriksson, N				Tung, Joyce Y.; Do, Chuong B.; Hinds, David A.; Kiefer, Amy K.; Macpherson, J. Michael; Chowdry, Arnab B.; Francke, Uta; Naughton, Brian T.; Mountain, Joanna L.; Wojcicki, Anne; Eriksson, Nicholas			Efficient Replication of over 180 Genetic Associations with Self-Reported Medical Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; VALIDATION; DISEASE; QUESTIONNAIRE; LOCI; PREVALENCE; VARIANTS; STROKE; ONSET	While the cost and speed of generating genomic data have come down dramatically in recent years, the slow pace of collecting medical data for large cohorts continues to hamper genetic research. Here we evaluate a novel online framework for obtaining large amounts of medical information from a recontactable cohort by assessing our ability to replicate genetic associations using these data. Using web-based questionnaires, we gathered self-reported data on 50 medical phenotypes from a generally unselected cohort of over 20,000 genotyped individuals. Of a list of genetic associations curated by NHGRI, we successfully replicated about 75% of the associations that we expected to (based on the number of cases in our cohort and reported odds ratios, and excluding a set of associations with contradictory published evidence). Altogether we replicated over 180 previously reported associations, including many for type 2 diabetes, prostate cancer, cholesterol levels, and multiple sclerosis. We found significant variation across categories of conditions in the percentage of expected associations that we were able to replicate, which may reflect systematic inflation of the effects in some initial reports, or differences across diseases in the likelihood of misdiagnosis or misreport. We also demonstrated that we could improve replication success by taking advantage of our recontactable cohort, offering more in-depth questions to refine self-reported diagnoses. Our data suggest that online collection of self-reported data from a recontactable cohort may be a viable method for both broad and deep phenotyping in large populations.	[Tung, Joyce Y.; Do, Chuong B.; Hinds, David A.; Kiefer, Amy K.; Macpherson, J. Michael; Chowdry, Arnab B.; Francke, Uta; Naughton, Brian T.; Mountain, Joanna L.; Wojcicki, Anne; Eriksson, Nicholas] 23andMe Inc, Mountain View, CA 94043 USA; [Francke, Uta] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Tung, JY (corresponding author), 23andMe Inc, Mountain View, CA 94043 USA.	joyce@23andme.com		Hinds, David/0000-0002-4911-803X				Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; BURGESS AM, 1971, J CHRON DIS, V24, P45, DOI 10.1016/0021-9681(71)90058-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; DO CB, 2011, PLOS GENETI IN PRESS; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Feldman DE, 2007, ARTHRIT RHEUM-ARTHR, V57, P1419, DOI 10.1002/art.23086; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Gasperini C, 2001, NEUROL SCI, V22, pS93, DOI 10.1007/s100720100043; *GEN, CAT PUBL GEN WID ASS; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; *INT PARK DIS GEN, 2011, PLOS GENETI IN PRESS; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kronz JD, 1999, CANCER, V86, P2426, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; Lee K, 2010, TRENDS GENET, V26, P241, DOI 10.1016/j.tig.2010.03.003; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; OMAHONY PG, 1995, STROKE, V26, P1334, DOI 10.1161/01.STR.26.8.1334; Patel BD, 2010, AM J RESP CRIT CARE, V181; Patsopoulos NA, 2010, ANN RHEUM DIS, V69, P561, DOI 10.1136/ard.2009.109447; Pelchat ML, 2011, CHEM SENSES, V36, P9, DOI 10.1093/chemse/bjq081; Perdigones N, 2009, RHEUMATOLOGY, V48, P618, DOI 10.1093/rheumatology/kep053; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Pinto Sanchez Maria Ines, 2009, Acta Gastroenterol Latinoam, V39, P250; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith B, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-37; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; van Durme YMTA, 2010, EUR RESPIR J, V36, P89, DOI 10.1183/09031936.00129509; Walker MK, 1998, AM J EPIDEMIOL, V148, P355; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398	47	91	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23473	10.1371/journal.pone.0023473	http://dx.doi.org/10.1371/journal.pone.0023473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858135	Green Submitted, gold, Green Published			2022-12-27	WOS:000294121300051
J	Woelke, AL; von Eichborn, J; Murgueitio, MS; Worth, CL; Castiglione, F; Preissner, R				Woelke, Anna Lena; von Eichborn, Joachim; Murgueitio, Manuela S.; Worth, Catherine L.; Castiglione, Filippo; Preissner, Robert			Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm	PLOS ONE			English	Article							CANCER VACCINES; MODEL; PREDICTION; BINDING; VIRUS; TOOLS	personalized treatment are difficult to access experimentally. In this respect, in silico models can help to narrow down the parameter space or to explain certain phenomena at a systems level. Herein, we develop two empirical interaction potentials specific to B-cell and T-cell receptor complexes and validate their applicability in comparison to a more general potential. The interaction potentials are applied to the model VaccImm which simulates the immune response against solid tumors under peptide vaccination therapy. This multi-agent system is derived from another immune system simulator (C-ImmSim) and now includes a module that enables the amino acid sequence of immune receptors and their ligands to be taken into account. The multi-agent approach is combined with approved methods for prediction of major histocompatibility complex (MHC)-binding peptides and the newly developed interaction potentials. In the analysis, we critically assess the impact of the different modules on the simulation with VaccImm and how they influence each other. In addition, we explore the reasons for failures in inducing an immune response by examining the activation states of the immune cell populations in detail. In summary, the present work introduces immune-specific interaction potentials and their application to the agent-based model VaccImm which simulates peptide vaccination in cancer therapy.	[Woelke, Anna Lena; von Eichborn, Joachim; Murgueitio, Manuela S.; Worth, Catherine L.; Preissner, Robert] Charite, Inst Physiol, D-13353 Berlin, Germany; [Castiglione, Filippo] Natl Res Council Italy, Inst Comp Applicat, Rome, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Consiglio Nazionale delle Ricerche (CNR)	Woelke, AL (corresponding author), Charite, Inst Physiol, D-13353 Berlin, Germany.	anna-lena.woelke@charite.de	Castiglione, Filippo/B-1366-2010	Castiglione, Filippo/0000-0002-1442-3552; preissner, robert/0000-0002-2407-1087; Worth, Catherine/0000-0002-1796-9606	Deutsche Forschungsgemeinschaft (DFG) [SFB 449]; European Union (EU); Deutsche Krebshilfe; Federal Ministry of Education and Research (BMBF) [0315450]; graduate school "Computational Systems Biology'' of DFG [GRK1772/1]; International Research Training Group "Genomics and Systems Biology of Molecular Networks'' of DFG [GRK1360]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union (EU)(CGIAREuropean Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); graduate school "Computational Systems Biology'' of DFG(German Research Foundation (DFG)); International Research Training Group "Genomics and Systems Biology of Molecular Networks'' of DFG(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) (SFB 449), the European Union (EU) project SynSys, the Deutsche Krebshilfe, and the Federal Ministry of Education and Research (BMBF) project MedSys (0315450). AW was funded by the graduate school "Computational Systems Biology'' (GRK1772/1 of the DFG). JvE was funded by the International Research Training Group "Genomics and Systems Biology of Molecular Networks'' (GRK1360 of the DFG). The open access charge was funded by DFG, BMBF and EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appella E, 1995, EXS, V73, P105; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Castiglione F, 2005, J THEOR BIOL, V237, P390, DOI 10.1016/j.jtbi.2005.04.024; Castiglione F, 2007, BIOINFORMATICS, V23, P1371, DOI 10.1093/bioinformatics/btm044; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; FARMER JD, 1986, PHYSICA D, V22, P187, DOI 10.1016/0167-2789(86)90240-X; Folcik VA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-1; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kalita J K, 2006, Int J Bioinform Res Appl, V2, P63; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Lollini PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-352; Mallet DG, 2006, J THEOR BIOL, V239, P334, DOI 10.1016/j.jtbi.2005.08.002; MEIERSCHELLERSH.M, 1999, SIMMUNE TOOL SIMULAT; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Miller AM, 2007, CANCER IMMUNOL IMMUN, V56, P81, DOI 10.1007/s00262-005-0110-x; Miyazawa S, 1999, PROTEINS, V36, P357, DOI 10.1002/(SICI)1097-0134(19990815)36:3<357::AID-PROT10>3.3.CO;2-L; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Pennisi M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S13; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Pichichero ME, 2008, HUM VACCINES, V4, P262, DOI 10.4161/hv.4.4.5742; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Santoni D, 2008, BIOINFORMATICS, V24, P1374, DOI 10.1093/bioinformatics/btn135; Siebert JC, 2010, IMMUNOTHERAPY-UK, V2, P799, DOI [10.2217/imt.10.76, 10.2217/IMT.10.76]; Tolar P, 2009, IMMUNOL REV, V232, P34, DOI 10.1111/j.1600-065X.2009.00833.x; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; von Eichborn Joachim, 2010, V22, P1; Woelke AL, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/271794	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23257	10.1371/journal.pone.0023257	http://dx.doi.org/10.1371/journal.pone.0023257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858048	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000294121300025
J	Reis, DG; Scopinho, AA; Guimaraes, FS; Correa, FMA; Resstel, LBM				Reis, Daniel G.; Scopinho, America A.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.			Behavioral and Autonomic Responses to Acute Restraint Stress Are Segregated within the Lateral Septal Area of Rats	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; MEDIAL PREFRONTAL CORTEX; MODULATES CARDIOVASCULAR-RESPONSES; DIFFERENTIAL NEURONAL ACTIVATION; ANXIETY-LIKE BEHAVIOR; UNANESTHETIZED RATS; STRIA TERMINALIS; CONDITIONED FEAR; BED NUCLEUS; C-FOS	Background: The Lateral Septal Area (LSA) is involved with autonomic and behavior responses associated to stress. In rats, acute restraint (RS) is an unavoidable stress situation that causes autonomic (body temperature, mean arterial pressure (MAP) and heart rate (HR) increases) and behavioral (increased anxiety-like behavior) changes in rats. The LSA is one of several brain regions that have been involved in stress responses. The aim of the present study was to investigate if the neurotransmission blockade in the LSA would interfere in the autonomic and behavioral changes induced by RS. Methodology/Principal Findings: Male Wistar rats with bilateral cannulae aimed at the LSA, an intra-abdominal datalogger (for recording internal body temperature), and an implanted catheter into the femoral artery (for recording and cardiovascular parameters) were used. They received bilateral microinjections of the non-selective synapse blocker cobalt chloride (CoCl2, 1 mM/ 100 nL) or vehicle 10 min before RS session. The tail temperature was measured by an infrared thermal imager during the session. Twenty-four h after the RS session the rats were tested in the elevated plus maze (EPM). Conclusions/Significance: Inhibition of LSA neurotransmission reduced the MAP and HR increases observed during RS. However, no changes were observed in the decrease in skin temperature and increase in internal body temperature observed during this period. Also, LSA inhibition did not change the anxiogenic effect induced by RS observed 24 h later in the EPM. The present results suggest that LSA neurotransmission is involved in the cardiovascular but not the temperature and behavioral changes induced by restraint stress.	[Reis, Daniel G.; Scopinho, America A.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo	Reis, DG (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil.	leoresstel@yahoo.com.br	Correa, Fernando/D-1614-2012; Guimaraes, Francisco Silveira/C-1059-2012; Resstel, Leonardo/C-6100-2012	Correa, Fernando/0000-0003-4067-9524; Guimaraes, Francisco Silveira/0000-0003-4092-7778; 	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brazil [PNPD0176087]; FAPESP [2009/03187-9]; CNPq [470042/2009-5, 305996/2008-8]; FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia)	D.G.R. is a FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) PhD fellow (2008/04069-7) and A.A.S. is a recipient of financial support from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brazil (PNPD0176087). Research was also supported by a grant from FAPESP (2009/03187-9), CNPq (470042/2009-5 and 305996/2008-8) and FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FHF, 2010, BRAIN RES, V1333, P57, DOI 10.1016/j.brainres.2010.03.077; BECK CHM, 1995, J NEUROSCI, V15, P709; Beig MI, 2009, NEUROSCIENCE, V159, P1185, DOI 10.1016/j.neuroscience.2009.01.038; Blessing WW, 2003, NEUROSCIENCE, V117, P939, DOI 10.1016/S0306-4522(02)00810-2; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Brown DR, 1999, AM J PHYSIOL-REG I, V277, pR650, DOI 10.1152/ajpregu.1999.277.3.R650; CALARESU FR, 1976, J PHYSIOL-LONDON, V260, P515, DOI 10.1113/jphysiol.1976.sp011529; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Chen HC, 2004, CHINESE J PHYSIOL, V47, P49; CORREA FMA, 1975, J PHARMACOL EXP THER, V192, P670; COVIAN MR, 1966, ACTA PHYSIOL LAT AM, VS 16, P119; Crestani CC, 2009, STRESS, V12, P268, DOI 10.1080/10253890802331477; Crestani CC, 2008, NEUROSCI LETT, V448, P189, DOI 10.1016/j.neulet.2008.10.055; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; DEAGUIARCORREA FM, 1978, ACTA PHYSIOL LAT AM, V28, P69; DeBeck LD, 2010, AM J PHYSIOL-REG I, V299, pR80, DOI 10.1152/ajpregu.00246.2009; Degroot A, 2001, PHARMACOL BIOCHEM BE, V69, P391, DOI 10.1016/S0091-3057(01)00541-X; DUNCAN GE, 1993, J NEUROSCI, V13, P3932; FELDON J, 1982, BEHAV NEURAL BIOL, V35, P121, DOI 10.1016/S0163-1047(82)91143-8; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; Fortaleza EAT, 2009, NEUROSCIENCE, V159, P717, DOI 10.1016/j.neuroscience.2009.01.003; GELSEMA AJ, 1987, AM J PHYSIOL, V252, pR760, DOI 10.1152/ajpregu.1987.252.4.R760; GUIMARAES FS, 1993, BEHAV BRAIN RES, V58, P133, DOI 10.1016/0166-4328(93)90098-B; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; Hsu HR, 2007, EUR J PHARMACOL, V566, P124, DOI 10.1016/j.ejphar.2007.03.040; KENNETT GA, 1985, EUR J PHARMACOL, V119, P143, DOI 10.1016/0014-2999(85)90290-0; KENNETT GA, 1987, EUR J PHARMACOL, V134, P265, DOI 10.1016/0014-2999(87)90357-8; Kenney MJ, 1999, J APPL PHYSIOL, V87, P732, DOI 10.1152/jappl.1999.87.2.732; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Kubo T, 2002, NEUROSCI LETT, V318, P25, DOI 10.1016/S0304-3940(01)02463-6; LACHUER J, 1994, BRAIN RES, V638, P196, DOI 10.1016/0006-8993(94)90650-5; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Li HY, 1998, J COMP NEUROL, V393, P244; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Martin J, 2010, AM J PHYSIOL-REG I, V298, pR1383, DOI 10.1152/ajpregu.00371.2009; Menard J, 1996, PHYSIOL BEHAV, V60, P845; Menard J, 2000, BEHAV PHARMACOL, V11, P99, DOI 10.1097/00008877-200004000-00001; Resstel LBM, 2008, CEREB CORTEX, V18, P2027, DOI 10.1093/cercor/bhm232; Morrison SF, 2001, ANN NY ACAD SCI, V940, P286; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Padovan CM, 2000, BRAZ J MED BIOL RES, V33, P79, DOI 10.1590/S0100-879X2000000100011; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Pelosi GG, 2007, AUTON NEUROSCI-BASIC, V131, P70, DOI 10.1016/j.autneu.2006.07.002; PERESPOLON VL, 1992, BRAZ J MED BIOL RES, V25, P257; PERESPOLON VL, 1994, NEUROPHARMACOLOGY, V33, P1537, DOI 10.1016/0028-3908(94)90127-9; Pesold C, 1996, BRAIN RES, V710, P161, DOI 10.1016/0006-8993(95)01359-8; PEZZONE MA, 1992, BRAIN RES, V597, P41, DOI 10.1016/0006-8993(92)91503-7; PIROLA CJ, 1987, NEUROPHARMACOLOGY, V26, P561, DOI 10.1016/0028-3908(87)90148-1; Reis DG, 2010, LEARN MEMORY, V17, P134, DOI 10.1101/lm.1534710; Resstel LBM, 2008, NEUROSCIENCE, V154, P869, DOI 10.1016/j.neuroscience.2008.04.007; Resstel LBM, 2006, EUR J NEUROSCI, V23, P481, DOI 10.1111/j.1460-9568.2005.04566.x; Resstel LBM, 2009, BRIT J PHARMACOL, V156, P181, DOI 10.1111/j.1476-5381.2008.00046.x; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; Scopinho AA, 2006, BRAIN RES, V1122, P126, DOI 10.1016/j.brainres.2006.09.002; Scopinho AA, 2007, AUTON NEUROSCI-BASIC, V137, P77, DOI 10.1016/j.autneu.2007.08.003; Sevgi S, 2006, METHOD FIND EXP CLIN, V28, P95, DOI 10.1358/mf.2006.28.2.977840; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Stornetta RL, 2009, J CHEM NEUROANAT, V38, P222, DOI 10.1016/j.jchemneu.2009.07.005; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; Tavares RF, 2009, J NEUROSCI RES, V87, P2601, DOI 10.1002/jnr.22070; Tavares RF, 2009, J NEUROSCI RES; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vianna DML, 2005, EUR J NEUROSCI, V21, P2505, DOI 10.1111/j.1460-9568.2005.04073.x; VOLZ HP, 1990, ANAT EMBRYOL, V181, P177; Whitehead MC, 2000, J COMP NEUROL, V422, P429; Xia Y, 2003, NEUROSCIENCE, V121, P219, DOI 10.1016/S0306-4522(03)00290-2; Xia Y, 2001, MOL BRAIN RES, V89, P71, DOI 10.1016/S0169-328X(01)00065-1	69	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23171	10.1371/journal.pone.0023171	http://dx.doi.org/10.1371/journal.pone.0023171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858017	gold, Green Submitted, Green Published			2022-12-27	WOS:000294125500016
J	Konate, AT; Yaro, JB; Ouedraogo, AZ; Diarra, A; Gansane, A; Soulama, I; Kangoye, DT; Kabore, Y; Ouedraogo, E; Ouedraogo, A; Tiono, AB; Ouedraogo, IN; Chandramohan, D; Cousens, S; Milligan, PJ; Sirima, SB; Greenwood, BM; Diallo, DA				Konate, Amadou T.; Yaro, Jean Baptiste; Ouedraogo, Amidou Z.; Diarra, Amidou; Gansane, Adama; Soulama, Issiaka; Kangoye, David T.; Kabore, Youssouf; Ouedraogo, Esperance; Ouedraogo, Alphonse; Tiono, Alfred B.; Ouedraogo, Issa N.; Chandramohan, Daniel; Cousens, Simon; Milligan, Paul J.; Sirima, Sodiomon B.; Greenwood, Brian M.; Diallo, Diadier A.			Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INFANTS; TRANSMISSION; MORTALITY; ANEMIA	Background: Interventions that reduce exposure to malaria infection may lead to delayed malaria morbidity and mortality. We investigated whether intermittent preventive treatment of malaria in children (IPTc) was associated with an increase in the incidence of malaria after cessation of the intervention. Methods: An individually randomised, trial of IPTc, comparing three courses of sulphadoxine pyrimethamine (SP) plus amodiaquine (AQ) with placebos was implemented in children aged 3-59 months during the 2008 malaria transmission season in Burkina Faso. All children in the trial were given a long lasting insecticide treated net; 1509 children received SP+AQ and 1505 received placebos. Passive surveillance for malaria was maintained until the end of the subsequent malaria transmission season in 2009, and active surveillance for malaria infection, anaemia and malnutrition was conducted. Results: On thousand, four hundred and sixteen children (93.8%) and 1399 children (93.0%) initially enrolled in the intervention and control arms of the trial respectively were followed during the 2009 malaria transmission season. During the period July 2009 to November 2009, incidence rates of clinical malaria were 3.84 (95% CI; 3.67-4.02) and 3.45 (95% CI; 3.29-3.62) episodes per child during the follow up period in children who had previously received IPT or placebos, indicating a small increase in risk for children in the former intervention arm (IRR = 1.12; 95% CI 1.04-1.20) (P = 0.003). Children who had received SP+AQ had a lower prevalence of malaria infection (adjusted PR: 0.88 95% CI: 0.79-0.98) (P = 0.04) but they had a higher parasite density (P = 0.001) if they were infected. There was no evidence that the risks of moderately severe anaemia (Hb <8 g/dL), wasting, stunting, or of being underweight in children differed between treatment arms. Conclusion: IPT with SP+AQ was associated with a small increase in the incidence of clinical malaria in the subsequent malaria transmission season.	[Konate, Amadou T.; Yaro, Jean Baptiste; Ouedraogo, Amidou Z.; Diarra, Amidou; Gansane, Adama; Soulama, Issiaka; Kangoye, David T.; Kabore, Youssouf; Ouedraogo, Esperance; Ouedraogo, Alphonse; Tiono, Alfred B.; Ouedraogo, Issa N.; Sirima, Sodiomon B.] CNRFP, Ouagadougou, Burkina Faso; [Chandramohan, Daniel; Milligan, Paul J.; Greenwood, Brian M.; Diallo, Diadier A.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Cousens, Simon] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Konate, AT (corresponding author), CNRFP, Ouagadougou, Burkina Faso.	Diadier.Diallo@lshtm.ac.uk	SOULAMA, Issiaka/Z-1254-2019; Milligan, Paul/D-8985-2017; OUEDRAOGO, Alphonse/F-7859-2019	SOULAMA, Issiaka/0000-0002-0993-0525; Milligan, Paul/0000-0003-3430-3395; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Nebie, Issa/0000-0003-3051-3600; Tiono, B. Alfred/0000-0002-5104-3946; Ouedraogo, Alphonse/0000-0002-3520-6637	Bill & Melinda Gates Foundation [41783]; trial Data Safety and Monitoring Board; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); trial Data Safety and Monitoring Board; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant to the London School of Hygiene & Tropical Medicine from the Bill & Melinda Gates Foundation (Grant number: 41783). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the study population, the Bousse District Health Officer and the district health staff, the CNRFP research personnel for their efforts in the implementation of the trial. We are grateful to members of the trial Data Safety and Monitoring Board (chaired by Prof Geoffrey Targett) for their support. We express gratitude to Dr. Amit Bhasin and Manuela Claite for support with logistics, to the Malaria Diagnosis Centre of Excellence at Kisumu for undertaking the external quality control of slides reading. We appreciated support from KINAPHARMA Limited who manufactured the trial drugs, World Swim against Malaria for help in obtaining and distributing LLINs and the Ministry of Health of Burkina Faso for its continued support.	Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; Dicko A, 2011, PLOS ONE UNPUB; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Tagbor H, 2011, TROP MED INT HEALTH, V16, P280, DOI 10.1111/j.1365-3156.2010.02699.x; *WHO, 2009, SOFTW ASS GROWTH DEV; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976	19	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23391	10.1371/journal.pone.0023391	http://dx.doi.org/10.1371/journal.pone.0023391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858097	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000293953500036
J	Lamy, JB; Bouffier, L; Burlett, R; Plomion, C; Cochard, H; Delzon, S				Lamy, Jean-Baptiste; Bouffier, Laurent; Burlett, Regis; Plomion, Christophe; Cochard, Herve; Delzon, Sylvain			Uniform Selection as a Primary Force Reducing Population Genetic Differentiation of Cavitation Resistance across a Species Range	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; PINUS-PINASTER POPULATIONS; QUANTITATIVE TRAIT LOCI; SPACE-TIME CLIMATE; MARITIME-PINE; HYDRAULIC ARCHITECTURE; PHYSIOLOGICAL TRAITS; XYLEM VULNERABILITY; HEIGHT GROWTH	Background: Cavitation resistance to water stress-induced embolism determines plant survival during drought. This adaptive trait has been described as highly variable in a wide range of tree species, but little is known about the extent of genetic and phenotypic variability within species. This information is essential to our understanding of the evolutionary forces that have shaped this trait, and for evaluation of its inclusion in breeding programs. Methodology: We assessed cavitation resistance (P-50), growth and carbon isotope composition in six Pinus pinaster populations in a provenance and progeny trial. We estimated the heritability of cavitation resistance and compared the distribution of neutral markers (F-ST) and quantitative genetic differentiation (Q(ST)), for retrospective identification of the evolutionary forces acting on these traits. Results/Discussion: In contrast to growth and carbon isotope composition, no population differentiation was found for cavitation resistance. Heritability was higher than for the other traits, with a low additive genetic variance (h(ns)(2) = 0.43+/-0.18, CVA = 4.4%). Q(ST) was significantly lower than F-ST, indicating uniform selection for P-50, rather than genetic drift. Putative mechanisms underlying Q(ST)<F-ST are discussed.	[Lamy, Jean-Baptiste; Bouffier, Laurent; Burlett, Regis; Plomion, Christophe; Delzon, Sylvain] INRA, UMR BIOGECO 1202, F-33610 Cestas, France; [Lamy, Jean-Baptiste; Burlett, Regis; Plomion, Christophe; Delzon, Sylvain] Univ Bordeaux, UMR BIOGECO 1202, F-33610 Cestas, France; [Lamy, Jean-Baptiste; Cochard, Herve] Univ Blaise Pascal, INRA, UMR PIAF 547, F-63100 Clermont Ferrand, France; [Bouffier, Laurent] FCBA, Stn Sud Ouest, Domaine Sivaillan, F-33480 Moulis En Medoc, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA)	Lamy, JB (corresponding author), INRA, UMR BIOGECO 1202, F-33610 Cestas, France.	sylvain.delzon@u-bordeaux1.fr	Delzon, Sylvain/R-9538-2018; plomion, christophe/F-7578-2013; Cochard, Hervé/P-7406-2015	Delzon, Sylvain/0000-0003-3442-1711; Cochard, Hervé/0000-0002-2727-7072; plomion, christophe/0000-0002-3176-2767; Lamy, Jean-Baptiste/0000-0002-6078-0905	INRA; European Union [TREESNIP-QLK3-CT2002-01973]; NOVELTREE project [FP7-211868]; Auvergne Region	INRA; European Union(European Commission); NOVELTREE project; Auvergne Region(Region Auvergne-Rhone-Alpes)	This research was supported by grants from INRA (innovative project 2010) and the European Union: i) the provenance trial was set up in 2003 by the experimental unit at INRA Pierroton, as part of the TREESNIP-QLK3-CT2002-01973 project. ii) measurements of carbon isotope discrimination and cavitation resistance were funded by the NOVELTREE project (FP7-211868). J-BL was supported by a doctoral fellowship from INRA and the Auvergne Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia R, 1997, CAN J FOREST RES, V27, P1548, DOI 10.1139/cjfr-27-10-1548; Baltunis BS, 2008, TREE GENET GENOMES, V4, P797, DOI 10.1007/s11295-008-0152-2; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Boos DD, 2003, STAT SCI, V18, P168, DOI 10.1214/ss/1063994971; Bouffier L, 2008, HEREDITY, V101, P156, DOI 10.1038/hdy.2008.41; Bouffier L, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2007078; Brendel O, 2002, PLANT CELL ENVIRON, V25, P945, DOI 10.1046/j.1365-3040.2002.00872.x; Brendel O, 2008, TREE GENET GENOMES, V4, P263, DOI 10.1007/s11295-007-0107-z; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Brodribb TJ, 2010, NEW PHYTOL, V188, P533, DOI 10.1111/j.1469-8137.2010.03393.x; Brodribb TJ, 2009, PLANT PHYSIOL, V149, P575, DOI 10.1104/pp.108.129783; Bucci G, 2007, MOL ECOL, V16, P2137, DOI 10.1111/j.1365-294X.2007.03275.x; Burban C, 2003, MOL ECOL, V12, P1487, DOI 10.1046/j.1365-294X.2003.01817.x; Burt DB, 2001, BIOL J LINN SOC, V72, P509, DOI 10.1006/bijl.2000.0512; Cai J, 2010, PHYSIOL PLANTARUM, V140, P311, DOI 10.1111/j.1399-3054.2010.01402.x; Caruso CM, 2006, EVOLUTION, V60, P980, DOI 10.1554/06-050.1; Caruso CM, 2005, EVOLUTION, V59, P826; Caruso CM, 2004, EVOLUTION, V58, P732, DOI 10.1111/j.0014-3820.2004.tb00406.x; Chagne D, 2004, THEOR APPL GENET, V109, P1204, DOI 10.1007/s00122-004-1683-z; Cochard H, 2005, PHYSIOL PLANTARUM, V124, P410, DOI 10.1111/j.1399-3054.2005.00526.x; Cochard H, 2002, PLANT CELL ENVIRON, V25, P815, DOI 10.1046/j.1365-3040.2002.00863.x; Cochard H, 2008, J PLANT PHYSIOL, V165, P976, DOI 10.1016/j.jplph.2007.07.020; Cochard H, 2010, PLANT CELL ENVIRON, V33, P1543, DOI 10.1111/j.1365-3040.2010.02163.x; Correia I, 2008, TREE PHYSIOL, V28, P1545, DOI 10.1093/treephys/28.10.1545; Delzon S, 2004, PLANT CELL ENVIRON, V27, P1077, DOI 10.1111/j.1365-3040.2004.01213.x; Delzon S, 2010, PLANT CELL IN PRESS; Ducrey M, 2008, TREE PHYSIOL, V28, P689, DOI 10.1093/treephys/28.5.689; Eveno E, 2008, THESIS U BORDEAUX 1, V1, P399; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Fichot R, 2010, PLANT CELL ENVIRON, V33, P1553, DOI 10.1111/j.1365-3040.2010.02164.x; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Field CA, 2008, CAN J STAT, V36, P521, DOI 10.1002/cjs.5550360403; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gonzalez-Martinez SC, 2002, HEREDITY, V89, P199, DOI 10.1038/sj.hdy.6800114; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Guehl J. M., 1993, Agricoltura Ricerca, V15, P31; GUEHL JM, 1995, NEW PHYTOL, V131, P149, DOI 10.1111/j.1469-8137.1995.tb05716.x; Guevara MA, 2005, MOL ECOL NOTES, V5, P57, DOI 10.1111/j.1471-8286.2004.00830.x; GUYON JP, 1982, CAN J FOREST RES, V12, P936, DOI 10.1139/x82-136; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Hansen TF, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P130; Hansen TF, 2006, EVOLUTION, V60, P1523; Herbette S, 2010, TREE PHYSL; Houle D, 1996, GENETICS, V143, P1467; HOULE D, 1992, GENETICS, V130, P195; Jacobsen AL, 2005, PLANT PHYSIOL, V139, P546, DOI 10.1104/pp.104.058404; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Johnsen KH, 1999, CAN J FOREST RES, V29, P1727, DOI 10.1139/cjfr-29-11-1727; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kosorok MR, 1999, BIOMETRIKA, V86, P909, DOI 10.1093/biomet/86.4.909; Kremer A., 1979, Comptes-rendus du 104eme Congres National des Societes Savantes., P340; Kruuk LEB, 2001, AM NAT, V158, P557, DOI 10.1086/323585; Le Corre V, 2003, GENETICS, V164, P1205; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lynch M., 1998, GENETICS ANAL QUANTI; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Maherali H, 2009, NEW PHYTOL, V184, P721, DOI 10.1111/j.1469-8137.2009.02997.x; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; Mariette S, 2001, ANN FOR SCI, V58, P203, DOI 10.1051/forest:2001119; Martin G, 2008, GENETICS, V180, P2135, DOI 10.1534/genetics.107.080820; Martinez-Meier A, 2008, FOREST ECOL MANAG, V256, P837, DOI 10.1016/j.foreco.2008.05.041; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; Matzner SL, 2001, J EXP BOT, V52, P783, DOI 10.1093/jexbot/52.357.783; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Michalakis Y, 1996, GENETICS, V142, P1061; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; Ogle K, 2009, NEW PHYTOL, V182, P541, DOI 10.1111/j.1469-8137.2008.02760.x; Pammenter NW, 1998, TREE PHYSIOL, V18, P589, DOI 10.1093/treephys/18.8-9.589; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pittermann J, 2010, PLANT PHYSIOL, V153, P1919, DOI 10.1104/pp.110.158824; Pot D, 2002, ANN FOREST SCI, V59, P563, DOI 10.1051/forest:2002042; Ramirez-Valiente JA, 2009, MOL ECOL, V18, P3803, DOI 10.1111/j.1365-294X.2009.04317.x; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Ribeiro MM, 2002, ANN FOR SCI, V59, P53, DOI [10.1051/forest:2001005, 10.1051/forest:2002100]; Richardson D. M., 1998, ECOLOGY BIOGEOGRAPHY; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rweyongeza DM, 2005, SILVAE GENET, V54, P228, DOI 10.1515/sg-2005-0033; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SPITZE K, 1993, GENETICS, V135, P367; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tyree MT, 2003, NATURE, V423, P923, DOI 10.1038/423923a; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Waldmann P, 2005, HEREDITY, V94, P623, DOI 10.1038/sj.hdy.6800672; Wang TL, 2003, TREES-STRUCT FUNCT, V17, P269, DOI 10.1007/s00468-002-0236-9; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Willson CJ, 2008, AM J BOT, V95, P299, DOI 10.3732/ajb.95.3.299; Wilson AJ, 2008, J EVOLUTION BIOL, V21, P647, DOI 10.1111/j.1420-9101.2008.01500.x	101	105	107	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23476	10.1371/journal.pone.0023476	http://dx.doi.org/10.1371/journal.pone.0023476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858137	Green Published, gold			2022-12-27	WOS:000293953500047
J	Dejean, T; Valentini, A; Duparc, A; Pellier-Cuit, S; Pompanon, F; Taberlet, P; Miaud, C				Dejean, Tony; Valentini, Alice; Duparc, Antoine; Pellier-Cuit, Stephanie; Pompanon, Francois; Taberlet, Pierre; Miaud, Claude			Persistence of Environmental DNA in Freshwater Ecosystems	PLOS ONE			English	Article							PLASMID DNA; PLANT DNA; ANCIENT; TRANSFORMATION; INFERENCES; STABILITY	The precise knowledge of species distribution is a key step in conservation biology. However, species detection can be extremely difficult in many environments, specific life stages and in populations at very low density. The aim of this study was to improve the knowledge on DNA persistence in water in order to confirm the presence of the focus species in freshwater ecosystems. Aquatic vertebrates (fish: Siberian sturgeon and amphibian: Bullfrog tadpoles) were used as target species. In control conditions (tanks) and in the field (ponds), the DNA detectability decreases with time after the removal of the species source of DNA. DNA was detectable for less than one month in both conditions. The density of individuals also influences the dynamics of DNA detectability in water samples. The dynamics of detectability reflects the persistence of DNA fragments in freshwater ecosystems. The short time persistence of detectable amounts of DNA opens perspectives in conservation biology, by allowing access to the presence or absence of species e. g. rare, secretive, potentially invasive, or at low density. This knowledge of DNA persistence will greatly influence planning of biodiversity inventories and biosecurity surveys.	[Dejean, Tony; Valentini, Alice] SPYGEN, Savoie Technolac, Le Bourget Du Lac, France; [Dejean, Tony] Parc Nat Reg Perigord Limousin, La Coquille, France; [Dejean, Tony; Valentini, Alice; Duparc, Antoine; Miaud, Claude] Univ Savoie, UMR CNRS 5553, Lab Ecol Alpine, Le Bourget Du Lac, France; [Pellier-Cuit, Stephanie; Pompanon, Francois; Taberlet, Pierre] Univ Grenoble 1, UMR CNRS 5553, Lab Ecol Alpine, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Dejean, T (corresponding author), SPYGEN, Savoie Technolac, BP 274, Le Bourget Du Lac, France.	claude.miaud@univ-savoie.fr	Pompanon, François/D-3459-2009; Taberlet, Pierre/D-1178-2010; Valentini, Alice/AFS-1389-2022; valentini, alice/S-2040-2019	Pompanon, François/0000-0003-4600-0172; Taberlet, Pierre/0000-0002-3554-5954; Valentini, Alice/0000-0001-5829-5479; 	Ministry of Research [966/2007]; European Community [1018]	Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); European Community(European Commission)	Tony Dejean was given a grant by the Ministry of Research (Grant CIFRE Number 966/2007), and Claude Miaud by the European Community (Marie Curie OIF grant Number 1018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AJ, 1996, ENVIRON TOXIC WATER, V11, P129, DOI 10.1002/(SICI)1098-2256(1996)11:2<129::AID-TOX8>3.0.CO;2-B; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Cooper A, 2000, SCIENCE, V289, P1139; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; DETAINT M, 2001, INVASION GRENOUILLE; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MARGURRAN AE, 2004, MEASURING BIOL DIVER; Matsui K, 2001, AQUAT MICROB ECOL, V26, P95, DOI 10.3354/ame026095; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Nichols JD, 2009, ENVIRON ECOL STAT SE, V3, P201, DOI 10.1007/978-0-387-78151-8_9; Pote J, 2009, ECOTOX ENVIRON SAFE, V72, P1378, DOI 10.1016/j.ecoenv.2009.04.010; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; ROMANOWSKI G, 1992, APPL ENVIRON MICROB, V58, P3012, DOI 10.1128/AEM.58.9.3012-3019.1992; Shapiro B, 2008, TRENDS BIOTECHNOL, V26, P285, DOI 10.1016/j.tibtech.2008.03.005; Smith DR, 2006, J N AM BENTHOL SOC, V25, P701, DOI 10.1899/0887-3593(2006)25[701:SDFDRF]2.0.CO;2; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Team RDC, 2010, R LANG ENV STAT COMP; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Valiere N, 2000, MOL ECOL, V9, P2150, DOI 10.1046/j.1365-294X.2000.11142.x; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Zhu B, 2006, WATER RES, V40, P3231, DOI 10.1016/j.watres.2006.06.040	31	341	374	17	315	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23398	10.1371/journal.pone.0023398	http://dx.doi.org/10.1371/journal.pone.0023398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858099	Green Published, gold			2022-12-27	WOS:000293773300026
J	Roberti, MJ; Jovin, TM; Jares-Erijman, E				Julia Roberti, M.; Jovin, Thomas M.; Jares-Erijman, Elizabeth			Confocal Fluorescence Anisotropy and FRAP Imaging of alpha-Synuclein Amyloid Aggregates in Living Cells	PLOS ONE			English	Article							MEMBRANE-INTERACTIONS; PROTEIN AGGREGATION; BINDING; MECHANISM; DYNAMICS; RFLIM; PHASE	We assessed the intracellular association states of the Parkinson's disease related protein alpha-synuclein (AS) in living cells by transfection with a functional recombinant mutant protein (AS-C4) bearing a tetracysteine tag binding the fluorogenic biarsenical ligands FlAsH and ReAsH, The aggregation states of AS-C4 were assessed by in situ microscopy of molecular translational mobility with FRAP (fluorescence recovery after photobleaching) and of local molecular density with confocal fluorescence anisotropy (CFA). FRAP recovery was quantitative and rapid in regions of free protein, whereas AS in larger aggregates was >80% immobile. A small 16% recovery characterized by an apparent diffusion constant of 0.03-0.04 mu m(2)/s was attributed to the dynamics of smaller, associated forms of AS-C4 and the exchange of mobile species with the larger immobile aggregates. By CFA, the larger aggregates exhibited high brightness and very low anisotropy, consistent with homoFRET between closely packed AS, for which a Forster distance (R-o) of 5.3 nm was calculated. Other bright regions had high anisotropy values, close to that of monomeric AS, and indicative of membrane-associated protein with both low mobility and low degree of association. The anisotropy-fluorescence intensity correlations also revealed regions of free protein or of small aggregates, undetectable by conventional fluorescence imaging alone. The combined strategy (FRAP+CFA) provides a highly sensitive means for elucidating both the dynamics and structural features of protein aggregates and other intracellular complexes in living cells, and can be extended to other amyloid systems and to drug screening protocols.	[Julia Roberti, M.; Jares-Erijman, Elizabeth] Max Planck Inst Biophys Chem, Lab Cellular Dynam, Gottingen, Germany; [Julia Roberti, M.; Jovin, Thomas M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR,CONICET, RA-1428 Buenos Aires, DF, Argentina	Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Roberti, MJ (corresponding author), Max Planck Inst Biophys Chem, Lab Cellular Dynam, Gottingen, Germany.	eli@qo.fcen.uba.ar			Max Planck Society; ANPCyT; CONICET; UBACyT; DFG Center for Molecular Physiology of the Brain (DFG CMPB); CMPB, in Gottingen, Germany	Max Planck Society(Max Planck SocietyFoundation CELLEX); ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT; DFG Center for Molecular Physiology of the Brain (DFG CMPB)(German Research Foundation (DFG)); CMPB, in Gottingen, Germany	E.A.J.-E. is funded by the Max Planck Society (Partner Group grant), ANPCyT, CONICET and UBACyT. This work was supported by the DFG Center for Molecular Physiology of the Brain (DFG CMPB), Cluster of Excellence 171 (Nanometer Microscopy) of the CMPB, in Gottingen, Germany, and the Max Planck Society (Toxic Protein Conformations project). M.J.R. received fellowship support from the DFG CMPB and CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Allsop D, 2001, BIOCHEM BIOPH RES CO, V285, P58, DOI 10.1006/bbrc.2001.5123; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bertoncini CW, 2011, CURR PROTEIN PEPT SC, V12, P206; Celej MS, 2008, BIOPHYS J, V94, P4867, DOI 10.1529/biophysj.107.125211; Daughdrill GW, 2005, PROTEIN FOLDING HANDBOOK; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Jovin TM, 2004, PROC SPIE, V5323, P1, DOI 10.1117/12.528469; Roberti MJ, 2011, CHEMPHYSCHEM, V12, P563, DOI 10.1002/cphc.201000925; Roberti MJ, 2009, J AM CHEM SOC, V131, P8102, DOI 10.1021/ja900225w; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Koo BW, 2005, PROTEIN SCI, V14, P231, DOI 10.1110/ps.041051205; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Luk KC, 2007, BIOCHEMISTRY-US, V46, P12522, DOI 10.1021/bi701128c; Madine J, 2009, DRUG FUTURE, V34, P655, DOI 10.1358/dof.2009.034.08.1391472; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Outeiro TF, 2009, CURR PHARM DESIGN, V15, P3968, DOI 10.2174/138161209789649321; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Roberti MJ, 2007, NAT METHODS, V4, P345, DOI 10.1038/NMETH1026; ROSS RA, 1983, J NATL CANCER I, V71, P741; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Valeur B, 2001, MOL FLUORESCENCE PRI, V2nd; van Ham TJ, 2010, J MOL BIOL, V395, P627, DOI 10.1016/j.jmb.2009.10.066	33	47	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23338	10.1371/journal.pone.0023338	http://dx.doi.org/10.1371/journal.pone.0023338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858077	Green Submitted, Green Published, gold			2022-12-27	WOS:000293773300023
J	Goldstein, E; Cowling, BJ; Aiello, AE; Takahashi, S; King, G; Lu, Y; Lipsitch, M				Goldstein, Edward; Cowling, Benjamin J.; Aiello, Allison E.; Takahashi, Saki; King, Gary; Lu, Ying; Lipsitch, Marc			Estimating Incidence Curves of Several Infections Using Symptom Surveillance Data	PLOS ONE			English	Article							INFLUENZA; DECONVOLUTION; ALGORITHM; EPIDEMIC; PROFILE; EM	We introduce a method for estimating incidence curves of several co-circulating infectious pathogens, where each infection has its own probabilities of particular symptom profiles. Our deconvolution method utilizes weekly surveillance data on symptoms from a defined population as well as additional data on symptoms from a sample of virologically confirmed infectious episodes. We illustrate this method by numerical simulations and by using data from a survey conducted on the University of Michigan campus. Last, we describe the data needs to make such estimates accurate.	[Goldstein, Edward; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Cowling, Benjamin J.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Aiello, Allison E.] Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Takahashi, Saki] Harvard Univ, Dept Appl Math, Cambridge, MA 02138 USA; [King, Gary] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Lu, Ying] NYU, Dept Humanities & Social Sci Profess, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Michigan System; University of Michigan; Harvard University; Harvard University; New York University; Harvard University; Harvard T.H. Chan School of Public Health	Goldstein, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.	egoldste@hsph.harvard.edu	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Takahashi, Saki/0000-0001-5413-5507; Goldstein, Edward/0000-0002-6795-0559; Lipsitch, Marc/0000-0003-1504-9213	United States National Institutes of Health Models of Infectious Disease [1 U54 GM088558]; Centers for Disease Control and Prevention [U01C1000441]; Hong Kong University Grants Committee [AoE/M-12/06]; Harvard College; RocheRpar; Pfizer/Wyeth; AIR Worldwide; Novartis Vaccines and Diagnostics; MedImmune Inc.; Avian/Pandemic Flu Registry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	United States National Institutes of Health Models of Infectious Disease; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Hong Kong University Grants Committee; Harvard College; RocheRpar; Pfizer/Wyeth(WyethPfizer); AIR Worldwide; Novartis Vaccines and Diagnostics; MedImmune Inc.(AstraZenecaMedimmune); Avian/Pandemic Flu Registry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the United States National Institutes of Health Models of Infectious Disease Agent Study program through cooperative agreement 1 U54 GM088558 (ML, EG, BC); by the Centers for Disease Control and Prevention grant U01C1000441 (AA); by the Area of Excellence Scheme of the Hong Kong University Grants Committee, grant no. AoE/M-12/06 (BC); and by the Harvard College Research Program (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ML discloses consulting income from the Avian/Pandemic Flu Registry (Outcome Sciences, funded in part by RocheRpar; until 2008, and from Pfizer/Wyeth, AIR Worldwide, and Novartis Vaccines and Diagnostics. BC has received study funding from MedImmune Inc., a manufacturer of influenza vaccines. All other authors declare no competing interests exist.	Aiello AE, 2009, IOM COMM RESP PROT H; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CDC FluView, CDC FLUVIEW; Cheng CKY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-339; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Egan JR, 2011, EPIDEMIOLOGY, V22, P188, DOI 10.1097/EDE.0b013e31820937c6; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Goldstein E, 2009, P NATL ACAD SCI USA, V106, P21825, DOI 10.1073/pnas.0902958106; King G, 2008, STAT SCI, V23, P78, DOI 10.1214/07-STS247; Lam EY, 2000, J OPT SOC AM A, V17, P1177, DOI 10.1364/JOSAA.17.001177; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; McLachlan GJ, 2008, EM ALGORITHM EXTENSI, pxxvii; MENG XL, 1991, J AM STAT ASSOC, V86, P899, DOI 10.2307/2290503; Pappas DE, 2008, PEDIATR INFECT DIS J, V27, P8, DOI 10.1097/INF.0b013e31814847d9; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; van Noort S P, 2007, Euro Surveill, V12, pE5; Wang TE, 2010, EPIDEMIOLOGY, V21, P726, DOI 10.1097/EDE.0b013e3181e94274; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	23	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23380	10.1371/journal.pone.0023380	http://dx.doi.org/10.1371/journal.pone.0023380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887246	Green Published, gold, Green Submitted			2022-12-27	WOS:000295832000016
J	Wang, ZF; Liu, XL; Zhao, ZD; Xu, CF; Zhang, K; Chen, CW; Sun, L; Gao, GF; Ye, X; Liu, WJ				Wang, Zengfu; Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Zhang, Ke; Chen, Caiwei; Sun, Lei; Gao, George F.; Ye, Xin; Liu, Wenjun			Cyclophilin E Functions as a Negative Regulator to Influenza Virus Replication by Impairing the Formation of the Viral Ribonucleoprotein Complex	PLOS ONE			English	Article							A VIRUS; RNA-BINDING; NS1 PROTEIN; MESSENGER-RNA; AMINO-ACIDS; NUCLEOPROTEIN; IDENTIFICATION; INTERACTS; CELLS; LOCALIZATION	Background: The nucleoprotein (NP) of influenza A virus is a multifunctional protein that plays a critical role in the replication and transcription of the viral genome. Therefore, examining host factors that interact with NP may shed light on the mechanism of host restriction barriers and the tissue tropism of influenza A virus. Here, Cyclophilin E (CypE), a member of the peptidyl-propyl cis-trans isomerase (PPIase) family, was found to bind to NP and inhibit viral replication and transcription. Methodology/Principal Findings: In the present study, CypE was found to interact with NP but not with the other components of the viral ribonucleoprotein complex (vRNP): PB1, PB2, and PA. Mutagenesis data revealed that the CypE domain comprised of residues 137-186 is responsible for its binding to NP. Functional analysis results indicated that CypE is a negative regulator in the influenza virus life cycle. Furthermore, knock-down of CypE resulted in increased levels of three types of viral RNA, suggesting that CypE negatively affects viral replication and transcription. Moreover, up-regulation of CypE inhibited the activity of influenza viral polymerase. We determined that the molecular mechanism by which CypE negatively regulates influenza virus replication and transcription is by interfering with NP self-association and the NP-PB1 and NP-PB2 interactions. Conclusions/Significance: CypE is a host restriction factor that inhibits the functions of NP, as well as viral replication and transcription, by impairing the formation of the vRNP. The data presented here will help us to better understand the molecular mechanisms of host restriction barriers, host adaptation, and tissue tropism of influenza A virus.	[Wang, Zengfu; Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Zhang, Ke; Chen, Caiwei; Sun, Lei; Gao, George F.; Ye, Xin; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, Ctr Mol Virol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Wang, Zengfu; Zhao, Zhendong; Xu, Chongfeng; Zhang, Ke; Chen, Caiwei; Gao, George F.; Ye, Xin; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gao, George F.; Ye, Xin; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, ZF (corresponding author), Chinese Acad Sci, Inst Microbiol, Ctr Mol Virol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	liuwj@im.ac.cn	Liu, Xiaoling/HGD-3566-2022; Gao, George Fu/ABD-5229-2021; SUN, LEI/B-3288-2018	SUN, LEI/0000-0003-0141-2093	National Basic Research Program (973) of China [2011CB504705]; Chinese Academy of Sciences [KSCX2-YW-N-054, KSCX2-YW-R-158]; National Natural Science Foundation of China [30972185, 30901073]; National Key Technologies Research and Development Program of China [2010BAD04B01]; National Natural Science Foundation of China (NSFC) [81021003]	National Basic Research Program (973) of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973) of China (2011CB504705), Chinese Academy of Sciences Innovation projects (KSCX2-YW-N-054, KSCX2-YW-R-158), the National Natural Science Foundation of China (30972185, 30901073), and the National Key Technologies Research and Development Program of China (2010BAD04B01). Wenjun Liu, George F Gao, and Xin Ye are the principal investigators of the Innovative Research Group of the National Natural Science Foundation of China (NSFC, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBO C, 1995, J VIROL, V69, P3799, DOI 10.1128/JVI.69.6.3799-3806.1995; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Boivin S, 2011, J BIOL CHEM, DOI [10.1074/jbc.M111.226225, DOI 10.1074/JBC.M111.226225]; Boivin S, 2011, J BIOL CHEM; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; DUESBERG PH, 1969, J MOL BIOL, V42, P485, DOI 10.1016/0022-2836(69)90237-X; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Goodman AG, 2007, J VIROL, V81, P2221, DOI 10.1128/JVI.02151-06; KINGSBURY DW, 1969, J VIROL, V4, P219, DOI 10.1128/JVI.4.3.219-225.1969; KINGSBURY DW, 1987, VIROLOGY, V156, P396, DOI 10.1016/0042-6822(87)90419-3; Kogure T, 2006, GLYCOCONJUGATE J, V23, P101, DOI 10.1007/s10719-006-5442-z; Kuchipudi Suresh V, 2009, J Mol Genet Med, V3, P143; Lai JP, 2003, CLIN DIAGN LAB IMMUN, V10, P1123, DOI 10.1128/CDLI.10.6.1123-1128.2003; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Liang YH, 2008, J VIROL, V82, P229, DOI 10.1128/JVI.01541-07; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Medcalf L, 1999, J VIROL, V73, P7349, DOI 10.1128/JVI.73.9.7349-7356.1999; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang T, 2005, BIOCHEM BIOPH RES CO, V333, P845, DOI 10.1016/j.bbrc.2005.06.006; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Xu CF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-372; YAMANAKA K, 1990, J BIOL CHEM, V265, P11151; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	48	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22625	10.1371/journal.pone.0022625	http://dx.doi.org/10.1371/journal.pone.0022625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887220	gold, Green Published, Green Submitted			2022-12-27	WOS:000295832000003
J	Garaud, JC; Schickel, JN; Blaison, G; Knapp, AM; Dembele, D; Ruer-Laventie, J; Korganow, AS; Martin, T; Soulas-Sprauel, P; Pasquali, JL				Garaud, Jean-Claude; Schickel, Jean-Nicolas; Blaison, Gilles; Knapp, Anne-Marie; Dembele, Doulaye; Ruer-Laventie, Julie; Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis			B Cell Signature during Inactive Systemic Lupus Is Heterogeneous: Toward a Biological Dissection of Lupus	PLOS ONE			English	Article							CD27(HIGH) PLASMA-CELLS; FALSE DISCOVERY RATE; DISEASE-ACTIVITY; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; TYROSINE KINASES; MESSENGER-RNA; ER STRESS; ERYTHEMATOSUS; PROTEIN	Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biological heterogeneity. B lymphocytes appear central to the development of SLE which is characterized by the production of a large variety of autoantibodies and hypergammaglobulinemia. In mice, immature B cells from spontaneous lupus prone animals are able to produce autoantibodies when transferred into immunodeficient mice, strongly suggesting the existence of intrinsic B cell defects during lupus. In order to approach these defects in humans, we compared the peripheral B cell transcriptomas of quiescent lupus patients to normal B cell transcriptomas. When the statistical analysis is performed on the entire group of patients, the differences between patients and controls appear quite weak with only 14 mRNA genes having a false discovery rate ranging between 11 and 17%, with 6 underexpressed genes (PMEPA1, TLR10, TRAF3IP2, LDOC1L, CD1C and EGR1). However, unforced hierarchical clustering of the microarrays reveals a subgroup of lupus patients distinct from both the controls and the other lupus patients. This subgroup has no detectable clinical or immunological phenotypic peculiarity compared to the other patients, but is characterized by 1/an IL-4 signature and 2/the abnormal expression of a large set of genes with an extremely low false discovery rate, mainly pointing to the biological function of the endoplasmic reticulum, and more precisely to genes implicated in the Unfolded Protein Response, suggesting that B cells entered an incomplete BLIMP1 dependent plasmacytic differentiation which was undetectable by immunophenotyping. Thus, this microarray analysis of B cells during quiescent lupus suggests that, despite a similar lupus phenotype, different biological roads can lead to human lupus.	[Garaud, Jean-Claude; Schickel, Jean-Nicolas; Knapp, Anne-Marie; Ruer-Laventie, Julie; Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis] CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France; [Blaison, Gilles] Hop Civil Colmar, Colmar, France; [Dembele, Doulaye] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis] Hop Univ Strasbourg, Strasbourg, France; [Knapp, Anne-Marie; Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis] Univ Strasbourg, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Garaud, JC (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France.	jean-louis.pasquali@chru-strasbourg.fr	Dembélé, Doulaye/O-6513-2017	Dembélé, Doulaye/0000-0003-3879-6940; Martin, Thierry/0000-0002-2776-2641; Korganow, Anne-Sophie/0000-0002-1664-6311; Soulas-Sprauel, Pauline/0000-0002-2058-4811	French Ministry of Health; Groupement d'Interet Scientifique (GIS) for rare diseases	French Ministry of Health; Groupement d'Interet Scientifique (GIS) for rare diseases	Grants: French Ministry of Health (Projet Hospitalier de Recherche Clinique), and the Groupement d'Interet Scientifique (GIS) for rare diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Breitling R, 2006, BBA-GENE STRUCT EXPR, V1759, P319, DOI 10.1016/j.bbaexp.2006.06.003; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Dorner T, 2004, LUPUS, V13, P283, DOI 10.1191/0961203304lu1014oa; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gao Y, 2009, J BIOL CHEM, V284, P7114, DOI 10.1074/jbc.M804801200; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; HOCHBERG MC, 1997, ARTHRITIS RHEUM, V40, P2, DOI DOI 10.1002/1529-0131(199709)40:9; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ickstadt K., 2006, RNEWS, V6, P45; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Korganow AS, 2010, J AUTOIMMUN, V34, P426, DOI 10.1016/j.jaut.2009.11.002; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Luciano F, 2001, ONCOGENE, V20, P4935, DOI 10.1038/sj.onc.1204661; Lyons PA, 2010, ANN RHEUM DIS, V69, P1208, DOI 10.1136/ard.2009.108043; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Maltzman JS, 1996, J EXP MED, V183, P1747, DOI 10.1084/jem.183.4.1747; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; Mora-Lopez F, 2008, EUR J IMMUNOL, V38, P2316, DOI 10.1002/eji.200737861; Nagy G, 2000, IMMUNOL LETT, V74, P207, DOI 10.1016/S0165-2478(00)00265-0; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Reininger L, 1996, J EXP MED, V184, P853, DOI 10.1084/jem.184.3.853; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; SIMON JL, 1995, M D COMPUT, V12, P115; Tao J, 2009, J EUR ACAD DERMATOL, V23, P433, DOI 10.1111/j.1468-3083.2009.03095.x; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Xu Y, 2009, ACTA BIOCH BIOPH SIN, V41, P488, DOI 10.1093/abbs/gmp034; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Youinou P, 2007, AUTOIMMUN REV, V7, P149, DOI 10.1016/j.autrev.2007.02.016; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Yu HH, 2010, LUPUS, V19, P1219, DOI 10.1177/0961203310371152; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	51	38	39	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23900	10.1371/journal.pone.0023900	http://dx.doi.org/10.1371/journal.pone.0023900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886837	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500037
J	Mangino, G; Percario, ZA; Fiorucci, G; Vaccari, G; Acconcia, F; Chiarabelli, C; Leone, S; Noto, A; Horenkamp, FA; Manrique, S; Romeo, G; Polticelli, F; Geyer, M; Affabris, E				Mangino, Giorgio; Percario, Zulema A.; Fiorucci, Gianna; Vaccari, Gabriele; Acconcia, Filippo; Chiarabelli, Cristiano; Leone, Stefano; Noto, Alessia; Horenkamp, Florian A.; Manrique, Santiago; Romeo, Giovanna; Polticelli, Fabio; Geyer, Matthias; Affabris, Elisabetta			HIV-1 Nef Induces Proinflammatory State in Macrophages through Its Acidic Cluster Domain: Involvement of TNF Alpha Receptor Associated Factor 2	PLOS ONE			English	Article							NF-KAPPA-B; VIRUS TYPE-1 NEF; HUMAN MONOCYTES/MACROPHAGES; HUMAN MONOCYTE/MACROPHAGES; REGULATORY FACTOR-3; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; PROTEIN; KINASE	Background: HIV-1 Nef is a virulence factor that plays multiple roles during HIV replication. Recently, it has been described that Nef intersects the CD40 signalling in macrophages, leading to modification in the pattern of secreted factors that appear able to recruit, activate and render T lymphocytes susceptible to HIV infection. The engagement of CD40 by CD40L induces the activation of different signalling cascades that require the recruitment of specific tumor necrosis factor receptor-associated factors (i.e. TRAFs). We hypothesized that TRAFs might be involved in the rapid activation of NF-kappa B, MAPKs and IRF-3 that were previously described in Nef-treated macrophages to induce the synthesis and secretion of proinflammatory cytokines, chemokines and IFN beta to activate STAT1, -2 and -3. Methodology/Principal Findings: Searching for possible TRAF binding sites on Nef, we found a TRAF2 consensus binding site in the AQEEEE sequence encompassing the conserved four-glutamate acidic cluster. Here we show that all the signalling effects we observed in Nef treated macrophages depend on the integrity of the acidic cluster. In addition, Nef was able to interact in vitro with TRAF2, but not TRAF6, and this interaction involved the acidic cluster. Finally silencing experiments in THP-1 monocytic cells indicate that both TRAF2 and, surprisingly, TRAF6 are required for the Nef-induced tyrosine phosphorylation of STAT1 and STAT2. Conclusions: Results reported here revealed TRAF2 as a new possible cellular interactor of Nef and highlighted that in monocytes/macrophages this viral protein is able to manipulate both the TRAF/NF-kappa B and TRAF/IRF-3 signalling axes, thereby inducing the synthesis of proinflammatory cytokines and chemokines as well as IFN beta.	[Mangino, Giorgio; Percario, Zulema A.; Acconcia, Filippo; Chiarabelli, Cristiano; Leone, Stefano; Noto, Alessia; Polticelli, Fabio; Affabris, Elisabetta] Univ Roma Tre, Dept Biol, Rome, Italy; [Mangino, Giorgio; Romeo, Giovanna] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Rome, Italy; [Fiorucci, Gianna] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Vaccari, Gabriele] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Horenkamp, Florian A.; Manrique, Santiago; Geyer, Matthias] MPI Mol Physiol, Abt Phys Biochem, Dortmund, Germany	Roma Tre University; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Istituto Superiore di Sanita (ISS); Max Planck Society	Mangino, G (corresponding author), Univ Roma Tre, Dept Biol, Rome, Italy.	affabris@uniroma3.it	Polticelli, Fabio/A-4573-2009; Manrique, Santiago/B-2461-2012; Mangino, Giorgio/C-7310-2009; Acconcia, Filippo/AAB-6247-2022; Vaccari, Gabriele/A-9597-2010; Acconcia, Filippo/K-4960-2016; Romeo, Giovanna/AAB-2613-2019; Fiorucci, Gianna/B-3064-2013; romeo, giovanna/P-8348-2015	Polticelli, Fabio/0000-0002-7657-2019; Mangino, Giorgio/0000-0002-8950-9780; Acconcia, Filippo/0000-0002-4651-2509; Vaccari, Gabriele/0000-0003-0215-3521; romeo, giovanna/0000-0002-7638-1001; AFFABRIS, Elisabetta/0000-0001-5142-8144; Leone, Stefano/0000-0001-6339-6397; Geyer, Matthias/0000-0002-7718-5002	Italian National Research Program on AIDS of Istituto Superiore di Sanita, Rome, Italy [N.40.G1]; PRIN-MIUR (Progetti Rilevante Interesse Nazionale - Ministero dell'Universita' e della Ricerca Scientifica), Italy [prot.20072J9RWM_002]; Deutsche Forschungsgemeinschaft [GE-976/6]	Italian National Research Program on AIDS of Istituto Superiore di Sanita, Rome, Italy; PRIN-MIUR (Progetti Rilevante Interesse Nazionale - Ministero dell'Universita' e della Ricerca Scientifica), Italy(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Italian National Research Program on AIDS of Istituto Superiore di Sanita (Affabris N.40.G1), Rome, Italy, and from PRIN-MIUR (Progetti Rilevante Interesse Nazionale - Ministero dell'Universita' e della Ricerca Scientifica) 2007 (Affabris prot.20072J9RWM_002), Italy. Dr. Geyer is supported by a grant from the Deutsche Forschungsgemeinschaft (GE-976/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LW, 1983, INFECT IMMUN, V41, P837, DOI 10.1128/IAI.41.2.837-840.1983; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; Arold S, 2000, PROTEIN SCI, V9, P1137, DOI 10.1110/ps.9.6.1137; Baugh LL, 2008, J VIROL, V82, P9657, DOI 10.1128/JVI.00107-08; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Brink N, 2000, INFLAMM RES, V49, P290, DOI 10.1007/PL00000209; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; COGSWELL JP, 1994, J IMMUNOL, V153, P712; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Dow SW, 1999, J VIROL, V73, P6852, DOI 10.1128/JVI.73.8.6852-6861.1999; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Garcia MI, 2007, J VIROL, V81, P2663, DOI 10.1128/JVI.01733-06; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1986, J VIROL, V58, P67, DOI 10.1128/JVI.58.1.67-74.1986; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gulizia RJ, 1997, J VIROL, V71, P4161, DOI 10.1128/JVI.71.5.4161-4164.1997; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Keller C, 2003, J PHYSIOL-LONDON, V550, P927, DOI 10.1113/jphysiol.2003.044883; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KUPRASH DV, 1995, ONCOGENE, V11, P97; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Li H, 2002, AM J PHYSIOL-RENAL, V282, pF1020, DOI 10.1152/ajprenal.00291.2001; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Muroi M, 2008, J LEUKOCYTE BIOL, V83, P702, DOI 10.1189/jlb.0907629; NARAYAN O, 1980, J GEN VIROL, V50, P69, DOI 10.1099/0022-1317-50-1-69; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Sandberg M, 1997, J VIROL, V71, P4649, DOI 10.1128/JVI.71.6.4649-4656.1997; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; WIDMER U, 1993, J IMMUNOL, V150, P4996; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	64	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22982	10.1371/journal.pone.0022982	http://dx.doi.org/10.1371/journal.pone.0022982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886773	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500006
J	Pang, RD; Wang, Z; Klosinski, LP; Guo, YM; Herman, DH; Celikel, T; Dong, HW; Holschneider, DP				Pang, Raina D.; Wang, Zhuo; Klosinski, Lauren P.; Guo, Yumei; Herman, David H.; Celikel, Tansu; Dong, Hong Wei; Holschneider, Daniel P.			Mapping Functional Brain Activation Using [C-14]-Iodoantipyrine in Male Serotonin Transporter Knockout Mice	PLOS ONE			English	Article							ANXIETY-RELATED TRAITS; CEREBRAL BLOOD-FLOW; DEFICIENT MICE; 5-HTTLPR GENOTYPE; INDICATOR FRACTIONATION; VENTRAL HIPPOCAMPUS; GENETIC-VARIATION; FEAR EXTINCTION; OUT MICE; AMYGDALA	Background: Serotonin transporter knockout mice have been a powerful tool in understanding the role played by the serotonin transporter in modulating physiological function and behavior. However, little work has examined brain function in this mouse model. We tested the hypothesis that male knockout mice show exaggerated limbic activation during exposure to an emotional stressor, similar to human subjects with genetically reduced transcription of the serotonin transporter. Methodology/Principal Findings: Functional brain mapping using [C-14]-iodoantipyrine was performed during recall of a fear conditioned tone. Regional cerebral blood flow was analyzed by statistical parametric mapping from autoradiographs of the three-dimensionally reconstructed brains. During recall, knockout mice compared to wild-type mice showed increased freezing, increased regional cerebral blood flow of the amygdala, insula, and barrel field somatosensory cortex, decreased regional cerebral blood flow of the ventral hippocampus, and conditioning-dependent alterations in regional cerebral blood flow in the medial prefrontal cortex (prelimbic, infralimbic, and cingulate). Anxiety tests relying on sensorimotor exploration showed a small (open field) or paradoxical effect (marble burying) of loss of the serotonin transporter on anxiety behavior, which may reflect known abnormalities in the knockout animal's sensory system. Experiments evaluating whisker function showed that knockout mice displayed impaired whisker sensation in the spontaneous gap crossing task and appetitive gap cross training. Conclusions: This study is the first to demonstrate altered functional activation in the serotonin transporter knockout mice of critical nodes of the fear conditioning circuit. Alterations in whisker sensation and functional activation of barrel field somatosensory cortex extend earlier reports of barrel field abnormalities, which may confound behavioral measures relying on sensorimotor exploration.	[Pang, Raina D.; Klosinski, Lauren P.; Herman, David H.; Celikel, Tansu; Holschneider, Daniel P.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Wang, Zhuo; Guo, Yumei; Holschneider, Daniel P.] Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA USA; [Holschneider, Daniel P.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Celikel, Tansu; Holschneider, Daniel P.] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA USA; [Dong, Hong Wei] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pang, RD (corresponding author), Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.	holschne@usc.edu	Celikel, Tansu/P-4235-2018	Holschneider, Daniel/0000-0002-4297-8280; Wang, Zhuo/0000-0003-1531-8065	NARSAD: The Brain & Behavior Research Fund	NARSAD: The Brain & Behavior Research Fund	NARSAD: The Brain & Behavior Research Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baganz NL, 2008, P NATL ACAD SCI USA, V105, P18976, DOI 10.1073/pnas.0800466105; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; Bissiere S, 2008, BIOL PSYCHIAT, V63, P821, DOI 10.1016/j.biopsych.2007.10.022; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chubakov A R, 1993, Neurosci Behav Physiol, V23, P271, DOI 10.1007/BF01182928; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Dong H.W., 2008, ALLEN REFERENCE ATLA; Dubois A, 2008, NEUROIMAGE, V40, P482, DOI 10.1016/j.neuroimage.2007.11.054; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gorton LM, 2010, BEHAV BRAIN RES, V213, P253, DOI 10.1016/j.bbr.2010.05.009; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hansen N, 2011, NEUROSCI LETT, V495, P93, DOI 10.1016/j.neulet.2011.03.035; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Hohoff C, 2009, J NEURAL TRANSM, V116, P679, DOI 10.1007/s00702-009-0215-z; Hoistad M, 2008, NEUROIMAGE, V40, P1016, DOI 10.1016/j.neuroimage.2007.12.043; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Holschneider DP, 2008, METHODS, V45, P255, DOI 10.1016/j.ymeth.2008.04.006; Holschneider DP, 2010, GASTROENTEROLOGY, V138, pS765; Holschneider DP, 2004, NEUROSCI BIOBEHAV R, V28, P449, DOI 10.1016/j.neubiorev.2004.06.007; JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55; Kalueff AV, 2006, NEUROREPORT, V17, P1347, DOI 10.1097/01.wnr.0000230514.08962.76; Karg K., 2011, ARCH GEN PSYCHIAT; Katsuragi S, 1999, BIOL PSYCHIAT, V45, P368, DOI 10.1016/S0006-3223(98)00090-0; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Lee JH, 2005, INT J CONTROL AUTOM, V3, P32; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Linder AE, 2008, AM J PHYSIOL-HEART C, V294, pH1745, DOI 10.1152/ajpheart.91415.2007; Line SJ, 2011, EUR NEUROPSYCHOPHARM, V21, P108, DOI 10.1016/j.euroneuro.2010.08.005; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Lukoyanov NV, 2006, BEHAV BRAIN RES, V173, P229, DOI 10.1016/j.bbr.2006.06.026; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Matsumoto M, 2004, BRAIN RES, V1022, P221, DOI 10.1016/j.brainres.2004.06.078; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Petrovic P, 2004, J COGNITIVE NEUROSCI, V16, P1289, DOI 10.1162/0898929041920469; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416; VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67; Vogel C, 2003, J NEUROSCI, V23, P708, DOI 10.1523/JNEUROSCI.23-02-00708.2003; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303; Zhang WN, 2001, BEHAV BRAIN RES, V126, P159, DOI 10.1016/S0166-4328(01)00256-X; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9	70	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23869	10.1371/journal.pone.0023869	http://dx.doi.org/10.1371/journal.pone.0023869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886833	gold, Green Published, Green Submitted			2022-12-27	WOS:000294253500035
J	Tao, HR; Okamoto, M; Nishikawa, M; Yoshikawa, H; Myoui, A				Tao, Huiren; Okamoto, Mina; Nishikawa, Masataka; Yoshikawa, Hideki; Myoui, Akira			P38 Mitogen-Activated Protein Kinase Inhibitor, FR167653, Inhibits Parathyroid Hormone Related Protein-Induced Osteoclastogenesis and Bone Resorption	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CALCIUM-SENSING RECEPTOR; BREAST-CANCER CELLS; FACTOR-ALPHA; ANTIINFLAMMATORY COMPOUND; DIFFERENTIATION FACTOR; SUPPRESSIVE AGENT; SIGNALING PATHWAY; DUAL INHIBITOR; TNF-ALPHA	p38 mitogen-activated protein kinase (MAPK) acts downstream in the signaling pathway that includes receptor activator of NF-kappa B (RANK), a powerful inducer of osteoclast formation and activation. We investigated the role of p38 MAPK in parathyroid hormone related protein (PTHrP)-induced osteoclastogenesis in vitro and PTHrP-induced bone resorption in vivo. The ability of FR167653 to inhibit osteoclast formation was evaluated by counting the number of tartrate-resistant acid phosphatase positive multinucleated cells (TRAP-positive MNCs) in in vitro osteoclastgenesis assays. Its mechanisms were evaluated by detecting the expression level of c-Fos and nuclear factor of activated T cells c1 (NFATc1) in bone marrow macrophages(BMMs) stimulated with sRANKL and M-CSF, and by detecting the expression level of osteoprotegerin (OPG) and RANKL in bone marrow stromal cells stimulated with PTHrP in the presence of FR167653. The function of FR167653 on bone resorption was assessed by measuring the bone resorption area radiographically and by counting osteoclast number per unit bone tissue area in calvaria in a mouse model of bone resorption by injecting PTHrP subcutaneously onto calvaria. Whole blood ionized calcium levels were also recorded. FR167653 inhibited PTHrP-induced osteoclast formation and PTHrP-induced c-Fos and NFATc1 expression in bone marrow macrophages, but not the expression levels of RANKL and OPG in primary bone marrow stromal cells treated by PTHrP. Furthermore, bone resorption area and osteoclast number in vivo were significantly decreased by the treatment of FR167653. Systemic hypercalcemia was also partially inhibited. Inhibition of p38 MAPK by FR167653 blocks PTHrP-induced osteoclastogenesis in vitro and PTHrP-induced bone resorption in vivo, suggesting that the p38 MAPK signaling pathway plays a fundamental role in PTHrP-induced osteoclastic bone resorption.	[Tao, Huiren; Okamoto, Mina; Nishikawa, Masataka; Yoshikawa, Hideki; Myoui, Akira] Osaka Univ, Grad Sch Med, Dept Orthoped, Osaka, Japan; [Tao, Huiren] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China	Osaka University; Air Force Military Medical University	Tao, HR (corresponding author), Osaka Univ, Grad Sch Med, Dept Orthoped, Osaka, Japan.	myoi@hp-mctr.med.osaka-u.ac.jp	Myoui, Akira/E-8296-2010		Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandarajah AP, 2009, TRENDS ENDOCRIN MET, V20, P88, DOI 10.1016/j.tem.2008.10.007; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142; Brandstrom H, 1998, BIOCHEM BIOPH RES CO, V247, P338, DOI 10.1006/bbrc.1998.8783; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cau J, 2009, J VASC SURG, V49, P728, DOI 10.1016/j.jvs.2008.09.056; Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003; Furuichi K, 2002, NEPHROL DIAL TRANSPL, V17, P399, DOI 10.1093/ndt/17.3.399; Gardiner SM, 1999, J CARDIOVASC PHARM, V34, P64, DOI 10.1097/00005344-199907000-00011; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Hou ZS, 2003, HEPATOL RES, V26, P40, DOI 10.1016/S1386-6346(02)00334-0; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Jimi E, 2011, ORAL DIS, V17, P462, DOI 10.1111/j.1601-0825.2010.01781.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Morgan R, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-51; Morony S, 1999, J BONE MINER RES, V14, P1478, DOI 10.1359/jbmr.1999.14.9.1478; Mundy GR, 1998, NEW ENGL J MED, V339, P398, DOI 10.1056/NEJM199808063390609; Nishikawa M, 2003, ARTHRITIS RHEUM-US, V48, P2670, DOI 10.1002/art.11227; Nishikori T, 2002, EUR J PHARMACOL, V451, P327, DOI 10.1016/S0014-2999(02)02238-0; Startchik I, 2002, J BIOL CHEM, V277, P24265, DOI 10.1074/jbc.M110947200; Takahashi S, 2001, J PHARMACOL EXP THER, V296, P48; Tfelt-Hansen J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329, DOI 10.1152/ajpendo.00489.2002; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Wada T, 2000, J AM SOC NEPHROL, V11, P1534, DOI 10.1681/ASN.V1181534; WYSOLMERSKI JJ, 1994, ANNU REV MED, V45, P189, DOI 10.1146/annurev.med.45.1.189; Yamamoto N, 1997, EUR J PHARMACOL, V327, P169, DOI 10.1016/S0014-2999(97)89657-4; Yamamoto N, 1996, EUR J PHARMACOL, V314, P137, DOI 10.1016/S0014-2999(96)00537-7; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoshinari D, 2001, CRIT CARE MED, V29, P628, DOI 10.1097/00003246-200103000-00029	37	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23199	10.1371/journal.pone.0023199	http://dx.doi.org/10.1371/journal.pone.0023199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886782	gold, Green Published, Green Submitted			2022-12-27	WOS:000294253500011
J	Wang, JF; Reis, BY; Hu, MG; Christakos, G; Yang, WZ; Sun, Q; Li, ZJ; Li, XZ; Lai, SJ; Chen, HY; Wang, DC				Wang, Jin-Feng; Reis, Ben Y.; Hu, Mao-Gui; Christakos, George; Yang, Wei-Zhong; Sun, Qiao; Li, Zhong-Jie; Li, Xiao-Zhou; Lai, Sheng-Jie; Chen, Hong-Yan; Wang, Dao-Chen			Area Disease Estimation Based on Sentinel Hospital Records	PLOS ONE			English	Article							SELECTION BIAS; UNCERTAINTY	Background: Population health attributes (such as disease incidence and prevalence) are often estimated using sentinel hospital records, which are subject to multiple sources of uncertainty. When applied to these health attributes, commonly used biased estimation techniques can lead to false conclusions and ineffective disease intervention and control. Although some estimators can account for measurement error (in the form of white noise, usually after de-trending), most mainstream health statistics techniques cannot generate unbiased and minimum error variance estimates when the available data are biased. Methods and Findings: A new technique, called the Biased Sample Hospital-based Area Disease Estimation (B-SHADE), is introduced that generates space-time population disease estimates using biased hospital records. The effectiveness of the technique is empirically evaluated in terms of hospital records of disease incidence (for hand-foot-mouth disease and fever syndrome cases) in Shanghai (China) during a two-year period. The B-SHADE technique uses a weighted summation of sentinel hospital records to derive unbiased and minimum error variance estimates of area incidence. The calculation of these weights is the outcome of a process that combines: the available space-time information; a rigorous assessment of both, the horizontal relationships between hospital records and the vertical links between each hospital's records and the overall disease situation in the region. In this way, the representativeness of the sentinel hospital records was improved, the possible biases of these records were corrected, and the generated area incidence estimates were best linear unbiased estimates (BLUE). Using the same hospital records, the performance of the B-SHADE technique was compared against two mainstream estimators. Conclusions: The B-SHADE technique involves a hospital network-based model that blends the optimal estimation features of the Block Kriging method and the sample bias correction efficiency of the ratio estimator method. In this way, B-SHADE can overcome the limitations of both methods: Block Kriging's inadequacy concerning the correction of sample bias and spatial clustering; and the ratio estimator's limitation as regards error minimization. The generality of the B-SHADE technique is further demonstrated by the fact that it reduces to Block Kriging in the case of unbiased samples; to ratio estimator if there is no correlation between hospitals; and to simple statistic if the hospital records are neither biased nor space-time correlated. In addition to the theoretical advantages of the B-SHADE technique over the two other methods above, two real world case studies (hand-foot-mouth disease and fever syndrome cases) demonstrated its empirical superiority, as well.	[Wang, Jin-Feng; Hu, Mao-Gui; Li, Xiao-Zhou] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Reis, Ben Y.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Christakos, George] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Yang, Wei-Zhong; Li, Zhong-Jie; Lai, Sheng-Jie] Chinese Ctr Dis Control & Prevent CDC, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Sun, Qiao] Shanghai Pudong New Area Ctr Dis Control & Preven, Shanghai, Peoples R China; [Chen, Hong-Yan] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Wang, Dao-Chen] MGS, Manchester, Lancs, England	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Harvard University; Boston Children's Hospital; Harvard Medical School; California State University System; San Diego State University; Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; University of Liverpool	Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	wangjf@igsnrr.ac.cn	Yang, Wei/HIA-0360-2022; Hu, Maogui/N-7105-2013	Hu, Maogui/0000-0002-7671-7863; Lai, Shengjie/0000-0001-9781-8148; Christakos, George/0000-0002-1865-5764; Wang, Jinfeng/0000-0002-6687-9420	MOST, China [2009ZX10602-01-04, 2008BAI56B02, 2007DFC20180, 2007AA12Z233, 2006BAK01A13]; NSFC [41023010]; CAS, China [KZCX2-YW-308]	MOST, China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); CAS, China(Chinese Academy of Sciences)	This study was supported by MOST, China (2009ZX10602-01-04, 2008BAI56B02, 2007DFC20180, 2007AA12Z233; 2006BAK01A13), NSFC (41023010) and CAS, China (KZCX2-YW-308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler D, 2010, NATURE, V467, P1015, DOI 10.1038/4671015a; Christakos G., 1992, RANDOM FIELD MODELS; Christakos G., 2011, HDB REGIONAL SCI; Christakos G., 1998, SPATIOTEMPORAL ENV H; Christakos G, 2011, INTEGRATIVE PROBLEM-SOLVING IN A TIME OF DECADENCE, P1, DOI 10.1007/978-90-481-9890-0; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Haining R., 2003, SPATIAL DATA ANAL TH; Harris P, 2011, STOCH ENV RES RISK A, V25, P123, DOI 10.1007/s00477-010-0444-6; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hoffman J, 2010, NATURE, V467, P1043, DOI 10.1038/4671043a; Isaaks E.H., 1989, ISA; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mikler AR, 2007, STOCH ENV RES RISK A, V21, P533, DOI 10.1007/s00477-007-0137-y; Orton TG, 2007, STOCH ENV RES RISK A, V21, P773, DOI 10.1007/s00477-006-0089-7; Panlilio AL, 2004, INFECT CONT HOSP EP, V25, P556, DOI 10.1086/502439; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Reis BY, 2007, PLOS MED, V4, P1019, DOI 10.1371/journal.pmed.0040210; Reis BY, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3677; ROSENBERG W, 1995, BMJ-BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122; Saito H, 2005, STOCH ENV RES RISK A, V19, P71, DOI 10.1007/s00477-004-0207-3; SNOW J, 1855, MODEL COMMUNICATION; Torner A, 2010, AM J EPIDEMIOL, V171, P602, DOI 10.1093/aje/kwp432; Wang JF, 2010, INT J GEOGR INF SCI, V24, P523, DOI 10.1080/13658810902873512; YU HL, 2010, STOCH ENV RES RISK A, V25, P485, DOI DOI 10.1007/S00477-010-0417-9	25	26	33	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23428	10.1371/journal.pone.0023428	http://dx.doi.org/10.1371/journal.pone.0023428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886791	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500015
J	Inceoglu, O; Abu Al-Soud, W; Salles, JF; Semenov, AV; van Elsas, JD				Inceoglu, Oezguel; Abu Al-Soud, Waleed; Salles, Joana Falcao; Semenov, Alexander V.; van Elsas, Jan Dirk			Comparative Analysis of Bacterial Communities in a Potato Field as Determined by Pyrosequencing	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE-CHAIN-REACTION; MICROBIAL-POPULATIONS; SOIL TYPE; DIVERSITY; RHIZOSPHERE; PLANT; MANAGEMENT; TAXA; MEMBERS	Background: Plants selectively attract particular soil microorganisms, in particular consumers of root-excreted compounds. It is unclear to what extent cultivar type and/or growth stage affect this process. Methodology/Principal Findings: DNA-based pyrosequencing was used to characterize the structure of bacterial communities in a field cropped with potato. The rhizospheres of six cultivars denoted Aveka, Aventra, Karnico, Modena, Premiere and Desiree, at three growth stages (young, flowering and senescence) were examined, in addition to corresponding bulk soils. Around 350,000 sequences were obtained (5,700 to 38,000 per sample). Across all samples, rank abundance distributions best fitted the power law model, which indicates a community composed of a few highly dominant species next to numerous rare species. Grouping of the sequences showed that members of the Actinobacteria, Alphaproteobacteria, next to as-yet-unclassified bacteria, dominated. Other groups that were consistently found, albeit at lower abundance, were Beta-, Gamma- and Deltaproteobacteria and Acidobacteria. Principal components analyses revealed that rhizosphere samples were significantly different from corresponding bulk soil in each growth stage. Furthermore, cultivar effects were found in the young plant stage, whereas these became insignificant in the flowering and senescence stages. Besides, an effect of time of season was observed for both rhizosphere and bulk soils. The analyzed rhizosphere samples of the potato cultivars were grouped into two groups, in accordance with the allocation of carbon to starch in their tubers, i.e. Aveka, Aventra and Karnico (high) versus Premiere and Desiree (low) and thus replicates per group were established. Conclusions: Across all potato cultivars, the young plant stages revealed cultivar-dependent bacterial community structures, which disappeared in the flowering and senescence stages. Furthermore, Pseudomonas, Beta-, Alpha- and Deltaproteobacteria flourished under different ecological conditions than the Acidobacteria.	[Inceoglu, Oezguel; Salles, Joana Falcao; Semenov, Alexander V.; van Elsas, Jan Dirk] Univ Groningen, Ctr Life Sci, Dept Microbial Ecol, Groningen, Netherlands; [Abu Al-Soud, Waleed] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Groningen; University of Copenhagen	Inceoglu, O (corresponding author), Univ Groningen, Ctr Life Sci, Dept Microbial Ecol, Nijenborgh 7, Groningen, Netherlands.	J.D.van.Elsas@rug.nl	Salles, Joana Falcao/AAG-7070-2020; Abu Al-Soud, Waleed/K-4408-2014; Falcao Salles, Joana/A-7313-2008; Abu Al-Soud, Waleed/AAH-3477-2021; Abu Al-Soud, Waleed/K-4408-2014	Salles, Joana Falcao/0000-0003-4317-7263; Abu Al-Soud, Waleed/0000-0002-1143-9233; Falcao Salles, Joana/0000-0003-4317-7263; Abu Al-Soud, Waleed/0000-0002-1143-9233; Abu Al-Soud, Waleed/0000-0002-1488-4826	University of Groningen (RUG); Dutch science foundation (NWO)	University of Groningen (RUG); Dutch science foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	The University of Groningen (RUG) and the Dutch science foundation (NWO, under the ERGO programme) have supported this project. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Becker R, 2008, FEMS MICROBIOL ECOL, V66, P411, DOI 10.1111/j.1574-6941.2008.00562.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; da Rocha UN, 2010, J MICROBIOL METH, V83, P141, DOI 10.1016/j.mimet.2010.08.003; da Rocha UN, 2009, FEMS MICROBIOL ECOL, V69, P313, DOI 10.1111/j.1574-6941.2009.00702.x; da Silva KRA, 2003, J MICROBIOL METH, V54, P213, DOI 10.1016/S0167-7012(03)00039-3; de Vetten N, 2003, NAT BIOTECHNOL, V21, P439, DOI 10.1038/nbt801; Doroghazi JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002910; Duineveld BM, 1998, APPL ENVIRON MICROB, V64, P4950; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gelsomino A, 1999, J MICROBIOL METH, V38, P1, DOI 10.1016/S0167-7012(99)00054-8; Germida JJ, 2001, BIOL FERT SOILS, V33, P410, DOI 10.1007/s003740100343; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; Hamp TJ, 2009, APPL ENVIRON MICROB, V75, P3263, DOI 10.1128/AEM.01931-08; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kielak A, 2009, ISME J, V3, P378, DOI 10.1038/ismej.2008.113; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Magurran A.E., 1983, ECOLOGICAL DIVERSITY; Magurran AE, 2008, MEASURING BIOL DIVER; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nannipieri P., 2008, V15, P339; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Pueyo S, 2006, OIKOS, V112, P392, DOI 10.1111/j.0030-1299.2006.14188.x; RICHARDS B, 1987, MICROBIAL TERRESTRIA; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Salles JF, 2006, MICROB ECOL, V52, P267, DOI 10.1007/s00248-006-9048-6; Schloss P.D., 2009, APPL ENV MICROBIOL; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Sorensen J., 2006, MODERN SOIL MICROBIO; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	55	160	163	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23321	10.1371/journal.pone.0023321	http://dx.doi.org/10.1371/journal.pone.0023321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886785	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100010
J	Kasang, C; Kalluvya, S; Majinge, C; Stich, A; Bodem, J; Kongola, G; Jacobs, GB; Mlewa, M; Mildner, M; Hensel, I; Horn, A; Preiser, W; van Zyl, G; Klinker, H; Koutsilieri, E; Rethwilm, A; Scheller, C; Weissbrich, B				Kasang, Christa; Kalluvya, Samuel; Majinge, Charles; Stich, August; Bodem, Jochen; Kongola, Gilbert; Jacobs, Graeme B.; Mlewa, Mathias; Mildner, Miriam; Hensel, Irina; Horn, Anne; Preiser, Wolfgang; van Zyl, Gert; Klinker, Hartwig; Koutsilieri, Eleni; Rethwilm, Axel; Scheller, Carsten; Weissbrich, Benedikt			HIV Drug Resistance (HIVDR) in Antiretroviral Therapy-Naive Patients in Tanzania Not Eligible for WHO Threshold HIVDR Survey Is Dramatically High	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; TRANSMITTED HIV; SOUTH-AFRICA; SURVEILLANCE; MUTATIONS; PHARMACOKINETICS; POPULATIONS; PERFORMANCE; DIVERSITY	Background: The World Health Organization (WHO) has recommended guidelines for a HIV drug resistance (HIVDR) survey for resource-limited countries. Eligibility criteria for patients include age below 25 years in order to focus on the prevalence of transmitted HIVDR (tHIVDR) in newly-infected individuals. Most of the participating sites across Africa have so far reported tHIVDR prevalences of below 5%. In this study we investigated whether the rate of HIVDR in patients <25 years is representative for HIVDR in the rest of the therapy-naive population. Methods and Findings: HIVDR was determined in 88 sequentially enrolled ART-naive patients from Mwanza, Tanzania (mean age 35.4 years). Twenty patients were aged <25 years and 68 patients were aged 25-63 years. The frequency of HIVDR in the study population was 14.8% (95%; CI 0.072-0.223) and independent of NVP-resistance induced by prevention of mother-to-child transmission programs. Patients >25 years had a significantly higher HIVDR frequency than younger patients (19.1%; 95% CI 0.095-0.28) versus 0%, P = 0.0344). In 2 out of the 16 patients with HIVDR we found traces of antiretrovirals (ARVs) in plasma. Conclusions: ART-naive patients aged over 25 years exhibited significantly higher HIVDR than younger patients. Detection of traces of ARVs in individuals with HIVDR suggests that besides transmission, undisclosed misuse of ARVs may constitute a significant factor in the generation of the observed high HIVDR rate. The current WHO tHIVDR survey that is solely focused on the transmission of HIVDR and that excludes patients over 25 years of age may therefore result in substantial underestimation of the prevalence of HIVDR in the therapy-naive population. Similar studies should be performed also in other areas to test whether the so far reported optimistic picture of low HIVDR prevalence in young individuals is really representative for the rest of the ART-naive HIV-infected population.	[Kasang, Christa; Bodem, Jochen; Jacobs, Graeme B.; Mildner, Miriam; Hensel, Irina; Horn, Anne; Koutsilieri, Eleni; Rethwilm, Axel; Scheller, Carsten; Weissbrich, Benedikt] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Kalluvya, Samuel; Majinge, Charles; Mlewa, Mathias] Bugando Med Ctr, Mwanza, Tanzania; [Kalluvya, Samuel; Kongola, Gilbert] BUCHS, Mwanza, Tanzania; [Stich, August] Med Mission Inst, Wurzburg, Germany; [Preiser, Wolfgang; van Zyl, Gert] Univ Stellenbosch, Div Med Virol, Dept Pathol, Natl Hlth Lab Serv, Cape Town, South Africa; [Klinker, Hartwig] Univ Wurzburg, Dept Internal Med, Div Infect Dis, D-8700 Wurzburg, Germany	University of Wurzburg; Stellenbosch University; University of Cape Town; University of Wurzburg	Kasang, C (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	scheller@vim.uni-wuerzburg.de	Klinker, Hartwig/AAC-1134-2021; Bodem, Jochen/H-9122-2019; Preiser, Wolfgang/J-4875-2016; van Zyl, Gert/I-7357-2019; Kasang, Christa/AAW-5048-2021	Bodem, Jochen/0000-0003-1908-4091; Preiser, Wolfgang/0000-0002-0254-7910; van Zyl, Gert/0000-0003-3021-5101; Kasang, Christa/0000-0003-0241-0321; Jacobs, Graeme/0000-0002-3259-1496	Deutsche Forschungsgemeinschaft [DFG IRTG 1522]; German Leprosy and Tuberculosis Relief Association; Evangelisches Studienwerk e.V. Villigst; Deutscher Akademischer Austauschdienst; Bayerische Staatsregierung; Gesellschaft fur AIDS-Forschung e.V. (Gottingen); University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Leprosy and Tuberculosis Relief Association; Evangelisches Studienwerk e.V. Villigst; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Bayerische Staatsregierung; Gesellschaft fur AIDS-Forschung e.V. (Gottingen); University of Wuerzburg	The study was funded by Deutsche Forschungsgemeinschaft (www.dfg.de; DFG IRTG 1522), German Leprosy and Tuberculosis Relief Association (www.dahw.de), Evangelisches Studienwerk e.V. Villigst (www.evstudienwerk.de), Deutscher Akademischer Austauschdienst (www.daad.de), Bayerische Staatsregierung (www.bayern.de), and Gesellschaft fur AIDS-Forschung e.V. (Gottingen, no URL). Publication costs were covered by Deutsche Forschungsgemeinschaft (www.dfg.de) and the University of Wuerzburg (www.uni-wuerzburg.de) by the funding programme "Open Access Publishing.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayouba A, 2009, AIDS RES HUM RETROV, V25, P1193, DOI 10.1089/aid.2009.0142; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Deeks SG, 2008, PLOS MED, V5, P1014, DOI 10.1371/journal.pmed.0050164; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Haas DW, 2009, J INFECT DIS, V199, P872, DOI 10.1086/597125; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P1009, DOI 10.1089/aid.2008.0028; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; *JOINT UN PROGR HI, 2007, FIN RES REQ ACH UN A, V3; Kamoto K, 2008, ANTIVIR THER, V13, P83; Langmann P, 2008, EUR J MED RES, V13, P52; Langmann P, 2002, EUR J MED RES, V7, P309; Maphalala G, 2008, ANTIVIR THER, V13, P95; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Nyombi Balthazar M, 2008, AIDS Res Ther, V5, P13, DOI 10.1186/1742-6405-5-13; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith PF, 2001, CLIN PHARMACOKINET, V40, P893, DOI 10.2165/00003088-200140120-00002; Somi GR, 2008, ANTIVIR THER, V13, P77; *STANDF U, STANDF U DRUG RES DA; *WHO, WHO HIVDR STAT REP; *WHO, 2010, WHO PROGR REP; NATL GUIDELINES MANA	30	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23091	10.1371/journal.pone.0023091	http://dx.doi.org/10.1371/journal.pone.0023091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886779	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100006
J	Seto, KC; Fragkias, M; Guneralp, B; Reilly, MK				Seto, Karen C.; Fragkias, Michail; Gueneralp, Burak; Reilly, Michael K.			A Meta-Analysis of Global Urban Land Expansion	PLOS ONE			English	Article							CLIMATE-CHANGE; COASTAL ZONES; UNITED-STATES; IMPACT; AREAS; CITIES; ENERGY; TRAVEL; RAIN	The conversion of Earth's land surface to urban uses is one of the most irreversible human impacts on the global biosphere. It drives the loss of farmland, affects local climate, fragments habitats, and threatens biodiversity. Here we present a meta-analysis of 326 studies that have used remotely sensed images to map urban land conversion. We report a worldwide observed increase in urban land area of 58,000 km(2) from 1970 to 2000. India, China, and Africa have experienced the highest rates of urban land expansion, and the largest change in total urban extent has occurred in North America. Across all regions and for all three decades, urban land expansion rates are higher than or equal to urban population growth rates, suggesting that urban growth is becoming more expansive than compact. Annual growth in GDP per capita drives approximately half of the observed urban land expansion in China but only moderately affects urban expansion in India and Africa, where urban land expansion is driven more by urban population growth. In high income countries, rates of urban land expansion are slower and increasingly related to GDP growth. However, in North America, population growth contributes more to urban expansion than it does in Europe. Much of the observed variation in urban expansion was not captured by either population, GDP, or other variables in the model. This suggests that contemporary urban expansion is related to a variety of factors difficult to observe comprehensively at the global level, including international capital flows, the informal economy, land use policy, and generalized transport costs. Using the results from the global model, we develop forecasts for new urban land cover using SRES Scenarios. Our results show that by 2030, global urban land cover will increase between 430,000 km(2) and 12,568,000 km(2), with an estimate of 1,527,000 km(2) more likely.	[Seto, Karen C.; Gueneralp, Burak] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT 06520 USA; [Fragkias, Michail] Arizona State Univ, Int Human Dimens Programme Global Environm Change, Urbanizat & Global Environm Change Project, Global Inst Sustainabil, Tempe, AZ USA; [Reilly, Michael K.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	Yale University; Arizona State University; Arizona State University-Tempe; Stanford University	Seto, KC (corresponding author), Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT 06520 USA.	karen.seto@yale.edu	Seto, Karen C./C-2722-2008; Guneralp, Burak/Y-3616-2019; Fragkias, Michail/B-5785-2008	Seto, Karen C./0000-0002-4928-2446; Guneralp, Burak/0000-0002-5825-0630; 	NSF	NSF(National Science Foundation (NSF))	Part of this work was funded by NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Bento AM, 2005, REV ECON STAT, V87, P466, DOI 10.1162/0034653054638292; Brownstone D, 2009, J URBAN ECON, V65, P91, DOI 10.1016/j.jue.2008.09.002; Center for International Earth Science Information Network (CIESIN), 2002, COUNTR LEV POP DOWNS; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gerxhani K, 2004, PUBLIC CHOICE, V120, P267, DOI 10.1023/B:PUCH.0000044287.88147.5e; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; *NAT BUR STAT P R, CHIN STAT YB NBS; National Research Council, 2009, DRIV BUILT ENV EFF C; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; PERLSTEIN A, CHINA BOOM IN PRESS; Potere D, 2007, GEOJOURNAL, V69, P55, DOI 10.1007/s10708-007-9102-z; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Seto KC, 2000, NATURE, V406, P121, DOI 10.1038/35018267; Shepherd JM, 2002, J APPL METEOROL, V41, P689, DOI 10.1175/1520-0450(2002)041<0689:RMBMUA>2.0.CO;2; UN, 2008, WORLD URB PROSP 2007; Vance C, 2007, TRANSPORTATION, V34, P575, DOI 10.1007/s11116-007-9128-6	22	1209	1285	47	486	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23777	10.1371/journal.pone.0023777	http://dx.doi.org/10.1371/journal.pone.0023777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810LN	21876770	Green Published, gold			2022-12-27	WOS:000294126900042
J	Etienne-Mesmin, L; Chassaing, B; Sauvanet, P; Denizot, J; Blanquet-Diot, S; Darfeuille-Michaud, A; Pradel, N; Livrelli, V				Etienne-Mesmin, Lucie; Chassaing, Benoit; Sauvanet, Pierre; Denizot, Jeremy; Blanquet-Diot, Stephanie; Darfeuille-Michaud, Arlette; Pradel, Nathalie; Livrelli, Valerie			Interactions with M Cells and Macrophages as Key Steps in the Pathogenesis of Enterohemorragic Escherichia coli Infections	PLOS ONE			English	Article							LONG POLAR FIMBRIAE; PEYERS PATCH; SALMONELLA-TYPHIMURIUM; TISSUE TROPISM; O157-H7; EXPRESSION; STRAINS; TRANSLOCATION; COLONIZATION; ADHESION	Enterohemorrhagic Escherichia coli (EHEC) are food-borne pathogens that can cause serious infections ranging from diarrhea to hemorrhagic colitis (HC) and hemolytic-uremic syndrome (HUS). Translocation of Shiga-toxins (Stx) from the gut lumen to underlying tissues is a decisive step in the development of the infection, but the mechanisms involved remain unclear. Many bacterial pathogens target the follicle-associated epithelium, which overlies Peyer's patches (PPs), cross the intestinal barrier through M cells and are captured by mucosal macrophages. Here, translocation across M cells, as well as survival and proliferation of EHEC strains within THP-1 macrophages were investigated using EHEC O157:H7 reference strains, isogenic mutants, and 15 EHEC strains isolated from HC/HUS patients. We showed for the first time that E. coli O157:H7 strains are able to interact in vivo with murine PPs, to translocate ex vivo through murine ileal mucosa with PPs and across an in vitro human M cell model. EHEC strains are also able to survive and to produce Stx in macrophages, which induce cell apoptosis and Stx release. In conclusion, our results suggest that the uptake of EHEC by M cells and underlying macrophages in the PP may be a critical step in Stx translocation and release in vivo. A new model for EHEC infection in humans is proposed that could help in a fuller understanding of EHEC-associated diseases.	[Etienne-Mesmin, Lucie; Chassaing, Benoit; Sauvanet, Pierre; Denizot, Jeremy; Darfeuille-Michaud, Arlette; Pradel, Nathalie; Livrelli, Valerie] Univ Auvergne, Clermont Univ, Ctr Rech Nutr Humaine Auvergne, JE Evolut Bacteries Pathogenes & Susceptibil Gene, Clermont Ferrand, France; [Etienne-Mesmin, Lucie; Chassaing, Benoit; Sauvanet, Pierre; Denizot, Jeremy; Darfeuille-Michaud, Arlette; Pradel, Nathalie; Livrelli, Valerie] INRA, Unite Contrat USC 2018, Clermont Ferrand, France; [Etienne-Mesmin, Lucie; Blanquet-Diot, Stephanie] Univ Auvergne, Clermont Univ, Ctr Rech Nutr Humaine Auvergne, ERT 18, Clermont Ferrand, France; [Etienne-Mesmin, Lucie; Blanquet-Diot, Stephanie; Livrelli, Valerie] Univ Auvergne, Clermont Univ, UFR Pharm, Clermont Ferrand, France; [Livrelli, Valerie] CHU Clermont Ferrand, Serv Bacteriol Mycol Parasitol, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); INRAE; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Etienne-Mesmin, L (corresponding author), Univ Auvergne, Clermont Univ, Ctr Rech Nutr Humaine Auvergne, JE Evolut Bacteries Pathogenes & Susceptibil Gene, Clermont Ferrand, France.	valerie.livrelli@u-clermont1.fr	Etienne-Mesmin, Lucie/AAD-3754-2019; Blanquet-Diot, Stéphanie/AAD-3759-2019; Chassaing, Benoit/R-3819-2017	Etienne-Mesmin, Lucie/0000-0001-6104-6043; Chassaing, Benoit/0000-0002-4285-769X; Denizot, Jeremy/0000-0003-0078-8996	Ministere de l'Enseignement Superieur et de la Recherche [JE2526]; Institut National de Recherche Agronomique [USC-2018]	Ministere de l'Enseignement Superieur et de la Recherche; Institut National de Recherche Agronomique	This study was supported by grants from the Ministere de l'Enseignement Superieur et de la Recherche (JE2526) (http://www.enseignementsuprecherche.gouv.fr/) and by the Institut National de Recherche Agronomique (USC-2018) (http://www.inra.fr/). There are no grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumler AJ, 1996, P NATL ACAD SCI USA, V93, P279, DOI 10.1073/pnas.93.1.279; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Beutin L, 2006, J VET MED B, V53, P299, DOI 10.1111/j.1439-0450.2006.00968.x; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Chong YW, 2007, MICROBIOL-SGM, V153, P794, DOI 10.1099/mic.0.2006/003178-0; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; DeVinney R, 2001, MOL MICROBIOL, V41, P1445, DOI 10.1046/j.1365-2958.2001.02617.x; Doughty S, 2002, INFECT IMMUN, V70, P6761, DOI 10.1128/IAI.70.12.6761-6769.2002; Etienne-Mesmin L, 2011, APPL ENVIRON MICROB, V77, P1127, DOI 10.1128/AEM.02130-10; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Fitzhenry R, 2006, MICROBES INFECT, V8, P1741, DOI 10.1016/j.micinf.2006.02.012; Frank C, 2011, N ENGL J ME IN PRESS; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Hamzaoui N, 2004, CELL MICROBIOL, V6, P817, DOI 10.1111/j.1462-5822.2004.00391.x; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; HITOTSUBASHI S, 1992, INFECT IMMUN, V60, P4468, DOI 10.1128/IAI.60.11.4468-4474.1992; Hurley BP, 2001, INFECT IMMUN, V69, P6148, DOI 10.1128/IAI.69.10.6148-6155.2001; INMAN LR, 1983, J CLIN INVEST, V71, P1, DOI 10.1172/JCI110737; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Lee SH, 2008, BIOMED MICRODEVICES, V10, P1, DOI 10.1007/s10544-007-9104-0; Lee SY, 2007, INFECT IMMUN, V75, P1291, DOI 10.1128/IAI.01700-06; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; Martinez-Argudo I, 2007, CELL MICROBIOL, V9, P1538, DOI 10.1111/j.1462-5822.2007.00891.x; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Phillips AD, 2000, GUT, V47, P377, DOI 10.1136/gut.47.3.377; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Pradel N, 2000, J CLIN MICROBIOL, V38, P1023, DOI 10.1128/JCM.38.3.1023-1031.2000; Pradel N, 2002, APPL ENVIRON MICROB, V68, P2316, DOI 10.1128/AEM.68.5.2316-2325.2002; Pradel N, 2008, APPL ENVIRON MICROB, V74, P2118, DOI 10.1128/AEM.02688-07; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Roberts CL, 2010, GUT, V59, P1331, DOI 10.1136/gut.2009.195370; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Struelens MJ, 2011, EURO SURVEILL, V16; TARR PI, 1989, J INFECT DIS, V159, P344, DOI 10.1093/infdis/159.2.344; Torres AG, 2008, INFECT IMMUN, V76, P5062, DOI 10.1128/IAI.00654-08; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7	46	40	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23594	10.1371/journal.pone.0023594	http://dx.doi.org/10.1371/journal.pone.0023594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858177	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300066
J	Korenstein, D; Keyhani, S; Mendelson, A; Ross, JS				Korenstein, Deborah; Keyhani, Salomeh; Mendelson, Ali; Ross, Joseph S.			Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines and Content for Safe Prescribing	PLOS ONE			English	Article							DRUG ADVERTISEMENTS; ACCURACY; QUALITY; PATIENT; LAW	Background: Physician-directed pharmaceutical advertising is regulated in the United States by the Food and Drug Administration (FDA); adherence to current FDA guidelines is unknown. Our objective was to determine adherence rates of physician-directed print advertisements in biomedical journals to FDA guidelines and describe content important for safe prescribing. Methods and Findings: Cross-sectional analysis of November 2008 pharmaceutical advertisements within top U. S.-based biomedical journals publishing original research. We excluded advertisements for devices, over the counter medications, and disease awareness. We utilized FDA guideline items identifying unique forms of advertisement bias to categorize advertisements as adherent to FDA guidelines, possibly non-adherent to at least 1 item, or non-adherent to at least 1 item. We also evaluated advertisement content important for safe prescribing, including benefit quantification, risk information and verifiable references. All advertisements were evaluated by 2 or more investigators, with differences resolved by discussion. Twelve journals met inclusion criteria. Nine contained pharmaceutical advertisements, including 192 advertisements for 82 unique products; median 2 per product (range 1-14). Six "teaser" advertisements presented only drug names, leaving 83 full unique advertisements. Fifteen advertisements (18.1%) adhered to all FDA guidelines, 41 (49.4%) were non-adherent with at least one form of FDA-described bias, and 27 (32.5%) were possibly non-adherent due to incomplete information. Content important for safe prescribing was often incomplete; 57.8% of advertisements did not quantify serious risks, 48.2% lacked verifiable references and 28.9% failed to present adequate efficacy quantification. Study limitations included its focus on advertisements from a single month, the subjectivity of FDA guidelines themselves, and the necessary subjectivity of determinations of adherence. Conclusions: Few physician-directed print pharmaceutical advertisements adhere to all FDA guidelines; over half fail to quantify serious risks. The FDA could better protect public health by creating new more objective advertisement guidelines requiring transparent presentation of basic safety and efficacy information.	[Korenstein, Deborah] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Keyhani, Salomeh] Mt Sinai Sch Med, Dept Hlth Evidence & Policy, New York, NY USA; [Keyhani, Salomeh] James J Peters VA Med Ctr, HSR&D Res Enhancement Award Program, Bronx, NY USA; [Keyhani, Salomeh] James J Peters VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; [Mendelson, Ali] Weill Cornell Med Coll, New York, NY USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Cornell University; Yale University; Yale University	Korenstein, D (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	deborah.korenstein@mssm.edu	Mendelson, Ali/O-8915-2019	Ross, Joseph/0000-0002-9218-3320	NIA NIH HHS [K08 AG032886] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brody H, 2011, AM J PUBLIC HEALTH, V101, P399, DOI 10.2105/AJPH.2010.199844; Dubois Robert W., 2003, HLTH AFFAIRS WEB E W, VW3, P96; *FDA, 2001, PRESCR DRUG ADV; Fugh-Berman A, 2006, PLOS MED, V3, P762, DOI 10.1371/journal.pmed.0030130; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Hamburg MA, COMMUNICATION; Korenstein D, 2010, ARCH SURG-CHICAGO, V145, P570, DOI 10.1001/archsurg.2010.75; Lankinen KS, 2004, PHARMACOEPIDEM DR S, V13, P789, DOI 10.1002/pds.1017; Lexchin J, 1999, CAN FAM PHYSICIAN, V45, P1213; McAlister FA, 2000, JAMA-J AM MED ASSOC, V283, P2829, DOI 10.1001/jama.283.21.2829; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; Mindell J, 1997, BRIT MED J, V315, P1622; Montgomery BD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-167; Neslin S, 2001, RAPP STUDY EXECUTIVE; Norris P, 2004, EDM RES SERIES, V032; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Santiago MG, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-61; Shuchman M, 2007, NEW ENGL J MED, V356, P2236, DOI 10.1056/NEJMp078080; Smart S, 1997, BRIT MED J, V315, P1622; Spielmans GI, 2008, J NERV MENT DIS, V196, P267, DOI 10.1097/NMD.0b013e31816a436b; Spiller L D, 2001, Health Mark Q, V19, P91, DOI 10.1300/J026v19n01_07; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; THAUL S, 2009, R40590 CONGR RES SER; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912	25	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23336	10.1371/journal.pone.0023336	http://dx.doi.org/10.1371/journal.pone.0023336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858076	Green Submitted, gold, Green Published			2022-12-27	WOS:000294121300037
J	Nyuyki, KD; Waldherr, M; Baeuml, S; Neumann, ID				Nyuyki, Kewir D.; Waldherr, Martin; Baeuml, Sandra; Neumann, Inga D.			Yes, I Am Ready Now: Differential Effects of Paced versus Unpaced Mating on Anxiety and Central Oxytocin Release in Female Rats	PLOS ONE			English	Article							PENILE-VAGINAL INTERCOURSE; RECEPTOR MESSENGER-RNA; SEXUAL-BEHAVIOR; PARAVENTRICULAR NUCLEUS; ESTROUS-CYCLE; STRESS; DOPAMINE; BRAIN; HYPOTHALAMUS; VASOPRESSIN	Sexual activity and partner intimacy results in several positive consequences in the context of stress-coping, both in males and females, such as reduced state anxiety in male rats after successful mating. However, in female rats, mating is a rewarding experience only when the estrous female is able to control sexual interactions, i.e., under paced-mating conditions. Here, we demonstrate that sex-steroid priming required for female mating is anxiolytic; subsequent sexual activity under paced mating conditions did not disrupt this anxiolytic priming effect, whereas mating under unpaced conditions increased anxiety-related behavior. In primed females, the release of the neuropeptide oxytocin (OT) within the hypothalamic paraventricular nucleus was found to be elevated and to further increase during paced, but not unpaced mating. Central administration of an OT receptor antagonist partly prevented priming/mating-induced anxiolysis indicating the involvement of brain OT in the anxiolysis triggered by priming and/or sexual activity. These findings reveal that the positive consequences of mating in females are dependent on her ability to control sexual interactions, and that brain OT release is at least in part the underlying neurobiological correlate.	[Nyuyki, Kewir D.; Waldherr, Martin; Baeuml, Sandra; Neumann, Inga D.] Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Bavaria, Germany	University of Regensburg	Nyuyki, KD (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Bavaria, Germany.	inga.neumann@biologie.uni-regensburg.de			Bayerische Forschungsstiftung (BFS); Federal Ministry of Education and Research (BMBF); German Research Foundation (DFG)	Bayerische Forschungsstiftung (BFS); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support from the Bayerische Forschungsstiftung (BFS) (KN), Federal Ministry of Education and Research (BMBF) (IDN) and German Research Foundation (DFG) (IDN) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiolas A, 2004, PHYSIOL BEHAV, V83, P309, DOI 10.1016/j.physbeh.2004.08.019; BALE TL, 1995, J NEUROSCI, V15, P5058; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; BEACH FA, 1976, HORM BEHAV, V7, P105, DOI 10.1016/0018-506X(76)90008-8; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Brody S, 2006, BIOL PSYCHOL, V71, P214, DOI 10.1016/j.biopsycho.2005.03.005; Brody S, 2008, MED HYPOTHESES, V71, P812, DOI 10.1016/j.mehy.2008.06.009; CALDWELL JD, 1986, NEUROPEPTIDES, V7, P175, DOI 10.1016/0143-4179(86)90093-4; CARMICHAEL MS, 1987, J CLIN ENDOCR METAB, V64, P27, DOI 10.1210/jcem-64-1-27; Costa RM, 2007, J SEX MARITAL THER, V33, P319, DOI 10.1080/00926230701385548; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Ditzen B, 2008, PSYCHOSOM MED, V70, P883, DOI 10.1097/PSY.0b013e318185c4fc; FLANAGAN LM, 1993, NEUROENDOCRINOLOGY, V58, P352, DOI 10.1159/000126562; Frye CA, 2008, BEHAV BRAIN RES, V187, P88, DOI 10.1016/j.bbr.2007.08.031; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gonzalez-Flores O, 2004, HORM BEHAV, V46, P151, DOI 10.1016/j.yhbeh.2004.02.006; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hirata H, 2007, PEPTIDES, V28, P1998, DOI 10.1016/j.peptides.2007.07.024; Kelley AE, 2002, J NEUROSCI, V22, P3306; LANDGRAF R, 1995, EUR J NEUROSCI, V7, P592, DOI 10.1111/j.1460-9568.1995.tb00663.x; Liberzon I, 1997, NEUROPSYCHOPHARMACOL, V17, P353, DOI 10.1016/S0893-133X(97)00070-5; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Martinez I, 2001, HORM BEHAV, V40, P510, DOI 10.1006/hbeh.2001.1712; MCCLINTOCK MK, 1978, BEHAVIOUR, V67, P67, DOI 10.1163/156853978X00260; McGregor IS, 2008, BRIT J PHARMACOL, V154, P358, DOI 10.1038/bjp.2008.132; Melis MR, 2007, EUR J NEUROSCI, V26, P1026, DOI 10.1111/j.1460-9568.2007.05721.x; MENDELSON SD, 1987, PHYSIOL BEHAV, V39, P67, DOI 10.1016/0031-9384(87)90345-3; Mora S, 1996, PSYCHONEUROENDOCRINO, V21, P609, DOI 10.1016/S0306-4530(96)00015-7; NEUMANN I, 1993, NEUROSCIENCE, V53, P65, DOI 10.1016/0306-4522(93)90285-N; Neumann I D, 2001, Prog Brain Res, V133, P143; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Neumann ID, 1998, J PHYSIOL-LONDON, V508, P289, DOI 10.1111/j.1469-7793.1998.289br.x; Neumann ID, 2009, FRONT NEUROENDOCRIN, V30, P483, DOI 10.1016/j.yfrne.2009.04.012; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Paredes RG, 1997, BEHAV NEUROSCI, V111, P123, DOI 10.1037/0735-7044.111.1.123; Paredes RG, 2001, BEHAV NEUROSCI, V115, P1363, DOI 10.1037//0735-7044.115.6.1363; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfaff D W, 1999, Results Probl Cell Differ, V26, P91; Pfaus JG, 1999, HORM BEHAV, V35, P224, DOI 10.1006/hbeh.1999.1516; Polston EK, 1998, ENDOCRINOLOGY, V139, P4849, DOI 10.1210/en.139.12.4849; Randall-Thompson JF, 2010, PSYCHOPHARMACOLOGY, V212, P585, DOI 10.1007/s00213-010-1980-y; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Sansone GR, 2002, NEUROENDOCRINOLOGY, V75, P306, DOI 10.1159/000057340; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Young LJ, 1997, J NEUROENDOCRINOL, V9, P859, DOI 10.1046/j.1365-2826.1997.00654.x	49	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23599	10.1371/journal.pone.0023599	http://dx.doi.org/10.1371/journal.pone.0023599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858181	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500037
J	Sauder, LA; Engel, K; Stearns, JC; Masella, AP; Pawliszyn, R; Neufeld, JD				Sauder, Laura A.; Engel, Katja; Stearns, Jennifer C.; Masella, Andre P.; Pawliszyn, Richard; Neufeld, Josh D.			Aquarium Nitrification Revisited: Thaumarchaeota Are the Dominant Ammonia Oxidizers in Freshwater Aquarium Biofilters	PLOS ONE			English	Article							MESOPHILIC CRENARCHAEOTA; NITRIFYING ARCHAEA; BACTERIA; MARINE; OXIDATION; DIVERSITY; COMMUNITY; ABUNDANCE; PROKARYOTES; GENES	Ammonia-oxidizing archaea (AOA) outnumber ammonia-oxidizing bacteria (AOB) in many terrestrial and aquatic environments. Although nitrification is the primary function of aquarium biofilters, very few studies have investigated the microorganisms responsible for this process in aquaria. This study used quantitative real-time PCR (qPCR) to quantify the ammonia monooxygenase (amoA) and 16S rRNA genes of Bacteria and Thaumarchaeota in freshwater aquarium biofilters, in addition to assessing the diversity of AOA amoA genes by denaturing gradient gel electrophoresis (DGGE) and clone libraries. AOA were numerically dominant in 23 of 27 freshwater biofilters, and in 12 of these biofilters AOA contributed all detectable amoA genes. Eight saltwater aquaria and two commercial aquarium nitrifier supplements were included for comparison. Both thaumarchaeal and bacterial amoA genes were detected in all saltwater samples, with AOA genes outnumbering AOB genes in five of eight biofilters. Bacterial amoA genes were abundant in both supplements, but thaumarchaeal amoA and 16S rRNA genes could not be detected. For freshwater aquaria, the proportion of amoA genes from AOA relative to AOB was inversely correlated with ammonium concentration. DGGE of AOA amoA genes revealed variable diversity across samples, with nonmetric multidimensional scaling (NMDS) indicating separation of freshwater and saltwater fingerprints. Composite clone libraries of AOA amoA genes revealed distinct freshwater and saltwater clusters, as well as mixed clusters containing both freshwater and saltwater amoA gene sequences. These results reveal insight into commonplace residential biofilters and suggest that aquarium biofilters may represent valuable biofilm microcosms for future studies of AOA ecology.	[Sauder, Laura A.; Engel, Katja; Stearns, Jennifer C.; Masella, Andre P.; Pawliszyn, Richard; Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Sauder, LA (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	jneufeld@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Andrews C., 1988, MANUAL FISH HLTH; Bartram AK, 2009, BIOTECHNIQUES, V47, P1016, DOI 10.2144/000113276; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Burrell PC, 2001, APPL ENVIRON MICROB, V67, P5791, DOI 10.1128/AEM.67.12.5791-5800.2001; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5; Foesel BU, 2008, FEMS MICROBIOL ECOL, V63, P192, DOI 10.1111/j.1574-6941.2007.00418.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Herrmann M, 2011, APPL ENVIRON MICROB, V77, P1896, DOI 10.1128/AEM.02879-10; Herrmann M, 2009, APPL ENVIRON MICROB, V75, P3127, DOI 10.1128/AEM.02806-08; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Hovanec TA, 1996, APPL ENVIRON MICROB, V62, P2888, DOI 10.1128/AEM.62.8.2888-2896.1996; Hovanec TA, 1998, APPL ENVIRON MICROB, V64, P258; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Limpiyakorn T, 2011, BIORESOURCE TECHNOL, V102, P3694, DOI 10.1016/j.biortech.2010.11.085; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neufeld JD, 2006, ENVIRON MICROBIOL, V8, P126, DOI 10.1111/j.1462-2920.2005.00875.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Parker R, 2002, AQUACULTURE SCI; Reigstad LJ, 2008, FEMS MICROBIOL ECOL, V64, P167, DOI 10.1111/j.1574-6941.2008.00466.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Taylor AE, 2010, APPL ENVIRON MICROB, V76, P7691, DOI 10.1128/AEM.01324-10; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Venables WN., 2002, MODERN APPL STAT S 4; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	47	43	44	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23281	10.1371/journal.pone.0023281	http://dx.doi.org/10.1371/journal.pone.0023281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858055	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500023
J	Ando, Y; Tomaru, Y; Morinaga, A; Burroughs, AM; Kawaji, H; Kubosaki, A; Kimura, R; Tagata, M; Ino, Y; Hirano, H; Chiba, J; Suzuki, H; Carninci, P; Hayashizaki, Y				Ando, Yoshinari; Tomaru, Yasuhiro; Morinaga, Ayako; Burroughs, Alexander Maxwell; Kawaji, Hideya; Kubosaki, Atsutaka; Kimura, Ryuichiro; Tagata, Maiko; Ino, Yoko; Hirano, Hisashi; Chiba, Joe; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide			Nuclear Pore Complex Protein Mediated Nuclear Localization of Dicer Protein in Human Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RNA-BINDING; TRANSPORT; IMPORT; TRBP; INTERFERENCE; ORGANIZATION; EXPRESSION; INTERACTS; TURNOVER	Human DICER1 protein cleaves double-stranded RNA into small sizes, a crucial step in production of single-stranded RNAs which are mediating factors of cytoplasmic RNA interference. Here, we clearly demonstrate that human DICER1 protein localizes not only to the cytoplasm but also to the nucleoplasm. We also find that human DICER1 protein associates with the NUP153 protein, one component of the nuclear pore complex. This association is detected predominantly in the cytoplasm but is also clearly distinguishable at the nuclear periphery. Additional characterization of the NUP153-DICER1 association suggests NUP153 plays a crucial role in the nuclear localization of the DICER1 protein.	[Ando, Yoshinari; Tomaru, Yasuhiro; Morinaga, Ayako; Burroughs, Alexander Maxwell; Kawaji, Hideya; Kubosaki, Atsutaka; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Kimura, Ryuichiro; Tagata, Maiko; Chiba, Joe] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Ino, Yoko; Hirano, Hisashi] Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 232, Japan	RIKEN; Tokyo University of Science; Yokohama City University	Ando, Y (corresponding author), RIKEN Omics Sci Ctr, Yokohama, Kanagawa, Japan.	rgscerg@gsc.riken.jp	Carninci, Piero/K-1568-2014; Ando, Yoshinari/AAK-5668-2020; Suzuki, Harukazu/N-9553-2015; Kawaji, Hideya/N-5116-2015; Hayashizaki, Yoshihide/N-6590-2015	Carninci, Piero/0000-0001-7202-7243; Ando, Yoshinari/0000-0002-8128-6201; Suzuki, Harukazu/0000-0002-8087-0836; Kawaji, Hideya/0000-0002-0575-0308; Burroughs, A. Max/0000-0002-2229-8771	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research Grant for RIKEN Omics Science Center from Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan to YH, Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT to YH, and grant for the Genome Network Project from MEXT to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ando Y, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-6; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Carninci P, 2002, BIOTECHNIQUES, V33, P306, DOI 10.2144/02332st01; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Intoh A, 2009, PROTEOMICS, V9, P126, DOI 10.1002/pmic.200800496; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leibovich Limor, 2010, Silence, V1, P17, DOI 10.1186/1758-907X-1-17; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Moser JJ, 2007, J NEUROSCI RES, V85, P3619, DOI 10.1002/jnr.21439; Muljo SA, 2010, WIRES SYST BIOL MED, V2, P148, DOI 10.1002/wsbm.53; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Takahashi N, 2008, BIOCHEM BIOPH RES CO, V374, P424, DOI 10.1016/j.bbrc.2008.06.128; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tomaru Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r121; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	59	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23385	10.1371/journal.pone.0023385	http://dx.doi.org/10.1371/journal.pone.0023385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858095	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700020
J	van der Heijden, M; Amerongen, GPV; van Bezu, J; Paul, MA; Groeneveld, ABJ; van Hinsbergh, VWM				van der Heijden, Melanie; Amerongen, Geerten P. van Nieuw; van Bezu, Jan; Paul, Marinus A.; Groeneveld, A. B. Johan; van Hinsbergh, Victor W. M.			Opposing Effects of the Angiopoietins on the Thrombin-Induced Permeability of Human Pulmonary Microvascular Endothelial Cells	PLOS ONE			English	Article							ACUTE LUNG INJURY; VASCULAR-PERMEABILITY; INDUCED INCREASE; BARRIER FUNCTION; GENE-THERAPY; VE-CADHERIN; IN-VIVO; TIE2; JUNCTIONS; KINASE	Background: Angiopoietin-2 (Ang-2) is associated with lung injury in ALI/ARDS. As endothelial activation by thrombin plays a role in the permeability of acute lung injury and Ang-2 may modulate the kinetics of thrombin-induced permeability by impairing the organization of vascular endothelial (VE-) cadherin, and affecting small Rho GTPases in human pulmonary microvascular endothelial cells (HPMVECs), we hypothesized that Ang-2 acts as a sensitizer of thrombin-induced hyperpermeability of HPMVECs, opposed by Ang-1. Methodology/Principal Findings: Permeability was assessed by measuring macromolecule passage and transendothelial electrical resistance (TEER). Angiopoietins did not affect basal permeability. Nevertheless, they had opposing effects on the thrombin-induced permeability, in particular in the initial phase. Ang-2 enhanced the initial permeability increase (passage, P = 0.010; TEER, P = 0.021) in parallel with impairment of VE-cadherin organization without affecting VE-cadherin Tyr685 phosphorylation or increasing RhoA activity. Ang-2 also increased intercellular gap formation. Ang-1 preincubation increased Rac1 activity, enforced the VE-cadherin organization, reduced the initial thrombin-induced permeability (TEER, P = 0.027), while Rac1 activity simultaneously normalized, and reduced RhoA activity at 15 min thrombin exposure (P = 0.039), but not at earlier time points. The simultaneous presence of Ang-2 largely prevented the effect of Ang-1 on TEER and macromolecule passage. Conclusions/Significance: Ang-1 attenuated thrombin-induced permeability, which involved initial Rac1 activation-enforced cell-cell junctions, and later RhoA inhibition. In addition to antagonizing Ang-1, Ang-2 had also a direct effect itself. Ang-2 sensitized the initial thrombin-induced permeability accompanied by destabilization of VE-cadherin junctions and increased gap formation, in the absence of increased RhoA activity.	[van der Heijden, Melanie; Groeneveld, A. B. Johan] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Inst Cardiovasc Res, Amsterdam, Netherlands; [van der Heijden, Melanie; Amerongen, Geerten P. van Nieuw; van Bezu, Jan; van Hinsbergh, Victor W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands; [Paul, Marinus A.] Vrije Univ Amsterdam, Med Ctr, Dept Cardiothorac Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van der Heijden, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Inst Cardiovasc Res, Amsterdam, Netherlands.	nieuwamerongen@vumc.nl			Netherlands Heart Foundation [2003T032]; European Society of Intensive Care Medicine	Netherlands Heart Foundation(Netherlands Heart Foundation); European Society of Intensive Care Medicine	GPvNA was supported by The Netherlands Heart Foundation (The Hague, grant 2003T032). MvdH was supported by the European Society of Intensive Care Medicine (ECCRN Levi Montalcini Biomedical Sciences Award 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Amerongen GPV, 2000, CIRCULATION, V102, P2803; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Beck GC, 1999, CLIN EXP IMMUNOL, V118, P298; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; Cascone I, 2003, BLOOD, V102, P2482, DOI 10.1182/blood-2003-03-0670; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2010, YAKUGAKU ZASSHI, V130, P1413, DOI 10.1248/yakushi.130.1413; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; Hoang MV, 2011, BLOOD, V117, P1751, DOI 10.1182/blood-2010-05-286831; Huang YQ, 2008, CRIT CARE MED, V36, P262, DOI 10.1097/01.CCM.0000297955.02633.A4; Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Kim SR, 2008, EXP MOL MED, V40, P320, DOI 10.3858/emm.2008.40.3.320; Kinney CM, 2008, AM J PHYSIOL-CELL PH, V294, pC241, DOI 10.1152/ajpcell.00187.2007; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; LANGELER EG, 1988, THROMB HAEMOSTASIS, V60, P240; LEEMREIS JR, 2006, CYTOM PART A, V69, P873; Li XC, 2004, BLOOD, V104, P1716, DOI 10.1182/blood-2003-11-3744; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Marcus BC, 1998, ANN VASC SURG, V12, P384, DOI 10.1007/s100169900173; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Peters S, 2007, CYTOKINE, V40, P144, DOI 10.1016/j.cyto.2007.09.001; Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Schubert SY, 2011, ARTERIOSCL THROM VAS, V31, P870, DOI 10.1161/ATVBAHA.110.218255; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; van der Heijden M, 2008, APOPTOSIS, V13, P404, DOI 10.1007/s10495-007-0173-6; van der Heijden M, 2009, INTENS CARE MED, V35, P1567, DOI 10.1007/s00134-009-1560-y; Wang YH, 2004, J CELL PHYSIOL, V198, P53, DOI 10.1002/jcp.10386; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	58	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23448	10.1371/journal.pone.0023448	http://dx.doi.org/10.1371/journal.pone.0023448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858121	gold, Green Published			2022-12-27	WOS:000293953700023
J	Liu, NN; Li, T; Reid, WR; Yang, T; Zhang, L				Liu, Nannan; Li, Ting; Reid, William R.; Yang, Ting; Zhang, Lee			Multiple Cytochrome P450 Genes: Their Constitutive Overexpression and Permethrin Induction in Insecticide Resistant Mosquitoes, Culex quinquefasciatus	PLOS ONE			English	Article							PYRETHROID-RESISTANT; EXPRESSION; CYP6D1; SUPERFAMILY; STRAINS; ENZYMES; FLORIDA; P450	Four cytochrome P450 cDNAs, CYP6AA7, CYP9J40, CYP9J34, and CYP9M10, were isolated from mosquitoes, Culex quinquefasciatus. The P450 gene expression and induction by permethrin were compared for three different mosquito populations bearing different resistance phenotypes, ranging from susceptible (S-Lab), through intermediate (HAmCq(G0), the field parental population) to highly resistant (HAmCq(G8), the 8(th) generation of permethrin selected offspring of HAmCq(G0)). A strong correlation was found for P450 gene expression with the levels of resistance and following permethrin selection at the larval stage of mosquitoes, with the highest expression levels identified in HAmCq(G8), suggesting the importance of CYP6AA7, CYP9J40, CYP9J34, and CYP9M10 in the permethrin resistance of larva mosquitoes. Only CYP6AA7 showed a significant overexpression in HAmCq(G8) adult mosquitoes. Other P450 genes had similar expression levels among the mosquito populations tested, suggesting different P450 genes may be involved in the response to insecticide pressure in different developmental stages. The expression of CYP6AA7, CYP9J34, and CYP9M10 was further induced by permethrin in resistant mosquitoes. Taken together, these results indicate that multiple P450 genes are up-regulated in insecticide resistant mosquitoes through both constitutive overexpression and induction mechanisms, thus increasing the overall expression levels of P450 genes.	[Liu, Nannan; Li, Ting; Reid, William R.; Yang, Ting] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Zhang, Lee] Auburn Univ, Genom & Sequencing Lab, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Liu, NN (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	liunann@auburn.edu	Li, Ting/L-2400-2016; Li, Ting/D-5181-2015; Li, Ting/ABG-2699-2021	Li, Ting/0000-0002-6004-4617; 	National Institute of Allergy and Infectious Diseases [R21AI076893]; AAES Hatch/Multistate Grants [ALA08-045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076893] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AAES Hatch/Multistate Grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R21AI076893 to N.L. from the National Institute of Allergy and Infectious Diseases and AAES Hatch/Multistate Grants ALA08-045 to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Berenbaum M.R., 1991, P221; CARINO F, 1992, ACS SYM SER, V505, P31; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Feyereisen R., 2005, P1; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Hardstone MC, 2010, INSECT MOL BIOL, V19, P717, DOI 10.1111/j.1365-2583.2010.01030.x; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Korytko PJ, 1998, ARCH INSECT BIOCHEM, V37, P57, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;57::AID-ARCH7&gt;3.0.CO;2-S; Li T, 2010, J MED ENTOMOL, V47, P1127, DOI 10.1603/ME10142; Li XC, 2002, INSECT BIOCHEM MOLEC, V32, P311, DOI 10.1016/S0965-1748(01)00092-3; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu N, 1997, INSECT MOL BIOL, V6, P77, DOI 10.1046/j.1365-2583.1997.00160.x; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Liu NN, 2004, GENE, V327, P81, DOI 10.1016/j.gene.2003.11.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nayar JK, 1999, J MED ENTOMOL, V36, P441, DOI 10.1093/jmedent/36.4.441; OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Terriere L. C., 1983, Pest resistance to pesticides, P265; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Zhu F, 2008, ARCH INSECT BIOCH PH, V34, P147; Zhu F., 2008, INSECT MOL BIOL, V20, P1365, DOI DOI 10.1186/1472-6793-8-18; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	37	85	90	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23403	10.1371/journal.pone.0023403	http://dx.doi.org/10.1371/journal.pone.0023403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858101	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953500037
J	Ash, MR; Maher, MJ; Guss, JM; Jormakka, M				Ash, Miriam-Rose; Maher, Megan J.; Guss, J. Mitchell; Jormakka, Mika			The Initiation of GTP Hydrolysis by the G-Domain of FeoB: Insights from a Transition-State Complex Structure	PLOS ONE			English	Article							FERROUS IRON UPTAKE; CATALYTIC GLUTAMINE; ACTIVATING PROTEIN; ESCHERICHIA-COLI; BINDING PROTEIN; MAJOR ROLE; GTPASES; ACQUISITION; SWITCH; EVOLUTION	The polytopic membrane protein FeoB is a ferrous iron transporter in prokaryotes. The protein contains a potassium-activated GTPase domain that is essential in regulating the import of iron and conferring virulence to many disease-causing bacteria. However, the mechanism by which the G-domain of FeoB hydrolyzes GTP is not well understood. In particular, it is not yet known how the pivotal step in GTP hydrolysis is achieved: alignment of a catalytic water molecule. In the current study, the crystal structure of the soluble domains from Streptococcus thermophilus FeoB (NFeoB(St)) in complex with the activating potassium ion and a transition-state analogue, GDP center dot AlF4-, reveals a novel mode of water alignment involving contacts with the protein backbone only. In parallel to the structural studies, a series of seven mutant proteins were constructed that targeted conserved residues at the active site of NFeoB(St), and the nucleotide binding and hydrolysis properties of these were measured and compared to the wild-type protein. The results show that mutations in Thr35 abolish GTPase activity of the protein, while other conserved residues (Tyr58, Ser64, Glu66 and Glu67) are not required for water alignment by NFeoB(St). Together with the crystal structure, the findings suggest a new mechanism for hydrolysis initiation in small G-proteins, in which the attacking water molecule is aligned by contacts with the protein backbone only.	[Ash, Miriam-Rose; Guss, J. Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Maher, Megan J.; Jormakka, Mika] Centenary Inst, Struct Biol Program, Sydney, NSW, Australia	University of Sydney; University of Sydney; Centenary Institute	Ash, MR (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	m.jormakka@centenary.org.au	Maher, Megan/B-2239-2012; Guss, Jules Mitchell/N-1387-2019	Guss, Jules Mitchell/0000-0003-4259-6079; Ash, Miriam-Rose/0000-0002-0573-9854; Maher, Megan/0000-0003-0848-9640	National Health and Medical Research Council [570784, 632703]; Australian Postgraduate Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This study was supported by the National Health and Medical Research Council (no. 570784 and 632703; http://www.nhmrc.gov.au). MJM is a Cancer Institute of NSW Career Development Fellow. MRA is a recipient of an Australian Postgraduate Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Birnbaumer L, 2010, J RECEPT SIG TRANSD, V30, P372, DOI 10.3109/10799893.2010.508165; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chakrabarti PP, 2007, J MOL BIOL, V367, P983, DOI 10.1016/j.jmb.2006.11.022; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eng ET, 2008, J MOL BIOL, V375, P1086, DOI 10.1016/j.jmb.2007.11.027; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; Guilfoyle A, 2009, EMBO J, V28, P2677, DOI 10.1038/emboj.2009.208; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hattori M, 2009, STRUCTURE, V17, P1345, DOI 10.1016/j.str.2009.08.007; Huang B, 2010, J BIOCHEM, V148, P103, DOI 10.1093/jb/mvq039; Hung KW, 2010, J STRUCT BIOL, V170, P501, DOI 10.1016/j.jsb.2010.01.017; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; JOHN J, 1993, J BIOL CHEM, V268, P923; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Koster S, 2009, J MOL BIOL, V392, P405, DOI 10.1016/j.jmb.2009.07.020; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Martin RB, 1996, COORDIN CHEM REV, V149, P23, DOI 10.1016/0010-8545(95)01170-6; MARTIN RB, 1988, BIOCHEM BIOPH RES CO, V155, P1194; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Robinson VL, 2002, STRUCTURE, V10, P1649, DOI 10.1016/S0969-2126(02)00905-X; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; TOMAR SK, 2011, BIOCH BIOPHYS RES CO; Tu C, 2009, P NATL ACAD SCI USA, V106, P14843, DOI 10.1073/pnas.0904032106; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yamanaka K, 2000, J BACTERIOL, V182, P7078, DOI 10.1128/JB.182.24.7078-7082.2000; Zurita A, 2010, P NATL ACAD SCI USA, V107, P9596, DOI 10.1073/pnas.1004803107	50	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23355	10.1371/journal.pone.0023355	http://dx.doi.org/10.1371/journal.pone.0023355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858085	Green Published, gold			2022-12-27	WOS:000293774300032
J	Moltzer, E; Riet, LT; Swagemakers, SMA; van Heijningen, PM; Vermeij, M; van Veghel, R; Bouhuizen, AM; van Esch, JHM; Lankhorst, S; Ramnath, NWM; de Waard, MC; Duncker, DJ; van der Spek, PJ; Rouwet, EV; Danser, AHJ; Essers, J				Moltzer, Els; Riet, Luuk Te; Swagemakers, Sigrid M. A.; van Heijningen, Paula M.; Vermeij, Marcel; van Veghel, Richard; Bouhuizen, Angelique M.; van Esch, Joep H. M.; Lankhorst, Stephanie; Ramnath, Natasja W. M.; de Waard, Monique C.; Duncker, Dirk J.; van der Spek, Peter J.; Rouwet, Ellen V.; Danser, A. H. Jan; Essers, Jeroen			Impaired Vascular Contractility and Aortic Wall Degeneration in Fibulin-4 Deficient Mice: Effect of Angiotensin II Type 1 (AT(1)) Receptor Blockade	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; MARFAN-SYNDROME; MOUSE MODEL; MEDIAL DEGENERATION; EXPRESSION; ARTERIAL; RENIN; PATHOGENESIS; MECHANISMS	Medial degeneration is a key feature of aneurysm disease and aortic dissection. In a murine aneurysm model we investigated the structural and functional characteristics of aortic wall degeneration in adult fibulin-4 deficient mice and the potential therapeutic role of the angiotensin (Ang) II type 1 (AT(1)) receptor antagonist losartan in preventing aortic media degeneration. Adult mice with 2-fold (heterozygous Fibulin-4(+/R)) and 4-fold (homozygous Fibulin-4(R/R)) reduced expression of fibulin-4 displayed the histological features of cystic media degeneration as found in patients with aneurysm or dissection, including elastin fiber fragmentation, loss of smooth muscle cells, and deposition of ground substance in the extracellular matrix of the aortic media. The aortic contractile capacity, determined by isometric force measurements, was diminished, and was associated with dysregulation of contractile genes as shown by aortic transcriptome analysis. These structural and functional alterations were accompanied by upregulation of TGF-beta signaling in aortas from fibulin-4 deficient mice, as identified by genome-scaled network analysis as well as by immunohistochemical staining for phosphorylated Smad2, an intracellular mediator of TGF-beta. Tissue levels of Ang II, a regulator of TGF-beta signaling, were increased. Prenatal treatment with the AT(1) receptor antagonist losartan, which blunts TGF-beta signaling, prevented elastic fiber fragmentation in the aortic media of newborn Fibulin-4(R/R) mice. Postnatal losartan treatment reduced haemodynamic stress and improved lifespan of homozygous knockdown fibulin-4 animals, but did not affect aortic vessel wall structure. In conclusion, the AT(1) receptor blocker losartan can prevent aortic media degeneration in a non-Marfan syndrome aneurysm mouse model. In established aortic aneurysms, losartan does not affect aortic architecture, but does improve survival. These findings may extend the potential therapeutic application of inhibitors of the renin-angiotensin system to the preventive treatment of aneurysm disease.	[Moltzer, Els; Riet, Luuk Te; van Veghel, Richard; Bouhuizen, Angelique M.; van Esch, Joep H. M.; Lankhorst, Stephanie; Danser, A. H. Jan] Erasmus MC, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van Heijningen, Paula M.; Ramnath, Natasja W. M.; de Waard, Monique C.; Essers, Jeroen] Erasmus MC, Canc Genom Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van der Spek, Peter J.] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Vermeij, Marcel] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Riet, Luuk Te; Lankhorst, Stephanie; Ramnath, Natasja W. M.; Rouwet, Ellen V.; Essers, Jeroen] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [de Waard, Monique C.; Duncker, Dirk J.] Erasmus MC, Thoraxctr, Div Expt Cardiol, Dept Cardiol, Rotterdam, Netherlands; [Essers, Jeroen] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Moltzer, E (corresponding author), Erasmus MC, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands.	j.essers@erasmusmc.nl	Danser, Jan/GLR-1479-2022		Netherlands Genomics Initiative (NGI)/NOW; Lijf en Leven	Netherlands Genomics Initiative (NGI)/NOW; Lijf en Leven	This work was supported by the Netherlands Genomics Initiative (NGI)/NOW (to SS and PvdS) and by the 'Lijf en Leven' grant (2008): 'Early Detection and Diagnosis of Aneurysms and Heart Valve Abnormalities' (to JE and PvH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Batenburg WW, 2008, ARTERIOSCL THROM VAS, V28, P1151, DOI 10.1161/ATVBAHA.108.164210; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Chew DKW, 2004, J VASC SURG, V40, P1001, DOI 10.1016/j.jvs.2004.08.035; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; DANSER AHJ, 1994, HYPERTENSION, V24, P37, DOI 10.1161/01.HYP.24.1.37; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X; Ford CM, 1999, ARTERIOSCL THROM VAS, V19, P1843, DOI 10.1161/01.ATV.19.8.1843; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HALME T, 1985, EXP MOL PATHOL, V43, P1, DOI 10.1016/0014-4800(85)90050-4; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hawinkels LJAC, 2009, CANCER SCI, V100, P663, DOI 10.1111/j.1349-7006.2009.01100.x; Henriques T, 2008, ARTERIOSCL THROM VAS, V28, P1251, DOI 10.1161/ATVBAHA.107.160382; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; JEREMY RW, 1994, AM J CARDIOL, V74, P369, DOI 10.1016/0002-9149(94)90405-7; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kaijzel EL, 2010, CIRC-CARDIOVASC IMAG, V3, P567, DOI 10.1161/CIRCIMAGING.109.933093; KAWASAKI T, 1987, CARDIOVASC RES, V21, P678, DOI 10.1093/cvr/21.9.678; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezCandales A, 1997, AM J PATHOL, V150, P993; Lu H, 2008, CURR HYPERTENS REP, V10, P99, DOI 10.1007/s11906-008-0020-3; Marque V, 2001, ARTERIOSCL THROM VAS, V21, P1184, DOI 10.1161/hq0701.092136; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Moltzer E, 2011, PHARMACOL THERAPEUT, V131, P50, DOI 10.1016/j.pharmthera.2011.04.002; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nagashima H, 2001, CIRCULATION, V104, pI282; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Sun YO, 1998, J MOL CELL CARDIOL, V30, P1559, DOI 10.1006/jmcc.1998.0721; van den Bos EJ, 2005, AM J PHYSIOL-HEART C, V289, pH1291, DOI 10.1152/ajpheart.00111.2005; van Esch JHM, 2010, CARDIOVASC RES, V86, P401, DOI 10.1093/cvr/cvq004; van Kats JP, 2001, KIDNEY INT, V60, P2311, DOI 10.1046/j.1523-1755.2001.00049.x; Vitarelli A, 2006, AM J CARDIOL, V97, P571, DOI 10.1016/j.amjcard.2005.09.089; WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400; Yang HHC, 2009, BRIT J PHARMACOL, V158, P1503, DOI 10.1111/j.1476-5381.2009.00443.x; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	51	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23411	10.1371/journal.pone.0023411	http://dx.doi.org/10.1371/journal.pone.0023411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858106	Green Published, gold			2022-12-27	WOS:000293774300034
J	Schneider, RR; Hauer, G; Farr, D; Adamowicz, WL; Boutin, S				Schneider, Richard R.; Hauer, Grant; Farr, Dan; Adamowicz, W. L.; Boutin, Stan			Achieving Conservation when Opportunity Costs Are High: Optimizing Reserve Design in Alberta's Oil Sands Region	PLOS ONE			English	Article							LARGE DISTURBANCES; MAXIMIZING RETURN; REAL-WORLD; BIODIVERSITY; SCALE; CONNECTIVITY; PATTERN; TARGETS; INVESTMENT; LANDSCAPE	Recent studies have shown that conservation gains can be achieved when the spatial distributions of biological benefits and economic costs are incorporated in the conservation planning process. Using Alberta, Canada, as a case study we apply these techniques in the context of coarse-filter reserve design. Because targets for ecosystem representation and other coarse-filter design elements are difficult to define objectively we use a trade-off analysis to systematically explore the relationship between conservation targets and economic opportunity costs. We use the Marxan conservation planning software to generate reserve designs at each level of conservation target to ensure that our quantification of conservation and economic outcomes represents the optimal allocation of resources in each case. Opportunity cost is most affected by the ecological representation target and this relationship is nonlinear. Although petroleum resources are present throughout most of Alberta, and include highly valuable oil sands deposits, our analysis indicates that over 30% of public lands could be protected while maintaining access to more than 97% of the value of the region's resources. Our case study demonstrates that optimal resource allocation can be usefully employed to support strategic decision making in the context of land-use planning, even when conservation targets are not well defined.	[Schneider, Richard R.; Farr, Dan; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hauer, Grant; Adamowicz, W. L.] Univ Alberta, Dept Rural Econ, Edmonton, AB, Canada	University of Alberta; University of Alberta	Schneider, RR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ministik99@telus.net	Boutin, Stan A/A-2619-2014	Boutin, Stan A/0000-0001-6317-038X; Adamowicz, Wiktor/0000-0002-7634-2985	Natural Sciences and Engineering Research Council of Canada; Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta Land-use Secretariat; Sustainable Forest Management Network; Social Science and Humanities Research Council of Canada; Forest Resource Improvement Association of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta Land-use Secretariat; Sustainable Forest Management Network; Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Forest Resource Improvement Association of Alberta	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada, Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta, Alberta Land-use Secretariat, Sustainable Forest Management Network, Social Science and Humanities Research Council of Canada, and the Forest Resource Improvement Association of Alberta. The Alberta Land-use Secretariat provided feedback regarding study design, but did not have a role in data collection and analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2010, BIOL CONSERV, V143, P439, DOI 10.1016/j.biocon.2009.11.011; *ALB DEP EN, 2007, ALB OIL SANDS FISC S; *ALB DEP EN, 2010, EN ANN REP 2009 2010; *ALB DEP EN, 2007, ALB CONV OIL GAS IND; Alberta Department of Energy, 2007, PREL FISC EV ALB OIL; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; BAKER WL, 1992, LANDSCAPE ECOL, V7, P181, DOI 10.1007/BF00133309; Bonn A, 2005, BIODIVERS CONSERV, V14, P1083, DOI 10.1007/s10531-004-8410-6; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Briers RA, 2002, BIOL CONSERV, V103, P77, DOI 10.1016/S0006-3207(01)00123-9; *CAN W FDN, GIBB D BLACK REP YEA; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Desmet P, 2004, ECOL SOC, V9; Energy Alberta, 2007, EUB SER PUBL; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; GAME ET, MARXAN USER MANUAL F; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; GLJ Petroleum Consultants, 2009, CRUD OIL NAT GAS LIQ; GLJ Petroleum Consultants, 2009, NAT GAS SULPH PRIC F; *GOV ALB, 2009, TERM REF DEV LOW ATH; Government of Alberta, 2008, LAND US FRAM; Gurd DB, 2001, CONSERV BIOL, V15, P1355, DOI 10.1046/j.1523-1739.2001.00188.x; Haight RG, 2002, CONSERV BIOL, V16, P1386, DOI 10.1046/j.1523-1739.2002.99510.x; HAUER G, NET PRESENT VALUE MO; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Horskins K, 2006, LANDSCAPE ECOL, V21, P641, DOI 10.1007/s10980-005-5203-6; Huber PR, 2010, LANDSCAPE ECOL, V25, P683, DOI 10.1007/s10980-010-9447-4; Hunter ML, 2005, CONSERV BIOL, V19, P1025, DOI 10.1111/j.1523-1739.2005.00172.x; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; KENNETT SA, NEXT STEPS CUMULATIV; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Leroux SJ, 2007, BIOL CONSERV, V138, P464, DOI 10.1016/j.biocon.2007.05.012; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDonald-Madden E, 2008, CONSERV BIOL, V22, P656, DOI 10.1111/j.1523-1739.2008.00918.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Natural Regions Committee, 2006, NAT REG SUBR ALB; Perhans K, 2008, CONSERV BIOL, V22, P1331, DOI 10.1111/j.1523-1739.2008.00976.x; *PETR SERV ASS CAN, 2008, WELL COST STUD; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Robinson JG, 2006, CONSERV BIOL, V20, P658, DOI 10.1111/j.1523-1739.2006.00469.x; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Schneider RR, 2003, CONSERV ECOL, V7; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Vazquez LB, 2008, BIODIVERS CONSERV, V17, P1367, DOI 10.1007/s10531-008-9320-9; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Young JE, 2006, FOREST ECOL MANAG, V230, P151, DOI 10.1016/j.foreco.2006.04.031	55	18	19	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23254	10.1371/journal.pone.0023254	http://dx.doi.org/10.1371/journal.pone.0023254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858046	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300024
J	Tumban, E; Peabody, J; Peabody, DS; Chackerian, B				Tumban, Ebenezer; Peabody, Julianne; Peabody, David S.; Chackerian, Bryce			A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; HUMAN-PAPILLOMAVIRUS TYPE-16; COTTONTAIL RABBIT PAPILLOMAVIRUS; AGED 16-26 YEARS; MOUSE MODEL; ANTIGEN L2; L1; INFECTION; PSEUDOVIRIONS; PROTECTION	Background: Current human papillomavirus (HPV) vaccines that are based on virus-like particles (VLPs) of the major capsid protein L1 largely elicit HPV type-specific antibody responses. In contrast, immunization with the HPV minor capsid protein L2 elicits antibodies that are broadly cross-neutralizing, suggesting that a vaccine targeting L2 could provide more comprehensive protection against infection by diverse HPV types. However, L2-based immunogens typically elicit much lower neutralizing antibody titers than L1 VLPs. We previously showed that a conserved broadly neutralizing epitope near the N-terminus of L2 is highly immunogenic when displayed on the surface of VLPs derived from the bacteriophage PP7. Here, we report the development of a panel of PP7 VLP-based vaccines targeting L2 that protect mice from infection with carcinogenic and non-carcinogenic HPV types that infect the genital tract and skin. Methodology/Principal Findings: L2 peptides from eight different HPV types were displayed on the surface of PP7 bacteriophage VLPs. These recombinant L2 VLPs, both individually and in combination, elicited high-titer anti-L2 IgG serum antibodies. Immunized mice were protected from high dose infection with HPV pseudovirus (PsV) encapsidating a luciferase reporter. Mice immunized with 16L2 PP7 VLPs or 18L2 PP7 VLPs were nearly completely protected from both PsV16 and PsV18 challenge. Mice immunized with the mixture of eight L2 VLPs were strongly protected from genital challenge with PsVs representing eight diverse HPV types and cutaneous challenge with HPV5 PsV. Conclusion/Significance: VLP-display of a cross-neutralizing HPV L2 epitope is an effective approach for inducing high-titer protective neutralizing antibodies and is capable of offering protection from a spectrum of HPVs associated with cervical cancer as well as genital and cutaneous warts.	[Tumban, Ebenezer; Peabody, Julianne; Peabody, David S.; Chackerian, Bryce] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico	Tumban, E (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	bchackerian@salud.unm.edu			United States National Institutes of Health (National Institute of Allergy and Infectious Diseases) [U19 AI084081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084081] Funding Source: NIH RePORTER	United States National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the United States National Institutes of Health (National Institute of Allergy and Infectious Diseases; U19 AI084081 to B.C.) establishing the University of New Mexico Interdisciplinary HPV Prevention Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Campo MS, 2010, J VIROL, V84, P1214, DOI 10.1128/JVI.01927-09; CAMPO MS, 1993, J GEN VIROL; Chackerian B, 2008, J IMMUNOL, V180, P5816, DOI 10.4049/jimmunol.180.9.5816; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; CHRISTENSEN ND, 1991, VIROLOGY, V181, P572, DOI 10.1016/0042-6822(91)90890-N; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DOORBAR J, 1987, J VIROL, V61, P2793, DOI 10.1128/JVI.61.9.2793-2799.1987; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Karanam B, 2009, IMMUNOL CELL BIOL, V87, P287, DOI 10.1038/icb.2009.13; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawana K, 1998, J VIROL, V72, P10298, DOI 10.1128/JVI.72.12.10298-10300.1998; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; LIN YL, 1992, VIROLOGY, V187, P612, DOI 10.1016/0042-6822(92)90463-Y; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	40	85	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23310	10.1371/journal.pone.0023310	http://dx.doi.org/10.1371/journal.pone.0023310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858066	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300032
J	Fryer, HR; McLean, AR				Fryer, Helen R.; McLean, Angela R.			There Is No Safe Dose of Prions	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE AGENT; LYMPHORETICULAR-SYSTEM; STRAIN DIFFERENCES; BRITISH SHEEP; DISEASE; PATHOGENESIS; PROTEIN; RISK; MOUSE	Understanding the circumstances under which exposure to transmissible spongiform encephalopathies (TSEs) leads to infection is important for managing risks to public health. Based upon ideas in toxicology and radiology, it is plausible that exposure to harmful agents, including TSEs, is completely safe if the dose is low enough. However, the existence of a threshold, below which infection probability is zero has never been demonstrated experimentally. Here we explore this question by combining data and mathematical models that describe scrapie infections in mice following experimental challenge over a broad range of doses. We analyse data from 4338 mice inoculated at doses ranging over ten orders of magnitude. These data are compared to results from a within-host model in which prions accumulate according to a stochastic birth-death process. Crucially, this model assumes no threshold on the dose required for infection. Our data reveal that infection is possible at the very low dose of a 1000 fold dilution of the dose that infects half the challenged animals (ID50). Furthermore, the dose response curve closely matches that predicted by the model. These findings imply that there is no safe dose of prions and that assessments of the risk from low dose exposure are right to assume a linear relationship between dose and probability of infection. We also refine two common perceptions about TSE incubation periods: that their mean values decrease linearly with logarithmic decreases in dose and that they are highly reproducible between hosts. The model and data both show that the linear decrease in incubation period holds only for doses above the ID50. Furthermore, variability in incubation periods is greater than predicted by the model, not smaller. This result poses new questions about the sources of variability in prion incubation periods. It also provides insight into the limitations of the incubation period assay.	[Fryer, Helen R.; McLean, Angela R.] Univ Oxford, Dept Zool, Inst Emerging Infect, Oxford Martin Sch, Oxford OX1 3PS, England	University of Oxford	Fryer, HR (corresponding author), Univ Oxford, Dept Zool, Inst Emerging Infect, Oxford Martin Sch, S Parks Rd, Oxford OX1 3PS, England.	angela.mclean@zoo.ox.ac.uk			Oxford Martin School; Foods Standards Agency [M03027]	Oxford Martin School; Foods Standards Agency	This research was supported by the Oxford Martin School (www.oxfordmartin.ox.ac.uk) and the Foods Standards Agency (www.food.gov.uk), grant number M03027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Boden LA, 2010, J GEN VIROL, V91, P2642, DOI 10.1099/vir.0.022566-0; BOLTON DC, 1991, J GEN VIROL, V72, P2905, DOI 10.1099/0022-1317-72-12-2905; Bolus N E, 2001, J Nucl Med Technol, V29, P67; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Cohen J.T., 2003, EVALUATION POTENTIAL; Comer PJ, 2003, STAT METHODS MED RES, V12, P279, DOI 10.1191/0962280203sm333ra; de Koeijer A, 2004, J MATH BIOL, V48, P1, DOI 10.1007/s00285-003-0206-x; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; DICKINSON AG, 1972, NATURE-NEW BIOL, V237, P244, DOI 10.1038/newbio237244a0; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Ferguson NM, 2003, P ROY SOC B-BIOL SCI, V270, P1579, DOI 10.1098/rspb.2003.2484; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Fryer HR, 2007, P R SOC B, V274, P1497, DOI 10.1098/rspb.2007.0353; GRIMMETT G, 1986, PROBABILITY INTRO; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JEFFREY M, 1995, MICRON, V26, P277, DOI 10.1016/0968-4328(95)00004-N; JENDROSKA K, 1991, NEUROLOGY, V41, P1482, DOI 10.1212/WNL.41.9.1482; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; KIMBERLIN RH, 1988, J GEN VIROL, V69, P2953, DOI 10.1099/0022-1317-69-12-2953; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Laurent M, 1998, BIOPHYS CHEM, V72, P211, DOI 10.1016/S0301-4622(98)00135-5; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1980, BIOCHEMISTRY-US, V19, P4883, DOI 10.1021/bi00562a028; Ross S. M., 1997, INTRO PROBABILITY MO; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392	35	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23664	10.1371/journal.pone.0023664	http://dx.doi.org/10.1371/journal.pone.0023664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858197	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700039
J	Liu, Q; Majdi, M; Cankar, K; Goedbloed, M; Charnikhova, T; Verstappen, FWA; de Vos, RCH; Beekwilder, J; van der Krol, S; Bouwmeester, HJ				Liu, Qing; Majdi, Mohammad; Cankar, Katarina; Goedbloed, Miriam; Charnikhova, Tatsiana; Verstappen, Francel W. A.; de Vos, Ric C. H.; Beekwilder, Jules; van der Krol, Sander; Bouwmeester, Harro J.			Reconstitution of the Costunolide Biosynthetic Pathway in Yeast and Nicotiana benthamiana	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; GERMACRENE-A SYNTHASE; NF-KAPPA-B; SESQUITERPENE LACTONES; ANTIMALARIAL-DRUG; EXPRESSION; CLONING; TRANSFORMATION; METABOLOMICS; PARTHENOLIDE	The sesquiterpene costunolide has a broad range of biological activities and is the parent compound for many other biologically active sesquiterpenes such as parthenolide. Two enzymes of the pathway leading to costunolide have been previously characterized: germacrene A synthase (GAS) and germacrene A oxidase (GAO), which together catalyse the biosynthesis of germacra-1(10), 4,11(13)-trien-12-oic acid. However, the gene responsible for the last step toward costunolide has not been characterized until now. Here we show that chicory costunolide synthase (CiCOS), CYP71BL3, can catalyse the oxidation of germacra-1(10), 4,11(13)-trien-12-oic acid to yield costunolide. Co-expression of feverfew GAS (TpGAS), chicory GAO (CiGAO), and chicory COS (CiCOS) in yeast resulted in the biosynthesis of costunolide. The catalytic activity of TpGAS, CiGAO and CiCOS was also verified in planta by transient expression in Nicotiana benthamiana. Mitochondrial targeting of TpGAS resulted in a significant increase in the production of germacrene A compared with the native cytosolic targeting. When the N. benthamiana leaves were co-infiltrated with TpGAS and CiGAO, germacrene A almost completely disappeared as a result of the presence of CiGAO. Transient expression of TpGAS, CiGAO and CiCOS in N. benthamiana leaves resulted in costunolide production of up to 60 ng.g(-1) FW. In addition, two new compounds were formed that were identified as costunolide-glutathione and costunolide-cysteine conjugates.	[Liu, Qing; Cankar, Katarina; Goedbloed, Miriam; Charnikhova, Tatsiana; Verstappen, Francel W. A.; Beekwilder, Jules; van der Krol, Sander; Bouwmeester, Harro J.] Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands; [Majdi, Mohammad] Univ Kurdistan, Fac Agr, Agron & Plant Breeding Dept, Sanandaj, Iran; [Cankar, Katarina; de Vos, Ric C. H.; Beekwilder, Jules] Plant Res Int, Wageningen, Netherlands; [de Vos, Ric C. H.] Ctr BioSyst Genom, Wageningen, Netherlands; [de Vos, Ric C. H.] Netherlands Metabol Ctr, Leiden, Netherlands	Wageningen University & Research; University of Kurdistan; Centre for BioSystems Genomics	Liu, Q (corresponding author), Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands.	harro.bouwmeester@wur.nl	van der Krol, Alexander/C-5720-2015; Liu, Qing/F-6756-2014; De Vos, Ric/F-5012-2017; Majdi, Mohammad/AAK-9122-2021; Beekwilder, Jules/A-6802-2011; Bouwmeester, Harro J/C-1414-2008	van der Krol, Alexander/0000-0001-6585-7572; Liu, Qing/0000-0002-0257-0694; Majdi, Mohammad/0000-0001-6959-4845; Beekwilder, Jules/0000-0003-3238-4427; Bouwmeester, Harro/0000-0003-0907-2732; Cankar, Katarina/0000-0001-5149-4192	EU [227448]	EU(European Commission)	This project is funded by the EU (Project acronym: TERPMED, grant agreement no.: 227448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero AF, 2000, FITOTERAPIA, V71, P60, DOI 10.1016/S0367-326X(99)00122-7; Bedoya LM, 2008, CURR SIGNAL TRANSD T, V3, P82, DOI 10.2174/157436208784223134; Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; Cankar K, 2011, FEBS LETT, V585, P178, DOI 10.1016/j.febslet.2010.11.040; CHEN HC, 1995, ANTIVIR RES, V27, P99, DOI 10.1016/0166-3542(94)00083-K; Choi JH, 2002, JPN J CANCER RES, V93, P1327, DOI 10.1111/j.1349-7006.2002.tb01241.x; de Kraker JW, 2002, PLANT PHYSIOL, V129, P257, DOI 10.1104/pp.010957; de Kraker JW, 2001, PHYTOCHEMISTRY, V58, P481, DOI 10.1016/S0031-9422(01)00291-6; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; DEKRAKER JW, 1998, TEST, V117, P1381; DEKRAKER JW, 2001, TEST, V125, P1930; Fischer N.H., 1990, BIOCH MEVALONIC ACID; HABIG WH, 1974, J BIOL CHEM, V249, P7130; IKEZAWA N, 2011, J BIOL CHEM; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Klein M, 2002, FEBS LETT, V520, P63, DOI 10.1016/S0014-5793(02)02767-9; KOHLEN W, 2010, PLANT PHYSL; Koo TH, 2001, PLANTA MED, V67, P103, DOI 10.1055/s-2001-11503; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Ma XC, 2007, ENZYME MICROB TECH, V40, P1013, DOI 10.1016/j.enzmictec.2006.07.043; MAJDI M, 2011, PHYTOCHEMIS IN PRESS, DOI DOI 10.1016/J.PHYTOCHEM.2011.1004.1021; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; MORI H, 1994, CANCER LETT, V83, P171, DOI 10.1016/0304-3835(94)90315-8; Nelson David R., 2009, Human Genomics, V4, P59; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Ohkama-Ohtsu N, 2007, PLANT J, V49, P878, DOI 10.1111/j.1365-313X.2006.03005.x; Outchkourov NS, 2003, PLANTA, V216, P1003, DOI 10.1007/s00425-002-0953-8; Park HeeJuhn, 2006, Natural Product Sciences, V12, P175; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; REA PA, 1999, TEST, V50, P895; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; SETO M, 1988, CHEM PHARM BULL, V36, P2423, DOI 10.1248/cpb.36.2423; SHIMIZU H, 1991, BIOTECHNOL BIOENG, V38, P196, DOI 10.1002/bit.260380212; Srivastava SK, 2006, BIOORG MED CHEM LETT, V16, P4195, DOI 10.1016/j.bmcl.2006.05.083; TANIGUCHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P2064, DOI 10.1271/bbb.59.2064; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Turner GW, 2004, PLANT PHYSIOL, V136, P4215, DOI 10.1104/pp.104.050229; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; van Herpen TWJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014222; VANBEEK TA, 1990, J AGR FOOD CHEM, V38, P1035, DOI 10.1021/jf00094a026; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Wedge DE, 2000, PHYTOCHEMISTRY, V53, P747, DOI 10.1016/S0031-9422(00)00008-X; YANG T, 2011, METABOLIC ENG; Zhang DL, 2009, MOL CANCER RES, V7, P1139, DOI 10.1158/1541-7786.MCR-08-0410; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976	53	64	68	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23255	10.1371/journal.pone.0023255	http://dx.doi.org/10.1371/journal.pone.0023255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858047	Green Published, gold			2022-12-27	WOS:000293953700011
J	Sarmady, M; Dampier, W; Tozeren, A				Sarmady, Mahdi; Dampier, William; Tozeren, Aydin			HIV Protein Sequence Hotspots for Crosstalk with Host Hub Proteins	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SHORT LINEAR MOTIFS; VIRAL-INFECTION; SH3 DOMAINS; TAT; NEF; BINDING; KINASE; PHOSPHORYLATION; REPLICATION	HIV proteins target host hub proteins for transient binding interactions. The presence of viral proteins in the infected cell results in out-competition of host proteins in their interaction with hub proteins, drastically affecting cell physiology. Functional genomics and interactome datasets can be used to quantify the sequence hotspots on the HIV proteome mediating interactions with host hub proteins. In this study, we used the HIV and human interactome databases to identify HIV targeted host hub proteins and their host binding partners (H2). We developed a high throughput computational procedure utilizing motif discovery algorithms on sets of protein sequences, including sequences of HIV and H2 proteins. We identified as HIV sequence hotspots those linear motifs that are highly conserved on HIV sequences and at the same time have a statistically enriched presence on the sequences of H2 proteins. The HIV protein motifs discovered in this study are expressed by subsets of H2 host proteins potentially outcompeted by HIV proteins. A large subset of these motifs is involved in cleavage, nuclear localization, phosphorylation, and transcription factor binding events. Many such motifs are clustered on an HIV sequence in the form of hotspots. The sequential positions of these hotspots are consistent with the curated literature on phenotype altering residue mutations, as well as with existing binding site data. The hotspot map produced in this study is the first global portrayal of HIV motifs involved in altering the host protein network at highly connected hub nodes.	[Sarmady, Mahdi; Dampier, William; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA	Drexel University	Sarmady, M (corresponding author), Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA.	at62@drexel.edu	Sarmady/M-9859-2019	Sarmady/0000-0001-6069-804X	Calhoun endowment funds; National Institutes of Health (NIH) [232240]	Calhoun endowment funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Calhoun endowment funds to Drexel University and by the National Institutes of Health (NIH) grant #232240. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada P, 2005, J VIROL, V79, P3627, DOI 10.1128/JVI.79.6.3627-3638.2005; Ackerson B, 1998, J VIROL, V72, P303, DOI 10.1128/JVI.72.1.303-308.1998; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Baier-Bitterlich G, 1998, BIOMED PHARMACOTHER, V52, P421, DOI 10.1016/S0753-3322(99)80019-5; Balakrishnan Sivaraman, 2009, BMC Genomics, V10 Suppl 3, pS30, DOI 10.1186/1471-2164-10-S3-S30; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Chen SSL, 2009, J VIROL, V83, P870, DOI 10.1128/JVI.01088-08; Craig HM, 1999, VIROLOGY, V262, P55, DOI 10.1006/viro.1999.9897; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Dickerson JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-80; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Evans P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008942; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; FRIBORG J, 1995, J ACQ IMMUN DEF SYND, V8, P10; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Haffar O, 2005, J VIROL, V79, P13028, DOI 10.1128/JVI.79.20.13028-13036.2005; HARADA K, 2009, ARTIFICIAL LIFE ROBO, V14, P4; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Henschel A, 2006, BIOINFORMATICS, V22, P550, DOI 10.1093/bioinformatics/bti782; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Jian H, 2003, J BIOL CHEM, V278, P44326, DOI 10.1074/jbc.C300378200; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Li HQ, 2006, BIOINFORMATICS, V22, P989, DOI 10.1093/bioinformatics/btl020; Liu YC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-349; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Meggio F, 2001, MOL CELL BIOCHEM, V227, P145, DOI 10.1023/A:1013177326481; Meggio F, 1996, BIOCHEM BIOPH RES CO, V226, P547, DOI 10.1006/bbrc.1996.1392; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Nie ZL, 1998, J VIROL, V72, P4104, DOI 10.1128/JVI.72.5.4104-4115.1998; Perez MAS, 2010, J PHYS CHEM B, V114, P2525, DOI 10.1021/jp910958u; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRASAD KVS, 1993, MOL CELL BIOL, V13, P7708, DOI 10.1128/MCB.13.12.7708; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schindler M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-1; Sei S, 2000, J VIROL, V74, P4621, DOI 10.1128/JVI.74.10.4621-4633.2000; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tan SH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-502; Tastan O, 2009, BIOPHYS J, V96, P2299, DOI 10.1016/j.bpj.2008.12.3894; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Vendel AC, 2003, BIOCHEMISTRY-US, V42, P910, DOI 10.1021/bi0270034; Wang Hui, 2010, Zhonghua Yi Xue Za Zhi, V90, P584; Yang X, 1996, J BIOL CHEM, V271, P10121, DOI 10.1074/jbc.271.17.10121; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879	67	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23293	10.1371/journal.pone.0023293	http://dx.doi.org/10.1371/journal.pone.0023293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858059	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700015
J	Gafuik, C; Steller, H				Gafuik, Christopher; Steller, Hermann			A Gain-of-Function Germline Mutation in Drosophila ras1 Affects Apoptosis and Cell Fate during Development	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ACTIVATED PROTEIN-KINASE; DNA-BINDING PROTEIN; SIGNALING PATHWAY; KRAS MUTATIONS; STRUCTURAL BASIS; RAS ONCOGENES; GROWTH-FACTOR; RHO GTPASE; DEATH	The RAS/MAPK signal transduction pathway is an intracellular signaling cascade that transmits environmental signals from activated receptor tyrosine kinases (RTKs) on the cell surface and other endomembranes to transcription factors in the nucleus, thereby linking extracellular stimuli to changes in gene expression. Largely as a consequence of its role in oncogenesis, RAS signaling has been the subject of intense research efforts for many years. More recently, it has been shown that milder perturbations in Ras signaling during embryogenesis also contribute to the etiology of a group of human diseases. Here we report the identification and characterization of the first gain-of-function germline mutation in Drosophila ras1 (ras85D), the Drosophila homolog of human K-ras, N-ras and H-ras. A single amino acid substitution (R68Q) in the highly conserved switch II region of Ras causes a defective protein with reduced intrinsic GTPase activity, but with normal sensitivity to GAP stimulation. The ras1(R68Q) mutant is homozygous viable but causes various developmental defects associated with elevated Ras signaling, including cell fate changes and ectopic survival of cells in the nervous system. These biochemical and functional properties are reminiscent of germline Ras mutants found in patients afflicted with Noonan, Costello or cardio-facio-cutaneous syndromes. Finally, we used ras1(R68Q) to identify novel genes that interact with Ras and suppress cell death.	[Gafuik, Christopher; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Gafuik, C (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	steller@rockefeller.edu			National Institutes of Health [R01GM60124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01GM60124 to HS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Asha H, 2003, GENETICS, V163, P203; Bader M, 2009, CURR OPIN CELL BIOL, V21, P878, DOI 10.1016/j.ceb.2009.09.005; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Bergmann A, 1998, ONCOGENE, V17, P3215, DOI 10.1038/sj.onc.1202586; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bilak A, 2009, APOPTOSIS, V14, P943, DOI 10.1007/s10495-009-0374-2; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOS JL, 1989, CANCER RES, V49, P4682; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brose MS, 2002, CANCER RES, V62, P6997; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Cagan RL, 2003, CURR BIOL, V13, pR600, DOI 10.1016/S0960-9822(03)00525-6; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; ELLIS MC, 1993, DEVELOPMENT, V119, P855; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Halfar K, 2001, DEVELOPMENT, V128, P1687; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kaplan Y, 2010, DEV CELL, V19, P160, DOI 10.1016/j.devcel.2010.06.009; Karim FD, 1998, DEVELOPMENT, V125, P1; Karim FD, 1996, GENETICS, V143, P315; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lee SH, 2003, ONCOGENE, V22, P6942, DOI 10.1038/sj.onc.1206749; Lisi S, 2000, GENETICS, V154, P669; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Morante J, 2007, CURR OPIN GENET DEV, V17, P314, DOI 10.1016/j.gde.2007.05.003; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Parrizas M, 1997, J BIOL CHEM, V272, P154; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Peverali FA, 1996, EMBO J, V15, P3943, DOI 10.1002/j.1460-2075.1996.tb00768.x; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rebay I, 2000, GENETICS, V154, P695; Rebay I, 2002, DEV BIOL, V251, P1, DOI 10.1006/dbio.2002.0806; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Sandu C, 2010, J CELL BIOL, V190, P1039, DOI 10.1083/jcb.201004086; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; SONNENFELD MJ, 1995, DEVELOPMENT, V121, P569; STELLER H, 1994, NEURON, V13, P1269, DOI 10.1016/0896-6273(94)90413-8; Steller H, 2008, NAT CELL BIOL, V10, P1387, DOI 10.1038/ncb1208-1387; Stemerdink C, 1997, DEVELOPMENT, V124, P3787; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yang LH, 2001, DEVELOPMENT, V128, P1183; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zachariou A, 2003, EMBO J, V22, P6642, DOI 10.1093/emboj/cdg617; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	101	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23535	10.1371/journal.pone.0023535	http://dx.doi.org/10.1371/journal.pone.0023535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858158	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500052
J	Bucci, MP; Kapoula, Z; Bui-Quoc, E; Bouet, A; Wiener-Vacher, S				Bucci, Maria Pia; Kapoula, Zoi; Bui-Quoc, Emmanuel; Bouet, Aurelie; Wiener-Vacher, Sylvette			Saccades and Vergence Performance in a Population of Children with Vertigo and Clinically Assessed Abnormal Vergence Capabilities	PLOS ONE			English	Article							SHORT REACTION-TIMES; EYE-MOVEMENTS; CONVERGENCE INSUFFICIENCY; VISUOSPATIAL ATTENTION; WARNING SIGNALS; STIMULUS ONSET; LATENCY; GAP; OFFSET; AGE	Purpose: Early studies reported some abnormalities in saccade and vergence eye movements in children with vertigo and vergence deficiencies. The purpose of this study was to further examine saccade and vergence performance in a population of 44 children (mean age: 12.3 +/- 1.6 years) with vertigo symptoms and with different levels of vergence abnormalities, as assessed by static orthoptic examination (near point of convergence, prism bar and cover-uncover test). Methods: Three groups were identified on the basis of the orthoptic tests: group 1 (n = 13) with vergence spasms and mildly perturbed orthoptic scores, group 2 (n = 14) with moderately perturbed orthoptic scores, and group 3 (n = 17) with severely perturbed orthoptic scores. Data were compared to those recorded from 28 healthy children of similar ages. Latency, accuracy and peak velocity of saccades and vergence movements were measured in two different conditions: gap (fixation offset 200 ms prior to target onset) and simultaneous paradigms. Binocular horizontal movements were recorded by a photoelectric device. Results: Group 2 of children with vergence abnormalities showed significantly longer latency than normal children in several types of eye movements recorded. For all three groups of children with vergence abnormalities, the gain was poor, particularly for vergence movement. The peak velocity values did not differ between the different groups of children examined. Interpretation: Eye movement measures together with static orthoptic evaluation allowed us to better identify children with vergence abnormalities based on their slow initiation of eye movements. Overall, these findings support the hypothesis of a central deficit in the programming and triggering of saccades and vergence in these children.	[Bucci, Maria Pia] Univ Paris 05, Lab Psychol & Neuropsychol Cognit, FRE CNRS IUPDP 3292, Boulogne Billancourt, France; [Kapoula, Zoi] CNRS, CESM, UMR 8194, Paris, France; [Bui-Quoc, Emmanuel; Bouet, Aurelie] Hop Robert Debre, Serv OPH, F-75019 Paris, France; [Wiener-Vacher, Sylvette] Hop Robert Debre, Serv ORL, F-75019 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Univ Paris 05, Lab Psychol & Neuropsychol Cognit, FRE CNRS IUPDP 3292, Boulogne Billancourt, France.	maria-pia.bucci@parisdescartes.fr	Zixuan, Huang/ABI-3557-2020					Anoh-Tanon MJ, 2000, PEDIATR NEUROL, V23, P49, DOI 10.1016/S0887-8994(00)00140-5; BACH M, 1983, J NEUROSCI METH, V9, P9, DOI 10.1016/0165-0270(83)90103-6; Brandt T., 2003, VERTIGO ITS MULTISEN; Bucci MP, 2008, EXP BRAIN RES, V188, P1, DOI 10.1007/s00221-008-1345-5; Bucci MP, 2006, VISION RES, V46, P3594, DOI 10.1016/j.visres.2006.06.001; Bucci MP, 2009, INVEST OPHTH VIS SCI, V50, P4678, DOI 10.1167/iovs.09-3537; Bucci MP, 2005, EXP BRAIN RES, V164, P48, DOI 10.1007/s00221-005-2214-0; Bucci MP, 2004, EXP BRAIN RES, V157, P286, DOI 10.1007/s00221-004-1842-0; Bucci MP, 2004, J NEUROL, V251, P204, DOI 10.1007/s00415-004-0304-8; BUCCI MP, 1999, J OPHTHALMOL; BUCCI MP, MOTOR CONTROL UNPUB; Clark JJ, 1999, VISION RES, V39, P585, DOI 10.1016/S0042-6989(98)00190-4; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Fischer B, 2000, PERCEPTION, V29, P531, DOI 10.1068/p2666c; FISCHER B, 1984, EXP BRAIN RES, V57, P191; FISCHER B, 1983, BRAIN RES, V260, P21, DOI 10.1016/0006-8993(83)90760-6; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; GRIFFIN JR, 1987, AM J OPTOM PHYS OPT, V64, P411; Jacot E, 2009, INT J PEDIATR OTORHI, V73, P209, DOI 10.1016/j.ijporl.2008.10.024; KINGSTONE A, 1993, J EXP PSYCHOL HUMAN, V19, P1251, DOI 10.1037/0096-1523.19.6.1251; Klein C, 2001, PSYCHOPHYSIOLOGY, V38, P179; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Moutakis K, 2004, ACTA OPHTHALMOL SCAN, V82, P547, DOI 10.1111/j.1600-0420.2004.00307.x; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; REUTERLORENZ PA, 1991, PERCEPT PSYCHOPHYS, V49, P167, DOI 10.3758/BF03205036; RIDDELL PM, 1990, PERCEPT MOTOR SKILL, V70, P707, DOI 10.2466/PMS.70.3.707-718; ROSS LE, 1980, PERCEPT PSYCHOPHYS, V27, P251, DOI 10.3758/BF03204262; ROSS RG, 1994, J AUTISM DEV DISORD, V24, P413, DOI 10.1007/BF02172126; ROSS SM, 1981, PERCEPT PSYCHOPHYS, V29, P429, DOI 10.3758/BF03207356; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Rutstein R P, 1988, J Am Optom Assoc, V59, P527; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Scheiman M, 2005, BRIT J OPHTHALMOL, V89, P1318, DOI 10.1136/bjo.2005.068197; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; STEIN JF, 1986, BRIT J OPHTHALMOL, V70, P317, DOI 10.1136/bjo.70.4.317; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; van Leeuwen AF, 1999, VISION RES, V39, P3095, DOI 10.1016/S0042-6989(99)00066-8; VONNOORDEN GK, 2006, BINOCULAR VISION OCU; WienerVacher SR, 1996, ACTA OTO-LARYNGOL, V116, P657	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23125	10.1371/journal.pone.0023125	http://dx.doi.org/10.1371/journal.pone.0023125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858007	Green Published, gold			2022-12-27	WOS:000293774300022
J	Acuna-Soto, R; Viboud, C; Chowell, G				Acuna-Soto, Rodolfo; Viboud, Cecile; Chowell, Gerardo			Influenza and Pneumonia Mortality in 66 Large Cities in the United States in Years Surrounding the 1918 Pandemic	PLOS ONE			English	Article							INCREASED SUSCEPTIBILITY; PNEUMOCOCCAL SURFACE; BACTERIAL PNEUMONIA; SPANISH INFLUENZA; EPIDEMIC; WAVE; SUPERINFECTION; INFECTION; PATTERNS; IMPACT	The 1918 influenza pandemic was a major epidemiological event of the twentieth century resulting in at least twenty million deaths worldwide; however, despite its historical, epidemiological, and biological relevance, it remains poorly understood. Here we examine the relationship between annual pneumonia and influenza death rates in the pre-pandemic (1910-17) and pandemic (1918-20) periods and the scaling of mortality with latitude, longitude and population size, using data from 66 large cities of the United States. The mean pre-pandemic pneumonia death rates were highly associated with pneumonia death rates during the pandemic period (Spearman rho = 0.64-0.72; P < 0.001). By contrast, there was a weak correlation between pre-pandemic and pandemic influenza mortality rates. Pneumonia mortality rates partially explained influenza mortality rates in 1918 (rho = 0.34, P = 0.005) but not during any other year. Pneumonia death counts followed a linear relationship with population size in all study years, suggesting that pneumonia death rates were homogeneous across the range of population sizes studied. By contrast, influenza death counts followed a power law relationship with a scaling exponent of similar to 0.81 (95% CI: 0.71, 0.91) in 1918, suggesting that smaller cities experienced worst outcomes during the pandemic. A linear relationship was observed for all other years. Our study suggests that mortality associated with the 1918-20 influenza pandemic was in part predetermined by pre-pandemic pneumonia death rates in 66 large US cities, perhaps through the impact of the physical and social structure of each city. Smaller cities suffered a disproportionately high per capita influenza mortality burden than larger ones in 1918, while city size did not affect pneumonia mortality rates in the pre-pandemic and pandemic periods.	[Acuna-Soto, Rodolfo] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Viboud, Cecile; Chowell, Gerardo] NIH, Div Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Chowell, Gerardo] Arizona State Univ, Sch Human Evolut & Social Change, Computat & Modeling Sci Ctr, Tempe, AZ USA	Universidad Nacional Autonoma de Mexico; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Arizona State University; Arizona State University-Tempe	Acuna-Soto, R (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.	acunasoto.rodolfo@gmail.com	Chowell, Gerardo/F-5038-2012	Chowell, Gerardo/0000-0003-2194-2251; Acuna-Soto, Rodolfo/0000-0002-8477-0170				Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; *BUR CENS, 1933, MORT RAT 1910 1920 P; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Chowell G, 2010, J INFECT DIS, V202, P567, DOI 10.1086/654897; Collins SD, 1930, AM J PUBLIC HEALTH N, V20, P119, DOI 10.2105/AJPH.20.2.119; Hakansson A, 2001, INFECT IMMUN, V69, P3372, DOI 10.1128/IAI.69.5.3372-3381.2001; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lim AJ, 1919, BRIT MED J, V1919, P154, DOI 10.1136/bmj.1.3032.154; Mamelund SE, 2006, SOC SCI MED, V62, P923, DOI 10.1016/j.socscimed.2005.06.051; *MIN HLTH, 1920, 81 MIN HLTH S, P48; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morse SS, 2007, P NATL ACAD SCI USA, V104, P7313, DOI 10.1073/pnas.0702659104; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; PATTERSON KD, 1991, B HIST MED, V65, P4; PEARL R, 1919, INFLUENZA STUDIES, V1; Pearl R., 1921, PUBLIC HLTH REPORTS, V36, P273, DOI [10.2307/4575894, DOI 10.2307/4575894]; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Small CL, 2010, J IMMUNOL, V184, P2048, DOI 10.4049/jimmunol.0902772; Stegemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004840; Taubenberger JK, 2007, ANTIVIR THER, V12, P581; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tomanek E, 1924, P NATL ACAD SCI USA, V10, P161, DOI 10.1073/pnas.10.5.161; *US BUR CENS, 1906, SPEC REP MORT STAT 1; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208	31	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23467	10.1371/journal.pone.0023467	http://dx.doi.org/10.1371/journal.pone.0023467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886792	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100014
J	Merica, H; Fortune, RD				Merica, Helli; Fortune, Ronald D.			The Neuronal Transition Probability (NTP) Model for the Dynamic Progression of Non-REM Sleep EEG: The Role of the Suprachiasmatic Nucleus	PLOS ONE			English	Article							VENTROLATERAL PREOPTIC NUCLEUS; ASCENDING AROUSAL SYSTEM; BRAIN-STEM; CIRCADIAN REGULATION; MATHEMATICAL-MODEL; SPINDLE ACTIVITY; DELTA-WAVES; SLOW; OSCILLATIONS; MECHANISMS	Little attention has gone into linking to its neuronal substrates the dynamic structure of non-rapid-eye-movement (NREM) sleep, defined as the pattern of time-course power in all frequency bands across an entire episode. Using the spectral power time-courses in the sleep electroencephalogram (EEG), we showed in the typical first episode, several moves towards-and-away from deep sleep, each having an identical pattern linking the major frequency bands beta, sigma and delta. The neuronal transition probability model (NTP) - in fitting the data well - successfully explained the pattern as resulting from stochastic transitions of the firing-rates of the thalamically-projecting brainstem-activating neurons, alternating between two steady dynamic-states (towards-and-away from deep sleep) each initiated by a so-far unidentified flip-flop. The aims here are to identify this flip-flop and to demonstrate that the model fits well all NREM episodes, not just the first. Using published data on suprachiasmatic nucleus (SCN) activity we show that the SCN has the information required to provide a threshold-triggered flip-flop for TIMING the towards-and-away alternations, information provided by sleep-relevant feedback to the SCN. NTP then determines the PATTERN of spectral power within each dynamic-state. NTP was fitted to individual NREM episodes 1-4, using data from 30 healthy subjects aged 20-30 years, and the quality of fit for each NREM measured. We show that the model fits well all NREM episodes and the best-fit probability-set is found to be effectively the same in fitting all subject data. The significant model-data agreement, the constant probability parameter and the proposed role of the SCN add considerable strength to the model. With it we link for the first time findings at cellular level and detailed time-course data at EEG level, to give a coherent picture of NREM dynamics over the entire night and over hierarchic brain levels all the way from the SCN to the EEG.	[Merica, Helli] Hop Univ Geneve, Lab Sommeil & Neurophysiol, Geneva, Switzerland; [Fortune, Ronald D.] CERN European Org Nucl Res, Geneva, Switzerland	University of Geneva; European Organization for Nuclear Research (CERN)	Merica, H (corresponding author), Hop Univ Geneve, Lab Sommeil & Neurophysiol, Geneva, Switzerland.	helli.merica@hcuge.ch			Swiss National Science Foundation [3100A0-112500]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funded by The Swiss National Science Foundation (www.snf.ch) Grant# 3100A0-112500 to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Borbely A A, 1982, Hum Neurobiol, V1, P195; CHOU TC, 2003, THESIS HARVARD U CAM; Contreras D, 1997, J NEUROSCI, V17, P1179; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; Deurveilher S, 2002, EUR J NEUROSCI, V16, P1195, DOI 10.1046/j.1460-9568.2002.02196.x; DIJK DJ, 1995, J NEUROSCI, V15, P3526; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; FERMI E, 1950, NUCL PHYS, P24; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gooley J, 2011, PRINCIPLES PRACTICE, V5, P376; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; JONES BE, 1994, PRINCIPLES PRACTICE, P145; Kryger MH, 2011, PRINCIPLES PRACTICE, P431, DOI [DOI 10.1016/B978-1-4160-6645-3.00037-2, DOI 10.1016/13978-1-4160-6645-3.00037-2]; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; LIN KH, 1973, CHEM ENG HDB, P4; Lu J, 1999, NEUROSCIENCE, V93, P209, DOI 10.1016/S0306-4522(99)00094-9; MCCARLEY RW, 1992, J SLEEP RES, V1, P132, DOI 10.1111/j.1365-2869.1992.tb00026.x; MCCARLEY RW, 1986, AM J PHYSIOL, V251, pR1011, DOI 10.1152/ajpregu.1986.251.6.R1011; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McGinty D, 2001, SLEEP MED REV, V5, P323, DOI 10.1053/smrv.2001.0170; Merica H, 2000, Sleep Res Online, V3, P53; Merica H, 2005, CEREB CORTEX, V15, P877, DOI 10.1093/cercor/bhh192; Merica H, 2003, CEREB CORTEX, V13, P1044, DOI 10.1093/cercor/13.10.1044; MERICA H, 1991, PHYSIOL BEHAV, V50, P1153, DOI 10.1016/0031-9384(91)90576-A; Merica H, 1997, PHYSIOL BEHAV, V62, P585, DOI 10.1016/S0031-9384(97)00165-0; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Molle M, 2002, J NEUROSCI, V22, P10941; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; NAUTA WJH, 1946, J NEUROPHYSIOL, V9, P285, DOI 10.1152/jn.1946.9.4.285; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Saint-Mleux B, 2007, J NEUROSCI, V27, P6412, DOI 10.1523/JNEUROSCI.1432-07.2007; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Steriade M, 1998, Sleep Res Online, V1, P1; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1991, J NEUROSCI, V11, P3200; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STERIADE M, 1984, DYNAMIC ASPECTS NEOC, P107; Steriade M, 1997, THALAMUS, VI; Szymusiak R, 1998, BRAIN RES, V803, P178, DOI 10.1016/S0006-8993(98)00631-3; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; von EC0N0M0 C., 1930, JOUR NERV & MENT DIS, V71, P249; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wurts SW, 2000, J NEUROSCI, V20, P4300	65	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23593	10.1371/journal.pone.0023593	http://dx.doi.org/10.1371/journal.pone.0023593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886801	gold, Green Submitted, Green Published			2022-12-27	WOS:000294128100021
J	Crispino, G; Di Pasquale, G; Scimemi, P; Rodriguez, L; Ramirez, FG; De Siati, RD; Santarelli, RM; Arslan, E; Bortolozzi, M; Chiorini, JA; Mammano, F				Crispino, Giulia; Di Pasquale, Giovanni; Scimemi, Pietro; Rodriguez, Laura; Ramirez, Fabian Galindo; De Siati, Romolo Daniele; Santarelli, Rosa Maria; Arslan, Edoardo; Bortolozzi, Mario; Chiorini, John A.; Mammano, Fabio			BAAV Mediated GJB2 Gene Transfer Restores Gap Junction Coupling in Cochlear Organotypic Cultures from Deaf Cx26Sox10Cre Mice	PLOS ONE			English	Article							BOVINE ADENOASSOCIATED VIRUS; CONNEXIN 26; INNER-EAR; HEARING IMPAIRMENT; ATP RELEASE; EXPRESSION; COMMUNICATION; PERMEABILITY; DEGENERATION; HEMICHANNELS	The deafness locus DFNB1 contains GJB2, the gene encoding connexin26 and GJB6, encoding connexin30, which appear to be coordinately regulated in the inner ear. In this work, we investigated the expression and function of connexin26 and connexin30 from postnatal day 5 to adult age in double transgenic Cx26(Sox10Cre) mice, which we obtained by crossing connexin26 floxed mice with a deleter Sox10-Cre line. Cx26(Sox10Cre) mice presented with complete connexin26 ablation in the epithelial gap junction network of the cochlea, whereas connexin30 expression was developmentally delayed; immunolabeling patterns for both connexins were normal in the cochlear lateral wall. In vivo electrophysiological measurements in Cx26(Sox10Cre) mice revealed profound hearing loss accompanied by reduction of endocochlear potential, and functional experiments performed in postnatal cochlear organotypic cultures showed impaired gap junction coupling. Transduction of these cultures with a bovine adeno associated virus vector restored connexin26 protein expression and rescued gap junction coupling. These results suggest that restoration of normal connexin levels by gene delivery via recombinant adeno associated virus could be a way to rescue hearing function in DFNB1 mouse models and, in future, lead to the development of therapeutic interventions in humans.	[Crispino, Giulia; Rodriguez, Laura; Ramirez, Fabian Galindo; Bortolozzi, Mario; Mammano, Fabio] Ist Veneto Med Mol, Fdn Ric Biomed Avanzata, Padua, Italy; [Crispino, Giulia; Rodriguez, Laura; Bortolozzi, Mario; Mammano, Fabio] Univ Padua, Dipartimento Fis G Galilei, Padua, Italy; [Di Pasquale, Giovanni; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Scimemi, Pietro; De Siati, Romolo Daniele; Santarelli, Rosa Maria; Arslan, Edoardo] Univ Padua, Dipartimento Specialita Med Chirurg, Padua, Italy; [Scimemi, Pietro; De Siati, Romolo Daniele; Santarelli, Rosa Maria; Arslan, Edoardo] Univ Padua, Serv Audiol, Padua, Italy; [Bortolozzi, Mario; Mammano, Fabio] Ist CNR Neurosci, Padua, Italy	Veneto Institute Molecular Medicine; University of Padua; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Padua; University of Padua	Crispino, G (corresponding author), Ist Veneto Med Mol, Fdn Ric Biomed Avanzata, Padua, Italy.	fabio.mammano@unipd.it	Mammano, Fabio/I-5064-2012; Scimemi, Pietro/T-5390-2017; Bortolozzi, Mario/H-6872-2015; Mammano, Fabio/AAM-3902-2020	Mammano, Fabio/0000-0003-3751-1691; Scimemi, Pietro/0000-0001-5273-1938; Bortolozzi, Mario/0000-0001-7198-9838; Mammano, Fabio/0000-0003-3751-1691; Galindo Ramirez, Fabian/0000-0001-5536-458X	European Commission [LSHGCT20054512063]; Fondazione Cariparo; Telethon Italy [GGP09137]; Italian Ministry of Research [2007BZ4RX3_003]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Cariparo(Fondazione Cariparo); Telethon Italy(Fondazione Telethon); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by grants to FM from: The European Commission [FP6 Integrated Project EuroHear, grant number LSHGCT20054512063]; Fondazione Cariparo [Progetti di Eccellenza 2006-2007], Telethon Italy [grant number GGP09137], Italian Ministry of Research [PRIN 2007, grant number 2007BZ4RX3_003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Bry C, 2004, DEV BIOL, V267, P418, DOI 10.1016/j.ydbio.2003.11.022; Chang Q, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004088; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Di Pasquale G, 2005, MOL THER, V11, P849, DOI 10.1016/j.ymthe.2005.02.004; Di Pasquale G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009336; DIVIRGILIO F, 1989, METHOD CELL BIOL, V31, P453; EGGSTON AA, 1947, EMBRYOLOGY EAR HISTO, P37; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Gasparini P, 1997, EUR J HUM GENET, V5, P83; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Kelly JJ, 2011, NEUROSCIENCE, V180, P360, DOI 10.1016/j.neuroscience.2011.02.011; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MAGUCHI S, 1991, Auris Nasus Larynx, V18, P1; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; Martinez AD, 2009, ANTIOXID REDOX SIGN, V11, P309, DOI 10.1089/ars.2008.2138; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Rozental R, 2001, METH MOL B, V154, P447; SADANAGA M, 1995, HEARING RES, V89, P155, DOI 10.1016/0378-5955(95)00133-X; Santarelli R, 2003, ACTA OTO-LARYNGOL, V123, P176, DOI 10.1080/0036554021000028108; SANTI PA, 1994, J HISTOCHEM CYTOCHEM, V42, P705, DOI 10.1177/42.6.8189033; Schmidt M, 2004, J VIROL, V78, P6509, DOI 10.1128/JVI.78.12.6509-6516.2004; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; Schutz M, 2010, HUM MOL GENET, V19, P4759, DOI 10.1093/hmg/ddq402; SHEFFIELD AM, 2011, HEAR RES; Shibata SB, 2009, GENE THER, V16, P990, DOI 10.1038/gt.2009.57; STEEL KP, 1989, DEVELOPMENT, V107, P453; Sun Y, 2009, J COMP NEUROL, V516, P569, DOI 10.1002/cne.22117; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; Watanabe K, 2000, MOL BRAIN RES, V84, P141, DOI 10.1016/S0169-328X(00)00236-9; Yoshikawa M, 2009, P NATL ACAD SCI USA, V106, P9483, DOI 10.1073/pnas.0903279106; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	50	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23279	10.1371/journal.pone.0023279	http://dx.doi.org/10.1371/journal.pone.0023279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876744	Green Published, Green Submitted, gold			2022-12-27	WOS:000294126900016
J	Aydin, I; Saijo-Hamano, Y; Namba, K; Thomas, C; Roujeinikova, A				Aydin, Inci; Saijo-Hamano, Yumiko; Namba, Keiichi; Thomas, Connor; Roujeinikova, Anna			Structural Analysis of the Essential Resuscitation Promoting Factor YeaZ Suggests a Mechanism of Nucleotide Regulation through Dimer Reorganization	PLOS ONE			English	Article							CRYSTALLOGRAPHIC ANALYSIS; NONCULTURABLE STATE; ESCHERICHIA-COLI; PROTEIN; KINASE; ACTIN; COMPLEX	Background: The yeaZ gene product forms part of the conserved network YjeE/YeaZ/YgjD essential for the survival of many Gram-negative eubacteria. Among other as yet unidentified roles, YeaZ functions as a resuscitation promoting factor required for survival and resuscitation of cells in a viable but non-culturable (VBNC) state. Methodology/Principal Findings: In order to investigate in detail the structure/function relationship of this family of proteins we have performed X-ray crystallographic studies of Vibrio parahaemolyticus YeaZ. The YeaZ structure showed that it has a classic actin-like nucleotide-binding fold. Comparisons of this crystal structure to that of available homologues from E. coli, T. maritima and S. typhimurium revealed two distinctly different modes of dimer formation. In one form, prevalent in the absence of nucleotide, the putative nucleotide-binding site is incomplete, lacking a binding pocket for a nucleotide base. In the second form, residues from the second subunit complete the nucleotide-binding site. This suggests that the two dimer architectures observed in the crystal structures correspond to a free and a nucleotide-bound form of YeaZ. A multiple sequence alignment of YeaZ proteins from different bacteria allowed us to identify a large conserved hydrophobic patch on the protein surface that becomes exposed upon nucleotide-driven dimer re-arrangement. We hypothesize that the transition between two dimer architectures represents the transition between the 'on' and 'off' states of YeaZ. The effect of this transition is to alternately expose and bury a docking site for the partner protein YgjD. Conclusions/Significance: This paper provides the first structural insight into the putative mechanism of nucleotide regulation of YeaZ through dimer reorganization. Our analysis suggests that nucleotide binding to YeaZ may act as a regulator or switch that changes YeaZ shape, allowing it to switch partners between YjeE and YgjD.	[Aydin, Inci; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Aydin, Inci; Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; [Saijo-Hamano, Yumiko; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Thomas, Connor] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Monash University; Monash University; Osaka University; University of Adelaide	Aydin, I (corresponding author), Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany.	anna.roujeinikova@monash.edu	Namba, Keiichi/A-9406-2016	Roujeinikova, Anna/0000-0001-8478-4751	Australian Research Council [DP1094619]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Research Fellowship to AR, DP1094619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin I, 2011, ACTA CRYSTALLOGR F, V67, P604, DOI 10.1107/S1744309111010219; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Buss KA, 2001, J BACTERIOL, V183, P680, DOI 10.1128/JB.183.2.680-686.2001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Hecker A, 2009, BIOCHEM SOC T, V37, P29, DOI 10.1042/BST0370029; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Jeudy S, 2005, ACTA CRYSTALLOGR F, V61, P848, DOI 10.1107/S1744309105025856; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Msadek T, 2009, J BACTERIOL, V191, P4701, DOI 10.1128/JB.00572-09; Nichols CE, 2006, PROTEINS, V64, P111, DOI 10.1002/prot.20982; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; Panutdaporn N, 2006, INT J FOOD MICROBIOL, V106, P241, DOI 10.1016/j.ijfoodmicro.2005.06.022; SRINIVASAN M, 2010, EMBO J, V29, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1230, DOI 10.1107/S1744309109022192; YACOUBI BE, 2011, EMBO J, V30, P882	30	18	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23245	10.1371/journal.pone.0023245	http://dx.doi.org/10.1371/journal.pone.0023245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858042	gold, Green Submitted, Green Published			2022-12-27	WOS:000294121300022
J	McCutcheon, S; Blanco, ARA; Houston, EF; de Wolf, C; Tan, BC; Smith, A; Groschup, MH; Hunter, N; Hornsey, VS; MacGregor, IR; Prowse, CV; Turner, M; Manson, JC				McCutcheon, Sandra; Blanco, Anthony Richard Alejo; Houston, E. Fiona; de Wolf, Christopher; Tan, Boon Chin; Smith, Antony; Groschup, Martin H.; Hunter, Nora; Hornsey, Valerie S.; MacGregor, Ian R.; Prowse, Christopher V.; Turner, Marc; Manson, Jean C.			All Clinically-Relevant Blood Components Transmit Prion Disease following a Single Blood Transfusion: A Sheep Model of vCJD	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; VARIANT CJD; INFECTIOUS PRIONS; SCRAPIE; PROTEIN; BSE; PATHOGENESIS; AGENT	Variant CJD (vCJD) is an incurable, infectious human disease, likely arising from the consumption of BSE-contaminated meat products. Whilst the epidemic appears to be waning, there is much concern that vCJD infection may be perpetuated in humans by the transfusion of contaminated blood products. Since 2004, several cases of transfusion-associated vCJD transmission have been reported and linked to blood collected from pre-clinically affected donors. Using an animal model in which the disease manifested resembles that of humans affected with vCJD, we examined which blood components used in human medicine are likely to pose the greatest risk of transmitting vCJD via transfusion. We collected two full units of blood from BSE-infected donor animals during the pre-clinical phase of infection. Using methods employed by transfusion services we prepared red cell concentrates, plasma and platelets units (including leucoreduced equivalents). Following transfusion, we showed that all components contain sufficient levels of infectivity to cause disease following only a single transfusion and also that leucoreduction did not prevent disease transmission. These data suggest that all blood components are vectors for prion disease transmission, and highlight the importance of multiple control measures to minimise the risk of human to human transmission of vCJD by blood transfusion.	[McCutcheon, Sandra; Blanco, Anthony Richard Alejo; de Wolf, Christopher; Tan, Boon Chin; Hunter, Nora; Manson, Jean C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [McCutcheon, Sandra; Blanco, Anthony Richard Alejo; de Wolf, Christopher; Tan, Boon Chin; Hunter, Nora; Manson, Jean C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Houston, E. Fiona] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Smith, Antony] Inst Anim Hlth, Compton, Berks, England; [Groschup, Martin H.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Riems Isl, Germany; [Hornsey, Valerie S.; MacGregor, Ian R.; Prowse, Christopher V.] SNBTS, Natl Sci Lab, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Friedrich Loeffler Institute	McCutcheon, S (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	jean.manson@roslin.ed.ac.uk		Tan, Kyle BC/0000-0001-5901-2418; manson, jean/0000-0002-0175-9890	Department of Health, UK [007/0162]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001161, BBS/E/D/05241339, BBS/E/D/05241340] Funding Source: researchfish; BBSRC [BBS/E/D/05241340, BBS/E/D/05241339] Funding Source: UKRI	Department of Health, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health, UK (007/0162). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Banks WA, 2004, BIOCHEM BIOPH RES CO, V318, P125, DOI 10.1016/j.bbrc.2004.04.009; Beekes M, 1998, J GEN VIROL, V79, P601, DOI 10.1099/0022-1317-79-3-601; Bishop MT, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-146; Bons N, 2002, TRANSFUSION, V42, P513, DOI 10.1046/j.1537-2995.2002.00098.x; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; *COMM JUNPA, 2010, POS STAT CREUTZF JAC; EDGEWORTH JA, 2011, LANCET; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, TRANSFUSION, V46, P1152, DOI 10.1111/j.1537-2995.2006.00865.x; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Krailadsiri P, 2006, TRANSFUSION, V46, P407, DOI 10.1111/j.1537-2995.2006.00737.x; Laegreid WW, 2008, J VIROL, V82, P10318, DOI 10.1128/JVI.00710-08; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Martin S, 2005, J GEN VIROL, V86, P839, DOI 10.1099/vir.0.80364-0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Mattei V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005057; McCutcheon S, 2005, J IMMUNOL METHODS, V298, P119, DOI 10.1016/j.jim.2005.01.012; Miekka SI, 2003, VOX SANG, V84, P36, DOI 10.1046/j.1423-0410.2003.00256.x; *NAT BLOOD SERV U, 2005, GUID BLOOD TRANSF SE; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Peden Alexander H, 2004, Folia Neuropathol, V42 Suppl A, P85; Prowse CV, 1999, BRIT J HAEMATOL, V106, P240; Saunders GC, 2009, J GEN VIROL, V90, P2569, DOI 10.1099/vir.0.012724-0; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Siso S, 2006, BLOOD, V108, P745, DOI 10.1182/blood-2005-12-5156; *UK NCJDSU, TRANSF MED EP REV TM; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	54	66	68	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23169	10.1371/journal.pone.0023169	http://dx.doi.org/10.1371/journal.pone.0023169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858015	Green Accepted, Green Published, gold			2022-12-27	WOS:000294121300015
J	Siegler, JC; Rehman, S; Bhumireddy, GP; Abdula, R; Klem, I; Brener, SJ; Lee, L; Dunbar, CC; Saul, B; Sacchi, TJ; Heitner, JF				Siegler, Jason C.; Rehman, Shafiq; Bhumireddy, Geetha P.; Abdula, Raushan; Klem, Igor; Brener, Sorin J.; Lee, Leonard; Dunbar, Christopher C.; Saul, Barry; Sacchi, Terrence J.; Heitner, John F.			The Accuracy of the Electrocardiogram during Exercise Stress Test Based on Heart Size	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; INCREMENTAL PROGNOSTIC VALUE; MYOCARDIAL-PERFUSION SPECT; CORONARY-ARTERY-DISEASE; GATED SPECT; DIAGNOSTIC-ACCURACY; WOMEN; VOLUME; MEN	Background: Multiple studies have shown that the exercise electrocardiogram (ECG) is less accurate for predicting ischemia, especially in women, and there is additional evidence to suggest that heart size may affect its diagnostic accuracy. Hypothesis: The purpose of this investigation was to assess the diagnostic accuracy of the exercise ECG based on heart size. Methods: We evaluated 1,011 consecutive patients who were referred for an exercise nuclear stress test. Patients were divided into two groups: small heart size defined as left ventricular end diastolic volume (LVEDV) < 65 mL (Group A) and normal heart size defined as LVEDV >= 65 mL (Group B) and associations between ECG outcome (false positive vs. no false positive) and heart size (small vs. normal) were analyzed using the Chi square test for independence, with a Yates continuity correction. LVEDV calculations were performed via a computer-processing algorithm. SPECT myocardial perfusion imaging was used as the gold standard for the presence of coronary artery disease (CAD). Results: Small heart size was found in 142 patients, 123 female and 19 male patients. There was a significant association between ECG outcome and heart size (chi(2) = 4.7, p = 0.03), where smaller hearts were associated with a significantly greater number of false positives. Conclusions: This study suggests a possible explanation for the poor diagnostic accuracy of exercise stress testing, especially in women, as the overwhelming majority of patients with small heart size were women.	[Siegler, Jason C.] Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Rehman, Shafiq; Bhumireddy, Geetha P.; Abdula, Raushan; Brener, Sorin J.; Dunbar, Christopher C.; Saul, Barry; Sacchi, Terrence J.; Heitner, John F.] New York Methodist Hosp, Div Cardiol, Brooklyn, NY USA; [Dunbar, Christopher C.] CUNY Brooklyn Coll, New York, NY USA; [Lee, Leonard] New York Methodist Hosp, Div Cardiothorac Surg, Brooklyn, NY USA; [Klem, Igor] Duke Med Ctr, Div Cardiol, Durham, NC USA	University of Hull; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; City University of New York (CUNY) System; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; Duke University	Siegler, JC (corresponding author), Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	john.heitner@gmail.com		Siegler, Jason/0000-0003-1346-4982; REHMAN, SHAFIQ/0000-0002-4357-849X				*AM HEART ASS SCI, 2005, CIRCULATION, V111, P682; American College., 2006, ACSMS GUID EX TEST P; BAROLSKY SM, 1979, CIRCULATION, V5, P1021; Bokhari S, 2002, J AM COLL CARDIOL, V40, P1092, DOI 10.1016/S0735-1097(02)02111-3; CWAJG E, 2000, REV PORT CAR S1 0219, P39; de Simone G, 1998, HYPERTENSION, V31, P1077, DOI 10.1161/01.HYP.31.5.1077; Feng B, 2002, J NUCL MED, V43, P786; Ford PV, 2001, J NUCL MED, V42, P454; Germano G, 1998, J NUCL CARDIOL, V5, P477, DOI 10.1016/S1071-3581(98)90178-7; Gimelli A, 2008, INT J CARDIOVAS IMAG, V24, P793, DOI 10.1007/s10554-008-9317-1; Hachamovitch R, 1996, J AM COLL CARDIOL, V28, P34, DOI 10.1016/0735-1097(96)00095-2; Hansen CL, 2007, J NUCL CARDIOL, V14, P134, DOI 10.1016/j.nuclcard.2006.11.009; Hansen CL, 1996, J AM COLL CARDIOL, V28, P1214, DOI 10.1016/S0735-1097(96)00304-X; Iskandrian AE, 1997, J NUCL CARDIOL, V4, P329, DOI 10.1016/S1071-3581(97)90111-2; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; MAGDY MK, 2005, NUCL MED COMMUN, V26, P885; Maruyama K, 2003, ANN NUCL MED, V17, P31, DOI 10.1007/BF02988256; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; MIERES JH, 2003, J NUCL CARDIOL   JAN; Miller TD, 2001, AM J CARDIOL, V87, P868, DOI 10.1016/S0002-9149(00)01528-9; MORISE AP, 1995, AM HEART J, V130, P741, DOI 10.1016/0002-8703(95)90072-1; Nakajima K, 2000, EUR J NUCL MED, V27, P1372, DOI 10.1007/s002590000299; Nichols K, 1998, J NUCL CARDIOL, V5, P295, DOI 10.1016/S1071-3581(98)90131-3; Nichols K, 2000, J NUCL MED, V41, P1308; OKIN PM, 1995, CIRCULATION, V92, P1209, DOI 10.1161/01.CIR.92.5.1209; PANCHOLY SB, 1995, J NUCL CARDIOL, V2, P110, DOI 10.1016/S1071-3581(06)80020-6; PRATT JP, 1999, J NUCL MED S, V40; Santana-Boado C, 1998, J NUCL MED, V39, P751; SCHWARTZ RG, 1999, J NUCL CARDIOL, V6, pS17; Sharir T, 1999, CIRCULATION, V100, P1035, DOI 10.1161/01.CIR.100.10.1035; SKETCH MH, 1975, AM J CARDIOL, V36, P169, DOI 10.1016/0002-9149(75)90521-4; Toba M, 2000, ANN NUCL MED, V14, P421, DOI 10.1007/BF02988287; VAL P G, 1982, Circulation, V65, P1465	33	0	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23044	10.1371/journal.pone.0023044	http://dx.doi.org/10.1371/journal.pone.0023044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857990	Green Published, gold			2022-12-27	WOS:000294121300011
J	Steger, D; Berry, D; Haider, S; Horn, M; Wagner, M; Stocker, R; Loy, A				Steger, Doris; Berry, David; Haider, Susanne; Horn, Matthias; Wagner, Michael; Stocker, Roman; Loy, Alexander			Systematic Spatial Bias in DNA Microarray Hybridization Is Caused by Probe Spot Position-Dependent Variability in Lateral Diffusion	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; NORMALIZATION; DYNAMICS; KINETICS; SINGLE; MODEL	Background: The hybridization of nucleic acid targets with surface-immobilized probes is a widely used assay for the parallel detection of multiple targets in medical and biological research. Despite its widespread application, DNA microarray technology still suffers from several biases and lack of reproducibility, stemming in part from an incomplete understanding of the processes governing surface hybridization. In particular, non-random spatial variations within individual microarray hybridizations are often observed, but the mechanisms underpinning this positional bias remain incompletely explained. Methodology/Principal Findings: This study identifies and rationalizes a systematic spatial bias in the intensity of surface hybridization, characterized by markedly increased signal intensity of spots located at the boundaries of the spotted areas of the microarray slide. Combining observations from a simplified single-probe block array format with predictions from a mathematical model, the mechanism responsible for this bias is found to be a position-dependent variation in lateral diffusion of target molecules. Numerical simulations reveal a strong influence of microarray well geometry on the spatial bias. Conclusions: Reciprocal adjustment of the size of the microarray hybridization chamber to the area of surface-bound probes is a simple and effective measure to minimize or eliminate the diffusion-based bias, resulting in increased uniformity and accuracy of quantitative DNA microarray hybridization.	[Steger, Doris; Berry, David; Haider, Susanne; Horn, Matthias; Wagner, Michael; Loy, Alexander] Univ Vienna, Fac Life Sci, Vienna Ecol Ctr, Dept Microbial Ecol, Vienna, Austria; [Stocker, Roman] MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	University of Vienna; Massachusetts Institute of Technology (MIT)	Steger, D (corresponding author), Univ Vienna, Fac Life Sci, Vienna Ecol Ctr, Dept Microbial Ecol, Vienna, Austria.	loy@microbial-ecology.net	Stocker, Roman/T-9456-2017; Berry, David/C-8455-2011; Horn, Matthias/G-1136-2011; Stocker, Roman/N-8987-2019; Wagner, Michael/A-7801-2011; Loy, Alexander/A-8182-2008	Stocker, Roman/0000-0002-3199-0508; Berry, David/0000-0002-8997-608X; Horn, Matthias/0000-0002-8309-5855; Wagner, Michael/0000-0002-9778-7684; Loy, Alexander/0000-0001-8923-5882	Austrian Science Fund [P18836-B17, P20185-B17, P16566-B14]; Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); National Institutes of Health [1-R21-EB008844]; National Science Foundation [OCE-0744641-CAREER]; Austrian Science Fund (FWF) [P 20185] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008844] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was financially supported by the Austrian Science Fund (P18836-B17, P20185-B17 to AL and P16566-B14 to MH), the Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota to DB, MW, and AL), the National Institutes of Health (1-R21-EB008844 to RS), and the National Science Foundation (OCE-0744641-CAREER to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adey NB, 2002, ANAL CHEM, V74, P6413, DOI 10.1021/ac026082m; Balazsi G, 2003, NUCLEIC ACIDS RES, V31, P4425, DOI 10.1093/nar/gkg485; Bodrossy L, 2003, ENVIRON MICROBIOL, V5, P566, DOI 10.1046/j.1462-2920.2003.00450.x; Brody JP, 2002, P NATL ACAD SCI USA, V99, P12975, DOI 10.1073/pnas.162468199; Burden CJ, 2006, J PHYS-CONDENS MAT, V18, P5545, DOI 10.1088/0953-8984/18/23/024; Burden CJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016004; Carlon E, 2006, PHYSICA A, V362, P433, DOI 10.1016/j.physa.2005.09.067; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Dandy DS, 2007, P NATL ACAD SCI USA, V104, P8223, DOI 10.1073/pnas.0606054104; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Dufva Martin, 2009, V509, P47, DOI 10.1007/978-1-59745-372-1_4; Fish DJ, 2007, NUCLEIC ACIDS RES, V35, P7197, DOI 10.1093/nar/gkm865; Gadgil C, 2004, J BIOTECHNOL, V114, P31, DOI 10.1016/j.jbiotec.2004.05.008; Gong P, 2008, P NATL ACAD SCI USA, V105, P5301, DOI 10.1073/pnas.0709416105; Hagan MF, 2004, J CHEM PHYS, V120, P4958, DOI 10.1063/1.1645786; HAIDER S, 2009, THESIS U WIEN; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Hesselsoe M, 2009, ISME J, V3, P1349, DOI 10.1038/ismej.2009.78; Holloway AJ, 2002, NAT GENET, V32, P481, DOI 10.1038/ng1030; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kechris K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-551; Koren A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-164; Lazazzera BA, 2005, CURR OPIN MICROBIOL, V8, P222, DOI 10.1016/j.mib.2005.02.015; Levicky R, 2005, TRENDS BIOTECHNOL, V23, P143, DOI 10.1016/j.tibtech.2005.01.004; Livshits MA, 1996, BIOPHYS J, V71, P2795, DOI 10.1016/S0006-3495(96)79473-0; Loy A, 2006, CLIN CHIM ACTA, V363, P106, DOI 10.1016/j.cccn.2005.05.041; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Loy A, 2011, METHODS MOL BIOL, V688, P187, DOI 10.1007/978-1-60761-947-5_13; MASKOS U, 1993, NUCLEIC ACIDS RES, V21, P4663, DOI 10.1093/nar/21.20.4663; McQuain MK, 2004, ANAL BIOCHEM, V325, P215, DOI 10.1016/j.ab.2003.10.032; Ono N, 2008, BIOINFORMATICS, V24, P1278, DOI 10.1093/bioinformatics/btn109; Pappaert K, 2003, CHEM ENG SCI, V58, P4921, DOI 10.1016/j.ces.2002.12.007; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schonmann S, 2009, ENVIRON MICROBIOL, V11, P779, DOI 10.1111/j.1462-2920.2008.01800.x; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Singh R, 2009, ANN BIOMED ENG, V37, P255, DOI 10.1007/s10439-008-9584-y; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Toegl Andreas, 2003, J Biomol Tech, V14, P197; Wagner M, 2007, MICROB ECOL, V53, P498, DOI 10.1007/s00248-006-9197-7; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yeh IC, 2004, BIOPHYS J, V86, P681, DOI 10.1016/S0006-3495(04)74147-8; Yoo SM, 2009, J MICROBIOL BIOTECHN, V19, P635, DOI 10.4014/jmb.0803.226; Yuan DS, 2006, BIOINFORMATICS, V22, P3054, DOI 10.1093/bioinformatics/btl542	49	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23727	10.1371/journal.pone.0023727	http://dx.doi.org/10.1371/journal.pone.0023727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858215	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300088
J	Tran, TA; Nguyen, AD; Chang, JJ; Goldberg, MS; Lee, JK; Tansey, MG				Tran, Thi A.; Nguyen, Andrew D.; Chang, Jianjun; Goldberg, Matthew S.; Lee, Jae-Kyung; Tansey, Malu G.			Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; TNF-ALPHA; DOPAMINERGIC-NEURONS; DIRECT INHIBITION; INFLAMMATION; ACTIVATION; MUTATIONS; BRAIN; MICE; GENE	Inflammation and oxidative stress have been implicated in the pathophysiology of Parkinson's disease (PD) and inhibition of microglial activation attenuates degeneration of dopaminergic (DA) neurons in animal models of PD. Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, cause autosomal recessive parkinsonism. While most studies on Parkin have focused on its function in neurons, here we demonstrate that Parkin mRNA and protein is detectable in brain-resident microglia and peripheral macrophages. Using pharmacologic and genetic approaches, we found that Parkin levels are regulated by inflammatory signaling. Specifically, exposure to LPS or Tumor Necrosis Factor (TNF) induced a transient and dose-dependent decrease in Parkin mRNA and protein in microglia, macrophages and neuronal cells blockable by inhibitors of Nuclear Factor-Kappa B (NF-kappa B) signaling and not observed in MyD88-null cells. Moreover, using luciferase reporter assays, we identified an NF-kappa B response element in the mouse parkin promoter responsible for mediating the transcriptional repression, which was abrogated when the consensus sequence was mutated. Functionally, activated macrophages from Parkin-null mice displayed increased levels of TNF, IL-1 beta, and iNOS mRNA compared to wild type macrophages but no difference in levels of Nrf2, HO-1, or NQO1. One implication of our findings is that chronic inflammatory conditions may reduce Parkin levels and phenocopy parkin loss-of-function mutations, thereby increasing the vulnerability for degeneration of the nigrostriatal pathway and development of PD.	[Tran, Thi A.; Tansey, Malu G.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Nguyen, Andrew D.; Chang, Jianjun; Lee, Jae-Kyung; Tansey, Malu G.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tran, TA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	malu.tansey@emory.edu	Goldberg, Matthew/T-7827-2019	LEE, JAE-KYUNG/0000-0003-0104-8623; Goldberg, Matthew/0000-0002-5172-9841; Nguyen, Andrew/0000-0002-9492-9472	NIH-NINDS [5R01NS049433]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049433] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NIH-NINDS 5R01NS049433 and The Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOUMAN L, 2010, CELL DEATH DIFFER; Casarejos MJ, 2006, J NEUROCHEM, V97, P934, DOI 10.1111/j.1471-4159.2006.03777.x; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Ferger B, 2004, J NEUROCHEM, V89, P822, DOI 10.1111/j.1471-4159.2004.02399.x; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hirsch EC, 2005, PARKINSONISM RELAT D, V11, pS9, DOI 10.1016/j.parkreldis.2004.10.013; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jeong JY, 1997, IMMUNOLOGY, V92, P267, DOI 10.1046/j.1365-2567.1997.00335.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; LEE JK, 2009, J NEUROIMMUNE PHARM; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; McNaught KSP, 2006, NEUROBIOL AGING, V27, P530, DOI 10.1016/j.neurobiolaging.2005.08.012; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schmidt S., 2011, HUM MOL GENET; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wersinger Christophe, 2002, Current Drug Targets - Inflammation and Allergy, V1, P221, DOI 10.2174/1568010023344580; West AB, 2004, J BIOL CHEM, V279, P28896, DOI 10.1074/jbc.M400126200; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhao CH, 2007, NEUROBIOL DIS, V26, P36, DOI 10.1016/j.nbd.2006.11.012	47	70	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23660	10.1371/journal.pone.0023660	http://dx.doi.org/10.1371/journal.pone.0023660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858193	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300074
J	Ensan, LS; Faghankhani, M; Javanbakht, A; Ahmadi, SF; Baradaran, HR				Ensan, Ladan Sayyah; Faghankhani, Masoomeh; Javanbakht, Anna; Ahmadi, Seyed-Foad; Baradaran, Hamid Reza			To Compare PubMed Clinical Queries and UpToDate in Teaching Information Mastery to Clinical Residents: A Crossover Randomized Controlled Trial	PLOS ONE			English	Article							CARE; QUESTIONS; KNOWLEDGE; ANSWERS	Purpose: To compare PubMed Clinical Queries and UpToDate regarding the amount and speed of information retrieval and users' satisfaction. Method: A cross-over randomized trial was conducted in February 2009 in Tehran University of Medical Sciences that included 44 year-one or two residents who participated in an information mastery workshop. A one-hour lecture on the principles of information mastery was organized followed by self learning slide shows before using each database. Subsequently, participants were randomly assigned to answer 2 clinical scenarios using either UpToDate or PubMed Clinical Queries then crossed to use the other database to answer 2 different clinical scenarios. The proportion of relevantly answered clinical scenarios, time to answer retrieval, and users' satisfaction were measured in each database. Results: Based on intention-to-treat analysis, participants retrieved the answer of 67 (76%) questions using UpToDate and 38 (43%) questions using PubMed Clinical Queries (P<0.001). The median time to answer retrieval was 17 min (95% CI: 16 to 18) using UpToDate compared to 29 min (95% CI: 26 to 32) using PubMed Clinical Queries (P<0.001). The satisfaction with the accuracy of retrieved answers, interaction with UpToDate and also overall satisfaction were higher among UpToDate users compared to PubMed Clinical Queries users (P<0.001). Conclusions: For first time users, using UpToDate compared to Pubmed Clinical Querries can lead to not only a higher proportion of relevant answer retrieval within a shorter time, but also a higher users' satisfaction. So, addition of tutoring pre-appraised sources such as UpToDate to the information mastery curricula seems to be highly efficient.	[Ensan, Ladan Sayyah; Faghankhani, Masoomeh; Javanbakht, Anna; Ahmadi, Seyed-Foad; Baradaran, Hamid Reza] Univ Tehran Med Sci, Med Educ & Dev Ctr, Ctr Educ Res Med Sci, Tehran, Iran	Tehran University of Medical Sciences	Ensan, LS (corresponding author), Univ Tehran Med Sci, Med Educ & Dev Ctr, Ctr Educ Res Med Sci, Tehran, Iran.	mfaghankhani@yahoo.com	Baradaran, Hamid Reza/C-1556-2017; Baradaran, Hamid R/N-2577-2019; Faghankhani, Masoomeh/GPF-9208-2022	Baradaran, Hamid Reza/0000-0002-5070-5864; Baradaran, Hamid R/0000-0002-5070-5864; Faghankhani, Masoomeh/0000-0003-0734-5047				Bonis PA, 2008, INT J MED INFORM, V77, P745, DOI 10.1016/j.ijmedinf.2008.04.002; Campbell R, 2006, J MED LIBR ASSOC, V94, P435; *CTR EV BAS MED, SYLL PRAC EBM SAMPL; DEMMERFUSHMAN D, 2006, AMIA ANN S P, P190; DiCenso A, 2009, ANN INTERN MED, V151, DOI 10.7326/0003-4819-151-6-200909150-02002; *DUK U MED CTR LIB, TUT TRAIN 2009 EBM C; Fenton SH, 2007, J MED LIBR ASSOC, V95, P255, DOI 10.3163/1536-5050.95.3.255; Haynes Brian, 2007, Evid Based Nurs, V10, P6, DOI 10.1136/ebn.10.1.6; Hoogendam A, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1012; *MCMASTER U, 2009 COURS MAT LARG; Patel MR, 2006, J MED LIBR ASSOC, V94, P382; Phillips R, 2008, POSTGRAD MED J, V84, P450, DOI 10.1136/pgmj.2008.069310; Straus S, 2009, CAN MED ASSOC J, V180, P942, DOI 10.1503/cmaj.081697; Thiele RH, 2010, POSTGRAD MED J, V86, P459, DOI 10.1136/pgmj.2010.098053; *U OXF CTR EV BAS, POW POINT PRES	15	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23487	10.1371/journal.pone.0023487	http://dx.doi.org/10.1371/journal.pone.0023487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858142	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500048
J	Lolignier, S; Amsalem, M; Maingret, F; Padilla, F; Gabriac, M; Chapuy, E; Eschalier, A; Delmas, P; Busserolles, J				Lolignier, Stephane; Amsalem, Muriel; Maingret, Francois; Padilla, Francoise; Gabriac, Melanie; Chapuy, Eric; Eschalier, Alain; Delmas, Patrick; Busserolles, Jerome			Nav1.9 Channel Contributes to Mechanical and Heat Pain Hypersensitivity Induced by Subacute and Chronic Inflammation	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNEL; PRIMARY SENSORY NEURONS; NA(V)1.9 KNOCKOUT MICE; PERSISTENT NA+ CURRENT; ROOT GANGLIA NEURONS; TETRODOTOXIN-RESISTANT; DRG NEURONS; EXPRESSION; RAT; MOUSE	Inflammation is known to be responsible for the sensitization of peripheral sensory neurons, leading to spontaneous pain and invalidating pain hypersensitivity. Given its role in regulating neuronal excitability, the voltage-gated Nav1.9 channel is a potential target for the treatment of pathological pain, but its implication in inflammatory pain is yet not fully described. In the present study, we examined the role of the Nav1.9 channel in acute, subacute and chronic inflammatory pain using Nav1.9-null mice and Nav1.9 knock-down rats. In mice we found that, although the Nav1.9 channel does not contribute to basal pain thresholds, it plays an important role in heat pain hypersensitivity induced by subacute paw inflammation (intraplantar carrageenan) and chronic ankle inflammation (complete Freund's adjuvant-induced monoarthritis). We showed for the first time that Nav1.9 also contributes to mechanical hypersensitivity in both models, as assessed using von Frey and dynamic weight bearing tests. Consistently, antisense-based Nav1.9 gene silencing in rats reduced carrageenan-induced heat and mechanical pain hypersensitivity. While no changes in Nav1.9 mRNA levels were detected in dorsal root ganglia (DRGs) during subacute and chronic inflammation, a significant increase in Nav1.9 immunoreactivity was observed in ipsilateral DRGs 24 hours following carrageenan injection. This was correlated with an increase in Nav1.9 immunolabeling in nerve fibers surrounding the inflamed area. No change in Nav1.9 current density could be detected in the soma of retrolabeled DRG neurons innervating inflamed tissues, suggesting that newly produced channels may be non-functional at this level and rather contribute to the observed increase in axonal transport. Our results provide evidence that Nav1.9 plays a crucial role in the generation of heat and mechanical pain hypersensitivity, both in subacute and chronic inflammatory pain models, and bring new elements for the understanding of its regulation in those models.	[Lolignier, Stephane; Chapuy, Eric; Eschalier, Alain; Busserolles, Jerome] Clermont Univ, Lab Pharmacol Fondamentale & Clin Douleur, Clermont Ferrand, France; [Lolignier, Stephane; Chapuy, Eric; Eschalier, Alain; Busserolles, Jerome] INSERM, U766, Clermont Ferrand, France; [Amsalem, Muriel; Maingret, Francois; Padilla, Francoise; Gabriac, Melanie; Delmas, Patrick] Univ Aix Marseille 2, CNRS, UMR 6231, Ctr Rech Neurobiol & Neurophysiol Marseille, Marseille, France; [Eschalier, Alain] CHU Clermont Ferrand, Serv Pharmacol, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CHU Clermont Ferrand	Lolignier, S (corresponding author), Clermont Univ, Lab Pharmacol Fondamentale & Clin Douleur, Clermont Ferrand, France.	jerome.busserolles@u-clermont1.fr	Busserolles, Jerome/K-4232-2014; Busserolles, Jerome/AAJ-1196-2020; Lolignier, Stéphane/K-1281-2015; ESCHALIER, Alain/L-9957-2015	Busserolles, Jerome/0000-0001-7542-9520; Lolignier, Stéphane/0000-0001-5407-4986; 	Agence Nationale de la Recherche; Institut UPSA de la Douleur (Union de Pharmacologie Scientifique Appliquee); Institut pour la Recherche sur la Moelle Epiniere; Fondation pour la Recherche Medicale; Fondation Schlumberger; Association pour la Recherche sur le Cancer; Institut National du Cancer; Institut National de la Santeet de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite d'Auvergne; Ministere de l'Education Nationale, de la Recherche et de la Technologie	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut UPSA de la Douleur (Union de Pharmacologie Scientifique Appliquee); Institut pour la Recherche sur la Moelle Epiniere; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Schlumberger(Schlumberger); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Institut National de la Santeet de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite d'Auvergne; Ministere de l'Education Nationale, de la Recherche et de la Technologie	This study was supported by grants from Agence Nationale de la Recherche, Institut UPSA de la Douleur (Union de Pharmacologie Scientifique Appliquee), Institut pour la Recherche sur la Moelle Epiniere, Fondation pour la Recherche Medicale, Fondation Schlumberger, Association pour la Recherche sur le Cancer, Institut National du Cancer and by Institut National de la Santeet de la Recherche Medicale, Centre National de la Recherche Scientifique and Universite d'Auvergne. S. Lolignier and M. Amsalem were supported by Ministere de l'Education Nationale, de la Recherche et de la Technologie fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Baker MD, 2003, J PHYSIOL-LONDON, V548, P373, DOI 10.1113/jphysiol.2003.039131; Baker MD, 2005, J PHYSIOL-LONDON, V567, P851, DOI 10.1113/jphysiol.2005.089771; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Blair NT, 2002, J NEUROSCI, V22, P10277; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; Coggeshall RE, 2004, NEUROSCI LETT, V355, P45, DOI 10.1016/j.neulet.2003.10.023; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; King DE, 2009, NEUROGASTROENT MOTIL, V21, P880, DOI 10.1111/j.1365-2982.2009.01279.x; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; Martinez V, 2008, EUR J PAIN, V12, P934, DOI 10.1016/j.ejpain.2007.12.011; McGaraughty S, 2003, BRIT J PHARMACOL, V140, P1381, DOI 10.1038/sj.bjp.0705574; Ostman JAR, 2008, J PHYSIOL-LONDON, V586, P1077, DOI 10.1113/jphysiol.2007.147942; Padilla F, 2007, MOL CELL NEUROSCI, V35, P138, DOI 10.1016/j.mcn.2007.02.008; Perlewitz A, 2010, NUCLEIC ACIDS RES, V38, P5746, DOI 10.1093/nar/gkq267; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2004, BRAIN RES, V1023, P264, DOI 10.1016/j.brainres.2004.07.042; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Wada A, 2004, FRONT BIOSCI-LANDMRK, V9, P1954, DOI 10.2741/1314; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; Yen YT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-1; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	42	73	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23083	10.1371/journal.pone.0023083	http://dx.doi.org/10.1371/journal.pone.0023083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857998	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500019
J	Ruiz-Ferrer, M; Torroglosa, A; Nunez-Torres, R; de Agustin, JC; Antinolo, G; Borrego, S				Ruiz-Ferrer, Macarena; Torroglosa, Ana; Nunez-Torres, Rocio; Carlos de Agustin, Juan; Antinolo, Guillermo; Borrego, Salud			Expression of PROKR1 and PROKR2 in Human Enteric Neural Precursor Cells and Identification of Sequence Variants Suggest a Role in HSCR	PLOS ONE			English	Article							NERVOUS-SYSTEM DEVELOPMENT; STEM-CELLS; HIRSCHSPRUNG-DISEASE; MUTATIONS; PROTEINS; DIFFERENTIATION; PROKINETICIN-2; PROLIFERATION; PATHOGENESIS; GENETICS	Background: The enteric nervous system (ENS) is entirely derived from neural crest and its normal development is regulated by specific molecular pathways. Failure in complete ENS formation results in aganglionic gut conditions such as Hirschsprung's disease (HSCR). Recently, PROKR1 expression has been demonstrated in mouse enteric neural crest derived cells and Prok-1 was shown to work coordinately with GDNF in the development of the ENS. Principal Findings: In the present report, ENS progenitors were isolated and characterized from the ganglionic gut from children diagnosed with and without HSCR, and the expression of prokineticin receptors was examined. Immunocytochemical analysis of neurosphere-forming cells demonstrated that both PROKR1 and PROKR2 were present in human enteric neural crest cells. In addition, we also performed a mutational analysis of PROKR1, PROKR2, PROK1 and PROK2 genes in a cohort of HSCR patients, evaluating them for the first time as susceptibility genes for the disease. Several missense variants were detected, most of them affecting highly conserved amino acid residues of the protein and located in functional domains of both receptors, which suggests a possible deleterious effect in their biological function. Conclusions: Our results suggest that not only PROKR1, but also PROKR2 might mediate a complementary signalling to the RET/GFR alpha 1/GDNF pathway supporting proliferation/survival and differentiation of precursor cells during ENS development. These findings, together with the detection of sequence variants in PROKR1, PROK1 and PROKR2 genes associated to HSCR and, in some cases in combination with RET or GDNF mutations, provide the first evidence to consider them as susceptibility genes for HSCR.	[Ruiz-Ferrer, Macarena; Torroglosa, Ana; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Inst Biomed Sevilla, Unidad Gest Clin Genet Reprod & Med Fetal, Seville, Spain; [Ruiz-Ferrer, Macarena; Torroglosa, Ana; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville, Spain; [Carlos de Agustin, Juan] Hosp Univ Virgen del Rocio, Unidad Gest Clin Cirugia Infantil, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Virgen del Rocio University Hospital	Ruiz-Ferrer, M (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Inst Biomed Sevilla, Unidad Gest Clin Genet Reprod & Med Fetal, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	De Agustin, Juan/AAT-1824-2021; Borrego, Salud/M-6314-2015; Ruiz-Ferrer, Macarena/M-6168-2015; Torroglosa, Ana/AAU-9812-2020; IBIS, GENETICA/P-3384-2015; IBIS, MALFORMACIONES/H-7372-2016; IBIS, REPRODUCCION/P-3399-2015	De Agustin, Juan/0000-0002-2413-2871; Antinolo Gil, Guillermo/0000-0002-2113-074X; Torroglosa, Ana/0000-0003-1911-7906	Fondo de Investigacion Sanitaria, Spain [PI070080, PI1001290, PI071315]; Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia [CTS 2590]; Consejeria de Salud de la Junta de Andalucia [PI0249-2008]	Fondo de Investigacion Sanitaria, Spain(Instituto de Salud Carlos III); Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia); Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This work was supported by Fondo de Investigacion Sanitaria, Spain (PI070080, PI1001290 and PI071315 for the E-Rare project), Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia (CTS 2590) and Consejeria de Salud de la Junta de Andalucia (PI0249-2008). The CIBER de Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958; Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Kaser A, 2003, EMBO REP, V4, P469, DOI 10.1038/sj.embor.embor830; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Le Douarin N., 1999, NEURAL CREST, P445; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Negri L, 2007, LIFE SCI, V81, P1103, DOI 10.1016/j.lfs.2007.08.011; Ngan ESW, 2008, INT J BIOCHEM CELL B, V40, P1679, DOI 10.1016/j.biocel.2008.03.010; Ngan ESW, 2008, BBA-MOL CELL RES, V1783, P467, DOI 10.1016/j.bbamcr.2007.09.005; Ngan ESW, 2007, BBA-MOL CELL RES, V1773, P536, DOI 10.1016/j.bbamcr.2007.01.013; Ngan ESW, 2007, CLIN CANCER RES, V13, P868, DOI 10.1158/1078-0432.CCR-06-2176; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Ruiz-Ferrer M, 2008, J PEDIATR SURG, V43, P1308, DOI 10.1016/j.jpedsurg.2008.02.076; Ruiz-Ferrer M, 2006, GENET MED, V8, P704, DOI 10.1097/01.gim.0000245632.06064.f1; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Sanchez-Mejias A, 2009, J MED GENET, V46, P862, DOI 10.1136/jmg.2009.067819; Sanchez-Mejias A, 2010, J MOL MED, V88, P507, DOI 10.1007/s00109-010-0592-7; Sanchez-Mejias A, 2010, GENET MED, V12, P39, DOI 10.1097/GIM.0b013e3181c371b0; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Tam PKH, 2009, PEDIATR SURG INT, V25, P543, DOI 10.1007/s00383-009-2402-2; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	32	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23475	10.1371/journal.pone.0023475	http://dx.doi.org/10.1371/journal.pone.0023475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858136	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500046
J	Zhou, RM; Jing, YY; Guo, Y; Gao, C; Zhang, BY; Chen, C; Shi, Q; Tian, C; Wang, ZY; Gong, HS; Han, J; Xu, BL; Dong, XP				Zhou, Rui-Min; Jing, Yuan-Yuan; Guo, Yan; Gao, Chen; Zhang, Bao-Yun; Chen, Cao; Shi, Qi; Tian, Chan; Wang, Zhao-Yun; Gong, Han-Shi; Han, Jun; Xu, Bian-Li; Dong, Xiao-Ping			Molecular Interaction of TPPP with PrP Antagonized the CytoPrP-Induced Disruption of Microtubule Structures and Cytotoxicity	PLOS ONE			English	Article							CYTOSOLIC PRION PROTEIN; TUBULIN; P25; OLIGODENDROCYTES; NEUROTOXICITY; ASSEMBLIES; APOPTOSIS; TRANSPORT; SH-SY5Y; BLOCKS	Background: Tubulin polymerization promoting protein/p25 (TPPP/p25), known as a microtubule-associated protein (MAP), is a brain-specific unstructured protein with a physiological function of stabilizing cellular microtubular ultrastructures. Whether TPPP involves in the normal functions of PrP or the pathogenesis of prion disease remains unknown. Here, we proposed the data that TPPP formed molecular complex with PrP. We also investigated its influence on the aggregation of PrP and fibrillization of PrP106-126 in vitro, its antagonization against the disruption of microtubule structures and cytotoxicity of cytosolic PrP in cells, and its alternation in the brains of scrapie-infected experimental hamsters. Methodology/Principal Findings: Using pull-down and immunoprecipitation assays, distinct molecular interaction between TPPP and PrP were identified and the segment of TPPP spanning residues 100-219 and the segment of PrP spanning residues 106-126 were mapped as the regions responsible for protein interaction. Sedimentation experiments found that TPPP increased the aggregation of full-length recombinant PrP (PrP23-231) in vitro. Transmission electron microscopy and Thioflavin T (ThT) assays showed that TPPP enhanced fibril formation of synthetic peptide PrP106-126 in vitro. Expression of TPPP in the cultured cells did not obviously change the microtubule networks observed by a tubulin-specific immunofluorescent assay and cell growth features measured by CCK8 tests, but significantly antagonized the disruption of microtubule structures and rescued the cytotoxicity caused by the accumulation of cytosolic PrP (CytoPrP). Furthermore, Western blots identified that the levels of the endogenous TPPP in the brains of scrapie-infected experimental hamsters were significantly reduced. Conclusion/Significance: Those data highlight TPPP may work as a protective factor for cells against the damage effects of the accumulation of abnormal forms of PrPs, besides its function as an agent for dynamic stabilization of microtubular ultrastructures.	[Zhou, Rui-Min; Jing, Yuan-Yuan; Guo, Yan; Gao, Chen; Zhang, Bao-Yun; Chen, Cao; Shi, Qi; Tian, Chan; Wang, Zhao-Yun; Gong, Han-Shi; Han, Jun; Dong, Xiao-Ping] Chinese Ctr Dis Control Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Rui-Min; Xu, Bian-Li] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan Province, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhou, RM (corresponding author), Chinese Ctr Dis Control Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	China Mega-Project for Infectious Disease [2009ZX10004-101, 2008ZX]; National Basic Research Program of China (973 Program) [2008SKLID102, 2007CB310505]; Chinese National Natural Science Foundation [30771914, 30800975]; Institution Technique RD [2008EG150300]	China Mega-Project for Infectious Disease; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Institution Technique RD	This work was supported by China Mega-Project for Infectious Disease (2009ZX10004-101, 2008ZX), SKLID Development Grant (2008SKLID102) National Basic Research Program of China (973 Program) (2007CB310505), Chinese National Natural Science Foundation Grants 30771914 and 30800975 and Institution Technique R&D Grant (2008EG150300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Bergstrom AL, 2005, J BIOL CHEM, V280, P23114, DOI 10.1074/jbc.M500210200; BRANDT R, 1996, FRONT BIOSCI, V1, P118; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chen L, 2007, J BIOCHEM MOL BIOL, V40, P662; Colello RJ, 2002, ELECTROPHORESIS, V23, P144, DOI 10.1002/1522-2683(200201)23:1<144::AID-ELPS144>3.0.CO;2-P; Dong CF, 2008, MED MICROBIOL IMMUN, V197, P361, DOI 10.1007/s00430-007-0071-0; Dong CF, 2008, ARCH BIOCHEM BIOPHYS, V470, P83, DOI 10.1016/j.abb.2007.11.007; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Hachiya NS, 2004, BIOCHEM BIOPH RES CO, V313, P818, DOI 10.1016/j.bbrc.2003.11.167; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Keshet GI, 2000, J NEUROCHEM, V75, P1889, DOI 10.1046/j.1471-4159.2000.0751889.x; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Kovacs GG, 2007, ACTA NEUROPATHOL, V113, P153, DOI 10.1007/s00401-006-0167-4; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Li P, 2009, ACTA BIOCH BIOPH SIN, V41, P42, DOI 10.1093/abbs/gmn005; Li XL, 2011, J MOL NEUROSCI, V43, P316, DOI 10.1007/s12031-010-9443-9; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Liu YH, 2011, INT J BIOCHEM CELL B, V43, P768, DOI 10.1016/j.biocel.2011.01.022; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Martin CP, 2002, BBA-MOL BASIS DIS, V1586, P113; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Nandi PK, 1997, ARCH VIROL, V142, P2537, DOI 10.1007/s007050050261; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; Nieznanski K, 2005, BIOCHEM BIOPH RES CO, V334, P403, DOI 10.1016/j.bbrc.2005.06.092; Norstrom EM, 2007, J VIROL, V81, P2831, DOI 10.1128/JVI.02157-06; Olah J, 2006, FEBS LETT, V580, P5807, DOI 10.1016/j.febslet.2006.09.037; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Ovadi J, 2009, BIOESSAYS, V31, P676, DOI 10.1002/bies.200900008; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Seki N, 1999, J HUM GENET, V44, P121, DOI 10.1007/s100380050122; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; TAKAHASHI M, 1991, FEBS LETT, V289, P37, DOI 10.1016/0014-5793(91)80903-G; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wang GR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-86; Wang XH, 2005, J BIOL CHEM, V280, P317, DOI 10.1074/jbc.M410649200; Wang XF, 2008, MOL CELL BIOCHEM, V310, P49, DOI 10.1007/s11010-007-9664-6; Wang X, 2009, BMB REP, V42, P444, DOI 10.5483/BMBRep.2009.42.7.444; Yao HL, 2005, J VET MED B, V52, P437, DOI 10.1111/j.1439-0450.2005.00897.x	49	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23079	10.1371/journal.pone.0023079	http://dx.doi.org/10.1371/journal.pone.0023079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857997	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500018
J	Crivat, G; Tokumasu, F; Sa, JM; Hwang, J; Wellems, TE				Crivat, Georgeta; Tokumasu, Fuyuki; Sa, Juliana Martha; Hwang, Jeeseong; Wellems, Thomas E.			Tetracysteine-Based Fluorescent Tags to Study Protein Localization and Trafficking in Plasmodium falciparum-Infected Erythrocytes	PLOS ONE			English	Article							MEMBRANE PROTEIN-1; CYTOADHERENCE; GREEN; VIRULENCE; SURFACE; PFEMP1; KNOBS; CELLS; EXPRESSION; ADHERENCE	Plasmodium falciparum (Pf) malaria parasites remodel host erythrocytes by placing membranous structures in the host cell cytoplasm and inserting proteins into the surrounding erythrocyte membranes. Dynamic imaging techniques with high spatial and temporal resolutions are required to study the trafficking pathways of proteins and the time courses of their delivery to the host erythrocyte membrane. Methodology and Findings: Using a tetracysteine (TC) motif tag and TC-binding biarsenical fluorophores (BAFs) including fluorescein arsenical hairpin (FlAsH) and resorufin arsenical hairpin (ReAsH), we detected knob-associated histidine-rich protein (KAHRP) constructs in Pf-parasitized erythrocytes and compared their fluorescence signals to those of GFP (green fluorescent protein)-tagged KAHRP. Rigorous treatment with BAL (2, 3 dimercaptopropanol; British anti-Lewisite) was required to reduce high background due to nonspecific BAF interactions with endogenous cysteine-rich proteins. After this background reduction, similar patterns of fluorescence were obtained from the TC- and GFP-tagged proteins. The fluorescence from FlAsH and ReAsH-labeled protein bleached at faster rates than the fluorescence from GFP-labeled protein. Conclusion: While TC/BAF labeling to Pf-infected erythrocytes is presently limited by high background signals, it may offer a useful complement or alternative to GFP labeling methods. Our observations are in agreement with the currently-accepted model of KAHRP movement through the cytoplasm, including transient association of KAHRP with Maurer's clefts before its incorporation into knobs in the host erythrocyte membrane.	[Crivat, Georgeta; Tokumasu, Fuyuki; Sa, Juliana Martha; Wellems, Thomas E.] NIAID, Lab Malaria & Vector Res, Malaria Genet Sect, NIH, Bethesda, MD 20892 USA; [Crivat, Georgeta; Hwang, Jeeseong] Natl Inst Stand & Technol, Phys Measurement Lab, Biophys Grp, Opt Technol Div, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute of Standards & Technology (NIST) - USA	Crivat, G (corresponding author), NIAID, Lab Malaria & Vector Res, Malaria Genet Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twellems@niaid.nih.gov	Tokumasu, Fuyuki/GQP-4413-2022; Crivat, Georgeta/AAJ-5714-2020	Tokumasu, Fuyuki/0000-0003-2790-1071; 	National Institutes of Health, National Institute of Allergy and Infectious Diseases; National Institute of Standards and Technology (NIST); National Research Council at NIST; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH); National Institute for Biomedical Imaging and Bioengineering of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000099, ZIAAI000483] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Standards and Technology (NIST)(National Institute of Standards & Technology (NIST) - USA); National Research Council at NIST; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Biomedical Imaging and Bioengineering of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases, and by the Innovations in Measurement Science program of the National Institute of Standards and Technology (NIST). GC held a National Research Council Research Associateship Award at NIST and National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH); funding for the award was provided by NIST and the Intramural Program of the National Institute for Biomedical Imaging and Bioengineering of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; ADAMS SR, 2007, CHEM BIOL SAMLL MOL; AIKAWA M, 1983, J PARASITOL, V69, P435, DOI 10.2307/3281259; ALHANATY E, 1981, J CELL BIOL, V91, P884, DOI 10.1083/jcb.91.3.884; APOSHIAN HV, 1984, FUND APPL TOXICOL, V4, pS58, DOI 10.1016/0272-0590(84)90138-6; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Hearps AC, 2007, J FLUORESC, V17, P593, DOI 10.1007/s10895-007-0225-x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; JENSEN JB, 1978, AM J TROP MED HYG, V27, P1274, DOI 10.4269/ajtmh.1978.27.1274; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Langhorst MF, 2006, HISTOCHEM CELL BIOL, V125, P743, DOI 10.1007/s00418-005-0136-3; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Machleidt T, 2007, METH MOL B, V356, P209; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Nagao E, 2000, J STRUCT BIOL, V130, P34, DOI 10.1006/jsbi.2000.4236; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Thompson J, 2007, CELL MICROBIOL, V9, P1466, DOI 10.1111/j.1462-5822.2006.00885.x; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; TRUONG HTN, 1993, BIOCHIM BIOPHYS ACTA, V1150, P51, DOI 10.1016/0005-2736(93)90120-O; Van Engelenburg SB, 2010, CHEMBIOCHEM, V11, P489, DOI 10.1002/cbic.200900689; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	50	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22975	10.1371/journal.pone.0022975	http://dx.doi.org/10.1371/journal.pone.0022975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860664	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200030
J	Armistead, PM; Liang, SD; Li, H; Lu, SJ; Van Bergen, CAM; Alatrash, G; John, LS; Hunsucker, SA; Sarantopoulos, S; Falkenburg, JHF; Molldrem, JJ				Armistead, Paul M.; Liang, Shoudan; Li, Hua; Lu, Sijie; Van Bergen, Cornelis A. M.; Alatrash, Gheath; John, Lisa St.; Hunsucker, Sally A.; Sarantopoulos, Stefanie; Falkenburg, J. H. Frederik; Molldrem, Jeffrey J.			Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; REDUCED-INTENSITY; T-CELLS; PATIENTS OLDER; LEUKEMIA; HLA; GENE; HA-1	Background: Minor histocompatibility antigens (mHA) mediate much of the graft vs. leukemia (GvL) effect and graft vs. host disease (GvHD) in patients who undergo allogeneic stem cell transplantation (SCT) [1,2,3,4]. Therapeutic decision making and treatments [5] based upon mHAs will require the evaluation of multiple candidate mHAs and the selection of those with the potential to have the greatest impact on clinical outcomes. We hypothesized that common, immunodominant mHAs, which are presented by HLA-A, B, and C molecules, can mediate clinically significant GvL and/or GvHD, and that these mHAs can be identified through association of genomic data with clinical outcomes. Methodology/Principal Findings: Because most mHAs result from donor/recipient cSNP disparities, we genotyped 57 myeloid leukemia patients and their donors at 13,917 cSNPs [6]. We correlated the frequency of genetically predicted mHA disparities with clinical evidence of an immune response and then computationally screened all peptides mapping to the highly associated cSNPs for their ability to bind to HLA molecules. As proof-of-concept, we analyzed one predicted antigen, T4A, whose mHA mismatch trended towards improved overall and disease free survival in our cohort. T4A mHA mismatches occurred at the maximum theoretical frequency for any given SCT. T4A-specific CD8+ T lymphocytes (CTLs) were detected in 3 of 4 evaluable post-transplant patients predicted to have a T4A mismatch. Conclusions/Significance: Our method is the first to combine clinical outcomes data with genomics and bioinformatics methods to predict and confirm a mHA. Refinement of this method should enable the discovery of clinically relevant mHAs in the majority of transplant patients and possibly lead to novel immunotherapeutics [5].	[Armistead, Paul M.; Liang, Shoudan; Lu, Sijie; Alatrash, Gheath; John, Lisa St.; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Sect Transplantat Immunol, Houston, TX 77030 USA; [Liang, Shoudan; Li, Hua] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Van Bergen, Cornelis A. M.; Falkenburg, J. H. Frederik] Leiden Univ, Med Ctr, Lab Expt Hematol, Leiden, Netherlands; [Armistead, Paul M.; Hunsucker, Sally A.; Sarantopoulos, Stefanie] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of North Carolina; University of North Carolina Chapel Hill	Armistead, PM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Sect Transplantat Immunol, Houston, TX 77030 USA.	paul_armistead@med.unc.edu	Van Bergen, Cornelis/N-4773-2019; Van Bergen, Cornelis A.M./P-5782-2016	Van Bergen, Cornelis/0000-0001-6386-4517; Van Bergen, Cornelis A.M./0000-0001-6386-4517; Armistead, Paul/0000-0003-3983-5534; Alatrash, Gheath/0000-0002-7648-4377; Hunsucker, Sally/0000-0002-7034-7355; LI, HUA/0000-0003-2153-2500	National Institutes of Health [CA100632, CA049639]; Leukemia and Lymphoma Society [6031-07, 7262-08]; ASCO; NIH [CA123344A1]; DOD/CDMRP [CM064108]; National Institutes of Health through M.D. Anderson's Cancer Center [CA016672]; Barbara Rattay Advanced Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA016672, K25CA123344, P01CA049639, P50CA100632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ASCO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD/CDMRP(United States Department of Defense); National Institutes of Health through M.D. Anderson's Cancer Center; Barbara Rattay Advanced Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: CA100632 and CA049639 from the National Institutes of Health to JJM, and 6031-07 and 7262-08 from the Leukemia and Lymphoma Society to JJM. This work was also sponsored through an ASCO Young Investigator Award to PMA and CA123344A1 from the NIH and CM064108 from the DOD/CDMRP for S. Liang. This work was also supported in part by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant CA016672. PMA and GA received salary support through the Barbara Rattay Advanced Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Alyea EP, 2005, BLOOD, V105, P1810, DOI 10.1182/blood-2004-05-1947; Aoudjhane M, 2005, LEUKEMIA, V19, P2304, DOI 10.1038/sj.leu.2403967; Barrett AJ, 2006, LEUKEMIA, V20, P1661, DOI 10.1038/sj.leu.2404334; Bleakley M, 2010, BLOOD, V115, P4923, DOI 10.1182/blood-2009-12-260539; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; Falkenburg JHF, 2003, EXP HEMATOL, V31, P743, DOI 10.1016/S0301-472X(03)00190-5; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; GALE RP, 1994, ANN INTERN MED, V120, P646, DOI 10.7326/0003-4819-120-8-199404150-00004; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; HOROWITZ MM, 1990, BLOOD, V75, P555; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kamei M, 2009, BLOOD, V113, P5041, DOI 10.1182/blood-2008-07-171678; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Lazarus HM, 2006, LEUKEMIA, V20, P1673, DOI 10.1038/sj.leu.2404328; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin MT, 2001, BLOOD, V98, P3172, DOI 10.1182/blood.V98.10.3172; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; McCarroll SA, 2009, NAT GENET, V41, P1341, DOI 10.1038/ng.490; Mullally A, 2007, BLOOD, V109, P1355, DOI 10.1182/blood-2006-06-030858; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ratanatharathorn V, 1998, BLOOD, V92, P2303; Spierings E, 2009, J IMMUNOL, V182, P4809, DOI 10.4049/jimmunol.0803911; Tseng LH, 1999, BLOOD, V94, P2911, DOI 10.1182/blood.V94.8.2911.420k21_2911_2914; van Bergen CAM, 2007, BLOOD, V109, P4089, DOI 10.1182/blood-2006-08-043935; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; VANELS CACM, 1992, IMMUNOGENETICS, V35, P161, DOI 10.1007/BF00185109; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V323, P9, DOI 10.1016/j.bbrc.2004.08.048; Warren EH, 2010, BLOOD, V115, P3869, DOI 10.1182/blood-2009-10-248997	34	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23217	10.1371/journal.pone.0023217	http://dx.doi.org/10.1371/journal.pone.0023217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858034	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300027
J	Bao, WK; Aravindhan, K; Alsaid, H; Chendrimada, T; Szapacs, M; Citerone, DR; Harpel, MR; Willette, RN; Lepore, JJ; Jucker, BM				Bao, Weike; Aravindhan, Karpagam; Alsaid, Hasan; Chendrimada, Thimmaiah; Szapacs, Matthew; Citerone, David R.; Harpel, Mark R.; Willette, Robert N.; Lepore, John J.; Jucker, Beat M.			Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Analog, Protects the Rat Heart against Ischemia/Reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency	PLOS ONE			English	Article							INTRAMUSCULAR GLUCOSE-METABOLISM; LEFT-VENTRICULAR PERFORMANCE; DILATED CARDIOMYOPATHY; INFARCT SIZE; MYOCARDIAL-INFARCTION; INDIVIDUAL TISSUES; CONSCIOUS DOGS; REPERFUSION; RECEPTOR; FAILURE	Background: The cardioprotective effects of glucagon-like peptide-1 (GLP-1) and analogs have been previously reported. We tested the hypothesis that albiglutide, a novel long half-life analog of GLP-1, may protect the heart against I/R injury by increasing carbohydrate utilization and improving cardiac energetic efficiency. Methods/Principal Findings: Sprague-Dawley rats were treated with albiglutide and subjected to 30 min myocardial ischemia followed by 24 h reperfusion. Left ventricle infarct size, hemodynamics, function and energetics were determined. In addition, cardiac glucose disposal, carbohydrate metabolism and metabolic gene expression were assessed. Albiglutide significantly reduced infarct size and concomitantly improved post-ischemic hemodynamics, cardiac function and energetic parameters. Albiglutide markedly increased both in vivo and ex vivo cardiac glucose uptake while reducing lactate efflux. Analysis of metabolic substrate utilization directly in the heart showed that albiglutide increased the relative carbohydrate versus fat oxidation which in part was due to an increase in both glucose and lactate oxidation. Metabolic gene expression analysis indicated upregulation of key glucose metabolism genes in the non-ischemic myocardium by albiglutide. Conclusion/Significance: Albiglutide reduced myocardial infarct size and improved cardiac function and energetics following myocardial I/R injury. The observed benefits were associated with enhanced myocardial glucose uptake and a shift toward a more energetically favorable substrate metabolism by increasing both glucose and lactate oxidation. These findings suggest that albiglutide may have direct therapeutic potential for improving cardiac energetics and function.	[Bao, Weike; Aravindhan, Karpagam; Harpel, Mark R.; Willette, Robert N.; Lepore, John J.; Jucker, Beat M.] GlaxoSmithKline Inc, Heart Failure Discovery Performance Unit, Metab Pathways & Cardiovasc Therapy Area Unit, King Of Prussia, PA 19406 USA; [Alsaid, Hasan; Chendrimada, Thimmaiah] GlaxoSmithKline Inc, Clin Imaging Ctr, King Of Prussia, PA USA; [Szapacs, Matthew; Citerone, David R.] GlaxoSmithKline Inc, Platform Technol & Sci, King Of Prussia, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Bao, WK (corresponding author), GlaxoSmithKline Inc, Heart Failure Discovery Performance Unit, Metab Pathways & Cardiovasc Therapy Area Unit, King Of Prussia, PA 19406 USA.	Beat.M.Jucker@gsk.com		Alsaid, Hasan/0000-0001-6600-2146	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The studies were funded by GlaxoSmithKline. GlaxoSmithKline was responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Aguilar David, 2008, Curr Treat Options Cardiovasc Med, V10, P465, DOI 10.1007/s11936-008-0039-4; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Barnett AH, 2009, CLIN ENDOCRINOL, V70, P343, DOI 10.1111/j.1365-2265.2008.03396.x; BLOCH G, 1993, MAGNET RESON MED, V30, P347, DOI 10.1002/mrm.1910300311; Bose AK, 2005, CARDIOVASC DRUG THER, V19, P9, DOI 10.1007/s10557-005-6892-4; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Bradley DP, 2010, NUTRITION, V26, P243, DOI 10.1016/j.nut.2009.07.008; Bush MA, 2009, DIABETES OBES METAB, V11, P498, DOI 10.1111/j.1463-1326.2008.00992.x; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Gropler RJ, 2010, J NUCL MED, V51, p88S, DOI 10.2967/jnumed.109.068197; Jucker BM, 1997, J BIOL CHEM, V272, P10464, DOI 10.1074/jbc.272.16.10464; Jucker BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE139, DOI 10.1152/ajpendo.1997.273.1.E139; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Kristensen J, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-31; Luptak I, 2007, CIRCULATION, V116, P901, DOI 10.1161/CIRCULATIONAHA.107.691253; Makinde AO, 1998, MOL CELL BIOCHEM, V188, P49, DOI 10.1023/A:1006860104840; Matthews JE, 2008, J CLIN ENDOCR METAB, V93, P4810, DOI 10.1210/jc.2008-1518; NEUBAUER S, 1992, CIRCULATION, V86, P1810, DOI 10.1161/01.CIR.86.6.1810; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; POOLEWILSON PA, 1989, MOL CELL BIOCHEM, V89, P151; Poornima I, 2008, CIRC-HEART FAIL, V1, P153, DOI 10.1161/CIRCHEARTFAILURE.108.766402; Pratley Richard E, 2008, Medscape J Med, V10, P171; Reffelmann T, 2002, AM J PHYSIOL-HEART C, V282, pH766, DOI 10.1152/ajpheart.00767.2001; Schwarz ER, 2000, J THROMB THROMBOLYS, V10, P181, DOI 10.1023/A:1018770711705; St Onge EL, 2010, EXPERT OPIN BIOL TH, V10, P801, DOI 10.1517/14712598.2010.481281; TAYLOR DJ, 1986, MAGNET RESON MED, V3, P44, DOI 10.1002/mrm.1910030107; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Yue TL, 2008, J PHARMACOL EXP THER, V325, P466, DOI 10.1124/jpet.107.135327; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Zhao TC, 2006, J PHARMACOL EXP THER, V317, P1106, DOI 10.1124/jpet.106.100982	38	75	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23570	10.1371/journal.pone.0023570	http://dx.doi.org/10.1371/journal.pone.0023570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887274	gold, Green Submitted, Green Published			2022-12-27	WOS:000294298800016
J	Martino, CF; Castello, PR				Martino, Carlos F.; Castello, Pablo R.			Modulation of Hydrogen Peroxide Production in Cellular Systems by Low Level Magnetic Fields	PLOS ONE			English	Article							RADICAL RECOMBINATION REACTIONS; OXYGEN; SUPEROXIDE; MECHANISMS; ROS; MAGNETORECEPTION; CELLS; BIRDS; MODEL	Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, suggesting that ROS might be involved in the development of these cells. However, recent studies suggest that inducing an excess of ROS in cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially modulate the development of these cells by controlling their ROS production. Low levels of ROS are also important for the development and survival of normal cells. In this manuscript, we present data on the influence of the suppression of the Earth's magnetic field (low level magnetic fields or LLF) which magnitudes range from 0.2 mu T to 2 mu T on the modulation of hydrogen peroxide (H(2)O(2)) in human fibrosarcoma cancer cell line HT1080, pancreatic AsPC-1 cancer cell line, and bovine pulmonary artery endothelial cells (PAEC) exposed to geomagnetic field (control; 45 mu T-60 mu T). Reduction of the Earth's magnetic field suppressed H(2)O(2) production in cancer cells and PAEC. The addition of catalase and superoxide dismutase (SOD) mimetic MnTBAP inhibited the magnetic field effect. Modulating ROS production by magnetic fields may open new venues of biomedical research and therapeutic strategies.	[Martino, Carlos F.] Univ Colorado, Elect Comp & Energy Dept, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Martino, CF (corresponding author), Univ Nevada, Reno, NV 89557 USA.	martino@colorado.edu	Martino, Carlos F/C-6597-2016; Castello, Pablo R/AAL-7069-2021	Martino, Carlos F/0000-0002-0560-2604; 	Gordon Prize	Gordon Prize	Funding was provided by The Gordon Prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKLEHURST B, 1976, J CHEM SOC FARAD T 2, V72, P1869, DOI 10.1039/f29767201869; Brocklehurst B, 1996, INT J RADIAT BIOL, V69, P3, DOI 10.1080/095530096146147; Castello PR, 2008, J PHARMACOL EXP THER, V324, P970, DOI 10.1124/jpet.107.132134; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Eveson RW, 2000, INT J RADIAT BIOL, V76, P1509, DOI 10.1080/09553000050176270; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GUYTON KZ, 1993, BRIT MED BULL, V49, P523, DOI 10.1093/oxfordjournals.bmb.a072628; KELLOGG EW, 1975, J BIOL CHEM, V250, P8812; KELLOGG EW, 1977, J BIOL CHEM, V252, P6721; MANNERLING AC, 2010, RAD ENV BIOPHYS; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P296, DOI 10.1002/bem.20565; MARTINO CF, 2010, BIOELECTROM IN PRESS; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; SALIKHOV KM, 1983, CHEM PHYS, V82, P163, DOI 10.1016/0301-0104(83)85354-3; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; Timmel CR, 1998, MOL PHYS, V95, P71, DOI 10.1080/00268979809483134; Timmel CR, 2004, PHILOS T ROY SOC A, V362, P2573, DOI 10.1098/rsta.2004.1459; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783	28	43	53	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e22753	10.1371/journal.pone.0022753	http://dx.doi.org/10.1371/journal.pone.0022753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887222	gold, Green Published, Green Submitted			2022-12-27	WOS:000294298800001
J	Wang, YG; Kheir, MM; Chai, YS; Hu, J; Xing, DM; Lei, F; Du, LJ				Wang, Yugang; Kheir, Michael M.; Chai, Yushuang; Hu, Jun; Xing, Dongming; Lei, Fan; Du, Lijun			Comprehensive Study in the Inhibitory Effect of Berberine on Gene Transcription, Including TATA Box	PLOS ONE			English	Article							COPTIDIS-RHIZOMA EXTRACT; UP-REGULATION; IN-VITRO; BINDING PROTEIN; DNA; EXPRESSION; MECHANISM; TOXICITY	Berberine (BBR) is an established natural DNA intercalator with numerous pharmacological functions. However, currently there are neither detailed reports concerning the distribution of this alkaloid in living cells nor reports concerning the relationship between BBR's association with DNA and the function of DNA. Here we report that the distribution of BBR within the nucleus can be observed 30 minutes after drug administration, and that the content of berberine in the nucleus peaks at around 4 mu mol, which is twelve hours after drug administration. The spatial conformation of DNA and chromatin was altered immediately after their association with BBR. Moreover, this association can effectively suppress the transcription of DNA in living cell systems and cell-free systems. Electrophoretic mobility shift assays (EMSA) demonstrated further that BBR can inhibit the association between the TATA binding protein (TBP) and the TATA box in the promoter, and this finding was also attained in living cells by chromatin immunoprecipitation (ChIP). Based on results from this study, we hypothesize that berberine can suppress the transcription of DNA in living cell systems, especially suppressing the association between TBP and the TATA box by binding with DNA and, thus, inhibiting TATA box-dependent gene expression in a non-specific way. This novel study has significantly expanded the sphere of knowledge concerning berberine's pharmacological effects, beginning at its paramount initial interaction with the TATA box.	[Wang, Yugang; Kheir, Michael M.; Chai, Yushuang; Hu, Jun; Xing, Dongming; Lei, Fan; Du, Lijun] Tsinghua Univ, Prot Sci Lab, Minist Educ, Lab Pharmaceut Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Yugang; Kheir, Michael M.; Chai, Yushuang; Hu, Jun; Xing, Dongming; Lei, Fan; Du, Lijun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Kheir, Michael M.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Tsinghua University; Tsinghua University; University of Michigan System; University of Michigan	Wang, YG (corresponding author), Tsinghua Univ, Prot Sci Lab, Minist Educ, Lab Pharmaceut Sci,Sch Life Sci, Beijing 100084, Peoples R China.	leifan@mail.tsinghua.edu.cn; lijundu@mail.tsinghua.edu.cn	Kheir, Michael/ABA-5760-2021; Wang, Yijun/F-3547-2012; Wang, Yijun/GXW-1763-2022	Kheir, Michael/0000-0001-6469-6746	National Natural Science Foundation of China [90713043, 30973896, 81073092]; National S&T Major Special Project for New Drug RD of China [2009ZX09103-301, 2009ZX09502, 2011ZX09101-002-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug RD of China	This study was supported by the National Natural Science Foundation of China (90713043, 30973896, and 81073092) and the National S&T Major Special Project for New Drug R&D of China (2009ZX09103-301, 2009ZX09502, and 2011ZX09101-002-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIHIKO T, 2001, BIOPHYS J, V81, P501; Bhadra K, 2008, BBA-GEN SUBJECTS, V1780, P1054, DOI 10.1016/j.bbagen.2008.05.005; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bonner J, 1968, METHODS ENZYMOL, V12, P3; BOVA S, 1992, J PHARMACOL EXP THER, V261, P318; Chen WH, 2005, BIOORGAN MED CHEM, V13, P1859, DOI 10.1016/j.bmc.2004.10.049; Chen YY, 2008, BIOMED CHROMATOGR, V22, P28, DOI 10.1002/bmc.889; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; CHIOU WF, 1991, EUR J PHARMACOL, V204, P35; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; KREY AK, 1969, SCIENCE, V166, P755, DOI 10.1126/science.166.3906.755; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; KUO CL, 1995, CANCER LETT, V93, P193, DOI 10.1016/0304-3835(95)03809-B; Lee S, 2007, BIOCHEM BIOPH RES CO, V362, P853, DOI 10.1016/j.bbrc.2007.08.060; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li WY, 1998, MICROCHEM J, V60, P84, DOI 10.1006/mchj.1998.1633; Lin CC, 2006, ANTICANCER RES, V26, P1097; Mazzini S, 2003, BIOORGAN MED CHEM, V11, P505, DOI 10.1016/S0968-0896(02)00466-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; STEPHEN KB, 1996, CURR OPIN STRUC BIOL, V6, P69; STEPHEN N, 2001, ROYAL SOC CHEM, V18, P291; STOCKERT JC, 1985, CHROMOSOMA, V93, P21, DOI 10.1007/BF01259441; Wang XL, 2005, NEUROSCI LETT, V379, P132, DOI 10.1016/j.neulet.2004.12.050; Wang Yugang, 2010, Zhongguo Zhong Yao Za Zhi, V35, P76; Wang Yugang, 2009, Zhongguo Zhong Yao Za Zhi, V34, P2261; Xu LH, 2005, CELL MOL IMMUNOL, V2, P295; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; [张小辉 ZHANG Xiaohui], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P1380; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064	34	365	379	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23495	10.1371/journal.pone.0023495	http://dx.doi.org/10.1371/journal.pone.0023495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887260	gold, Green Submitted, Green Published			2022-12-27	WOS:000294251800013
J	Borge-Holthoefer, J; Rivero, A; Garcia, I; Cauhe, E; Ferrer, A; Ferrer, D; Francos, D; Iniguez, D; Perez, MP; Ruiz, G; Sanz, F; Serrano, F; Vinas, C; Tarancon, A; Moreno, Y				Borge-Holthoefer, Javier; Rivero, Alejandro; Garcia, Inigo; Cauhe, Elisa; Ferrer, Alfredo; Ferrer, Dario; Francos, David; Iniguez, David; Pilar Perez, Maria; Ruiz, Gonzalo; Sanz, Francisco; Serrano, Fermin; Vinas, Cristina; Tarancon, Alfonso; Moreno, Yamir			Structural and Dynamical Patterns on Online Social Networks: The Spanish May 15th Movement as a Case Study	PLOS ONE			English	Article							COMPLEX NETWORKS; GROUP-SIZE	The number of people using online social networks in their everyday life is continuously growing at a pace never saw before. This new kind of communication has an enormous impact on opinions, cultural trends, information spreading and even in the commercial success of new products. More importantly, social online networks have revealed as a fundamental organizing mechanism in recent country-wide social movements. In this paper, we provide a quantitative analysis of the structural and dynamical patterns emerging from the activity of an online social network around the ongoing May 15th (15M) movement in Spain. Our network is made up by users that exchanged tweets in a time period of one month, which includes the birth and stabilization of the 15M movement. We characterize in depth the growth of such dynamical network and find that it is scale-free with communities at the mesoscale. We also find that its dynamics exhibits typical features of critical systems such as robustness and power-law distributions for several quantities. Remarkably, we report that the patterns characterizing the spreading dynamics are asymmetric, giving rise to a clear distinction between information sources and sinks. Our study represents a first step towards the use of data from online social media to comprehend modern societal dynamics.	[Borge-Holthoefer, Javier; Rivero, Alejandro; Cauhe, Elisa; Ferrer, Alfredo; Ferrer, Dario; Francos, David; Iniguez, David; Pilar Perez, Maria; Ruiz, Gonzalo; Sanz, Francisco; Serrano, Fermin; Vinas, Cristina; Tarancon, Alfonso; Moreno, Yamir] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Tarancon, Alfonso; Moreno, Yamir] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain; [Garcia, Inigo] Cierzo Dev SL, Zaragoza, Spain; [Iniguez, David] Fdn ARAID, Zaragoza, Spain; [Moreno, Yamir] Inst Sci Interchange, Complex Networks & Syst Lagrange Lab, Turin, Italy	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza	Borge-Holthoefer, J (corresponding author), Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain.	yamir.moreno@gmail.com	Borge-Holthoefer, Javier/J-9187-2013; Tarancon, Alfonso/F-2030-2010; Ruiz, Gonzalo/A-4092-2012; Iñiguez, David/A-3556-2012; Rivero, Alejandro/G-9552-2011; Serrano, Fermin/A-4069-2012; Moreno, Yamir/A-1076-2009	Borge-Holthoefer, Javier/0000-0001-9036-8463; Tarancon, Alfonso/0000-0003-2772-3762; Iñiguez, David/0000-0003-2916-5493; Rivero, Alejandro/0000-0002-6689-214X; Moreno, Yamir/0000-0002-0895-1893; Sanz, Francisco/0000-0002-3953-9471	Spanish Ministerio de Ciencia e Innovacion (MICINN) [FIS2008-01240, FIS2009-13364-C02-01, FIS-164-50]; Government of Aragon through a Fundacion Aragon I+D; European Commission [233847]; Comunidad de Aragon (Spain) [FMI22/10]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Aragon through a Fundacion Aragon I+D; European Commission(European CommissionEuropean Commission Joint Research Centre); Comunidad de Aragon (Spain)	J.B.-H. is supported by Spanish Ministerio de Ciencia e Innovacion (MICINN) through project FIS2008-01240. D. I. is supported by the Government of Aragon through a Fundacion Aragon I+D contract. Y.M. was partially supported by the Future and Emerging Technologies Open project DYNANETS (grant no. 233847) funded by the European Commission, by Spanish Ministerio de Ciencia e Innovacion (MICINN) through projects FIS2008-01240 and FIS2009-13364-C02-01 and by Comunidad de Aragon (Spain) through the project FMI22/10. The authors also acknowledge the Spanish Ministerio de Ciencia e Innovacion (MICINN) for financial support through the project FIS-164-50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Arenas A, 2004, EUR PHYS J B, V38, P373, DOI 10.1140/epjb/e2004-00130-1; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borge-Holthoefer J, 2010, EUR PHYS J B, V74, P265, DOI 10.1140/epjb/e2010-00058-9; CONOVER M, 2011, P 5 INT C WEBL SOC M; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; EDLER D, MAP GENERATOR SOFTWA; Fortunato S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.218701; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; GONCALVES B, 2011, PLOS ONE IN PRESS; Lozano S, 2008, J ECON INTERACT COOR, V3, P183, DOI 10.1007/s11403-008-0041-7; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.055101; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; SIMON H, 1971, COMPUTERS COMMUNICAT, P33	22	103	105	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23883	10.1371/journal.pone.0023883	http://dx.doi.org/10.1371/journal.pone.0023883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886834	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100038
J	Oda, GA; Friesen, WO				Oda, Gisele A.; Friesen, W. Otto			Modeling Two-Oscillator Circadian Systems Entrained by Two Environmental Cycles	PLOS ONE			English	Article							FOOD-ANTICIPATORY ACTIVITY; SUPRACHIASMATIC NUCLEUS; MATHEMATICAL-MODEL; CLOCK NEURONS; LIGHT-DARK; TEMPERATURE; RHYTHMS; OSCILLATORS; PACEMAKER; ORGANIZATION	Several experimental studies have altered the phase relationship between photic and non-photic environmental, 24 h cycles (zeitgebers) in order to assess their role in the synchronization of circadian rhythms. To assist in the interpretation of the complex activity patterns that emerge from these "conflicting zeitgeber'' protocols, we present computer simulations of coupled circadian oscillators forced by two independent zeitgebers. This circadian system configuration was first employed by Pittendrigh and Bruce (1959), to model their studies of the light and temperature entrainment of the eclosion oscillator in Drosophila. Whereas most of the recent experiments have restricted conflicting zeitgeber experiments to two experimental conditions, by comparing circadian oscillator phases under two distinct phase relationships between zeitgebers (usually 0 and 12 h), Pittendrigh and Bruce compared eclosion phase under 12 distinct phase relationships, spanning the 24 h interval. Our simulations using non-linear differential equations replicated complex non-linear phenomena, such as "phase jumps'' and sudden switches in zeitgeber preferences, which had previously been difficult to interpret. Our simulations reveal that these phenomena generally arise when inter-oscillator coupling is high in relation to the zeitgeber strength. Manipulations in the structural symmetry of the model indicated that these results can be expected to apply to a wide range of system configurations. Finally, our studies recommend the use of the complete protocol employed by Pittendrigh and Bruce, because different system configurations can generate similar results when a "conflicting zeitgeber experiment'' incorporates only two phase relationships between zeitgebers.	[Oda, Gisele A.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Friesen, W. Otto] Univ Virginia, Dept Biol, Charlottesville, VA USA	Universidade de Sao Paulo; University of Virginia	Oda, GA (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	gaoda@ib.usp.br	oda, gisele a/F-4283-2012	oda, gisele a/0000-0001-7776-5368	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [06/61276-0]; USA National Science Foundation [IOB-061563]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USA National Science Foundation(National Science Foundation (NSF))	This work was supported by grant (06/61276-0; GAO) from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), and grant (IOB-061563; WOF) from USA National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; BRUCE VG, 1960, COLD SPRING HARB SYM, V25, P29, DOI 10.1101/SQB.1960.025.01.005; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; CHALLET E, 1998, AM J PHYSIOL, V274, P1751; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; FRIESEN WO, 2009, NEURODYNAMIX, V2; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GWINNER E, 1966, EXPERIENTIA, V22, P765, DOI 10.1007/BF01901370; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Huang GC, 2006, EMBO J, V25, P5349, DOI 10.1038/sj.emboj.7601397; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; KRONAUER RE, 1982, AM J PHYSIOL, V242, pR3, DOI 10.1152/ajpregu.1982.242.1.R3; Lague M, 2000, PHYSIOL BEHAV, V70, P55, DOI 10.1016/S0031-9384(00)00246-8; Menaker M, 2006, P NATL ACAD SCI USA, V103, P3015, DOI 10.1073/pnas.0600360103; MENAKER M, 1966, SCIENCE, V154, P1579, DOI 10.1126/science.154.3756.1579; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Michael TP, 2003, P NATL ACAD SCI USA, V100, P6878, DOI 10.1073/pnas.1131995100; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Nagano M, 2003, J NEUROSCI, V23, P6141; NEUMANN D, 1985, J INSECT PHYSIOL, V31, P549, DOI 10.1016/0022-1910(85)90111-8; Oda GA, 2002, J BIOL RHYTHM, V17, P76, DOI 10.1177/074873002129002357; Oda GA, 2000, J BIOL RHYTHM, V15, P246, DOI 10.1177/074873040001500306; PAGE TL, 1985, COMPREHENSIVE INSECT, V6, P632; PAVLIDIS T, 1967, B MATH BIOPHYS, V29, P291, DOI 10.1007/BF02476901; PITTENDRIGH C, 1958, P NATL ACAD SCI USA, V44, P965, DOI 10.1073/pnas.44.9.965; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Pittendrigh CS, 1959, PHOTOPERIODISM RELAT, P475, DOI DOI 10.1177/0748730413516309; Refinetti R, 2010, J BIOL RHYTHM, V25, P247, DOI 10.1177/0748730410372074; Reierth E, 1998, J BIOL RHYTHM, V13, P393, DOI 10.1177/074873098129000219; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Roces F, 1996, PHYSIOL ENTOMOL, V21, P138, DOI 10.1111/j.1365-3032.1996.tb00846.x; SANCHEZVAZQUEZ FJ, 1995, PHYSIOL BEHAV, V58, P705, DOI 10.1016/0031-9384(95)00116-Z; Schwartz MD, 2009, P NATL ACAD SCI USA, V106, P17540, DOI 10.1073/pnas.0906382106; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; SWEENEY BM, 1960, COLD SPRING HARB SYM, V25, P87, DOI 10.1101/SQB.1960.025.01.009; TAKAHASHI JS, 1982, J COMP PHYSIOL, V146, P245, DOI 10.1007/BF00610244; Tanaka K, 2003, NATURWISSENSCHAFTEN, V90, P76, DOI 10.1007/s00114-002-0390-3; van der Veen DR, 2006, P NATL ACAD SCI USA, V103, P3393, DOI 10.1073/pnas.0507825103; Watari Y, 2010, J INSECT PHYSIOL, V56, P1192, DOI 10.1016/j.jinsphys.2010.03.022; WEVER R, 1972, J THEOR BIOL, V36, P119, DOI 10.1016/0022-5193(72)90181-6; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	50	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23895	10.1371/journal.pone.0023895	http://dx.doi.org/10.1371/journal.pone.0023895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886835	Green Published, gold, Green Submitted			2022-12-27	WOS:000294128100039
J	Lai, KK; Stogios, PJ; Vu, C; Xu, X; Cui, H; Molloy, S; Savchenko, A; Yakunin, A; Gonzalez, CF				Lai, Kin-Kwan; Stogios, Peter J.; Vu, Clara; Xu, Xiaohui; Cui, Hong; Molloy, Sara; Savchenko, Alexei; Yakunin, Alexander; Gonzalez, Claudio F.			An Inserted alpha/beta Subdomain Shapes the Catalytic Pocket of Lactobacillus johnsonii Cinnamoyl Esterase	PLOS ONE			English	Article							FERULOYL ESTERASE; SUBSTRATE-SPECIFICITY; HUMAN VALACYCLOVIRASE; MAXIMUM-LIKELIHOOD; MOLECULAR-BASIS; PROTEIN; ACID; HYDROLASE; CRYSTALLIZATION; IDENTIFICATION	Background: Microbial enzymes produced in the gastrointestinal tract are primarily responsible for the release and biochemical transformation of absorbable bioactive monophenols. In the present work we described the crystal structure of LJ0536, a serine cinnamoyl esterase produced by the probiotic bacterium Lactobacillus johnsonii N6.2. Methodology/Principal Findings: We crystallized LJ0536 in the apo form and in three substrate-bound complexes. The structure showed a canonical alpha/beta fold characteristic of esterases, and the enzyme is dimeric. Two classical serine esterase motifs (GlyXSerXGly) can be recognized from the amino acid sequence, and the structure revealed that the catalytic triad of the enzyme is formed by Ser(106), His(225), and Asp(197), while the other motif is non-functional. In all substrate-bound complexes, the aromatic acyl group of the ester compound was bound in the deepest part of the catalytic pocket. The binding pocket also contained an unoccupied area that could accommodate larger ligands. The structure revealed a prominent inserted alpha/beta subdomain of 54 amino acids, from which multiple contacts to the aromatic acyl groups of the substrates are made. Inserts of this size are seen in other esterases, but the secondary structure topology of this subdomain of LJ0536 is unique to this enzyme and its closest homolog (Est1E) in the Protein Databank. Conclusions: The binding mechanism characterized (involving the inserted alpha/beta subdomain) clearly differentiates LJ0536 from enzymes with similar activity of a fungal origin. The structural features herein described together with the activity profile of LJ0536 suggest that this enzyme should be clustered in a new group of bacterial cinnamoyl esterases.	[Lai, Kin-Kwan; Vu, Clara; Molloy, Sara; Gonzalez, Claudio F.] Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA; [Stogios, Peter J.; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Vu, Clara; Molloy, Sara] Univ Florida, Dept Microbiol & Cell Sci, UF Undergrad Res Program MCB4905, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of Toronto; State University System of Florida; University of Florida	Lai, KK (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	cfgonzalez@ufl.edu	Yakunin, Alexander/J-1519-2014	Stogios, Peter/0000-0001-8663-1425; Yakunin, Alexander/0000-0003-0813-6490	Institute of Food and Agricultural Sciences, University of Florida; University of Florida	Institute of Food and Agricultural Sciences, University of Florida(University of Florida); University of Florida(University of Florida)	This work was supported by the Research Innovation Award, Institute of Food and Agricultural Sciences, University of Florida. Publication of this article was also funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasen MF, 2001, J AGR FOOD CHEM, V49, P5679, DOI 10.1021/jf010668c; Benoit I, 2007, APPL ENVIRON MICROB, V73, P5624, DOI 10.1128/AEM.00374-07; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Choo WS, 2009, LIPIDS, V44, P145, DOI 10.1007/s11745-008-3242-x; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Dalrymple BP, 1996, FEMS MICROBIOL LETT, V143, P115, DOI 10.1016/0378-1097(96)00306-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faulds CB, 2005, FEBS J, V272, P4362, DOI 10.1111/j.1742-4658.2005.04849.x; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Hermoso JA, 2004, J MOL BIOL, V338, P495, DOI 10.1016/j.jmb.2004.03.003; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOPE H, 1988, ACTA CRYSTALLOGR B, V44, P22, DOI 10.1107/S0108768187008632; Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r; Karlsson PC, 2005, J NUTR, V135, P2343; Kim I, 2003, J BIOL CHEM, V278, P25348, DOI 10.1074/jbc.M302055200; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; Konishi Y, 2005, J AGR FOOD CHEM, V53, P4740, DOI 10.1021/jf0478307; Konishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P583, DOI 10.1271/bbb.69.583; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroon PA, 1997, J AGR FOOD CHEM, V45, P661, DOI 10.1021/jf9604403; Lai KK, 2009, APPL ENVIRON MICROB, V75, P5018, DOI 10.1128/AEM.02837-08; Lai LS, 2008, J BIOL CHEM, V283, P9318, DOI 10.1074/jbc.M709530200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mastihuba V, 2002, ANAL BIOCHEM, V309, P96, DOI 10.1016/S0003-2697(02)00241-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Schubot FD, 2001, BIOCHEMISTRY-US, V40, P12524, DOI 10.1021/bi011391c; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Udatha DBRKG, 2011, BIOTECHNOL ADV, V29, P94, DOI 10.1016/j.biotechadv.2010.09.003; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Yin DL, 2010, BIOCHEMISTRY-US, V49, P1931, DOI 10.1021/bi9021268	53	41	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23269	10.1371/journal.pone.0023269	http://dx.doi.org/10.1371/journal.pone.0023269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876742	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900014
J	Marchal, M; Briandet, R; Halter, D; Koechler, S; Dubow, MS; Lett, MC; Bertin, PN				Marchal, Marie; Briandet, Romain; Halter, David; Koechler, Sandrine; DuBow, Michael S.; Lett, Marie-Claire; Bertin, Philippe N.			Subinhibitory Arsenite Concentrations Lead to Population Dispersal in Thiomonas sp.	PLOS ONE			English	Article							BIOFILMS; BIOREMEDIATION; METABOLISM; TOLERANCE; VIABILITY; OXIDATION; STRAINS; STRESS; CELLS	Biofilms represent the most common microbial lifestyle, allowing the survival of microbial populations exposed to harsh environmental conditions. Here, we show that the biofilm development of a bacterial species belonging to the Thiomonas genus, frequently found in arsenic polluted sites and playing a key role in arsenic natural remediation, is markedly modified when exposed to subinhibitory doses of this toxic element. Indeed, arsenite [As(III)] exposure led to a considerable impact on biofilm maturation by strongly increasing the extracellular matrix synthesis and by promoting significant cell death and lysis within microcolonies. These events were followed by the development of complex 3D-biofilm structures and subsequently by the dispersal of remobilized cells observed inside the previously formed hollow voids. Our results demonstrate that this biofilm community responds to arsenite stress in a multimodal way, enhancing both survival and dispersal. Addressing this complex bacterial response to As(III) stress, which might be used by other microorganisms under various adverse conditions, may be essential to understand how Thiomonas strains persist in extreme environments.	[Marchal, Marie; Halter, David; Koechler, Sandrine; Lett, Marie-Claire; Bertin, Philippe N.] CNRS, UMR7156, Strasbourg, France; [Marchal, Marie; Halter, David; Koechler, Sandrine; Lett, Marie-Claire; Bertin, Philippe N.] Univ Strasbourg, Strasbourg, France; [Briandet, Romain] INRA, MICALIS UMR1319, Jouy En Josas, France; [Briandet, Romain] AgroParisTech, UMR MICALIS, Massy, France; [DuBow, Michael S.] Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR 8621, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Marchal, M (corresponding author), CNRS, UMR7156, Strasbourg, France.	philippe.bertin@unistra.fr	Briandet, Romain/AAD-2102-2020	Briandet, Romain/0000-0002-8123-3492; Philippe, Bertin/0000-0003-1158-6396	ANR; French Ministry of Education	ANR(French National Research Agency (ANR)); French Ministry of Education	MM was supported by a studentship from the ANR COBIAS project (PRECODD 2007}, and by Agence Nationale de la Recherche (http://cobias.brgm.fr/). DH was supported by a grant from the French Ministry of Education. This work was performed as part of the program of the "Groupement de Recherche Metabolisme de l'Arsenic chez les Microorganismes (GDR2909-CNRS)" (http://gdr2909.alsace.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Arsene-Ploetze F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000859; Barreto M, 2005, APPL ENVIRON MICROB, V71, P2902, DOI 10.1128/AEM.71.6.2902-2909.2005; Battaglia-Brunet F, 2006, ANTON LEEUW INT J G, V89, P99, DOI 10.1007/s10482-005-9013-2; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BERTIN PN, ISME J IN PRESS; Biggerstaff JP, 2006, MOL CELL PROBE, V20, P141, DOI 10.1016/j.mcp.2005.11.006; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Bruneel O, 2003, J APPL MICROBIOL, V95, P492, DOI 10.1046/j.1365-2672.2003.02004.x; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Cleiss-Arnold J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-709; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Kuehn M, 1998, APPL ENVIRON MICROB, V64, P4115; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Mai-Prochnow A, 2006, APPL ENVIRON MICROB, V72, P5414, DOI 10.1128/AEM.00546-06; Michel C, 2007, APPL MICROBIOL BIOT, V77, P457, DOI 10.1007/s00253-007-1169-4; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053	26	35	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23181	10.1371/journal.pone.0023181	http://dx.doi.org/10.1371/journal.pone.0023181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876737	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900009
J	Haldipur, P; Bharti, U; Alberti, C; Sarkar, C; Gulati, G; Iyengar, S; Gressens, P; Mani, S				Haldipur, Parthiv; Bharti, Upasna; Alberti, Corinne; Sarkar, Chitra; Gulati, Geetika; Iyengar, Soumya; Gressens, Pierre; Mani, Shyamala			Preterm Delivery Disrupts the Developmental Program of the Cerebellum	PLOS ONE			English	Article							1,4,5-TRISPHOSPHATE INSP3 RECEPTOR; CORTICAL LAYERS; PURKINJE-CELL; INFLAMMATION; INFANT; GROWTH	A rapid growth in human cerebellar development occurs in the third trimester, which is impeded by preterm delivery. The goal of this study was to characterize the impact of preterm delivery on the developmental program of the human cerebellum. Still born infants, which meant that all development up to that age had taken place in-utero, were age paired with preterm delivery infants, who had survived in an ex-utero environment, which meant that their development had also taken place outside the uterus. The two groups were assessed on quantitative measures that included molecular markers of granule neuron, purkinje neuron and bergmann glia differentiation, as well as the expression of the sonic hedgehog signaling pathway, that is important for cerebellar growth. We report that premature birth and development in an ex-utero environment leads to a significant decrease in the thickness and an increase in the packing density of the cells within the external granular layer and the inner granular layer well, as a reduction in the density of bergmann glial fibres. In addition, this also leads to a reduced expression of sonic hedgehog in the purkinje layer. We conclude that the developmental program of the cerebellum is specifically modified by events that follow preterm delivery.	[Haldipur, Parthiv; Bharti, Upasna; Iyengar, Soumya; Mani, Shyamala] Natl Brain Res Ctr, Manesar, Haryana, India; [Alberti, Corinne] CIE 5, INSERM, Paris, France; [Alberti, Corinne] Robert Debre Hosp, Assistance Publ Hop Paris, Unite Epidemiol Clin, Paris, France; [Alberti, Corinne; Gressens, Pierre] Univ Paris 07, Fac Med Denis Diderot, Paris, France; [Sarkar, Chitra; Gulati, Geetika] All India Inst Med Sci, New Delhi, India; [Gressens, Pierre] INSERM, U676, Paris, France; [Gressens, Pierre] PremUP, Paris, France	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; All India Institute of Medical Sciences (AIIMS) New Delhi; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Haldipur, P (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	shyamala@cns.iisc.ernet.in	gressens, pierre/M-7557-2017; Haldipur, Parthiv/ABH-8875-2020	gressens, pierre/0000-0002-0909-4221; HALDIPUR, PARTHIV/0000-0003-2865-8683	Indo-French Centre for the Promotion of Advanced Research [3803-3]; National Brain Research Centre, Manesar, India; Assistance Publique-Hospitaux de Paris (Contrat d'Interface)	Indo-French Centre for the Promotion of Advanced Research(French National Research Agency (ANR)); National Brain Research Centre, Manesar, India; Assistance Publique-Hospitaux de Paris (Contrat d'Interface)	This project was supported by Indo-French Centre for the Promotion of Advanced Research grant number 3803-3 to SM and PG, core support from the National Brain Research Centre, Manesar, India and a grant from Assistance Publique-Hospitaux de Paris (Contrat d'Interface to PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2001, INT J DEV NEUROSCI, V19, P53, DOI 10.1016/S0736-5748(00)00065-4; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P496, DOI 10.1016/j.clineuro.2008.01.003; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Baillieux H, 2009, BRAIN LANG, V108, P122, DOI 10.1016/j.bandl.2008.10.001; BAKALIAN A, 1995, J NEUROGENET, V9, P207, DOI 10.3109/01677069509084157; Beaino G, 2010, DEV MED CHILD NEUROL, V52, pE119, DOI 10.1111/j.1469-8749.2010.03612.x; Bellebaum C, 2011, CORTEX, V47, P128, DOI 10.1016/j.cortex.2009.07.016; Ben-Yehudah G, 2008, ANN NY ACAD SCI, V1145, P260, DOI 10.1196/annals.1416.015; Bueter W, 2009, PEDIATR RES, V66, P487, DOI 10.1203/PDR.0b013e3181baa083; Bugalho Paulo, 2006, Acta Med Port, V19, P257; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Cox C, 2001, LARYNGOSCOPE, V111, P696, DOI 10.1097/00005537-200104000-00024; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DEBLAS AL, 1985, BRAIN RES, V342, P234, DOI 10.1016/0006-8993(85)91121-7; Degos V, 2010, J NEURAL TRANSM, V117, P1009, DOI 10.1007/s00702-010-0411-x; Gordon N, 2007, EUR J PAEDIATR NEURO, V11, P232, DOI 10.1016/j.ejpn.2007.02.003; Haldipur P, 2011, STEM CELLS IN PRESS; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Limperopoulos C, 2005, PEDIATRICS, V116, P717, DOI 10.1542/peds.2005-0556; Limperopoulos C, 2005, PEDIATRICS, V115, P688, DOI 10.1542/peds.2004-1169; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; Marien P, 2009, CORTEX, V45, P527, DOI 10.1016/j.cortex.2007.12.010; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rollins NK, 1995, PEDIATR RADIOL, V25, pS20; Steer P, 2005, J PERINAT MED, V33, P273, DOI 10.1515/JPM.2005.053; Thoma P, 2008, CEREBELLUM, V7, P433, DOI 10.1007/s12311-008-0046-8; VINORES SA, 1994, HISTOCHEM J, V26, P678, DOI 10.1007/BF00158293; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0	39	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23449	10.1371/journal.pone.0023449	http://dx.doi.org/10.1371/journal.pone.0023449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858122	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300047
J	Moon, JR; Kondo, N; Glymour, MM; Subramanian, SV				Moon, J. Robin; Kondo, Naoki; Glymour, M. Maria; Subramanian, S. V.			Widowhood and Mortality: A Meta-Analysis	PLOS ONE			English	Article							MARITAL-STATUS; CONJUGAL BEREAVEMENT; SOCIAL-CONTROL; HEALTH; DEATH; SPOUSE; WIDOWERS; FAMILY; IMPACT; RISK	Background: While the "widowhood effect" is well known, there is substantial heterogeneity in the magnitude of effects reported in different studies. We conducted a meta-analysis of widowhood and mortality, focusing on longitudinal studies with follow-up from the time of bereavement. Methods and Findings: A random-effects meta-analysis was conducted to calculate the overall relative risk (RR) for subsequent mortality among 2,263,888 subjects from 15 prospective cohort studies. We found a statistically significant positive association between widowhood and mortality, but the widowhood effect was stronger in the period earlier than six months since bereavement (overall RR = 1.41, 95% CI: 1.26, 1.57) compared to the effect after six months (overall RR = 1.14, 95% CI: 1.10, 1.18). Meta-regression showed that the widowhood effect was not different for those aged younger than 65 years compared to those older than 65 (P = 0.25). There was, however, a difference in the magnitude of the widowhood effect by gender; for women the RR was not statistically significantly different from the null (overall RR = 1.04, 95% CI: 1.00, 1.08), while it was for men (overall RR = 1.23, 95% CI: 1.18, 1.28). Conclusions: The results suggest that further studies should focus more on the mechanisms that generate this association especially among men.	[Moon, J. Robin; Glymour, M. Maria; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Kondo, Naoki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Chuo, Yamanashi, Japan	Harvard University; Harvard T.H. Chan School of Public Health; University of Yamanashi	Moon, JR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Kondo, Naoki/K-3898-2012; Kondo, Naoki/ABC-5865-2020; Moon, J Robin/AAX-6709-2021	Kondo, Naoki/0000-0002-6425-6844; Kondo, Naoki/0000-0002-6425-6844; Moon, J Robin/0000-0002-1793-936X	National Institutes of Health [5R21AG37889]; National Research Service [T32-HL098048-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG037889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a National Institutes of Health grant (5R21AG37889, PI: SVS). JRM is supported by a National Research Service Award training grant (T32-HL098048-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman L F, 1988, Annu Rev Gerontol Geriatr, V8, P37; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DELEON CFM, 1993, J CLIN EPIDEMIOL, V46, P519, DOI 10.1016/0895-4356(93)90124-J; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; Elwert F, 2006, AM SOCIOL REV, V71, P16, DOI 10.1177/000312240607100102; Glass G.V., 1976, ED RES, V5, P3, DOI [10.2307/1174772, DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; Hart CL, 2007, J EPIDEMIOL COMMUN H, V61, P455, DOI 10.1136/jech.2006.052043; HELSING KJ, 1982, AM J EPIDEMIOL, V116, P524, DOI 10.1093/oxfordjournals.aje.a113436; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HU YR, 1990, DEMOGRAPHY, V27, P233, DOI 10.2307/2061451; Hughes ME, 2009, J HEALTH SOC BEHAV, V50, P344, DOI 10.1177/002214650905000307; KAPRIO J, 1987, AM J PUBLIC HEALTH, V77, P283, DOI 10.2105/AJPH.77.3.283; KRAUS A S, 1959, J Chronic Dis, V10, P207, DOI 10.1016/0021-9681(59)90003-7; Lichtenstein P, 1998, PSYCHOL MED, V28, P635, DOI 10.1017/S0033291798006692; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; Manor O, 2003, SOC SCI MED, V56, P405, DOI 10.1016/S0277-9536(02)00046-1; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Martikainen P, 1996, J EPIDEMIOL COMMUN H, V50, P264, DOI 10.1136/jech.50.3.264; Mineau GP, 2002, SOC SCI MED, V54, P245, DOI 10.1016/S0277-9536(01)00024-7; Nagata C, 2003, ANN EPIDEMIOL, V13, P218, DOI 10.1016/S1047-2797(02)00409-X; PARKES CM, 1969, BMJ-BRIT MED J, V1, P740, DOI 10.1136/bmj.1.5646.740; ROGERS RG, 1995, J MARRIAGE FAM, V57, P515, DOI 10.2307/353703; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; ROSS CE, 1995, J MARRIAGE FAM, V57, P129, DOI 10.2307/353822; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Smith KR, 1996, SOC BIOL, V43, P59; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stimpson JP, 2007, ANN EPIDEMIOL, V17, P313, DOI 10.1016/j.annepidem.2006.10.006; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; UMBERSON D, 1987, J HEALTH SOC BEHAV, V28, P306, DOI 10.2307/2136848; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S	36	118	118	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23465	10.1371/journal.pone.0023465	http://dx.doi.org/10.1371/journal.pone.0023465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21858130	Green Submitted, gold, Green Published			2022-12-27	WOS:000294121300048
J	Nasidze, I; Li, J; Schroeder, R; Creasey, JL; Li, MK; Stoneking, M				Nasidze, Ivan; Li, Jing; Schroeder, Roland; Creasey, Jean L.; Li, Mingkun; Stoneking, Mark			High Diversity of the Saliva Microbiome in Batwa Pygmies	PLOS ONE			English	Article							WATER; NOV.	We describe the saliva microbiome diversity in Batwa Pygmies, a former hunter-gatherer group from Uganda, using next-generation sequencing of partial 16S rRNA sequences. Microbial community diversity in the Batwa is significantly higher than in agricultural groups from Sierra Leone and the Democratic Republic of Congo. We found 40 microbial genera in the Batwa, which have previously not been described in the human oral cavity. The distinctive composition of the salvia microbiome of the Batwa may have been influenced by their recent different lifestyle and diet.	[Nasidze, Ivan; Li, Jing; Schroeder, Roland; Li, Mingkun; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Creasey, Jean L.] DDS, Nevada City, CA USA	Max Planck Society	Nasidze, I (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	nasidze@eva.mpg.de	Li, Mingkun/G-7161-2012		Max Planck Society, Germany	Max Planck Society, Germany(Max Planck Society)	This research was funded by the Max Planck Society, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2006, INT J SYST EVOL MICR, V56, P1311, DOI 10.1099/ijs.0.64218-0; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Cao SJ, 2010, INT J SYST EVOL MICR, V60, P2023, DOI 10.1099/ijs.0.017681-0; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Conover WJ, 1998, PRACTICAL NONPARAMET; Gusinde M, 1955, ANTHR Q, V28, P3; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; SCHNEIDER S, 2000, ARELQUIN VERSION 2 0; *STATSOFT INC, 1984, STATISTICA PACK 6 1; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; WALKER PL, 1990, AM ANTHROPOL, V92, P383, DOI 10.1525/aa.1990.92.2.02a00080	16	70	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23352	10.1371/journal.pone.0023352	http://dx.doi.org/10.1371/journal.pone.0023352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858083	gold, Green Published, Green Submitted			2022-12-27	WOS:000294125500030
J	Eleore, L; Lopez-Ramos, JC; Guerra-Narbona, R; Delgado-Garcia, JM				Eleore, Lyndell; Carlos Lopez-Ramos, Juan; Guerra-Narbona, Rafael; Delgado-Garcia, Jose M.			Role of Reuniens Nucleus Projections to the Medial Prefrontal Cortex and to the Hippocampal Pyramidal CA1 Area in Associative Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PAIRED-PULSE FACILITATION; SYNAPTIC-TRANSMISSION; MIDLINE THALAMUS; CA3-CA1 SYNAPSE; IN-VIVO; RAT; PLASTICITY; STIMULATION; MEMORY	We studied the interactions between short- and long-term plastic changes taking place during the acquisition of a classical eyeblink conditioning and following high-frequency stimulation (HFS) of the reuniens nucleus in behaving mice. Synaptic changes in strength were studied at the reuniens-medial prefrontal cortex (mPFC) and the reuniens-CA1 synapses. Input/output curves and a paired-pulse study enabled determining the functional capabilities of the two synapses and the optimal intensities to be applied at the reuniens nucleus during classical eyeblink conditioning and for HFS applied to the reuniens nucleus. Animals were conditioned using a trace paradigm, with a tone as conditioned stimulus (CS) and an electric shock to the trigeminal nerve as unconditioned stimulus (US). A single pulse was presented to the reuniens nucleus to evoke field EPSPs (fEPSPs) in mPFC and CA1 areas during the CS-US interval. No significant changes in synaptic strength were observed at the reuniens-mPFC and reuniens-CA1 synapses during the acquisition of eyelid conditioned responses (CRs). Two successive HFS sessions carried out during the first two conditioning days decreased the percentage of CRs, without evoking any long-term potentiation (LTP) at the recording sites. HFS of the reuniens nucleus also prevented the proper acquisition of an object discrimination task. A subsequent study revealed that HFS of the reuniens nucleus evoked a significant decrease of paired-pulse facilitation. In conclusion, reuniens nucleus projections to prefrontal and hippocampal circuits seem to participate in the acquisition of associative learning through a mechanism that does not required the development of LTP.	[Eleore, Lyndell; Carlos Lopez-Ramos, Juan; Guerra-Narbona, Rafael; Delgado-Garcia, Jose M.] Univ Pablo de Olavide, Div Neurociencias, Seville, Spain	Universidad Pablo de Olavide	Eleore, L (corresponding author), Univ Pablo de Olavide, Div Neurociencias, Seville, Spain.	jmdelgar@upo.es	Delgado-Garcia, Jose M./V-1567-2019; Ramos, Juan Carlos López/K-9336-2014	Lopez Ramos, Juan Carlos/0000-0003-0943-8802	Spanish Ministry of Research and Innovation: Fundamental Biology [(BFU)-2008-0899]; Spanish "Junta de Andalucia" [Biology-122, Biology-2487]	Spanish Ministry of Research and Innovation: Fundamental Biology; Spanish "Junta de Andalucia"(Junta de Andalucia)	This work was supported by grants from the Spanish Ministry of Research and Innovation: Fundamental Biology (BFU)-2008-0899, and Spanish "Junta de Andalucia": Biology-122 and Biology-2487. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Burette F, 1997, J NEUROPHYSIOL, V78, P1155, DOI 10.1152/jn.1997.78.2.1155; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Davoodi FG, 2009, BEHAV BRAIN RES, V198, P130, DOI 10.1016/j.bbr.2008.10.037; de Sevilla DF, 2002, J PHYSIOL-LONDON, V545, P51, DOI 10.1113/jphysiol.2002.029165; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; DEJONGE M, 1985, BRAIN RES, V328, P181, DOI 10.1016/0006-8993(85)91341-1; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Dolleman-van der Weel MJ, 2009, BRAIN STRUCT FUNCT, V213, P329, DOI 10.1007/s00429-008-0200-6; DollemanVanderWeel MJ, 1997, J NEUROSCI, V17, P5640; Eichenbaum H, 1999, NAT NEUROSCI, V2, P775, DOI 10.1038/12137; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; HEMBROOK JR, 2011, HIPPOCAMPUS IN PRESS; Izaki Y, 2003, BRAIN RES, V992, P142, DOI 10.1016/S0006-8993(03)03538-8; Jay TM, 2004, NEUROTOX RES, V6, P233, DOI 10.1007/BF03033225; JAY TM, 1992, EUR J NEUROSCI, V4, P1285, DOI 10.1111/j.1460-9568.1992.tb00154.x; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Lagostena L, 2008, NEUROPHARMACOLOGY, V54, P676, DOI 10.1016/j.neuropharm.2007.11.016; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Leal-Campanario R, 2007, P NATL ACAD SCI USA, V104, P11459, DOI 10.1073/pnas.0704548104; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.007.2009; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; McKenna JT, 2004, J COMP NEUROL, V480, P115, DOI 10.1002/cne.20342; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Mulder AB, 1997, EUR J NEUROSCI, V9, P1603, DOI 10.1111/j.1460-9568.1997.tb01518.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Saviane C, 2002, J PHYSIOL-LONDON, V544, P469, DOI 10.1113/jphysiol.2002.026609; Schulz PE, 1997, J NEUROPHYSIOL, V78, P321, DOI 10.1152/jn.1997.78.1.321; Sokolov MV, 1998, NEUROSCIENCE, V85, P1, DOI 10.1016/S0306-4522(97)00592-7; THOMPSON RF, 1988, TRENDS NEUROSCI, V11, P152, DOI 10.1016/0166-2236(88)90141-5; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Urban Z, 2002, ACTA BIOL HUNG, V53, P205, DOI 10.1556/ABiol.53.2002.1-2.19; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	40	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23538	10.1371/journal.pone.0023538	http://dx.doi.org/10.1371/journal.pone.0023538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858159	gold, Green Submitted, Green Published			2022-12-27	WOS:000293953700031
J	Laing, R; Hunt, M; Protasio, AV; Saunders, G; Mungall, K; Laing, S; Jackson, F; Quail, M; Beech, R; Berriman, M; Gilleard, JS				Laing, Roz; Hunt, Martin; Protasio, Anna V.; Saunders, Gary; Mungall, Karen; Laing, Steven; Jackson, Frank; Quail, Michael; Beech, Robin; Berriman, Matthew; Gilleard, John S.			Annotation of Two Large Contiguous Regions from the Haemonchus contortus Genome Using RNA-seq and Comparative Analysis with Caenorhabditis elegans	PLOS ONE			English	Article							READ ALIGNMENT; SEQUENCE; ARTEMIS; MICROSATELLITES; REARRANGEMENT; EXPRESSION; RESISTANCE; DROSOPHILA	The genomes of numerous parasitic nematodes are currently being sequenced, but their complexity and size, together with high levels of intra-specific sequence variation and a lack of reference genomes, makes their assembly and annotation a challenging task. Haemonchus contortus is an economically significant parasite of livestock that is widely used for basic research as well as for vaccine development and drug discovery. It is one of many medically and economically important parasites within the strongylid nematode group. This group of parasites has the closest phylogenetic relationship with the model organism Caenorhabditis elegans, making comparative analysis a potentially powerful tool for genome annotation and functional studies. To investigate this hypothesis, we sequenced two contiguous fragments from the H. contortus genome and undertook detailed annotation and comparative analysis with C. elegans. The adult H. contortus transcriptome was sequenced using an Illumina platform and RNA-seq was used to annotate a 409 kb overlapping BAC tiling path relating to the X chromosome and a 181 kb BAC insert relating to chromosome I. In total, 40 genes and 12 putative transposable elements were identified. 97.5% of the annotated genes had detectable homologues in C. elegans of which 60% had putative orthologues, significantly higher than previous analyses based on EST analysis. Gene density appears to be less in H. contortus than in C. elegans, with annotated H. contortus genes being an average of two-to-three times larger than their putative C. elegans orthologues due to a greater intron number and size. Synteny appears high but gene order is generally poorly conserved, although areas of conserved microsynteny are apparent. C. elegans operons appear to be partially conserved in H. contortus. Our findings suggest that a combination of RNA-seq and comparative analysis with C. elegans is a powerful approach for the annotation and analysis of strongylid nematode genomes.	[Laing, Roz; Hunt, Martin; Protasio, Anna V.; Quail, Michael; Berriman, Matthew] Welcome Trust Sanger Inst, Cambridge, England; [Laing, Roz; Saunders, Gary; Laing, Steven] Univ Glasgow, Fac Vet Med, Glasgow, Strathclyde, Scotland; [Mungall, Karen] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Jackson, Frank] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Beech, Robin] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Gilleard, John S.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada	Wellcome Trust Sanger Institute; University of Glasgow; British Columbia Cancer Agency; Moredun Research Institute; McGill University; University of Calgary	Laing, R (corresponding author), Welcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	jsgillea@ucalgary.ca	Protasio, Anna V./AAJ-8991-2020; Protasio, Anna/F-7751-2016; Berriman, Matthew/A-7618-2011; Quail, michael/ABE-6131-2020; Beech, Robin/U-7759-2019	Protasio, Anna V./0000-0003-1723-800X; Protasio, Anna/0000-0003-1723-800X; Berriman, Matthew/0000-0002-9581-0377; Saunders, Gary/0000-0002-7468-0008; Gilleard, John/0000-0002-6787-4699; Laing, Roz/0000-0002-6191-0759; Hunt, Martin/0000-0002-8060-4335	Quality Meat Scotland (QMS); English Beef and Sheep Sectors (EBLEX); Hybu Cig Cymru (HCC); Pfizer Animal Health PLC; Wellcome Trust [WT 085775/Z/08/Z]; BBSRC [BB/E018130/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E018130/1] Funding Source: researchfish	Quality Meat Scotland (QMS); English Beef and Sheep Sectors (EBLEX); Hybu Cig Cymru (HCC); Pfizer Animal Health PLC; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RL was funded by Quality Meat Scotland (QMS), English Beef and Sheep Sectors (EBLEX), Hybu Cig Cymru (HCC) and Pfizer Animal Health PLC. The sequencing was funded by the Wellcome Trust (grant number WT 085775/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Bessereau Jean-Louis, 2006, WormBook, P1; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; CALLAGHAN MJ, 1994, INT J PARASITOL, V24, P137, DOI 10.1016/0020-7519(94)90068-X; Carver T, 2010, BIOINFORMATICS, V26, P676, DOI 10.1093/bioinformatics/btq010; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Couthier A, 2004, MOL BIOCHEM PARASIT, V133, P241, DOI 10.1016/j.molbiopara.2003.10.012; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Duret L, 2000, GENETICS, V156, P1661; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; Gilleard JS, 2004, PARASITOLOGY, V128, pS49, DOI 10.1017/S003118200400647X; Graber JH, 2007, RNA, V13, P1409, DOI 10.1261/rna.596707; Grillo V, 2006, MOL BIOCHEM PARASIT, V148, P181, DOI 10.1016/j.molbiopara.2006.03.014; Guiliano DB, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0057; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; Hoekstra R, 1997, MOL BIOCHEM PARASIT, V89, P97, DOI 10.1016/S0166-6851(97)00108-4; Jackson F, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P25, DOI 10.1007/978-90-481-3297-3_3; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Knox DP, 2003, INT J PARASITOL, V33, P1129, DOI 10.1016/S0020-7519(03)00167-X; LAUGHTON DL, 1994, RECEPTOR CHANNEL, V2, P155; LeJambre LF, 2008, VET PARASITOL, V153, P302, DOI 10.1016/j.vetpar.2008.01.032; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CH, 2010, INT J PARASITOL, V40, P63, DOI 10.1016/j.ijpara.2009.07.001; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Prichard RK, 2001, TRENDS PARASITOL, V17, P445, DOI 10.1016/S1471-4922(01)01983-3; Qian WF, 2008, GENOME RES, V18, P412, DOI 10.1101/gr.7112608; Ranz JM, 2001, GENOME RES, V11, P230, DOI 10.1101/gr.162901; Redman E, 2008, GENETICS, V180, P1877, DOI 10.1534/genetics.108.094623; Redmond DL, 2001, MOL BIOCHEM PARASIT, V117, P107, DOI 10.1016/S0166-6851(01)00331-0; Rufener L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000380; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SPIETH J, 2006, OVERVIEW GENE STRUCT, P1; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; VANFLETEREN JR, 1994, MOL PHYLOGENET EVOL, V3, P92, DOI 10.1006/mpev.1994.1012; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	44	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23216	10.1371/journal.pone.0023216	http://dx.doi.org/10.1371/journal.pone.0023216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858033	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000293953700008
J	Meiners, C; Sagaon-Teyssier, L; Hasenclever, L; Moatti, JP				Meiners, Constance; Sagaon-Teyssier, Luis; Hasenclever, Lia; Moatti, Jean-Paul			Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?	PLOS ONE			English	Article							UNIVERSAL ACCESS; AIDS TREATMENT; POLICY; SUSTAINABILITY; CHALLENGES; HEALTH; COSTS	Background: Brazil became the first developing country to guarantee free and universal access to HIV/AIDS treatment, with antiretroviral drugs (ARVs) being delivered to nearly 190,000 patients. The analysis of ARV price evolution and market dynamics in Brazil can help anticipate issues soon to afflict other developing countries, as the 2010 revision of the World Health Organization guidelines shifts demand towards more expensive treatments, and, at the same time, current evolution of international legislation and trade agreements on intellectual property rights may reduce availability of generic drugs for HIV care. Methods and Findings: Our analyses are based on effective prices paid for ARV procurement in Brazil between 1996 and 2009. Data panel structure was exploited to gather ex-ante and ex-post information and address various sources of statistical bias. In-difference estimation offered in-depth information on ARV market characteristics which significantly influence prices. Although overall ARV prices follow a declining trend, changing characteristics in the generic segment help explain recent increase in generic ARV prices. Our results show that generic suppliers are more likely to respond to factors influencing demand size and market competition, while originator suppliers tend to set prices strategically to offset compulsory licensing threats and generic competition. Significance: In order to guarantee the long term sustainability of access to antiretroviral treatment, our findings highlight the importance of preserving and stimulating generic market dynamics to sustain developing countries' bargaining power in price negotiations undertaken with originator companies.	[Meiners, Constance; Sagaon-Teyssier, Luis; Moatti, Jean-Paul] Aix Marseille Univ, IRD, INSERM, UMR 912, Marseille, France; [Meiners, Constance; Hasenclever, Lia] Univ Fed Rio de Janeiro, Inst Econ, Rio De Janeiro, Brazil; [Meiners, Constance] Minist Planning Budget & Adm, Brasilia, DF, Brazil; [Sagaon-Teyssier, Luis; Moatti, Jean-Paul] ORS PACA Reg Observ Dis Control SE France, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universidade Federal do Rio de Janeiro	Meiners, C (corresponding author), Aix Marseille Univ, IRD, INSERM, UMR 912, Marseille, France.	constance.meiners@inserm.fr	Hasenclever, Lia/GPF-5925-2022	Hasenclever, Lia/0000-0003-1384-6323; Sagaon-Teyssier, Luis/0000-0001-7318-6596	French AIDS Research Agency - ANRS, France; Sidaction, France; Unitaid	French AIDS Research Agency - ANRS, France; Sidaction, France; Unitaid	This study has been financed by the French AIDS Research Agency - ANRS (http://www.anrs.fr/) and Sidaction (http://www.sidaction.org/), both situated in France. Additional funding was received by Unitaid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors take entire responsibility for the views presented in this article.	*BRAZ MIN HLTH DEP, 2011, BRAS PROD VERS GEN M; *CNAIDS, 2010, TARG COMM MAD MEMB S; Crowley S, 2010, LANCET, V375, P874, DOI 10.1016/S0140-6736(09)62064-X; Davidson R, 1993, ESTIMATION INFERENCE; FIUZA EPS, 2010, 1511 IPEA; Galvao J, 2005, AM J PUBLIC HEALTH, V95, P1110, DOI 10.2105/AJPH.2004.044313; Grangeiro A, 2006, REV SAUDE PUBL, V40, P60, DOI 10.1590/S0034-89102006000800009; Greco DB, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000279705.24428.a3; HASENCLEVER L, 2006, PROPRIEDADE INTELECT; HASENCLEVER L, 2011, COLECOES AN IN PRESS; LISBOA M, 2001, 8 SEAEMF; Loyola MA, 2008, CIENC SAUDE COLETIVA, V13, P763, DOI 10.1590/S1413-81232008000700027; LUCCHINI S, 2003, EC AIDS ACCESS HIV A, P169; Meiners CMMA, 2008, CAD SAUDE PUBLICA, V24, P1467, DOI 10.1590/S0102-311X2008000700002; Moatti JP., 2003, EC AIDS ACCESS HIV A, P109; Morris K, 2010, LANCET INFECT DIS, V10, P11, DOI 10.1016/S1473-3099(09)70341-X; Mullard A, 2010, LANCET, V375, P1335, DOI 10.1016/S0140-6736(10)60560-0; Nakamura A, 1998, J ECONOMETRICS, V83, P213, DOI 10.1016/S0304-4076(97)00070-5; *NAT PROGR SEX TRA, 2008, REC TER ANT AD INF H; Nunn AS, 2007, PLOS MED, V4, P1804, DOI 10.1371/journal.pmed.0040305; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; Orsi F, 2010, LANCET, V375, P1693, DOI 10.1016/S0140-6736(10)60737-4; Orsi F, 2010, CURR OPIN HIV AIDS, V5, P237, DOI 10.1097/COH.0b013e32833860ba; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; Scheffer Mario C., 2005, SERIE LEGISLACAO, V1st; Vieira FS, 2009, REV SAUDE PUBL, V43, P674, DOI 10.1590/S0034-89102009005000041; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Waning B, 2009, B WORLD HEALTH ORGAN, V87, P520, DOI 10.2471/BLT.08.058925; Wirtz VJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S6; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	30	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23478	10.1371/journal.pone.0023478	http://dx.doi.org/10.1371/journal.pone.0023478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808CV	21858138	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953700026
J	Yarbrough, DK; Eckert, R; He, J; Hagerman, E; Qi, FX; Lux, R; Wu, B; Anderson, MH; Shi, WY				Yarbrough, Daniel K.; Eckert, Randal; He, Jian; Hagerman, Elizabeth; Qi, Fengxia; Lux, Renate; Wu, Ben; Anderson, Maxwell H.; Shi, Wenyuan			Rapid Probing of Biological Surfaces with a Sparse-Matrix Peptide Library	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; ANTIMICROBIAL PEPTIDES; CELL-SURFACE; PROTEIN MICROARRAYS; MYXOCOCCUS-XANTHUS; BIOACTIVE PEPTIDES; RATIONAL DESIGN; SOCIAL MOTILITY; PHAGE DISPLAY; CANCER-CELLS	Finding unique peptides to target specific biological surfaces is crucial to basic research and technology development, though methods based on biological arrays or large libraries limit the speed and ease with which these necessary compounds can be found. We reasoned that because biological surfaces, such as cell surfaces, mineralized tissues, and various extracellular matrices have unique molecular compositions, they present unique physicochemical signatures to the surrounding medium which could be probed by peptides with appropriately corresponding physicochemical properties. To test this hypothesis, a naive pilot library of 36 peptides, varying in their hydrophobicity and charge, was arranged in a two-dimensional matrix and screened against various biological surfaces. While the number of peptides in the matrix library was very small, we obtained "hits'' against all biological surfaces probed. Sequence refinement of the "hits'' led to peptides with markedly higher specificity and binding activity against screened biological surfaces. Genetic studies revealed that peptide binding to bacteria was mediated, at least in some cases, by specific cell-surface molecules, while examination of human tooth sections showed that this method can be used to derive peptides with highly specific binding to human tissue.	[Yarbrough, Daniel K.; Eckert, Randal; Anderson, Maxwell H.] C3 Jian Inc, Inglewood, CA 90301 USA; [He, Jian; Lux, Renate; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Hagerman, Elizabeth; Wu, Ben] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA; [Qi, Fengxia] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma Health Sciences Center	Yarbrough, DK (corresponding author), C3 Jian Inc, Inglewood, CA 90301 USA.	wenyuan@ucla.edu	SHI, wen/GPW-9531-2022	Wu, Benjamin/0000-0001-5236-8534	UC Discovery Grant	UC Discovery Grant	This work was supported by a UC Discovery Grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; AOKI H, 1986, INFECT IMMUN, V53, P587, DOI 10.1128/IAI.53.3.587-594.1986; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; CALIS S, 1995, PHARM RES-DORDR, V12, P1072, DOI 10.1023/A:1016278902839; Chen L, 2005, J CLIN MICROBIOL, V43, P3574, DOI 10.1128/JCM.43.7.3574-3575.2005; CLACKSON T, 1994, TRENDS BIOTECHNOL, V12, P173, DOI 10.1016/0167-7799(94)90079-5; Dahlin S, 1998, EUR J ORAL SCI, V106, P239, DOI 10.1111/j.1600-0722.1998.tb02182.x; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Duburcq X, 2004, BIOCONJUGATE CHEM, V15, P307, DOI 10.1021/bc034226d; Duval E, 2009, PEPTIDES, V30, P1608, DOI 10.1016/j.peptides.2009.06.022; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P1480, DOI 10.1128/AAC.50.4.1480-1488.2006; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P3651, DOI 10.1128/AAC.00622-06; Falciani C, 2005, CHEM BIOL, V12, P417, DOI 10.1016/j.chembiol.2005.02.009; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fujisawa R, 1998, EUR J ORAL SCI, V106, P249, DOI 10.1111/j.1600-0722.1998.tb02183.x; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Groenink J, 1998, ANTON LEEUW INT J G, V73, P279, DOI 10.1023/A:1001543514171; Gu F, 2005, J MICROBIOL METH, V62, P145, DOI 10.1016/j.mimet.2005.02.013; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; He J, 2010, ANTIMICROB AGENTS CH, V54, P2143, DOI 10.1128/AAC.01391-09; Hu SJ, 2006, BIOCHEM BIOPH RES CO, V341, P964, DOI 10.1016/j.bbrc.2006.01.047; Katz BA, 1997, ANNU REV BIOPH BIOM, V26, P27, DOI 10.1146/annurev.biophys.26.1.27; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; Kazmierski WM, 2006, CHEM BIOL DRUG DES, V67, P13, DOI 10.1111/j.1747-0285.2005.00319.x; Klemm P, 2000, MICROBIOL-SGM, V146, P3025, DOI 10.1099/00221287-146-12-3025; Kreutzberger J, 2006, APPL MICROBIOL BIOT, V70, P383, DOI 10.1007/s00253-006-0312-y; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li L, 2010, CHEM BIOL DRUG DES, V75, P127, DOI 10.1111/j.1747-0285.2009.00904.x; Marasco D, 2008, CURR PROTEIN PEPT SC, V9, P447, DOI 10.2174/138920308785915209; Meloen R, 2004, MOL DIVERS, V8, P57, DOI 10.1023/B:MODI.0000025698.16766.11; Nikaido H, 1999, J BACTERIOL, V181, P4, DOI 10.1128/JB.181.1.4-8.1999; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; SCOGNAMIGLIO PL, 2011, CHEM BIOL DRUG DES; Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002; Thorgeirsson TE, 1996, BIOCHEMISTRY-US, V35, P1803, DOI 10.1021/bi952300c; Tomizaki KY, 2005, CHEMBIOCHEM, V6, P783, DOI 10.1002/cbic.200400232; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tozzi C, 2006, CURR PHARM DESIGN, V12, P191, DOI 10.2174/138161206775193082; VANDERNOOT TJ, 1991, J ELECTROANAL CHEM, V300, P191, DOI 10.1016/0022-0728(91)85394-5; WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Yang ZM, 1998, J BACTERIOL, V180, P218, DOI 10.1128/JB.180.2.218-224.1998; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Yarbrough DK, 2010, CALCIFIED TISSUE INT, V86, P58, DOI 10.1007/s00223-009-9312-0; Zhu L, 2006, MICROBIOL-SGM, V152, P2395, DOI 10.1099/mic.0.28883-0; Zhuang ZY, 2011, BIOPHYS J, V100, P1306, DOI 10.1016/j.bpj.2010.12.3735; Zita A, 1997, FEMS MICROBIOL LETT, V152, P299, DOI 10.1016/S0378-1097(97)00214-0	48	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23551	10.1371/journal.pone.0023551	http://dx.doi.org/10.1371/journal.pone.0023551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858167	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700033
J	DeVries, AS; Lesher, L; Schlievert, PM; Rogers, T; Villaume, LG; Danila, R; Lynfield, R				DeVries, Aaron S.; Lesher, Lindsey; Schlievert, Patrick M.; Rogers, Tyson; Villaume, Lourdes G.; Danila, Richard; Lynfield, Ruth			Staphylococcal Toxic Shock Syndrome 2000-2006: Epidemiology, Clinical Features, and Molecular Characteristics	PLOS ONE			English	Article							UNITED-STATES; SYNDROME TSS; AUREUS; SURVEILLANCE; GENE; INFECTIONS; ANTIBODY; UPDATE; WOMEN	Introduction: Circulating strains of Staphylococcus aureus (SA) have changed in the last 30 years including the emergence of community-associated methicillin-resistant SA (MRSA). A report suggested staphylococcal toxic shock syndrome (TSS) was increasing over 2000-2003. The last population-based assessment of TSS was 1986. Methods: Population-based active surveillance for TSS meeting the CDC definition using ICD-9 codes was conducted in the Minneapolis-St. Paul area (population 2,642,056) from 2000-2006. Medical records of potential cases were reviewed for case criteria, antimicrobial susceptibility, risk factors, and outcome. Superantigen PCR testing and PFGE were performed on available isolates from probable and confirmed cases. Results: Of 7,491 hospitalizations that received one of the ICD-9 study codes, 61 TSS cases (33 menstrual, 28 non-menstrual) were identified. The average annual incidence per 100,000 of all, menstrual, and non-menstrual TSS was 0.52 (95% CI, 0.32-0.77), 0.69 (0.39-1.16), and 0.32 (0.12-0.67), respectively. Women 13-24 years had the highest incidence at 1.41 (0.63-2.61). No increase in incidence was observed from 2000-2006. MRSA was isolated in 1 menstrual and 3 non-menstrual cases (7% of TSS cases); 1 isolate was USA400. The superantigen gene tst-1 was identified in 20 (80%) of isolates and was more common in menstrual compared to non-menstrual isolates (89% vs. 50%, p = 0.07). Superantigen genes sea, seb and sec were found more frequently among non-menstrual compared to menstrual isolates [100% vs 25% (p = 0.4), 60% vs 0% (p < 0.01), and 25% vs 13% (p = 0.5), respectively]. Discussion: TSS incidence remained stable across our surveillance period of 2000-2006 and compared to past population-based estimates in the 1980s. MRSA accounted for a small percentage of TSS cases. tst-1 continues to be the superantigen associated with the majority of menstrual cases. The CDC case definition identifies the most severe cases and has been consistently used but likely results in a substantial underestimation of the total TSS disease burden.	[DeVries, Aaron S.; Lesher, Lindsey; Villaume, Lourdes G.; Danila, Richard; Lynfield, Ruth] Minnesota Dept Hlth, Emerging Infect Program, St Paul, MN 55101 USA; [Schlievert, Patrick M.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Rogers, Tyson; Villaume, Lourdes G.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	DeVries, AS (corresponding author), Minnesota Dept Hlth, Emerging Infect Program, St Paul, MN 55101 USA.	aaron.devries@state.mn.us		Schlievert, Patrick/0000-0001-8314-9369; DeVries, Aaron/0000-0001-9211-0722	National Institutes of Health from the Great Lakes Regional Center of Excellence in Biodefense Emerging Infectious Diseases [U54-AI57153, R01-AI06461]; Ruth L. Kirschstein National Research Service Awards [T32 AI 055433-2]; National Institutes of Health; National Institute of Allergy and Infectious Disease [L30 AI 071582-01]; Centers for Disease Control and Prevention [CDC 5 R01 CI000209]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055433, U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health from the Great Lakes Regional Center of Excellence in Biodefense Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (U54-AI57153 from the Great Lakes Regional Center of Excellence in Biodefense Emerging Infectious Diseases [of which PMS is a member] and R01-AI06461, Ruth L. Kirschstein National Research Service Awards T32 AI 055433-2, National Institutes of Health, Loan Repayment Program, the National Institute of Allergy and Infectious Disease, Extramural Clinical Research L30 AI 071582-01, and from the Centers for Disease Control and Prevention, Emerging Infections Program CDC 5 R01 CI000209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BONVENTRE PF, 1984, J INFECT DIS, V150, P662, DOI 10.1093/infdis/150.5.662; *CDCP, 2009, ABCS REP GROUP STREP; *CDCP, 2009, ABCS REP NEISS MEN; *CDCP, 2010, ACT BACT COR SURV; Centers for Disease Control and Prevention, 2011, TOX SHOCK SYNDR 2011; Centers for Disease Control Prevention, 1997, TOX SHOCK SYNDR 1997; Chini V, 2006, J CLIN MICROBIOL, V44, P1881, DOI 10.1128/JCM.44.5.1881-1883.2006; Como-Sabetti K, 2009, PUBLIC HEALTH REP, V124, P427, DOI 10.1177/003335490912400312; DAVIS JP, 1980, NEW ENGL J MED, V303, P1429, DOI 10.1056/NEJM198012183032501; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Durand G, 2006, J CLIN MICROBIOL, V44, P847, DOI 10.1128/JCM.44.3.847-853.2006; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Ferrero S, 2006, CONTRACEPTION, V73, P537, DOI 10.1016/j.contraception.2006.01.004; Ferry T, 2006, J CLIN MICROBIOL, V44, P2642, DOI 10.1128/JCM.00430-06; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; GAVENTA S, 1989, REV INFECT DIS, V11, pS28; Hajjeh RA, 2002, EMERG INFECT DIS, V8, P145, DOI 10.3201/eid0802.010165; Hajjeh RA, 1999, EMERG INFECT DIS, V5, P807, DOI 10.3201/eid0506.990611; Jamart S, 2005, EMERG INFECT DIS, V11, P636, DOI 10.3201/eid1104.040893; KAIN KC, 1993, CLIN INFECT DIS, V16, P100, DOI 10.1093/clinids/16.1.100; LANGE J, 2005, 43 IDSA C, V101; Lesher L, 2009, EMERG INFECT DIS, V15, P770, DOI 10.3201/eid1505.080826; Matsuda Y, 2003, EMERG INFECT DIS, V9, P387, DOI 10.3201/eid0903.020360; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nelson AL, 2006, J FAM PRACTICE, pS1; Okii K, 2006, J HOSP INFECT, V62, P37, DOI 10.1016/j.jhin.2005.05.013; OSTERHOLM MT, 1982, J INFECT DIS, V145, P458, DOI 10.1093/infdis/145.4.458; PETITTI DB, 1989, REV INFECT DIS, V11, pS22; REINGOLD AL, 1982, ANN INTERN MED, V96, P871, DOI 10.7326/0003-4819-96-6-871; ROSENE KA, 1982, ANN INTERN MED, V96, P865, DOI 10.7326/0003-4819-96-6-865; Schlievert Patrick M., 2007, V391, P113; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; SCHLIEVERT PM, 2004, REEMERGENCE STAPHYLO, P2875; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Stevens FA, 1927, J AMER MED ASSOC, V88, P1957, DOI 10.1001/jama.1927.02680510015006; STOLZ SJ, 1985, J INFECT DIS, V151, P883, DOI 10.1093/infdis/151.5.883; TODD J, 1978, LANCET, V2, P1116	42	79	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22997	10.1371/journal.pone.0022997	http://dx.doi.org/10.1371/journal.pone.0022997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860665	Green Published, gold			2022-12-27	WOS:000295454200032
J	MacDonald, BT; Semenov, MV; Huang, H; He, X				MacDonald, Bryan T.; Semenov, Mikhail V.; Huang, He; He, Xi			Dissecting Molecular Differences between Wnt Coreceptors LRP5 and LRP6	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; HIGH-BONE-MASS; SIGNAL-TRANSDUCTION; PPPSP MOTIFS; BETA-CATENIN; DENSITY; MICE; INHIBITION; MUTATION; DISEASE	Low-density lipoprotein receptor-related proteins 5 and 6 (LRP5 and LRP6) serve as Wnt co-receptors for the canonical beta-catenin pathway. While LRP6 is essential for embryogenesis, both LRP5 and LRP6 play critical roles for skeletal remodeling, osteoporosis pathogenesis and cancer formation, making LRP5 and LRP6 key therapeutic targets for cancer and disease treatment. LRP5 and LRP6 each contain in the cytoplasmic domain five conserved PPPSPxS motifs that are pivotal for signaling and serve collectively as phosphorylation-dependent docking sites for the scaffolding protein Axin. However existing data suggest that LRP6 is more effective than LRP5 in transducing the Wnt signal. To understand the molecular basis that accounts for the different signaling activity of LRP5 and LRP6, we generated a series of chimeric receptors via swapping LRP5 and LRP6 cytoplasmic domains, LRP5C and LRP6C, and studied their Wnt signaling activity using biochemical and functional assays. We demonstrate that LRP6C exhibits strong signaling activity while LRP5C is much less active in cells. Recombinant LRP5C and LRP6C upon in vitro phosphorylation exhibit similar Axin-binding capability, suggesting that LRP5 and LRP6 differ in vivo at a step prior to Axin-binding, likely at receiving phosphorylation. We identified between the two most carboxyl PPPSPxS motifs an intervening "gap4" region that appears to account for much of the difference between LRP5C and LRP6C, and showed that alterations in this region are sufficient to enhance LRP5 PPPSPxS phosphorylation and signaling to levels comparable to LRP6 in cells. In addition we provide evidence that binding of phosphorylated LRP5 or LRP6 to Axin is likely direct and does not require the GSK3 kinase as a bridging intermediate as has been proposed. Our studies therefore uncover a new and important molecular tuning mechanism for differential regulation of LRP5 and LRP6 phosphorylation and signaling activity.	[MacDonald, Bryan T.; Semenov, Mikhail V.; Huang, He; He, Xi] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	MacDonald, BT (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu			National Institutes of Health [RO1 GM74241]; Ruth L. Kirschstein National Research Service; Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health grant (RO1 GM74241) to XH, who was a Leukemia and Lymphoma Society Scholar. BTM and HH were supported by a Ruth L. Kirschstein National Research Service Award and Institutes of Health Research postdoctoral fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Houston DW, 2002, MECH DEVELOP, V117, P337, DOI 10.1016/S0925-4773(02)00205-8; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu WZ, 2008, CIRC RES, V103, P1280, DOI 10.1161/CIRCRESAHA.108.183863; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yum S, 2009, BIOCHEM BIOPH RES CO, V381, P345, DOI 10.1016/j.bbrc.2009.02.044; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	42	41	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23537	10.1371/journal.pone.0023537	http://dx.doi.org/10.1371/journal.pone.0023537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887268	gold, Green Submitted, Green Published			2022-12-27	WOS:000295832000025
J	Wang, H; Gottfries, J; Barrenas, F; Benson, M				Wang, Hui; Gottfries, Johan; Barrenas, Fredrik; Benson, Mikael			Identification of Novel Biomarkers in Seasonal Allergic Rhinitis by Combining Proteomic, Multivariate and Pathway Analysis	PLOS ONE			English	Article							GLUCOCORTICOID RESISTANCE; ALPHA(1)-ACID GLYCOPROTEIN; INDUCIBLE EXPRESSION; ASTHMA; NEUTROPHILS; PROTEIN; GENES; RAT	Background: Glucocorticoids (GCs) play a key role in the treatment of seasonal allergic rhinitis (SAR). However, some patients show a low response to GC treatment. We hypothesized that proteins that correlated to discrimination between symptomatic high and low responders (HR and LR) to GC treatment might be regulated by GCs and therefore suitable as biomarkers for GC treatment. Methodology/Principal Findings: We identified 953 nasal fluid proteins in symptomatic HR and LR with a LC MS/MS based-quantitative proteomics analysis and performed multivariate analysis to identify a combination of proteins that best separated symptomatic HR and LR. Pathway analysis showed that those proteins were most enriched in the acute phase response pathway. We prioritized candidate biomarkers for GC treatment based on the multivariate and pathway analysis. Next, we tested if those candidate biomarkers differed before and after GC treatment in nasal fluids from 40 patients with SAR using ELISA. Several proteins including ORM (P<0.0001), APOH (P<0.0001), FGA (P<0.01), CTSD (P<0.05) and SERPINB3 (P<0.05) differed significantly before and after GC treatment. Particularly, ORM (P<0.01), FGA (P<0.05) and APOH (P<0.01) that belonged to the acute phase response pathway decreased significantly in HR but not LR before and after GC treatment. Conclusions/Significance: We identified several novel biomarkers for GC treatment response in SAR with combined proteomics, multivariate and pathway analysis. The analytical principles may be generally applicable to identify biomarkers in clinical studies of complex diseases.	[Wang, Hui] Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden; [Gottfries, Johan] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Wang, Hui; Barrenas, Fredrik; Benson, Mikael] Linkoping Univ, Ctr Individualized Medicat, Linkoping, Sweden; [Benson, Mikael] Linkoping Univ Hosp, Dept Pediat, S-58185 Linkoping, Sweden	University of Gothenburg; University of Gothenburg; Linkoping University; Linkoping University	Wang, H (corresponding author), Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden.	hui.wang@gu.se	Gottfries, Johan/M-3445-2016	Gottfries, Johan/0000-0001-7135-4664	European Commission [223367]; MultiMod; Swedish Medical Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); MultiMod; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This research has been supported by the European Commission under the Seventh Framework Programme, grant agreement number 223367, MultiMod, the Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, pS125, DOI 10.1164/ajrccm/152.6_Pt_2.S125; Benson LM, 2009, J SEP SCI, V32, P44, DOI 10.1002/jssc.200800474; Benson M, 2004, J ALLERGY CLIN IMMUN, V113, P1137, DOI 10.1016/j.jaci.2004.02.028; Benson M, 2000, J ALLERGY CLIN IMMUN, V106, P307, DOI 10.1067/mai.2000.108111; Boot JD, 2008, J INVEST ALLERG CLIN, V18, P433; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2010, ALLERGY, V65, P1212, DOI [10.1111/j.1398-9995.2010.02439.x, 10.1111/j.1398-9995.2010.02480.x]; Crestani B, 1998, J IMMUNOL, V160, P4596; de Jong EP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011148; Diamant Z, 2010, PULM PHARMACOL THER, V23, P468, DOI 10.1016/j.pupt.2010.06.006; Fournier T, 1999, J IMMUNOL, V163, P2883; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com; Kirwan JR, 2007, SCAND J RHEUMATOL, V36, P165, DOI 10.1080/03009740701340263; Meyer P, 2003, PEDIAT ALLERG IMM-UK, V14, P60, DOI 10.1034/j.1399-3038.2003.02102.x; Moazzami AA, 2010, NMR BIOMED; NORBACK D, 2000, INDOOR AIR, V55, P163; Okano M, 2009, CLIN EXP IMMUNOL, V158, P164, DOI 10.1111/j.1365-2249.2009.04010.x; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Sousa AR, 2000, J ALLERGY CLIN IMMUN, V105, P943, DOI 10.1067/mai.2000.106486; Theilgaard-Monch K, 2005, J LEUKOCYTE BIOL, V78, P462, DOI 10.1189/jlb.0105042; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; VINAY P, 1980, KIDNEY INT, V17, P312, DOI 10.1038/ki.1980.37; Wang H, 2011, ALLERGY, V66, P132, DOI 10.1111/j.1398-9995.2010.02444.x; Wang H, 2009, J ALLERGY CLIN IMMUN, V124, P1360, DOI 10.1016/j.jaci.2009.09.037; Wang WY, 2009, ALLERGY, V64, P1102, DOI 10.1111/j.1398-9995.2009.01996.x; Whelehan OP, 2006, CHEMOMETR INTELL LAB, V84, P82, DOI 10.1016/j.chemolab.2006.03.008; Woodfolk JA, 2007, J ALLERGY CLIN IMMUN, V119, P280, DOI 10.1016/j.jaci.2006.11.008; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972	30	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23563	10.1371/journal.pone.0023563	http://dx.doi.org/10.1371/journal.pone.0023563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887273	Green Published, gold, Green Submitted			2022-12-27	WOS:000295832000029
J	Waddell, J; Kim, J; Alger, BE; McCarthy, MM				Waddell, Jaylyn; Kim, Jimok; Alger, Bradley E.; McCarthy, Margaret M.			The Depolarizing Action of GABA in Cultured Hippocampal Neurons Is Not Due to the Absence of Ketone Bodies	PLOS ONE			English	Article							IMMATURE NEOCORTICAL NEURONS; POSTSYNAPTIC ACTIVITY; MEDIATED EXCITATION; RAT; COTRANSPORTER; PROMOTES; CL; DIFFERENTIATION; AVAILABILITY; EXPRESSION	Two recent reports propose that the depolarizing action of GABA in the immature brain is an artifact of in vitro preparations in which glucose is the only energy source. The authors argue that this does not mimic the physiological environment because the suckling rats use ketone bodies and pyruvate as major sources of metabolic energy. Here, we show that availability of physiologically relevant levels of ketone bodies has no impact on the excitatory action of GABA in immature cultured hippocampal neurons. Addition of beta-hydroxybutyrate (BHB), the primary ketone body in the neonate rat, affected neither intracellular calcium elevation nor membrane depolarizations induced by the GABA-A receptor agonist muscimol, when assessed with calcium imaging or perforated patch-clamp recording, respectively. These results confirm that the addition of ketone bodies to the extracellular environment to mimic conditions in the neonatal brain does not reverse the chloride gradient and therefore render GABA hyperpolarizing. Our data are consistent with the existence of a genuine "developmental switch'' mechanism in which GABA goes from having a predominantly excitatory role in immature cells to a predominantly inhibitory one in adults.	[Waddell, Jaylyn; Kim, Jimok; Alger, Bradley E.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Waddell, J (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	jaylyn.waddell@gmail.com	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726	National Institute of Neurological Disorders and Stroke at the National Institutes of Health [R01 NS050525]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050525] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01 NS050525 awarded to MMM by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger AP, 2001, P NATL ACAD SCI USA, V98, P8059, DOI 10.1073/pnas.131016298; Balena T, 2008, EUR J NEUROSCI, V27, P2402, DOI 10.1111/j.1460-9568.2008.06194.x; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Galanopoulou AS, 2003, EXP NEUROL, V184, P1003, DOI 10.1016/S0014-4886(03)00387-X; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Holmgren CD, 2010, J NEUROCHEM, V112, P900, DOI 10.1111/j.1471-4159.2009.06506.x; Kandler K, 2002, PHYSIOL BEHAV, V77, P583, DOI 10.1016/S0031-9384(02)00905-8; Kirmse K, 2010, J NEUROSCI, V30, P16002, DOI 10.1523/JNEUROSCI.2534-10.2010; Lagostena L, 2010, J NEUROSCI, V30, P885, DOI 10.1523/JNEUROSCI.3326-09.2010; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Lust WD, 2003, METAB BRAIN DIS, V18, P195, DOI 10.1023/A:1025503115837; Nehlig A, 1996, DEV NEUROSCI-BASEL, V18, P426, DOI 10.1159/000111437; Nunez JL, 2005, EUR J NEUROSCI, V21, P3251, DOI 10.1111/j.1460-9568.2005.04175.x; Nunez JL, 2007, DEV NEUROBIOL, V67, P1879, DOI 10.1002/dneu.20567; Owens DF, 1996, J NEUROSCI, V16, P6414; Perrot-Sinal TS, 2001, ENDOCRINOLOGY, V142, P2238, DOI 10.1210/en.142.6.2238; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Prins M, 2008, EPILEPSIA, V49, P111, DOI 10.1111/j.1528-1167.2008.01852.x; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rheims S, 2009, J NEUROCHEM, V110, P1330, DOI 10.1111/j.1471-4159.2009.06230.x; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Ruusuvuori E, 2010, J NEUROSCI, V30, P15638, DOI 10.1523/JNEUROSCI.3355-10.2010; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tyzio R, 2011, J NEUROSCI, V31, P34, DOI 10.1523/JNEUROSCI.3314-10.2011; Wasterlain CG, 2010, NEUROCHEM RES, V35, P2193, DOI 10.1007/s11064-010-0339-4; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23020	10.1371/journal.pone.0023020	http://dx.doi.org/10.1371/journal.pone.0023020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886776	gold, Green Published, Green Submitted			2022-12-27	WOS:000294128100005
J	Zhang, QC; Zhang, Y; Feng, HH; Guo, R; Jin, L; Wan, R; Wang, LN; Chen, C; Li, SN				Zhang, Qichun; Zhang, Yun; Feng, Haihua; Guo, Rui; Jin, Lai; Wan, Rong; Wang, Lina; Chen, Cheng; Li, Shengnan			High Density Lipoprotein (HDL) Promotes Glucose Uptake in Adipocytes and Glycogen Synthesis in Muscle Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN SKELETAL-MUSCLE; APOLIPOPROTEIN-A-I; SELECTIVE LIPID UPTAKE; SCAVENGER RECEPTOR-BI; SR-BI; SIGNALING PATHWAYS; INSULIN-RESISTANCE; TRANSPORTER GLUT4; 3T3-L1 ADIPOCYTES	Background: High density lipoprotein (HDL) was reported to decrease plasma glucose and promote insulin secretion in type 2 diabetes patients. This investigation was designed to determine the effects and mechanisms of HDL on glucose uptake in adipocytes and glycogen synthesis in muscle cells. Methods and Results: Actions of HDL on glucose uptake and GLUT4 translocation were assessed with 1-[(3)H]-2-deoxyglucose and plasma membrane lawn, respectively, in 3T3-L1 adipocytes. Glycogen analysis was performed with amyloglucosidase and glucose oxidase-peroxidase methods in normal and palmitate-treated L6 cells. Small interfering RNA was used to observe role of scavenger receptor type I (SR-BI) in glucose uptake of HDL. Corresponding signaling molecules were detected by immunoblotting. HDL stimulated glucose uptake in a time-and concentration-dependent manner in 3T3-L1 adipocytes. GLUT4 translocation was significantly increased by HDL. Glycogen deposition got enhanced in L6 muscle cells paralleling with elevated glycogen synthase kinase3 (GSK3) phosphorylation. Meanwhile, increased phosphorylations of Akt-Ser473 and AMP activated protein kinase (AMPK) alpha were detected in 3T3-L1 adipocytes. Glucose uptake and Akt-Ser473 activation but not AMPK-a were diminished in SR-BI knock-down 3T3-L1 cells. Conclusions: HDL stimulates glucose uptake in 3T3-L1 adipocytes through enhancing GLUT4 translocation by mechanisms involving PI3K/Akt via SR-BI and AMPK signaling pathways, and increases glycogen deposition in L6 muscle cells through promoting GSK3 phosphorylation.	[Zhang, Qichun; Zhang, Yun; Feng, Haihua; Guo, Rui; Jin, Lai; Wan, Rong; Wang, Lina; Chen, Cheng; Li, Shengnan] Nanjing Med Univ, Dept Pharmacol, Jiangsu Prov Key Lab Cardiovasc Dis & Mol Interve, Nanjing, Peoples R China; [Zhang, Qichun] Nanjing Univ Chinese Med, Sch Pharm, Nanjing, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine	Zhang, QC (corresponding author), Nanjing Med Univ, Dept Pharmacol, Jiangsu Prov Key Lab Cardiovasc Dis & Mol Interve, Nanjing, Peoples R China.	snli@njmu.edu.cn	Feng, Haihua/ABE-2440-2021		National Foundation of Science of China [81072668]; Natural Science Foundation of Jiangsu Province [BK2010078]	National Foundation of Science of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	National Foundation of Science of China (No. 81072668), http://www.nsfc.gov.cn/Portal0/default124.htm, Natural Science Foundation of Jiangsu Province (No. BK2010078), http://www.jsnsf.gov.cn/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Baldan A, 2006, CURR OPIN LIPIDOL, V17, P227, DOI 10.1097/01.mol.0000226113.89812.bb; BORTHWICK AC, 1995, BIOCHEM BIOPH RES CO, V210, P738, DOI 10.1006/bbrc.1995.1721; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Chen GL, 2006, MOL ENDOCRINOL, V20, P857, DOI 10.1210/me.2005-0255; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Gantman A, 2010, BIOCHEM BIOPH RES CO, V391, P523, DOI 10.1016/j.bbrc.2009.11.091; Guan F, 2008, ARCH MED RES, V39, P52, DOI 10.1016/j.arcmed.2007.06.022; Han R, 2007, DIABETOLOGIA, V50, P1960, DOI 10.1007/s00125-007-0752-7; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Koneru S, 2007, AM J PHYSIOL-HEART C, V292, pH2060, DOI 10.1152/ajpheart.01169.2006; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Lamarche B, 1999, J CLIN INVEST, V103, P1191, DOI 10.1172/JCI5286; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Li XA, 2002, J BIOL CHEM, V277, P11058, DOI 10.1074/jbc.M110985200; Link JJ, 2007, CURR PROB CARDIOLOGY, V32, P268, DOI 10.1016/j.cpcardiol.2007.01.004; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Nakhjavani M, 2008, DIABETES RES CLIN PR, V81, P38, DOI 10.1016/j.diabres.2008.01.018; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Rodriguez C, 2009, THROMB HAEMOSTASIS, V101, P665, DOI 10.1160/TH08-10-0675; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Storey SM, 2007, BIOCHEMISTRY-US, V46, P13891, DOI 10.1021/bi700690s; von Eckardstein A, 2011, CURR OPIN LIPIDOL, V22, P26, DOI 10.1097/MOL.0b013e3283412279; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Westendorf T, 2005, MOL CELL BIOCHEM, V277, P143, DOI 10.1007/s11010-005-5873-z; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhang Y, 2007, J LIPID RES, V48, P405, DOI 10.1194/jlr.M600326-JLR200	41	41	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23556	10.1371/journal.pone.0023556	http://dx.doi.org/10.1371/journal.pone.0023556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886796	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100018
J	Jongsma, MLA; Postma, SAE; Souren, P; Arns, M; Gordon, E; Vissers, K; Wilder-Smith, O; van Rijn, CM; van Goor, H				Jongsma, Marijtje L. A.; Postma, Simone A. E.; Souren, Pierre; Arns, Martijn; Gordon, Evian; Vissers, Kris; Wilder-Smith, Oliver; van Rijn, Clementina M.; van Goor, Harry			Neurodegenerative Properties of Chronic Pain: Cognitive Decline in Patients with Chronic Pancreatitis	PLOS ONE			English	Article							CHRONIC BACK-PAIN; QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL PERFORMANCE; GRAY-MATTER; ATTENTIONAL CONTROL; MAJOR DEPRESSION; ALCOHOLIC WOMEN; PERSISTENT PAIN; MEMORY; FIBROMYALGIA	Chronic pain has been associated with impaired cognitive function. We examined cognitive performance in patients with severe chronic pancreatitis pain. We explored the following factors for their contribution to observed cognitive deficits: pain duration, comorbidity (depression, sleep disturbance), use of opioids, and premorbid alcohol abuse. The cognitive profiles of 16 patients with severe pain due to chronic pancreatitis were determined using an extensive neuropsychological test battery. Data from three cognitive domains (psychomotor performance, memory, executive functions) were compared to data from healthy controls matched for age, gender and education. Multivariate multilevel analysis of the data showed decreased test scores in patients with chronic pancreatitis pain in different cognitive domains. Psychomotor performance and executive functions showed the most prominent decline. Interestingly, pain duration appeared to be the strongest predictor for observed cognitive decline. Depressive symptoms, sleep disturbance, opioid use and history of alcohol abuse provided additional explanations for the observed cognitive decline in some of the tests, but to a lesser extent than pain duration. The negative effect of pain duration on cognitive performance is compatible with the theory of neurodegenerative properties of chronic pain. Therefore, early and effective therapeutic interventions might reduce or prevent decline in cognitive performance, thereby improving outcomes and quality of life in these patients.	[Jongsma, Marijtje L. A.; Postma, Simone A. E.; van Rijn, Clementina M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands; [Jongsma, Marijtje L. A.] Radboud Univ Nijmegen, Inst Behav Sci, Dept Learning & Dev, NL-6525 ED Nijmegen, Netherlands; [Souren, Pierre] Radboud Univ Nijmegen, Dept Social Psychol, Res Tech Support Grp RTOG, NL-6525 ED Nijmegen, Netherlands; [Arns, Martijn] Res Inst Brainclin, Nijmegen, Netherlands; [Gordon, Evian] Brain Resource Int Database, Ultimo, Australia; [Gordon, Evian] Brain Resource Co, Ultimo, Australia; [Vissers, Kris; Wilder-Smith, Oliver] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Med, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands; [van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Total Brain; Radboud University Nijmegen; Radboud University Nijmegen	Jongsma, MLA (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands.	t.vanrijn@donders.ru.nl	Vissers, Kris C.P./D-3569-2009; Vissers, Kris/H-8110-2014; van Goor, H./H-8035-2014; Wilder-Smith, Oliver H.G./E-7541-2012; Souren, Pierre/E-9003-2012; Postma, Simone/D-5051-2016; van Rijn, Clementina/D-5828-2012	Vissers, Kris C.P./0000-0002-2919-6356; Vissers, Kris/0000-0002-2919-6356; van Goor, H./0000-0003-0323-4876; Wilder-Smith, Oliver H.G./0000-0003-4390-2381; van Rijn, Clementina/0000-0002-1103-6338; Arns, Martijn/0000-0002-0610-7613				Andren-Sandberg A, 2002, EUR J GASTROEN HEPAT, V14, P957, DOI 10.1097/00042737-200209000-00006; Apkarian A.V., 2006, DRUG DISCOV TODAY DI, V3, P319, DOI DOI 10.1016/J.DDRNEC.2006.09.006; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Attree EA, 2003, APPL NEUROPSYCHOL, V10, P96, DOI 10.1207/S15324826AN1002_05; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; BROWNE W, 2004, MULTILEVEL MODELLING; Buscher HCJL, 2008, SURGERY, V143, P715, DOI 10.1016/j.surg.2008.03.001; Buscher HG, 2006, EUR J PAIN, V10, P363, DOI 10.1016/j.ejpain.2005.06.006; Clark CR, 2006, ARCH CLIN NEUROPSYCH, V21, P449, DOI 10.1016/j.acn.2006.06.005; Demir IE, 2011, LANGENBECK ARCH SURG, V396, P151, DOI 10.1007/s00423-010-0731-1; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Drewes AM, 2008, WORLD J GASTROENTERO, V14, P4020, DOI 10.3748/wjg.14.4020; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; ECCLESTON C, 1995, PAIN, V63, P3, DOI 10.1016/0304-3959(95)00093-8; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Ende G, 2005, BIOL PSYCHIAT, V58, P974, DOI 10.1016/j.biopsych.2005.05.038; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Fein G, 2006, ALCOHOL CLIN EXP RES, V30, P1538, DOI 10.1111/j.1530-0277.2006.00185.x; Gallassi R, 2006, J AFFECT DISORDERS, V91, P243, DOI 10.1016/j.jad.2006.01.018; Gallassi R, 2001, ARCH GERONTOL GERIAT, P163; Gardner TB, 2010, PANCREAS, V39, P498, DOI 10.1097/MPA.0b013e3181c5c693; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Glass JM, 2009, RHEUM DIS CLIN N AM, V35, P299, DOI 10.1016/j.rdc.2009.06.002; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gomez RG, 2006, BIOL PSYCHIAT, V60, P472, DOI 10.1016/j.biopsych.2005.11.010; Grisart JM, 2001, PAIN, V94, P305, DOI 10.1016/S0304-3959(01)00366-9; Grossi ML, 2001, J OROFAC PAIN, V15, P329; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Harman K, 2005, CLIN J PAIN, V21, P216, DOI 10.1097/00002508-200505000-00004; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; KEWMAN DG, 1991, INT J PSYCHIAT MED, V21, P253, DOI 10.2190/FRYK-TMGA-AULW-BM5G; LEEUW JD, HDB MULTILEVEL ANAL; Majer M, 2008, PSYCHOSOM MED, V70, P829, DOI 10.1097/PSY.0b013e31817b9793; Mergener L, 1997, LANCET, V350, P1379, DOI 10.1016/S0140-6736(97)07332-7; Oosterman JM, 2011, CLIN J PAIN, V27, P70, DOI 10.1097/AJP.0b013e3181f15cf5; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Park DC, 2001, ARTHRITIS RHEUM, V44, P2125, DOI 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1; Pezzilli R, 2006, WORLD J GASTROENTERO, V12, P6249, DOI 10.3748/wjg.v12.i39.6249; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; Riley JL, 2001, J PAIN, V2, P354, DOI 10.1054/jpai.2001.27000; Rosenbloom MJ, 2004, NEUROPSYCHOLOGY, V18, P589, DOI 10.1037/0894-4105.18.3.589; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Sjogren P, 2005, EUR J PAIN, V9, P453, DOI 10.1016/j.ejpain.2004.10.005; Sjogren P, 2000, PAIN, V86, P237, DOI 10.1016/S0304-3959(00)00248-7; Sjogren P, 2000, J PAIN SYMPTOM MANAG, V19, P100, DOI 10.1016/S0885-3924(99)00143-8; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Sullivan EV, 2002, NEUROPSYCHOLOGY, V16, P74, DOI 10.1037//0894-4105.16.1.74; van Esch AAJ, 2006, DIGEST LIVER DIS, V38, P518, DOI 10.1016/j.dld.2006.02.002; van Loo ES, 2010, BRIT J SURG, V97, P1079, DOI 10.1002/bjs.7103; Wehler M, 2004, AM J GASTROENTEROL, V99, P138, DOI 10.1111/j.1572-0241.2004.04005.x; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	60	43	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23363	10.1371/journal.pone.0023363	http://dx.doi.org/10.1371/journal.pone.0023363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810LN	21876748	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900020
J	Song, ZF; Jin, R; Yu, SY; Rivet, JJ; Smyth, SS; Nanda, A; Granger, DN; Li, GH				Song, Zifang; Jin, Rong; Yu, Shiyong; Rivet, Joshua J.; Smyth, Susan S.; Nanda, Anil; Granger, D. Neil; Li, Guohong			CD40 Is Essential in the Upregulation of TRAF Proteins and NF-KappaB-Dependent Proinflammatory Gene Expression after Arterial Injury	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; REDUCES NEOINTIMAL FORMATION; RECEPTOR-ASSOCIATED FACTOR-6; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; VASCULAR INJURY; CAROTID-ARTERY; BALLOON INJURY; B PATHWAY; ATHEROSCLEROSIS	Despite extensive investigations, restenosis, which is characterized primarily by neointima formation, remains an unsolved clinical problem after vascular interventions. A recent study has shown that CD40 signaling through TNF receptor associated factor 6 (TRAF6) plays a key role in neointima formation after carotid artery injury; however, underlying mechanisms are not clearly elucidated. Because neointima formation may vary significantly depending on the type of injury, we first assessed the effect of CD40 deficiency on neointima formation in 2 injury models, carotid artery ligation and femoral artery denudation injury. Compared with wild-type mice, CD40 deficiency significantly reduced neointima formation and lumen stenosis in two different models. Further, we investigated the mechanism by which CD40 signaling affects neointima formation after arterial injury. In wild-type mice, the expression levels of CD40, several TRAF proteins, including TRAF1, TRAF2, TRAF3, TRAF5, and TRAF6, as well as total NF-kB p65 and phospho-NF-kB p65, in the carotid artery were markedly upregulated within 3-7 days after carotid ligation. Deficiency of CD40 abolished the injury-induced upregulation of TRAFs including TRAF6 and NF-kB-p65 in the injured vessel wall. Further, CD40-/- mice showed a significant decrease in the recruitment of neutrophils (at 3, 7d) and macrophages (at 7, 21d) into injured artery; this effect was most likely attributed to inhibition of NF-kB activation and marked downregulation of NF-kB-related gene expression, including cytokines (TNF alpha, IL-1 beta, IL-6), chemokines (MCP-1), and adhesion molecules (ICAM-1, VCAM-1). Moreover, neutrophil recruitment in a model of thioglycollate-induced peritonitis is impaired in CD40-deficient mice. In vitro data revealed that CD40 deficiency blocked CD40L-induced NF-kB p65 nuclear translocation in leukocytes. Altogether, our data identified for the first time that CD40 is essential in the upregulation of TRAF6, NF-kB activation, and NF-kB-dependent proinflammatory genes in vivo. Our findings firmly established the role for CD40 in neointima formation in 2 distinct injury models.	[Song, Zifang; Jin, Rong; Yu, Shiyong; Rivet, Joshua J.; Nanda, Anil; Li, Guohong] LSU Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA USA; [Granger, D. Neil; Li, Guohong] LSU Hlth Sci Ctr Shreveport, Dept Physiol, Shreveport, LA USA; [Smyth, Susan S.] Univ Kentucky, Dept Med, Lexington, KY 40506 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Kentucky	Song, ZF (corresponding author), LSU Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA USA.	gli@lsuhsc.edu	Song, Zifang/AAA-8467-2022		National Institutes of Health [HL087990]; American Heart Association [0530166N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL087990 (GL) and by a scientist development grant (0530166N, GL) from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Breuss JM, 2002, CIRCULATION, V105, P633, DOI 10.1161/hc0502.102966; Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje; Cercek B, 1997, ATHEROSCLEROSIS, V131, P59, DOI 10.1016/S0021-9150(96)06767-6; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Chung JY, 2002, J CELL SCI, V115, P679; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Engel D, 2009, SEMIN IMMUNOL, V21, P308, DOI 10.1016/j.smim.2009.06.004; Evans DJW, 2009, CIRCULATION, V119, P116, DOI 10.1161/CIRCULATIONAHA.107.762690; Ferro D, 2007, ARTERIOSCL THROM VAS, V27, P2763, DOI 10.1161/ATVBAHA.107.152777; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Ialenti A, 2001, N-S ARCH PHARMACOL, V364, P343, DOI 10.1007/s002100100467; Iwata H, 2010, CIRCULATION, V122, P2048, DOI 10.1161/CIRCULATIONAHA.110.965202; Koga J, 2009, ARTERIOSCL THROM VAS, V29, P458, DOI 10.1161/ATVBAHA.109.183772; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Landry DB, 1997, AM J PATHOL, V151, P1085; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Li GH, 2007, ARTERIOSCL THROM VAS, V27, P1850, DOI 10.1161/ATVBAHA.107.144576; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Lutgens E, 2007, TRENDS CARDIOVAS MED, V17, P118, DOI 10.1016/j.tcm.2007.02.004; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Missiou A, 2010, CIRC RES, V107, P757, DOI 10.1161/CIRCRESAHA.110.219295; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Miyahara T, 2006, J VASC SURG, V43, P592, DOI 10.1016/j.jvs.2005.11.010; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Qu YM, 2009, J VASC SURG, V50, P1452, DOI 10.1016/j.jvs.2009.08.050; Remskar M, 2001, CIRC RES, V88, P390; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stachon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011589; Su CH, 2007, INT J RADIAT BIOL, V83, P707, DOI 10.1080/09553000701596126; Takada Y, 2004, J BIOL CHEM, V279, P4750, DOI 10.1074/jbc.M304546200; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Yamasaki K, 2003, GENE THER, V10, P356, DOI 10.1038/sj.gt.3301875; Zapata JM, 2003, EXPERT OPIN THER TAR, V7, P411, DOI 10.1517/14728222.7.3.411; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	49	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23239	10.1371/journal.pone.0023239	http://dx.doi.org/10.1371/journal.pone.0023239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876738	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900010
J	Wong, LSM; Huzen, J; de Boer, RA; van Gilst, WH; van Veldhuisen, DJ; van der Harst, P				Wong, Liza S. M.; Huzen, Jardi; de Boer, Rudolf A.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.; van der Harst, Pim			Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; CD34(+) CELLS; HUMAN-DISEASE; ATHEROSCLEROSIS; RISK; SHORTER; TISSUES	Background: We aimed to find support for the hypothesis that telomere length (TL) is causally involved in the pathogenesis of ischemic heart failure (IHF). We measured TL in IHF patients and their high-risk offspring and determined whether mean leukocyte TL reflects TL in CD34+ progenitor. We additionally measured TL of offspring of patients and controls to examine heritability throughout different cell types. Methods and Results: TL was measured by qPCR in overall leukocytes, CD34+ progenitor cells, mononuclear cells (MNCs), and buccal cells in 27 IHF patients, 24 healthy controls and 60 offspring. TL in IHF patients was shorter than healthy controls in leukocytes (p = 0.002), but not in CD34+ cells (p = 0.39), MNCs (p = 0.31) or buccal cells (p = 0.19). Offspring of IHF patients had shorter TL in leukocytes than offspring of healthy subjects (p = 0.04) but not in other cell types. Controls and offspring showed a good within person correlation between leukocytes and CD34+ cells (r 0.562; p = 0.004 and r 0.602; p = 0.001, respectively). In IHF patients and offspring the correlation among cell types was blunted. Finally, we found strong correlations between parent and offspring TL in all four cell types. Conclusions: Reduced leukocyte TL in offspring of IHF subjects suggests a potential causal link of TL in ischemic heart disease. However, this causality is unlikely to originate from exhaustion of TL in CD34+ progenitor or MNC cells as their lengths are not well captured by overall leukocyte TL. Additionally, we found strong correlations between parent and offspring TL in all examined cell types, suggesting high heritability of TL among cell types.	[Wong, Liza S. M.; Huzen, Jardi; de Boer, Rudolf A.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Wong, Liza S. M.] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Huzen, Jardi] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen	Wong, LSM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	p.van.der.harst@thorax.umcg.nl	de Boer, Rudolf/ABE-9879-2020; van Veldhuisen, Dirk Jan/E-8967-2014; van Gilst, Wiek/R-1806-2019	van Gilst, Wiek/0000-0003-2968-8585	Netherlands Organisation for Scientific Research [NWO] [916.76.170]; Netherlands Heart Foundation [2008T028, 2006T003, 2004T046, D97-017]; Interuniversitair Cardiologisch Instituut Nederland (ICIN)	Netherlands Organisation for Scientific Research [NWO](Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); Interuniversitair Cardiologisch Instituut Nederland (ICIN)	This work was supported by the Innovational Research Incentives Scheme program of the Netherlands Organisation for Scientific Research [NWO VENI, grant number 916.76.170 to P. van der Harst] and the Netherlands Heart Foundation [E. Dekker grant, grant number 2008T028 to L.S.M. Wong]. P. van der Harst and R.A. de Boer are research fellows of the Netherlands Heart Foundation [grant numbers 2006T003 and 2004T046, respectively] and the Interuniversitair Cardiologisch Instituut Nederland (ICIN). D.J. van Veldhuisen is an Established Investigators of the Netherlands Heart Foundation [grant numbers D97-017]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2008, HEART, V94, P422, DOI 10.1136/hrt.2007.139675; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Desai A, 2010, J LEUKOCYTE BIOL, V87, P1001, DOI 10.1189/jlb.0809542; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Ogami M, 2004, ARTERIOSCL THROM VAS, V24, P546, DOI 10.1161/01.ATV.0000117200.46938.e7; Pasquet S, 2009, CYTOTHERAPY, V11, P1002, DOI 10.3109/14653240903164963; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sebastian C, 2009, J IMMUNOL, V183, P2356, DOI 10.4049/jimmunol.0901131; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Spyridopoulos I, 2009, CIRCULATION, V120, P1364, DOI 10.1161/CIRCULATIONAHA.109.854299; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; van der Harst P, 2010, ANN MED, V42, P36, DOI 10.3109/07853890903321567; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang JX, 2010, CIRC RES, V106, P1904, DOI 10.1161/CIRCRESAHA.110.221762; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Wong LSM, 2010, EUR J HEART FAIL, V12, P348, DOI 10.1093/eurjhf/hfq007; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228	26	50	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23118	10.1371/journal.pone.0023118	http://dx.doi.org/10.1371/journal.pone.0023118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876736	Green Published, Green Submitted, gold			2022-12-27	WOS:000294126900008
J	Romaguera, D; Angquist, L; Du, HD; Jakobsen, MU; Forouhi, NG; Halkjaer, J; Feskens, EJM; van der A, DL; Masala, G; Steffen, A; Palli, D; Wareham, NJ; Overvad, K; Tjonneland, A; Boeing, H; Riboli, E; Sorensen, TI				Romaguera, Dora; Angquist, Lars; Du, Huaidong; Jakobsen, Marianne Uhre; Forouhi, Nita G.; Halkjaer, Jytte; Feskens, Edith J. M.; van der A, Daphne L.; Masala, Giovanna; Steffen, Annika; Palli, Domenico; Wareham, Nicholas J.; Overvad, Kim; Tjonneland, Anne; Boeing, Heiner; Riboli, Elio; Sorensen, Thorkild I.			Food Composition of the Diet in Relation to Changes in Waist Circumference Adjusted for Body Mass Index	PLOS ONE			English	Article							MIDDLE-AGED MEN; SUBSEQUENT CHANGES; EUROPEAN MEN; BLOOD-PRESSURE; CALCIUM INTAKE; EATING PLAN; WEIGHT; RISK; PATTERNS; OBESITY	Background: Dietary factors such as low energy density and low glycemic index were associated with a lower gain in abdominal adiposity. A better understanding of which food groups/items contribute to these associations is necessary. Objective: To ascertain the association of food groups/items consumption on prospective annual changes in "waist circumference for a given BMI" (WCBMI), a proxy for abdominal adiposity. Design: We analyzed data from 48,631 men and women from 5 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Anthropometric measurements were obtained at baseline and after a median follow-up time of 5.5 years. WCBMI was defined as the residuals of waist circumference regressed on BMI, and annual change in WCBMI (Delta WCBMI, cm/y) was defined as the difference between residuals at follow-up and baseline, divided by follow-up time. The association between food groups/items and Delta WCBMI was modelled using centre-specific adjusted linear regression, and random-effects meta-analyses to obtain pooled estimates. Results: Higher fruit and dairy products consumption was associated with a lower gain in WCBMI whereas the consumption of white bread, processed meat, margarine, and soft drinks was positively associated with Delta WCBMI. When these six food groups/items were analyzed in combination using a summary score, those in the highest quartile of the score - indicating a more favourable dietary pattern - showed a Delta WCBMI of -0.11 (95% CI -0.09 to -0.14) cm/y compared to those in the lowest quartile. Conclusion: A dietary pattern high in fruit and dairy and low in white bread, processed meat, margarine, and soft drinks may help to prevent abdominal fat accumulation.	[Romaguera, Dora; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London SW7 2AZ, England; [Angquist, Lars; Sorensen, Thorkild I.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Du, Huaidong; van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Du, Huaidong] Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Jakobsen, Marianne Uhre] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Forouhi, Nita G.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Halkjaer, Jytte; Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Masala, Giovanna; Palli, Domenico] ISPO Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Steffen, Annika; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Nuthetal, Germany; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark	Imperial College London; University of Copenhagen; Netherlands National Institute for Public Health & the Environment; Maastricht University; Aarhus University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Danish Cancer Society; Wageningen University & Research; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Romaguera, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London SW7 2AZ, England.	d.romaguera-bosch@imperial.ac.uk	Romaguera, Dora/ABE-7004-2020; Romaguera, Dora/AAB-2852-2020; Masala, Giovanna/AAC-5474-2022; Jakobsen, Marianne Uhre/I-8550-2018; Feskens, Edith/ABI-1446-2020; Steffen, Annika/H-7709-2018; Steffen, Annika/E-8540-2016; Feskens, Edith JM/A-3757-2012	Romaguera, Dora/0000-0002-5762-8558; Masala, Giovanna/0000-0002-5758-9069; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Feskens, Edith/0000-0001-5819-2488; Steffen, Annika/0000-0003-4072-9245; Steffen, Annika/0000-0003-4072-9245; Forouhi, Nita/0000-0002-5041-248X; Tjonneland, Anne/0000-0003-4385-2097; tumino, rosario/0000-0003-2666-414X; Overvad, Kim/0000-0001-6429-7921; Du, Huaidong/0000-0002-9814-0049; PALLI, Domenico/0000-0002-5558-2437; Angquist, Lars/0000-0002-9516-4424; Riboli, Elio/0000-0001-6795-6080	European Union [FOOD-CT-2005-513946]; Danish Strategic Research Council (GENDINOB); MRC [MC_UP_A100_1003] Funding Source: UKRI; Medical Research Council [MC_U106179471, MC_UP_A100_1003] Funding Source: researchfish	European Union(European Commission); Danish Strategic Research Council (GENDINOB)(Danske Strategiske Forskningsrad (DSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DiOGenes is the acronym of the project "Diet, Obesity and Genes" supported by the European Union (Contract no. FOOD-CT-2005-513946). The study was also supported by a grant from the Danish Strategic Research Council (GENDINOB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Azadbakht L, 2011, DIABETES CARE, V34, P55, DOI 10.2337/dc10-0676; Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; Bigaard J, 2005, J NUTR, V135, P2263; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Bradlee ML, 2010, PUBLIC HEALTH NUTR, V13, P797, DOI 10.1017/S1368980009991546; Busetto L, 2000, INT J OBESITY, V24, P60, DOI 10.1038/sj.ijo.0801086; Bush NC, 2010, OBESITY, V18, P2101, DOI 10.1038/oby.2010.39; Du H, 2009, INT J OBESITY, V33, P1280, DOI 10.1038/ijo.2009.163; Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191; Du HD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005339; Forouhi NG, 2009, AM J CLIN NUTR, V90, P1632, DOI 10.3945/ajcn.2009.27828; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Halkjaer J, 2004, BRIT J NUTR, V92, P735, DOI 10.1079/BJN20041246; Halton TL, 2006, AM J CLIN NUTR, V83, P284; Han TS, 1998, INT J EPIDEMIOL, V27, P422, DOI 10.1093/ije/27.3.422; Iacobellis G, 2008, OBESITY, V16, P1693, DOI 10.1038/oby.2008.251; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; McKeown NM, 2010, AM J CLIN NUTR, V92, P1165, DOI 10.3945/ajcn.2009.29106; McKeown NM, 2009, J NUTR, V139, P1950, DOI 10.3945/jn.108.103762; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Okosun IS, 2001, J HUM HYPERTENS, V15, P307, DOI 10.1038/sj.jhh.1001179; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Romaguera D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011588; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shahar DR, 2010, AM J CLIN NUTR, V92, P1017, DOI 10.3945/ajcn.2010.29355; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439	36	66	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23384	10.1371/journal.pone.0023384	http://dx.doi.org/10.1371/journal.pone.0023384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858094	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300041
J	Shigehara, K; Yokomuro, S; Ishibashi, O; Mizuguchi, Y; Arima, Y; Kawahigashi, Y; Kanda, T; Akagi, I; Tajiri, T; Yoshida, H; Takizawa, T; Uchida, E				Shigehara, Kengo; Yokomuro, Shigeki; Ishibashi, Osamu; Mizuguchi, Yoshiaki; Arima, Yasuo; Kawahigashi, Yutaka; Kanda, Tomohiro; Akagi, Ichiro; Tajiri, Takashi; Yoshida, Hiroshi; Takizawa, Toshihiro; Uchida, Eiji			Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BRUSH CYTOLOGY; ENDOSCOPIC ULTRASOUND; HUMAN CHOLANGIOCARCINOMA; CIRCULATING MICRORNAS; EXPRESSION PROFILES; E-CADHERIN; CELL; STRICTURES; EUS	Biliary tract cancer (BTC) is often difficult to diagnose definitively, even through histological examination. MicroRNAs (miRNAs) regulate a variety of physiological processes. In recent years, it has been suggested that profiles for circulating miRNAs, as well as those for tissue miRNAs, have the potential to be used as diagnostic biomarkers for cancer. The aim of this study was to confirm the existence of miRNAs in human bile and to assess their potential as clinical biomarkers for BTC. We sampled bile from patients who underwent biliary drainage for biliary diseases such as BTC and choledocholithiasis. PCR-based miRNA detection and miRNA cloning were performed to identify bile miRNAs. Using high-throughput real-time PCR-based miRNA microarrays, the expression profiles of 667 miRNAs were compared in patients with malignant disease (n = 9) and age-matched patients with the benign disease choledocholithiasis (n = 9). We subsequently characterized bile miRNAs in terms of stability and localization. Through cloning and using PCR methods, we confirmed that miRNAs exist in bile. Differential analysis of bile miRNAs demonstrated that 10 of the 667 miRNAs were significantly more highly expressed in the malignant group than in the benign group at P<0.0005. Setting the specificity threshold to 100% showed that some miRNAs (miR-9, miR-302c*, miR-199a-3p and miR-222*) had a sensitivity level of 88.9%, and receiver-operating characteristic analysis demonstrated that miR-9 and miR-145* could be useful diagnostic markers for BTC. Moreover, we verified the long-term stability of miRNAs in bile, a characteristic that makes them suitable for diagnostic use in clinical settings. We also confirmed that bile miRNAs are localized to the malignant/benign biliary epithelia. These findings suggest that bile miRNAs could be informative biomarkers for hepatobiliary disease and that some miRNAs, particularly miR-9, may be helpful in the diagnosis and clinical management of BTC.	[Shigehara, Kengo; Yokomuro, Shigeki; Mizuguchi, Yoshiaki; Arima, Yasuo; Kawahigashi, Yutaka; Kanda, Tomohiro; Akagi, Ichiro; Tajiri, Takashi; Yoshida, Hiroshi; Uchida, Eiji] Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, Tokyo 113, Japan; [Ishibashi, Osamu; Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Med & Anat, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Shigehara, K (corresponding author), Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, 1-1-5 Sendagi, Tokyo 113, Japan.	t-takizawa@nms.ac.jp; uchida@nms.ac.jp	Ishibashi, Osamu/J-8413-2019	Ishibashi, Osamu/0000-0003-4698-460X	Ministry of Education, Culture, Sports, Science and Technology, Japan [S0801034]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid and the "Research Core" Project for Private University: Matching Fund Subsidy (S0801034) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljiffry M, 2009, WORLD J GASTROENTERO, V15, P4240, DOI 10.3748/wjg.15.4240; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Byrne MF, 2004, ENDOSCOPY, V36, P715, DOI 10.1055/s-2004-825657; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Eloubeidi MA, 2004, CLIN GASTROENTEROL H, V2, P209, DOI 10.1016/S1542-3565(04)00005-9; Endo K, 2002, HEPATOLOGY, V36, P439, DOI 10.1053/jhep.2002.34435; Esteller A, 2008, WORLD J GASTROENTERO, V14, P5641, DOI 10.3748/wjg.14.5641; FISCHER HP, 1987, AM J PATHOL, V127, P530; Fritscher-Ravens A, 2004, AM J GASTROENTEROL, V99, P45, DOI 10.1046/j.1572-0241.2003.04006.x; Fritscher-Ravens A, 2000, GASTROINTEST ENDOSC, V52, P534, DOI 10.1067/mge.2000.109589; Garrow D, 2007, CLIN GASTROENTEROL H, V5, P616, DOI 10.1016/j.cgh.2007.02.027; Glasbrenner B, 1999, ENDOSCOPY, V31, P712; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Jailwala J, 2000, GASTROINTEST ENDOSC, V51, P383, DOI 10.1016/S0016-5107(00)70435-4; Jarnagin WR, 2006, J CLIN ONCOL, V24, P1152, DOI 10.1200/JCO.2005.04.6631; Khan SA, 2002, GUT, V51, P1; KUBOTA Y, 1993, ABDOM IMAGING, V18, P145; Kuroki T, 2005, J HEPATO-BILIARY-PAN, V12, P463, DOI 10.1007/s00534-005-1004-1; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; LEE JG, 1995, AM J GASTROENTEROL, V90, P722; Lee JH, 2004, AM J GASTROENTEROL, V99, P1069, DOI 10.1111/j.1572-0241.2004.30223.x; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mansfield JC, 1997, GUT, V40, P671, DOI 10.1136/gut.40.5.671; Masyuk AI, 2010, AM J PHYSIOL-GASTR L, V299, pG990, DOI 10.1152/ajpgi.00093.2010; Melkonyan HS, 2008, ANN NY ACAD SCI, V1137, P73, DOI 10.1196/annals.1448.015; Menzel J, 2000, AM J GASTROENTEROL, V95, P605; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Okaro AC, 2001, J CLIN PATHOL, V54, P927, DOI 10.1136/jcp.54.12.927; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; PONCHON T, 1995, GASTROINTEST ENDOSC, V42, P565, DOI 10.1016/S0016-5107(95)70012-9; PUGLIESE V, 1995, GASTROINTEST ENDOSC, V42, P520, DOI 10.1016/S0016-5107(95)70004-8; RAJ V, 2000, AM J SURG PATHOL, V24, P870; Rosch T, 2004, GASTROINTEST ENDOSC, V60, P390, DOI 10.1016/S0016-5107(04)01732-8; Rosch T, 2002, GASTROINTEST ENDOSC, V55, P870, DOI 10.1067/mge.2002.124206; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Stewart CJR, 2001, J CLIN PATHOL, V54, P449, DOI 10.1136/jcp.54.6.449; Tajiri T, 2008, WORLD J GASTROENTERO, V14, P3000, DOI 10.3748/wjg.14.3000; Tamada K, 1998, GASTROINTEST ENDOSC, V47, P341, DOI 10.1016/S0016-5107(98)70216-0; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VANEYKEN P, 1988, HEPATOLOGY, V8, P1586, DOI 10.1002/hep.1840080619; Varghese JC, 1999, CLIN RADIOL, V54, P513, DOI 10.1016/S0009-9260(99)90848-6; Vazquez-Sequeiros E, 2002, GASTROINTEST ENDOSC, V56, P372, DOI 10.1067/mge.2002.126907; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	61	109	117	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23584	10.1371/journal.pone.0023584	http://dx.doi.org/10.1371/journal.pone.0023584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858175	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300064
J	Diring, J; Camuzeaux, B; Donzeau, M; Vigneron, M; Rosa-Calatrava, M; Kedinger, C; Chatton, B				Diring, Jessica; Camuzeaux, Barbara; Donzeau, Mariel; Vigneron, Marc; Rosa-Calatrava, Manuel; Kedinger, Claude; Chatton, Bruno			A Cytoplasmic Negative Regulator Isoform of ATF7 Impairs ATF7 and ATF2 Phosphorylation and Transcriptional Activity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ELEMENT-BINDING PROTEIN; AMP RESPONSE ELEMENT; C-JUN; MELANOMA-CELLS; IN-VIVO; FUNCTIONAL-ANALYSIS; FIREFLY LUCIFERASE; FACTOR-2 ATF2; DNA-BINDING	Alternative splicing and post-translational modifications are processes that give rise to the complexity of the proteome. The nuclear ATF7 and ATF2 (activating transcription factor) are structurally homologous leucine zipper transcription factors encoded by distinct genes. Stress and growth factors activate ATF2 and ATF7 mainly via sequential phosphorylation of two conserved threonine residues in their activation domain. Distinct protein kinases, among which mitogen-activated protein kinases (MAPK), phosphorylate ATF2 and ATF7 first on Thr71/Thr53 and next on Thr69/Thr51 residues respectively, resulting in transcriptional activation. Here, we identify and characterize a cytoplasmic alternatively spliced isoform of ATF7. This variant, named ATF7-4, inhibits both ATF2 and ATF7 transcriptional activities by impairing the first phosphorylation event on Thr71/Thr53 residues. ATF7-4 indeed sequesters the Thr53-phosphorylating kinase in the cytoplasm. Upon stimulus-induced phosphorylation, ATF7-4 is poly-ubiquitinated and degraded, enabling the release of the kinase and ATF7/ATF2 activation. Our data therefore conclusively establish that ATF7-4 is an important cytoplasmic negative regulator of ATF7 and ATF2 transcription factors.	[Diring, Jessica; Camuzeaux, Barbara; Donzeau, Mariel; Vigneron, Marc; Kedinger, Claude; Chatton, Bruno] Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Illkirch Graffenstaden, France; [Rosa-Calatrava, Manuel] Univ Lyon 1, Lab Virol & Pathol Humaine VirPath, Hosp Civils Lyon, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Diring, J (corresponding author), Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, BP10413, Illkirch Graffenstaden, France.	bchatton@unistra.fr	Rosa-calatrava, Manuel/M-7263-2014; CHATTON, Bruno/R-3813-2019	CHATTON, Bruno/0000-0003-4515-7119; Diring, Jessica/0000-0003-2348-3941; Rosa-calatrava, Manuel/0000-0002-7559-9527; Donzeau, Mariel/0000-0002-1145-9218	Universite de Strasbourg; Centre National de la Recherche Scientifique; Ministere de l'Enseignement Superieur et de la Recherche; Ligue contre le Cancer - Comites Haut-Rhin et Bas-Rhin; Fondation pour la Recherche Medicale, Alsace contre le Cancer; Ecos-Sud [A06B02]; Institut National du Cancer [PLBIO-127]	Universite de Strasbourg; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Ligue contre le Cancer - Comites Haut-Rhin et Bas-Rhin; Fondation pour la Recherche Medicale, Alsace contre le Cancer(Fondation pour la Recherche Medicale); Ecos-Sud; Institut National du Cancer(Institut National du Cancer (INCA) France)	This study was supported by Universite de Strasbourg, the Centre National de la Recherche Scientifique, the Ministere de l'Enseignement Superieur et de la Recherche, the Ligue contre le Cancer - Comites Haut-Rhin et Bas-Rhin, the Fondation pour la Recherche Medicale, Alsace contre le Cancer, the Ecos-Sud (action A06B02), and the Institut National du Cancer (PLBIO-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baan B, 2006, MOL ENDOCRINOL, V20, P1786, DOI 10.1210/me.2005-0289; Baan B, 2009, MOL CELL ENDOCRINOL, V311, P94, DOI 10.1016/j.mce.2009.07.023; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Bailey J, 2002, J CLIN ENDOCR METAB, V87, P1717, DOI 10.1210/jcem.87.4.8360; Bhoumik A, 2002, J CLIN INVEST, V110, P643, DOI 10.1172/JCI200216081; Bhoumik A, 2004, CANCER RES, V64, P8222, DOI 10.1158/0008-5472.CAN-04-0714; Bhoumik A, 2004, P NATL ACAD SCI USA, V101, P4222, DOI 10.1073/pnas.0400195101; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bhoumik A, 2007, PIGM CELL RES, V20, P498, DOI 10.1111/j.1600-0749.2007.00414.x; Birzele F, 2008, NUCLEIC ACIDS RES, V36, P550, DOI 10.1093/nar/gkm1054; Bocco JL, 1996, ONCOGENE, V12, P1971; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; Buschmann T, 2000, J BIOL CHEM, V275, P16590, DOI 10.1074/jbc.M910045199; Camuzeaux B, 2008, J MOL BIOL, V384, P980, DOI 10.1016/j.jmb.2008.10.008; Chao LC, 1999, MOL CELL BIOL, V19, P5588; CHATTON B, 1993, MOL CELL BIOL, V13, P561, DOI 10.1128/MCB.13.1.561; CHATTON B, 1994, ONCOGENE, V9, P375; De Graeve F, 1999, ONCOGENE, V18, P3491, DOI 10.1038/sj.onc.1202723; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dutertre S, 2002, J BIOL CHEM, V277, P6280, DOI 10.1074/jbc.M105735200; Duyndam MCA, 1999, ONCOGENE, V18, P2311, DOI 10.1038/sj.onc.1202584; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; Fuchs SY, 1999, MOL CELL BIOL, V19, P3289; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GAIRE M, 1990, NUCLEIC ACIDS RES, V18, P3467, DOI 10.1093/nar/18.12.3467; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; GEORGOPOULOS K, 1992, MOL CELL BIOL, V12, P747, DOI 10.1128/MCB.12.2.747; Goetz J, 1996, J BIOL CHEM, V271, P29589, DOI 10.1074/jbc.271.47.29589; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hai TW, 1989, MOLCELL BIOL, V9, P4390; Hamard PJ, 2007, NUCLEIC ACIDS RES, V35, P1134, DOI 10.1093/nar/gkl1168; Hamard PJ, 2005, ONCOGENE, V24, P3472, DOI 10.1038/sj.onc.1208565; Hirose N, 2009, BIOCHEM BIOPH RES CO, V385, P72, DOI 10.1016/j.bbrc.2009.05.001; Hong SH, 2004, J BIOL CHEM, V279, P16996, DOI 10.1074/jbc.M311752200; Huber AV, 2006, PLACENTA, V27, P127, DOI 10.1016/j.placenta.2005.02.012; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jin S, 2007, CANCER BIOL THER, V6, P261, DOI 10.4161/cbt.6.2.3621; KARA CJ, 1990, MOL CELL BIOL, V10, P1347, DOI 10.1128/MCB.10.4.1347; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Karlsson M, 2006, BIOCHEM SOC T, V34, P842, DOI 10.1042/BST0340842; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavigne AC, 1999, MOL CELL BIOL, V19, P5050; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lutz P, 1997, J VIROL, V71, P5102, DOI 10.1128/JVI.71.7.5102-5109.1997; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mesbah K, 2006, MOL CELL BIOL, V26, P7760, DOI 10.1128/MCB.00913-06; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; NOMURA N, 1993, J BIOL CHEM, V268, P4259; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Peterson ML, 2002, MOL CELL BIOL, V22, P5606, DOI 10.1128/MCB.22.15.5606-5615.2002; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rosa-Calatrava M, 2003, EMBO REP, V4, P969, DOI 10.1038/sj.embor.embor943; Rosa-Calatrava M, 2001, J VIROL, V75, P7131, DOI 10.1128/JVI.75.15.7131-7141.2001; Smerc A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019645; Steghens JP, 1998, BIOCHEM J, V336, P109, DOI 10.1042/bj3360109; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Winter N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018837; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426; Zimmerman T, 2006, J IMMUNOL METHODS, V314, P67, DOI 10.1016/j.jim.2006.05.012	80	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23351	10.1371/journal.pone.0023351	http://dx.doi.org/10.1371/journal.pone.0023351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858082	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500029
J	Lundberg, J; Jonsson, S; Holmin, S				Lundberg, Johan; Jonsson, Stefan; Holmin, Staffan			Long Term Follow-Up of the Endovascular Trans-Vessel Wall Technique for Parenchymal Access in Rabbit with Full Clinical Integration	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; IMPLANTATION; STROKE; TYPE-1	Objective: Endovascular techniques are providing options to surgical/percutaneous cell transplantation methods. Some cells, e. g. insulin producing cells, are not suitable for intra-luminal transplantation and for such cells, other options must be found. We have constructed a "nanocatheter'' with a penetrating tip for vessel perforation, thereby creating a working channel for parenchymal access by endovascular technique. To finish the procedure safely, the distal tip is detached to provide a securing plug in the vessel wall defect. Materials and Methods: We have performed interventions with full clinical integration in the superior mesenteric artery (SMA), the subclavian artery and the external carotid artery in rabbits. No hemorrhagic-or thromboembolic events occurred during the procedure. Stenosis formation and distal embolisation were analyzed by angiography and macroscopic inspection during autopsy at five, 30 and 80 days. All animals and implanted devices were also evaluated by micro-dissections and histochemical analysis. Results: In this study we show safety data on the trans-vessel wall technique by behavioral, angiographical and histological analysis. No stenosis formation was observed at any of the follow-up time points. No animals or organs have shown any signs of distress due to the intervention. Histological examination showed no signs of hemorrhage, excellent biocompatibility with no inflammation and a very limited fibrous capsule formation around the device, comparable to titanium implants. Further, no histological changes were detected in the endothelia of the vessels subject to intervention. Conclusions: The trans-vessel wall technique can be applied for e. g. cell transplantations, local substance administration and tissue sampling with low risk for complications during the procedure and low risk for hemorrhage, stenosis development or adverse tissue reactions with an 80 days follow-up time. The benefit should be greatest in organs that are difficult or risky to reach with surgical techniques, such as the pancreas, the CNS and the heart.	[Lundberg, Johan; Holmin, Staffan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Jonsson, Stefan] Royal Inst Technol, Dept Mat Sci & Engn, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Lundberg, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	staffan.holmin@karolinska.se		Holmin, Staffan/0000-0002-1628-1615	Swedish Research Council [K2006-73X-20139-01-3]; Karolinska Institutet; Karolinska Institutet Innovations; Swedish Society of Medicine and Strokefonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska Institutet Innovations; Swedish Society of Medicine and Strokefonden	This study was supported by grants from the Swedish Research Council (K2006-73X-20139-01-3), Karolinska Institutet funds, Karolinska Institutet Innovations, the Swedish Society of Medicine and Strokefonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER PH, 1990, SCRIPTA METALL MATER, V24, P943, DOI 10.1016/0956-716X(90)90142-4; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gordon PH, 2004, ARCH NEUROL-CHICAGO, V61, P858, DOI 10.1001/archneur.61.6.858; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Hirshberg B, 2002, DIABETES, V51, P2135, DOI 10.2337/diabetes.51.7.2135; Humar A, 2000, ANN SURG, V231, P269, DOI 10.1097/00000658-200002000-00017; Kandaswamy R, 1999, TRANSPL P, V31, P602, DOI 10.1016/S0041-1345(98)01574-7; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; LUNDBERG J, 2011, CELL TRANSP IN PRESS; Lundberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010449; Lundberg J, 2009, NEURORADIOLOGY, V51, P661, DOI 10.1007/s00234-009-0551-6; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; SCHARP DW, 1991, TRANSPLANTATION, V51, P76, DOI 10.1097/00007890-199101000-00012; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23328	10.1371/journal.pone.0023328	http://dx.doi.org/10.1371/journal.pone.0023328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858072	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500027
J	Hampton, DD; Hale, LP				Hampton, Daniel D.; Hale, Laura P.			Mast Cells Are Critical for Protection against Peptic Ulcers Induced by the NSAID Piroxicam	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INDUCED GASTRIC-ULCERATION; FIBROBLAST-GROWTH-FACTOR; HISTAMINE-RELEASE; SKIN WOUNDS; BILE-DUCT; MUCOSAL; ROFECOXIB; ASPIRIN; STOMACH	Many commonly used non-steroidal anti-inflammatory drugs (NSAIDs) also cause gastrointestinal toxicity, including the development of life-threatening peptic ulcers. We report that mast cell-deficient mice have an extremely high incidence of severe peptic ulceration when exposed to the NSAID piroxicam. This enhanced ulcer susceptibility can be reversed by reconstitution with mast cells. Furthermore, wild type mice treated with diphenhydramine hydrochloride, a commonly used antihistamine that blocks histamine H1 receptors, develop a similarly high incidence of peptic ulcers following piroxicam exposure. The protective effect of mast cells is independent of TNF, blockade of H2 receptors, or acid secretion. These data indicate a critical role for mast cells and the histamine that they produce in prevention and/or repair of piroxicam-induced gastric mucosal injury. Additional studies will be required to determine whether this represents a NSAID class effect that can be exploited to develop novel therapeutic strategies to limit the incidence of NSAID-induced side effects in humans.	[Hampton, Daniel D.] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Hampton, DD (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.	laura.hale@duke.edu			National Institutes of Health [R21DK75522, CA115480]; NATIONAL CANCER INSTITUTE [R01CA115480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the National Institutes of Health (R21DK75522 and CA115480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABTAHI FS, 1975, BRIT J SURG, V62, P113, DOI 10.1002/bjs.1800620208; Azuma T, 1999, DIGEST DIS SCI, V44, P1177, DOI 10.1023/A:1026684425642; Barkun A, 2010, AM J MED, V358, P366; Barozzi N, 2007, PHARMACOEPIDEM DR S, V16, P1184, DOI 10.1002/pds.1451; Basso D, 1999, J CLIN PATHOL, V52, P210, DOI 10.1136/jcp.52.3.210; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cairns JA, 1996, J IMMUNOL, V156, P275; Chichlowski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012220; Darling RL, 2004, GASTROENTEROLOGY, V127, P94, DOI 10.1053/j.gastro.2004.04.003; dePaulis A, 1997, ARTHRITIS RHEUM-US, V40, P469, DOI 10.1002/art.1780400313; DJAHANGUIRI B, 1973, GASTROENTEROLOGY, V65, P630; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Egozi EI, 2003, WOUND REPAIR REGEN, V11, P46, DOI 10.1046/j.1524-475X.2003.11108.x; EHSANULLAH RSB, 1988, BRIT MED J, V297, P1017, DOI 10.1136/bmj.297.6655.1017; GOMES JC, 1988, AGENTS ACTIONS, V24, P266, DOI 10.1007/BF02028282; GOMPERTZ RHK, 1991, AGENTS ACTIONS, V33, P161, DOI 10.1007/BF01993155; Grosman N, 2007, INT IMMUNOPHARMACOL, V7, P532, DOI 10.1016/j.intimp.2006.12.010; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Hsiao FY, 2009, CLIN THER, V31, P2618, DOI 10.1016/j.clinthera.2009.11.022; Hull MA, 1997, GUT, V40, P204, DOI 10.1136/gut.40.2.204; HULL MA, 1995, GUT, V37, P610, DOI 10.1136/gut.37.5.610; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Kumar V, 2012, ROBBINS COTRAN PATHO; LACY ER, 1984, LAB INVEST, V51, P573; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malhotra Samir, 2004, MedGenMed, V6, P6; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Nakajima S, 1996, APMIS, V104, P19, DOI 10.1111/j.1699-0463.1996.tb00681.x; Ng FH, 2008, DIGESTION, V77, P173, DOI 10.1159/000141264; Oehmichen M, 2009, FORENSIC SCI INT, V191, P1, DOI 10.1016/j.forsciint.2009.05.020; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; Rudzki Zbigniew, 1995, Polish Journal of Pathology, V46, P225; Scheiman JM, 2010, CLIN THER, V32, P667, DOI 10.1016/j.clinthera.2010.04.009; SHIMADA M, 1980, NATURE, V283, P662, DOI 10.1038/283662a0; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Singh G, 1999, J RHEUMATOL, V26, P18; SOMASUNDARAM S, 1995, SCAND J GASTROENTERO, V30, P289, DOI 10.3109/00365529509093280; Sung JJY, 2009, ALIMENT PHARM THER, V29, P938, DOI 10.1111/j.1365-2036.2009.03960.x; Taha AS, 2009, LANCET, V374, P119, DOI 10.1016/S0140-6736(09)61246-0; TALLEY NJ, 1995, DIGEST DIS SCI, V40, P1345, DOI 10.1007/BF02065549; Tamblyn R, 1997, ANN INTERN MED, V127, P429, DOI 10.7326/0003-4819-127-6-199709150-00003; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; USPENSKY VM, 1980, ARK PATOL, V42, P14; Wallace JL, 1996, FASEB J, V10, P731, DOI 10.1096/fasebj.10.7.8635690; WALLACE JL, 1990, GASTROENTEROLOGY, V99, P295, DOI 10.1016/0016-5085(90)91009-U; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Yuan YH, 2006, NAT CLIN PRACT GASTR, V3, P80, DOI 10.1038/ncpgasthep0393; Zhu Amy, 2008, Curr Gastroenterol Rep, V10, P548, DOI 10.1007/s11894-008-0101-0	57	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23669	10.1371/journal.pone.0023669	http://dx.doi.org/10.1371/journal.pone.0023669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858200	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500061
J	Hu, G; He, B				Hu, Gang; He, Bin			Magnetoacoustic Imaging of Electrical Conductivity of Biological Tissues at a Spatial Resolution Better than 2 mm	PLOS ONE			English	Article							FINITE-ELEMENT-METHOD; INDUCTION MAT-MI; MAGNETIC INDUCTION; IMPEDANCE TOMOGRAPHY; BIOELECTRIC CURRENTS; RESISTIVITY; ALGORITHM; MHZ	Magnetoacoustic tomography with magnetic induction (MAT-MI) is an emerging approach for noninvasively imaging electrical impedance properties of biological tissues. The MAT-MI imaging system measures ultrasound waves generated by the Lorentz force, having been induced by magnetic stimulation, which is related to the electrical conductivity distribution in tissue samples. MAT-MI promises to provide fine spatial resolution for biological tissue imaging as compared to ultrasound resolution. In the present study, we first estimated the imaging spatial resolution by calculating the full width at half maximum (FWHM) of the system point spread function (PSF). The actual spatial resolution of our MAT-MI system was experimentally determined to be 1.51 mm by a parallel-line-source phantom with Rayleigh criterion. Reconstructed images made from tissue-mimicking gel phantoms, as well as animal tissue samples, were consistent with the morphological structures of the samples. The electrical conductivity value of the samples was determined directly by a calibrated four-electrode system. It has been demonstrated that MAT-MI is able to image the electrical impedance properties of biological tissues with better than 2 mm spatial resolution. These results suggest the potential of MAT-MI for application to early detection of small-size diseased tissues (e. g. small breast cancer).	[Hu, Gang; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hu, G (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	binhe@umn.edu			National Institutes of Health [R21EB006070]; National Science Foundation [BES-0602957]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health R21EB006070 and National Science Foundation BES-0602957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; FALLERT MA, 1993, CIRCULATION, V87, P199, DOI 10.1161/01.CIR.87.1.199; FRICKE HUGO, 1926, JOUR CANCER RES, V10, P340; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Gao N, 2005, PHYS MED BIOL, V50, P2675, DOI 10.1088/0031-9155/50/11/016; Hu G, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3543630; Hu G, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3486685; Jossinet J, 1998, PHYSIOL MEAS, V19, P61, DOI 10.1088/0967-3334/19/1/006; JOY M, 1989, MAGN RESON IMAGING, V7, P89, DOI 10.1016/0730-725X(89)90328-7; Kruger RA, 2000, PROC SPIE, V3916, P150, DOI 10.1117/12.386316; Kwon O, 2002, IEEE T BIO-MED ENG, V49, P160, DOI 10.1109/10.979355; Li X, 2006, J APPL PHYS, V99, DOI 10.1063/1.2186371; Li X, 2007, IEEE T BIO-MED ENG, V54, P323, DOI 10.1109/TBME.2006.883827; Li X, 2009, PHYS MED BIOL, V54, P2667, DOI 10.1088/0031-9155/54/9/005; Ma QY, 2008, IEEE T BIO-MED ENG, V55, P813, DOI 10.1109/TBME.2007.912674; Metherall P, 1996, NATURE, V380, P509, DOI 10.1038/380509a0; Morse P.M., 1953, METHODS THEORETICAL; Mueller JL, 1999, IEEE T BIO-MED ENG, V46, P1379, DOI 10.1109/10.797998; PAULSON K, 1993, IEEE T MED IMAGING, V12, P681, DOI 10.1109/42.251118; Peyton AJ, 1996, MEAS SCI TECHNOL, V7, P261, DOI 10.1088/0957-0233/7/3/006; ROTH BJ, 1994, IEEE T BIO-MED ENG, V41, P723, DOI 10.1109/10.310087; Scharfetter H, 2005, PHYSIOL MEAS, V26, pS307, DOI 10.1088/0967-3334/26/2/028; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; TOWE BC, 1988, IEEE T BIO-MED ENG, V35, P892, DOI 10.1109/10.7300; Tsai JZ, 2002, IEEE T BIO-MED ENG, V49, P472, DOI 10.1109/10.995686; WANG WP, 1994, IEEE T MAGN, V30, P5015; Wen H, 1998, IEEE T BIO-MED ENG, V45, P119, DOI 10.1109/10.650364; Xia R, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772763; Xu Y, 2005, PHYS MED BIOL, V50, P5175, DOI 10.1088/0031-9155/50/21/015; Xu Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033902; Yang S, 2007, MED PHYS, V34, P3294, DOI 10.1118/1.2757088	32	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23421	10.1371/journal.pone.0023421	http://dx.doi.org/10.1371/journal.pone.0023421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858111	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500039
J	McIntosh, KB; Bhattacharya, A; Willis, IM; Warner, JR				McIntosh, Kerri B.; Bhattacharya, Arpita; Willis, Ian M.; Warner, Jonathan R.			Eukaryotic Cells Producing Ribosomes Deficient in Rpl1 Are Hypersensitive to Defects in the Ubiquitin-Proteasome System	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; L1 STALK; YEAST; GENE; RNA; BIOSYNTHESIS; DEGRADATION; SUBUNIT	It has recently become clear that the misassembly of ribosomes in eukaryotic cells can have deleterious effects that go far beyond a simple shortage of ribosomes. In this work we find that cells deficient in ribosomal protein L1 (Rpl1; Rpl10a in mammals) produce ribosomes lacking Rpl1 that are exported to the cytoplasm and that can be incorporated into polyribosomes. The presence of such defective ribosomes leads to slow growth and appears to render the cells hypersensitive to lesions in the ubiquitin-proteasome system. Several genes that were reasonable candidates for degradation of 60S subunits lacking Rpl1 fail to do so, suggesting that key players in the surveillance of ribosomal subunits remain to be found. Interestingly, in spite of rendering the cells hypersensitive to the proteasome inhibitor MG132, shortage of Rpl1 partially suppresses the stress-invoked temporary repression of ribosome synthesis caused by MG132.	[McIntosh, Kerri B.; Bhattacharya, Arpita; Warner, Jonathan R.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McIntosh, KB (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.	jon.warner@einstein.yu.edu		Bhattacharya, Arpita/0000-0002-0252-1550; Willis, Ian/0000-0001-6599-2395	National Institutes of Health [GM25532, ARRAGM25532-S1, GM085177, CAI-3330]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085177, R01GM025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grants from the National Institutes of Health: GM25532 and ARRAGM25532-S1 to JRW, GM085177 to IMW, and CAI-3330 to the Albert Einstein Cancer Center. KBM was the recipient of a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bhattacharya A, 2010, MOL CELL BIOL, V30, P5562, DOI 10.1128/MCB.00618-10; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ellis SR, 2011, SEMIN HEMATOL, V48, P89, DOI 10.1053/j.seminhematol.2011.02.005; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Fewell SW, 1999, MOL CELL BIOL, V19, P826; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FIROOZAN M, 1991, YEAST, V7, P173, DOI 10.1002/yea.320070211; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; KRUSE C, 1985, P NATL ACAD SCI USA, V82, P7515, DOI 10.1073/pnas.82.22.7515; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493, DOI 10.1128/MCB.14.4.2493; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Park KC, 1997, ARCH BIOCHEM BIOPHYS, V347, P78, DOI 10.1006/abbi.1997.0311; PEARSON NJ, 1982, CELL, V29, P347, DOI 10.1016/0092-8674(82)90151-9; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; UDEM SA, 1973, J BIOL CHEM, V248, P1412; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao Y, 2003, MOL CELL BIOL, V23, P699, DOI 10.1128/MCB.23.2.699-707.2003	48	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23579	10.1371/journal.pone.0023579	http://dx.doi.org/10.1371/journal.pone.0023579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858174	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953500057
J	Vojnov, L; Martins, MA; Almeida, JR; Ende, Z; Rakasz, EG; Reynolds, MR; Leon, EJ; Weisgrau, KL; Burwitz, BJ; Folkvord, JM; de Santana, MGV; Neves, PCC; Connick, E; Skinner, PJ; Gostick, E; O'Connor, DH; Wilson, NA; Bonaldo, MC; Galler, R; Price, DA; Douek, DC; Watkins, DI				Vojnov, Lara; Martins, Mauricio A.; Almeida, Jorge R.; Ende, Zachary; Rakasz, Eva G.; Reynolds, Matthew R.; Leon, Enrique J.; Weisgrau, Kim L.; Burwitz, Benjamin J.; Folkvord, Joy M.; Veloso de Santana, Marlon G.; Costa Neves, Patricia C.; Connick, Elizabeth; Skinner, Pamela J.; Gostick, Emma; O'Connor, David H.; Wilson, Nancy A.; Bonaldo, Myrna C.; Galler, Ricardo; Price, David A.; Douek, Danny C.; Watkins, David I.			GagCM9-Specific CD8(+) T Cells Expressing Limited Public TCR Clonotypes Do Not Suppress SIV Replication In Vivo	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES; RHESUS-MONKEYS; LYMPHOCYTE RESPONSE; HIV-1 INFECTION; MAMU-B-ASTERISK-08-POSITIVE MACAQUES; GASTROINTESTINAL-TRACT; SIVMAC239 REPLICATION; VIRAL REPLICATION; ESCAPE MUTATIONS	Several lines of evidence suggest that HIV/SIV-specific CD8(+) T cells play a critical role in the control of viral replication. Recently we observed high levels of viremia in Indian rhesus macaques vaccinated with a segment of SIVmac239 Gag (Gag(45-269)) that were subsequently infected with SIVsmE660. These seven Mamu-A*01(+) animals developed CD8(+) T cell responses against an immunodominant epitope in Gag, GagCM9, yet failed to control virus replication. We carried out a series of immunological and virological assays to understand why these Gag-specific CD8(+) T cells could not control virus replication in vivo. GagCM9-specific CD8(+) T cells from all of the animals were multifunctional and were found in the colonic mucosa. Additionally, GagCM9-specific CD8(+) T cells accessed B cell follicles, the primary residence of SIV-infected cells in lymph nodes, with effector to target ratios between 20-250 GagCM9-specific CD8(+) T cells per SIV-producing cell. Interestingly, vaccinated animals had few public TCR clonotypes within the GagCM9-specific CD8(+) T cell population pre- and post-infection. The number of public TCR clonotypes expressed by GagCM9-specific CD8(+) T cells post-infection significantly inversely correlated with chronic phase viral load. It is possible that these seven animals failed to control viral replication because of the narrow TCR repertoire expressed by the GagCM9-specific CD8(+) T cell population elicited by vaccination and infection.	[Vojnov, Lara; Martins, Mauricio A.; Rakasz, Eva G.; Reynolds, Matthew R.; Burwitz, Benjamin J.; O'Connor, David H.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Almeida, Jorge R.; Ende, Zachary; Douek, Danny C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Rakasz, Eva G.; Leon, Enrique J.; Weisgrau, Kim L.; Watkins, David I.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Folkvord, Joy M.; Connick, Elizabeth] Univ Colorado, Sch Med, Denver, CO USA; [Veloso de Santana, Marlon G.; Costa Neves, Patricia C.; Bonaldo, Myrna C.] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil; [Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Gostick, Emma; Price, David A.] Cardiff Univ, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales	University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Fundacao Oswaldo Cruz; University of Minnesota System; University of Minnesota Twin Cities; Fundacao Oswaldo Cruz; Cardiff University	Vojnov, L (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	Watkins@primate.wisc.edu	Bonaldo, Myrna C/D-9494-2013; Bonaldo, Myrna/AAE-2799-2021; Martins, Mauricio/AAU-9226-2020; Price, David A/C-7876-2013; Ende, Zachary/AAD-3800-2019; Galler, Ricardo/B-3280-2014; Rakasz, Eva G/H-9197-2019; Veloso de Santana, Marlon Gilsepp/H-8146-2017	Martins, Mauricio/0000-0001-8336-216X; Price, David A/0000-0001-9416-2737; Ramos de Almeida, Jorge/0000-0002-5009-8478; Wilson, Nancy/0000-0002-9472-6026; Veloso de Santana, Marlon Gilsepp/0000-0002-3427-841X; Vojnov, Lara/0000-0003-0488-1012; Skinner, Pamela/0000-0003-3388-1687; o'connor, david/0000-0003-2139-470X	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease [R01 AI076114, R01 AI049120, R24 RR015371, R24 RR016038]; National Center for Research Resources (NCRR) [R51 RR000167]; Medical Research Council [G0501963] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016038, P51RR000167, R24RR015371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049120, R01AI076114] Funding Source: NIH RePORTER; MRC [G0501963] Funding Source: UKRI	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease grants R01 AI076114, R01 AI049120, R24 RR015371, and R24 RR016038 and in part by grant R51 RR000167 from the National Center for Research Resources (NCRR) awarded to the WNPRC, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2002, J VIROL, V76, P10507, DOI 10.1128/JVI.76.20.10507-10511.2002; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Cline AN, 2005, J MED PRIMATOL, V34, P303; Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363; Folkvord JM, 2003, JAIDS-J ACQ IMM DEF, V32, P469, DOI 10.1097/00126334-200304150-00001; Friedrich TC, 2004, J VIROL, V78, P10064, DOI 10.1128/JVI.78.18.10064-10073.2004; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Liang XP, 2005, J VIROL, V79, P12321, DOI 10.1128/JVI.79.19.12321-12331.2005; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Venturi V, 2008, J IMMUNOL, V181, P2597, DOI 10.4049/jimmunol.181.4.2597; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23515	10.1371/journal.pone.0023515	http://dx.doi.org/10.1371/journal.pone.0023515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887264	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000294298800011
J	Kaplan, GB; Leite-Morris, KA; Fan, WY; Young, AJ; Guy, MD				Kaplan, Gary B.; Leite-Morris, Kimberly A.; Fan, WenYing; Young, Angela J.; Guy, Marsha D.			Opiate Sensitization Induces FosB/Delta FosB Expression in Prefrontal Cortical, Striatal and Amygdala Brain Regions	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE RELEASE; VENTRAL TEGMENTAL AREA; DELTA-FOSB; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; LOCOMOTOR-ACTIVITY; DISTINCT PATTERNS; CHRONIC COCAINE; C-FOS; MORPHINE	Sensitization to the effects of drugs of abuse and associated stimuli contributes to drug craving, compulsive drug use, and relapse in addiction. Repeated opiate exposure produces behavioral sensitization that is hypothesized to result from neural plasticity in specific limbic, striatal and cortical systems. Delta FosB and FosB are members of the Fos family of transcription factors that are implicated in neural plasticity in addiction. This study examined the effects of intermittent morphine treatment, associated with motor sensitization, on FosB/Delta FosB levels using quantitative immunohistochemistry. Motor sensitization was tested in C57BL/6 mice that received six intermittent pre-treatments (on days 1, 3, 5, 8, 10, 12) with either subcutaneous morphine (10 mg/kg) or saline followed by a challenge injection of morphine or saline on day 16. Mice receiving repeated morphine injections demonstrated significant increases in locomotor activity on days 8, 10, and 12 of treatment (vs. day 1), consistent with development of locomotor sensitization. A morphine challenge on day 16 significantly increased locomotor activity of saline pre-treated mice and produced even larger increases in motor activity in the morphine pre-treated mice, consistent with the expression of opiate sensitization. Intermittent morphine pre-treatment on these six pre-treatment days produced a significant induction of FosB/Delta FosB, measured on day 16, in multiple brain regions including prelimbic (PL) and infralimbic (IL) cortex, nucleus accumbens (NAc) core, dorsomedial caudate-putamen (CPU), basolateral amygdala (BLA) and central nucleus of the amygdala (CNA) but not in a motor cortex control region. Opiate induced sensitization may develop via Fos/Delta FosB plasticity in motivational pathways (NAc), motor outputs (CPU), and associative learning (PL, IL, BLA) and stress pathways (CNA).	[Kaplan, Gary B.] VA Boston Healthcare Syst, Mental Hlth Serv, Boston, MA USA; [Kaplan, Gary B.; Leite-Morris, Kimberly A.; Fan, WenYing; Young, Angela J.; Guy, Marsha D.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Leite-Morris, Kimberly A.; Fan, WenYing] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Leite-Morris, Kimberly A.; Fan, WenYing] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Boston University	Kaplan, GB (corresponding author), VA Boston Healthcare Syst, Mental Hlth Serv, Boston, MA USA.	Gary.Kaplan@va.gov; kleitemo@bu.edu	Kaplan, Gary B./AAJ-5099-2020	Leite-Morris, Kimberly/0000-0003-3407-7375; Kaplan, M.D., Gary B./0000-0003-1316-2749	Department of Veterans Affairs; Department of Defense	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense(United States Department of Defense)	This work was supported by a Merit Review Grant from the Department of Veterans Affairs and from the Department of Defense to G.B.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABBINI M, 1972, BRIT J PHARMACOL, V46, P213, DOI 10.1111/j.1476-5381.1972.tb06866.x; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bjijou Y, 2002, NEUROSCIENCE, V109, P499, DOI 10.1016/S0306-4522(01)00508-5; Brenhouse HC, 2006, NEUROSCIENCE, V137, P773, DOI 10.1016/j.neuroscience.2005.09.039; Carle TL, 2007, EUR J NEUROSCI, V25, P3009, DOI 10.1111/j.1460-9568.2007.05575.x; Chen JS, 1997, J NEUROSCI, V17, P4933; Colby CR, 2003, J NEUROSCI, V23, P2488; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Eitan S, 2003, J NEUROSCI, V23, P8360; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Ghasemzadeh MB, 1999, J NEUROCHEM, V72, P157, DOI 10.1046/j.1471-4159.1999.0720157.x; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; KALIVAS PW, 1987, J PHARMACOL EXP THER, V241, P204; Kaste K, 2009, PHARMACOL BIOCHEM BE, V92, P655, DOI 10.1016/j.pbb.2009.03.004; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Leite-Morris KA, 2004, J PHARMACOL EXP THER, V308, P667, DOI 10.1124/jpet.103.058412; LETT BT, 1989, PSYCHOPHARMACOLOGY, V98, P357, DOI 10.1007/BF00451687; Martiila K, 2006, NEUROPHARMACOLOGY, V51, P44, DOI 10.1016/j.neuropharm.2006.02.014; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McDaid J, 2006, NEUROPSYCHOPHARMACOL, V31, P1212, DOI 10.1038/sj.npp.1300854; Mickiewicz AL, 2009, NEUROPSYCHOPHARMACOL, V34, P874, DOI 10.1038/npp.2008.111; Muller DL, 2005, J PHARMACOL EXP THER, V314, P148, DOI 10.1124/jpet.105.083410; Murphy NP, 2001, J NEUROCHEM, V79, P626, DOI 10.1046/j.1471-4159.2001.00599.x; Narita M, 2005, J NEUROCHEM, V93, P1463, DOI 10.1111/j.1471-4159.2005.03136.x; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Nye HE, 1996, MOL PHARMACOL, V49, P636; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Powell KR, 2001, DRUG ALCOHOL DEPEN, V62, P83, DOI 10.1016/S0376-8716(00)00167-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Shippenberg TS, 1996, EUR J PHARMACOL, V299, P33, DOI 10.1016/0014-2999(95)00852-7; SPANAGEL R, 1993, SYNAPSE, V14, P243, DOI 10.1002/syn.890140307; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 1997, PSYCHOPHARMACOLOGY, V131, P115, DOI 10.1007/s002130050273; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zar JH, 1984, BIOSTAT ANAL, P83	48	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23574	10.1371/journal.pone.0023574	http://dx.doi.org/10.1371/journal.pone.0023574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886798	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500016
J	Huang, CW; Jha, A; Sweany, R; DeRobertis, C; Damann, KE				Huang, Changwei; Jha, Archana; Sweany, Rebecca; DeRobertis, Catherine; Damann, Kenneth E., Jr.			Intraspecific Aflatoxin Inhibition in Aspergillus flavus Is Thigmoregulated, Independent of Vegetative Compatibility Group and Is Strain Dependent	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; ATOXIGENIC STRAINS; ASSOCIATION; COMPETITION; RESISTANCE; MYCOTOXIN	Biological control of preharvest aflatoxin contamination by atoxigenic stains of Aspergillus flavus has been demonstrated in several crops. The assumption is that some form of competition suppresses the fungus's ability to infect or produce aflatoxin when challenged. Intraspecific aflatoxin inhibition was demonstrated by others. This work investigates the mechanistic basis of that phenomenon. A toxigenic and atoxigenic isolate of A. flavus which exhibited intraspecific aflatoxin inhibition when grown together in suspended disc culture were not inhibited when grown in a filter insert-plate well system separated by a .4 or 3 mu m membrane. Toxigenic and atoxigenic conidial mixtures (50: 50) placed on both sides of these filters restored inhibition. There was similar to 50% inhibition when a 12 mu m pore size filter was used. Conidial and mycelial diameters were in the 3.5-7.0 mu m range and could pass through the 12 mu m filter. Larger pore sizes in the initially separated system restored aflatoxin inhibition. This suggests isolates must come into physical contact with one another. This negates a role for nutrient competition or for soluble diffusible signals or antibiotics in aflatoxin inhibition. The toxigenic isolate was maximally sensitive to inhibition during the first 24 hrs of growth while the atoxigenic isolate was always inhibition competent. The atoxigenic isolate when grown with a green fluorescent protein (GFP) toxigenic isolate failed to inhibit aflatoxin indicating that there is specificity in the touch inhibiton. Several atoxigenic isolates were found which inhibited the GFP isolate. These results suggest that an unknown signaling pathway is initiated in the toxigenic isolate by physical interaction with an appropriate atoxigenic isolate in the first 24 hrs which prevents or down-regulates normal expression of aflatoxin after 3-5 days growth. We suspect thigmo-downregulation of aflatoxin synthesis is the mechanistic basis of intraspecific aflatoxin inhibition and the major contributor to biological control of aflatoxin contamination.	[Huang, Changwei; Jha, Archana; Sweany, Rebecca; DeRobertis, Catherine; Damann, Kenneth E., Jr.] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Huang, CW (corresponding author), Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA.	kdamann@agcenter.lsu.edu		Sweany, Rebecca/0000-0002-5275-8943	Louisiana Soybean and Grain Research and Promotion Board	Louisiana Soybean and Grain Research and Promotion Board	The Louisiana Soybean and Grain Research and Promotion Board provided the funding in support of this research under the grant entitled "Managing Mycotoxin Contamination of Louisiana Corn: Biological Control''. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjaiah V, 1998, MOL PLANT MICROBE IN, V11, P847, DOI 10.1094/MPMI.1998.11.9.847; BANDYOPADHYAY R, 2004, BIOL CONTROL INTEGRA, P193; BOTHAST RJ, 1974, MYCOLOGIA, V66, P365, DOI 10.2307/3758375; BROWN RL, 1991, J FOOD PROTECT, V54, P623, DOI 10.4315/0362-028X-54.8.623; *CAST, 1989, MYCOTOXINS EC HLTH R; Chang PK, 2007, INT J FOOD MICROBIOL, V114, P275, DOI 10.1016/j.ijfoodmicro.2006.09.017; COTTY PJ, 1994, PHYTOPATHOLOGY, V84, P1270, DOI 10.1094/Phyto-84-1270; COTTY PJ, 1993, PHYTOPATHOLOGY, V83, P1283, DOI 10.1094/Phyto-83-1283; COTTY PJ, 1990, PLANT DIS, V74, P233, DOI 10.1094/PD-74-0233; COVE DJ, 1976, HEREDITY, V36, P191, DOI 10.1038/hdy.1976.24; ELLIS JG, 1979, PHYSIOL PLANT PATHOL, V15, P311, DOI 10.1016/0048-4059(79)90082-1; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Geiser DM, 2000, FUNGAL GENET BIOL, V31, P169, DOI 10.1006/fgbi.2000.1215; Horn BW, 1996, MYCOLOGIA, V88, P574, DOI 10.2307/3761151; Horn BW, 2002, MYCOLOGIA, V94, P741, DOI 10.2307/3761688; Jaime-Garcia R, 2003, PHYTOPATHOLOGY, V93, P1190, DOI 10.1094/PHYTO.2003.93.9.1190; Janisiewicz WJ, 2000, PHYTOPATHOLOGY, V90, P1196, DOI 10.1094/PHYTO.2000.90.11.1196; JOSHUA H, 1993, J CHROMATOGR A, V654, P247, DOI 10.1016/0021-9673(93)83367-2; KERR A, 1980, PLANT DIS, V64, P25; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Pal KK, 2006, PLANT HLTH INSTRUCTO, V2, P1117, DOI [DOI 10.1094/PHI-A-2006-1117-02, 10.1094/PHI-A-2006-1117-02]; PAPA KE, 1986, MYCOLOGIA, V78, P98, DOI 10.2307/3793383; PITT JI, 1983, J APPL BACTERIOL, V54, P109, DOI 10.1111/j.1365-2672.1983.tb01307.x; Rajasekaran K, 2008, MYCOPATHOLOGIA, V165, P89, DOI 10.1007/s11046-007-9085-9; Sobolev VS, 2002, J AOAC INT, V85, P642; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Wicklow Donald T., 2007, Mycoscience, V48, P267, DOI 10.1007/s10267-007-0363-7; Wicklow DT, 2003, MYCOL RES, V107, P617, DOI 10.1017/S0953756203007792; ZUMMO N, 1991, PLANT DIS, V75, P910, DOI 10.1094/PD-75-0910	29	33	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23470	10.1371/journal.pone.0023470	http://dx.doi.org/10.1371/journal.pone.0023470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886793	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100015
J	Brouwer, MSM; Warburton, PJ; Roberts, AP; Mullany, P; Allan, E				Brouwer, Michael S. M.; Warburton, Philip J.; Roberts, Adam P.; Mullany, Peter; Allan, Elaine			Genetic Organisation, Mobility and Predicted Functions of Genes on Integrated, Mobile Genetic Elements in Sequenced Strains of Clostridium difficile	PLOS ONE			English	Article							CONJUGATIVE TRANSPOSON TN916; AUREUS COLLAGEN ADHESIN; ENTEROCOCCUS-FAECALIS; RESISTANCE; PROTEIN; IDENTIFICATION; PERFRINGENS; INFECTION; GENOME; TOXIN	Background: Clostridium difficile is the leading cause of hospital-associated diarrhoea in the US and Europe. Recently the incidence of C. difficile-associated disease has risen dramatically and concomitantly with the emergence of 'hypervirulent' strains associated with more severe disease and increased mortality. C. difficile contains numerous mobile genetic elements, resulting in the potential for a highly plastic genome. In the first sequenced strain, 630, there is one proven conjugative transposon (CTn), Tn5397, and six putative CTns (CTn1, CTn2 and CTn4-7), of which, CTn4 and CTn5 were capable of excision. In the second sequenced strain, R20291, two further CTns were described. Results: CTn1, CTn2 CTn4, CTn5 and CTn7 were shown to excise from the genome of strain 630 and transfer to strain CD37. A putative CTn from R20291, misleadingly termed a phage island previously, was shown to excise and to contain three putative mobilisable transposons, one of which was capable of excision. In silico probing of C. difficile genome sequences with recombinase gene fragments identified new putative conjugative and mobilisable transposons related to the elements in strains 630 and R20291. CTn5-like elements were described occupying different insertion sites in different strains, CTn1-like elements that have lost the ability to excise in some ribotype 027 strains were described and one strain was shown to contain CTn5-like and CTn7-like elements arranged in tandem. Additionally, using bioinformatics, we updated previous gene annotations and predicted novel functions for the accessory gene products on these new elements. Conclusions: The genomes of the C. difficile strains examined contain highly related CTns suggesting recent horizontal gene transfer. Several elements were capable of excision and conjugative transfer. The presence of antibiotic resistance genes and genes predicted to promote adaptation to the intestinal environment suggests that CTns play a role in the interaction of C. difficile with its human host.	[Brouwer, Michael S. M.; Warburton, Philip J.; Roberts, Adam P.; Mullany, Peter; Allan, Elaine] UCL, UCL Eastman Dent Inst, Dept Microbial Dis, London, England	University of London; University College London	Brouwer, MSM (corresponding author), UCL, UCL Eastman Dent Inst, Dept Microbial Dis, London, England.	e.allan@ucl.ac.uk	Brouwer, Mike/Z-1653-2019; Roberts, Adam P/C-1787-2008; Warburton, Philip/AAV-1606-2021; Roberts, Adam/AAU-5493-2021	Roberts, Adam P/0000-0002-0760-3088; Roberts, Adam/0000-0002-0760-3088; Warburton, Philip/0000-0002-5810-0296	European Community [223585]; Medical Research Council [G0601176]; Wellcome Trust [WT078131AIA]; MRC [G0601176] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 223585, the Medical Research Council (grant no. G0601176) and the Wellcome Trust (grant no. WT078131AIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM LJ, 1987, J BACTERIOL, V169, P1579, DOI 10.1128/jb.169.4.1579-1584.1987; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], [No title captured]; BANNAM TL, 1995, MOL MICROBIOL, V16, P535, DOI 10.1111/j.1365-2958.1995.tb02417.x; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Bauer MP, 2009, CLIN MICROBIOL INFEC, V15, P1087, DOI 10.1111/j.1469-0691.2009.02853.x; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; COLEMAN JP, 1995, APPL ENVIRON MICROB, V61, P2514, DOI 10.1128/AEM.61.7.2514-2520.1995; FLANNAGAN SE, 1994, PLASMID, V32, P350, DOI 10.1006/plas.1994.1077; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gal M, 2005, J HOSP INFECT, V61, P231, DOI 10.1016/j.jhin.2005.01.017; Gomez A, 2008, PROTEIN J, V27, P130, DOI 10.1007/s10930-007-9116-x; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METHODS; Hernandez S, 2009, CURR MICROBIOL, V59, P451, DOI 10.1007/s00284-009-9459-y; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lyras D, 2004, MOL MICROBIOL, V51, P1787, DOI 10.1111/j.1365-2958.2003.03950.x; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Marsden GL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-389; McBride SM, 2011, INFECT IMMUN, V79, P167, DOI 10.1128/IAI.00731-10; MULLANY P, 1995, J ANTIMICROB CHEMOTH, V35, P305, DOI 10.1093/jac/35.2.305; MULLANY P, 1990, J GEN MICROBIOL, V136, P1343, DOI 10.1099/00221287-136-7-1343; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OLSSON A, 1986, GENE, V45, P175, DOI 10.1016/0378-1119(86)90252-0; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Rich RL, 1998, BIOCHEMISTRY-US, V37, P15423, DOI 10.1021/bi981773r; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Roberts AP, 2009, TRENDS MICROBIOL, V17, P251, DOI 10.1016/j.tim.2009.03.002; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCOTT JR, 1988, P NATL ACAD SCI USA, V85, P4809, DOI 10.1073/pnas.85.13.4809; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; UNDERWOOD A, DOUBLEACT V2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; WUST J, 1983, ANTIMICROB AGENTS CH, V23, P784, DOI 10.1128/AAC.23.5.784; Zafar MA, 2011, J MOL BIOL, V407, P333, DOI 10.1016/j.jmb.2010.12.037	47	70	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23014	10.1371/journal.pone.0023014	http://dx.doi.org/10.1371/journal.pone.0023014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876735	Green Published, gold			2022-12-27	WOS:000294126900007
J	Erban, T				Erban, Tomas			Purification of Tropomyosin, Paramyosin, Actin, Tubulin, Troponin and Kinases for Chemiproteomics and Its Application to Different Scientific Fields	PLOS ONE			English	Article							AFFINITY-CHROMATOGRAPHY; PARA-AMINOBENZAMIDINE; SERINE PROTEASES; IDENTIFICATION; ENTEROKINASE; PROTEINS	Background: p-aminobenzamidine (p-ABA) is used as a ligand in the purification of many serine proteases and in their removal from heterogeneous samples. Moreover, p-ABA has a potent ability to bind Ca(2+)-binding proteins. The binding ability and use of p-ABA in purification processes is still not fully understood. Methodology/Principal Findings: A p-Aminobenzamidine (p-ABA) ligand enabled the purification of the panallergenic proteins tropomyosin and paramyosin, as well as actin, tubulin, troponin and several kinases and annexins, with variable specificity depending on the tissue source and slight modifications to the purification process. The high affinity of p-ABA to tropomyosin, paramyosin, actin, troponin and myosin is calcium-dependent, since calcium regulates the function of these proteins. In addition, p-ABA probably simulates phosphorylated serine and therefore purified appropriate kinases. Because p-ABA binds to calcium-dependent proteins, and probably those with binding sites containing serine, it is not a suitable inhibitor of proteolysis during the purification of such proteins. p-ABA is widely used to inhibit proteases during protein purification processes, but it is used in columns here to purify non-protease proteins. Two strategies were applied; the first was the inactivation of proteases that were not of interest using protease inhibitors. The second strategy employed was the use of a Ca(2+) wash solution to remove calcium-dependent proteins. The removal of calcium-dependent proteins from rabbit hind muscle pointed out even more selective purification. It is possible to obtain two purified samples: a) calcium dependent proteins and b) calcium independent proteins. Moreover, p-ABA may be useful as a model to study processes involving the phosphorylation of serine. Conclusion: A p-Aminobenzamidine (p-ABA) ligand enabled the purification of non-protease proteins, with variable specificity depending on the tissue source and slight modifications to the purification process. The method is applicable to various scientific branches, but is especially practical for medicinal applications.	Crop Res Inst, Dept Stored Prod Pest Control & Food Safety, Lab Prote, Prague, Czech Republic	Czech Crop Research Institute (CRI)	Erban, T (corresponding author), Crop Res Inst, Dept Stored Prod Pest Control & Food Safety, Lab Prote, Prague, Czech Republic.	arachnid@centrum.cz	Erban, Tomas/F-9615-2011	Erban, Tomas/0000-0003-1730-779X	Grant Agency of the Ministry of Agriculture of the Czech Republic [MZE0002700604]; Ministry of Education, Youth and Sports of the Czech Republic [OC10019]	Grant Agency of the Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by grants from the Grant Agency of the Ministry of Agriculture of the Czech Republic (http://eagri.cz/public/web/mze/), Grant No: MZE0002700604 and the Ministry of Education, Youth and Sports (http://www.msmt.cz/) of the Czech Republic, Grant No: OC10019 (COST CM0804 action; Chemical Biology with Natural Products). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian L, 2009, EXP APPL ACAROL, V47, P159, DOI 10.1007/s10493-008-9199-x; BROSCHAT KO, 1986, J BIOL CHEM, V261, P3350; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brushia R. J., 1999, FRONT BIOSCI, V4, pD618; COTE GP, 1981, J BIOL CHEM, V256, P1004; De-Simone SG, 2005, J CHROMATOGR B, V822, P1, DOI 10.1016/j.jchromb.2005.04.018; ELFVIN M, 1976, J CELL BIOL, V71, P261, DOI 10.1083/jcb.71.1.261; EVANS SA, 1982, J BIOL CHEM, V257, P3014; GRANT DAW, 1984, CLIN CHIM ACTA, V142, P39, DOI 10.1016/0009-8981(84)90099-8; GRANT DAW, 1978, EUR J BIOCHEM, V88, P183, DOI 10.1111/j.1432-1033.1978.tb12436.x; Hu LH, 2009, EXPERT REV PROTEOMIC, V6, P433, DOI [10.1586/epr.09.55, 10.1586/EPR.09.55]; Jeong KY, 2006, PROTEIN PEPTIDE LETT, V13, P835; Jiz M, 2008, INFECT IMMUN, V76, P3164, DOI 10.1128/IAI.00409-08; LIU HP, 1989, P NATL ACAD SCI USA, V86, P90, DOI 10.1073/pnas.86.1.90; Nakamura K, 2003, J CHROMATOGR A, V1009, P133, DOI 10.1016/S0021-9673(03)00569-7; Panzani RC, 2001, ALLERGY, V56, P1, DOI 10.1111/j.1398-9995.2001.tb04419.x; Preetha S, 1997, WORLD J MICROB BIOT, V13, P573, DOI 10.1023/A:1018525711573; Ramos JDA, 2003, ALLERGY, V58, P412, DOI 10.1034/j.1398-9995.2003.00106.x; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Tian RJ, 2006, J CHROMATOGR A, V1134, P134, DOI 10.1016/j.chroma.2006.08.097; Vazquez-Talavera J, 2001, INFECT IMMUN, V69, P5412, DOI 10.1128/IAI.69.9.5412-5416.2001; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	25	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22860	10.1371/journal.pone.0022860	http://dx.doi.org/10.1371/journal.pone.0022860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876731	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900003
J	Chuang, PY; Dai, Y; Liu, RJ; He, HL; Kretzler, M; Jim, B; Cohen, CD; He, JC				Chuang, Peter Y.; Dai, Yan; Liu, Ruijie; He, Helen; Kretzler, Matthias; Jim, Belinda; Cohen, Clemens D.; He, John C.			Alteration of Forkhead Box O (Foxo4) Acetylation Mediates Apoptosis of Podocytes in Diabetes Mellitus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ACETYLATION; GENE-EXPRESSION; GLOMERULAR-DISEASE; OXIDATIVE STRESS; OXIDANT STRESS; SIRT1; NEPHROPATHY; ACTIVATION; GLYCATION; INJURY	The number of kidney podocytes is reduced in diabetic nephropathy. Advanced glycation end products (AGEs) accumulate in patients with diabetes and promote the apoptosis of podocyte by activating the forkhead box O4 (Foxo4) transcription factor to increase the expression of a pro-apoptosis gene, Bcl2l11. Using chromatin immunoprecipitation we demonstrate that AGE-modified bovine serum albumin (AGE-BSA) enhances Foxo4 binding to a forkhead binding element in the promoter of Bcl2lll. AGE-BSA also increases the acetylation of Foxo4. Lysine acetylation of Foxo4 is required for Foxo4 binding and transcription of Bcl2l11 in podocytes treated with AGE-BSA. The expression of a protein deacetylase that targets Foxo4 for deacetylation, sirtuin (Sirt1), is down regulated in cultured podocytes by AGE-BSA treatment and in glomeruli of diabetic patients. SIRT1 over expression in cultured murine podocytes prevents AGE-induced apoptosis. Glomeruli isolated from diabetic db/db mice have increased acetylation of Foxo4, suppressed expression of Sirt1, and increased expression of Bcl2l11 compared to non-diabetic littermates. Together, our data provide evidence that alteration of Foxo4 acetylation and down regulation of Sirt1 expression in diabetes promote podocyte apoptosis. Strategies to preserve Sirt1 expression or reduce Foxo4 acetylation could be used to prevent podocyte loss in diabetes.	[Chuang, Peter Y.; Dai, Yan; He, Helen; He, John C.] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Dai, Yan; He, John C.] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Nephrol, Shanghai 200030, Peoples R China; [Liu, Ruijie] James J Peters VA Med Ctr, Bronx, NY USA; [Kretzler, Matthias] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Jim, Belinda] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Div Nephrol, Bronx, NY 10467 USA; [Cohen, Clemens D.] Univ Zurich, Div Nephrol, Zurich, Switzerland; [Cohen, Clemens D.] Univ Zurich, Inst Physiol, Zurich, Switzerland	Icahn School of Medicine at Mount Sinai; Shanghai Jiao Tong University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Michigan System; University of Michigan; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Zurich; University of Zurich	Chuang, PY (corresponding author), Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA.	peter.chuang@mssm.edu	Wang, Ruzhu/A-6727-2012	Wang, Ruzhu/0000-0003-3586-5728	NIH [DK082760R01]; Else Kroner-Fresenius Foundation [P09/05//A62/04]; U.S. Department of Veterans Affairs [1I01BX000345]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK082760] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Else Kroner-Fresenius Foundation; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by an NIH career development award (DK082760R01) to P.Y.C., the Else Kroner-Fresenius Foundation (P09/05//A62/04) award to C. D. C., and a U.S. Department of Veterans Affairs Merit Review Award (1I01BX000345) to J.C.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; BAELDE JJ, 1994, NEPHROL DIAL TRANSPL, V9, P304; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Cohen CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002937; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Forbes JM, 2003, J AM SOC NEPHROL, V14, pS254, DOI 10.1097/01.ASN.0000077413.41276.17; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; KUME S, J CLIN INVEST, V120, P1043; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; LIU D, 2010, ANTIOXID REDOX SIGNA; Menini S, 2007, DIABETOLOGIA, V50, P2591, DOI 10.1007/s00125-007-0821-y; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Rasband W., 2006, IMAGEJ; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sharma S, 2006, PHARMACOLOGY, V76, P69, DOI 10.1159/000089720; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Yamagishi SI, 2007, CURR DRUG TARGETS, V8, P952; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yoo TH, 2007, KIDNEY INT, V71, P1019, DOI 10.1038/sj.ki.5002195; You H, 2005, CELL CYCLE, V4, P37, DOI 10.4161/cc.4.1.1401; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	50	90	97	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23566	10.1371/journal.pone.0023566	http://dx.doi.org/10.1371/journal.pone.0023566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858169	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300061
J	Eriksson, M; Andreasson, K; Weidmann, J; Lundberg, K; Tegerstedt, K; Dalianis, T; Ramqvist, T				Eriksson, Mathilda; Andreasson, Kalle; Weidmann, Joachim; Lundberg, Kajsa; Tegerstedt, Karin; Dalianis, Tina; Ramqvist, Torbjorn			Murine Polyomavirus Virus-Like Particles Carrying Full-Length Human PSA Protect BALB/c Mice from Outgrowth of a PSA Expressing Tumor	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS; T-CELLS; CANCER-PATIENTS; VACCINE; PEPTIDE; IMMUNOTHERAPY; RECOGNITION; INDUCTION	Virus-like particles (VLPs) consist of capsid proteins from viruses and have been shown to be usable as carriers of protein and peptide antigens for immune therapy. In this study, we have produced and assayed murine polyomavirus (MPyV) VLPs carrying the entire human Prostate Specific Antigen (PSA) (PSA-MPyVLPs) for their potential use for immune therapy in a mouse model system. BALB/c mice immunized with PSA-MPyVLPs were only marginally protected against outgrowth of a PSA-expressing tumor. To improve protection, PSA-MPyVLPs were co-injected with adjuvant CpG, either alone or loaded onto murine dendritic cells (DCs). Immunization with PSA-MPyVLPs loaded onto DCs in the presence of CpG was shown to efficiently protect mice from tumor outgrowth. In addition, cellular and humoral immune responses after immunization were examined. PSA-specific CD4(+) and CD8(+) cells were demonstrated, but no PSA-specific IgG antibodies. Vaccination with DCs loaded with PSA-MPyVLPs induced an eight-fold lower titre of anti-VLP antibodies than vaccination with PSA-MPyVLPs alone. In conclusion, immunization of BALB/c mice with PSA-MPyVLPs, loaded onto DCs and co-injected with CpG, induces an efficient PSA-specific tumor protective immune response, including both CD4(+) and CD8(+) cells with a low induction of anti-VLP antibodies.	[Eriksson, Mathilda; Andreasson, Kalle; Weidmann, Joachim; Lundberg, Kajsa; Tegerstedt, Karin; Dalianis, Tina; Ramqvist, Torbjorn] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Eriksson, M (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Mathilda.Eriksson@ki.se	duan, hf/F-9166-2011	Dalianis, Tina/0000-0001-7022-2424; Andreasson, Karl-Magnus/0000-0002-5981-1962	Swedish Cancer Society [100258]; Swedish Medical Research Council [K2011-56X-15282-07-06]; Stockholm Cancer Society [101081]; Konung Gustaf V:s Jubileumsfond [104062]; Karolinska Institutet; Stockholm City Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Cancer Society; Konung Gustaf V:s Jubileumsfond; Karolinska Institutet(Karolinska Institutet); Stockholm City Council	The Swedish Cancer Society (contract number 100258), the Swedish Medical Research Council (grant number K2011-56X-15282-07-06), the Stockholm Cancer Society (grant number 101081), Konung Gustaf V:s Jubileumsfond (grant number 104062), Karolinska Institutet and the Stockholm City Council are greatly acknowledged for their financial support. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 1998, UROLOGY, V51, P150, DOI 10.1016/S0090-4295(97)00480-9; *AMERICANCANCERSOC, 2007, GLOB CANC STAT; Andreasson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011580; Andreasson K, 2009, INT J CANCER, V124, P150, DOI 10.1002/ijc.23920; Chakraborty NG, 2003, CANCER IMMUNOL IMMUN, V52, P497, DOI 10.1007/s00262-003-0377-8; CHU TM, 1984, TRANSPLANT P, V16, P481; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Elkord E, 2005, INT IMMUNOL, V17, P1315, DOI 10.1093/intimm/dxh309; Feyerabend S, 2009, PROSTATE, V69, P917, DOI 10.1002/pros.20941; Forsberg O, 2009, PROSTATE, V69, P70, DOI 10.1002/pros.20858; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; ISAACS JT, 1994, VITAM HORM, V49, P433; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; LEPOR H, 1982, J UROLOGY, V128, P335, DOI 10.1016/S0022-5347(17)52915-8; LERNER SP, 1991, J UROLOGY, V146, P1040, DOI 10.1016/S0022-5347(17)37997-1; Lubaroff DM, 2006, VACCINE, V24, P6155, DOI 10.1016/j.vaccine.2006.04.022; MCCORMACK RT, 1995, UROLOGY, V45, P729, DOI 10.1016/S0090-4295(99)80076-4; Milowsky MI, 2004, J CLIN ONCOL, V22, P2522, DOI 10.1200/JCO.2004.09.154; MONTGOMERY BT, 1992, PROSTATE, V21, P63, DOI 10.1002/pros.2990210107; NILSSON SV, 1984, J VIROL, V51, P768, DOI 10.1128/JVI.51.3.768-775.1984; Pandha HS, 2004, BJU INT, V94, P412, DOI 10.1111/j.1464-410X.2004.04922.x; Pavlenko M, 2005, PROSTATE, V64, P50, DOI 10.1002/pros.20221; Pavlenko M, 2004, BRIT J CANCER, V91, P688, DOI 10.1038/sj.bjc.6602019; PEEHL DM, 2005, CANCER, P2021; Perambakam S, 2006, CANCER IMMUNOL IMMUN, V55, P1033, DOI 10.1007/s00262-005-0090-x; REDMOND MJ, 1993, VACCINE, V11, P273, DOI 10.1016/0264-410X(93)90029-W; SAJJA R, 2003, I J RAD ONCOLOGY, V57, P388; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Schafer K, 1999, INT J CANCER, V81, P881, DOI 10.1002/(SICI)1097-0215(19990611)81:6<881::AID-IJC8>3.3.CO;2-K; Simons JW, 2006, UROL ONCOL-SEMIN ORI, V24, P419, DOI 10.1016/j.urolonc.2005.08.021; SINHA AA, 1986, J UROLOGY, V136, P722, DOI 10.1016/S0022-5347(17)45036-1; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; Tegerstedt K, 2003, J GEN VIROL, V84, P3443, DOI 10.1099/vir.0.19443-0; Tegerstedt K, 2007, CANCER IMMUNOL IMMUN, V56, P1335, DOI 10.1007/s00262-007-0281-8; Turner MJ, 2001, J IMMUNOL METHODS, V256, P107, DOI 10.1016/S0022-1759(01)00436-7; Ziada A, 2004, PROSTATE, V60, P332, DOI 10.1002/pros.20065	39	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23828	10.1371/journal.pone.0023828	http://dx.doi.org/10.1371/journal.pone.0023828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858228	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300099
J	Qi, J; Zhang, H; Guo, J; Yang, L; Wang, W; Chen, T; Li, H; Wu, SX; Li, YQ				Qi, Jian; Zhang, Hua; Guo, Jun; Yang, Le; Wang, Wen; Chen, Tao; Li, Hui; Wu, Sheng-Xi; Li, Yun-Qing			Synaptic Connections of the Neurokinin 1 Receptor-Like Immunoreactive Neurons in the Rat Medullary Dorsal Horn	PLOS ONE			English	Article							SUBSTANCE-P RECEPTOR; ROSTRAL VENTROMEDIAL MEDULLA; SEROTONIN-CONTAINING AXONS; SPINAL TRIGEMINAL NUCLEUS; I PROJECTION NEURONS; LAMINA-I; INHIBITORY NEUROTRANSMISSION; SUPERFICIAL LAMINAE; NOXIOUS-STIMULATION; GELATINOSA NEURONS	The synaptic connections between neurokinin 1 (NK1) receptor-like immunoreactive (LI) neurons and gamma-aminobutyric acid (GABA)-, glycine (Gly)-, serotonin (5-HT)-or dopamine-beta-hydroxylase (DBH, a specific marker for norepinephrinergic neuronal structures)-LI axon terminals in the rat medullary dorsal horn (MDH) were examined under electron microscope by using a pre-embedding immunohistochemical double-staining technique. NK1 receptor-LI neurons were observed principally in laminae I and III, only a few of them were found in lamina II of the MDH. GABA-, Gly-, 5-HT-, or DBH-LI axon terminals were densely encountered in laminae I and II, and sparsely in lamina III of the MDH. Some of these GABA-, Gly-, 5-HT-, or DBH-LI axon terminals were observed to make principally symmetric synapses with NK1 receptor-LI neuronal cell bodies and dendritic processes in laminae I, II and III of the MDH. The present results suggest that neurons expressing NK1 receptor within the MDH might be modulated by GABAergic and glycinergic inhibitory intrinsic neurons located in the MDH and 5-HT- or norepinephrine (NE)-containing descending fibers originated from structures in the brainstem.	[Qi, Jian; Zhang, Hua; Wang, Wen; Chen, Tao; Li, Hui; Wu, Sheng-Xi; Li, Yun-Qing] Fourth Mil Med Univ, Dept Anat, Xian 710032, Peoples R China; [Qi, Jian; Zhang, Hua; Wang, Wen; Chen, Tao; Li, Hui; Wu, Sheng-Xi; Li, Yun-Qing] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Guo, Jun] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Qi, J (corresponding author), Fourth Mil Med Univ, Dept Anat, Xian 710032, Peoples R China.	deptanat@fmmu.edu.cn			National Natural Science Foundation of China [30771133, 30971123, 31010103909]; National Program of Basic Research of China [G2006CB500808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Basic Research of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China ( Nos. 30771133, 30971123, 31010103909) and the National Program of Basic Research of China (G2006CB500808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghamdi KS, 2009, NEUROSCIENCE, V164, P1794, DOI 10.1016/j.neuroscience.2009.09.071; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; CARLTON SM, 1992, J COMP NEUROL, V322, P528, DOI 10.1002/cne.903220407; DING YQ, 1995, NEUROSCI RES, V23, P415, DOI 10.1016/0168-0102(95)00961-R; Guan ZL, 1998, NEUROSCI RES, V30, P213, DOI 10.1016/S0168-0102(97)00131-4; Hoyer D, 1996, BEHAV BRAIN RES, V73, P263; Ito A, 2000, J NEUROSCI, V20, P6302, DOI 10.1523/JNEUROSCI.20-16-06302.2000; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; Kawasaki Y, 2003, ANESTHESIOLOGY, V98, P682, DOI 10.1097/00000542-200303000-00016; KWIAT GC, 1992, SOMATOSENS MOT RES, V9, P157, DOI 10.3109/08990229209144768; Labrakakis C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-24; Li H, 2000, BRAIN RES BULL, V53, P163, DOI 10.1016/S0361-9230(00)00320-8; Li H, 2002, BRAIN RES BULL, V58, P593, DOI 10.1016/S0361-9230(02)00826-2; Li JL, 1997, J COMP NEUROL, V384, P127, DOI 10.1002/(SICI)1096-9861(19970721)384:1<127::AID-CNE8>3.0.CO;2-3; Li JL, 2002, NEUROSCI LETT, V324, P9, DOI 10.1016/S0304-3940(02)00138-6; Li YQ, 2000, J COMP NEUROL, V424, P24, DOI 10.1002/1096-9861(20000814)424:1<24::AID-CNE2>3.0.CO;2-M; Li YQ, 1999, J COMP NEUROL, V411, P399; Li YQ, 1999, J BRAIN RES, V39, P277; Mackie M, 2003, NEUROSCIENCE, V119, P461, DOI 10.1016/S0306-4522(03)00174-X; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Martin WJ, 1999, PAIN, V80, P57, DOI 10.1016/S0304-3959(98)00194-8; MAXWELL DJ, 1983, BRAIN RES, V266, P253, DOI 10.1016/0006-8993(83)90656-X; Naim M, 1997, J NEUROSCI, V17, P5536; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; Polgar E, 2002, NEUROSCIENCE, V109, P799, DOI 10.1016/S0306-4522(01)00304-9; Puskar Z, 2001, NEUROSCIENCE, V102, P167, DOI 10.1016/S0306-4522(00)00445-0; Rahman W, 2007, NEUROSCI LETT, V419, P278, DOI 10.1016/j.neulet.2007.04.039; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; Taylor BK, 2009, CURR PAIN HEADACHE R, V13, P208, DOI 10.1007/s11916-009-0035-8; Todd AJ, 2002, EXP PHYSIOL, V87, P245, DOI 10.1113/eph8702351; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trafton JA, 1999, J NEUROSCI, V19, P9642; Wang D, 2000, NEUROSCI LETT, V288, P187, DOI 10.1016/S0304-3940(00)01226-X; WESTLUND KN, 1990, J COMP NEUROL, V299, P178, DOI 10.1002/cne.902990205; WILLIS WD, 1995, PAIN, P725; Worsley MA, 2005, EXP BRAIN RES, V160, P360, DOI 10.1007/s00221-004-2018-7; Xu Z, 2006, CURR OPIN NEUROBIOL, V16, P460, DOI 10.1016/j.conb.2006.06.002; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; 2010, PROG NEUROBIOL, V91, P38	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23275	10.1371/journal.pone.0023275	http://dx.doi.org/10.1371/journal.pone.0023275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858052	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300026
J	Qin, TC; Castoro, R; El Ahdab, S; Jelinek, J; Wang, XD; Si, JL; Shu, JM; He, R; Zhang, NX; Chung, WB; Kantarjian, HM; Issa, JPJ				Qin, Taichun; Castoro, Ryan; El Ahdab, Samih; Jelinek, Jaroslav; Wang, Xiaodan; Si, Jiali; Shu, Jingmin; He, Rong; Zhang, Nianxiang; Chung, Woonbok; Kantarjian, Hagop M.; Issa, Jean-Pierre J.			Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DEOXYCYTIDINE KINASE GENE; DNA METHYLATION; CYTOSINE-ARABINOSIDE; SCORING SYSTEM; MESSENGER-RNA; CANCER-CELLS; DCK GENE; 5-AZA-2'-DEOXYCYTIDINE; INACTIVATION	Purpose: The DNA methylation inhibitor 5-aza-2'-deoxycytidine (DAC) is approved for the treatment of myelodysplastic syndromes (MDS), but resistance to DAC develops during treatment and mechanisms of resistance remain unknown. Therefore, we investigated mechanisms of primary and secondary resistance to DAC in MDS. Patients and Methods: We performed Quantitative Real-Time PCR to examine expression of genes related to DAC metabolism prior to therapy in 32 responders and non-responders with MDS as well as 14 patients who achieved a complete remission and subsequently relapsed while on therapy (secondary resistance). We then performed quantitative methylation analyses by bisulfite pyrosequencing of 10 genes as well as Methylated CpG Island Amplification Microarray (MCAM) analysis of global methylation in secondary resistance. Results: Most genes showed no differences by response, but the CDA/DCK ratio was 3 fold higher in non-responders than responders (P,. 05), suggesting that this could be a mechanism of primary resistance. There were no significant differences at relapse in DAC metabolism genes, and no DCK mutations were detected. Global methylation measured by the LINE1 assay was lower at relapse than at diagnosis (P,. 05). On average, the methylation of 10 genes was lower at relapse (16.1%) compared to diagnosis (18.1%) (P<.05). MCAM analysis showed decreased methylation of an average of 4.5% (range 0.6%-9.7%) of the genes at relapse. By contrast, new cytogenetic changes were found in 20% of patients. Conclusion: Pharmacological mechanisms are involved in primary resistance to DAC, whereas hypomethylation does not prevent a relapse for patients with DAC treatment.	[Qin, Taichun; Castoro, Ryan; El Ahdab, Samih; Jelinek, Jaroslav; Si, Jiali; Shu, Jingmin; He, Rong; Zhang, Nianxiang; Chung, Woonbok; Kantarjian, Hagop M.; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Wang, Xiaodan] Harbin Inst Hematol & Oncol, Harbin, Peoples R China	University of Texas System; UTMD Anderson Cancer Center	Qin, TC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	jpissa@mdanderson.org	Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/O-6876-2019	Jelinek, Jaroslav/0000-0002-2533-0220; Castoro, Ryan/0000-0002-3242-3775; Castoro, Ryan/0000-0003-3619-484X; Issa, Jean-Pierre/0000-0003-2258-5030	National Institutes of Health [CA100632, CA121104, CA108631]; NATIONAL CANCER INSTITUTE [P50CA100632, P01CA108631, R01CA121104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA100632, CA121104 and CA108631. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Madhoun AS, 2004, BIOCHEM PHARMACOL, V68, P601, DOI 10.1016/j.bcp.2004.05.007; AUL C, 1992, BRIT J HAEMATOL, V82, P358, DOI 10.1111/j.1365-2141.1992.tb06430.x; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; CHABOT GG, 1983, BIOCHEM PHARMACOL, V32, P1327, DOI 10.1016/0006-2952(83)90293-9; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; FLASSHOVE M, 1994, LEUKEMIA, V8, P780; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Herman JG, 1996, CANCER RES, V56, P722; Hopfer O, 2007, EXP HEMATOL, V35, P712, DOI 10.1016/j.exphem.2007.01.054; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1351, DOI 10.1002/cncr.23697; KOBAYASHI T, 1994, LEUKEMIA LYMPHOMA, V15, P503, DOI 10.3109/10428199409049755; Konopleva M, 2007, CURR DRUG TARGETS, V8, P685, DOI 10.2174/138945007780830827; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Kroep JR, 2002, MOL CANCER THER, V1, P371; Liu ZJ, 2004, FEBS LETT, V567, P327, DOI 10.1016/j.febslet.2004.04.044; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; OWENS JK, 1992, CANCER RES, V52, P2389; Plimack ER, 2007, LEUKEMIA LYMPHOMA, V48, P1472, DOI 10.1080/10428190701471981; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Roman-Gomez J, 2003, J CLIN ONCOL, V21, P1472, DOI 10.1200/JCO.2003.08.166; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; STEGMANN APA, 1993, LEUKEMIA, V7, P1005; van den Heuvel-Eibrink MM, 2001, LEUKEMIA, V15, P855, DOI 10.1038/sj.leu.2402112; Veuger MJ, 2003, LEUKEMIA RES, V27, P445, DOI 10.1016/S0145-2126(02)00224-2; Wong KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019027	32	102	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23372	10.1371/journal.pone.0023372	http://dx.doi.org/10.1371/journal.pone.0023372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858090	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300040
J	Zong, M; Wu, XG; Chan, CWL; Choi, MY; Chan, HC; Tanner, JA; Yu, S				Zong, Min; Wu, Xing-gang; Chan, Cecilia W. L.; Choi, Mei Y.; Chan, Hsiao Chang; Tanner, Julian A.; Yu, Sidney			The Adaptor Function of TRAPPC2 in Mammalian TRAPPs Explains TRAPPC2-Associated SEDT and TRAPPC9-Associated Congenital Intellectual Disability	PLOS ONE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA TARDA; RECESSIVE MENTAL-RETARDATION; VESICLE DOCKING; GOLGI TRANSPORT; IDENTIFICATION; GENE; COMPLEXES; AUTOPHAGY; BINDING; PROTEIN	Background: The TRAPP (Transport protein particle) complex is a conserved protein complex functioning at various steps in vesicle transport. Although yeast has three functionally and structurally distinct forms, TRAPPI, II and III, emerging evidence suggests that mammalian TRAPP complex may be different. Mutations in the TRAPP complex subunit 2 (TRAPPC2) cause X-linked spondyloepiphyseal dysplasia tarda, while mutations in the TRAPP complex subunit 9 (TRAPPC9) cause postnatal mental retardation with microcephaly. The structural interplay between these subunits found in mammalian equivalent of TRAPPI and those specific to TRAPPII and TRAPPIII remains largely unknown and we undertook the present study to examine the interaction between these subunits. Here, we reveal that the mammalian equivalent of the TRAPPII complex is structurally distinct from the yeast counterpart thus leading to insight into mechanism of disease. Principal Findings: We analyzed how TRAPPII- or TRAPPIII-specific subunits interact with the six-subunit core complex of TRAPP by co-immunoprecipitation in mammalian cells. TRAPPC2 binds to TRAPPII-specific subunit TRAPPC9, which in turn binds to TRAPPC10. Unexpectedly, TRAPPC2 can also bind to the putative TRAPPIII-specific subunit, TRAPPC8. Endogenous TRAPPC9-positive TRAPPII complex does not contain TRAPPC8, suggesting that TRAPPC2 binds to either TRAPPC9 or TRAPPC8 during the formation of the mammalian equivalents of TRAPPII or TRAPPIII, respectively. Therefore, TRAPPC2 serves as an adaptor for the formation of these complexes. A disease-causing mutation of TRAPPC2, D47Y, failed to interact with either TRAPPC9 or TRAPPC8, suggesting that aspartate 47 in TRAPPC2 is at or near the site of interaction with TRAPPC9 or TRAPPC8, mediating the formation of TRAPPII and/or TRAPPIII. Furthermore, disease-causing deletional mutants of TRAPPC9 all failed to interact with TRAPPC2 and TRAPPC10. Conclusions: TRAPPC2 serves as an adaptor for the formation of TRAPPII or TRAPPIII in mammalian cells. The mammalian equivalent of TRAPPII is likely different from the yeast TRAPPII structurally.	[Zong, Min; Wu, Xing-gang; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Chan, Cecilia W. L.; Choi, Mei Y.; Tanner, Julian A.] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Zong, M (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	Sidney.yu@cuhk.edu.hk	Zong, Min/B-6706-2016; Tanner, Julian A./C-4412-2009; Chan, Hsiao Chang/E-1507-2016; Bin Sidney Yu, Siu/R-4936-2018	Zong, Min/0000-0001-9381-5791; Tanner, Julian A./0000-0002-5459-1526; Bin Sidney Yu, Siu/0000-0001-9643-2729	Hong Kong UGC GRF [479410]; Chinese University of Hong Kong; AoE	Hong Kong UGC GRF; Chinese University of Hong Kong(Chinese University of Hong Kong); AoE	This work was supported by Hong Kong UGC GRF grant 479410 (SY), by one-line budget of the Chinese University of Hong Kong (SY) and by AoE grant "Developmental Genomics and Skeletal Research'' (JAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Bar-Yosef U, 2004, AM J MED GENET A, V125A, P45, DOI 10.1002/ajmg.a.20435; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; CHOI C, ORG ASSEMBLY TRAPPII; Choi MY, 2009, BIOCHEM J, V423, P233, DOI 10.1042/BJ20090541; Christie PT, 2001, J CLIN ENDOCR METAB, V86, P3233, DOI 10.1210/jc.86.7.3233; Fiedler Jorg, 2004, Hum Mutat, V24, P103, DOI 10.1002/humu.9254; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; HU WH, 2005, TEST, V280, P29233; JEYABALAN J, PLOS ONE, V5; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Loh E, 2005, J CELL SCI, V118, P1209, DOI 10.1242/jcs.01723; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Matsui Y, 2001, AM J MED GENET, V99, P328, DOI 10.1002/ajmg.1179; Meiling-Wesse K, 2005, J BIOL CHEM, V280, P33669, DOI 10.1074/jbc.M501701200; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Montpetit B, 2009, TRAFFIC, V10, P713, DOI 10.1111/j.1600-0854.2009.00895.x; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nazarko TY, 2005, AUTOPHAGY, V1, P37, DOI 10.4161/auto.1.1.1512; Philippe O, 2009, AM J HUM GENET, V85, P903, DOI 10.1016/j.ajhg.2009.11.007; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sacher M, 2008, TRAFFIC, V9, P2032, DOI 10.1111/j.1600-0854.2008.00833.x; SAVARIRAYAN R, EUR J HUM GENET, V11, P639; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Siu KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018458; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Xiao CY, 2003, MUTAT RES-FUND MOL M, V525, P61, DOI 10.1016/S0027-5107(02)00315-9; YAMASAKI A, 2009, MOL BIOL CELL; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044; ZAHOOR MA, J GEN VIROL, V91, P1939	39	44	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23350	10.1371/journal.pone.0023350	http://dx.doi.org/10.1371/journal.pone.0023350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858081	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700017
J	Maurage, P; Callot, C; Chang, B; Philippot, P; Rombaux, P; de Timary, P				Maurage, Pierre; Callot, Christophe; Chang, Betty; Philippot, Pierre; Rombaux, Philippe; de Timary, Philippe			Olfactory Impairment Is Correlated with Confabulation in Alcoholism: Towards a Multimodal Testing of Orbitofrontal Cortex	PLOS ONE			English	Article							STOP SIGNAL TASK; ODOR IDENTIFICATION; SEX-DIFFERENCES; OLDER-ADULTS; SCHIZOPHRENIA; DEFICITS; MEMORY; DISCRIMINATION; PERFORMANCE; PERCEPTION	Background: Olfactory abilities are now a flourishing field in psychiatry research. As the orbitofrontal cortex appears to be simultaneously implicated in odour processing and executive impairments, it has been proposed that olfaction could constitute a cognitive marker of psychiatric states. While this assumption appears promising, very few studies have been conducted on this topic among psychopathological populations. The present study thus aimed at exploring the links between olfaction and executive functions. These links were evaluated using two tasks of comparable difficulty, one known to rely on orbitofrontal cortex processing (i.e., a confabulation task), and one not associated with this area (i.e., Stop-Signal task). Methodology/Principal Findings: Twenty recently detoxified alcoholic individuals and twenty paired controls took part in an experiment evaluating olfactory abilities and executive functioning (i.e., Stop-Signal task and confabulation task). Comorbidities and potential biasing variables were also controlled for. Alcoholic individuals exhibited impaired performance for high-level olfactory processing and significant confabulation problems as compared to controls (but no deficit in Stop-Signal task), even when the influence of comorbidities was taken into account. Most importantly, olfactory abilities and confabulation rates were significantly correlated in both groups. Conclusions/Significance: Alcoholism jointly leads to olfactory and memory source impairments, and these two categories of deficits are associated. These results strongly support the proposition that olfactory and confabulation measures both index orbitofrontal functioning, and suggest that olfaction could become a reliable cognitive marker in psychiatric disorders. Moreover, it underlines the need to take into account these olfactory and source memory impairments in a clinical context.	[Maurage, Pierre; Callot, Christophe] Catholic Univ Louvain, Inst Psychol, Neurosci Syst & Cognit NEUROCS Res Unit, B-3000 Louvain, Belgium; [Maurage, Pierre; Callot, Christophe; Chang, Betty; Philippot, Pierre; de Timary, Philippe] Catholic Univ Louvain, Inst Psychol, Hlth & Psychol Dev CSDP Res Unit, B-3000 Louvain, Belgium; [Rombaux, Philippe] Catholic Univ Louvain, St Luc Hosp, Dept Otorhinolaryngol, Brussels, Belgium; [Rombaux, Philippe; de Timary, Philippe] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [de Timary, Philippe] Catholic Univ Louvain, St Luc Hosp, Dept Psychiat, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Maurage, P (corresponding author), Catholic Univ Louvain, Inst Psychol, Neurosci Syst & Cognit NEUROCS Res Unit, B-3000 Louvain, Belgium.	pierre.maurage@uclouvain.be		Maurage, Pierre/0000-0003-0197-0810	National Fund for Scientific Research (FNRS, Belgium)	National Fund for Scientific Research (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS)	Pierre Maurage and Philippe de Timary are supported by grants from the National Fund for Scientific Research (FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasova B, 2008, NEUROSCI BIOBEHAV R, V32, P1315, DOI 10.1016/j.neubiorev.2008.05.003; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Beck A.T., 1987, BECK DEPRESSION INVE; Brewer WJ, 1996, BIOL PSYCHIAT, V40, P1021, DOI 10.1016/0006-3223(95)00594-3; CAREY GB, 1989, OCCUP MED, V4, P311; Chevrier A, 2010, NEUROIMAGE, V53, P664, DOI 10.1016/j.neuroimage.2010.06.056; Clepce M, 2010, NEUROSCI LETT, V471, P139, DOI 10.1016/j.neulet.2010.01.027; Corcoran C, 2005, SCHIZOPHR RES, V80, P283, DOI 10.1016/j.schres.2005.07.028; DITRAGLIA GM, 1991, ALCOHOL, V8, P109, DOI 10.1016/0741-8329(91)91318-V; Dulay MF, 2008, J CLIN EXP NEUROPSYC, V30, P327, DOI 10.1080/13803390701415892; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; Fukatsu R, 1998, NEUROLOGY, V50, P539, DOI 10.1212/WNL.50.2.539; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Hedner M, 2010, J CLIN EXP NEUROPSYC, V30, P1; Heilmann S, 2002, ARCH OTOLARYNGOL, V128, P414, DOI 10.1001/archotol.128.4.414; Hendrick OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013155; Hummel T, 2008, CHEM BIODIVERS, V5, P853, DOI 10.1002/cbdv.200890100; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; JONES BP, 1978, NEUROPSYCHOLOGIA, V16, P323, DOI 10.1016/0028-3932(78)90026-X; KESSLAK JP, 1991, PERCEPT MOTOR SKILL, V73, P551, DOI 10.2466/PMS.73.5.551-554; Kim YY, 2009, PSYCHIAT RES, V165, P47, DOI 10.1016/j.psychres.2008.03.025; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; LEEVY CM, 1970, MED CLIN N AM, V54, P1567, DOI 10.1016/S0025-7125(16)32572-X; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Logan Gordon D., 1994, P189; Lombion S, 2010, PSYCHIAT RES, V177, P135, DOI 10.1016/j.psychres.2009.01.018; Luzzi S, 2007, NEUROPSYCHOLOGIA, V45, P1823, DOI 10.1016/j.neuropsychologia.2006.12.008; MAIR RG, 1986, NEUROPSYCHOLOGIA, V24, P831, DOI 10.1016/0028-3932(86)90082-5; Mann K, 1999, ALCOHOL ALCOHOLISM, V34, P567, DOI 10.1093/alcalc/34.4.567; Martzke JS, 1997, BIOL PSYCHIAT, V42, P721, DOI 10.1016/S0006-3223(96)00442-8; Metcalf K, 2007, COGN NEUROPSYCHOL, V24, P23, DOI 10.1080/02643290600694901; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Ohtake H, 2005, J NEUROL NEUROSUR PS, V76, P1309, DOI 10.1136/jnnp.2004.061846; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Potter H, 1979, Curr Alcohol, V7, P261; Price J.L., 1987, P179; Ptak R, 1999, NEUROCASE, V5, P243, DOI 10.1093/neucas/5.3.243; Purdon SE, 1998, J PSYCHIATR NEUROSCI, V23, P163; Roessner V, 2005, EUR ARCH PSY CLIN N, V255, P6, DOI 10.1007/s00406-004-0525-y; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2010, J COGNITIVE NEUROSCI, V22, P1069, DOI 10.1162/jocn.2009.21231; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rupp CI, 2004, ALCOHOL ALCOHOLISM, V39, P514, DOI 10.1093/alcalc/agh100; Rupp CI, 2003, ALCOHOL CLIN EXP RES, V27, P432, DOI 10.1097/01.ALC.0000057945.57330.2C; Rupp CI, 2006, ALCOHOL CLIN EXP RES, V30, P1355, DOI 10.1111/j.1530-0277.2006.00162.x; Rupp CI, 2010, CURR OPIN PSYCHIATR, V23, P97, DOI 10.1097/YCO.0b013e328336643f; Saoud M, 1998, PSYCHIAT RES, V81, P251, DOI 10.1016/S0165-1781(98)00104-8; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Schillerstrom JE, 2003, PSYCHOSOMATICS, V44, P290, DOI 10.1176/appi.psy.44.4.290; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 2001, BRAIN RES REV, V36, P150, DOI 10.1016/S0165-0173(01)00090-X; Scinska A, 2008, PSYCHIAT CLIN NEUROS, V62, P450, DOI 10.1111/j.1440-1819.2008.01824.x; Seidman LJ, 1997, BIOL PSYCHIAT, V42, P104, DOI 10.1016/S0006-3223(96)00300-9; SHEAR PK, 1992, ALCOHOL, V9, P247, DOI 10.1016/0741-8329(92)90061-E; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Spielberger C, 1983, MANUAL STATE TRAIT A; Strauss GP, 2010, SCHIZOPHRENIA BULL, V36, P860, DOI 10.1093/schbul/sbn178; Turetsky BI, 2003, BIOL PSYCHIAT, V53, P403, DOI 10.1016/S0006-3223(02)01865-6; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; Westervelt HJ, 2005, ARCH CLIN NEUROPSYCH, V20, P761, DOI 10.1016/j.acn.2005.04.010; Wiggins LD, 2009, J AUTISM DEV DISORD, V39, P1087, DOI 10.1007/s10803-009-0711-x; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zhang S, 2011, HUM BRAIN M IN PRESS	72	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23190	10.1371/journal.pone.0023190	http://dx.doi.org/10.1371/journal.pone.0023190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808CT	21858026	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500023
J	Al Alam, D; Green, M; Irani, RT; Parsa, S; Danopoulos, S; Sala, FG; Branch, J; El Agha, E; Tiozzo, C; Voswinckel, R; Jesudason, EC; Warburton, D; Bellusci, S				Al Alam, Denise; Green, Melissa; Irani, Reza Tabatabai; Parsa, Sara; Danopoulos, Soula; Sala, Frederic G.; Branch, Jonathan; El Agha, Elie; Tiozzo, Caterina; Voswinckel, Robert; Jesudason, Edwin C.; Warburton, David; Bellusci, Saverio			Contrasting Expression of Canonical Wnt Signaling Reporters TOPGAL, BATGAL and Axin2(LacZ) during Murine Lung Development and Repair	PLOS ONE			English	Article							BETA-CATENIN; INJURY; MORPHOGENESIS; ACTIVATION; PROMOTES; TUMORS; CELLS	Canonical Wnt signaling plays multiple roles in lung organogenesis and repair by regulating early progenitor cell fates: investigation has been enhanced by canonical Wnt reporter mice, TOPGAL, BATGAL and Axin2(LacZ). Although widely used, it remains unclear whether these reporters convey the same information about canonical Wnt signaling. We therefore compared beta-galactosidase expression patterns in canonical Wnt signaling of these reporter mice in whole embryo versus isolated prenatal lungs. To determine if expression varied further during repair, we analyzed comparative pulmonary expression of beta-galactosidase after naphthalene injury. Our data show important differences between reporter mice. While TOPGAL and BATGAL lines demonstrate Wnt signaling well in early lung epithelium, BATGAL expression is markedly reduced in late embryonic and adult lungs. By contrast, Axin2(LacZ) expression is sustained in embryonic lung mesenchyme as well as epithelium. Three days into repair after naphthalene, BATGAL expression is induced in bronchial epithelium as well as TOPGAL expression (already strongly expressed without injury). Axin2(LacZ) expression is increased in bronchial epithelium of injured lungs. Interestingly, both TOPGAL and Axin2(LacZ) are up regulated in parabronchial smooth muscle cells during repair. Therefore the optimal choice of Wnt reporter line depends on whether up- or down-regulation of canonical Wnt signal reporting in either lung epithelium or mesenchyme is being compared.	[Al Alam, Denise; Green, Melissa; Irani, Reza Tabatabai; Parsa, Sara; Danopoulos, Soula; Sala, Frederic G.; Branch, Jonathan; Tiozzo, Caterina; Jesudason, Edwin C.; Warburton, David; Bellusci, Saverio] Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA; [El Agha, Elie; Bellusci, Saverio] Univ Giessen, Lung Ctr, Dept Internal Med 2, Giessen, Germany; [Voswinckel, Robert] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Jesudason, Edwin C.] Univ Liverpool, Dept Child Hlth, Alder Hey Childrens Hosp, Liverpool L69 3BX, Merseyside, England	Children's Hospital Los Angeles; Justus Liebig University Giessen; Max Planck Society; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Al Alam, D (corresponding author), Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA.	sbellusci@chla.usc.edu	Warburton, David/AAD-5709-2020; Alam, Denise Al/AAG-9406-2019; tiozzo, caterina/AAD-1170-2022	El Agha, Elie/0000-0001-7504-3417; Tiozzo, Caterina/0000-0001-8317-7183	American Lung association; NIH [HL074832, HL086322]; Excellence Cluster in Cardio-Pulmonary Systems (ECCPS); DFG [62280319]; Medical Research Council [G0802057] Funding Source: researchfish; MRC [G0802057] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086322, R01HL074832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096195] Funding Source: NIH RePORTER	American Lung association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Cluster in Cardio-Pulmonary Systems (ECCPS)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Denise Al Alam was supported by American Lung association postdoctoral National Award. SB was supported by the NIH (HL074832 and HL086322), the Excellence Cluster in Cardio-Pulmonary Systems (ECCPS) and the DFG (62280319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; De Langhe Stijn P, 2008, Organogenesis, V4, P100; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; KNEIDINGER N, 2010, AM J RESP CRIT CARE; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MAHVI D, 1977, AM J PATHOL, V86, P559; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Stripp BR, 1995, AM J PHYSIOL-LUNG C, V269, pL791, DOI 10.1152/ajplung.1995.269.6.L791; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Winkle LS, 2002, AM J PHYSIOL-LUNG C, V282, pL1122, DOI 10.1152/ajplung.00309.2001; vanWinkle LS, 1995, AM J PHYSIOL-LUNG C, V269, pL800, DOI 10.1152/ajplung.1995.269.6.L800; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	25	68	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23139	10.1371/journal.pone.0023139	http://dx.doi.org/10.1371/journal.pone.0023139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858009	gold, Green Submitted, Green Published			2022-12-27	WOS:000293774300023
J	Carroll, DS; Emerson, GL; Li, Y; Sammons, S; Olson, V; Frace, M; Nakazawa, Y; Czerny, CP; Tryland, M; Kolodziejek, J; Nowotny, N; Olsen-Rasmussen, M; Khristova, M; Govil, D; Karem, K; Damon, IK; Meyer, H				Carroll, Darin S.; Emerson, Ginny L.; Li, Yu; Sammons, Scott; Olson, Victoria; Frace, Michael; Nakazawa, Yoshinori; Czerny, Claus Peter; Tryland, Morten; Kolodziejek, Jolanta; Nowotny, Norbert; Olsen-Rasmussen, Melissa; Khristova, Marina; Govil, Dhwani; Karem, Kevin; Damon, Inger K.; Meyer, Hermann			Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification	PLOS ONE			English	Article							CELL-SURFACE; ORTHOPOXVIRUSES; GENOME; CAT; SEQUENCES; DIVERSITY; WILDLIFE	Cowpox virus (CPXV) is described as the source of the first vaccine used to prevent the onset and spread of an infectious disease. It is one of the earliest described members of the genus Orthopoxvirus, which includes the viruses that cause smallpox and monkeypox in humans. Both the historic and current literature describe "cowpox" as a disease with a single etiologic agent. Genotypic data presented herein indicate that CPXV is not a single species, but a composite of several (up to 5) species that can infect cows, humans, and other animals. The practice of naming agents after the host in which the resultant disease manifests obfuscates the true taxonomic relationships of "cowpox" isolates. These data support the elevation of as many as four new species within the traditional "cowpox" group and suggest that both wild and modern vaccine strains of Vaccinia virus are most closely related to CPXV of continental Europe rather than the United Kingdom, the homeland of the vaccine.	[Carroll, Darin S.; Emerson, Ginny L.; Li, Yu; Olson, Victoria; Nakazawa, Yoshinori; Karem, Kevin; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA; [Sammons, Scott; Frace, Michael; Olsen-Rasmussen, Melissa; Khristova, Marina; Govil, Dhwani] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Atlanta, GA USA; [Nakazawa, Yoshinori] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Czerny, Claus Peter] Univ Gottingen, Dept Anim Sci, Div Microbiol & Anim Hyg, Gottingen, Germany; [Tryland, Morten] Norwegian Sch Vet Sci, Sect Arctic Vet Med, Dept Food Safety & Infect Biol, Tromso, Norway; [Tryland, Morten] Genok, Ctr Biosafety, Tromso, Norway; [Kolodziejek, Jolanta; Nowotny, Norbert] Univ Vet Med Vienna, Dept Pathobiol, Zoonoses & Emerging Infect Grp, Vienna, Austria; [Nowotny, Norbert] Sultan Qaboos Univ, Fac Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman; [Meyer, Hermann] Bundeswehr Inst Microbiol, Munich, Germany	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; University of Gottingen; Norwegian University of Life Sciences; University of Veterinary Medicine Vienna; Sultan Qaboos University; Bundeswehr Institute of Microbiology (IMB)	Carroll, DS (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA.	DCarroll@cdc.gov	Nowotny, Norbert/A-5474-2019	Nowotny, Norbert/0000-0002-3548-571X; Tryland, Morten/0000-0001-5394-5196				Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Baxby D., 1981, TRENDS IMMUNOL, V3, P26; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258; CZERNY CP, 1991, J VET MED B, V38, P421, DOI 10.1111/j.1439-0450.1991.tb00891.x; da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217; EISHUBINGER AM, 1990, LANCET, V336, P880, DOI 10.1016/0140-6736(90)92387-W; Emerson GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007666; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Jenner E, 1798, INQUIRY CAUSES EFFEC; Jenner E, 1799, FURTHER OBSERVATIONS; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kaysser P, 2010, VET MICROBIOL, V141, P282, DOI 10.1016/j.vetmic.2009.09.029; NAIDOO J, 1992, ARCH VIROL, V125, P261, DOI 10.1007/BF01309643; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; PILASKI J, 1986, ARCH VIROL, V88, P135, DOI 10.1007/BF01310898; Sandvik T, 1998, J CLIN MICROBIOL, V36, P2542, DOI 10.1128/JCM.36.9.2542-2547.1998; Shchelkunov SN, 1998, VIROLOGY, V243, P432, DOI 10.1006/viro.1998.9039; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THOMSETT LR, 1978, VET REC, V103, P567, DOI 10.1136/vr.103.25.567-b; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Yeruham I, 1996, Rev Elev Med Vet Pays Trop, V49, P299	25	70	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23086	10.1371/journal.pone.0023086	http://dx.doi.org/10.1371/journal.pone.0023086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858000	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300018
J	Matera, JT; Monroe, J; Smelser, W; Gabay-Laughnan, S; Newton, KJ				Matera, John T.; Monroe, Jessica; Smelser, Woodson; Gabay-Laughnan, Susan; Newton, Kathleen J.			Unique Changes in Mitochondrial Genomes Associated with Reversions of S-Type Cytoplasmic Male Sterility in Maizemar	PLOS ONE			English	Article							CMS-S; OF-FERTILITY; REVERTANTS; RESTORER; RECOMBINATION; TEOSINTE; GENE	Cytoplasmic male sterility (CMS) in plants is usually associated with the expression of specific chimeric regions within rearranged mitochondrial genomes. Maize CMS-S plants express high amounts of a 1.6-kb mitochondrial RNA during microspore maturation, which is associated with the observed pollen abortion. This transcript carries two chimeric open reading frames, orf355 and orf77, both unique to CMS-S. CMS-S mitochondria also contain free linear DNA plasmids bearing terminal inverted repeats (TIRs). These TIRs recombine with TIR-homologous sequences that precede orf355/orf77 within the main mitochondrial genome to produce linear ends. Transcription of the 1.6-kb RNA is initiated from a promoter within the TIRs only when they are at linear ends. Reversions of CMS-S to fertility occur in certain nuclear backgrounds and are usually associated with loss of the S plasmids and/or the sterility-associated region. We describe an unusual set of independently recovered revertants from a single maternal lineage that retain both the S plasmids and an intact orf355/orf77 region but which do not produce the 1.6-kb RNA. A 7.3-kb inversion resulting from illegitmate recombination between 14-bp microrepeats has separated the genomic TIR sequences from the CMS-associated region. Although RNAs containing orf355/orf77 can still be detected in the revertants, they are not highly expressed during pollen development and they are no longer initiated from the TIR promoter at a protein-stabilized linear end. They appear instead to be co-transcribed with cytochrome oxidase subunit 2. The 7.3-kb inversion was not detected in CMS-S or in other fertile revertants. Therefore, this inversion appears to be a de novo mutation that has continued to sort out within a single maternal lineage, giving rise to fertile progeny in successive generations.	[Matera, John T.; Monroe, Jessica; Smelser, Woodson; Newton, Kathleen J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Gabay-Laughnan, Susan] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	University of Missouri System; University of Missouri Columbia; University of Illinois System; University of Illinois Urbana-Champaign	Matera, JT (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	newtonk@missouri.edu			United States National Science Foundation; Department of Energy; University of Missouri; MU-Monsanto Undergraduate Research Fund; Colleges of Arts and Sciences and of Agriculture, Food and Natural Resources	United States National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); University of Missouri; MU-Monsanto Undergraduate Research Fund; Colleges of Arts and Sciences and of Agriculture, Food and Natural Resources	This research was funded by grants from the United States National Science Foundation (to KJN) and the Department of Energy (to SGL). Undergraduate fellowships for JTM, JM and WS were provided by the University of Missouri Life Sciences Undergraduate Research Opportunity Program, the MU-Monsanto Undergraduate Research Fund, as well as by the Colleges of Arts and Sciences and of Agriculture, Food and Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Allen JO, 2005, GENETICS, V169, P863, DOI 10.1534/genetics.104.027300; ALLEN JO, 1992, THESIS U WISCONSIN M; BECKETT JB, 1971, CROP SCI, V11, P724; BUCHERT JG, 1961, P NATL ACAD SCI USA, V47, P1436, DOI 10.1073/pnas.47.9.1436; ESCOTE LJ, 1985, PLASMID, V14, P264, DOI 10.1016/0147-619X(85)90011-3; ESCOTECARLSON LJ, 1988, THEOR APPL GENET, V75, P659, DOI 10.1007/BF00289135; FAURON C, 1995, TRENDS GENET, V11, P228, DOI 10.1016/S0168-9525(00)89056-3; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; Gabay-Laughnan S, 2005, MAYDICA, V50, P349; Gabay-Laughnan S, 2000, MAYDICA, V45, P117; Gabay-Laughnan S, 2004, GENETICS, V166, P959, DOI 10.1534/genetics.166.2.959; Gabay-Laughnan S, 1995, ADV CELLULAR MOL BIO, V2, P395; Gabay-Laughnan Susan, 1994, P418; Gabay-Laughnan S, 2009, GENETICS, V182, P91, DOI 10.1534/genetics.108.099895; ISHIGE T, 1985, JPN J BREED, V35, P285; KEMBLE R J, 1983, Journal of Molecular and Applied Genetics, V2, P161; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; LAUER M, 1990, New Biologist, V2, P179; LAUGHNAN JR, 1981, CHARACTERISTICS CMS, P93; LEVINGS CS, 1980, SCIENCE, V209, P1021, DOI 10.1126/science.209.4460.1021; Lupold DS, 1999, J BIOL CHEM, V274, P3897, DOI 10.1074/jbc.274.6.3897; Lupold DS, 1999, P NATL ACAD SCI USA, V96, P11670, DOI 10.1073/pnas.96.20.11670; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Newton Kathleen J., 1994, P549; NEWTON KJ, 1990, PLANT CELL, V2, P107, DOI 10.1105/tpc.2.2.107; Newton KJ, 2004, ADV PHOTO RESPIRAT, V17, P121; NEWTON KJ, 1986, P NATL ACAD SCI USA, V83, P7363, DOI 10.1073/pnas.83.19.7363; Newton KJ, 1996, DEV GENET, V19, P277, DOI 10.1002/(SICI)1520-6408(1996)19:3<277::AID-DVG11>3.0.CO;2-X; NEWTON KJ, 2009, MITOCHONDRIA CHLOROP, P481; PRING DR, 1977, P NATL ACAD SCI USA, V74, P2904, DOI 10.1073/pnas.74.7.2904; SCHARDL CL, 1985, CELL, V43, P361, DOI 10.1016/0092-8674(85)90041-8; SCHARDL CL, 1984, NATURE, V310, P292, DOI 10.1038/310292a0; Singer T, 2003, METH MOL B, V236, P241; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; SMALL ID, 1988, THEOR APPL GENET, V76, P609, DOI 10.1007/BF00260916; STERN DB, 1986, METHOD ENZYMOL, V118, P488; Wen LY, 1999, CURR GENET, V35, P521, DOI 10.1007/s002940050448; Zabala G, 1997, GENETICS, V147, P847	39	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23405	10.1371/journal.pone.0023405	http://dx.doi.org/10.1371/journal.pone.0023405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858103	gold, Green Published, Green Submitted			2022-12-27	WOS:000293773300027
J	Rederstorff, M; Castets, P; Arbogast, S; Laine, J; Vassilopoulos, S; Beuvin, M; Dubourg, O; Vignaud, A; Ferry, A; Krol, A; Allamand, V; Guicheney, P; Ferreiro, A; Lescure, A				Rederstorff, Mathieu; Castets, Perrine; Arbogast, Sandrine; Laine, Jeanne; Vassilopoulos, Stephane; Beuvin, Maud; Dubourg, Odile; Vignaud, Alban; Ferry, Arnaud; Krol, Alain; Allamand, Valerie; Guicheney, Pascale; Ferreiro, Ana; Lescure, Alain			Increased Muscle Stress-Sensitivity Induced by Selenoprotein N Inactivation in Mouse: A Mammalian Model for SEPN1-Related Myopathy	PLOS ONE			English	Article							FORCED SWIMMING TEST; OXIDATIVE STRESS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; MUTATIONS; PHENOTYPE; ARCHITECTURE; DISEASE; SEPN1; MICE	Selenium is an essential trace element and selenoprotein N (SelN) was the first selenium-containing protein shown to be directly involved in human inherited diseases. Mutations in the SEPN1 gene, encoding SelN, cause a group of muscular disorders characterized by predominant affection of axial muscles. SelN has been shown to participate in calcium and redox homeostasis, but its pathophysiological role in skeletal muscle remains largely unknown. To address SelN function in vivo, we generated a Sepn1-null mouse model by gene targeting. The Sepn1(-/-) mice had normal growth and lifespan, and were macroscopically indistinguishable from wild-type littermates. Only minor defects were observed in muscle morphology and contractile properties in SelN-deficient mice in basal conditions. However, when subjected to challenging physical exercise and stress conditions (forced swimming test), Sepn1(-/-) mice developed an obvious phenotype, characterized by limited motility and body rigidity during the swimming session, as well as a progressive curvature of the spine and predominant alteration of paravertebral muscles. This induced phenotype recapitulates the distribution of muscle involvement in patients with SEPN1-Related Myopathy, hence positioning this new animal model as a valuable tool to dissect the role of SelN in muscle function and to characterize the pathophysiological process.	[Rederstorff, Mathieu; Krol, Alain; Lescure, Alain] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, Strasbourg, France; [Castets, Perrine; Arbogast, Sandrine; Laine, Jeanne; Vassilopoulos, Stephane; Beuvin, Maud; Dubourg, Odile; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie; Guicheney, Pascale; Ferreiro, Ana] Univ Paris 06, IFR14, Paris, France; [Castets, Perrine; Laine, Jeanne; Beuvin, Maud; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie] CNRS, UMR7215, Paris, France; [Castets, Perrine; Laine, Jeanne; Beuvin, Maud; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie] INSERM, U974, Paris, France; [Castets, Perrine; Arbogast, Sandrine; Laine, Jeanne; Vassilopoulos, Stephane; Beuvin, Maud; Dubourg, Odile; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie; Ferreiro, Ana] Inst Myol, Paris, France; [Arbogast, Sandrine; Vassilopoulos, Stephane; Dubourg, Odile; Ferreiro, Ana] INSERM, UMR, U787, Paris, France; [Laine, Jeanne] Univ Paris 06, Dept Physiol, Paris, France; [Ferry, Arnaud] Univ Paris 05, Paris, France; [Guicheney, Pascale] INSERM, U956, Paris, France; [Ferreiro, Ana] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rederstorff, M (corresponding author), Nancy Univ, CNRS, UMR 7214, AREMS, Vandoeuvre Les Nancy, France.	a.lescure@ibmc-cnrs.unistra.fr	Guicheney, Pascale/D-1034-2017; Arbogast, Sandrine/F-1965-2016; Ferreiro, Ana/F-5371-2011; vassilopoulos, stephane/AAF-3865-2021; REDERSTORFF, Mathieu/A-8270-2008; vassilopoulos, stéphane/F-6041-2014; ferry, arnaud/D-2816-2019; Allamand, Valerie/M-4333-2017; Allamand, Valérie/AAH-6272-2021	Guicheney, Pascale/0000-0002-7663-2050; Arbogast, Sandrine/0000-0001-5228-2255; Ferreiro, Ana/0000-0003-2806-5386; vassilopoulos, stephane/0000-0003-0172-330X; REDERSTORFF, Mathieu/0000-0002-4931-0777; ferry, arnaud/0000-0002-6050-4556; Allamand, Valérie/0000-0001-8997-9742	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); Contrat d'Interface INSERM-APHP; Ministere de la recherche et de l'enseignement; University Strasbourg; UPMC	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Contrat d'Interface INSERM-APHP; Ministere de la recherche et de l'enseignement; University Strasbourg; UPMC	This work was supported by funds from the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Association Francaise contre les Myopathies (AFM). A. Ferreiro is the recipient of a Contrat d'Interface INSERM-APHP. M. R. received PhD fellowships from the Ministere de la recherche et de l'enseignement and University Strasbourg. P. C. received PhD fellowships from the Ministere de la recherche et de l'enseignement, UPMC Univ Paris 06 and AFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Arbogast S, 2010, ANTIOXID REDOX SIGN, V12, P893, DOI 10.1089/ars.2009.2890; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Barker T, 2007, J PHYSIOL-LONDON, V583, P421, DOI 10.1113/jphysiol.2007.139378; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; BRADFORD DS, 1974, J BONE JOINT SURG AM, VA 56, P740, DOI 10.2106/00004623-197456040-00009; Cagliani R, 2011, J NEUROL SCI, V300, P107, DOI 10.1016/j.jns.2010.09.011; CASTETS P, 2010, HUM MOL GENET; Castets P, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-46; Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832; Clarke NF, 2006, ANN NEUROL, V59, P546, DOI 10.1002/ana.20761; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Deniziak M, 2007, EXP CELL RES, V313, P156, DOI 10.1016/j.yexcr.2006.10.005; Ferreiro A, 2004, ANN NEUROL, V55, P676, DOI 10.1002/ana.20077; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Jurynec MJ, 2008, P NATL ACAD SCI USA, V105, P12485, DOI 10.1073/pnas.0806015105; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Lescure A, 2009, BBA-GEN SUBJECTS, V1790, P1569, DOI 10.1016/j.bbagen.2009.03.002; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; MACLENNAN DH, 2010, BIOCH BIOPHYS ACTA; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Rederstorff M, 2006, CELL MOL LIFE SCI, V63, P52, DOI 10.1007/s00018-005-5313-y; RUDERT CP, 1978, VET REC, V102, P374, DOI 10.1136/vr.102.17.374; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Schara U, 2008, EUR J PAEDIATR NEURO, V12, P224, DOI 10.1016/j.ejpn.2007.08.011; Scoto M, 2011, NEUROLOGY, V76, P2073, DOI 10.1212/WNL.0b013e31821f467c; Serrano AL, 2001, P NATL ACAD SCI USA, V98, P13108, DOI 10.1073/pnas.231148598; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Taille C, 2001, AM J RESP CRIT CARE, V163, P753, DOI 10.1164/ajrccm.163.3.2004202; Thisse C, 2003, GENE EXPR PATTERNS, V3, P525, DOI 10.1016/S1567-133X(03)00054-1; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Vignaud A, 2005, TOXICON, V45, P789, DOI 10.1016/j.toxicon.2005.02.001; Wang WX, 2008, PROG NEURO-PSYCHOPH, V32, P1179, DOI 10.1016/j.pnpbp.2007.12.021; Xia X, 2007, J ETHNOPHARMACOL, V110, P356, DOI 10.1016/j.jep.2006.09.042	47	54	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23094	10.1371/journal.pone.0023094	http://dx.doi.org/10.1371/journal.pone.0023094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858002	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300020
J	Cheung, CHA; Lin, WH; Hsu, JTA; Hour, TC; Yeh, TK; Ko, SK; Lien, TW; Coumar, MS; Liu, JF; Lai, WY; Shiao, HY; Lee, TR; Hsieh, HP; Chang, JY				Cheung, Chun Hei Antonio; Lin, Wen-Hsing; Hsu, John Tsu-An; Hour, Tzyh-Chyuan; Yeh, Teng-Kuang; Ko, Shengkai; Lien, Tzu-Wen; Coumar, Mohane Selvaraj; Liu, Jin-Fen; Lai, Wen-Yang; Shiao, Hui-Yi; Lee, Tian-Ren; Hsieh, Hsing-Pang; Chang, Jang-Yang			BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; B-KINASE; DRUG-RESISTANCE; FREQUENT OVEREXPRESSION; SELECTIVE INHIBITOR; ANTITUMOR-ACTIVITY; LUNG-CARCINOMA; IN-VITRO; GENE; EXPRESSION	Background: Over-expression of Aurora kinases promotes the tumorigenesis of cells. The aim of this study was to determine the preclinical profile of a novel pan-Aurora kinase inhibitor, BPR1K653, as a candidate for anti-cancer therapy. Since expression of the drug efflux pump, MDR1, reduces the effectiveness of various chemotherapeutic compounds in human cancers, this study also aimed to determine whether the potency of BPR1K653 could be affected by the expression of MDR1 in cancer cells. Principal Findings: BPR1K653 specifically inhibited the activity of Aurora-A and Aurora-B kinase at low nano-molar concentrations in vitro. Anti-proliferative activity of BPR1K653 was evaluated in various human cancer cell lines. Results of the clonogenic assay showed that BPR1K653 was potent in targeting a variety of cancer cell lines regardless of the tissue origin, p53 status, or expression of MDR1. At the cellular level, BPR1K653 induced endo-replication and subsequent apoptosis in both MDR1-negative and MDR1-positive cancer cells. Importantly, it showed potent activity against the growth of xenograft tumors of the human cervical carcinoma KB and KB-derived MDR1-positive KB-VIN10 cells in nude mice. Finally, BPR1K653 also exhibited favorable pharmacokinetic properties in rats. Conclusions and Significance: BPR1K653 is a novel potent anti-cancer compound, and its potency is not affected by the expression of the multiple drug resistant protein, MDR1, in cancer cells. Therefore, BPR1K653 is a promising anti-cancer compound that has potential for the management of various malignancies, particularly for patients with MDR1-related drug resistance after prolonged chemotherapeutic treatments.	[Cheung, Chun Hei Antonio; Liu, Jin-Fen; Lai, Wen-Yang; Lee, Tian-Ren; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Lin, Wen-Hsing; Hsu, John Tsu-An; Yeh, Teng-Kuang; Ko, Shengkai; Lien, Tzu-Wen; Shiao, Hui-Yi; Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Miaoli County, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [Coumar, Mohane Selvaraj] Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Kalapet, Puducherry, India; [Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Tainan 70428, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Pondicherry University; National Cheng Kung University; National Cheng Kung University Hospital	Cheung, CHA (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	hphsieh@nhri.org.tw; jychang@nhri.org.tw	Lin, Wen-Hsing/K-8580-2013; Selvaraj, Mohane C/M-5095-2015; Hsieh, Hsing-Pang/B-2649-2010; Coumar, Mohane/C-3393-2008; Hsu, John Tsu-An/C-1199-2010; Chang, Jang-Yang/D-2099-2010; Chang, Jang-Yang/M-3656-2014	Lin, Wen-Hsing/0000-0001-5023-310X; Selvaraj, Mohane C/0000-0002-0505-568X; Hsieh, Hsing-Pang/0000-0002-1332-005X; Cheung, Chun Hei Antonio/0000-0003-4181-1435	National Science Council [NSC99-2323-B-400-006, NSC99-2323-B-400-007, NSC99-2120-M-006-005]; Department of Health [DOH99-TD-C-111-004]; National Health Research Institutes, Taiwan R.O.C. [CA-099-PP-02]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; National Health Research Institutes, Taiwan R.O.C.(National Health Research Institutes - Taiwan)	The study was supported by grants from the National Science Council (NSC99-2323-B-400-006, NSC99-2323-B-400-007, NSC99-2120-M-006-005), Department of Health (DOH99-TD-C-111-004), and National Health Research Institutes (CA-099-PP-02), Taiwan R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2009, BIOCHEM J, V420, P259, DOI 10.1042/BJ20090121; Arbitrario JP, 2010, CANCER CHEMOTH PHARM, V65, P707, DOI 10.1007/s00280-009-1076-8; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Cheung CH, 2010, EXPERT OPIN INV DRUG, V19, P1; Cheung CHA, 2011, EXPERT OPIN THER PAT, V21, P857, DOI 10.1517/13543776.2011.574614; Cheung CHA, 2009, EXPERT OPIN INV DRUG, V18, P379, DOI [10.1517/13543780902806392 , 10.1517/13543780902806392]; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Coumar MS, 2010, CHEMMEDCHEM, V5, P255, DOI 10.1002/cmdc.200900339; Coumar MS, 2009, EXPERT OPIN THER PAT, V19, P321, DOI 10.1517/13543770802646949; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; FERGUSON PJ, 1988, CANCER RES, V48, P5956; Gaj CL, 1998, BIOCHEM PHARMACOL, V55, P1199, DOI 10.1016/S0006-2952(97)00614-X; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; GOLDSTEIN LJ, 1990, J CLIN ONCOL, V8, P128, DOI 10.1200/JCO.1990.8.1.128; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Guo J, 2009, PHARMACOGENOMICS J, V9, P90, DOI 10.1038/tpj.2008.20; Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hsieh CC, 2010, BIOCHEM PHARMACOL, V79, P1261, DOI 10.1016/j.bcp.2009.12.017; Huang GC, 2004, JPN J CLIN ONCOL, V34, P499, DOI 10.1093/jjco/hyh091; KANAMARU H, 1989, J NATL CANCER I, V81, P844, DOI 10.1093/jnci/81.11.844; Keshelava N, 2001, CANCER RES, V61, P6185; Kitajima S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000944; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Liou JP, 2007, J PHARMACOL EXP THER, V323, P398, DOI 10.1124/jpet.107.126680; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; Lukasiewicz KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021291; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; PARK JG, 1994, J NATL CANCER I, V86, P700, DOI 10.1093/jnci/86.9.700; Payton MN, 2010, CANCER RES, V70; PELLATDECEUNYNK C, 1995, BLOOD, V86, P4001, DOI 10.1182/blood.V86.10.4001.bloodjournal86104001; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Sabatino MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-259; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Susa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010764; Tsuno T, 2007, J NEURO-ONCOL, V83, P249, DOI 10.1007/s11060-007-9335-1; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Usanova S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-248; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Warmann S, 2003, ANTICANCER RES, V23, P4607; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zeng WFF, 2007, J CLIN PATHOL, V60, P218, DOI 10.1136/jcp.2006.036806	51	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23485	10.1371/journal.pone.0023485	http://dx.doi.org/10.1371/journal.pone.0023485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887256	Green Published, Green Submitted, gold			2022-12-27	WOS:000295832000020
J	Gandapu, U; Chaitanya, RK; Kishore, G; Reddy, RC; Kondapi, AK				Gandapu, Upendhar; Chaitanya, R. K.; Kishore, Golla; Reddy, Raju C.; Kondapi, Anand K.			Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TARGETED DRUG-DELIVERY; LONG TERMINAL REPEAT; ENCAPSULATED CURCUMIN; RECEIVING ZIDOVUDINE; DIFERULOYL METHANE; GENE-EXPRESSION; RATS; INTEGRASE; CELLS	Background: Curcumin (diferuloylmethane) shows significant activity across a wide spectrum of conditions, but its usefulness is rather limited because of its low bioavailability. Use of nanoparticle formulations to enhance curcumin bioavailability is an emerging area of research. Methodology/Principal Findings: In the present study, curcumin-loaded apotransferrin nanoparticles (nano-curcumin) prepared by sol-oil chemistry and were characterized by electron and atomic force microscopy. Confocal studies and fluorimetric analysis revealed that these particles enter T cells through transferrin-mediated endocytosis. Nano-curcumin releases significant quantities of drug gradually over a fairly long period, similar to 50% of curcumin still remaining at 6 h of time. In contrast, intracellular soluble curcumin (sol-curcumin) reaches a maximum at 2 h followed by its complete elimination by 4 h. While sol-curcumin (GI(50) = 15.6 mu M) is twice more toxic than nano-curcumin (GI(50) = 32.5 mu M), nano-curcumin (IC50 < 1.75 mu M) shows a higher anti-HIV activity compared to sol-curcumin (IC50 = 5.1 mu M). Studies in vitro showed that nano-curcumin prominently inhibited the HIV-1 induced expression of Topo II alpha, IL-1 beta and COX-2, an effect not seen with sol-curcumin. Nano-curcumin did not affect the expression of Topoisomerase II beta and TNF alpha. This point out that nano-curcumin affects the HIV-1 induced inflammatory responses through pathways downstream or independent of TNF alpha. Furthermore, nano-curcumin completely blocks the synthesis of viral cDNA in the gag region suggesting that the nano-curcumin mediated inhibition of HIV-1 replication is targeted to viral cDNA synthesis. Conclusion: Curcumin-loaded apotransferrin nanoparticles are highly efficacious inhibitors of HIV-1 replication in vitro and promise a high potential for clinical usefulness.	[Gandapu, Upendhar; Chaitanya, R. K.; Kondapi, Anand K.] Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Kishore, Golla; Kondapi, Anand K.] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Kishore, Golla; Kondapi, Anand K.] Univ Hyderabad, Ctr Nanotechnol, Hyderabad 500134, Andhra Pradesh, India; [Reddy, Raju C.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA	University of Hyderabad; University of Hyderabad; University of Hyderabad; Emory University	Gandapu, U (corresponding author), Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	akksl@uohyd.ernet.in	Reddy, Raju C/GLR-5338-2022	Reddy, Raju C/0000-0001-7079-1520	National Institutes of Health [AI079539]; Indian Council of Medical Research [Indo-US/67/2007-ECD-II]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI079539 and Indian Council of Medical Research grant Indo-US/67/2007-ECD-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; Barthelemy S, 1998, RES VIROLOGY, V149, P43, DOI 10.1016/S0923-2516(97)86899-9; Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3; Bouille P, 1999, J MOL BIOL, V285, P945, DOI 10.1006/jmbi.1998.2360; Cheng AL, 2001, ANTICANCER RES, V21, P2895; DEODHAR SD, 1980, INDIAN J MED RES, V71, P632; Deveaud C, 2005, BIOCHEM PHARMACOL, V70, P90, DOI 10.1016/j.bcp.2005.04.015; Garcea G, 2004, BRIT J CANCER, V90, P1011, DOI 10.1038/sj.bjc.6601623; KISO Y, 1983, PLANTA MED, V49, P185, DOI 10.1055/s-2007-969845; Kondapi AK, 2006, ARCH BIOCHEM BIOPHYS, V450, P123, DOI 10.1016/j.abb.2006.04.003; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; KUMAR DR, 2010, NANOMED-NANOTECHNOL, V6, P153; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; LI CJ, 1993, P NATL ACAD SCI USA, V90, P1839, DOI 10.1073/pnas.90.5.1839; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Mahady GB, 2002, ANTICANCER RES, V22, P4179; Mandraju RK, 2007, ARCH BIOCHEM BIOPHYS, V461, P40, DOI 10.1016/j.abb.2007.01.026; Martin-Cordero C, 2003, J ENZYM INHIB MED CH, V18, P505, DOI 10.1080/14756360310001613085; MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A; MHIRI C, 1991, ANN NEUROL, V29, P606, DOI 10.1002/ana.410290607; Moh R, 2005, ANTIVIR THER, V10, P615; Nirmala C, 1996, MOL CELL BIOCHEM, V159, P85, DOI 10.1007/BF00420910; OLANO JP, 1995, CLIN INFECT DIS, V21, P973, DOI 10.1093/clinids/21.4.973; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Savarino A, 1999, CELL BIOCHEM FUNCT, V17, P47, DOI 10.1002/(SICI)1099-0844(199903)17:1<47::AID-CBF810>3.0.CO;2-V; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; SINNWELL TM, 1995, J CLIN INVEST, V96, P126, DOI 10.1172/JCI118012; SMITH SD, 1984, CANCER RES, V44, P5657; SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x; SRIVASTAVA R, 1985, THROMB RES, V40, P413, DOI 10.1016/0049-3848(85)90276-2; Sui Z, 1993, Bioorg Med Chem, V1, P415, DOI 10.1016/S0968-0896(00)82152-5; Sun AM, 2006, J MED CHEM, V49, P3153, DOI 10.1021/jm051141k; Taher MM, 2003, MOL CELL BIOCHEM, V254, P289, DOI 10.1023/A:1027393719610; THORSTENSEN K, 1993, SCAND J CLIN LAB INV, V53, P113, DOI 10.3109/00365519309090703; Venkatesan N, 2000, BRIT J PHARMACOL, V129, P231, DOI 10.1038/sj.bjp.0703067	41	48	51	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23388	10.1371/journal.pone.0023388	http://dx.doi.org/10.1371/journal.pone.0023388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887247	gold, Green Submitted, Green Published			2022-12-27	WOS:000294251800010
J	Chapman, JA; Ho, I; Sunkara, S; Luo, SJ; Schroth, GP; Rokhsar, DS				Chapman, Jarrod A.; Ho, Isaac; Sunkara, Sirisha; Luo, Shujun; Schroth, Gary P.; Rokhsar, Daniel S.			Meraculous: De Novo Genome Assembly with Short Paired-End Reads	PLOS ONE			English	Article							SEQUENCE; CHALLENGES; ALIGNMENT; ALLPATHS; MILLIONS; VELVET	We describe a new algorithm, meraculous, for whole genome assembly of deep paired-end short reads, and apply it to the assembly of a dataset of paired 75-bp Illumina reads derived from the 15.4 megabase genome of the haploid yeast Pichia stipitis. More than 95% of the genome is recovered, with no errors; half the assembled sequence is in contigs longer than 101 kilobases and in scaffolds longer than 269 kilobases. Incorporating fosmid ends recovers entire chromosomes. Meraculous relies on an efficient and conservative traversal of the subgraph of the k-mer (deBruijn) graph of oligonucleotides with unique high quality extensions in the dataset, avoiding an explicit error correction step as used in other short-read assemblers. A novel memory-efficient hashing scheme is introduced. The resulting contigs are ordered and oriented using paired reads separated by similar to 280 bp or similar to 3.2 kbp, and many gaps between contigs can be closed using paired-end placements. Practical issues with the dataset are described, and prospects for assembling larger genomes are discussed.	[Chapman, Jarrod A.; Ho, Isaac; Sunkara, Sirisha; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Luo, Shujun] Illumina Inc, Hayward, CA USA; [Schroth, Gary P.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Illumina; University of California System; University of California Berkeley	Chapman, JA (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	jchapman@lbl.gov		Rokhsar, Daniel/0000-0002-8704-2224	U.S. Department of Energy's Office of Science; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Center for Integrative Genomics at UC Berkeley; Gordon and Betty Moore Foundation	U.S. Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Center for Integrative Genomics at UC Berkeley; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was performed under the auspices of the U.S. Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, and at the Center for Integrative Genomics at UC Berkeley supported by a grant from the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors G. P. S. and S. L. are employees of Illumina and are also shareholders in the company. Illumina Inc. funded data collection and their contributions to this manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; EDWARDS A, 1991, Methods (Orlando), V3, P41, DOI 10.1016/S1046-2023(05)80162-8; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2004, APPL MICROBIOL BIOT, V63, P495, DOI 10.1007/s00253-003-1450-0; LANDER E S, 1988, Genomics, V2, P231; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	38	118	129	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23501	10.1371/journal.pone.0023501	http://dx.doi.org/10.1371/journal.pone.0023501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876754	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900026
J	Erlwein, O; Robinson, MJ; Dustan, S; Weber, J; Kaye, S; McClure, MO				Erlwein, Otto; Robinson, Mark J.; Dustan, Simon; Weber, Jonathan; Kaye, Steve; McClure, Myra O.			DNA Extraction Columns Contaminated with Murine Sequences	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; RETROVIRUS XMRV; MOUSE DNA; ABSENCE; PREVALENCE; FAILURE; SAMPLES; TUMORS	Sequences of the novel gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV) have been described in human prostate cancer tissue, although the amounts of DNA are low. Furthermore, XMRV sequences and polytropic (p) murine leukemia viruses (MLVs) have been reported in patients with chronic fatigue syndrome (CFS). In assessing the prevalence of XMRV in prostate cancer tissue samples we discovered that eluates from naive DNA purification columns, when subjected to PCR with primers designed to detect genomic mouse DNA contamination, occasionally gave rise to amplification products. Further PCR analysis, using primers to detect XMRV, revealed sequences derived from XMRV and pMLVs from mouse and human DNA and DNA of unspecified origin. Thus, DNA purification columns can present problems when used to detect minute amounts of DNA targets by highly sensitive amplification techniques.	[Erlwein, Otto; Robinson, Mark J.; Dustan, Simon; Weber, Jonathan; Kaye, Steve; McClure, Myra O.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Jefferiss Res Trust Labs, London, England	Imperial College London	Erlwein, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Jefferiss Res Trust Labs, London, England.	m.mcclure@imperial.ac.uk		McClure, Myra/0000-0002-5494-407X	NIHR Biomedical Research Centre; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors are grateful for support of this work from the NIHR Biomedical Research Centre funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Dupressoir A, 1997, ONCOGENE, V14, P2951, DOI 10.1038/sj.onc.1201148; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schutzer SE, 2011, ANN NEUROL, V69, P735, DOI 10.1002/ana.22389; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018	24	59	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23484	10.1371/journal.pone.0023484	http://dx.doi.org/10.1371/journal.pone.0023484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876752	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900024
J	Liu, JF; Obi, IR; Thanikkal, EJ; Kieselbach, T; Francis, MS				Liu, Junfa; Obi, Ikenna R.; Thanikkal, Edvin J.; Kieselbach, Thomas; Francis, Matthew S.			Phosphorylated CpxR Restricts Production of the RovA Global Regulator in Yersinia pseudotuberculosis	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; ASSISTED-LASER-DESORPTION/IONIZATION; HIGHLY SELECTIVE ENRICHMENT; ESCHERICHIA-COLI; RESPONSE REGULATOR; OUTER-MEMBRANE; DNA-BINDING; ACETYL PHOSPHATE; RNA-POLYMERASE; TRANSCRIPTIONAL ACTIVATION	Background: RovA is a global transcriptional regulator of gene expression in pathogenic Yersinia. RovA levels are kept in check by a sophisticated layering of distinct transcriptional and post-transcriptional regulatory mechanisms. In the enteropathogen Y. pseudotuberculosis, we have previously reported that the extracytoplasmic stress sensing CpxA-CpxR two-component regulatory system modulates rovA expression. Methodology/Principal Findings: In this study, we characterized CpxR phosphorylation (CpxR similar to P) in vitro, and determined that phosphorylation was necessary for CpxR to efficiently bind to the PCR-amplified upstream regulatory region of rovA. The precise CpxR similar to P binding site was mapped by a nuclease protection assay and directed mutagenesis confirmed that in vivo binding to the rovA promoter inhibits transcription. Reduced RovA production was most pronounced following CpxR, P accumulation in the Yersinia cytoplasm during chronic Cpx pathway activation and by the indiscriminate phosphodonor action of acetyl phosphate. Conclusions/Significance: Cpx pathway activation restricts levels of the RovA global regulator. The regulatory influence of CpxR similar to P must therefore extend well beyond periplasmic quality control in the Yersinia envelope, to include genes involved in environmental survival and pathogenicity.	[Liu, Junfa; Obi, Ikenna R.; Thanikkal, Edvin J.; Francis, Matthew S.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Liu, Junfa; Obi, Ikenna R.; Thanikkal, Edvin J.; Francis, Matthew S.] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Kieselbach, Thomas] Umea Univ, Dept Chem, Umea, Sweden; [Liu, Junfa] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China	Umea University; Umea University; Umea University; Huazhong Agricultural University	Liu, JF (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	matthew.francis@molbiol.umu.se	Kieselbach, Thomas/O-6023-2015	Kieselbach, Thomas/0000-0001-5577-2938; Obi, Ikenna/0000-0003-0364-8964; Francis, Matthew/0000-0001-6817-9535	Swedish Research Council [2006-3869, 2009-3660]; Carl Tryggers Foundation for Scientific Research [04:110, 06:141]; Medical Research Foundation at Umea University; Carl Tryggers Post-doctoral fellowship; Umea Centre for Microbial Research (UCMR); Wallenberg foundation; Kempe foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation for Scientific Research; Medical Research Foundation at Umea University; Carl Tryggers Post-doctoral fellowship; Umea Centre for Microbial Research (UCMR); Wallenberg foundation(European Commission); Kempe foundation	This work was principally supported by grants 2006-3869 and 2009-3660 from the Swedish Research Council (http://www.vr.se/) and 04:110 and 06:141 from Carl Tryggers Foundation for Scientific Research (http://www.carltryggersstiftelse.se). Partial funding was also received from the Medical Research Foundation at Umea University. JL was sponsored in part by a Carl Tryggers Post-doctoral fellowship and IRO is a Post-doctoral fellow supported by Umea Centre for Microbial Research (UCMR) Linnaeus Program (LP) (http://www.ucmr.umu.se/). The authors also thank the Wallenberg foundation (http://www.wallenberg.com/) and Kempe foundation (http://www.kempe.com/index_start.html) for their support of the instruments and bioinformatics infrastructure at the Umea Protein Analysis Facility. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; BOLIN I, 1984, INFECT IMMUN, V43, P72; Brzostek K, 2007, MICROBIOL-SGM, V153, P2416, DOI 10.1099/mic.0.2006/003202-0; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Carlsson KE, 2007, INFECT IMMUN, V75, P4386, DOI 10.1128/IAI.01450-06; Carlsson KE, 2007, INFECT IMMUN, V75, P3913, DOI 10.1128/IAI.01346-06; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; COSMA CL, 1995, MOL MICROBIOL, V18, P491, DOI 10.1111/j.1365-2958.1995.mmi_18030491.x; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; DANESE PN, 1995, J BACTERIOL, V177, P4969, DOI 10.1128/jb.177.17.4969-4973.1995; De Wulf P, 1999, J BACTERIOL, V181, P6772, DOI 10.1128/JB.181.21.6772-6778.1999; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; De Wulf P, 2000, J BACTERIOL, V182, P1423, DOI 10.1128/JB.182.5.1423-1426.2000; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Ellison DW, 2006, J BACTERIOL, V188, P5101, DOI 10.1128/JB.00862-05; Ellison DW, 2003, J BACTERIOL, V185, P7153, DOI 10.1128/JB.185.24.7153-7159.2003; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hirano Y, 2007, STRUCTURE, V15, P963, DOI 10.1016/j.str.2007.06.014; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Jubelin G, 2005, J BACTERIOL, V187, P2038, DOI 10.1128/JB.187.6.2038-2049.2005; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kussmann M, 1997, J MASS SPECTROM, V32, P483; Labandeira-Rey M, 2010, INFECT IMMUN, V78, P4779, DOI 10.1128/IAI.00678-10; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lau-Wong IC, 2008, MOL MICROBIOL, V67, P516, DOI 10.1111/j.1365-2958.2007.06055.x; Lawrenz MB, 2007, J BACTERIOL, V189, P5963, DOI 10.1128/JB.00528-07; Li L, 2008, MOL MICROBIOL, V68, P286, DOI 10.1111/j.1365-2958.2008.06151.x; MACRITCHIE DM, 2009, ECOSAL ESCHERICHIA C; MAKINO K, 1993, GENE DEV, V7, P149, DOI 10.1101/gad.7.1.149; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Miyadai H, 2004, J BIOL CHEM, V279, P39807, DOI 10.1074/jbc.M406390200; Mizrahi I, 2009, RES MICROBIOL, V160, P80, DOI 10.1016/j.resmic.2008.10.007; Mizrahi I, 2006, MOL MICROBIOL, V62, P201, DOI 10.1111/j.1365-2958.2006.05360.x; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Naktin J, 1999, CLIN LAB MED, V19, P523; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Perron-Savard P, 2005, MICROBIOL-SGM, V151, P3979, DOI 10.1099/mic.0.28236-0; Pogliano J, 1998, J BACTERIOL, V180, P3486, DOI 10.1128/JB.180.13.3486-3490.1998; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Purich DL, 2002, METHOD ENZYMOL, V354, P168; Raivio TL, 1997, J BACTERIOL, V179, P7724, DOI 10.1128/jb.179.24.7724-7733.1997; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; RAMANI N, 1992, MOL GEN GENET, V231, P248, DOI 10.1007/BF00279798; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; Suntharalingam P, 2003, J BACTERIOL, V185, P432, DOI 10.1128/JB.185.2.432-443.2003; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2003, MOL MICROBIOL, V48, P977, DOI 10.1046/j.1365-2958.2003.03457.x; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Yang YX, 1997, MOL MICROBIOL, V24, P499, DOI 10.1046/j.1365-2958.1997.3511719.x; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200	78	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23314	10.1371/journal.pone.0023314	http://dx.doi.org/10.1371/journal.pone.0023314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876746	Green Published, Green Submitted, gold			2022-12-27	WOS:000294126900018
J	Chono, H; Saito, N; Tsuda, H; Shibata, H; Ageyama, N; Terao, K; Yasutomi, Y; Mineno, J; Kato, I				Chono, Hideto; Saito, Naoki; Tsuda, Hiroshi; Shibata, Hiroaki; Ageyama, Naohide; Terao, Keiji; Yasutomi, Yasuhiro; Mineno, Junichi; Kato, Ikunoshin			In Vivo Safety and Persistence of Endoribonuclease Gene-Transduced CD4+T Cells in Cynomolgus Macaques for HIV-1 Gene Therapy Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; PROTEIN-SYNTHESIS; INFECTION; MEMORY; DEPLETION; REPLICATION; RESTORATION; EXPANSION; DELIVERY	Background: MazF is an endoribonuclease encoded by Escherichia coli that specifically cleaves the ACA sequence of mRNA. In our previous report, conditional expression of MazF in the HIV-1 LTR rendered CD4+ T lymphocytes resistant to HIV-1 replication. In this study, we examined the in vivo safety and persistence of MazF-transduced cynomolgus macaque CD4+ T cells infused into autologous monkeys. Methodology/Principal Findings: The in vivo persistence of the gene-modified CD4+ T cells in the peripheral blood was monitored for more than half a year using quantitative real-time PCR and flow cytometry, followed by experimental autopsy in order to examine the safety and distribution pattern of the infused cells in several organs. Although the levels of the MazF-transduced CD4+ T cells gradually decreased in the peripheral blood, they were clearly detected throughout the experimental period. Moreover, the infused cells were detected in the distal lymphoid tissues, such as several lymph nodes and the spleen. Histopathological analyses of tissues revealed that there were no lesions related to the infused gene modified cells. Antibodies against MazF were not detected. These data suggest the safety and the low immunogenicity of MazF-transduced CD4+ T cells. Finally, gene modified cells harvested from the monkey more than half a year post-infusion suppressed the replication of SHIV 89.6P. Conclusions/Significance: The long-term persistence, safety and continuous HIV replication resistance of the mazF gene-modified CD4+ T cells in the non-human primate model suggests that autologous transplantation of mazF gene-modified cells is an attractive strategy for HIV gene therapy.	[Chono, Hideto; Saito, Naoki; Tsuda, Hiroshi; Mineno, Junichi; Kato, Ikunoshin] Takara Bio Inc, Ctr Cell & Gene Therapy, Shiga, Japan; [Shibata, Hiroaki; Ageyama, Naohide; Terao, Keiji; Yasutomi, Yasuhiro] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan	Takara Bio Inc.; National Institute of Health Sciences - Japan	Chono, H (corresponding author), Takara Bio Inc, Ctr Cell & Gene Therapy, Shiga, Japan.	chonoh@takara-bio.co.jp	Ageyama, Naohide/ABG-5014-2020	Ageyama, Naohide/0000-0002-5722-2638				Ageyama N, 2003, J CLIN APHERESIS, V18, P26, DOI 10.1002/jca.10043; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baik S, 2009, J BACTERIOL, V191, P6157, DOI 10.1128/JB.00699-09; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chono H, 2011, HUM GENE THER, V22, P35, DOI 10.1089/hum.2010.001; DROPULIC B, 1994, HUM GENE THER, V5, P927, DOI 10.1089/hum.1994.5.8-927; Dropulic B, 2006, HUM GENE THER, V17, P577, DOI 10.1089/hum.2006.17.577; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kuramoto K, 2004, BLOOD, V104, P1273, DOI 10.1182/blood-2003-08-2935; Laurent J, 2010, J IMMUNOTHER, V33, P723, DOI 10.1097/CJI.0b013e3181ea7e6e; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Masuda S, 2009, EXP HEMATOL, V37, P1250, DOI 10.1016/j.exphem.2009.07.008; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Miyake A, 2006, J GEN VIROL, V87, P1311, DOI 10.1099/vir.0.81307-0; Onlamoon N, 2007, J MED PRIMATOL, V36, P206, DOI 10.1111/j.1600-0684.2007.00238.x; Onlamoon N, 2006, J MED PRIMATOL, V35, P178, DOI 10.1111/j.1600-0684.2006.00182.x; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; *PRIM SOC JAP, 1986, PRIMATE RES, V2, P111; Ranga U, 1998, P NATL ACAD SCI USA, V95, P1201, DOI 10.1073/pnas.95.3.1201; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; SARVER N, 1993, AIDS RES HUM RETROV, V9, P483, DOI 10.1089/aid.1993.9.483; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; van Lunzen J, 2007, MOL THER, V15, P1024, DOI 10.1038/mt.sj.6300124; Verzeletti S, 1998, HUM GENE THER, V9, P2243, DOI 10.1089/hum.1998.9.15-2243; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	39	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23585	10.1371/journal.pone.0023585	http://dx.doi.org/10.1371/journal.pone.0023585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858176	Green Submitted, gold, Green Published			2022-12-27	WOS:000294121300065
J	Yallowitz, AR; Hrycaj, SM; Short, KM; Smyth, IM; Wellik, DM				Yallowitz, Alisha R.; Hrycaj, Steven M.; Short, Kieran M.; Smyth, Ian M.; Wellik, Deneen M.			Hox10 Genes Function in Kidney Development in the Differentiation and Integration of the Cortical Stroma	PLOS ONE			English	Article							MICE LACKING GDNF; NEPHRON PROGENITOR POPULATION; ENTERIC NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; METANEPHRIC MESENCHYME; MAMMALIAN KIDNEY; EPITHELIAL TRANSFORMATION; INTERMEDIATE MESODERM; EXPRESSION PATTERN; RENAL DEVELOPMENT	Organogenesis requires the differentiation and integration of distinct populations of cells to form a functional organ. In the kidney, reciprocal interactions between the ureter and the nephrogenic mesenchyme are required for organ formation. Additionally, the differentiation and integration of stromal cells are also necessary for the proper development of this organ. Much remains to be understood regarding the origin of cortical stromal cells and the pathways involved in their formation and function. By generating triple mutants in the Hox10 paralogous group genes, we demonstrate that Hox10 genes play a critical role in the developing kidney. Careful examination of control kidneys show that Foxd1-expressing stromal precursor cells are first observed in a cap-like pattern anterior to the metanephric mesenchyme and these cells subsequently integrate posteriorly into the kidney periphery as development proceeds. While the initial cap-like pattern of Foxd1-expressing cortical stromal cells is unaffected in Hox10 mutants, these cells fail to become properly integrated into the kidney, and do not differentiate to form the kidney capsule. Consistent with loss of cortical stromal cell function, Hox10 mutant kidneys display reduced and aberrant ureter branching, decreased nephrogenesis. These data therefore provide critical novel insights into the cellular and genetic mechanisms governing cortical cell development during kidney organogenesis. These results, combined with previous evidence demonstrating that Hox11 genes are necessary for patterning the metanephric mesenchyme, support a model whereby distinct populations in the nephrogenic cord are regulated by unique Hox codes, and that differential Hox function along the AP axis of the nephrogenic cord is critical for the differentiation and integration of these cell types during kidney organogenesis.	[Yallowitz, Alisha R.; Hrycaj, Steven M.; Wellik, Deneen M.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Short, Kieran M.; Smyth, Ian M.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Smyth, Ian M.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia	University of Michigan System; University of Michigan; Monash University; Monash University	Yallowitz, AR (corresponding author), SUNY Stony Brook, Med Ctr, Dept Pathol, Stony Brook, NY 11794 USA.	dwellik@umich.edu	Short, Kieran/A-2604-2012; Short, Kieran/O-4476-2019	Short, Kieran/0000-0001-9137-008X; Short, Kieran/0000-0001-9137-008X; Smyth, Ian/0000-0002-1727-7829	National Institutes of Health [DK071929]; University of Michigan [T32-HD007505, T32-DK065517]; National Institutes of Health through University of Michigan's Cancer Center [5 P30 CA46592]; National Health and Medical Research Council (NHMRC); Monash University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071929, T32DK065517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); National Institutes of Health through University of Michigan's Cancer Center; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grant DK071929 (DW), by the University of Michigan's Training Program in Organogenesis T32-HD007505 (AY), by University of Michigan's Pediatric Nephrology fellowship T32-DK065517 (AY AND SH), and in part by the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (5 P30 CA46592). This work was also supported in part by fellowship support from the National Health and Medical Research Council (NH&MRC) and Monash University and Project Grant funding from the NH&MRC (IS and KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2002, KIDNEY INT, V61, P387, DOI 10.1046/j.1523-1755.2002.00164.x; Alcorn D, 1999, PEDIATR NEPHROL, V13, P347, DOI 10.1007/s004670050624; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Cho EA, 1998, DEVELOPMENT, V125, P803; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Cullen-McEwen LA, 2005, NEPHRON EXP NEPHROL, V99, pE1, DOI 10.1159/000081792; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Di Giacomo G, 2006, GENE EXPR PATTERNS; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Dudley AT, 1997, DEV DYNAM, V208, P349; EKBLOM P, 1991, KIDNEY INT, V39, P394, DOI 10.1038/ki.1991.51; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Guillaume R, 2009, DEV BIOL, V329, P169, DOI 10.1016/j.ydbio.2009.02.034; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hedlund E, 2004, J NEUROSCI RES, V75, P307, DOI 10.1002/jnr.10844; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; Hostikka SL, 1998, MECH DEVELOP, V70, P133, DOI 10.1016/S0925-4773(97)00182-2; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Levinson R, 2003, SEMIN CELL DEV BIOL, V14, P225, DOI 10.1016/S1084-9521(03)00025-9; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mugford JW, 2008, DEV BIOL, V319, P396, DOI 10.1016/j.ydbio.2008.03.044; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Nelson LT, 2008, DEV DYNAM, V237, P3410, DOI 10.1002/dvdy.21756; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Patterson LT, 2004, DEV DYNAM, V229, P771, DOI 10.1002/dvdy.10474; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Schnabel CA, 2003, GENESIS, V37, P123, DOI 10.1002/gene.10235; Schnabel CA, 2003, DEV BIOL, V254, P262, DOI 10.1016/S0012-1606(02)00038-6; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Short KM, 2010, KIDNEY INT IN PRESS; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Torres M, 1995, DEVELOPMENT, V121, P4057; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; Vega QC, 1996, P NATL ACAD SCI USA, V93, P10657, DOI 10.1073/pnas.93.20.10657; Wellik DM, 2002, GENE DEV, V16, P1423, DOI 10.1101/gad.993302; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yallowitz AR, 2009, DEV BIOL, V335, P156, DOI 10.1016/j.ydbio.2009.08.020; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9	72	41	42	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23410	10.1371/journal.pone.0023410	http://dx.doi.org/10.1371/journal.pone.0023410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858105	Green Submitted, gold, Green Published			2022-12-27	WOS:000294125500032
J	Khalife, M; Young, R; Passet, B; Halliez, S; Vilotte, M; Jaffrezic, F; Marthey, S; Beringue, V; Vaiman, D; Le Provost, F; Laude, H; Vilotte, JL				Khalife, Manal; Young, Rachel; Passet, Bruno; Halliez, Sophie; Vilotte, Marthe; Jaffrezic, Florence; Marthey, Sylvain; Beringue, Vincent; Vaiman, Daniel; Le Provost, Fabienne; Laude, Hubert; Vilotte, Jean-Luc			Transcriptomic Analysis Brings New Insight into the Biological Role of the Prion Protein during Mouse Embryogenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION PROFILE; DEVELOPMENTAL EXPRESSION; PRP; MICE; PROLIFERATION; LACKING; DIFFERENTIATION; IDENTIFICATION; SUPPRESSES	The biological function of the Prion protein remains largely unknown but recent data revealed its implication in early zebrafish and mammalian embryogenesis. To gain further insight into its biological function, comparative transcriptomic analysis between FVB/N and FVB/N Prnp knockout mice was performed at early embryonic stages. RNAseq analysis revealed the differential expression of 73 and 263 genes at E6.5 and E7.5, respectively. The related metabolic pathways identified in this analysis partially overlap with those described in PrP1 and PrP2 knockdown zebrafish embryos and prion-infected mammalian brains and emphasize a potentially important role for the PrP family genes in early developmental processes.	[Khalife, Manal; Young, Rachel; Passet, Bruno; Vilotte, Marthe; Jaffrezic, Florence; Marthey, Sylvain; Le Provost, Fabienne; Vilotte, Jean-Luc] INRA, UMR1313, Jouy En Josas, France; [Halliez, Sophie; Beringue, Vincent; Laude, Hubert] INRA, UR892, Jouy En Josas, France; [Vaiman, Daniel] Inst Cochin Genet Mol, INSERM, U567, F-75014 Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Khalife, M (corresponding author), INRA, UMR1313, Jouy En Josas, France.	jean-luc.vilotte@jouy.inra.fr	Vaiman, Daniel/O-6030-2015; Halliez, Sophie/ABA-1356-2020; Vilotte, Jean-Luc/AAF-4688-2019	Vaiman, Daniel/0000-0002-1915-0717; Halliez, Sophie/0000-0002-6173-9752; 	INRA; INRA AIP BioRessource PRIFASTEM;  [ANR-09-BLAN-0015-01]	INRA; INRA AIP BioRessource PRIFASTEM; 	R.Y. is a post-doctoral scientist supported by the ANR-09-BLAN-0015-01. S. H. is a post-doctoral scientist supported by an INRA-Transfert fellowship and by the ANR-09-BLAN-0015-01. This work was supported by the ANR-09-BLAN-0015-01 and by the INRA AIP BioRessource PRIFASTEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; Bedi A, 2010, J SHOULDER ELB SURG, V19, P384, DOI 10.1016/j.jse.2009.07.010; Benvegnu S, 2011, PHYSIOL GENOMICS, V43, P711, DOI 10.1152/physiolgenomics.00205.2010; Bianco C, 2010, AM J PATHOL, V177, P532, DOI 10.2353/ajpath.2010.100102; Biswas S, 2010, J CELL BIOL, V191, P1029, DOI 10.1083/jcb.201007008; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CERVENAKOVA L, 2011, TRANSFUSION; Chadi S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-448; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Crecelius AC, 2008, NEUROREPORT, V19, P1027, DOI 10.1097/WNR.0b013e3283046157; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gao F, 2004, MOL CELL BIOL, V24, P9899, DOI 10.1128/MCB.24.22.9899-9910.2004; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Hajj GNM, 2009, J COMP NEUROL, V517, P371, DOI 10.1002/cne.22157; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hidaka K, 2010, CIRC RES, V106, P111, DOI 10.1161/CIRCRESAHA.109.209478; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Hwang HS, 2010, ACTA OBSTET GYN SCAN, V89, P1155, DOI 10.3109/00016349.2010.498497; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kovacs GG, 2009, INT J MOL SCI, V10, P976, DOI 10.3390/ijms10030976; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Lee YJ, 2010, J NEUROCHEM, V114, P362, DOI 10.1111/j.1471-4159.2010.06601.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Malaga-Trillo E, 2011, BBA-MOL BASIS DIS, V1812, P402, DOI 10.1016/j.bbadis.2010.09.013; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON J, 1992, DEVELOPMENT, V115, P117; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; Miele G, 2003, GENE EXPRESSION, V11, P1, DOI 10.3727/000000003783992324; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Natale DRC, 2009, DEV BIOL, V335, P120, DOI 10.1016/j.ydbio.2009.08.022; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Ostlund P, 2001, J BIOL CHEM, V276, P36110, DOI 10.1074/jbc.M105710200; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pelton TA, 2002, J CELL SCI, V115, P329; Peralta OA, 2011, DIFFERENTIATION, V81, P68, DOI 10.1016/j.diff.2010.09.181; Prcina M, 2011, MED HYPOTHESES, V76, P567, DOI 10.1016/j.mehy.2011.01.002; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Satoh J, 2000, AM J PATHOL, V157, P59, DOI 10.1016/S0002-9440(10)64517-8; Schneider B, 2011, FRONT BIOSCI-LANDMRK, V16, P169, DOI 10.2741/3682; Screen M, 2008, DEVELOPMENT, V135, P3311, DOI 10.1242/dev.025627; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Strom A, 2011, EUR J CELL BIOL, V90, P414, DOI 10.1016/j.ejcb.2010.11.015; Tremblay P, 2007, BRAIN RES, V1139, P60, DOI 10.1016/j.brainres.2006.12.055; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhang HJ, 2008, PLACENTA, V29, P549, DOI 10.1016/j.placenta.2008.03.003; Zhang YH, 1997, J CLIN INVEST, V99, P894, DOI 10.1172/JCI119254; Zhong W, 2006, MOL REPROD DEV, V73, P540, DOI 10.1002/mrd.20417; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	74	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23253	10.1371/journal.pone.0023253	http://dx.doi.org/10.1371/journal.pone.0023253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858045	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700010
J	Bhattacharyya, S; Tian, JM; Bouhassira, EE; Locker, J				Bhattacharyya, Sanchari; Tian, Jianmin; Bouhassira, Eric E.; Locker, Joseph			Systematic Targeted Integration to Study Albumin Gene Control Elements	PLOS ONE			English	Article							HEPATOMA-CELL LINES; CHROMOSOMAL INTEGRATION; TRANSCRIPTION FACTOR; ENHANCER ELEMENTS; EXPRESSION; CHROMATIN; PROMOTER; INTERFERENCE; ORGANIZATION; EFFICIENT	To study transcriptional regulation by distant enhancers, we devised a system of easilymodified reporter plasmids for integration into single-copy targeting cassettes in clones of HuH7, a human hepatocellular carcinoma. The plasmid constructs tested transcriptional function of a 35-kb region that contained the rat albumin gene and its upstream flanking region. Expression of integrants was analyzed in two orientations, and compared to transient expression of non-integrated plasmids. Enhancers were studied in their natural positions relative to the promoter and localized by deletion. All constructs were also analyzed by transient transfection assays. In addition to the known albumin gene enhancer (E1 at -10 kb), we demonstrated two new enhancers, E2 at -13, and E4 at +1.2 kb. All three enhancers functioned in both transient assays and integrated constructs. However, chromosomal integration demonstrated several differences from transient expression. For example, analysis of E2 showed that enhancer function within the chromosome required a larger gene region than in transient assays. Another conserved region, E3 at -0.7 kb, functioned as an enhancer in transient assays but inhibited the function of E1 and E2 when chromosomally integrated. The enhancers did not show additive or synergistic behavior, an effect consistent with competition for the promoter or inhibitory interactions among enhancers. Growth arrest by serum starvation strongly stimulated the function of some integrated enhancers, consistent with the expected disruption of enhancer-promoter looping during the cell cycle.	[Bhattacharyya, Sanchari; Tian, Jianmin; Locker, Joseph] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Tian, Jianmin; Locker, Joseph] Albert Einstein Coll Med, Marion Bessin Liver Ctr, Bronx, NY 10467 USA; [Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bhattacharyya, S (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	joseph.locker@einstein.yu.edu	Bouhassira, Eric/AAZ-4184-2021		National Institutes of Health [CA68440, CA76394, CA104292, HL088467]; NATIONAL CANCER INSTITUTE [R01CA104292, R01CA068440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants, CA68440, CA76394, and CA104292 to JL and HL088467 to EEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; BUTTGEREIT D, 1993, J CELL SCI, V105, P721; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; FUKUSHIGE S, 1992, P NATL ACAD SCI USA, V89, P7905, DOI 10.1073/pnas.89.17.7905; FULTON R, 1994, NUCLEIC ACIDS RES, V22, P4216, DOI 10.1093/nar/22.20.4216; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Grosveld F, 1987, Prog Clin Biol Res, V251, P133; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HERBST RS, 1989, P NATL ACAD SCI USA, V86, P1553, DOI 10.1073/pnas.86.5.1553; Holohan EE, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-53; JIN JR, 1995, DNA CELL BIOL, V14, P267, DOI 10.1089/dna.1995.14.267; Jin L, 2009, DEV BIOL, V336, P294, DOI 10.1016/j.ydbio.2009.09.026; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kohler S, 2010, J BIOL CHEM, V285, P464, DOI 10.1074/jbc.M109.063149; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3237, DOI 10.1073/pnas.0605730104; LOCKER J, 1989, AM J PATHOL, V135, P977; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; MILLAND J, 1990, AM J PHYSIOL, V259, pG340, DOI 10.1152/ajpgi.1990.259.3.G340; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Narlikar Leelavati, 2009, Briefings in Functional Genomics & Proteomics, V8, P215, DOI 10.1093/bfgp/elp014; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Visel A, 2009, GENOMICS, V93, P509, DOI 10.1016/j.ygeno.2009.02.002; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vorachek WR, 2000, J BIOL CHEM, V275, P29031, DOI 10.1074/jbc.M003039200; WEBER F, 1984, CELL, V36, P983, DOI 10.1016/0092-8674(84)90048-5; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; ZARET KS, 1990, P NATL ACAD SCI USA, V87, P5469, DOI 10.1073/pnas.87.14.5469; ZARET KS, 1988, P NATL ACAD SCI USA, V85, P9076, DOI 10.1073/pnas.85.23.9076; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	48	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23234	10.1371/journal.pone.0023234	http://dx.doi.org/10.1371/journal.pone.0023234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858039	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953500027
J	Lin, JH; Chiu, SC; Cheng, JC; Chang, HW; Hsiao, KL; Lin, YC; Wu, HS; Salemi, M; Liu, HF				Lin, Jih-Hui; Chiu, Shu-Chun; Cheng, Ju-Chien; Chang, Hui-Wen; Hsiao, Kuang-Liang; Lin, Yung-Cheng; Wu, Ho-Sheng; Salemi, Marco; Liu, Hsin-Fu			Phylodynamics and Molecular Evolution of Influenza A Virus Nucleoprotein Genes in Taiwan between 1979 and 2009	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; ORIGIN; H3N2; INFERENCE; DYNAMICS; BINDING; RECOGNITION; SEQUENCES; HISTORY; SKYLINE	Background: Many studies concentrate on variation in the hemagglutinin glycoprotein (HA) because of its significance in host immune response, the evolution of this virus is even more complex when other genome segments are considered. Recently, it was found that cytotoxic T lymphocytes (CTL) play an important role in immunity against influenza and most CTL epitopes of human influenza viruses were remarkably conserved. The NP gene has evolved independently in human and avian hosts after 1918 flu pandemic and it has been assigned a putative role as a determinant of host range. Methods and Findings: Phylodynamic patterns of the genes encoding nucleoprotein (NP) of influenza A viruses isolated from 1979-2009 were analyzed by applying the Bayesian Markov Chain Monte Carlo framework to better understand the evolutionary mechanisms of these Taiwanese isolates. Phylogenetic analysis of the NP gene showed that all available H3 worldwide isolates collected so far were genetically similar and divided into two major clades after the year 2004. We compared the deduced amino acid sequences of the NP sequences from human, avian and swine hosts to investigate the emergence of potential adaptive mutations. Overall, selective pressure on the NP gene of human influenza A viruses appeared to be dominated by purifying selection with a mean d(N)/d(S) ratio of 0.105. Site-selection analysis of 488 codons, however, also revealed 3 positively selected sites in addition to 139 negatively selected ones. Conclusions: The demographic history inferred by Bayesian skyline plot showed that the effective number of infections underwent a period of smooth and steady growth from 1998 to 2001, followed by a more recent rise in the rate of spread. Further understanding the correlates of interspecies transmission of influenza A virus genes from other host reservoirs to the human population may help to elucidate the mechanisms of variability among influenza A virus.	[Lin, Jih-Hui; Chiu, Shu-Chun; Chang, Hui-Wen; Wu, Ho-Sheng] Ctr Dis Control, Ctr Res & Diagnost, Taipei, Taiwan; [Lin, Jih-Hui; Hsiao, Kuang-Liang; Lin, Yung-Cheng; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Chiu, Shu-Chun] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Cheng, Ju-Chien] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, New Taipei City, Taiwan; [Liu, Hsin-Fu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Centers For Disease Control - Taiwan; National Taiwan Ocean University; National Yang Ming Chiao Tung University; China Medical University Taiwan; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Lin, JH (corresponding author), Ctr Dis Control, Ctr Res & Diagnost, Taipei, Taiwan.	salemi@pathology.ufl.edu; hsinfu@ms1.mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269; Hsiao, Kuang-Liang/0000-0003-4397-7762	Centers for Disease Control, Taiwan [DOH96-DC2402]; National Science Council [NSC 98-2314-B-195-010-MY3]; Mackay Memorial Hospital [MMH 9843]	Centers for Disease Control, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This study was supported by the Centers for Disease Control, Taiwan (grant DOH96-DC2402), and was funded in part by the National Science Council (grant NSC 98-2314-B-195-010-MY3) and Mackay Memorial Hospital (grant MMH 9843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the funding agency.	Andersen MH, 1999, TISSUE ANTIGENS, V54, P185, DOI 10.1034/j.1399-0039.1999.540210.x; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; Fu TM, 1997, J VIROL, V71, P2715, DOI 10.1128/JVI.71.4.2715-2721.1997; GAMMELIN M, 1990, MOL BIOL EVOL, V7, P194; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; GORMAN OT, 1990, J VIROL, V64, P4893, DOI 10.1128/JVI.64.10.4893-4902.1990; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HINSHAW VS, 1982, BASIC APPLIED INFLUE, P79; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; KIDA H, 1988, VIROLOGY, V162, P160, DOI 10.1016/0042-6822(88)90405-9; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kingman JFC, 1982, COALESCENT STOCH P A, V13, P235; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lamb R.A., 1989, INFLUENZA VIRUSES, P1; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P362; Lin JH, 2011, CLIN MICROBIOL INFEC, V17, P214, DOI 10.1111/j.1469-0691.2010.03228.x; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2000, GENETICS, V155, P1429; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Rimmelzwaan GF, 2004, VIRUS RES, V103, P97, DOI 10.1016/j.virusres.2004.02.020; Rodrigo AG, 1999, EVOLUTION OF HIV, P233; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shih ACC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-63; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Suzuki Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/molbev/msl050; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Varich NL, 2011, VIRAL IMMUNOL, V24, P101, DOI 10.1089/vim.2010.0088; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	49	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23454	10.1371/journal.pone.0023454	http://dx.doi.org/10.1371/journal.pone.0023454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858124	Green Published, gold			2022-12-27	WOS:000293953500041
J	Atkinson, GC; Tenson, T; Hauryliuk, V				Atkinson, Gemma C.; Tenson, Tanel; Hauryliuk, Vasili			The RelA/SpoT Homolog (RSH) Superfamily: Distribution and Functional Evolution of ppGpp Synthetases and Hydrolases across the Tree of Life	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI; STRINGENT RESPONSE; GUANOSINE TETRAPHOSPHATE; PROTEIN-SYNTHESIS; (P)PPGPP SYNTHETASE; MYCOBACTERIUM-TUBERCULOSIS; COMPARATIVE GENOMICS; GUANINE-NUCLEOTIDES	RelA/SpoT Homologue (RSH) proteins, named for their sequence similarity to the RelA and SpoT enzymes of Escherichia coli, comprise a superfamily of enzymes that synthesize and/or hydrolyze the alarmone ppGpp, activator of the "stringent" response and regulator of cellular metabolism. The classical "long" RSHs Rel, RelA and SpoT with the ppGpp hydrolase, synthetase, TGS and ACT domain architecture have been found across diverse bacteria and plant chloroplasts, while dedicated single domain ppGpp-synthesizing and -hydrolyzing RSHs have also been discovered in disparate bacteria and animals respectively. However, there is considerable confusion in terms of nomenclature and no comprehensive phylogenetic and sequence analyses have previously been carried out to classify RSHs on a genomic scale. We have performed high-throughput sensitive sequence searching of over 1000 genomes from across the tree of life, in combination with phylogenetic analyses to consolidate previous ad hoc identification of diverse RSHs in different organisms and provide a much-needed unifying terminology for the field. We classify RSHs into 30 subgroups comprising three groups: long RSHs, small alarmone synthetases (SASs), and small alarmone hydrolases (SAHs). Members of nineteen previously unidentified RSH subgroups can now be studied experimentally, including previously unknown RSHs in archaea, expanding the "stringent response" to this domain of life. We have analyzed possible combinations of RSH proteins and their domains in bacterial genomes and compared RSH content with available RSH knock-out data for various organisms to determine the rules of combining RSHs. Through comparative sequence analysis of long and small RSHs, we find exposed sites limited in conservation to the long RSHs that we propose are involved in transmitting regulatory signals. Such signals may be transmitted via NTD to CTD intra-molecular interactions, or inter-molecular interactions either among individual RSH molecules or among long RSHs and other binding partners such as the ribosome.	[Atkinson, Gemma C.; Tenson, Tanel; Hauryliuk, Vasili] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu	Atkinson, GC (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	gemma.atkinson@ut.ee	Hauryliuk, Vasili/J-3930-2019; Tenson, Tanel/I-6431-2015; Atkinson, Gemma/L-9655-2019	Hauryliuk, Vasili/0000-0003-2389-5057; Tenson, Tanel/0000-0002-0260-3601; Atkinson, Gemma/0000-0002-4861-4584	Estonian Science Foundation [MJD99, 7616]; Center of Excellence in Chemical Biology [RLOTITIPP]	Estonian Science Foundation; Center of Excellence in Chemical Biology	This work was supported financially by Estonian Science Foundation grants (codes MJD99 to GCA, and 7616 to VH) and European Regional Development Fund through the Center of Excellence in Chemical Biology (code RLOTITIPP to VH and TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Atkinson GC, 2011, MOL BIOL EVOL, V28, P1281, DOI 10.1093/molbev/msq316; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Battesti A, 2009, J BACTERIOL, V191, P616, DOI 10.1128/JB.01195-08; Boutte CC, 2011, MOL MICROBIOL, V80, P695, DOI 10.1111/j.1365-2958.2011.07602.x; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; CHEUNG MY, 2010, J BIOL CHEM; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Das B, 2009, MOL MICROBIOL, V72, P380, DOI 10.1111/j.1365-2958.2009.06653.x; Devos DP, 2010, SCIENCE, V330, P1187, DOI 10.1126/science.1196720; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ENGLISH BP, 2011, P NATL ACAD SCI US; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLARDH K, 1994, J BACTERIOL, V176, P5949; GALLANT J, 1977, CELL, V11, P181, DOI 10.1016/0092-8674(77)90329-4; Ghosh S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-18; Godfrey HP, 2002, TRENDS MICROBIOL, V10, P349, DOI 10.1016/S0966-842X(02)02403-4; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gribaldo S, 2009, RES MICROBIOL, V160, P513, DOI 10.1016/j.resmic.2009.07.006; Gropp M, 2001, J BACTERIOL, V183, P570, DOI 10.1128/JB.183.2.570-579.2001; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Gupta RS, 1998, J MOL EVOL, V46, P716, DOI 10.1007/PL00006352; HAMEL E, 1974, ARCH BIOCHEM BIOPHYS, V162, P293, DOI 10.1016/0003-9861(74)90128-3; HAMEL E, 1973, P NATL ACAD SCI USA, V70, P3250, DOI 10.1073/pnas.70.11.3250; HARA A, 1983, J BIOL CHEM, V258, P1678; HASELTIN.WA, 1972, NATURE, V238, P381, DOI 10.1038/238381a0; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; HEINEMEYER EA, 1978, P NATL ACAD SCI USA, V75, P4180, DOI 10.1073/pnas.75.9.4180; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; Jin W, 2004, MICROBIOL-SGM, V150, P1485, DOI 10.1099/mic.0.26811-0; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; LAZZARINI RA, 1971, J BIOL CHEM, V246, P4381; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maciag M, 2010, PLASMID, V63, P61, DOI 10.1016/j.plasmid.2009.11.002; Martinez-Costa OH, 1998, J BACTERIOL, V180, P4123; MartinezCosta OH, 1996, J BIOL CHEM, V271, P10627, DOI 10.1074/jbc.271.18.10627; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mitkevich VA, 2010, J MOL BIOL, V402, P838, DOI 10.1016/j.jmb.2010.08.016; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ohno S., 1970, EVOLUTION GENE DUPLI; OKI T, 1975, BIOCHIM BIOPHYS ACTA, V410, P262, DOI 10.1016/0005-2744(75)90228-4; Ooga T, 2009, J BIOL CHEM, V284, P15549, DOI 10.1074/jbc.M900582200; PEDERSEN FS, 1977, EUR J BIOCHEM, V76, P91, DOI 10.1111/j.1432-1033.1977.tb11573.x; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Polkinghorne A, 2011, MICROB PATHOGENESIS, V50, P200, DOI 10.1016/j.micpath.2010.12.005; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rovery C, 2005, RES MICROBIOL, V156, P211, DOI 10.1016/j.resmic.2004.09.002; Sajish M, 2007, J BIOL CHEM, V282, P34977, DOI 10.1074/jbc.M704828200; Sajish M, 2009, J BIOL CHEM, V284, P9115, DOI 10.1074/jbc.M807187200; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; SILVERMAN RH, 1979, MICROBIOL REV, V43, P27, DOI 10.1128/MMBR.43.1.27-41.1979; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; SPRINZL M, 1976, EUR J BIOCHEM, V71, P171, DOI 10.1111/j.1432-1033.1976.tb11103.x; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun D, 2010, NAT STRUCT MOL BIOL, V17, P1188, DOI 10.1038/nsmb.1906; Sun JH, 2001, J BACTERIOL, V183, P3488, DOI 10.1128/JB.183.11.3488-3498.2001; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; TOZAWA Y, 2011, PLANT BIOL IN PRESS; Tozawa Y, 2007, J BIOL CHEM, V282, P35536, DOI 10.1074/jbc.M703820200; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Vrentas CE, 2008, J MOL BIOL, V377, P551, DOI 10.1016/j.jmb.2008.01.042; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yang XM, 2001, BIOCHEM CELL BIOL, V79, P729, DOI 10.1139/bcb-79-6-729	101	272	279	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23479	10.1371/journal.pone.0023479	http://dx.doi.org/10.1371/journal.pone.0023479			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858139	Green Published, gold, Green Submitted			2022-12-27	WOS:000293774300036
J	Cardenas, C; Quesada, AR; Medina, MA				Cardenas, Casimiro; Quesada, Ana R.; Medina, Miguel A.			Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; MATRIX METALLOPROTEINASES; INHIBIT ANGIOGENESIS; KEY STEPS; CANCER; RISK; CONSUMPTION; GROWTH; METAANALYSIS	Background: Epidemiological studies have shown that unfiltered coffee consumption is associated with a low incidence of cancer. This study aims to identify the effects of kahweol, an antioxidant diterpene contained in unfiltered coffee, on angiogenesis and key inflammatory molecules. Methodology/Principal Findings: The experimental procedures included in vivo angiogenesis assays (both the chicken and quail choriallantoic membrane assay and the angiogenesis assay with fluorescent zebrafish), the ex vivo mouse aortic ring assay and the in vitro analysis of the effects of treatment of human endothelial cells with kahweol in cell growth, cell viability, cell migration and zymographic assays, as well as the tube formation assay on Matrigel. Additionally, two inflammation markers were determined, namely, the expression levels of cyclooxygenase 2 and the levels of secreted monocyte chemoattractant protein-1. We show for the first time that kahweol is an anti-angiogenic compound with inhibitory effects in two in vivo and one ex vivo angiogenesis models, with effects on specific steps of the angiogenic process: endothelial cell proliferation, migration, invasion and tube formation on Matrigel. We also demonstrate the inhibitory effect of kahweol on the endothelial cell potential to remodel extracellular matrix by targeting two key molecules involved in the process, MMP-2 and uPA. Finally, the anti-inflammatory potential of this compound is demonstrated by its inhibition of both COX-2 expression and MCP-1 secretion in endothelial cells. Conclusion/Significance: Taken together, our data indicate that, indeed, kahweol behaves as an anti-inflammatory and anti-angiogenic compound with potential use in antitumoral therapies. These data may contribute to the explanation of the reported antitumoral effects of kahweol, including the recent epidemiological meta-analysis showing that drinking coffee could decrease the risk of certain cancers.	[Cardenas, Casimiro; Quesada, Ana R.; Medina, Miguel A.] Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Quesada, Ana R.; Medina, Miguel A.] CIBER Enfermedades Raras CIBERER, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Cardenas, C (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain.	medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Cardenas, Casimiro/L-1051-2014	Medina, Miguel Ángel/0000-0001-7275-6462; Cardenas, Casimiro/0000-0001-6259-8296; Rodriguez Quesada, Ana Maria/0000-0002-6419-8867	Spanish Ministry of Science and Innovation [PS09/02216, TRACE PT2008-0145]; group BIO-267 (Andalusian Government); Instituto de Salud Carlos III (Spain);  [PIE P08-CTS-3759];  [CVI-6585]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); group BIO-267 (Andalusian Government); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); ; 	Our experimental work is supported by grants PS09/02216 and TRACE PT2008-0145 (Spanish Ministry of Science and Innovation, www.micinn.es, www.juntadeandalucia.es), and PIE P08-CTS-3759, CVI-6585, and funds from group BIO-267 (Andalusian Government). The "CIBER de Enfermedades Raras" (www.ciberer.es) is an initiative from the Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Medina MA, 2007, J CELL MOL MED, V11, P374, DOI 10.1111/j.1582-4934.2007.00056.x; Bellisle F, 1998, BRIT J NUTR, V80, pS173, DOI 10.1079/BJN19980109; Bengis RO, 1932, J BIOL CHEM, V97, P99; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Cardenas C, 2006, CELL MOL LIFE SCI, V63, P3083, DOI 10.1007/s00018-006-6399-6; Cardenas C, 2004, BIOCHEM BIOPH RES CO, V320, P402, DOI 10.1016/j.bbrc.2004.05.183; Castro ME, 2004, INT J CANCER, V110, P31, DOI 10.1002/ijc.20068; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Friberg E, 2009, INT J CANCER, V125, P2413, DOI 10.1002/ijc.24543; Futagami S, 2008, PROSTAG LEUKOTR ESS, V78, P137, DOI 10.1016/j.plefa.2007.10.030; Giovannucci E, 1998, AM J EPIDEMIOL, V147, P1043, DOI 10.1093/oxfordjournals.aje.a009398; Gonzalez-Iriarte Mauricio, 2003, Angiogenesis, V6, P251, DOI 10.1023/B:AGEN.0000021388.59617.6b; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Igura K, 2001, CANCER LETT, V171, P11, DOI 10.1016/S0304-3835(01)00443-8; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim HG, 2009, TOXICOL LETT, V187, P28, DOI 10.1016/j.toxlet.2009.01.022; Kim JY, 2004, FEBS LETT, V569, P321, DOI 10.1016/j.febslet.2004.05.070; Kim MS, 2000, INT J CANCER, V87, P269, DOI 10.1002/1097-0215(20000715)87:2&lt;269::AID-IJC19&gt;3.0.CO;2-W; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044; Lee KJ, 2007, TOXICOL LETT, V173, P80, DOI 10.1016/j.toxlet.2007.06.008; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Martinez-Poveda B, 2005, INT J CANCER, V117, P775, DOI 10.1002/ijc.21246; Martinez-Poveda B, 2005, EUR J PHARMACOL, V516, P97, DOI 10.1016/j.ejphar.2005.03.047; Martinez-Poveda B, 2007, MOL CANCER THER, V6, P2675, DOI 10.1158/1535-7163.MCT-07-0136; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; NICOSIA RF, 1990, LAB INVEST, V63, P115; Nkondjock A, 2009, CANCER LETT, V277, P121, DOI 10.1016/j.canlet.2008.08.022; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Quesada AR, 2010, CURR PHARM DESIGN, V16, P3932; Rabbani SA, 1998, IN VIVO, V12, P135; Rakic JM, 2003, CELL MOL LIFE SCI, V60, P463, DOI 10.1007/s000180300039; Rodriguez-Nieto S, 2001, ANTICANCER RES, V21, P3457; Rodriguez-Nieto S, 2001, FASEB J, V15, P261, DOI 10.1096/fj.01-0427fje; Rodriguez-Nieto S, 2002, BIOCHEM BIOPH RES CO, V293, P497, DOI 10.1016/S0006-291X(02)00232-2; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Shimamura M, 2001, BIOCHEM BIOPH RES CO, V289, P220, DOI 10.1006/bbrc.2001.5934; Spiller M A, 1984, Prog Clin Biol Res, V158, P91; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Totzke G, 2003, ONCOGENE, V22, P8021, DOI 10.1038/sj.onc.1206837	47	98	101	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23407	10.1371/journal.pone.0023407	http://dx.doi.org/10.1371/journal.pone.0023407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858104	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300033
J	Poschmann, J; Drouin, S; Jacques, PE; El Fadili, K; Newmarch, M; Robert, F; Ramotar, D				Poschmann, Jeremie; Drouin, Simon; Jacques, Pierre-Etienne; El Fadili, Karima; Newmarch, Michael; Robert, Francois; Ramotar, Dindial			The Peptidyl Prolyl Isomerase Rrd1 Regulates the Elongation of RNA Polymerase II during Transcriptional Stresses	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; GENOME-WIDE LOCATION; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TERMINAL DOMAIN; IN-VIVO; YEAST; TOR; ACTIVATOR; 6-AZAURACIL	Rapamycin is an anticancer agent and immunosuppressant that acts by inhibiting the TOR signaling pathway. In yeast, rapamycin mediates a profound transcriptional response for which the RRD1 gene is required. To further investigate this connection, we performed genome-wide location analysis of RNA polymerase II (RNAPII) and Rrd1 in response to rapamycin and found that Rrd1 colocalizes with RNAPII on actively transcribed genes and that both are recruited to rapamycin responsive genes. Strikingly, when Rrd1 is lacking, RNAPII remains inappropriately associated to ribosomal genes and fails to be recruited to rapamycin responsive genes. This occurs independently of TATA box binding protein recruitment but involves the modulation of the phosphorylation status of RNAPII CTD by Rrd1. Further, we demonstrate that Rrd1 is also involved in various other transcriptional stress responses besides rapamycin. We propose that Rrd1 is a novel transcription elongation factor that fine-tunes the transcriptional stress response of RNAPII.	[Poschmann, Jeremie; El Fadili, Karima; Newmarch, Michael; Ramotar, Dindial] Univ Montreal, Dept Med, Res Ctr, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada; [Drouin, Simon; Jacques, Pierre-Etienne; Robert, Francois] Inst Rech Clin Montreal, Montreal, PQ, Canada; [Robert, Francois] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Poschmann, J (corresponding author), Univ Montreal, Dept Med, Res Ctr, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada.	francois.robert@ircm.qc.ca; dramotar.hmr@ssss.gouv.qc.ca	Robert, Francois/D-2316-2012		Canadian Institutes of Health Research [CIHR-82891, MOP-13152]; Canadian foundation for Innovation [202432-01]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian foundation for Innovation(Canada Foundation for Innovation)	This work was supported by the grants CIHR-82891 and MOP-13152 from the Canadian Institutes of Health Research. The authors also thank the Canadian foundation for Innovation for the leader funding opportunity grant (202432-01) to D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aureliano M, 2009, J INORG BIOCHEM, V103, P536, DOI 10.1016/j.jinorgbio.2008.11.010; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; CAYLA X, 1990, BIOCHEMISTRY-US, V29, P658, DOI 10.1021/bi00455a010; CAYLA X, 1994, J BIOL CHEM, V269, P15668; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheung AC, NATURE; Cho EJ, 2007, EXP MOL MED, V39, P247, DOI 10.1038/emm.2007.28; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Douville J, 2006, GENETICS, V172, P1369, DOI 10.1534/genetics.105.046110; Dowling RJO, 2009, BIODRUGS, V23, P77, DOI 10.2165/00063030-200923020-00002; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Ghavi-Helm Y, 2008, GENE DEV, V22, P1934, DOI 10.1101/gad.471908; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Jouvet N, BMC MOL BIOL, V11, P92; Kops O, 2002, FEBS LETT, V513, P305, DOI 10.1016/S0014-5793(02)02288-3; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Lloyd A, 2009, EUKARYOT CELL, V8, P257, DOI 10.1128/EC.00348-08; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Ralser M, 2005, BIOTECHNIQUES, V39, P165, DOI 10.2144/05392BM01; Ramotar D, 1998, J BIOL CHEM, V273, P21489, DOI 10.1074/jbc.273.34.21489; Rempola B, 2000, MOL GEN GENET, V262, P1081, DOI 10.1007/PL00008651; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Ronald TKN, 2008, P NATL ACAD SCI USA, V105, P15166, DOI 10.1073/pnas.0807712105; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Uffenbeck SR, 2006, BIOCHEM CELL BIOL, V84, P477, DOI 10.1139/O06-079; Vance JR, 2001, MOL CELL BIOL, V21, P7191, DOI 10.1128/MCB.21.21.7191-7198.2001; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Wu XY, 2003, GENETICS, V165, P1687; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wysocki R, 2004, MOL BIOL CELL, V15, P2049, DOI 10.1091/mbc.E03-04-0236; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Zheng Y, 2005, MOL BIOL CELL, V16, P2119, DOI 10.1091/mbc.e04-09-0797	60	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23159	10.1371/journal.pone.0023159	http://dx.doi.org/10.1371/journal.pone.0023159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887235	Green Published, gold			2022-12-27	WOS:000295832000009
J	Basu, A; Banerjee, P; Contreras, AG; Flynn, E; Pal, S				Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro			Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; KINASE C-ZETA; PROTEIN-KINASE; POSTTRANSPLANT MALIGNANCY; CYCLOSPORINE-A; KIDNEY-TRANSPLANTATION; ORGAN-TRANSPLANTATION; MAMMALIAN TARGET; ONCOGENIC RAS; RAPAMYCIN	Malignancy is a major problem in patients treated with immunosuppressive agents. We have demonstrated that treatment with calcineurin inhibitors (CNIs) can induce the activation of proto-oncogenic Ras, and may promote a rapid progression of human renal cancer through the overexpression of vascular endothelial growth factor (VEGF). Interestingly, we found that CNI-induced VEGF overexpression and cancer cell proliferation was inhibited by rapamycin treatment, indicating potential involvement of the mammalian target of rapamycin (mTOR) pathway in this tumorigenic process. Here, we examined the role of mTOR pathway in mediating CNI- and Ras-induced overexpression of VEGF in human renal cancer cells (786-0 and Caki-1). We found that the knockdown of raptor (using siRNA) significantly decreased CNI-induced VEGF promoter activity as observed by promoter-luciferase assay, suggesting the role of mTOR complex1 (mTORC1) in CNI-induced VEGF transcription. It is known that mTOR becomes activated following phosphorylation of its negative regulator PRAS40, which is a part of mTORC1. We observed that CNI treatment and activation of H-Ras (through transfection of an active H-Ras plasmid) markedly increased the phosphorylation of PRAS40, and the transfection of cells using a dominant-negative plasmid of Ras, significantly decreased PRAS40 phosphorylation. Protein kinase C (PKC)-zeta and PKC-delta, which are critical intermediary signaling molecules for CNI-induced tumorigenic pathway, formed complex with PRAS40; and we found that the CNI treatment increased the complex formation between PRAS40 and PKC, particularly (PKC)-zeta. Inhibition of PKC activity using pharmacological inhibitor markedly decreased H-Ras-induced phosphorylation of PRAS40. The overexpression of PRAS40 in renal cancer cells significantly down-regulated CNI- and H-Ras-induced VEGF transcriptional activation. Finally, it was observed that CNI treatment increased the expression of phosho-PRAS40 in renal tumor tissues in vivo. Together, the phosphorylation of PRAS40 is critical for the activation of mTOR in CNI-induced VEGF overexpression and renal cancer progression.	[Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro] Childrens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Basu, A (corresponding author), Childrens Hosp, Div Nephrol, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu		CONTRERAS, AlAN/0000-0003-4960-2240	National Institutes of Health [R01 CA131145]; John-Merrill Grant ASN-AST; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John-Merrill Grant ASN-AST; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by the following: 1) National Institutes of Health Grant R01 CA131145 (to S. P.); 2) John-Merrill Grant ASN-AST (to S. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2008, CANCER RES, V68, P5689, DOI 10.1158/0008-5472.CAN-07-6603; Basu A, 2010, J BIOL CHEM, V285, P25196, DOI 10.1074/jbc.M110.119446; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bustami RT, 2004, AM J TRANSPLANT, V4, P87, DOI 10.1046/j.1600-6135.2003.00274.x; Campistol Josep M, 2010, G Ital Nefrol, V27 Suppl 50, pS81; Campistol JM, 2009, TRANSPLANTATION, V87, pS19, DOI 10.1097/TP.0b013e3181a07a57; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chen CG, 2009, J SURG RES, V153, P156, DOI 10.1016/j.jss.2008.03.017; Cho CS, 2003, CELL SIGNAL, V15, P85, DOI 10.1016/S0898-6568(02)00046-3; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; Durrbach A, 2010, NAT REV NEPHROL, V6, P160, DOI 10.1038/nrneph.2009.233; DVORAK HF, 1995, AM J PATHOL, V146, P1029; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Garcia JA, 2008, MOL CANCER THER, V7, P1347, DOI 10.1158/1535-7163.MCT-07-2408; Geissler EK, 2010, KIDNEY INT, V78, P1075, DOI 10.1038/ki.2010.324; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Han WN, 2010, J BIOL CHEM, V285, P11369, DOI 10.1074/jbc.M109.028142; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jamil B, 1999, TRANSPLANTATION, V68, P1597, DOI 10.1097/00007890-199911270-00027; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Leseux L, 2008, BLOOD, V111, P285, DOI 10.1182/blood-2007-04-085092; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Minhajuddin M, 2009, J BIOL CHEM, V284, P4052, DOI 10.1074/jbc.M805032200; Mireuta M, 2010, GROWTH FACTORS, V28, P243, DOI 10.3109/08977191003745472; Monaco AP, 2009, TRANSPLANTATION, V87, P157, DOI 10.1097/TP.0b013e318193886e; Morath C, 2004, J AM SOC NEPHROL, V15, P1582, DOI 10.1097/01.ASN.0000126194.77004.9B; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Pal S, 2001, J BIOL CHEM, V276, P2395, DOI 10.1074/jbc.M007818200; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Peddi VR, 2001, SEMIN DIALYSIS, V14, P218, DOI 10.1046/j.1525-139X.2001.00054.x; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Webster AC, 2007, AM J TRANSPLANT, V7, P2140, DOI 10.1111/j.1600-6143.2007.01908.x; Wimmer CD, 2007, KIDNEY INT, V71, P1271, DOI 10.1038/sj.ki.5002154; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	50	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23919	10.1371/journal.pone.0023919	http://dx.doi.org/10.1371/journal.pone.0023919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886838	Green Submitted, Green Published, gold			2022-12-27	WOS:000294253500038
J	Dang, UJ; Bauch, CT				Dang, Utkarsh J.; Bauch, Chris T.			Can Interactions between Timing of Vaccine-Altered Influenza Pandemic Waves and Seasonality in Influenza Complications Lead to More Severe Outcomes?	PLOS ONE			English	Article							UNITED-STATES; TRANSMISSION; MORTALITY; MORBIDITY; IMPACT; VIRUS; STRATEGIES; PNEUMONIA; INFECTION; RADIATION	Vaccination can delay the peak of a pandemic influenza wave by reducing the number of individuals initially susceptible to influenza infection. Emerging evidence indicates that susceptibility to severe secondary bacterial infections following a primary influenza infection may vary seasonally, with peak susceptibility occurring in winter. Taken together, these two observations suggest that vaccinating to prevent a fall pandemic wave might delay it long enough to inadvertently increase influenza infections in winter, when primary influenza infection is more likely to cause severe outcomes. This could potentially cause a net increase in severe outcomes. Most pandemic models implicitly assume that the probability of severe outcomes does not vary seasonally and hence cannot capture this effect. Here we show that the probability of intensive care unit (ICU) admission per influenza infection in the 2009 H1N1 pandemic followed a seasonal pattern. We combine this with an influenza transmission model to investigate conditions under which a vaccination program could inadvertently shift influenza susceptibility to months where the risk of ICU admission due to influenza is higher. We find that vaccination in advance of a fall pandemic wave can actually increase the number of ICU admissions in situations where antigenic drift is sufficiently rapid or where importation of a cross-reactive strain is possible. Moreover, this effect is stronger for vaccination programs that prevent more primary influenza infections. Sensitivity analysis indicates several mechanisms that may cause this effect. We also find that the predicted number of ICU admissions changes dramatically depending on whether the probability of ICU admission varies seasonally, or whether it is held constant. These results suggest that pandemic planning should explore the potential interactions between seasonally varying susceptibility to severe influenza outcomes and the timing of vaccine-altered pandemic influenza waves.	[Dang, Utkarsh J.; Bauch, Chris T.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Bauch, Chris T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Guelph; Princeton University	Dang, UJ (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	cbauch@uoguelph.ca		Dang, Utkarsh/0000-0003-4120-2015	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; BARKER WH, 1981, AM J PUBLIC HEALTH, V71, P643, DOI 10.2105/AJPH.71.6.643; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; *CDCP, 2009, PREV PNEUM INF SEC S; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Dimitrov NB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016094; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; FEIGIN RD, 2004, TXB PEDIAT INFECTIOU, V2, pCH181; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; FISMAN DN, 2009, CANADIAN MED ASS J, V171, P181; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Handel A, 2009, EPIDEMICS-NETH, V1, P185, DOI 10.1016/j.epidem.2009.09.001; HE D, 2011, THEORETICAL ECOLOGY; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; *MATHW INC, 2007, MATHL VERS 7 5 NAT; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; Nichol KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009548; *ONT PUBL HLTH AG, 2010, SER STUD PAND H1N1 I; *PUBL HLTH AG CAN, 2010, WEEKL REP 2009 2010; *PUBL HLTH AG CAN, 2010, ANN INT INFL SURV RE; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rios-Doria D, 2009, J THEOR BIOL, V261, P584, DOI 10.1016/j.jtbi.2009.08.020; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Sagripanti JL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1278, DOI 10.1111/j.1751-1097.2007.00177.x; Sertsou G, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-38; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; White ANJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-196	51	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23580	10.1371/journal.pone.0023580	http://dx.doi.org/10.1371/journal.pone.0023580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886799	Green Submitted, Green Published, gold			2022-12-27	WOS:000294253500017
J	Henriksen, R; Groothuis, TG; Rettenbacher, S				Henriksen, Rie; Groothuis, Ton G.; Rettenbacher, Sophie			Elevated Plasma Corticosterone Decreases Yolk Testosterone and Progesterone in Chickens: Linking Maternal Stress and Hormone-Mediated Maternal Effects	PLOS ONE			English	Article							GALLUS-GALLUS-DOMESTICUS; AVIAN GRANULOSA-CELLS; OFFSPRING PHENOTYPE; STEROID-HORMONES; LAYING HENS; OVARIAN-FUNCTION; SEX-DIFFERENCES; EGG-YOLK; BIRDS; GLUCOCORTICOIDS	Despite considerable research on hormone-mediated maternal effects in birds, the underlying physiology remains poorly understood. This study investigated a potential regulation mechanism for differential accumulation of gonadal hormones in bird eggs. Across vertebrates, glucocorticoids can suppress reproduction by downregulating gonadal hormones. Using the chicken as a model species, we therefore tested whether elevated levels of plasma corticosterone in female birds influence the production of gonadal steroids by the ovarian follicles and thus the amount of reproductive hormones in the egg yolk. Adult laying hens of two different strains (ISA brown and white Leghorn) were implanted subcutaneously with corticosterone pellets that elevated plasma corticosterone concentrations over a period of nine days. Steroid hormones were subsequently quantified in plasma and yolk. Corticosterone-implanted hens of both strains had lower plasma progesterone and testosterone levels and their yolks contained less progesterone and testosterone. The treatment also reduced egg and yolk mass. Plasma estrogen concentrations decreased in white Leghorns only whereas in both strains yolk estrogens were unaffected. Our results demonstrate for the first time that maternal plasma corticosterone levels influence reproductive hormone concentrations in the yolk. Maternal corticosterone could therefore mediate environmentally induced changes in yolk gonadal hormone concentrations. In addition, stressful situations experienced by the bird mother might affect the offspring via reduced amounts of reproductive hormones present in the egg as well as available nutrients for the embryo.	[Henriksen, Rie; Groothuis, Ton G.] Univ Groningen, Inst Behav Neurosci, Groningen, Netherlands; [Henriksen, Rie; Rettenbacher, Sophie] Univ Vet Med Vienna, Vienna, Austria	University of Groningen; University of Veterinary Medicine Vienna	Henriksen, R (corresponding author), Univ Groningen, Inst Behav Neurosci, Groningen, Netherlands.	Sophie.Rettenbacher@vetmeduni.ac.at			Austrian Science Foundation (FWF) [19169]	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (FWF Proj. No. 19169 to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DG, 1984, J ENDOCRINOL, V100, P81, DOI 10.1677/joe.0.1000081; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Deviche PJ, 2010, GEN COMP ENDOCR, V169, P82, DOI 10.1016/j.ygcen.2010.07.009; Dong H, 2007, COMP BIOCHEM PHYS A, V147, P189, DOI 10.1016/j.cbpa.2006.12.034; Downing JA, 2008, PHYSIOL BEHAV, V95, P381, DOI 10.1016/j.physbeh.2008.07.001; DOWNING JA, 2002, RIRDC PUBLICATION, V1143; ETCHES RJ, 1984, J REPROD FERTIL, V70, P121, DOI 10.1530/jrf.0.0700121; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2003, ARDEOLA, V50, P281; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; GILBERT AB, 1983, J REPROD FERTIL, V69, P221, DOI 10.1530/jrf.0.0690221; Goutte A, 2010, GEN COMP ENDOCR, V169, P108, DOI 10.1016/j.ygcen.2010.07.016; GRAU CR, 1976, POULTRY SCI, V55, P1418, DOI 10.3382/ps.0551418; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hartmann S, 1998, FOOD CHEM, V62, P7, DOI 10.1016/S0308-8146(97)00150-7; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Johnson A.L., 2002, STURKIES AVIAN PHYSL, P569; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Michael AE, 2003, REPRODUCTION, V126, P425, DOI 10.1530/rep.0.1260425; Millet S, 2006, BRIT POULTRY SCI, V47, P294, DOI 10.1080/00071660600741818; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller C, 2009, GEN COMP ENDOCR, V160, P59, DOI 10.1016/j.ygcen.2008.10.018; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Okuliarova M, 2011, AM NAT, V177, P824, DOI 10.1086/659996; Okuliarova M, 2010, GEN COMP ENDOCR, V165, P91, DOI 10.1016/j.ygcen.2009.06.007; Okuliarova M, 2009, COMP BIOCHEM PHYS A, V154, P530, DOI 10.1016/j.cbpa.2009.08.012; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 1997, Z SAUGETIERKD, V62, P192; PORTER TE, 1989, ENDOCRINOLOGY, V125, P109, DOI 10.1210/endo-125-1-109; RASBASH J, 2000, MULTILEVEL MODELS PR; Rettenbacher S, 2005, ANN NY ACAD SCI, V1046, P193, DOI 10.1196/annals.1343.016; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Rozenboim I, 2007, POULTRY SCI, V86, P1760, DOI 10.1093/ps/86.8.1760; SAKETOS M, 1993, BIOL REPROD, V49, P1270, DOI 10.1095/biolreprod49.6.1270; Salvante KG, 2003, GEN COMP ENDOCR, V130, P205, DOI 10.1016/S0016-6480(02)00637-8; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHAR B, 1967, EXPERIENTIA, V23, P716, DOI 10.1007/BF02154131; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwarzenberger F, 1996, ZOO BIOL, V15, P159, DOI 10.1002/(SICI)1098-2361(1996)15:2<159::AID-ZOO6>3.0.CO;2-A; Tetsuka M, 2007, ANIM SCI J, V78, P112, DOI 10.1111/j.1740-0929.2007.00414.x; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/ror.0.0050105; TILLY JL, 1991, BIOL REPROD, V44, P305, DOI 10.1095/biolreprod44.2.305; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; Wagner CK, 2008, ENDOCRINOLOGY, V149, P2743, DOI 10.1210/en.2008-0049; Warren DC, 1934, SCIENCE, V80, P461, DOI 10.1126/science.80.2081.461; WIEBE JP, 1990, J STEROID BIOCHEM, V37, P113, DOI 10.1016/0960-0760(90)90379-Y; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010	55	49	51	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23824	10.1371/journal.pone.0023824	http://dx.doi.org/10.1371/journal.pone.0023824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886826	Green Submitted, Green Published, gold			2022-12-27	WOS:000294253500031
J	Yuan, ZW; Liu, DC; Zhang, LQ; Zhang, L; Chen, WJ; Yan, ZH; Zheng, YL; Zhang, HG; Yen, Y				Yuan, Zhongwei; Liu, Dengcai; Zhang, Lianquan; Zhang, Li; Chen, Wenjie; Yan, Zehong; Zheng, Youliang; Zhang, Huaigang; Yen, Yang			Mitotic Illegitimate Recombination Is a Mechanism for Novel Changes in High-Molecular-Weight Glutenin Subunits in Wheat-Rye Hybrids	PLOS ONE			English	Article							GENE-EXPRESSION; BRASSICA-NAPUS; GENOME; EVOLUTION; ALLOPOLYPLOIDIZATION; TRANSCRIPTOME; DIVERGENCE; RESISTANCE; RESPONSES; ALTERS	Wide hybrids can have novel traits or changed expression of a quantitative trait that their parents do not have. These phenomena have long been noticed, yet the mechanisms are poorly understood. High-molecular-weight glutenin subunits (HMW-GS) are seed storage proteins encoded by Glu-1 genes that only express in endosperm in wheat and its related species. Novel HMW-GS compositions have been observed in their hybrids. This research elucidated the molecular mechanisms by investigating the causative factors of novel HMW-GS changes in wheat-rye hybrids. HMW-GS compositions in the endosperm and their coding sequences in the leaves of F-1 and F-2 hybrids between wheat landrace Shinchunaga and rye landrace Qinling were investigated. Missing and/or additional novel HMW-GSs were observed in the endosperm of 0.5% of the 2078 F-1 and 22% of 36 F-2 hybrid seeds. The wildtype Glu-1Ax null allele was found to have 42 types of short repeat sequences of 3-60 bp long that appeared 2 to 100 times. It also has an in-frame stop codon in the central repetitive region. Analyzing cloned allele sequences of HMW-GS coding gene Glu-1 revealed that deletions involving the in-frame stop codon had happened, resulting in novel similar to 1.8-kb Glu-1Ax alleles in some F-1 and F-2 plants. The cloned mutant Glu-1Ax alleles were expressed in Escherichia coli, and the HMW-GSs produced matched the novel HMW-GSs found in the hybrids. The differential changes between the endosperm and the plant of the same hybrids and the data of E. coli expression of the cloned deletion alleles both suggested that mitotic illegitimate recombination between two copies of a short repeat sequence had resulted in the deletions and thus the changed HMW-GS compositions. Our experiments have provided the first direct evidence to show that mitotic illegitimate recombination is a mechanism that produces novel phenotypes in wide hybrids.	[Yuan, Zhongwei; Liu, Dengcai; Zhang, Lianquan; Zhang, Li; Chen, Wenjie; Yan, Zehong; Zheng, Youliang] Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang, Sichuan, Peoples R China; [Liu, Dengcai; Zhang, Huaigang] Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, NW Inst Plateau Biol, Xining, Peoples R China; [Yen, Yang] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA	Chinese Academy of Sciences; South Dakota State University	Yuan, ZW (corresponding author), Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang, Sichuan, Peoples R China.	dcliu7@yahoo.com; yang.yen@sdstate.edu	陈, 文杰·/HHN-5495-2022	陈, 文杰·/0000-0003-0556-7391; Liu, Dengcai/0000-0001-5508-1125	973 Program [2009CB118300, 2010CB134402]; Chinese Academy of Sciences; National Natural Science Foundation of China [31071418, 31071420]; South Dakota Agricultural Experiment Station	973 Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South Dakota Agricultural Experiment Station	This research was supported by the 973 Program (2009CB118300, 2010CB134402), the 100-Talent Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (31071418, 31071420), and the South Dakota Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Anderson O. D., 2003, Functional & Integrative Genomics, V3, P56; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Gu YQ, 2003, GENOME, V46, P1084, DOI [10.1139/g03-071, 10.1139/G03-071]; He P, 2003, PLANT MOL BIOL, V52, P401, DOI 10.1023/A:1023965400532; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Johnson RC, 2008, STRUCTURE, V16, P653, DOI 10.1016/j.str.2008.04.005; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Khasdan V, 2010, GENETICS, V185, P387, DOI 10.1534/genetics.110.116178; Kong XY, 2004, PLANT MOL BIOL, V54, P55, DOI 10.1023/B:PLAN.0000028768.21587.dc; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; Liu DC, 1999, EUPHYTICA, V108, P79, DOI 10.1023/A:1003691925501; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Nakamura H, 2001, EUPHYTICA, V120, P227, DOI 10.1023/A:1017514423061; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Schranz ME, 2004, AM J BOT, V91, P174, DOI 10.3732/ajb.91.2.174; UDELL JA, 2006, CROP SCI S, V46, pS1; Wan Y, 2000, THEOR APPL GENET, V101, P879, DOI 10.1007/s001220051556; Wan Y, 2002, THEOR APPL GENET, V104, P828, DOI 10.1007/s00122-001-0793-0; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, PLANT J, V51, P631, DOI 10.1111/j.1365-313X.2007.03164.x; Xie RL, 2001, CHINESE SCI BULL, V46, P309, DOI 10.1007/BF03187192; Yan ZH, 2002, CHINESE SCI BULL, V47, P220, DOI 10.1360/02tb9053; Zhang LQ, 2007, SEX PLANT REPROD, V20, P159, DOI 10.1007/s00497-007-0052-x; Zhao JW, 2006, THEOR APPL GENET, V112, P509, DOI 10.1007/s00122-005-0154-5	39	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23511	10.1371/journal.pone.0023511	http://dx.doi.org/10.1371/journal.pone.0023511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887262	Green Published, Green Submitted, gold			2022-12-27	WOS:000294251800014
J	Mead, RJ; Bennett, EJ; Kennerley, AJ; Sharp, P; Sunyach, C; Kasher, P; Berwick, J; Pettmann, B; Battaglia, G; Azzouz, M; Grierson, A; Shaw, PJ				Mead, Richard J.; Bennett, Ellen J.; Kennerley, Aneurin J.; Sharp, Paul; Sunyach, Claire; Kasher, Paul; Berwick, Jason; Pettmann, Brigitte; Battaglia, Guiseppe; Azzouz, Mimoun; Grierson, Andrew; Shaw, Pamela J.			Optimised and Rapid Pre-clinical Screening in the SOD1(G93A) Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; LINKED SOD1 MUTANTS; SPINAL-CORD; MOTOR-NEURONS; FALS MICE; AXONAL-TRANSPORT; OXIDATIVE DAMAGE; GAIT ANALYSIS; RAT MODEL; DEGENERATION	The human SOD1(G93A) transgenic mouse has been used extensively since its development in 1994 as a model for amyotrophic lateral sclerosis (ALS). In that time, a great many insights into the toxicity of mutant SOD1 have been gained using this and other mutant SOD transgenic mouse models. They all demonstrate a selective toxicity towards motor neurons and in some cases features of the pathology seen in the human disease. These models have two major drawbacks. Firstly the generation of robust preclinical data in these models has been highlighted as an area for concern. Secondly, the amount of time required for a single preclinical experiment in these models (3-4 months) is a hurdle to the development of new therapies. We have developed an inbred C57BL/6 mouse line from the original mixed background (SJLxC57BL/6) SOD1(G93A) transgenic line and show here that the disease course is remarkably consistent and much less prone to background noise, enabling reduced numbers of mice for testing of therapeutics. Secondly we have identified very early readouts showing a large decline in motor function compared to normal mice. This loss of motor function has allowed us to develop an early, sensitive and rapid screening protocol for the initial phases of denervation of muscle fibers, observed in this model. We describe multiple, quantitative readouts of motor function that can be used to interrogate this early mechanism. Such an approach will increase throughput for reduced costs, whilst reducing the severity of the experimental procedures involved.	[Mead, Richard J.; Bennett, Ellen J.; Sharp, Paul; Kasher, Paul; Azzouz, Mimoun; Grierson, Andrew; Shaw, Pamela J.] Univ Sheffield, Sch Med & Biomed Sci, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Kennerley, Aneurin J.; Berwick, Jason] Univ Sheffield, Dept Psychol, Fac Sci, Sheffield S10 2TN, S Yorkshire, England; [Sunyach, Claire; Pettmann, Brigitte] Mediterranean Inst Neurobiol, Inserm Avenir Team, Marseille, France; [Sunyach, Claire; Pettmann, Brigitte] Aix Marseille Univ, Fac Sci, Marseille, France; [Sharp, Paul; Battaglia, Guiseppe] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Sheffield	Mead, RJ (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.	Pamela.Shaw@sheffield.ac.uk	Grierson, Andy/A-5067-2009; Mead, Richard J/B-4779-2009; Battaglia, Giuseppe/I-2142-2013; Battaglia, Giuseppe/A-2253-2012; Berwick, Jason/P-6950-2017; Azzouz, Mimoun/B-3979-2009	Grierson, Andy/0000-0001-7039-6731; Mead, Richard J/0000-0002-3207-0068; Battaglia, Giuseppe/0000-0003-3349-6770; Kennerley, Aneurin James/0000-0002-7599-7461; Berwick, Jason/0000-0003-4026-0088; Kasher, Paul/0000-0002-9213-502X; Azzouz, Mimoun/0000-0001-6564-5967; Shaw, Pamela/0000-0002-8925-2567; Bennett, Ellen/0000-0002-9818-827X	Wellcome Trust; EPSRC/BBSRC [EP/G062137/1]; European Union [HEALTH-F2-2008-223388]; EPSRC [EP/G062137/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G062137/1] Funding Source: researchfish; National Centre for the Replacement [G0700628/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC/BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for the Replacement	This work was funded by a program grant to Dr. Shaw from the Wellcome Trust (http://www.wellcome.ac.uk/), an NC3Rs project grant (http://www.nc3rs.org.uk/) to Dr. Grierson, Dr. Mead, Dr. Azzouz and Dr. Sharp, an EPSRC/BBSRC collaborative project grant (EP/G062137/1, http://www.epsrc.ac.uk/) to Dr. Battaglia, Dr. Mead, Dr. Azzouz and Dr. Shaw, and by the European Union under the 7th Framework Program for RTD (http://cordis.europa.eu/fp7/home_en.html) -Project MitoTarget - Grant Agreement HEALTH-F2-2008-223388 awarded to Dr. Shaw, Dr. Grierson, Dr. Sunyach and Dr. Pettmann and the Moody Trust (Dr. Kasher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060; Amendola J, 2004, EUR J NEUROSCI, V20, P2822, DOI 10.1111/j.1460-9568.2004.03745.x; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bendotti C, 2001, J NEUROCHEM, V79, P737, DOI 10.1046/j.1471-4159.2001.00572.x; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bories C, 2007, EUR J NEUROSCI, V25, P451, DOI 10.1111/j.1460-9568.2007.05306.x; Brooks KJ, 2004, NMR BIOMED, V17, P28, DOI 10.1002/nbm.861; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Festing M.F.W., 2002, DESIGN ANIMAL EXPT R; Festing MFW, 2010, METHODS MOL BIOL, V602, P1, DOI 10.1007/978-1-60761-058-8_1; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; GOODRICK CL, 1975, J GERONTOL, V30, P257, DOI 10.1093/geronj/30.3.257; Graber DJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-8; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kennel PF, 1996, NEUROREPORT, V7, P1427, DOI 10.1097/00001756-199605310-00021; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim K, 2006, EUR J PHARMACOL, V542, P100, DOI 10.1016/j.ejphar.2006.05.025; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; Kong JM, 1998, J NEUROSCI, V18, P3241; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Miana-Mena FJ, 2005, AMYOTROPH LATERAL SC, V6, P55, DOI 10.1080/14660820510026162; Morrison BM, 1996, J COMP NEUROL, V373, P619, DOI 10.1002/(SICI)1096-9861(19960930)373:4<619::AID-CNE9>3.0.CO;2-4; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Reinholz MM, 1999, EXP NEUROL, V159, P204, DOI 10.1006/exnr.1999.7142; Russell WMS., 1959, MED J AUSTRALIA; Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Taft RA, 2006, TRENDS GENET, V22, P649, DOI 10.1016/j.tig.2006.09.010; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; van Zundert B, 2008, J NEUROSCI, V28, P10864, DOI 10.1523/JNEUROSCI.1340-08.2008; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	53	58	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23244	10.1371/journal.pone.0023244	http://dx.doi.org/10.1371/journal.pone.0023244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876739	Green Published, Green Accepted, gold			2022-12-27	WOS:000294126900011
J	Storoni, M; Petzold, A; Plant, GT				Storoni, Mithu; Petzold, Axel; Plant, Gordon T.			The Use of Serum Glial Fibrillary Acidic Protein Measurements in the Diagnosis of Neuromyelitis Optica Spectrum Optic Neuritis	PLOS ONE			English	Article							ASTROCYTIC DAMAGE; NEUROPATHY; CRITERIA; NMO	Background: Glial fibrillary acidic protein (GFAP) is a specific intermediate filament of the cytoskeleton of the astrocyte and may be used as a specific marker for astrocytic damage. It is detectable in the cerebrospinal fluid following a relapse caused by Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) spectrum disease. Higher levels are found following an NMO-related relapse. It is not known if GFAP is also detectable in the serum following such relapses. In particular, it is not known if lesions limited to the optic nerve release GFAP in sufficient quantities to be detectable within the serum. The aim of this study was to ascertain the extent to which serum GFAP levels can distinguish between an episode of optic neuritis (ON) related to NMO spectrum disease and ON from other causes. Methodology/Principal Findings: Out of 150 patients consecutively presenting to our eye hospital over the period March 2009 until July 2010, we were able to collect a serum sample from 12 patients who had presented with MS-related ON and from 10 patients who had presented with NMO spectrum disease-related ON. We also identified 8 patients with recurrent isolated ON and 8 patients with a corticosteroid-dependent optic neuropathy in the absence of any identified aetiology. GFAP was detectable in the serum of all but three patients (two patients with MS-related ON and one with recurrent optic neuritis). The median serum GFAP level in the patient group with NMO spectrum disease was 4.63 pg/mL whereas in all other cases combined together, this was 2.14 pg/mL. The difference was statistically significant (P = 0.01). A similar statistically significant difference was found when cases with pathology limited to the optic nerve were compared (P = 0.03). Conclusions: Glial pathology in NMO related optic neuritis is reflected in elevated serum GFAP levels independently of whether or not there is extra-optic nerve disease.	[Storoni, Mithu; Petzold, Axel; Plant, Gordon T.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Storoni, Mithu; Plant, Gordon T.] Moorfields Eye Hosp, London, England; [Petzold, Axel] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Storoni, M (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	m.storoni@doctors.net.uk	Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749	UCLH/UCL Comprehensive Biomedical Research Centre; Fight for Sight; Stichting MS Research, The Netherlands [09-687 MS]	UCLH/UCL Comprehensive Biomedical Research Centre; Fight for Sight; Stichting MS Research, The Netherlands(Netherlands Government)	This research reported in this article is supported by the UCLH/UCL Comprehensive Biomedical Research Centre. Mithu Storoni was supported by a Fight for Sight Clinical Research Fellowship Grant. Axel Petzold received funding from Stichting MS Research, The Netherlands (grant 09-687 MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt C, 2008, J FR OPHTALMOL, V31, P363, DOI 10.1016/S0181-5512(08)71430-X; AXELSSON M, 2011, J NEUROL        0101; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Beck RW, 2008, ARCH OPHTHALMOL-CHIC, V126, P994, DOI 10.1001/archopht.126.7.994; Burman J, 2011, ACTA NEUROL SCAND, V123, P207, DOI 10.1111/j.1600-0404.2010.01388.x; FUJIHARA K, 2011, J NEUROL SCI    0309; Kidd D, 2003, BRAIN, V126, P276, DOI 10.1093/brain/awg045; KUPERSMITH MJ, 1988, J NEUROL NEUROSUR PS, V51, P1381, DOI 10.1136/jnnp.51.11.1381; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Misu T, 2009, J NEUROL NEUROSUR PS, V80, P575, DOI 10.1136/jnnp.2008.150698; Nakamura M, 2010, GRAEF ARCH CLIN EXP, V248, P1777, DOI 10.1007/s00417-010-1344-7; Petzold A, 2004, J NEUROL NEUROSUR PS, V75, P1178, DOI 10.1136/jnnp.2003.017236; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	20	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23489	10.1371/journal.pone.0023489	http://dx.doi.org/10.1371/journal.pone.0023489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876753	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900025
J	Baldi, A; Piccolo, MT; Boccellino, MR; Donizetti, A; Cardillo, I; La Porta, R; Quagliuolo, L; Spugnini, EP; Cordero, F; Citro, G; Menegozzo, M; Calogero, RA; Crispi, S				Baldi, Alfonso; Piccolo, Maria Teresa; Boccellino, Maria Rosaria; Donizetti, Aldo; Cardillo, Irene; La Porta, Raffaele; Quagliuolo, Lucio; Spugnini, Enrico P.; Cordero, Francesca; Citro, Gennaro; Menegozzo, Massimo; Calogero, Raffaele A.; Crispi, Stefania			Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; CYCLOOXYGENASE-2 COX-2; INHIBITOR; CANCER; EXPRESSION; SURVIVIN; GENE; IDENTIFICATION; CELECOXIB; GROWTH	Background: Malignant mesothelioma (MM) is a rare, highly aggressive tumor, associated to asbestos exposure. To date no chemotherapy regimen for MM has proven to be definitively curative, and new therapies for MM treatment need to be developed. We have previously shown in vivo that piroxicam/cisplatin combined treatment in MM, specifically acts on cell cycle regulation triggering apoptosis, with survival increase. Methodology/Principal Findings: We analyzed, at molecular level, the apoptotic increase caused by piroxicam/cisplatin treatment in MM cell lines. By means of genome wide analyses, we analyzed transcriptional gene deregulation both after the single piroxicam or cisplatin and the combined treatment. Here we show that apoptotic increase following combined treatment is mediated by p21, since apoptotic increase in piroxicam/cisplatin combined treatment is abolished upon p21 silencing. Conclusions/Significance: Piroxicam/cisplatin combined treatment determines an apoptosis increase in MM cells, which is dependent on the p21 expression. The results provided suggest that piroxicam/cisplatin combination might be tested in clinical settings in tumor specimens that express p21.	[Baldi, Alfonso; Boccellino, Maria Rosaria; La Porta, Raffaele; Quagliuolo, Lucio] Univ Naples 2, Sect Pathol, Dept Biochem, Naples, Italy; [Piccolo, Maria Teresa; Donizetti, Aldo; Crispi, Stefania] CNR, Inst Genet & Biophys, Gene Express & Human Mol Genet Lab, I-80125 Naples, Italy; [Cardillo, Irene; Spugnini, Enrico P.; Citro, Gennaro] Regina Elena Inst Canc Res, SAFU Dept, Rome, Italy; [Menegozzo, Massimo] Univ Naples 2, Dept Expt Med, Natl Mesothelioma Registry ReNaM, Campania Reg Operating Ctr COR, Naples, Italy; [Cordero, Francesca; Calogero, Raffaele A.] Univ Turin, Dept Clin & Biol Sci, Bioinformat & Genom Unit, Turin, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Universita della Campania Vanvitelli; University of Turin	Baldi, A (corresponding author), Univ Naples 2, Sect Pathol, Dept Biochem, Naples, Italy.	stefania.crispi@igb.cnr.it	Calogero, Raffaele/K-9428-2019; Cordero, Francesca/AAB-3655-2019; Baldi, Alfonso/ABG-2397-2021	Calogero, Raffaele/0000-0002-2848-628X; Cordero, Francesca/0000-0002-3143-3330; DONIZETTI, Aldo/0000-0002-4344-0140; QUAGLIUOLO, Lucio/0000-0003-0651-3264; La Porta, Raffaele/0000-0002-0569-369X; Baldi, Alfonso/0000-0002-8693-3842; Crispi, Stefania/0000-0002-7566-1554; BOCCELLINO, MARIAROSARIA/0000-0001-6989-010X	Campania Region [2072]; Italian Ministry of Health; "AiCC'' Grant; FUTURA-onlus Grant; Second University of Naples	Campania Region(Regione Campania); Italian Ministry of Health(Ministry of Health, Italy); "AiCC'' Grant; FUTURA-onlus Grant; Second University of Naples	This work was supported by Campania Region (Del. 12-14-06 n.2072) to Registro Regionale Mesoteliomi - COR Campania del RENAM to S. C. and M. M; by "Grant 2008'' of the Italian Ministry of Health and by a "AiCC'' Grant to E. P. S and G. C., and by a FUTURA-onlus Grant and a Second University of Naples Grant to A. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altorki NK, 2003, J CLIN ONCOL, V21, P2645, DOI 10.1200/JCO.2003.07.127; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baldi A, 2004, THORAX, V59, P428, DOI 10.1136/thx.2003.008912; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Caraglia M, 2007, INT J CANCER, V121, P2317, DOI 10.1002/ijc.22964; Catalano A, 2004, INT J CANCER, V109, P322, DOI 10.1002/ijc.11710; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Crispi S, 2010, CURR CANCER DRUG TAR, V10, P19, DOI 10.2174/156800910790980232; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Favaretto AG, 2003, CANCER, V97, P2791, DOI 10.1002/cncr.11405; Fischgrabe J, 2008, CURR CLIN PHARMACOL, V3, P85, DOI 10.2174/157488408784293732; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Gordon GJ, 2008, CANCER CHEMOTH PHARM, V61, P549, DOI 10.1007/s00280-007-0500-1; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Ishitsuka K, 2008, BRIT J HAEMATOL, V141, P598, DOI 10.1111/j.1365-2141.2008.07044.x; Kim KW, 2007, INT J RADIAT ONCOL, V67, P1519, DOI 10.1016/j.ijrobp.2006.12.018; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Leaper D J, 1980, Adv Prostaglandin Thromboxane Res, V6, P591; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Marrogi A, 2000, CANCER RES, V60, P3696; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pistolesi M, 2004, CHEST, V126, P1318, DOI 10.1378/chest.126.4.1318; Pruthi RS, 2004, BJU INT, V93, P275, DOI 10.1111/j.1464-410X.2004.04601.x; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Roe OD, 2010, LUNG CANCER, V67, P57, DOI 10.1016/j.lungcan.2009.03.016; Romagnoli S, 2009, AM J PATHOL, V174, P762, DOI 10.2353/ajpath.2009.080721; Sambrook J., 2001, MOL CLONING LAB MANU; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spugnini EP, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-58; Spugnini EP, 2006, CLIN CANCER RES, V12, P6133, DOI 10.1158/1078-0432.CCR-06-1056; STOPPOLONI D, MOL CANC, V9, P27; Treasure T, 2004, BRIT MED J, V329, P424, DOI 10.1136/bmj.38176.444745.63; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Verdina A, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-27; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; VONHEYDEBRECK A, 2004, BIOCONDUCTOR PROJECT; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wu Z., 2004, STOCHASTIC MODELS IN, P98; Zaffaroni N, 2007, CELL ONCOL, V29, P453	51	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23569	10.1371/journal.pone.0023569	http://dx.doi.org/10.1371/journal.pone.0023569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858171	Green Submitted, gold, Green Published			2022-12-27	WOS:000294121300062
J	Dahlbom, SJ; Lagman, D; Lundstedt-Enkel, K; Sundstrom, LF; Winberg, S				Dahlbom, S. Josefin; Lagman, David; Lundstedt-Enkel, Katrin; Sundstrom, L. Fredrik; Winberg, Svante			Boldness Predicts Social Status in Zebrafish (Danio rerio)	PLOS ONE			English	Article							DOMINANT-SUBORDINATE RELATIONSHIPS; BRAIN SEROTONERGIC ACTIVITY; INDIVIDUAL-DIFFERENCES; STRESS RESPONSIVENESS; BEHAVIORAL SYNDROMES; AGONISTIC BEHAVIOR; SALVELINUS-ALPINUS; RAINBOW-TROUT; COPING STYLES; AGGRESSION	This study explored if boldness could be used to predict social status. First, boldness was assessed by monitoring individual zebrafish behaviour in (1) an unfamiliar barren environment with no shelter (open field), (2) the same environment when a roof was introduced as a shelter, and (3) when the roof was removed and an unfamiliar object (Lego (R) brick) was introduced. Next, after a resting period of minimum one week, social status of the fish was determined in a dyadic contest and dominant/subordinate individuals were determined as the winner/loser of two consecutive contests. Multivariate data analyses showed that males were bolder than females and that the behaviours expressed by the fish during the boldness tests could be used to predict which fish would later become dominant and subordinate in the ensuing dyadic contest. We conclude that bold behaviour is positively correlated to dominance in zebrafish and that boldness is not solely a consequence of social dominance.	[Dahlbom, S. Josefin; Lagman, David; Winberg, Svante] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lundstedt-Enkel, Katrin] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden; [Sundstrom, L. Fredrik] Uppsala Univ, Dept Anim Ecol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Dahlbom, SJ (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	josefin.dahlbom@neuro.uu.se	Lundstedt-Enkel, Katrin/A-8913-2012; Winberg, Svante/ABB-6458-2021; Sundstrom, Fred/E-6736-2011	Winberg, Svante/0000-0003-4252-3144; Sundstrom, Fred/0000-0002-3157-7289	Facias Foundation	Facias Foundation	The work was financially supported by the Facias Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basquill SP, 1998, CAN J ZOOL, V76, P770, DOI 10.1139/cjz-76-4-770; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bernier NJ, 2008, J ENDOCRINOL, V196, P637, DOI 10.1677/JOE-07-0568; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Filby AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-498; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Hoglund E, 2001, PHYSIOL BEHAV, V74, P381, DOI 10.1016/S0031-9384(01)00571-6; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P694, DOI 10.1016/S0003-3472(76)80083-8; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; JOHNSSON JI, 2005, BEHAV PHYSL FISH, P151; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Larson ET, 2001, BEHAV BRAIN RES, V121, P95, DOI 10.1016/S0166-4328(00)00393-4; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Overli O, 1998, CAN J ZOOL, V76, P1366, DOI 10.1139/cjz-76-7-1366; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Schjolden J, 2005, PHYSIOL BIOCHEM ZOOL, V78, P715, DOI 10.1086/432153; Schjolden J, 2005, HORM BEHAV, V48, P537, DOI 10.1016/j.yhbeh.2005.04.008; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Wright D, 2006, BEHAV GENET, V36, P271, DOI 10.1007/s10519-005-9029-4	41	140	140	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23565	10.1371/journal.pone.0023565	http://dx.doi.org/10.1371/journal.pone.0023565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858168	Green Published, gold			2022-12-27	WOS:000294121300060
J	Dong, J; Sutor, S; Jiang, GJ; Cao, YJ; Asmann, YW; Wigle, DA				Dong, Jie; Sutor, Shari; Jiang, Guoqian; Cao, Yajun; Asmann, Yan W.; Wigle, Dennis A.			c-Myc Regulates Self-Renewal in Bronchoalveolar Stem Cells	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; TRANSGENIC MICE; LUNG-CANCER; BRANCHING MORPHOGENESIS; GENE-EXPRESSION; TENASCIN-C; MOUSE LUNG; MICRORNAS; DIFFERENTIATION; IDENTIFICATION	Background: Bronchoalveolar stem cells (BASCs) located in the bronchoalveolar duct junction are thought to regenerate both bronchiolar and alveolar epithelium during homeostatic turnover and in response to injury. The mechanisms directing self-renewal in BASCs are poorly understood. Methods: BASCs (Sca-1(+), CD34(+), CD31(-) and, CD45(-)) were isolated from adult mouse lung using FACS, and their capacity for self-renewal and differentiation were demonstrated by immunostaining. A transcription factor network of 53 genes required for pluripotency in embryonic stem cells was assessed in BASCs, Kras-initiated lung tumor tissue, and lung organogenesis by real-time PCR. c-Myc was knocked down in BASCs by infection with c-Myc shRNA lentivirus. Comprehensive miRNA and mRNA profiling for BASCs was performed, and significant miRNAs and mRNAs potentially regulated by c-Myc were identified. We explored a c-Myc regulatory network in BASCs using a number of statistical and computational approaches through two different strategies; 1) c-Myc/Max binding sites within individual gene promoters, and 2) miRNA-regulated target genes. Results: c-Myc expression was upregulated in BASCs and downregulated over the time course of lung organogenesis in vivo. The depletion of c-Myc in BASCs resulted in decreased proliferation and cell death. Multiple mRNAs and miRNAs were dynamically regulated in c-Myc depleted BASCs. Among a total of 250 dynamically regulated genes in c-Myc depleted BASCs, 57 genes were identified as potential targets of miRNAs through miRBase and TargetScan-based computational mapping. A further 88 genes were identified as potential downstream targets through their c-Myc binding motif. Conclusion: c-Myc plays a critical role in maintaining the self-renewal capacity of lung bronchoalveolar stem cells through a combination of miRNA and transcription factor regulatory networks.	[Dong, Jie; Sutor, Shari; Cao, Yajun; Wigle, Dennis A.] Mayo Clin, Dept Surg, Div Gen Thorac Surg, Rochester, MN 55905 USA; [Jiang, Guoqian; Asmann, Yan W.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Dong, J (corresponding author), Mayo Clin, Dept Surg, Div Gen Thorac Surg, Rochester, MN 55905 USA.	wigle.dennis@mayo.edu			NIH through the Mayo Clinic Cancer Center; International Society for Heart and Lung Transplantation (ISHLT)	NIH through the Mayo Clinic Cancer Center; International Society for Heart and Lung Transplantation (ISHLT)	Dr. Wigle is supported by an NIH K12 Career Development Award through the Mayo Clinic Cancer Center, and a Career Development Award from the International Society for Heart and Lung Transplantation (ISHLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Couillard M, 2009, DEV DYNAM, V238, P405, DOI 10.1002/dvdy.21841; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; DONG J, PLOS ONE, V5; Dong J, 2009, CANCER BIOL THER, V8, P312, DOI 10.4161/cbt.8.4.7522; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; GUERVILLY JH, HUM MOL GENET; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kaarteenaho-Wiik R, 2001, AM J RESP CELL MOL, V25, P341, DOI 10.1165/ajrcmb.25.3.4460; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morettin A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-319; MOROY T, 1991, ONCOGENE, V6, P1941; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; YOUNG SL, 1994, DEV BIOL, V161, P615, DOI 10.1006/dbio.1994.1057; Zhang XJ, 2000, PROSTATE, V43, P278; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	51	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23707	10.1371/journal.pone.0023707	http://dx.doi.org/10.1371/journal.pone.0023707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858211	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300085
J	Rojas, M; Masip, D; Todorov, A; Vitria, J				Rojas Q, Mario; Masip, David; Todorov, Alexander; Vitria, Jordi			Automatic Prediction of Facial Trait Judgments: Appearance vs. Structural Models	PLOS ONE			English	Article							FACE RECOGNITION; FEATURES	Evaluating other individuals with respect to personality characteristics plays a crucial role in human relations and it is the focus of attention for research in diverse fields such as psychology and interactive computer systems. In psychology, face perception has been recognized as a key component of this evaluation system. Multiple studies suggest that observers use face information to infer personality characteristics. Interactive computer systems are trying to take advantage of these findings and apply them to increase the natural aspect of interaction and to improve the performance of interactive computer systems. Here, we experimentally test whether the automatic prediction of facial trait judgments (e. g. dominance) can be made by using the full appearance information of the face and whether a reduced representation of its structure is sufficient. We evaluate two separate approaches: a holistic representation model using the facial appearance information and a structural model constructed from the relations among facial salient points. State of the art machine learning methods are applied to a) derive a facial trait judgment model from training data and b) predict a facial trait value for any face. Furthermore, we address the issue of whether there are specific structural relations among facial points that predict perception of facial traits. Experimental results over a set of labeled data (9 different trait evaluations) and classification rules (4 rules) suggest that a) prediction of perception of facial traits is learnable by both holistic and structural approaches; b) the most reliable prediction of facial trait judgments is obtained by certain type of holistic descriptions of the face appearance; and c) for some traits such as attractiveness and extroversion, there are relationships between specific structural features and social perceptions.	[Rojas Q, Mario] Univ Autonoma Barcelona, Comp Vis Ctr, E-08193 Barcelona, Spain; [Masip, David] Univ Oberta Catalunya, Dept Estudis Informat Multimedia & Telecomunicaci, Barcelona, Spain; [Todorov, Alexander] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Vitria, Jordi] Univ Barcelona, Dept Matemat Aplicada & Anal, Barcelona, Spain	Autonomous University of Barcelona; Centre de Visio per Computador (CVC); UOC Universitat Oberta de Catalunya; Princeton University; University of Barcelona	Rojas, M (corresponding author), Univ Autonoma Barcelona, Comp Vis Ctr, Edifici O,Campus Bellaterra, E-08193 Barcelona, Spain.	mrojas@cvc.uab.es	Masip, David/B-1709-2009; Vitrià, Jordi/AAF-9668-2020	Vitrià, Jordi/0000-0003-1484-539X; Masip Rodo, David/0000-0001-7898-1847	MICINN (Ministerio de Ciencia e Innovacion - Ministry of Science and Innovation); CONSOLIDER-INGENIO [CSD2007-00018]; National Science Foundation [NSF 0823749]; Direct For Social, Behav & Economic Scie [0823749] Funding Source: National Science Foundation	MICINN (Ministerio de Ciencia e Innovacion - Ministry of Science and Innovation)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the MICINN grant (Ministerio de Ciencia e Innovacion - Ministry of Science and Innovation, http://www.boe.es/boe/dias/2010/04/13/pdfs/BOE-A-2010-5939.pdf) TIN2009-14404-C02-01, the CONSOLIDER-INGENIO 2010 grant (CSD2007-00018) http://www.ingenio2010.es/contenido.asp?menu1=3&menu2=1&menu3=&dir=./02_instrumentos/02_Caracteristicas/01_CONSOLIDER&id=En(), and the National Science Foundation grant NSF 0823749. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, PLOS ONE, DOI DOI 10.1371/journal.pone.0003526; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Bishop C.M., 1995, NEURAL NETWORKS PATT; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; BRAHNAM S, 2009, PREDICTING TRAIT IMP, P403; BRAHNAM SA, P MOD OTH AG OBS MOO, P57; Brahnam S, 2010, EXPERT SYST APPL, V37, P5086, DOI 10.1016/j.eswa.2009.12.002; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; Buhmann M. D., 2000, Acta Numerica, V9, P1, DOI 10.1017/S0962492900000015; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; DONATO G, 2002, IEEE T, V21, P974; Duda R.O., 2006, PATTERN CLASSIFICATI; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Ekman P., 2002, FACIAL ACTION CODING; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; GARY L, FACE DETERMINING FAC; KAMENSKAYA E, METODY INFORM STOSOW; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lundqvist D, KAROLINSKA DIRECTED; MAZUR A, 1994, ETHOL SOCIOBIOL, V15, P87, DOI 10.1016/0162-3095(94)90019-1; MAZUR A, 1996, RES BIOPOLITICS, V4, P99; MOVELLAN JR, TUTORIAL GABOR FILTE; Naumann LP, 2009, PERS SOC PSYCHOL B, V35, P1661, DOI 10.1177/0146167209346309; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; PRtools, MATL TOOLB PATT REC; ROJAS QM, 2010, COMPUTER VISION PATT, P2715; Schlicht EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011663; Sproull L, 1996, HUM-COMPUT INTERACT, V11, P97, DOI 10.1207/s15327051hci1102_1; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; TODOROV ONN, 2011, SIGNAL PROCESSING MA, P1053; TOWHIDI F, 2009, BINARY DECISION DIAG; WALKER JH, 1994, HUMAN FACTORS IN COMPUTING SYSTEMS, CHI '94 CONFERENCE PROCEEDINGS - CELEBRATING INTERDEPENDENCE, P85, DOI 10.1145/191666.191708; WANG L, 1990, PATTERN RECOGN, V23, P905, DOI 10.1016/0031-3203(90)90135-8; SINGULAR INVERSIONS	38	28	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23323	10.1371/journal.pone.0023323	http://dx.doi.org/10.1371/journal.pone.0023323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21858069	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300034
J	Bansal, R; Hulbert, S; Schemerhorn, B; Reese, JC; Whitworth, RJ; Stuart, JJ; Chen, MS				Bansal, Raman; Hulbert, Scot; Schemerhorn, Brandi; Reese, John C.; Whitworth, R. Jeff; Stuart, Jeffrey J.; Chen, Ming-Shun			Hessian Fly-Associated Bacteria: Transmission, Essentiality, and Composition	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; ACYRTHOSIPHON-PISUM; SYMBIOTIC BACTERIA; NITROGEN-FIXATION; APHIDS; HOST; REPRODUCTION; PROTEINS; INSECTS; DIPTERA	Plant-feeding insects have been recently found to use microbes to manipulate host plant physiology and morphology. Gall midges are one of the largest groups of insects that manipulate host plants extensively. Hessian fly (HF, Mayetiola destructor) is an important pest of wheat and a model system for studying gall midges. To examine the role of bacteria in parasitism, a systematic analysis of bacteria associated with HF was performed for the first time. Diverse bacteria were found in different developmental HF stages. Fluorescent in situ hybridization detected a bacteriocyte-like structure in developing eggs. Bacterial DNA was also detected in eggs by PCR using primers targeted to different bacterial groups. These results indicated that HF hosted different types of bacteria that were maternally transmitted to the next generation. Eliminating bacteria from the insect with antibiotics resulted in highmortality of HF larvae, indicating that symbiotic bacteria are essential for the insect to survive on wheat seedlings. A preliminary survey identified various types of bacteria associated with different HF stages, including the genera Enterobacter, Pantoea, Stenotrophomonas, Pseudomonas, Bacillus, Ochrobactrum, Acinetobacter, Alcaligenes, Nitrosomonas, Arcanobacterium, Microbacterium, Paenibacillus, and Klebsiella. Similar bacteria were also found specifically in HF-infested susceptible wheat, suggesting that HF larvae had either transmitted bacteria into plant tissue or brought secondary infection of bacteria to the wheat host. The bacteria associated with wheat seedlings may play an essential role in the wheat-HF interaction.	[Bansal, Raman; Reese, John C.; Whitworth, R. Jeff; Chen, Ming-Shun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Hulbert, Scot] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Schemerhorn, Brandi] Purdue Univ, USDA ARS, W Lafayette, IN 47907 USA; [Schemerhorn, Brandi; Stuart, Jeffrey J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Chen, Ming-Shun] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA	Kansas State University; Washington State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kansas State University; United States Department of Agriculture (USDA)	Bansal, R (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	ming-shun.chen@ars.usda.gov		Bansal, Raman/0000-0001-7133-0785	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan TN, BIOL GALL INSECTS; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; BOOSALIS MG, 1954, PHYTOPATHOLOGY, V44, P224; Brune A., 2003, ENCY INSECTS, P1102; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; BYERS RA, 1972, J ECON ENTOMOL, V65, P955, DOI 10.1093/jee/65.4.955; Chen MS, 2008, J INSECT PHYSIOL, V54, P1, DOI 10.1016/j.jinsphys.2007.07.007; Chen MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-296; Chen MS, 2009, J ECON ENTOMOL, V102, P1663, DOI 10.1603/029.102.0434; Chen MS, 2004, INSECT MOL BIOL, V13, P101, DOI 10.1111/j.1365-2583.2004.00465.x; Costa HS, 1996, ANN ENTOMOL SOC AM, V89, P694, DOI 10.1093/aesa/89.5.694; DENLINGER DL, 1975, ANN NY ACAD SCI, V266, P162, DOI 10.1111/j.1749-6632.1975.tb35097.x; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Doyle J. J., 1987, PHYTOCHEM B, P11; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; FEBVAY G, 1995, ARCH INSECT BIOCHEM, V29, P45, DOI 10.1002/arch.940290106; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; GAGNE RJ, 1989, ANN ENTOMOL SOC AM, V82, P73, DOI 10.1093/aesa/82.1.73; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Giovanini MP, 2006, MOL PLANT MICROBE IN, V19, P1023, DOI 10.1094/MPMI-19-1023; HARRIS MO, 1989, ENTOMOL EXP APPL, V53, P17, DOI 10.1007/BF00369228; Harris MO, 2006, ANN ENTOMOL SOC AM, V99, P305, DOI 10.1603/0013-8746(2006)099[0305:VHFDCL]2.0.CO;2; Hatchett J. H., 1987, Agronomy, P625; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; HOWARD DJ, 1985, EVOLUTION, V39, P405, DOI 10.1111/j.1558-5646.1985.tb05677.x; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; Kneip C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-55; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Liu X, 2007, J CHEM ECOL, V33, P2171, DOI 10.1007/s10886-007-9382-2; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; Mittapalli O, 2006, J INSECT PHYSIOL, V52, P1143, DOI 10.1016/j.jinsphys.2006.08.007; Moran NA, 2001, P NATL ACAD SCI USA, V292, P1096; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; NOGGE G, 1976, EXPERIENTIA, V32, P995, DOI 10.1007/BF01933932; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Pauly PJ, 2002, ENV HIST, V7, P385; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; SASAKI T, 1991, J INSECT PHYSIOL, V37, P749, DOI 10.1016/0022-1910(91)90109-D; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schaefer CW., 2000, HETEROPTERA EC IMPOR, V1; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Stuart Jeffrey J., 2008, V1, P93, DOI 10.1007/978-3-540-73833-6_7; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Vorburger C, 2009, BIOL LETT; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; WILKINSON TL, 1995, J INSECT PHYSIOL, V41, P635, DOI 10.1016/0022-1910(95)00036-T; Wilkinson TL, 1996, ENTOMOL EXP APPL, V80, P279, DOI 10.1007/BF00194774; Wilkinson TL, 1998, COMP BIOCHEM PHYS A, V119, P871, DOI 10.1016/S1095-6433(98)00013-0; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Zhu L, 2008, MOL PLANT MICROBE IN, V21, P70, DOI 10.1094/MPMI-21-1-0070	59	42	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23170	10.1371/journal.pone.0023170	http://dx.doi.org/10.1371/journal.pone.0023170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858016	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500015
J	Griffin, MR; Monto, AS; Belongia, EA; Treanor, JJ; Chen, QX; Chen, JF; Talbot, HK; Ohmit, SE; Coleman, LA; Lofthus, G; Petrie, JG; Meece, JK; Hall, CB; Williams, JV; Gargiullo, P; Berman, L; Shay, DK				Griffin, Marie R.; Monto, Arnold S.; Belongia, Edward A.; Treanor, John J.; Chen, Qingxia; Chen, Jufu; Talbot, H. Keipp; Ohmit, Suzanne E.; Coleman, Laura A.; Lofthus, Gerry; Petrie, Joshua G.; Meece, Jennifer K.; Hall, Caroline Breese; Williams, John V.; Gargiullo, Paul; Berman, LaShondra; Shay, David K.		US Flu-VE Network	Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 US Communities	PLOS ONE			English	Article							2009 H1N1 VACCINE; SEASONAL INFLUENZA; ANTIBODY-RESPONSE; CHILDREN; IMMUNOGENICITY; TRIVALENT; EFFICACY; SAFETY	We estimated the effectiveness of four monovalent pandemic influenza A (H1N1) vaccines (three unadjuvanted inactivated, one live attenuated) available in the U.S. during the pandemic. Patients with acute respiratory illness presenting to inpatient and outpatient facilities affiliated with four collaborating institutions were prospectively recruited, consented, and tested for influenza. Analyses were restricted to October 2009 through April 2010, when pandemic vaccine was available. Patients testing positive for pandemic influenza by real-time RT-PCR were cases; those testing negative were controls. Vaccine effectiveness was estimated in logistic regression models adjusted for study community, patient age, timing of illness, insurance status, enrollment site, and presence of high-risk medical conditions. Pandemic virus was detected in 1,011 (15%) of 6,757 enrolled patients. Fifteen (1%) of 1,011 influenza positive cases and 1,042 (18%) of 5,746 test-negative controls had record-verified pandemic vaccination > 14 days prior to illness onset. Adjusted effectiveness (95% confidence interval) for pandemic vaccines combined was 56% (-23%, 75%). Adjusted effectiveness for inactivated vaccines alone (79% of total) was 62% (25%, 81%) overall and 32% (-92%, 76%), 89% (15%, 99%), and -6% (-231%, 66%) in those aged 0.5 to 9, 10 to 49, and 50+ years, respectively. Effectiveness for the live attenuated vaccine in those aged 2 to 49 years was only demonstrated if vaccination >7 rather than >14 days prior to illness onset was considered (61%: 12%, 82%). Inactivated non-adjuvanted pandemic vaccines offered significant protection against confirmed pandemic influenza-associated medical care visits in young adults.	[Griffin, Marie R.] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37235 USA; [Griffin, Marie R.; Talbot, H. Keipp] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Chen, Qingxia] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Talbot, H. Keipp; Williams, John V.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Williams, John V.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN USA; [Monto, Arnold S.; Ohmit, Suzanne E.; Petrie, Joshua G.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Belongia, Edward A.; Coleman, Laura A.; Meece, Jennifer K.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Treanor, John J.; Lofthus, Gerry; Hall, Caroline Breese] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Hall, Caroline Breese] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Chen, Jufu; Gargiullo, Paul; Berman, LaShondra; Shay, David K.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Michigan System; University of Michigan; University of Rochester; University of Rochester; Centers for Disease Control & Prevention - USA	Griffin, MR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37235 USA.	marie.griffin@vanderbilt.edu	Williams, John/F-6962-2010; Williams, John/ABE-3227-2020	Williams, John/0000-0001-8377-5175; Williams, John/0000-0001-8377-5175; Belongia, Edward/0000-0001-7478-0415; Shay, David/0000-0001-9619-4820; Irving, Stephanie/0000-0001-7437-6797	Centers for Disease Control and Prevention; Marshfield Clinic Research Foundation [U01 IP000183]; University of Michigan [U01 IP000170]; University of Rochester [U01 IP000172]; Vanderbilt University [U01 IP000184]; NIAID [1K23AI074863-01]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U18IP000183, U18IP000184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI074863] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Marshfield Clinic Research Foundation; University of Michigan(University of Michigan System); University of Rochester; Vanderbilt University; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Centers for Disease Control and Prevention through cooperative agreements with the Marshfield Clinic Research Foundation (U01 IP000183), the University of Michigan (U01 IP000170), the University of Rochester (U01 IP000172), and Vanderbilt University (U01 IP000184). Internal CDC funds were used to support CDC investigators and to provide laboratory validation of RT-PCR methods at the enrolling site laboratories. As part of the cooperative agreement, CDC investigators participated in study design, analysis, decision to publish and preparation of the manuscript. Dr. Talbot received salary support from the NIAID (1K23AI074863-01). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; Arguedas A, 2010, NEW ENGL J MED, V362, P370, DOI 10.1056/NEJMc0909988; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Brammer L., 2009, Morbidity and Mortality Weekly Report, V58, P1236; Carmona A, 2010, VACCINE, V28, P5837, DOI 10.1016/j.vaccine.2010.06.065; Fleming DM, 2010, BMJ-BRIT MED J, P1; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Kelley NS, 2011, NEW ENGL J MED, V364, P1181, DOI 10.1056/NEJMc1100442; Kendal A, 1982, HEMAGGLUTINATION INH, pB17; Kunzel W, 1996, VACCINE, V14, P1108, DOI 10.1016/0264-410X(96)00061-8; Lambkin R, 2000, VACCINE, V18, P2307, DOI 10.1016/S0264-410X(99)00437-5; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Neuzil Kathleen M, 2009, N Engl J Med, V361, pe59, DOI 10.1056/NEJMe0908224; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Van Buynder PG, 2010, INFLUENZA OTHER RESP, V4, P171, DOI 10.1111/j.1750-2659.2010.00146.x; Wichmann O, 2010, EURO SURVEILL, V15; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736	29	100	100	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23085	10.1371/journal.pone.0023085	http://dx.doi.org/10.1371/journal.pone.0023085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857999	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953500020
J	Wu, SG; Chang, YL; Lin, JW; Wu, CT; Chen, HY; Tsai, MF; Lee, YC; Yu, CJ; Shih, JY				Wu, Shang-Gin; Chang, Yih-Leong; Lin, Jou-Wei; Wu, Chen-Tu; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; Yu, Chong-Jen; Shih, Jin-Yuan			Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction	PLOS ONE			English	Article							CELL LUNG-CANCER; EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR MUTATIONS; TYROSINE KINASE; IMMUNOHISTOCHEMICAL DETECTION; GEFITINIB; ADENOCARCINOMA; TUMORS; CHEMOTHERAPY; INHIBITOR	Epidermal growth factor receptor (EGFR) is a novel target for therapy in subsets of non-small cell lung cancer, especially adenocarcinoma. Tumors with EGFR mutations showed good response to EGFR tyrosine kinase inhibitors (TKIs). We aimed to identify the discriminating capacity of immunohistochemical (IHC) scoring to detect L858R and E746-A750 deletion mutation in lung adenocarcinoma patients and predict EGFR TKIs response. Patients with surgically resected lung adenocarcinoma were enrolled. EGFR mutation status was genotyped by PCR and direct sequencing. Mutation-specific antibodies for L858R and E746-A750 deletion were used for IHC staining. Receiver operating characteristic (ROC) curves were used to determine the capacity of IHC, including intensity and/or quickscore (Q score), in differentiating L858R and E746-A750 deletion. We enrolled 143 patients during September 2000 to May 2009. Logistic-regression-model-based scoring containing both L858R Q score and total EGFR expression Q score was able to obtain a maximal area under the curve (AUC: 0.891) to differentiate the patients with L858R. Predictive model based on IHC Q score of E746-A750 deletion and IHC intensity of total EGFR expression reached an AUC of 0.969. The predictive model of L858R had a significantly higher AUC than L858R intensity only (p = 0.036). Of the six patients harboring complex EGFR mutations with classical mutation patterns, five had positive IHC staining. For EGFR TKI treated cancer recurrence patients, those with positive mutation-specific antibody IHC staining had better EGFR TKI response (p = 0.008) and longer progression-free survival (p = 0.012) than those without. In conclusion, total EGFR expression should be included in the IHC interpretation of L858R. After adjusting for total EGFR expression, the scoring method decreased the false positive rate and increased diagnostic power. According to the scoring method, the IHC method is useful to predict the clinical outcome and refine personalized therapy.	[Wu, Shang-Gin; Lin, Jou-Wei] Natl Taiwan Univ Hosp, Coll Med, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Lee, Yung-Chie] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Meng-Feng] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan; [Yu, Chong-Jen; Shih, Jin-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Da Yeh University; National Taiwan University; National Taiwan University Hospital	Wu, SG (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan.	jyshih@ntu.edu.tw	Wu, Shang-Gin/X-6183-2018; Chen, Hsuan-Yu/AAE-8428-2019	Yu, Chong-Jen/0000-0001-5664-9392; WU, CHEN-TU/0000-0001-8458-4119; CHANG, YIH-LEONG/0000-0001-5309-0554	National Science Council, Taiwan [98-2314-B-002-117-MY3, 98-2628-B-002-087-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from the National Science Council, Taiwan (98-2314-B-002-117-MY3 and 98-2628-B-002-087-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES DM, 1993, HUM PATHOL, V24, P469, DOI 10.1016/0046-8177(93)90158-D; BRAMBILLA E, 2004, PATHOLOGY GENETICS T, P9; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; DAVIES RL, 1980, P NATL ACAD SCI-BIOL, V77, P4188, DOI 10.1073/pnas.77.7.4188; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gow CH, 2009, ANN ONCOL, V20, P696, DOI 10.1093/annonc/mdn679; Ilie MI, 2010, VIRCHOWS ARCH, V457, P483, DOI 10.1007/s00428-010-0963-z; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; KOZU Y, LUNG CANC IN PRESS; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shih JY, 2006, INT J CANCER, V118, P963, DOI 10.1002/ijc.21458; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Wu JY, 2010, LUNG CANCER, V67, P348, DOI 10.1016/j.lungcan.2009.04.018; Wu SG, 2008, ONCOLOGIST, V13, P1276, DOI 10.1634/theoncologist.2008-0093; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739	24	41	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23303	10.1371/journal.pone.0023303	http://dx.doi.org/10.1371/journal.pone.0023303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858063	gold, Green Published, Green Submitted			2022-12-27	WOS:000293774300030
J	Liu, Q; Jiang, HY; Liu, ZJ; Wang, Y; Zhao, MN; Hao, CY; Feng, SA; Guo, HY; Xu, B; Yang, QF; Gong, YQ; Shao, CS				Liu, Qiao; Jiang, Haiyan; Liu, Zhaojian; Wang, Yu; Zhao, Minnan; Hao, Chunyan; Feng, Shuai; Guo, Haiyang; Xu, Bing; Yang, Qifeng; Gong, Yaoqin; Shao, Changshun			Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51	PLOS ONE			English	Article							HUMAN HEPATOMA-CELLS; LUNG-CANCER; CYCLE ARREST; TUMOR-CELLS; CARCINOMA-CELLS; APOPTOSIS; EXPRESSION; PATHWAY; DNA; OVEREXPRESSION	Background: Esophageal squamous cell carcinomas (ESCC) have poor prognosis. While combined modality of chemotherapy and radiotherapy increases survival, most patients die within five years. Development of agents that confer cancer cell-specific chemo- and radiosensitivity may improve the therapy of ESCC. We here reported the discovery of berberine as a potent radiosensitizing agent on ESCC cells. Principal Findings: Berberine at low concentrations (< 15 mu M) substantially radiosensitized ESCC cells. X-ray induced DNA double-strand breaks (DSBs) persist longer in ESCC cells pretreated with berberine. Berberine pretreatment led to a significant downregulation of RAD51, a key player in homologous recombination repair, in ESCC cells, but not in nonmalignant human cells. Downregulation of RAD51 by RNA interference similarly radiosensitized the cancer cells, and, conversely, introduction of exogenous RAD51 was able to significantly counteract the radiosensitizing effect of berberine, thus establishing RAD51 as a key determinant in radiation sensitivity. We also observed that RAD51 was commonly overexpressed in human ESCC tissues, suggesting that it is necessary to downregulate RAD51 to achieve high radio- or chemotherapeutic efficacy of ESCC in clinic, because overexpression of RAD51 is known to confer radio- and chemoresistance. Conclusions/Significance: Berberine can effectively downregulate RAD51 in conferring radiosensitivity on esophageal cancer cells. Its clinical application as an adjuvant in chemotherapy and radiotherapy of esophageal cancers should be explored.	[Liu, Qiao; Jiang, Haiyan; Liu, Zhaojian; Wang, Yu; Zhao, Minnan; Feng, Shuai; Guo, Haiyang; Xu, Bing; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Liu, Qiao; Jiang, Haiyan; Liu, Zhaojian; Wang, Yu; Zhao, Minnan; Feng, Shuai; Guo, Haiyang; Xu, Bing; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China; [Hao, Chunyan] Shandong Univ, Dept Pathol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Liu, Q (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China.	yxg8@sdu.edu.cn; changshun.shao@gmail.com	yang, qiang/GYJ-0971-2022; Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342; Yang, Qifeng/0000-0003-0576-8513; guo, haiyang/0000-0001-5503-6922	National Natural Science Foundation of China; Ministry of Science and Technology of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The study was funded by National Natural Science Foundation of China; Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Chen RS, 2009, EXP CELL RES, V315, P2658, DOI 10.1016/j.yexcr.2009.06.002; Chen TC, 2009, INT J ONCOL, V34, P1681, DOI 10.3892/ijo_00000299; Chendil D, 2004, ONCOGENE, V23, P1599, DOI 10.1038/sj.onc.1207284; Choudhury A, 2009, MOL CANCER THER, V8, P203, DOI 10.1158/1535-7163.MCT-08-0959; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; EARLAM R, 1980, BRIT J SURG, V67, P457, DOI 10.1002/bjs.1800670702; EARLAM R, 1980, BRIT J SURG, V67, P381, DOI 10.1002/bjs.1800670602; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; Hur JM, 2009, J CELL BIOCHEM, V107, P955, DOI 10.1002/jcb.22198; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Javvadi P, 2008, MOL PHARMACOL, V73, P1491, DOI 10.1124/mol.107.043554; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Ko JC, 2008, CARCINOGENESIS, V29, P1448, DOI 10.1093/carcin/bgn130; Ko JC, 2010, BIOCHEM PHARMACOL, V79, P655, DOI 10.1016/j.bcp.2009.09.024; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kvols LK, 2005, J NUCL MED, V46, p187S; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin CC, 2006, ANTICANCER RES, V26, P1097; Lin CC, 2007, ANTICANCER RES, V27, P3371; Lin JP, 2006, WORLD J GASTROENTERO, V12, P21, DOI 10.3748/wjg.v12.i1.21; Lin SK, 2004, MOL PHARMACOL, V66, P612; Liu ZJ, 2009, MUTAT RES-FUND MOL M, V662, P75, DOI 10.1016/j.mrfmmm.2008.12.009; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Mitra A, 2009, HISTOPATHOLOGY, V55, P696, DOI 10.1111/j.1365-2559.2009.03448.x; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Pandey MK, 2008, CANCER RES, V68, P5370, DOI 10.1158/0008-5472.CAN-08-0511; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Raderschall E, 2002, CANCER RES, V62, P219; Russell JS, 2003, CANCER RES, V63, P7377; Sanders MM, 1998, BIOCHEM PHARMACOL, V56, P1157, DOI 10.1016/S0006-2952(98)00243-3; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tsai MS, 2010, J PHARMACOL EXP THER, V335, P830, DOI 10.1124/jpet.110.173146; Yamamoto A, 1996, MOL GEN GENET, V251, P1; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Zhang XL, 2010, CANCER RES, V70, P9895, DOI 10.1158/0008-5472.CAN-10-1546; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404	47	58	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23427	10.1371/journal.pone.0023427	http://dx.doi.org/10.1371/journal.pone.0023427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858113	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300028
J	Song, XR; Shen, JL; Wen, HQ; Zhong, ZR; Luo, QL; Chu, DY; Qi, Y; Xu, YH; Wei, W				Song, Xiaorong; Shen, Jilong; Wen, Huiqin; Zhong, Zhengrong; Luo, Qinli; Chu, Deyong; Qi, Yao; Xu, Yuanhong; Wei, Wei			Impact of Schistosoma japonicum Infection on Collagen-Induced Arthritis in DBA/1 Mice: A Murine Model of Human Rheumatoid Arthritis	PLOS ONE			English	Article							REGULATORY T-CELLS; TRICHURIS-SUIS THERAPY; HELMINTH INFECTION; AUTOIMMUNE-DISEASE; MANSONI INFECTION; TH2 POLARIZATION; DENDRITIC CELLS; INFLAMMATION; INTERPLAY; RESPONSES	Background: The hygiene hypothesis suggests that helminth infections prevent a range of autoimmune diseases. Methodology/Principal Findings: To investigate the effects of S. japonicum infection on collagen-induced arthritis (CIA), male DBA/1 mice were challenged with unisexual or bisexual S. japonicum cercariae two weeks prior to bovine type II collagen (CII) immunization or at the onset of CIA. S. japonicum infection prior to CII immunization significantly reduced the severity of CIA. ELISA (enzyme linked immunosorbent assay) showed that the levels of anti-CII IgG and IgG2a were reduced in prior schistosome-infected mice, while anti-CII IgG1 was elevated. Splenocyte proliferation against both polyclonal and antigen-specific stimuli was reduced by prior schistosome infection as measured by tritiated thymidine incorporation ((3)H-TdR). Cytokine profiles and CD4(+) T cells subpopulation analysis by ELISA and flow cytometry (FCM) demonstrated that prior schistosome infection resulted in a significant down-regulation of pro-inflammatory cytokines (IFN-gamma, TNF-alpha, IL-1 beta and IL-6) and Th1 cells, together with up-regulation of the anti-inflammatory cytokine IL-10 and Th2 cells. Interestingly, the expansion of Treg cells and the reduction of Th17 cells were only observed in bisexually infected mice. In addition, prior schistosome infection notably reduced the expression of pro-inflammatory cytokines and receptor activator of NF-kappa B ligand (RANKL) in the inflamed joint. However, the disease was exacerbated at one week after infection when established CIA mice were challenged with bisexual cercariae. Conclusion/Significance: Our data provide direct evidence that the Th2 response evoked by prior S. japonicum infection can suppress the Th1 response and pro-inflammatory mediator and that bisexual infection with egg-laying up-regulates the Treg response and down-regulates the Th17 response, resulting in an amelioration of autoimmune arthritis. The beneficial effects might depend on the establishment of a Th2-dominant response rather than the presence of the eggs. Our results suggest that anti-inflammatory molecules from the parasite could treat autoimmune diseases.	[Song, Xiaorong; Shen, Jilong; Wei, Wei] Anhui Med Univ, Inst Clin Pharmacol, Hefei, Anhui, Peoples R China; [Song, Xiaorong; Shen, Jilong; Wen, Huiqin; Zhong, Zhengrong; Luo, Qinli; Chu, Deyong; Qi, Yao; Xu, Yuanhong] Anhui Med Univ, Key Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Song, Xiaorong; Shen, Jilong; Wen, Huiqin; Zhong, Zhengrong; Luo, Qinli; Chu, Deyong; Qi, Yao; Xu, Yuanhong] Anhui Med Univ, Key Lab Zoonoses, Hefei, Anhui, Peoples R China; [Song, Xiaorong] Anhui Prov Hosp, Inst Anhui Cardiovasc Res, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Song, XR (corresponding author), Anhui Med Univ, Inst Clin Pharmacol, Hefei, Anhui, Peoples R China.	shenjilong53@126.com			National Nature Science Foundation of China [81071376, 30872209]; Research Fund for the Doctoral Program of Higher Education of China [200803660003]; Provincial Natural Science Foundation of Anhui [090413089]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Provincial Natural Science Foundation of Anhui	This work was funded by: the National Nature Science Foundation of China (No. 81071376, No. 30872209) http://www.nsfc.gov.cn/Portal0/default124.htm; the Research Fund for the Doctoral Program of Higher Education of China (No. 200803660003) http://www.cutech.edu.cn/cn/index.htm; and the Provincial Natural Science Foundation of Anhui (No. 090413089) http://www.ahinfo.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisakwattana P, 2009, ADV EXP MED BIOL, V666, P95; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Rocha FAC, 2008, INFECT IMMUN, V76, P2736, DOI 10.1128/IAI.01085-07; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Fraga LAD, 2010, J INFECT DIS, V201, P464, DOI 10.1086/649841; DeMarco R, 2009, DRUG DISCOV TODAY, V14, P472, DOI 10.1016/j.drudis.2009.01.011; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Esensten JH, 2009, NAT REV RHEUMATOL, V5, P560, DOI 10.1038/nrrheum.2009.183; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; GERMANN T, 1995, P NATL ACAD SCI USA, V92, P4823, DOI 10.1073/pnas.92.11.4823; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Layland LE, 2010, J IMMUNOL, V184, P713, DOI 10.4049/jimmunol.0901435; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Liu P, 2010, PARASITE IMMUNOL, V32, P57, DOI 10.1111/j.1365-3024.2009.01161.x; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Reddy A, 2009, PARASITOL RES, V104, P217, DOI 10.1007/s00436-008-1297-5; Rutitzky LI, 2009, EUR J IMMUNOL, V39, P2470, DOI 10.1002/eji.200939325; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2010, MICROBES INFECT, V12, P881, DOI 10.1016/j.micinf.2010.06.001; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Williams Richard O, 2007, Methods Mol Biol, V361, P265; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x; Zaccone P, 2008, TRENDS PARASITOL, V24, P35, DOI 10.1016/j.pt.2007.10.006; Zaccone P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795210; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	41	37	66	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23453	10.1371/journal.pone.0023453	http://dx.doi.org/10.1371/journal.pone.0023453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858123	Green Submitted, Green Published, gold			2022-12-27	WOS:000293773300031
J	Ghosn, J; Galimand, J; Raymond, S; Meyer, L; Deveau, C; Goujard, C; Izopet, J; Rouzioux, C; Chaix, ML				Ghosn, Jade; Galimand, Julie; Raymond, Stephanie; Meyer, Laurence; Deveau, Christiane; Goujard, Cecile; Izopet, Jacques; Rouzioux, Christine; Chaix, Marie-Laure		ANRS CO 06 PRIMO Cohort	X4 Tropic Multi-Drug Resistant Quasi-Species Detected at the Time of Primary HIV-1 Infection Remain Exclusive or at Least Dominant Far from PHI	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; GENOTYPIC PREDICTION; DISEASE PROGRESSION; CORECEPTOR USAGE; TYPE-1 INFECTION; TRANSMISSION; VIRUS; PERSISTENCE; COHORT	Our objective was to analyze the evolution of resistance mutations (RM) and viral tropism of multi-drug-resistant (MDR) strains detected at primary HIV-1 infection (PHI). MDR HIV strain was defined as the presence of genotypic resistance to at least 1 antiretroviral of the 3 classes. Tropism determinations (CCR5 or CXCR4) were performed on baseline plasma HIV-RNA and/or PBMC-HIV-DNA samples, then during follow-up using population-based sequencing of V3 loop and phenotypic tests. Clonal analysis was performed at baseline for env, RT and protease genes, and for HIV-DNA env gene during follow-up. Five patients were eligible. At baseline, RT, protease and env clones from HIV-RNA and HIV-DNA were highly homogenous for each patient; genotypic tropism was R5 in 3 (A, B, C) and X4 in 2 patients (D, E). MDR strains persisted in HIV-DNA throughout follow-up in all patients. For patient A, tropism remained R5 with concordance between phenotypic and genotypic tests. Clonal analysis on Month (M) 78 HIV-DNA evidenced exclusively R5 (21/21) variants. In patient B, clonal analysis at M36 showed exclusively R5 variants (19/19) using both genotypic and phenotypic tests. In patient C, baseline tropism was R5 by genotypic test and R5/X4 by phenotypic test. An expansion of these X4 clones was evidenced by clonal analysis on M72 HIV-DNA (12/14 X4 and 2/14 R5 variants). In patient D, baseline tropism was X4 with concordance between both techniques and HIV-RNA and HIV-DNA remained X4-tropic up to M72, confirmed by the clonal analysis. Patient E harboured highly homogenous X4-using population at baseline; tropism was unchanged at M1 and M18. In all patients, the initial MDR population was highly homogenous initially, supporting the early expansion of a monoclonal population and its long-term persistence. X4-tropic variants present at baseline were still exclusive (patients D and E) or dominant (at least one time point, patient C) far from PHI.	[Ghosn, Jade; Galimand, Julie; Rouzioux, Christine; Chaix, Marie-Laure] Univ Paris 05, CHU Necker Enfants Malad, EA 3620, Paris, France; [Ghosn, Jade; Goujard, Cecile] CHU Bicetre, AP HP, Serv Med Interne & Malad Infect, Le Kremlin Bicetre, France; [Galimand, Julie; Rouzioux, Christine; Chaix, Marie-Laure] CHU Necker Enfants Malad, AP HP, Virol Lab, Paris, France; [Raymond, Stephanie; Izopet, Jacques] Hop Purpan, INSERM U563, Virol Lab, Toulouse, France; [Meyer, Laurence; Deveau, Christiane; Goujard, Cecile] Univ Paris 11, Fac Med Paris Sud, Hop Bicetre, AP HP,INSERM U1018,Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Ghosn, J (corresponding author), Univ Paris 05, CHU Necker Enfants Malad, EA 3620, Paris, France.	jade.ghosn@bct.aphp.fr	Raymond, Stephanie/L-8401-2019; IZOPET, Jacques/L-5756-2014; Raymond, Stephanie/K-4507-2014; Boucherit, Soraya/I-1704-2017; Bergmann, Jean-Francois/L-6044-2017	Raymond, Stephanie/0000-0002-3780-5844; Boucherit, Soraya/0000-0002-8819-7594; Bergmann, Jean-Francois/0000-0001-6861-9748; ABEL, Sylvie/0000-0002-3351-0547; Cabie, Andre/0000-0003-0117-3061	French National Agency for Research on AIDS (ANRS)	French National Agency for Research on AIDS (ANRS)(ANRS)	This work was supported by the French National Agency for Research on AIDS (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Balandya E, 2010, J IMMUNOL, V185, P7596, DOI 10.4049/jimmunol.1002846; Bhaskaran K, 2004, AIDS, V18, P1471, DOI 10.1097/01.aids.0000131341.45795.33; Bomsel M, 2002, NAT MED, V8, P114, DOI 10.1038/nm0202-114; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Chaix ML, 2007, ANTIVIR THER, V12, P1305; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Dalmau J, 2009, CLIN INFECT DIS, V48, P229, DOI 10.1086/595704; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; de Mendoza C, 2007, J ANTIMICROB CHEMOTH, V59, P698, DOI 10.1093/jac/dkm012; DEJONG JJ, 1992, J VIROL, V66, P757, DOI 10.1128/JVI.66.2.757-765.1992; Delaugerre C, 2004, ANTIVIR THER, V9, P415; Delaugerre C, 2007, AIDS, V21, P1365, DOI 10.1097/QAD.0b013e3280d6edf1; Desquilbet L, 2004, AIDS, V18, P2361; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Frange P, 2009, J ANTIMICROB CHEMOTH, V64, P135, DOI 10.1093/jac/dkp151; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Ghosn J, 2005, AIDS, V19, P1643, DOI 10.1097/01.aids.0000181322.17679.b2; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Goujard C, 2009, CLIN INFECT DIS, V49, P982, DOI 10.1086/605504; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; Nischalke HD, 2004, AIDS RES HUM RETROV, V20, P750, DOI 10.1089/0889222041524634; Pasquier C, 2001, J VIROL METHODS, V94, P45, DOI 10.1016/S0166-0934(01)00272-5; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Raymond S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/j.jcv.2009.11.018; Raymond S, 2010, JAIDS-J ACQ IMM DEF, V53, P167, DOI 10.1097/QAI.0b013e3181c8413b; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Schiffer V, 2004, HIV MED, V5, P326, DOI 10.1111/j.1468-1293.2004.00231.x; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Smith DM, 2007, J INFECT DIS, V196, P356, DOI 10.1086/519164; Soulie C, 2007, AIDS, V21, P2243, DOI 10.1097/QAD.0b013e3282f0e3d0; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Sucupira MCA, 2010, ANTIVIR THER, V15, pA163; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wagner TA, 2010, ANTIVIR THER, V15, pA45; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Wei X, 2003, VIROLOGY, V311, P202, DOI 10.1016/S0042-6822(03)00173-9; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Yeni P, 2010, PRISE CHARGE MED PER; Yerly S, 2004, ANTIVIR THER, V9, P375; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	51	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23301	10.1371/journal.pone.0023301	http://dx.doi.org/10.1371/journal.pone.0023301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887243	Green Submitted, gold, Green Published			2022-12-27	WOS:000295832000013
J	Ojeda, L; Gao, JL; Hooten, KG; Wang, EY; Thonhoff, JR; Dunn, TJ; Gao, TY; Wu, P				Ojeda, Luis; Gao, Junling; Hooten, Kristopher G.; Wang, Enyin; Thonhoff, Jason R.; Dunn, Tiffany J.; Gao, Tianyan; Wu, Ping			Critical Role of PI3K/Akt/GSK3 beta in Motoneuron Specification from Human Neural Stem Cells in Response to FGF2 and EGF	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; PROTEIN-KINASE-C; SPINAL MOTOR-NEURONS; PHOSPHOINOSITIDE 3-KINASE; ADULT-RAT; CHOLINE-ACETYLTRANSFERASE; DIFFERENTIATION; CORD; PROLIFERATION; ACTIVATION	Fibroblast growth factor (FGF) and epidermal growth factor (EGF) are critical for the development of the nervous system. We previously discovered that FGF2 and EGF had opposite effects on motor neuron differentiation from human fetal neural stem cells (hNSCs), but the underlying mechanisms remain unclear. Here, we show that FGF2 and EGF differentially affect the temporal patterns of Akt and glycogen synthase kinase 3 beta (GSK3 beta) activation. High levels of phosphatidylinositol 3-kinase (PI3K)/Akt activation accompanied with GSK3b inactivation result in reduction of the motor neuron transcription factor HB9. Inhibition of PI3K/Akt by chemical inhibitors or RNA interference or overexpression of a constitutively active form of GSK3b enhances HB9 expression. Consequently, PI3K inhibition increases hNSCs differentiation into HB9(+)/microtubule-associated protein 2 (MAP2)(+) motor neurons in vitro. More importantly, blocking PI3K not only enhances motor neuron differentiation from hNSCs grafted into the ventral horn of adult rat spinal cords, but also permits ectopic generation of motor neurons in the dorsal horn by overriding environmental influences. Our data suggest that FGF2 and EGF affect the motor neuron fate decision in hNSCs differently through a fine tuning of the PI3K/AKT/GSK3 beta pathway, and that manipulation of this pathway can enhance motor neuron generation.	[Ojeda, Luis; Gao, Junling; Wang, Enyin; Thonhoff, Jason R.; Dunn, Tiffany J.; Wu, Ping] Univ Texas Med Branch Galveston, Dept Neurosci & Cell Biol, Galveston, TX USA; [Hooten, Kristopher G.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Wang, Enyin] Sichuan Univ, W China Sch Preclin & Forens Med, Chengdu 610064, Sichuan, Peoples R China; [Gao, Tianyan] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida; Sichuan University; University of Kentucky; University of Kentucky	Ojeda, L (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	piwu@utmb.edu			John S. Dunn Research Foundation; Cullen Foundation; TIRR Foundation; Gillson Longenbaugh Foundation; Moody Foundation; NIH [F30NS060387, R01 CA133429]; NATIONAL CANCER INSTITUTE [R01CA133429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS060387] Funding Source: NIH RePORTER	John S. Dunn Research Foundation; Cullen Foundation; TIRR Foundation; Gillson Longenbaugh Foundation; Moody Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the John S. Dunn Research Foundation, the Cullen Foundation, the TIRR Foundation, the Gillson Longenbaugh Foundation, the Moody Foundation, and the NIH (F30NS060387 to J.R.T. and R01 CA133429 to T.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER RP, 1984, J COMP NEUROL, V229, P329, DOI 10.1002/cne.902290305; BORGES LF, 1986, BRAIN RES, V362, P140, DOI 10.1016/0006-8993(86)91407-1; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Bruno L, 2008, CELL CYCLE, V7, P2296, DOI 10.4161/cc.6444; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Coffer PJ, 1998, BIOCHEM J, V335, P1; Corti S, 2010, BRAIN, V133, P465, DOI 10.1093/brain/awp318; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gao J, 2005, NEUROSCIENCE, V131, P257, DOI 10.1016/j.neuroscience.2004.10.033; Gao JL, 2007, NEUROREPORT, V18, P565, DOI 10.1097/WNR.0b013e3280b10c2c; Gremo F, 2000, INT J DEV NEUROSCI, V18, P271, DOI 10.1016/S0736-5748(99)00095-7; Hedlund E, 2007, EUR J NEUROSCI, V26, P1721, DOI 10.1111/j.1460-9568.2007.05780.x; Ho WC, 2005, MOL CELL BIOCHEM, V271, P29, DOI 10.1007/s11010-005-3458-5; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nayak MS, 2006, BBA-MOL BASIS DIS, V1762, P1128, DOI 10.1016/j.bbadis.2006.06.004; Oliva JL, 2005, GROWTH FACTORS, V23, P245, DOI 10.1080/08977190500366043; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Raballo R, 2000, J NEUROSCI, V20, P5012; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Thonhoff JR, 2009, CURR STEM CELL RES T, V4, P178, DOI 10.2174/157488809789057392; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; Wada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006722; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Weiss S, 1996, J NEUROSCI, V16, P7599; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	46	57	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23414	10.1371/journal.pone.0023414	http://dx.doi.org/10.1371/journal.pone.0023414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887250	Green Submitted, Green Published, gold			2022-12-27	WOS:000295832000018
J	Appia-Ayme, C; Patrick, E; Sullivan, MJ; Alston, MJ; Field, SJ; AbuOun, M; Anjum, MF; Rowley, G				Appia-Ayme, Corinne; Patrick, Elaine; Sullivan, Matthew J.; Alston, Mark J.; Field, Sarah J.; AbuOun, Manal; Anjum, Muna F.; Rowley, Gary			Novel Inducers of the Envelope Stress Response BaeSR in Salmonella Typhimurium: BaeR Is Critically Required for Tungstate Waste Disposal	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; ALTERNATIVE SIGMA-FACTOR; SHOCK PROTEIN OPERON; ESCHERICHIA-COLI; GENE-EXPRESSION; RPOE GENE; CHROMOSOMAL GENES; RESISTANCE; VIRULENCE; TRANSPORT	The RpoE and CpxR regulated envelope stress responses are extremely important for SalmonellaTyphimurium to cause infection in a range of hosts. Until now the role for BaeSR in both the Salmonella Typhimurium response to stress and its contribution to infection have not been fully elucidated. Here we demonstrate stationary phase growth, iron and sodium tungstate as novel inducers of the BaeRregulon, with BaeR critically required for Salmonella resistance to sodium tungstate. We show that functional overlap between the resistance nodulation-cell division (RND) multidrug transporters, MdtA, AcrD and AcrB exists for the waste disposal of tungstate from the cell. We also point to a role for enterobactinsiderophores in the protection of enteric organisms from tungstate, akin to the scenario in nitrogen fixing bacteria. Surprisingly, BaeR is the first envelope stress response pathway investigated in S. Typhimurium that is not required for murine typhoid in either ity(S) or ity(R) mouse backgrounds. BaeR is therefore either required for survival in larger mammals such as pigs or calves, an avian host such as chickens, or survival out with the host altogether where Salmonella and related enterics must survive in soil and water.	[Appia-Ayme, Corinne; Patrick, Elaine; Sullivan, Matthew J.; Field, Sarah J.; Rowley, Gary] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [AbuOun, Manal; Anjum, Muna F.] Anim Hlth & Vet Labs Agcy Weybridge, Surrey, England; [Alston, Mark J.] Genome Anal Ctr, Norwich, Norfolk, England	University of East Anglia; Veterinary Laboratories Agency; The Genome Analysis Centre (TGAC)	Appia-Ayme, C (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	c.appia-ayme@uea.ac.uk; g.rowley@uea.ac.uk	Sullivan, Matthew J/C-3857-2009; anjum, muna/C-5213-2011; ABUOUN, MANAL/D-8456-2011; Rowley, Gary/F-7869-2011	Sullivan, Matthew J/0000-0003-2276-3132; Alston, Mark/0000-0002-1645-3982	Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/G020582/1]; BBSRC [BB/G020582/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G020582/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (United Kingdom), grant ref BB/G020582/1, http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alston MJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-73; Andreesen JR, 2008, ANN NY ACAD SCI, V1125, P215, DOI 10.1196/annals.1419.003; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Becker LA, 2005, MOL MICROBIOL, V56, P1004, DOI 10.1111/j.1365-2958.2005.04604.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Braun V, 2002, FEBS LETT, V529, P78, DOI 10.1016/S0014-5793(02)03185-X; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cornish AS, 2000, APPL ENVIRON MICROB, V66, P1580, DOI 10.1128/AEM.66.4.1580-1586.2000; Craig JE, 2002, INFECT IMMUN, V70, P708, DOI 10.1128/IAI.70.2.708-715.2002; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DONG JM, 1993, GENE, V136, P227; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GEMSKI P, 1967, J BACTERIOL, V93, P1588, DOI 10.1128/JB.93.5.1588-1597.1967; Helling RB, 2002, J BACTERIOL, V184, P3699, DOI 10.1128/JB.184.13.3699-3703.2002; Hirakawa H, 2003, J ANTIMICROB CHEMOTH, V52, P576, DOI 10.1093/jac/dkg406; HIRATSU K, 1995, J BACTERIOL, V177, P2918, DOI 10.1128/jb.177.10.2918-2922.1995; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Imperial J, 1998, BBA-BIOMEMBRANES, V1370, P337, DOI 10.1016/S0005-2736(98)00003-0; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; Karlinsey JE, 2010, MOL MICROBIOL, V78, P669, DOI 10.1111/j.1365-2958.2010.07357.x; Kenyon WJ, 2002, MICROBIOL-SGM, V148, P113, DOI 10.1099/00221287-148-1-113; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; LEBLANC SK, 2011, J BACTERIOL; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Miticka H, 2003, FEMS MICROBIOL LETT, V226, P307, DOI 10.1016/S0378-1097(03)00600-1; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; NAGASAWA S, 1993, J BIOCHEM-TOKYO, V114, P350, DOI 10.1093/oxfordjournals.jbchem.a124180; Nishino K, 2005, J BACTERIOL, V187, P1763, DOI 10.1128/JB.187.5.1763-1772.2005; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Pullinger GD, 2010, MICROBIOL-SGM, V156, P3108, DOI 10.1099/mic.0.041830-0; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Skovierova H, 2006, MICROBIOL-SGM, V152, P1347, DOI 10.1099/mic.0.28744-0; Smart JP, 2009, MOL MICROBIOL, V74, P742, DOI 10.1111/j.1365-2958.2009.06902.x; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; TAKAHASHI H, 1957, BIOCHIM BIOPHYS ACTA, V23, P433, DOI 10.1016/0006-3002(57)90351-7; Tedin K, 1996, J BIOL CHEM, V271, P17675, DOI 10.1074/jbc.271.30.17675; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; WEINER L, 1994, P NATL ACAD SCI USA, V91, P2191, DOI 10.1073/pnas.91.6.2191; Wichard T, 2008, ENVIRON SCI TECHNOL, V42, P2408, DOI 10.1021/es702651f; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yamamoto K, 2008, J BIOTECHNOL, V133, P196, DOI 10.1016/j.jbiotec.2007.08.002; Ygberg SE, 2006, INFECT IMMUN, V74, P1243, DOI 10.1128/IAI.74.2.1243-1254.2006; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zoetendal EG, 2008, APPL ENVIRON MICROB, V74, P535, DOI 10.1128/AEM.02271-07	62	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23713	10.1371/journal.pone.0023713	http://dx.doi.org/10.1371/journal.pone.0023713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886814	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000294253500026
J	Bonnet, M; Pardini, M; Meacci, F; Orru, G; Yesilkaya, H; Jarosz, T; Andrew, PW; Barer, M; Checchi, F; Rinder, H; Orefici, G; Rusch-Gerdes, S; Fattorini, L; Oggioni, MR; Melzer, J; Niemann, S; Varaine, F				Bonnet, Maryline; Pardini, Manuela; Meacci, Francesca; Orru, Germano; Yesilkaya, Hasan; Jarosz, Thierry; Andrew, Peter W.; Barer, Mike; Checchi, Francesco; Rinder, Heinz; Orefici, Graziella; Ruesch-Gerdes, Sabine; Fattorini, Lanfranco; Oggioni, Marco Rinaldo; Melzer, Juliet; Niemann, Stefan; Varaine, Francis			Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EMERGENCE	Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. Methods: We combined drug susceptibility results and molecular strain typing data with treatment outcome reports to assess the influence of drug resistance on TB treatment outcomes in a prospective cohort of patients from Abkhazia (Georgia). Patients received individualized treatment regimens based on drug susceptibility testing (DST) results. Definitions for antituberculosis drug resistance and treatment outcomes were in line with current WHO recommendations. First and second line DST, and molecular typing were performed in a supranational laboratory for Mycobacterium tuberculosis (MTB) strains from consecutive sputum smear-positive TB patients at baseline and during treatment. Results: At baseline, MTB strains were fully drug-susceptible in 189/326 (58.0%) of patients. Resistance to at least H or R (PDR-TB) and multidrug-resistance (MDR-TB) were found in 69/326 (21.2%) and 68/326 (20.9%) of strains, respectively. Three MDR-TB strains were also extensively resistant (XDR-TB). During treatment, 3/189 (1.6%) fully susceptible patients at baseline were re-infected with a MDR-TB strain and 2/58 (3.4%) PDR-TB patients became MDR-TB due to resistance amplification. 5/47 (10.6%) MDR-patients became XDR-TB during treatment. Treatment success was observed in 161/189 (85.2%), 54/69 (78.3%) and 22/68 (32.3%) of patients with fully drug susceptible, PDR- and MDR-TB, respectively. Development of ofloxacin resistance was significantly associated with a negative treatment outcome. Conclusion: In Abkhazia, a region with high prevalence of drug resistant TB, the use of individualized MDR-TB treatment regimens resulted in poor treatment outcomes and XDR-TB amplification. Nosocomial transmission of MDR-TB emphasizes the importance of infection control in hospitals.	[Bonnet, Maryline; Checchi, Francesco] Epictr, Dept Clin Res, Geneva, Switzerland; [Pardini, Manuela; Orefici, Graziella; Fattorini, Lanfranco] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Meacci, Francesca; Oggioni, Marco Rinaldo] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy; [Orru, Germano] Univ Cagliari, Dipartimento Sci Odontostomatol, Cagliari, Italy; [Yesilkaya, Hasan; Andrew, Peter W.; Barer, Mike] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Jarosz, Thierry] Essai Clin Evaluat Epidemiol Stat, Paris, France; [Rinder, Heinz] Sachgebiet Parasitol Bayer Landesamt Gesundheit &, Oberschleissheim, Germany; [Ruesch-Gerdes, Sabine; Niemann, Stefan] Forschungszentrum Borstel, Natl Reference Ctr Mycobacteriol, Borstel, Germany; [Melzer, Juliet; Varaine, Francis] Med Sans Frontieres, Dept Med, Paris, France	Istituto Superiore di Sanita (ISS); University of Siena; University of Cagliari; University of Leicester; Bavarian Health & Food Safety Authority; Forschungszentrum Borstel; Doctors Without Borders; Sanofi-Aventis; Sanofi France	Bonnet, M (corresponding author), Epictr, Dept Clin Res, Geneva, Switzerland.	maryline.bonnet@geneva.msf.org	Fattorini, Lanfranco/C-1032-2016; Yesilkaya, Hasan/D-7271-2011; PARDINI, MANUELA/M-4365-2015; Niemann, Stefan/C-9327-2011; Oggioni, Marco Rinaldo/K-3839-2016; Andrew, Peter W/G-7526-2012	Fattorini, Lanfranco/0000-0003-1673-1804; PARDINI, MANUELA/0000-0002-3625-1309; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Barer, Michael/0000-0002-0377-3100; Niemann, Stefan/0000-0002-6604-0684; Orru, Germano/0000-0003-1032-4431; Checchi, Francesco/0000-0001-9030-5382	European Community [QLK-CT-2002-01612]; Medical Research Council [G0501435] Funding Source: researchfish	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the European Community grant QLK-CT-2002-01612 (LONG-DRUG study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], 2008, GUID PROGR MAN DRUG; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Bonnet M, 2005, INT J TUBERC LUNG D, V9, P1147; Brito RC, 2010, INT J TUBERC LUNG D, V14, P24; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Devasia RA, 2009, AM J RESP CRIT CARE, V180, P365, DOI 10.1164/rccm.200901-0146OC; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; MENZIES R, 2010, 41 UN WORLD C LUNG H; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pardini M, 2005, EMERG INFECT DIS, V11, P501, DOI 10.3201/eid1103.040903; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin SS, 2010, AM J RESP CRIT CARE, V182, P426, DOI 10.1164/rccm.200911-1768OC; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; *WHO, 2009, GLOB TUB CONTR REP 2; WHO, 2010, 4 WHO; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476	29	30	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23081	10.1371/journal.pone.0023081	http://dx.doi.org/10.1371/journal.pone.0023081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886778	Green Published, gold			2022-12-27	WOS:000294253500009
J	Cui, P; Lin, Q; Zhang, LF; Ding, F; Xin, CQ; Zhang, DY; Sun, FL; Hu, SN; Yu, J				Cui, Peng; Lin, Qiang; Zhang, Lingfang; Ding, Feng; Xin, Chengqi; Zhang, Daoyong; Sun, Fanglin; Hu, Songnian; Yu, Jun			The Disequilibrium of Nucleosomes Distribution along Chromosomes Plays a Functional and Evolutionarily Role in Regulating Gene Expression	PLOS ONE			English	Article							HIGH-RESOLUTION; ORGANIZATION; OCCUPANCY; SEQUENCE; TRANSPORT; REVEALS; REGIONS	To further understand the relationship between nucleosome-space occupancy (NO) and global transcriptional activity in mammals, we acquired a set of genome-wide nucleosome distribution and transcriptome data from the mouse cerebrum and testis based on ChIP (H3)-seq and RNA-seq, respectively. We identified a nearly consistent NO patterns among three mouse tissues-cerebrum, testis, and ESCs- and found, through clustering analysis for transcriptional activation, that the NO variations among chromosomes are closely associated with distinct expression levels between house-keeping (HK) genes and tissue-specific (TS) genes. Both TS and HK genes form clusters albeit the obvious majority. This feature implies that NO patterns, i.e. nucleosome binding and clustering, are coupled with gene clustering that may be functionally and evolutionarily conserved in regulating gene expression among different cell types.	[Cui, Peng; Lin, Qiang; Zhang, Lingfang; Ding, Feng; Xin, Chengqi; Hu, Songnian; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhang, Daoyong; Sun, Fanglin] Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China; [Cui, Peng; Ding, Feng] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Lin, Qiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Tsinghua University; King Abdullah University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, P (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	husn@big.ac.cn; junyu@big.ac.cn	郑, 征/C-8514-2011; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111; Ding, Feng/0000-0001-8237-4062	National Basic Research Program (973 Program) [2011CB944100, 2011CB944101]; National Natural Science Foundation of China [90919024]; Chinese Academy of Sciences [KSCX2-EW-R-01-04]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program (973 Program; 2011CB944100 and 2011CB944101), National Natural Science Foundation of China (90919024), and Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-01-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi AS, 2003, WASTE MANAGE RES, V21, P474, DOI 10.1177/0734242X0302100510; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cui P, 2010, BIOCHEM BIOPH RES CO, V391, P884, DOI 10.1016/j.bbrc.2009.11.157; Dessau Ram Benny, 2008, Ugeskr Laeger, V170, P328; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Marella NV, 2009, J CELL PHYSIOL, V221, P130, DOI 10.1002/jcp.21836; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nili EL, 2010, GENOME RES, V20, P1361, DOI 10.1101/gr.103945.109; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Shimizu M, 1993, Tanpakushitsu Kakusan Koso, V38, P971; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Westenberger SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-610; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	38	12	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23219	10.1371/journal.pone.0023219	http://dx.doi.org/10.1371/journal.pone.0023219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886783	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100008
J	Koyanagi, M; Asahara, S; Matsuda, T; Hashimoto, N; Shigeyama, Y; Shibutani, Y; Kanno, A; Fuchita, M; Mikami, T; Hosooka, T; Inoue, H; Matsumoto, M; Koike, M; Uchiyama, Y; Noda, T; Seino, S; Kasuga, M; Kido, Y				Koyanagi, Maki; Asahara, Shun-ichiro; Matsuda, Tomokazu; Hashimoto, Naoko; Shigeyama, Yutaka; Shibutani, Yuki; Kanno, Ayumi; Fuchita, Megumi; Mikami, Tomoko; Hosooka, Tetsutya; Inoue, Hiroshi; Matsumoto, Michihiro; Koike, Masato; Uchiyama, Yasuo; Noda, Tetsuo; Seino, Susumu; Kasuga, Masato; Kido, Yoshiaki			Ablation of TSC2 Enhances Insulin Secretion by Increasing the Number of Mitochondria through Activation of mTORC1	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; TUBEROUS SCLEROSIS GENE; PROTEIN-KINASE; RENAL CARCINOGENESIS; NATURAL-HISTORY; SKELETAL-MUSCLE; PKC-LAMBDA; MICE; BIOGENESIS; RESISTANCE	Aim: We previously found that chronic tuberous sclerosis protein 2 (TSC2) deletion induces activation of mammalian target of rapamycin Complex 1 (mTORC1) and leads to hypertrophy of pancreatic beta cells from pancreatic beta cell-specific TSC2 knockout (beta TSC2(-/-)) mice. The present study examines the effects of TSC2 ablation on insulin secretion from pancreatic beta cells. Methods: Isolated islets from beta TSC2(-/-) mice and TSC2 knockdown insulin 1 (INS-1) insulinoma cells treated with small interfering ribonucleic acid were used to investigate insulin secretion, ATP content and the expression of mitochondrial genes. Results: Activation of mTORC1 increased mitochondrial DNA expression, mitochondrial density and ATP production in pancreatic beta cells of beta TSC2(-/-) mice. In TSC2 knockdown INS-1 cells, mitochondrial DNA expression, mitochondrial density and ATP production were increased compared with those in control INS-1 cells, consistent with the phenotype of beta TSC2(-/-) mice. TSC2 knockdown INS-1 cells also exhibited augmented insulin secretory response to glucose. Rapamycin inhibited mitochondrial DNA expression and ATP production as well as insulin secretion in response to glucose. Thus, beta TSC2(-/-) mice exhibit hyperinsulinemia due to an increase in the number of mitochondria as well as enlargement of individual beta cells via activation of mTORC1 Conclusion: Activation of mTORC1 by TSC2 ablation increases mitochondrial biogenesis and enhances insulin secretion from pancreatic beta cells.	[Koyanagi, Maki; Asahara, Shun-ichiro; Matsuda, Tomokazu; Hashimoto, Naoko; Shigeyama, Yutaka; Shibutani, Yuki; Kanno, Ayumi; Hosooka, Tetsutya; Seino, Susumu; Kido, Yoshiaki] Kobe Univ, Div Diabet & Endocrinol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan; [Fuchita, Megumi; Mikami, Tomoko; Kido, Yoshiaki] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 657, Japan; [Inoue, Hiroshi] Kanazawa Univ, Frontier Sci Org, Kanazawa, Ishikawa, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 170, Japan; [Matsumoto, Michihiro; Kasuga, Masato] Natl Ctr Global Hlth & Med, Res Inst, Tokyo, Japan	Kobe University; Kobe University; Kobe University; Kanazawa University; Juntendo University; Japanese Foundation for Cancer Research; National Center for Global Health & Medicine - Japan	Koyanagi, M (corresponding author), Kobe Univ, Div Diabet & Endocrinol, Grad Sch Med, Kobe, Hyogo 657, Japan.	kido@med.kobe-u.ac.jp	Noda, Tetsuo/B-1667-2016; Asahara, Shun-ichiro/I-6645-2019; Koike, Masato/F-9584-2010	Asahara, Shun-ichiro/0000-0001-6661-9402; Koike, Masato/0000-0002-3174-5684; Inoue, Hiroshi/0000-0002-7724-6637	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT [18GS0317, 22590981]; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Grants-in-Aid for Scientific Research [22790863, 22790861, 21249057, 23300274] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for the Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, to M. Kasuga; a Grant-in-Aid for Creative Scientific Research from MEXT to M. Kasuga (18GS0317), a Grant-in-Aid for Scientific Research from MEXT to Y. Kido (22590981) and the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN) to H. Inoue. The funders, however, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Asahara S, 2009, BIOCHEM BIOPH RES CO, V381, P367, DOI 10.1016/j.bbrc.2009.02.047; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hino O, 2003, GENE CHROMOSOME CANC, V38, P357, DOI 10.1002/gcc.10265; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Iwabu M., NATURE, V464; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kobayashi T, 1999, CANCER RES, V59, P1206; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; LEAHY JL, 1990, DIABETES CARE, V13, P992, DOI 10.2337/diacare.13.9.992; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; NELLIST M, 1993, CELL, V75, P1305; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	48	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23238	10.1371/journal.pone.0023238	http://dx.doi.org/10.1371/journal.pone.0023238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886784	gold, Green Published, Green Submitted			2022-12-27	WOS:000294128100009
J	Xu, ZS; Du, X; Li, TT; Gan, F; Tang, B; Tang, XF				Xu, Zhisheng; Du, Xin; Li, Tingting; Gan, Fei; Tang, Bing; Tang, Xiao-Feng			Functional Insight into the C-Terminal Extension of Halolysin SptA from Haloarchaeon Natrinema sp J7	PLOS ONE			English	Article							ALKALINE SERINE-PROTEASE; COLLAGEN-BINDING DOMAIN; CRYSTAL-STRUCTURE; GENE CLONING; EXTRACELLULAR PROTEASE; DISULFIDE BOND; SUBTILISIN; EXPRESSION; STABILIZATION; REQUIREMENT	Halolysin SptA from haloarchaeon Natrinema sp. J7 consists of a subtilisin-like catalytic domain and a C-terminal extension (CTE) containing two cysteine residues. In this report, we have investigated the function of the CTE using recombinant enzymes expressed in Haloferax volcanii WFD11. Deletion of the CTE greatly reduced but did not abolish protease activity, which suggests that the CTE is not essential for enzyme folding. Mutational analysis suggests that residues Cys303 and Cys338 within the CTE form a disulfide bond that make this domain resistant to autocleavage and proteolysis under hypotonic conditions. Characterization of full-length and CTE-truncation enzymes indicates the CTE not only confers extra stability to the enzyme but also assists enzyme activity on protein substrates by facilitating binding at high salinities. Interestingly, homology modeling of the CTE yields a beta-jelly roll-like structure similar to those seen in Claudin-binding domain of Clostridium perfringens enterotoxin (clostridial C-CPE) and collagen binding domain (CBD), and the CTE also possesses collagen-binding activity, making it a potential candidate as an anchoring unit in drug delivery systems.	[Xu, Zhisheng; Du, Xin; Li, Tingting; Gan, Fei; Tang, Bing; Tang, Xiao-Feng] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Xu, ZS (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	tangxf@whu.edu.cn	Gan, Fei/I-8599-2017		National Natural Science Foundation of China [30870063, 30970071]; Natural Science Foundation of Hubei Province [2007ABB022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported in part by the National Natural Science Foundation of China (30870063 and 30970071) and the Natural Science Foundation of Hubei Province for Distinguished Young Scientists (2007ABB022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian Y, 2006, FEBS LETT, V580, P6007, DOI 10.1016/j.febslet.2006.09.068; Brown CK, 2005, P NATL ACAD SCI USA, V102, P18391, DOI 10.1073/pnas.0504954102; Capiralla H, 2002, PROCESS BIOCHEM, V38, P571, DOI 10.1016/S0032-9592(02)00180-2; Cheng GY, 2009, MICROBIOL-SGM, V155, P3661, DOI 10.1099/mic.0.031336-0; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; De Castro RE, 2006, FEMS MICROBIOL REV, V30, P17, DOI 10.1111/j.1574-6976.2005.00003.x; De Castro RE, 2008, EXTREMOPHILES, V12, P677, DOI 10.1007/s00792-008-0174-6; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Foophow T, 2010, J MOL BIOL, V400, P865, DOI 10.1016/j.jmb.2010.05.064; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRIFFIN HL, 1992, CURR MICROBIOL, V24, P111, DOI 10.1007/BF01570907; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Kagawa TF, 2009, J MOL BIOL, V386, P754, DOI 10.1016/j.jmb.2008.12.074; KAMEKURA M, 1992, J BACTERIOL, V174, P736, DOI 10.1128/jb.174.3.736-742.1992; Kamekura M, 1996, BBA-PROTEIN STRUCT M, V1294, P159, DOI 10.1016/0167-4838(96)00016-7; Kim DW, 2000, BIOCHEM BIOPH RES CO, V277, P216, DOI 10.1006/bbrc.2000.3657; Kim JS, 2004, J MOL BIOL, V335, P787, DOI 10.1016/j.jmb.2003.11.006; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; RYU KG, 1994, ENZYME MICROB TECH, V16, P266, DOI 10.1016/0141-0229(94)90165-1; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shi WL, 2006, EXTREMOPHILES, V10, P599, DOI 10.1007/s00792-006-0003-8; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107	36	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23562	10.1371/journal.pone.0023562	http://dx.doi.org/10.1371/journal.pone.0023562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886797	gold, Green Published, Green Submitted			2022-12-27	WOS:000294128100019
J	Yu, SL; Wong, CK; Wong, PTY; Chen, DP; Szeto, CC; Li, EK; Tam, LS				Yu, Shui-Lian; Wong, Chun-Kwok; Wong, Purple Tsz-Yan; Chen, Da-Peng; Szeto, Cheuk-Chun; Li, Edmund K.; Tam, Lai-Shan			Down-Regulated NOD2 by Immunosuppressants in Peripheral Blood Cells in Patients with SLE Reduces the Muramyl Dipeptide-Induced IL-10 Production	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; HUMAN B-LYMPHOCYTES; EPSTEIN-BARR-VIRUS; T-HELPER-CELL; DISEASE-ACTIVITY; CYTOKINE PRODUCTION; AUTOIMMUNE-DISEASE; CROHNS-DISEASE; MYCOBACTERIUM-TUBERCULOSIS	Background: Pattern recognition receptors (PRRs) such as Toll-like receptors are aberrantly expressed of peripheral blood mononuclear cells (PBMCs) in systemic lupus erythematosus (SLE) patients, for playing immunopathological roles. Methodology/Principal Findings: We investigated the expression and function of the PRR nucleotide-binding oligomerization domain (NOD2) in SLE. NOD2 expression in T, B lymphocytes, monocytes, myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs) was assessed in SLE patients and healthy controls (HCs) using flow cytometric analysis. Ex vivo production of cytokines from PBMCs upon NOD2 agonist muramyl dipeptide (MDP) stimulation was assessed using Cytometric Bead Array. Over-expression of NOD2 in monocytes was observed in immunosuppressant naive SLE patients, and was positively associated with longer disease duration. Immunosuppressive therapy was an independent explanatory variable for downregulating NOD2 expression in CD8+ T, monocytes, mDCs and pDCs. Ex vivo basal productions of cytokines (IL-6, IL-8 and IL-10) were significantly increased in immunosuppressant naive patients and patients with active disease despite immunosuppressants compared with HCs. Upon MDP stimulaiton, relative induction (%) of cytokines (IL-1 beta) from PBMC was significantly increased in immunosuppressant naive patients with inactive disease, and patients with active disease despite immunosuppressant treatment compared with HCs. Immunosuppressant usage was associated with a decreased basal production and MDP induced relative induction (%) of IL-10 in patients with inactive disease compared with immunosuppressant naive patients and HCs. Conclusions/Significance: Bacterial exposure may increase the NOD2 expression in monocytes in immunosuppressant naive SLE patients which can subsequently lead to aberrant activation of PBMCs to produce proinflammatory cytokines, implicating the innate immune response for extracellular pathogens in the immunopathological mechanisms in SLE. Immunosuppressant therapy may downregulate NOD2 expression in CD8+ T lymphocytes, monocytes, and DCs in SLE patients which subsequently IL-10 reduction, contributing towards the regulation of immunopathological mechanisms of SLE, at the expense of increasing risk of bacterial infection.	[Yu, Shui-Lian; Szeto, Cheuk-Chun; Li, Edmund K.; Tam, Lai-Shan] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Wong, Chun-Kwok; Wong, Purple Tsz-Yan; Chen, Da-Peng] Chinese Univ Hong Kong, Dept Chem Pathol, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Chen, Da-Peng] Chongqing Med Univ, Childrens Hosp, Dept Clin Lab, Chongqing, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chongqing Medical University	Yu, SL (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China.	lstam@cuhk.edu.hk	Wong, CK/H-3256-2016; Tam, Lai-Shan/K-4980-2014; Szeto, Cheuk Chun/N-4954-2015; Tam, Lai-Shan/U-7044-2019	Wong, CK/0000-0002-5637-8331; Tam, Lai-Shan/0000-0001-6410-8852; Szeto, Cheuk Chun/0000-0002-8898-8505; Tam, Lai-Shan/0000-0001-6410-8852; Yu, Shui Lian/0000-0002-0739-1441	The Chinese University of Hong Kong	The Chinese University of Hong Kong(Chinese University of Hong Kong)	This study is supported by research grant from The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Al-Mutairi S, 2007, RHEUMATOL INT, V27, P621, DOI 10.1007/s00296-006-0268-3; Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brennan FM, 1996, CURR OPIN IMMUNOL, V8, P872, DOI 10.1016/S0952-7915(96)80018-5; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dean GS, 2000, ANN RHEUM DIS, V59, P243, DOI 10.1136/ard.59.4.243; DING L, 1993, J IMMUNOL, V151, P1224; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Doria A, 2004, ARTHRIT RHEUM-ARTHR, V51, P989, DOI 10.1002/art.20837; Ferreiros-Vidal I, 2003, RHEUMATOLOGY, V42, P570, DOI 10.1093/rheumatology/keg192; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; HANDWERGER BS, 1994, SPRINGER SEMIN IMMUN, V16, P153, DOI 10.1007/BF00197515; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; HEDL M, 2011, J BIOL CHEM; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Joosten LAB, 2008, P NATL ACAD SCI USA, V105, P9017, DOI 10.1073/pnas.0710445105; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Khan N, 2010, HUM IMMUNOL, V71, P372, DOI 10.1016/j.humimm.2010.01.018; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Koval'chuk L. V., 2011, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P93; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Lacki JK, 1997, CLIN RHEUMATOL, V16, P275, DOI 10.1007/BF02238963; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Lun SWM, 2009, J CLIN IMMUNOL, V29, P330, DOI 10.1007/s10875-008-9269-1; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; MALEFYT RD, 1991, J EXP MED, V174, P915; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Means TK, 1999, J IMMUNOL, V163, P3920; Miyazaki M, 2008, J MED VIROL, V80, P980, DOI 10.1002/jmv.21174; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ospelt C, 2009, ARTHRITIS RHEUM, V60, P355, DOI 10.1002/art.24226; PETRI M, 1991, ARTHRITIS RHEUM, V34, P937, DOI 10.1002/art.1780340802; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Ribeiro FM, 2010, CLIN REV ALLERG IMMU, V38, P163, DOI 10.1007/s12016-009-8149-7; Rosenzweig HL, 2008, J LEUKOCYTE BIOL, V84, P529, DOI 10.1189/jlb.0108015; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Sabry A, 2006, CYTOKINE, V35, P148, DOI 10.1016/j.cyto.2006.07.023; Schiffenbauer J, 2004, LUPUS, V13, P398, DOI 10.1191/0961203303lu1033oa; Segal R, 1997, J IMMUNOL, V158, P3009; Shin JN, 2010, IMMUNOL CELL BIOL, V88, P343, DOI 10.1038/icb.2010.19; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; Tam LS, 2004, ARTHRITIS RHEUM-US, V50, P3619, DOI 10.1002/art.20616; Tam LS, 2002, SCAND J RHEUMATOL, V31, P296, DOI 10.1080/030097402760375205; Tomita H, 2003, CLIN EXP RHEUMATOL, V21, P497; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Van Beek MJ, 2001, DERMATOL CLIN, V19, P147, DOI 10.1016/S0733-8635(05)70236-9; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Verdolini R, 2002, BRIT J DERMATOL, V146, P877, DOI 10.1046/j.1365-2133.2002.04627.x; Voronov E, 2006, EUR CYTOKINE NETW, V17, P109; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Wong CK, 2010, CLIN EXP IMMUNOL, V159, P11, DOI 10.1111/j.1365-2249.2009.04036.x; Zandman-Goddard G, 2003, CLIN REV ALLERG IMMU, V25, P29, DOI 10.1385/CRIAI:25:1:29; Zandman-Goddard G, 2005, AUTOIMMUNITY, V38, P473, DOI 10.1080/08916930500285352	71	16	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23855	10.1371/journal.pone.0023855	http://dx.doi.org/10.1371/journal.pone.0023855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886831	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100037
J	Marquez-Villavicencio, MD; Weber, B; Witherell, RA; Willis, DK; Charkowski, AO				Marquez-Villavicencio, Maria del Pilar; Weber, Brooke; Witherell, R. Andrews; Willis, David K.; Charkowski, Amy O.			The 3-Hydroxy-2-Butanone Pathway Is Required for Pectobacterium carotovorum Pathogenesis	PLOS ONE			English	Article							BACTERIAL SOFT-ROT; SEED-CORN MAGGOT; ERWINIA-CAROTOVORA; VAR ATROSEPTICA; INSECT TRANSMISSION; BACILLUS-SUBTILIS; SUBSP CAROTOVORA; MATE CHOICE; GENES; ACETOIN	Pectobacterium species are necrotrophic bacterial pathogens that cause soft rot diseases in potatoes and several other crops worldwide. Gene expression data identified Pectobacterium carotovorum subsp. carotovorum budB, which encodes the alpha-acetolactate synthase enzyme in the 2,3-butanediol pathway, as more highly expressed in potato tubers than potato stems. This pathway is of interest because volatiles produced by the 2,3-butanediol pathway have been shown to act as plant growth promoting molecules, insect attractants, and, in other bacterial species, affect virulence and fitness. Disruption of the 2,3-butanediol pathway reduced virulence of P. c. subsp. carotovorum WPP14 on potato tubers and impaired alkalinization of growth medium and potato tubers under anaerobic conditions. Alkalinization of the milieu via this pathway may aid in plant cell maceration since Pectobacterium pectate lyases are most active at alkaline pH.	[Marquez-Villavicencio, Maria del Pilar; Weber, Brooke; Witherell, R. Andrews; Willis, David K.; Charkowski, Amy O.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Willis, David K.] USDA, Agr Res Serv, Vegetable Crops Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Marquez-Villavicencio, MD (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	acharkowski@plantpath.wisc.edu		Charkowski, Amy/0000-0002-8913-2071	National Science Foundation [0412599]; United States Department of Agriculture [2006-398 35319-17396]; Wisconsin Potato and Vegetable Growers Association	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Wisconsin Potato and Vegetable Growers Association	This work was funded by the National Science Foundation Genomics in the Environment Program award number 0412599, the United States Department of Agriculture NRI program grant 2006-398 35319-17396, and the Wisconsin Potato and Vegetable Growers Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Bengtsson JM, 2009, J CHEM ECOL, V35, P1063, DOI 10.1007/s10886-009-9684-7; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; BRENNER DJ, 2004, PROTEOBACTERIA; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BUTTERY RG, 1984, J AGR FOOD CHEM, V32, P254, DOI 10.1021/jf00122a019; Byers JT, 2002, J BACTERIOL, V184, P1163, DOI 10.1128/jb.184.4.1163-1171.2002; Cho SM, 2008, MOL PLANT MICROBE IN, V21, P1067, DOI 10.1094/MPMI-21-8-1067; Dalmacio SC, 2007, PLANT DIS, V91, P346, DOI 10.1094/PDIS-91-4-0346; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DINDONIS LL, 1980, ENVIRON ENTOMOL, V9, P467, DOI 10.1093/ee/9.4.467; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; FRUND C, 1989, J BACTERIOL, V171, P6539; Geraats BPJ, 2003, PHYTOPATHOLOGY, V93, P813, DOI 10.1094/PHYTO.2003.93.7.813; Glasner JD, 2008, MOL PLANT MICROBE IN, V21, P1549, DOI 10.1094/MPMI-21-12-1549; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; Glasner JD, 2006, NUCLEIC ACIDS RES, V34, pD41, DOI 10.1093/nar/gkj164; Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; GRUNDY FJ, 1993, MOL MICROBIOL, V10, P259, DOI 10.1111/j.1365-2958.1993.tb01952.x; HABERLACH GT, 1985, PLANT SCI, V39, P67, DOI 10.1016/0168-9452(85)90194-3; HARRISON M D, 1977, Potato Research, V20, P37, DOI 10.1007/BF02362299; HOWARD CM, 1963, PHYTOPATHOLOGY, V53, P1190; Hsieh SC, 2007, MICROBES INFECT, V9, P1402, DOI 10.1016/j.micinf.2007.07.004; Huang M, 1999, J BACTERIOL, V181, P3837, DOI 10.1128/JB.181.12.3837-3841.1999; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; JOHANSEN L, 1975, J BACTERIOL, V123, P1124, DOI 10.1128/JB.123.3.1124-1130.1975; KLOEPPER JW, 1979, AM POTATO J, V56, P351, DOI 10.1007/BF02853850; KLOEPPER JW, 1981, AM POTATO J, V58, P585, DOI 10.1007/BF02853468; KLOEPPER JW, 1981, AM POTATO J, V58, P165, DOI 10.1007/BF02854416; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Kramer-Haimovich H, 2006, APPL ENVIRON MICROB, V72, P1034, DOI 10.1128/AEM.72.2.1034-1039.2006; LEACH J. G., 1933, ZEITSCHR ANGEW ENT, V20, P150; Leach JG, 1931, PHYTOPATHOLOGY, V21, P387; Leach JG, 1926, PHYTOPATHOLOGY, V16, P149; LEI SP, 1988, GENE, V62, P159, DOI 10.1016/0378-1119(88)90590-2; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Levine M, 1916, J BACTERIOL, V1, P153, DOI 10.1128/JB.1.2.153-164.1916; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Llama-Palacios A, 2002, APPL ENVIRON MICROB, V68, P1624, DOI 10.1128/AEM.68.4.1624-1630.2002; LOPEZ JM, 1975, EUR J BIOCHEM, V57, P425, DOI 10.1111/j.1432-1033.1975.tb02317.x; Lui LH, 2005, AM J POTATO RES, V82, P1, DOI 10.1007/BF02894914; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; MAYER D, 1995, J BACTERIOL, V177, P5261, DOI 10.1128/jb.177.18.5261-5269.1995; MOLINA JJ, 1974, AM POTATO J, V51, P245, DOI 10.1007/BF02851435; MOONS P, 2011, APPL ENV MICROBIOL; Moore AJ, 2001, P ROY SOC B-BIOL SCI, V268, P517, DOI 10.1098/rspb.2000.1399; Moore AJ, 2003, J EVOLUTION BIOL, V16, P523, DOI 10.1046/j.1420-9101.2003.00527.x; Moore AJ, 2002, AM NAT, V160, pS186, DOI 10.1086/342899; Moore AJ, 1999, P ROY SOC B-BIOL SCI, V266, P711, DOI 10.1098/rspb.1999.0694; Nachin L, 2000, MOL PLANT MICROBE IN, V13, P882, DOI 10.1094/MPMI.2000.13.8.882; Noel JT, 2010, MOL PLANT MICROBE IN, V23, P273, DOI 10.1094/MPMI-23-3-0273; Nout MJR, 1998, J CHEM ECOL, V24, P1217, DOI 10.1023/A:1022451020013; PEROMBELON MCM, 1979, PHYTOPATHOLOGY, V69, P167, DOI 10.1094/Phyto-69-167; PHILLIPS JA, 1982, PHYTOPATHOLOGY, V72, P898, DOI 10.1094/Phyto-72-898; PURCELL AH, 1982, ANNU REV PHYTOPATHOL, V20, P397, DOI 10.1146/annurev.py.20.090182.002145; RENNA MC, 1993, J BACTERIOL, V175, P3863, DOI 10.1128/JB.175.12.3863-3875.1993; RIED JL, 1986, APPL ENVIRON MICROB, V52, P305, DOI 10.1128/AEM.52.2.305-310.1986; Robacker DC, 2002, J CHEM ECOL, V28, P1549, DOI 10.1023/A:1019920328062; Rochat D, 2002, J CHEM ECOL, V28, P479, DOI 10.1023/A:1014531810037; ROTENBERG DT, 2006, VIROLOGICAL METHODS, P1; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Sambrook J., 2001, MOL CLONING LAB MANU; THIND BS, 1976, CURR SCI INDIA, V45, P117; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC; Vikram A, 2006, ANN APPL BIOL, V148, P17, DOI 10.1111/j.1744-7348.2005.00036.x; Wells JM, 1997, PLANT DIS, V81, P867, DOI 10.1094/PDIS.1997.81.8.867; Wevers E, 2009, INT J FOOD MICROBIOL, V134, P63, DOI 10.1016/j.ijfoodmicro.2008.12.017; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Yap MN, 2004, APPL ENVIRON MICROB, V70, P3013, DOI 10.1128/AEM.70.5.3013-3023.2004; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06	78	45	45	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22974	10.1371/journal.pone.0022974	http://dx.doi.org/10.1371/journal.pone.0022974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876734	Green Submitted, gold, Green Published			2022-12-27	WOS:000294126900006
J	Xu, X; Gupta, S; Hu, WL; McGrath, BC; Cavener, DR				Xu, Xu; Gupta, Sounak; Hu, Wenli; McGrath, Barbara C.; Cavener, Douglas R.			Hyperthermia Induces the ER Stress Pathway	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; HEAT-SHOCK RESPONSE; GLUCOSE-REGULATED PROTEIN; PERK EIF2-ALPHA KINASE; ENDOPLASMIC-RETICULUM; TRANSLATION INITIATION; EXPRESSION; MICE; PHOSPHORYLATION; RECOVERY	Background: The ER chaperone GRP78/BiP is a homolog of the Hsp70 family of heat shock proteins, yet GRP78/BiP is not induced by heat shock but instead by ER stress. However, previous studies had not considered more physiologically relevant temperature elevation associated with febrile hyperthermia. In this report we examine the response of GRP78/BiP and other components of the ER stress pathway in cells exposed to 40 degrees C. Methodology: AD293 cells were exposed to 43 degrees C heat shock to confirm inhibition of the ER stress response genes. Five mammalian cell types, including AD293 cells, were then exposed to 40 degrees C hyperthermia for various time periods and induction of the ER stress pathway was assessed. Principal Findings: The inhibition of the ER stress pathway by heat shock (43 degrees C) was confirmed. In contrast cells subjected to more mild temperature elevation (40 degrees C) showed either a partial or full ER stress pathway induction as determined by downstream targets of the three arms of the ER stress pathway as well as a heat shock response. Cells deficient for Perk or Gcn2 exhibit great sensitivity to ER stress induction by hyperthermia. Conclusions: The ER stress pathway is induced partially or fully as a consequence of hyperthermia in parallel with induction of Hsp70. These findings suggest that the ER and cytoplasm of cells contain parallel pathways to coordinately regulate adaptation to febrile hyperthermia associated with disease or infection.	[Xu, Xu; Gupta, Sounak; Hu, Wenli; McGrath, Barbara C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Xu, X (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu			National Institutes of Health [R01-GM56957]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institutes of Health (R01-GM56957) to D. R. C. and from the American Heart Association fellowship to S. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBURNER M, 1970, CHROMOSOMA, V31, P356, DOI 10.1007/BF00321231; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; CHANG SC, 1987, P NATL ACAD SCI USA, V84, P680, DOI 10.1073/pnas.84.3.680; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; DIDOMENICO BJ, 1982, CELL, V31, P593, DOI 10.1016/0092-8674(82)90315-4; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; DUNCAN RF, 1995, BIOCHEMISTRY-US, V34, P2985, DOI 10.1021/bi00009a030; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; IKEGUCHI M, 1991, DNA CELL BIOL, V10, P639, DOI 10.1089/dna.1991.10.639; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Li YL, 2003, ENDOCRINOLOGY, V144, P3505, DOI 10.1210/en.2003-0236; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LINDQUIST S, 1975, P NATL ACAD SCI USA, V72, P1117, DOI 10.1073/pnas.72.3.1117; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; MURTHARIEL P, 1993, J BIOL CHEM, V268, P12946; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHWARTZ AL, 1981, J BIOL CHEM, V256, P8878; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; SITIA R, 2004, SCI STKE, pPE27; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	40	43	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23740	10.1371/journal.pone.0023740	http://dx.doi.org/10.1371/journal.pone.0023740			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876766	Green Submitted, Green Published, gold			2022-12-27	WOS:000294126900038
J	Mans, BJ; de Klerk, D; Pienaar, R; Latif, AA				Mans, Ben J.; de Klerk, Daniel; Pienaar, Ronel; Latif, Abdalla A.			Nuttalliella namaqua: A Living Fossil and Closest Relative the Ancestral Tick Lineage: Implications for the Evolution of Blood-Feeding in Ticks	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; KAROO BASIN; SOFT TICKS; HARD TICKS; ACARI; SYSTEMATICS; MORPHOLOGY; ALIGNMENT; IXODIDAE; GENUS	Ticks are monophyletic and composed of the hard ( Ixodidae) and soft ( Argasidae) tick families, as well as the Nuttalliellidae, a family with a single species, Nuttalliella namaqua. Significant biological differences in lifestyle strategies for hard and soft ticks suggest that various blood-feeding adaptations occurred after their divergence. The phylogenetic relationships between the tick families have not yet been resolved due to the lack of molecular data for N. namaqua. This tick possesses a pseudo-scutum and apical gnathostoma as observed for ixodids, has a leathery cuticle similar to argasids and has been considered the evolutionary missing link between the two families. Little knowledge exists with regard to its feeding biology or host preferences. Data on its biology and systematic relationship to the other tick families could therefore be crucial in understanding the evolution of blood-feeding behaviour in ticks. Live specimens were collected and blood meal analysis showed the presence of DNA for girdled lizards from the Cordylid family. Feeding of ticks on lizards showed that engorgement occurred rapidly, similar to argasids, but that blood meal concentration occurs via malpighian excretion of water. Phylogenetic analysis of the 18S nuclear and 16S mitochondrial genes indicate that N. namaqua grouped basal to the main tick families. The data supports the monophyly of all tick families and suggests the evolution of argasid-like blood-feeding behaviour in the ancestral tick lineage. Based on the data and considerations from literature we propose an origin for ticks in the Karoo basin of Gondwanaland during the late Permian. The nuttalliellid family almost became extinct during the End Permian event, leaving N. namaqua as the closest living relative to the ancestral tick lineage and the evolutionary missing link between the tick families.	[Mans, Ben J.; de Klerk, Daniel; Pienaar, Ronel; Latif, Abdalla A.] Agr Res Council, Onderstepoort Vet Inst, Onderstepoort, South Africa; [Mans, Ben J.; Latif, Abdalla A.] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Mans, BJ (corresponding author), Agr Res Council, Onderstepoort Vet Inst, Onderstepoort, South Africa.	mansb@arc.agric.za	Mans, Ben J./M-2427-2017; Pienaar, Ronel/T-6705-2018	Mans, Ben J./0000-0002-0177-0029; Pienaar, Ronel/0000-0002-9096-0237; Latif, Abdalla/0000-0003-3138-3975	Joy Liebenberg Trust [21/19/JT02]; South African National Research Foundation	Joy Liebenberg Trust; South African National Research Foundation(National Research Foundation - South Africa)	This project was funded by the Joy Liebenberg Trust (21/19/JT02) allocated to BM and a South African National Research Foundation grant allocated to AL (NRF-Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks JPH., 1988, MEMOIRS BOT SURVEY S, P1, DOI DOI 10.2307/212246; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aragao H.de B., 1936, Memorias do Instituto Oswaldo Cruz, V31, P759; BALASHOV YS, 1989, PARAZITOLOGIYA+, V23, P368; Balashov YS., 1972, MISCELLANEOUS PUBLIC, V8, P268; Balashov Yu. S., 1994, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V73, P42; Barker SC, 2004, PARASITOLOGY, V129, pS15, DOI 10.1017/S0031182004005207; BEDFORD G. A. H., 1931, PARASITOLOGY, V23, P230, DOI 10.1017/S0031182000013573; Black WC, 1997, MOL PHYLOGENET EVOL, V7, P129, DOI 10.1006/mpev.1996.0382; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Bordy EM, 2011, LETHAIA, V44, P33, DOI 10.1111/j.1502-3931.2010.00223.x; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; Claver JA, 2009, J EXOT PET MED, V18, P87, DOI 10.1053/j.jepm.2009.04.006; Coons L.B., 1986, P248; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Desmet P.G., 1999, KAROO ECOLOGICAL PAT, P3; Dobson SJ, 1999, MOL PHYLOGENET EVOL, V11, P288, DOI 10.1006/mpev.1998.0565; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Durand JF, 2005, J AFR EARTH SCI, V43, P53, DOI 10.1016/j.jafrearsci.2005.07.014; ELSHOURA SM, 1984, J PARASITOL, V70, P114; ELSHOURA SM, 1990, ACAROLOGIA, V31, P349; FILLIPOVA NA, 1977, IXODID TICKS IXODINA; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; HOOGSTRAAL H, 1985, ADV PARASIT, V24, P135, DOI 10.1016/S0065-308X(08)60563-1; HOOGSTRAAL H, 1982, B SOC ENTOMOL SUISSE, V55, P5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; JUPP PG, 1987, MED VET ENTOMOL, V1, P361, DOI 10.1111/j.1365-2915.1987.tb00367.x; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kaufman W.R., 1983, Current Topics in Vector Research, V1, P215; KEIRANS JE, 1976, ANN ENTOMOL SOC AM, V69, P926, DOI 10.1093/aesa/69.5.926; KENNER T, 1989, BASIC RES CARDIOL, V84, P111, DOI 10.1007/BF01907921; Klompen H, 2007, MOL PHYLOGENET EVOL, V43, P936, DOI 10.1016/j.ympev.2006.10.024; Klompen Hans, 2010, Acarologia (Paris), V50, P269, DOI 10.1051/acarologia/20101970; Klompen JSH, 1996, ANNU REV ENTOMOL, V41, P141, DOI 10.1146/annurev.en.41.010196.001041; Klompen JSH, 1997, SYST PARASITOL, V38, P1, DOI 10.1023/A:1005815925466; Klompen JSH, 2000, CLADISTICS, V16, P79, DOI 10.1111/j.1096-0031.2000.tb00349.x; LAVOIPIERRE M. M. J., 1955, ANN TROP MED AND PARASITOL, V49, P96; LEES AD, 1946, PARASITOLOGY, V37, P172, DOI 10.1017/S0031182000013330; Lehtinen Pekka T., 1999, Acta Amazonica, V29, P325; LEHTINEN PT, 1991, MODERN ACAROLOGY, VOLS 1 AND 2, pB101; Lindquist E. E., 1984, ACAROLOGY 6, V1, P28; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Mans BJ, 2002, MOL BIOL EVOL, V19, P1695, DOI 10.1093/oxfordjournals.molbev.a003992; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Moyes CD, 2002, BBA-MOL CELL RES, V1591, P11, DOI 10.1016/S0167-4889(02)00224-0; Nuttall George H. F., 1911, Parasitology Cambridge, V4; OLIVER JH, 1989, ANNU REV ECOL SYST, V20, P397, DOI 10.1146/annurev.es.20.110189.002145; Ponsen S., 2008, International Journal of Zoological Research, V4, P119; Reisz RR, 2000, S AFR J SCI, V96, P443; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Rutherford M. C., 1997, P91; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; SCHULZE P[AUL], 1935, ZEITSCHR MORPH U OKOL TIERE, V30, P1; SELLERS JC, 1980, J HERPETOL, V14, P185, DOI 10.2307/1563853; Sonenshine D.E, 1991, BIOL TICKS, P447; Stanley EL, 2011, MOL PHYLOGENET EVOL, V58, P53, DOI 10.1016/j.ympev.2010.08.024; Stutzer C, 2009, EXP PARASITOL, V122, P318, DOI 10.1016/j.exppara.2009.04.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TATCHELL RJ, 1967, NATURE, V213, P940, DOI 10.1038/213940a0; THEILER G, 1962, ARTHROPOD PARASITES, P1; van der Hammen L., 1983, Zoologische Mededelingen (Leiden), V57, P209; Van der Hammen L, 1983, ZOOL VERHAND, V207, P3; VISSER JNJ, 1995, PALAEOGEOGR PALAEOCL, V118, P213, DOI 10.1016/0031-0182(95)00008-3; Wardell-Johnson G, 2000, POPULATION DEV ENV N, P17; Whiting AS, 2003, MOL PHYLOGENET EVOL, V29, P582, DOI 10.1016/S1055-7903(03)00142-8	74	58	60	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23675	10.1371/journal.pone.0023675	http://dx.doi.org/10.1371/journal.pone.0023675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858204	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300080
J	Minozzi, M; Lattanzi, G; Benz, R; Costi, MP; Venturelli, A; Carloni, P				Minozzi, Manuela; Lattanzi, Gianluca; Benz, Roland; Costi, Maria P.; Venturelli, Alberto; Carloni, Paolo			Permeation through the Cell Membrane of a Boron-Based beta-Lactamase Inhibitor	PLOS ONE			English	Article							LIPID-BILAYER; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; PERMEABILITY; TRANSPORT; CHANNELS; PORIN; ACID; PENICILLINS; SIMULATION	Bacteria express beta-lactamases to counteract the beneficial action of antibiotics. Benzo[b]-thiophene-2-boronic acid (BZB) derivatives are beta-lactamase inhibitors and, as such, promising compounds to be associated with beta-lactam antibacterial therapies. The uncharged form of BZB, in particular, is suggested to diffuse through the outer membrane of Gram negative bacteria. In this study, through the combination of electrophysiological experiments across reconstituted PC/n-decane bilayers and metadynamics-based free energy calculations, we investigate the permeation mechanism of boronic compounds. Our experimental data establish that BZB passes through the membrane, while computer simulations provide hints for the existence of an aqueous, water-filled monomolecular channel. These findings provide new perspectives for the design of boronic acid derivatives with high membrane permeability.	[Minozzi, Manuela] Univ Roma Tre, Modeling & Simulat Lab, Dept Studies Struct, Rome, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Dept Basic Med Sci, TIRES Ctr, Bari, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Ist Nazl Fis Nucl, Bari, Italy; [Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, Bremen, Germany; [Costi, Maria P.; Venturelli, Alberto] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, Modena, Italy; [Carloni, Paolo] Forschungszentrum Julich, German Res Sch Simulat Sci, D-52425 Julich, Germany; [Carloni, Paolo] Rhein Westfal TH Aachen, Julich, Germany	Roma Tre University; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Jacobs University; Universita di Modena e Reggio Emilia; Helmholtz Association; Research Center Julich; RWTH Aachen University	Minozzi, M (corresponding author), Univ Roma Tre, Modeling & Simulat Lab, Dept Studies Struct, Rome, Italy.	gl.lattanzi@gmail.com	Lattanzi, Gianluca/AAA-3173-2019; Lattanzi, Gianluca/E-1753-2011; Venturelli, Alberto/AAG-2701-2019; Costi, Maria Paola/F-4747-2015; Minozzi, Manuela/AAS-6547-2020; Carloni, Paolo/H-8736-2013	Lattanzi, Gianluca/0000-0002-0808-6457; Lattanzi, Gianluca/0000-0002-0808-6457; Costi, Maria Paola/0000-0002-0443-5402; Carloni, Paolo/0000-0002-9010-0149; Benz, Roland/0000-0002-9510-9265	Instituto Nazionale per la Fisica della Materia - National Institute for the Physics of Matter, Italy center DEMOCRITOS; Italian Ministry for University and Research [2007B57EAB_003]; Fonds der Chemischen Industrie; NIH [GM63815]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063815] Funding Source: NIH RePORTER	Instituto Nazionale per la Fisica della Materia - National Institute for the Physics of Matter, Italy center DEMOCRITOS; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Instituto Nazionale per la Fisica della Materia - National Institute for the Physics of Matter, Italy center DEMOCRITOS. We also acknowledge financial support from the Italian Ministry for University and Research under the scheme PRIN2007 no. 2007B57EAB_003 (GL), the Fonds der Chemischen Industrie (RB) and NIH Grant GM63815 (to Brian Shoichet, subcontract to University of Modena and Reggio Emilia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 1997, TRENDS ECOL EVOL, V12, P482, DOI 10.1016/S0169-5347(97)01223-8; Bemporad D, 2004, BIOPHYS J, V87, P1, DOI 10.1529/biophysj.103.030601; Bemporad D, 2005, BBA-BIOMEMBRANES, V1718, P1, DOI 10.1016/j.bbamem.2005.07.009; BENNETT PM, 1993, ANTIMICROB AGENTS CH, V37, P153, DOI 10.1128/AAC.37.2.153; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1976, BIOCHIM BIOPHYS ACTA, V455, P701, DOI 10.1016/0005-2736(76)90042-0; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026; Buzzoni V, 2004, BIOORG MED CHEM LETT, V14, P3979, DOI 10.1016/j.bmcl.2004.05.054; Ceccarelli M, 2009, FRONT BIOSCI-LANDMRK, V14, P3222, DOI 10.2741/3446; COLLU F, 2009, DRUG DESIGN INSIGH C, V32; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cseh R, 1998, BIOPHYS J, V74, P1399, DOI 10.1016/S0006-3495(98)77852-X; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Fenollar-Ferrer C, 2003, PROTEINS, V51, P442, DOI 10.1002/prot.10358; Fiorin G, 2006, BIOPHYS J, V91, P2768, DOI 10.1529/biophysj.106.086611; Guidoni L, 2000, FEBS LETT, V477, P37, DOI 10.1016/S0014-5793(00)01712-9; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; LINDQUIST RN, 1974, ARCH BIOCHEM BIOPHYS, V160, P135, DOI 10.1016/S0003-9861(74)80018-4; LOBKOVSKY E, 1994, BIOCHEMISTRY-US, V33, P6762, DOI 10.1021/bi00188a004; MARRINK SJ, 1994, J PHYS CHEM-US, V98, P4155, DOI 10.1021/j100066a040; Marrink SJ, 1996, J PHYS CHEM-US, V100, P16729, DOI 10.1021/jp952956f; Micheletti C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.170601; Morandi F, 2003, J AM CHEM SOC, V125, P685, DOI 10.1021/ja0288338; Neves P, 2005, BIOPHYS CHEM, V113, P123, DOI 10.1016/j.bpc.2004.08.004; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1985, PHARMACOL THERAPEUT, V27, P197, DOI 10.1016/0163-7258(85)90069-5; Powers RA, 1999, PROTEIN SCI, V8, P2330; Powers RA, 2002, J MED CHEM, V45, P3222, DOI 10.1021/jm020002p; Tafi A, 2005, EUR J MED CHEM, V40, P1134, DOI 10.1016/j.ejmech.2005.06.011; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Venturelli A, 2007, J MED CHEM, V50, P5644, DOI 10.1021/jm070643q; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Weston GS, 1998, J MED CHEM, V41, P4577, DOI 10.1021/jm980343w; YAMAGUCHI A, 1985, FEBS LETT, V181, P143, DOI 10.1016/0014-5793(85)81130-3; Yang WQ, 2003, MED RES REV, V23, P346, DOI 10.1002/med.10043	41	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23187	10.1371/journal.pone.0023187	http://dx.doi.org/10.1371/journal.pone.0023187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858024	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300018
J	van der Meersch, A; Dechartres, A; Ravaud, P				van der Meersch, Amelie; Dechartres, Agnes; Ravaud, Philippe			Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review	PLOS ONE			English	Article							EQUIVALENCE; SUBSTITUTION; ISSUES	Background: Generic drugs are used by millions of patients for economic reasons, so their evaluation must be highly transparent. Objective: To assess the quality of reporting of bioequivalence trials comparing generic to brand-name drugs. Methodology/Principal Findings: PubMed was searched for reports of bioequivalence trials comparing generic to brand-name drugs between January 2005 and December 2008. Articles were included if the aim of the study was to assess the bioequivalency of generic and brand-name drugs. We excluded case studies, pharmaco-economic evaluations, and validation dosage assays of drugs. We evaluated whether important information about funding, methodology, location of trials, and participants were reported. We also assessed whether the criteria required by the Food and Drug Administration (FDA) and the European Medicine Agency (EMA) to conclude bioequivalence were reported and that the conclusions were in agreement with the results. We identified 134 potentially relevant articles but eliminated 55 because the brand-name or generic drug status of the reference drug was unknown. Thus, we evaluated 79 articles. The funding source and location of the trial were reported in 41% and 56% of articles, respectively. The type of statistical analysis was reported in 94% of articles, but the methods to generate the randomization sequence and to conceal allocation were reported in only 15% and 5%, respectively. In total, 65 articles of single-dose trials (89%) concluded bioequivalence. Of these, 20 (31%) did not report the 3 criteria within the limits required by the FDA and 11 (17%) did not report the 2 criteria within the limits required by the EMA. Conclusions/Significance: Important information to judge the validity and relevance of results are frequently missing in published reports of trials assessing generic drugs. The quality of reporting of such trials is in need of improvement.	[van der Meersch, Amelie; Dechartres, Agnes; Ravaud, Philippe] INSERM, U738, Paris, France; [van der Meersch, Amelie; Dechartres, Agnes; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [van der Meersch, Amelie; Dechartres, Agnes; Ravaud, Philippe] Univ Paris 05, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	van der Meersch, A (corresponding author), INSERM, U738, Paris, France.	agnes.dechartres@htd.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206				Borgherini G, 2003, CLIN THER, V25, P1578, DOI 10.1016/S0149-2918(03)80157-1; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Djulbegovic B, 2001, JAMA-J AM MED ASSOC, V285, P1206, DOI 10.1001/jama.285.9.1206; *EMEA CMPH US, GUID INV BIOEQ; *FDA, FDA DRUG APPR REP; *FDA GUID IND, BIOAV BIOEQ STUD OR; Frank RG, 2007, NEW ENGL J MED, V357, P1993, DOI 10.1056/NEJMp078193; Friesen MH, 1999, J PHARM PHARM SCI, V2, P15; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2010, DRUGS, V70, P605, DOI 10.2165/10898530-000000000-00000; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; Lesser RP, 2001, NEUROLOGY, V57, P571, DOI 10.1212/WNL.57.4.571; Mastoraki E, 2008, J INFECTION, V56, P35, DOI 10.1016/j.jinf.2007.09.011; McCartney M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1514; Sabatini S, 1999, AM J KIDNEY DIS, V33, P389, DOI 10.1016/S0272-6386(99)70318-5; Wangge G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013550; Wassef AA, 2005, AM J PSYCHIAT, V162, P330, DOI 10.1176/appi.ajp.162.2.330; *WHO, WHO AN THER CHEM CLA; Wilner AN, 2004, EPILEPSY BEHAV, V5, P995, DOI 10.1016/j.yebeh.2004.05.011; Yim DS, 2009, J KOREAN MED SCI, V24, P7, DOI 10.3346/jkms.2009.24.1.7	22	24	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23611	10.1371/journal.pone.0023611	http://dx.doi.org/10.1371/journal.pone.0023611			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858184	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300069
J	Zhang, ZY; Li, H; Chen, LY; Lu, XY; Zhang, J; Xu, P; Lin, K; Wu, G				Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Zhang, Jian; Xu, Ping; Lin, Kui; Wu, Geng			Molecular Basis for the Recognition of Adenomatous Polyposis Coli by the Discs Large 1 Protein	PLOS ONE			English	Article							2ND PDZ DOMAIN; HUMAN HOMOLOG; CRYSTAL-STRUCTURE; LIGAND-BINDING; BETA-CATENIN; APC; COMPLEX; PSD-95; ACTIVATION; MUTATIONS	The human Discs Large 1 (DLG1) protein uses two of its three PDZ domains to interact with the C-terminal peptide of the Adenomatous Polyposis Coli (APC) tumor suppressor protein. The DLG1/APC complex inhibits the cell cycle progression from the G0/G1 to the S phase, regulates epithelial cell migration and morphogenesis, and is required for polarization of the microtubule cytoskeleton. However, the molecular details of how DLG1 recognizes APC is not clear. In this study, we performed biochemical and biophysical assays to investigate the interactions between PDZ domains of DLG1 and the C-terminal peptide of APC. In addition, we determined the crystal structures of the PDZ1 and PDZ2 domains of DLG1 each in complex with the C-terminal 11-residue peptide of APC. Our biochemical, biophysical, and structural results revealed structural elements and residues on PDZ1 and PDZ2 domains of DLG1 and on APC crucial for their mutual interaction. In particular, our results show that the beta 2/beta 3 loops of PDZ1 and PDZ2 play important roles in contributing to the binding affinities between PDZ domains and APC, through interacting with the residues upstream of the canonical PDZ-binding S/T-X-V motif. The results provide new insights into the binding mode of a defined C-terminal segment of APC by the PDZ domains of DLG1.	[Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Xu, Ping; Lin, Kui; Wu, Geng] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Xu, Ping; Lin, Kui; Wu, Geng] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Lin, Kui; Wu, Geng] Shanghai Jiao Tong Univ, Key Lab MOE Dev Genet & Neuropsychiat Dis, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	klin@sjtu.edu.cn; geng.wu@sjtu.edu.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X	National Natural Science Foundation of China [30900225, 30821005, 90919021]; Shanghai Municipal Education Commission [09ZZ23]; Shanghai Education Commission [08SG11]; Shanghai Pujiang Program [09PJ1405500]; Chinese Ministry of Education [109060]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD [2009ZX09301-007]; State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China); State Key Laboratory of Drug Research (China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Commission; Shanghai Pujiang Program(Shanghai Pujiang Program); Chinese Ministry of Education(Ministry of Education, China); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD; State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China)(Chinese Academy of Sciences); State Key Laboratory of Drug Research (China)	This work was supported by grants from the National Natural Science Foundation of China (grant numbers 30900225, 30821005, and 90919021), the Innovation Program of Shanghai Municipal Education Commission (grant number 09ZZ23), the "Dawn" Program of Shanghai Education Commission (grant number 08SG11), Shanghai Pujiang Program (grant number 09PJ1405500), the Key Project of Chinese Ministry of Education (grant number 109060), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the National Comprehensive Technology Platforms for Innovative Drug R&D (2009ZX09301-007), the State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China) and the State Key Laboratory of Drug Research (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; JOSLYN G, 1993, P NATL ACAD SCI USA, V90, P11109, DOI 10.1073/pnas.90.23.11109; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Marfatia SM, 1996, J CELL BIOL, V135, P753, DOI 10.1083/jcb.135.3.753; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Mimori-Kiyosue Y, 2007, GENES CELLS, V12, P219, DOI 10.1111/j.1365-2443.2007.01045.x; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Pedemonte S, 1998, GENE CHROMOSOME CANC, V22, P257, DOI 10.1002/(SICI)1098-2264(199808)22:4<257::AID-GCC1>3.0.CO;2-U; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Wang L, 2005, J BIOL CHEM, V280, P26992, DOI 10.1074/jbc.M503555200; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23507	10.1371/journal.pone.0023507	http://dx.doi.org/10.1371/journal.pone.0023507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858148	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300053
J	Harris, JR; Marston, BJ; Sangrujee, N; DuPlessis, D; Park, B				Harris, Julie R.; Marston, Barbara J.; Sangrujee, Nalinee; DuPlessis, Desiree; Park, Benjamin			Cost-Effectiveness Analysis of Diagnostic Options for Pneumocystis Pneumonia (PCP)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN-IMMUNODEFICIENCY-VIRUS; BRONCHOALVEOLAR LAVAGE SPECIMENS; REAL-TIME PCR; HIV-INFECTED PATIENTS; MEDIATED ISOTHERMAL AMPLIFICATION; TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; ORAL-WASH SAMPLES; CARINII-PNEUMONIA; RESPIRATORY SPECIMENS	Background: Diagnosis of Pneumocystis jirovecii pneumonia (PCP) is challenging, particularly in developing countries. Highly sensitive diagnostic methods are costly, while less expensive methods often lack sensitivity or specificity. Cost-effectiveness comparisons of the various diagnostic options have not been presented. Methods and Findings: We compared cost-effectiveness, as measured by cost per life-years gained and proportion of patients successfully diagnosed and treated, of 33 PCP diagnostic options, involving combinations of specimen collection methods [oral washes, induced and expectorated sputum, and bronchoalveolar lavage (BAL)] and laboratory diagnostic procedures [various staining procedures or polymerase chain reactions (PCR)], or clinical diagnosis with chest x-ray alone. Our analyses were conducted from the perspective of the government payer among ambulatory, HIV-infected patients with symptoms of pneumonia presenting to HIV clinics and hospitals in South Africa. Costing data were obtained from the National Institutes of Communicable Diseases in South Africa. At 50% disease prevalence, diagnostic procedures involving expectorated sputum with any PCR method, or induced sputum with nested or real-time PCR, were all highly cost-effective, successfully treating 77-90% of patients at $26-51 per life-year gained. Procedures using BAL specimens were significantly more expensive without added benefit, successfully treating 68-90% of patients at costs of $189-232 per life-year gained. A relatively cost-effective diagnostic procedure that did not require PCR was Toluidine Blue O staining of induced sputum ($25 per life-year gained, successfully treating 68% of patients). Diagnosis using chest x-rays alone resulted in successful treatment of 77% of patients, though cost-effectiveness was reduced ($109 per life-year gained) compared with several molecular diagnostic options. Conclusions: For diagnosis of PCP, use of PCR technologies, when combined with less-invasive patient specimens such as expectorated or induced sputum, represent more cost-effective options than any diagnostic procedure using BAL, or chest x-ray alone.	[Harris, Julie R.; Park, Benjamin] Ctr Dis Control & Prevent, Mycot Dis Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA; [Marston, Barbara J.; Sangrujee, Nalinee] Ctr Dis Control & Prevent, Global AIDS Program, Ctr Global Hlth, Atlanta, GA USA; [DuPlessis, Desiree] Natl Inst Communicable Dis, Parasitol Reference Unit, Natl Hlth Lab Serv, Johannesburg, South Africa	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Harris, JR (corresponding author), Ctr Dis Control & Prevent, Mycot Dis Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA.	ggt5@cdc.gov						Aderaye G, 2008, INFECTION, V36, P237, DOI 10.1007/s15010-007-7191-8; Aderaye G, 2003, AIDS, V17, P435, DOI 10.1097/00002030-200302140-00018; Aderaye G, 2007, SCAND J INFECT DIS, V39, P1045, DOI 10.1080/00365540701474508; Adrian PV, 1997, ANTIMICROB AGENTS CH, V41, P2406, DOI 10.1128/AAC.41.11.2406; Alvarez F, 1997, CRIT CARE MED, V25, P948, DOI 10.1097/00003246-199706000-00009; Alvarez-Martinez MJ, 2006, DIAGN MICR INFEC DIS, V56, P153, DOI 10.1016/j.diagmicrobio.2006.03.010; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Archontoulis NK, 2009, EXP CLIN TRANSPLANT, V7, P129; Atzori C, 1998, Int J Infect Dis, V3, P76; Atzori C, 1998, EUR J CLIN MICROBIOL, V17, P241, DOI 10.1007/s100960050056; Bakeera-Kitaka S, 2004, ANN TROP PAEDIATR, V24, P227, DOI 10.1179/027249304225019046; Bandt D, 2007, TRANSPL INFECT DIS, V9, P196, DOI 10.1111/j.1399-3062.2007.00246.x; BASELSKI VS, 1990, J CLIN MICROBIOL, V28, P393, DOI 10.1128/JCM.28.2.393-394.1990; BHOOPAT L, 1994, ASIAN PAC J ALLERGY, V12, P95; Bijl AMH, 1998, CLIN EXP ALLERGY, V28, P510, DOI 10.1046/j.1365-2222.1998.00258.x; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brancart F, 2005, J MICROBIOL METH, V61, P381, DOI 10.1016/j.mimet.2005.01.001; Caliendo AM, 1998, J CLIN MICROBIOL, V36, P979, DOI 10.1128/JCM.36.4.979-982.1998; Capra C, 2000, INTENS CARE MED, V26, P212, DOI 10.1007/s001340050048; CARMICHAEL A, 1991, CYTOPATHOLOGY, V2, P61, DOI 10.1111/j.1365-2303.1991.tb00388.x; CARTWRIGHT CP, 1994, J CLIN MICROBIOL, V32, P1634, DOI 10.1128/JCM.32.7.1634-1638.1994; Chakaya J M, 2003, East Afr Med J, V80, P30; Chawla K, 2011, INDIAN J PATHOL MICR, V54, P326, DOI 10.4103/0377-4929.81624; Chiller T M, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P165, DOI 10.1177/1545109709333112; CHOUAID C, 1995, AM J CLIN PATHOL, V104, P72, DOI 10.1093/ajcp/104.1.72; CHUMPITAZI BF, 2011, MED MYCOL; Contini C, 1998, J MED MICROBIOL, V47, P329, DOI 10.1099/00222615-47-4-329; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; Crans CA, 1999, CRIT REV DIAGN IMAG, V40, P251; CREGAN P, 1990, J CLIN MICROBIOL, V28, P2432, DOI 10.1128/JCM.28.11.2432-2436.1990; Fillaux J, 2008, J MICROBIOL METH, V75, P258, DOI 10.1016/j.mimet.2008.06.009; Fischer S, 2001, J INFECT DIS, V184, P1485, DOI 10.1086/324520; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Flori P, 2004, J MED MICROBIOL, V53, P603, DOI 10.1099/jmm.0.45528-0; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Gerhart JL, 2010, J AM ACAD DERMATOL, V62, P957, DOI 10.1016/j.jaad.2009.07.042; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; GOSEY LL, 1985, J CLIN MICROBIOL, V22, P803, DOI 10.1128/JCM.22.5.803-807.1985; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Gupta R, 2009, DIAGN MICR INFEC DIS, V64, P381, DOI 10.1016/j.diagmicrobio.2009.04.008; Gwanzura L, 2003, INT J ANTIMICROB AG, V21, P557, DOI 10.1016/S0924-8579(03)00052-9; Hargreaves NJ, 2001, T ROY SOC TROP MED H, V95, P402, DOI 10.1016/S0035-9203(01)90197-X; Helweg-Larsen J, 1998, J CLIN MICROBIOL, V36, P2068, DOI 10.1128/JCM.36.7.2068-2072.1998; Helweg-Larsen J, 1997, J EUKARYOT MICROBIOL, V44, p59S; Hua Liwei, 2002, Zhonghua Nei Ke Za Zhi, V41, P610; Huang SN, 1999, DIAGN MICR INFEC DIS, V35, P27, DOI 10.1016/S0732-8893(99)00050-4; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Iliades P, 2005, MICROB DRUG RESIST, V11, P1, DOI 10.1089/mdr.2005.11.1; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kelley CF, 2009, CHEST, V136, P190, DOI 10.1378/chest.08-2859; KIRSCH CM, 1990, AM J MED SCI, V299, P386, DOI 10.1097/00000441-199006000-00006; KOVACS JA, 1988, NEW ENGL J MED, V318, P589, DOI 10.1056/NEJM198803103181001; Krajicek BJ, 2009, CLIN CHEST MED, V30, P265, DOI 10.1016/j.ccm.2009.02.005; Kubo T, 2010, J CLIN MICROBIOL, V48, P728, DOI 10.1128/JCM.01481-09; Larsen HH, 2004, J INFECT DIS, V189, P1679, DOI 10.1086/383322; Larsen HH, 2002, J CLIN MICROBIOL, V40, P490, DOI 10.1128/JCM.40.2.490-494.2002; Lautenschlager I, 1996, J CLIN MICROBIOL, V34, P728, DOI 10.1128/JCM.34.3.728-730.1996; Le Minor O, 2008, JAIDS-J ACQ IMM DEF, V48, P620, DOI 10.1097/QAI.0b013e31817efb3c; LEIGH TR, 1989, LANCET, V2, P205; LEIGH TR, 1993, J CLIN PATHOL, V46, P140, DOI 10.1136/jcp.46.2.140; LEIGH TR, 1992, TRANSPLANTATION, V54, P468, DOI 10.1097/00007890-199209000-00016; LIPSCHIK GY, 1992, LANCET, V340, P203, DOI 10.1016/0140-6736(92)90469-J; Lishimpi K, 2002, AIDS, V16, P932, DOI 10.1097/00002030-200204120-00017; LU JJ, 1995, J CLIN MICROBIOL, V33, P2785, DOI 10.1128/JCM.33.10.2785-2788.1995; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; Lumbiganon Pagakrong, 2000, Journal of the Medical Association of Thailand, V83, P652; Madhi SA, 2002, CLIN INFECT DIS, V35, P1120, DOI 10.1086/343049; MALIN AS, 1995, LANCET, V346, P1258, DOI 10.1016/S0140-6736(95)91862-0; Mandomando I, 2009, ANTIMICROB AGENTS CH, V53, P2450, DOI 10.1128/AAC.01282-08; Marais E, 2009, SAMJ S AFR MED J, V99, P170; Mathis A, 1997, J CLIN MICROBIOL, V35, P1691, DOI 10.1128/JCM.35.7.1691-1695.1997; Matos O, 2001, EUR J CLIN MICROBIOL, V20, P573, DOI 10.1007/s100960100563; McWilliams T, 2002, THORAX, V57, P1010, DOI 10.1136/thorax.57.12.1010; Metersky ML, 1998, CHEST, V113, P1555, DOI 10.1378/chest.113.6.1555; MOONENS F, 1995, SCAND J INFECT DIS, V27, P358, DOI 10.3109/00365549509032731; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Nahimana A, 2004, ANTIMICROB AGENTS CH, V48, P4301, DOI 10.1128/AAC.48.11.4301-4305.2004; Neff RT, 2009, TRANSPLANTATION, V88, P135, DOI 10.1097/TP.0b013e3181aad256; Nicolay N., 2008, SUMMARY PROVINCIAL H; Nyamande K, 2005, CHEST, V128, P167, DOI 10.1378/chest.128.1.167; OGNIBENE FP, 1984, AM REV RESPIR DIS, V129, P929; Onyango AO, 2009, TRAVEL MED INFECT DI, V7, P359, DOI 10.1016/j.tmaid.2009.07.005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pinlaor S, 2004, PARASITOL RES, V94, P213, DOI 10.1007/s00436-004-1200-y; PITCHENIK AE, 1986, AM REV RESPIR DIS, V133, P226; Procop GW, 2004, J CLIN MICROBIOL, V42, P3333, DOI 10.1128/JCM.42.7.3333-3335.2004; RAAB SS, 1994, MODERN PATHOL, V7, P599; Rabodonirina M, 1997, J CLIN MICROBIOL, V35, P2748, DOI 10.1128/JCM.35.11.2748-2751.1997; Ribes JA, 1997, J CLIN MICROBIOL, V35, P830, DOI 10.1128/JCM.35.4.830-835.1997; Rohner P, 2009, INFECTION, V37, P261, DOI 10.1007/s15010-008-8027-x; ROUX P, 1994, J CLIN MICROBIOL, V32, P2324, DOI 10.1128/JCM.32.9.2324-2326.1994; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; Saksirisampant Wilai, 2002, Journal of the Medical Association of Thailand, V85, pS407; Savoia D, 1997, DIAGN MICR INFEC DIS, V29, P61, DOI 10.1016/S0732-8893(97)00126-0; Schneider M, 2004, NATURAL HIST MORTALI; Serraino D, 2003, AIDS, V17, P2109, DOI 10.1097/00002030-200309260-00012; Sing A, 2000, J CLIN MICROBIOL, V38, P1461, DOI 10.1128/JCM.38.4.1461-1467.2000; STRATTON N, 1991, J CLIN MICROBIOL, V29, P645, DOI 10.1128/JCM.29.3.645-647.1991; Tamburrini E, 1997, J EUKARYOT MICROBIOL, V44, p48S, DOI 10.1111/j.1550-7408.1997.tb05769.x; TAMBURRINI E, 1993, J MED MICROBIOL, V38, P449, DOI 10.1099/00222615-38-6-449; Torres J, 2000, CLIN INFECT DIS, V30, P141, DOI 10.1086/313584; *UNAIDS, 2011, AIDSINFO COUNTR FACT; VANDENBERG O, PEDIAT INFECT DIS J, V29, P504; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004; Zingale A, 2003, J CLIN MICROBIOL, V41, P2709, DOI 10.1128/JCM.41.6.2709-2712.2003	111	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23158	10.1371/journal.pone.0023158	http://dx.doi.org/10.1371/journal.pone.0023158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858013	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700005
J	Shapiro, MD; Bagley, J; Latz, J; Godwin, JG; Ge, XP; Tullius, SG; Iacomini, J				Shapiro, Michael D.; Bagley, Jessamyn; Latz, Jeff; Godwin, Jonathan G.; Ge, Xupeng; Tullius, Stefan G.; Iacomini, John			MicroRNA Expression Data Reveals a Signature of Kidney Damage following Ischemia Reperfusion Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; EPITHELIAL-CELLS	Ischemia reperfusion injury (IRI) is a leading cause of acute kidney injury, a common problem worldwide associated with significant morbidity and mortality. We have recently examined the role of microRNAs (miRs) in renal IRI using expression profiling. Here we conducted mathematical analyses to determine if differential expression of miRs can be used to define a biomarker of renal IRI. Principal component analysis (PCA) was combined with spherical geometry to determine whether samples that underwent renal injury as a result of IRI can be distinguished from controls based on alterations in miR expression using our data set consisting of time series measuring 571 miRs. Using PCA, we examined whether changes in miR expression in the kidney following IRI have a distinct direction when compared to controls based on the trajectory of the first three principal components (PCs) for our time series. We then used Monte Carlo methods and spherical geometry to assess the statistical significance of these directions. We hypothesized that if IRI and control samples exhibit distinct directions, then miR expression can be used as a biomarker of injury. Our data reveal that the pattern of miR expression in the kidney following IRI has a distinct direction based on the trajectory of the first three PCs and can be distinguished from changes observed in sham controls. Analyses of samples from immunodeficient mice indicated that the changes in miR expression observed following IRI were lymphocyte independent, and therefore represent a kidney intrinsic response to injury. Together, these data strongly support the notion that IRI results in distinct changes in miR expression that can be used as a biomarker of injury.	[Shapiro, Michael D.; Latz, Jeff] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Pathol, Boston, MA 02111 USA; [Bagley, Jessamyn; Iacomini, John] Tufts Med Ctr, Translat Immunol Sci Ctr, Mol Cardiol Res Ctr, Boston, MA USA; [Godwin, Jonathan G.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Godwin, Jonathan G.] Childrens Hosp, Boston, MA 02115 USA; [Ge, Xupeng; Tullius, Stefan G.] Harvard Univ, Sch Med, Div Transplant Surg, Boston, MA USA; [Ge, Xupeng; Tullius, Stefan G.] Harvard Univ, Sch Med, Transplant Surg Res Lab, Boston, MA USA; [Iacomini, John] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Iacomini, John] Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Program Immunol, Boston, MA 02111 USA; [Iacomini, John] Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA	Tufts University; Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Shapiro, MD (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Pathol, Boston, MA 02111 USA.	john.iacomini@tufts.edu		Shapiro, Michael/0000-0002-2769-9320	Roche Organ Transplantation Research Foundation; Instituto Carlos Slim de la Salud; American Heart Association; National Institutes of Health (NIH) [K25AI079404-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI079404] Funding Source: NIH RePORTER	Roche Organ Transplantation Research Foundation; Instituto Carlos Slim de la Salud; American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the Roche Organ Transplantation Research Foundation to Dr. Tullius and Dr. Iacomini, a grant by the Instituto Carlos Slim de la Salud to Dr. Tullius, an American Heart Association Scientist Development Grant to Dr. Bagley, and a National Institutes of Health (NIH) grant K25AI079404-02 to Dr. Shapiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; FISHER NI, STAT ANAL SPHERICAL; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Kim VN, 2005, MOL CELLS, V19, P1; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214	15	44	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23011	10.1371/journal.pone.0023011	http://dx.doi.org/10.1371/journal.pone.0023011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21887224	Green Published, gold			2022-12-27	WOS:000293953700003
J	Shen, T; Chen, XM; Zhang, WD; Xi, YL; Cao, GH; Zhi, YH; Wang, SW; Xu, CH; Wei, L; Lu, FM; Zhuang, H				Shen, Tao; Chen, Xiangmei; Zhang, Weidong; Xi, Yuanlin; Cao, Guanghua; Zhi, Yuhong; Wang, Shuiwang; Xu, Chunhui; Wei, Lai; Lu, Fengmin; Zhuang, Hui			A Higher Correlation of HCV Core Antigen with CD4+T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; COMMERCIAL PLASMA DONORS; RISK-FACTORS; ANTIRETROVIRAL THERAPY; LIVER-DISEASE; BLOOD-DONORS; ENZYME-IMMUNOASSAY; INFECTED PATIENTS; PREVALENCE; HIV	Development of HCV infection is typically followed by chronic hepatitis C (CHC) in most patients, while spontaneous HCV viral clearance (SVC) occurs in only a minority of subjects. Compared with the widespread application of HCV RNA testing by quantitative RT-PCR technique, HCV core antigen detection may be an alternative indicator in the diagnosis of hepatitis C virus infections and in monitoring the status of infectious individuals. However, the correlation and differences between these two indicators in HCV infection need more investigation, especially in patients coinfected by HIV-1. In this study, a total of 354 anti-HCV and/or anti-HIV serum positive residents from a village of central China were enrolled. Besides HCV-related hepatopathic variables including clinical status, ALT, AST, anti-HCV Abs, as well as the altered CD4+/CD8+ T cell counts, HCV core antigen and HCV viral load were also measured. The concentration of serum HCV core antigen was highly correlated with level of HCV RNA in CHC patients with or without HIV-1 coinfection. Of note, HCV core antigen concentration was negatively correlated with CD4+ T cell count, while no correlation was found between HCV RNA level and CD4+ T cell count. Our findings suggested that quantitative detection of plasma HCV core antigen may be an alternative indicator of HCV RNA qPCR assay when evaluating the association between HCV replication and host immune status in HCV/HIV-1 coinfected patients.	[Shen, Tao; Chen, Xiangmei; Xu, Chunhui; Lu, Fengmin; Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Shen, Tao; Chen, Xiangmei; Xu, Chunhui; Lu, Fengmin; Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Ctr Infect Dis, Beijing 100871, Peoples R China; [Zhang, Weidong; Xi, Yuanlin] Zhengzhou Univ, Dept Epidemiol, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China; [Cao, Guanghua] Shangcai Cty Peoples Hosp, Shangcai, Henan, Peoples R China; [Zhi, Yuhong; Wang, Shuiwang] Shangcai Ctr Dis Control & Prevent, Shangcai, Henan, Peoples R China; [Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China	Peking University; Peking University; Zhengzhou University; Shanghai Center for Disease Control & Prevention; Peking University	Shen, T (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China.	lu.fengmin@hsc.pku.edu.cn; zhuangbmu@126.com		Zhang, Weidong/0000-0002-0314-7820; Chen, Xiangmei/0000-0003-0302-6866; Shen, Tao/0000-0002-1365-9862	National Science and Technology Major Project for Infectious Diseases [2008ZX10002-012, 2008ZX10002-013, 2009ZX10004-903]	National Science and Technology Major Project for Infectious Diseases	This work was supported by grants from the National Science and Technology Major Project for Infectious Diseases (2008ZX10002-012, 2008ZX10002-013, and 2009ZX10004-903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Aoyagi K, 1999, J CLIN MICROBIOL, V37, P1802, DOI 10.1128/JCM.37.6.1802-1808.1999; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Bouvier-Alias M, 2002, HEPATOLOGY, V36, P211, DOI 10.1053/jhep.2002.34130; Busch MP, 2006, TRANSFUSION, V46, P469, DOI 10.1111/j.1537-2995.2006.00745.x; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Dienstag JL, 1997, HEPATOLOGY, V26, pS66, DOI 10.1002/hep.510260712; Gerlich WHVA, 2010, HIGHLY SENSITIVE ASS; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kovari H, 2010, CLIN INFECT DIS, V50, P502, DOI 10.1086/649922; Lee PL, 2004, T ROY SOC TROP MED H, V98, P367, DOI 10.1016/j.trstmh.2003.10.013; Maida I, 2006, JAIDS-J ACQ IMM DEF, V42, P177, DOI 10.1097/01.qai.0000221683.44940.62; Merchante N, 2010, ANTIVIR THER, V15, P753, DOI 10.3851/IMP1612; Messick K, 2001, HAEMOPHILIA, V7, P568, DOI 10.1046/j.1365-2516.2001.00559.x; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Muller R, 1996, J HEPATOL, V24, P52; Nakamuta M, 2001, HEPATOL RES, V19, P254, DOI 10.1016/S1386-6346(00)00115-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; ROCKSTROH JK, 1995, INFECTION, V23, P29, DOI 10.1007/BF01710054; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Sterling RK, 2008, DIGEST DIS SCI, V53, P1375, DOI 10.1007/s10620-007-9999-6; Takahashi M, 2005, J CLIN MICROBIOL, V43, P186, DOI 10.1128/JCM.43.1.186-191.2005; Tanaka Y, 2003, HEPATOL RES, V26, P261, DOI 10.1016/S1386-6346(03)00113-X; Thomas DL, 2002, HEPATOLOGY, V36, pS201, DOI 10.1053/jhep.2002.36380; THOMAS DL, 1995, J INFECT DIS, V171, P768, DOI 10.1093/infdis/171.4.768; Uto H, 2009, HEPATOLOGY, V50, P393, DOI 10.1002/hep.23002; Valdez H, 2000, AIDS, V14, P2239, DOI 10.1097/00002030-200010200-00004; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	35	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23550	10.1371/journal.pone.0023550	http://dx.doi.org/10.1371/journal.pone.0023550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858166	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500055
J	Kreutzman, A; Rohon, P; Faber, E; Indrak, K; Juvonen, V; Kairisto, V; Voglova, J; Sinisalo, M; Flochova, E; Vakkila, J; Arstila, P; Porkka, K; Mustjoki, S				Kreutzman, Anna; Rohon, Peter; Faber, Edgar; Indrak, Karel; Juvonen, Vesa; Kairisto, Veli; Voglova, Jaroslava; Sinisalo, Marjatta; Flochova, Emilia; Vakkila, Jukka; Arstila, Petteri; Porkka, Kimmo; Mustjoki, Satu			Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-alpha Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; T-CELLS; BCR-ABL; IMMUNE-SURVEILLANCE; DASATINIB THERAPY; CHRONIC-PHASE; NK CELLS	Before the era of tyrosine kinase inhibitors (TKIs), interferon-alpha (IFN-alpha) was the treatment of choice in chronic myeloid leukemia (CML). Curiously, some IFN-alpha treated patients were able to discontinue therapy without disease progression. The aim of this project was to study the immunomodulatory effects of IFN-alpha in CML patients in prolonged remission and isolate biological markers predicting response. Due to rarity of patients on IFN-alpha monotherapy, a relatively small cohort of patients still on treatment (IFN-ON, n = 10, median therapy duration 11.8 years) or had discontinued IFN-alpha therapy but remained in remission for >2 years (IFN-OFF, n = 9) were studied. The lymphocyte immunophenotype was analyzed with a comprehensive flow cytometry panel and plasma cytokine levels were measured with multiplex bead-based assay. In addition, the clonality status of different lymphocyte subpopulations was analyzed by TCR gamma/delta rearrangement assay. Median NK-cell absolute number and proportion from lymphocytes in blood was higher in IFN-OFF patients as compared to IFN-ON patients or controls (0.42, 0.19, 0.21x10(9)/L; 26%, 12%, 11%, respectively, p<0.001). The proportion of CD8+ T-cells was significantly increased in both patient groups and a larger proportion of T-cells expressed CD45RO. Most (95%) patients had significant numbers of oligoclonal lymphocytes characterized by T-cell receptor gamma/delta rearrangements. Strikingly, in the majority of patients (79%) a distinct clonal V gamma 9 gene rearrangement was observed residing in gamma delta(+) T-cell population. Similar unique clonality pattern was not observed in TKI treated CML patients. Plasma eotaxin and MCP-1 cytokines were significantly increased in IFN-OFF patients. Despite the limited number of patients, our data indicates that IFN-alpha treated CML patients in remission have increased numbers of NK-cells and clonal gamma delta(+) T-cells and a unique plasma cytokine profile. These factors may relate to anti-leukemic effects of IFN-alpha in this specific group of patients and account for prolonged therapy responses even after drug discontinuation.	[Kreutzman, Anna; Rohon, Peter; Vakkila, Jukka; Porkka, Kimmo; Mustjoki, Satu] HUCH, Biomedicum Helsinki, Hematol Res Unit, Helsinki, Finland; [Rohon, Peter; Faber, Edgar; Indrak, Karel] Univ Hosp Olomouc, Dept Hematooncol, Olomouc, Czech Republic; [Juvonen, Vesa; Kairisto, Veli] Turku Univ Cent Hosp, Dept Clin Chem, Turku, Finland; [Juvonen, Vesa; Kairisto, Veli] Turku Univ Cent Hosp, TYKSLAB, Turku, Finland; [Voglova, Jaroslava] Univ Hosp Hradec Kralove, Dept Internal Med 2, Hradec Kralove, Czech Republic; [Sinisalo, Marjatta] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Flochova, Emilia] Univ Hosp Martin, Dept Hematol & Transfusiol, Martin, Slovakia; [Arstila, Petteri] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Porkka, Kimmo; Mustjoki, Satu] HUCH, Dept Med, Div Hematol, Helsinki, Finland; [Mustjoki, Satu] HUCH, Dept Clin Chem, Hematol Lab, Helsinki, Finland	University of Helsinki; University Hospital Olomouc; University of Turku; University of Turku; University Hospital Hradec Kralove; Tampere University; Tampere University Hospital; University of Helsinki	Kreutzman, A (corresponding author), HUCH, Biomedicum Helsinki, Hematol Res Unit, Helsinki, Finland.	satu.mustjoki@helsinki.fi	Kreutzman, Anna/V-5769-2019; Mustjoki, Satu/AAD-9974-2020; Voglová, Jaroslava/D-4227-2019; ROHOŇ, Peter/ABE-5177-2021; Porkka, Kimmo/O-2323-2016	Kreutzman, Anna/0000-0002-5587-8844; Mustjoki, Satu/0000-0002-0816-8241; Porkka, Kimmo/0000-0003-4112-5902	Finnish special government; Finnish Cancer Societies; Emil Aaltonen Foundation; Academy of Finland; Finnish Medical Foundation; Blood Disease Foundation; Finnish Association of Haematology; KA Johansson Foundation; MSMT CR [6198959205, 6198959223, LF_2010_004]; Cancer Foundation Finland sr [110101, 100118] Funding Source: researchfish	Finnish special government; Finnish Cancer Societies; Emil Aaltonen Foundation; Academy of Finland(Academy of Finland); Finnish Medical Foundation; Blood Disease Foundation; Finnish Association of Haematology; KA Johansson Foundation; MSMT CR(Ministry of Education, Youth & Sports - Czech Republic); Cancer Foundation Finland sr	This work was supported by the Finnish special governmental subsidy for health sciences, research and training, by the Finnish Cancer Societies, Emil Aaltonen Foundation, Academy of Finland, Finnish Medical Foundation, Blood Disease Foundation, Finnish Association of Haematology, KA Johansson Foundation, MSMT CR 6198959205 and 6198959223 and LF_2010_004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DF, 1987, CANCER RES, V47, P6629; Barrett AJ, 2009, LEUKEMIA, V23, P53, DOI 10.1038/leu.2008.273; Bhatia R, 1996, BLOOD, V87, P3883, DOI 10.1182/blood.V87.9.3883.bloodjournal8793883; Bocchia M, 2005, LANCET, V365, P657; Bonifazi F, 2001, BLOOD, V98, P3074, DOI 10.1182/blood.V98.10.3074; BREIT TM, 1994, J IMMUNOL, V152, P2860; Burchert A, 2003, BLOOD, V101, P259, DOI 10.1182/blood-2002-02-0659; Burchert A, 2010, J CLIN ONCOL, V28, P1429, DOI 10.1200/JCO.2009.25.5075; Cortes J, 1998, LEUKEMIA, V12, P455, DOI 10.1038/sj.leu.2400965; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Deng M, 2001, BLOOD, V97, P3491, DOI 10.1182/blood.V97.11.3491; DOWDING C, 1991, BLOOD, V78, P499; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferrarini M, 2002, TRENDS IMMUNOL, V23, P14, DOI 10.1016/S1471-4906(01)02110-X; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hochhaus A, 1997, LEUKEMIA, V11, P933, DOI 10.1038/sj.leu.2400723; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Kanodia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011770; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kreutzman A, 2010, BLOOD, V116, P772, DOI 10.1182/blood-2009-12-256800; LEE MS, 1992, BLOOD, V79, P1920; Mahon FX, 2002, J CLIN ONCOL, V20, P214, DOI 10.1200/JCO.20.1.214; Molldrem JJ, 1999, CANCER RES, V59, P2675; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Monti P, 2003, CANCER RES, V63, P7451; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Nicolini FE, 2011, LEUKEMIA RES, V35, P80, DOI 10.1016/j.leukres.2010.04.010; Oka T, 1998, LEUKEMIA, V12, P155, DOI 10.1038/sj.leu.2400919; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Palandri F, 2010, HAEMATOL-HEMATOL J, V95, P1415, DOI 10.3324/haematol.2009.021246; Pane F, 1999, BLOOD, V94, P2200, DOI 10.1182/blood.V94.7.2200.419a33_2200_2207; Pongers-Willemse MJ, 1999, LEUKEMIA, V13, P110, DOI 10.1038/sj.leu.2401245; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Rey J, 2009, TRENDS MOL MED, V15, P275, DOI 10.1016/j.molmed.2009.04.005; Rezvani K, 2003, BLOOD, V102, P2892, DOI 10.1182/blood-2003-01-0150; Rohon P, 2010, EUR J HAEMATOL, V85, P387, DOI 10.1111/j.1600-0609.2010.01501.x; Rojas JM, 2007, LEUKEMIA, V21, P2287, DOI 10.1038/sj.leu.2404858; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Saudemont A, 2005, BLOOD, V105, P2428, DOI 10.1182/blood-2004-09-3458; Savani BN, 2007, LEUKEMIA, V21, P2145, DOI 10.1038/sj.leu.2404892; Siegers GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016700; Simonsson B, 2011, CURR DRUG TARGETS, V12, P420, DOI 10.2174/138945011794815301; TALPAZ M, 1991, ANN INTERN MED, V114, P532, DOI 10.7326/0003-4819-114-7-532; Usuki Kensuke, 2009, Leuk Res, V33, pe164, DOI 10.1016/j.leukres.2009.03.024; Yong ASM, 2009, BLOOD, V113, P875, DOI 10.1182/blood-2008-05-158253	47	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23022	10.1371/journal.pone.0023022	http://dx.doi.org/10.1371/journal.pone.0023022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857985	Green Published, gold, Green Submitted			2022-12-27	WOS:000293774300016
J	Boy, S; Sauerbruch, S; Kraemer, M; Schormann, T; Schlachetzki, F; Schuierer, G; Luerding, R; Hennemann, B; Orso, E; Dabringhaus, A; Winkler, J; Bogdahn, U				Boy, Sandra; Sauerbruch, Sophie; Kraemer, Mathias; Schormann, Thorsten; Schlachetzki, Felix; Schuierer, Gerhard; Luerding, Ralph; Hennemann, Burkhard; Orso, Evelyn; Dabringhaus, Andreas; Winkler, Juergen; Bogdahn, Ulrich		RAIS Study Grp	Mobilisation of Hematopoietic CD34(+) Precursor Cells in Patients with Acute Stroke Is Safe - Results of an Open-Labeled Non Randomized Phase I/II Trial	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; VOXEL-GUIDED MORPHOMETRY; FACTOR G-CSF; BONE-MARROW; FUNCTIONAL RECOVERY; PERIPHERAL-BLOOD; STEM-CELLS; WORKING-MEMORY; INFARCT VOLUME	Background: Regenerative strategies in the treatment of acute stroke may have great potential. Hematopoietic growth factors mobilize hematopoietic stem cells and may convey neuroprotective effects. We examined the safety, potential functional and structural changes, and CD34(+) cell-mobilization characteristics of G-CSF treatment in patients with acute ischemic stroke. Methods and Results: Three cohorts of patients (8, 6, and 6 patients per cohort) were treated subcutaneously with 2.5, 5, or 10 mu g/kg body weight rhG-CSF for 5 consecutive days within 12 hrs of onset of acute stroke. Standard treatment included IV thrombolysis. Safety monitoring consisted of obtaining standardized clinical assessment scores, monitoring of CD34(+) stem cells, blood chemistry, serial neuroradiology, and neuropsychology. Voxel-guided morphometry (VGM) enabled an assessment of changes in the patients' structural parenchyma. 20 patients (mean age 55 yrs) were enrolled in this study, 5 of whom received routine thrombolytic therapy with r-tPA. G-CSF treatment was discontinued in 4 patients because of unrelated adverse events. Mobilization of CD34(+) cells was observed with no concomitant changes in blood chemistry, except for an increase in the leukocyte count up to 75,500/mu l. Neuroradiological and neuropsychological follow-up studies did not disclose any specific G-CSF toxicity. VGM findings indicated substantial atrophy of related hemispheres, a substantial increase in the CSF space, and a localized increase in parenchyma within the ischemic area in 2 patients. Conclusions: We demonstrate a good safety profile for daily administration of G-CSF when begun within 12 hours after onset of ischemic stroke and, in part in combination with routine IV thrombolysis. Additional analyses using VGM and a battery of neuropsychological tests indicated a positive functional and potentially structural effect of G-CSF treatment in some of our patients.	[Boy, Sandra; Sauerbruch, Sophie; Schlachetzki, Felix; Luerding, Ralph; Winkler, Juergen; Bogdahn, Ulrich] Univ Regensburg, Bezirksklinikum Regensburg, Dept Neurol, Regensburg, Germany; [Kraemer, Mathias] Neurol Therapy Ctr, Cologne, Germany; [Kraemer, Mathias] St Marien Hosp, Cologne, Germany; [Schormann, Thorsten] Univ Med Ctr, Dept Neurol, Dusseldorf, Germany; [Schuierer, Gerhard] Univ Regensburg, Med Ctr, Dist Med Ctr Regensburg, Inst Neuroradiol, Regensburg, Germany; [Hennemann, Burkhard] Univ Regensburg, Med Ctr, Dept Hematooncol, Regensburg, Germany; [Orso, Evelyn] Univ Regensburg, Med Ctr, Dept Clin Chem, Regensburg, Germany; [Dabringhaus, Andreas] St Mauritius Therapy Clin, Meerbusch, Germany	University of Regensburg; St. Marien Hospital; University of Regensburg; University of Regensburg; University of Regensburg	Boy, S (corresponding author), Univ Regensburg, Bezirksklinikum Regensburg, Dept Neurol, Regensburg, Germany.	sandra.boy@medbo.de	Kraemer, Matthias/GLR-0951-2022	Winkler, Jurgen/0000-0003-0630-9204	AMGEN Inc. Germany	AMGEN Inc. Germany	The initiation of the study protocol was supported by an unrestricted educational grant from AMGEN Inc. Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2007, LANCET, V369, P249, DOI 10.1016/S0140-6736(07)60120-2; ALBERTS MJ, 1993, STROKE, V24, P1817, DOI 10.1161/01.STR.24.12.1817; American Heart Association, 2006, HEART DIS STROK STAT; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; BEGLEY CG, 1986, BLOOD, V68, P162; Bratane BT, 2009, STROKE, V40, P3102, DOI 10.1161/STROKEAHA.109.553958; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BRUGGER W, 1995, NEW ENGL J MED, V333, P283, DOI 10.1056/NEJM199508033330503; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hennemann B, 2008, CYTOTHERAPY, V10, P303, DOI 10.1080/14653240801949994; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; Hirose L, 2004, EXERC IMMUNOL REV, V10, P75; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Karl C, 2005, J NEUROCHEM, V92, P264, DOI 10.1111/j.1471-4159.2004.02879.x; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kleinschnitz C, 2004, MOL BRAIN RES, V131, P73, DOI 10.1016/j.molbrainres.2004.08.011; Kraemer M, 2004, J NEUROIMAGING, V14, P265, DOI 10.1177/1051228404264950; Lin Q, 2006, J BIOL CHEM, V281, P30678, DOI 10.1074/jbc.C600120200; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; METCALF D, 1990, CANCER-AM CANCER SOC, V65, P2185, DOI 10.1002/1097-0142(19900515)65:10<2185::AID-CNCR2820651005>3.0.CO;2-4; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Minnerup J, 2008, STROKE, V39, P1855, DOI 10.1161/STROKEAHA.107.506816; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Root RK, 2003, CRIT CARE MED, V31, P367, DOI 10.1097/01.CCM.0000048629.32625.5D; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schormann T, 2003, IEEE T MED IMAGING, V22, P62, DOI 10.1109/TMI.2002.806571; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Suzuki K, 2003, MED SCI SPORT EXER, V35, P348, DOI 10.1249/01.MSS.0000048861.57899.04; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; von Aulock S, 2003, IMMUNOBIOLOGY, V208, P413, DOI 10.1078/0171-2985-00285; Weiss M, 2001, CYTOKINE, V13, P51, DOI 10.1006/cyto.2000.0796; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Zhang Y, 2004, AM J PHYSIOL-RENAL, V286, pF1193, DOI 10.1152/ajprenal.00379.2002; Ziemus B, 2007, NEUROPSYCHOLOGIA, V45, P2016, DOI 10.1016/j.neuropsychologia.2007.02.012	54	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23099	10.1371/journal.pone.0023099	http://dx.doi.org/10.1371/journal.pone.0023099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887230	Green Published, Green Submitted, gold			2022-12-27	WOS:000294298800005
J	Banci, L; Barbieri, L; Bertini, I; Cantini, F; Luchinat, E				Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Cantini, Francesca; Luchinat, Enrico			In-cell NMR in E. coli to Monitor Maturation Steps of hSOD1	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MITOCHONDRIAL INTERMEMBRANE SPACE; ESCHERICHIA-COLI; REDUCED FORM; COPPER; SOD1; DISMUTASE; METAL; SPECTROSCOPY; APO	In-cell NMR allows characterizing the folding state of a protein as well as posttranslational events at molecular level, in the cellular context. Here, the initial maturation steps of human copper, zinc superoxide dismutase 1 are characterized in the E. coli cytoplasm by in-cell NMR: from the apo protein, which is partially unfolded, to the zinc binding which causes its final quaternary structure. The protein selectively binds only one zinc ion, whereas in vitro also the copper site binds a non-physiological zinc ion. However, no intramolecular disulfide bridge formation occurs, nor copper uptake, suggesting the need of a specific chaperone for those purposes.	[Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Cantini, Francesca; Luchinat, Enrico] Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy; [Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Cantini, Francesca; Luchinat, Enrico] Univ Florence, Dept Chem, Sesto Fiorentino, Italy	University of Florence; University of Florence	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy.	banci@cerm.unifi.it; bertini@cerm.unifi.it	Cantini, Francesca/O-1220-2015; Luchinat, Enrico/O-1776-2014	Cantini, Francesca/0000-0003-0526-6732; Luchinat, Enrico/0000-0003-4183-4311; BANCI, LUCIA/0000-0003-0562-5774; Barbieri, Letizia/0000-0002-7457-490X	Italian FIRB PROTEOMICA MIUR [RBRN07BMCT]; European Commission [261863]	Italian FIRB PROTEOMICA MIUR(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Italian FIRB PROTEOMICA MIUR contract RBRN07BMCT, and is part of the JRA2 of the Bio-Nuclear Magnetic Resonance project (European Commission's FP7, project number 261863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; CHENG H, 1995, ARCH BIOCHEM BIOPHYS, V316, P619, DOI 10.1006/abbi.1995.1082; Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kawamata H, 2010, ANTIOXID REDOX SIGN, V13, P1375, DOI 10.1089/ars.2010.3212; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Reckel S, 2007, PROG NUCL MAG RES SP, V51, P91, DOI 10.1016/j.pnmrs.2007.02.002; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	27	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23561	10.1371/journal.pone.0023561	http://dx.doi.org/10.1371/journal.pone.0023561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887272	gold, Green Published, Green Submitted			2022-12-27	WOS:000295832000028
J	Espinoza, LJ; Takami, A; Nakata, K; Yamada, K; Onizuka, M; Kawase, T; Sao, H; Akiyama, H; Miyamura, K; Okamoto, S; Inoue, M; Fukuda, T; Morishima, Y; Kodera, Y; Nakao, S				Espinoza, Luis J.; Takami, Akiyoshi; Nakata, Katsuya; Yamada, Kayoko; Onizuka, Makoto; Kawase, Takakazu; Sao, Hiroshi; Akiyama, Hideki; Miyamura, Koichi; Okamoto, Shinichiro; Inoue, Masami; Fukuda, Takahiro; Morishima, Yasuo; Kodera, Yoshihisa; Nakao, Shinji		Japan Marrow Donor Program	Genetic Variants of Human Granzyme B Predict Transplant Outcomes after HLA Matched Unrelated Bone Marrow Transplantation for Myeloid Malignancies	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; CHRONIC GRAFT; ACUTE GVHD; RISK; POLYMORPHISM; PERFORIN; ALLELE; INHIBITOR; MECHANISM	Serine protease granzyme B plays important roles in infections, autoimmunity, transplant rejection, and antitumor immunity. A triple-mutated granzyme B variant that encodes three amino substitutions (Q48R, P88A, and Y245H) has been reported to have altered biological functions. In the polymorphism rs8192917 (2364A>G), the A and G alleles represent wild type QPY and RAH mutant variants, respectively. In this study, we analyzed the impact of granzyme B polymorphisms on transplant outcomes in recipients undergoing unrelated HLA-fully matched T-cell-replete bone marrow transplantation (BMT) through the Japan Donor Marrow Program. The granzyme B genotypes were retrospectively analyzed in a cohort of 613 pairs of recipients with hematological malignancies and their unrelated donors. In patients with myeloid malignancies consisting of acute myeloid leukemia and myelodysplastic syndrome, the donor G/G or A/G genotype was associated with improved overall survival (OS; adjusted hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.41-0.89; P = 0.01) as well as transplant related mortality (TRM; adjusted HR, 0.48; 95% CI, 0.27-0.86, P = 0.01). The recipient G/G or A/G genotype was associated with a better OS (adjusted HR, 0.68; 95% CI, 0.47-0.99; P = 0.05) and a trend toward a reduced TRM (adjusted HR, 0.61; 95% CI, 0.35-1.06; P = 0.08). Granzyme B polymorphism did not have any effect on the transplant outcomes in patients with lymphoid malignancies consisting of acute lymphoid leukemia and malignant lymphoma. These data suggest that there is an association between the granzyme B genotype and better clinical outcomes in patients with myeloid malignancies after unrelated BMT.	[Espinoza, Luis J.; Takami, Akiyoshi; Nakata, Katsuya; Yamada, Kayoko; Nakao, Shinji] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Onizuka, Makoto] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Kawase, Takakazu] Aichi Canc Ctr Hosp, Div Epidemiol, Nagoya, Aichi 464, Japan; [Morishima, Yasuo] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Sao, Hiroshi] Meitetsu Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Akiyama, Hideki] Ebara Hosp, Dept Internal Med, Tokyo, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Okamoto, Shinichiro] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Inoue, Masami] Osaka Med Ctr, Dept Hematol & Oncol, Osaka, Japan; [Inoue, Masami] Res Inst Maternal & Child Hlth, Osaka, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Dept Promot Blood & Marrow Transplantat, Nagoya, Aichi, Japan	Kanazawa University; Tokai University; Aichi Cancer Center; Aichi Cancer Center; Red Cross Nagoya Daiichi Hospital; Keio University; Osaka Medical Center for Cancer & Cardiovascular Diseases; National Cancer Center - Japan; Aichi Medical University	Espinoza, LJ (corresponding author), Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan.	takami@med3.m.kanazawa-u.ac.jp	Espinoza, Luis/L-1586-2013; Takami, Akiyoshi/O-5677-2019	Espinoza, Luis/0000-0002-1794-6666; Takami, Akiyoshi/0000-0002-1822-9976; ONIZUKA, MAKOTO/0000-0003-3864-0823	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports and Technology; Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan)	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan)	This study was supported by grants from the Ministry of Health, Labor and Welfare, and the Ministry of Education, Culture, Sports and Technology, and funds from the Mitani Research and Development Assistance Organization (Kanazawa, Japan) and by the Japan Leukemia Research Fund (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bladergroen BA, 2002, BLOOD, V99, P232, DOI 10.1182/blood.V99.1.232; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Classen CF, 2004, HAEMATOLOGICA, V89, P1314; de Boer MGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018403; Dickinson AM, 2004, BRIT J HAEMATOL, V127, P479, DOI 10.1111/j.1365-2141.2004.05216.x; Elmaagacli AH, 2008, BONE MARROW TRANSPL, V41, P821, DOI 10.1038/sj.bmt.1705980; Espinoza JL, 2009, HAEMATOL-HEMATOL J, V94, P1427, DOI 10.3324/haematol.2009.008318; ESPINOZA JL, 2011, BONE MARROW TRANSPLA; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Gaafar A, 2009, EXP HEMATOL, V37, P838, DOI 10.1016/j.exphem.2009.04.003; Gerbitz A, 2008, BIOL BLOOD MARROW TR, V14, P1180, DOI 10.1016/j.bbmt.2008.08.002; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Gratwohl A, 2005, BONE MARROW TRANSPL, V36, P757, DOI 10.1038/sj.bmt.1705140; Graubert TA, 1997, J CLIN INVEST, V100, P904, DOI 10.1172/JCI119606; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Higaki Y, 2001, DERMATOLOGY, V202, P94, DOI 10.1159/000051606; Jahrsdorfer B, 2010, BLOOD, V115, P1156, DOI 10.1182/blood-2009-07-235382; KANDA Y, 2011, EZR ON R COMMANDER; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Kim DH, 2007, TRANSPLANTATION, V84, P917, DOI 10.1097/01.tp.0000284583.15810.6e; Kircher B, 2009, BONE MARROW TRANSPL, V43, P787, DOI 10.1038/bmt.2008.395; Krupnick AS, 2002, TRANSPLANTATION, V74, P871, DOI 10.1097/00007890-200209270-00022; Lauw FN, 2000, J INFECT DIS, V182, P206, DOI 10.1086/315642; McDermott DH, 2010, BLOOD, V115, P2311, DOI 10.1182/blood-2009-08-237768; McIlroy D, 2003, P NATL ACAD SCI USA, V100, P2562, DOI 10.1073/pnas.0437935100; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Morishima Y, 2007, BIOL BLOOD MARROW TR, V13, P315, DOI 10.1016/j.bbmt.2006.10.027; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Noori-Daloill MR, 2007, ANN TRANSPL, V12, P5; Ostrovsky O, 2010, BLOOD, V115, P2319, DOI 10.1182/blood-2009-08-236455; Pascoe MD, 2000, TRANSPLANTATION, V69, P2547, DOI 10.1097/00007890-200006270-00013; Prakash MD, 2009, IMMUNOL CELL BIOL, V87, P249, DOI 10.1038/icb.2008.98; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rousalova I, 2010, INT J ONCOL, V37, P1361, DOI 10.3892/ijo_00000788; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Sugimoto K, 2008, INT J HEMATOL, V87, P451, DOI 10.1007/s12185-008-0061-z; Sun JR, 2004, J BIOL CHEM, V279, P16907, DOI 10.1074/jbc.M400563200; Sutton VR, 1997, J IMMUNOL, V158, P5783; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; TAKAMI A, 2010, BONE MARROW TRANSPLA; Viel DO, 2007, SCAND J IMMUNOL, V66, P703, DOI 10.1111/j.1365-3083.2007.02021.x; Wagner C, 2004, BLOOD, V103, P1099, DOI 10.1182/blood-2003-04-1069; Zaitsu M, 2004, TISSUE ANTIGENS, V64, P611, DOI 10.1111/j.1399-0039.2004.00325.x	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23827	10.1371/journal.pone.0023827	http://dx.doi.org/10.1371/journal.pone.0023827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886827	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500032
J	Pesonen, AK; Sjosten, NM; Matthews, KA; Heinonen, K; Martikainen, S; Kajantie, E; Tammelin, T; Eriksson, JG; Strandberg, T; Raikkonen, KR				Pesonen, Anu-Katriina; Sjosten, Noora M.; Matthews, Karen A.; Heinonen, Kati; Martikainen, Silja; Kajantie, Eero; Tammelin, Tuija; Eriksson, Johan G.; Strandberg, Timo; Raikkonen, Katri			Temporal Associations between Daytime Physical Activity and Sleep in Children	PLOS ONE			English	Article							LICORICE CONSUMPTION; SALIVARY CORTISOL; RISK-FACTORS; DURATION; EXERCISE; ACTIGRAPHY; INFANCY; TEMPERAMENT; PREVALENCE; CONTINUITY	Objectives: We examined temporal associations between objectively-measured physical activity (PA) during the day and in the evening, and sleep quantity and quality. Study Design: PA and sleep were measured by actigraphs for an average of one week in an epidemiological cohort study of 275 eight-year-old children. Results: For each one standard deviation (SD) unit of increased PA during the day, sleep duration was decreased by 0.30, sleep efficiency by 0.16, and sleep fragmentation increased by 0.08 SD units that night. For each one SD unit increase in sleep duration and efficiency the preceding night, PA the following day decreased by 0.09 and 0.16 SD units, respectively. When we contrasted days with a high amount of moderate to vigorous activity during the day or in the evening to days with a more sedentary profile, the results were essentially similar. However, moderate to vigorous PA in the evening shortened sleep latency. Conclusions: The relationship between a higher level of PA and poorer sleep is bidirectional. These within-person findings challenge epidemiological findings showing that more active people report better sleep. Since only a few studies using objective measurements of both PA and sleep have been conducted in children, further studies are needed to confirm/refute these results.	[Pesonen, Anu-Katriina; Sjosten, Noora M.; Heinonen, Kati; Martikainen, Silja; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Fac Behav Sci, Helsinki, Finland; [Sjosten, Noora M.] Ctr Expertise Work Org, Finnish Inst Occupat Hlth, Turku, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Inst Clin Med, Clin Children & Adolescent, Helsinki, Finland; [Matthews, Karen A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Tammelin, Tuija] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Strandberg, Timo] Univ Oulu, Unit Gen Practice, Dept Hlth Sci Geriatr, Oulu, Finland	University of Helsinki; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; University of Oulu	Pesonen, AK (corresponding author), Univ Helsinki, Inst Behav Sci, Fac Behav Sci, Helsinki, Finland.	Anukatriina.pesonen@helsinki.fi		strandberg, timo/0000-0001-6299-925X; Pesonen, Anu-Katriina/0000-0002-0662-6261; Heinonen, Kati/0000-0002-1262-5599; Eriksson, Johan/0000-0002-2516-2060; Raikkonen, Katri/0000-0003-3124-3470; Martikainen, Silja/0000-0001-7986-1580	John D. and Catherine T. MacArthur Foundation; European Science Foundation (EuroSTRESS); Finnish Academy; Ministry fo Culture and Education in Finland	John D. and Catherine T. MacArthur Foundation; European Science Foundation (EuroSTRESS)(European Science Foundation (ESF)); Finnish Academy(Academy of Finland); Ministry fo Culture and Education in Finland	The study was sponsored by grants from the John D. and Catherine T. MacArthur Foundation, the European Science Foundation (EuroSTRESS), the Finnish Academy, and the Ministry fo Culture and Education in Finland. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chen Kong Y, 2003, Diabetes Technol Ther, V5, P1023, DOI 10.1089/152091503322641088; Committee PAGA, 2008, PHYS ACT GUID ADV CO; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Danielsen YS, 2010, INT J PEDIATR OBES, V5, P214, DOI 10.3109/17477160903473739; DELCORRAL P, 1994, MED SCI SPORT EXER, V26, P1297; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Dworak M, 2008, SLEEP MED, V9, P266, DOI 10.1016/j.sleep.2007.04.017; Fillipas S, 2010, J ASSOC NURSE AIDS C, V21, P173, DOI 10.1016/j.jana.2009.11.003; Fricke-Oerkermann L, 2007, SLEEP, V30, P1371, DOI 10.1093/sleep/30.10.1371; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Hyde M, 2007, J SLEEP RES, V16, P213, DOI 10.1111/j.1365-2869.2007.00588.x; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Kim K, 2000, SLEEP, V23, P41; Komsi N, 2008, INFANT BEHAV DEV, V31, P239, DOI 10.1016/j.infbeh.2007.10.002; Komsi N, 2006, INFANT BEHAV DEV, V29, P494, DOI 10.1016/j.infbeh.2006.05.002; Kos D, 2007, CHRONOBIOL INT, V24, P345, DOI 10.1080/07420520701282364; Kumahara H, 2004, INT J OBESITY, V28, P1105, DOI 10.1038/sj.ijo.0802712; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Liu XC, 2000, SLEEP, V23, P27; Morgan K, 2003, J SLEEP RES, V12, P231, DOI 10.1046/j.1365-2869.2003.00355.x; Nixon GM, 2009, ARCH DIS CHILD, V94, P686, DOI 10.1136/adc.2009.157453; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Paccotti P, 2005, INT J SPORTS MED, V26, P747, DOI 10.1055/s-2004-830449; Pesonen AK, 2009, SLEEP, V32, P1086, DOI 10.1093/sleep/32.8.1086; Raikkonen K, 2010, J CLIN ENDOCR METAB, V95, P2254, DOI 10.1210/jc.2009-0943; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P1137, DOI 10.1093/aje/kwp272; Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894; Singh GK, 2008, J COMMUN HEALTH, V33, P206, DOI 10.1007/s10900-008-9094-8; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Strandberg TE, 2001, AM J EPIDEMIOL, V153, P1085, DOI 10.1093/aje/153.11.1085; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; URPONEN H, 1988, SOC SCI MED, V26, P443, DOI 10.1016/0277-9536(88)90313-9; Westerterp KR, 1999, INT J OBESITY, V23, pS45, DOI 10.1038/sj.ijo.0800883; Wood AC, 2008, BEHAV GENET, V38, P266, DOI 10.1007/s10519-008-9196-1; Yen CF, 2010, PSYCHIAT RES, V179, P69, DOI 10.1016/j.psychres.2009.02.016; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; [No title captured]; [No title captured]; [No title captured]	45	88	88	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22958	10.1371/journal.pone.0022958	http://dx.doi.org/10.1371/journal.pone.0022958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811YA	21886770	Green Published, Green Accepted, gold			2022-12-27	WOS:000294253500004
J	Eliyahu, E; Wolfson, T; Ge, Y; Jepsen, KJ; Schuchman, EH; Simonaro, CM				Eliyahu, Efrat; Wolfson, Theodore; Ge, Yi; Jepsen, Karl J.; Schuchman, Edward H.; Simonaro, Calogera M.			Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI	PLOS ONE			English	Article							ARYLSULFATASE-B; JOINT DISEASE; MECHANISM; BONE; IDENTIFICATION; GENE	Background: Although enzyme replacement therapy (ERT) is available for several lysosomal storage disorders, the benefit of this treatment to the skeletal system is very limited. Our previous work has shown the importance of the Toll-like receptor 4/TNF-alpha inflammatory pathway in the skeletal pathology of the mucopolysaccharidoses (MPS), and we therefore undertook a study to examine the additive benefit of combining anti-TNF-alpha therapy with ERT in a rat model of MPS type VI. Methodology/Principal Findings: MPS VI rats were treated for 8 months with Naglazyme(R) (recombinant human N-acetyl-galactosamine-4-sulfatase), or by a combined protocol using Naglazyme(R) and the rat-specific anti-TNF-alpha drug, CNTO1081. Both protocols led to markedly reduced serum levels of TNF-alpha and RANKL, although only the combined treatment reduced TNF-alpha in the articular cartilage. Analysis of cultured articular chondrocytes showed that the combination therapy also restored collagen IIA1 expression, and reduced expression of the apoptotic marker, PARP. Motor activity and mobility were improved by ERT, and these were significantly enhanced by combination treatment. Tracheal deformities in the MPS VI animals were only improved by combination therapy, and there was a modest improvement in bone length. Ceramide levels in the trachea also were markedly reduced. MicroCT analysis did not demonstrate any significant positive effects on bone microarchitecture from either treatment, nor was there histological improvement in the bone growth plates. Conclusions/Significance: The results demonstrate that combining ERT with anti-TNF-alpha therapy improved the treatment outcome and led to significant clinical benefit. They also further validate the usefulness of TNF-alpha, RANKL and other inflammatory molecules as biomarkers for the MPS disorders. Further evaluation of this combination approach in other MPS animal models and patients is warranted.	[Eliyahu, Efrat; Ge, Yi; Schuchman, Edward H.; Simonaro, Calogera M.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Wolfson, Theodore; Jepsen, Karl J.] Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Eliyahu, E (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	calogera.simonaro@mssm.edu	Wolfson, Theodore/ABB-2629-2020	Wolfson, Theodore/0000-0002-2593-1755	National Institutes of Health [1R01DK087185, AR44927]; National Mucopolysaccharidosis Society; Isaac Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044927, R56AR044927, R29AR044927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Mucopolysaccharidosis Society; Isaac Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by grants from the National Institutes of Health ((http://grants.nih.gov/grants/oer.htm) 1R01DK087185 and AR44927), The National Mucopolysaccharidosis Society (http://www.mpssociety.org/), and The Isaac Foundation (www.theisaacfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair D, 2007, MOL GENET METAB, V91, P352, DOI 10.1016/j.ymgme.2007.04.009; Becker KA, 2010, BIOCHEM BIOPH RES CO, V403, P368, DOI 10.1016/j.bbrc.2010.11.038; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; Connor V, 2011, RHEUMATOL INT, V31, P327, DOI 10.1007/s00296-009-1292-x; Coppa GV, 2010, GLYCOBIOLOGY, V20, P1259, DOI 10.1093/glycob/cwq088; Cotugno G, 2010, HUM GENE THER, V21, P555, DOI 10.1089/hum.2009.189; Cox-Brinkman J, 2010, ULTRASTRUCT PATHOL, V34, P126, DOI 10.3109/01913121003648485; Decker C, 2010, J PEDIATR REHAB MED, V3, P89, DOI 10.3233/PRM-2010-0113; GLAMUZINA E, 2011, J INHERIT METAB 0216; Herati RS, 2008, MOL GENET METAB, V95, P142, DOI 10.1016/j.ymgme.2008.07.003; Klaasen R, 2011, ARTHRITIS RHEUM-US, V63, P359, DOI 10.1002/art.30136; KUNIEDA T, 1995, GENOMICS, V29, P582, DOI 10.1006/geno.1995.9962; LU JZ, 2011, BIOTECHNOL BIOE 0223; McGill JJ, 2010, CLIN GENET, V77, P492, DOI 10.1111/j.1399-0004.2009.01324.x; Metcalf JA, 2009, MOL GENET METAB, V97, P202, DOI 10.1016/j.ymgme.2009.03.005; Miebach E, 2005, ACTA PAEDIATR, V94, P58, DOI 10.1080/08035320510028120; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249; Rodgers M, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI [10.3310/hta15100, 10.3310/hta15suppl1/01]; RUTELLA S, 2011, AM J GASTROENTE 0301; SEMENZA GL, 1988, MEDICINE, V67, P209, DOI 10.1097/00005792-198807000-00002; Shinhar SY, 2004, ARCH OTOLARYNGOL, V130, P233, DOI 10.1001/archotol.130.2.233; Simonardo CM, 1997, TRANSPLANTATION, V63, P1386, DOI 10.1097/00007890-199705270-00003; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Valayannopoulos V, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-5; Weaver Arthur L, 2004, Mod Rheumatol, V14, P101; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; YOSHIDA M, 1993, J CLIN INVEST, V91, P1099, DOI 10.1172/JCI116268	31	56	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e22447	10.1371/journal.pone.0022447	http://dx.doi.org/10.1371/journal.pone.0022447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887218	Green Published, Green Submitted, gold			2022-12-27	WOS:000294251800005
J	Berleman, JE; Vicente, JJ; Davis, AE; Jiang, SY; Seo, YE; Zusman, DR				Berleman, James E.; Vicente, Juan J.; Davis, Annie E.; Jiang, Sharon Y.; Seo, Young-Eun; Zusman, David R.			FrzS Regulates Social Motility in Myxococcus xanthus by Controlling Exopolysaccharide Production	PLOS ONE			English	Article							GLIDING MOTILITY; CELL-INTERACTIONS; IV PILUS; GENES; LOCALIZATION; MYXOBACTERIA; EVOLUTION; MOVEMENT; SYSTEMS; PATHWAY	Myxococcus xanthus Social (S) motility occurs at high cell densities and is powered by the extension and retraction of Type IV pili which bind ligands normally found in matrix exopolysaccharides (EPS). Previous studies showed that FrzS, a protein required for S-motility, is organized in polar clusters that show pole-to-pole translocation as cells reverse their direction of movement. Since the leading cell pole is the site of both the major FrzS cluster and type IV pilus extension/retraction, it was suggested that FrzS might regulate S-motility by activating pili at the leading cell pole. Here, we show that FrzS regulates EPS production, rather than type IV pilus function. We found that the frzS phenotype is distinct from that of Type IV pilus mutants such as pilA and pilT, but indistinguishable from EPS mutants, such as epsZ. Indeed, frzS mutants can be rescued by the addition of purified EPS, 1% methylcellulose, or co-culturing with wildtype cells. Our data also indicate that the cell density requirement in S-motility is likely a function of the ability of cells to construct functional multicellular clusters surrounding an EPS core.	[Berleman, James E.; Vicente, Juan J.; Davis, Annie E.; Jiang, Sharon Y.; Seo, Young-Eun; Zusman, David R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berleman, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	zusman@berkeley.edu		Vicente, Juan Jesus/0000-0002-3402-3046	National Institutes of Health [GM020509, GM020509-36S1, GM020509-37S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants GM020509, GM020509-36S1 and GM020509-37S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD JW, 1988, J BACTERIOL, V170, P5765, DOI 10.1128/jb.170.12.5765-5770.1988; Berleman JE, 2007, J BACTERIOL, V189, P5675, DOI 10.1128/JB.00544-07; Berleman JE, 2009, FEMS MICROBIOL REV, V33, P942, DOI 10.1111/j.1574-6976.2009.00185.x; Black WP, 2006, MOL MICROBIOL, V61, P447, DOI 10.1111/j.1365-2958.2006.05230.x; Black WP, 2010, J BACTERIOL, V192, P4267, DOI 10.1128/JB.00403-10; Black WP, 2009, MICROBIOL-SGM, V155, P3599, DOI 10.1099/mic.0.031070-0; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Bustamante VH, 2004, MOL MICROBIOL, V53, P1501, DOI 10.1111/j.1365-2958.2004.04221.x; CAMPOS JM, 1975, P NATL ACAD SCI USA, V72, P518, DOI 10.1073/pnas.72.2.518; Cole JL, 2003, MOL MICROBIOL, V49, P1671, DOI 10.1046/j.1365-2958.2003.03664.x; DANA JR, 1993, J BACTERIOL, V175, P3636, DOI 10.1128/jb.175.11.3636-3647.1993; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; GLUCKSMANN MA, 1993, J BACTERIOL, V175, P7033, DOI 10.1128/jb.175.21.7033-7044.1993; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Guo YZ, 2010, INFECT IMMUN, V78, P1390, DOI 10.1128/IAI.01188-09; Hillesland KL, 2005, MICROBIAL ECOL, V49, P558, DOI 10.1007/s00248-004-0069-8; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; Hu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016102; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; KAISER D, 1983, CELL MOTILITY, P227; Kim SH, 1999, J BACTERIOL, V181, P1496, DOI 10.1128/JB.181.5.1496-1507.1999; Lancero H, 2002, J BACTERIOL, V184, P1462, DOI 10.1128/JB.184.5.1462-1465.2002; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Mignot T, 2007, MOL MICROBIOL, V65, P363, DOI 10.1111/j.1365-2958.2007.05789.x; Nan BY, 2011, P NATL ACAD SCI USA, V108, P2498, DOI 10.1073/pnas.1018556108; Palsdottir H, 2009, J BACTERIOL, V191, P2077, DOI 10.1128/JB.01333-08; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; SHIMKETS LJ, 1986, J BACTERIOL, V166, P837, DOI 10.1128/jb.166.3.837-841.1986; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; Velicer GJ, 2009, ANNU REV MICROBIOL, V63, P599, DOI 10.1146/annurev.micro.091208.073158; Vlamakis HC, 2004, MOL MICROBIOL, V52, P1799, DOI 10.1111/j.1365-2958.2004.04098.x; Ward MJ, 2000, MOL MICROBIOL, V37, P1357, DOI 10.1046/j.1365-2958.2000.02079.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Xu Q, 2005, J BACTERIOL, V187, P6410, DOI 10.1128/JB.187.18.6410-6418.2005; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x	52	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23920	10.1371/journal.pone.0023920	http://dx.doi.org/10.1371/journal.pone.0023920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886839	Green Submitted, Green Published, gold			2022-12-27	WOS:000294128100040
J	Feng, JX; Yang, JX; Zheng, SY; Qiu, YR; Chai, CW				Feng, Jiexiong; Yang, Jixin; Zheng, Shuaiyu; Qiu, Yinrong; Chai, Chengwei			Silencing of the Rotavirus NSP4 Protein Decreases the Incidence of Biliary Atresia in Murine Model	PLOS ONE			English	Article							EPITHELIAL-CELLS; PATHOGENESIS; OBSTRUCTION; CHILDREN; DISEASE; MICE; RNA	Biliary atresia is a common disease in neonates which causes obstructive jaundice and progressive hepatic fibrosis. Our previous studies indicate that rotavirus infection is an initiator in the pathogenesis of experimental biliary atresia (BA) through the induction of increased nuclear factor-kappaB and abnormal activation of the osteopontin inflammation pathway. In the setting of rotavirus infection, rotavirus nonstructural protein 4 (NSP4) serves as an important immunogen, viral protein 7 (VP7) is necessary in rotavirus maturity and viral protein 4 (VP4) is a virulence determiner. The purpose of the current study is to clarify the roles of NSP4, VP7 and VP4 in the pathogenesis of experimental BA. Primary cultured extrahepatic biliary epithelia were infected with Rotavirus (mmu18006). Small interfering RNA targeting NSP4, VP7 or VP4 was transfected before rotavirus infection both in vitro and in vivo. We analyzed the incidence of BA, morphological change, morphogenesis of viral particles and viral mRNA and protein expression. The in vitro experiments showed NSP4 silencing decreased the levels of VP7 and VP4, reduced viral particles and decreased cytopathic effect. NSP4-positive cells had strongly positive expression of integrin subunit alpha 2. Silencing of VP7 or VP4 partially decreased epithelial injury. Animal experiments indicated after NSP4 silencing, mouse pups had lower incidence of BA than after VP7 or VP4 silencing. However, 33.3% of VP4-silenced pups (N = 6) suffered BA and 50% of pups (N = 6) suffered biliary injury after VP7 silencing. Hepatic injury was decreased after NSP4 or VP4 silencing. Neither VP4 nor VP7 were detected in the biliary ducts after NSP4. All together, NSP4 silencing down-regulates VP7 and VP4, resulting in decreased incidence of BA.	[Feng, Jiexiong; Yang, Jixin; Zheng, Shuaiyu; Qiu, Yinrong; Chai, Chengwei] Huazhong Univ Sci & Technol, Dept Pediat Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Feng, JX (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	fengjiexiong@126.com		Feng, Jiexiong/0000-0001-9596-2330	National Natural Science Foundation of China [81070284, 30672195]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81070284 and No. 30672195; http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANGARU B, 1980, LAB INVEST, V43, P456; Chai CW, 2010, IN VITRO CELL DEV-AN, V46, P820, DOI 10.1007/s11626-010-9346-7; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; Dector MA, 2002, EMBO REP, V3, P1175, DOI 10.1093/embo-reports/kvf234; Enouf V, 2003, J VIROL, V77, P7041, DOI 10.1128/JVI.77.12.7041-7047.2003; ESPARZA J, 1980, J GEN VIROL, V47, P461, DOI 10.1099/0022-1317-47-2-461; Feng JX, 2008, CURR PEDIATR REV, V4, P164, DOI 10.2174/157339608785856054; Feng JX, 2005, J PEDIATR SURG, V40, P630, DOI 10.1016/j.jpedsurg.2004.12.004; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Harada K, 2007, HEPATOLOGY, V46, P1146, DOI 10.1002/hep.21797; Huang L, 2008, EUR J PEDIATR SURG, V18, P224, DOI 10.1055/s-2008-1038483; Jafri M, 2007, SURGERY, V142, P192, DOI 10.1016/j.surg.2007.03.008; LANDAU SM, 1982, ARCH VIROL, V73, P79, DOI 10.1007/BF01341731; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Mack CL, 2007, SEMIN LIVER DIS, V27, P233, DOI 10.1055/s-2007-985068; MARIA GC, 2009, GASTROENTEROLOGY S, V136, pA808; Mohanty SK, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-14; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Petersen C, 2007, PEDIATR SURG INT, V23, P521, DOI 10.1007/s00383-007-1922-x; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; Zarnbrano JL, 2008, J VIROL, V82, P5815, DOI 10.1128/JVI.02719-07	23	70	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23655	10.1371/journal.pone.0023655	http://dx.doi.org/10.1371/journal.pone.0023655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876759	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900031
J	House, PK; Vyas, A; Sapolsky, R				House, Patrick K.; Vyas, Ajai; Sapolsky, Robert			Predator Cat Odors Activate Sexual Arousal Pathways in Brains of Toxoplasma gondii Infected Rats	PLOS ONE			English	Article							HOST BEHAVIOR; SCHIZOPHRENIA; MANIPULATION; SPECIFICITY; ANTIBODIES; PARASITES; AMYGDALA; AGENTS	Cat odors induce rapid, innate and stereotyped defensive behaviors in rats at first exposure, a presumed response to the evolutionary pressures of predation. Bizarrely, rats infected with the brain parasite Toxoplasma gondii approach the cat odors they typically avoid. Since the protozoan Toxoplasma requires the cat to sexually reproduce, this change in host behavior is thought to be a remarkable example of a parasite manipulating a mammalian host for its own benefit. Toxoplasma does not influence host response to non-feline predator odor nor does it alter behavior on olfactory, social, fear or anxiety tests, arguing for specific manipulation in the processing of cat odor. We report that Toxoplasma infection alters neural activity in limbic brain areas necessary for innate defensive behavior in response to cat odor. Moreover, Toxoplasma increases activity in nearby limbic regions of sexual attraction when the rat is exposed to cat urine, compelling evidence that Toxoplasma overwhelms the innate fear response by causing, in its stead, a type of sexual attraction to the normally aversive cat odor.	[House, Patrick K.] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Vyas, Ajai] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Sapolsky, Robert] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sapolsky, Robert] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Sapolsky, Robert] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University; Stanford University; Stanford University	House, PK (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA 94305 USA.	pathouse@stanford.edu	Vyas, Ajai/A-2223-2011	Vyas, Ajai/0000-0002-2592-6796	National Institutes of Health [5R01 MH079296]; Stanley Medical Research Institute [06R-1463]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (5R01 MH079296) and The Stanley Medical Research Institute (06R-1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Cetinkaya Z, 2007, SCHIZOPHRENIA BULL, V33, P789, DOI 10.1093/schbul/sbm021; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Goodson JL, 2009, FRONT NEUROENDOCRIN, V30, P429, DOI 10.1016/j.yfrne.2009.05.007; Kuris AM, 2007, INT J PARASITOL, V37, P539, DOI 10.1016/j.ijpara.2006.12.003; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; Leweke FM, 2004, EUR ARCH PSY CLIN N, V254, P4, DOI 10.1007/s00406-004-0481-6; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Maras PM, 2006, EUR J NEUROSCI, V24, P3541, DOI 10.1111/j.1460-9568.2006.05216.x; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413	21	94	97	1	263	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23277	10.1371/journal.pone.0023277	http://dx.doi.org/10.1371/journal.pone.0023277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858053	Green Published, gold			2022-12-27	WOS:000294121300027
J	Atsumi, Y; Fujimori, H; Fukuda, H; Inase, A; Shinohe, K; Yoshioka, Y; Shikanai, M; Ichijima, Y; Unno, J; Mizutani, S; Tsuchiya, N; Hippo, Y; Nakagama, H; Masutani, M; Teraoka, H; Yoshioka, K				Atsumi, Yuko; Fujimori, Hiroaki; Fukuda, Hirokazu; Inase, Aki; Shinohe, Keitaro; Yoshioka, Yoshiko; Shikanai, Mima; Ichijima, Yosuke; Unno, Junya; Mizutani, Shuki; Tsuchiya, Naoto; Hippo, Yoshitaka; Nakagama, Hitoshi; Masutani, Mitsuko; Teraoka, Hirobumi; Yoshioka, Ken-ichi			Onset of Quiescence Following p53 Mediated Down-Regulation of H2AX in Normal Cells	PLOS ONE			English	Article							DNA-DAMAGE; GENOMIC INSTABILITY; ARF/P53 PATHWAY; HISTONE H2AX; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; CANCER; MICE; ACTIVATION; LESIONS	Normal cells, both in vivo and in vitro, become quiescent after serial cell proliferation. During this process, cells can develop immortality with genomic instability, although the mechanisms by which this is regulated are unclear. Here, we show that a growth-arrested cellular status is produced by the down-regulation of histone H2AX in normal cells. Normal mouse embryonic fibroblast cells preserve an H2AX diminished quiescent status through p53 regulation and stable-diploidy maintenance. However, such quiescence is abrogated under continuous growth stimulation, inducing DNA replication stress. Because DNA replication stress-associated lesions are cryptogenic and capable of mediating chromosome-bridge formation and cytokinesis failure, this results in tetraploidization. Arf/p53 module-mutation is induced during tetraploidization with the resulting H2AX recovery and immortality acquisition. Thus, although cellular homeostasis is preserved under quiescence with stable diploidy, tetraploidization induced under growth stimulation disrupts the homeostasis and triggers immortality acquisition.	[Atsumi, Yuko; Fujimori, Hiroaki; Masutani, Mitsuko; Yoshioka, Ken-ichi] Natl Canc Ctr, Res Inst, Div Genome Stabil Res, Tokyo 104, Japan; [Fukuda, Hirokazu; Inase, Aki; Tsuchiya, Naoto; Hippo, Yoshitaka; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Fujimori, Hiroaki; Shinohe, Keitaro; Yoshioka, Yoshiko; Shikanai, Mima; Ichijima, Yosuke; Teraoka, Hirobumi; Yoshioka, Ken-ichi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo, Japan; [Unno, Junya; Mizutani, Shuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Atsumi, Y (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Stabil Res, Tokyo 104, Japan.	kyoshiok@ncc.go.jp			MEXT KAKENHI [20770136, 20659047]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT KAKENHI (20770136 and 20659047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; DANES BS, 1978, CANCER-AM CANCER SOC, V41, P2330, DOI 10.1002/1097-0142(197806)41:6<2330::AID-CNCR2820410635>3.0.CO;2-X; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Geigl JB, 2004, CANCER RES, V64, P8550, DOI 10.1158/0008-5472.CAN-04-2151; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lengauer C, 1997, NATURE, V386, P632; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tatemichi M, 2004, INT J CANCER, V111, P819, DOI 10.1002/ijc.20350; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	38	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23432	10.1371/journal.pone.0023432	http://dx.doi.org/10.1371/journal.pone.0023432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858116	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953500040
J	Bates, AJ; Sadler, JP; Fairbrass, AJ; Falk, SJ; Hale, JD; Matthews, TJ				Bates, Adam J.; Sadler, Jon P.; Fairbrass, Alison J.; Falk, Steven J.; Hale, James D.; Matthews, Tom J.			Changing Bee and Hoverfly Pollinator Assemblages along an Urban-Rural Gradient	PLOS ONE			English	Article							LAND-USE; FORAGING RANGES; HYMENOPTERA; LANDSCAPE; CONSERVATION; ENVIRONMENT; COMMUNITIES; BUMBLEBEE; DECLINES; DIPTERA	Background: The potential for reduced pollination ecosystem service due to global declines of bees and other pollinators is cause for considerable concern. Habitat degradation, destruction and fragmentation due to agricultural intensification have historically been the main causes of this pollinator decline. However, despite increasing and accelerating levels of global urbanization, very little research has investigated the effects of urbanization on pollinator assemblages. We assessed changes in the diversity, abundance and species composition of bee and hoverfly pollinator assemblages in urban, suburban, and rural sites across a UK city. Methodology/Principal Findings: Bees and hoverflies were trapped and netted at 24 sites of similar habitat character (churchyards and cemeteries) that varied in position along a gradient of urbanization. Local habitat quality (altitude, shelter from wind, diversity and abundance of flowers), and the broader-scale degree of urbanization (e. g. percentage of built landscape and gardens within 100 m, 250 m, 500 m, 1 km, and 2.5 km of the site) were assessed for each study site. The diversity and abundance of pollinators were both significantly negatively associated with higher levels of urbanization. Assemblage composition changed along the urbanization gradient with some species positively associated with urban and suburban land-use, but more species negatively so. Pollinator assemblages were positively affected by good site habitat quality, in particular the availability of flowering plants. Conclusions/Significance: Our results show that urban areas can support diverse pollinator assemblages, but that this capacity is strongly affected by local habitat quality. Nonetheless, in both urban and suburban areas of the city the assemblages had fewer individuals and lower diversity than similar rural habitats. The unique development histories of different urban areas, and the difficulty of assessing mobile pollinator assemblages in just part of their range, mean that complementary studies in different cities and urban habitats are required to discover if these findings are more widely applicable.	[Bates, Adam J.; Sadler, Jon P.; Fairbrass, Alison J.; Hale, James D.; Matthews, Tom J.] Univ Birmingham, Birmingham, W Midlands, England; [Falk, Steven J.] Warwickshire Museum, Warwick, England	University of Birmingham	Bates, AJ (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	a.j.bates@bham.ac.uk	Bates, Adam/G-1795-2011; Fairbrass, Alison/K-6563-2016	Fairbrass, Alison/0000-0002-4907-9683; Bates, Adam/0000-0001-7854-5260; Matthews, Thomas/0000-0002-7624-244X; Hale, James/0000-0001-9662-1853; Sadler, Jonathan/0000-0003-0443-4458	National Lottery (UK);  [EP/E021603]; EPSRC [EP/F007426/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F007426/1] Funding Source: researchfish	National Lottery (UK); ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research is part of the OPAL (Open Air Laboratories) project (http://www.opalexplorenature.org/) which is funded by The National Lottery (UK) through the Big Lottery Fund (http://www.biglotteryfund.org.uk/). The GIS work forms part of the Urban Futures (SUE II) program (EP/E021603) (http://www.epsrc.ac.uk/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Almohamad R, 2009, BIOTECHNOL AGRON SOC, V13, P467; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Braak Ter C., 1998, CANOCO REFERENCE MAN; Brodgar, 2010, SOFTWARE PACKAGE DAT; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Colwell RK, 2009, ESTIMATES STAT ESTIM; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; DISNEY R H L, 1982, Field Studies, V5, P607; Drescher AW, 2004, ACTA HORTIC, P227, DOI 10.17660/ActaHortic.2004.643.29; Falk SJ, 2009, WARWICKSHIRES WILDFL; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Ghazoul J, 2010, FRONT ECOL ENVIRON, V8, P9, DOI 10.1890/10.WB.001; GILBERT F, 1990, J ANIM ECOL, V59, P21, DOI 10.2307/5156; Gill S.E., 2007, BUILT ENV, V33, P115, DOI [10.2148/benv.33.1.115, 10.2148/benv.33.1.115., DOI 10.2148/BENV.33.1.115]; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Heard MS, 2007, BIOL LETTERS, V3, P638, DOI 10.1098/rsbl.2007.0425; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kearns CA, 2009, J INSECT CONSERV, V13, P655, DOI 10.1007/s10841-009-9215-4; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Laubertie EA, 2006, ANN APPL BIOL, V148, P173, DOI 10.1111/j.1744-7348.2006.00046.x; Leong JM, 1999, ECOL ENTOMOL, V24, P329, DOI 10.1046/j.1365-2311.1999.00196.x; Leps J, 2003, MULTIVARIATE ANAL EC; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marlin JC, 2001, CONSERV ECOL, V5, part. no.; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Maxwell D, 1998, FOOD POLICY, V23, P411, DOI 10.1016/S0306-9192(98)00047-5; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING GE; Mortberg U, 2000, LANDSCAPE URBAN PLAN, V50, P215, DOI 10.1016/S0169-2046(00)00090-6; Niemela J, 2000, J INSECT CONSERV, V4, P3, DOI 10.1023/A:1009655127440; Niemela J, 2009, LANDSCAPE URBAN PLAN, V92, P65, DOI 10.1016/j.landurbplan.2009.05.016; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Ordnance Survey, 2006, MASTERMAP US GUID VE; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Owen J., 2010, WILDLIFE GARDEN 30 Y; Owen SM, 2006, LANDSCAPE URBAN PLAN, V78, P311, DOI 10.1016/j.landurbplan.2005.11.002; Parris KM, 2006, J ANIM ECOL, V75, P757, DOI 10.1111/j.1365-2656.2006.01096.x; Potts SG, 1997, ECOL ENTOMOL, V22, P319, DOI 10.1046/j.1365-2311.1997.00071.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Development Core Team, 2006, R LANG ENV STAT COMP; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; Samways MJ, 2010, INSECT CONSERVATION; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Small EC, 2002, J INSECT CONSERV, V6, P233, DOI 10.1023/A:1024491111572; Stubbs A. E., 2002, British hoverflies: an illustrated identification guide; Thompson K, 2008, J ECOL, V96, P853, DOI 10.1111/j.1365-2745.2008.01383.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Wheater C. Philip, 2000, USING STAT UNDERSTAN; Williams NSG, 2005, J ECOL, V93, P1203, DOI 10.1111/j.1365-2745.2005.01039.x; Wilson JS, 2008, J KANSAS ENTOMOL SOC, V81, P288, DOI 10.2317/JKES-802.06.1; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	85	213	217	5	361	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23459	10.1371/journal.pone.0023459	http://dx.doi.org/10.1371/journal.pone.0023459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858128	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500043
J	Sirbu, BM; Lachmayer, SJ; Wulfing, V; Marten, LM; Clarkson, KE; Lee, LW; Gheorghiu, L; Zou, L; Powell, SN; Dahm-Daphi, J; Willers, H				Sirbu, Bianca M.; Lachmayer, Sarah J.; Wuelfing, Verena; Marten, Lara M.; Clarkson, Katie E.; Lee, Linda W.; Gheorghiu, Liliana; Zou, Lee; Powell, Simon N.; Dahm-Daphi, Jochen; Willers, Henning			ATR-p53 Restricts Homologous Recombination in Response to Replicative Stress but Does Not Limit DNA Interstrand Crosslink Repair in Lung Cancer Cells	PLOS ONE			English	Article							WILD-TYPE P53; STRAND BREAK REPAIR; TRANSACTIVATION DOMAIN; HOLLIDAY JUNCTIONS; BLM HELICASE; MUTANT P53; PROTEIN-A; CHECKPOINT; PHOSPHORYLATION; DAMAGE	Homologous recombination (HR) is required for the restart of collapsed DNA replication forks and error-free repair of DNA double-strand breaks (DSB). However, unscheduled or hyperactive HR may lead to genomic instability and promote cancer development. The cellular factors that restrict HR processes in mammalian cells are only beginning to be elucidated. The tumor suppressor p53 has been implicated in the suppression of HR though it has remained unclear why p53, as the guardian of the genome, would impair an error-free repair process. Here, we show for the first time that p53 downregulates foci formation of the RAD51 recombinase in response to replicative stress in H1299 lung cancer cells in a manner that is independent of its role as a transcription factor. We find that this downregulation of HR is not only completely dependent on the binding site of p53 with replication protein A but also the ATR/ATM serine 15 phosphorylation site. Genetic analysis suggests that ATR but not ATM kinase modulates p53's function in HR. The suppression of HR by p53 can be bypassed under experimental conditions that cause DSB either directly or indirectly, in line with p53's role as a guardian of the genome. As a result, transactivation-inactive p53 does not compromise the resistance of H1299 cells to the interstrand crosslinking agent mitomycin C. Altogether, our data support a model in which p53 plays an anti-recombinogenic role in the ATR-dependent mammalian replication checkpoint but does not impair a cell's ability to use HR for the removal of DSB induced by cytotoxic agents.	[Sirbu, Bianca M.; Lachmayer, Sarah J.; Wuelfing, Verena; Marten, Lara M.; Clarkson, Katie E.; Lee, Linda W.; Gheorghiu, Liliana; Willers, Henning] Massachusetts Gen Hosp, Ctr Canc, Lab Cellular & Mol Radiat Oncol, Charlestown, MA 02129 USA; [Lachmayer, Sarah J.; Wuelfing, Verena; Marten, Lara M.; Dahm-Daphi, Jochen] Univ Hamburg, Dept Radiat Oncol, Hamburg, Germany; [Zou, Lee] Massachusetts Gen Hosp, Ctr Canc, Ctr Canc Res, Charlestown, MA USA; [Powell, Simon N.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Zou, Lee; Dahm-Daphi, Jochen] Univ Marburg, Inst Radiobiol & Mol Radiat Oncol, Marburg, Germany; [Willers, Henning] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of Hamburg; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Philipps University Marburg; Harvard University; Harvard Medical School	Sirbu, BM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Lab Cellular & Mol Radiat Oncol, Charlestown, MA 02129 USA.	hwillers@partners.org			NCI [R01 CA58985, R01 GM076388]; NCI Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer [P50 CA090578]; Department of Defense [W81XWH-06-1-0309]; Massachusetts General Hospital [C06 CA059267]; Proton Therapy Research and Treatment Center; Deutsche Krebshilfe (German Cancer Aid) [10-1843-Da]; NATIONAL CANCER INSTITUTE [R01CA058985, P50CA090578, C06CA059267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Massachusetts General Hospital(General Electric); Proton Therapy Research and Treatment Center; Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI grants R01 CA58985 (SNP) and R01 GM076388 (LZ), the NCI Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer P50 CA090578 (HW, LZ), Department of Defense W81XWH-06-1-0309 (HW), Federal Share of program income earned by Massachusetts General Hospital on C06 CA059267, Proton Therapy Research and Treatment Center (HW), and Deutsche Krebshilfe (German Cancer Aid) 10-1843-Da (JDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Al Rashid ST, 2005, CANCER RES, V65, P10810, DOI 10.1158/0008-5472.CAN-05-0729; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boehden GS, 2003, ONCOGENE, V22, P4111, DOI 10.1038/sj.onc.1206632; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Bunz F, 2002, CANCER RES, V62, P1129; Dahm-Daphi J, 2000, STRAHLENTHER ONKOL, V176, P278, DOI 10.1007/s000660050010; Dahm-Daphi J, 2005, ONCOGENE, V24, P1663, DOI 10.1038/sj.onc.1208396; Dudenhoffer C, 1999, ONCOGENE, V18, P5773, DOI 10.1038/sj.onc.1202964; Dudenhoffer C, 1998, MOL CELL BIOL, V18, P5332, DOI 10.1128/MCB.18.9.5332; FAN SJ, 1995, CANCER RES, V55, P1649; Fan SJ, 1997, ONCOGENE, V14, P2127, DOI 10.1038/sj.onc.1201052; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Hawkins DS, 1996, CANCER RES, V56, P892; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Huang P, 1998, ONCOGENE, V17, P261, DOI 10.1038/sj.onc.1201946; Janz C, 2002, ONCOGENE, V21, P2130, DOI 10.1038/sj.onc.1205292; Janz C, 2002, ONCOGENE, V21, P5929, DOI 10.1038/sj.onc.1205757; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Linke SP, 2003, CANCER RES, V63, P2596; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Lowry DF, 2008, PROTEINS, V71, P587, DOI 10.1002/prot.21721; Luo CM, 1996, J BIOL CHEM, V271, P4497; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; MOSNER J, 1994, ONCOGENE, V9, P3321; OConnor PM, 1997, CANCER RES, V57, P4285; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Reliene R, 2007, ADV GENET, V58, P67, DOI 10.1016/S0065-2660(06)58003-4; Restle A, 2008, NUCLEIC ACIDS RES, V36, P5362, DOI 10.1093/nar/gkn503; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Saintigny Y, 1999, ONCOGENE, V18, P3553, DOI 10.1038/sj.onc.1202941; Saintigny Y, 2002, ONCOGENE, V21, P488, DOI 10.1038/sj.onc.1205040; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; SHAULSKY G, 1990, ONCOGENE, V5, P1707; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Subramanian D, 2005, BIOCHEMISTRY-US, V44, P2536, DOI 10.1021/bi048700u; Susse S, 2000, ONCOGENE, V19, P4500, DOI 10.1038/sj.onc.1203809; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Warnock LJ, 2008, ONCOGENE, V27, P1639, DOI 10.1038/sj.onc.1210787; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Willers H, 2000, INT J RADIAT BIOL, V76, P1055; Willers H, 2000, ONCOGENE, V19, P632, DOI 10.1038/sj.onc.1203142; Willers H, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/821529; Yang Q, 2002, J BIOL CHEM, V277, P31980, DOI 10.1074/jbc.M204111200; Yun S, 2004, NUCLEIC ACIDS RES, V32, P6479, DOI 10.1093/nar/gkh986; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhou JM, 2003, NUCLEIC ACIDS RES, V31, P3881, DOI 10.1093/nar/gkg468; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	68	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23053	10.1371/journal.pone.0023053	http://dx.doi.org/10.1371/journal.pone.0023053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857991	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500016
J	Tsuji, T; Matsuzaki, J; Ritter, E; Miliotto, A; Ritter, G; Odunsi, K; Old, LJ; Gnjatic, S				Tsuji, Takemasa; Matsuzaki, Junko; Ritter, Erika; Miliotto, Anthony; Ritter, Gerd; Odunsi, Kunle; Old, Lloyd J.; Gnjatic, Sacha			Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4(+) but Not CD8(+) T Cell Responses against p53 in Cancer Patients and Healthy Donors	PLOS ONE			English	Article							LONG PEPTIDE VACCINE; HUMAN COLON-CANCER; NY-ESO-1 PROTEIN; DENDRITIC CELLS; TUMOR-ANTIGEN; BREAST-CANCER; HUMAN CTL; IN-VITRO; IDENTIFICATION; LYMPHOCYTES	Analyses of NY-ESO-1-specific spontaneous immune responses in cancer patients revealed that antibody and both CD4(+) and CD8(+) T cell responses were induced together in cancer patients. To explore whether such integrated immune responses are also spontaneously induced for other tumor antigens, we have evaluated antibody and T cell responses against self/tumor antigen p53 in ovarian cancer patients and healthy individuals. We found that 21% (64/298) of ovarian cancer patients but no healthy donors showed specific IgG responses against wild-type p53 protein. While none of 12 patients with high titer p53 antibody showed spontaneous p53-specific CD8(+) T cell responses following a single in vitro sensitization, significant p53-specific IFN-gamma producing CD4(+) T cells were detected in 6 patients. Surprisingly, similar levels of p53-specific CD4(+) T cells but not CD8(+) T cells were also detected in 5/10 seronegative cancer patients and 9/12 healthy donors. Importantly, p53-specific CD4(+) T cells in healthy donors originated from a CD45RA(-) antigen-experienced T cell population and recognized naturally processed wild-type p53 protein. These results raise the possibility that p53-specific CD4(+) T cells reflect abnormalities in p53 occurring in normal individuals and that they may play a role in processes of immunosurveillance or immunoregulation of p53-related neoplastic events.	[Tsuji, Takemasa; Ritter, Erika; Ritter, Gerd; Old, Lloyd J.; Gnjatic, Sacha] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res Ltd, New York Branch, New York, NY 10021 USA; [Matsuzaki, Junko; Miliotto, Anthony; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA	Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute	Tsuji, T (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res Ltd, New York Branch, 1275 York Ave, New York, NY 10021 USA.	gnjatics@mskcc.org		Ritter, Erika/0000-0002-5161-7874; Matsuzaki, Junko/0000-0002-2555-1234; Tsuji, Takemasa/0000-0001-7563-2211; Gnjatic, Sacha/0000-0001-5643-9520	Cancer Research Institute Ovarian Cancer Working Group; Cancer Research Institute; Ludwig Institute for Cancer Research Ltd.	Cancer Research Institute Ovarian Cancer Working Group; Cancer Research Institute; Ludwig Institute for Cancer Research Ltd.	This work was supported in part by Cancer Research Institute Ovarian Cancer Working Group Grant and the Cancer Vaccine Collaborative funded by Cancer Research Institute and Ludwig Institute for Cancer Research Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AE, 2009, HEAD NECK-J SCI SPEC, V31, P773, DOI 10.1002/hed.21031; Amyes E, 2005, J IMMUNOL, V175, P5765, DOI 10.4049/jimmunol.175.9.5765; Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Barfoed AM, 2000, SCAND J IMMUNOL, V51, P128; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Decraene D, 2001, J PHOTOCH PHOTOBIO B, V63, P78, DOI 10.1016/S1011-1344(01)00204-4; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Enelow RI, 1996, J CLIN INVEST, V98, P914, DOI 10.1172/JCI118874; Eura M, 2000, CLIN CANCER RES, V6, P979; Ferries E, 2001, HUM IMMUNOL, V62, P791, DOI 10.1016/S0198-8859(01)00266-X; GNJATIC S, 1995, EUR J IMMUNOL, V25, P1638, DOI 10.1002/eji.1830250625; Gnjatic S, 2003, P NATL ACAD SCI USA, V100, P8862, DOI 10.1073/pnas.1133324100; Gnjatic S, 1998, J IMMUNOL, V160, P328; Gnjatic S, 2010, INT J CANCER, V127, P381, DOI 10.1002/ijc.25058; Gnjatic Sacha, 2009, V520, P11, DOI 10.1007/978-1-60327-811-9_2; Hasegawa K, 2006, CLIN CANCER RES, V12, P1921, DOI 10.1158/1078-0432.CCR-05-1900; Hernandez J, 2001, J IMMUNOL, V166, P3908, DOI 10.4049/jimmunol.166.6.3908; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kuball J, 2002, GENE THER, V9, P833, DOI 10.1038/sj.gt.3301709; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lauwen MM, 2008, CANCER RES, V68, P893, DOI 10.1158/0008-5472.CAN-07-3166; Leffers N, 2008, GYNECOL ONCOL, V110, P365, DOI 10.1016/j.ygyno.2008.04.043; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Li YL, 2005, INT J CANCER, V114, P157, DOI 10.1002/ijc.20715; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Nijman HW, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-34; Nishikawa H, 2005, BLOOD, V106, P1008, DOI 10.1182/blood-2005-02-0607; Nishikawa H, 2006, J IMMUNOL, V176, P6340, DOI 10.4049/jimmunol.176.10.6340; NOGUCHI Y, 1994, P NATL ACAD SCI USA, V91, P3171, DOI 10.1073/pnas.91.8.3171; NOGUCHI Y, 1995, P NATL ACAD SCI USA, V92, P2219, DOI 10.1073/pnas.92.6.2219; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Offringa R, 2000, ANN NY ACAD SCI, V910, P223; Ohkuri T, 2007, CANCER SCI, V98, P1092, DOI 10.1111/j.1349-7006.2007.00501.x; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Piura B, 2009, J ONCOL, V2009, DOI 10.1155/2009/581939; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Ropke M, 1996, P NATL ACAD SCI USA, V93, P14704, DOI 10.1073/pnas.93.25.14704; Scanlan M J, 2001, Cancer Immun, V1, P4; Scanlan MJ, 2002, CANCER RES, V62, P4041; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Sorensen RB, 2009, CLIN CANCER RES, V15, P1543, DOI 10.1158/1078-0432.CCR-08-1412; Soussi T, 2006, CLIN CANCER RES, V12, P62, DOI 10.1158/1078-0432.CCR-05-0413; Soussi T, 2000, CANCER RES, V60, P1777; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Svane IM, 2007, CANCER IMMUNOL IMMUN, V56, P1485, DOI 10.1007/s00262-007-0293-4; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Theoret MR, 2008, HUM GENE THER, V19, P1219, DOI [10.1089/hum.2008.083, 10.1089/hgt.2008.083]; Tominaga O, 2001, BRIT J CANCER, V84, P57, DOI 10.1054/bjoc.2000.1542; Tsuji T, 2009, J IMMUNOL, V183, P4800, DOI 10.4049/jimmunol.0900903; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; van der Burg SH, 2001, EUR J IMMUNOL, V31, P146, DOI 10.1002/1521-4141(200101)31:1<146::AID-IMMU146>3.0.CO;2-T; Wurtzen PA, 2002, INT J CANCER, V99, P568, DOI 10.1002/ijc.10375; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	60	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23651	10.1371/journal.pone.0023651	http://dx.doi.org/10.1371/journal.pone.0023651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858191	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500060
J	Campanharo, ASLO; Sirer, MI; Malmgren, RD; Ramos, FM; Amaral, LAN				Campanharo, Andriana S. L. O.; Sirer, M. Irmak; Malmgren, R. Dean; Ramos, Fernando M.; Amaral, Luis A. Nunes			Duality between Time Series and Networks	PLOS ONE			English	Article							COMPLEX NETWORKS	Studying the interaction between a system's components and the temporal evolution of the system are two common ways to uncover and characterize its internal workings. Recently, several maps from a time series to a network have been proposed with the intent of using network metrics to characterize time series. Although these maps demonstrate that different time series result in networks with distinct topological properties, it remains unclear how these topological properties relate to the original time series. Here, we propose a map from a time series to a network with an approximate inverse operation, making it possible to use network statistics to characterize time series and time series statistics to characterize networks. As a proof of concept, we generate an ensemble of time series ranging from periodic to random and confirm that application of the proposed map retains much of the information encoded in the original time series (or networks) after application of the map (or its inverse). Our results suggest that network analysis can be used to distinguish different dynamic regimes in time series and, perhaps more importantly, time series analysis can provide a powerful set of tools that augment the traditional network analysis toolkit to quantify networks in new and useful ways.	[Campanharo, Andriana S. L. O.] Inst Nacl Pesquisas Espaciais, Lab Comp & Appl Math, Sao Paulo, Brazil; [Campanharo, Andriana S. L. O.; Sirer, M. Irmak; Malmgren, R. Dean; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Campanharo, Andriana S. L. O.] Pontificia Univ Catolica Minas Gerais, Dept Comp Engn, Belo Horizonte, MG, Brazil; [Malmgren, R. Dean] Datascope Analyt, Chicago, IL USA; [Ramos, Fernando M.] Inst Nacl Pesquisas Espaciais, Ctr Earth Syst Sci, Sao Paulo, Brazil; [Amaral, Luis A. Nunes] Northwestern Univ, NW Inst Complex Syst, Evanston, IL USA; [Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA	Instituto Nacional de Pesquisas Espaciais (INPE); Northwestern University; Pontificia Universidade Catolica de Minas Gerais; Instituto Nacional de Pesquisas Espaciais (INPE); Northwestern University; Howard Hughes Medical Institute; Northwestern University	Campanharo, ASLO (corresponding author), Inst Nacl Pesquisas Espaciais, Lab Comp & Appl Math, Sao Paulo, Brazil.	amaral@northwestern.edu	Sirer, Mehmet Irmak/E-1072-2013; Campanharo, Andriana S L O/J-4600-2013; Amaral, LAN/A-4980-2008; Amaral, Luis N./C-5485-2009	Sirer, Mehmet Irmak/0000-0002-0300-5582; Campanharo, Andriana S L O/0000-0002-0501-5303; Amaral, LAN/0000-0002-3762-789X; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); National Science Foundation (NSF) [SBE 0624318]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil - doctoral fellowship), and National Science Foundation (NSF) award SBE 0624318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aguchi Y., 2009, ICANN 09; [Anonymous], 2011, PHYS RES RES COMPL P, V23; Ao Sio-Long, 2010, APPL TIME SERIES ANA; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Donner RV, 2010, INT J BIFUR IN PRESS; Eckmann J. P., 1987, EUROPHYSICS LETT, V4; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Gao ZK, 2009, CHAOS, V19, DOI 10.1063/1.3227736; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Kantz H., 2003, NONLINEAR TIME SERIE; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Korner T.W., 1988, FOURIER ANAL; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lai C, 2010, EXPERT SYSTEMS APPL, V37; Li P, 2007, PHYSICA A, V378, P519, DOI 10.1016/j.physa.2006.10.089; Lind D., 1995, INTRO SYMBOLIC DYNAM, DOI 10.1017/CBO9780511626302; Lorenz E.N, 1963, J ATMOSPHERIC SCI, V20; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Marwan N., 2009, PHYS LETT A, V46; NetGeo, NETGEO INTERNET GEOG; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicolis G., 2005, INT J BIFURCATION CH, V15; Ramos FM, 2008, PHIL T R SOC A, V366; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Shirazi AH, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07046; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Verplancke T, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-4; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu X., 2008, P NATL ACAD SCI US, V105; Yang Y, 2008, PHYSICA A, V387, P1381, DOI 10.1016/j.physa.2007.10.055; Zaldivar J. M., 2009, JRC SCI TECHNICAL RE; Zhang JJ, 2006, Progress on Post-Genome Technologies, P73; Zhang JY, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.093201	39	134	136	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23378	10.1371/journal.pone.0023378	http://dx.doi.org/10.1371/journal.pone.0023378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21858093	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953400041
J	Sacilotto, N; Espert, A; Castillo, J; Franco, L; Lopez-Rodas, G				Sacilotto, Natalia; Espert, Antonio; Castillo, Josefa; Franco, Luis; Lopez-Rodas, Gerardo			Epigenetic Transcriptional Regulation of the Growth Arrest-Specific gene 1 (Gas1) in Hepatic Cell Proliferation at Mononucleosomal Resolution	PLOS ONE			English	Article							ARREST-SPECIFIC GENE; C-MYC PROMOTER; GROWTH ARREST; LIVER-REGENERATION; CHROMATIN MODIFICATIONS; NUCLEOSOME ORGANIZATION; HISTONE MODIFICATIONS; MAMMALIAN CHROMATIN; HUMAN GENOME; MECHANISMS	Background: Gas1 (growth arrest-specific 1) gene is known to inhibit cell proliferation in a variety of models, but its possible implication in regulating quiescence in adult tissues has not been examined to date. The knowledge of how Gas1 is regulated in quiescence may contribute to understand the deregulation occurring in neoplastic diseases. Methodology/Principal Findings: Gas1 expression has been studied in quiescent murine liver and during the naturally synchronized cell proliferation after partial hepatectomy. Chromatin immunoprecipitation at nucleosomal resolution (Nuc-ChIP) has been used to carry out the study preserving the in vivo conditions. Transcription has been assessed at real time by quantifying the presence of RNA polymerase II in coding regions (RNApol-ChIP). It has been found that Gas1 is expressed not only in quiescent liver but also at the cell cycle G(1)/S transition. The latter expression peak had not been previously reported. Two nucleosomes, flanking a nucleosome-free region, are positioned close to the transcription start site. Both nucleosomes slide in going from the active to the inactive state and vice versa. Nuc-ChIP analysis of the acquisition of histone epigenetic marks show distinctive features in both active states: H3K9ac and H3K4me2 are characteristic of transcription in G(0) and H4R3me2 in G(1)/S transition. Sequential-ChIP analysis revealed that the "repressing" mark H3K9me2 colocalize with several "activating" marks at nucleosome N-1 when Gas1 is actively transcribed suggesting a greater plasticity of epigenetic marks than proposed until now. The recruitment of chromatin-remodeling or modifying complexes also displayed distinct characteristics in quiescence and the G(1)/S transition. Conclusions/Significance: The finding that Gas1 is transcribed at the G(1)/S transition suggests that the gene may exert a novel function during cell proliferation. Transcription of this gene is modulated by specific "activating" and "repressing" epigenetic marks, and by chromatin remodeling and histone modifying complexes recruitment, at specific nucleosomes in Gas1 promoter.	[Sacilotto, Natalia; Espert, Antonio; Castillo, Josefa; Franco, Luis; Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem & Mol Biol, Chromatin Lab, Valencia, Spain	University of Valencia	Sacilotto, N (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Chromatin Lab, Valencia, Spain.	gerardo.lopez@uv.es	; LOPEZ-RODAS, GERARDO/I-1349-2015	Espert, Antonio/0000-0002-7434-9622; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X; Castillo Aliaga, Josefa/0000-0002-4092-0085; Franco, Luis/0000-0001-9610-6448	Ministerio de Ciencia y Tecnologia [BFU2007-63120, CSD2006-49]; Conselleria d'Educacio [ACOM2010/133]; Conselleria d'Educacio, Generalitat Valenciana	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria d'Educacio; Conselleria d'Educacio, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	Grant support is provided by Ministerio de Ciencia y Tecnologia [BFU2007-63120, and Consolider-Ingenio CSD2006-49] and by Conselleria d'Educacio [ACOM2010/133] to G. Lopez-Rodas. N. Sacilotto was recipient of a fellow grant of Formacion de Personal Investigador Predoctoral from Conselleria d'Educacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez JA, 2007, CANCER GENE THER, V14, P836, DOI 10.1038/sj.cgt.7701076; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; DELSAL G, 1994, P NATL ACAD SCI USA, V91, P1848, DOI 10.1073/pnas.91.5.1848; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; DEMARTIN R, 1993, J BIOL CHEM, V268, P22788; Dominguez-Monzon G, 2009, INT J DEV NEUROSCI, V27, P305, DOI 10.1016/j.ijdevneu.2009.03.009; Evdokiou A, 1998, EXP CELL RES, V240, P359, DOI 10.1006/excr.1998.4011; Evdokiou A, 1998, INT J CANCER, V75, P568, DOI 10.1002/(SICI)1097-0215(19980209)75:4<568::AID-IJC13>3.0.CO;2-5; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Grossi M, 1998, ONCOGENE, V17, P1629, DOI 10.1038/sj.onc.1202090; Higgins GM, 1931, ARCH PATHOL, V12, P186; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; KURINNA S, 2010, INT J BIOCH CEL 0320; Lee KKH, 2001, DEV BIOL, V234, P188, DOI 10.1006/dbio.2001.0249; Lee TC, 1997, P NATL ACAD SCI USA, V94, P12886, DOI 10.1073/pnas.94.24.12886; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mellstrom B, 2002, MOL CELL NEUROSCI, V19, P417, DOI 10.1006/mcne.2001.1092; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; NIMURA K, 2010, J MOL MED       0817; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Rizzi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003617; Rodriguez JL, 2007, INT J BIOCHEM CELL B, V39, P842, DOI 10.1016/j.biocel.2007.01.009; Rodriguez JL, 2006, BIOCHEM J, V398, P431, DOI 10.1042/BJ20060380; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sandoval J, 2010, CELL MOL LIFE SCI, V67, P1687, DOI 10.1007/s00018-010-0272-3; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Zamorano A, 2004, NEUROBIOL DIS, V15, P483, DOI 10.1016/j.nbd.2003.11.022; Zamorano A, 2003, J NEUROSCI RES, V71, P256, DOI 10.1002/jnr.10461; Zhao L, 2009, J BIOL CHEM, V284, P26273, DOI 10.1074/jbc.M109.028068	58	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23318	10.1371/journal.pone.0023318	http://dx.doi.org/10.1371/journal.pone.0023318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858068	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300031
J	Daegling, DJ; McGraw, WS; Ungar, PS; Pampush, JD; Vick, AE; Bitty, EA				Daegling, David J.; McGraw, W. Scott; Ungar, Peter S.; Pampush, James D.; Vick, Anna E.; Bitty, E. Anderson			Hard-Object Feeding in Sooty Mangabeys (Cercocebus atys) and Interpretation of Early Hominin Feeding Ecology	PLOS ONE			English	Article							MICROWEAR TEXTURE ANALYSIS; MOLAR ENAMEL THICKNESS; DENTAL MICROWEAR; CRANIAL MORPHOLOGY; DIPHYLETIC ORIGIN; FALLBACK FOODS; TOOTH USE; DIET; AUSTRALOPITHECUS; EVOLUTION	Morphology of the dentofacial complex of early hominins has figured prominently in the inference of their dietary adaptations. Recent theoretical analysis of craniofacial morphology of Australopithecus africanus proposes that skull form in this taxon represents adaptation to feeding on large, hard objects. A modern analog for this specific dietary specialization is provided by the West African sooty mangabey, Cercocebus atys. This species habitually feeds on the large, exceptionally hard nuts of Sacoglottis gabonensis, stereotypically crushing the seed casings using their premolars and molars. This type of behavior has been inferred for A. africanus based on mathematical stress analysis and aspects of dental wear and morphology. While postcanine megadontia, premolar enlargement and thick molar enamel characterize both A. africanus and C. atys, these features are not universally associated with durophagy among living anthropoids. Occlusal microwear analysis reveals complex microwear textures in C. atys unlike those observed in A. africanus, but more closely resembling textures observed in Paranthropus robustus. Since sooty mangabeys process hard objects in a manner similar to that proposed for A. africanus, yet do so without the craniofacial buttressing characteristic of this hominin, it follows that derived features of the australopith skull are sufficient but not necessary for the consumption of large, hard objects. The adaptive significance of australopith craniofacial morphology may instead be related to the toughness, rather than the hardness, of ingested foods.	[Daegling, David J.; Pampush, James D.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [McGraw, W. Scott] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Vick, Anna E.] Santa Fe Coll, Dept Social & Behav Sci, Gainesville, FL USA; [Bitty, E. Anderson] Univ Abidjan Cocody, Lab Zool, Abidjan, Cote Ivoire	State University System of Florida; University of Florida; University System of Ohio; Ohio State University; University of Arkansas System; University of Arkansas Fayetteville	Daegling, DJ (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	daegling@ufl.edu			NSF BCS [0840110, 0921770, 0922429, 0315157]	NSF BCS(National Science Foundation (NSF))	Supported by NSF BCS 0840110, 0921770, 0922429, 0315157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; Caldecott J. O., 1996, P73; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; Cooke C, 2010, AM J PRIMATOL, V72, P38; DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302; DAEGLING DJ, 1992, INT J PRIMATOL, V13, P545, DOI 10.1007/BF02547832; Daegling DJ, 1999, PRIMATES, V40, P559, DOI 10.1007/BF02574831; DECHOW PC, 1990, AM J PHYS ANTHROPOL, V83, P219, DOI 10.1002/ajpa.1330830211; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; DEMES B, 1988, J HUM EVOL, V17, P657, DOI 10.1016/0047-2484(88)90023-1; DUBRUL EL, 1977, AM J PHYS ANTHROPOL, V47, P305, DOI 10.1002/ajpa.1330470211; DUMONT ER, 1995, J MAMMAL, V76, P1127, DOI 10.2307/1382604; Fleagle JG, 1999, P NATL ACAD SCI USA, V96, P1157, DOI 10.1073/pnas.96.3.1157; FORD S M, 1980, Primates, V21, P31, DOI 10.1007/BF02383822; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Gilbert CC, 2007, J HUM EVOL, V53, P69, DOI 10.1016/j.jhevol.2007.03.004; Grine F.E., 1988, P3; GRINE FE, 1981, S AFR J SCI, V77, P203; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Grine FE, 2010, J HUM EVOL, V58, P293, DOI 10.1016/j.jhevol.2009.12.001; HAPPEL R, 1988, AM J PHYS ANTHROPOL, V75, P303, DOI 10.1002/ajpa.1330750303; HOSHINO J, 1985, Primates, V26, P248, DOI 10.1007/BF02382401; Hylander W.L., 1988, P55; Hylander WL, 2006, AM J PHYS ANTHROPOL, P107; HYLANDER WL, 1979, J MORPHOL, V160, P223, DOI 10.1002/jmor.1051600208; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; KAY RF, 1985, ANNU REV ANTHROPOL, V14, P315, DOI 10.1146/annurev.an.14.100185.001531; KAY RF, 1977, J HUM EVOL, V6, P19, DOI 10.1016/S0047-2484(77)80040-7; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; LUCAS PW, 1985, J HUM EVOL, V14, P187, DOI 10.1016/S0047-2484(85)80006-3; LUCAS PW, 1994, AM J PHYS ANTHROPOL, V94, P365, DOI 10.1002/ajpa.1330940306; Martin LB, 2003, J HUM EVOL, V45, P351, DOI 10.1016/j.jhevol.2003.08.005; McGraw WS, 2011, AM J PHYS ANTHROPOL, V144, P140, DOI 10.1002/ajpa.21402; MCHENRY HM, 1984, AM J PHYS ANTHROPOL, V64, P297, DOI 10.1002/ajpa.1330640312; MOLNAR S, 1977, AM J PHYS ANTHROPOL, V46, P447, DOI 10.1002/ajpa.1330460310; Norconk Marilyn A., 2009, P279, DOI 10.1007/978-0-387-78705-3_11; OBrien TG, 1997, INT J PRIMATOL, V18, P321, DOI 10.1023/A:1026330332061; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; PETERS CR, 1987, AM J PHYS ANTHROPOL, V73, P333, DOI 10.1002/ajpa.1330730306; Prinz JF, 2001, J ORAL REHABIL, V28, P614, DOI 10.1046/j.1365-2842.2001.00732.x; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Ravosa MJ, 1996, INT J PRIMATOL, V17, P909, DOI 10.1007/BF02735294; RAVOSA MJ, 1990, AM J PHYS ANTHROPOL, V82, P199, DOI 10.1002/ajpa.1330820209; Rosenberger A.L., 1984, PRIMATOLOGIA BRASIL, P159, DOI DOI 10.1002/AR.A.20248; Rubin C. T., 1991, CRANIOFACIAL GROWTH, P75; RUBIN CT, 1990, J BIOMECH, V23, P43, DOI 10.1016/0021-9290(90)90040-A; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Shellis RP, 1998, J HUM EVOL, V35, P507, DOI 10.1006/jhev.1998.0238; Singleton M, 2004, J ANTHROPOL SCI, V82, P27; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Spencer MA, 1999, AM J PHYS ANTHROPOL, V108, P483, DOI 10.1002/(SICI)1096-8644(199904)108:4<483::AID-AJPA7>3.0.CO;2-L; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; STRUHSAKER TT, 1977, BIOTROPICA, V9, P124, DOI 10.2307/2387666; SUSSMAN RW, 1984, AM J PHYS ANTHROPOL, V64, P419, DOI 10.1002/ajpa.1330640407; Swindler D.R., 2002, PRIMATE DENTITION; Szalay F.S., 1979, EVOLUTIONARY HIST PR; SZALAY FS, 1975, MAN, V10, P420, DOI 10.2307/2799811; Taylor AB, 2006, J HUM EVOL, V50, P377, DOI 10.1016/j.jhevol.2005.10.006; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; WHITE TD, 1981, S AFR J SCI, V77, P445; Wieczkowski J, 2009, AM J PHYS ANTHROPOL, V140, P572, DOI 10.1002/ajpa.21132; Williams SH, 2005, AM J PRIMATOL, V67, P329, DOI 10.1002/ajp.20189; Wrangham R, 2009, AM J PHYS ANTHROPOL, V140, P630, DOI 10.1002/ajpa.21122; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006; Yamashita N, 2003, AM J PHYS ANTHROPOL, V121, P125, DOI 10.1002/ajpa.10206; Yamashita N, 1996, INT J PRIMATOL, V17, P355, DOI 10.1007/BF02736627	81	91	93	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23095	10.1371/journal.pone.0023095	http://dx.doi.org/10.1371/journal.pone.0023095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887229	Green Submitted, gold, Green Published			2022-12-27	WOS:000294298800004
J	de Voer, RM; van der Klis, FRM; Schepp, RM; Rijkers, GT; Sanders, EAM; Berbers, GAM				de Voer, Richarda M.; van der Klis, Fiona R. M.; Schepp, Rutger M.; Rijkers, Ger T.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.			Age-Related Immunity to Meningococcal Serogroup C Vaccination: An Increase in the Persistence of IgG2 Correlates with a Decrease in the Avidity of IgG	PLOS ONE			English	Article							MEMORY B-CELLS; CONJUGATE VACCINE; IMMUNOLOGICAL MEMORY; SUBCLASS RESPONSE; UNITED-KINGDOM; ANTIGEN-DRIVEN; IMMUNIZATION; ANTIBODIES; POLYSACCHARIDE; SEROPREVALENCE	Background: All children and adolescents between 1 and 19 years of age in The Netherlands received a single meningococcal serogroup C conjugate (MenCC) vaccine in 2002. During follow-up 4-5 years later, the persistence of MenC polysaccharide-specific IgG was found to be dependent on age of vaccination with higher IgG levels in the oldest immunized age categories. Methods and Findings: Two cross-sectional population-based serum banks, collected in 1995/1996 and in 2006/2007, were used for this study. We measured MenC polysaccharide-specific IgM, the IgG1 and IgG2 subclasses and determined the avidity of the IgG antibodies. We report that the age-related persistence of IgG after immunization with the MenCC vaccine seemed to result from an increase of IgG2 levels with age, while IgG1 levels remained stable throughout the different age-cohorts. Furthermore, an age-related increase in IgM levels was observed, correlating with the persistence of IgG antibodies with age. It is noteworthy that the increase in IgG2 correlated with a reduced IgG-avidity with age. Conclusion: These date indicate that the classical characteristics of a T-cell-dependent antibody response as elicited by protein based vaccines might not be completely applicable when conjugate vaccines are administered to older children and adolescents up to 18 years of age. The response elicited by the MenCC vaccine seemed to be more a mixture of both T cell dependent and T cell independent responses in terms of humoral immunological characteristics.	[de Voer, Richarda M.; van der Klis, Fiona R. M.; Schepp, Rutger M.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands; [de Voer, Richarda M.] Univ Med Ctr, Dept Immunol, Utrecht, Netherlands; [Rijkers, Ger T.] St Antonius Hosp, Lab Med Microbiol & Immunol, Nieuwegein, Netherlands; [Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	de Voer, RM (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands.	Guy.Berbers@rivm.nl	Rijkers, Ger/R-7236-2019; de Voer, Richarda M/GSD-6097-2022; de Voer, Richarda/P-5728-2015; Rijkers, Ger/AAW-6143-2020; de Voer, Richarda M/ABD-1525-2021	Rijkers, Ger/0000-0001-6948-6123; de Voer, Richarda M/0000-0002-8222-0343; 	Ministry of Health, Welfare and Sport, The Hague, The Netherlands; Wyeth; Baxter; GlaxoSmithKline	Ministry of Health, Welfare and Sport, The Hague, The Netherlands; Wyeth(Wyeth); Baxter; GlaxoSmithKline(GlaxoSmithKline)	This study was supported by the Ministry of Health, Welfare and Sport, The Hague, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Sanders reports receiving unrestricted grants from Wyeth and Baxter for research, consulting fees from Wyeth and GlaxoSmithKline, lecturing fees from Wyeth and grant support from Wyeth and GlaxoSmithKline for vaccine studies. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have no conflicts to declare.	Ada G, 2003, CLIN MICROBIOL INFEC, V9, P79, DOI 10.1046/j.1469-0691.2003.00530.x; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; CAPPEL R, 1981, J MED VIROL, V8, P201, DOI 10.1002/jmv.1890080307; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Voer RM, 2008, CLIN VACCINE IMMUNOL, V15, P1188, DOI 10.1128/CVI.00478-07; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; de Voer RM, 2009, VACCINE, V27, P6974, DOI 10.1016/j.vaccine.2009.09.082; Findlow H, 2006, CLIN VACCINE IMMUNOL, V13, P507, DOI 10.1128/CVI.13.4.507-510.2006; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Goldblatt D, 2002, J INFECT DIS, V185, P397, DOI 10.1086/338474; GRANOFF DM, 1988, PEDIATR RES, V24, P180, DOI 10.1203/00006450-198808000-00008; Kamboj KK, 2001, J INFECT DIS, V184, P931, DOI 10.1086/323342; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Laher G, 2006, FEMS IMMUNOL MED MIC, V48, P34, DOI 10.1111/j.1574-695X.2006.00121.x; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Neppelenbroek SE, 2002, GOED GEDAAN WOORDVER; Neves AR, 2003, CLIN DIAGN LAB IMMUN, V10, P802, DOI 10.1128/CDLI.10.5.802-807.2003; Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; ROBBINS JB, 1972, INFECT IMMUN, V6, P651, DOI 10.1128/IAI.6.5.651-656.1972; Sakou II, 2009, VACCINE, V27, P4408, DOI 10.1016/j.vaccine.2009.05.047; Snape MD, 2008, BRIT MED J, V336, P1487, DOI 10.1136/bmj.39563.545255.AE; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Sterla S, 1999, PARASITE IMMUNOL, V21, P27, DOI 10.1046/j.1365-3024.1999.00197.x; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; TEW JG, 1980, IMMUNOL REV, V53, P175; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; van der Klis FRM, 2009, NETH J MED, V67, P301; VANN WF, 1976, INFECT IMMUN, V13, P1654, DOI 10.1128/IAI.13.6.1654-1662.1976; Vinuesa CG, 2003, EUR J IMMUNOL, V33, P297, DOI 10.1002/immu.200310003; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Wuorimaa T, 2001, J INFECT DIS, V184, P1211, DOI 10.1086/323648	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23497	10.1371/journal.pone.0023497	http://dx.doi.org/10.1371/journal.pone.0023497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887261	Green Published, gold, Green Submitted			2022-12-27	WOS:000295832000023
J	Kang, S; Tang, JJ; Schaeffer, SW; Bader, DA				Kang, Seunghwa; Tang, Jijun; Schaeffer, Stephen W.; Bader, David A.			Rec-DCM-Eigen: Reconstructing a Less Parsimonious but More Accurate Tree in Shorter Time	PLOS ONE			English	Article							GENOME REARRANGEMENT; EVOLUTION; PERFORMANCE; REVERSALS; ALGORITHM	Maximum parsimony (MP) methods aim to reconstruct the phylogeny of extant species by finding the most parsimonious evolutionary scenario using the species' genome data. MP methods are considered to be accurate, but they are also computationally expensive especially for a large number of species. Several disk-covering methods (DCMs), which decompose the input species to multiple overlapping subgroups (or disks), have been proposed to solve the problem in a divide-and-conquer way. We design a new DCM based on the spectral method and also develop the COGNAC (Comparing Orders of Genes using Novel Algorithms and high-performance Computers) software package. COGNAC uses the new DCM to reduce the phylogenetic tree search space and selects an output tree from the reduced search space based on the MP principle. We test the new DCM using gene order data and inversion distance. The new DCM not only reduces the number of candidate tree topologies but also excludes erroneous tree topologies which can be selected by original MP methods. Initial labeling of internal genomes affects the accuracy of MP methods using gene order data, and the new DCM enables more accurate initial labeling as well. COGNAC demonstrates superior accuracy as a consequence. We compare COGNAC with FastME and the combination of the state of the art DCM (Rec-I-DCM3) and GRAPPA. COGNAC clearly outperforms FastME in accuracy. COGNAC -using the new DCM- also reconstructs a much more accurate tree in significantly shorter time than GRAPPA with Rec-I-DCM3.	[Kang, Seunghwa] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Schaeffer, Stephen W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Bader, David A.] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; Georgia Institute of Technology	Kang, S (corresponding author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	bader@cc.gatech.edu	Bader, David/AAI-4029-2021; Tang, Jijun/ABH-6528-2020; Schaeffer, Stephen/AAA-2303-2021	Bader, David/0000-0002-7380-5876; Schaeffer, Stephen/0000-0003-2070-5342	National Science Foundation (NSF) [NSF OCI-0904461, OCI-0904179, OCI-0904166]; Direct For Computer & Info Scie & Enginr [0904179] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [0904461] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation (NSF) PetaApps project (grant numbers: NSF OCI-0904461, OCI-0904179 and OCI-0904166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt W, 2007, LECT N BIOINFORMAT, V4751, P30; Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Bader DA, 2001, J COMPUT BIOL, V8, P483, DOI 10.1089/106652701753216503; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bernt M, 2006, IEEE ACM T COMPUT BI, V3, P275, DOI 10.1109/TCBB.2006.38; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Blanchette M, 1996, GENE, V172, pGC11, DOI 10.1016/0378-1119(95)00878-0; Bourque G, 2002, GENOME RES, V12, P26; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Fertin G, 2009, COMBINATORICS GENOME; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; HARTIGAN JA, 1973, BIOMETRICS, V29, P53, DOI 10.2307/2529676; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Huson DH, 1999, J COMPUT BIOL, V6, P369, DOI 10.1089/106652799318337; Huson DH, 1999, P INT C INT SYST MOL; Li GL, 2007, LECT N BIOINFORMAT, V4751, P110; Lin Y, 2010, P RECOMB SAT WORKSH; Lin Y, 2008, BIOINFORMATICS, V24, pI114, DOI 10.1093/bioinformatics/btn148; Mohar B., 1991, GRAPH THEORY COMBINA, P12; Moret BME, 2002, LECT NOTES COMPUT SC, V2452, P521; Moret BME, 2002, J COMPUT SYST SCI, V65, P508, DOI 10.1016/S0022-0000(02)00007-7; Moret BME, 2002, J SUPERCOMPUT, V22, P99, DOI 10.1023/A:1014362705613; Moret BME, 2001, P PAC S BIOC PSB BIG; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pattengale ND, 2010, LECT N BIOINFORMAT, V6053, P128, DOI 10.1007/978-3-642-13078-6_16; POTHEN A, 1990, SIAM J MATRIX ANAL A, V11, P430, DOI 10.1137/0611030; Roshan UW, 2004, P COMP SYST BIOINF C; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson M, R8S SOFTWARE PACKAGE; Sankoff D, 2002, CURRENT TOPICS COMPU, P135; Stewart CA, 2010, CYBERINFRASTRUCTURE; Swenson KM, 2009, BMC BIOINFORMATICS; Tang JJ, 2003, BIOINFORMATICS, V19, pi305, DOI 10.1093/bioinformatics/btg1042; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Xu AW, 2009, J COMPUT BIOL, V16, P1369, DOI 10.1089/cmb.2009.0087	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22483	10.1371/journal.pone.0022483	http://dx.doi.org/10.1371/journal.pone.0022483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887219	Green Published, gold, Green Submitted			2022-12-27	WOS:000295832000002
J	Wu, HY; Quintana, FJ; da Cunha, AP; Dake, BT; Koeglsperger, T; Starossom, SC; Weiner, HL				Wu, Henry Yim; Quintana, Francisco J.; da Cunha, Andre Pires; Dake, Benjamin T.; Koeglsperger, Thomas; Starossom, Sarah C.; Weiner, Howard L.			In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling	PLOS ONE			English	Article							REGULATORY T-CELLS; RETINOIC-ACID; C-MAF; LAMINA PROPRIA; INTERLEUKIN-10; RECEPTOR; IL-10; DIFFERENTIATION; GENERATION; FOXP3(+)	Background: Type 1 regulatory T (Tr1) cells, characterized by the secretion of high levels of the anti-inflammatory cytokine interleukin-10 (IL-10), play an important role in the regulation of autoimmune diseases and transplantation. However, effective strategies that specifically induce Tr1 cells in vivo are limited. Furthermore, the pathways controlling the induction of these cells in vivo are not well understood. Methodology/Principal Findings: Here we report that nasal administration of anti-CD3 antibody induces suppressive Tr1 cells in mice. The in vivo induction of Tr1 cells by nasal anti-CD3 is dependent on IL-27 produced by upper airway resident dendritic cells (DCs), and is controlled by the transcription factors aryl hydrocarbon receptor (AHR) and c-Maf. Subsequently, IL-21 acts in an autocrine fashion to expand and maintain the Tr1 cells induced in vivo by nasally administered anti-CD3. Conclusions/Significance: Our findings identify a unique approach to generate Tr1 cells in vivo and provide insights into the mechanisms by which these cells are induced.	[Wu, Henry Yim; Quintana, Francisco J.; da Cunha, Andre Pires; Dake, Benjamin T.; Koeglsperger, Thomas; Starossom, Sarah C.; Weiner, Howard L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wu, HY (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020	Starossom, Sarah/0000-0001-7935-9910	NIH [R01 AI43458, R00 AI75285-02]; Susan Furbacher Conroy Fellowship; National Multiple Sclerosis Society [RG4111A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043458, R56AI093903, R00AI075285] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Furbacher Conroy Fellowship; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH (R01 AI43458 to HLW), Susan Furbacher Conroy Fellowship to HYW, and R00 AI75285-02 from the National Institutes of Health and RG4111A1 from the National Multiple Sclerosis Society to FJQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; OKEY AB, 1989, MOL PHARMACOL, V35, P823; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123	31	76	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23618	10.1371/journal.pone.0023618	http://dx.doi.org/10.1371/journal.pone.0023618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886804	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500020
J	Kozina, V; Cappallo-Obermann, H; Gromoll, J; Spiess, AN				Kozina, Viviana; Cappallo-Obermann, Heike; Gromoll, Joerg; Spiess, Andrej-Nikolai			A One-Step Real-Time Multiplex PCR for Screening Y-Chromosomal Microdeletions without Downstream Amplicon Size Analysis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MELTING CURVE ANALYSIS; SYBR-GREEN-I; MALE-INFERTILITY; SEVERE OLIGOZOOSPERMIA; AZOOSPERMIC MEN; AZFC REGIONS; DELETIONS; IDENTIFICATION; GENE	Backgound: Y-chromosomal microdeletions (YCMD) are one of the major genetic causes for non-obstructive azoospermia. Genetic testing for YCMD by multiplex polymerase chain reaction (PCR) is an established method for quick and robust screening of deletions in the AZF regions of the Y-chromosome. Multiplex PCRs have the advantage of including a control gene in every reaction and significantly reducing the number of reactions needed to screen the relevant genomic markers. Principal Findings: The widely established "EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions (2004)" were used as a basis for designing a real-time multiplex PCR system, in which the YCMD can simply be identified by their melting points. For this reason, some AZF primers were substituted by primers for regions in their genomic proximity, and the ZFX/ZFY control primer was exchanged by the AMELX/AMELY control primer. Furthermore, we substituted the classical SybrGreen I dye by the novel and high-performing DNA-binding dye EvaGreen(TM) and put substantial effort in titrating the primer combinations in respect to optimal melting peak separation and peak size. Significance: With these changes, we were able to develop a platform-independent and robust real-time based multiplex PCR, which makes the need for amplicon identification by electrophoretic sizing expendable. By using an open-source system for real-time PCR analysis, we further demonstrate the applicability of automated melting point and YCMD detection.	[Kozina, Viviana] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Cappallo-Obermann, Heike; Spiess, Andrej-Nikolai] Univ Hosp Hamburg Eppendorf, Dept Androl, Hamburg, Germany; [Gromoll, Joerg] Univ Hosp Munster, Ctr Reprod Med & Androl, Munster, Germany	University of Zagreb; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster	Kozina, V (corresponding author), Univ Zagreb, Sch Med, Zagreb 41001, Croatia.	a.spiess@uke.de	Spiess, Andrej-Nikolai/A-2941-2015; Gromoll, Joerg/AAB-2146-2019	Spiess, Andrej-Nikolai/0000-0002-9630-4724; Gromoll, Joerg/0000-0002-7788-8138	DAAD; Ministry of Science, Croatia [108-1080399-0383]; German Research Foundation [Sp721/1-3]	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Science, Croatia; German Research Foundation(German Research Foundation (DFG))	Financial support for this work was paid in part by the DAAD stability pack/special program for South East Europe and by grant 108-1080399-0383 of the Ministry of Science, Croatia, to Dr. Kozina. Financial support from grant Sp721/1-3 of the German Research Foundation, awarded to Dr. Spiess and Dr. Cappallo-Obermann, is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aknin-Seifer IE, 2003, HUM REPROD, V18, P257, DOI 10.1093/humrep/deg067; Bor P, 2003, J ASSIST REPROD GEN, V20, P46, DOI 10.1023/A:1021215006775; Bor P, 2001, J ASSIST REPROD GEN, V18, P291, DOI 10.1023/A:1016618418319; Brandell RA, 1998, HUM REPROD, V13, P2812, DOI 10.1093/humrep/13.10.2812; Buch B, 2003, FERTIL STERIL, V80, P907, DOI 10.1016/S0015-0282(03)01155-5; Charpenel C, 2002, GENET TEST, V6, P207, DOI 10.1089/109065702761403379; Costa P, 2008, MOL HUM REPROD, V14, P251, DOI 10.1093/molehr/gan014; Cram DS, 2006, MED J AUSTRALIA, V185, P433, DOI 10.5694/j.1326-5377.2006.tb00641.x; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Feig C, 2007, MOL HUM REPROD, V13, P33, DOI 10.1093/molehr/gal097; Fodor F, 2007, GENET TEST, V11, P139, DOI 10.1089/gte.2006.0506; Foresta C, 2000, J ENDOCRINOL INVEST, V23, P646, DOI 10.1007/BF03343788; Foresta C, 2005, J CLIN ENDOCR METAB, V90, P152, DOI 10.1210/jc.2004-1469; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Fujisawa M, 2001, FERTIL STERIL, V76, P491, DOI 10.1016/S0015-0282(01)01955-0; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; HENEGARIU O, 1994, ANDROLOGIA, V26, P97; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Hopps CV, 2003, HUM REPROD, V18, P1660, DOI 10.1093/humrep/deg348; Jabasini M, 2005, J CHROMATOGR SCI, V43, P221, DOI 10.1093/chromsci/43.5.221; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kent-First M, 1999, MOL REPROD DEV, V53, P27, DOI 10.1002/(SICI)1098-2795(199905)53:1<27::AID-MRD4>3.0.CO;2-W; Kent-First MG, 1996, MOL HUM REPROD, V2, P943, DOI 10.1093/molehr/2.12.943; Kim SW, 1999, FERTIL STERIL, V72, P349, DOI 10.1016/S0015-0282(99)00255-1; Kleiman SE, 2007, HUM REPROD, V22, P151, DOI 10.1093/humrep/del341; Krausz C, 2001, HUM MOL GENET, V10, P1873, DOI 10.1093/hmg/10.18.1873; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lin YW, 2006, MOL HUM REPROD, V12, P347, DOI 10.1093/molehr/gal038; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Martinez MC, 2000, J ANDROL, V21, P651; Mitra A, 2008, INDIAN J MED RES, V127, P124; Moro E, 2000, J CLIN ENDOCR METAB, V85, P4069, DOI 10.1210/jc.85.11.4069; Oates RD, 2002, HUM REPROD, V17, P2813, DOI 10.1093/humrep/17.11.2813; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; Rajender S, 2006, MOL HUM REPROD, V12, P341, DOI 10.1093/molehr/gal030; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x; Simoni M, 1997, FERTIL STERIL, V67, P542, DOI 10.1016/S0015-0282(97)80083-0; Simoni M, 2008, REPROD BIOMED ONLINE, V16, P289, DOI 10.1016/S1472-6483(10)60588-3; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Thornhill AR, 2002, INT J ANDROL, V25, P352, DOI 10.1046/j.1365-2605.2002.00377.x; Umeno M, 2006, J MED INVESTIG, V53, P147, DOI 10.2152/jmi.53.147; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Zhang J, 2008, MOL HUM REPROD, V14, P371, DOI 10.1093/molehr/gan022	52	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23174	10.1371/journal.pone.0023174	http://dx.doi.org/10.1371/journal.pone.0023174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887237	Green Published, gold, Green Submitted			2022-12-27	WOS:000294251800008
J	Abe, M; Tsai, SY; Jin, SG; Pfeifer, GP; Szabo, PE				Abe, Masanobu; Tsai, Shirley Y.; Jin, Seung-Gi; Pfeifer, Gerd P.; Szabo, Piroska E.			Sex-Specific Dynamics of Global Chromatin Changes in Fetal Mouse Germ Cells	PLOS ONE			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; IMPRINTED GENES; MAMMALIAN DEVELOPMENT; OOCYTE GROWTH; MICE; EXPRESSION; HETEROCHROMATIN; GENOME; ESTABLISHMENT	Mammalian germ cells undergo global reprogramming of DNA methylation during their development. Global DNA demethylation occurs around the time when the primordial germ cells colonize the embryonic gonads and this coincides with dynamic changes in chromatin composition. Global de novo DNA methylation takes place with remarkably different dynamics between the two sexes, prospermatogonia attaining methylation during fetal stages and oocytes attaining methylation postnatally. Our hypothesis was that dynamic changes in chromatin composition may precede or accompany the wave of global DNA de novo methylation as well. We used immunocytochemistry to measure global DNA methylation and chromatin components in male and female mouse fetal germ cells compared to control somatic cells of the gonad. We found that global DNA methylation levels sharply increased in male germ cells at 17.5 days post coitum, but remained low in female germ cells at all fetal stages. Global changes in chromatin composition: i, preceded global DNA methylation in fetal germ cells; ii, sex specifically occurred in male but not in female germ cells; iii, affected active and repressive histone marks and iv, included histone tail and histone globular domain modifications. Our data suggest that dynamic changes of chromatin composition may provide a framework for the pattern of male-specific de novo DNA methylation in prospermatogonia.	[Abe, Masanobu; Tsai, Shirley Y.; Szabo, Piroska E.] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Abe, Masanobu; Tsai, Shirley Y.; Jin, Seung-Gi; Pfeifer, Gerd P.; Szabo, Piroska E.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Jin, Seung-Gi; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Abe, M (corresponding author), Tokyo Univ Hosp, Dept Oral & Maxillofacial Surg, Tokyo 113, Japan.	pszabo@coh.org		Szabo, Piroska/0000-0001-9314-7009; Jin, Seung-Gi/0000-0001-5041-0559	National Institutes of Health [RO1GM064378, RO1ES015185]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants RO1GM064378 and RO1ES015185 to PES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Cheng X., BIOCHEMISTRY, V49, P2999; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Ferguson-Smith A, 2003, SEMIN CELL DEV BIOL, V14, P43, DOI 10.1016/S1084-9521(02)00171-4; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Lee DH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001224; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Mann JR, 2000, CRIT REV EUKAR GENE, V10, P241; MONK M, 1987, DEVELOPMENT, V99, P371; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sato S, 2003, MOL REPROD DEV, V65, P41, DOI 10.1002/mrd.10264; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Singh P, 2011, MOL CELL BIOL, V31, P1757, DOI 10.1128/MCB.00961-10; Singh P, 2010, MOL CELL BIOL, V30, P2693, DOI 10.1128/MCB.01537-09; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Thorvaldsen JL, 2000, SCIENCE, V288, P2145, DOI 10.1126/science.288.5474.2145; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Yoshioka H, 2009, BIOL REPROD, V80, P804, DOI 10.1095/biolreprod.108.072603	40	28	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23848	10.1371/journal.pone.0023848	http://dx.doi.org/10.1371/journal.pone.0023848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886830	Green Published, gold, Green Submitted			2022-12-27	WOS:000294128100036
J	Zhu, ZJ; Fu, CL; Li, XX; Song, YM; Li, CH; Zou, MH; Guan, YF; Zhu, Y				Zhu, Zhenjiu; Fu, Chenglai; Li, Xiaoxia; Song, Yimeng; Li, Chenghong; Zou, Minghui; Guan, Youfei; Zhu, Yi			Prostaglandin E2 Promotes Endothelial Differentiation from Bone Marrow-Derived Cells through AMPK Activation	PLOS ONE			English	Article							ADIPONECTIN STIMULATES ANGIOGENESIS; TRANSPLANTED HUMAN HEART; PROTEIN-KINASE; PROGENITOR CELLS; CANCER CELLS; CYCLOOXYGENASE-2 EXPRESSION; MYOCARDIAL-INFARCTION; COX-2 EXPRESSION; RECEPTOR SUBTYPE; IN-VIVO	Prostaglandin E2 (PGE2) has been reported to modulate angiogenesis, the process of new blood vessel formation, by promoting proliferation, migration and tube formation of endothelial cells. Endothelial progenitor cells are known as a subset of circulating bone marrow mononuclear cells that have the capacity to differentiate into endothelial cells. However, the mechanism underlying the stimulatory effects of PGE2 and its specific receptors on bone marrow-derived cells (BMCs) in angiogenesis has not been fully characterized. Treatment with PGE2 significantly increased the differentiation and migration of BMCs. Also, the markers of differentiation to endothelial cells, CD31 and von Willebrand factor, and the genes associated with migration, matrix metalloproteinases 2 and 9, were significantly upregulated. This upregulation was abolished by dominant-negative AMP-activated protein kinase (AMPK) and AMPK inhibitor but not protein kinase, a inhibitor. As a functional consequence of differentiation and migration, the tube formation of BMCs was reinforced. Along with altered BMCs functions, phosphorylation and activation of AMPK and endothelial nitric oxide synthase, the target of activated AMPK, were both increased which could be blocked by EP4 blocking peptide and simulated by the agonist of EP4 but not EP1, EP2 or EP3. The pro-angiogenic role of PGE2 could be repressed by EP4 blocking peptide and retarded in EP4(+/-) mice. Therefore, by promoting the differentiation and migration of BMCs, PGE2 reinforced their neovascularization by binding to the receptor of EP4 in an AMPK-dependent manner. PGE2 may have clinical value in ischemic heart disease.	[Zhu, Zhenjiu; Fu, Chenglai; Li, Xiaoxia; Song, Yimeng; Li, Chenghong; Guan, Youfei; Zhu, Yi] Peking Univ, Key Lab Mol Cardiovasc Sci, Educ Minist, Dept Physiol & Pathophysiol,Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zou, Minghui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK USA	Peking University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, ZJ (corresponding author), Peking Univ, Key Lab Mol Cardiovasc Sci, Educ Minist, Dept Physiol & Pathophysiol,Hlth Sci Ctr, Beijing 100871, Peoples R China.	youfeiguan@hsc.pku.edu.cn; zhuyi@hsc.pku.edu.cn	Fu, Chenglai/H-5330-2018	Fu, Chenglai/0000-0003-4300-9948; guan, youfei/0000-0002-5231-0209	Major National Basic Research Grant of China [2010CB912504]; National Natural Science Foundation of China [308201001, 810701113, 81028002]; "111" plan of China	Major National Basic Research Grant of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" plan of China(Ministry of Education, China - 111 Project)	This work was supported in part by grants from the Major National Basic Research Grant of China (2010CB912504) (http://www.973.gov.cn/); the National Natural Science Foundation of China (308201001, 810701113, 81028002) (http://www.nsfc.gov.cn/Portal0/default124.htm) and the "111" plan of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no additional external funding received for this study.	Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Cui X, 2007, STEM CELLS, V25, P2777, DOI 10.1634/stemcells.2007-0169; Faour WH, 2008, CELL SIGNAL, V20, P2156, DOI 10.1016/j.cellsig.2008.08.007; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Fukuda R, 2003, CANCER RES, V63, P2330; Funahashi K, 2009, PROSTAG OTH LIPID M, V88, P31, DOI 10.1016/j.prostaglandins.2008.09.002; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Jin F, 2008, BONE MARROW TRANSPL, V42, P581, DOI 10.1038/bmt.2008.222; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Kaye DM, 2006, CIRCULATION, V113, pE844, DOI 10.1161/CIRCULATIONAHA.105.601989; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Ogawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P720, DOI 10.1016/j.bbrc.2009.03.094; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Pino MS, 2005, CANCER BIOL THER, V4, P1263, DOI 10.4161/cbt.4.11.2138; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Stahmann N, 2010, J BIOL CHEM, V285, P10638, DOI 10.1074/jbc.M110.108688; Steinert D, 2009, AM J PHYSIOL-CELL PH, V296, pC75, DOI 10.1152/ajpcell.00024.2008; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tsuji T, 2009, PROSTAG OTH LIPID M, V90, P85, DOI 10.1016/j.prostaglandins.2009.09.002; Uefuji K, 2000, CLIN CANCER RES, V6, P135; Ueno T, 2010, BIOMED PHARMACOTHER, V64, P93, DOI 10.1016/j.biopha.2009.04.034; Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Yanni SE, 2009, INVEST OPHTH VIS SCI, V50, P5479, DOI 10.1167/iovs.09-3652; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98	46	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23554	10.1371/journal.pone.0023554	http://dx.doi.org/10.1371/journal.pone.0023554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876756	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900028
J	Crist, RC; Roth, JJ; Waldman, SA; Buchberg, AM				Crist, Richard C.; Roth, Jacquelyn J.; Waldman, Scott A.; Buchberg, Arthur M.			A Conserved Tissue-Specific Homeodomain-Less Isoform of MEIS1 Is Downregulated in Colorectal Cancer	PLOS ONE			English	Article							PROTEIN EXPRESSION; HOMEOBOX GENES; MESSENGER-RNA; RISK; GENETICS	Colorectal cancer is one of the most common cancers in developed nations and is the result of both environmental and genetic factors. Many of the genetic lesions observed in colorectal cancer alter expression of homeobox genes, which encode homeodomain transcription factors. The MEIS1 homeobox gene is known to be involved in several hematological malignancies and solid tumors and recent evidence suggests that expression of the MEIS1 transcript is altered in colorectal cancer. Despite this potential connection, little is known about the role of the gene in the intestines. We probed murine gastrointestinal tissue samples with an N-terminal Meis1 antibody, revealing expression of two previously described isoforms, as well as two novel Meis1 products. A 32 kD Meis1 product was expressed in the nuclei of non-epithelial cells in the stomach and colon, while a 27 kD product was expressed in the cytoplasm of epithelial cells in the proximal colon. Our data suggest that the 27 kD and 32 kD Meis1 proteins are both forms of the Meis1d protein, a homeodomain-less isoform whose transcript was previously identified in cDNA screens. Both the MEIS1D transcript and protein were expressed in human colon mucosa. Expression of the MEIS1D protein was downregulated in 83% (10/12) of primary colorectal cancer samples compared to matched normal mucosa, indicating that MEIS1D is a biomarker of colorectal tumorigenesis. The decreased expression of MEIS1D in colon tumors also suggests that this conserved homeodomain-less isoform may act as a tumor suppressor in human colorectal cancer.	[Crist, Richard C.; Roth, Jacquelyn J.; Buchberg, Arthur M.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Waldman, Scott A.] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Crist, RC (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	Arthur.Buchberg@jefferson.edu		Buchberg, Arthur/0000-0002-0543-5631; Waldman, Scott/0000-0001-6619-175X	National Institutes of Health [T32-CA09678, T32-CA09683]; National Cancer Institute; NATIONAL CANCER INSTITUTE [T32CA009678, T32CA009683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [T32-CA09678 to RCC, T32-CA09683 to JJR] and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; CANTILE M, 2009, INT J CANC; Cantile M, 2009, INT J CANCER, V125, P1532, DOI 10.1002/ijc.24438; Chariot A, 1999, BIOCHEM PHARMACOL, V58, P1851, DOI 10.1016/S0006-2952(99)00234-8; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Diergaarde B, 2007, CLIN GASTROENTEROL H, V5, P736, DOI 10.1016/j.cgh.2007.02.019; EE HC, 1995, AM J PATHOL, V147, P586; Fearnhead NS, 2002, BRIT MED BULL, V64, P27, DOI 10.1093/bmb/64.1.27; Geerts D, 2005, CANCER LETT, V228, P43, DOI 10.1016/j.canlet.2005.01.047; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Jung C, 2005, BRIT J CANCER, V92, P2233, DOI 10.1038/sj.bjc.6602631; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Lamba JK, 2004, J PHARMACOL EXP THER, V311, P811, DOI 10.1124/jpet.104.069310; Magnani E, 2008, PLANT CELL, V20, P875, DOI 10.1105/tpc.108.058495; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; Spieker N, 2001, GENOMICS, V71, P214, DOI 10.1006/geno.2000.6408; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Tucker SC, 1999, J BIOL CHEM, V274, P32325, DOI 10.1074/jbc.274.45.32325; van Engeland M, 2003, CANCER RES, V63, P3133; Vider BZ, 1997, BIOCHEM BIOPH RES CO, V232, P742, DOI 10.1006/bbrc.1997.6364; Vider BZ, 2000, BIOCHEM BIOPH RES CO, V272, P513, DOI 10.1006/bbrc.2000.2804; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Watson AJM, 2004, GUT, V53, P1701, DOI 10.1136/gut.2004.052704; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199	41	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23665	10.1371/journal.pone.0023665	http://dx.doi.org/10.1371/journal.pone.0023665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858198	gold, Green Published			2022-12-27	WOS:000294121300076
J	Inagaki, A; Sleddens-Linkels, E; van Cappellen, WA; Hibbert, RG; Sixma, TK; Hoeijmakers, JHJ; Grootegoed, JA; Baarends, WM				Inagaki, Akiko; Sleddens-Linkels, Esther; van Cappellen, Wiggert A.; Hibbert, Richard G.; Sixma, Titia K.; Hoeijmakers, Jan H. J.; Grootegoed, J. Anton; Baarends, Willy M.			Human RAD18 Interacts with Ubiquitylated Chromatin Components and Facilitates RAD9 Recruitment to DNA Double Strand Breaks	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DEFECTIVE POSTREPLICATION REPAIR; UBIQUITIN-CONJUGATING ACTIVITY; HISTONE H2AX PHOSPHORYLATION; 9-1-1 CHECKPOINT CLAMP; ZINC-FINGER DOMAIN; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; PCNA MONOUBIQUITINATION; GENOMIC INSTABILITY	RAD18 is an ubiquitin ligase involved in replicative damage bypass and DNA double-strand break (DSB) repair processes. We found that RPA is required for the dynamic pattern of RAD18 localization during the cell cycle, and for accumulation of RAD18 at sites of c-irradiation-induced DNA damage. In addition, RAD18 colocalizes with chromatin-associated conjugated ubiquitin and ubiquitylated H2A throughout the cell cycle and following irradiation. This localization pattern depends on the presence of an intact, ubiquitin-binding Zinc finger domain. Using a biochemical approach, we show that RAD18 directly binds to ubiquitylated H2A and several other unknown ubiquitylated chromatin components. This interaction also depends on the RAD18 Zinc finger, and increases upon the induction of DSBs by gamma-irradiation. Intriguingly, RAD18 does not always colocalize with regions that show enhanced H2A ubiquitylation. In human female primary fibroblasts, where one of the two X chromosomes is inactivated to equalize X-chromosomal gene expression between male (XY) and female (XX) cells, this inactive X is enriched for ubiquitylated H2A, but only rarely accumulates RAD18. This indicates that the binding of RAD18 to ubiquitylated H2A is context-dependent. Regarding the functional relevance of RAD18 localization at DSBs, we found that RAD18 is required for recruitment of RAD9, one of the components of the 9-1-1 checkpoint complex, to these sites. Recruitment of RAD9 requires the functions of the RING and Zinc finger domains of RAD18. Together, our data indicate that association of RAD18 with DSBs through ubiquitylated H2A and other ubiquitylated chromatin components allows recruitment of RAD9, which may function directly in DSB repair, independent of downstream activation of the checkpoint kinases CHK1 and CHK2.	[Inagaki, Akiko; Sleddens-Linkels, Esther; van Cappellen, Wiggert A.; Grootegoed, J. Anton; Baarends, Willy M.] Erasmus MC, Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands; [Hoeijmakers, Jan H. J.] Erasmus MC, Univ Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Hibbert, Richard G.; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands; [Hibbert, Richard G.; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; Netherlands Cancer Institute	Inagaki, A (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Chromosome Biol, 1275 York Ave, New York, NY 10021 USA.	w.baarends@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021	Sixma, Titia K/0000-0001-6180-0632	Netherlands Organization for Scientific Research (NWO) through ALW [VIDI 864.05.003]	Netherlands Organization for Scientific Research (NWO) through ALW(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO) through ALW (VIDI 864.05.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baarends WM, 2003, MOL CELL BIOL, V23, P1151, DOI 10.1128/MCB.23.4.1151-1162.2003; Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Davies AA, 2010, CELL, V141, P1080, DOI 10.1016/j.cell.2010.04.039; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Greer DA, 2003, CANCER RES, V63, P4829; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Inagaki A, 2009, DNA REPAIR, V8, P190, DOI 10.1016/j.dnarep.2008.10.008; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Medhurst AL, 2008, J CELL SCI, V121, P3933, DOI 10.1242/jcs.033688; Melo JA, 2001, GENE DEV, V15, P2809; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sorkin A, 2007, MOL CELL, V26, P771, DOI 10.1016/j.molcel.2007.06.003; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Warmerdam DO, 2009, CELL CYCLE, V8, P1765, DOI 10.4161/cc.8.11.8721; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xin H, 2000, NUCLEIC ACIDS RES, V28, P2847, DOI 10.1093/nar/28.14.2847; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	78	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23155	10.1371/journal.pone.0023155	http://dx.doi.org/10.1371/journal.pone.0023155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858012	gold, Green Published			2022-12-27	WOS:000294121300014
J	Jonczyk, M; Sobkowiak, A; Siedlecki, P; Biecek, P; Trzcinska-Danielewicz, J; Tiuryn, J; Fronk, J; Sowinski, P				Jonczyk, Maciej; Sobkowiak, Alicja; Siedlecki, Pawel; Biecek, Przemyslaw; Trzcinska-Danielewicz, Joanna; Tiuryn, Jerzy; Fronk, Jan; Sowinski, Pawel			Rhythmic Diel Pattern of Gene Expression in Juvenile Maize Leaf	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ARABIDOPSIS; PROTEINS; CLOCK; PHOTOSYNTHESIS; QUINTET; PLANTS; CCA1	Background: Numerous biochemical and physiological parameters of living organisms follow a circadian rhythm. Although such rhythmic behavior is particularly pronounced in plants, which are strictly dependent on the daily photoperiod, data on the molecular aspects of the diurnal cycle in plants is scarce and mostly concerns the model species Arabidopsis thaliana. Here we studied the leaf transcriptome in seedlings of maize, an important C4 crop only distantly related to A. thaliana, throughout a cycle of 10 h darkness and 14 h light to look for rhythmic patterns of gene expression. Results: Using DNA microarrays comprising ca. 43,000 maize-specific probes we found that ca. 12% of all genes showed clear-cut diel rhythms of expression. Cluster analysis identified 35 groups containing from four to ca. 1,000 genes, each comprising genes of similar expression patterns. Perhaps unexpectedly, the most pronounced and most common (concerning the highest number of genes) expression maxima were observed towards and during the dark phase. Using Gene Ontology classification several meaningful functional associations were found among genes showing similar diel expression patterns, including massive induction of expression of genes related to gene expression, translation, protein modification and folding at dusk and night. Additionally, we found a clear-cut tendency among genes belonging to individual clusters to share defined transcription factor-binding sequences. Conclusions: Co-expressed genes belonging to individual clusters are likely to be regulated by common mechanisms. The nocturnal phase of the diurnal cycle involves gross induction of fundamental biochemical processes and should be studied more thoroughly than was appreciated in most earlier physiological studies. Although some general mechanisms responsible for the diel regulation of gene expression might be shared among plants, details of the diurnal regulation of gene expression seem to differ between taxa.	[Jonczyk, Maciej; Sowinski, Pawel] Univ Warsaw, Fac Biol, Inst Plant Expt Biol & Biotechnol, Dept Plant Mol Ecophysiol, Warsaw, Poland; [Sobkowiak, Alicja; Sowinski, Pawel] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Plant Biochem & Physiol Dept, Radzikow, Poland; [Siedlecki, Pawel] Univ Warsaw, Fac Biol, Inst Plant Expt Biol & Biotechnol, Dept Plant Mol Biol, Warsaw, Poland; [Biecek, Przemyslaw] Univ Warsaw, Fac Math Informat & Mech, Inst Appl Math & Mech, Warsaw, Poland; [Trzcinska-Danielewicz, Joanna; Fronk, Jan] Univ Warsaw, Fac Biol, Inst Biochem, Dept Mol Biol, Warsaw, Poland; [Tiuryn, Jerzy] Univ Warsaw, Fac Math Informat & Mech, Inst Informat, Warsaw, Poland	University of Warsaw; Institute of Plant Breeding & Acclimatization; University of Warsaw; University of Warsaw; University of Warsaw; University of Warsaw	Jonczyk, M (corresponding author), Univ Warsaw, Fac Biol, Inst Plant Expt Biol & Biotechnol, Dept Plant Mol Ecophysiol, Warsaw, Poland.	pawes@biol.uw.edu.pl	Siedlecki, Pawel/Q-3265-2017	Siedlecki, Pawel/0000-0002-7482-1341; Sobkowiak, Alicja/0000-0003-4879-1254; Tiuryn, Jerzy/0000-0002-0285-5606; Trzcinska-Danielewicz, Joanna/0000-0001-5504-1553; Biecek, Przemyslaw/0000-0001-8423-1823; Jonczyk, Maciej/0000-0002-8865-6586; Sowinski, Pawel/0000-0001-5222-8128; Fronk, Jan/0000-0002-6564-4339	Ministry of Science and Higher Education [N303 032/1109, N310 133638]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grants N303 032/1109 and N310 133638 from the Ministry of Science and Higher Education (www.nauka.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carpita NC, 2008, TRENDS PLANT SCI, V13, P415, DOI 10.1016/j.tplants.2008.06.002; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Fujimori T, 2005, BIOSCI BIOTECH BIOCH, V69, P426, DOI 10.1271/bbb.69.426; FURBANK RT, 1988, NEW PHYTOL, V109, P265, DOI 10.1111/j.1469-8137.1988.tb04195.x; Gardiner JM, 2005, MAYDICA, V50, P425; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayes KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012887; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; KALTTORRES W, 1987, PLANT PHYSIOL, V83, P283, DOI 10.1104/pp.83.2.283; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Kondo T, 1999, TRENDS PLANT SCI, V4, P171, DOI 10.1016/S1360-1385(99)01410-7; Ledford H, 2010, NATURE, V464, P154, DOI 10.1038/464154a; Martinez-Garcia JF, 1998, PLANT J, V13, P489, DOI 10.1046/j.1365-313X.1998.00050.x; Marzabal P, 2008, PLANT MOL BIOL, V67, P441, DOI 10.1007/s11103-008-9325-5; Millar AJ, 2000, CURR BIOL, V10, pR529, DOI 10.1016/S0960-9822(00)00586-8; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; PRIOUL JL, 1996, PHOTOASSIMILATE DIST, P549; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Sowinski P, 2007, ENVIRON EXP BOT, V61, P74, DOI 10.1016/j.envexpbot.2007.03.002; STAMP P, 1984, ADV AGRONOMY CROP SC, V7; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thain SC, 2002, PLANT PHYSIOL, V130, P102, DOI 10.1104/pp.005405; Trzcinska-Danielewicz J, 2009, PLANT SCI, V177, P648, DOI 10.1016/j.plantsci.2009.09.001; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Woodger FJ, 2003, J PLANT GROWTH REGUL, V22, P176, DOI 10.1007/s00344-003-0025-8; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75	43	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23628	10.1371/journal.pone.0023628	http://dx.doi.org/10.1371/journal.pone.0023628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858187	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300072
J	Ko, JH; Reilhac, A; Ray, N; Rusjan, P; Bloomfield, P; Pellecchia, G; Houle, S; Strafella, AP				Ko, Ji Hyun; Reilhac, Anthonin; Ray, Nicola; Rusjan, Pablo; Bloomfield, Peter; Pellecchia, Giovanna; Houle, Sylvain; Strafella, Antonio P.			Analysis of Variance in Neuroreceptor Ligand Imaging Studies	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; STRIATAL DOPAMINE RELEASE; PARTIAL VOLUME CORRECTION; PARKINSONS-DISEASE; PET-SORTEO; BINDING; QUANTIFICATION; CORTEX; REGISTRATION	Radioligand positron emission tomography (PET) with dual scan paradigms can provide valuable insight into changes in synaptic neurotransmitter concentration due to experimental manipulation. The residual t-test has been utilized to improve the sensitivity of the t-test in PET studies. However, no further development of statistical tests using residuals has been proposed so far to be applied in cases when there are more than two conditions. Here, we propose the residual f-test, a one-way analysis of variance (ANOVA), and examine its feasibility using simulated [C-11] raclopride PET data. We also re-visit data from our previously published [C-11] raclopride PET study, in which 10 individuals underwent three PET scans under different conditions. We found that the residual f-test is superior in terms of sensitivity than the conventional f-test while still controlling for type 1 error. The test will therefore allow us to reliably test hypotheses in the smaller sample sizes often used in explorative PET studies.	[Ko, Ji Hyun; Ray, Nicola; Rusjan, Pablo; Bloomfield, Peter; Pellecchia, Giovanna; Houle, Sylvain; Strafella, Antonio P.] Univ Toronto, Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada; [Ko, Ji Hyun; Ray, Nicola; Pellecchia, Giovanna; Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Ko, Ji Hyun; Ray, Nicola; Pellecchia, Giovanna; Strafella, Antonio P.] Univ Toronto, Res Inst, Toronto, ON, Canada; [Reilhac, Anthonin] Australian Nucl Sci & Technol Org, Dept Life Sci, Lucas Heights, NSW, Australia	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Australian Nuclear Science & Technology Organisation	Ko, JH (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada.	jihyun.ko@camhpet.ca	Ko, Ji Hyun/E-5150-2011	Ko, Ji Hyun/0000-0002-9700-7692; Houle, Sylvain/0000-0002-4231-6316; Reilhac, Anthonin/0000-0002-9997-9540; Rusjan, Pablo/0000-0003-0075-2918; Ray, Nicola/0000-0001-9645-0812	Canadian Institutes of Health Research [MOP 64423]; Edmond J. Safra Philanthropic Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Edmond J. Safra Philanthropic Foundation	This work was supported in part by a grant from the Canadian Institutes of Health Research [grant number MOP 64423 to APS] and the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Aston JAD, 2000, NEUROIMAGE, V12, P245, DOI 10.1006/nimg.2000.0620; COLLINS DL, 1995, COMP IMAG VIS, V3, P139; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; FARDE L, 1989, J CEREBR BLOOD F MET, V9, P696, DOI 10.1038/jcbfm.1989.98; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Harri M, 2007, J MED PHYS, V32, P108, DOI 10.4103/0971-6203.35723; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Ko JH, 2009, NEUROIMAGE, V46, P516, DOI 10.1016/j.neuroimage.2009.02.031; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Monchi O, 2006, NEUROIMAGE, V33, P907, DOI 10.1016/j.neuroimage.2006.06.058; Montgomery AJ, 2006, J NUCL MED, V47, P1936; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; Perruchot F, 2004, IEEE NUCL SCI CONF R, P3186; Reilhac A, 2005, IEEE T NUCL SCI, V52, P1321, DOI 10.1109/TNS.2005.858242; Reilhac A, 2004, IEEE T NUCL SCI, V51, P46, DOI 10.1109/TNS.2003.823011; Reilhac A, 2008, NEUROIMAGE, V39, P359, DOI 10.1016/j.neuroimage.2007.07.038; Reilhac A, 2006, IEEE T MED IMAGING, V25, P1431, DOI 10.1109/TMI.2006.879922; Rousset OG, 2000, SYNAPSE, V37, P81, DOI 10.1002/1098-2396(200008)37:2<81::AID-SYN1>3.3.CO;2-R; Rousset OG, 1998, J NUCL MED, V39, P904; Rousset OG, 2008, J NUCL MED, V49, P1097, DOI 10.2967/jnumed.107.048330; Seber G., 1989, NONLINEAR REGRESSION; Steeves TDL, 2010, ANN NEUROL, V67, P170, DOI 10.1002/ana.21809; Strafella AP, 2006, NEUROIMAGE, V31, P1666, DOI 10.1016/j.neuroimage.2006.02.005; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Strafella AP, 2005, EUR J NEUROSCI, V22, P2946, DOI 10.1111/j.1460-9568.2005.04476.x; Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268; Talairach J., 1988, COPLANAR STEREOTAXIC; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23298	10.1371/journal.pone.0023298	http://dx.doi.org/10.1371/journal.pone.0023298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858062	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300031
J	Pasha, Z; Haider, HK; Ashraf, M				Pasha, Zeeshan; Haider, Husnain Kh; Ashraf, Muhammad			Efficient Non-Viral Reprogramming of Myoblasts to Stemness with a Single Small Molecule to Generate Cardiac Progenitor Cells	PLOS ONE			English	Article							INDUCTION; MOUSE; OCT4; PLURIPOTENCY; FIBROBLASTS; MYC	The current protocols for generation of induced pluripotent stem (iPS) cells involve genome integrating viral vectors which may induce tumorgenesis. The aim of this study was to develop and optimize a non-viral method without genetic manipulation for reprogramming of skeletal myoblasts (SMs) using small molecules. Methods and Results: SMs from young male Oct3/4-GFP(+) transgenic mouse were treated with DNA methyltransferase (DNMT) inhibitor, RG108. Two weeks later, GFP(+) colonies of SM derived iPS cells (SiPS) expressing GFP and with morphological similarity of mouse embryonic stem (ESCs) were formed and propagated in vitro. SiPS were positive for alkaline phosphatase activity, expressed SSEA1, displayed ES cell specific pluripotency markers and formed teratoma in nude mice. Optimization of culture conditions for embryoid body (EBs) formation yielded spontaneously contracting EBs having morphological, molecular, and ultra-structural similarities with cardiomyocytes and expressed early and late cardiac markers. miR profiling showed abrogation of let-7 family and upregulation of ESCs specific miR-290-295 cluster thus indicating that SiPS were similar to ESCs in miR profile. Four weeks after transplantation into the immunocompetent mice model of acute myocardial infarction (n = 12 per group), extensive myogenesis was observed in SiPS transplanted hearts as compared to DMEM controls (n = 6 per group). A significant reduction in fibrosis and improvement in global heart function in the hearts transplanted with SiPS derived cardiac progenitor cells were observed. Conclusions: Reprogramming of SMs by DNMT inhibitor is a simple, reproducible and efficient technique more likely to generate transgene integration-free iPS cells. Cardiac progenitors derived from iPS cells propagated extensively in the infarcted myocardium without tumorgenesis and improved cardiac function.	[Pasha, Zeeshan; Haider, Husnain Kh; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Pasha, Z (corresponding author), Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA.	ashrafm@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health (NIH) [R37-HL074272, HL-080686, HL-087246, HL 107957, HL-087288, HL-089535, HL106190-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL074272, R01HL107957, R01HL089535, R01HL087288, R01HL080686, R01HL106190, R01HL087246] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants R37-HL074272; HL-080686; HL-087246; HL 107957 (M.A.) and HL-087288; HL-089535; HL106190-01 (H.K.H.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Ahmed RPH, 2011, REGEN MED, V6, P171, DOI 10.2217/RME.10.103; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Haider HK, 2004, J MOL MED, V82, P539, DOI 10.1007/s00109-004-0546-z; Han JW, 2011, ANTIOXID REDOX SIGN, V15, P1799, DOI 10.1089/ars.2010.3814; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jain M, 2001, CIRCULATION, V103, P1920; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stefani G, 2006, COLD SPRING HARB SYM, V71, P129, DOI 10.1101/sqb.2006.71.032; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang YG, 2006, J MOL CELL CARDIOL, V40, P736, DOI 10.1016/j.yjmcc.2006.02.004; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863	28	44	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23667	10.1371/journal.pone.0023667	http://dx.doi.org/10.1371/journal.pone.0023667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21886809	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300077
J	Seoane, M; Mosquera-Miguel, A; Gonzalez, T; Fraga, M; Salas, A; Costoya, JA				Seoane, Marcos; Mosquera-Miguel, Ana; Gonzalez, Teresa; Fraga, Maximo; Salas, Antonio; Costoya, Jose A.			The Mitochondrial Genome Is a "Genetic Sanctuary" during the Oncogenic Process	PLOS ONE			English	Article							N-ACETYLCYSTEINE; DNA-DAMAGE; MTDNA; CELLS; INSTABILITY; DYSFUNCTION; POPULATION; SUPEROXIDE; MUTATIONS; EVOLUTION	Since Otto Warburg linked mitochondrial physiology and oncogenesis in the 1930s, a number of studies have focused on the analysis of the genetic basis for the presence of aerobic glycolysis in cancer cells. However, little or no evidence exists today to indicate that mtDNA mutations are directly responsible for the initiation of tumor onset. Based on a model of gliomagenesis in the mouse, we aimed to explore whether or not mtDNA mutations are associated with the initiation of tumor formation, maintenance and aggressiveness. We reproduced the different molecular events that lead from tumor initiation to progression in the mouse glioma. In human gliomas, most of the genetic alterations that have been previously identified result in the aberrant activation of different signaling pathways and deregulation of the cell cycle. Our data indicates that mitochondrial dysfunction is associated with reactive oxygen species (ROS) generation, leading to increased nuclear DNA (nDNA) mutagenesis, but maintaining the integrity of the mitochondrial genome. In addition, mutational stability has been observed in entire mtDNA of human gliomas; this is in full agreement with the results obtained in the cancer mouse model. We use this model as a paradigm of oncogenic transformation due to the fact that mutations commonly found in gliomas appear to be the most common molecular alterations leading to tumor development in most types of human cancer. Our results indicate that the mtDNA genome is kept by the cell as a "genetic sanctuary" during tumor development in the mouse and humans. This is compatible with the hypothesis that the mtDNA molecule plays an essential role in the control of the cellular adaptive survival response to tumor-induced oxidative stress. The integrity of mtDNA seems to be a necessary element for responding to the increased ROS production associated with the oncogenic process.	[Seoane, Marcos; Costoya, Jose A.] Univ Santiago de Compostela, Dept Fisiol, Fac Med, Mol Oncol Lab, Galicia, Spain; [Mosquera-Miguel, Ana; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Inst Med Legal, Fac Med, Galicia, Spain; [Gonzalez, Teresa] Fdn Galega Med Xenom, Serv Galego Saude, Santiago De Compostela, Galicia, Spain; [Fraga, Maximo; Salas, Antonio] Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Seoane, M (corresponding author), Univ Santiago de Compostela, Dept Fisiol, Fac Med, Mol Oncol Lab, Galicia, Spain.	josea.costoya@usc.es	Salas, Antonio/U-2029-2019; Fraga, Máximo/AAC-9417-2020; Costoya, Jose A./B-2718-2009; Miguel, Ana Mosquera/ABG-9735-2020; Souto, Marcos Seoane/I-3380-2018; Salas, Antonio/E-3977-2012	Salas, Antonio/0000-0002-2336-702X; Costoya, Jose A./0000-0003-3691-6419; Miguel, Ana Mosquera/0000-0003-3939-8338; Salas, Antonio/0000-0002-2336-702X; Fraga Rodriguez, Maximo/0000-0001-6185-9562	Spanish Ministry of Education and Science [SAF2008-00543, SAF2009-08629, SAF2008-02971]; Xunta de Galicia [INCITE08PXIB208091PR]; Fundacion de Investigacion Medica Mutua Madrilena [2008/CL444]	Spanish Ministry of Education and Science(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena	This study was supported by the Spanish Ministry of Education and Science SAF2008-00543 (JAC), SAF2009-08629 (JAC), SAF2008-02971 (AS), Xunta de Galicia INCITE08PXIB208091PR (JAC) and Fundacion de Investigacion Medica Mutua Madrilena 2008/CL444 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bandelt HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-113; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Dai JG, 2005, J EXP BIOL, V208, P4445, DOI 10.1242/jeb.01920; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishikawa K, 2008, MITOCHONDRION, V8, P339, DOI 10.1016/j.mito.2008.07.006; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Marino S, 2000, GENE DEV, V14, P994; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Sathyan KM, 2007, MODERN PATHOL, V20, P1141, DOI 10.1038/modpathol.3800948; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; SINGH G, 1992, PHARMACOL THERAPEUT, V54, P217, DOI 10.1016/0163-7258(92)90033-V; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Toschi A, 2010, CANCER LETT, V299, P72, DOI 10.1016/j.canlet.2010.08.006; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Warburg O, 1926, STOFFWECHSEL TUMORE; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	41	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23327	10.1371/journal.pone.0023327	http://dx.doi.org/10.1371/journal.pone.0023327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858071	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300035
J	Valva, P; Casciato, P; Carrasco, JMD; Gadano, A; Galdame, O; Galoppo, MC; Mullen, E; De Matteo, E; Preciado, MV				Valva, Pamela; Casciato, Paola; Diaz Carrasco, Juan M.; Gadano, Adrian; Galdame, Omar; Cristina Galoppo, Maria; Mullen, Eduardo; De Matteo, Elena; Victoria Preciado, Maria			The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic Infection	PLOS ONE			English	Article							LIVER FIBROSIS; HYALURONIC-ACID; TRANSFORMING GROWTH-FACTOR-BETA-1; NONINVASIVE ASSESSMENT; DIAGNOSTIC EVALUATION; STELLATE CELLS; CHILDREN; BIOPSY; MARKERS; APOPTOSIS	Background/Aims: Liver biopsy represents the gold standard for damage evaluation, but noninvasive serum markers that mirror liver fibrosis progression are actual goals both in adults and especially in children. The aim was to determine specific serum markers that correlate with liver fibrosis progression during chronic HCV infection. Methods: Liver biopsies and concomitant serum samples from 22 pediatric and 22 adult HCV patients were analyzed. Histological parameters were evaluated. On serum TGF-beta 1, tissue inhibitor of matrix metalloprotein inhibitor-1 (TIMP-1), hyaluronic acid (HA) and aminoterminal peptide of procollagen type III (PIIINP) were tested. Results: Significant fibrosis (F >= 2) and advanced fibrosis (F >= 3) represented 64% and 20%, respectively in children; while 54% F >= 2 and 23% F >= 3 in adults. Hyaluronic acid (p = 0.011) and PIIINP (p = 0.016) were related to worse fibrosis stages only in adults, along with TIMP-1 (p = 0.039) just in children; but TGF-beta 1 was associated with mild fibrosis (p = 0.022) in adults. The AUROC of TIMP-1 in children to discriminate advanced fibrosis was 0.800 (95% IC 0.598-0.932). In adults, the best AUROCs were that of HA, PIIINP and TGF-beta 1 [ 0.929 (IC95% 0.736-0.994), 0.894 (IC95% 0.689-0.984) and 0.835 (IC95% 0.617-0.957)], respectively. In children, according to the cut off (165.7 ng/mL) value for TIMP-1, biopsies could have been avoided in 72% (18/25). Considering the cut off for HA (109.7 ng/mL), PIIINP (9.1 mg/L), and TGF-beta 1 (10,848.3 pg/mL), biopsies could have been avoided in 87% (19/22) of adult patients by using HA and 73% (16/22) using PIIINP or TGF-beta 1. Conclusions: In adults given the diagnostic accuracy of HA, PIIINP, TGF-beta 1, their combination may provide a potential useful tool to assess liver fibrosis. This first pediatric study suggests that TIMP-1 is clinically useful for predicting liver fibrosis in HCV patients.	[Valva, Pamela; Diaz Carrasco, Juan M.; De Matteo, Elena; Victoria Preciado, Maria] Ricardo Gutierrez Childrens Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, DF, Argentina; [Casciato, Paola; Gadano, Adrian; Galdame, Omar] Hosp Italiano Buenos Aires, Liver Unit, Buenos Aires, DF, Argentina; [Cristina Galoppo, Maria] Univ Buenos Aires, Liver Unit, Ricardo Gutierrez Childrens Hosp, Buenos Aires, DF, Argentina; [Mullen, Eduardo] Hosp Italiano Buenos Aires, Div Pathol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	Valva, P (corresponding author), Ricardo Gutierrez Childrens Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, DF, Argentina.	valvapamela@yahoo.com	Carrasco, Juan Diaz/AAO-2693-2020	Preciado, Maria Victoria/0000-0003-4082-0698	International Society for Infectious Diseases; National Research Council (CONICET)	International Society for Infectious Diseases; National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by grants from the International Society for Infectious Diseases (2009). No additional external funding received for this study. PV and JMDC are supported by a fellowship from National Research Council (CONICET), MVP is a member of the CONICET Research Career Program, and EDM is a member of the Research Career of Buenos Aires City Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; *AS ARG EST ENF HI, 2007, CONS ARG HEP C; Badizadegan K, 1998, HEPATOLOGY, V28, P1416, DOI 10.1002/hep.510280534; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Dienstag JL, 2002, HEPATOLOGY, V36, pS152, DOI 10.1053/jhep.2002.36381; El-Shabrawi MH, 2010, EUR J GASTROEN HEPAT, V22, P946, DOI 10.1097/MEG.0b013e328336ec84; Elmetwally IM, 2009, SAUDI MED J, V30, P638; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Fontana RJ, 2009, CLIN GASTROENTEROL H, V7, P219, DOI 10.1016/j.cgh.2008.10.034; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Gismondi MI, 2004, J CLIN MICROBIOL, V42, P1199, DOI 10.1128/JCM.42.3.1199-1202.2004; Goto Takashi, 2004, Pathophysiology, V11, P153, DOI 10.1016/j.pathophys.2004.07.003; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Hartley JL, 2006, J PEDIATR GASTR NUTR, V43, P217, DOI 10.1097/01.mpg.0000228121.44606.9f; Hermeziu B, 2010, GASTROEN CLIN BIOL, V34, P16, DOI 10.1016/j.gcb.2009.06.007; Jara P, 2003, CLIN INFECT DIS, V36, P275, DOI 10.1086/345908; Kage M, 1997, HEPATOLOGY, V26, P771, DOI 10.1002/hep.510260333; Lebensztejn DM, 2006, WORLD J GASTROENTERO, V12, P3338, DOI 10.3748/wjg.v12.i21.3338; Lebensztejn DM, 2004, HEPATOLOGY, V39, P868, DOI 10.1002/hep.20147; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Macias J, 2011, HIV MED, V12, P14, DOI 10.1111/j.1468-1293.2010.00836.x; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; Moreno S, 2009, J VIRAL HEPATITIS, V16, P249, DOI 10.1111/j.1365-2893.2009.01088.x; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Murray KF, 2005, J PEDIATR GASTR NUTR, V41, P634, DOI 10.1097/01.mpg.0000179758.82919.1f; Nelson DR, 1997, J VIRAL HEPATITIS, V4, P29, DOI 10.1046/j.1365-2893.1997.00124.x; Nobili V, 2010, TRANSL RES, V156, P229, DOI 10.1016/j.trsl.2010.05.008; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Patel K, 2003, J GASTROEN HEPATOL, V18, P253, DOI 10.1046/j.1440-1746.2003.02930.x; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Plebani M, 2007, CLIN CHIM ACTA, V381, P39, DOI 10.1016/j.cca.2007.02.019; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Rallon NI, 2011, EUR J CLIN INVEST, V41, P70, DOI 10.1111/j.1365-2362.2010.02381.x; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Resino S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-244; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476, DOI 10.3748/wjg.v11.i4.476; Saltik-Temizel Inci Nur, 2004, Indian J Gastroenterol, V23, P129; Sanai FM, 2008, LIVER INT, V28, P1011, DOI 10.1111/j.1478-3231.2008.01733.x; Sanvisens A, 2009, J VIRAL HEPATITIS, V16, P513, DOI 10.1111/j.1365-2893.2009.01103.x; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; Soliman Gamal M. M., 2010, Journal of the Egyptian Society of Parasitology, V40, P759; Taniguchi H, 2004, J MED VIROL, V72, P52, DOI 10.1002/jmv.10545; Thampanitchawong P, 1999, WORLD J GASTROENTERO, V5, P301; THEISE N, 2007, MACSWEENS PATHOLOGY, P418	59	38	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23218	10.1371/journal.pone.0023218	http://dx.doi.org/10.1371/journal.pone.0023218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858035	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300020
J	Bonomelli, C; Doores, KJ; Dunlop, DC; Thaney, V; Dwek, RA; Burton, DR; Crispin, M; Scanlan, CN				Bonomelli, Camille; Doores, Katie J.; Dunlop, D. Cameron; Thaney, Victoria; Dwek, Raymond A.; Burton, Dennis R.; Crispin, Max; Scanlan, Christopher N.			The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SITE-SPECIFIC ANALYSIS; ANTIBODY 2G12; VACCINE DESIGN; LINKED OLIGOSACCHARIDES; ENVELOPE GLYCOPROTEINS; GP120; RECOGNITION; ANTIGENS; CELLS	The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design. The extent of cross-clade conservation of HIV oligomannose glycans is therefore a critical consideration for the development of HIV prophylaxes. We measured the oligomannose content of virion-associated gp120 from primary virus from PBMCs for a range of viral isolates and showed cross-clade elevation (62-79%) of these glycans relative to recombinant, monomeric gp120 (similar to 30%). We also confirmed that pseudoviral production systems can give rise to notably elevated gp120 oligomannose levels (similar to 98%), compared to gp120 derived from a single-plasmid viral system using the HIV(LAI) backbone (56%). This study highlights differences in glycosylation between virion-associated and recombinant gp120.	[Bonomelli, Camille; Dwek, Raymond A.; Crispin, Max; Scanlan, Christopher N.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Doores, Katie J.; Dunlop, D. Cameron; Thaney, Victoria; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Doores, Katie J.; Dunlop, D. Cameron; Thaney, Victoria; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Doores, Katie J.; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA USA	University of Oxford; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Bonomelli, C (corresponding author), Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England.	chris.scanlan@bioch.ox.ac.uk	Crispin, Max/AAG-4098-2020	Crispin, Max/0000-0002-1072-2694; Doores, Katie/0000-0002-5507-1725	International AIDS Vaccine Initiative [UOXFORCOA1101]; Glycobiology Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative; Glycobiology Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a project grant from the International AIDS Vaccine Initiative (#UOXFORCOA1101). CB was supported by a Glycobiology Institute graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal-Gamse C, 2011, J VIROL, V85, P470, DOI 10.1128/JVI.01349-10; Alexandre KB, 2010, VIROLOGY, V402, P187, DOI 10.1016/j.virol.2010.03.021; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Crispin M, 2009, J BIOL CHEM, V284, P21684, DOI 10.1074/jbc.M109.006254; CROOKS ET, 2011, J VIROL; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Dunlop DC, 2008, AIDS, V22, P2214, DOI 10.1097/QAD.0b013e328314b5df; Dunlop DC, 2010, GLYCOBIOLOGY, V20, P812, DOI 10.1093/glycob/cwq020; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Kabanova A, 2010, GLYCOCONJUGATE J, V27, P501, DOI 10.1007/s10719-010-9295-0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Lee HK, 2004, ANGEW CHEM INT EDIT, V43, P1000, DOI 10.1002/anie.200353105; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Luallen RJ, 2008, J VIROL, V82, P6447, DOI 10.1128/JVI.00412-08; Luallen RJ, 2010, GLYCOBIOLOGY, V20, P280, DOI 10.1093/glycob/cwp184; Luallen RJ, 2009, J VIROL, V83, P4861, DOI 10.1128/JVI.02537-08; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Provine NM, 2009, J VIROL, V83, P9002, DOI 10.1128/JVI.00423-09; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, J MOL BIOL, V372, P16, DOI 10.1016/j.jmb.2007.06.027; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shapiro J, 1997, J HISTOCHEM CYTOCHEM, V45, P3, DOI 10.1177/002215549704500102; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	46	171	173	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23521	10.1371/journal.pone.0023521	http://dx.doi.org/10.1371/journal.pone.0023521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858152	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000294125500036
J	Gasse, P; Riteau, N; Vacher, R; Michel, ML; Fautrel, A; di Padova, F; Fick, L; Charron, S; Lagente, V; Eberl, G; Le Bert, M; Quesniaux, VFJ; Huaux, F; Leite-de-Moraes, M; Ryffel, B; Couillin, I				Gasse, Pamela; Riteau, Nicolas; Vacher, Rachel; Michel, Marie-Laure; Fautrel, Alain; di Padova, Franco; Fick, Lizette; Charron, Sabine; Lagente, Vincent; Eberl, Gerard; Le Bert, Marc; Quesniaux, Valerie F. J.; Huaux, Francois; Leite-de-Moraes, Maria; Ryffel, Bernhard; Couillin, Isabelle			IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis	PLOS ONE			English	Article							DELTA-T-CELLS; COLLAGEN-INDUCED ARTHRITIS; ROR-GAMMA-T; NEUTROPHIL RECRUITMENT; AIRWAY NEUTROPHILIA; RECEPTOR ANTAGONIST; HELPER-CELLS; LUNG INJURY; TH17 CELLS; TGF-BETA	Background: Idiopathic pulmonary fibrosis is a devastating as yet untreatable disease. We demonstrated recently the predominant role of the NLRP3 inflammasome activation and IL-1 beta expression in the establishment of pulmonary inflammation and fibrosis in mice. Methods: The contribution of IL-23 or IL-17 in pulmonary inflammation and fibrosis was assessed using the bleomycin model in deficient mice. Results: We show that bleomycin or IL-1 beta-induced lung injury leads to increased expression of early IL-23p19, and IL-17A or IL-17F expression. Early IL-23p19 and IL-17A, but not IL-17F, and IL-17RA signaling are required for inflammatory response to BLM as shown with gene deficient mice or mice treated with neutralizing antibodies. Using FACS analysis, we show a very early IL-17A and IL-17F expression by ROR gamma t(+) gamma delta cells and to a lesser extent by CD4 alpha beta(+) T cells, but not by iNKT cells, 24 hrs after BLM administration. Moreover, IL-23p19 and IL-17A expressions or IL-17RA signaling are necessary to pulmonary TGF-beta 1 production, collagen deposition and evolution to fibrosis. Conclusions: Our findings demonstrate the existence of an early IL-1 beta-IL-23-IL-17A axis leading to pulmonary inflammation and fibrosis and identify innate IL-23 and IL-17A as interesting drug targets for IL-1 beta driven lung pathology.	[Gasse, Pamela; Riteau, Nicolas; Vacher, Rachel; Charron, Sabine; Le Bert, Marc; Quesniaux, Valerie F. J.; Ryffel, Bernhard; Couillin, Isabelle] Univ Orleans, Orleans, France; [Gasse, Pamela; Riteau, Nicolas; Vacher, Rachel; Charron, Sabine; Le Bert, Marc; Quesniaux, Valerie F. J.; Ryffel, Bernhard; Couillin, Isabelle] CNRS, UMR6218, F-45071 Orleans, France; [Michel, Marie-Laure; Leite-de-Moraes, Maria] Univ Paris 05, Paris, France; [Michel, Marie-Laure; Leite-de-Moraes, Maria] CNRS, UMR8147, Paris, France; [Fautrel, Alain] Univ Rennes 1, INSERM, U991, IFR140,Histopathol Platform H2P2, Rennes, France; [di Padova, Franco] Novartis Pharmaceut, Basel, Switzerland; [Fick, Lizette; Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Eberl, Gerard] Inst Pasteur, CNRS, URA 1961, Lab Lymphoid Tissue Dev, Paris, France; [Huaux, Francois] Catholic Univ Louvain, Brussels, Belgium; [Couillin, Isabelle] Key Obs SAS, Orleans, France	Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Novartis; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Catholique Louvain	Gasse, P (corresponding author), Univ Orleans, Orleans, France.	couillin@cnrs-orleans.fr	Riteau, Nicolas/ABC-1764-2020; Le Bert, Marc/AAR-4577-2021; Fautrel, Alain/AAL-7391-2020; Eberl, Gerard/A-1160-2013; de Moraes, Maria Leite/AAV-9159-2020	Riteau, Nicolas/0000-0003-1306-6466; Le Bert, Marc/0000-0002-5945-3800; de Moraes, Maria Leite/0000-0002-2891-2269; Eberl, Gerard/0000-0002-1119-5638; FAUTREL, Alain/0000-0002-3449-0779; Michel, Marie-Laure/0000-0003-2657-4662; Lagente, Vincent/0000-0003-4920-009X				Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Crossgrove K, 2008, MOL BIOCHEM PARASIT, V157, P92, DOI 10.1016/j.molbiopara.2007.08.010; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huaux F, 2002, J IMMUNOL, V169, P2653, DOI 10.4049/jimmunol.169.5.2653; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Joosten LAB, 2008, ARTHRITIS RHEUM-US, V58, P98, DOI 10.1002/art.23152; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Komura K, 2008, J RHEUMATOL, V35, P120; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pons J, 2005, EUR RESPIR J, V25, P441, DOI 10.1183/09031936.05.00069304; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Shainheit MG, 2008, J IMMUNOL, V181, P8559, DOI 10.4049/jimmunol.181.12.8559; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sparwasser T, 2004, GENESIS, V38, P39, DOI 10.1002/gene.10249; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Suga M, 2000, AM J RESP CRIT CARE, V162, P1949, DOI 10.1164/ajrccm.162.5.9906096; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	47	144	159	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23185	10.1371/journal.pone.0023185	http://dx.doi.org/10.1371/journal.pone.0023185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858022	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500019
J	Stehle, J; Voirin, N; Barrat, A; Cattuto, C; Isella, L; Pinton, JF; Quaggiotto, M; Van den Broeck, W; Regis, C; Lina, B; Vanhems, P				Stehle, Juliette; Voirin, Nicolas; Barrat, Alain; Cattuto, Ciro; Isella, Lorenzo; Pinton, Jean-Francois; Quaggiotto, Marco; Van den Broeck, Wouter; Regis, Corinne; Lina, Bruno; Vanhems, Philippe			High-Resolution Measurements of Face-to-Face Contact Patterns in a Primary School	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; TRANSMISSION PARAMETERS; SPREAD; INFLUENZA; NETWORKS; CHILDREN	Background: Little quantitative information is available on the mixing patterns of children in school environments. Describing and understanding contacts between children at school would help quantify the transmission opportunities of respiratory infections and identify situations within schools where the risk of transmission is higher. We report on measurements carried out in a French school (6-12 years children), where we collected data on the time-resolved face-to-face proximity of children and teachers using a proximity-sensing infrastructure based on radio frequency identification devices. Methods and Findings: Data on face-to-face interactions were collected on Thursday, October 1(st) and Friday, October 2(nd) 2009. We recorded 77,602 contact events between 242 individuals (232 children and 10 teachers). In this setting, each child has on average 323 contacts per day with 47 other children, leading to an average daily interaction time of 176 minutes. Most contacts are brief, but long contacts are also observed. Contacts occur mostly within each class, and each child spends on average three times more time in contact with classmates than with children of other classes. We describe the temporal evolution of the contact network and the trajectories followed by the children in the school, which constrain the contact patterns. We determine an exposure matrix aimed at informing mathematical models. This matrix exhibits a class and age structure which is very different from the homogeneous mixing hypothesis. Conclusions: We report on important properties of the contact patterns between school children that are relevant for modeling the propagation of diseases and for evaluating control measures. We discuss public health implications related to the management of schools in case of epidemics and pandemics. Our results can help define a prioritization of control measures based on preventive measures, case isolation, classes and school closures, that could reduce the disruption to education during epidemics.	[Stehle, Juliette; Barrat, Alain] CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France; [Voirin, Nicolas; Vanhems, Philippe] Hop Edouard Herriot, Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France; [Voirin, Nicolas; Regis, Corinne; Vanhems, Philippe] Univ Lyon 1, CNRS, Equipe Epidemiol & Sante Publ, Lab Biometrie & Biol Evolut,UMR 5558, F-69365 Lyon, France; [Barrat, Alain; Cattuto, Ciro; Isella, Lorenzo; Quaggiotto, Marco; Van den Broeck, Wouter] Inst Sci interchange ISI Fdn, Data Sci Lab, Turin, Italy; [Pinton, Jean-Francois] CNRS, UMR 5672, Ecole Normale Super, Phys Lab, Lyon, France; [Lina, Bruno] Hosp Civils Lyon, Natl Influenza Ctr, Virol Lab, Lyon, France; [Lina, Bruno] Univ Lyon, Fac Med, RTH Laennec, CNRS,VIRPATH,FRE 3011,UCBL, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Stehle, J (corresponding author), CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France.	alain.barrat@cpt.univ-mrs.fr	LINA, bruno/M-4572-2014; lina, bruno/N-3663-2019	lina, bruno/0000-0002-8959-2123; Quaggiotto, Marco/0000-0003-4195-2369; Voirin, Nicolas/0000-0003-3317-056X; Isella, Lorenzo/0000-0001-9525-4123	Programme de Recherche, A(H1N1); Institut de Microbiologie et Maladies Infectieuses; EC [233847]	Programme de Recherche, A(H1N1); Institut de Microbiologie et Maladies Infectieuses; EC(European CommissionEuropean Commission Joint Research Centre)	This project was partially supported by a grant from the "Programme de Recherche, A(H1N1)" co-ordinated by the "Institut de Microbiologie et Maladies Infectieuses". L.I. acknowledges the support of the EC FET-Open project DYNANETS (contract number 233847). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani H, 2009, LECT NOTES COMPUT SC, V5823, P698, DOI 10.1007/978-3-642-04930-9_44; [Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Conlan AJK, 2011, P ROY SOC B-BIOL SCI, V278, P1467, DOI 10.1098/rspb.2010.1807; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Hui P., 2005, P 2005 ACM SIGCOMM W; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Jackson C, 2011, EMERG INFECT DIS, V17, P245, DOI 10.3201/eid1702.100458; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; O'Neill E, 2006, LECT NOTES COMPUT SC, V4206, P315; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Zagheni E, 2008, AM J EPIDEMIOLOGY, V168	24	395	407	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23176	10.1371/journal.pone.0023176	http://dx.doi.org/10.1371/journal.pone.0023176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858018	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500017
J	Abdelkarim, M; Vintonenko, N; Starzec, A; Robles, A; Aubert, J; Martin, ML; Mourah, S; Podgorniak, MP; Rodrigues-Ferreira, S; Nahmias, C; Couraud, PO; Doliger, C; Sainte-Catherine, O; Peyri, N; Chen, L; Mariau, J; Etienne, M; Perret, GY; Crepin, M; Poyet, JL; Khatib, AM; Di Benedetto, M				Abdelkarim, Mohamed; Vintonenko, Nadejda; Starzec, Anna; Robles, Aniela; Aubert, Julie; Martin, Marie-Laure; Mourah, Samia; Podgorniak, Marie-Pierre; Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier; Doliger, Christelle; Sainte-Catherine, Odile; Peyri, Nicole; Chen, Lei; Mariau, Jeremie; Etienne, Monique; Perret, Gerard-Yves; Crepin, Michel; Poyet, Jean-Luc; Khatib, Abdel-Majid; Di Benedetto, Melanie			Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TGF-BETA; GROWTH; EXPRESSION; ANGIOGENESIS; CARCINOMA; PROTEINS	Introduction: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM) environment to this phenomenon, we isolated ECM surrogate invading cell populations from MDA-MB-231 breast cancer cells and studied their genotype and malignant phenotype. Methods: We isolated invasive subpopulations (INV) from non invasive populations (REF) using a 2D-Matrigel assay, a surrogate of basal membrane passage. INV and REF populations were investigated by microarray assay and for their capacities to adhere, invade and transmigrate in vitro, and to form metastases in nude mice. Results: REF and INV subpopulations were stable in culture and present different transcriptome profiles. INV cells were characterized by reduced expression of cell adhesion and cell-cell junction genes (44% of down regulated genes) and by a gain in expression of anti-apoptotic and pro-angiogenic gene sets. In line with this observation, in vitro INV cells showed reduced adhesion and increased motility through endothelial monolayers and fibronectin. When injected into the circulation, INV cells induced metastases formation, and reduced injected mice survival by up to 80% as compared to REF cells. In nude mice, INV xenografts grew rapidly inducing vessel formation and displaying resistance to apoptosis. Conclusion: Our findings reveal that the in vitro ECM microenvironment per se was sufficient to select for tumor cells with a stable metastatic phenotype in vivo characterized by loss of adhesion molecules expression and induction of proangiogenic and survival factors.	[Abdelkarim, Mohamed; Vintonenko, Nadejda; Robles, Aniela; Sainte-Catherine, Odile; Peyri, Nicole; Di Benedetto, Melanie] Univ Paris 13, CNRS FRE CSPBAT, UFR SMBH, Lab Chim Struct Biomol, Bobigny, France; [Abdelkarim, Mohamed; Vintonenko, Nadejda; Chen, Lei; Mariau, Jeremie; Crepin, Michel] INSERM 553 Endothelium & Angiogenese, Hemostase Lab, Paris, France; [Starzec, Anna; Perret, Gerard-Yves] Univ Paris 13, EA4222, Li2P, Bobigny, France; [Robles, Aniela; Mourah, Samia; Podgorniak, Marie-Pierre; Peyri, Nicole; Poyet, Jean-Luc; Khatib, Abdel-Majid; Di Benedetto, Melanie] Univ Paris 07, UMRS 940, Equipe Avenir, IGM, Paris, France; [Aubert, Julie; Martin, Marie-Laure] AgroParisTech, UMR 518, Paris, France; [Martin, Marie-Laure] URGV UMR INRA 1165 CNRS 8114 UEVE, Evry, France; [Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier] CNRS, UMR 8104, Paris, France; [Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier] Univ Paris 05, Paris, France; [Doliger, Christelle] Hop St Louis, Inst Hematol, Serv Commun Imagerie, Paris, France; [Etienne, Monique] Univ Paris 13, Histol Lab, Bobigny, France; [Khatib, Abdel-Majid] Univ Bordeaux 1, INSERM, U1029, Bordeaux, France	Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Abdelkarim, M (corresponding author), Univ Paris 13, CNRS FRE CSPBAT, UFR SMBH, Lab Chim Struct Biomol, Bobigny, France.	dibenedetto22@yahoo.fr	Di Benedetto, Melanie MD/C-1512-2018; AUBERT, Julie/D-9120-2011; abdelkarim, mohamed/AAK-5563-2020; AUBERT, Julie/AAJ-8960-2021; PERRET, gerard/A-7379-2008; KHATIB, Abdel-Majid/A-9948-2015; Poyet, Jean-Luc/G-7114-2017	Di Benedetto, Melanie MD/0000-0003-1119-3752; abdelkarim, mohamed/0000-0002-0984-6083; AUBERT, Julie/0000-0001-5203-5748; PERRET, gerard/0000-0003-0645-3337; KHATIB, Abdel-Majid/0000-0001-6957-0384; Poyet, Jean-Luc/0000-0002-3747-255X	"La Ligue nationale contre le cancer Comite Ile-de France'' the INCA [PL06_130]; Association pour la Recherche contre le Cancer (ARC); Association Martine Midy	"La Ligue nationale contre le cancer Comite Ile-de France'' the INCA; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Association Martine Midy	The authors thank "La Ligue nationale contre le cancer Comite Ile-de France'' the INCA PL06_130, the Association pour la Recherche contre le Cancer (ARC) and the Association Martine Midy for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004685; Aesoy R, 2008, MOL CANCER RES, V6, P1630, DOI 10.1158/1541-7786.MCR-07-2172; ALBINI A, 1987, CANCER RES, V47, P3239; AOKAGE K, 2010, INT J CANC IN PRESS; Bachelder RE, 2001, CANCER RES, V61, P5736; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; CUNHA GR, 1992, J ANDROL, V13, P465; De Angelis PM, 2004, INT J ONCOL, V24, P1279; Delmar P, 2005, BIOINFORMATICS, V21, P502, DOI 10.1093/bioinformatics/bti023; Di Benedetto M, 2006, GENE, V380, P127, DOI 10.1016/j.gene.2006.05.021; Di Benedetto M, 2003, BRIT J CANCER, V88, P1987, DOI 10.1038/sj.bjc.6600985; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Hamma-Kourbali Y, 2003, BIOCHEM BIOPH RES CO, V310, P816, DOI 10.1016/j.bbrc.2003.09.083; Haslam SZ, 2001, BREAST CANCER RES, V3, P365, DOI 10.1186/bcr324; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kleinman H K, 2001, Surg Oncol Clin N Am, V10, P329; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Kranz A, 1999, INT J CANCER, V84, P293, DOI 10.1002/(SICI)1097-0215(19990621)84:3<293::AID-IJC16>3.0.CO;2-T; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; PERRET GY, 2008, FUNDAMENTAL CLIN PHA, V5, P465; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Rajaraman R, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-25; Shekhar MPV, 2003, BREAST CANCER RES, V5, P130, DOI 10.1186/bcr580; Shekhar MPV, 2001, CANCER RES, V61, P1320; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney KJ, 1997, ONCOGENE, V14, P1329, DOI 10.1038/sj.onc.1200951; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Wang T, 2010, INT J CANCER, V126, P362, DOI 10.1002/ijc.24753; WEIGAND M, 2005, ANGIOGENESIS, V3, P197; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; WEISS L, 1986, J PATHOL, V150, P195, DOI 10.1002/path.1711500308; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yang L, 2010, CANCER METAST REV, V29, P263, DOI 10.1007/s10555-010-9226-3; Yang SH, 2007, BBA-MOL CELL RES, V1773, P903, DOI 10.1016/j.bbamcr.2007.03.021	46	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23334	10.1371/journal.pone.0023334	http://dx.doi.org/10.1371/journal.pone.0023334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858074	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953700016
J	Hashimoto, A; Hashimoto, S; Ando, R; Noda, K; Ogawa, E; Kotani, H; Hirose, M; Menju, T; Morishige, M; Manabe, T; Toda, Y; Ishida, S; Sabe, H				Hashimoto, Ari; Hashimoto, Shigeru; Ando, Ryo; Noda, Kosuke; Ogawa, Eiji; Kotani, Hirokazu; Hirose, Mayumi; Menju, Toshi; Morishige, Masaki; Manabe, Toshiaki; Toda, Yoshinobu; Ishida, Susumu; Sabe, Hisataka			GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; IN-VIVO; CHOROIDAL NEOVASCULARIZATION; SIGNALING PROMOTES; DRUG-RESISTANCE; VE-CADHERIN; ARF6; GROWTH; CELLS; PERMEABILITY	Angiogenesis and cancer invasiveness greatly contribute to cancer malignancy. Arf6 and its effector, AMAP1, are frequently overexpressed in breast cancer, and constitute a central pathway to induce the invasion and metastasis. In this pathway, Arf6 is activated by EGFR via GEP100. Arf6 is highly expressed also in human umbilical vein endothelial cells (HUVECs) and is implicated in angiogenesis. Here, we found that HUVECs also highly express AMAP1, and that vascular endothelial growth factor receptor-2 (VEGFR2) recruits GEP100 to activate Arf6. AMAP1 functions by binding to cortactin in cancer invasion and metastasis. We demonstrate that the same GEP100-Arf6-AMAP1-cortactin pathway is essential for angiogenesis activities, including cell migration and tubular formation, as well as for the enhancement of cell permeability and VE-cadherin endocytosis of VEGF-stimulated HUVECs. Components of this pathway are highly expressed in pathologic angiogenesis, and blocking of this pathway effectively inhibits VEGF-or tumor-induced angiogenesis and choroidal neovascularization. The GEP100-Arf6-AMAP1-cortactin pathway, activated by receptor tyrosine kinases, appears to be common in angiogenesis and cancer invasion and metastasis, and provides their new therapeutic targets.	[Hashimoto, Ari; Hashimoto, Shigeru; Sabe, Hisataka] Hokkaido Univ, Dept Mol Biol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hashimoto, Ari; Hashimoto, Shigeru; Ogawa, Eiji; Menju, Toshi; Morishige, Masaki; Sabe, Hisataka] Osaka Biosci Inst, Dept Mol Biol, Suita, Osaka 565, Japan; [Ando, Ryo; Noda, Kosuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Ogawa, Eiji; Manabe, Toshiaki] Kyoto Univ, Fac Med, Lab Diagnost Pathol, Kyoto, Japan; [Ogawa, Eiji; Kotani, Hirokazu; Menju, Toshi] Kyoto Univ, Fac Med, Dept Thorac Surg, Kyoto, Japan; [Kotani, Hirokazu; Toda, Yoshinobu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto, Japan; [Hirose, Mayumi] Osaka Univ, Inst Prot Res, Lab Supramol Crystallog, Osaka, Japan; [Morishige, Masaki] Oita Univ, Sch Med, Dept Neurosurg, Oita 87011, Japan	Hokkaido University; Hokkaido University; Kyoto University; Kyoto University; Kyoto University; Osaka University; Oita University	Hashimoto, A (corresponding author), Hokkaido Univ, Dept Mol Biol, Grad Sch Med, Sapporo, Hokkaido, Japan.	sabeh@med.hokudai.ac.jp	Sabe, Hisataka/A-4066-2012; Hashimoto, Shigeru/D-7138-2012; まゆみ, 廣瀬/AAK-5735-2020; ISHIDA, SUSUMU/D-7067-2012; Hashimoto, Ari/D-7125-2012; Sabe, Hisataka/GPF-4385-2022	Menju, Toshi/0000-0002-7341-6002	Ministry of Education, Science, Sports and Culture of Japan (MESSC); Takeda Science Foundation; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [23590323] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan (MESSC)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (MESSC), the Takeda Science Foundation, and the Mitsubishi Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hashimoto S, 2004, J BIOL CHEM, V279, P37677, DOI 10.1074/jbc.M404196200; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; KAWAI Y, AM J PHYSL CELL PHYS, V295, pC1123; Kerbel RS, 2001, CANCER METAST REV, V20, P1, DOI 10.1023/A:1013129128673; LIOTTA LA, 2003, CANC MED, P151; MADRI JA, 1986, J HISTOCHEM CYTOCHEM, V34, P85, DOI 10.1177/34.1.2416801; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987	49	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23359	10.1371/journal.pone.0023359	http://dx.doi.org/10.1371/journal.pone.0023359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858086	Green Published, gold			2022-12-27	WOS:000293953700018
J	Ren, HY; Zhang, XJ; Song, ZY; Rupert, W; Gao, GJ; Guo, SX; Zhao, LP				Ren, Hong-Yan; Zhang, Xiao-Jun; Song, Zhi-yong; Rupert, Wieger; Gao, Guang-Jun; Guo, Sheng-xue; Zhao, Li-Ping			Comparison of Microbial Community Compositions of Injection and Production Well Samples in a Long-Term Water-Flooded Petroleum Reservoir	PLOS ONE			English	Article							CONTINENTAL HIGH-TEMPERATURE; PHYLOGENETIC DIVERSITY; NORTH-SEA; OIL-FIELD; SP-NOV.; BACTERIAL; ASSEMBLAGES; ARCHAEA	Water flooding plays an important role in recovering oil from depleted petroleum reservoirs. Exactly how the microbial communities of production wells are affected by microorganisms introduced with injected water has previously not been adequately studied. Using denaturing gradient gel electrophoresis (DGGE) approach and 16S rRNA gene clone library analysis, the comparison of microbial communities is carried out between one injection water and two production waters collected from a working block of the water-flooded Gudao petroleum reservoir located in the Yellow River Delta. DGGE fingerprints showed that the similarities of the bacterial communities between the injection water and production waters were lower than between the two production waters. It was also observed that the archaeal composition among these three samples showed no significant difference. Analysis of the 16S rRNA gene clone libraries showed that the dominant groups within the injection water were Betaproteobacteria, Gammaproteobacteria and Methanomicrobia, while the dominant groups in the production waters were Gammaproteobacteria and Methanobacteria. Only 2 out of 54 bacterial operational taxonomic units (OTUs) and 5 out of 17 archaeal OTUs in the injection water were detected in the production waters, indicating that most of the microorganisms introduced by the injection water may not survive to be detected in the production waters. Additionally, there were 55.6% and 82.6% unique OTUs in the two production waters respectively, suggesting that each production well has its specific microbial composition, despite both wells being flooded with the same injection water.	[Ren, Hong-Yan; Zhang, Xiao-Jun; Rupert, Wieger; Zhao, Li-Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Ren, Hong-Yan; Zhang, Xiao-Jun; Rupert, Wieger; Zhao, Li-Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Song, Zhi-yong; Gao, Guang-Jun; Guo, Sheng-xue] Shengli Oil Field Ltd, Inst Oil Recovery Res, Dongying, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ren, HY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xjzhangsjtu@gmail.com	Zhang, Xiaojun/AAH-2256-2019; Zhang, Xiaojun/E-9521-2016	Zhang, Xiaojun/0000-0002-4559-0177; Zhang, Xiaojun/0000-0002-4559-0177; Song, Zhiyong/0000-0002-0352-5051	National Natural Science Foundation of China [NSFC 20677041]; National "863'' High-tech RD Program [2007AA021301]; Shanghai Leading Academic Discipline Project [B203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "863'' High-tech RD Program(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was financially supported by National Natural Science Foundation of China (NSFC 20677041), and National "863'' High-tech R&D Program (2007AA021301), and the Shanghai Leading Academic Discipline Project (B203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahring BK, 2001, WATER RES, V35, P2446, DOI 10.1016/S0043-1354(00)00526-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Bastin ES, 1926, SCIENCE, V63, P21, DOI 10.1126/science.63.1618.21; Bodtker G, 2009, J IND MICROBIOL BIOT, V36, P439, DOI 10.1007/s10295-008-0515-6; Bonch-Osmolovskaya EA, 2003, APPL ENVIRON MICROB, V69, P6143, DOI 10.1128/AEM.69.10.6143-6151.2003; Bowman JP, 1996, INT J SYST BACTERIOL, V46, P841, DOI 10.1099/00207713-46-4-841; Brakstad OG, 2008, MICROB ECOL, V55, P540, DOI 10.1007/s00248-007-9299-x; Brakstad OG, 2008, INT J OIL GAS COAL T, V1, P211, DOI 10.1504/IJOGCT.2008.019843; Brown LR, 2010, CURR OPIN MICROBIOL, V13, P316, DOI 10.1016/j.mib.2010.01.011; Celik GY, 2008, J ENVIRON BIOL, V29, P867; Cheng L, 2008, FEMS MICROBIOL LETT, V285, P65, DOI 10.1111/j.1574-6968.2008.01212.x; Dahle H, 2008, ANTON LEEUW INT J G, V93, P37, DOI 10.1007/s10482-007-9177-z; Grassia GS, 1996, FEMS MICROBIOL ECOL, V21, P47; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Hubert C, 2009, SCIENCE, V325, P1541, DOI 10.1126/science.1174012; JACK TR, 1991, DEV PETR SCI, V31, P433; Jones B, 2003, PALAIOS, V18, P87, DOI 10.1669/0883-1351(2003)18<87:SMIAGM>2.0.CO;2; LANE DJ, 1991, NUCL ACID TECHNIQUES, P5; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Li H, 2007, CURR MICROBIOL, V55, P382, DOI 10.1007/s00284-007-9002-y; Li H, 2007, FEMS MICROBIOL ECOL, V60, P74, DOI 10.1111/j.1574-6941.2006.00266.x; Li X., 2008, ACTA MICROBIOLOGICA, V48, P1574; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Pornsunthorntawee O, 2008, BIOCHEM ENG J, V42, P172, DOI 10.1016/j.bej.2008.06.016; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1241, DOI 10.1128/AEM.60.4.1241-1248.1994; Romanenko LA, 2005, J GEN APPL MICROBIOL, V51, P65, DOI 10.2323/jgam.51.65; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; [佘跃惠 She Yuehui], 2005, [生态学报, Acta Ecologica Sinica], V25, P237; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Vela AI, 2003, INT J SYST EVOL MICR, V53, P415, DOI 10.1099/ijs.0.02413-0; Wentzel A, 2007, APPL MICROBIOL BIOT, V76, P1209, DOI 10.1007/s00253-007-1119-1; Whitby C., 2009, 2 INT S APPL MICROBI; Yoshida N, 2005, J BIOSCI BIOENG, V99, P143, DOI 10.1263/jbb.99.143; Yuan San-qing, 2007, Weishengwu Xuebao, V47, P290; Zhang ML, 2007, J CLIN MICROBIOL, V45, P496, DOI 10.1128/JCM.01720-06	44	68	76	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23258	10.1371/journal.pone.0023258	http://dx.doi.org/10.1371/journal.pone.0023258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858049	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700012
J	Shahin, K; Doran, PM				Shahin, Kifah; Doran, Pauline M.			Strategies for Enhancing the Accumulation and Retention of Extracellular Matrix in Tissue-Engineered Cartilage Cultured in Bioreactors	PLOS ONE			English	Article							POLYGLYCOLIC ACID SCAFFOLDS; ARTICULAR CHONDROCYTES; MECHANICAL-PROPERTIES; GEL-ELECTROPHORESIS; IN-VITRO; PROTEOGLYCANS; DIFFERENTIATION; EXPRESSION; PERFUSION; FETAL	Production of tissue-engineered cartilage involves the synthesis and accumulation of key constituents such as glycosaminoglycan (GAG) and collagen type II to form insoluble extracellular matrix (ECM). During cartilage culture, macromolecular components are released from nascent tissues into the medium, representing a significant waste of biosynthetic resources. This work was aimed at developing strategies for improving ECM retention in cartilage constructs and thus the quality of engineered tissues produced in bioreactors. Human chondrocytes seeded into polyglycolic acid (PGA) scaffolds were cultured in perfusion bioreactors for up to 5 weeks. Analysis of the size and integrity of proteoglycans in the constructs and medium showed that full-sized aggrecan was being stripped from the tissues without proteolytic degradation. Application of low (0.075 mL min(-1)) and gradually increasing (0.075-0.2 mL min(-1)) medium flow rates in the bioreactor resulted in the generation of larger constructs, a 4.0-4.4-fold increase in the percentage of GAG retained in the ECM, and a 4.8-5.2-fold increase in GAG concentration in the tissues compared with operation at 0.2 mL min(-1). GAG retention was also improved by pre-culturing seeded scaffolds in flasks for 5 days prior to bioreactor culture. In contrast, GAG retention in PGA scaffolds infused with alginate hydrogel did not vary significantly with medium flow rate or pre-culture treatment. This work demonstrates that substantial improvements in cartilage quality can be achieved using scaffold and bioreactor culture strategies that specifically target and improve ECM retention.	[Shahin, Kifah] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Doran, Pauline M.] Monash Univ, Sch Biol Sci, Dept Chem Engn, Melbourne, Vic 3004, Australia	University of New South Wales Sydney; Monash University	Shahin, K (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	pauline.doran@monash.edu			Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	This work was funded by the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]; Choi BY, 2002, INT J PHARMACEUT, V239, P81, DOI 10.1016/S0378-5173(02)00054-6; Cioffi M, 2006, BIOTECHNOL BIOENG, V93, P500, DOI 10.1002/bit.20740; Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492; Davisson T, 2002, TISSUE ENG, V8, P807, DOI 10.1089/10763270260424169; Devarapalli M, 2009, BIOTECHNOL BIOENG, V103, P1003, DOI 10.1002/bit.22333; Dodge G R, 2001, Methods Mol Biol, V171, P149; Duda GN, 2000, J BIOMED MATER RES, V53, P673, DOI 10.1002/1097-4636(2000)53:6<673::AID-JBM9>3.0.CO;2-V; DUNKELMAN NS, 1995, BIOTECHNOL BIOENG, V46, P299, DOI 10.1002/bit.260460402; Eichhorn SJ, 2010, J R SOC INTERFACE, V7, P641, DOI 10.1098/rsif.2009.0374; Feng C, 2010, J BIOMED MATER RES A, V94A, P317, DOI 10.1002/jbm.a.32729; Fertala A, 1996, J BIOL CHEM, V271, P14864, DOI 10.1074/jbc.271.25.14864; FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710; Freyria AM, 2005, TISSUE ENG, V11, P674, DOI 10.1089/ten.2005.11.674; Freyria AM, 2004, BIOMATERIALS, V25, P687, DOI 10.1016/S0142-9612(03)00568-4; Garvican ER, 2010, VET J, V185, P36, DOI 10.1016/j.tvjl.2010.04.011; Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469; Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q; Hardmeier R, 2010, J TISSUE ENG REGEN M, V4, P1, DOI 10.1002/term.211; HAUSELMANN HJ, 1992, MATRIX, V12, P116; Heath CA, 1996, BIOTECHNOL BIOENG, V50, P430, DOI 10.1002/(SICI)1097-0290(19960520)50:4<430::AID-BIT10>3.0.CO;2-N; HEINEGARD D, 1985, ANAL BIOCHEM, V151, P41, DOI 10.1016/0003-2697(85)90050-8; Kinner B, 2001, J ORTHOP RES, V19, P233, DOI 10.1016/S0736-0266(00)00081-4; LAVIETES BB, 1971, EXP CELL RES, V68, P43, DOI 10.1016/0014-4827(71)90584-2; Mahmoudifar N, 2005, BIOTECHNOL BIOENG, V91, P338, DOI 10.1002/bit.20490; MAHMOUDIFAR N, 2007, MAT SCI RES HORIZONS, P171; Mahmoudifar N, 2006, TISSUE ENG, V12, P1675, DOI 10.1089/ten.2006.12.1675; Mahmoudifar N, 2010, BIOTECHNOL BIOENG, V107, P393, DOI 10.1002/bit.22798; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; MCDEVITT CA, 1971, ANAL BIOCHEM, V44, P612, DOI 10.1016/0003-2697(71)90250-8; McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V; Mow Van C., 1997, P113; Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997; Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v; Pierre J, 2008, BIOMECH MODEL MECHAN, V7, P497, DOI 10.1007/s10237-007-0107-9; Sandy J D, 2001, Methods Mol Biol, V171, P335; Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1; Shahin K, 2011, BIOTECHNOL PROGR, V27, P191, DOI 10.1002/btpr.509; Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345; VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323; Yanagishita M, 2001, Methods Mol Biol, V171, P3	44	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23119	10.1371/journal.pone.0023119	http://dx.doi.org/10.1371/journal.pone.0023119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858004	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700004
J	Wei, HY; Masterson, SP; Petry, HM; Bickford, ME				Wei, Haiyang; Masterson, Sean P.; Petry, Heywood M.; Bickford, Martha E.			Diffuse and Specific Tectopulvinar Terminals in the Tree Shrew: Synapses, Synapsins, and Synaptic Potentials	PLOS ONE			English	Article							DORSAL LATERAL GENICULATE; VESICULAR GLUTAMATE TRANSPORTERS; PROTEIN-KINASE-II; PULVINAR NUCLEUS; THALAMOCORTICAL NEURONS; PERIGENICULATE NUCLEUS; SUPERIOR COLLICULUS; ORGANIZATION; PROJECTIONS; CORTEX	The pulvinar nucleus of the tree shrew receives both topographic (specific) and nontopographic (diffuse) projections from superior colliculus (SC), which form distinct synaptic arrangements. We characterized the physiological properties of these synapses and describe two distinct types of excitatory postsynaptic potentials (EPSPs) that correlate with structural properties of the specific and diffuse terminals. Synapses formed by specific terminals were found to be significantly longer than those formed by diffuse terminals. Stimulation of these two terminal types elicited two types of EPSPs that differed in their latency and threshold amplitudes. In addition, in response to repetitive stimulation (0.5-20 Hz) one type of EPSP displayed frequency-dependent depression whereas the amplitudes of the second type of EPSP were not changed by repetitive stimulation of up to 20Hz. To relate these features to vesicle release, we compared the synapsin content of terminals in the pulvinar nucleus and the dorsal lateral geniculate (dLGN) by combining immunohistochemical staining for synapsin I or II with staining for the type 1 or type 2 vesicular glutamate transporters (markers for corticothalamic and tectothalamic/retinogeniculate terminals, respectively). We found that retinogeniculate terminals do not contain either synapsin I or synapsin II, corticothalamic terminals in the dLGN and pulvinar contain synapsin I, but not synapsin II, whereas tectopulvinar terminals contain both synapsin I and synapsin II. Finally, both types of EPSPs showed a graded increase in amplitude with increasing stimulation intensity, suggesting convergence; this was confirmed using a combination of anterograde tract tracing and immunocytochemisty. We suggest that the convergent synaptic arrangements, as well as the unique synapsin content of tectopulvinar terminals, allow them to relay a dynamic range of visual signals from the SC.	[Wei, Haiyang; Masterson, Sean P.; Bickford, Martha E.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Petry, Heywood M.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Wei, HY (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	martha.bickford@louisville.edu		Wei, Haiyang/0000-0002-0145-9353	National Institutes of Health [EY01655, NS35377]; NATIONAL EYE INSTITUTE [R01EY001655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035377, R01NS035377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Grant sponsor: National Institutes of Health, Grant Number EY01655 and Grant Number NS35377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANO JE, 1978, J NEUROPHYSIOL, V41, P1140, DOI 10.1152/jn.1978.41.5.1140; Baldauf ZB, 2005, J COMP NEUROL, V485, P87, DOI 10.1002/cne.20480; BENFENATI F, 1991, P NATL ACAD SCI USA, V88, P575, DOI 10.1073/pnas.88.2.575; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; Bickford ME, 2010, J COMP NEUROL, V518, P622, DOI 10.1002/cne.22223; Bickford ME, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-17-j0004.1999; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; BRUNSOBECHTOLD JK, 1985, DEV BRAIN RES, V23, P310, DOI 10.1016/0165-3806(85)90057-4; CASSEDAY JH, 1979, J COMP NEUROL, V185, P253, DOI 10.1002/cne.901850204; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chomsung RD, 2008, J COMP NEUROL, V510, P24, DOI 10.1002/cne.21763; Chomsung RD, 2010, CEREB CORTEX, V20, P997, DOI 10.1093/cercor/bhp162; Day-Brown JD, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00143; De Graan P N, 1990, Adv Exp Med Biol, V268, P347; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Erisir A, 1997, P NATL ACAD SCI USA, V94, P1517, DOI 10.1073/pnas.94.4.1517; FITZPATRICK D, 1988, J COMP NEUROL, V272, P43, DOI 10.1002/cne.902720105; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Gitler D, 2008, J NEUROSCI, V28, P10835, DOI 10.1523/JNEUROSCI.0924-08.2008; GRAHAM J, 1980, J COMP NEUROL, V191, P133, DOI 10.1002/cne.901910108; Granseth B, 2002, J PHYSIOL-LONDON, V544, P477, DOI 10.1113/jphysiol.2002.024703; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P1, DOI 10.1007/BF00321474; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kelly LR, 2003, J COMP NEUROL, V464, P472, DOI 10.1002/cne.10800; Kielland A, 2002, J PHYSIOL-LONDON, V542, P99, DOI 10.1113/jphysiol.2002.019240; Kielland A, 2006, J NEUROSCI, V26, P5786, DOI 10.1523/JNEUROSCI.4631-05.2006; Li JL, 2003, J NEUROPHYSIOL, V90, P3429, DOI 10.1152/jn.00456.2003; Li JL, 2003, J COMP NEUROL, V460, P394, DOI 10.1002/cne.10646; LINDSTROM S, 1990, EXP BRAIN RES, V79, P313, DOI 10.1007/BF00608240; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LUPPINO G, 1988, J COMP NEUROL, V273, P67, DOI 10.1002/cne.902730107; Lyon DC, 2003, J COMP NEUROL, V467, P593, DOI 10.1002/cne.10939; Masterson SP, 2010, J NEUROPHYSIOL, V104, P1758, DOI 10.1152/jn.00010.2010; Masterson SP, 2009, J COMP NEUROL, V515, P647, DOI 10.1002/cne.22077; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MONTERO VM, 1989, EXP BRAIN RES, V75, P65; MOONEY RD, 1984, J NEUROPHYSIOL, V51, P407, DOI 10.1152/jn.1984.51.3.407; OGREN MP, 1979, J COMP NEUROL, V188, P147, DOI 10.1002/cne.901880112; OGREN MP, 1979, J COMP NEUROL, V188, P179, DOI 10.1002/cne.901880113; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; ROBSON JA, 1977, J COMP NEUROL, V173, P389, DOI 10.1002/cne.901730211; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Samigullin D, 2004, J PHYSIOL-LONDON, V561, P149, DOI 10.1113/jphysiol.2004.073494; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Smith PH, 2007, J NEUROPHYSIOL, V98, P681, DOI 10.1152/jn.00235.2007; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; WILSON JR, 1993, ACTA ANAT, V147, P1	61	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23781	10.1371/journal.pone.0023781	http://dx.doi.org/10.1371/journal.pone.0023781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858222	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700042
J	Yang, JS; Nam, HJ; Seo, M; Han, SK; Choi, Y; Nam, HG; Lee, SJ; Kim, S				Yang, Jae-Seong; Nam, Hyun-Jun; Seo, Mihwa; Han, Seong Kyu; Choi, Yonghwan; Nam, Hong Gil; Lee, Seung-Jae; Kim, Sanguk			OASIS: Online Application for the Survival Analysis of Lifespan Assays Performed in Aging Research	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; LONGEVITY; DAF-16; INGESTION; ONSET; LONG; MICE	Background: Aging is a fundamental biological process. Characterization of genetic and environmental factors that influence lifespan is a crucial step toward understanding the mechanisms of aging at the organism level. To capture the different effects of genetic and environmental factors on lifespan, appropriate statistical analyses are needed. Methodology/Principal Findings: We developed an online application for survival analysis (OASIS) that helps conduct various novel statistical tasks involved in analyzing survival data in a user-friendly manner. OASIS provides standard survival analysis results including Kaplan-Meier estimates and mean/median survival time by taking censored survival data. OASIS also provides various statistical tests including comparison of mean survival time, overall survival curve, and survival rate at specific time point. To visualize survival data, OASIS generates survival and log cumulative hazard plots that enable researchers to easily interpret their experimental results. Furthermore, we provide statistical methods that can analyze variances among survival datasets. In addition, users can analyze proportional effects of risk factors on survival. Conclusions/Significance: OASIS provides a platform that is essential to facilitate efficient statistical analyses of survival data in the field of aging research. Web application and a detailed description of algorithms are accessible from http://sbi.postech.ac.kr/oasis.	[Yang, Jae-Seong; Nam, Hyun-Jun; Seo, Mihwa; Choi, Yonghwan; Nam, Hong Gil; Lee, Seung-Jae; Kim, Sanguk] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Han, Seong Kyu; Nam, Hong Gil; Lee, Seung-Jae; Kim, Sanguk] Pohang Univ Sci & Technol, Dept Mol Life Sci, Pohang, South Korea; [Lee, Seung-Jae; Kim, Sanguk] Pohang Univ Sci & Technol, World Class Univ Informat Technol Convergence Eng, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Yang, JS (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	seungjaelee@postech.ac.kr; sukim@postech.ac.kr	Yang, Jae-Seong/AAH-6965-2019; Lee, Seung Jae V/E-2468-2019	Yang, Jae-Seong/0000-0001-9910-3170; Lee, Seung-Jae/0000-0002-6103-156X; Kim, Sanguk/0000-0002-3449-3814	National Core Research Center for Systems Bio-Dynamics [20090091509]; World Class University [R31-2010-000-10100-0]; POSTECH BRI	National Core Research Center for Systems Bio-Dynamics; World Class University; POSTECH BRI	This work was supported by the National Core Research Center for Systems Bio-Dynamics (20090091509); World Class University program (R31-2010-000-10100-0), and POSTECH BRI Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 2005, BIOL LETT-UK, V1, P276, DOI 10.1098/rsbl.2005.0318; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; COX DR, 1972, J R STAT SOC B, V34, P187; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fleming TR, 1991, COUNTING PROCESSES S; Gallagher IM, 2000, NEUROSCI LETT, V289, P221, DOI 10.1016/S0304-3940(00)01279-9; Guarente L, 2007, MOL BIOL AGING; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kraus D, 2009, J STAT PLAN INFER, V139, P3559, DOI 10.1016/j.jspi.2009.04.009; Lambert HE, 2004, INT J GYNECOL CANCER, V14, P772, DOI 10.1111/j.1048-891X.2004.014507.x; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Li WQ, 2000, DEV BIOL, V218, P172, DOI 10.1006/dbio.1999.9593; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LUDER HU, 1993, MECH AGEING DEV, V67, P247, DOI 10.1016/0047-6374(93)90003-A; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; MILLER RG, 1983, BIOMETRICS, V39, P1077, DOI 10.2307/2531341; Minder CE, 1996, STAT MED, V15, P1033, DOI 10.1002/(SICI)1097-0258(19960530)15:10<1033::AID-SIM215>3.0.CO;2-Y; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PETO R, 1973, BIOMETRICS, V29, P579, DOI 10.2307/2529177; Promislow DEL, 1996, GENETICS, V143, P839; *R DEV COR TEAM, 2008, R DEV COR TEAM CONTR; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Sheridan RL, 2000, ARCH PEDIAT ADOL MED, V154, P245, DOI 10.1001/archpedi.154.3.245; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; WU D, 2009, EXP GERONTOL	42	198	198	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23525	10.1371/journal.pone.0023525	http://dx.doi.org/10.1371/journal.pone.0023525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858155	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953700030
J	Yan, CG; He, Y				Yan, Chaogan; He, Yong			Driving and Driven Architectures of Directed Small-World Human Brain Functional Networks	PLOS ONE			English	Article							DEFAULT-MODE; GRANGER CAUSALITY; BASAL GANGLIA; MODULAR ORGANIZATION; CORTICAL THICKNESS; LOW-FREQUENCY; CONNECTIVITY; CORTEX; FMRI; MRI	Recently, increasing attention has been focused on the investigation of the human brain connectome that describes the patterns of structural and functional connectivity networks of the human brain. Many studies of the human connectome have demonstrated that the brain network follows a small-world topology with an intrinsically cohesive modular structure and includes several network hubs in the medial parietal regions. However, most of these studies have only focused on undirected connections between regions in which the directions of information flow are not taken into account. How the brain regions causally influence each other and how the directed network of human brain is topologically organized remain largely unknown. Here, we applied linear multivariate Granger causality analysis (GCA) and graph theoretical approaches to a resting-state functional MRI dataset with a large cohort of young healthy participants (n = 86) to explore connectivity patterns of the population-based whole-brain functional directed network. This directed brain network exhibited prominent small-world properties, which obviously improved previous results of functional MRI studies showing weak small-world properties in the directed brain networks in terms of a kernel-based GCA and individual analysis. This brain network also showed significant modular structures associated with 5 well known subsystems: fronto-parietal, visual, paralimbic/limbic, subcortical and primary systems. Importantly, we identified several driving hubs predominantly located in the components of the attentional network (e. g., the inferior frontal gyrus, supplementary motor area, insula and fusiform gyrus) and several driven hubs predominantly located in the components of the default mode network (e. g., the precuneus, posterior cingulate gyrus, medial prefrontal cortex and inferior parietal lobule). Further split-half analyses indicated that our results were highly reproducible between two independent subgroups. The current study demonstrated the directions of spontaneous information flow and causal influences in the directed brain networks, thus providing new insights into our understanding of human brain functional connectome.	[Yan, Chaogan; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Yan, CG (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	Yan, Chao-Gan/D-1713-2015; He, Yong/Q-5756-2018; He, Yong/C-2161-2009	Yan, Chao-Gan/0000-0003-3413-5977; 	National Natural Science Foundation of China [81030028, 30870667]; Beijing Municipal Natural Science Foundation [7102090]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry); Beijing Normal University [08046]; Ministry of Education, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Beijing Normal University; Ministry of Education, China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81030028 and 30870667), Beijing Municipal Natural Science Foundation (Grant No. 7102090), the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry, YH), Fund for Outstanding Doctoral Dissertation of Beijing Normal University (08046, CY) and Fund for Outstanding Young Scholar (for doctoral candidates, Ministry of Education, China, CY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BARBAS H, 1995, NEUROSCI BIOBEHAV R, V19, P499, DOI 10.1016/0149-7634(94)00053-4; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Booth JR, 2007, BRAIN RES, V1133, P136, DOI 10.1016/j.brainres.2006.11.074; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; da Silva FL, 2004, MAGN RESON IMAGING, V22, P1533, DOI 10.1016/j.mri.2004.10.010; David O, NEUROIMAGE IN PRESS; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston K, NEUROIMAGE IN PRESS; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gomez-Herrero G, 2008, NEUROIMAGE, V43, P497, DOI 10.1016/j.neuroimage.2008.07.032; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Marinazzo D, 2011, NEUROIMAGE, V58, P330, DOI 10.1016/j.neuroimage.2010.01.099; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MICHEL CM, 1992, ELECTROEN CLIN NEURO, V82, P38, DOI 10.1016/0013-4694(92)90180-P; Nakano K, 2000, J NEUROL, V247, P1; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Roebroeck A, NEUROIMAGE IN PRESS; Rosa MJ, 2010, NEUROIMAGE, V49, P1496, DOI 10.1016/j.neuroimage.2009.09.011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	93	45	48	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23460	10.1371/journal.pone.0023460	http://dx.doi.org/10.1371/journal.pone.0023460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858129	Green Published, gold			2022-12-27	WOS:000293953500044
J	Yurkov, AM; Kemler, M; Begerow, D				Yurkov, Andrey M.; Kemler, Martin; Begerow, Dominik			Species Accumulation Curves and Incidence-Based Species Richness Estimators to Appraise the Diversity of Cultivable Yeasts from Beech Forest Soils	PLOS ONE			English	Article							BASIDIOMYCETOUS YEAST; POLYPHASIC TAXONOMY; COMMUNITY STRUCTURE; POPULATION-SIZE; GEN. NOV.; FUNGI; IDENTIFICATION; BIODIVERSITY; RHODOTORULA; SYSTEMATICS	Background: Yeast-like fungi inhabit soils throughout all climatic zones in a great abundance. While recent estimations predicted a plethora of prokaryotic taxa in one gram of soil, similar data are lacking for fungi, especially yeasts. Methodology/Principal Findings: We assessed the diversity of soil yeasts in different forests of central Germany using cultivation-based techniques with subsequent identification based on rDNA sequence data. Based on experiments using various pre-cultivation sample treatment and different cultivation media we obtained the highest number of yeasts by analysing mixed soil samples with a single nutrient-rich medium. Additionally, several species richness estimators were applied to incidence-based data of 165 samples. All of them predicted a similar range of yeast diversity, namely 14 to 16 species. Randomized species richness curves reached saturation in all applied estimators, thus indicating that the majority of species is detected after approximately 30 to 50 samples analysed. Conclusions/Significance: In this study we demonstrate that robust species identification as well as mathematical approaches are essential to reliably estimate the sampling effort needed to describe soil yeast communities. This approach has great potential for optimisation of cultivation techniques and allows high throughput analysis in the future.	[Yurkov, Andrey M.; Kemler, Martin; Begerow, Dominik] Ruhr Univ Bochum, Dept Evolut & Biodivers Plants, Fac Biol & Biotechnol, Bochum, Germany; [Kemler, Martin] Univ Pretoria, Ctr Excellence Tree Hlth Biotechnol, FABI, ZA-0002 Pretoria, South Africa	Ruhr University Bochum; National Research Foundation - South Africa; University of Pretoria	Yurkov, AM (corresponding author), Ruhr Univ Bochum, Dept Evolut & Biodivers Plants, Fac Biol & Biotechnol, Bochum, Germany.	andrey.yurkov@rub.de	Kemler, Martin/GSD-6740-2022; Yurkov, Andrey M./E-7854-2011	Kemler, Martin/0000-0002-0738-4233; Yurkov, Andrey M./0000-0002-1072-5166; Begerow, Dominik/0000-0002-8286-1597	German Research Foundation (DFG) [BE 2201/9-1]; German Academic Exchange Service (DAAD) [A/07/94549]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was funded by the German Research Foundation (DFG) Priority Program 1374 "Biodiversity Exploratories" (BE 2201/9-1) and by the German Academic Exchange Service (DAAD) Program "Sustainable forestry and forest products" (A/07/94549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AD-HOC-AG BODEN, 2005, BOD KART KA5; Bab'eva IP, 1995, PHYSL GEN BIOL REV 3, V9, P1; Babjeva IP, 1987, SOIL YEASTS, P87; Barnett JA, 2004, YEAST, V21, P1141, DOI 10.1002/yea.1154; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Boundy-Mills K, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P67, DOI 10.1007/3-540-30985-3_5; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; BROWN M. E., 1962, Plant and Soil, V17, P309, DOI 10.1007/BF01377670; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Chernov IY, 2005, ZH OBSHCH BIOL, V66, P123; Collado J, 2007, FEMS MICROBIOL ECOL, V60, P521, DOI 10.1111/j.1574-6941.2007.00294.x; Colwell R. K., 2006, BIOTA BIODIVERSITY D; Cornelissen S, 2003, CAN J MICROBIOL, V49, P425, DOI 10.1139/W03-057; DANIELSON RM, 1973, MYCOPATH MYCOL APPL, V51, P191, DOI 10.1007/BF02141110; DiMENNA MARGARET E., 1965, NEW ZEAL J BOT, V3, P194; FAO, 2006, GUID SOIL DESCR; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x; Fonseca A, 2000, CAN J MICROBIOL, V46, P7, DOI 10.1139/cjm-46-1-7; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Fredlund E, 2002, FEMS YEAST RES, V2, P395, DOI 10.1111/j.1567-1364.2002.tb00109.x; Gadanho M, 2002, FEMS YEAST RES, V2, P47, DOI 10.1111/j.1567-1364.2002.tb00068.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Golubev VI, 2000, MICROBIOLOGY+, V69, P490, DOI 10.1007/BF02756776; Golubev WI, 2006, ANTON LEEUW INT J G, V89, P45, DOI 10.1007/s10482-005-9008-z; Golubev WI, 2009, J GEN APPL MICROBIOL, V55, P441; Golubtsova YV, 2007, EURASIAN SOIL SCI+, V40, P875, DOI 10.1134/S1064229307080108; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P1, DOI 10.1007/3-540-30985-3_1; LARUE TA, 1967, CAN J MICROBIOL, V13, P789, DOI 10.1139/m67-104; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; Maksimova IA, 2004, MICROBIOLOGY+, V73, P474, DOI 10.1023/B:MICI.0000036994.21650.3a; Marinoni G, 2004, FEMS YEAST RES, V4, P587, DOI 10.1016/j.femsyr.2003.12.005; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Okoli I, 2007, FEMS YEAST RES, V7, P339, DOI 10.1111/j.1567-1364.2006.00164.x; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sampaio Jose Paulo, 2003, Mycological Progress, V2, P53, DOI 10.1007/s11557-006-0044-5; Sampaio JP, 2004, INT J SYST EVOL MICR, V54, P1401, DOI 10.1099/ijs.0.03037-0; Sampaio JP, 2001, INT J SYST EVOL MICR, V51, P687, DOI 10.1099/00207713-51-2-687; Schonrogge K, 2002, BIOL J LINN SOC, V75, P291, DOI 10.1111/j.1095-8312.2002.tb02070.x; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Slavikova E, 2000, J BASIC MICROB, V40, P207, DOI 10.1002/1521-4028(200007)40:3<207::AID-JOBM207>3.0.CO;2-H; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Starkey RL, 1927, SOIL SCI, V23, P33, DOI 10.1097/00010694-192701000-00004; Takashima M, 2003, INT J SYST EVOL MICR, V53, P1187, DOI 10.1099/ijs.0.02498-0; Takashima M, 2001, INT J SYST EVOL MICR, V51, P2199, DOI 10.1099/00207713-51-6-2199; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Unterseher M, 2008, FEMS MICROBIOL LETT, V282, P205, DOI 10.1111/j.1574-6968.2008.01128.x; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Unterseher M, 2009, MYCOL RES, V113, P645, DOI 10.1016/j.mycres.2009.02.002; VANDERWALT JP, 1992, ANTON LEEUW INT J G, V62, P247, DOI 10.1007/BF00572591; Vishniac HS, 2006, MICROB ECOL, V52, P90, DOI 10.1007/s00248-006-9066-4; Vishniac HS, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P419, DOI 10.1007/3-540-30985-3_16; Wuczkowski M, 2004, MICROBIOL RES, V159, P263, DOI 10.1016/j.micres.2004.05.001; Yurkov A., 2009, PERSOONIA, V23, P188; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004; Yurkov AM, 2009, PERSOONIA, V23, P182	70	46	48	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23671	10.1371/journal.pone.0023671	http://dx.doi.org/10.1371/journal.pone.0023671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858201	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500062
J	Reddington, K; O'Grady, J; Dorai-Raj, S; Niemann, S; van Soolingen, D; Barry, T				Reddington, Kate; O'Grady, Justin; Dorai-Raj, Siobhan; Niemann, Stefan; van Soolingen, Dick; Barry, Thomas			A Novel Multiplex Real-Time PCR for the Identification of Mycobacteria Associated with Zoonotic Tuberculosis	PLOS ONE			English	Article							BOVIS SUBSP CAPRAE; RAPID IDENTIFICATION; NONTUBERCULOUS MYCOBACTERIA; DISCRIMINATORY POWER; COMPARATIVE GENOMICS; COMPLEX STRAINS; HUMANS; ASSAY; HIV; DIFFERENTIATION	Background: Tuberculosis (TB) is the leading cause of death worldwide from a single infectious agent. An ability to detect the Mycobacterium tuberculosis complex (MTC) in clinical material while simultaneously differentiating its members is considered important. This allows for the gathering of epidemiological information pertaining to the prevalence, transmission and geographical distribution of the MTC, including those MTC members associated with zoonotic TB infection in humans. Also differentiating between members of the MTC provides the clinician with inherent MTC specific drug susceptibility profiles to guide appropriate chemotherapy. Methodology/Principal Findings: The aim of this study was to develop a multiplex real-time PCR assay using novel molecular targets to identify and differentiate between the phylogenetically closely related M. bovis, M. bovis BCG and M. caprae. The lpqT gene was explored for the collective identification of M. bovis, M. bovis BCG and M. caprae, the lepA gene was targeted for the specific identification of M. caprae and a Region of Difference 1 (RD1) assay was incorporated in the test to differentiate M. bovis BCG. The multiplex real-time PCR assay was evaluated on 133 bacterial strains and was determined to be 100% specific for the members of the MTC targeted. Conclusions/Significance: The multiplex real-time PCR assay developed in this study is the first assay described for the identification and simultaneous differentiation of M. bovis, M. bovis BCG and M. caprae in one internally controlled reaction. Future validation of this multiplex assay should demonstrate its potential in the rapid and accurate diagnosis of TB caused by these three mycobacteria. Furthermore, the developed assay may be used in conjunction with a recently described multiplex real-time PCR assay for identification of the MTC and simultaneous differentiation of M. tuberculosis, M. canettii resulting in an ability to differentiate five of the eight members of the MTC.	[Reddington, Kate; O'Grady, Justin; Dorai-Raj, Siobhan; Barry, Thomas] Natl Univ Ireland, Sch Nat Sci, Galway, Ireland; [Reddington, Kate; O'Grady, Justin; Dorai-Raj, Siobhan; Barry, Thomas] Natl Univ Ireland, NCBES, Mol Diagnost Res Grp, Galway, Ireland; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Natl TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [Niemann, Stefan] Res Ctr Borstel, Borstel, Germany	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Netherlands National Institute for Public Health & the Environment; Forschungszentrum Borstel	Reddington, K (corresponding author), Natl Univ Ireland, Sch Nat Sci, Galway, Ireland.	thomas.barry@nuigalway.ie	Niemann, Stefan/C-9327-2011; Reddington, Kate/J-7868-2015; O'Grady, Justin/I-2982-2012	Reddington, Kate/0000-0002-9559-5638; O'Grady, Justin/0000-0001-5412-7152; Barry, Thomas/0000-0002-1869-0172; Niemann, Stefan/0000-0002-6604-0684	College of Sciences, National University of Ireland Galway	College of Sciences, National University of Ireland Galway	College of Sciences, National University of Ireland Galway funded KR Postgraduate Scholarship (http://www.nuigalway.ie/science/scholarshipsandprizes.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2010, EUR RESPIR J, V35, P692, DOI 10.1183/09031936.00137309; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BLAKEMORE R, 2010, J CLIN MICROBIOL; Brosch R, 2000, INT J MED MICROBIOL, V290, P143; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Cicero R, 2009, EUR J CLIN MICROBIOL, V28, P455, DOI 10.1007/s10096-008-0649-5; Cleary TJ, 2003, J CLIN MICROBIOL, V41, P4783, DOI 10.1128/JCM.41.10.4783-4786.2003; Cole ST, 2002, MICROBIOL-SGM, V148, P2919, DOI 10.1099/00221287-148-10-2919; Coll P, 2003, INT J TUBERC LUNG D, V7, P886; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Cvetnic Z, 2007, INT J TUBERC LUNG D, V11, P652; Das S, 2007, MICROBIOL IMMUNOL, V51, P231, DOI 10.1111/j.1348-0421.2007.tb03905.x; De Baere T, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-4; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Djelouadji Z, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000253; Dorak MT, REAL TIME PCR; Ereqat S, 2010, J CLIN MICROBIOL, V48, P4269, DOI 10.1128/JCM.00943-10; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Hofmann-Thiel S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-95; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; Kiers A, 2008, INT J TUBERC LUNG D, V12, P1469; Kjeldsen MK, 2009, SCAND J INFECT DIS, V41, P635, DOI 10.1080/00365540903127425; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kubica T, 2003, J CLIN MICROBIOL, V41, P3070, DOI 10.1128/JCM.41.7.3070-3077.2003; Majoor CJ, 2011, EMERG INFECT DIS, V17, P457, DOI 10.3201/eid1703.101111; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; Niemann S, 2002, INT J SYST EVOL MICR, V52, P433, DOI 10.1099/00207713-52-2-433; O' Grady J, 2008, FOOD MICROBIOL, V25, P75, DOI 10.1016/j.fm.2007.07.007; OJO O, 2008, MYCOBACTERIUM BOVIS, P1931; Panteix G, 2010, J MED MICROBIOL, V59, P984, DOI 10.1099/jmm.0.019372-0; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Pinsky BA, 2008, J CLIN MICROBIOL, V46, P2241, DOI 10.1128/JCM.00347-08; Prodinger WM, 2005, J CLIN MICROBIOL, V43, P4984, DOI 10.1128/JCM.43.10.4984-4992.2005; Prodinger WM, 2002, J CLIN MICROBIOL, V40, P2270, DOI 10.1128/JCM.40.6.2270-2272.2002; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Reddington K, 2011, J CLIN MICROBIOL, V49, P651, DOI 10.1128/JCM.01426-10; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Rezwan M, 2007, MICROBIOL-SGM, V153, P652, DOI 10.1099/mic.0.2006/000216-0; Richardson ET, 2009, J CLIN MICROBIOL, V47, P1497, DOI 10.1128/JCM.01868-08; Richter E, 2004, J CLIN MICROBIOL, V42, P4303, DOI 10.1128/JCM.42.9.4303-4306.2004; ROBERTSON JM, 1998, INTRO PCR PRIMER DES, P121; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SOMOSKOVI A, 2006, J CLIN MICROBIOL; Somoskovi A, 2009, J CLIN MICROBIOL, V47, P255, DOI 10.1128/JCM.01268-08; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; van Soolingen D, 1998, J CLIN MICROBIOL, V36, P1840, DOI 10.1128/JCM.36.7.1840-1845.1998; VANEECHOUTTE M, 1993, J CLIN MICROBIOL, V31, P2061, DOI 10.1128/JCM.31.8.2061-2065.1993; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1992, J CLIN MICROBIOL, V30, P1772, DOI 10.1128/JCM.30.7.1772-1777.1992; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Wauters G, 2005, J CLIN MICROBIOL, V43, P2624, DOI 10.1128/JCM.43.6.2624-2628.2005; *WHO, 2006, JOINT WHO DFID AHP M, P62; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; 2008, LIGHTCYCLER 480 INST, P248	63	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23481	10.1371/journal.pone.0023481	http://dx.doi.org/10.1371/journal.pone.0023481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858140	Green Published, gold, Green Accepted			2022-12-27	WOS:000293774300037
J	Levi, JE; Nascimento, MC; Sumita, LM; de Souza, VAUF; Freire, WS; Mayaud, P; Pannuti, CS				Levi, Jose Eduardo; Nascimento, Maria Claudia; Sumita, Laura Masami; Ueda Fick de Souza, Vanda Akico; Freire, Wilton S.; Mayaud, Philippe; Pannuti, Claudio S.			Non-Detection of Human Herpesvirus 8 (HHV-8) DNA in HHV-8-Seropositive Blood Donors from Three Brazilian Regions	PLOS ONE			English	Article							HUMAN-HERPESVIRUS TYPE-8; LATENT CLASS ANALYSIS; KAPOSIS-SARCOMA; MONONUCLEAR-CELLS; RISK-FACTORS; VIRAL LOAD; TRANSMISSION; TRANSFUSION; PREVALENCE; INFECTION	Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the etiologic agent of all forms of Kaposi's sarcoma, primary effusion lymphoma and the plasmablastic cell variant of multicentric Castleman disease. In endemic areas of sub-Saharan Africa, blood transfusions have been associated with a substantial risk of HHV-8 transmission. By contrast, several studies among healthy blood donors from North America have failed to detect HHV-8 DNA in samples of seropositive individuals. In this study, using a real-time PCR assay, we investigated the presence of HHV-8 DNA in whole-blood samples of 803 HHV-8 blood donors from three Brazilian states (Sao Paulo, Amazon, Bahia) who tested positive for HHV-8 antibodies, in a previous multicenter study. HHV-8 DNA was not detected in any sample. Our findings do not support the introduction of routine HHV-8 screening among healthy blood donors in Brazil. (WC = 140).	[Levi, Jose Eduardo; Nascimento, Maria Claudia; Sumita, Laura Masami; Ueda Fick de Souza, Vanda Akico; Freire, Wilton S.; Pannuti, Claudio S.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil; [Ueda Fick de Souza, Vanda Akico; Pannuti, Claudio S.] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias LIM HC, Sao Paulo, Brazil; [Nascimento, Maria Claudia; Mayaud, Philippe] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine	Levi, JE (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.	cpannuti@usp.br	Pannuti, Claudio/B-7649-2012	MAYAUD, Philippe/0000-0001-5730-947X	Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq); agency of the Brazilian Ministry of Science and Technology [304879/2003-7, 305258/2006-0, 473867/2006-0]; UK's Department for International Development (DFID); HIV in Developing Countries of the LSHTM	Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); agency of the Brazilian Ministry of Science and Technology; UK's Department for International Development (DFID); HIV in Developing Countries of the LSHTM	The study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq), an agency of the Brazilian Ministry of Science and Technology (Grants 304879/2003-7, 305258/2006-0 and 473867/2006-0). Additional financial support was provided by the UK's Department for International Development (DFID)-funded Research Programme Consortium on Research and Capacity Building on Sexual and Reproductive Health and HIV in Developing Countries of the LSHTM. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript. The views expressed herein do not necessarily represent the views and policies of CNPq and DFID.	Belec L, 1998, TRANSFUSION, V38, P771, DOI 10.1046/j.1537-2995.1998.38898375517.x; Bigoni B, 1996, J INFECT DIS, V173, P542, DOI 10.1093/infdis/173.3.542; Blackbourn DJ, 1997, LANCET, V349, P609, DOI 10.1016/S0140-6736(96)10004-0; Brown EE, 2005, INT J EPIDEMIOL, V34, P1110, DOI 10.1093/ije/dyi131; Brown EE, 2006, CANCER, V107, P2282, DOI 10.1002/cncr.22236; Cannon MJ, 2009, J INFECT DIS, V199, P1592, DOI 10.1086/598859; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.6600745; Enbom M, 2002, J MED VIROL, V68, P264, DOI 10.1002/jmv.10183; Engels EA, 1999, J NATL CANCER I, V91, P1773, DOI 10.1093/jnci/91.20.1773; Engels EA, 2000, INT J CANCER, V88, P1003, DOI 10.1002/1097-0215(20001215)88:6&lt;1003::AID-IJC26&gt;3.0.CO;2-9; Ferreira S, 2003, TRANSFUSION, V43, P1764, DOI 10.1111/j.0041-1132.2003.00602.x; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Hudnall SD, 2008, TRANSFUSION, V48, P1180, DOI 10.1111/j.1537-2995.2008.01685.x; Hudnall SD, 2003, TRANSFUSION, V43, P85, DOI 10.1046/j.1537-2995.2003.00272.x; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lam LL, 2002, J CLIN MICROBIOL, V40, P325, DOI 10.1128/JCM.40.02.325-329.2002; Martro E, 2004, J VIROL, V78, P11707, DOI 10.1128/JVI.78.21.11707-11714.2004; Mbulaiteye SM, 2003, J NATL CANCER I, V95, P1330, DOI 10.1093/jnci/djg039; Nascimento MC, 2008, J MED VIROL, V80, P1202, DOI 10.1002/jmv.21188; Nascimento MC, 2007, J CLIN MICROBIOL, V45, P715, DOI 10.1128/JCM.01264-06; Pellett PE, 2003, TRANSFUSION, V43, P1260, DOI 10.1046/j.1537-2995.2003.00490.x; Polstra AM, 2003, J CLIN MICROBIOL, V41, P5488, DOI 10.1128/JCM.41.12.5488-5491.2003; Qu L, 2011, VOX SANG, V100, P267, DOI 10.1111/j.1423-0410.2010.01404.x; Qu LR, 2010, TRANSFUSION, V50, P1050, DOI 10.1111/j.1537-2995.2009.02559.x; Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x; Uldrick TS, 2011, CANCER LETT, V305, P150, DOI 10.1016/j.canlet.2011.02.006; Vitale F, 2000, EPIDEMIOL INFECT, V125, P671, DOI 10.1017/S0950268800004726	27	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23546	10.1371/journal.pone.0023546	http://dx.doi.org/10.1371/journal.pone.0023546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858163	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000293773300032
J	Yearsley, JM; Sigwart, JD				Yearsley, Jon M.; Sigwart, Julia D.			Larval Transport Modeling of Deep-Sea Invertebrates Can Aid the Search for Undiscovered Populations	PLOS ONE			English	Article							CALANUS-FINMARCHICUS; NORTH-ATLANTIC; HYDROTHERMAL VENTS; PROFILING FLOATS; TEMPERATURE; DISPERSAL; OCEAN; ECOLOGY; LIFE; CONSERVATION	Background: Many deep-sea benthic animals occur in patchy distributions separated by thousands of kilometres, yet because deep-sea habitats are remote, little is known about their larval dispersal. Our novel method simulates dispersal by combining data from the Argo array of autonomous oceanographic probes, deep-sea ecological surveys, and comparative invertebrate physiology. The predicted particle tracks allow quantitative, testable predictions about the dispersal of benthic invertebrate larvae in the south-west Pacific. Principal Findings: In a test case presented here, using non-feeding, non-swimming (lecithotrophic trochophore) larvae of polyplacophoran molluscs (chitons), we show that the likely dispersal pathways in a single generation are significantly shorter than the distances between the three known population centres in our study region. The large-scale density of chiton populations throughout our study region is potentially much greater than present survey data suggest, with intermediate 'stepping stone' populations yet to be discovered. Conclusions/Significance: We present a new method that is broadly applicable to studies of the dispersal of deep-sea organisms. This test case demonstrates the power and potential applications of our new method, in generating quantitative, testable hypotheses at multiple levels to solve the mismatch between observed and expected distributions: probabilistic predictions of locations of intermediate populations, potential alternative dispersal mechanisms, and expected population genetic structure. The global Argo data have never previously been used to address benthic biology, and our method can be applied to any non-swimming larvae of the deep-sea, giving information upon dispersal corridors and population densities in habitats that remain intrinsically difficult to assess.	[Yearsley, Jon M.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Sigwart, Julia D.] Queens Univ Belfast, Sch Biol Sci, Marine Lab, Portaferry, North Ireland	University College Dublin; Queens University Belfast	Yearsley, JM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	jon.yearsley@ucd.ie	Sigwart, Julia D/J-2928-2014; Yearsley, Jon/H-5301-2011	Sigwart, Julia D/0000-0002-3005-6246; Yearsley, Jon/0000-0003-1838-0454	Science Foundation Ireland; IRCSET; Institut de la Recherche pour le Developement	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); IRCSET(Irish Research Council for Science, Engineering and Technology); Institut de la Recherche pour le Developement	This study was supported by the Science Foundation Ireland (CoBiD-UREKA Site award; http://www.sfi.ie) and IRCSET Mathematical Biology Summer Studentships http://www.ircset.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Frederique Viard, Sophie Plouvier and Stephane Hourdez for stimulating discussion and comments that improved this study. We also thank the anonymous reviewers for the helpful comments. The float data for this study were collected and made freely available by the International Argo Project and the national initiatives that contribute to it (http://www.argo.net). Argo is a pilot programme of the Global Ocean Observing System. Biological records are from specimens in the Museum National d'Histoire Naturelle, Paris (MNHN), collected onboard the RV M/V DA-BFAR in the Philippines (expedition led by the Philippe Bouchet and the National Fisheries Research and Development Institute Ludivina Labe), and the RV ALIS in Vanuatu and Solomon Islands (funding by the Institut de la Recherche pour le Developement to Bertrand Richer de Forges, Sarah Samadi, and Philippe Bouchet). All records used here represent preserved specimens in the MNHN collections. Preliminary work that led to this project was assisted by Katie Murphy and Iarliath Kirrane, who were supported by Science Foundation Ireland (CoBiD-UREKA Site award) and IRCSET.	Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; ARELLANO SM, 2008, THESIS U OREGON CHAR, P218; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; BIRKELAND C, 1971, BIOL BULL-US, V141, P99, DOI 10.2307/1539994; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Campbell RW, 2008, DEEP-SEA RES PT I, V55, P630, DOI 10.1016/j.dsr.2008.02.009; CHRISTIANSEN MARIT ELLEN, 1954, NYTT MAG ZOOL [OSLO], V2, P52; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Forget G, 2008, OCEAN MODEL, V20, P1, DOI 10.1016/j.ocemod.2007.06.001; GAGE JD, 1996, DEEP SEA BIOL NATURA; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Grave BH, 1922, BIOL BULL-US, V42, P234, DOI 10.2307/1536471; HAIN S, 1992, POLAR BIOL, V12, P303; Heath MR, 2004, ICES J MAR SCI, V61, P698, DOI 10.1016/j.icesjms.2004.03.013; HOEGHGULDBERG O, 1995, AM ZOOL, V35, P415; HOLLISTER CD, 1984, NATURE, V309, P220, DOI 10.1038/309220a0; JAECKLE WB, 1989, MAR BIOL, V103, P87, DOI 10.1007/BF00391067; KILLINGLEY J, 2005, DEEP-SEA RES PT 1, V32, P809; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; LEBEDEV KV, 2007, 4 INT PAC RES CTR, P16; *MATHW INC, 2009, MATL; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Metaxas A, 2004, LIMNOL OCEANOGR, V49, P1949, DOI 10.4319/lo.2004.49.6.1949; MILEIKOVSKY SA, 1973, MAR BIOL, V23, P11, DOI 10.1007/BF00394107; Molcard A, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001240; Mullineaux LS, 2005, MAR ECOL PROG SER, V293, P1, DOI 10.3354/meps293001; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Pailleret M, 2007, MAR ECOL-EVOL PERSP, V28, P233, DOI 10.1111/j.1439-0485.2006.00149.x; PEARSE JS, 1979, REPRODUCTION MARINE, V5, P27; R Development Core Team, 2005, R LANG ENV STAT COMP; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; Roemmich D, 2009, OCEANOGRAPHY, V22, P34, DOI 10.5670/oceanog.2009.36; Scheltema RS, 2009, DEEP-SEA RES PT II, V56, P1835, DOI 10.1016/j.dsr2.2009.05.024; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Sigwart J.D., 2008, THESIS QUEENS U BELF; SIGWART JD, 2011, DEEP SEA CHITONS SUN; Sigwart JD, 2009, J NAT HIST, V43, P447, DOI 10.1080/00222930802604157; Sirenko B., 2004, BOLL MALACOL, V5, P111; Sirenko Boris, 2001, Memoires du Museum National d'Histoire Naturelle, V185, P39; Speirs DC, 2005, FISH OCEANOGR, V14, P333, DOI 10.1111/j.1365-2419.2005.00339.x; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Todt Christiane, 2008, P71; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; WATTS SA, 1982, BIOL BULL-US, V163, P348, DOI 10.2307/1541272; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Young CM, 1997, MAR ECOL PROG SER, V154, P197, DOI 10.3354/meps154197; Young Craig M., 1994, P1	49	29	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23063	10.1371/journal.pone.0023063	http://dx.doi.org/10.1371/journal.pone.0023063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857992	gold, Green Submitted, Green Published			2022-12-27	WOS:000293773300017
J	McCracken, KG; Wilson, RE				McCracken, Kevin G.; Wilson, Robert E.			Gene Flow and Hybridization between Numerically Imbalanced Populations of Two Duck Species in the Falkland Islands	PLOS ONE			English	Article							MALLARDS ANAS-PLATYRHYNCHOS; MITOCHONDRIAL-DNA; REPRODUCTIVE ISOLATION; CONTROL REGION; HALDANES RULE; SEX-RATIO; INTROGRESSION; COMPLEX; PHYLOGEOGRAPHY; EXTINCTION	Interspecific hybridization is common in plants and animals, particularly in waterfowl (Anatidae). One factor shown to contribute to hybridization is restricted mate choice, which can occur when two species occur in sympatry but one is rare. The Hubbs principle, or "desperation hypothesis," states that under such circumstances the rarer species is more likely to mate with heterospecifics. Here we report interspecific hybridization between two waterfowl species that coexist in broad sympatry and mixed flocks throughout southern South America. Speckled teal (Anas flavirostris) and yellow-billed pintails (Anas georgica) are abundant in continental South America, but in the Falkland Islands speckled teal outnumber yellow-billed pintails approximately ten to one. Using eight genetic loci (mtDNA and 7 nuclear introns) coupled with Bayesian assignment tests and relatedness analysis, we identified a speckled teal x yellow-billed pintail F(1) hybrid female and her duckling sired by a male speckled teal. Although our sample in the Falkland Islands was small, we failed to identify unequivocal evidence of hybridization or introgression in a much larger sample from Argentina using a three-population "isolation with migration" coalescent analysis. While additional data are needed to determine if this event in the Falkland Islands was a rare singular occurrence, our results provide further support for the "desperation hypothesis," which states that scarcity in one population and abundance of another will often lead to hybridization.	[McCracken, Kevin G.] Univ Alaska Museum, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	McCracken, KG (corresponding author), Univ Alaska Museum, Inst Arctic Biol, Fairbanks, AK 99775 USA.	kmccrack@iab.alaska.edu			Institute of Arctic Biology at the University of Alaska, Fairbanks; National Science Foundation [NSF] [EPS-0092040, EPS-0346770]; Delta Waterfowl Foundation; American Museum of Natural History; NSF [DEB-0444748, DEB-0746365, IOS-0949439]	Institute of Arctic Biology at the University of Alaska, Fairbanks; National Science Foundation [NSF](National Science Foundation (NSF)); Delta Waterfowl Foundation; American Museum of Natural History; NSF(National Science Foundation (NSF))	Funding was provided by the Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF] EPS-0092040 and EPS-0346770), grants from the Delta Waterfowl Foundation and Frank M. Chapman Fund at the American Museum of Natural History to REW, and NSF grants DEB-0444748, DEB-0746365, and IOS-0949439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Balakrishnan CN, 2009, P ROY SOC B-BIOL SCI, V276, P219, DOI 10.1098/rspb.2008.0733; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BOTTEMA CDK, 1993, METHOD ENZYMOL, V218, P388; CALKELL EM, 1961, IBIS, V103, P1; Carling MD, 2008, EVOLUTION, V62, P2600, DOI 10.1111/j.1558-5646.2008.00477.x; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fowler AC, 2009, CONSERV GENET, V10, P1747, DOI 10.1007/s10592-008-9778-8; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grant V., 1981, PLANT SPECIATION; GRAY AP, 1958, BRID HYBRIDS CHECK L; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; HUDSON RR, 1985, GENETICS, V111, P147; JOHNSGARD PAUL A., 1960, CONDOR, V62, P25, DOI 10.2307/1365656; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Kirby RE, 2004, CAN J ZOOL, V82, P1827, DOI 10.1139/Z04-169; Kirby RE, 2000, USGSBRDBSR20000002; Kulikova IV, 2010, RUSS J GENET+, V46, P976, DOI 10.1134/S1022795410080090; Kulikova IV, 2005, AUK, V122, P949, DOI 10.1642/0004-8038(2005)122[0949:POTMAP]2.0.CO;2; Kulikova IV, 2004, AUK, V121, P930, DOI 10.1642/0004-8038(2004)121[0930:AHASGF]2.0.CO;2; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; MAC ARTHUR ROBERT H., 1967; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mank JE, 2004, CONSERV GENET, V5, P395, DOI 10.1023/B:COGE.0000031139.55389.b1; Masta SE, 2002, MOL PHYLOGENET EVOL, V24, P302, DOI 10.1016/S1055-7903(02)00216-6; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; McCracken KG, 2009, MOL BIOL EVOL, V26, P815, DOI 10.1093/molbev/msp007; Morando M, 2004, EVOLUTION, V58, P842, DOI 10.1111/j.0014-3820.2004.tb00416.x; Munoz-Fuentes V, 2007, MOL ECOL, V16, P629, DOI 10.1111/j.1365-294X.2006.03170.x; Panov, 1989, NATURAL HYBRIDIZATIO; Pearce JM, 2009, AUK, V126, P784, DOI 10.1525/auk.2009.08182; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; Phillips JC, 1914, J EXP ZOOL, V16, P131, DOI 10.1002/jez.1400160105; POSADA D, 2006, COLL DESCR HAPL SEQ; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2005, MOL ECOL, V14, P1421, DOI 10.1111/j.1365-294X.2005.02493.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Randler C, 2002, ANIM BEHAV, V63, P103, DOI 10.1006/anbe.2001.1884; Randler C, 2008, WATERBIRDS, V31, P143, DOI 10.1675/1524-4695(2008)31[143:HWICEA]2.0.CO;2; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RHYMER JM, 1994, AUK, V111, P970, DOI 10.2307/4088829; Rohwer FC, 1988, CURRENT ORNITHOLOGY, V5, P187; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schwacke L, 2005, RE RAT RELATEDNESS E; Sefc KM, 2005, MOL ECOL, V14, P1407, DOI 10.1111/j.1365-294X.2005.02492.x; Simpson G.G., 1934, ATTENDING MARVELS; Sonsthagen SA, 2010, MOL ECOL, V19, P647, DOI 10.1111/j.1365-294X.2009.04495.x; Steeves TE, 2010, MOL ECOL, V19, P5090, DOI 10.1111/j.1365-294X.2010.04895.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; WELLER M W, 1972, Wildfowl, V23, P25; Weller M.W., 1980, ISLAND WATERFOWL; Wetlands International, 2006, WAT POP EST; Williams CL, 2005, CONSERV GENET, V6, P445, DOI 10.1007/s10592-005-4978-y; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Woods RW, 1997, ATLAS BREEDING BIRDS	69	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23173	10.1371/journal.pone.0023173	http://dx.doi.org/10.1371/journal.pone.0023173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887236	gold, Green Published, Green Submitted			2022-12-27	WOS:000294298800006
J	Goel, M; Sienkiewicz, AE; Picciani, R; Lee, RK; Bhattacharya, SK				Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Lee, Richard K.; Bhattacharya, Sanjoy K.			Cochlin Induced TREK-1 Co-Expression and Annexin A2 Secretion: Role in Trabecular Meshwork Cell Elongation and Motility	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; CHANNEL TREK-1; OPTIC ATROPHY; PROFILIN-I; PROTEIN; OUTFLOW; GENE; PHOSPHORYLATION; TRANSDUCTION; CYTOSKELETON	Fluid flow through large interstitial spaces is sensed at the cellular level, and mechanistic responses to flow changes enables expansion or contraction of the cells modulating the surrounding area and brings about changes in fluid flow. In the anterior eye chamber, aqueous humor, a clear fluid, flows through trabecular meshwork (TM), a filter like region. Cochlin, a secreted protein in the extracellular matrix, was identified in the TM of glaucomatous patients but not controls by mass spectrometry. Cochlin undergoes shear induced multimerization and plays a role in mechanosensing of fluid shear. Cytoskeletal changes in response to mechanosensing in the ECM by cochlin will necessitate transduction of mechanosensing. TREK-1, a stretch activated outward rectifying potassium channel protein known to act as mechanotransducer was found to be expressed in TM. Cochlin expression results in co-expression of TREK-1 and filopodia formation. Prolonged cochlin expression results in expression and subsequent secretion of annexin A2, a protein known to play a role in cytoskeletal remodeling. Cochlin interacts with TREK-1 and annexin A2. Cochlin-TREK-1 interaction has functional consequences and results in changes in cell shape and motility. Annexin A2 expression and secretion follows cochlin-TREK-1 syn-expression and correlates with cell elongation. Thus cytoskeleton changes in response to fluid shear sensed by cochlin are further mediated by TREK-1 and annexin A2.	[Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Lee, Richard K.; Bhattacharya, Sanjoy K.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Bascom Palmer Eye Institute; University of Miami	Goel, M (corresponding author), Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA.	Sbhattacharya@med.miami.edu			National Institutes of Health [EY016112, EY016112S1, EY015266, EY016775, EY014801]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY014801, R03EY015266, R01EY016112, K08EY016775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health Grants EY016112, EY016112S1, EY015266, EY016775, and EY014801; a career development and an unrestricted grant to the University of Miami from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Asrani S, 2000, J GLAUCOMA, V9, P134; Bhattacharya SK, 2009, INVEST OPHTH VIS SCI, V50, P551, DOI 10.1167/iovs.08-2632; Bhattacharya SK, 2005, J BIOL CHEM, V280, P6080, DOI 10.1074/jbc.M411233200; Chan ME, 2009, CELL MOL BIOENG, V2, P405, DOI 10.1007/s12195-009-0075-5; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Ilagan RM, 2010, BIOTECHNIQUES, V48, P153, DOI 10.2144/000113349; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Kalapesi FB, 2005, CLIN EXP OPHTHALMOL, V33, P210, DOI 10.1111/j.1442-9071.2005.00981.x; Katoh M, 2004, INT J ONCOL, V24, P757; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lambrechts A, 2006, J CELL SCI, V119, P1570, DOI 10.1242/jcs.02884; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee ES, 2010, INVEST OPHTH VIS SCI, V51, P2060, DOI 10.1167/iovs.09-4521; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Morales M, 2007, EUR J PHARMACOL, V567, P145, DOI 10.1016/j.ejphar.2007.04.020; Nawrot M, 2004, INVEST OPHTH VIS SCI, V45, P393, DOI 10.1167/iovs.03-0989; Naz S, 2003, J MED GENET, V40, P360, DOI 10.1136/jmg.40.5.360; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Picciani R, 2007, PROG RETIN EYE RES, V26, P453, DOI 10.1016/j.preteyeres.2007.06.002; Rao VP, 2007, BIODRUGS, V21, P167, DOI 10.2165/00063030-200721030-00004; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; WuDunn D, 2009, EXP EYE RES, V88, P718, DOI 10.1016/j.exer.2008.11.008	40	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23070	10.1371/journal.pone.0023070	http://dx.doi.org/10.1371/journal.pone.0023070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886777	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500008
J	Benabdellah, K; Cobo, M; Munoz, P; Toscano, MG; Martin, F				Benabdellah, Karim; Cobo, Marien; Munoz, Pilar; Toscano, Miguel G.; Martin, Francisco			Development of an All-in-One Lentiviral Vector System Based on the Original TetR for the Easy Generation of Tet-ON Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMALIAN-CELLS; TETRACYCLINE; TRANSACTIVATOR; LEVEL; TRANSDUCTION; PERFORMANCE; INHIBITION; THERAPY; VITRO	Lentiviral vectors (LVs) are considered one of the most promising vehicles to efficiently deliver genetic information for basic research and gene therapy approaches. Combining LVs with drug-inducible expression systems should allow tight control of transgene expression with minimal side effect on relevant target cells. A new doxycycline-regulated system based on the original TetR repressor was developed in 1998 as an alternative to the TetR-VP16 chimeras (tTA and rtTA) to avoid secondary effects due to the expression of transactivator domains. However, previously described TetR-based systems required cell cloning and/or antibiotic selection of tetracycline-responsive cells in order to achieve good regulation. In the present manuscript we have constructed a dual Tet-ON system based on two lentiviral vectors, one expressing the TetR through the spleen focus forming virus (SFFV) promoter (STetR) and a second expressing eGFP through the regulatable CMV-TetO promoter (CTetOE). Using these vectors we have demonstrated that the TetR repressor, contrary to the reverse transactivator (rtTA), can be expressed in excess to bind and modulate a high number of TetO operons. We have also showed that this dual vector system can generate regulatable bulk cell lines (expressing high levels of TetR) that are able to modulate transgene expression either by varying doxycycline concentration and/or by varying the amount of CTetOE vector genomes per cell. Based on these results we have developed a new all-in-one lentiviral vector (CEST) driving the expression of TetR through the SFFV promoter and the expression of eGFP through the doxycycline-responsive CMV-TetO operon. This vector efficiently produced Tet-ON regulatable immortalized (293T) and primary (human mesenchymal stem cells and human primary fibroblasts) cells. Bulk doxycycline-responsive cell lines express high levels of the transgene with low amount of doxycycline and are phenotypically indistinct from its parental cells.	[Benabdellah, Karim; Cobo, Marien; Munoz, Pilar; Toscano, Miguel G.; Martin, Francisco] Univ Granada, Andalusian Stem Cell Bank, Ctr Invest Biomed, Granada, Spain	University of Granada	Benabdellah, K (corresponding author), Pfizer Univ Granada Andalusian Govt Ctr Genom & O, GENYO, Parque Tecnol Ciencias Salud, Granada, Spain.	francisco.martin.molina@juntadeandalucia.es	Benabdellah, karim/L-4569-2014; Martin, Francisco/K-8763-2014; Toscano, Miguel G. G/I-1053-2015; Munoz, Pilar/N-2277-2016; Benabdellah, karim/F-4209-2016	Benabdellah, karim/0000-0003-4673-2111; Martin, Francisco/0000-0003-1961-8612; Toscano, Miguel G. G/0000-0002-6384-3123; Munoz, Pilar/0000-0002-7985-9859; Benabdellah, karim/0000-0003-2790-562X	Fondo de Investigaciones Sanitarias (FIS) [PS09/00340]; Junta de Andalucia [P09-CTS-04532, PI0001/2009]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia)	Fondo de Investigaciones Sanitarias (FIS) grant: PS09/00340. Junta de Andalucia grants: P09-CTS-04532 and PI0001/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; BARDE I, 2005, MOL THER; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Haack K, 2004, MOL THER, V10, P585, DOI 10.1016/j.ymthe.2004.06.109; Judelson HS, 2007, CURR GENET, V51, P297, DOI 10.1007/s00294-007-0125-2; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Ogueta SB, 2001, MOL MED, V7, P569, DOI 10.1007/BF03401863; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Sisson TH, 2006, AM J RESP CELL MOL, V34, P552, DOI 10.1165/rcmb.2005-0378OC; Toniatti C, 2004, GENE THER, V11, P649, DOI 10.1038/sj.gt.3302251; Toscano MG, 2004, GENE THER, V11, P956, DOI 10.1038/sj.gt.3302259; Toscano MG, 2009, HUM GENE THER, V20, P1279, DOI 10.1089/hum.2009.118; Trapani JG, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-15; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vieyra DS, 2007, STEM CELLS, V25, P2559, DOI 10.1634/stemcells.2007-0248; Wells KD, 1999, TRANSGENIC RES, V8, P371, DOI 10.1023/A:1008952302539; Whitsett JA, 2006, AM J RESP CELL MOL, V34, P519, DOI 10.1165/rcmb.F310; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Yao F, 2006, MOL THER, V13, P1133, DOI 10.1016/j.ymthe.2006.01.009	29	33	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23734	10.1371/journal.pone.0023734	http://dx.doi.org/10.1371/journal.pone.0023734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876765	Green Submitted, Green Published, gold			2022-12-27	WOS:000294126900037
J	Lecube, A; Pachon, G; Petriz, J; Hernandez, C; Simo, R				Lecube, Albert; Pachon, Gisela; Petriz, Jordi; Hernandez, Cristina; Simo, Rafael			Phagocytic Activity Is Impaired in Type 2 Diabetes Mellitus and Increases after Metabolic Improvement	PLOS ONE			English	Article							INFECTIONS; OBESITY	Objective: 1) To evaluate whether peripheral blood mononuclear cells (PBMCs) from type 2 diabetic patients present an impairment of phagocytic activity; 2) To determine whether the eventual impairment in phagocytic activity is related to glycemic control and can be reversed by improving blood glucose levels. Methods: 21 type 2 diabetic patients and 21 healthy volunteers were prospectively recruited for a case-control study. In addition, those patients in whom HbA1c was higher than 8% (n = 12) were hospitalized in order to complete a 5-day intensification treatment of blood glucose. Phagocytic activity was assessed by using a modified flow cytometry procedure developed in our laboratory based on DNA/RNA viable staining to discriminate erythrocytes and debris. This method is simple, highly sensitive and reproducible and it takes advantage of classic methods that are widely used in flow cytometry. Results: Type 2 diabetic patients showed a lower percentage of activated macrophages in comparison with non-diabetic subjects (54.00 +/- 18.93 vs 68.53 +/- 12.77%; p = 0.006) Significant negative correlations between phagocytic activity and fasting glucose (r = 20.619, p = 0.004) and HbA1c (r = -20.506, p = 0.019) were detected. In addition, multiple linear regression analyses showed that either fasting plasma glucose or HbA1c were independently associated with phagocytic activity. Furthermore, in the subset of patients who underwent metabolic optimization a significant increase in phagocytic activity was observed (p = 0.029). Conclusions: Glycemic control is related to phagocytic activity in type 2 diabetes. Our results suggest that improvement in phagocytic activity can be added to the beneficial effects of metabolic optimization.	[Lecube, Albert; Pachon, Gisela; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, ISCIII,VHIR, Diabet & Metab Res Unit,CIBER Diabet & Enfermedad, E-08193 Barcelona, Spain; [Pachon, Gisela; Petriz, Jordi] Univ Autonoma Barcelona, VHIR, Res Unit Biomed & Translat & Pediat Oncol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Lecube, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, ISCIII,VHIR, Diabet & Metab Res Unit,CIBER Diabet & Enfermedad, E-08193 Barcelona, Spain.	rsimo@ir.vhebron.net	Lecube, Albert/H-3813-2019; Petriz, Jordi/AAS-4943-2020; Petriz, Jordi/AAB-7293-2019	Lecube, Albert/0000-0001-9684-0183; Petriz, Jordi/0000-0003-1085-0511; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721	CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Spanish Ministry of Health [PI081132]	CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This study was supported by the CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM). CIBERDEM is an initiative of the Instituto de Salud Carlos III (ISCIII). This work was also supported by grants to Jordi Petriz from the Spanish Ministry of Health (PI081132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXIEWICZ JM, 1995, ANN INTERN MED, V123, P919, DOI 10.7326/0003-4819-123-12-199512150-00004; Allard R, 2010, DIABETES CARE, V33, P1491, DOI 10.2337/dc09-2215; Andrews T, 2003, CLIN MICROBIOL REV, V16, P597, DOI 10.1128/CMR.16.4.597-621.2003; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; DESCAMPSLATSCHA B, 1990, J AUTOIMMUN, V3, P201, DOI 10.1016/0896-8411(90)90141-E; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fisher TK, 2010, INT J LOW EXTR WOUND, V9, P31, DOI 10.1177/1534734610363459; Fornas O, 2000, NAT MED, V6, P833, DOI 10.1038/77571; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; GEISLER C, 1982, ACTA PATH MICRO IM C, V90, P33; Inoue S, 1996, DIABETES RES CLIN PR, V33, P119, DOI 10.1016/0168-8227(96)01287-9; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Komura T, 2010, DIABETES, V59, P634, DOI 10.2337/db09-0659; MARKHOFFER W, 1992, DIABETES CARE, V15, P256; McManus LM, 2001, J LEUKOCYTE BIOL, V70, P395; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; O'Rourke RW, 2005, OBES SURG, V15, P1463, DOI 10.1381/096089205774859308; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; POZZILLI P, 1994, DIABETIC MED, V11, P935, DOI 10.1111/j.1464-5491.1994.tb00250.x; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Tanaka S, 2001, CLIN ENDOCRINOL, V54, P347, DOI 10.1046/j.1365-2265.2001.1139/cn2155.x; TEBBS SE, 1991, CLIN EXP IMMUNOL, V84, P482; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WIERUSZWYSOCKA B, 1987, J LEUKOCYTE BIOL, V42, P519, DOI 10.1002/jlb.42.5.519; Yende S, 2010, THORAX, V65, P870, DOI 10.1136/thx.2010.136317	26	121	124	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23366	10.1371/journal.pone.0023366	http://dx.doi.org/10.1371/journal.pone.0023366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876749	gold, Green Published, Green Submitted			2022-12-27	WOS:000294126900021
J	Tabata, J; De Moraes, CM; Mescher, MC				Tabata, Jun; De Moraes, Consuelo M.; Mescher, Mark C.			Olfactory Cues from Plants Infected by Powdery Mildew Guide Foraging by a Mycophagous Ladybird Beetle	PLOS ONE			English	Article							ATTRACT INSECT VECTORS; COLEOPTERA-COCCINELLIDAE; PLEUROTUS-PULMONARIUS; BIOLOGICAL-CONTROL; VIRUS ATTRACT; LINOLEIC-ACID; VOLATILES; HOST; FUNGI; BIOSYNTHESIS	Powdery mildews (Erysiphales) are economically important plant pathogens that attack many agricultural crops. Conventional management strategies involving fungicide application face challenges, including the evolution of resistance and concerns over impacts on non-target organisms, that call for investigation of more sustainable alternatives. Mycophagous ladybird beetles (Coleoptera: Coccinellidae) feed on powdery mildew and have considerable potential as biological control agents; however, the foraging ecology and behavior of these beetles is not well understood. Here we document the olfactory cues presented by squash plants (Cucurbita moschata) infected by powdery mildew (Podosphaera sp.) and the behavioral responses of twenty-spotted ladybird beetles (Psyllobora vigintimaculata) to these cues. Volatile analyses through gas chromatography revealed a number of volatile compounds characteristic of infected plants, including 3-octanol and its analogues 1-octen-3-ol and 3-octanone. These compounds are typical "moldy'' odorants previously reported in volatiles collected from other fungi. In addition, infected plants exhibited elevated emissions of several compounds also observed in collections from healthy leaves, including linalool and benzyl alcohol, which are reported to have anti-fungal properties. In Y-tube choice assays, P. vigintimaculata beetles displayed a significant preference for the odors of infected plants compared to those of healthy plants. Moreover, beetles exhibited strong attraction to one individual compound, 1-octen-3-ol, which was the most abundant of the characteristic fungal compounds identified. These results enhance our understanding of the olfactory cues that guide foraging by mycophagous insects and may facilitate the development of integrated disease-management strategies informed by an understanding of underlying ecological mechanisms.	[Tabata, Jun; De Moraes, Consuelo M.; Mescher, Mark C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Tabata, Jun] Natl Inst Agroenvironm Sci, Biodivers Div, Tsukuba, Ibaraki 305, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute for Agro-Environmental Sciences (NIAES) Japan	Tabata, J (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	mcmescher@psu.edu		Tabata, Jun/0000-0001-9095-2694	Japan Society for the Promotion of Science (JSPS) [21-7080]; U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative [2008-35302-04577]; David and Lucile Packard Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This research was supported by the Excellent Young Researchers Overseas Visit Program (No. 21-7080) of the Japan Society for the Promotion of Science (JSPS). Additional support was provided by Grant 2008-35302-04577 from the U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative and by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 1986, HOST RANGE GEOGRAPHI; ASSAF S, 1995, J AGR FOOD CHEM, V43, P2173, DOI 10.1021/jf00056a040; Assaf S, 1997, ENZYME MICROB TECH, V21, P484, DOI 10.1016/S0141-0229(97)00019-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Combet Emilie, 2006, Mycoscience, V47, P317, DOI 10.1007/s10267-006-0318-4; D'Auria FD, 2005, MED MYCOL, V43, P391, DOI 10.1080/13693780400004810; Darriet P, 2002, J AGR FOOD CHEM, V50, P3277, DOI 10.1021/jf011527d; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dik AJ, 1998, EUR J PLANT PATHOL, V104, P413, DOI 10.1023/A:1008025416672; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Eilenberg J, 2006, ECOLOGICAL AND SOCIETAL APPROACH TO BIOLOGICAL CONTROL, P1; English-Loeb G, 1999, BIOL CONTROL, V14, P97, DOI 10.1006/bcon.1998.0681; English-Loeb G, 2005, ECOL APPL, V15, P1679, DOI 10.1890/04-1939; English-Loeb G, 2007, PLANT DIS, V91, P421, DOI 10.1094/PDIS-91-4-0421; Faldt J, 1999, J CHEM ECOL, V25, P567, DOI 10.1023/A:1020958005023; Francis F, 2004, J CHEM ECOL, V30, P741, DOI 10.1023/B:JOEC.0000028429.13413.a2; Giorgi JA, 2009, BIOL CONTROL, V51, P215, DOI 10.1016/j.biocontrol.2009.05.019; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; GORDON RD, 1985, J NEW YORK ENTOMOL S, V93, P1; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; GROVE JF, 1983, J SCI FOOD AGR, V34, P181, DOI 10.1002/jsfa.2740340211; Guevara R, 2000, PHYSIOL ENTOMOL, V25, P288, DOI 10.1046/j.1365-3032.2000.00194.x; HIJWEGEN T, 1992, EUR J PLANT PATHOL, V98, P221; Ichiki RT, 2008, J CHEM ECOL, V34, P614, DOI 10.1007/s10886-008-9459-6; ITO T, 1995, BIOSCI BIOTECH BIOCH, V59, P1944, DOI 10.1271/bbb.59.1944; Jamal E, 2001, ENVIRON ENTOMOL, V30, P1012, DOI 10.1603/0046-225X-30.6.1012; Jimenez-Martinez ES, 2004, ENVIRON ENTOMOL, V33, P1207, DOI 10.1603/0046-225X-33.5.1207; Koitabashi Motoo, 2002, Journal of General Plant Pathology, V68, P183, DOI 10.1007/PL00013074; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; McLeod G, 2005, P ROY SOC B-BIOL SCI, V272, P2499, DOI 10.1098/rspb.2005.3202; Morawicki RO, 2005, PROCESS BIOCHEM, V40, P131, DOI 10.1016/j.procbio.2003.11.037; Naef A, 2002, NEW PHYTOL, V154, P717, DOI 10.1046/j.1469-8137.2002.00406.x; NAKAMUTA K, 1991, APPL ENTOMOL ZOOL, V26, P1; Ngugi HK, 2006, FEMS MICROBIOL LETT, V257, P171, DOI 10.1111/j.1574-6968.2006.00168.x; Ninkovic V, 2001, BIOL CONTROL, V21, P191, DOI 10.1006/bcon.2001.0935; Norton AP, 2000, ECOLOGY, V81, P490, DOI 10.1890/0012-9658(2000)081[0490:MMAFPL]2.0.CO;2; Parrella AM, 2006, CAL C BIOL CONTR RIV, V5, P188; Pettersson J, 2008, APPL ENTOMOL ZOOL, V43, P315, DOI 10.1303/aez.2008.315; Pickett JA, 2006, WAG UR FRON, V16, P161; Price P.W., 1981, P251; Raguso RA, 1998, MOL ECOL, V7, P1127, DOI 10.1046/j.1365-294x.1998.00426.x; Razdan V. K., 2009, P369, DOI 10.1007/978-1-4020-8992-3_15; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Sasaji H, 1998, NATURAL HIST LADYBIR; Sutherland AM, 2009, BIOL CONTROL, V51, P284, DOI 10.1016/j.biocontrol.2009.05.012; Sutherland AM, 2009, ANN ENTOMOL SOC AM, V102, P484, DOI 10.1603/008.102.0319; Takeuchi M, 2000, JPN J APPL ENTOMOL Z, V44, P89, DOI 10.1303/jjaez.2000.89; URQUHART EJ, 1994, PHYTOPATHOLOGY, V84, P342; Verhaar MA, 1996, BIOL CONTROL, V6, P353, DOI 10.1006/bcon.1996.0045; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028	51	30	33	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23799	10.1371/journal.pone.0023799	http://dx.doi.org/10.1371/journal.pone.0023799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876772	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900044
J	Kasperaviciute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; Cohen, H; Adalat, S; Bockenhauer, D; Pope, SA; Lench, N; Koltzenburg, M; Duncan, JS; Hammond, P; Hennekam, RCM; Land, JM; Sisodiya, SM				Kasperaviciute, Dalia; Catarino, Claudia B.; Chinthapalli, Krishna; Clayton, Lisa M. S.; Thom, Maria; Martinian, Lillian; Cohen, Hannah; Adalat, Shazia; Bockenhauer, Detlef; Pope, Simon A.; Lench, Nicholas; Koltzenburg, Martin; Duncan, John S.; Hammond, Peter; Hennekam, Raoul C. M.; Land, John M.; Sisodiya, Sanjay M.			Uncovering Genomic Causes of Co-Morbidity in Epilepsy: Gene-Driven Phenotypic Characterization of Rare Microdeletions	PLOS ONE			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; 15Q13.3 MICRODELETIONS; 16P13.11 PREDISPOSE; CHROMOSOME 17Q12; COMORBIDITY; MUTATIONS; DISEASE; RISK; DEFICIENCIES; DYSFUNCTION	Background: Patients with epilepsy often suffer from other important conditions. The existence of such co-morbidities is frequently not recognized and their relationship with epilepsy usually remains unexplained. Methodology/Principal Findings: We describe three patients with common, sporadic, non-syndromic epilepsies in whom large genomic microdeletions were found during a study of genetic susceptibility to epilepsy. We performed detailed gene-driven clinical investigations in each patient. Disruption of the function of genes in the deleted regions can explain comorbidities in these patients. Conclusions/Significance: Co-morbidities in patients with epilepsy can be part of a genomic abnormality even in the absence of (known) congenital malformations or intellectual disabilities. Gene-driven phenotype examination can also reveal clinically significant unsuspected condition.	[Kasperaviciute, Dalia; Catarino, Claudia B.; Chinthapalli, Krishna; Clayton, Lisa M. S.; Thom, Maria; Martinian, Lillian; Duncan, John S.; Sisodiya, Sanjay M.] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Catarino, Claudia B.; Duncan, John S.; Sisodiya, Sanjay M.] Natl Soc Epilepsy, Gerrards Cross, Bucks, England; [Cohen, Hannah] UCL, Dept Haematol, London, England; [Cohen, Hannah] Univ Coll London Hosp NHS Fdn Trust, London, England; [Adalat, Shazia; Bockenhauer, Detlef] UCL, Inst Child Hlth, Renal Unit, London, England; [Adalat, Shazia; Bockenhauer, Detlef] Great Ormond St Hosp NHS Trust, London, England; [Pope, Simon A.; Land, John M.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England; [Lench, Nicholas] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 3JH, England; [Koltzenburg, Martin] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Koltzenburg, Martin] Natl Hosp Neurol & Neurosurg, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Hammond, Peter] UCL, Inst Child Hlth, Mol Med Unit, London, England; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam	Kasperaviciute, D (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England.	s.sisodiya@ion.ucl.ac.uk	Catarino, Claudia Bacanhim/ABC-2316-2021; Lench, Nicholas/AAB-1791-2021; Catarino, Claudia B/A-7719-2010; Chinthapalli, Krishna/P-8428-2019; Bockenhauer, Detlef/AAF-6495-2020; Koltzenburg, Martin/C-1349-2008	Catarino, Claudia B/0000-0002-6528-7570; Chinthapalli, Krishna/0000-0003-4136-4882; Bockenhauer, Detlef/0000-0001-5878-941X; Koltzenburg, Martin/0000-0001-9181-5966; Lench, Nicholas/0000-0002-6108-0759; Pope, Simon Alexander Samuel/0000-0002-2991-3722; Duncan, John S/0000-0002-1373-0681	The Wellcome Trust [084730]; United Kingdom Medical Research Council [G0400126]; UCLH CRDC [F136]; The National Institute for Health Research [08-08-SCC]; Epilepsy Society; Arthur James Paterson Charitable Trust; Department of Health's NIHR Biomedical Research Centres; MRC [G0601943, G0400126] Funding Source: UKRI; Medical Research Council [G0400126, G0601943] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish	The Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCLH CRDC; The National Institute for Health Research; Epilepsy Society; Arthur James Paterson Charitable Trust; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	This work was supported by grants from The Wellcome Trust (www.wellcome.ac.uk, grant code 084730), the United Kingdom Medical Research Council (www.mrc.ac.uk, grant code G0400126), UCLH CRDC (www.uclhcharity.org.uk, grant code F136), The National Institute for Health Research (www.nihr.ac.uk, grant code 08-08-SCC), the Epilepsy Society (www.epilepsysociety.org.uk), the Arthur James Paterson Charitable Trust and the Special Trustees of Great Ormond Street Hospital. This work was partly undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2010, CEREB CORTEX, V20, P1788, DOI 10.1093/cercor/bhp242; Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; Bingham C, 2004, NEPHROL DIAL TRANSPL, V19, P2703, DOI 10.1093/ndt/gfh348; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Dibbens LM, 2009, HUM MOL GENET, V18, P3626, DOI 10.1093/hmg/ddp311; Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643; Franck N, 2011, J CLIN ENDOCR METAB, V96, pE413, DOI 10.1210/jc.2009-2534; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Heeb MJ, 2008, EXPERT REV HEMATOL, V1, P9, DOI 10.1586/17474086.1.1.9; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hunter C, 2005, MOL BIOL REP, V32, P67, DOI 10.1007/s11033-004-7657-z; Kahn LS, 2007, J NATL MED ASSOC, V99, P377; Kenet G, 2010, CIRCULATION, V121, P1838, DOI 10.1161/CIRCULATIONAHA.109.913673; Lillicrap D, 2009, J THROMB HAEMOST, V7, P65, DOI 10.1111/j.1538-7836.2009.03367.x; Loirat C, 2010, NEPHROL DIAL TRANSPL, V25, P3430, DOI 10.1093/ndt/gfq380; Malow BA, 2008, NEUROLOGY, V71, P572, DOI 10.1212/01.wnl.0000323927.13250.54; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Nagamani SCS, 2010, EUR J HUM GENET, V18, P278, DOI 10.1038/ejhg.2009.174; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113; Rea R, 2002, J PHYSIOL-LONDON, V538, P5, DOI 10.1113/jphysiol.2001.013242; Taylor MRG, 2006, AM J MED GENET C, V142C, P294, DOI 10.1002/ajmg.c.30105; Thom M, 2009, J NEUROPATH EXP NEUR, V68, P928, DOI 10.1097/NEN.0b013e3181b05d67; Tomlinson SE, 2010, BRAIN, V133, P3530, DOI 10.1093/brain/awq318; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Wiebe Samuel, 2007, Epilepsy Curr, V7, P145, DOI 10.1111/j.1535-7511.2007.00207.x; Winawer MR, 2010, NEUROLOGY, V74, P1166, DOI 10.1212/WNL.0b013e3181d90065; WOLF B, 1982, AM J HUM GENET, V34, P699; Zaccara G, 2009, ACTA NEUROL SCAND, V120, P1, DOI 10.1111/j.1600-0404.2008.01146.x; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104	38	22	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23182	10.1371/journal.pone.0023182	http://dx.doi.org/10.1371/journal.pone.0023182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858020	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300016
J	Zhao, DQ; Ai, HB				Zhao, Dong-Qin; Ai, Hong-Bin			Oxytocin and Vasopressin Involved in Restraint Water-Immersion Stress Mediated by Oxytocin Receptor and Vasopressin 1b Receptor in Rat Brain	PLOS ONE			English	Article							DORSAL MOTOR NUCLEUS; MESSENGER RIBONUCLEIC-ACIDS; C-FOS IMMUNOREACTIVITY; PARAVENTRICULAR NUCLEUS; GASTRIC-MOTILITY; VAGAL COMPLEX; NEURONS; EXPRESSION; HYPOTHALAMUS; VAGUS	Aims: Vasopressin (AVP) and oxytocin (OT) are considered to be related to gastric functions and the regulation of stress response. The present study was to study the role of vasopressinergic and oxytocinergic neurons during the restraint water-immersion stress. Methods: Ten male Wistar rats were divided into two groups, control and RWIS for 1h. The brain sections were treated with a dual immunohistochemistry of Fos and oxytocin (OT) or vasopressin (AVP) or OT receptor or AVP 1b receptor (V1bR). Results: (1) Fos-immunoreactive (Fos-IR) neurons dramatically increased in the hypothalamic paraventricular nucleus (PVN), the supraoptic nucleus (SON), the neucleus of solitary tract (NTS) and motor nucleus of the vagus (DMV) in the RWIS rats; (2) OT-immunoreactive (OT-IR) neurons were mainly observed in the medial magnocellular part of the PVN and the dorsal portion of the SON, while AVP-immunoreactive (AVP-IR) neurons mainly distributed in the magnocellular part of the PVN and the ventral portion of the SON. In the RWIS rats, Fos-IR neurons were indentified in 31% of OT-IR neurons and 40% of AVP-IR neurons in the PVN, while in the SON it represented 28%, 53% respectively; (3) V1bR-IR and OTR-IR neurons occupied all portions of the NTS and DMV. In the RWIS rats, more than 10% of OTR-IR and V1bR-IR neurons were activated in the DMV, while lower ratio in the NTS. Conclusion: RWIS activates both oxytocinergic and vasopressinergic neurons in the PVN and SON, which may project to the NTS or DMV mediating the activity of the neurons by OTR and V1bR.	[Zhao, Dong-Qin; Ai, Hong-Bin] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Shandong Prov, Jinan, Shandong, Peoples R China	Shandong Normal University	Zhao, DQ (corresponding author), Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Shandong Prov, Jinan, Shandong, Peoples R China.	aihongbin@sdnu.edu.cn			National Science Foundation of China [30770277, 30970354, 31071920]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (No. 30770277, 30970354, 31071920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscipt.	AI H-B, 1990, Acta Physiologica Sinica, V42, P496; Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119; Benarroch EE, 2005, CLIN AUTON RES, V15, P254, DOI 10.1007/s10286-005-0290-7; BONAZ B, 1994, BRAIN RES, V652, P56, DOI 10.1016/0006-8993(94)90316-6; Briski K, 2001, BRAIN RES BULL, V55, P401, DOI 10.1016/S0361-9230(01)00532-9; CECCATELLI S, 1989, NEUROENDOCRINOLOGY, V49, P309, DOI 10.1159/000125133; Cruz MT, 2007, AM J PHYSIOL-REG I, V292, pR291, DOI 10.1152/ajpregu.00863.2005; du Plessis I, 2006, BRAIN RES, V1120, P124, DOI 10.1016/j.brainres.2006.08.062; GARRICK T, 1986, AM J PHYSIOL, V250, pG191, DOI 10.1152/ajpgi.1986.250.2.G191; GEORGE JM, 1975, BRAIN RES, V93, P363, DOI 10.1016/0006-8993(75)90360-1; GIOVANNELLI L, 1992, BRAIN RES, V588, P41, DOI 10.1016/0006-8993(92)91342-C; GIOVANNELLI L, 1990, BRAIN RES, V531, P299, DOI 10.1016/0006-8993(90)90789-E; Harrison TA, 2001, BRAIN RES, V904, P54, DOI 10.1016/S0006-8993(01)02449-0; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Higa KT, 2002, AM J PHYSIOL-REG I, V282, pR537, DOI 10.1152/ajpregu.00806.2000; KREMARIK P, 1995, BRAIN RES BULL, V36, P195, DOI 10.1016/0361-9230(94)00196-8; Krowicki ZK, 2002, AM J PHYSIOL-GASTR L, V283, pG465, DOI 10.1152/ajpgi.00264.2001; MCCANN MJ, 1990, J PHYSIOL-LONDON, V428, P95, DOI 10.1113/jphysiol.1990.sp018202; Michelini LC, 2001, ANN NY ACAD SCI, V940, P206; MIYATA S, 1995, BRAIN RES BULL, V37, P391, DOI 10.1016/0361-9230(95)00017-8; Nishitani S, 2004, CELL MOL NEUROBIOL, V24, P283, DOI 10.1023/B:CEMN.0000018622.44317.14; OKUMURA T, 1990, J AUTONOM NERV SYST, V29, P157, DOI 10.1016/0165-1838(90)90181-H; OSTROWSKI NL, 1992, ENDOCRINOLOGY, V131, P533, DOI 10.1210/en.131.1.533; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Palkovits M, 2000, EUR J PHARMACOL, V405, P161, DOI 10.1016/S0014-2999(00)00549-5; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pirnik Z, 2005, BRAIN RES BULL, V65, P423, DOI 10.1016/j.brainresbull.2005.02.023; Pirnik Z, 2004, NEUROCHEM INT, V45, P597, DOI 10.1016/j.neuint.2004.04.003; Rinaman L, 1998, J COMP NEUROL, V399, P101, DOI 10.1002/(SICI)1096-9861(19980914)399:1<101::AID-CNE8>3.0.CO;2-5; ROGERS RC, 1987, PEPTIDES, V8, P505, DOI 10.1016/0196-9781(87)90017-9; Rogers RC, 1999, J PHYSIOL-LONDON, V514, P369, DOI 10.1111/j.1469-7793.1999.369ae.x; Rogers RC, 1996, NEUROSCI BIOBEHAV R, V20, P57, DOI 10.1016/0149-7634(95)00040-L; SOFRONIEW MV, 1980, J COMP NEUROL, V193, P659, DOI 10.1002/cne.901930305; SOFRONIEW MV, 1981, NEUROSCIENCE, V6, P619, DOI 10.1016/0306-4522(81)90147-0; Sun HZ, 2010, CHINESE MED J-PEKING, V123, P1052, DOI 10.3760/cma.j.issn.0366-6999.2010.08.014; SWAAB DF, 1975, J ENDOCRINOL, V67, P461, DOI 10.1677/joe.0.0670461; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; Volpi S, 2004, STRESS, V7, P75, DOI 10.1080/10253890410001733535; Wang LX, 2009, BRAIN RES, V1247, P79, DOI 10.1016/j.brainres.2008.09.094; Wang YH, 2007, SCAND J CLIN LAB INV, V67, P489, DOI 10.1080/00365510601161505; Xiong JJ, 1996, BRAIN RES, V719, P143, DOI 10.1016/0006-8993(95)01466-7; Young WS, 2006, NEUROSCIENCE, V143, P1031, DOI 10.1016/j.neuroscience.2006.08.040; Zhang JF, 1997, BRAIN RES, V761, P203, DOI 10.1016/S0006-8993(97)00257-6; Zhang YY, 2009, J PHYSIOL SCI, V59, P367, DOI 10.1007/s12576-009-0044-8; Zhang YY, 2009, CHINESE J PHYSIOL, V52, P143, DOI 10.4077/CJP.2009.AMH045; Zhao DQ, 2011, J PHYSIOL SCI, V61, P37, DOI 10.1007/s12576-010-0119-6; Zhou SY, 2008, AM J PHYSIOL-GASTR L, V294, pG1201, DOI 10.1152/ajpgi.00309.2006; ZIMMERMANN M, 1986, ACTA PHYSIOL SCAND, V128, P221	53	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23362	10.1371/journal.pone.0023362	http://dx.doi.org/10.1371/journal.pone.0023362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858088	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300039
J	Fernandez-Alarcon, C; Singer, RS; Johnson, TJ				Fernandez-Alarcon, Claudia; Singer, Randall S.; Johnson, Timothy J.			Comparative Genomics of Multidrug Resistance-Encoding IncA/C Plasmids from Commensal and Pathogenic Escherichia coli from Multiple Animal Sources	PLOS ONE			English	Article							VIBRIO-CHOLERAE O139; SALMONELLA-ENTERICA; ANTIMICROBIAL RESISTANCE; H-NS; FLORFENICOL RESISTANCE; MEDIATED FLORFENICOL; NUCLEOTIDE-SEQUENCE; BETA-LACTAMASES; FISH PATHOGEN; ISCR ELEMENTS	Incompatibility group A/C (IncA/C) plasmids have received recent attention for their broad host range and ability to confer resistance to multiple antimicrobial agents. Due to the potential spread of multidrug resistance (MDR) phenotypes from foodborne pathogens to human pathogens, the dissemination of these plasmids represents a public health risk. In this study, four animal-source IncA/C plasmids isolated from Escherichia coli were sequenced and analyzed, including isolates from commercial dairy cows, pigs and turkeys in the U. S. and Chile. These plasmids were initially selected because they either contained the floR and tetA genes encoding for florfenicol and tetracycline resistance, respectively, and/or the bla(CMY-2) gene encoding for extended spectrum beta-lactamase resistance. Overall, sequence analysis revealed that each of the four plasmids retained a remarkably stable and conserved backbone sequence, with differences observed primarily within their accessory regions, which presumably have evolved via horizontal gene transfer events involving multiple modules. Comparison of these plasmids with other available IncA/C plasmid sequences further defined the core and accessory elements of these plasmids in E. coli and Salmonella. Our results suggest that the bla(CMY-2) plasmid lineage appears to have derived from an ancestral IncA/C plasmid type harboring floR-tetAR-strAB and Tn21-like accessory modules. Evidence is mounting that IncA/C plasmids are widespread among enteric bacteria of production animals and these emergent plasmids have flexibility in their acquisition of MDR-encoding modules, necessitating further study to understand the evolutionary mechanisms involved in their dissemination and stability in bacterial populations.	[Fernandez-Alarcon, Claudia; Singer, Randall S.; Johnson, Timothy J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Singer, Randall S.] Univ Austral Chile, Fac Ciencias Vet, Inst Med Prevent Vet, Valdivia, Chile	University of Minnesota System; University of Minnesota Twin Cities; Universidad Austral de Chile	Fernandez-Alarcon, C (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	joh04207@umn.edu		Johnson, Timothy/0000-0001-7556-9347; Fernandez-Alarcon, Claudia/0000-0003-2210-7792	USDA NRICGP [2000-35212-9398, 2003-35212-13853]; NSF [0405419]; Minnesota Pork Board	USDA NRICGP(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Minnesota Pork Board	This project was supported in part by USDA NRICGP Grants 2000-35212-9398 and 2003-35212-13853 (Singer), NSF Grant 0405419 (Singer), and the Minnesota Pork Board (Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alcaine SD, 2005, ANTIMICROB AGENTS CH, V49, P4061, DOI 10.1128/AAC.49.10.4061-4067.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AOKI T, 1971, J GEN MICROBIOL, V65, P343, DOI 10.1099/00221287-65-3-343; BRADLEY DE, 1989, RES MICROBIOL, V140, P439, DOI 10.1016/0923-2508(89)90064-8; Brinas L, 2003, ANTIMICROB AGENTS CH, V47, P2056, DOI 10.1128/AAC.47.6.2056-2058.2003; Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Carattoli A, 2002, ANTIMICROB AGENTS CH, V46, P1269, DOI 10.1128/AAC.46.5.1269-1272.2002; Cloeckaert A, 2001, ANTIMICROB AGENTS CH, V45, P2381, DOI 10.1128/AAC.45.8.2381-2382.2001; D'Andrea MM, 2011, ANTIMICROB AGENTS CH, V55, P2735, DOI 10.1128/AAC.01736-10; DebRoy C, 2010, PLASMID, V63, P53, DOI 10.1016/j.plasmid.2009.10.003; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Dillon SC, 2010, MOL MICROBIOL, V76, P1250, DOI 10.1111/j.1365-2958.2010.07173.x; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Doublet B, 2004, FEMS MICROBIOL LETT, V233, P301, DOI [10.1016/j.femsle.2004.02.023, 10.1111/j.1574-6968.2004.tb09496.x]; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Folster JP, 2010, FOODBORNE PATHOG DIS, V7, P181, DOI 10.1089/fpd.2009.0376; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Frye JG, 2007, INT J ANTIMICROB AG, V30, P134, DOI 10.1016/j.ijantimicag.2007.03.013; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Glenn LM, 2011, MICROB DRUG RESIST; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; Gonzalez-Sanz R, 2009, J ANTIMICROB CHEMOTH, V64, P1181, DOI 10.1093/jac/dkp361; Gonzalez-Zorn B, 2005, EMERG INFECT DIS, V11, P954; Hammerum AM, 2009, CLIN INFECT DIS, V48, P916, DOI 10.1086/597292; Hochhut B, 2001, ANTIMICROB AGENTS CH, V45, P2991, DOI 10.1128/AAC.45.11.2991-3000.2001; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2009, METHODS MOL BIOL, V551, P27, DOI 10.1007/978-1-60327-999-4_3; Johnson TJ, 2004, AVIAN DIS, V48, P351, DOI 10.1637/7121; Kim EH, 1996, MICROBIOL IMMUNOL, V40, P665, DOI 10.1111/j.1348-0421.1996.tb01125.x; Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P606, DOI 10.1128/AAC.01216-07; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Lindsey RL, 2011, MICROB DRUG RESIST, V17, P157, DOI 10.1089/mdr.2010.0148; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Noguchi N, 2000, J BACTERIOL, V182, P5052, DOI 10.1128/JB.182.18.5052-5058.2000; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Pan JC, 2008, ANTIMICROB AGENTS CH, V52, P3829, DOI 10.1128/AAC.00375-08; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Poiret L, 2011, J ANTIMICROB CHEMOTH; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shintani M, 2010, ENVIRON MICROBIOL, V12, P1413, DOI 10.1111/j.1462-2920.2009.02110.x; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; Singh A, 2011, PLASMID REPLICON TYP; Subbiah M, 2011, APPL ENVIRON MICROB, V77, P4486, DOI 10.1128/AEM.02788-10; Suzuki H, 2010, J BACTERIOL, V192, P6045, DOI 10.1128/JB.00277-10; Tadesse DA, PLASMED DIVERSITY HI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Toleman MA, 2011, FEMS MICROBIOL REV; Toleman MA, 2008, ANTIMICROB AGENTS CH, V52, P3789, DOI 10.1128/AAC.00479-08; Toleman MA, 2010, ANTIMICROB AGENTS CH, V54, P3534, DOI 10.1128/AAC.00383-10; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welch TJ, 2009, ANTIMICROB AGENTS CH, V53, P845, DOI 10.1128/AAC.01312-08; Wiesner M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-9; Yun CS, 2010, J BACTERIOL, V192, P4720, DOI 10.1128/JB.00591-10; Zaidi MB, 2007, J ANTIMICROB CHEMOTH, V60, P398, DOI 10.1093/jac/dkm168; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao S, 2008, APPL ENVIRON MICROB, V74, P6656, DOI 10.1128/AEM.01249-08	61	106	108	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23415	10.1371/journal.pone.0023415	http://dx.doi.org/10.1371/journal.pone.0023415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858108	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953500038
J	Hesse, K; Vaupel, K; Kurt, S; Buettner, R; Kirfel, J; Moser, M				Hesse, Katrin; Vaupel, Kristina; Kurt, Simone; Buettner, Reinhard; Kirfel, Jutta; Moser, Markus			AP-2 delta Is a Crucial Transcriptional Regulator of the Posterior Midbrain	PLOS ONE			English	Article							DNA-BINDING; FACTOR AP-2; MOUSE EMBRYOGENESIS; FACTOR AP-2-GAMMA; EPITHELIAL-CELLS; FACTOR AP-2-BETA; GENE-EXPRESSION; MUTANT MICE; AP-2-EPSILON; POU4F3	Ap-2 transcription factors comprise a family of 5 closely related sequence-specific DNA binding proteins that play pivotal and non-redundant roles in embryonic organogenesis. To investigate the function of Ap-2 delta, w delta e analyzed its expression during embryogenesis and generated Ap-2 delta-deficient mice. In line with the specific expression pattern of Ap-2 delta in the mesencephalic tectum and the dorsal midbrain, Ap-2 delta-deficient mice failed to maintain the colliculus inferior, a derivative of the dorsal midbrain, as a consequence of increased apoptotic cell death. To identify specific Ap-2 delta target genes in cells of the developing dorsal midbrain, we performed whole genome analysis of cDNA expression levels. This approach identified a set of 12 putative target genes being expressed in the developing midbrain, including the transcription factors Pitx2, Mef2c, Bhlhb4 and Pou4f3. Using chromatin immunoprecipitation (CHIP) we showed that some of these genes are direct targets of Ap-2 delta. Consistently, we demonstrate that Ap-2 delta d occupies and activates the Pou4f3 and Bhlhb4 promoters. In addition, known Pou4f3 target genes were downregulated in the posterior midbrain of Ap-2 delta-deficient mice. Despite the absence of a central part of the auditory pathway, the presence of neuronal responses to sounds in the neocortex of Ap-2 delta-deficient mice indicates that auditory information from the brainstem still reaches the neocortex. In summary, our data define Ap-2 delta as an important transcription factor, specifying gene expression patterns required for the development of the posterior midbrain.	[Hesse, Katrin; Kirfel, Jutta] Univ Bonn, Inst Pathol, D-5300 Bonn, Germany; [Vaupel, Kristina; Moser, Markus] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kurt, Simone] Univ Ulm, Inst Neurobiol, Ulm, Germany; [Buettner, Reinhard] Univ Cologne, Inst Pathol, Cologne, Germany	University of Bonn; Max Planck Society; Ulm University; University of Cologne	Hesse, K (corresponding author), Univ Bonn, Inst Pathol, D-5300 Bonn, Germany.	moser@biochem.mpg.de	Kurt, Simone/I-2927-2012	Kurt, Simone/0000-0002-1820-2597	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	M.M. and R.B. were funded by grants from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish or preparartion of the manuscript.	ABELES M, 1975, HDB SENSORY PHYSL; Auman HJ, 2002, DEVELOPMENT, V129, P2733; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; CASSEDAY JH, 1989, J COMP NEUROL, V287, P247, DOI 10.1002/cne.902870208; Chazaud C, 1996, MECH DEVELOP, V54, P83, DOI 10.1016/0925-4773(95)00463-7; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; Clough RL, 2004, BIOCHEM BIOPH RES CO, V324, P372, DOI 10.1016/j.bbrc.2004.09.074; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Feng W, 2009, MOL CELL NEUROSCI, V42, P161, DOI 10.1016/j.mcn.2009.06.010; Feng WG, 2003, MOL CELL NEUROSCI, V24, P460, DOI 10.1016/S1044-7431(03)00209-4; Gurung B, 2004, J COMP NEUROL, V479, P309, DOI 10.1002/cne.20328; Hertzano R, 2007, EUR J NEUROSCI, V25, P999, DOI 10.1111/j.1460-9568.2007.05332.x; Jafari MR, 2007, CEREB CORTEX, V17, P71, DOI 10.1093/cercor/bhj125; KOBLER JB, 1987, SCIENCE, V236, P824, DOI 10.1126/science.2437655; LIM S, CARCINOGENESIS, V31, P512; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; Moser M, 1997, GENE DEV, V11, P1938, DOI 10.1101/gad.11.15.1938; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; Moser M, 2003, LAB INVEST, V83, P571, DOI 10.1097/01.LAB.0000064703.92382.50; MOSER M, 1995, DEVELOPMENT, V121, P2779; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Pfeffer PL, 2000, DEVELOPMENT, V127, P1017; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Schwarz M, 1997, P NATL ACAD SCI USA, V94, P14518, DOI 10.1073/pnas.94.26.14518; Shi DQ, 1998, J BIOL CHEM, V273, P27331, DOI 10.1074/jbc.273.42.27331; Sun LY, 2007, FRONT BIOSCI-LANDMRK, V12, P1699, DOI 10.2741/2182; Tan CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008535; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wang HV, 2004, DEV DYNAM, V231, P128, DOI 10.1002/dvdy.20119; Wenke AK, 2006, BIOCHEM BIOPH RES CO, V345, P495, DOI 10.1016/j.bbrc.2006.04.123; Werling U, 2002, MOL CELL BIOL, V22, P3149, DOI 10.1128/MCB.22.9.3149-3156.2002; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WURST W, 1994, DEVELOPMENT, V120, P2065; Xiang MQ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-2; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhao F, 2003, GENE EXPR PATTERNS, V3, P213, DOI 10.1016/S1567-133X(02)00067-4	44	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23483	10.1371/journal.pone.0023483	http://dx.doi.org/10.1371/journal.pone.0023483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858141	Green Published, gold, Green Submitted			2022-12-27	WOS:000293774300038
J	Peng, A; Wu, TF; Zeng, CH; Rakheja, D; Zhu, JK; Ye, T; Hutcheson, J; Vaziri, ND; Liu, ZH; Mohan, C; Zhou, XJ				Peng, Ai; Wu, Tianfu; Zeng, Caihong; Rakheja, Dinesh; Zhu, Jiankun; Ye, Ting; Hutcheson, Jack; Vaziri, Nosratola D.; Liu, Zhihong; Mohan, Chandra; Zhou, Xin J.			Adverse Effects of Simulated Hyper- and Hypo-Phosphatemia on Endothelial Cell Function and Viability	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PHASE PROTEIN MICROARRAYS; CARDIOVASCULAR-DISEASE; POTENTIAL CONSEQUENCES; INTRACELLULAR CALCIUM; FLOW-CYTOMETRY; APOPTOSIS; DYSFUNCTION; PATHWAYS; KINASE	Background: Dysregulaiton of phosphate homeostasis as occurs in chronic kidney disease is associated with cardiovascular complications. It has been suggested that both hyperphosphatemia and hypophosphatemia can cause cardiovascular disease. The molecular mechanisms by which high or low serum phosphate levels adversely affect cardiovascular function are poorly understood. The purpose of this study was to explore the mechanisms of endothelial dysfunction in the presence of non-physiologic phosphate levels. Methodology/Principal Findings: We studied the effects of simulated hyper- and hypophosphatemia in human umbilical vein endothelial cells in vitro. We found both simulated hyperphosphatemia and hypophosphatemia decrease eNOS expression and NO production. This was associated with reduced intracellular calcium, increased protein kinase C beta 2 (PKC beta 2), reduced cell viability, and increased apoptosis. While simulated hyperphosphatemia was associated with decreased Akt/p-Akt, Bcl-xl/Bax ratios, NFkB-p65 and p-Erk abundance, simulated hypophosphatemia was associated with increased Akt/p-Akt and Bcl-xl/Bax ratios and p-Mek, p38, and p-p38 abundance. Conclusions/Significance: This is the first demonstration of endothelial dysfunction with hypophosphatemia. Our data suggests that both hyperphosphatemia and hypophosphatemia decrease eNOS activity via reduced intracellular calcium and increased PKCb2. Hyperphosphatemia also appears to reduce eNOS transcription via reduced signaling through PI3K/Akt/NF-kB and MAPK/NF-kB pathways. On the other hand, hypophosphatemia appears to activate these pathways. Our data provides the basis for further studies to elucidate the relationship between altered phosphate homeostasis and cardiovascular disease. As a corollary, our data suggests that the level of phosphate in the culture media, if not in the physiologic range, may inadvertently affect experimental results.	[Peng, Ai] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nephrol, Shanghai 200092, Peoples R China; [Peng, Ai; Rakheja, Dinesh; Ye, Ting; Zhou, Xin J.] UT SW Med Ctr, Dept Pathol, Dallas, TX USA; [Wu, Tianfu; Zhu, Jiankun; Hutcheson, Jack; Mohan, Chandra] UT SW Med Ctr, Dept Internal Med, Div Rheumatol, Dallas, TX USA; [Zeng, Caihong; Liu, Zhihong] Nanjing Univ, Jinling Hosp, Sch Med, Res Inst Nephrol, Nanjing 210008, Peoples R China; [Vaziri, Nosratola D.] Univ Calif Irvine, Div Nephrol & Hypertens, Irvine, CA USA	Tongji University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Nanjing University; University of California System; University of California Irvine	Peng, A (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Nephrol, Shanghai 200092, Peoples R China.	zhihong-liu@hotmail.com; Chandra.mohan@utsouthwestern.edu; joseph.zhou@ymail.com	Wu, Tianfu/G-6672-2019; Mohan, Chandra/GPX-8233-2022	Wu, Tianfu/0000-0003-4406-1449; Hutcheson, Jack/0000-0002-6317-2788; Wu, Tianfu/0000-0001-8235-5929	National Institutes of Health [AR055600]; National Natural Science Foundation of China [30472163, 30871202]; High Technology Research and Development Program of China [2009AA02Z416]; Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from the National Institutes of Health (AR055600), the National Natural Science Foundation of China (30472163 and 30871202), and the High Technology Research and Development Program of China (2009AA02Z416), and by funds from the Drs. George and Anne Race Distinguished Professorship in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2002, CAN J APPL PHYSIOL, V27, P83, DOI 10.1139/h02-006; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chae HD, 2008, ONCOGENE, V27, P4115, DOI 10.1038/onc.2008.46; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Chicoine LM, 2004, J NEUROSCI RES, V75, P408, DOI 10.1002/jnr.10871; Deo R, 2008, AM HEART J, V155, P62, DOI 10.1016/j.ahj.2007.08.012; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ditzel J, 2010, VASC HEALTH RISK MAN, V6, P829, DOI 10.2147/VHRM.S13368; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Duncan JS, 2010, BBA-PROTEINS PROTEOM, V1804, P505, DOI 10.1016/j.bbapap.2009.11.001; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Farrow EG, 2010, NAT REV NEPHROL, V6, P207, DOI 10.1038/nrneph.2010.17; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Heames RM, 2006, ANAESTHESIA, V61, P1211, DOI 10.1111/j.1365-2044.2006.04839.x; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Hirata Y, 2010, INT HEART J, V51, P1, DOI 10.1536/ihj.51.1; Jeon YJ, 2000, J PHARMACOL EXP THER, V294, P548; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Malinowsky K, 2010, J CELL PHYSIOL, V225, P364, DOI 10.1002/jcp.22307; Matsubara M, 2003, J BIOCHEM, V133, P773, DOI 10.1093/jb/mvg099; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Musicki B, 2009, J SEX MED, V6, P247, DOI 10.1111/j.1743-6109.2008.01122.x; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; Osuka A, 2009, INTERNAL MED, V48, P1391, DOI 10.2169/internalmedicine.48.2236; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; SZCZEPANSKAKONKEL M, 1986, J BIOL CHEM, V261, P6375; Takeda E, 2006, ADV ENZYME REGUL, V46, P154, DOI 10.1016/j.advenzreg.2006.01.003; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Vangamudi B, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-32; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Vaziri ND, 2010, NAT REV NEPHROL, V6, P287, DOI 10.1038/nrneph.2010.36; Wang XD, 2001, GENE DEV, V15, P2922; Westerblad H, 1996, PFLUG ARCH EUR J PHY, V431, P964, DOI 10.1007/s004240050092; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Xian M, 2000, BIOCHEM BIOPH RES CO, V268, P310, DOI 10.1006/bbrc.2000.2117; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	42	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23268	10.1371/journal.pone.0023268	http://dx.doi.org/10.1371/journal.pone.0023268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858050	gold, Green Published			2022-12-27	WOS:000293774300029
J	Li, HM; Peng, RR; Li, J; Yin, YP; Wang, BX; Cohen, MS; Chen, XS				Li, Hong-Min; Peng, Rui-Rui; Li, Jing; Yin, Yue-Ping; Wang, Baoxi; Cohen, Myron S.; Chen, Xiang-Sheng			HIV Incidence among Men Who Have Sex with Men in China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							CAPTURE ENZYME-IMMUNOASSAY; HEPATITIS-B; INFECTIONS; PREVALENCE; VIRUS; PREVENTION; SYPHILIS; MUNICIPALITY; TRANSMISSION; POPULATIONS	Background: Men who have sex with men (MSM) have now become one of the priority populations for prevention and control of HIV pandemic in China. Information of HIV incidence among MSM is important to describe the spreading of the infection and predict its trends in this population. We reviewed the published literature on the incidence of HIV infection among MSM in China. Methods: We identified relevant studies by use of a comprehensive strategy including searches of Medline and two Chinese electronic publication databases from January 2005 to September 2010. Point estimate of random effects incidence with corresponding 95% confidence intervals (CI) of HIV infection was carried out using the Comprehensive Meta-Analysis software. Subgroup analyses were examined separately, stratified by study design and geographic location. Results: Twelve studies were identified, including three cohort studies and nine cross-sectional studies. The subgroup analyses revealed that the sub-overall incidence estimates were 3.5% (95% CI, 1.7%-5.3%) and 6.7% (95% CI, 4.8%-8.6%) for cohort and cross-sectional studies, respectively (difference between the sub-overalls, Q = 5.54, p = 0.02); and 8.3% (95% CI, 6.9%-9.7%) and 4.6% (95% CI, 2.4%-6.9%) for studies in Chongqing and other areas, respectively (difference between the sub-overalls, Q = 7.58, p<0.01). Syphilis infection (RR = 3.33, p<0.001), multiple sex partnerships (RR = 2.81, p<0.001), and unprotected receptive anal intercourse in the past six months (RR = 3.88, p = 0.007) represented significant risk for HIV seroconversion. Conclusions: Findings from this meta-analysis indicate that HIV incidence is substantial in MSM in China. High incidence of HIV infection and unique patterns of sexual risk behaviors in this population serve as a call for action that should be answered with the innovative social and public health intervention strategies, and development of biological prevention strategies.	[Li, Hong-Min; Peng, Rui-Rui; Li, Jing; Yin, Yue-Ping; Wang, Baoxi; Chen, Xiang-Sheng] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Peoples R China; [Yin, Yue-Ping; Wang, Baoxi; Chen, Xiang-Sheng] Natl Ctr STD Control, China Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Cohen, Myron S.] Univ N Carolina, Sch Med, Ctr Infect Dis, Chapel Hill, NC USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Center for Disease Control & Prevention; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Li, HM (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Nanjing, Peoples R China.	chenxs@ncstdlc.org			Mega Project of China National Science Research [2008ZX10001-005]; World Health Organization (WHO) [UNICEF/UNDP/World Bank/WHO A70577]; National Institutes of Health (NIH) [R24 TW007988]; University of North Carolina (UNC) Center for AIDS Research; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Mega Project of China National Science Research; World Health Organization (WHO)(World Health Organization); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC) Center for AIDS Research; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is supported by grants from the Mega Project of China National Science Research for the 11th Five-Year Plan (2008ZX10001-005), the World Health Organization (WHO) Project (UNICEF/UNDP/World Bank/WHO A70577), and the National Institutes of Health (NIH) Fogarty International Clinical Research Scholars Program (R24 TW007988) and the University of North Carolina (UNC) Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BED CEIA INCIDENCE A; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; BROOKMEYER R, 1995, AM J EPIDEMIOL, V142, P709, DOI 10.1093/oxfordjournals.aje.a117700; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Feng Lian-Gui, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P455; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS98, DOI 10.1097/QAI.0b013e3181c7df71; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Han Mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P878; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; [胡海洋 HU Hai-yang], 2009, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V29, P1395; [胡海洋 Hu Haiyang], 2010, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V30, P467; Hurtado I, 2007, SEX TRANSM INFECT, V83, P23, DOI 10.1136/sti.2005.019299; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Marcus U, 2006, Euro Surveill, V11, P157, DOI 10.2807/esm.11.09.00645-en; Ministry of Health, 2010, CHIN 2010 UNGASS COU; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Parekh BS, 2001, AIDS RES HUM RETROV, V17, P137, DOI 10.1089/08892220150217229; Praparattanapan J, 2011, AIDS RES HUM RETROVI; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; *UNAIDS, 2005, UNAIDS REF GROUP EST; van der Bij AK, 2005, SEX TRANSM INFECT, V81, P34, DOI 10.1136/sti.2003.007997; Wang Mei-Zhen, 2007, THESIS; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Xiao Y, 2007, CLIN VACCINE IMMUNOL, V14, P1384, DOI 10.1128/CVI.00356-06; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Xu JJ, 2010, INT J INFECT DIS, V14, pE608, DOI 10.1016/j.ijid.2009.09.004; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; [杨旭 YANG Xu], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P260; Yin YP, 2008, SEX TRANSM INFECT, V84, P350, DOI 10.1136/sti.2007.028837; Zhang B, 2002, CHIN J AIDS STD, V8, P197; Zhang BC, 2005, CELL RES, V15, P858, DOI 10.1038/sj.cr.7290359; [张北川 Zhang Beichuan], 2002, [中华皮肤科杂志, Chinese Journa of Dermatology], V35, P214; Zhang Yi, 2008, Endemic Diseases Bulletin / Di Fang Bing Tong Bao, V23, P26	49	64	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23431	10.1371/journal.pone.0023431	http://dx.doi.org/10.1371/journal.pone.0023431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812MY	21887251	Green Published, Green Submitted, gold			2022-12-27	WOS:000294298800008
J	Lin, JS; Nazarenus, TJ; Frey, JL; Liang, XW; Wilson, MA; Stone, JM				Lin, Jiusheng; Nazarenus, Tara J.; Frey, Jeanine L.; Liang, Xinwen; Wilson, Mark A.; Stone, Julie M.			A Plant DJ-1 Homolog Is Essential for Arabidopsis thaliana Chloroplast Development	PLOS ONE			English	Article							PARKINSONISM PROTEIN DJ-1; SQUAMOUS-CELL CARCINOMA; CYSTEINE-SULFINIC ACID; OXIDATIVE DAMAGE; ALPHA-SYNUCLEIN; INTRACELLULAR PROTEASE; MITOCHONDRIAL-FUNCTION; ANTIOXIDATIVE STRESS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE	Protein superfamilies can exhibit considerable diversification of function among their members in various organisms. The DJ-1 superfamily is composed of proteins that are principally involved in stress response and are widely distributed in all kingdoms of life. The model flowering plant Arabidopsis thaliana contains three close homologs of animal DJ-1, all of which are tandem duplications of the DJ-1 domain. Consequently, the plant DJ-1 homologs are likely pseudo-dimeric proteins composed of a single polypeptide chain. We report that one A. thaliana DJ-1 homolog (AtDJ1C) is the first DJ-1 homolog in any organism that is required for viability. Homozygous disruption of the AtDJ1C gene results in non-viable, albino seedlings that can be complemented by expression of wild-type or epitope-tagged AtDJ1C. The plastids from these dj1c plants lack thylakoid membranes and granal stacks, indicating that AtDJ1C is required for proper chloroplast development. AtDJ1C is expressed early in leaf development when chloroplasts mature, but is downregulated in older tissue, consistent with a proposed role in plastid development. In addition to its plant-specific function, AtDJ1C is an atypical member of the DJ-1 superfamily that lacks a conserved cysteine residue that is required for the functions of most other superfamily members. The essential role for AtDJ1C in chloroplast maturation expands the known functional diversity of the DJ-1 superfamily and provides the first evidence of a role for specialized DJ-1-like proteins in eukaryotic development.	[Lin, Jiusheng; Nazarenus, Tara J.; Frey, Jeanine L.; Liang, Xinwen; Wilson, Mark A.; Stone, Julie M.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Wilson, Mark A.; Stone, Julie M.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA; [Stone, Julie M.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Lin, JS (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	jstone2@unl.edu		Van Nostrand, Jeanine/0000-0003-1363-9527	National Institutes of Health (NIH) [P20 RR017675, R01 GM092999]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) grants P20 RR017675 (Nebraska Redox Biology Center) and R01 GM092999 to MAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Cahoon AB, 2008, PLANT MOL BIOL, V66, P33, DOI 10.1007/s11103-007-9250-z; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Emanuelsson O, 2001, BBA-MOL CELL RES, V1541, P114, DOI 10.1016/S0167-4889(01)00145-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gadjev I, 2008, INT REV CEL MOL BIO, V270, P87, DOI 10.1016/S1937-6448(08)01403-2; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Goda M, 2001, J BIOL CHEM, V276, P23480, DOI 10.1074/jbc.M007856200; Halio SB, 1997, APPL ENVIRON MICROB, V63, P289, DOI 10.1128/AEM.63.1.289-295.1997; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Lakshminarasimhan M, 2010, J BIOL CHEM, V285, P29651, DOI 10.1074/jbc.M110.147934; Lee DW, 2008, PLANT CELL, V20, P1603, DOI 10.1105/tpc.108.060541; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Oh KJ, 2004, J BIOCHEM MOL BIOL, V37, P343; Polanska L, 2007, J EXP BOT, V58, P637, DOI 10.1093/jxb/erl235; Ramsey CP, 2010, J NEUROSCI RES, V88, P3111, DOI 10.1002/jnr.22477; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Stern DB, 2004, TRENDS PLANT SCI, V9, P293, DOI 10.1016/j.tplants.2004.04.001; Sun Q, 2004, PLANT PHYSIOL, V135, P723, DOI 10.1104/pp.104.040717; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yabe T, 2008, J MOL BIOL, V381, P160, DOI 10.1016/j.jmb.2008.05.072; Yamaguchi H, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-10; Yamazaki H, 2004, MOL MICROBIOL, V53, P555, DOI 10.1111/j.1365-2958.2004.04153.x; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yuen HF, 2008, CANCER EPIDEM BIOMAR, V17, P3593, DOI 10.1158/1055-9965.EPI-08-0214; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhu XL, 2010, CANCER SCI, V101, P1320, DOI 10.1111/j.1349-7006.2010.01531.x	59	22	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23731	10.1371/journal.pone.0023731	http://dx.doi.org/10.1371/journal.pone.0023731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886817	Green Published, gold			2022-12-27	WOS:000294253500027
J	Deng, YM; Caldwell, N; Barr, IG				Deng, Yi-Mo; Caldwell, Natalie; Barr, Ian G.			Rapid Detection and Subtyping of Human Influenza A Viruses and Reassortants by Pyrosequencing	PLOS ONE			English	Article							SWINE; RESISTANCE; SEASON; H1N1	Background: Given the continuing co-circulation of the 2009 H1N1 pandemic influenza A viruses with seasonal H3N2 viruses, rapid and reliable detection of newly emerging influenza reassortant viruses is important to enhance our influenza surveillance. Methodology/Principal Findings: A novel pyrosequencing assay was developed for the rapid identification and subtyping of potential human influenza A virus reassortants based on all eight gene segments of the virus. Except for HA and NA genes, one universal set of primers was used to amplify and subtype each of the six internal genes. With this method, all eight gene segments of 57 laboratory isolates and 17 original specimens of seasonal H1N1, H3N2 and 2009 H1N1 pandemic viruses were correctly matched with their corresponding subtypes. In addition, this method was shown to be capable of detecting reassortant viruses by correctly identifying the source of all 8 gene segments from three vaccine production reassortant viruses and three H1N2 viruses. Conclusions/Significance: In summary, this pyrosequencing assay is a sensitive and specific procedure for screening large numbers of viruses for reassortment events amongst the commonly circulating human influenza A viruses, which is more rapid and cheaper than using conventional sequencing approaches.	[Deng, Yi-Mo; Caldwell, Natalie; Barr, Ian G.] WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia; [Barr, Ian G.] Monash Univ, Sch Appl Sci, Churchill, Vic, Australia	Victorian Infectious Diseases Reference Laboratory; World Health Organization; Monash University	Deng, YM (corresponding author), WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia.	yi-mo.deng@influenzacentre.org		Deng, Yi-Mo/0000-0003-2177-8308; Barr, Ian/0000-0002-7351-418X	Australian Government Department of Health and Ageing	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faress S, 2008, VIRUS RES, V132, P33, DOI 10.1016/j.virusres.2007.10.007; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DENG YM, 2009, ANTIVIR RES, V90, P87; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Diggle MA, 2004, MOL BIOTECHNOL, V28, P129, DOI 10.1385/MB:28:2:129; Ducatez MF, 2010, J VIROL METHODS, V168, P78, DOI 10.1016/j.jviromet.2010.04.020; Duwe S, 2008, J VIROL METHODS, V153, P134, DOI 10.1016/j.jviromet.2008.07.017; Ellis JS, 2003, EMERG INFECT DIS, V9, P304; Fourment M, 2010, J CLIN MICROBIOL, V48, P295, DOI 10.1128/JCM.01687-09; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Komadina N, 2007, VIRUS GENES, V35, P161, DOI 10.1007/s11262-007-0097-9; Lackenby A, 2008, ANTIVIR THER, V13, P809; Mak PWY, 2011, EMERG INFECT DIS, V17, P691, DOI 10.3201/eid1704.101726; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Paget W J, 2002, Euro Surveill, V7, P147; Palese P., 2007, FIELDS VIROLOGY, P1647; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; STARICK E, 2011, J GEN VIROL; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132	21	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23400	10.1371/journal.pone.0023400	http://dx.doi.org/10.1371/journal.pone.0023400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886790	gold, Green Published			2022-12-27	WOS:000294128100013
J	Hall, GL; Logie, KM; Parsons, F; Schulzke, SM; Nolan, G; Murray, C; Ranganathan, S; Robinson, P; Sly, PD; Stick, SM				Hall, Graham L.; Logie, Karla M.; Parsons, Faith; Schulzke, Sven M.; Nolan, Gary; Murray, Conor; Ranganathan, Sarath; Robinson, Phil; Sly, Peter D.; Stick, Stephen M.		AREST CF	Air Trapping on Chest CT Is Associated with Worse Ventilation Distribution in Infants with Cystic Fibrosis Diagnosed following Newborn Screening	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; MULTIPLE-BREATH WASHOUT; ULTRASONIC FLOW METER; INERT-GAS WASHOUT; LUNG-DISEASE; HEALTHY INFANTS; CHILDREN; VOLUME	Background: In school-aged children with cystic fibrosis (CF) structural lung damage assessed using chest CT is associated with abnormal ventilation distribution. The primary objective of this analysis was to determine the relationships between ventilation distribution outcomes and the presence and extent of structural damage as assessed by chest CT in infants and young children with CF. Methods: Data of infants and young children with CF diagnosed following newborn screening consecutively reviewed between August 2005 and December 2009 were analysed. Ventilation distribution (lung clearance index and the first and second moment ratios [LCI, M-1/M-0 and M-2/M-0, respectively]), chest CT and airway pathology from bronchoalveolar lavage were determined at diagnosis and then annually. The chest CT scans were evaluated for the presence or absence of bronchiectasis and air trapping. Results: Matched lung function, chest CT and pathology outcomes were available in 49 infants (31 male) with bronchiectasis and air trapping present in 13 (27%) and 24 (49%) infants, respectively. The presence of bronchiectasis or air trapping was associated with increased M-2/M-0 but not LCI or M-1/M-0. There was a weak, but statistically significant association between the extent of air trapping and all ventilation distribution outcomes. Conclusion: These findings suggest that in early CF lung disease there are weak associations between ventilation distribution and lung damage from chest CT. These finding are in contrast to those reported in older children. These findings suggest that assessments of LCI could not be used to replace a chest CT scan for the assessment of structural lung disease in the first two years of life. Further research in which both MBW and chest CT outcomes are obtained is required to assess the role of ventilation distribution in tracking the progression of lung damage in infants with CF.	[Hall, Graham L.; Nolan, Gary; Murray, Conor; Sly, Peter D.; Stick, Stephen M.] Princess Margaret Hosp Children, Perth, WA, Australia; [Hall, Graham L.; Logie, Karla M.; Stick, Stephen M.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Hall, Graham L.; Logie, Karla M.; Parsons, Faith; Nolan, Gary; Sly, Peter D.; Stick, Stephen M.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Hall, Graham L.; Logie, Karla M.; Parsons, Faith; Nolan, Gary; Sly, Peter D.; Stick, Stephen M.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Schulzke, Sven M.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Ranganathan, Sarath; Robinson, Phil] Royal Childrens Hosp, Melbourne, Vic, Australia; [Ranganathan, Sarath; AREST CF] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ranganathan, Sarath; Robinson, Phil] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Schulzke, Sven M.] Univ Childrens Hosp Basel, Basel, Switzerland	University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Queensland; University of Basel	Hall, GL (corresponding author), Princess Margaret Hosp Children, Perth, WA, Australia.	grahamh@ichr.uwa.edu.au	Sly, Peter D/F-1486-2010; Garratt, Luke Wisely/N-2371-2013; Hall, Graham/C-4775-2008; Stick, Stephen/AAA-5945-2021; Hall, Graham/AAB-6418-2019; Stick, Stephen/O-5683-2014; Schulzke, Sven/ABA-2339-2020; Stick, Stephen/GZG-7584-2022; Simpson, Shannon/C-4651-2013	Sly, Peter D/0000-0001-6305-2201; Garratt, Luke Wisely/0000-0001-9381-326X; Stick, Stephen/0000-0002-5386-8482; Hall, Graham/0000-0002-6217-9494; Simpson, Shannon/0000-0002-4895-0975; Logie, Karla/0000-0001-7671-098X; Schulzke, Sven/0000-0002-5475-6239; Ranganathan, Sarath/0000-0002-6975-0307	Cystic Fibrosis Foundation, Australia; Cystic Fibrosis Foundation Therapeutics [SLY04A0, STICK09A0]; National Health and Medical Research Council [513730]	Cystic Fibrosis Foundation, Australia; Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The AREST CF would like to thank the contributions of Princess Margaret Hospital for Children, The Telethon Institute for Child Health Research, Royal Children's Hospital Melbourne and Murdoch Children's Research Institute. We would also like to thank the participants and their families who contribute to the AREST CF program. We also acknowledge the support of the Cystic Fibrosis Foundation, Australia to the AREST CF program.; This study was funded by the Cystic Fibrosis Foundation Therapeutics (SLY04A0, STICK09A0) and the National Health and Medical Research Council (513730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2010, EUR RESP J; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; AURORA P, 2010, AM J RESP CRIT CARE; BELESSIS Y, 2010, ASSESSMENT NONINVASI; Cooper P, 2006, PAEDIATR RESPIR REV, V7, P197, DOI 10.1016/j.prrv.2006.04.005; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; de Jong PA, 2006, PEDIATR RADIOL, V36, P50, DOI 10.1007/s00247-005-0006-0; ELLEMUNTER H, 2010, RESP MED; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; HOO AF, IS LUNG FUNCTION DIM; Huelskamp G, 2009, THORAX, V64, P240, DOI 10.1136/thx.2008.101758; Kraemer R, 2005, AM J RESP CRIT CARE, V171, P371, DOI 10.1164/rccm.200407-948OC; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Latzin P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004635; Linnane B, 2008, PAEDIATR RESPIR REV, V9; Linnane B, 2008, PAEDIATR RESPIR REV, V9, P168, DOI 10.1016/j.prrv.2008.05.009; Lum S, 2007, THORAX, V62, P341, DOI 10.1136/thx.2006.068262; Martinez TM, 2005, AM J RESP CRIT CARE, V172, P1133, DOI 10.1164/rccm.200412-1665OC; Owens CM, 2011, THORAX, V66, P481, DOI 10.1136/thx.2010.150375; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Robinson PD, 2009, PEDIATR PULM, V44, P733, DOI 10.1002/ppul.20956; SAIDEL GM, 1975, J APPL PHYSIOL, V38, P328, DOI 10.1152/jappl.1975.38.2.328; Schibler A, 2002, EUR RESPIR J, V20, P912, DOI 10.1183/09031936.02.00226002; Schulzke SM, 2010, J PEDIATR-US, V156, P542, DOI 10.1016/j.jpeds.2009.10.017; Sinhal S, 2010, PEDIATR PULM, V45, P62, DOI 10.1002/ppul.21113; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; SONNAPPA S, 2010, J ALLERGY CLIN IMMUN; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Tiddens HAWM, 2006, PAEDIATR RESPIR REV, V7, P202, DOI 10.1016/j.prrv.2006.04.002	32	92	92	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23932	10.1371/journal.pone.0023932	http://dx.doi.org/10.1371/journal.pone.0023932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886842	Green Published, gold			2022-12-27	WOS:000294128100042
J	Kuhn, T; Ihalainen, TO; Hyvaluoma, J; Dross, N; Willman, SF; Langowski, J; Vihinen-Ranta, M; Timonen, J				Kuhn, Thomas; Ihalainen, Teemu O.; Hyvaluoma, Jari; Dross, Nicolas; Willman, Sami F.; Langowski, Jorg; Vihinen-Ranta, Maija; Timonen, Jussi			Protein Diffusion in Mammalian Cell Cytoplasm	PLOS ONE			English	Article							FLUORESCENCE RECOVERY; ANOMALOUS DIFFUSION; MOBILITY; RESOLUTION; DYNAMICS	We introduce a new method for mesoscopic modeling of protein diffusion in an entire cell. This method is based on the construction of a three-dimensional digital model cell from confocal microscopy data. The model cell is segmented into the cytoplasm, nucleus, plasma membrane, and nuclear envelope, in which environment protein motion is modeled by fully numerical mesoscopic methods. Finer cellular structures that cannot be resolved with the imaging technique, which significantly affect protein motion, are accounted for in this method by assigning an effective, position-dependent porosity to the cell. This porosity can also be determined by confocal microscopy using the equilibrium distribution of a non-binding fluorescent protein. Distinction can now be made within this method between diffusion in the liquid phase of the cell (cytosol/nucleosol) and the cytoplasm/nucleoplasm. Here we applied the method to analyze fluorescence recovery after photobleach (FRAP) experiments in which the diffusion coefficient of a freely-diffusing model protein was determined for two different cell lines, and to explain the clear difference typically observed between conventional FRAP results and those of fluorescence correlation spectroscopy (FCS). A large difference was found in the FRAP experiments between diffusion in the cytoplasm/nucleoplasm and in the cytosol/nucleosol, for all of which the diffusion coefficients were determined. The cytosol results were found to be in very good agreement with those by FCS.	[Kuhn, Thomas; Hyvaluoma, Jari; Timonen, Jussi] Univ Jyvaskyla, Dept Phys, NanoSci Ctr, Jyvaskyla, Finland; [Ihalainen, Teemu O.; Willman, Sami F.; Vihinen-Ranta, Maija] Univ Jyvaskyla, Dept Biol, NanoSci Ctr, Jyvaskyla, Finland; [Hyvaluoma, Jari] MTT Agrifood Res Finland, Jokioinen, Finland; [Dross, Nicolas; Langowski, Jorg] German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany	University of Jyvaskyla; University of Jyvaskyla; Natural Resources Institute Finland (Luke); Helmholtz Association; German Cancer Research Center (DKFZ)	Kuhn, T (corresponding author), Univ Jyvaskyla, Dept Phys, NanoSci Ctr, Jyvaskyla, Finland.	thomas.h.kuehn@jyu.fi	Kühn, Thomas/AAZ-6834-2020; Langowski, Jörg/A-1843-2011; Ihalainen, Teemu/C-9500-2016; Kühn, Thomas/AAS-1949-2021	Kühn, Thomas/0000-0001-5978-0601; Langowski, Jörg/0000-0001-8600-0666; Vihinen-Ranta, Maija/0000-0003-0959-1153; Ihalainen, Teemu/0000-0003-4351-8697	Emil Aaltonen Foundation; Academy of Finland [107311]; National Graduate School in NanoScience	Emil Aaltonen Foundation; Academy of Finland(Academy of Finland); National Graduate School in NanoScience	The contribution of the Department of Physics, University of Jyvaskylaw was supported by the Emil Aaltonen Foundation. The contribution of the Department of Biology, University of Jyvaskyla was supported by grants from the Academy of Finland (Contract No. 107311) and National Graduate School in NanoScience. The group at the DKFZ received no external funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; BRAECKMANS K, 2007, BIOPHSY J, V92, P1482; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Bronstein I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018102; Burov S, 2011, PHYS CHEM CHEM PHYS, V13, P1800, DOI 10.1039/c0cp01879a; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hinde E, 2010, P NATL ACAD SCI USA, V107, P16560, DOI 10.1073/pnas.1006731107; Ihalainen TO, 2007, CELL MICROBIOL, V9, P1946, DOI 10.1111/j.1462-5822.2007.00926.x; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Kaviany M., 2002, PRINCIPLES HEAT TRAN; KUBITSCHECK U, 1994, BIOPHYS J, V67, P948, DOI 10.1016/S0006-3495(94)80596-X; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Meyvis TKL, 1999, PHARM RES-DORDR, V16, P1153, DOI 10.1023/A:1011924909138; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; PARRISH CR, 1988, VIROLOGY, V163, P230, DOI 10.1016/0042-6822(88)90255-3; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Rojo M, 2000, J CELL SCI, V113, P1043; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; Schaff J, 1997, BIOPHYS J, V73, P1135, DOI 10.1016/S0006-3495(97)78146-3; Schuldt A, 2010, NAT REV MOL CELL BIO, V11, DOI [10.1038/nrm2989, 10.1038/nrm2983]; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Succi S, 2001, LATTICE BOLTZMANN EQ, P290; TEWES M, 2001, Patent No. 0941470; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; WACHSMUTH M, 2001, THESIS R KARLS U HEI; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; WOLFGLADROW D, 1995, J STAT PHYS, V79, P1023, DOI 10.1007/BF02181215; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053	39	124	125	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e22962	10.1371/journal.pone.0022962	http://dx.doi.org/10.1371/journal.pone.0022962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886771	gold, Green Published, Green Submitted			2022-12-27	WOS:000294128100003
J	Zhao, RM; Cui, SJ; Guo, L; Wu, C; Gonzalez, R; Paranhos-Baccala, G; Vernet, G; Wang, JW; Hung, T				Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Paranhos-Baccala, Glaucia; Vernet, Guy; Wang, Jianwei; Hung, Tao			Identification of a Highly Conserved H1 Subtype-Specific Epitope with Diagnostic Potential in the Hemagglutinin Protein of Influenza A Virus	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; UNIVERSAL ANTIBODIES; ANTIGENIC STRUCTURE; SYNTHETIC PEPTIDE; BLOCKING ELISA; FUSION; LESSONS; BINDING; ENTRY	Subtype specificity of influenza A virus (IAV) is determined by its two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). For HA, 16 distinct subtypes (H1-H16) exist, while nine exist for NA. The epidemic strains of H1N1 IAV change frequently and cause annual seasonal epidemics as well as occasional pandemics, such as the notorious 1918 influenza pandemic. The recent introduction of pandemic A/H1N1 IAV (H1N1pdm virus) into humans re-emphasizes the public health concern about H1N1 IAV. Several studies have identified conserved epitopes within specific HA subtypes that can be used for diagnostics. However, immune specific epitopes in H1N1 IAV have not been completely assessed. In this study, linear epitopes on the H1N1pdm viral HA protein were identified by peptide scanning using libraries of overlapping peptides against convalescent sera from H1N1pdm patients. One epitope, P5 (aa 58-72) was found to be immunodominant in patients and to evoke high titer antibodies in mice. Multiple sequence alignments and in silico coverage analysis showed that this epitope is highly conserved in influenza H1 HA [with a coverage of 91.6% (9,860/10,767)] and almost completely absent in other subtypes [with a coverage of 3.3% (792/23,895)]. This previously unidentified linear epitope is located outside the five well-recognized antigenic sites in HA. A peptide ELISA method based on this epitope was developed and showed high correlation (chi(2) = 51.81, P < 0.01, Pearson correlation coefficient R = 0.741) with a hemagglutination inhibition test. The highly conserved H1 subtype-specific immunodominant epitope may form the basis for developing novel assays for sero-diagnosis and active surveillance against H1N1 IAVs.	[Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, State Key Lab Mol Virol & Genet Engn, Beijing 100021, Peoples R China; [Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, Christophe Merieux Lab, Beijing 100021, Peoples R China; [Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Gonzalez, Richard; Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhao, RM (corresponding author), Peking Union Med Coll, State Key Lab Mol Virol & Genet Engn, Beijing 100021, Peoples R China.	wangjw28@163.com	Wang, Jianwei/AAW-9499-2020; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; 	International Science and Technology Cooperation Program of China [2010DFB33270]; National Basic Research Program (973 Program) of China [2010CB534003]	International Science and Technology Cooperation Program of China; National Basic Research Program (973 Program) of China(National Basic Research Program of China)	This study is supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn/) and by the National Basic Research Program (973 Program) of China (2010CB534003) (http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2010, CLIN VACCINE IMMUNOL, V17, P1481, DOI 10.1128/CVI.00223-10; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; BROWN LE, 1988, J VIROL, V62, P1746, DOI 10.1128/JVI.62.5.1746-1752.1988; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Carter, 2004, CARTOGR PERSPECT, V49, P4, DOI [10.14714/CP49.437, DOI 10.14714/CP49.437]; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; COLIGAN JE, 2001, CURR PROTOC NEUROSCI, P5; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; DEL RC, 2010, T AM CLIN CLIMAT ASS, V121; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Guo Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-39; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; He YX, 2005, J CLIN MICROBIOL, V43, P3718, DOI 10.1128/JCM.43.8.3718-3726.2005; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Li CG, 2010, NAT PROTOC, V5, P14, DOI 10.1038/nprot.2009.200; Li OTW, 2009, EXPERT REV ANTI-INFE, V7, P687, DOI [10.1586/eri.09.48, 10.1586/ERI.09.48]; Liu DB, 2011, J VIROL METHODS, V172, P16, DOI 10.1016/j.jviromet.2010.12.007; LIVINGSTON PO, 1995, IMMUNOL REV, V145, P147, DOI 10.1111/j.1600-065X.1995.tb00080.x; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; MASSICOT J, 1977, J INFECT DIS, V136, pS472, DOI 10.1093/infdis/136.Supplement_3.S472; Mueller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009097; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; *OIE, 2010, MAN DIAGN TEST VACC, V1; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PALESE P, 2007, FIELDS VIROLOGY ORTH; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Shahsavandi S, 2011, J VIROL METHODS, V171, P260, DOI 10.1016/j.jviromet.2010.11.012; Shien JH, 2008, J MICROBIOL IMMUNOL, V41, P369; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Squires B, 2008, NUCLEIC ACIDS RES, V36, pD497, DOI 10.1093/nar/gkm905; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; TANG XL, 1988, J VIROL, V62, P4745, DOI 10.1128/JVI.62.12.4745-4751.1988; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; Vareckova E, 2002, J CLIN MICROBIOL, V40, P2220, DOI 10.1128/JCM.40.6.2220-2223.2002; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018016; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	51	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23374	10.1371/journal.pone.0023374	http://dx.doi.org/10.1371/journal.pone.0023374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886787	Green Submitted, gold, Green Published			2022-12-27	WOS:000294128100011
J	Mitra, A; Kalayarasan, S; Gupta, V; Radha, V				Mitra, Aninda; Kalayarasan, Srinivasan; Gupta, Vijay; Radha, Vegesna			TC-PTP Dephosphorylates the Guanine Nucleotide Exchange Factor C3G (RapGEF1) and Negatively Regulates Differentiation of Human Neuroblastoma Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; NEURITE OUTGROWTH; ACTIVATION; RECEPTOR; GROWTH; RAP1; CRK; INSULIN; BINDING; IDENTIFICATION	The guanine nucleotide exchange factor, C3G (RapGEF1), functions in multiple signaling pathways involved in cell adhesion, proliferation, apoptosis and actin reorganization. C3G is regulated by tyrosine phosphorylation on Y504, known to be mediated by c-Abl and Src family kinases. In the present study we explored the possibility of cellular phospho-C3G (pC3G) being a substrate of the intracellular T-cell protein tyrosine phosphatase TC-PTP (PTPN2) using the human neuroblastoma cell line, IMR-32. In vivo and in vitro binding assays demonstrated interaction between C3G and TC-PTP. Interaction is mediated through the Crk-binding region of C3G and C-terminal noncatalytic residues of TC-PTP. C3G interacted better with a substrate trap mutant of TC48 and this complex formation was inhibited by vanadate. Endogenous pC3G colocalized with catalytically inactive mutant TC48 in the Golgi. Expression of TC48 abrogated pervanadate and c-Src induced phosphorylation of C3G without affecting total cellular phospho-tyrosine. Insulin-like growth factor treatment of c-Src expressing cells resulted in dephosphorylation of C3G dependent on the activity of endogenous TC48. TC48 expression inhibited forskolin induced tyrosine phosphorylation of C3G and neurite outgrowth in IMR-32 cells. Our results identify a novel Golgi localized substrate of TC48 and delineate a role for TC48 in dephosphorylation of substrates required during differentiation of human neuroblastoma cells.	[Mitra, Aninda; Kalayarasan, Srinivasan; Gupta, Vijay; Radha, Vegesna] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Mitra, A (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	vradha@ccmb.res.in		Gupta, Dr. Vijay/0000-0002-3613-6378	Department of Biotechnology, Govt. of India [BT/PR11921/BRB/10/698/2009]; DBT	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India)	This work was supported in part by a grant awarded to VR by the Department of Biotechnology, Govt. of India (BT/PR11921/BRB/10/698/2009). SK was a recipient of a postdoctoral fellowship from DBT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Faux C, 2007, BBA-MOL CELL RES, V1773, P1689, DOI 10.1016/j.bbamcr.2007.06.008; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Kamatkar S, 1996, J BIOL CHEM, V271, P26755, DOI 10.1074/jbc.271.43.26755; KENNER KA, 1993, J BIOL CHEM, V268, P25455; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Konstantopoulos N, 1996, BIOCHEM J, V314, P387, DOI 10.1042/bj3140387; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Martin-Encabo S, 2007, EXP CELL RES, V313, P3881, DOI 10.1016/j.yexcr.2007.07.036; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mitra A, 2010, ONCOGENE, V29, P4528, DOI 10.1038/onc.2010.113; Mitra SK, 2001, EXP CELL RES, V270, P32, DOI 10.1006/excr.2001.5313; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Paul S, 2003, CELL MOL LIFE SCI, V60, P2465, DOI 10.1007/s00018-003-3123-7; Radha V, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-31; RADHA V, 1994, BIOCHEM J, V299, P41, DOI 10.1042/bj2990041; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Radha V, 2011, BIOSCIENCE REP, V31, P231, DOI 10.1042/BSR20100094; Radha V, 2008, J NEUROCHEM, V107, P1424, DOI 10.1111/j.1471-4159.2008.05710.x; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Savchenko A, 2001, P NATL ACAD SCI USA, V98, P5880, DOI 10.1073/pnas.101524998; Schonherr C, 2010, ONCOGENE, V29, P2817, DOI 10.1038/onc.2010.27; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Shintani T, 2001, DEV NEUROSCI-BASEL, V23, P55, DOI 10.1159/000048696; Shivakrupa R, 2003, J BIOL CHEM, V278, P52188, DOI 10.1074/jbc.M310656200; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; TILLMANN U, 1994, MOL CELL BIOL, V14, P3030, DOI 10.1128/MCB.14.5.3030; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217; Voss AK, 2006, EMBO J, V25, P3652, DOI 10.1038/sj.emboj.7601234; Wang SF, 2008, BLOOD, V111, P2878, DOI 10.1182/blood-2007-07-103119; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683	56	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23681	10.1371/journal.pone.0023681	http://dx.doi.org/10.1371/journal.pone.0023681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876762	Green Submitted, Green Published, gold			2022-12-27	WOS:000294126900034
J	Trosch, R; Jarvis, P				Troesch, Raphael; Jarvis, Paul			The Stromal Processing Peptidase of Chloroplasts is Essential in Arabidopsis, with Knockout Mutations Causing Embryo Arrest after the 16-Cell Stage	PLOS ONE			English	Article							PLASTID PROTEIN IMPORT; TRANSIT PEPTIDES; IN-VIVO; INSERTIONAL MUTAGENESIS; PLANT DEVELOPMENT; THALIANA; ENZYME; GENE; EMBRYOGENESIS; MITOCHONDRIA	Stromal processing peptidase (SPP) is a metalloendopeptidase located in the stroma of chloroplasts, and it is responsible for the cleavage of transit peptides from preproteins upon their import into the organelle. Two independent mutant Arabidopsis lines with T-DNA insertions in the SPP gene were analysed (spp-1 and spp-2). For both lines, no homozygous mutant plants could be detected, and the segregating progeny of spp heterozygotes contained heterozygous and wild-type plants in a ratio of 2:1. The siliques of heterozygous spp-1 and spp-2 plants contained many aborted seeds, at a frequency of similar to 25%, suggesting embryo lethality. By contrast, transmission of the spp mutations through the male and female gametes was found to be normal, and so gametophytic effects could be ruled out. To further elucidate the timing of the developmental arrest, mutant and wild-type seeds were cleared and analysed by Nomarski microscopy. A significant proportion (similar to 25%) of the seeds in mutant siliques exhibited delayed embryogenesis compared to those in wild type. Moreover, the mutant embryos never progressed normally beyond the 16-cell stage, with cell divisions not completing properly thereafter. Heterozygous spp mutant plants were phenotypically indistinguishable from the wild type, indicating that the spp knockout mutations are completely recessive and suggesting that one copy of the SPP gene is able to produce sufficient SPP protein for normal development under standard growth conditions.	[Troesch, Raphael; Jarvis, Paul] Univ Leicester, Dept Biol, Leicester, Leics, England	University of Leicester	Trosch, R (corresponding author), Univ Leicester, Dept Biol, Leicester, Leics, England.	rpj3@le.ac.uk		Jarvis, Paul/0000-0003-2127-5671; Trosch, Raphael/0000-0002-0632-3324	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council [BB/D016541/1, BB/F020325/1, BB/H008039/1]; BBSRC [BB/H008039/1, BB/D016541/1, BB/F020325/1] Funding Source: UKRI	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Gatsby Charitable Foundation Sainsbury PhD Studentship (http://www.gatsby.org.uk/) (to RT), and by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) grants BB/D016541/1, BB/F020325/1, and BB/H008039/1 (to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, PLANT J, V46, P641, DOI 10.1111/j.1365-313X.2006.02727.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Aronsson H, 2010, PLANT J, V63, P297, DOI 10.1111/j.1365-313X.2010.04242.x; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; BLAIR GE, 1973, BIOCHIM BIOPHYS ACTA, V319, P223, DOI 10.1016/0005-2787(73)90013-0; Blobel G., 1971, BIOMEMBRANE, P193; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; BRYANT N, 2011, PLANT PHYSL IN PRESS; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Goubet F, 2003, PLANT PHYSIOL, V131, P547, DOI 10.1104/pp.014555; Howden R, 1998, GENETICS, V149, P621; Hsu SC, 2010, CURR GENOMICS, V11, P338, DOI 10.2174/138920210791616716; Hust B, 2006, PLANT BIOLOGY, V8, P18, DOI 10.1055/s-2005-873044; Inaba T, 2005, PLANT CELL, V17, P1482, DOI 10.1105/tpc.105.030700; Inaba T, 2008, BIOCHEM J, V413, P15, DOI 10.1042/BJ20080490; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kasmati AR, 2011, PLANT J, V66, P877, DOI 10.1111/j.1365-313X.2011.04551.x; KASMATI AR, 2011, PLANT J IN PRESS; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; Krimm I, 1999, EUR J BIOCHEM, V265, P171, DOI 10.1046/j.1432-1327.1999.00701.x; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Ling QH, 2011, PHOTOSYNTH RES, V107, P209, DOI 10.1007/s11120-010-9606-0; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; McElver J, 2001, GENETICS, V159, P1751; Moberg P, 2003, PLANT J, V36, P616, DOI 10.1046/j.1365-313X.2003.01904.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Richter S, 2005, PHYSIOL PLANTARUM, V123, P362, DOI 10.1111/j.1399-3054.2005.00476.x; Richter S, 2003, J BIOL CHEM, V278, P39497, DOI 10.1074/jbc.M305729200; Richter S, 2002, J BIOL CHEM, V277, P43888, DOI 10.1074/jbc.M206020200; Richter S, 1998, P NATL ACAD SCI USA, V95, P7463, DOI 10.1073/pnas.95.13.7463; Rudhe C, 2004, J MOL BIOL, V343, P639, DOI 10.1016/j.jmb.2004.08.053; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; VANDERVERE PS, 1995, P NATL ACAD SCI USA, V92, P7177, DOI 10.1073/pnas.92.16.7177; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; Wan JX, 1998, PLANT J, V15, P459, DOI 10.1046/j.1365-313X.1998.00224.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yue RQ, 2010, PLANT CELL PHYSIOL, V51, P475, DOI 10.1093/pcp/pcq012; Zhong R, 2003, PLANT J, V34, P802, DOI 10.1046/j.1365-313X.2003.01772.x	53	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23039	10.1371/journal.pone.0023039	http://dx.doi.org/10.1371/journal.pone.0023039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857988	Green Published, gold			2022-12-27	WOS:000294125500014
J	Segawa, S; Fujiya, M; Konishi, H; Ueno, N; Kobayashi, N; Shigyo, T; Kohgo, Y				Segawa, Shuichi; Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Kobayashi, Naoyuki; Shigyo, Tatsuro; Kohgo, Yutaka			Probiotic-Derived Polyphosphate Enhances the Epithelial Barrier Function and Maintains Intestinal Homeostasis through Integrin-p38 MAPK Pathway	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; SHOCK-PROTEIN 27; NF-KAPPA-B; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; EXTRACELLULAR SEGMENT; BACTERIAL LIGANDS; CRYSTAL-STRUCTURE; SOLUBLE FACTORS; TIGHT JUNCTION	Probiotics exhibit beneficial effects on human health, particularly in the maintenance of intestinal homeostasis in a complex manner notwithstanding the diversity of an intestinal flora between individuals. Thus, it is highly probable that some common molecules secreted by probiotic and/or commensal bacteria contribute to the maintenance of intestinal homeostasis and protect the intestinal epithelium from injurious stimuli. To address this question, we aimed to isolate the cytoprotective compound from a lactobacillus strain, Lactobacillus brevis SBC8803 which possess the ability to induce cytoprotective heat shock proteins in mouse small intestine. L. brevis was incubated in MRS broth and the supernatant was passed through with a 0.2-mu m filter. Caco2/bbe cells were treated with the culture supernatant, and HSP27 expression was evaluated by Western blotting. HSP27-inducible components were separated by ammonium sulfate precipitation, DEAE anion exchange chromatography, gel filtration, and HPLC. Finally, we identified that the HSP27-inducible fraction was polyphosphate (poly P), a simple repeated structure of phosphates, which is a common product of lactobacilli and other bacteria associated with intestinal microflora without any definitive physiological functions. Then, poly P was synthesized by poly P-synthesizing enzyme polyphosphate kinase. The synthesized poly P significantly induced HSP27 from Caco2/BBE cells. In addition, Poly P suppressed the oxidant-induced intestinal permeability in the mouse small intestine and pharmacological inhibitors of p38 MAPK and integrins counteract its protective effect. Daily intrarectal administration of poly P (10 mu g) improved the inflammation grade and survival rate in 4% sodium dextran sulfate-administered mice. This study, for the first time, demonstrated that poly P is the molecule responsible for maintaining intestinal barrier actions which are mediated through the intestinal integrin beta 1-p38 MAPK.	[Segawa, Shuichi; Kobayashi, Naoyuki; Shigyo, Tatsuro] Sapporo Breweries Ltd, Frontier Labs Value Creat, Yaizu, Japan; [Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan	Sapporo Holdings Limited; Asahikawa Medical College	Segawa, S (corresponding author), Sapporo Breweries Ltd, Frontier Labs Value Creat, Yaizu, Japan.	fjym@asahikawa-med.ac.jp	Kohgo, Yutaka/AAN-4863-2020		Ministry of Education, Culture, Sports, Science and Technology in Japan [20590734]; Sapporo Bio Cluster "Bio-S''; Sapporo Breweries Ltd	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Bio Cluster "Bio-S''; Sapporo Breweries Ltd	This study was supported by a Grant-in Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology in Japan to M.F. (#20590734), Sapporo Bio Cluster "Bio-S'', the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sapporo Breweries Ltd also funded this study and their role was to provide the lactic acid bacteira strain. Through the employment of Shuichi Segawa, Naoyuki Kobayashi and Tatsuro Shigyo they were also involved in conceiving, designing and performing the experiments and also with analyzing the data.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Coulson BS, 1997, P NATL ACAD SCI USA, V94, P5389, DOI 10.1073/pnas.94.10.5389; De Keersmaecker SCJ, 2006, FEMS MICROBIOL LETT, V259, P89, DOI 10.1111/j.1574-6968.2006.00250.x; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Garcia MC, 2009, J BIOL CHEM, V284, P20936, DOI 10.1074/jbc.M109.020271; Guay J, 1997, J CELL SCI, V110, P357; Heuvelin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005184; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kumar CC, 1997, J PHARMACOL EXP THER, V283, P843; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; Nishimura T, 2008, WORLD J GASTROENTERO, V14, P5851, DOI 10.3748/wjg.14.5851; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; RAO NN, 1985, J BACTERIOL, V162, P242, DOI 10.1128/JB.162.1.242-247.1985; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Tafazoli F, 2000, INFECT IMMUN, V68, P5335, DOI 10.1128/IAI.68.9.5335-5343.2000; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; TINSLEY CR, 1995, INFECT IMMUN, V63, P1624, DOI 10.1128/IAI.63.5.1624-1630.1995; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; UENO N, 2011, INFLAMM BOWEL D 0106; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	42	128	138	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23278	10.1371/journal.pone.0023278	http://dx.doi.org/10.1371/journal.pone.0023278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858054	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700014
J	Gazeau, F; Gattuso, JP; Greaves, M; Elderfield, H; Peene, J; Heip, CHR; Middelburg, JJ				Gazeau, Frederic; Gattuso, Jean-Pierre; Greaves, Mervyn; Elderfield, Henry; Peene, Jan; Heip, Carlo H. R.; Middelburg, Jack J.			Effect of Carbonate Chemistry Alteration on the Early Embryonic Development of the Pacific Oyster (Crassostrea gigas)	PLOS ONE			English	Article							OCEAN ACIDIFICATION; MYTILUS-EDULIS; DIOXIDE CONCENTRATIONS; SACCOSTREA-GLOMERATA; LARVAL DEVELOPMENT; FUTURE; CALCIFICATION; SHELLFISH; SURVIVAL; SEAWATER	Ocean acidification, due to anthropogenic CO2 absorption by the ocean, may have profound impacts on marine biota. Calcareous organisms are expected to be particularly sensitive due to the decreasing availability of carbonate ions driven by decreasing pH levels. Recently, some studies focused on the early life stages of mollusks that are supposedly more sensitive to environmental disturbances than adult stages. Although these studies have shown decreased growth rates and increased proportions of abnormal development under low pH conditions, they did not allow attribution to pH induced changes in physiology or changes due to a decrease in aragonite saturation state. This study aims to assess the impact of several carbonate-system perturbations on the growth of Pacific oyster (Crassostrea gigas) larvae during the first 3 days of development (until shelled D-veliger larvae). Seawater with five different chemistries was obtained by separately manipulating pH, total alkalinity and aragonite saturation state (calcium addition). Results showed that the developmental success and growth rates were not directly affected by changes in pH or aragonite saturation state but were highly correlated with the availability of carbonate ions. In contrast to previous studies, both developmental success into viable D-shaped larvae and growth rates were not significantly altered as long as carbonate ion concentrations were above aragonite saturation levels, but they strongly decreased below saturation levels. These results suggest that the mechanisms used by these organisms to regulate calcification rates are not efficient enough to compensate for the low availability of carbonate ions under corrosive conditions.	[Gazeau, Frederic; Gattuso, Jean-Pierre] CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Gazeau, Frederic; Gattuso, Jean-Pierre] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France; [Greaves, Mervyn; Elderfield, Henry] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Peene, Jan; Heip, Carlo H. R.; Middelburg, Jack J.] Netherlands Inst Ecol, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Heip, Carlo H. R.] Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, Den Burg, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Cambridge; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Gazeau, F (corresponding author), CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France.	f.gazeau@obs-vlfr.fr	Gattuso, Jean-Pierre/E-6631-2010; Gattuso, Jean-Pierre/AAG-8643-2019; Gazeau, Frédéric/G-3050-2011; Middelburg, Jack/B-4951-2011	Gattuso, Jean-Pierre/0000-0002-4533-4114; Gattuso, Jean-Pierre/0000-0002-4533-4114; Gazeau, Frédéric/0000-0001-8807-4597; Middelburg, Jack/0000-0003-3601-9072; Greaves, Mervyn/0000-0001-8014-8627	Netherlands Organization of Scientific Research; European Community [211384]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This research has received support from the Netherlands Organization of Scientific Research and is a contribution to the "European Project on Ocean Acidification" (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne B.L., 1976, MARINE MUSSELS THEIR; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Caldeira K, 2007, GEOPHYS RES LETT, V34, P3; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; His E, 1997, WATER RES, V31, P351, DOI 10.1016/S0043-1354(96)00244-8; IP YK, 1991, J EXP ZOOL, V258, P273, DOI 10.1002/jez.1402580219; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lavigne H., 2011, SEACARB SEAWATER CAR; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; Medakovic D, 2000, HELGOLAND MAR RES, V54, P1, DOI 10.1007/s101520050030; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tambutte E, 1996, J EXP BIOL, V199, P1029; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004	28	70	71	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23010	10.1371/journal.pone.0023010	http://dx.doi.org/10.1371/journal.pone.0023010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860666	Green Published, gold			2022-12-27	WOS:000295454200034
J	Liu, XS; Chopp, M; Zhang, RL; Tao, T; Wang, XL; Kassis, H; Hozeska-Solgot, A; Zhang, L; Chen, C; Zhang, ZG				Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Tao, Tang; Wang, Xin Li; Kassis, Haifa; Hozeska-Solgot, Ann; Zhang, Li; Chen, Charles; Zhang, Zheng Gang			MicroRNA Profiling in Subventricular Zone after Stroke: MiR-124a Regulates Proliferation of Neural Progenitor Cells through Notch Signaling Pathway	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; GENE-EXPRESSION DATA; QUANTITATIVE PCR; DOWN-REGULATION; STEM-CELLS; BRAIN; DIFFERENTIATION; NEUROGENESIS; RAT; MOUSE	Background: The Notch signaling pathway regulates adult neurogenesis under physiological and pathophysiological conditions. MicroRNAs are small non-coding RNA molecules that regulate gene expression. The present study investigated the effect of miR-124a on the Notch signaling pathway in stroke-induced neurogenesis. Methodology and Principal Findings: We found that adult rats subjected to focal cerebral ischemia exhibited substantial reduction of miR-124a expression, a neuron specific miRNA, in the neural progenitor cells of the subventricular zone (SVZ) of the lateral ventricle, which was inversely associated with activation of Notch signals. In vitro, transfection of neural progenitor cells harvested from the SVZ of adult rat with miR-124a repressed Jagged-1 (JAG1), a ligand of Notch, in a luciferase construct containing the JAG1 target site. Introduction of miR-124a in neural progenitor cells significantly reduced JAG1 transcript and protein levels, leading to inactivation of Notch signals. Transfection of neural progenitor cells with miR-124a significantly reduced progenitor cell proliferation and promoted neuronal differentiation measured by an increase in the number of Doublecortin positive cells, a marker of neuroblasts. Furthermore, introduction of miR-124a significantly increased p27Kip1 mRNA and protein levels, a downstream target gene of the Notch signaling pathway. Conclusions: Collectively, our study demonstrated that in vivo, stroke alters miRNA expression in SVZ neural progenitor cells and that in vitro, miR-124a mediates stroke-induced neurogenesis by targeting the JAG-Notch signaling pathway.	[Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Tao, Tang; Wang, Xin Li; Kassis, Haifa; Hozeska-Solgot, Ann; Zhang, Li; Chen, Charles; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Liu, XS (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	Kassis, Haifa/0000-0003-3546-2590	National Institutes of Health [PO1 NS23393, RO1 HL064766]; AHA [10SDG2790012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156, P01NS023393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants PO1 NS23393 (MC), RO1 HL064766 (ZGZ) and AHA Scientist Development Grant 10SDG2790012 (XL). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Crombez L, 2007, BIOCHEM SOC T, V35, P44, DOI 10.1042/BST0350044; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Goodsaid FM, 2004, ENVIRON HEALTH PERSP, V112, P456, DOI 10.1289/ehp.6695; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Liu XS, 2009, J CEREBR BLOOD F MET, V29, P297, DOI 10.1038/jcbfm.2008.119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Murata J, 2009, J NEUROSCI RES, V87, P3521, DOI 10.1002/jnr.22169; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; OZCELIK T, 1992, GENOMICS, V13, P1157, DOI 10.1016/0888-7543(92)90031-M; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Papagiannakopoulos T, 2009, CELL STEM CELL, V4, P375, DOI 10.1016/j.stem.2009.04.007; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Solomon A, 2008, DEV BIOL, V316, P191, DOI 10.1016/j.ydbio.2007.12.046; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Suh Y, 2009, MOL CELL NEUROSCI, V42, P308, DOI 10.1016/j.mcn.2009.08.003; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vohradsky J, 2010, NUCLEIC ACIDS RES, V38, P4579, DOI 10.1093/nar/gkq220; Wang L, 2009, NEUROSCIENCE, V158, P1356, DOI 10.1016/j.neuroscience.2008.10.064; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	61	177	196	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23461	10.1371/journal.pone.0023461	http://dx.doi.org/10.1371/journal.pone.0023461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887253	gold, Green Published, Green Submitted			2022-12-27	WOS:000294298800009
J	Osborne, BJW; Sheth, PM; Kovacs, C; Mazzulli, T; Kaul, R				Osborne, Brendan J. W.; Sheth, Prameet M.; Kovacs, Colin; Mazzulli, Tony; Kaul, Rupert			Impact of Collection Method on Assessment of Semen HIV RNA Viral Load	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; SEMINAL PLASMA; TRANSMISSION; MEN	Background: The blood HIV RNA viral load is the best-defined predictor of HIV transmission, in part due to ease of measurement and the correlation of blood and genital tract (semen or cervico-vaginal) viral load, although recent studies found semen HIV RNA concentration to be a stronger predictor of HIV transmission. There is currently no standardized method for semen collection when measuring HIV RNA concentration. Therefore, we compared two collection techniques in order to study of the impact of antiretroviral therapy on the semen viral load. Methodology/Principal Findings: Semen was collected by masturbation from HIV-infected, therapy-naive men who have sex with men (MSM) either undiluted (Visit 1) or directly into transport medium (Visit 2). Seminal plasma was then isolated, and the HIV RNA concentration obtained with each collection technique was measured and corrected for dilution if necessary. Collection of semen directly into transport medium resulted in a median HIV RNA viral load that was 0.4 log10 higher than undiluted samples. Conclusions/Significance: The method of semen collection is an important consideration when quantifying the HIV RNA viral load in this compartment.	[Osborne, Brendan J. W.; Sheth, Prameet M.; Mazzulli, Tony; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Kovacs, Colin] Maple Leaf Med Ctr, Toronto, ON, Canada; [Mazzulli, Tony] Mt Sinai Hosp, Dept Med Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Osborne, BJW (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	brendan.osborne@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093	Canadian Institutes of Health Research [HOP-81735]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The present study is supported by a grant from the Canadian Institutes of Health Research (R.K.: HOP-81735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Chan DJ, 2008, CURR HIV RES, V6, P138, DOI 10.2174/157016208783885074; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunne AL, 2003, J CLIN VIROL, V26, P239, DOI 10.1016/S1386-6532(02)00122-1; Dyer JR, 1996, J VIROL METHODS, V60, P161, DOI 10.1016/0166-0934(96)02063-0; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Politch JA, 2007, HUM REPROD, V22, P2928, DOI 10.1093/humrep/dem281; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RESNICK L, 1986, JAMA-J AM MED ASSOC, V255, P1887, DOI 10.1001/jama.255.14.1887; Sheth PM, 2005, J IMMUNOL, V175, P4789, DOI 10.4049/jimmunol.175.7.4789; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04	11	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23654	10.1371/journal.pone.0023654	http://dx.doi.org/10.1371/journal.pone.0023654			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886808	gold, Green Published, Green Submitted			2022-12-27	WOS:000294128100023
J	Foerder, P; Galloway, M; Barthel, T; Moore, DE; Reiss, D				Foerder, Preston; Galloway, Marie; Barthel, Tony; Moore, Donald E., III; Reiss, Diana			Insightful Problem Solving in an Asian Elephant	PLOS ONE			English	Article							SELF-RECOGNITION; MAXIMUS; INTELLIGENCE; EVOLUTION; BEHAVIOR; BRAIN; TRUNK	The "aha" moment or the sudden arrival of the solution to a problem is a common human experience. Spontaneous problem solving without evident trial and error behavior in humans and other animals has been referred to as insight. Surprisingly, elephants, thought to be highly intelligent, have failed to exhibit insightful problem solving in previous cognitive studies. We tested whether three Asian elephants (Elephas maximus) would use sticks or other objects to obtain food items placed out-of-reach and overhead. Without prior trial and error behavior, a 7-year-old male Asian elephant showed spontaneous problem solving by moving a large plastic cube, on which he then stood, to acquire the food. In further testing he showed behavioral flexibility, using this technique to reach other items and retrieving the cube from various locations to use as a tool to acquire food. In the cube's absence, he generalized this tool utilization technique to other objects and, when given smaller objects, stacked them in an attempt to reach the food. The elephant's overall behavior was consistent with the definition of insightful problem solving. Previous failures to demonstrate this ability in elephants may have resulted not from a lack of cognitive ability but from the presentation of tasks requiring trunk-held sticks as potential tools, thereby interfering with the trunk's use as a sensory organ to locate the targeted food.	[Foerder, Preston; Reiss, Diana] CUNY, Grad Ctr, Biopsychol & Behav Neurosci Program, New York, NY 10021 USA; [Galloway, Marie; Barthel, Tony; Moore, Donald E., III] Smithsonian Natl Zool Pk, Washington, DC USA; [Reiss, Diana] CUNY, Hunter Coll, Dept Psychol, New York, NY 10021 USA	City University of New York (CUNY) System; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; City University of New York (CUNY) System; Hunter College (CUNY)	Foerder, P (corresponding author), CUNY, Grad Ctr, Biopsychol & Behav Neurosci Program, New York, NY 10021 USA.	dlr28@columbia.edu			Graduate Center of the City University of New York	Graduate Center of the City University of New York	Funding was provided by a Graduate Center of the City University of New York Doctoral Student Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK B B, 1973, Science (Washington D C), V182, P594, DOI 10.1126/science.182.4112.594; Bird CD, 2009, P NATL ACAD SCI USA, V106, pE77, DOI 10.1073/pnas.0906351106; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Byrne RW, 2009, COMP COGN BEHAV REV, V4, P65, DOI 10.3819/ccbr.2009.40009; CHEVALIERSKOLNIKOFF S, 1993, ANIM BEHAV, V46, P209, DOI 10.1006/anbe.1993.1183; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Hart BL, 2008, NEUROSCI BIOBEHAV R, V32, P86, DOI 10.1016/j.neubiorev.2007.05.012; Hart BL, 2001, ANIM BEHAV, V62, P839, DOI 10.1006/anbe.2001.1815; HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203; Irie-Sugimoto N, 2008, ANIM COGN, V11, P359, DOI 10.1007/s10071-007-0126-z; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; Jacobs B, 2011, BRAIN STRUCT FUNCT, V215, P273, DOI 10.1007/s00429-010-0288-3; Kacelnik A, 2009, P NATL ACAD SCI USA, V106, P10071, DOI 10.1073/pnas.0904735106; Kohler W., 1925, MENTALITY APES; Nissani Moti, 2004, P227; Pettigrew JD, 2010, BRAIN BEHAV EVOLUT, V75, P251, DOI 10.1159/000314898; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Plotnik JM, 2010, ZOO BIOL, V29, P179, DOI 10.1002/zoo.20257; Poole Joyce H., 2008, P69; Rasmussen L.E.L., 2006, P409, DOI 10.1002/9780470344484.ch32; Rasmussen LEL, 1996, ANAT REC, V246, P127; RENSCH B, 1957, SCI AM, V196, P44, DOI 10.1038/scientificamerican0257-44; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; SUKUMAR R, 1997, ILLUSTRATED ENCY ELE, P158; Thorpe, 1963, LEARNING INSTINCT AN; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; ZEDTWITZ FRANZ XAVER, 1930, ZOOL GARTEN [LEIPZIG], V3, P250	32	51	53	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23251	10.1371/journal.pone.0023251	http://dx.doi.org/10.1371/journal.pone.0023251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876741	Green Published, gold			2022-12-27	WOS:000294126900013
J	Devera, TS; Joshi, SK; Aye, LM; Lang, GA; Ballard, JD; Lang, ML				Devera, T. Scott; Joshi, Sunil K.; Aye, Lindsay M.; Lang, Gillian A.; Ballard, Jimmy D.; Lang, Mark L.			Regulation of Anthrax Toxin-Specific Antibody Titers by Natural Killer T Cell-Derived IL-4 and IFN gamma	PLOS ONE			English	Article							PROTECTIVE-ANTIGEN; BACILLUS-ANTHRACIS; LETHAL TOXIN; ALPHA-GALACTOSYLCERAMIDE; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; NKT CELLS; VACCINE ADJUVANT; NOD MICE; MECHANISMS	Activation of Natural Killer-like T cells (NKT) with the CD1d ligand alpha-GC leads to enhanced production of anthrax toxin protective Ag (PA)-neutralizing Abs, yet the underlying mechanism for this adjuvant effect is not known. In the current study we examined the role of Th1 and Th2 type responses in NKT-mediated enhancement of antibody responses to PA. First, the contribution of IL-4 and IFN gamma to the production of PA-specific toxin-neutralizing Abs was examined. By immunizing C57Bl/6 controls IL-4(-/-) mice and IFN gamma(-/-) mice and performing passive serum transfer experiments, it was observed that sera containing PA-specific IgG1, IgG2b and IgG2c neutralized toxin in vitro and conferred protection in vivo. Sera containing IgG2b and IgG2c neutralized toxin in vitro but were not sufficient for protection in vivo. Sera containing IgG1 and IgG2b neutralized toxin in vitro and conferred protection in vivo. IgG1 therefore emerged as a good correlate of protection. Next, C57Bl/6 mice were immunized with PA alone or PA plus a Th2-skewing alpha-GC derivative known as OCH. Neutralizing PA-specific IgG1 responses were modestly enhanced by OCH in C57Bl/6 mice. Conversely, IgG2b and IgG2c were considerably enhanced in PA/OCH-immunized IL-4(-/-) mice but did not confer protection. Finally, bone marrow chimeras were generated such that NKT cells were unable to express IL-4 or IFN gamma. NKT-derived IL-4 was required for OCH-enhanced primary IgG1 responses but not recall responses. NKT-derived IL-4 and IFN gamma also influenced primary and recall IgG2b and IgG2c titers. These data suggest targeted skewing of the Th2 response by alpha-GC derivatives can be exploited to optimize anthrax vaccination.	[Devera, T. Scott; Joshi, Sunil K.; Aye, Lindsay M.; Lang, Gillian A.; Ballard, Jimmy D.; Lang, Mark L.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Devera, TS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	mark-lang@ouhsc.edu			Defense Threat Reduction Agency (DTRA) [HDTRA1-08-C-0013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Defense Threat Reduction Agency (DTRA) contract HDTRA1-08-C-0013 to MLL. Approval for public release of the information herein was required and obtained from DTRA prior to submission of the manuscript. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Abboud N, 2008, CLIN VACCINE IMMUNOL, V15, P1115, DOI 10.1128/CVI.00015-08; Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Belperron AA, 2005, J IMMUNOL, V174, P5681, DOI 10.4049/jimmunol.174.9.5681; Boyaka PN, 2003, J IMMUNOL, V170, P5636, DOI 10.4049/jimmunol.170.11.5636; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Devera TS, 2008, EUR J IMMUNOL, V38, P1001, DOI 10.1002/eji.200738000; Devera TS, 2010, INFECT IMMUN, V78, P1610, DOI 10.1128/IAI.00002-10; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Joshi SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000588; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lang GA, 2004, IMMUNOLOGY, V112, P386, DOI 10.1111/j.1365-2567.2004.01896.x; Lang GA, 2008, BLOOD, V111, P2158, DOI 10.1182/blood-2007-10-117309; Lang GA, 2006, IMMUNOLOGY, V119, P116, DOI 10.1111/j.1365-2567.2006.02413.x; LEPPLA SH, 1984, ADV CYCLIC NUCL PROT, V17, P189; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mizuno M, 2004, J AUTOIMMUN, V23, P293, DOI 10.1016/j.jaut.2004.09.008; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Mohamed N, 2004, INFECT IMMUN, V72, P3276, DOI 10.1128/IAI.72.6.3276-3283.2004; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nguyen ML, 2009, INFECT IMMUN, V77, P4714, DOI 10.1128/IAI.00749-09; Nguyen ML, 2009, INFECT IMMUN, V77, P162, DOI 10.1128/IAI.00788-08; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park YS, 2008, INFECT IMMUN, V76, P1952, DOI 10.1128/IAI.01722-07; Peachman KK, 2006, INFECT IMMUN, V74, P794, DOI 10.1128/IAI.74.1.794-797.2006; Pittman PR, 2005, CLIN DIAGN LAB IMMUN, V12, P713, DOI 10.1128/CDLI.12.6.713-721.2005; Quinn CP, 2004, J INFECT DIS, V190, P1228, DOI 10.1086/423937; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Salles II, 2006, CELL MICROBIOL, V8, P1272, DOI 10.1111/j.1462-5822.2006.00708.x; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; Williamson ED, 1999, J APPL MICROBIOL, V87, P315, DOI 10.1046/j.1365-2672.1999.00901.x	40	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23817	10.1371/journal.pone.0023817	http://dx.doi.org/10.1371/journal.pone.0023817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858226	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300097
J	Gardner, AF; Guan, C; Jack, WE				Gardner, Andrew F.; Guan, Chudi; Jack, William E.			Biochemical Characterization of a Structure-Specific Resolving Enzyme from Sulfolobus islandicus Rod-Shaped Virus 2	PLOS ONE			English	Article							HOLLIDAY JUNCTION RESOLVASE; BACTERIOPHAGE-T7 ENDONUCLEASE-I; BRANCHED DNA-STRUCTURE; PYROCOCCUS-FURIOSUS; T7 ENDONUCLEASE; VACCINIA VIRUS; CLEAVAGE; RESOLUTION; GENOME; HJC	Sulfolobus islandicus rod shaped virus 2 (SIRV2) infects the archaeon Sulfolobus islandicus at extreme temperature (70 degrees C-80 degrees C) and acidity (pH 3). SIRV2 encodes a Holliday junction resolving enzyme (SIRV2 Hjr) that has been proposed as a key enzyme in SIRV2 genome replication. The molecular mechanism for SIRV2 Hjr four-way junction cleavage bias, minimal requirements for four-way junction cleavage, and substrate specificity were determined. SIRV2 Hjr cleaves four-way DNA junctions with a preference for cleavage of exchange strand pairs, in contrast to host-derived resolving enzymes, suggesting fundamental differences in substrate recognition and cleavage among closely related Sulfolobus resolving enzymes. Unlike other viral resolving enzymes, such as T4 endonuclease VII or T7 endonuclease I, that cleave branched DNA replication intermediates, SIRV2 Hjr cleavage is specific to four-way DNA junctions and inactive on other branched DNA molecules. In addition, a specific interaction was detected between SIRV2 Hjr and the SIRV2 virion body coat protein (SIRV2gp26). Based on this observation, a model is proposed linking SIRV2 Hjr genome resolution to viral particle assembly.	[Gardner, Andrew F.; Guan, Chudi; Jack, William E.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Gardner, AF (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	gardner@neb.com			New England Biolabs, Inc	New England Biolabs, Inc	This work was supported by New England Biolabs, Inc (www.neb.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annamalai P, 2008, J VIROL, V82, P1484, DOI 10.1128/JVI.01540-07; BALTIMORE D, 1969, BIOCH VIRUSES, P101; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Birkenbihl RP, 2001, J MOL BIOL, V309, P1067, DOI 10.1006/jmbi.2001.4761; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Blum H, 2001, VIROLOGY, V281, P6, DOI 10.1006/viro.2000.0776; Bond CS, 2001, P NATL ACAD SCI USA, V98, P5509, DOI 10.1073/pnas.091613398; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Culyba MJ, 2007, J BIOL CHEM, V282, P34644, DOI 10.1074/jbc.M705322200; Culyba MJ, 2006, VIROLOGY, V352, P466, DOI 10.1016/j.virol.2006.05.007; Culyba MJ, 2009, J BIOL CHEM, V284, P1190, DOI 10.1074/jbc.M807864200; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; DICKIE P, 1987, J BIOL CHEM, V262, P14826; Dorazi R, 2006, J MOL BIOL, V364, P243, DOI 10.1016/j.jmb.2006.09.011; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Grubisha O, 2003, J VIROL, V77, P10929, DOI 10.1128/JVI.77.20.10929-10942.2003; Guan C, 2005, NUCLEIC ACIDS RES, V33, P6225, DOI 10.1093/nar/gki921; Hadden JM, 2007, NATURE, V449, P621, DOI 10.1038/nature06158; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; KEMPER B, 1976, J VIROL, V18, P1000, DOI 10.1128/JVI.18.3.1000-1015.1976; KEMPER B, 1997, BIOCH GENETICS CELL, P179; Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001; KOERNER JF, 1979, MICROBIOL REV, V43, P199, DOI 10.1128/MMBR.43.2.199-223.1979; Komori K, 1999, P NATL ACAD SCI USA, V96, P8873, DOI 10.1073/pnas.96.16.8873; Komori K, 2000, NUCLEIC ACIDS RES, V28, P4544, DOI 10.1093/nar/28.22.4544; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Kvaratskhelia M, 2000, J BIOL CHEM, V275, P25540, DOI 10.1074/jbc.M003420200; Kvaratskhelia M, 2000, J MOL BIOL, V297, P923, DOI 10.1006/jmbi.2000.3624; Kvaratskhelia M, 2001, FEBS LETT, V491, P243, DOI 10.1016/S0014-5793(01)02200-1; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Mansky LM, 1998, J VIROL, V72, P3196, DOI 10.1128/JVI.72.4.3196-3204.1998; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; McBride MS, 1997, J VIROL, V71, P4544, DOI 10.1128/JVI.71.6.4544-4554.1997; Middleton CL, 2004, NUCLEIC ACIDS RES, V32, P5442, DOI 10.1093/nar/gkh869; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; MULLER B, 1990, NUCLEIC ACIDS RES, V18, P5633, DOI 10.1093/nar/18.19.5633; MURCHIE AIH, 1991, EMBO J, V10, P713, DOI 10.1002/j.1460-2075.1991.tb08001.x; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Neef K, 2002, EXTREMOPHILES, V6, P359, DOI 10.1007/s00792-002-0265-8; Parker JL, 2005, J MOL BIOL, V350, P1, DOI 10.1016/j.jmb.2005.04.056; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; PICKSLEY SM, 1990, J MOL BIOL, V212, P723, DOI 10.1016/0022-2836(90)90233-C; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; White MF, 1997, J MOL BIOL, V269, P647, DOI 10.1006/jmbi.1997.1097; Zeffman A, 2000, J MOL BIOL, V297, P877, DOI 10.1006/jmbi.2000.3611	49	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23668	10.1371/journal.pone.0023668	http://dx.doi.org/10.1371/journal.pone.0023668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858199	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300078
J	Wang, S; Yang, S; An, BY; Wang, SC; Yin, YJ; Lu, Y; Xu, Y; Hao, DY				Wang, Shan; Yang, Shuo; An, Baiyi; Wang, Shichen; Yin, Yuejia; Lu, Yang; Xu, Ying; Hao, Dongyun			Molecular Dynamics Analysis Reveals Structural Insights into Mechanism of Nicotine N-Demethylation Catalyzed by Tobacco Cytochrome P450 Mono-Oxygenase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ACTIVE-SITE; HETEROLOGOUS EXPRESSION; ACCESS CHANNELS; RESOLUTION; SIMULATION; BINDING; MODEL; 3A4; CRYSTALLOGRAPHY	CYP82E4, a cytochrome P450 monooxygenase, has nicotine N-demethylase (NND) activity, which mediates the bioconversion of nicotine into nornicotine in senescing tobacco leaves. Nornicotine is a precursor of the carcinogen, tobacco-specific nitrosamine. CYP82E3 is an ortholog of CYP82E4 with 95% sequence identity, but it lacks NND activity. A recent site-directed mutagenesis study revealed that a single amino acid substitution, i.e., cysteine to tryptophan at the 330 position in the middle of protein, restores the NND activity of CYP82E3 entirely. However, the same amino acid change caused the loss of the NND activity of CYP82E4. To determine the mechanism of the functional turnover of the two molecules, four 3D structures, i.e., the two molecules and their corresponding cys-trp mutants were modeled. The resulting structures exhibited that the mutation site is far from the active site, which suggests that no direct interaction occurs between the two sites. Simulation studies in different biological scenarios revealed that the mutation introduces a conformation drift with the largest change at the F-G loop. The dynamics trajectories analysis using principal component analysis and covariance analysis suggests that the single amino acid change causes the opening and closing of the transfer channels of the substrates, products, and water by altering the motion of the F-G and B-C loops. The motion of helix I is also correlated with the motion of both the F-G loop and the B-C loop and; the single amino acid mutation resulted in the curvature of helix I. These results suggest that the single amino acid mutation outside the active site region may have indirectly mediated the flexibility of the F-G and B-C loops through helix I, causing a functional turnover of the P450 monooxygenase.	[Wang, Shan; Yang, Shuo; An, Baiyi; Lu, Yang; Hao, Dongyun] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Peoples R China; [Wang, Shichen; Yin, Yuejia; Hao, Dongyun] Jilin Acad Agr Sci, Biotechnol Res Ctr, Changchun, Peoples R China; [Xu, Ying] Univ Georgia, Computat Syst Biol Lab, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Jilin University; Jilin Academy of Agricultural Sciences; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University	Wang, S (corresponding author), Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Peoples R China.	dyhao@cjaas.com			National High-Technology R&D Program of China [2007AA10Z110, 2007AA021307]; Jilin University [200903094]; Structure Prediction of Helical Transmembrane Proteins (NIH) [1R01GM075331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	National High-Technology R&D Program of China; Jilin University(Jilin University); Structure Prediction of Helical Transmembrane Proteins (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was financially supported by the National High-Technology R&D Program of China (Grant No. 2007AA10Z110) (Grant No. 2007AA021307), Scientific Forefront and Interdisciplinary Innovation Project, Jilin University (Grant No. 200903094), and Structure Prediction of Helical Transmembrane Proteins (NIH 1R01GM075331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Baudry B, 2005, IEEE SOFTWARE, V22, P76, DOI 10.1109/MS.2005.30; Billeter S.R., 1996, GROMOS96 MANUAL USER; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; de Graaf C, 2007, CURR DRUG METAB, V8, P59, DOI 10.2174/138920007779315062; Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612; Domanski TL, 2001, ARCH BIOCHEM BIOPHYS, V394, P21, DOI 10.1006/abbi.2001.2504; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gavilano LB, 2007, J BIOL CHEM, V282, P249, DOI 10.1074/jbc.M609512200; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HECHT SS, 1989, CANCER SURV, V8, P273; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Kemp CA, 2005, ARCH BIOCHEM BIOPHYS, V433, P361, DOI 10.1016/j.abb.2004.08.026; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lauria A, 2009, COMPUT BIOL CHEM, V33, P386, DOI 10.1016/j.compbiolchem.2009.07.010; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; LUNDEMANN SK, 2000, J MOL BIOL, V303, P797; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott EE, 2004, ARCH BIOCHEM BIOPHYS, V423, P266, DOI 10.1016/j.abb.2003.12.035; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Tang L, 2000, SCIENCE, V287, P640, DOI 10.1126/science.287.5453.640; TELEMAN O, 1987, MOL PHYS, V60, P193, DOI 10.1080/00268978700100141; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wade RC, 2004, J INORG BIOCHEM, V98, P1175, DOI 10.1016/j.jinorgbio.2004.02.007; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; XU J, 2005, BIOINFORMATICS, V26, P889; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; [No title captured], DOI DOI 10.1038/NBT0795-658	46	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23342	10.1371/journal.pone.0023342	http://dx.doi.org/10.1371/journal.pone.0023342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858078	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500028
J	Larriba, MJ; Ordonez-Moran, P; Chicote, I; Martin-Fernandez, G; Puig, I; Munoz, A; Palmer, HG				Jesus Larriba, Maria; Ordonez-Moran, Paloma; Chicote, Irene; Martin-Fernandez, Genesis; Puig, Isabel; Munoz, Alberto; Palmer, Hector G.			Vitamin D Receptor Deficiency Enhances Wnt/beta-Catenin Signaling and Tumor Burden in Colon Cancer	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; E-CADHERIN; WNT; EXPRESSION; GROWTH; DIFFERENTIATION; PHENOTYPE; APC; PHOSPHORYLATION	Aberrant activation of the Wnt/beta-catenin pathway is critical for the initiation and progression of most colon cancers. This activation provokes the accumulation of nuclear beta-catenin and the induction of its target genes. Apc(min/+) mice are the most commonly used model for colon cancer. They harbor a mutated Apc allele and develop intestinal adenomas and carcinomas during the first months of life. This phenotype is caused by the mutation of the second Apc allele and the consequent accumulation of nuclear beta-catenin in the affected cells. Here we describe that vitamin D receptor (VDR) is a crucial modulator of nuclear beta-catenin levels in colon cancer in vivo. By appropriate breeding of Apc(min/+) mice and Vdr(+/-) mice we have generated animals expressing a mutated Apc allele and two, one, or none Vdr wild type alleles. Lack of Vdr increased the number of colonic Aberrant Crypt Foci (ACF) but not that of adenomas or carcinomas in either small intestine or colon. Importantly, colon ACF and tumors of Apc(min/+) Vdr(-/-) mice had increased nuclear beta-catenin and the tumors reached a larger size than those of Apc(min/+) Vdr(+/+). Both ACF and carcinomas in Apc(min/+) Vdr(-/-) mice showed higher expression of beta-catenin/TCF target genes. In line with this, VDR knock-down in cultured human colon cancer cells enhanced beta-catenin nuclear content and target gene expression. Consistently, VDR depletion abrogated the capacity of 1,25(OH)(2)D-3 to promote the relocation of beta-catenin from the nucleus to the plasma membrane and to inhibit beta-catenin/TCF target genes. In conclusion, VDR controls the level of nuclear beta-catenin in colon cancer cells and can therefore attenuate the impact of oncogenic mutations that activate the Wnt/beta-catenin pathway.	[Jesus Larriba, Maria; Ordonez-Moran, Paloma; Martin-Fernandez, Genesis; Munoz, Alberto] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Chicote, Irene; Puig, Isabel; Palmer, Hector G.] Vall dHebron Inst Oncol, Stem Cells & Canc Lab, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Vall d'Hebron Institut d'Oncologia (VHIO)	Larriba, MJ (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain.	hgpalmer@vhio.net	LARRIBA, MARIA JESUS/O-4652-2014; Palmer, Héctor G./AAG-8332-2019; Munoz, Alberto/O-6393-2014; Seoane, Joan/AAG-9173-2019; Ordonez-Moran, Paloma/B-6371-2016	LARRIBA, MARIA JESUS/0000-0001-9035-7414; Munoz, Alberto/0000-0003-3890-4251; Seoane, Joan/0000-0002-6541-5974; Puig Borreil, Isabel/0000-0001-5614-4298; Palmer, Hector/0000-0002-9823-5638; Martin Fernandez, Genesis/0000-0002-1052-9763; Ordonez-Moran, Paloma/0000-0001-7688-1252	Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (ISCIII) [PI081356]; Vall d'Hebron Institute of Oncology; Olga Torres Foundation; Fundacion de la Asociacion Espanola de Lucha Contra el Cancer (AECC); Ministerio de Ciencia e Innovacion [SAF2010-18302]; Red Tematica de Investigacion Cooperativa en Cancer (ISCIII) [RD06/0020/0009]	Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III); Vall d'Hebron Institute of Oncology; Olga Torres Foundation; Fundacion de la Asociacion Espanola de Lucha Contra el Cancer (AECC); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer (ISCIII)(Instituto de Salud Carlos III)	This work was supported by Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (ISCIII, PI081356), Vall d'Hebron Institute of Oncology, Olga Torres Foundation, Fundacion de la Asociacion Espanola de Lucha Contra el Cancer (AECC), Ministerio de Ciencia e Innovacion (SAF2010-18302) and Red Tematica de Investigacion Cooperativa en Cancer (ISCIII, RD06/0020/0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Campbell MJ, 2006, EXPERT OPIN THER TAR, V10, P735, DOI 10.1517/14728222.10.5.735; Cross HS, 1996, ANTICANCER RES, V16, P2333; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Eelen G, 2007, CURR MED CHEM, V14, P1893; Egan JB, 2010, MOL CARCINOGEN, V49, P337, DOI 10.1002/mc.20603; Evans SRT, 1998, CLIN CANCER RES, V4, P1591; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Garcia SB, 2000, INT J EXP PATHOL, V81, P89, DOI 10.1046/j.1365-2613.2000.00142.x; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Huerta S, 2002, CANCER RES, V62, P741; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Larriba MJ, 2010, J STEROID BIOCHEM, V121, P106, DOI 10.1016/j.jsbmb.2010.01.014; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Larriba MJ, 2007, ENDOCR-RELAT CANCER, V14, P141, DOI 10.1677/ERC-06-0028; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Ordonez-Moran P, 2008, J CELL BIOL, V183, P697, DOI 10.1083/jcb.200803020; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Xu HB, 2010, CARCINOGENESIS, V31, P1434, DOI 10.1093/carcin/bgq098; Xu HB, 2009, MOL CARCINOGEN, V48, P758, DOI 10.1002/mc.20520; ZHENG W, 2011, INT J CANC IN PRESS	45	104	112	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23524	10.1371/journal.pone.0023524	http://dx.doi.org/10.1371/journal.pone.0023524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858154	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700029
J	Corfield, JR; Gsell, AC; Brunton, D; Heesy, CP; Hall, MI; Acosta, ML; Iwaniuk, AN				Corfield, Jeremy R.; Gsell, Anna C.; Brunton, Dianne; Heesy, Christopher P.; Hall, Margaret I.; Acosta, Monica L.; Iwaniuk, Andrew N.			Anatomical Specializations for Nocturnality in a Critically Endangered Parrot, the Kakapo (Strigops habroptilus)	PLOS ONE			English	Article							BINOCULAR VISUAL-FIELD; EYE SIZE; ORBIT ORIENTATION; STEATORNIS-CARIPENSIS; MOLECULAR PHYLOGENY; ACTIVITY PATTERN; BRAIN SIZE; AVIAN EYE; BIRDS; EVOLUTION	The shift from a diurnal to nocturnal lifestyle in vertebrates is generally associated with either enhanced visual sensitivity or a decreased reliance on vision. Within birds, most studies have focused on differences in the visual system across all birds with respect to nocturnality-diurnality. The critically endangered Kakapo (Strigops habroptilus), a parrot endemic to New Zealand, is an example of a species that has evolved a nocturnal lifestyle in an otherwise diurnal lineage, but nothing is known about its' visual system. Here, we provide a detailed morphological analysis of the orbits, brain, eye, and retina of the Kakapo and comparisons with other birds. Morphometric analyses revealed that the Kakapo's orbits are significantly more convergent than other parrots, suggesting an increased binocular overlap in the visual field. The Kakapo exhibits an eye shape that is consistent with other nocturnal birds, including owls and nightjars, but is also within the range of the diurnal parrots. With respect to the brain, the Kakapo has a significantly smaller optic nerve and tectofugal visual pathway. Specifically, the optic tectum, nucleus rotundus and entopallium were significantly reduced in relative size compared to other parrots. There was no apparent reduction to the thalamofugal visual pathway. Finally, the retinal morphology of the Kakapo is similar to that of both diurnal and nocturnal birds, suggesting a retina that is specialised for a crepuscular niche. Overall, this suggests that the Kakapo has enhanced light sensitivity, poor visual acuity and a larger binocular field than other parrots. We conclude that the Kakapo possesses a visual system unlike that of either strictly nocturnal or diurnal birds and therefore does not adhere to the traditional view of the evolution of nocturnality in birds.	[Corfield, Jeremy R.; Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Gsell, Anna C.; Brunton, Dianne] Massey Univ, Inst Nat Sci, Auckland, New Zealand; [Heesy, Christopher P.] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Hall, Margaret I.] Midwestern Univ, Dept Physiol, Glendale, AZ USA; [Acosta, Monica L.] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand	University of Lethbridge; Massey University; Midwestern University; Midwestern University; University of Auckland	Corfield, JR (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	jr.corfield@gmail.com	Heesy, Christopher P./AAP-8737-2021; Acosta, Monica/H-2700-2019; Iwaniuk, Andrew/H-7255-2019	Heesy, Christopher P./0000-0003-1258-2506; Acosta, Monica/0000-0002-5018-339X; Iwaniuk, Andrew/0000-0001-9273-3655	Midwestern University; Smithsonian Office of Grants and Fellowships; Natural Sciences and Engineering Research Council (NSERC); Institute for Natural Sciences, Massey University, Auckland, New Zealand	Midwestern University; Smithsonian Office of Grants and Fellowships; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Institute for Natural Sciences, Massey University, Auckland, New Zealand	Funding for this study was provided by intramural funds from Midwestern University to CPH and MIH, and the Smithsonian Office of Grants and Fellowships and the Natural Sciences and Engineering Research Council (NSERC) to ANI and the Institute for Natural Sciences, Massey University, Auckland, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Barton RA, 2004, P NATL ACAD SCI USA, V101, P10113, DOI 10.1073/pnas.0401955101; BEYER W. H., 1979, CRC STANDARD MATH TA; BOWMAKER JK, 1978, VISION RES, V18, P1125, DOI 10.1016/0042-6989(78)90095-0; Braun MJ, 2009, MOL PHYLOGENET EVOL, V53, P948, DOI 10.1016/j.ympev.2009.08.025; Brauth SE, BUDGERIGAR BRAIN ATL; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; Burton RF, 2008, VISION RES, V48, P2345, DOI 10.1016/j.visres.2008.08.001; Butler D, 1989, QUEST KAKAPO; CAMPBELL FW, 1965, NATURE, V208, P191, DOI 10.1038/208191a0; Catania KC, 2000, BRAIN BEHAV EVOLUT, V55, P311, DOI 10.1159/000006666; CORFIELD JR, 2009, THESIS U AUCKLAND AU; Crish SD, 2006, ANAT REC PART A, V288A, P205, DOI 10.1002/ar.a.20288; Dowling J. E., 1987, RETINA APPROACHABLE; Eason Daryl K., 2006, Notornis, V53, P27; Eberhard JR, 1998, AUK, V115, P455, DOI 10.2307/4089204; EBINGER P, 1995, BRAIN BEHAV EVOLUT, V45, P286, DOI 10.1159/000113557; EBINGER P, 1992, CELL TISSUE RES, V268, P81, DOI 10.1007/BF00338056; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fernandez P, 1997, REV CHIL HIST NAT, V70, P269; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Hagelin JC, 2004, IBIS, V146, P161, DOI 10.1111/j.1474-919X.2004.00212.x; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Hall MI, 2008, J ANAT, V212, P781, DOI 10.1111/j.1469-7580.2008.00897.x; Hall MI, 2009, ANAT REC, V292, P1827, DOI 10.1002/ar.21007; Harmening WM, 2007, VISION RES, V47, P1020, DOI 10.1016/j.visres.2007.01.005; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Heesy CP, 2008, BRAIN BEHAV EVOLUT, V71, P54, DOI 10.1159/000108621; Heesy CP, 2010, BRAIN BEHAV EVOLUT, V75, P195, DOI 10.1159/000314278; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; Heesy CP, 2004, ANAT REC PART A, V281A, P1104, DOI 10.1002/ar.a.20116; Husband S., 2001, AVIAN VISUAL COGNITI; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Iwaniuk AN, 2010, BRAIN BEHAV EVOLUT, V75, P122, DOI 10.1159/000311729; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; Juniper T, 1998, PARROTS GUIDE PARROT; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Konig C, 2008, OWLS WORLD; Krutzfeldt NOE, 2005, J COMP NEUROL, V490, P40, DOI 10.1002/cne.20627; Krutzfeldt NOE, 2004, J COMP NEUROL, V468, P452, DOI 10.1002/cne.10972; Land MF., 2001, ANIMAL EYES; Lockwood CA, 2002, J ANAT, V201, P447, DOI 10.1046/j.1469-7580.2002.00122.x; Lythgoe J.N., 1979, ECOLOGY VISION; Maddison WP, 2019, MESQUITE MODULAR SYS; Martin G, 2004, NATURWISSENSCHAFTEN, V91, P26, DOI 10.1007/s00114-003-0495-3; MARTIN GR, 1986, IBIS, V128, P266, DOI 10.1111/j.1474-919X.1986.tb02674.x; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; Martin Graham R., 1993, P5; MATOCHIK JA, 1991, BRAIN BEHAV EVOLUT, V37, P215, DOI 10.1159/000114360; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Midford P. E., 2008, PDAP PDTREE PACKAGE; Mpodozis J, 1996, J COMP NEUROL, V374, P204, DOI 10.1002/(SICI)1096-9861(19961014)374:2<204::AID-CNE4>3.0.CO;2-6; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Nieder A, 2000, J NEUROPHYSIOL, V83, P2967, DOI 10.1152/jn.2000.83.5.2967; Pettigrew J.D., 1986, P208; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; Pirenne MH, 1943, NATURE, V152, P698, DOI 10.1038/152698a0; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Powlesland Ralph G., 2006, Notornis, V53, P3; PUELLES L, CHICK BRAIN STEREOTA; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P125, DOI 10.1159/000114353; Ritland S. M., 1982, ALLOMETRY VERTEBRATE; Rojas LM, 2004, BRAIN BEHAV EVOLUT, V64, P19, DOI 10.1159/000077540; Russello MA, 2004, MOL PHYLOGENET EVOL, V30, P421, DOI 10.1016/S1055-7903(03)00192-1; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Thomas RJ, 2002, P ROY SOC B-BIOL SCI, V269, P831, DOI 10.1098/rspb.2001.1941; TURBOTT EG, 1967, BULLERS BIRDS NZ; WAGNER H, 1993, NATURE, V364, P796, DOI 10.1038/364796a0; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant E. J., 2008, SENSES COMPREHENSIVE, V2, P53; WATHEY JC, 1989, BRAIN BEHAV EVOLUT, V33, P279, DOI 10.1159/000115936; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; [No title captured]	84	32	32	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22945	10.1371/journal.pone.0022945	http://dx.doi.org/10.1371/journal.pone.0022945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860663	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200028
J	Chung, S; Sundar, IK; Hwang, JW; Yull, FE; Blackwell, TS; Kinnula, VL; Bulger, M; Yao, HW; Rahman, I				Chung, Sangwoon; Sundar, Isaac K.; Hwang, Jae-Woong; Yull, Fiona E.; Blackwell, Timothy S.; Kinnula, Vuokko L.; Bulger, Michael; Yao, Hongwei; Rahman, Irfan			NF-kappa B Inducing Kinase, NIK Mediates Cigarette Smoke/TNF alpha-Induced Histone Acetylation and Inflammation through Differential Activation of IKKs	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR EPITHELIAL-CELLS; PROINFLAMMATORY CYTOKINE RELEASE; INDUCED LUNG INFLAMMATION; GENE-EXPRESSION; OXIDATIVE STRESS; CHROMATIN MODIFICATION; DEACETYLASE ACTIVITY; PHOSPHORYLATION; PATHWAY	Background: Nuclear factor (NF)-kappa B inducing kinase (NIK) is a central player in the non-canonical NF kappa B pathway, which phosphorylates I kappa B kinase alpha (IKK alpha) resulting in enhancement of target gene expression. We have recently shown that IKK alpha responds to a variety of stimuli including oxidants and cigarette smoke (CS) regulating the histone modification in addition to its role in NF-kappa B activation. However, the primary signaling mechanism linking CS-mediated oxidative stress and TNF alpha with histone acetylation and pro-inflammatory gene transcription is not well understood. We hypothesized that CS and TNF alpha increase NIK levels causing phosphorylation of IKKa, which leads to histone acetylation. Methodology: To test this hypothesis, we investigated whether NIK mediates effects of CS and TNF alpha on histone acetylation in human lung epithelial cells in vitro and in lungs of mouse exposed to CS in vivo. CS increased the phosphorylation levels of IKK alpha/NIK in lung epithelial cells and mouse lungs. NIK is accumulated in the nuclear compartment, and is recruited to the promoters of pro-inflammatory genes, to induce posttranslational acetylation of histones in response to CS and TNF alpha. Cells in which NIK is knocked down using siRNA showed partial attenuation of CSE- and TNF alpha-induced acetylation of histone H3 on pro-inflammatory gene promoters. Additional study to determine the role of IKK beta/NF-kappa B pathway in CS-induced histone acetylation suggests that the canonical pathway does not play a role in histone acetylation particularly in response to CS in mouse lungs. Conclusions: Overall, our findings provide a novel role for NIK in CS- and TNF alpha-induced histone acetylation, especially on histone H3K9.	[Chung, Sangwoon; Sundar, Isaac K.; Hwang, Jae-Woong; Yao, Hongwei; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Yull, Fiona E.; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Kinnula, Vuokko L.] Univ Helsinki, Div Pulm, Dept Med, Helsinki, Finland; [Kinnula, Vuokko L.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Bulger, Michael] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA	University of Rochester; Vanderbilt University; Vanderbilt University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Rochester	Chung, S (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.	Irfan_Rahman@urmc.rochester.edu	Yao, Hongwei/G-6444-2010; Sundar, Isaac K/F-8764-2012	Sundar, Isaac K/0000-0001-6742-3460	National Institutes of Health - National Heart, Lung, and Blood Institute [R01-HL085613]; National Institute of Environmental Health Sciences Center [NIEHS P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health - National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health - National Heart, Lung, and Blood Institute Grant R01-HL085613, and the National Institute of Environmental Health Sciences Center Grant NIEHS P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Azim AC, 2007, J IMMUNOL, V179, P7868, DOI 10.4049/jimmunol.179.11.7868; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hirata Y, 2006, INFECT IMMUN, V74, P1452, DOI 10.1128/IAI.74.3.1452-1461.2006; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jiang X, 2003, BIOCHEM BIOPH RES CO, V301, P583, DOI 10.1016/S0006-291X(03)00011-1; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Li Q, 2006, J BIOL CHEM, V281, P1495, DOI 10.1074/jbc.M511153200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Millington GWM, 2008, PHARMACOGENOMICS, V9, P1835, DOI 10.2217/14622416.9.12.1835; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rahman I, 1999, J BIOL CHEM, V274, P5088, DOI 10.1074/jbc.274.8.5088; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; Rajendrasozhan S, 2010, PULM PHARMACOL THER, V23, P172, DOI 10.1016/j.pupt.2010.01.002; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; RODKEY FL, 1979, CLIN CHEM, V25, P1388; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Song YS, 2010, J CEREBR BLOOD F MET, V30, P1265, DOI 10.1038/jcbfm.2010.6; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Tuder RM, 2006, AM J RESP CRIT CARE, V174, P490, DOI 10.1164/rccm.200607-924ED; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022; Yao HW, 2010, J BIOL CHEM, V285, P5405, DOI 10.1074/jbc.M109.041418; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105	65	36	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23488	10.1371/journal.pone.0023488	http://dx.doi.org/10.1371/journal.pone.0023488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887257	Green Submitted, Green Published, gold			2022-12-27	WOS:000295832000021
J	Mahlokozera, T; Kang, HH; Goonetilleke, N; Stacey, AR; Lovingood, RV; Denny, TN; Kalilani, L; Bunn, JEG; Meshnick, SR; Borrow, P; Letvin, NL; Permar, SR				Mahlokozera, Tatenda; Kang, Helen H.; Goonetilleke, Nilu; Stacey, Andrea R.; Lovingood, Rachel V.; Denny, Thomas N.; Kalilani, Linda; Bunn, James E. G.; Meshnick, Steve R.; Borrow, Persephone; Letvin, Norman L.; Permar, Sallie R.		Ctr HIV AIDS Vaccine Immunology	The Magnitude and Kinetics of the Mucosal HIV-Specific CD8+T Lymphocyte Response and Virus RNA Load in Breast Milk	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; SUBCLINICAL MASTITIS; CELL RESPONSES; TYPE-1 RNA; CHILD TRANSMISSION; VIRAL LOAD; CLASS-I; RISK; INFECTION	Background: The risk of postnatal HIV transmission is associated with the magnitude of the milk virus load. While HIV-specific cellular immune responses control systemic virus load and are detectable in milk, the contribution of these responses to the control of virus load in milk is unknown. Methods: We assessed the magnitude of the immunodominant GagRY11 and subdominant EnvKY9-specific CD8+ T lymphocyte response in blood and milk of 10 A*3002+, HIV-infected Malawian women throughout the period of lactation and correlated this response to milk virus RNA load and markers of breast inflammation. Results: The magnitude and kinetics of the HIV-specific CD8+ T lymphocyte responses were discordant in blood and milk of the right and left breast, indicating independent regulation of these responses in each breast. However, there was no correlation between the magnitude of the HIV-specific CD8+ T lymphocyte response and the milk virus RNA load. Further, there was no correlation between the magnitude of this response and markers of breast inflammation. Conclusions: The magnitude of the HIV-specific CD8+ T lymphocyte response in milk does not appear to be solely determined by the milk virus RNA load and is likely only one of the factors contributing to maintenance of low virus load in milk.	[Mahlokozera, Tatenda; Kang, Helen H.; Letvin, Norman L.; Permar, Sallie R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA; [Goonetilleke, Nilu] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford, England; [Stacey, Andrea R.; Borrow, Persephone] Univ Oxford, Jenner Inst, Nuffield Dept Clin Med, Newbury, Berks, England; [Lovingood, Rachel V.; Denny, Thomas N.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Kalilani, Linda; Bunn, James E. G.] Univ Malawi, Coll Med, Blantyre, Malawi; [Bunn, James E. G.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Meshnick, Steve R.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Permar, Sallie R.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Oxford; University of Oxford; Jenner Institute; Duke University; University of Malawi; Alder Hey Children's NHS Foundation Trust; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard Medical School	Mahlokozera, T (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA.	sallie.permar@childrens.harvard.edu		Denny, Thomas/0000-0002-7364-8276; Borrow, Persephone/0000-0002-3877-9780	Center for HIV/AIDS Vaccine Immunology [AI067854]; National Institutes of Health (NIH) [K08AI087992]; Pediatric Infectious Disease Society/St. Jude Children's Hospital; Doris Duke Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, P30AI060354, K08AI087992, U01AI067854] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Infectious Disease Society/St. Jude Children's Hospital; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for HIV/AIDS Vaccine Immunology (AI067854), the National Institutes of Health (NIH) grant K08AI087992 (S. R. P.), the Pediatric Infectious Disease Society/St. Jude Children's Hospital Basic Science Research Award (S. R. P.), and the Doris Duke Foundation Clinical Scientist Development Award (S. R. P.). P. B. is a Jenner Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosire R, 2007, BREASTFEED MED, V2, P129, DOI 10.1089/bfm.2007.0009; Bunce Mike, 2003, Methods Mol Biol, V210, P143; Cromwell MA, 2011, AM J REPROD IMMUNOL, V65, P242, DOI 10.1111/j.1600-0897.2010.00966.x; Embree JE, 2000, AIDS, V14, P2535, DOI 10.1097/00002030-200011100-00016; Farquhar C, 2005, CURR HIV RES, V3, P361, DOI 10.2174/157016205774370393; FUJIWARA S, 1986, J IMMUNOL METHODS, V90, P265; Gantt S, 2010, J VIROL, V84, P10812, DOI 10.1128/JVI.00543-10; Gomo E, 2003, T ROY SOC TROP MED H, V97, P212, DOI 10.1016/S0035-9203(03)90124-6; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Goulder PJR, 2001, J VIROL, V75, P1339, DOI 10.1128/JVI.75.3.1339-1347.2001; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; HALE ML, 1976, NATURE, V260, P44, DOI 10.1038/260044a0; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; HEAD JR, 1977, SEMIN PERINATOL, V1, P195; Heath L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010213; Hel Z, 2001, J VIROL, V75, P11483, DOI 10.1128/JVI.75.23.11483-11495.2001; Hoffman IF, 2003, J INFECT DIS, V188, P1209, DOI 10.1086/378414; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; John G C, 2001, East Afr Med J, V78, P75; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KELLER MA, 1987, PEDIATR RES, V22, P277, DOI 10.1203/00006450-198709000-00008; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Lunney KM, 2010, CLIN INFECT DIS, V50, P762, DOI 10.1086/650535; MOHR JA, 1973, J PEDIATR-US, V82, P1062, DOI 10.1016/S0022-3476(73)80448-2; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; OGRA SS, 1977, J IMMUNOL, V119, P245; Permar SR, 2008, J IMMUNOL, V181, P3643, DOI 10.4049/jimmunol.181.5.3643; Permar SR, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-7; Pillay K, 2000, J ACQ IMMUN DEF SYND, V24, P330, DOI 10.1097/00126334-200008010-00006; Read JS, 2003, PEDIATRICS, V112, P1196, DOI 10.1542/peds.112.5.1196; Roehr Bob, 2008, BMJ, V337, pa1099, DOI 10.1136/bmj.a1099; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Sabbaj S, 2002, J VIROL, V76, P7365, DOI 10.1128/JVI.76.15.7365-7373.2002; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; SCHLESINGER JJ, 1977, LANCET, V2, P529; Schmitz JE, 2001, BLOOD, V98, P3757, DOI 10.1182/blood.V98.13.3757; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; Semba R D, 1999, J Hum Lact, V15, P301, DOI 10.1177/089033449901500407; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Shacklett BL, 2000, AIDS, V14, P1911, DOI 10.1097/00002030-200009080-00005; Shacklett BL, 2000, AIDS RES HUM RETROV, V16, P1157, DOI 10.1089/088922200415009; Shepard RN, 2000, J CLIN MICROBIOL, V38, P1414, DOI 10.1128/JCM.38.4.1414-1418.2000; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; Veazey RS, 2003, J MED PRIMATOL, V32, P194, DOI 10.1034/j.1600-0684.2003.00025.x; VENKATARAMAN M, 1986, CRYOBIOLOGY, V23, P199, DOI 10.1016/0011-2240(86)90045-3; Walter J, 2007, JAIDS-J ACQ IMM DEF, V46, P200, DOI 10.1097/QAI.0b013e318141f942; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; Willumsen JF, 2003, AIDS, V17, P407, DOI 10.1097/00002030-200302140-00015; Willumsen JF, 2001, AIDS, V15, P1896, DOI 10.1097/00002030-200109280-00026; Willumsen JF, 2000, ADV EXP MED BIOL, V478, P211	57	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23735	10.1371/journal.pone.0023735	http://dx.doi.org/10.1371/journal.pone.0023735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886819	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500029
J	Yuan, J; Wei, BY; Shi, MM; Gao, HC				Yuan, Jie; Wei, Buyun; Shi, Miaomiao; Gao, Haichun			Functional Assessment of EnvZ/OmpR Two-Component System in Shewanella oneidensis	PLOS ONE			English	Article							GLOBAL TRANSCRIPTOME ANALYSIS; ENTERICA SEROVAR TYPHIMURIUM; ACID TOLERANCE RESPONSE; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; REGULATORY SYSTEM; ACETYL PHOSPHATE; SHOCK RESPONSE; SP-NOV.; OMPR	EnvZ and OmpR constitute the bacterial two-component signal transduction system known to mediate osmotic stress response in a number of Gram-negative bacteria. In an effort to understand the mechanism through which Shewanella oneidensis senses and responds to environmental osmolarity changes, structure of the ompR-envZ operon was determined with Northern blotting assay and roles of the EnvZ/OmpR two-component system in response to various stresses were investigated with mutational analysis, quantitative reverse transcriptase PCR (qRT-PCR), and phenotype microarrays. Results from the mutational analysis and qRT-PCR suggested that the EnvZ/OmpR system contributed to osmotic stress response of S. oneidensis and very likely engaged a similar strategy employed by E. coli, which involved reciprocal regulation of two major porin coding genes. Additionally, the ompR-envZ system was also found related to cell motility. We further showed that the ompR-envZ dependent regulation of porin genes and motility resided almost completely on ompR and only partially on envZ, indicating additional mechanisms for OmpR phosphorylation. In contrast to E. coli lacking ompR-envZ, however, growth of S. oneidensis did not show a significant dependence on ompR-envZ even under osmotic stress. Further analysis with phenotype microarrays revealed that the S. oneidensis strains lacking a complete ompR-envZ system displayed hypersensitivities to a number of agents, especially in alkaline environment. Taken together, our results suggest that the function of the ompR-envZ system in S. oneidensis, although still connected with osmoregulation, has diverged considerably from that of E. coli. Additional mechanism must exist to support growth of S. oneidensis under osmotic stress.	[Yuan, Jie; Wei, Buyun; Shi, Miaomiao; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yuan, J (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Science and Technology Department of Zhejiang [2009C12061]; Fundamental Research Funds for the Central Universities; Major State Basic Research Development Program (973 Program) [2010CB833803]; Zhejiang RD program [2009R50G2010001]; Department of education of Zhejiang Province [Z200909658]	Science and Technology Department of Zhejiang; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); Zhejiang RD program; Department of education of Zhejiang Province	This study was financially supported by Major Program of Science and Technology Department of Zhejiang (2009C12061), by the Fundamental Research Funds for the Central Universities, and by Major State Basic Research Development Program (973 Program: 2010CB833803) to HG; and by Zhejiang R&D program (2009R50G2010001) and Department of education of Zhejiang Province (Z200909658) to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1990, FEBS LETT, V261, P19, DOI 10.1016/0014-5793(90)80626-T; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Bang IS, 2000, J BACTERIOL, V182, P2245, DOI 10.1128/JB.182.8.2245-2252.2000; Bang IS, 2002, MOL MICROBIOL, V44, P1235, DOI 10.1046/j.1365-2958.2002.02937.x; BERNARDINI ML, 1990, J BACTERIOL, V172, P6274, DOI 10.1128/jb.172.11.6274-6281.1990; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; BRETTAR I, 1993, MAR ECOL PROG SER, V94, P253, DOI 10.3354/meps094253; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Csonka L. N., 1996, ESCHERICHIA COLI SAL, P1210; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gao WM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-76; Goh EB, 2004, J BACTERIOL, V186, P4019, DOI 10.1128/JB.186.12.4019-4024.2004; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Heyde M, 2000, J BACTERIOL, V182, P198, DOI 10.1128/JB.182.1.198-202.2000; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; Liang YL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-291; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Matsubara M, 2000, GENES CELLS, V5, P555, DOI 10.1046/j.1365-2443.2000.00347.x; Matsubara M, 1999, BIOSCI BIOTECH BIOCH, V63, P408, DOI 10.1271/bbb.63.408; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; Mills SD, 1998, INFECT IMMUN, V66, P1806, DOI 10.1128/IAI.66.4.1806-1811.1998; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; MIZUNO T, 1988, J BIOL CHEM, V263, P1008; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Pagani L, 2003, J CLIN MICROBIOL, V41, P2240, DOI 10.1128/JCM.41.5.2240-2241.2003; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Rodriguez-Morales O, 2006, INFECT IMMUN, V74, P1398, DOI 10.1128/IAI.74.2.1398-1402.2006; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; SEMPLE KM, 1987, CAN J MICROBIOL, V33, P366, DOI 10.1139/m87-064; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Skerratt JH, 2002, INT J SYST EVOL MICR, V52, P2101, DOI [10.1099/ijs.0.02351-0, 10.1099/00207713-52-6-2101]; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yamada M, 2000, J BACTERIOL, V182, P2945, DOI 10.1128/JB.182.10.2945-2952.2000; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	51	49	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23701	10.1371/journal.pone.0023701	http://dx.doi.org/10.1371/journal.pone.0023701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886811	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500024
J	Rubio, M; Villain, H; Docagne, F; Roussel, BD; Ramos, JA; Vivien, D; Fernandez-Ruiz, J; Ali, C				Rubio, Marina; Villain, Helene; Docagne, Fabian; Roussel, Benoit D.; Ramos, Jose Antonio; Vivien, Denis; Fernandez-Ruiz, Javier; Ali, Carine			Pharmacological Activation/Inhibition of the Cannabinoid System Affects Alcohol Withdrawal-Induced Neuronal Hypersensitivity to Excitotoxic Insults	PLOS ONE			English	Article							BRAIN-DAMAGE; ENDOCANNABINOID CONTENTS; PRECLINICAL EVIDENCE; HIPPOCAMPAL-NEURONS; RECEPTOR AGONISTS; CORTICAL-NEURONS; PRIMARY CULTURES; CB1 RECEPTORS; ETHANOL; ANANDAMIDE	Cessation of chronic ethanol consumption can increase the sensitivity of the brain to excitotoxic damages. Cannabinoids have been proposed as neuroprotectants in different models of neuronal injury, but their effect have never been investigated in a context of excitotoxicity after alcohol cessation. Here we examined the effects of the pharmacological activation/inhibition of the endocannabinoid system in an in vitro model of chronic ethanol exposure and withdrawal followed by an excitotoxic challenge. Ethanol withdrawal increased N-methyl-D-aspartate (NMDA)-evoked neuronal death, probably by altering the ratio between GluN2A and GluN2B NMDA receptor subunits. The stimulation of the endocannabinoid system with the cannabinoid agonist HU-210 decreased NMDA-induced neuronal death exclusively in ethanol-withdrawn neurons. This neuroprotection could be explained by a decrease in NMDA-stimulated calcium influx after the administration of HU-210, found exclusively in ethanol-withdrawn neurons. By contrast, the inhibition of the cannabinoid system with the CB1 receptor antagonist rimonabant (SR141716) during ethanol withdrawal increased death of ethanol-withdrawn neurons without any modification of NMDA-stimulated calcium influx. Moreover, chronic administration of rimonabant increased NMDA-stimulated toxicity not only in withdrawn neurons, but also in control neurons. In summary, we show for the first time that the stimulation of the endocannabinoid system is protective against the hyperexcitability developed during alcohol withdrawal. By contrast, the blockade of the endocannabinoid system is highly counterproductive during alcohol withdrawal.	[Rubio, Marina; Villain, Helene; Docagne, Fabian; Roussel, Benoit D.; Vivien, Denis; Ali, Carine] UMR CNRS 6232 CINAPS, INSERM U919, Serine Protease & Pathophysiol Neurovasc Unit, Caen, France; [Rubio, Marina; Ramos, Jose Antonio; Fernandez-Ruiz, Javier] Univ Complutense, Dept Bioquim & Biol Mol, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Ramos, Jose Antonio; Fernandez-Ruiz, Javier] Univ Complutense, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-28040 Madrid, Spain; [Ramos, Jose Antonio; Fernandez-Ruiz, Javier] Univ Complutense, Fac Med, IRYCIS, E-28040 Madrid, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Complutense University of Madrid; CIBERNED; Complutense University of Madrid; Complutense University of Madrid	Rubio, M (corresponding author), UMR CNRS 6232 CINAPS, INSERM U919, Serine Protease & Pathophysiol Neurovasc Unit, Caen, France.	rubio@cyceron.fr	Docagne, Fabian/S-8308-2018; Roussel, Benoit/L-9520-2018; Roussel, Benoit/P-9309-2019; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018	Roussel, Benoit/0000-0003-0575-8112; Rubio, Marina/0000-0002-6120-4053; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Ali, Carine/0000-0001-8007-7910; VIVIEN, DENIS/0000-0002-7636-2185; Docagne, Fabian/0000-0003-1745-0625	INSERM; French Ministry of Research and Technology; Regional Council of Lower Normandy; University of Caen Basse-Normandie; Spanish Ministry of Education and Science [AP2003-1262]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Research and Technology; Regional Council of Lower Normandy(Region Normandie); University of Caen Basse-Normandie(Region Normandie); Spanish Ministry of Education and Science(Spanish Government)	This work was supported by grants from the INSERM, the French Ministry of Research and Technology, the Regional Council of Lower Normandy, the University of Caen Basse-Normandie. MR had a grant from the Spanish Ministry of Education and Science (AP2003-1262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basavarajappa BS, 1999, J NEUROCHEM, V72, P522, DOI 10.1046/j.1471-4159.1999.0720522.x; Basavarajappa BS, 2003, EUR J PHARMACOL, V466, P73, DOI 10.1016/S0014-2999(03)01557-7; Basavarajappa BS, 2002, PROSTAG LEUKOTR ESS, V66, P287, DOI 10.1054/plef.2001.0352; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Colombo G, 2007, MOL NEUROBIOL, V36, P102, DOI 10.1007/s12035-007-0017-y; De Witte P, 2003, NEUROSCI BIOBEHAV R, V27, P189, DOI 10.1016/S0149-7634(03)00030-7; Docagne F, 2007, MOL CELL NEUROSCI, V34, P551, DOI 10.1016/j.mcn.2006.12.005; Fernandez-Lopez D, 2006, PEDIATR RES, V60, P169, DOI 10.1203/01.pdr.0000228839.00122.6c; Fernandez-Ruiz J, 2009, BRIT J PHARMACOL, V156, P1029, DOI 10.1111/j.1476-5381.2008.00088.x; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; George DT, 2010, PSYCHOPHARMACOLOGY, V208, P37, DOI 10.1007/s00213-009-1704-3; Gilbert GL, 2007, BRAIN RES, V1128, P61, DOI 10.1016/j.brainres.2006.03.011; Gonzalez S, 2004, BRIT J PHARMACOL, V143, P455, DOI 10.1038/sj.bjp.0705963; Gonzalez S, 2002, BRAIN RES, V954, P73, DOI 10.1016/S0006-8993(02)03344-9; Hampson AJ, 1998, J NEUROCHEM, V70, P671; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Liu Q, 2009, J PHARMACOL EXP THER, V331, P1062, DOI 10.1124/jpet.109.156216; Maccioni P, 2010, CNS NEUROL DISORD-DR, V9, P55, DOI 10.2174/187152710790966623; McKeon A, 2008, J NEUROL NEUROSUR PS, V79, P854, DOI 10.1136/jnnp.2007.128322; Nagy J, 2002, NEUROCHEM INT, V40, P585, DOI 10.1016/S0197-0186(01)00131-0; Nagy J, 2001, DRUG ALCOHOL DEPEN, V61, P155, DOI 10.1016/S0376-8716(00)00132-0; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Rivers Jack Rocky-Jay, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P47; Rubio M, 2007, NEUROSCI LETT, V421, P270, DOI 10.1016/j.neulet.2007.05.052; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Soyka M, 2008, J CLIN PSYCHOPHARM, V28, P317, DOI 10.1097/JCP.0b013e318172b8bc; Vinod KY, 2012, ADDICT BIOL, V17, P62, DOI 10.1111/j.1369-1600.2010.00299.x; Vinod KY, 2010, J PSYCHIATR RES, V44, P591, DOI 10.1016/j.jpsychires.2009.11.013; Ward RJ, 2009, ALCOHOL ALCOHOLISM, V44, P128, DOI 10.1093/alcalc/agn100; Warnault V, 2007, J NEUROCHEM, V102, P741, DOI 10.1111/j.1471-4159.2007.04577.x; Zhuang SY, 2005, NEUROPHARMACOLOGY, V48, P1086, DOI 10.1016/j.neuropharm.2005.01.005	32	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23690	10.1371/journal.pone.0023690	http://dx.doi.org/10.1371/journal.pone.0023690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886913	Green Published, gold, Green Submitted			2022-12-27	WOS:000294128100025
J	Shibata, K; Sugawara, T; Fujishita, K; Shinozaki, Y; Matsukawa, T; Suzuki, T; Koizumi, S				Shibata, Keisuke; Sugawara, Takeshi; Fujishita, Kayoko; Shinozaki, Youichi; Matsukawa, Takashi; Suzuki, Tsutomu; Koizumi, Schuichi			The Astrocyte-Targeted Therapy by Bushi for the Neuropathic Pain in Mice	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; NERVE INJURY; MECHANICAL ALLODYNIA; PATHOLOGICAL PAIN; SPINAL ASTROCYTES; MICROGLIA; GLIA; IMMUNE; CELLS; INTERLEUKIN-1-BETA	Background: There is accumulating evidence that the activation of spinal glial cells, especially microglia, is a key event in the pathogenesis of neuropathic pain. However, the inhibition of microglial activation is often ineffective, especially for long-lasting persistent neuropathic pain. So far, neuropathic pain remains largely intractable and a new therapeutic strategy for the pain is still required. Methods/Principal Findings: Using Seltzer model mice, we investigated the temporal aspect of two types of neuropathic pain behaviors, i.e., thermal hyperalgesia and mechanical allodynia, as well as that of morphological changes in spinal microglia and astrocytes by immunohistochemical studies. Firstly, we analyzed the pattern of progression in the pain behaviors, and found that the pain consisted of an "early induction phase'' and subsequent "late maintenance phase''. We next analyzed the temporal changes in spinal glial cells, and found that the induction and the maintenance phase of pain were associated with the activation of microglia and astrocytes, respectively. When Bushi, a Japanese herbal medicine often used for several types of persistent pain, was administered chronically, it inhibited the maintenance phase of pain without affecting the induction phase, which was in accordance with the inhibition of astrocytic activation in the spinal cord. These analgesic effects and the inhibition of astrocytic activation by Bushi were mimicked by the intrathecal injection of fluorocitrate, an inhibitor of astrocytic activation. Finally, we tested the direct effect of Bushi on astrocytic activation, and found that Bushi suppressed the IL-1b- or IL-18-evoked ERK1/2-phosphorylation in cultured astrocytes but not the ATP-evoked p38- and ERK1/2-phosphorylation in microglia in vitro. Conclusions: Our results indicated that the activation of spinal astrocytes was responsible for the late maintenance phase of neuropathic pain in the Seltzer model mice and, therefore, the inhibition of astrocytic activation by Bushi could be a useful therapeutic strategy for treating neuropathic pain.	[Shibata, Keisuke; Fujishita, Kayoko; Shinozaki, Youichi; Koizumi, Schuichi] Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Sugawara, Takeshi] Kenyudo Clin, Yamanashi, Japan; [Sugawara, Takeshi; Matsukawa, Takashi] Univ Yamanashi, Dept Anesthesiol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Suzuki, Tsutomu] Hoshi Univ, Dept Toxicol, Sch Pharm & Pharmaceut Sci, Tokyo 142, Japan	University of Yamanashi; University of Yamanashi; Hoshi University	Shibata, K (corresponding author), Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan.	skoizumi@yamanashi.ac.jp	Shinozaki, Youichi/AAC-9431-2019; Shinozaki, Youichi/E-8594-2010; Koizumi, Schuichi/E-8568-2010	Shinozaki, Youichi/0000-0002-6448-1304; Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106	Ministry of Education, Culture, Sports, Science and Technology; JSPS; University of Yamanashi; Takeda Science Foundation; Sumitomo Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Yamanashi(University of Yamanashi); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This study was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid for Scientific Research (A) from JSPS (S. K.); Grants-in-Aid for a Scientific Base-Forming program (S. K.) and for an Encouragement of Young Investigators (K. S) from University of Yamanashi; and by grants from Takeda Science Foundation, Sumitomo Foundation and Uehara Memorial Foundation (S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; AFTANAS LI, 2002, NIPPON SEIRIGAKU ZAS, V64, P143; Araque A, 2008, NEURON GLIA BIOL, V4, P3, DOI 10.1017/S1740925X09000064; Bardia A, 2006, J CLIN ONCOL, V24, P5457, DOI 10.1200/JCO.2006.08.3725; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Benarroch EE, 2010, NEUROLOGY, V75, P273, DOI 10.1212/WNL.0b013e3181e8e984; Brunelli B, 2004, J NEUROL SCI, V218, P59, DOI 10.1016/j.jns.2003.10.013; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; de Leo JA, 2006, PAIN, V122, P17, DOI 10.1016/j.pain.2006.02.034; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Goncharov NV, 2006, J APPL TOXICOL, V26, P148, DOI 10.1002/jat.1118; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Inoue K, 2009, GLIA, V57, P1469, DOI 10.1002/glia.20871; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; MURAYAMA M, 1991, J ETHNOPHARMACOL, V35, P159, DOI 10.1016/0378-8741(91)90068-O; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Proudfoot Alex T, 2006, Toxicol Rev, V25, P213, DOI 10.2165/00139709-200625040-00002; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Suter MR, 2007, NEURON GLIA BIOL, V3, P255, DOI 10.1017/S1740925X08000100; Suzuki Y, 1999, JPN J PHARMACOL, V79, P169, DOI 10.1254/jjp.79.169; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Takasaki I, 2000, PAIN, V86, P95, DOI 10.1016/S0304-3959(00)00240-2; TAWATA M, 1994, DIABETES RES CLIN PR, V26, P121, DOI 10.1016/0168-8227(94)90149-X; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; VANDAM AM, 1995, NEUROSCIENCE, V65, P815, DOI 10.1016/0306-4522(94)00549-K; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Wegert S, 1997, PAIN, V71, P57, DOI 10.1016/S0304-3959(97)03337-X; Wei F, 2008, J NEUROSCI, V28, P10482, DOI 10.1523/JNEUROSCI.3593-08.2008; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yamamoto Tomoya, 2009, Gan To Kagaku Ryoho, V36, P89; Yang S, 2005, BRAIN RES, V1034, P172, DOI 10.1016/j.brainres.2004.11.018; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	54	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23510	10.1371/journal.pone.0023510	http://dx.doi.org/10.1371/journal.pone.0023510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876755	Green Published, Green Submitted, gold			2022-12-27	WOS:000294126900027
J	Martin, AR; Thomas, SC				Martin, Adam R.; Thomas, Sean C.			A Reassessment of Carbon Content in Tropical Trees	PLOS ONE			English	Article							CARBOHYDRATE STORAGE; WOOD DENSITY; FOREST; BIOMASS; EMISSIONS; PATTERNS; BALANCE; TRAITS; HEIGHT; STOCKS	Accurate knowledge of carbon (C) content in live wood is essential for quantifying tropical forest C stocks, yet generic assumptions (such as biomass consisting of 50% carbon on a weight/weight basis) remain widely used despite being supported by little chemical analysis. Empirical data from stem cores of 59 Panamanian rainforest tree species demonstrate that wood C content is highly variable among co-occurring species, with an average (47.4+/-2.51% S. D.) significantly lower than widely assumed values. Prior published values have neglected to account for volatile C content of tropical woods. By comparing freeze- and oven-dried wood samples, we show that volatile C is non-negligible, and excluding the volatile fraction underestimates wood C content by 2.48+/-1.28% (S. D.) on average. Wood C content varied substantially among species (from 41.9-51.6%), but was neither strongly phylogenetically conserved, nor correlated to ecological (i.e. wood density, maximum tree height) or demographic traits (i.e. relative growth rate, mortality rate). Overall, assuming generic C fractions in tropical wood overestimates forest C stocks by similar to 3.3-5.3%, a non-trivial margin of error leading to overestimates of 4.1-6.8 Mg C ha(-1) in a 50-ha forest dynamics plot on Barro Colorado Island, Panama. In addition to addressing other sources of error in tropical forest C accounting, such as uncertainties in allometric models and belowground biomass, compilation and use of species-specific C fractions for tropical tree species would substantially improve both local and global estimates of terrestrial C stocks and fluxes.	[Martin, Adam R.; Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada	University of Toronto	Martin, AR (corresponding author), Univ Toronto, Fac Forestry, Earth Sci Bldg, Toronto, ON, Canada.	adam.martin@utoronto.ca	THOMAS, Sean C./B-6089-2008	THOMAS, Sean C./0000-0002-0686-2483; Martin, Adam Robert/0000-0002-7207-4004	Hong Kong and Shanghai Banking Corporation Limited; Natural Sciences and Engineering Research Council of Canada; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; University of Toronto Centre for Global Change Science	Hong Kong and Shanghai Banking Corporation Limited; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of Toronto Centre for Global Change Science	Funding was provided by the Hong Kong and Shanghai Banking Corporation Limited Climate Partnership; Natural Sciences and Engineering Research Council of Canada; The Center for Tropical Forest Science; The Smithsonian Tropical Research Institute; and The University of Toronto Centre for Global Change Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Bates D. M., 2010, LME4 MIXED EFFECTS M; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bremer B, 2003, BOT J LINN SOC, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2001, J TROP ECOL, V17, P79, DOI 10.1017/S0266467401001055; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Coomes OT, 2008, ECOL ECON, V65, P207, DOI 10.1016/j.ecolecon.2007.12.028; Croat T.B., 1978, FLORA BARRO COLORADO; Elias M, 2003, CAN J FOREST RES, V33, P1039, DOI [10.1139/x03-018, 10.1139/X03-018]; Feldpausch TR, 2004, ECOL APPL, V14, pS164; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hubbell S.P., 2005, BARRO COLORADO FORES; Hughes RF, 2000, ECOL APPL, V10, P515, DOI 10.1890/1051-0761(2000)010[0515:ESIODA]2.0.CO;2; *IPCC, 2006, IPCC GOOD PRACT GUID, pCH4; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; King DA, 2006, J TROP ECOL, V22, P11, DOI 10.1017/S0266467405002774; Kirby KR, 2007, FOREST ECOL MANAG, V246, P208, DOI 10.1016/j.foreco.2007.03.072; Kraenzel M, 2003, FOREST ECOL MANAG, V173, P213, DOI 10.1016/S0378-1127(02)00002-6; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lamlom SH, 2006, TREE PHYSIOL, V26, P459, DOI 10.1093/treephys/26.4.459; Lamlom SH, 2003, BIOMASS BIOENERG, V25, P381, DOI 10.1016/S0961-9534(03)00033-3; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P492; Newell EA, 2002, OECOLOGIA, V131, P333, DOI 10.1007/s00442-002-0888-6; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P1853, DOI 10.1016/j.foreco.2008.07.022; Pastore TCM, 2004, BIORESOURCE TECHNOL, V93, P37, DOI 10.1016/j.biortech.2003.10.035; PETTERSEN RC, 1984, ADV CHEM SER, P57; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2007, ECOLOGY, V88, P1000, DOI 10.1890/06-0984; Pyle EH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000592; Rana R, 2010, WOOD SCI TECHNOL, V44, P225, DOI 10.1007/s00226-009-0281-2; Thomas SC, 2007, J ENVIRON MANAGE, V85, P659, DOI 10.1016/j.jenvman.2006.04.022; Thomas SC, 1999, ECOLOGY, V80, P1607; UNFCCC, 2007, 2 WORKSH RED EM DEF; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; ZANNE AE, 2009, DRYAD GLOBAL WOOD DE	53	170	182	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23533	10.1371/journal.pone.0023533	http://dx.doi.org/10.1371/journal.pone.0023533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858157	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300057
J	Sisti, HM; Geurts, M; Clerckx, R; Gooijers, J; Coxon, JP; Heitger, MH; Caeyenberghs, K; Beets, IAM; Serbruyns, L; Swinnen, SP				Sisti, Helene M.; Geurts, Monique; Clerckx, Rene; Gooijers, Jolien; Coxon, James P.; Heitger, Marcus H.; Caeyenberghs, Karen; Beets, Iseult A. M.; Serbruyns, Leen; Swinnen, Stephan P.			Testing Multiple Coordination Constraints with a Novel Bimanual Visuomotor Task	PLOS ONE			English	Article							INTERLIMB COORDINATION; PHASE-TRANSITIONS; PARKINSONS-DISEASE; AUGMENTED FEEDBACK; COUPLING STRENGTH; MOVEMENT; INTERFERENCE; PERFORMANCE; GENERATION; HANDEDNESS	The acquisition of a new bimanual skill depends on several motor coordination constraints. To date, coordination constraints have often been tested relatively independently of one another, particularly with respect to isofrequency and multifrequency rhythms. Here, we used a new paradigm to test the interaction of multiple coordination constraints. Coordination constraints that were tested included temporal complexity, directionality, muscle grouping, and hand dominance. Twenty-two healthy young adults performed a bimanual dial rotation task that required left and right hand coordination to track a moving target on a computer monitor. Two groups were compared, either with or without four days of practice with augmented visual feedback. Four directional patterns were tested such that both hands moved either rightward (clockwise), leftward (counterclockwise), inward or outward relative to each other. Seven frequency ratios (3:1, 2:1, 3:2, 1:1, 2:3. 1:2, 1:3) between the left and right hand were introduced. As expected, isofrequency patterns (1:1) were performed more successfully than multifrequency patterns (non 1:1). In addition, performance was more accurate when participants were required to move faster with the dominant right hand (1:3, 1:2 and 2:3) than with the non-dominant left hand (3:1, 2:1, 3:2). Interestingly, performance deteriorated as the relative angular velocity between the two hands increased, regardless of whether the required frequency ratio was an integer or non-integer. This contrasted with previous finger tapping research where the integer ratios generally led to less error than the non-integer ratios. We suggest that this is due to the different movement topologies that are required of each paradigm. Overall, we found that this visuomotor task was useful for testing the interaction of multiple coordination constraints as well as the release from these constraints with practice in the presence of augmented visual feedback.	[Sisti, Helene M.; Geurts, Monique; Clerckx, Rene; Gooijers, Jolien; Coxon, James P.; Heitger, Marcus H.; Caeyenberghs, Karen; Beets, Iseult A. M.; Serbruyns, Leen; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Dept Biomed Kinesiol, Motor Control Lab,Res Ctr Movement Control & Neur, Louvain, Belgium	KU Leuven	Sisti, HM (corresponding author), Katholieke Univ Leuven, Grp Biomed Sci, Dept Biomed Kinesiol, Motor Control Lab,Res Ctr Movement Control & Neur, Louvain, Belgium.	Helene.Sisti@faber.kuleuven.be	Gooijers, Jolien/AAH-9202-2020; Coxon, James/S-1286-2019	Coxon, James/0000-0003-2351-8489; Caeyenberghs, Karen/0000-0001-7009-6843; Gooijers, Jolien/0000-0002-7569-7223	Research Program of the Research Foundation - Flanders (FWO) [G.0593.08, G.0483.010]; Research Fund K.U. Leuven [OT/07/073]; Belgian federal government [P6/29]; Research Foundation - Flanders (FWO)	Research Program of the Research Foundation - Flanders (FWO)(FWO); Research Fund K.U. Leuven(KU Leuven); Belgian federal government; Research Foundation - Flanders (FWO)(FWO)	Support for this study was provided through grants from the Research Program of the Research Foundation - Flanders (FWO) (G.0593.08; G.0483.010), the Research Fund K.U. Leuven (OT/07/073) and Grant P6/29 from the Interuniversity Attraction Poles program of the Belgian federal government. KC and MH are postdoctoral fellows of the Research Foundation - Flanders (FWO). JG is funded by a PhD fellowship of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2009, CORTEX, V45, P377, DOI 10.1016/j.cortex.2007.11.012; BEEK PJ, 1995, BIOL CYBERN, V73, P499, DOI 10.1007/BF00199542; Bingham GP, 1999, PERCEPT PSYCHOPHYS, V61, P246, DOI 10.3758/BF03206886; BYBLOW WD, 1995, J MOTOR BEHAV, V27, P123, DOI 10.1080/00222895.1995.9941705; Carson RG, 2000, EXP BRAIN RES, V131, P196, DOI 10.1007/s002219900272; de Poel HJ, 2007, ACTA PSYCHOL, V124, P209, DOI 10.1016/j.actpsy.2006.03.003; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; DEUTSCH D, 1983, PERCEPT PSYCHOPHYS, V34, P331, DOI 10.3758/BF03203045; Dounskaia N, 2010, J NEUROPHYSIOL, V103, P2027, DOI 10.1152/jn.00778.2009; ESSENS PJ, 1985, PERCEPT PSYCHOPHYS, V37, P1, DOI 10.3758/BF03207132; Fontaine RJ, 1997, CAN J EXP PSYCHOL, V51, P1, DOI 10.1037/1196-1961.51.1.1; Franz EA, 2002, J MOTOR BEHAV, V34, P402, DOI 10.1080/00222890209601956; Franz EA, 2001, J MOTOR BEHAV, V33, P103, DOI 10.1080/00222890109601906; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hurley SR, 2006, HUM MOVEMENT SCI, V25, P339, DOI 10.1016/j.humov.2006.03.006; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; KLAPP ST, 1985, J EXP PSYCHOL HUMAN, V11, P814, DOI 10.1037/0096-1523.11.6.814; Kovacs AJ, 2010, J EXP PSYCHOL HUMAN, V36, P936, DOI 10.1037/a0019259; Kovacs AJ, 2010, EXP BRAIN RES, V202, P519, DOI 10.1007/s00221-009-2154-1; Kurtz S, 2003, NEUROSCI LETT, V338, P205, DOI 10.1016/S0304-3940(02)01394-0; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Levin O, 2004, BEHAV BRAIN RES, V152, P437, DOI 10.1016/j.bbr.2003.10.029; Li Y, 2009, ACTA PSYCHOL, V130, P183, DOI 10.1016/j.actpsy.2008.12.003; MAGILL RA, MOTOR LEARNING CONTR; Maslovat D, 2004, MOTOR CONTROL, V8, P213, DOI 10.1123/mcj.8.2.213; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Meesen RLJ, 2008, BEHAV BRAIN RES, V187, P361, DOI 10.1016/j.bbr.2007.09.030; Neilson PD, 2002, HUM MOVEMENT SCI, V21, P723, DOI 10.1016/S0167-9457(02)00181-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira FTP, 2008, CURR DIR PSYCHOL SCI, V17, P130, DOI 10.1111/j.1467-8721.2008.00562.x; Peper CE, 2008, NEUROSCI LETT, V437, P10, DOI 10.1016/j.neulet.2008.03.066; PEPER CE, 1995, BIOL CYBERN, V73, P301, DOI 10.1007/BF00199466; Peters M., 1994, INTERLIMB COORDINATI, P595, DOI [10.1016/B978-0-12-679270-6.50032-2, DOI 10.1016/B978-0-12-679270-6.50032-2]; PREILOWSKI BF, 1972, NEUROPSYCHOLOGIA, V10, P267, DOI 10.1016/0028-3932(72)90018-8; Proteau L., 1992, VISION MOTOR CONTROL; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Ronsse R, 2011, CEREB CORTEX, V21, P1283, DOI 10.1093/cercor/bhq209; ROSENBAUM DA, 1995, PSYCHOL REV, V102, P28, DOI 10.1037/0033-295X.102.1.28; Rosenbaum DA, 2001, MOTOR CONTROL, V5, P99, DOI 10.1123/mcj.5.2.99; SALMONI AW, 1983, HUM MOVEMENT SCI, V2, P77, DOI 10.1016/0167-9457(83)90008-8; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Serrien DJ, 2008, NEUROPSYCHOLOGIA, V46, P419, DOI 10.1016/j.neuropsychologia.2007.08.011; Serrien DJ, 2009, EXP BRAIN RES, V199, P195, DOI 10.1007/s00221-009-1998-8; Serrien DJ, 2009, EXP BRAIN RES, V197, P269, DOI 10.1007/s00221-009-1910-6; Serrien DJ, 1998, PSYCHOL RES-PSYCH FO, V61, P191, DOI 10.1007/s004260050024; Spencer RMC, 2005, J NEUROPHYSIOL, V94, P2901, DOI 10.1152/jn.00363.2005; Summers J, 2002, BRAIN COGNITION, V48, P166, DOI 10.1006/brcg.2001.1311; Summers J J, 1998, Motor Control, V2, P106; SUMMERS JJ, 1993, J EXP PSYCHOL HUMAN, V19, P416, DOI 10.1037/0096-1523.19.2.416; Swinnen SP, 1998, BEHAV BRAIN RES, V90, P79, DOI 10.1016/S0166-4328(97)00083-1; Swinnen SP, 1997, MOVEMENT DISORD, V12, P958, DOI 10.1002/mds.870120619; Swinnen SP, 1996, NEUROPSYCHOLOGIA, V34, P1203, DOI 10.1016/0028-3932(96)00047-4; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Swinnen SP, 2002, ACTA PSYCHOL, V110, P129, DOI 10.1016/S0001-6918(02)00030-6; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Temprado JJ, 2007, HUM MOVEMENT SCI, V26, P235, DOI 10.1016/j.humov.2007.01.012; Temprado JJ, 2003, HUM MOVEMENT SCI, V22, P339, DOI 10.1016/S0167-9457(03)00049-6; TREFFNER PJ, 1993, J EXP PSYCHOL HUMAN, V19, P1221, DOI 10.1037/0096-1523.19.6.1221; van der Wel RPRD, 2010, EXP BRAIN RES, V205, P351, DOI 10.1007/s00221-010-2368-2; Verschueren SMP, 1997, EXP BRAIN RES, V113, P497, DOI 10.1007/PL00005602; von Holst E, 1973, BEHAV PHYSL ANIMALS; Walter CB, 2002, J MOTOR BEHAV, V34, P183, DOI 10.1080/00222890209601940; Walter CB, 1997, PSYCHOL RES-PSYCH FO, V60, P202, DOI 10.1007/BF00419405; WALTER CB, 1990, BRAIN COGNITION, V14, P185, DOI 10.1016/0278-2626(90)90028-M; Wenderoth N, 2009, J NEUROPHYSIOL, V102, P302, DOI 10.1152/jn.91090.2008; Wiesendanger M, 2004, PROG BRAIN RES, V143, P491, DOI 10.1016/S0079-6123(03)43046-X; Wilson AD, 2005, EXP BRAIN RES, V165, P351, DOI 10.1007/s00221-005-2301-2; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	73	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23619	10.1371/journal.pone.0023619	http://dx.doi.org/10.1371/journal.pone.0023619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21858185	Green Published, gold			2022-12-27	WOS:000294121300070
J	Swei, A; Rowley, JJL; Rodder, D; Diesmos, MLL; Diesmos, AC; Briggs, CJ; Brown, R; Cao, TT; Cheng, TL; Chong, RA; Han, B; Hero, JM; Hoang, HD; Kusrini, MD; Duong, TTL; McGuire, JA; Meegaskumbura, M; Min, MS; Mulcahy, DG; Neang, T; Phimmachak, S; Rao, DQ; Reeder, NM; Schoville, SD; Sivongxay, N; Srei, N; Stock, M; Stuart, BL; Torres, LS; Dao, TAT; Tunstall, TS; Vieites, D; Vredenburg, VT				Swei, Andrea; Rowley, Jodi J. L.; Roedder, Dennis; Diesmos, Mae L. L.; Diesmos, Arvin C.; Briggs, Cheryl J.; Brown, Rafe; Trung Tien Cao; Cheng, Tina L.; Chong, Rebecca A.; Han, Ben; Hero, Jean-Marc; Huy Duc Hoang; Kusrini, Mirza D.; Duong Thi Thuy Le; McGuire, Jimmy A.; Meegaskumbura, Madhava; Min, Mi-Sook; Mulcahy, Daniel G.; Thy Neang; Phimmachak, Somphouthone; Rao, Ding-Qi; Reeder, Natalie M.; Schoville, Sean D.; Sivongxay, Niane; Srei, Narin; Stoeck, Matthias; Stuart, Bryan L.; Torres, Lilia S.; Dao Thi Anh Tran; Tunstall, Tate S.; Vieites, David; Vredenburg, Vance T.			Is Chytridiomycosis an Emerging Infectious Disease in Asia?	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; PREVALENCE; DECLINES; FROGS; HAPLOTYPES; INTENSITY; DYNAMICS; TIME	The disease chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis (Bd), has caused dramatic amphibian population declines and extinctions in Australia, Central and North America, and Europe. Bd is associated with >200 species extinctions of amphibians, but not all species that become infected are susceptible to the disease. Specifically, Bd has rapidly emerged in some areas of the world, such as in Australia, USA, and throughout Central and South America, causing population and species collapse. The mechanism behind the rapid global emergence of the disease is poorly understood, in part due to an incomplete picture of the global distribution of Bd. At present, there is a considerable amount of geographic bias in survey effort for Bd, with Asia being the most neglected continent. To date, Bd surveys have been published for few Asian countries, and infected amphibians have been reported only from Indonesia, South Korea, China and Japan. Thus far, there have been no substantiated reports of enigmatic or suspected disease-caused population declines of the kind that has been attributed to Bd in other areas. In order to gain a more detailed picture of the distribution of Bd in Asia, we undertook a widespread, opportunistic survey of over 3,000 amphibians for Bd throughout Asia and adjoining Papua New Guinea. Survey sites spanned 15 countries, approximately 36 degrees latitude, 111 degrees longitude, and over 2000 m in elevation. Bd prevalence was very low throughout our survey area (2.35% overall) and infected animals were not clumped as would be expected in epizootic events. This suggests that Bd is either newly emerging in Asia, endemic at low prevalence, or that some other ecological factor is preventing Bd from fully invading Asian amphibians. The current observed pattern in Asia differs from that in many other parts of the world.	[Swei, Andrea] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Rowley, Jodi J. L.] Australian Museum, Dept Herpetol, Sydney, NSW 2000, Australia; [Roedder, Dennis] Zool Forsch Museum Alexander Koenig, Bonn, N Rhine Westpha, Germany; [Diesmos, Mae L. L.] Univ Santo Tomas, Dept Biol Sci, Manila, Philippines; [Diesmos, Arvin C.] Natl Museum Philippines, Manila, Philippines; [Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Brown, Rafe] Univ Kansas, KU Biodivers Inst, Lawrence, KS 66045 USA; [Trung Tien Cao] Vinh Univ, Fac Biol, Vinh City, Nghe An, Vietnam; [Cheng, Tina L.; Reeder, Natalie M.; Torres, Lilia S.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Chong, Rebecca A.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Han, Ben] SW Forestry Univ, Fac Life Sci, Kunming, Yunnan, Peoples R China; [Hero, Jean-Marc] Griffith Univ Gold Coast Campus, Sch Environm, Gold Coast, Qld, Australia; [Huy Duc Hoang; Duong Thi Thuy Le; Dao Thi Anh Tran] Univ Sci Ho Chi Minh City, Fac Biol, Ho Chi Minh City, Vietnam; [Kusrini, Mirza D.] Bogor Agr Univ Darmaga Campus, Fac Forestry, Dept Forest Resources Conservat & Ecotourism, Bogor, W Java, Indonesia; [McGuire, Jimmy A.; Tunstall, Tate S.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Meegaskumbura, Madhava] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Min, Mi-Sook] Seoul Natl Univ, Res Inst Vet Sci Vet Med, Seoul, South Korea; [Mulcahy, Daniel G.] Smithsonian Inst, Suitland, MD USA; [Thy Neang] Minist Environm, Dept Natl Pk, Phnom Penh, Cambodia; [Phimmachak, Somphouthone; Sivongxay, Niane] Natl Univ Laos, Fac Sci, Dept Biol, Viangchan, Laos; [Rao, Ding-Qi] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China; [Schoville, Sean D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Srei, Narin] Royal Univ Phnom Penh, Dept Biol, Phnom Penh, Cambodia; [Srei, Narin] Royal Univ Phnom Penh, Ctr Biodivers Conservat, Phnom Penh, Cambodia; [Stoeck, Matthias] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Vaud, Switzerland; [Stuart, Bryan L.] N Carolina Museum Nat Sci, Raleigh, NC USA; [Vieites, David] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Cary Institute of Ecosystem Studies; Australian Museum; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Santo Tomas; National Museum of the Philippines; University of California System; University of California Santa Barbara; University of Kansas; Vinh University; California State University System; San Francisco State University; Colorado State University; Griffith University; Bogor Agricultural University; University of California System; University of California Berkeley; Harvard University; Seoul National University (SNU); Smithsonian Institution; Chinese Academy of Sciences; Kunming Institute of Zoology; University of California System; University of California Berkeley; University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Swei, A (corresponding author), Cary Inst Ecosyst Studies, Millbrook, NY USA.	swei@berkeley.edu	Schoville, Sean D./AAY-5324-2020; Kusrini, Mirza Dikari/GQB-2150-2022; Rödder, Dennis/AAT-8644-2021; Swei, Andrea/AAD-9649-2021; Schoville, Sean D./J-8061-2012; Diesmos, Arvin C./AGG-8542-2022; Diesmos, Mae Lowe/AGG-8517-2022; Stöck, Matthias/E-7245-2014; Meegaskumbura, Madhava/F-8782-2013; McGuire, Jimmy/N-7357-2019; Briggs, Cheryl/F-7456-2013; Rowley, Jodi J. L./F-2466-2012; Vieites, David/B-4481-2009	Schoville, Sean D./0000-0001-7364-434X; Rödder, Dennis/0000-0002-6108-1639; Schoville, Sean D./0000-0001-7364-434X; Stöck, Matthias/0000-0003-4888-8371; Meegaskumbura, Madhava/0000-0002-4599-6724; Vieites, David/0000-0001-5551-7419; Vredenburg, Vance/0000-0002-9682-1190; Mulcahy, Daniel G./0000-0001-6614-2405; Rowley, Jodi/0000-0002-2011-9143; Tien Trung, Cao/0000-0002-4256-8951	National Science Foundation-National Institutes of Health Ecology of Infectious Diseases [EF-0723563]; California Academy of Sciences; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	National Science Foundation-National Institutes of Health Ecology of Infectious Diseases(National Science Foundation (NSF)); California Academy of Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the joint National Science Foundation-National Institutes of Health Ecology of Infectious Diseases (EF-0723563, http://www.nsf.gov). Additional funding was secured by David A. Neeley through the California Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CM, 2010, ECOHEALTH, V7, P127, DOI 10.1007/s10393-010-0307-0; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bolker B, 2008, ECOLOGICAL MODELS DA; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Clough HE, 2003, PREV VET MED, V58, P145, DOI 10.1016/S0167-5877(03)00050-3; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher MC, 2009, MOL ECOL, V18, P4731, DOI 10.1111/j.1365-294X.2009.04385.x; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; IUCN, 2008, AN AMPH 2008 IUCN RE; Jimenez-Valverde A, 2011, BIOL INVASIONS; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kusrini MD, 2008, DIS AQUAT ORGAN, V82, P187, DOI 10.3354/dao01981; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; MURRAY KA, J APPL ECOL IN PRESS; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2006, J WILDLIFE DIS, V42, P301, DOI 10.7589/0090-3558-42.2.301; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rota CT, 2011, ECOGRAPHY; Rowley JJL, 2007, DIS AQUAT ORGAN, V78, P87, DOI 10.3354/dao01861; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Une Y, 2008, DIS AQUAT ORGAN, V82, P157, DOI 10.3354/dao02006; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wei Y, 2010, DIS AQUAT ORGAN, V92, P241, DOI 10.3354/dao02172; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Yang H, 2009, DIS AQUAT ORGAN, V86, P9, DOI 10.3354/dao02098	51	73	74	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23179	10.1371/journal.pone.0023179	http://dx.doi.org/10.1371/journal.pone.0023179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21887238	gold, Green Published			2022-12-27	WOS:000294125500018
J	Xayarath, B; Volz, KW; Smart, JI; Freitag, NE				Xayarath, Bobbi; Volz, Karl W.; Smart, Jennifer I.; Freitag, Nancy E.			Probing the Role of Protein Surface Charge in the Activation of PrfA, the Central Regulator of Listeria monocytogenes Pathogenesis	PLOS ONE			English	Article							VIRULENCE REGULATOR; TRANSCRIPTIONAL ACTIVATOR; INTRACELLULAR GROWTH; BINDING-AFFINITY; RECEPTOR PROTEIN; HOST-CELLS; IN-VITRO; MUTATION; ACTA; EXPRESSION	Listeria monocytogenes is a food-borne intracellular bacterial pathogen capable of causing serious human disease. L. monocytogenes survival within mammalian cells depends upon the synthesis of a number of secreted virulence factors whose expression is regulated by the transcriptional activator PrfA. PrfA becomes activated following bacterial entry into host cells where it induces the expression of gene products required for bacterial spread to adjacent cells. Activation of PrfA appears to occur via the binding of a small molecule cofactor whose identity remains unknown. Electrostatic modeling of the predicted PrfA cofactor binding pocket revealed a highly positively charged region with two lysine residues, K64 and K122, located at the edge of the pocket and another (K130) located deep within the interior. Mutational analysis of these residues indicated that K64 and K122 contribute to intracellular activation of PrfA, whereas a K130 substitution abolished protein activity. The requirement of K64 and K122 for intracellular PrfA activation could be bypassed via the introduction of the prfA G145S mutation that constitutively activates PrfA in the absence of cofactor binding. Our data indicate that the positive charge of the PrfA binding pocket contributes to intracellular activation of PrfA, presumably by facilitating binding of an anionic cofactor.	[Xayarath, Bobbi; Volz, Karl W.; Smart, Jennifer I.; Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xayarath, B (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.	nfreitag@uic.edu			Public Health Service, National Institute of Allergy and Infectious Diseases (NIAID) [AI41816]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041816, R01AI041816, R56AI041816] Funding Source: NIH RePORTER	Public Health Service, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI41816 (NEF) from the National Institute of Allergy and Infectious Diseases (NIAID). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Alonzo 3rd F, 2009, INFECT IMMUN; Alonzo F, 2009, INFECT IMMUN, V77, P2612, DOI 10.1128/IAI.00280-09; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bitar AP, 2008, J BACTERIOL, V190, P107, DOI 10.1128/JB.00852-07; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Bruno JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015138; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; CAMILLI A, 1989, P NATL ACAD SCI USA, V86, P5522, DOI 10.1073/pnas.86.14.5522; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Czuprynski Charles J., 2005, Animal Health Research Reviews, V6, P211, DOI 10.1079/AHR2005111; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freitag NE, 2006, FUTURE MICROBIOL, V1, P89, DOI 10.2217/17460913.1.1.89; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; FREITAG NE, 1994, MOL MICROBIOL, V12, P845, DOI 10.1111/j.1365-2958.1994.tb01070.x; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; HARMAN JG, 1986, J BIOL CHEM, V261, P6332; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; LAMPIDIS R, 1994, MOL MICROBIOL, V13, P141, DOI 10.1111/j.1365-2958.1994.tb00409.x; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; MARQUIS H, 1995, INFECT IMMUN, V63, P4531, DOI 10.1128/IAI.63.11.4531-4534.1995; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Miner MD, 2008, MICROB PATHOGENESIS, V45, P273, DOI 10.1016/j.micpath.2008.06.006; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Mueller KJ, 2005, INFECT IMMUN, V73, P1917, DOI 10.1128/IAI.73.4.1917-1926.2005; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Shetron-Rama LM, 2003, MOL MICROBIOL, V48, P1537, DOI 10.1046/j.1365-2958.2003.03534.x; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Swaminathan B, 2006, FOODBORNE PATHOG DIS, V3, P316, DOI 10.1089/fpd.2006.3.316; TAN GS, 1991, BIOCHEMISTRY-US, V30, P5076, DOI 10.1021/bi00234a034; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vega Y, 2004, MOL MICROBIOL, V52, P1553, DOI 10.1111/j.1365-2958.2004.04052.x; Vega Y, 1998, J BACTERIOL, V180, P6655, DOI 10.1128/JB.180.24.6655-6660.1998; Velge P, 2007, MICROBIOL-SGM, V153, P995, DOI 10.1099/mic.0.2006/002238-0; Vugia D., 2004, Morbidity and Mortality Weekly Report, V53, P340; Wong KKY, 2004, J BACTERIOL, V186, P6265, DOI 10.1128/JB.186.18.6265-6276.2004; Wong KKY, 2004, CELL MICROBIOL, V6, P155, DOI 10.1046/j.1462-5822.2003.00348.x; YOUNGMAN P, 1987, PLASMIDS PRACTICAL A, P79	57	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23502	10.1371/journal.pone.0023502	http://dx.doi.org/10.1371/journal.pone.0023502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858145	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500050
J	Maina, J; McClanahan, TR; Venus, V; Ateweberhan, M; Madin, J				Maina, Joseph; McClanahan, Tim R.; Venus, Valentijn; Ateweberhan, Mebrahtu; Madin, Joshua			Global Gradients of Coral Exposure to Environmental Stresses and Implications for Local Management	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; MODELING SUSCEPTIBILITY; CHAGOS ARCHIPELAGO; REEF DEVELOPMENT; SOLAR-RADIATION; WATER-QUALITY; OCEAN; RESILIENCE; MORTALITY	Background: The decline of coral reefs globally underscores the need for a spatial assessment of their exposure to multiple environmental stressors to estimate vulnerability and evaluate potential counter-measures. Methodology/Principal Findings: This study combined global spatial gradients of coral exposure to radiation stress factors (temperature, UV light and doldrums), stress-reinforcing factors (sedimentation and eutrophication), and stress-reducing factors (temperature variability and tidal amplitude) to produce a global map of coral exposure and identify areas where exposure depends on factors that can be locally managed. A systems analytical approach was used to define interactions between radiation stress variables, stress reinforcing variables and stress reducing variables. Fuzzy logic and spatial ordinations were employed to quantify coral exposure to these stressors. Globally, corals are exposed to radiation and reinforcing stress, albeit with high spatial variability within regions. Based on ordination of exposure grades, regions group into two clusters. The first cluster was composed of severely exposed regions with high radiation and low reducing stress scores (South East Asia, Micronesia, Eastern Pacific and the central Indian Ocean) or alternatively high reinforcing stress scores (the Middle East and the Western Australia). The second cluster was composed of moderately to highly exposed regions with moderate to high scores in both radiation and reducing factors (Caribbean, Great Barrier Reef (GBR), Central Pacific, Polynesia and the western Indian Ocean) where the GBR was strongly associated with reinforcing stress. Conclusions/Significance: Despite radiation stress being the most dominant stressor, the exposure of coral reefs could be reduced by locally managing chronic human impacts that act to reinforce radiation stress. Future research and management efforts should focus on incorporating the factors that mitigate the effect of coral stressors until long-term carbon reductions are achieved through global negotiations.	[Maina, Joseph; Madin, Joshua] Macquarie Univ, Dept Biol Sci, Computat Ecol Grp, Sydney, NSW 2109, Australia; [Maina, Joseph; McClanahan, Tim R.; Ateweberhan, Mebrahtu] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [Venus, Valentijn] Univ Twente, Fac Geoinformat Sci & Earth Observat, NL-7500 AE Enschede, Netherlands; [Ateweberhan, Mebrahtu] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Macquarie University; Wildlife Conservation Society; University of Twente; University of Warwick	Maina, J (corresponding author), Macquarie Univ, Dept Biol Sci, Computat Ecol Grp, Sydney, NSW 2109, Australia.	joseph.mbui@mq.edu.au	McClanahan, Tim/K-4998-2019; Venus, Valentijn/N-7766-2015	Venus, Valentijn/0000-0002-8313-9627; Maina, Joseph/0000-0003-1268-6137; Madin, Joshua/0000-0002-5005-6227; McClanahan, Timothy/0000-0001-5821-3584	Macquarie University; Australian Research Council; Wildlife Conservation Society; John D and Catherine T MacArthur Foundation	Macquarie University; Australian Research Council(Australian Research Council); Wildlife Conservation Society; John D and Catherine T MacArthur Foundation	This work was supported by Macquarie University's Higher Degree Research program, the Australian Research Council, and the Wildlife Conservation Society marine programs through financial support from the John D and Catherine T MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; ALBIETZ JM, 2006, WATERSHED PROT UNPUB; An P., 1991, CANADIAN J EXPLORATI, V27, P1; [Anonymous], 1987, HUMAN EXPOSURE ULTRA; Anthony KRN, 2007, MAR BIOL, V151, P1623, DOI 10.1007/s00227-006-0573-0; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Boss E, 2003, LIMNOL OCEANOGR, V48, P346, DOI 10.4319/lo.2003.48.1_part_2.0346; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; BURROUGH P. A., 2005, PRINCIPLES GEOGRAPHI; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carreiro-Silva M, 2009, MAR ECOL PROG SER, V392, P1, DOI 10.3354/meps08251; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Crabbe MJC, 2008, COMPUT BIOL CHEM, V32, P311, DOI 10.1016/j.compbiolchem.2008.04.001; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dunne RP, 2008, ECOL MODEL, V218, P188, DOI 10.1016/j.ecolmodel.2008.04.004; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Dunne RP, 1996, MAR ECOL PROG SER, V144, P109, DOI 10.3354/meps144109; Dunne RP, 2001, CORAL REEFS, V20, P201; Eastman J.R., 2003, IDRISI KILIMANJARO G; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fleitmann D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028525; Furnas M., 2003, CATCHMENTS CORALS TE; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Gibson J, 1998, OCEAN COAST MANAGE, V39, P229, DOI 10.1016/S0964-5691(98)00007-6; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Herman JR, 1999, J GEOPHYS RES-ATMOS, V104, P12059, DOI 10.1029/1999JD900062; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013913; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; ISUKAPALLI SS, 2001, COMPUTATIONAL METHOD; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Le Provost C, 1998, J GEOPHYS RES-OCEANS, V103, P5513, DOI 10.1029/97JC01733; Legendre P., 2012, NUMERICAL ECOLOGY; Li AN, 2006, ECOL MODEL, V192, P175, DOI 10.1016/j.ecolmodel.2005.07.005; Liu X, 2003, ATMOS CHEM PHYS, V3, P1113, DOI 10.5194/acp-3-1113-2003; LOYA Y, 1976, B MAR SCI, V26, P450; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2009, MAR ECOL PROG SER, V380, P117, DOI 10.3354/meps07879; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; McClanahan TR, 2003, MAR ECOL PROG SER, V261, P135, DOI 10.3354/meps261135; McClanahan TR, 2002, ENVIRON CONSERV, V29, P460, DOI 10.1017/S0376892902000334; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V209, P103, DOI 10.1016/S0022-0981(96)02663-9; McKergow LA, 2005, MAR POLLUT BULL, V51, P200, DOI 10.1016/j.marpolbul.2004.11.029; Meesters EH, 1998, CONSERV BIOL, V12, P957, DOI 10.1046/j.1523-1739.1998.96421.x; MORA M, 2008, P ROYAL SOC B, V275, P767; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Morel A, 2006, REMOTE SENS ENVIRON, V102, P237, DOI 10.1016/j.rse.2006.01.022; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Palumbi SR, 2005, NATURE, V434, P713, DOI 10.1038/434713a; Parinet B, 2004, ECOL MODEL, V178, P295, DOI 10.1016/j.ecolmodel.2004.03.007; Qian SS, 2003, ECOL MODEL, V166, P87, DOI 10.1016/S0304-3800(03)00097-8; RAKOTOARISON HF, 2003, MEMOIRE FIN ETUDES U; Schroeder T, 2007, INT J REMOTE SENS, V28, P1469, DOI 10.1080/01431160600962574; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 1999, AMBIO, V28, P472; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Silvert W, 1997, ECOL MODEL, V96, P1, DOI 10.1016/S0304-3800(96)00051-8; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Vasilkov A, 2001, J GEOPHYS RES-OCEANS, V106, P27205, DOI 10.1029/2000JC000373; Vasilkov AP, 2005, APPL OPTICS, V44, P2863, DOI 10.1364/AO.44.002863; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wang HQ, 2010, INT J REMOTE SENS, V31, P439, DOI 10.1080/01431160902893485; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90046-8; Zhang HM, 2009, B AM METEOROL SOC, V90, P31, DOI 10.1175/2008BAMS2577.1; Zhang HM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027086; Zhao DZ, 2010, INT J REMOTE SENS, V31, P39, DOI 10.1080/01431160902882512	97	99	100	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23064	10.1371/journal.pone.0023064	http://dx.doi.org/10.1371/journal.pone.0023064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860667	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200039
J	Jiang, N; Wang, MH; Jia, TY; Wang, L; Leach, L; Hackett, C; Marshall, D; Luo, ZW				Jiang, Ning; Wang, Minghui; Jia, Tianye; Wang, Lin; Leach, Lindsey; Hackett, Christine; Marshall, David; Luo, Zewei			A Robust Statistical Method for Association-Based eQTL Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; COMPLEX TRAITS; COMMON DISEASE; HAPLOTYPE MAP; MODEL; STRATIFICATION; VARIANTS	Background: It has been well established that theoretical kernel for recently surging genome-wide association study (GWAS) is statistical inference of linkage disequilibrium (LD) between a tested genetic marker and a putative locus affecting a disease trait. However, LD analysis is vulnerable to several confounding factors of which population stratification is the most prominent. Whilst many methods have been proposed to correct for the influence either through predicting the structure parameters or correcting inflation in the test statistic due to the stratification, these may not be feasible or may impose further statistical problems in practical implementation. Methodology: We propose here a novel statistical method to control spurious LD in GWAS from population structure by incorporating a control marker into testing for significance of genetic association of a polymorphic marker with phenotypic variation of a complex trait. The method avoids the need of structure prediction which may be infeasible or inadequate in practice and accounts properly for a varying effect of population stratification on different regions of the genome under study. Utility and statistical properties of the new method were tested through an intensive computer simulation study and an association-based genome-wide mapping of expression quantitative trait loci in genetically divergent human populations. Results/Conclusions: The analyses show that the new method confers an improved statistical power for detecting genuine genetic association in subpopulations and an effective control of spurious associations stemmed from population structure when compared with other two popularly implemented methods in the literature of GWAS.	[Jiang, Ning; Wang, Minghui; Jia, Tianye; Leach, Lindsey; Luo, Zewei] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wang, Lin; Luo, Zewei] Fudan Univ, Lab Populat & Quantitat Genet, Inst Biostat, Shanghai 200433, Peoples R China; [Jiang, Ning; Hackett, Christine] Invergowrie, BioSS, Dundee, Scotland; [Marshall, David] Invergowrie, Scottish Crop Res Inst, Dundee, Scotland	University of Birmingham; Fudan University; James Hutton Institute; University of Dundee; James Hutton Institute	Jiang, N (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	z.luo@bham.ac.uk	Jia, Tianye/AAC-3925-2019; Wang, Minghui/P-8300-2017; Marshall, David F/F-2471-2011; Hackett, Christine/F-1196-2011	Jia, Tianye/0000-0001-5399-2953; Wang, Minghui/0000-0001-9171-4962; Marshall, David F/0000-0001-9309-2570; Compton, Lindsey/0000-0002-8441-2381	Biotechnology and Biological Sciences Research Council [RRAD11534]; Leverhulme Trust [RCEJ14713]; University of Birmingham and Biomathematics and Statistics Scotland (BioSS)	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); University of Birmingham and Biomathematics and Statistics Scotland (BioSS)	The research was funded by the Biotechnology and Biological Sciences Research Council (RRAD11534) and the Leverhulme Trust (RCEJ14713). NJ was also supported by a joint studentship between the University of Birmingham and Biomathematics and Statistics Scotland (BioSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P3071, DOI 10.1073/pnas.85.9.3071; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Ching OY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003362; Cochran W.G., 1967, STAT METHODS; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Johnson N.L., 1970, DISTRIBUTIONS STAT C; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Luo ZW, 1998, HEREDITY, V80, P198, DOI 10.1046/j.1365-2540.1998.00275.x; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peng Jie, 2007, BMC Proc, V1 Suppl 1, pS157; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wang MH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-328; Wang YT, 2005, HUM HERED, V59, P165, DOI 10.1159/000085940; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	56	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23192	10.1371/journal.pone.0023192	http://dx.doi.org/10.1371/journal.pone.0023192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858027	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300025
J	Kang, HT; Lee, KB; Kim, SY; Choi, HR; Park, SC				Kang, Hyun Tae; Lee, Ki Baek; Kim, Sung Young; Choi, Hae Ri; Park, Sang Chul			Autophagy Impairment Induces Premature Senescence in Primary Human Fibroblasts	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CELL BIOLOGY; INHIBITION; RESISTANCE; GENES; PATHOGENESIS; SUPPRESSION; DISRUPTION	Background: Recent studies have demonstrated that activation of autophagy increases the lifespan of organisms from yeast to flies. In contrast to the lifespan extension effect in lower organisms, it has been reported that overexpression of unc-51-like kinase 3 (ULK3), the mammalian homolog of autophagy-specific gene 1 (ATG1), induces premature senescence in human fibroblasts. Therefore, we assessed whether the activation of autophagy would genuinely induce premature senescence in human cells. Methodology/Principal Findings: Depletion of ATG7, ATG12, or lysosomal-associated membrane protein 2 (Lamp2) by transfecting siRNA or infecting cells with a virus containing gene-specific shRNA resulted in a senescence-like state in two strains of primary human fibroblasts. Prematurely senescent cells induced by autophagy impairment exhibited the senescent phenotypes, similar to the replicatively senescent cells, such as increased senescence associated beta-galactosidase (SA-beta-gal) activity, reactive oxygen species (ROS) generation, and accumulation of lipofuscin. In addition, expression levels of ribosomal protein S6 kinase1 (S6K1), p-S6K1, p-S6, and eukaryotic translation initiation factor 4E (eIF4E) binding protein 1 (4E-BP1) in the mammalian target of rapamycin (mTOR) pathway and beclin-1, ATG7, ATG12-ATG5 conjugate, and the sequestosome 1 (SQSTM1/p62) monomer in the autophagy pathway were decreased in both the replicatively and the autophagy impairment-induced prematurely senescent cells. Furthermore, it was found that ROS scavenging by N-acetylcysteine (NAC) and inhibition of p53 activation by pifithrin-alpha or knockdown of p53 using siRNA, respectively, delayed autophagy impairment-induced premature senescence and restored the expression levels of components in the mTOR and autophagy pathways. Conclusion: Taken together, we concluded that autophagy impairment induces premature senescence through a ROS- and p53-dependent manner in primary human fibroblasts.	[Kang, Hyun Tae; Park, Sang Chul] Seoul Natl Univ, Coll Med, Inst Aging, Seoul, South Korea; [Lee, Ki Baek; Kim, Sung Young; Choi, Hae Ri; Park, Sang Chul] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Park, Sang Chul] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Gachon University	Kang, HT (corresponding author), Seoul Natl Univ, Coll Med, Inst Aging, Seoul, South Korea.	scpark@snu.ac.kr	Kim, Sung Young/GMW-7968-2022	Kim, Sung Young/0000-0003-4702-8265; Lee, Ki Baek/0000-0002-0208-272X	Korean government (MEST) [2010-0029150]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation (NRF) grant funded by the Korean government (MEST) (No. 2010-0029150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; CUERVO AM, 2003, SCI AGING KNOWLEDGE, pPE25; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; DOLBEARE FA, 1977, CLIN CHEM, V23, P1485; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hashimoto Y, 2009, GENES CELLS, V14, P717, DOI 10.1111/j.1365-2443.2009.01306.x; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ren CL, 2009, EXP GERONTOL, V44, P228, DOI 10.1016/j.exger.2008.10.002; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Straniero S, 2009, REJUV RES, V12, P77, DOI 10.1089/rej.2008.0806; Stroikin Y, 2007, BIOGERONTOLOGY, V8, P43, DOI 10.1007/s10522-006-9029-7; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Terman A, 1999, EXP GERONTOL, V34, P943, DOI 10.1016/S0531-5565(99)00070-4; Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015; VANNOORDEN CJF, 1987, HISTOCHEM J, V19, P483, DOI 10.1007/BF01675418; Wang A.L., 2009, PLOS ONE, V4; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang H, 2000, EXP CELL RES, V259, P284, DOI 10.1006/excr.2000.4965; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838	57	166	172	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23367	10.1371/journal.pone.0023367	http://dx.doi.org/10.1371/journal.pone.0023367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858089	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300025
J	Takahashi, H; Ohuchi, A; Miya, S; Izawa, Y; Kimura, B				Takahashi, Hajime; Ohuchi, Ayumi; Miya, Satoko; Izawa, Yukino; Kimura, Bon			Effect of Food Residues on Norovirus Survival on Stainless Steel Surfaces	PLOS ONE			English	Article							FELINE CALICIVIRUS; MURINE NOROVIRUS; INACTIVATION; SURROGATE; GASTROENTERITIS; DISINFECTANTS; OUTBREAK; VIRUS; CONSUMPTION; INFECTION	Background: In households and food processing plants, minute food residues left behind from improper cleaning may influence the survivability of human norovirus on surfaces. In this study, the survivability of norovirus on desiccated food residue-attached stainless steel coupons was investigated. Methodology/Principal Findings: Using murine norovirus-1 (MNV-1) as a surrogate of human norovirus, the survivability of norovirus was investigated on lettuce, cabbage, or ground pork-attached stainless steel coupons. A 6.2 log MPN/ml of MNV-1 infectivity was completely lost at day 30 in residue-free coupons, whereas only a 1.4 log MPN/ml reduction was observed in coupons with residues. Moreover, the disinfective effect of sodium hypochlorite was reduced when residues were present on the coupons. Conclusions/Significance: This study revealed that the food residues increased the survivability and the resistance to chemicals of norovirus, indicating the need of thorough cleaning in food processing plants and household settings.	[Takahashi, Hajime; Ohuchi, Ayumi; Miya, Satoko; Izawa, Yukino; Kimura, Bon] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Fac Marine Sci, Tokyo, Japan	Tokyo University of Marine Science & Technology	Takahashi, H (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Fac Marine Sci, Tokyo, Japan.	kimubo@kaiyodai.ac.jp	Kimbo, Bon/O-1879-2014	Kimbo, Bon/0000-0002-3071-1343	Tokyo University of Marine Science and Technology	Tokyo University of Marine Science and Technology	This study was supported by Tokyo University of Marine Science and Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Belliot G, 2008, APPL ENVIRON MICROB, V74, P3315, DOI 10.1128/AEM.02148-07; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Centers for Disease Control and Prevention, 2010, NOR TECHN FACT SHEET; Doultree JC, 1999, J HOSP INFECT, V41, P51, DOI 10.1016/S0195-6701(99)90037-3; Duizer E, 2004, APPL ENVIRON MICROB, V70, P4538, DOI 10.1128/AEM.70.8.4538-4543.2004; ENTIS P, 2002, FOOD MICROBIOLOGY LA, P18; Friedman DS, 2005, EPIDEMIOL INFECT, V133, P1057, DOI 10.1017/S0950268805004760; GARTHRIGHT WE, 1995, FDA BACTERIOLOGICAL; Girard M, 2010, J FOOD PROTECT, V73, P400, DOI 10.4315/0362-028X-73.2.400; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; Gulati BR, 2001, J FOOD PROTECT, V64, P1430, DOI 10.4315/0362-028X-64.9.1430; HOOVER EA, 1975, J AM VET MED ASSOC, V166, P463; Jimenez L, 2006, AM J INFECT CONTROL, V34, P269, DOI 10.1016/j.ajic.2005.11.009; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Katayama H, 2008, WATER RES, V42, P1441, DOI 10.1016/j.watres.2007.10.029; KURITSKY JN, 1984, ANN INTERN MED, V100, P519, DOI 10.7326/0003-4819-100-4-519; Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118; Mattison K, 2007, J FOOD PROTECT, V70, P500, DOI 10.4315/0362-028X-70.2.500; *MIN HLTH LAB WELF, 2009, FOOD POIS SURV REP; Moe C., 1999, 1 INT WORKSH HUM CAL; Parashar UD, 1998, EPIDEMIOL INFECT, V121, P615, DOI 10.1017/S0950268898001150; Park GW, 2007, APPL ENVIRON MICROB, V73, P4463, DOI 10.1128/AEM.02839-06; Patterson W, 1997, Commun Dis Rep CDR Rev, V7, pR101; Stals A, 2009, J VIROL METHODS, V161, P247, DOI 10.1016/j.jviromet.2009.06.019; Urakami H, 2007, APPL ENVIRON MICROB, V73, P5679, DOI 10.1128/AEM.00083-07; Whitehead K, 2010, AM J INFECT CONTROL, V38, P26, DOI 10.1016/j.ajic.2009.03.015; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; [No title captured]	31	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e21951	10.1371/journal.pone.0021951	http://dx.doi.org/10.1371/journal.pone.0021951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887215	Green Published, gold, Green Submitted			2022-12-27	WOS:000294251800003
J	Bohnsack, BL; Gallina, D; Kahana, A				Bohnsack, Brenda L.; Gallina, Donika; Kahana, Alon			Phenothiourea Sensitizes Zebrafish Cranial Neural Crest and Extraocular Muscle Development to Changes in Retinoic Acid and IGF Signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EMBRYONIC-DEVELOPMENT; THYROID-HORMONE; GENE-EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; TOXICITY; PHENYLTHIOUREA; MORPHOGENESIS; PIGMENTATION; MUTATIONS	1-phenyl 2-thiourea (PTU) is a tyrosinase inhibitor commonly used to block pigmentation and aid visualization of zebrafish development. At the standard concentration of 0.003% (200 mu M), PTU inhibits melanogenesis and reportedly has minimal other effects on zebrafish embryogenesis. We found that 0.003% PTU altered retinoic acid and insulin-like growth factor (IGF) regulation of neural crest and mesodermal components of craniofacial development. Reduction of retinoic acid synthesis by the pan-aldehyde dehydrogenase inhibitor diethylbenzaldehyde, only when combined with 0.003% PTU, resulted in extraocular muscle disorganization. PTU also decreased retinoic acid-induced teratogenic effects on pharyngeal arch and jaw cartilage despite morphologically normal appearing PTU-treated controls. Furthermore, 0.003% PTU in combination with inhibition of IGF signaling through either morpholino knockdown or pharmacologic inhibition of tyrosine kinase receptor phosphorylation, disrupted jaw development and extraocular muscle organization. PTU in and of itself inhibited neural crest development at higher concentrations (0.03%) and had the greatest inhibitory effect when added prior to 22 hours post fertilization (hpf). Addition of 0.003% PTU between 4 and 20 hpf decreased thyroxine (T4) in thyroid follicles in the nasopharynx of 96 hpf embryos. Treatment with exogenous triiodothyronine (T3) and T4 improved, but did not completely rescue, PTU-induced neural crest defects. Thus, PTU should be used with caution when studying zebrafish embryogenesis as it alters the threshold of different signaling pathways important during craniofacial development. The effects of PTU on neural crest development are partially caused by thyroid hormone signaling.	[Bohnsack, Brenda L.; Gallina, Donika; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bohnsack, BL (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	akahana@med.umich.edu		Bohnsack, Brenda/0000-0001-8961-6343; Kahana, Alon/0000-0002-5667-2274	National Eye Institute of the National Institutes of Health [T32 EY013934, K08 EY018689]; Fight for Sight Post-Doctoral Award; Knights Templar Eye Foundation; Research to Prevent Blindness; Vision Research Core Award [P30 EY007003]; NIHNCRR [P40 RR012546]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY013934, K08EY018689, P30EY007003] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Fight for Sight Post-Doctoral Award; Knights Templar Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Vision Research Core Award; NIHNCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by postdoctoral training grant T32 EY013934 from the National Eye Institute of the National Institutes of Health (BLB), Fight for Sight Post-Doctoral Award (BLB), Knights Templar Eye Foundation (BLB), a Research to Prevent Blindness Career Development Award (AK), grant K08 EY018689 (AK) from the National Eye Institute of the National Institutes of Health, and a Vision Research Core Award P30 EY007003 to the Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan. AK acknowledges the generous support of The Alliance for Vision Research, Southfield, Michigan. The Zebrafish International Resource Center is supported by grant P40 RR012546 from the NIHNCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt B, 2006, DEV DYNAM, V235, P1872, DOI 10.1002/dvdy.20831; BOHNSACK BL, 2011, ARCH OPHTHA IN PRESS; BOHNSACK BL, 2011, ZEBRAFISH MODE UNPUB; Bohula EA, 2003, ANTI-CANCER DRUG, V14, P669, DOI 10.1097/01.cad.0000092782.37568.04; Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Craig MP, 2006, LAB ANIMAL, V35, P41, DOI 10.1038/laban1006-41; Deltour L, 1996, FASEB J, V10, P1050, DOI 10.1096/fasebj.10.9.8801166; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Dutton K, 2001, GENESIS, V30, P188, DOI 10.1002/gene.1062; Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3; Gitton Y, 2010, SEMIN CELL DEV BIOL, V21, P301, DOI 10.1016/j.semcdb.2010.01.008; Hellawell GO, 2002, CANCER RES, V62, P2942; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Hove Jay R, 2004, Birth Defects Res C Embryo Today, V72, P277, DOI 10.1002/bdrc.20019; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KISH PE, 2011, GENESIS; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kumar S, 2010, DEV BIOL, V340, P67, DOI 10.1016/j.ydbio.2010.01.027; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Langenberg T, 2008, DEV DYNAM, V237, P1645, DOI 10.1002/dvdy.21577; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MILLOT N, 1966, NATURE, V209, P99, DOI 10.1038/209099b0; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; ROSA FW, 1986, TERATOLOGY, V33, P355, DOI 10.1002/tera.1420330315; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SCHEVEN G, 2006, DEVELOPMENT, V133, P2731; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Smith TJ, 2008, THYROID, V18, P983, DOI 10.1089/thy.2007.0404; Teraoka H, 2002, TOXICOL SCI, V65, P192, DOI 10.1093/toxsci/65.2.192; Teraoka H, 2006, AQUAT TOXICOL, V78, P103, DOI 10.1016/j.aquatox.2006.02.009; Thisse B., 2001, EXPRESSION ZEBRAFISH; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Wang WD, 2004, BIOCHEM PHARMACOL, V68, P63, DOI 10.1016/j.bcp.2004.03.010; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; WHITTAKE.JR, 1966, DEV BIOL, V14, P1, DOI 10.1016/0012-1606(66)90003-0; Zacharias AL, 2011, DEV BIOL, V349, P395, DOI 10.1016/j.ydbio.2010.10.028	43	44	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e22991	10.1371/journal.pone.0022991	http://dx.doi.org/10.1371/journal.pone.0022991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886774	Green Published, gold			2022-12-27	WOS:000294128100004
J	Wei, WH; Hemani, G; Hicks, AA; Vitart, V; Cabrera-Cardenas, C; Navarro, P; Huffman, J; Hayward, C; Knott, SA; Rudan, I; Pramstaller, PP; Wild, SH; Wilson, JF; Campbell, H; Dunlop, MG; Hastie, N; Wright, AF; Haley, CS				Wei, Wenhua; Hemani, Gibran; Hicks, Andrew A.; Vitart, Veronique; Cabrera-Cardenas, Claudia; Navarro, Pau; Huffman, Jennifer; Hayward, Caroline; Knott, Sara A.; Rudan, Igor; Pramstaller, Peter P.; Wild, Sarah H.; Wilson, James F.; Campbell, Harry; Dunlop, Malcolm G.; Hastie, Nicholas; Wright, Alan F.; Haley, Chris S.			Characterisation of Genome-Wide Association Epistasis Signals for Serum Uric Acid in Human Population Isolates	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRANSPORTER GENE SLC2A9; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; COMMON VARIANTS; GOUT; ISLAND; SUSCEPTIBILITY; EPIDEMIOLOGY; HERITABILITY	Genome-wide association (GWA) studies have identified a number of loci underlying variation in human serum uric acid (SUA) levels with the SLC2A9 gene having the largest effect identified so far. Gene-gene interactions (epistasis) are largely unexplored in these GWA studies. We performed a full pair-wise genome scan in the Italian MICROS population (n = 1201) to characterise epistasis signals in SUA levels. In the resultant epistasis profile, no SNP pairs reached the Bonferroni adjusted threshold for the pair-wise genome-wide significance. However, SLC2A9 was found interacting with multiple loci across the genome, with NFIA - SLC2A9 and SLC2A9 - ESRRAP2 being significant based on a threshold derived for interactions between GWA significant SNPs and the genome and jointly explaining 8.0% of the phenotypic variance in SUA levels (3.4% by interaction components). Epistasis signal replication in a CROATIAN population (n = 1772) was limited at the SNP level but improved dramatically at the gene ontology level. In addition, gene ontology terms enriched by the epistasis signals in each population support links between SUA levels and neurological disorders. We conclude that GWA epistasis analysis is useful despite relatively low power in small isolated populations.	[Wei, Wenhua; Vitart, Veronique; Cabrera-Cardenas, Claudia; Navarro, Pau; Huffman, Jennifer; Hayward, Caroline; Dunlop, Malcolm G.; Hastie, Nicholas; Wright, Alan F.; Haley, Chris S.] Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Hemani, Gibran; Haley, Chris S.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hemani, Gibran; Haley, Chris S.] Univ Edinburgh, R D SVS, Roslin, Midlothian, Scotland; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Knott, Sara A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Rudan, Igor; Wild, Sarah H.; Wilson, James F.; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor] Univ Split, Croatian Ctr Global Hlth, Split, Croatia; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; European Academy of Bozen-Bolzano; University of Lubeck; University of Edinburgh; University of Edinburgh; University of Split; Krankenhaus Bozen; University of Lubeck	Wei, WH (corresponding author), Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	wenhua.wei@hgu.mrc.ac.uk; chris.haley@hgu.mrc.ac.uk	Hicks, Andrew Anthony/E-9518-2017; Knott, Sara A/H-2466-2013; Campbell, Harry/E-2959-2010; Wei, Wenhua/A-6454-2012; Hayward, Caroline/M-8818-2016; Dunlop, Malcolm G/F-1973-2011; Rudan, Igor/I-1467-2012; Wilson, James F/A-5704-2009; Haley, Chris S/F-3110-2013; Pramstaller, Peter P/C-2357-2008; Navarro, Pau/AAJ-8091-2021	Hicks, Andrew Anthony/0000-0001-6320-0411; Knott, Sara A/0000-0002-4568-2928; Campbell, Harry/0000-0002-6169-6262; Wei, Wenhua/0000-0001-5774-5941; Hayward, Caroline/0000-0002-9405-9550; Dunlop, Malcolm G/0000-0002-3033-5851; Rudan, Igor/0000-0001-6993-6884; Wilson, James F/0000-0001-5751-9178; Navarro, Pau/0000-0001-5576-8584; Pramstaller, Peter P/0000-0002-9831-8302; Haley, Chris/0000-0002-9811-0210; Hemani, Gibran/0000-0003-0920-1055	MRC Core Fund; BBSRC [BB/H024484/1]; Ministry of Health; Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; BBSRC [BBS/E/R/00001604] Funding Source: UKRI; MRC [MC_U127592696, MC_PC_U127592696, MC_U127527198, MC_U127561128, MC_PC_U127527198, MC_PC_U127561128] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001604, BB/H024484/1] Funding Source: researchfish; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_U127592696, MC_U127527198, MC_U127561128, MC_PC_U127561128, MC_PC_U127592696, MC_PC_U127527198] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish	MRC Core Fund(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Health; Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The authors acknowledge the financial support provided by the MRC Core Fund. BBSRC funded WHW and CSH's time in part (grant reference: BB/H024484/1). The MICROS study was supported by the Ministry of Health and the Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annanmaki T, 2008, PARKINSONISM RELAT D, V14, P576, DOI 10.1016/j.parkreldis.2007.11.001; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Doherty M, 2009, RHEUMATOLOGY, V48, P2, DOI 10.1093/rheumatology/kep086; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Facheris MF, 2011, J MOL NEUROSCI, V43, P246, DOI 10.1007/s12031-010-9409-y; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Guan M, 2011, CLIN RHEUMATOL, V30, P29, DOI 10.1007/s10067-010-1597-x; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffjan S, 2010, MOL CELL PROBE, V24, P237, DOI 10.1016/j.mcp.2010.04.006; Hollis-Moffatt JE, 2009, ARTHRITIS RHEUM-US, V60, P3485, DOI 10.1002/art.24938; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; Houlihan LM, 2010, HUM MOL GENET, V19, P2321, DOI 10.1093/hmg/ddq097; Jannink JL, 2001, GENETICS, V157, P445; Jeroncic I, 2010, CROAT MED J, V51, P40, DOI 10.3325/cmj.2010.51.40; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Lam Alex C, 2009, BMC Proc, V3 Suppl 1, pS6; Lorentzen AR, 2010, J NEUROIMMUNOL, V226, P194, DOI 10.1016/j.jneuroim.2010.07.003; Lu WN, 2007, PLOS GENET, V3, P830, DOI 10.1371/journal.pgen.0030080; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Markowitz Alison J B, 2007, Cellscience, V4, P111; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mero IL, 2011, GENES IMMUN, V12, P191, DOI 10.1038/gene.2010.59; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Nischwitz S, 2011, ACTA NEUROL SCAND, V123, P400, DOI 10.1111/j.1600-0404.2010.01421.x; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Polasek O, 2009, CROAT MED J, V50, P7, DOI 10.3325/cmj.2009.50.7; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Rule AD, 2011, RHEUMATOLOGY, V50, P871, DOI 10.1093/rheumatology/keq425; Schretlen DJ, 2007, NEUROLOGY, V69, P1418, DOI 10.1212/01.wnl.0000277468.10236.f1; Schupbach T, 2010, BIOINFORMATICS, V26, P1468, DOI 10.1093/bioinformatics/btq147; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Spitsin S, 2008, CURR TOP MICROBIOL, V318, P325; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; VanderWeele TJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1517; Vannorsdall TD, 2008, STROKE, V39, P3418, DOI 10.1161/STROKEAHA.108.521591; Vitart V, 2006, EUR J HUM GENET, V14, P478, DOI 10.1038/sj.ejhg.5201589; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wei WH, 2010, HEREDITY, V104, P401, DOI 10.1038/hdy.2009.129; WHITFIELD JB, 1983, ACTA GENET MED GEMEL, V32, P117, DOI 10.1017/S0001566000006401; Wright AF, 2010, KIDNEY INT, V78, P446, DOI 10.1038/ki.2010.206; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131	56	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23836	10.1371/journal.pone.0023836	http://dx.doi.org/10.1371/journal.pone.0023836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886828	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100035
J	Jiang, JT; Zheng, X; Xu, X; Zhou, Q; Yan, HJ; Zhang, XG; Lu, BF; Wu, CP; Ju, JF				Jiang, Jingting; Zheng, Xiao; Xu, Xiao; Zhou, Qi; Yan, Haijiao; Zhang, Xueguang; Lu, Binfeng; Wu, Changping; Ju, Jingfang			Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin	PLOS ONE			English	Article							MICRORNA EXPRESSION; PATHOGENESIS; INHIBITION; SIGNATURE	Background: The goal of this study is to evaluate the effectiveness of S-1/Oxaliplatin vs. Doxifluridine/Oxaliplatin regimen and to identify miRNAs as potential prognostic biomarkers in gastric cancer patients. The expression of candidate miRNAs was quantified from fifty-five late stage gastric cancer FFPE specimens. Experimental Design: Gastric cancer patients with KPS>70 were recruited for the trial. The control group was treated with 400 mg/twice/day Doxifluridine plus i.v. with Oxaliplatin at 130 mg/m(2)/first day/4 week cycle. The testing group was treated with S-1 at 40 mg/twice/day/4 week cycle plus i.v. with Oxaliplatin at 130 mg/m(2)/first day/4 week cycle. Total RNAs were extracted from normal and gastric tumor specimens. The levels of miRNAs were quantified using real time qRT-PCR expression analysis. Results: The overall objective response rate (CR+PR) of patients treated with S-1/Oxaliplatin was 33.3% (CR+PR) vs. 17.6% (CR+PR) with Doxifluridine/Oxaliplatin for advanced stage gastric cancer patients. The average overall survival for patients treated with S-1/Oxaliplatin was 7.80 month vs. 7.30 month with patients treated with Doxifluridine/Oxaliplatin. The expression of miR-181b (P = 0.022) and miR-21 (P = 0.0029) was significantly overexpressed in gastric tumors compared to normal gastric tissues. Kaplan-Meier survival analysis revealed that low levels of miR-21 expression (Log rank test, hazard ratio: 0.17, CI = 0.06-0.45; P = 0.0004) and miR-181b (Log rank test, hazard ratio: 0.37, CI = 0.16-0.87; P = 0.018) are closely associated with better patient's overall survival for both S-1 and Doxifluridine based regimens. Conclusion: Patients treated with S-1/Oxaliplatin had a better response than those treated with Doxifluridine/Oxaliplatin. miR-21 and miR-181b hold great potential as prognostic biomarkers in late stage gastric cancer.	[Jiang, Jingting; Zheng, Xiao; Zhou, Qi; Yan, Haijiao; Wu, Changping] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Jiangsu Prov, Peoples R China; [Xu, Xiao; Ju, Jingfang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zhang, Xueguang] Soochow Univ, Key Lab Clin Immunol Jiangsu Prov, Key Lab Stem Cell Jiangsu Prov, Suzhou, Jiangsu Prov, Peoples R China; [Lu, Binfeng] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA	Soochow University - China; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jiang, JT (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Jiangsu Prov, Peoples R China.	newjjt@163.com; jiju@notes.cc.sunysb.edu		Ju, Jingfang/0000-0002-4821-7458	National Natural Science Foundation of China [30950022, 30972703]; Society Developing Plans, Department of Science and Technology Changzhou [BS20092019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Society Developing Plans, Department of Science and Technology Changzhou	This research project was supported by the National Natural Science Foundation of China (30950022 and 30972703) and Society Developing Plans, Department of Science and Technology Changzhou (BS20092019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COCHRANE DR, 2009, J ONCOL, V2010; DONY C, 1985, NATURE, V317, P636, DOI 10.1038/317636a0; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Park DJ, 2006, CURR OPIN PHARMACOL, V6, P337, DOI 10.1016/j.coph.2006.05.002; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Ruvkun G, 2006, SCIENCE, V311, P36; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; SCHRAMEDEI K, 2011, ONCOGENE; Shang J, 2005, WORLD J GASTROENTERO, V11, P4131; SONG B, 2009, ONCOGENE; Song B, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001663; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Varadhachary Gauri, 2005, Clin Adv Hematol Oncol, V3, P118; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu JG, 2010, OPT EXPRESS, V18, P6661, DOI 10.1364/OE.18.006661; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260	26	63	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23271	10.1371/journal.pone.0023271	http://dx.doi.org/10.1371/journal.pone.0023271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876743	Green Published, gold			2022-12-27	WOS:000294126900015
J	Gehring, M; Missirian, V; Henikoff, S				Gehring, Mary; Missirian, Victor; Henikoff, Steven			Genomic Analysis of Parent-of-Origin Allelic Expression in Arabidopsis thaliana Seeds	PLOS ONE			English	Article							POLYCOMB GROUP GENE; DNA HYPOMETHYLATION; IMPRINTED GENES; ENDOSPERM; MEDEA; PROTEIN; AUXIN; MAIZE; EMBRYOGENESIS; DEMETHYLATION	Differential expression of maternally and paternally inherited alleles of a gene is referred to as gene imprinting, a form of epigenetic gene regulation common to flowering plants and mammals. In plants, imprinting primarily occurs in the endosperm, a seed tissue that supports the embryo during its growth and development. Previously, we demonstrated that widespread DNA demethylation at remnants of transposable elements accompanies endosperm development and that a subset of these methylation changes are associated with gene imprinting. Here we assay imprinted gene expression genome-wide by performing high-throughput sequencing of RNA derived from seeds of reciprocal intraspecific crosses. We identify more than 200 loci that exhibit parent-of-origin effects on gene expression in the endosperm, including a large number of transcription factors, hormone biosynthesis and response genes, and genes that encode regulators of epigenetic information, such as methylcytosine binding proteins, histone methyltransferases, and chromatin remodelers. The majority of these genes are partially, rather than completely, imprinted, suggesting that gene dosage regulation is an important aspect of imprinted gene expression.	[Gehring, Mary; Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Gehring, Mary; Missirian, Victor; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gehring, Mary] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gehring, Mary] MIT, Dept Biol, Cambridge, MA USA; [Missirian, Victor] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Davis	Gehring, M (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	mgehring@wi.mit.edu		Henikoff, Steven/0000-0002-7621-8685	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funded by Howard Hughes Medical Institute (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Baroux C, 2007, PLANT CELL, V19, P1782, DOI 10.1105/tpc.106.046235; Becerra C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-38; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Bomblies K, 2007, CURR OPIN GENET DEV, V17, P500, DOI 10.1016/j.gde.2007.09.006; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Bureau M, 2010, PLANT MOL BIOL, V74, P479, DOI 10.1007/s11103-010-9688-2; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jahnke S, 2009, CURR BIOL, V19, P1677, DOI 10.1016/j.cub.2009.08.053; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; KERMICLE JL, 1970, GENETICS, V66, P69; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; Stupar RM, 2007, PLANT PHYSIOL, V145, P411, DOI 10.1104/pp.107.101428; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tiwari S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-72; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Yang S, 2008, DEVELOPMENT, V135, P3501, DOI 10.1242/dev.026708; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	59	138	145	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23687	10.1371/journal.pone.0023687	http://dx.doi.org/10.1371/journal.pone.0023687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858209	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300084
J	Jang, Y; Hahm, EH; Lee, HJ; Park, S; Won, YJ; Choe, JC				Jang, Yikweon; Hahm, Eun Hye; Lee, Hyun-Jung; Park, Soyeon; Won, Yong-Jin; Choe, Jae C.			Geographic Variation in Advertisement Calls in a Tree Frog Species: Gene Flow and Selection Hypotheses	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; GRYLLUS-FULTONI ORTHOPTERA; FEMALE MATE CHOICE; ALLOPATRIC POPULATIONS; DETERMINISTIC CHAOS; SEXUAL SELECTION; CANYON TREEFROG; XENOPUS-LAEVIS; SPECIATION; DIVERGENCE	Background: In a species with a large distribution relative to its dispersal capacity, geographic variation in traits may be explained by gene flow, selection, or the combined effects of both. Studies of genetic diversity using neutral molecular markers show that patterns of isolation by distance (IBD) or barrier effect may be evident for geographic variation at the molecular level in amphibian species. However, selective factors such as habitat, predator, or interspecific interactions may be critical for geographic variation in sexual traits. We studied geographic variation in advertisement calls in the tree frog Hyla japonica to understand patterns of variation in these traits across Korea and provide clues about the underlying forces for variation. Methodology: We recorded calls of H. japonica in three breeding seasons from 17 localities including localities in remote Jeju Island. Call characters analyzed were note repetition rate (NRR), note duration (ND), and dominant frequency (DF), along with snout-to-vent length. Results: The findings of a barrier effect on DF and a longitudinal variation in NRR seemed to suggest that an open sea between the mainland and Jeju Island and mountain ranges dominated by the north-south Taebaek Mountains were related to geographic variation in call characters. Furthermore, there was a pattern of IBD in mitochondrial DNA sequences. However, no comparable pattern of IBD was found between geographic distance and call characters. We also failed to detect any effects of habitat or interspecific interaction on call characters. Conclusions: Geographic variations in call characters as well as mitochondrial DNA sequences were largely stratified by geographic factors such as distance and barriers in Korean populations of H. japoinca. Although we did not detect effects of habitat or interspecific interaction, some other selective factors such as sexual selection might still be operating on call characters in conjunction with restricted gene flow.	[Jang, Yikweon; Hahm, Eun Hye; Lee, Hyun-Jung; Park, Soyeon; Won, Yong-Jin; Choe, Jae C.] Ewha Womans Univ, Div EcoSci, Seoul, South Korea	Ewha Womans University	Jang, Y (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	jangy@ewha.ac.kr; won@ewha.ac.kr; jaechoe@ewha.ac.kr			National Academy of Agricultural Science [PJ006788]; National Research Foundation of Korea [371-2009-1-C00001]	National Academy of Agricultural Science; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported financially by a research grant of the National Academy of Agricultural Science (PJ006788) to YJ and by a National Research Foundation of Korea grant (371-2009-1-C00001) to Y-JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barber PH, 1999, MOL ECOL, V8, P563, DOI 10.1046/j.1365-294x.1999.00594.x; Barber PH, 1999, MOL ECOL, V8, P547, DOI 10.1046/j.1365-294x.1999.00593.x; Benko TP, 2006, J BIOL SYST, V14, P555, DOI 10.1142/S0218339006002008; Benko TP, 2007, J BIOSCIENCES, V32, P797, DOI 10.1007/s12038-007-0081-5; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Bradbury Jack W., 1998, pi; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Carr JA, 2003, ENVIRON TOXICOL CHEM, V22, P396, DOI [10.1897/1551-5028(2003)022&lt;0396:ROLXLT&gt;2.0.CO;2, 10.1002/etc.5620220222]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cuenca A, 2003, MOL ECOL, V12, P2087, DOI 10.1046/j.1365-294X.2003.01890.x; Davidson C, 2002, CONSERV BIOL, V16, P1588, DOI 10.1046/j.1523-1739.2002.01030.x; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Doutrelant C, 1999, BEHAVIOUR, V136, P481, DOI 10.1163/156853999501432; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; FOUQUETTE MJ, 1975, SYST ZOOL, V24, P16, DOI 10.2307/2412694; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gabor CR, 2001, P ROY SOC B-BIOL SCI, V268, P1063, DOI 10.1098/rspb.2001.1626; GERHARDT HC, 1994, ANIM BEHAV, V47, P959, DOI 10.1006/anbe.1994.1127; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Guarnizo CE, 2009, MOL PHYLOGENET EVOL, V50, P84, DOI 10.1016/j.ympev.2008.10.005; Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hitchings SP, 1997, HEREDITY, V79, P117, DOI 10.1038/hdy.1997.134; Hobel G, 2003, EVOLUTION, V57, P894; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Jang Y, 2006, J EVOLUTION BIOL, V19, P459, DOI 10.1111/j.1420-9101.2005.01014.x; Jang Y, 2007, J INSECT BEHAV, V20, P33, DOI 10.1007/s10905-006-9061-0; Jang Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P150, DOI 10.1007/s00265-005-0151-3; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1983, NEUTRAL THEORY MOL E; Knoll S, 1998, HEREDITY, V81, P412, DOI 10.1046/j.1365-2540.1998.00411.x; Kodba S, 2005, EUR J PHYS, V26, P205, DOI 10.1088/0143-0807/26/1/021; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KURAMOTO M, 1984, COPEIA, P609; KURAMOTO M, 1980, COPEIA, P100; Lee Jung Eun, 1999, Korean Journal of Biological Sciences, V3, P295; Lefebvre T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-38; LOFTUSHILLS JJ, 1992, EVOLUTION, V46, P896, DOI 10.1111/j.1558-5646.1992.tb00607.x; Marquez R, 1997, ANIM BEHAV, V54, P1333, DOI 10.1006/anbe.1997.0529; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Monsen KJ, 2004, CONSERV GENET, V5, P827, DOI 10.1007/s10592-004-1981-z; Ohta T, 1972, J Mol Evol, V1, P150, DOI 10.1007/BF01659161; Palo JU, 2004, MOL ECOL, V13, P2631, DOI 10.1111/j.1365-294X.2004.02269.x; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Prohl H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-146; Prohl H, 2006, EVOLUTION, V60, P1669; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Ryan MJ, 1996, EVOLUTION, V50, P2435, DOI 10.1111/j.1558-5646.1996.tb03630.x; RYAN MJ, 2002, ACOUSTIC COMMUNICATI, P225; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Siva-Jothy MT, 1999, BEHAVIOUR, V136, P1365, DOI 10.1163/156853999500776; Slabbekoom H, 2004, J ACOUST SOC AM, V116, P3727, DOI 10.1121/1.1811121; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1978, J THEOR BIOL, V70, P213, DOI 10.1016/0022-5193(78)90348-X; Sokal R.R., 2012, BIOMETRY; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; Svensson EI, 2004, HEREDITY, V93, P423, DOI 10.1038/sj.hdy.6800519; Tavera-Mendoza L, 2002, ENVIRON TOXICOL CHEM, V21, P527, DOI 10.1897/1551-5028(2002)021&lt;0527:ROTATX&gt;2.0.CO;2; Thompson DB, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P33; van Dongen WFD, 2006, J AVIAN BIOL, V37, P349, DOI 10.1111/j.2006.0908-8857.03578.x; WALDMANN B, 1993, INBREEDING OUTBREEDI; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2; WRIGHT S., 1938, Science (Washington), V87, P430; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; Wycherley J, 2002, J ZOOL, V258, P479, DOI 10.1017/S0952836902001632; YANG S-Y, 1988, Korean Journal of Zoology, V31, P11; Yang SY, 1997, KOREAN J GENETIC, V19, P71; YANG SY, 2000, MONOGRAPH KOREAN AMP; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21	86	36	36	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23297	10.1371/journal.pone.0023297	http://dx.doi.org/10.1371/journal.pone.0023297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858061	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300030
J	Piro, RM; Molineris, I; Ala, U; Di Cunto, F				Piro, Rosario M.; Molineris, Ivan; Ala, Ugo; Di Cunto, Ferdinando			Evaluation of Candidate Genes from Orphan FEB and GEFS plus Loci by Analysis of Human Brain Gene Expression Atlases	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; FEBRILE SEIZURES PLUS; CHILDHOOD ABSENCE EPILEPSY; GENERALIZED EPILEPSY; SODIUM-CHANNEL; SUSCEPTIBILITY LOCUS; BIPOLAR DISORDER; MENKES-DISEASE; LOBE EPILEPSY; NAPG GENE	Febrile seizures, or febrile convulsions (FEB), represent the most common form of childhood seizures and are believed to be influenced by variations in several susceptibility genes. Most of the associated loci, however, remain 'orphan', i.e. the susceptibility genes they contain still remain to be identified. Further orphan loci have been mapped for a related disorder, genetic (generalized) epilepsy with febrile seizures plus (GEFS+). We show that both spatially mapped and 'traditional' gene expression data from the human brain can be successfully employed to predict the most promising candidate genes for FEB and GEFS+, apply our prediction method to the remaining orphan loci and discuss the validity of the predictions. For several of the orphan FEB/GEFS+ loci we propose excellent, and not always obvious, candidates for mutation screening in order to aid in gaining a better understanding of the genetic origin of the susceptibility to seizures.	Univ Turin, Ctr Mol Biotechnol, Turin, Italy; Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	University of Turin; University of Turin	Piro, RM (corresponding author), German Canc Res Ctr, Dept Theoret Bioinformat, Heidelberg, Germany.	r.piro@dkfz.de	Di Cunto, Ferdinando/K-5575-2016; Piro, Rosario M./AAT-6937-2020; Ala, Ugo/K-2029-2016	Piro, Rosario M./0000-0002-3066-7397; Ala, Ugo/0000-0001-5408-6397; di cunto, ferdinando/0000-0001-9367-6357; Molineris, Ivan/0000-0003-2102-0804	Regione Piemonte; Italian Ministry of Education, University and Research; Fondazione San Paolo; Progetto Neuroscienze	Regione Piemonte(Regione Piemonte); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione San Paolo(Compagnia di San Paolo); Progetto Neuroscienze	Funding was provided by Regione Piemonte (to F.D.C.); the FIRB-Italbionet program of the Italian Ministry of Education, University and Research (to F.D.C.); the Fondazione San Paolo (to F.D.C.); and Progetto Neuroscienze (to F.D.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; Audenaert D, 2005, J MED GENET, V42, P947, DOI 10.1136/jmg.2005.031393; Bahi-Buisson N, 2006, EPILEPSIA, V47, P380, DOI 10.1111/j.1528-1167.2006.00432.x; BARAM TZ, 1991, DEV BRAIN RES, V61, P97, DOI 10.1016/0165-3806(91)90118-3; Baram TZ, 1998, TRENDS NEUROSCI, V21, P471, DOI 10.1016/S0166-2236(98)01275-2; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Bousquet-Moore D, 2010, NEUROBIOL DIS, V37, P130, DOI 10.1016/j.nbd.2009.09.016; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Brunson KL, 2001, BRAIN DEV-JPN, V23, P533, DOI 10.1016/S0387-7604(01)00312-6; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Dai XH, 2008, HUM GENET, V124, P423, DOI 10.1007/s00439-008-0566-9; Deprez L, 2006, HUM GENET, V118, P618, DOI 10.1007/s00439-005-0077-x; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; EIPPER BA, 1993, ANN NY ACAD SCI, V680, P147, DOI 10.1111/j.1749-6632.1993.tb19681.x; Empson RM, 2001, NEUROSCIENCE, V102, P297, DOI 10.1016/S0306-4522(00)00494-2; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Hedera P, 2006, EPILEPSIA, V47, P1622, DOI 10.1111/j.1528-1167.2006.00637.x; Howlett E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000277; *HUM BRAIN, HUM BRAIN ATL; Ito M, 2006, EPILEPSY RES, V70, pS199, DOI 10.1016/j.eplepsyres.2005.11.028; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V219, P795, DOI 10.1006/bbrc.1996.0313; Kaler SG, 2010, J INHERIT METAB DIS, V33, P583, DOI 10.1007/s10545-010-9118-2; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klaassen A, 2006, P NATL ACAD SCI USA, V103, P19152, DOI 10.1073/pnas.0608215103; Koyama R, 2010, J PHARMACOL SCI, V113, P14, DOI 10.1254/jphs.09R19FM; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Lewis D V, 1999, Curr Opin Neurol, V12, P197, DOI 10.1097/00019052-199904000-00011; Li XW, 2009, NEUROSCI LETT, V457, P159, DOI 10.1016/j.neulet.2009.03.070; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Nabbout R, 2007, NEUROLOGY, V68, P1374, DOI 10.1212/01.wnl.0000260062.02829.e3; Nabbout R, 2002, BRAIN, V125, P2668, DOI 10.1093/brain/awf281; Nakayama J, 2000, HUM MOL GENET, V9, P87, DOI 10.1093/hmg/9.1.87; Nakayama J, 2004, NEUROLOGY, V63, P1803, DOI 10.1212/01.WNL.0000144499.34164.E0; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Nakayama J, 2006, EPILEPSY RES, V70, pS190, DOI 10.1016/j.eplepyres.2005.11.023; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; PESTANA K, 2009, EPILEPTIC DISORD, V11, P138; Piro RM, 2010, BIOINFORMATICS, V26, pI618, DOI 10.1093/bioinformatics/btq396; Poduri A, 2009, NEUROLOGY, V73, P1264, DOI 10.1212/WNL.0b013e3181bd10d3; Prashanth LK, 2010, J NEUROL SCI, V291, P44, DOI 10.1016/j.jns.2010.01.007; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Reid AY, 2009, CAN J NEUROL SCI, V36, P679, DOI 10.1017/S0317167100008246; Russ J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-305; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Scheffer IE, 2008, EPILEPSY COMPREHENSI, V2nd, P2553; Schlachter K, 2009, NEUROLOGY, V72, P974, DOI 10.1212/01.wnl.0000344401.02915.00; Shinnar, 2002, FEBRILE SEIZURES, P63; Shinoda S, 2004, J CLIN INVEST, V113, P1059, DOI 10.1172/JCI200419971; Sijben AEJ, 2009, EPILEPSIA, V50, P953, DOI 10.1111/j.1528-1167.2009.02023.x; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Singleton WCJ, 2010, J BIOL CHEM, V285, P27111, DOI 10.1074/jbc.M110.154468; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Skradski SL, 1998, GENOMICS, V49, P188, DOI 10.1006/geno.1998.5229; SMITH BN, 1994, J NEUROPHYSIOL, V72, P2328, DOI 10.1152/jn.1994.72.5.2328; Stocker M, 1998, BIOCHEM BIOPH RES CO, V248, P927, DOI 10.1006/bbrc.1998.9072; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Taylor GA, 2008, GENES BRAIN BEHAV, V7, P786, DOI 10.1111/j.1601-183X.2008.00420.x; Tran V, 1999, EPILEPSIA, V40, P1190, DOI 10.1111/j.1528-1157.1999.tb00847.x; Valdivia CR, 2009, AM J PHYSIOL-HEART C, V297, pH1446, DOI 10.1152/ajpheart.00513.2009; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; Weller AE, 2006, PSYCHIAT GENET, V16, P3, DOI 10.1097/01.ypg.0000180678.88169.b0; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; Xu L, 2008, J CLIN INVEST, V118, P272, DOI 10.1172/JCI33009; Yosifova A, 2009, J AFFECT DISORDERS, V117, P87, DOI 10.1016/j.jad.2008.12.021; Yuhas Y, 2004, J NEUROIMMUNOL, V153, P36, DOI 10.1016/j.jneuroim.2004.04.009; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001	86	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23149	10.1371/journal.pone.0023149	http://dx.doi.org/10.1371/journal.pone.0023149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858011	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300013
J	Shono, T; Kurokawa, D; Miyake, T; Okabe, M				Shono, Takanori; Kurokawa, Daisuke; Miyake, Tsutomu; Okabe, Masataka			Acquisition of glial cells missing 2 Enhancers Contributes to a Diversity of Ionocytes in Zebrafish	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CHLORIDE CELLS; HUMAN HOMOLOG; H+-ATPASE; DROSOPHILA; DIFFERENTIATION; FISH; GCM2; SPECIFICATION; EXPRESSION	Glial cells missing 2 (gcm2) encoding a GCM-motif transcription factor is expressed in the parathyroid in amniotes. In contrast, gcm2 is expressed in pharyngeal pouches (a homologous site of the parathyroid), gills, and H+-ATPase-rich cells (HRCs), a subset of ionocytes on the skin surface of the teleost fish zebrafish. Ionocytes are specialized cells that are involved in osmotic homeostasis in aquatic vertebrates. Here, we showed that gcm2 is essential for the development of HRCs and Na+-Cl- co-transporter-rich cells (NCCCs), another subset of ionocytes in zebrafish. We also identified gcm2 enhancer regions that control gcm2 expression in ionocytes of zebrafish. Comparisons of the gcm2 locus with its neighboring regions revealed no conserved elements between zebrafish and tetrapods. Furthermore, We observed gcm2 expression patterns in embryos of the teleost fishes Medaka (Oryzias latipes) and fugu (Fugu niphobles), the extant primitive ray-finned fishes Polypterus (Polypterus senegalus) and sturgeon (a hybrid of Huso huso x Acipenser ruhenus), and the amphibian Xenopus (Xenopus laevis). Although gcm2-expressing cells were observed on the skin surface of Medaka and fugu, they were not found in Polypterus, sturgeon, or Xenopus. Our results suggest that an acquisition of enhancers for the expression of gcm2 contributes to a diversity of ionocytes in zebrafish during evolution.	[Shono, Takanori; Miyake, Tsutomu; Okabe, Masataka] Jikei Univ, Dept Anat, Sch Med, Tokyo 105, Japan; [Kurokawa, Daisuke] Univ Tokyo, Misaki Marine Biol Stn, Kanagawa, Japan	Jikei University; University of Tokyo	Shono, T (corresponding author), Jikei Univ, Dept Anat, Sch Med, Tokyo 105, Japan.	maokabe@jikei.ac.jp		Miyake, Tsutomu/0000-0001-9066-3219	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Altshuller Y, 1996, FEBS LETT, V393, P201, DOI 10.1016/0014-5793(96)00890-3; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; BALLARD WW, 1964, J MORPHOL, V114, P465, DOI 10.1002/jmor.1051140307; Basyuk E, 1999, DEV DYNAM, V214, P303, DOI 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.3.CO;2-2; Bernardoni R, 1997, DEV BIOL, V191, P118; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chang WJ, 2009, AM J PHYSIOL-REG I, V296, pR1192, DOI 10.1152/ajpregu.90973.2008; Dubaissi E, 2011, DIS MODEL MECH, V4, P179, DOI 10.1242/dmm.006494; Esaki M, 2009, DEV BIOL, V329, P116, DOI 10.1016/j.ydbio.2009.02.026; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hanaoka R, 2004, MECH DEVELOP, V121, P1235, DOI 10.1016/j.mod.2004.05.011; Hashemolhosseini S, 2002, MECH DEVELOP, V118, P175, DOI 10.1016/S0925-4773(02)00239-3; Hirose S, 2003, COMP BIOCHEM PHYS B, V136, P593, DOI 10.1016/S1096-4959(03)00287-2; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hogan BM, 2004, DEV BIOL, V276, P508, DOI 10.1016/j.ydbio.2004.09.018; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Hwang PP, 2009, J EXP BIOL, V212, P1745, DOI 10.1242/jeb.026054; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Janicke M, 2007, DEV BIOL, V307, P258, DOI 10.1016/j.ydbio.2007.04.044; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 1999, CYTOGENET CELL GENET, V84, P43, DOI 10.1159/000015210; Kaneko T, 2002, FISHERIES SCI, V68, P1, DOI 10.1046/j.1444-2906.2002.00382.x; Kanemura Y, 1999, FEBS LETT, V442, P151, DOI 10.1016/S0014-5793(98)01650-0; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Nait-Oumesmar B, 2000, J HISTOCHEM CYTOCHEM, V48, P915, DOI 10.1177/002215540004800704; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ohno S., 1970, EVOLUTION GENE DUPLI; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; PHILPOTT CW, 1980, AM J PHYSIOL, V238, pR171, DOI 10.1152/ajpregu.1980.238.3.R171; Quigley IK, 2011, DEVELOPMENT, V138, P705, DOI 10.1242/dev.055699; Vincent S, 1996, DEVELOPMENT, V122, P131; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010; Wang YF, 2009, AM J PHYSIOL-REG I, V296, pR1650, DOI 10.1152/ajpregu.00119.2009; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	50	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23746	10.1371/journal.pone.0023746	http://dx.doi.org/10.1371/journal.pone.0023746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858216	gold, Green Submitted, Green Published			2022-12-27	WOS:000294121300090
J	Prevorovsky, M; Atkinson, SR; Ptackova, M; McLean, JR; Gould, K; Folk, P; Puta, F; Bahler, J				Prevorovsky, Martin; Atkinson, Sophie R.; Ptackova, Martina; McLean, Janel R.; Gould, Kathleen; Folk, Petr; Puta, Frantisek; Baehler, Juerg			N-Termini of Fungal CSL Transcription Factors Are Disordered, Enriched in Regulatory Motifs and Inhibit DNA Binding in Fission Yeast	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; UNSTRUCTURED PROTEINS; CRYSTAL-STRUCTURE; NOTCH; SUPPRESSOR; PREDICTION; HAIRLESS; COMPLEX; GENOME; CELL	Background: CSL (CBF1/RBP-J kappa/Suppressor of Hairless/LAG-1) transcription factors are the effector components of the Notch receptor signalling pathway, which is critical for metazoan development. The metazoan CSL proteins (class M) can also function in a Notch-independent manner. Recently, two novel classes of CSL proteins, designated F1 and F2, have been identified in fungi. The role of the fungal CSL proteins is unclear, because the Notch pathway is not present in fungi. In fission yeast, the Cbf11 and Cbf12 CSL paralogs play antagonistic roles in cell adhesion and the coordination of cell and nuclear division. Unusually long N-terminal extensions are typical for fungal and invertebrate CSL family members. In this study, we investigate the functional significance of these extended N-termini of CSL proteins. Methodology/Principal Findings: We identify 15 novel CSL family members from 7 fungal species and conduct bioinformatic analyses of a combined dataset containing 34 fungal and 11 metazoan CSL protein sequences. We show that the long, non-conserved N-terminal tails of fungal CSL proteins are likely disordered and enriched in phosphorylation sites and PEST motifs. In a case study of Cbf12 (class F2), we provide experimental evidence that the protein is proteolytically processed and that the N-terminus inhibits the Cbf12-dependent DNA binding activity in an electrophoretic mobility shift assay. Conclusions/Significance: This study provides insight into the characteristics of the long N-terminal tails of fungal CSL proteins that may be crucial for controlling DNA-binding and CSL function. We propose that the regulation of DNA binding by Cbf12 via its N-terminal region represents an important means by which fission yeast strikes a balance between the class F1 and class F2 paralog activities. This mode of regulation might be shared with other CSL-positive fungi, some of which are relevant to human disease and biotechnology.	[Prevorovsky, Martin; Atkinson, Sophie R.; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London, England; [Prevorovsky, Martin; Atkinson, Sophie R.; Baehler, Juerg] UCL, UCL Canc Inst, London, England; [Prevorovsky, Martin; Ptackova, Martina; Folk, Petr; Puta, Frantisek] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic; [McLean, Janel R.; Gould, Kathleen] Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37212 USA; [McLean, Janel R.; Gould, Kathleen] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA	University of London; University College London; University of London; University College London; Charles University Prague; Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Prevorovsky, M (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	m.prevorovsky@ucl.ac.uk	Folk, Petr/V-7545-2017; Převorovský, Martin/R-5191-2016; Bahler, Jurg/B-4572-2009; Půta, František/K-6731-2017	Folk, Petr/0000-0003-3813-7777; Převorovský, Martin/0000-0003-0277-8361; Bahler, Jurg/0000-0003-4036-1532; Půta, František/0000-0002-8313-878X; Gould, Kathleen/0000-0002-3810-4070	Cancer Research UK; Czech Ministry of Education, Youth and Sports [MSM0021620858, LC07032]; Charles University Grant Agency [92009]; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Charles University Grant Agency; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by Cancer Research UK, and Grants No. MSM0021620858 and LC07032 of the Czech Ministry of Education, Youth and Sports, and No. 92009 of the Charles University Grant Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Edwards YJK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r50; Erchiga VC, 2002, CURR OPIN INFECT DIS, V15, P133, DOI 10.1097/00001432-200204000-00006; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Gsponer J, 2009, PROGR BIOPHYSICS MOL; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hayward SD, 2004, SEMIN CANCER BIOL, V14, P387, DOI 10.1016/j.semcancer.2004.04.018; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XH, 2006, BIOINFORMATICS, V22, P2980, DOI 10.1093/bioinformatics/btl495; Liu F, 2004, J BIOL CHEM, V279, P34537, DOI 10.1074/jbc.M402475200; Liu ZQ, 1996, FEBS LETT, V385, P109, DOI 10.1016/0014-5793(96)00360-2; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mendes-Giannini MJS, 2005, FEMS IMMUNOL MED MIC, V45, P383, DOI 10.1016/j.femsim.2005.05.014; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Prabhu RM, 2004, CLIN MICROBIOL INFEC, V10, P31, DOI 10.1111/j.1470-9465.2004.00843.x; Prevorovsky M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-233; Prevorovsky M, 2009, EXP CELL RES, V315, P1533, DOI 10.1016/j.yexcr.2008.12.001; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Raijmakers R, 2010, ANAL CHEM, V82, P824, DOI 10.1021/ac901764g; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts-Galbraith RH, 2009, J CELL BIOL, V184, P113, DOI 10.1083/jcb.200806044; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; Singh GP, 2006, PROTEINS, V62, P309, DOI 10.1002/prot.20746; Snellinx Z, 2002, ENVIRON SCI POLLUT R, V9, P48, DOI 10.1007/BF02987316; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warringer J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-61; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	67	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23650	10.1371/journal.pone.0023650	http://dx.doi.org/10.1371/journal.pone.0023650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858190	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500059
J	Rahman, TJ; Walker, EA; Mayosi, BM; Hall, DH; Avery, PJ; Connell, JMC; Watkins, H; Stewart, PM; Keavney, B				Rahman, Thahira J.; Walker, Elizabeth A.; Mayosi, Bongani M.; Hall, Darroch H.; Avery, Peter J.; Connell, John M. C.; Watkins, Hugh; Stewart, Paul M.; Keavney, Bernard			Genotype at the P554L Variant of the Hexose-6 Phosphate Dehydrogenase Gene Is Associated with Carotid Intima-Medial Thickness	PLOS ONE			English	Article							HEXOSE-6-PHOSPHATE DEHYDROGENASE; BLOOD-PRESSURE; ATHEROSCLEROSIS; POLYMORPHISMS; DISEASE; TYPE-1; FAMILY; MAPS	Objective: The combined thickness of the intima and media of the carotid artery (carotid intima-medial thickness, CIMT) is associated with cardiovascular disease and stroke. Previous studies indicate that carotid intima-medial thickness is a significantly heritable phenotype, but the responsible genes are largely unknown. Hexose-6 phosphate dehydrogenase (H6PDH) is a microsomal enzyme whose activity regulates corticosteroid metabolism in the liver and adipose tissue; variability in measures of corticosteroid metabolism within the normal range have been associated with risk factors for cardiovascular disease. We performed a genetic association study in 854 members of 224 families to assess the relationship between polymorphisms in the gene coding for hexose-6 phosphate dehydrogenase (H6PD) and carotid intima-medial thickness. Methods: Families were ascertained via a hypertensive proband. CIMT was measured using B-mode ultrasound. Single nucleotide polymorphisms (SNPs) tagging common variation in the H6PD gene were genotyped. Association was assessed following adjustment for significant covariates including "classical" cardiovascular risk factors. Functional studies to determine the effect of particular SNPs on H6PDH were performed. Results: There was evidence of association between the single nucleotide polymorphism rs17368528 in exon five of the H6PD gene, which encodes an amino-acid change from proline to leucine in the H6PDH protein, and mean carotid intimamedial thickness (p = 0.00065). Genotype was associated with a 5% (or 0.04 mm) higher mean carotid intima-medial thickness measurement per allele, and determined 2% of the population variability in the phenotype. Conclusions: Our results suggest a novel role for the H6PD gene in atherosclerosis susceptibility.	[Rahman, Thahira J.; Hall, Darroch H.; Keavney, Bernard] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Walker, Elizabeth A.; Stewart, Paul M.] Univ Birmingham, Dept Med, Birmingham, W Midlands, England; [Mayosi, Bongani M.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Avery, Peter J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Connell, John M. C.] Univ Dundee, Dept Med, Dundee, Scotland; [Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England	Newcastle University - UK; University of Birmingham; University of Cape Town; Newcastle University - UK; University of Dundee; University of Oxford	Rahman, TJ (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	b.d.keavney@ncl.ac.uk		s, hema/0000-0002-3440-9475; Keavney, Bernard/0000-0001-9573-0812; Mayosi, Bongani/0000-0001-6641-8950; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Watkins, Hugh/0000-0002-5287-9016	British Heart Foundation; MRC [G0400874] Funding Source: UKRI; British Heart Foundation [RG/08/012/25941] Funding Source: researchfish; Medical Research Council [G0400874] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ADAMS MR, 1995, CIRCULATION, V92, P2127, DOI 10.1161/01.CIR.92.8.2127; Baker M, 2005, DIABETES, V54, P2492, DOI 10.2337/diabetes.54.8.2492; Banhegyi G, 2009, J MOL ENDOCRINOL, V42, P283, DOI 10.1677/JME-08-0156; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; Hewitt KN, 2005, ENDOCRINOLOGY, V146, P2539, DOI 10.1210/en.2005-0117; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Lanktree MB, 2009, STROKE, V40, P3173, DOI 10.1161/STROKEAHA.109.556563; Lavery GG, 2008, J CLIN ENDOCR METAB, V93, P3827, DOI 10.1210/jc.2008-0743; Mayosi BM, 2005, STROKE, V36, P2215, DOI 10.1161/01.STR.0000182254.47941.96; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Palomino-Doza J, 2008, HYPERTENSION, V52, P980, DOI 10.1161/HYPERTENSIONAHA.108.113282; Paternoster L, 2010, CIRC-CARDIOVASC GENE, V3, P15, DOI 10.1161/CIRCGENETICS.108.834366; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; SZARAZ P, 2002, INT J BIOCHEM CELL B, V42, P157; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Zhang YL, 2009, ARCH BIOCHEM BIOPHYS, V483, P45, DOI 10.1016/j.abb.2008.12.004	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23248	10.1371/journal.pone.0023248	http://dx.doi.org/10.1371/journal.pone.0023248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858044	Green Published, gold			2022-12-27	WOS:000293953500028
J	Honda, Y; Fujita, Y; Maruyama, H; Araki, Y; Ichihara, K; Sato, A; Kojima, T; Tanaka, M; Nozawa, Y; Ito, M; Honda, S				Honda, Yoko; Fujita, Yasunori; Maruyama, Hiroe; Araki, Yoko; Ichihara, Kenji; Sato, Akira; Kojima, Toshio; Tanaka, Masashi; Nozawa, Yoshinori; Ito, Masafumi; Honda, Shuji			Lifespan-Extending Effects of Royal Jelly and Its Related Substances on the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; IN-VITRO; SIGNALING PATHWAY; APIS-MELLIFERA; 10-HYDROXY-2-DECENOIC ACID; STRESS RESISTANCE; MAMMALIAN PROTEIN; NEURITE OUTGROWTH; REDOX REGULATION; GENE-EXPRESSION	Background: One of the most important challenges in the study of aging is to discover compounds with longevity-promoting activities and to unravel their underlying mechanisms. Royal jelly (RJ) has been reported to possess diverse beneficial properties. Furthermore, protease-treated RJ (pRJ) has additional pharmacological activities. Exactly how RJ and pRJ exert these effects and which of their components are responsible for these effects are largely unknown. The evolutionarily conserved mechanisms that control longevity have been indicated. The purpose of the present study was to determine whether RJ and its related substances exert a lifespan-extending function in the nematode Caenorhabditis elegans and to gain insights into the active agents in RJ and their mechanism of action. Principal Findings: We found that both RJ and pRJ extended the lifespan of C. elegans. The lifespan-extending activity of pRJ was enhanced by Octadecyl-silica column chromatography (pRJ-Fraction 5). pRJ-Fr.5 increased the animals' lifespan in part by acting through the FOXO transcription factor DAF-16, the activation of which is known to promote longevity in C. elegans by reducing insulin/IGF-1 signaling (IIS). pRJ-Fr.5 reduced the expression of ins-9, one of the insulin-like peptide genes. Moreover, pRJ-Fr.5 and reduced IIS shared some common features in terms of their effects on gene expression, such as the up-regulation of dod-3 and the down-regulation of dod-19, dao-4 and fkb-4. 10-Hydroxy-2-decenoic acid (10-HDA), which was present at high concentrations in pRJ-Fr.5, increased lifespan independently of DAF-16 activity. Conclusions/Significance: These results demonstrate that RJ and its related substances extend lifespan in C. elegans, suggesting that RJ may contain longevity-promoting factors. Further analysis and characterization of the lifespan-extending agents in RJ and pRJ may broaden our understanding of the gene network involved in longevity regulation in diverse species and may lead to the development of nutraceutical interventions in the aging process.	[Honda, Yoko; Tanaka, Masashi; Honda, Shuji] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo, Japan; [Fujita, Yasunori; Nozawa, Yoshinori; Ito, Masafumi] Gifu Int Inst Biotechnol, Dept Longev & Aging Res, Gifu, Japan; [Maruyama, Hiroe; Araki, Yoko; Ichihara, Kenji] API Co Ltd, Nagaragawa Res Ctr, Gifu, Japan; [Sato, Akira; Kojima, Toshio] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Tsurumi Ku, Kanagawa, Japan; [Kojima, Toshio] Hamamatsu Univ Sch Med, Higashi Ku, Shizuoka, Japan; [Nozawa, Yoshinori] Tokai Gakuin Univ, Dept Food & Hlth, Gifu, Japan	Tokyo Metropolitan Institute of Gerontology; RIKEN	Honda, Y (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Sakaecho, Tokyo, Japan.	hondas@center.tmig.or.jp	HONDA, Yoko/F-4558-2018	HONDA, Yoko/0000-0002-9978-8672	Tokyo Metropolitan Institute of Gerontology; API Company Limited; Gifu Prefecture, Japan	Tokyo Metropolitan Institute of Gerontology; API Company Limited; Gifu Prefecture, Japan	This work was essentially supported by Tokyo Metropolitan Institute of Gerontology financially, and was partially funded by API Company Limited and partially by a Grant for Biological Research from Gifu Prefecture, Japan. API Co. Ltd. played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Bincoletto C, 2005, INT IMMUNOPHARMACOL, V5, P679, DOI 10.1016/j.intimp.2004.11.015; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BLUM MS, 1959, SCIENCE, V130, P452, DOI 10.1126/science.130.3373.452; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRENNER S, 1974, GENETICS, V77, P71; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; BUTENANDT A, 1957, HOPPESEYLERS Z PHYSL, V203, P284; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Driver C, 2003, BIOGERONTOLOGY, V4, P91, DOI 10.1023/A:1023347803932; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Erem C, 2006, ENDOCRINE, V30, P175, DOI 10.1385/ENDO:30:2:175; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJII A, 1990, JPN J PHARMACOL, V53, P331, DOI 10.1254/jjp.53.331; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GARDNER TS, 1948, J GERONTOL, V3, P1; Gasic S, 2007, IMMUNOPHARM IMMUNOT, V29, P521, DOI 10.1080/08923970701690977; Guo H, 2008, J NUTR SCI VITAMINOL, V54, P191, DOI 10.3177/jnsv.54.191; HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Hattori N, 2007, BIOMED RES-TOKYO, V28, P261, DOI 10.2220/biomedres.28.261; Hattori N, 2007, BIOMED RES-TOKYO, V28, P139, DOI 10.2220/biomedres.28.139; Hattori N, 2010, EVID-BASED COMPL ALT, V7, P63, DOI 10.1093/ecam/nem146; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HENSCHLER D, 1956, H-S Z PHYSIOL CHEM, V305, P34, DOI 10.1515/bchm2.1956.305.1.34; Hidaka S, 2006, EVID-BASED COMPL ALT, V3, P339, DOI 10.1093/ecam/nel019; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Honda Y, 2010, GERIATR GERONTOL INT, V10, pS59, DOI 10.1111/j.1447-0594.2010.00591.x; Inoue S, 2003, EXP GERONTOL, V38, P965, DOI 10.1016/S0531-5565(03)00165-7; Izuta H, 2009, EVID-BASED COMPL ALT, V6, P489, DOI 10.1093/ecam/nem152; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394, DOI 10.3177/jnsv.47.394; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KATAOKA M, 2001, J NAT MED, V55, P174; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kawano T, 2006, BIOSCI BIOTECH BIOCH, V70, P3084, DOI 10.1271/bbb.60472; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KINOSHITA G, 1975, CAN J ZOOL, V53, P311, DOI 10.1139/z75-040; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kohno K, 2004, BIOSCI BIOTECH BIOCH, V68, P138, DOI 10.1271/bbb.68.138; Koya-Miyata S, 2004, BIOSCI BIOTECH BIOCH, V68, P767, DOI 10.1271/bbb.68.767; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Malone EA, 1996, GENETICS, V143, P1193; Matsui T, 2002, J NUTR BIOCHEM, V13, P80, DOI 10.1016/S0955-2863(01)00198-X; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nagai T, 2006, J MED FOOD, V9, P363, DOI 10.1089/jmf.2006.9.363; Narita Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2508, DOI 10.1271/bbb.60240; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PHILPOTT DE, 1974, AEROSPACE MED, V45, P283; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4; Sabatini DM, 1997, MOL NEUROBIOL, V15, P223, DOI 10.1007/BF02740635; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Sultana A, 2008, INT J MOL MED, V21, P677; Suzuki KM, 2003, J JPN SOC FOOD SCI, V50, P286, DOI 10.3136/nskkk.50.286; Takenaka T., 1982, Honeybee Science, V3, P69; Taniguchi Y, 2003, INT IMMUNOPHARMACOL, V3, P1313, DOI 10.1016/S1567-5769(03)00132-2; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; TOWNSEND GF, 1960, CANCER RES, V20, P503; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; VITTEK J, 1995, EXPERIENTIA, V51, P927, DOI 10.1007/BF01921742; Wei W, 2009, ELECTROPHORESIS, V30, P1949, DOI 10.1002/elps.200800721; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; WINSTON ML, 1991, BIOL HONEY BEE, P56; Winter AD, 2007, J BIOL CHEM, V282, P12813, DOI 10.1074/jbc.M700274200; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Yang XY, 2010, J ETHNOPHARMACOL, V128, P314, DOI 10.1016/j.jep.2010.01.055; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210; Zou SG, 2007, MECH AGEING DEV, V128, P222, DOI 10.1016/j.mad.2006.11.026	96	58	64	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23527	10.1371/journal.pone.0023527	http://dx.doi.org/10.1371/journal.pone.0023527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858156	gold, Green Published, Green Submitted			2022-12-27	WOS:000293774300039
J	Sanz, C; Velayos, A; Alvarez, MI; Benito, EP; Eslava, AP				Sanz, Catalina; Velayos, Antonio; Isabel Alvarez, Maria; Benito, Ernesto P.; Eslava, Arturo P.			Functional Analysis of the Phycomyces carRA Gene Encoding the Enzymes Phytoene Synthase and Lycopene Cyclase	PLOS ONE			English	Article							BETA-CAROTENE BIOSYNTHESIS; BLUE-LIGHT PHOTORECEPTOR; MUCOR-CIRCINELLOIDES; DEHYDROGENASE GENE; SUBSTRATE TRANSFER; NEUROSPORA-CRASSA; WHITE COLLAR-1; BLAKESLEEANUS; EXPRESSION; COMPLEMENTATION	Phycomyces carRA gene encodes a protein with two domains. Domain R is characterized by red carR mutants that accumulate lycopene. Domain A is characterized by white carA mutants that do not accumulate significant amounts of carotenoids. The carRA-encoded protein was identified as the lycopene cyclase and phytoene synthase enzyme by sequence homology with other proteins. However, no direct data showing the function of this protein have been reported so far. Different Mucor circinelloides mutants altered at the phytoene synthase, the lycopene cyclase or both activities were transformed with the Phycomyces carRA gene. Fully transcribed carRA mRNA molecules were detected by Northern assays in the transformants and the correct processing of the carRA messenger was verified by RT-PCR. These results showed that Phycomyces carRA gene was correctly expressed in Mucor. Carotenoids analysis in these transformants showed the presence of beta-carotene, absent in the untransformed strains, providing functional evidence that the Phycomyces carRA gene complements the M. circinelloides mutations. Co-transformation of the carRA cDNA in E. coli with different combinations of the carotenoid structural genes from Erwinia uredovora was also performed. Newly formed carotenoids were accumulated showing that the Phycomyces CarRA protein does contain lycopene cyclase and phytoene synthase activities. The heterologous expression of the carRA gene and the functional complementation of the mentioned activities are not very efficient in E. coli. However, the simultaneous presence of both carRA and carB gene products from Phycomyces increases the efficiency of these enzymes, presumably due to an interaction mechanism.	[Sanz, Catalina; Velayos, Antonio; Isabel Alvarez, Maria; Eslava, Arturo P.] Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Benito, Ernesto P.] Univ Salamanca, Ctr Hispano Luso Invest Agr, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca	Sanz, C (corresponding author), Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	catsof@usal.es	Sanz, Catalina/H-6759-2015; Benito, Ernesto/M-4371-2019; Velayos-Baeza, Antonio/K-6310-2019; Benito, Ernesto/B-5437-2017	Sanz, Catalina/0000-0003-2974-0873; Benito, Ernesto/0000-0002-9873-0970; Velayos-Baeza, Antonio/0000-0002-7717-4477; Benito, Ernesto/0000-0002-9873-0970	Junta de Castilla y Leon, Spain [WAS GR64]	Junta de Castilla y Leon, Spain(Junta de Castilla y Leon)	This work was supported by Grant WAS GR64 (Junta de Castilla y Leon, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Almeida ERA, 2008, CURR GENET, V53, P129, DOI 10.1007/s00294-007-0170-x; ALVAREZ MI, 1983, GENETICS, V105, P873; ARAGON CMG, 1976, EUR J BIOCHEM, V63, P71, DOI 10.1111/j.1432-1033.1976.tb10208.x; ARNAU J, 1993, CURR GENET, V23, P542, DOI 10.1007/BF00312649; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; BEJARANO ER, 1988, ARCH MICROBIOL, V150, P209, DOI 10.1007/BF00407781; Blasco JL, 2001, J PLANT RES, V114, P25, DOI 10.1007/PL00013965; CANDAU R, 1991, P NATL ACAD SCI USA, V88, P4936, DOI 10.1073/pnas.88.11.4936; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cerda-Olmedo E, 2001, FEMS MICROBIOL REV, V25, P503; Cerda-Olmedo E, 1987, PHYCOMYCES, P199; CERDAOLMEDO E, 1975, GENET RES, V25, P285, DOI 10.1017/S0016672300015718; CHOI HT, 1988, GENE, V71, P85, DOI 10.1016/0378-1119(88)90080-7; DELAGUARDIA MD, 1971, P NATL ACAD SCI USA, V68, P2012; ESLAVA AP, 1974, PLANT SCI LETT, V2, P9, DOI 10.1016/0304-4211(74)90032-7; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Fraser PD, 1996, BBA-GEN SUBJECTS, V1289, P203, DOI 10.1016/0304-4165(95)00169-7; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; GAUGER WL, 1980, EXP MYCOL, V4, P49; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; ITURRIAGA EA, 1992, CURR GENET, V21, P215, DOI 10.1007/BF00336844; Iturriaga EA., 2000, BIOTECHNOL BIOPROC E, V5, P263; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; MURILLO FJ, 1981, EUR J BIOCHEM, V119, P511, DOI 10.1111/j.1432-1033.1981.tb05637.x; Namitha KK, 2010, CRIT REV FOOD SCI, V50, P728, DOI 10.1080/10408398.2010.499811; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; OOTAKI T, 1973, MOL GEN GENET, V121, P57, DOI 10.1007/BF00353693; OREJAS M, 1987, MOL GEN GENET, V210, P69, DOI 10.1007/BF00337760; Rodriguez-Saiz M, 2004, APPL ENVIRON MICROB, V70, P5589, DOI 10.1128/AEM.70.9.5589-5594.2004; Ruiz-Hidalgo MJ, 1999, CURR MICROBIOL, V39, P259, DOI 10.1007/s002849900456; RuizHidalgo MJ, 1997, MOL GEN GENET, V253, P734, DOI 10.1007/s004380050378; RUIZHIDALGO MJ, 1995, BOT ACTA, V108, P396, DOI 10.1111/j.1438-8677.1995.tb00511.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sandmann G, 2002, PHYSIOL PLANTARUM, V116, P431, DOI 10.1034/j.1399-3054.2002.1160401.x; Sandmann G, 2002, CHEMBIOCHEM, V3, P629, DOI 10.1002/1439-7633(20020703)3:7<629::AID-CBIC629>3.0.CO;2-5; Sandmann G, 2006, BBA-MOL CELL BIOL L, V1761, P1085, DOI 10.1016/j.bbalip.2006.06.002; Sanz C, 2002, EUR J BIOCHEM, V269, P902, DOI 10.1046/j.0014-2956.2001.02724.x; Sanz C, 2010, FUNGAL GENET BIOL, V47, P773, DOI 10.1016/j.fgb.2010.05.009; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; SCHMIDHAUSER TJ, 1994, J BIOL CHEM, V269, P12060; SUTTER RP, 1975, P NATL ACAD SCI USA, V72, P127, DOI 10.1073/pnas.72.1.127; TORRESMARTINEZ S, 1980, GENET RES, V36, P299, DOI 10.1017/S0016672300019911; VANHEESWIJCK R, 1984, CARLSBERG RES COMMUN, V49, P578; Velayos A, 1997, FUNGAL GENET BIOL, V22, P19, DOI 10.1006/fgbi.1997.0998; Velayos A, 2000, PLANTA, V210, P938, DOI 10.1007/s004250050701; Velayos A, 2000, EUR J BIOCHEM, V267, P5509, DOI 10.1046/j.1432-1327.2000.01612.x; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	53	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23102	10.1371/journal.pone.0023102	http://dx.doi.org/10.1371/journal.pone.0023102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858003	Green Submitted, gold, Green Published			2022-12-27	WOS:000293774300021
J	Li, W; Wang, XR; Li, Y				Li, Wei; Wang, Xiaoru; Li, Yue			Stability in and Correlation between Factors Influencing Genetic Quality of Seed Lots in Seed Orchard of Pinus tabuliformis Carr. over a 12-Year Span	PLOS ONE			English	Article							REPRODUCTIVE PHENOLOGY; DIVERSITY; GAIN; SUCCESS; IMPACT	Coniferous seed orchards require a long period from initial seed harvest to stable seed production. Differential reproductive success and asynchrony are among the main factors for orchard crops year-to-year variation in terms of parental gametic contribution and ultimately the genetic gain. It is fundamental in both making predictions about the genetic composition of the seed crop and decisions about orchard roguing and improved seed orchard establishment. In this paper, a primary Chinese pine seed orchard with 49 clones is investigated for stability, variation and correlation analysis of factors which influence genetic quality of the seed lots from initial seed harvest to the stable seed production over a 12 years span. Results indicated that the reproductive synchrony index of pollen shedding has shown to be higher than that of the strobili receptivity, and both can be drastically influenced by the ambient climate factors. Reproductive synchrony index of the clones has certain relative stability and it could be used as an indication of the seed orchard status during maturity stage; clones in the studied orchard have shown extreme differences in terms of the gametic and genetic contribution to the seed crop at the orchard's early production phase specifically when they severe as either female or male parents. Those differences are closely related to clonal sex tendency at the time of orchard's initial reproduction. Clonal gamete contribution as male and female parent often has a negative correlation. Clone utilization as pollen, seed or both pollen and seed donors should consider the role it would play in the seed crop; due to numerous factors influencing on the mating system in seed orchards, clonal genetic contribution as male parent is uncertain, and it has major influence on the genetic composition in the seed orchard during the initial reproductive and seed production phase.	[Li, Wei; Li, Yue] Beijing Forestry Univ, Natl Engn Lab Forest Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Beijing, Peoples R China; [Wang, Xiaoru] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Li, Y (corresponding author), Beijing Forestry Univ, Natl Engn Lab Forest Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Beijing, Peoples R China.	liyue@bjfu.edu.cn	Wang, Xiao-Ru/H-6811-2012	Wang, Xiao-Ru/0000-0002-6150-7046	Fundamental Research Funds for the Central Universities [JD2011-4]; Special Fund for Forestry Scientific Research in the Public Interest [201104022]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Forestry Scientific Research in the Public Interest	This work was supported by grants from The Fundamental Research Funds for the Central Universities (No.JD2011-4) and Special Fund for Forestry Scientific Research in the Public Interest (No. 201104022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKEW GR, 1988, SILVAE GENET, V37, P227; ASKEW GR, 1990, SILVAE GENET, V39, P168; Codesido V, 2005, SILVAE GENET, V54, P246, DOI 10.1515/sg-2005-0035; Codesido V, 2001, 3 C FOR ESP ACT C, VIII, P69; El-Kassaby YA, 2010, J HERED, V101, P164, DOI 10.1093/jhered/esp126; ELKASSABY YA, 1991, FOREST SCI, V37, P827; ELKASSABY YA, 1994, SILVAE GENET, V43, P243; Funda T, 2009, TREE GENET GENOMES, V5, P583, DOI 10.1007/s11295-009-0211-3; Gomory D., 1992, Journal of Genetics and Breeding, V46, P309; Gomory D., 2000, Forest Genetics, V7, P65; Gomory D, 2003, FOREST ECOL MANAG, V174, P117, DOI 10.1016/S0378-1127(02)00031-2; Hansen OK, 2008, FOREST ECOL MANAG, V256, P1167, DOI 10.1016/j.foreco.2008.06.032; Huang ZH, 1993, J BEIJING FOR U, V15, P39; Kang KS, 2001, THEOR APPL GENET, V103, P1099, DOI 10.1007/s001220100700; KOSKI V, 1980, Silva Fennica, V14, P136; Li Y, 2010, J BEIJING FORESTRY U, V32; Li Y., 1994, AS PAC S FOR GEN IMP; MATZIRIS DI, 1994, SILVAE GENET, V43, P321; SHEN X. H., 1985, J BEIJING FORESTRY U, V3, P1; Stoehr M, 2004, FORESTRY, V77, P297, DOI 10.1093/forestry/77.4.297; Torimaru T, 2009, SILVAE GENET, V58, P262, DOI 10.1515/sg-2009-0033; Wang SS, 1985, J BEIJING FORESTRY U, V4, P72; Zhang DongMei, 2004, Scientia Silvae Sinicae, V40, P70; ZHANG H. X., 1995, HEBEI J FOR ORCH RES, V10, P199	24	8	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23544	10.1371/journal.pone.0023544	http://dx.doi.org/10.1371/journal.pone.0023544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887269	Green Published, gold, Green Submitted			2022-12-27	WOS:000295832000026
J	Rowe, AH; Xiao, YC; Scales, J; Linse, KD; Rowe, MP; Cummins, TR; Zakon, HH				Rowe, Ashlee H.; Xiao, Yucheng; Scales, Joseph; Linse, Klaus D.; Rowe, Matthew P.; Cummins, Theodore R.; Zakon, Harold H.			Isolation and Characterization of CvIV4: A Pain Inducing alpha- Scorpion Toxin	PLOS ONE			English	Article							MICE ONYCHOMYS SPP.; SODIUM-CHANNELS; NA+ CHANNELS; BMK-I; PEPTIDES; MODULATION; EXPRESSION; NA(V)1.7; ENVENOMATION; MECHANISMS	Background: Among scorpion species, the Buthidae produce the most deadly and painful venoms. However, little is known regarding the venom components that cause pain and their mechanism of action. Using a paw-licking assay (Mus musculus), this study compared the pain-inducing capabilities of venoms from two species of New World scorpion (Centruroides vittatus, C. exilicauda) belonging to the neurotoxin-producing family Buthidae with one species of non-neurotoxin producing scorpion (Vaejovis spinigerus) in the family Vaejovidae. A pain-inducing alpha-toxin (CvIV4) was isolated from the venom of C. vittatus and tested on five Na+ channel isoforms. Principal Findings: C. vittatus and C. exilicauda venoms produced significantly more paw licking in Mus than V. spinigerus venom. CvIV4 produced paw licking in Mus equivalent to the effects of whole venom. CvIV4 slowed the fast inactivation of Na(v)1.7, a Na+ channel expressed in peripheral pain-pathway neurons (nociceptors), but did not affect the Na(v)1.8-based sodium currents of these neurons. CvIV4 also slowed the fast inactivation of Na(v)1.2, Na(v)1.3 and Na(v)1.4. The effects of CvIV4 are similar to Old World a-toxins that target Na(v)1.7 (AahII, BmK MI, LqhIII, OD1), however the primary structure of CvIV4 is not similar to these toxins. Mutant Na(v)1.7 channels (D1586A and E1589Q, DIV S3-S4 linker) reduced but did not abolish the effects of CvIV4. Conclusions: This study: 1) agrees with anecdotal evidence suggesting that buthid venom is significantly more painful than non-neurotoxic venom; 2) demonstrates that New World buthids inflict painful stings via toxins that modulate Na+ channels expressed in nociceptors; 3) reveals that Old and New World buthids employ similar mechanisms to produce pain. Old and New World alpha-toxins that target Na(v)1.7 have diverged in sequence, but the activity of these toxins is similar. Pain-inducing toxins may have evolved in a common ancestor. Alternatively, these toxins may be the product of convergent evolution.	[Rowe, Ashlee H.; Scales, Joseph; Zakon, Harold H.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Linse, Klaus D.] Univ Texas Austin, Inst Cell & Mol Biol, Prot & Mass Spect Facil, Austin, TX 78712 USA; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Stark Neurosci Res Inst, Indianapolis, IN USA; [Rowe, Matthew P.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Indiana University System; Indiana University Bloomington; Texas State University System; Sam Houston State University	Rowe, AH (corresponding author), Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA.	ahrowe@mail.utexas.edu	Xiao, Yucheng/H-3600-2012		Army Research Office (ARO) Life Sciences Division [W911NF-06-1-0213, W911NF-09-1-0355]; National Institute of General Medical Sciences (NIGMS); National Institute of Neurological Disorders and Stroke (NINDS) [NS053422]; University of Texas at Austin College of Natural Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422] Funding Source: NIH RePORTER	Army Research Office (ARO) Life Sciences Division; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Texas at Austin College of Natural Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part or in whole, by Department of The Army Grants W911NF-06-1-0213 and W911NF-09-1-0355 from the Army Research Office (ARO) Life Sciences Division (to Dr. Rowe and Dr. Zakon) and by National Institutes of Health Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship from the National Institute of General Medical Sciences (NIGMS) (to Dr. Rowe). This research was also supported by National Institutes of Health Grant NS053422 from the National Institute of Neurological Disorders and Stroke (NINDS) (to Dr. Cummins), and by a University of Texas at Austin College of Natural Sciences Undergraduate Research Fellowship (to Dr. Scales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Asmari AK, 2004, SAUDI MED J, V25, P64; Bai ZT, 2010, EXP NEUROL, V226, P159, DOI 10.1016/j.expneurol.2010.08.018; Ben-Abraham R, 2000, HUM EXP TOXICOL, V19, P663, DOI 10.1191/096032700666836486; BOGOMOLSKIYAHALOM V, 1995, J TOXICOL-CLIN TOXIC, V33, P79, DOI 10.3109/15563659509020220; Bonhaus DW, 1996, NEUROPHARMACOLOGY, V35, P605, DOI 10.1016/0028-3908(96)84631-4; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Chen B, 2001, NEUROTOXICOL TERATOL, V23, P675, DOI 10.1016/S0892-0362(01)00174-X; Chen HJ, 2002, EUR J NEUROSCI, V16, P767, DOI 10.1046/j.1460-9568.2002.02142.x; Chen J, 2005, NEUROSCI LETT, V390, P66, DOI 10.1016/j.neulet.2005.08.003; Corona M, 2001, TOXICON, V39, P1893, DOI 10.1016/S0041-0101(01)00174-X; Couraud F., 1984, HDB NATURAL TOXINS E, V2, P659; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Fet V, 2000, CATALOG SCORPIONS WO, P54; Froy O, 2003, TOXICON, V42, P549, DOI 10.1016/S0041-0101(03)00236-8; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; O'Leary ME, 1998, CAN J PHYSIOL PHARM, V76, P1041, DOI 10.1139/y98-137; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rowe AH, 2006, ANIM BEHAV, V71, P725, DOI 10.1016/j.anbehav.2005.08.003; Rowe AH, 2008, TOXICON, V52, P597, DOI 10.1016/j.toxicon.2008.07.004; Sadeghian H, 2003, NEUROLOGY, V60, P346, DOI 10.1212/01.WNL.0000044158.90246.9F; Simard J.M., 1992, NATURAL TOXINS TOXIC, P236; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Vandendriessche T, 2010, TOXICON, V56, P613, DOI 10.1016/j.toxicon.2010.06.008; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Wilson MJ, 2011, J PHARM EXPT THERAPE	38	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23520	10.1371/journal.pone.0023520	http://dx.doi.org/10.1371/journal.pone.0023520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887265	Green Published, gold			2022-12-27	WOS:000295832000024
J	Chico, L; Ciudad, T; Hsu, M; Lue, NF; Larriba, G				Chico, Lidia; Ciudad, Toni; Hsu, Min; Lue, Neal F.; Larriba, German			The Candida albicans Ku70 Modulates Telomere Length and Structure by Regulating Both Telomerase and Recombination	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DNA-REPAIR; END; MAINTENANCE; YEAST; COMPONENTS; MUTANTS; CIRCLES; PROTEIN; CELLS	The heterodimeric Ku complex has been shown to participate in DNA repair and telomere regulation in a variety of organisms. Here we report a detailed characterization of the function of Ku70 in the diploid fungal pathogen Candida albicans. Both ku70 heterozygous and homozygous deletion mutants have a wild-type colony and cellular morphology, and are not sensitive to MMS or UV light. Interestingly, we observed complex effects of KU70 gene dosage on telomere lengths, with the KU70/ku70 heterozygotes exhibiting slightly shorter telomeres, and the ku70 null strain exhibiting long and heterogeneous telomeres. Analysis of combination mutants suggests that the telomere elongation in the ku70 null mutant is due mostly to unregulated telomerase action. In addition, elevated levels of extrachromosomal telomeric circles were detected in the null mutant, consistent with activation of aberrant telomeric recombination. Altogether, our observations point to multiple mechanisms of the Ku complex in telomerase regulation and telomere protection in C. albicans, and reveal interesting similarities and differences in the mechanisms of the Ku complex in disparate systems.	[Chico, Lidia; Ciudad, Toni; Larriba, German] Univ Extremadura, Fac Sci, Dept Biomed Sci, Badajoz, Spain; [Hsu, Min; Lue, Neal F.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, WR Hearst Microbiol Res Ctr, New York, NY 10021 USA	Universidad de Extremadura; Cornell University	Chico, L (corresponding author), Univ Extremadura, Fac Sci, Dept Biomed Sci, Badajoz, Spain.	glarriba@unex.es	Larriba, Germán/E-3563-2013; CIUDAD, TONI/H-5594-2015; Lue, Neal/AAO-6759-2020	CIUDAD, TONI/0000-0002-9303-1628; Lue, Neal/0000-0001-9700-6895	Ministerio de Educacion y Ciencia [SAF2007-60810]; Junta de Extremadura [PRI07A029]; National Institutes of Health (NIH) [GM069507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069507] Funding Source: NIH RePORTER	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Extremadura; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by SAF2007-60810 from Ministerio de Educacion y Ciencia and PRI07A029 from Junta de Extremadura to G. L., and GM069507 from the National Institutes of Health (NIH) to N.F.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaluz E, 2011, MOL MICROBIOL, V79, P1462, DOI 10.1111/j.1365-2958.2011.07532.x; Andaluz E, 2001, INFECT IMMUN, V69, P137, DOI 10.1128/IAI.69.01.137-147.2001; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Carter SD, 2007, GENETICS, V175, P1035, DOI 10.1534/genetics.106.067447; Ciudad T, 2004, MOL MICROBIOL, V53, P1177, DOI 10.1111/j.1365-2958.2004.04197.x; Cohen S, 1996, MOL CELL BIOL, V16, P2002; Conway C, 2002, J BIOL CHEM, V277, P21269, DOI 10.1074/jbc.M200550200; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; FONZI WA, 1993, GENETICS, V134, P717; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Grandin N, 2003, MOL CELL BIOL, V23, P3721, DOI 10.1128/MCB.23.11.3721-3734.2003; Grandin N, 2009, MOL CELL BIOL, V29, P965, DOI 10.1128/MCB.00817-08; Gravel S, 2002, MOL CELL BIOL, V22, P2182, DOI 10.1128/MCB.22.7.2182-2193.2002; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hsu M, 2007, P NATL ACAD SCI USA, V104, P11682, DOI 10.1073/pnas.0700327104; Hsu M, 2007, EUKARYOT CELL, V6, P1330, DOI 10.1128/EC.00069-07; Larriba G, 2004, PATHOGENIC FUNGI: HOST INTERACTIONS AND EMERGING STRATEGIES FOR CONTROL, P285; Legrand M, 2007, EUKARYOT CELL, V6, P2194, DOI 10.1128/EC.00299-07; Lephart PR, 2006, GENETICS, V174, P1737, DOI 10.1534/genetics.106.063271; Magee P. T., 2007, Candida: comparative and functional genomics, P7; Myung K, 2004, MOL CELL BIOL, V24, P5050, DOI 10.1128/MCB.24.11.5050-5059.2004; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Riha K, 2003, P NATL ACAD SCI USA, V100, P611, DOI 10.1073/pnas.0236128100; Riha K, 2002, EMBO J, V21, P2819, DOI 10.1093/emboj/21.11.2819; Rosas-Hernandez LL, 2008, EUKARYOT CELL, V7, P2168, DOI 10.1128/EC.00228-08; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Siede W, 1996, GENETICS, V142, P91; Singh SM, 2002, EUKARYOT CELL, V1, P967, DOI 10.1128/EC.1.6.967-977.2002; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Tomaska L, 2009, NAT STRUCT MOL BIOL, V16, P1010, DOI 10.1038/nsmb.1660; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; Yu EY, 2010, MOL CELL BIOL, V30, P1254, DOI 10.1128/MCB.00986-09; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025	52	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23732	10.1371/journal.pone.0023732	http://dx.doi.org/10.1371/journal.pone.0023732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886818	Green Published, Green Submitted, gold			2022-12-27	WOS:000294253500028
J	Cahn, P; Montaner, J; Junod, P; Patterson, P; Krolewiecki, A; Andrade-Villanueva, J; Cassetti, I; Sierra-Madero, J; Casiro, AD; Bortolozzi, R; Lupo, SH; Longo, N; Rampakakis, E; Ackad, N; Sampalis, JS				Cahn, Pedro; Montaner, Julio; Junod, Patrice; Patterson, Patricia; Krolewiecki, Alejandro; Andrade-Villanueva, Jaime; Cassetti, Isabel; Sierra-Madero, Juan; Casiro, Arnaldo David; Bortolozzi, Raul; Lupo, Sergio Horacio; Longo, Nadia; Rampakakis, Emmanouil; Ackad, Nabil; Sampalis, John S.			Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1(st) PI-Based Regimen	PLOS ONE			English	Article							LOPINAVIR-RITONAVIR MONOTHERAPY; INFECTED PATIENTS; LACTIC-ACIDOSIS; LOPINAVIR/RITONAVIR MONOTHERAPY; MITOCHONDRIAL TOXICITY; ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; NAIVE PATIENTS; 2 NUCLEOSIDES; FOLLOW-UP	Objectives: To compare the efficacy and safety of an individualized treatment-simplification strategy consisting of switching from a highly-active anti-retroviral treatment (HAART) with a ritonavir-boosted protease inhibitor (PI/r) and 2 nucleoside reverse-transcriptase inhibitors (NRTIs) to lopinavir/ritonavir (LPV/r) monotherapy, with intensification by 2 NRTIs if necessary, to that of continuing their HAART. Methods: This is a one-year, randomized, open-label, multi-center study in virologically-suppressed HIV-1-infected adults on their first PI/r-containing treatment, randomized to either LPV/r-monotherapy or continue their current treatment. Treatment efficacy was determined by plasma HIV-1 RNA viral load (VL), time-to-virologic rebound, patient-reported outcomes (PROs) and CD4+T-cell-count changes. Safety was assessed with the incidence of treatment-emergent adverse events (AE). Results: Forty-one patients were randomized to LPV/r and 39 to continue their HAART. No statistically-significant differences between the two study groups in demographics and baseline characteristics were observed. At day-360, 71(39: LPV/r; 32: HAART) patients completed treatment, while 9(2: LPV/r; 7: HAART) discontinued. In a Last Observation Carried Forward Intent-to-Treat analysis, 40(98%) patients on LPV/r and 37(95%) on HAART had VL, 200copies/mL (P = 0.61). Time-to-virologic rebound, changes in PROs, CD4+T-cell-count and VL from baseline, also exhibited no statistically-significant between-group differences. Most frequent AEs were diarrhea (19%), headache (18%) and influenza (16%). Four (10%) patients on LPV/r were intensified with 2 NRTIs, all regaining virologic control. Eight serious AEs were reported by 5(2: LPV/r; 3: HAART) patients. Conclusion: At day-360, virologic efficacy and safety of LPV/r appears comparable to that of a PI+2NRTIs HAART. These results suggest that our individualized, simplified maintenance strategy with LPV/r-monotherapy and protocol-mandated NRTI re-introduction upon viral rebound, in virologically-suppressed patients merits further prospective long-term evaluation.	[Montaner, Julio] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Junod, Patrice] Clin Med Quartier Latin, Montreal, PQ, Canada; [Andrade-Villanueva, Jaime] Univ Guadalajara, Antiguo Hosp Civil Guadalajara Fray Antonio Alcal, CUCS, Guadalajara 44430, Jalisco, Mexico; [Cahn, Pedro; Patterson, Patricia; Krolewiecki, Alejandro] Fdn Huesped, Buenos Aires, DF, Argentina; [Cassetti, Isabel] Helios Salud, Buenos Aires, DF, Argentina; [Sierra-Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Casiro, Arnaldo David] Hosp Gen Agudos Teodoro Alvarez, Buenos Aires, DF, Argentina; [Bortolozzi, Raul] Ctr Diagnost Med Alta Complejidad SA CIBIC, Div Estudios Clin, Santa Fe, Argentina; [Lupo, Sergio Horacio] Inst CAICI, Santa Fe, Argentina; [Longo, Nadia; Rampakakis, Emmanouil; Sampalis, John S.] JSS Med Res, Westmount, PQ, Canada; [Ackad, Nabil] Abbott Labs, Montreal, PQ, Canada; [Sampalis, John S.] McGill Univ, Montreal, PQ, Canada	University of British Columbia; Universidad de Guadalajara; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; McGill University	Cahn, P (corresponding author), Fdn Huesped, Buenos Aires, DF, Argentina.	jsampalis@jssresearch.com	Montaner, Julio/K-7621-2012; Krolewiecki, Alejandro/AAK-2047-2021; Sierra Madero, Juan/AAW-8825-2021; Andrade-Villanueva, Jaime Federico/GPK-6845-2022	Krolewiecki, Alejandro/0000-0001-9054-1211; Rampakakis, Emmanouil/0000-0002-7427-8246; Andrade-Villanueva, Jaime Federico/0000-0003-1948-655X	Abbott Canada	Abbott Canada(Abbott Laboratories)	This study was supported by a grant-in-aid by Abbott Canada. The funder was involved in the conception and design of the experiment but had no role in data collection and analysis, decision to publish, or writing of the manuscript. JSS Medical Research, a CRO contracted by Abbott, analyzed the data and wrote the manuscript.	Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; CAMERON DW, J INFECT DIS, V198, P234; Carr A, 2001, LANCET, V357, P1412, DOI 10.1016/S0140-6736(00)04579-7; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; Domingo P, 2008, J ANTIMICROB CHEMOTH, V61, P1348, DOI 10.1093/jac/dkn121; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gulick RM, 2003, AIDS, V17, P2345, DOI 10.1097/00002030-200311070-00009; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Hicks C, 2004, AIDS, V18, P775, DOI 10.1097/00002030-200403260-00008; Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679; Kakuda TN, 1999, AIDS, V13, P2311, DOI 10.1097/00002030-199911120-00019; McKinnon JE, 2009, ANTIVIR THER, V14, P1; Miller KD, 2000, ANN INTERN MED, V133, P192, DOI 10.7326/0003-4819-133-3-200008010-00010; Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594; Murphy RL, 2008, HIV CLIN TRIALS, V9, P1, DOI 10.1310/hct0901-1; Nunes EP, 2009, HIV CLIN TRIALS, V10, P368, DOI 10.1310/hct1006-368; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Pulido F, 2008, J ANTIMICROB CHEMOTH, V61, P1359, DOI 10.1093/jac/dkn103; Pulido F, 2008, AIDS, V22, pF1, DOI 10.1097/QAD.0b013e3282f4243b; Sham HL, 1998, ANTIMICROB AGENTS CH, V42, P3218, DOI 10.1128/AAC.42.12.3218; Stein D. S., 1994, AIDS Clinical Care, V6, P17; Sundar K, 1997, CRIT CARE MED, V25, P1425, DOI 10.1097/00003246-199708000-00034; *US FDA, DRUG SAF COMM US FOO; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x	31	27	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23726	10.1371/journal.pone.0023726	http://dx.doi.org/10.1371/journal.pone.0023726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886816	Green Submitted, gold, Green Published			2022-12-27	WOS:000294128100028
J	Lee, SB; Doberstein, K; Baumgarten, P; Wieland, A; Ungerer, C; Burger, C; Hardt, K; Boehncke, WH; Pfeilschifter, J; Mihic-Probst, D; Mittelbronn, M; Gutwein, P				Lee, Sophia Boyoung; Doberstein, Kai; Baumgarten, Peter; Wieland, Anja; Ungerer, Christopher; Buerger, Claudia; Hardt, Katja; Boehncke, Wolf-Henning; Pfeilschifter, Josef; Mihic-Probst, Daniela; Mittelbronn, Michel; Gutwein, Paul			PAX2 Regulates ADAM10 Expression and Mediates Anchorage-Independent Cell Growth of Melanoma Cells	PLOS ONE			English	Article							CANCER; CARCINOMA; APOPTOSIS; GENES; OLIGONUCLEOTIDES; RESISTANCE; ONCOGENE; BINDING; TUMOR; P53	PAX transcription factors play an important role during development and carcinogenesis. In this study, we investigated PAX2 protein levels in melanocytes and melanoma cells by Western Blot and immunofluorescence analysis and characterized the role of PAX2 in the pathogenesis of melanoma. In vitro we found weak PAX2 protein expression in keratinocytes and melanocytes. Compared to melanocytes increased PAX2 protein levels were detectable in melanoma cell lines. Interestingly, in tissue sections of melanoma patients nuclear PAX2 expression strongly correlated with nuclear atypia and the degree of prominent nucleoli, indicating an association of PAX2 with a more atypical cellular phenotype. In addition, with chromatin immunoprecipitation assay, PAX2 overexpression and PAX2 siRNA we present compelling evidence that PAX2 can regulate ADAM10 expression, a metalloproteinase known to play important roles in melanoma metastasis. In human tissue samples we found co-expression of PAX2 and ADAM10 in melanocytes of benign nevi and in melanoma cells of patients with malignant melanoma. Importantly, the downregulation of PAX2 by specific siRNA inhibited the anchorage independent cell growth and decreased the migratory and invasive capacity of melanoma cells. Furthermore, the downregulation of PAX2 abrogated the chemoresistance of melanoma cells against cisplatin, indicating that PAX2 expression mediates cell survival and plays important roles during melanoma progression.	[Lee, Sophia Boyoung; Doberstein, Kai; Ungerer, Christopher; Pfeilschifter, Josef; Gutwein, Paul] Goethe Univ Frankfurt, Univ Hosp Goethe, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Baumgarten, Peter; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Wieland, Anja] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, Bonn, Germany; [Wieland, Anja] Hertie Fdn, Bonn, Germany; [Buerger, Claudia; Hardt, Katja; Boehncke, Wolf-Henning] Clin Goethe Univ, Dept Dermatol, Frankfurt, Germany; [Mihic-Probst, Daniela] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt; University of Bonn; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Zurich; University Zurich Hospital	Lee, SB (corresponding author), Goethe Univ Frankfurt, Univ Hosp Goethe, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	p.gutwein@med.uni-frankfurt.de	Baumgarten, Peter/AAE-1140-2021; Mihic-Probst, Daniela/AAB-6374-2021; Baumgarten, Peter/AAS-6061-2020	Baumgarten, Peter/0000-0002-2563-2691; Baumgarten, Peter/0000-0002-2563-2691; Doberstein, Kai/0000-0002-9114-9913; Mittelbronn, Michel/0000-0002-2998-052X; Buerger, Claudia/0000-0002-7838-197X				Buttiglieri S, 2004, J BIOL CHEM, V279, P4136, DOI 10.1074/jbc.M306824200; Cazzaniga G, 2001, CANCER RES, V61, P4666; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; GNARRA JR, 1995, CANCER RES, V55, P4092; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Hewitt SM, 1997, ANTICANCER RES, V17, P3211; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kaufmann R, 1998, ACTA DERM-VENEREOL, V78, P136; Koyanagi K, 2005, J CLIN ONCOL, V23, P8057, DOI 10.1200/JCO.2005.02.0958; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lee SB, 2010, J INVEST DERMATOL, V130, P763, DOI 10.1038/jid.2009.335; Luu VD, 2009, CLIN CANCER RES, V15, P3297, DOI 10.1158/1078-0432.CCR-08-2779; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Scholl FA, 2001, CANCER RES, V61, P823; Silberstein GB, 2002, ONCOGENE, V21, P1009, DOI 10.1038/sj.onc.1205172; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Takeuchi H, 2004, J CLIN ONCOL, V22, P2671, DOI 10.1200/JCO.2004.12.009; Torban E, 2000, AM J PATHOL, V157, P833, DOI 10.1016/S0002-9440(10)64597-X; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250	32	80	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22312	10.1371/journal.pone.0022312	http://dx.doi.org/10.1371/journal.pone.0022312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876729	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000294126900001
J	Cisneros, KO; Smit, AJ; Laudien, J; Schoeman, DS				Cisneros, Kelly Ortega; Smit, Albertus J.; Laudien, Juergen; Schoeman, David S.			Complex, Dynamic Combination of Physical, Chemical and Nutritional Variables Controls Spatio-Temporal Variation of Sandy Beach Community Structure	PLOS ONE			English	Article							MACROFAUNA COMMUNITIES; FOOD AVAILABILITY; SPECIES RICHNESS; ECOSYSTEMS; ABUNDANCE; PATTERNS; MICROPHYTOBENTHOS; PHYTOPLANKTON; ESTIMATORS; BONFERRONI	Sandy beach ecological theory states that physical features of the beach control macrobenthic community structure on all but the most dissipative beaches. However, few studies have simultaneously evaluated the relative importance of physical, chemical and biological factors as potential explanatory variables for meso-scale spatio-temporal patterns of intertidal community structure in these systems. Here, we investigate macroinfaunal community structure of a micro-tidal sandy beach that is located on an oligotrophic subtropical coast and is influenced by seasonal estuarine input. We repeatedly sampled biological and environmental variables at a series of beach transects arranged at increasing distances from the estuary mouth. Sampling took place over a period of five months, corresponding with the transition between the dry and wet season. This allowed assessment of biological-physical relationships across chemical and nutritional gradients associated with a range of estuarine inputs. Physical, chemical, and biological response variables, as well as measures of community structure, showed significant spatio-temporal patterns. In general, bivariate relationships between biological and environmental variables were rare and weak. However, multivariate correlation approaches identified a variety of environmental variables (i.e., sampling session, the C:N ratio of particulate organic matter, dissolved inorganic nutrient concentrations, various size fractions of photopigment concentrations, salinity and, to a lesser extent, beach width and sediment kurtosis) that either alone or combined provided significant explanatory power for spatio-temporal patterns of macroinfaunal community structure. Overall, these results showed that the macrobenthic community on Mtunzini Beach was not structured primarily by physical factors, but instead by a complex and dynamic blend of nutritional, chemical and physical drivers. This emphasises the need to recognise ocean-exposed sandy beaches as functional ecosystems in their own right.	[Cisneros, Kelly Ortega] Leibnitz Ctr Marine Trop Ecol, Bremen, Germany; [Cisneros, Kelly Ortega; Smit, Albertus J.; Schoeman, David S.] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa; [Laudien, Juergen] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Schoeman, David S.] Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland	University of Kwazulu Natal; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ulster University	Cisneros, KO (corresponding author), Leibnitz Ctr Marine Trop Ecol, Bremen, Germany.	kortegac@gmail.com	Ortega, Kelly/I-4520-2019; Smit, Albertus/K-3826-2012	Ortega-Cisneros, Kelly/0000-0003-2511-5448; Laudien, Jurgen/0000-0003-2663-4821; Schoeman, David/0000-0003-1258-0885	NRF-IRDP [ICD2006072700035]; DAAD (Deutscher Akademischer Austausch Dienst); Royal Society	NRF-IRDP; DAAD (Deutscher Akademischer Austausch Dienst)(Deutscher Akademischer Austausch Dienst (DAAD)); Royal Society(Royal Society of London)	This study was financed within the framework of the NRF-IRDP project (KZN Coastal Trophic Flows, ICD2006072700035). Additional financial support was provided by a DAAD (Deutscher Akademischer Austausch Dienst) scholarship to KOC, a Royal Society grant to DSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; AMBROSE WG, 1984, J EXP MAR BIOL ECOL, V81, P115, DOI 10.1016/0022-0981(84)90002-9; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2010, R LANG ENV STAT COMP; Basaguren A, 1996, INT REV GES HYDROBIO, V81, P79, DOI 10.1002/iroh.19960810109; Begon M., 2009, ECOLOGY INDIVIDUALS; Bergamino L, 2009, ECOL INDIC, V9, P584, DOI 10.1016/j.ecolind.2008.07.008; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Blott S., 2000, GRADISTAT VERSION 4; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Bosley KL, 1999, CAN J FISH AQUAT SCI, V56, P2181, DOI 10.1139/cjfas-56-11-2181; Brazeiro A, 1996, ESTUAR COAST SHELF S, V42, P523, DOI 10.1006/ecss.1996.0033; Celentano E, 2010, MAR ECOL PROG SER, V398, P193, DOI 10.3354/meps08342; Clarke KR, 1994, CHANGE MARINE COMMUN; Cooper J.A.G., 1999, ESTUARIES S AFRICA, P5, DOI DOI 10.1017/CBO9780511525490.002; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Day J.H., 1981, ESTUARINE ECOLOGY PA, P1; Dean R.G., 1973, P C ENG DYN SURF ZON, P208; Defeo O, 1997, ESTUAR COAST SHELF S, V45, P453, DOI 10.1006/ecss.1996.0200; Defeo O, 2005, MAR ECOL PROG SER, V295, P1, DOI 10.3354/meps295001; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Defeo Omar, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P257; Duarte C, 2009, REV BIOL MAR OCEANOG, V44, P691; Dugan JE, 2004, OECOLOGIA, V139, P630, DOI 10.1007/s00442-004-1547-x; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Froneman PW, 2006, ESTUAR COAST SHELF S, V70, P693, DOI 10.1016/j.ecss.2006.07.008; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gorley C.K., 2006, GETTING STARTED PRIM; Gourlay M.R, 1968, M935M936 DELFT HYDR; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; Grant J., 1987, Biological Oceanography, V4, P243; Gray J S, 1981, ECOLOGY MARINE SEDIM; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hewitt JE, 1997, LIMNOL OCEANOGR, V42, P282, DOI 10.4319/lo.1997.42.2.0282; HILL B. J., 1966, ZOOL AFRICANA, V2, P1; HODGSON AN, 1987, S AFR J ZOOL, V22, P153; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Lercari D, 2003, ESTUAR COAST SHELF S, V58, P17, DOI 10.1016/S0272-7714(03)00043-X; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; MCLACHLAN A, 1990, J COASTAL RES, V6, P57; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A, 2006, ECOLOGY SANDY SHORES; MCLACHLAN A, 1983, SANDY BEACHES ECOSYS, P321; McLachlan A, 2007, OCEANOLOGIA, V49, P91; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mosterd S.A., 1983, S AFR J MARINE SCI, V1, P189, DOI [10.2989/025776183784447584, DOI 10.2989/025776183784447584]; Norkko A, 2001, MAR ECOL PROG SER, V212, P131, DOI 10.3354/meps212131; Oksanen J., 2013, R PACKAGE VERSION 2, P292; PEARCE AF, 1978, S AFR J SCI, V74, P328; Pearson T.H., 1987, P373; Peres-Neto PR, 1999, MAR ECOL PROG SER, V176, P303, DOI 10.3354/meps176303; Perissinotto R, 2003, ACTA OECOL, V24, pS307, DOI 10.1016/S1146-609X(03)00028-6; Perissinotto R, 2002, ESTUAR COAST SHELF S, V55, P47, DOI 10.1006/ecss.2001.0885; Ponsard S, 1999, CR ACAD SCI III-VIE, V322, P35, DOI 10.1016/S0764-4469(99)80015-8; Quinn GP, 2003, EXPT DESIGN DATA ANA; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Rodil IF, 2007, HYDROBIOLOGIA, V579, P301, DOI 10.1007/s10750-006-0443-2; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Schlacher TA, 2008, INT REV HYDROBIOL, V93, P641, DOI 10.1002/iroh.200711050; Schlacher TA, 2009, ECOSYSTEMS, V12, P311, DOI 10.1007/s10021-008-9224-2; Schoeman DS, 2008, MAR ECOL-EVOL PERSP, V29, P134, DOI 10.1111/j.1439-0485.2008.00223.x; Schoeman DS, 2003, ESTUAR COAST SHELF S, V58, P5, DOI 10.1016/S0272-7714(03)00038-6; Schoeman DS, 2002, J EXP MAR BIOL ECOL, V276, P67, DOI 10.1016/S0022-0981(02)00239-3; Sheppard N, 2009, J EXP MAR BIOL ECOL, V380, P113, DOI 10.1016/j.jembe.2009.09.009; Short AD, 1996, REV CHIL HIST NAT, V69, P589; Skinner T, 2006, ESTUAR COAST SHELF S, V70, P161, DOI 10.1016/j.ecss.2006.04.007; Stein R., 1991, ACCUMULATION ORGANIC; THOMPSON JK, 1988, J EXP MAR BIOL ECOL, V116, P43, DOI 10.1016/0022-0981(88)90245-6; Vorwerk PD, 2003, ENVIRON BIOL FISH, V66, P237, DOI 10.1023/A:1023922521835; Whitfield A. K., 1992, Southern African Journal of Aquatic Sciences, V18, P89; Wooldridge Tris, 1999, P141, DOI 10.1017/CBO9780511525490.007; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	82	41	44	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23724	10.1371/journal.pone.0023724	http://dx.doi.org/10.1371/journal.pone.0023724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858213	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300086
J	Haagsma, AC; Podasca, I; Koul, A; Andries, K; Guillemont, J; Lill, H; Bald, D				Haagsma, Anna C.; Podasca, Ioana; Koul, Anil; Andries, Koen; Guillemont, Jerome; Lill, Holger; Bald, Dirk			Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase	PLOS ONE			English	Article							DRUG CANDIDATE; TUBERCULOSIS; R207910; PYRAZINAMIDE; HYDROLYSIS; MECHANISMS; GENERATION; RESISTANCE; ROTATION	Infections with Mycobacterium tuberculosis are substantially increasing on a worldwide scale and new antibiotics are urgently needed to combat concomitantly emerging drug-resistant mycobacterial strains. The diarylquinoline TMC207 is a highly promising drug candidate for treatment of tuberculosis. This compound kills M. tuberculosis by binding to a new target, mycobacterial ATP synthase. In this study we used biochemical assays and binding studies to characterize the interaction between TMC207 and ATP synthase. We show that TMC207 acts independent of the proton motive force and does not compete with protons for a common binding site. The drug is active on mycobacterial ATP synthesis at neutral and acidic pH with no significant change in affinity between pH 5.25 and pH 7.5, indicating that the protonated form of TMC207 is the active drug entity. The interaction of TMC207 with ATP synthase can be explained by a one-site binding mechanism, the drug molecule thus binds to a defined binding site on ATP synthase. TMC207 affinity for its target decreases with increasing ionic strength, suggesting that electrostatic forces play a significant role in drug binding. Our results are consistent with previous docking studies and provide experimental support for a predicted function of TMC207 in mimicking key residues in the proton transfer chain and blocking rotary movement of subunit c during catalysis. Furthermore, the high affinity of TMC207 at low proton motive force and low pH values may in part explain the exceptional ability of this compound to efficiently kill mycobacteria in different microenvironments.	[Haagsma, Anna C.; Podasca, Ioana; Lill, Holger; Bald, Dirk] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Biol, Amsterdam, Netherlands; [Haagsma, Anna C.; Podasca, Ioana; Lill, Holger; Bald, Dirk] AIMMS, Amsterdam, Netherlands; [Koul, Anil; Andries, Koen] Johnson & Johnson Pharmaceut Res & Dev, Tibotec NV, Dept Antimicrobial Res, Beerse, Belgium; [Guillemont, Jerome] Johnson & Johnson, Janssen Res & Dev, Dept Med Chem, Val De Reuil, France	Vrije Universiteit Amsterdam; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Haagsma, AC (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Biol, Amsterdam, Netherlands.	dirk.bald@falw.vu.nl		Haagsma, Anna C./0000-0001-7656-3932; Lill, H./0000-0001-9336-5428	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-ECHO) [700.55.017]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-ECHO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-ECHO grant 700.55.017, http://www.nwo.nl). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AK, KA and JG are employees of Tibotec NV and contributed to the analysis of the experiment and provided expertise.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Bald D, 1998, J BIOL CHEM, V273, P865, DOI 10.1074/jbc.273.2.865; Bald D, 1999, EUR J BIOCHEM, V262, P563, DOI 10.1046/j.1432-1327.1999.00410.x; Bald D, 2010, FEMS MICROBIOL LETT, V308, P1, DOI 10.1111/j.1574-6968.2010.01959.x; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; de Jonge MR, 2007, PROTEINS, V67, P971, DOI 10.1002/prot.21376; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gaurrand S, 2006, CHEM BIOL DRUG DES, V68, P77, DOI 10.1111/j.1747-0285.2006.00410.x; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; Haagsma AC, 2009, ANTIMICROB AGENTS CH, V53, P1290, DOI 10.1128/AAC.01393-08; Huang Q, 2007, CHEMOTHERAPY, V53, P338, DOI 10.1159/000107723; Huitric E, 2010, ANTIMICROB AGENTS CH, V54, P1022, DOI 10.1128/AAC.01611-09; Huitric E, 2007, ANTIMICROB AGENTS CH, V51, P4202, DOI 10.1128/AAC.00181-07; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lounis N, 2006, ANTIMICROB AGENTS CH, V50, P3543, DOI 10.1128/AAC.00766-06; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Mandavilli A, 2007, NAT MED, V13, P271, DOI 10.1038/nm0307-271a; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Petrella S, 2006, ANTIMICROB AGENTS CH, V50, P2853, DOI 10.1128/AAC.00244-06; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; SYROESHKIN AV, 1995, FEBS LETT, V366, P29, DOI 10.1016/0014-5793(95)00487-T; Tran SL, 2005, J BACTERIOL, V187, P5023, DOI 10.1128/JB.187.14.5023-5028.2005; Upadhayaya RS, 2009, BIOORGAN MED CHEM, V17, P2830, DOI 10.1016/j.bmc.2009.02.026; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6	40	96	99	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23575	10.1371/journal.pone.0023575	http://dx.doi.org/10.1371/journal.pone.0023575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858172	Green Published, gold			2022-12-27	WOS:000294121300063
J	Karmarkar, SW; Bottum, KM; Krager, SL; Tischkau, SA				Karmarkar, Sumedha W.; Bottum, Kathleen M.; Krager, Stacey L.; Tischkau, Shelley A.			ERK/MAPK Is Essential for Endogenous Neuroprotection in SCN2.2 Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SUPRACHIASMATIC NUCLEUS ABLATION; PYRUVATE-DEHYDROGENASE ACTIVITY; SIGNAL-REGULATED KINASE; D-ASPARTATE RECEPTORS; CYTOCHROME-C RELEASE; N-TERMINAL KINASES; PHASE-SHIFTS; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH	Background: Glutamate (Glu) is essential to central nervous system function; however excessive Glu release leads to neurodegenerative disease. Strategies to protect neurons are underdeveloped, in part due to a limited understanding of natural neuroprotective mechanisms, such as those present in the suprachiasmatic nucleus (SCN). This study tests the hypothesis that activation of ERK/MAPK provides essential protection to the SCN after exposure to excessive Glu using the SCN2.2 cells as a model. Methodology: Immortalized SCN2.2 cells (derived from SCN) and GT1-7 cells (neurons from the neighboring hypothalamus) were treated with 10 mM Glu in the presence or absence of the ERK/MAPK inhibitor PD98059. Cell death was assessed by Live/Dead assay, MTS assay and TUNEL. Caspase 3 activity was also measured. Activation of MAPK family members was determined by immunoblot. Bcl2, neuritin and Bid mRNA (by quantitative-PCR) and protein levels (by immunoblot) were also measured. Principal Findings: As expected Glu treatment increased caspase 3 activity and cell death in the GT1-7 cells, but Glu alone did not induce cell death or affect caspase 3 activity in the SCN2.2 cells. However, pretreatment with PD98059 increased caspase 3 activity and resulted in cell death after Glu treatment in SCN2.2 cells. This effect was dependent on NMDA receptor activation. Glu treatment in the SCN2.2 cells resulted in sustained activation of the anti-apoptotic pERK/MAPK, without affecting the pro-apoptotic p-p38/MAPK. In contrast, Glu exposure in GT1-7 cells caused an increase in p-p38/MAPK and a decrease in pERK/MAPK. Bcl2-protein increased in SCN2.2 cells following Glu treatment, but not in GT1-7 cells; bid mRNA and cleaved-Bid protein increased in GT1-7, but not SCN2.2 cells. Conclusions: Facilitation of ERK activation and inhibition of caspase activation promotes resistance to Glu excitotoxicity in SCN2.2 cells. Significance: Further research will explore ERK/MAPK as a key molecule in the prevention of neurodegenerative processes.	[Karmarkar, Sumedha W.; Tischkau, Shelley A.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Bottum, Kathleen M.; Krager, Stacey L.] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Karmarkar, SW (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	stischkau@siumed.edu			Southern Illinois University (SIU) School of Medicine [561306]; Central Research Committee, SIU School of Medicine	Southern Illinois University (SIU) School of Medicine; Central Research Committee, SIU School of Medicine	Funding for this work was provided by an Excellence in Academic Medicine Grant (#561306) from Southern Illinois University (SIU) School of Medicine to ST and a Central Research Committee grant from SIU School of Medicine to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Anderson CNG, 1999, J NEUROSCI, V19, P664; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Bendova Z, 2009, NEUROSCIENCE, V159, P599, DOI 10.1016/j.neuroscience.2009.01.016; Bottum K, 2010, EXP BIOL MED, V235, P237, DOI 10.1258/ebm.2009.009244; BUIJS RM, 1994, J COMP NEUROL, V340, P381, DOI 10.1002/cne.903400308; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clark JP, 2010, J NEUROPHYSIOL, V103, P3448, DOI 10.1152/jn.01069.2009; COLWELL CS, 1992, CHRONOBIOL INT, V9, P163, DOI 10.3109/07420529209064528; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Eminel S, 2008, J NEUROCHEM, V104, P957, DOI 10.1111/j.1471-4159.2007.05101.x; Eminel S, 2004, J BIOL CHEM, V279, P55385, DOI 10.1074/jbc.M405858200; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Jiang XJ, 2009, ANESTHESIOLOGY, V111, P1197, DOI 10.1097/ALN.0b013e3181bf1d93; KAFKA MS, 1985, BRAIN RES, V327, P344, DOI 10.1016/0006-8993(85)91533-1; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li WM, 2007, MOL PHARMACOL, V71, P1258, DOI 10.1124/mol.106.029108; LIOU SY, 1986, BRAIN RES BULL, V16, P527, DOI 10.1016/0361-9230(86)90182-6; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Marais R, 1996, CANCER SURV, V27, P101; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; Mintz EM, 1999, J NEUROSCI, V19, P5124; MOSKO S, 1978, P NATL ACAD SCI USA, V75, P6243, DOI 10.1073/pnas.75.12.6243; MOSKO SS, 1979, NEUROENDOCRINOLOGY, V29, P350, DOI 10.1159/000122944; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; O'Sullivan AW, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-89; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Park MA, 2008, MOL CANCER THER, V7, P2633, DOI 10.1158/1535-7163.MCT-08-0400; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Phong MS, 2010, MOL CELL BIOL, V30, P3816, DOI 10.1128/MCB.00949-09; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; PROSSER RA, 1989, P NATL ACAD SCI USA, V86, P6812, DOI 10.1073/pnas.86.17.6812; REPPERT SM, 1981, J NEUROSCI, V1, P1414; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Saitoh Y, 1987, Acta Neurochir Suppl (Wien), V41, P41; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SAWAKI Y, 1984, Neuroscience Research, V1, P67, DOI 10.1016/0168-0102(84)90031-2; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Sinor JD, 2000, J NEUROSCI, V20, P8831; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Tischkau S A, 1999, J Neurosci, V19, pRC15; Tischkau SA, 2003, J NEUROSCI, V23, P7543; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Tovar-y-Romo LB, 2010, J NEUROCHEM, V115, P1090, DOI 10.1111/j.1471-4159.2010.06766.x; Verheij M, 1998, RADIOTHER ONCOL, V47, P225, DOI 10.1016/S0167-8140(98)00007-3; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Waetzig V, 2003, MOL CELL NEUROSCI, V24, P238, DOI 10.1016/S1044-7431(03)00126-X; Waetzig V, 2004, NEUROSCI LETT, V361, P64, DOI 10.1016/j.neulet.2004.02.041; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; WANG S, 2011, J MOL NEUROSCI; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Yazlovitskaya EM, 1999, MOL CARCINOGEN, V25, P14, DOI 10.1002/(SICI)1098-2744(199905)25:1<14::AID-MC2>3.0.CO;2-V; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069; Yustein JT, 2000, ONCOGENE, V19, P710, DOI 10.1038/sj.onc.1203342; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	81	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23493	10.1371/journal.pone.0023493	http://dx.doi.org/10.1371/journal.pone.0023493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858143	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300052
J	Mowles, SL; Rundle, SD; Cotton, PA				Mowles, Sophie L.; Rundle, Simon D.; Cotton, Peter A.			Susceptibility to Predation Affects Trait-Mediated Indirect Interactions by Reversing Interspecific Competition	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; TROPHIC CASCADES; PREY INTERACTIONS; FOOD-WEB; LITTORINA-LITTOREA; AVOIDANCE-BEHAVIOR; LYMNAEA-STAGNALIS; CRAB PREDATOR; TRADE-OFFS; SNAIL	Numerous studies indicate that the behavioral responses of prey to the presence of predators can have an important role in structuring assemblages through trait-mediated indirect interactions. Few studies, however, have addressed how relative susceptibility to predation influences such interactions. Here we examine the effect of chemical cues from the common shore crab Carcinus maenas on the foraging behavior of two common intertidal gastropod molluscs. Of the two model consumers studied, Littorina littorea is morphologically more vulnerable to crab predation than Gibbula umbilicalis, and it exhibited greater competitive ability in the absence of predation threat. However, Littorina demonstrated a greater antipredator response when experimentally exposed to predation cues, resulting in a lower level of foraging. This reversed the competitive interaction, allowing Gibbula substantially increased access to shared resources. Our results demonstrate that the susceptibility of consumers to predation can influence species interactions, and suggest that inter-specific differences in trait-mediated indirect interactions are another mechanism through which non-consumptive predator effects may influence trophic interactions.	[Mowles, Sophie L.; Rundle, Simon D.; Cotton, Peter A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Mowles, Sophie L.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of Plymouth; University of Nottingham	Mowles, SL (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	sophie.mowles@gmail.com		Cotton, Peter/0000-0002-4830-0868				Abrams P., 1987, P38; Abrams Peter A., 1996, P371; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Bertness MD., 1999, ECOLOGY ATLANTIC SHO; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Cotton PA, 2004, ECOLOGY, V85, P1581, DOI 10.1890/03-3104; Dalesman S, 2006, ANIM BEHAV, V71, P789, DOI 10.1016/j.anbehav.2005.05.028; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; Dalesman S, 2009, ANIM BEHAV, V78, P987, DOI 10.1016/j.anbehav.2009.07.018; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; DUDLEY R, 1980, NAUTILUS, V94, P108; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Grabowski JH, 2005, ECOLOGY, V86, P1312, DOI 10.1890/04-1216; Jacobsen HP, 1999, MAR BIOL, V134, P551, DOI 10.1007/s002270050570; Little C., 1996, BIOL ROCKY SHORES; LUBCHENCO L, 1978, AM NAT, V112, P23; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peacor SD, 2002, ECOL LETT, V5, P77, DOI 10.1046/j.1461-0248.2002.00287.x; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peacor SD, 2000, ECOLOGY, V81, P1998, DOI 10.2307/177288; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Rundle SD, 2001, P ROY SOC B-BIOL SCI, V268, P1463, DOI 10.1098/rspb.2001.1682; RUNDLE SD, 2004, P ROY SOC LOND B BIO, V271, P67, DOI DOI 10.1098/RSBL.2003.0106); Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2002, ECOL LETT, V5, P241, DOI 10.1046/j.1461-0248.2002.00304.x; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; Trussell GC, 2008, ECOLOGY, V89, P2798, DOI 10.1890/08-0250.1; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Vermeij G.J., 1993, NATURAL HIST SHELLS; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	47	29	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23068	10.1371/journal.pone.0023068	http://dx.doi.org/10.1371/journal.pone.0023068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857993	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300012
J	Salton, M; Elkon, R; Borodina, T; Davydov, A; Yaspo, ML; Halperin, E; Shiloh, Y				Salton, Maayan; Elkon, Ran; Borodina, Tatiana; Davydov, Aleksey; Yaspo, Marie-Laure; Halperin, Eran; Shiloh, Yosef			Matrin 3 Binds and Stabilizes mRNA	PLOS ONE			English	Article							NUCLEAR SCAFFOLD PROTEIN; SMALL NUCLEOLAR RNAS; HELICASE-A; P-TEFB; TRANSCRIPTIONAL COACTIVATOR; POLYMERASE-II; DNA-DAMAGE; 7SK SNRNP; HNRNP-K; LOCALIZATION	Matrin 3 (MATR3) is a highly conserved, inner nuclear matrix protein with two zinc finger domains and two RNA recognition motifs (RRM), whose function is largely unknown. Recently we found MATR3 to be phosphorylated by the protein kinase ATM, which activates the cellular response to double strand breaks in the DNA. Here, we show that MATR3 interacts in an RNA-dependent manner with several proteins with established roles in RNA processing, and maintains its interaction with RNA via its RRM2 domain. Deep sequencing of the bound RNA (RIP-seq) identified several small noncoding RNA species. Using microarray analysis to explore MATR39s role in transcription, we identified 77 transcripts whose amounts depended on the presence of MATR3. We validated this finding with nine transcripts which were also bound to the MATR3 complex. Finally, we demonstrated the importance of MATR3 for maintaining the stability of several of these mRNA species and conclude that it has a role in mRNA stabilization. The data suggest that the cellular level of MATR3, known to be highly regulated, modulates the stability of a group of gene transcripts.	[Salton, Maayan; Shiloh, Yosef] Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Canc Res, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Elkon, Ran] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Borodina, Tatiana; Davydov, Aleksey; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Berlin, Germany; [Halperin, Eran] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Netherlands Cancer Institute; Max Planck Society; Tel Aviv University	Salton, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Canc Res, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	maayan.salton@gmail.com		Borodina, Tatiana/0000-0002-6978-016X; Salton, Maayan/0000-0001-8812-5577	A-T Medical Research Foundation; Israel Cancer Research Fund; Israeli Science Foundation [04514831]	A-T Medical Research Foundation; Israel Cancer Research Fund; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the A-T Medical Research Foundation and The Israel Cancer Research Fund. M. Salton is a Joseph Sassoon Fellow. Y. Shiloh is a Research Professor of the Israel Cancer Research Fund. E. Halperin is supported by the Israeli Science Foundation, grant no. 04514831. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Bernert G, 2002, PROTEOMICS, V2, P1752, DOI 10.1002/1615-9861(200212)2:12<1752::AID-PROT1752>3.0.CO;2-Y; Bimpaki EI, 2010, CLIN ENDOCRINOL, V72, P744, DOI 10.1111/j.1365-2265.2009.03725.x; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Butcher SE, 2005, BIOCHEM SOC T, V33, P447, DOI 10.1042/BST0330447; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Fuchs D, 2006, MOL NUTR FOOD RES, V50, P58, DOI 10.1002/mnfr.200500133; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hibino Y, 2000, BIOCHEM BIOPH RES CO, V279, P282, DOI 10.1006/bbrc.2000.3938; Hibino Y, 2006, BBA-GENE STRUCT EXPR, V1759, P195, DOI 10.1016/j.bbaexp.2006.04.010; Hisada-Ishii S, 2007, BIOCHEM BIOPH RES CO, V354, P72, DOI 10.1016/j.bbrc.2006.12.191; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Martin AN, 2007, CELL RES, V17, P219, DOI 10.1038/sj.cr.7310120; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; RIMOLDI OJ, 1993, MOL CELL BIOL, V13, P4382, DOI 10.1128/MCB.13.7.4382; RUFF EA, 1993, P NATL ACAD SCI USA, V90, P635, DOI 10.1073/pnas.90.2.635; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V361, P281, DOI 10.1016/j.bbrc.2007.06.156; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	39	103	106	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23882	10.1371/journal.pone.0023882	http://dx.doi.org/10.1371/journal.pone.0023882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858232	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300103
J	Kanatsu-Shinohara, M; Takashima, S; Ishii, K; Shinohara, T				Kanatsu-Shinohara, Mito; Takashima, Seiji; Ishii, Kei; Shinohara, Takashi			Dynamic Changes in EPCAM Expression during Spermatogonial Stem Cell Differentiation in the Mouse Testis	PLOS ONE			English	Article							LONG-TERM CULTURE; FUNCTIONAL-CHARACTERISTICS; ADHESION MOLECULE; SELF-RENEWAL; SPERMATOGENESIS; TRANSPLANTATION; MAINTENANCE; GONOCYTES; SHARE	Background: Spermatogonial stem cells (SSCs) have the unique ability to undergo self-renewal division. However, these cells are morphologically indistinguishable from committed spermatogonia, which have limited mitotic activity. To establish a system for SSC purification, we analyzed the expression of SSC markers CD9 and epithelial cell adhesion molecule (EPCAM), both of which are also expressed on embryonic stem (ES) cells. We examined the correlation between their expression patterns and SSC activities. Methodology and Principal Findings: By magnetic cell sorting, we found that EPCAM-selected mouse germ cells have limited clonogenic potential in vitro. Moreover, these cells showed stronger expression of progenitor markers than CD9-selected cells, which are significantly more enriched in SSCs. Fluorescence-activated cell sorting of CD9-selected cells indicated a significantly higher frequency of SSCs among the CD9(+)EPCAM(low/-) population than among the CD9(+)EPCAM(+) population. Overexpression of the active form of EPCAM in germline stem (GS) cell cultures did not significantly influence SSC activity, whereas EPCAM suppression by short hairpin RNA compromised GS cell proliferation and increased the concentration of SSCs, as revealed by germ cell transplantation. Conclusions/Significance: These results show that SSCs are the most concentrated in CD9(+)EPCAM(low/-) population and also suggest that EPCAM plays an important role in progenitor cell amplification in the mouse spermatogenic system. The establishment of a method to distinguish progenitor spermatogonia from SSCs will be useful for developing an improved purification strategy for SSCs from testis cells.	[Kanatsu-Shinohara, Mito; Takashima, Seiji; Ishii, Kei; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto, Japan; [Shinohara, Takashi] Japan Sci & Technol Agcy, CREST, Kyoto, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kanatsu-Shinohara, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto, Japan.	takashi@mfour.med.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019	Takashima, Seiji/0000-0002-9176-3139; Ishii, Kei/0000-0002-5303-842X	Genome Network; Japan Science and Technology Agency (CREST); Program for Promotion of Basic and Applied Researches for Innovation in Bio-orientated Industry; Ministry of Health, Labour, and Welfare; Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Genome Network; Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Researches for Innovation in Bio-orientated Industry; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this research was supported by the Genome Network Project, Japan Science and Technology Agency (CREST), Program for Promotion of Basic and Applied Researches for Innovation in Bio-orientated Industry, the Ministry of Health, Labour, and Welfare, The Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers," and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; De Rooij DG, 2000, J ANDROL, V21, P776; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2007, BIOL REPROD, V76, P55, DOI 10.1095/biolreprod.106.055863; Kanatsu-Shinohara M, 2010, METHOD ENZYMOL, V477, P17, DOI 10.1016/S0076-6879(10)77002-6; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lolicato F, 2008, DEV BIOL, V313, P725, DOI 10.1016/j.ydbio.2007.11.011; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Moore TJ, 2002, ENDOCRINOLOGY, V143, P3171, DOI 10.1210/en.143.8.3171; Morimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007909; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	37	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23663	10.1371/journal.pone.0023663	http://dx.doi.org/10.1371/journal.pone.0023663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858196	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953700038
J	Lahiri, S; Shen, KL; Klein, M; Tang, AJ; Kane, E; Gershow, M; Garrity, P; Samuel, ADT				Lahiri, Subhaneil; Shen, Konlin; Klein, Mason; Tang, Anji; Kane, Elizabeth; Gershow, Marc; Garrity, Paul; Samuel, Aravinthan D. T.			Two Alternating Motor Programs Drive Navigation in Drosophila Larva	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEURONS; THERMOTAXIS; CHEMOTAXIS; LOCOMOTION; AVOIDANCE; SEROTONIN; BEHAVIOR; CIRCUIT; LIGHT	When placed on a temperature gradient, a Drosophila larva navigates away from excessive cold or heat by regulating the size, frequency, and direction of reorientation maneuvers between successive periods of forward movement. Forward movement is driven by peristalsis waves that travel from tail to head. During each reorientation maneuver, the larva pauses and sweeps its head from side to side until it picks a new direction for forward movement. Here, we characterized the motor programs that underlie the initiation, execution, and completion of reorientation maneuvers by measuring body segment dynamics of freely moving larvae with fluorescent muscle fibers as they were exposed to temporal changes in temperature. We find that reorientation maneuvers are characterized by highly stereotyped spatiotemporal patterns of segment dynamics. Reorientation maneuvers are initiated with head sweeping movement driven by asymmetric contraction of a portion of anterior body segments. The larva attains a new direction for forward movement after head sweeping movement by using peristalsis waves that gradually push posterior body segments out of alignment with the tail (i.e., the previous direction of forward movement) into alignment with the head. Thus, reorientation maneuvers during thermotaxis are carried out by two alternating motor programs: (1) peristalsis for driving forward movement and (2) asymmetric contraction of anterior body segments for driving head sweeping movement.	[Lahiri, Subhaneil; Shen, Konlin; Klein, Mason; Tang, Anji; Kane, Elizabeth; Gershow, Marc; Samuel, Aravinthan D. T.] Harvard Univ, Dept Phys, Ctr Brain Sci, Cambridge, MA 02138 USA; [Garrity, Paul] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Harvard University; Brandeis University	Lahiri, S (corresponding author), Harvard Univ, Dept Phys, Ctr Brain Sci, Cambridge, MA 02138 USA.	samuel@physics.harvard.edu	Lahiri, Subhaneil/AGI-0957-2022	Lahiri, Subhaneil/0000-0003-2028-6635; Garrity, Paul/0000-0002-8274-6564; Gershow, Marc/0000-0001-7528-6101	National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105383] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Samuel was the recipient of a National Institutes of Health (NIH) Pioneer Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERRIGAN D, 1993, J EXP BIOL, V179, P245; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Dixit R, 2008, DEV NEUROBIOL, V68, P309, DOI 10.1002/dneu.20589; FRAENKEL GS, 1940, ORIENTATION ANIMALS, V6; Holmes SJ, 1905, J COMP NEUROL PSYCHO, V15, P98, DOI 10.1002/cne.920150203; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Neckameyer WS, 2010, DEV NEUROSCI-BASEL, V32, P217, DOI 10.1159/000304888; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576	24	69	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23180	10.1371/journal.pone.0023180	http://dx.doi.org/10.1371/journal.pone.0023180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858019	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953700006
J	Doyle, GA; Wang, MJ; Chou, AD; Oleynick, JU; Arnold, SE; Buono, RJ; Ferraro, TN; Berrettini, WH				Doyle, Glenn A.; Wang, Min-Jung; Chou, Andrew D.; Oleynick, John U.; Arnold, Steven E.; Buono, Russell J.; Ferraro, Thomas N.; Berrettini, Wade H.			In Vitro and Ex Vivo Analysis of CHRNA3 and CHRNA5 Haplotype Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; RECEPTOR SUBUNIT GENE; NICOTINE DEPENDENCE; ALLELIC EXPRESSION; LUNG-CANCER; CANDIDATE GENES; RISK; SMOKING; ASSOCIATION; POLYMORPHISMS	Genome-wide association studies implicate variations in CHRNA5 and CHRNA3 as being associated with nicotine addiction (NA). Multiple common haplotypes ("risk", "mixed" and "protective") exist in Europeans; however, high linkage disequilibrium between variations in CHRNA5 and CHRNA3 makes assigning causative allele(s) for NA difficult through genotyping experiments alone. We investigated whether CHRNA5 or CHRNA3 promoter haplotypes, associated previously with NA, might influence allelic expression levels. For in vitro analyses, promoter haplotypes were sub-cloned into a luciferase reporter vector. When assessed in BE(2)-C cells, luciferase expression was equivalent among CHRNA3 haplotypes, but the combination of deletion at rs3841324 and variation at rs503464 decreased CHRNA5 promoter-derived luciferase activity, possibly due to loss of an SP-1 and other site(s). Variation within the CHRNA5 5'UTR at rs55853698 and rs55781567 also altered luciferase expression in BE(2)-C cells. Allelic expression imbalance (AEI) from the "risk" or "protective" haplotypes was assessed in post-mortem brain tissue from individuals heterozygous at coding polymorphisms in CHRNA3 (rs1051730) or CHRNA5 (rs16969968). In most cases, equivalent allelic expression was observed; however, one individual showed CHRNA5 AEI that favored the "protective" allele and that was concordant with heterozygosity at polymorphisms similar to 13.5 kb upstream of the CHRNA5 transcription start site. Putative enhancer activity from these distal promoter elements was assessed using heterologous promoter constructs. We observed no differences in promoter activity from the two distal promoter haplotypes examined, but found that the distal promoter region strongly repressed transcription. We conclude that CHRNA5 promoter variants may affect relative risk for NA in some heterozygous individuals.	[Doyle, Glenn A.; Wang, Min-Jung; Chou, Andrew D.; Arnold, Steven E.; Ferraro, Thomas N.; Berrettini, Wade H.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Oleynick, John U.] Johnson & Johnson, Malvern, PA USA; [Buono, Russell J.] Dept Vet Affairs Med Ctr, Res Serv, Coatesville, PA USA	University of Pennsylvania; Pennsylvania Medicine; Johnson & Johnson; Johnson & Johnson USA	Doyle, GA (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	gadoyle@mail.med.upenn.edu	Arnold, Steven E/J-7546-2012	Ferraro, Thomas/0000-0003-2250-8772	National Institutes of Health [R01 DA025201, AG10124, MH64045]; Tzedakah Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tzedakah Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funding from the National Institutes of Health [grant number R01 DA025201 to WHB] and from the Tzedakah Foundation. Brain tissue from the University of Pennsylvania Brain Bank was acquired through funding from the National Institutes of Health [grant numbers AG10124, MH64045]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Buckland PR, 2005, HUM MUTAT, V26, P214, DOI 10.1002/humu.20207; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Falvella FS, 2010, J NATL CANCER I, V102, P1366, DOI 10.1093/jnci/djq264; Flora A, 2000, EUR J PHARMACOL, V393, P85, DOI 10.1016/S0014-2999(00)00040-6; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mineur YS, 2008, BIOCHEM PHARMACOL, V75, P323, DOI 10.1016/j.bcp.2007.06.010; Nicita-Mauro V, 2010, CURR PHARM DESIGN, V16, P775, DOI 10.2174/138161210790883552; Paliwal A, 2010, CANCER RES, V70, P2779, DOI 10.1158/0008-5472.CAN-09-4550; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Quinn EM, 2010, BIPOLAR DISORD, V12, P440, DOI 10.1111/j.1399-5618.2010.00817.x; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sasaki H, 2010, J SURG RES, V162, P75, DOI 10.1016/j.jss.2009.01.008; Smith RM, 2011, EUR J HUM GENET, V19, P76, DOI 10.1038/ejhg.2010.120; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200	34	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23373	10.1371/journal.pone.0023373	http://dx.doi.org/10.1371/journal.pone.0023373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858091	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500034
J	Jensen, H; Andresen, L; Nielsen, J; Christensen, JP; Skov, S				Jensen, Helle; Andresen, Lars; Nielsen, Jens; Christensen, Jan Pravsgaard; Skov, Soren			Vesicular Stomatitis Virus Infection Promotes Immune Evasion by Preventing NKG2D-Ligand Surface Expression	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NKG2D LIGANDS; HUMAN CYTOMEGALOVIRUS; MATRIX PROTEIN; INTRACELLULAR SEQUESTRATION; CLINICAL-SIGNIFICANCE; MIC LIGANDS; T-CELLS; NK; TRANSLATION	Vesicular stomatitis virus (VSV) has recently gained attention for its oncolytic ability in cancer treatment. Initially, we hypothesized that VSV infection could increase immune recognition of cancer cells through induction of the immune stimulatory NKG2D-ligands. Here we show that VSV infection leads to a robust induction of MICA mRNA expression, however the subsequent surface expression is potently hindered. Thus, VSV lines up with human cytomegalovirus (HCMV) and adenovirus, which actively subvert the immune system by negatively affecting NKG2D-ligand surface expression. VSV infection caused an active suppression of NKG2D-ligand surface expression, affecting both endogenous and histone deacetylase (HDAC)-inhibitor induced MICA, MICB and ULBP-2 expression. The classical immune escape mechanism of VSV (i.e., the M protein blockade of nucleocytoplasmic mRNA transport) was not involved, as the VSV mutant strain, VSV DM51, which possess a defective M protein, prevented MICA surface expression similarly to wild-type VSV. The VSV mediated down modulation of NKG2D-ligand expression did not involve apoptosis. Constitutive expression of MICA bypassed the escape mechanism, suggesting that VSV affect NKG2D-ligand expression at an early post-transcriptional level. Our results show that VSV possess an escape mechanism, which could affect the immune recognition of VSV infected cancer cells. This may also have implications for immune recognition of cancer cells after combined treatment with VSV and chemotherapeutic drugs.	[Jensen, Helle; Andresen, Lars; Skov, Soren] Univ Copenhagen, LIFE, Sect Biomed, Immunol Lab, Copenhagen, Denmark; [Nielsen, Jens] Tech Univ Denmark, Natl Vet Inst, Lindholm, Denmark; [Christensen, Jan Pravsgaard] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	Jensen, H (corresponding author), Univ Copenhagen, LIFE, Sect Biomed, Immunol Lab, Copenhagen, Denmark.	sosk@life.ku.dk	Andresen, Lars/O-2271-2019; Christensen, Jan Pravsgaard/I-4782-2017; Andresen, Lars/K-1287-2012	Andresen, Lars/0000-0002-6362-7973; Christensen, Jan Pravsgaard/0000-0002-4299-9479; Skov, Soren/0000-0003-0732-0026	The Novo Nordisk Foundation; Grosserer M. Brogaard og Hustrus Mindefond, Odense; Fru Astrid Thaysens Legat for laegevidenskabelig Grundforskning	The Novo Nordisk Foundation(Novo Nordisk Foundation); Grosserer M. Brogaard og Hustrus Mindefond, Odense; Fru Astrid Thaysens Legat for laegevidenskabelig Grundforskning	This work was supported by The Novo Nordisk Foundation (www.novonordiskfonden.dk); "Grosserer M. Brogaard og Hustrus Mindefond, Odense" and "Fru Astrid Thaysens Legat for laegevidenskabelig Grundforskning." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomonte J, 2009, CANCER GENE THER, V16, P266, DOI 10.1038/cgt.2008.74; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Armeanu S, 2005, CANCER RES, V65, P6321, DOI 10.1158/0008-5472.CAN-04-4252; Ashiru O, 2009, J VIROL, V83, P12345, DOI 10.1128/JVI.01175-09; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; CLINTON GM, 1978, CELL, V15, P1455, DOI 10.1016/0092-8674(78)90069-7; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Ireland DDC, 2006, VIRAL IMMUNOL, V19, P536, DOI 10.1089/vim.2006.19.536; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; Jensen H, 2009, J LEUKOCYTE BIOL, V86, P923, DOI 10.1189/jlb.0209056; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; von K.C., 2000, MOL CELL, V6, P1243; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Whitlow ZW, 2006, J VIROL, V80, P11733, DOI 10.1128/JVI.00971-06; Wu J, 2003, J IMMUNOL, V170, P4196, DOI 10.4049/jimmunol.170.8.4196; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206	49	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23023	10.1371/journal.pone.0023023	http://dx.doi.org/10.1371/journal.pone.0023023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857986	Green Published, gold, Green Submitted			2022-12-27	WOS:000293774300017
J	Fernando, C; Vasas, V; Szathmary, E; Husbands, P				Fernando, Chrisantha; Vasas, Vera; Szathmary, Eoers; Husbands, Phil			Evolvable Neuronal Paths: A Novel Basis for Information and Search in the Brain	PLOS ONE			English	Article							SELECTION; COMPUTATION; EVOLUTION; LINKAGE; ORIGIN; STDP	We propose a previously unrecognized kind of informational entity in the brain that is capable of acting as the basis for unlimited hereditary variation in neuronal networks. This unit is a path of activity through a network of neurons, analogous to a path taken through a hidden Markov model. To prove in principle the capabilities of this new kind of informational substrate, we show how a population of paths can be used as the hereditary material for a neuronally implemented genetic algorithm, (the swiss-army knife of black-box optimization techniques) which we have proposed elsewhere could operate at somatic timescales in the brain. We compare this to the same genetic algorithm that uses a standard 'genetic' informational substrate, i.e. non-overlapping discrete genotypes, on a range of optimization problems. A path evolution algorithm (PEA) is defined as any algorithm that implements natural selection of paths in a network substrate. A PEA is a previously unrecognized type of natural selection that is well suited for implementation by biological neuronal networks with structural plasticity. The important similarities and differences between a standard genetic algorithm and a PEA are considered. Whilst most experiments are conducted on an abstract network model, at the conclusion of the paper a slightly more realistic neuronal implementation of a PEA is outlined based on Izhikevich spiking neurons. Finally, experimental predictions are made for the identification of such informational paths in the brain.	[Fernando, Chrisantha; Husbands, Phil] Univ Sussex, Dept Informat, Brighton, E Sussex, England; [Fernando, Chrisantha] Natl Inst Med Res, MRC, London NW7 1AA, England; [Vasas, Vera] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Biol Evolut, E-08193 Barcelona, Spain; [Szathmary, Eoers] Coll Budapest, Inst Adv Study, Budapest, Hungary; [Szathmary, Eoers] Parmenides Ctr Study Thinking, Pullach Munich, Germany; [Szathmary, Eoers] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary	University of Sussex; MRC National Institute for Medical Research; Autonomous University of Barcelona; Eotvos Lorand University	Fernando, C (corresponding author), Univ Sussex, Dept Informat, Brighton, E Sussex, England.	ctf20@sussex.ac.uk	Szathmary, Eors/AAS-1202-2021; Husbands, Philip/AAA-6052-2022	Szathmary, Eors/0000-0001-5227-2997; Husbands, Philip/0000-0002-5164-4004	FP7 E-FLUX (Evolutionary microfluidix); FET Open [225167]	FP7 E-FLUX (Evolutionary microfluidix); FET Open	Funding was provided by FP7 E-FLUX (Evolutionary microfluidix), FET Open Contract no, 225167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P, 1998, J THEOR BIOL, V195, P419, DOI 10.1006/jtbi.1997.0620; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chu PC, 1998, J HEURISTICS, V4, P63, DOI 10.1023/A:1009642405419; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Fernando C., 2009, THEORY THINKING, P291; Fernando C, 2010, GECCO 10 PORTL OR, P153; Fernando C, 2009, EXTENDED EVOLUTIONAR, P209; Fernando C, 2011, J THEOR BIOL, V275, P29, DOI 10.1016/j.jtbi.2011.01.009; Fernando C, 2010, NEURAL COMPUT, V22, P2809, DOI 10.1162/NECO_a_00031; Fernando C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003775; FONTANA W, 1994, P NATL ACAD SCI USA, V91, P757, DOI 10.1073/pnas.91.2.757; Frank SA, 1997, J THEOR BIOL, V184, P31, DOI 10.1006/jtbi.1996.0241; Frank SA, 1997, BIOSYSTEMS, V40, P237, DOI 10.1016/S0303-2647(96)01658-9; Harvey I., 2009, P EUR C ART LIF BERL, P126; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Holland J.H., 1975, ADAPTATION NATURAL A; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Izhikevich EM, 2009, INT J BIFURCAT CHAOS, V19, P1733, DOI 10.1142/S0218127409023809; IZQUIERDO EJ, 2008, ARTIF LIFE, V11, P265; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Khuri S., 1994, P ACM S APPL COMPUTI, P188, DOI DOI 10.1145/326619.326694.(HTTP://D0LACM.0RG/10.1145/326619.326694); Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Masquelier T, 2009, NEURAL COMPUT, V21, P1259, DOI 10.1162/neco.2008.06-08-804; Maynard Smith J., 1988, EVOLUTIONARY PROGR, P219; Maynard Smith J., 1986, PROBLEMS BIOL; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Pelikan M, 2000, EVOL COMPUT, V8, P311, DOI 10.1162/106365600750078808; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Poli Riccardo, 2007, Swarm Intelligence, V1, P33, DOI 10.1007/s11721-007-0002-0; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Schmidhuber J, 2000, IEEE IND ELEC, P2992, DOI 10.1109/IECON.2000.972474; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stutzle T, 2004, ANT COLONY OPTIMIZAT; Sutton Richard S., 1998, REINFORCEMENT LEARNI; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Thomsen R., 2002, Parallel Problem Solving from Nature - PPSN VII. 7th International Conference. Proceedings (Lecture Notes in Computer Science Vol.2439), P861; Toussaint M, 2003, EVOLUTION GENETIC RE; Vasas V, 2010, P NATL ACAD SCI USA, V107, P1470, DOI 10.1073/pnas.0912628107; Watson R.A., 2009, EFFECT HEBBIAN LEARN; Watson RA, 1998, LECT NOTES COMPUT SC, V1498, P97, DOI 10.1007/BFb0056853; WATSON RA, 2006, COMPOSITIONAL EVOLUT	52	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23534	10.1371/journal.pone.0023534	http://dx.doi.org/10.1371/journal.pone.0023534			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887266	Green Submitted, Green Published, gold			2022-12-27	WOS:000294298800012
J	Barsov, EV; Trivett, MT; Minang, JT; Sun, HS; Ohlen, C; Ott, DE				Barsov, Eugene V.; Trivett, Matthew T.; Minang, Jacob T.; Sun, Haosi; Ohlen, Claes; Ott, David E.			Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECEPTOR GENES; VIRAL ESCAPE; RETROVIRAL TRANSFER; CANCER REGRESSION; ADOPTIVE IMMUNOTHERAPY; EFFECTOR FUNCTIONS; IMMUNE ESCAPE; LYMPHOCYTES; THERAPY	Background: The SIV/rhesus macaque model for HIV/AIDS is a powerful system for examining the contribution of T cells in the control of AIDS viruses. To better our understanding of CD8(+) T-cell control of SIV replication in CD4(+) T cells, we asked whether TCRs isolated from rhesus macaque CD8(+) T-cell clones that exhibited varying abilities to suppress SIV replication could convey their suppressive properties to CD8(+) T cells obtained from an uninfected/unvaccinated animal. Principal Findings: We transferred SIV-specific TCR genes isolated from rhesus macaque CD8(+) T-cell clones with varying abilities to suppress SIV replication in vitro into CD8(+) T cells obtained from an uninfected animal by retroviral transduction. After sorting and expansion, transduced CD8(+) T-cell lines were obtained that specifically bound their cognate SIV tetramer. These cell lines displayed appropriate effector function and specificity, expressing intracellular IFN gamma upon peptide stimulation. Importantly, the SIV suppression properties of the transduced cell lines mirrored those of the original TCR donor clones: cell lines expressing TCRs transferred from highly suppressive clones effectively reduced wild-type SIV replication, while expression of a non-suppressing TCR failed to reduce the spread of virus. However, all TCRs were able to suppress the replication of an SIV mutant that did not downregulate MHC-I, recapitulating the properties of their donor clones. Conclusions: Our results show that antigen-specific SIV suppression can be transferred between allogenic T cells simply by TCR gene transfer. This advance provides a platform for examining the contributions of TCRs versus the intrinsic effector characteristics of T-cell clones in virus suppression. Additionally, this approach can be applied to develop non-human primate models to evaluate adoptive T-cell transfer therapy for AIDS and other diseases.	[Barsov, Eugene V.; Trivett, Matthew T.; Minang, Jacob T.; Sun, Haosi; Ohlen, Claes; Ott, David E.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Barsov, EV (corresponding author), NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA.	ottde@mail.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organization imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H, 2007, AIDS RES HUM RETROV, V23, P456, DOI 10.1089/aid.2006.0194; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berry LJ, 2009, TISSUE ANTIGENS, V74, P277, DOI 10.1111/j.1399-0039.2009.01336.x; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bollard CM, 2004, J EXP MED, V200, P1623, DOI 10.1084/jem.20040890; Bolton DL, 2010, J IMMUNOL, V184, P303, DOI 10.4049/jimmunol.0902413; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Calogero A, 2000, ANTICANCER RES, V20, P1793; Carlson JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/j.micinf.2008.01.013; Chung C, 2007, J VIROL, V81, P1517, DOI 10.1128/JVI.01780-06; Clay TM, 2002, EXPERT OPIN BIOL TH, V2, P353; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Engels B, 2005, HUM GENE THER, V16, P799, DOI 10.1089/hum.2005.16.799; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Frahm Nicole, 2007, Curr Infect Dis Rep, V9, P161, DOI 10.1007/s11908-007-0012-5; Fujio K, 2000, J IMMUNOL, V165, P528, DOI 10.4049/jimmunol.165.1.528; Fujita Y, 2008, BONE MARROW TRANSPL, V41, P193, DOI 10.1038/sj.bmt.1705906; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Jorritsma A, 2007, BLOOD, V110, P3564, DOI 10.1182/blood-2007-02-075010; Joseph A, 2008, J VIROL, V82, P3078, DOI 10.1128/JVI.01812-07; Kapp M, 2007, CYTOTHERAPY, V9, P699, DOI 10.1080/14653240701656046; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kollgaard T, 2009, CYTOTHERAPY, V11, P631, DOI 10.1080/14653240902923146; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Ling B, 2007, AIDS, V21, P2377, DOI 10.1097/QAD.0b013e3282f08b32; Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152; Loffredo JT, 2007, J VIROL, V81, P2624, DOI 10.1128/JVI.01912-06; Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064; Loh L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040012; Mandl JN, 2007, J VIROL, V81, P11982, DOI 10.1128/JVI.00946-07; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Marcu-Malina V, 2009, EXPERT OPIN BIOL TH, V9, P579, DOI [10.1517/14712590902887018 , 10.1517/14712590902887018]; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Minang JT, 2008, VIROLOGY, V372, P430, DOI 10.1016/j.virol.2007.11.013; Minang JT, 2010, J IMMUNOL, V184, P315, DOI 10.4049/jimmunol.0902410; Minang JT, 2009, VIROLOGY, V391, P130, DOI 10.1016/j.virol.2009.06.008; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Orentas RJ, 2003, SCAND J IMMUNOL, V58, P33, DOI 10.1046/j.1365-3083.2003.01277.x; Peggs KS, 2009, CLIN INFECT DIS, V49, P1851, DOI 10.1086/648422; Peggs KS, 2009, EXPERT OPIN BIOL TH, V9, P725, DOI 10.1517/14712590902967588; Pogulis RJ, 1998, HUM GENE THER, V9, P2299, DOI 10.1089/hum.1998.9.15-2299; Riddell Stanley R, 2007, Hematology Am Soc Hematol Educ Program, P250; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; Rosenberg SA, 2008, P NATL ACAD SCI USA, V105, P12643, DOI 10.1073/pnas.0806877105; Rosenberg SA, 2008, NEW ENGL J MED, V359, P1072, DOI 10.1056/NEJMc081511; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rubinstein MP, 2003, J IMMUNOL, V170, P1209, DOI 10.4049/jimmunol.170.3.1209; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Sadagopal S, 2008, J VIROL, V82, P4149, DOI 10.1128/JVI.02242-07; Schmitz JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000691; Schweighardt B, 2010, JAIDS-J ACQ IMM DEF, V53, P36, DOI 10.1097/QAI.0b013e3181c4b885; Shao HW, 2010, MOL BIOL REP, V37, P3951, DOI 10.1007/s11033-010-0053-y; Sommermeyer D, 2006, EUR J IMMUNOL, V36, P3052, DOI 10.1002/eji.200636539; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Ueno T, 2004, EUR J IMMUNOL, V34, P3379, DOI 10.1002/eji.200425568; Ueno T, 2007, J IMMUNOL, V178, P5513, DOI 10.4049/jimmunol.178.9.5513; van Loenen MM, 2010, P NATL ACAD SCI USA, V107, P10972, DOI 10.1073/pnas.1005802107; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718	72	16	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23703	10.1371/journal.pone.0023703	http://dx.doi.org/10.1371/journal.pone.0023703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886812	gold, Green Submitted, Green Published			2022-12-27	WOS:000294253500025
J	Takeuchi, H; Taki, Y; Sassa, Y; Hashizume, H; Sekiguchi, A; Fukushima, A; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta			Working Memory Training Using Mental Calculation Impacts Regional Gray Matter of the Frontal and Parietal Regions	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BRAIN STRUCTURE CHANGES; INDIVIDUAL-DIFFERENCES; CREATIVITY; CHILDREN; SCHIZOPHRENIA; ADHD; ACTIVATION; PLASTICITY; COGNITION	Training working memory (WM) improves performance on untrained cognitive tasks and alters functional activity. However, WM training's effects on gray matter morphology and a wide range of cognitive tasks are still unknown. We investigated this issue using voxel-based morphometry (VBM), various psychological measures, such as non-trained WM tasks and a creativity task, and intensive adaptive training of WM using mental calculations (IATWMMC), all of which are typical WM tasks. IATWMMC was associated with reduced regional gray matter volume in the bilateral fronto-parietal regions and the left superior temporal gyrus. It improved verbal letter span and complex arithmetic ability, but deteriorated creativity. These results confirm the training-induced plasticity in psychological mechanisms and the plasticity of gray matter structures in regions that have been assumed to be under strong genetic control.	[Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Takeuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan.	takehi@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694	Japan Science and Technology Agency (JST)/Research Institute of Science and Technology for Society; JST/Core Research for Evolutional Science and Technology	Japan Science and Technology Agency (JST)/Research Institute of Science and Technology for Society(Japan Science & Technology Agency (JST)); JST/Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by Japan Science and Technology Agency (JST)/Research Institute of Science and Technology for Society and JST/Core Research for Evolutional Science and Technology (no particular numbers exist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova E, 2005, BIOL PSYCHIAT, V58, P457, DOI 10.1016/j.biopsych.2005.04.036; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BEECH A, 1987, BRIT J PSYCHOL, V78, P349, DOI 10.1111/j.2044-8295.1987.tb02252.x; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Butterworth B., 1999, MATH BRAIN; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Colom R, 2004, INTELLIGENCE, V32, P277, DOI 10.1016/j.intell.2003.12.002; Court J., 1998, MANUAL RAVENS PROGRE; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; DYKES M, 1976, BRIT J PSYCHIAT, V128, P50, DOI 10.1192/bjp.128.1.50; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; GASER C, VBM TOOLBOX SPM2 VBM; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Hakoda Y., 1990, KYOIKUSHINRIGAKUKENK, V38, P389, DOI DOI 10.5926/JJEP1953.38.4_; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Healey D, 2006, CHILD NEUROPSYCHOL, V12, P421, DOI 10.1080/09297040600806086; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hogarty GE, 2004, ARCH GEN PSYCHIAT, V61, P866, DOI 10.1001/archpsyc.61.9.866; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kawashima R, 2005, J GERONTOL A-BIOL, V60, P380, DOI 10.1093/gerona/60.3.380; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; KRISTOFFERSON MW, 1972, CAN J PSYCHOLOGY, V26, P54, DOI 10.1037/h0082415; Leff AP, 2009, BRAIN, V132, P3401, DOI 10.1093/brain/awp273; Lu LH, 2009, CEREB CORTEX, V19, P2595, DOI 10.1093/cercor/bhp011; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mehta MA, 2004, J CHILD PSYCHOL PSYC, V45, P293, DOI 10.1111/j.1469-7610.2004.00221.x; Minds Society For Creative, 1969, MAN S A CREAT TEST; NECKA E, 1999, POLISH PSYCHOL B, V30, P85; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Osaka M, 2000, BRAIN WORKING MEMORY; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; RAWLINGS D, 1985, PERS INDIV DIFFER, V6, P737, DOI 10.1016/0191-8869(85)90084-4; SASAKI M, 1993, JPN J PSYCHOL, V64, P43, DOI 10.4992/jjpsy.64.43; SASAKI M, 1985, P JAP ED PSYH 27 ANN; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Snow R. E., 1989, EDUC RES, V18, P8, DOI DOI 10.3102/0013189X018009008; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Stavridou A, 1996, PERS INDIV DIFFER, V21, P143, DOI 10.1016/0191-8869(96)00030-X; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; Swartwood MO, 2003, CREATIVITY RES J, V15, P417, DOI 10.1207/S15326934CRJ1504_9; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; TAKEUCHI H, REV NEUROSC IN PRESS; TAKEUCHI H, J NEUROSCIE IN PRESS; Takeuchi H, HUMAN BRAIN IN PRESS; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Testa C, 2004, J MAGN RESON IMAGING, V19, P274, DOI 10.1002/jmri.20001; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida S, 2008, AGE, V30, P21, DOI 10.1007/s11357-007-9044-x; WECHSLER D, 1997, WAIS 3 ADMINISTRATIO; Weinfurt K. P., 2002, READING UNDERSTANDIN, P317; White HA, 2006, PERS INDIV DIFFER, V40, P1121, DOI 10.1016/j.paid.2005.11.007	79	82	87	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23175	10.1371/journal.pone.0023175	http://dx.doi.org/10.1371/journal.pone.0023175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811YA	21886781	gold, Green Published, Green Submitted			2022-12-27	WOS:000294253500010
J	Elpek, KG; Bellemare-Pelletier, A; Malhotra, D; Reynoso, ED; Lukacs-Kornek, V; DeKruyff, RH; Turley, SJ				Elpek, Kutlu G.; Bellemare-Pelletier, Angelique; Malhotra, Deepali; Reynoso, Erika D.; Lukacs-Kornek, Veronika; DeKruyff, Rosemarie H.; Turley, Shannon J.			Lymphoid Organ-Resident Dendritic Cells Exhibit Unique Transcriptional Fingerprints Based on Subset and Site	PLOS ONE			English	Article							IN-VIVO; RETINOIC ACID; CROSS-PRESENTATION; T-CELLS; REGULATORY FACTOR-4; ADAPTIVE IMMUNITY; GENE-EXPRESSION; SELF-ANTIGENS; DYING CELLS; MOUSE	Lymphoid organ-resident DC subsets are thought to play unique roles in determining the fate of T cell responses. Recent studies focusing on a single lymphoid organ identified molecular pathways that are differentially operative in each DC subset and led to the assumption that a given DC subset would more or less exhibit the same genomic and functional profiles throughout the body. Whether the local milieu in different anatomical sites can also influence the transcriptome of DC subsets has remained largely unexplored. Here, we interrogated the transcriptional relationships between lymphoid organ-resident DC subsets from spleen, gut-and skin-draining lymph nodes, and thymus of C57BL/6 mice. For this purpose, major resident DC subsets including CD4 and CD8 DCs were sorted at high purity and gene expression profiles were compared using microarray analysis. This investigation revealed that lymphoid organ-resident DC subsets exhibit divergent genomic programs across lymphoid organs. Interestingly, we also found that transcriptional and biochemical properties of a given DC subset can differ between lymphoid organs for lymphoid organ-resident DC subsets, but not plasmacytoid DCs, suggesting that determinants of the tissue milieu program resident DCs for essential site-specific functions.	[Elpek, Kutlu G.; Bellemare-Pelletier, Angelique; Malhotra, Deepali; Reynoso, Erika D.; Lukacs-Kornek, Veronika; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Malhotra, Deepali] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [DeKruyff, Rosemarie H.] Harvard Univ, Sch Med, Div Immunol, Childrens Hosp Boston, Boston, MA USA; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Elpek, KG (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	shannon_turley@dfci.harvard.edu		Malhotra, Deepali/0000-0002-8215-7639	AACR; Baruj Benacerraf Postdoctoral Fellowship; American Cancer Society; National Institutes of Health (NIH) [R01 DK074500, P01 AI045757, R24 AI072073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI089955, R24AI072073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER	AACR; Baruj Benacerraf Postdoctoral Fellowship; American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by research funding from the AACR Centennial Postdoctoral Fellowship in Cancer Research to KGE, Baruj Benacerraf Postdoctoral Fellowship to VLK, American Cancer Society Research Scholar Award, National Institutes of Health (NIH) grants (R01 DK074500 and P01 AI045757) to SJT and NIH R24 AI072073 to the Immunological Genome Project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2002, J IMMUNOL, V168, P6066, DOI 10.4049/jimmunol.168.12.6066; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Park DJ, 2010, AM J PATHOL, V176, P2831, DOI 10.2353/ajpath.2010.090845; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104	50	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23921	10.1371/journal.pone.0023921	http://dx.doi.org/10.1371/journal.pone.0023921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886840	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100041
J	Fuchs, H; Mendler, MR; Scharnbeck, D; Ebsen, M; Hummler, HD				Fuchs, Hans; Mendler, Marc R.; Scharnbeck, Dominik; Ebsen, Michael; Hummler, Helmut D.			Very Low Tidal Volume Ventilation with Associated Hypercapnia - Effects on Lung Injury in a Model for Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							FACTOR-KAPPA-B; PERMISSIVE HYPERCAPNIA; CARBON-DIOXIDE; MECHANICAL VENTILATION; AIRWAY PRESSURES; NEONATAL-RATS; GAS-EXCHANGE; ACIDOSIS; ASSIST; PERMEABILITY	Background: Ventilation using low tidal volumes with permission of hypercapnia is recommended to protect the lung in acute respiratory distress syndrome. However, the most lung protective tidal volume in association with hypercapnia is unknown. The aim of this study was to assess the effects of different tidal volumes with associated hypercapnia on lung injury and gas exchange in a model for acute respiratory distress syndrome. Methodology/Principal Findings: In this randomized controlled experiment sixty-four surfactant-depleted rabbits were exposed to 6 hours of mechanical ventilation with the following targets: Group 1: tidal volume = 8-10 ml/kg/ PaCO(2) = 40 mm Hg; Group 2: tidal volume = 4-5 ml/kg/PaCO(2) = 80 mm Hg; Group 3: tidal volume = 3-4 ml/kg/ PaCO(2) = 120 mm Hg; Group 4: tidal volume = 2-3 ml/kg/PaCO(2) = 160 mm Hg. Decreased wet-dry weight ratios of the lungs, lower histological lung injury scores and higher PaO(2) were found in all low tidal volume/hypercapnia groups (group 2, 3, 4) as compared to the group with conventional tidal volume/normocapnia (group 1). The reduction of the tidal volume below 4-5 ml/kg did not enhance lung protection. However, oxygenation and lung protection were maintained at extremely low tidal volumes in association with very severe hypercapnia and no adverse hemodynamic effects were observed with this strategy. Conclusion: Ventilation with low tidal volumes and associated hypercapnia was lung protective. A tidal volume below 45 ml/kg/PaCO(2) 80 mm Hg with concomitant more severe hypercapnic acidosis did not increase lung protection in this surfactant deficiency model. However, even at extremely low tidal volumes in association with severe hypercapnia lung protection and oxygenation were maintained.	[Fuchs, Hans; Mendler, Marc R.; Scharnbeck, Dominik; Hummler, Helmut D.] Univ Ulm, Div Neonatol & Pediat Crit Care, Dept Pediat & Adolescent Med, Ulm, Germany; [Ebsen, Michael] Stadt Krankenhaus Kiel, Med Versorgungszentrum, Kiel, Germany	Ulm University	Fuchs, H (corresponding author), Univ Ulm, Div Neonatol & Pediat Crit Care, Dept Pediat & Adolescent Med, Ulm, Germany.	hans.fuchs@uniklinik-ulm.de	Hummler, Helmut/AAN-7297-2021					Bein T, 2009, ANAESTHESIA, V64, P195, DOI 10.1111/j.1365-2044.2008.05735.x; Broccard AF, 2001, AM J RESP CRIT CARE, V164, P802, DOI 10.1164/ajrccm.164.5.2007060; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carvalho CRR, 1997, AM J RESP CRIT CARE, V156, P1458, DOI 10.1164/ajrccm.156.5.9604081; Chonghaile MN, 2008, CRIT CARE MED, V36, P3135, DOI 10.1097/CCM.0b013e31818f0d13; COSTELLO J, 2009, CRIT CARE MED, V111, P1317; Dembinski R, 2007, CRIT CARE MED, V35, P2359, DOI 10.1097/01.CCM.0000281857.87354.A5; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Feihl F, 2000, AM J RESP CRIT CARE, V162, P209, DOI 10.1164/ajrccm.162.1.9907119; Galluccio Steven T, 2008, Crit Care Resusc, V10, P235; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Hummler HD, 2001, PEDIATR RES, V49, P572, DOI 10.1203/00006450-200104000-00021; Ketabchi F, 2009, AM J PHYSIOL-LUNG C, V297, pL977, DOI 10.1152/ajplung.00074.2009; Komori M, 2007, CRIT CARE MED, V35, P2171, DOI 10.1097/01.ccm.0000281445.77223.31; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; Lang JD, 2005, AM J RESP CRIT CARE, V171, P147, DOI 10.1164/rccm.200302-305OC; MacCarrick MJ, 2010, LUNG, V188, P235, DOI 10.1007/s00408-009-9211-1; Masood A, 2009, AM J PHYSIOL-LUNG C, V297, pL920, DOI 10.1152/ajplung.00139.2009; Muellenbach RM, 2008, EUR J ANAESTH, V25, P897, DOI 10.1017/S0265021508004870; Muellenbach RM, 2009, MED SCI MONITOR, V15, pBR213; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; PARKER JC, 1984, J APPL PHYSIOL, V57, P1809, DOI 10.1152/jappl.1984.57.6.1809; Pfeiffer B, 2002, CRIT CARE MED, V30, P285, DOI 10.1097/00003246-200202000-00003; Randolph AG, 2009, CRIT CARE MED, V37, P2448, DOI 10.1097/CCM.0b013e3181aee5dd; Ricard JD, 2003, AM J RESP CRIT CARE, V167, P1297, DOI 10.1164/rccm.2303003; Sinclair SE, 2002, AM J RESP CRIT CARE, V166, P403, DOI 10.1164/rccm.200112-117OC; SWENSON ER, 1994, AM J RESP CRIT CARE, V149, P1563, DOI 10.1164/ajrccm.149.6.8004314; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Wang Z, 2008, AM J RESP CRIT CARE, V177, P178, DOI 10.1164/rccm.200706-906OC; Yoshikawa S, 2004, J APPL PHYSIOL, V97, P2190, DOI 10.1152/japplphysiol.00324.2004; Zimmermann M, 2009, CRIT CARE, V13, DOI 10.1186/cc7703	36	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23816	10.1371/journal.pone.0023816	http://dx.doi.org/10.1371/journal.pone.0023816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886825	gold, Green Published, Green Submitted			2022-12-27	WOS:000294128100034
J	Uosaki, H; Fukushima, H; Takeuchi, A; Matsuoka, S; Nakatsuji, N; Yamanaka, S; Yamashita, JK				Uosaki, Hideki; Fukushima, Hiroyuki; Takeuchi, Ayako; Matsuoka, Satoshi; Nakatsuji, Norio; Yamanaka, Shinya; Yamashita, Jun K.			Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression	PLOS ONE			English	Article							DIFFERENTIATION; MOUSE; SELECTION; LINES	Rationale: Human embryonic and induced pluripotent stem cells (hESCs/hiPSCs) are promising cell sources for cardiac regenerative medicine. To realize hESC/hiPSC-based cardiac cell therapy, efficient induction, purification, and transplantation methods for cardiomyocytes are required. Though marker gene transduction or fluorescent-based purification methods have been reported, fast, efficient and scalable purification methods with no genetic modification are essential for clinical purpose but have not yet been established. In this study, we attempted to identify cell surface markers for cardiomyocytes derived from hESC/hiPSCs. Method and Result: We adopted a previously reported differentiation protocol for hESCs based on high density monolayer culture to hiPSCs with some modification. Cardiac troponin-T (TNNT2)-positive cardiomyocytes appeared robustly with 30-70% efficiency. Using this differentiation method, we screened 242 antibodies for human cell surface molecules to isolate cardiomyocytes derived from hiPSCs and identified anti-VCAM1 (Vascular cell adhesion molecule 1) antibody specifically marked cardiomyocytes. TNNT2-positive cells were detected at day 7-8 after induction and 80% of them became VCAM1-positive by day 11. Approximately 95-98% of VCAM1-positive cells at day 11 were positive for TNNT2. VCAM1 was exclusive with CD144 (endothelium), CD140b (pericytes) and TRA-1-60 (undifferentiated hESCs/hiPSCs). 95% of MACS-purified cells were positive for TNNT2. MACS purification yielded 5-10x10(5) VCAM1-positive cells from a single well of a six-well culture plate. Purified VCAM1-positive cells displayed molecular and functional features of cardiomyocytes. VCAM1 also specifically marked cardiomyocytes derived from other hESC or hiPSC lines. Conclusion: We succeeded in efficiently inducing cardiomyocytes from hESCs/hiPSCs and identifying VCAM1 as a potent cell surface marker for robust, efficient and scalable purification of cardiomyocytes from hESC/hiPSCs. These findings would offer a valuable technological basis for hESC/hiPSC-based cell therapy.	[Uosaki, Hideki; Fukushima, Hiroyuki; Yamashita, Jun K.] Kyoto Univ, Lab Stem Cell Differentiat, Stem Cell Res Ctr, Inst Frontier Med Sci, Kyoto, Japan; [Uosaki, Hideki; Fukushima, Hiroyuki; Yamashita, Jun K.] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Takeuchi, Ayako] Kyoto Univ, Dept Physiol & Biophys, Grad Sch Med, Kyoto, Japan; [Matsuoka, Satoshi] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Kyoto, Japan; [Nakatsuji, Norio] Kyoto Univ, Dept Dev & Differentiat, Inst Frontier Med Sci, Kyoto, Japan; [Yamanaka, Shinya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Uosaki, H (corresponding author), Kyoto Univ, Lab Stem Cell Differentiat, Stem Cell Res Ctr, Inst Frontier Med Sci, Kyoto, Japan.	juny@frontier.kyoto-u.ac.jp	matsuoka, satoshi/GWD-0440-2022; Uosaki, Hideki/AAQ-2619-2020	matsuoka, satoshi/0000-0003-3321-9749; Uosaki, Hideki/0000-0002-8964-8609	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour and Welfare; Project for Realization of Regenerative Medicine; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23650258, 23122509, 23689011] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan, the Ministry of Health, Labour and Welfare, the Project for Realization of Regenerative Medicine, and Japan Science and Technology Agency. H.U. and H.F. are supported by the fellowship from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; KWEE L, 1995, DEVELOPMENT, V121, P489; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Murakami Y, 2007, MECH DEVELOP, V124, P830, DOI 10.1016/j.mod.2007.09.004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Rust W, 2009, REGEN MED, V4, P225, DOI 10.2217/17460751.4.2.225; SIMMONS PJ, 1992, BLOOD, V80, P388; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917	19	212	225	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23657	10.1371/journal.pone.0023657	http://dx.doi.org/10.1371/journal.pone.0023657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876760	gold, Green Submitted, Green Published			2022-12-27	WOS:000294126900032
J	Grubb, AM; Easterbrook, SM				Grubb, Alicia M.; Easterbrook, Steve M.			On the Lack of Consensus over the Meaning of Openness: An Empirical Study	PLOS ONE			English	Article							REPRODUCIBLE RESEARCH; SCIENTIFIC-RESEARCH; PROVENANCE	This study set out to explore the views and motivations of those involved in a number of recent and current advocacy efforts (such as open science, computational provenance, and reproducible research) aimed at making science and scientific artifacts accessible to a wider audience. Using a exploratory approach, the study tested whether a consensus exists among advocates of these initiatives about the key concepts, exploring the meanings that scientists attach to the various mechanisms for sharing their work, and the social context in which this takes place. The study used a purposive sampling strategy to target scientists who have been active participants in these advocacy efforts, and an open-ended questionnaire to collect detailed opinions on the topics of reproducibility, credibility, scooping, data sharing, results sharing, and the effectiveness of the peer review process. We found evidence of a lack of agreement on the meaning of key terminology, and a lack of consensus on some of the broader goals of these advocacy efforts. These results can be explained through a closer examination of the divergent goals and approaches adopted by different advocacy efforts. We suggest that the scientific community could benefit from a broader discussion of what it means to make scientific research more accessible and how this might best be achieved.	[Grubb, Alicia M.; Easterbrook, Steve M.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto	Grubb, AM (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.	amgrubb@cs.toronto.edu		Easterbrook, Steve/0000-0002-3261-6446	NSERC [227669]; Canadian National Science and Engineering Research Council	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC, the Canadian National Science and Engineering Research Council. NSERC Grant File Number: 227669. www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZ J, 2006, OGDANOFF AFFAIR; BRADLEY JC, 2008, NATURE NEWS     0915; CORNELIUS DK, 1964, CULTURES CONICT PERS; Donoho DL, 2009, COMPUT SCI ENG, V11, P8, DOI 10.1109/MCSE.2009.15; FJALLBRANT N, 1997, P 18 IATUL C 30 JUN; Fomel S, 2009, COMPUT SCI ENG, V11, P5, DOI 10.1109/MCSE.2009.14; Freire J, 2008, COMPUT SCI ENG, V10, P11, DOI 10.1109/MCSE.2008.79; GEZELTER D, 2009, OPEN SCI PROJECT OPE; GOETZ T, 2007, WIRED MAGAZINE, P15; Hendler J, 2007, IEEE INTELL SYST, V22, P2, DOI 10.1109/MIS.2007.4338485; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1438, DOI 10.1001/jama.263.10.1438; KRONICK DA, 1990, JAMA-J AM MED ASSOC, V263, P1321, DOI 10.1001/jama.263.10.1321; McGuigan G.S., 2008, ELECT J ACAD SPECIAL, V9; Miles S, 2008, COMPUT SCI ENG, V10, P38, DOI 10.1109/MCSE.2008.82; Miller JD, 2004, PUBLIC UNDERST SCI, V13, P273, DOI 10.1177/0963662504044908; Mooney Chris, 2009, UNSCIENTIFIC AM SCI; REICH ES, 2009, PHYS WORLD       MAY, P24; RUSSELL C, 2006, 20064 JOAN SHOR CTR; RUTHERFORD A, 2008, PALIN FRUIT FLY; Silva CT, 2008, COMPUT SCI ENG, V10, P9, DOI 10.1109/MCSE.2008.71; SOKAL AD, 1996, LINGUA FRANCA, V4; Stodden V, 2009, COMPUT SCI ENG, V11, P35, DOI 10.1109/MCSE.2009.19; Strauss A., 1998, BASICS QUALITATIVE R; Willinsky J, 2003, J Postgrad Med, V49, P263; 2008, STATE NEWS MEDIA 200; 2009, OPEN NOTEBOOK SCI CH; 2009, REPRODUCIBLE RES REP; 2009, PROVENANCE CHALLENGE	28	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23420	10.1371/journal.pone.0023420	http://dx.doi.org/10.1371/journal.pone.0023420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858110	gold, Green Submitted, Green Published			2022-12-27	WOS:000294121300044
J	Sinnberg, T; Menzel, M; Ewerth, D; Sauer, B; Schwarz, M; Schaller, M; Garbe, C; Schittek, B				Sinnberg, Tobias; Menzel, Moritz; Ewerth, Daniel; Sauer, Birgit; Schwarz, Michael; Schaller, Martin; Garbe, Claus; Schittek, Birgit			beta-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; IN-VITRO; MALIGNANT-MELANOMA; EXPRESSION; COMPLEX; GROWTH; WNT; INHIBITION; ADHESION; PROLIFERATION	Beta-catenin plays an important role in embryogenesis and carcinogenesis by controlling either cadherin-mediated cell adhesion or transcriptional activation of target gene expression. In many types of cancers nuclear translocation of beta-catenin has been observed. Our data indicate that during melanoma progression an increased dependency on the transcriptional function of beta-catenin takes place. Blockade of beta-catenin in metastatic melanoma cell lines efficiently induces apoptosis, inhibits proliferation, migration and invasion in monolayer and 3-dimensional skin reconstructs and decreases chemoresistance. In addition, subcutaneous melanoma growth in SCID mice was almost completely inhibited by an inducible beta-catenin knockdown. In contrast, the survival of benign melanocytes and primary melanoma cell lines was less affected by beta-catenin depletion. However, enhanced expression of beta-catenin in primary melanoma cell lines increased invasive capacity in vitro and tumor growth in the SCID mouse model. These data suggest that beta-catenin is an essential survival factor for metastatic melanoma cells, whereas it is dispensable for the survival of benign melanocytes and primary, non-invasive melanoma cells. Furthermore, beta-catenin increases tumorigenicity of primary melanoma cell lines. The differential requirements for beta-catenin signaling in aggressive melanoma versus benign melanocytic cells make betacatenin a possible new target in melanoma therapy.	[Sinnberg, Tobias; Menzel, Moritz; Ewerth, Daniel; Sauer, Birgit; Garbe, Claus; Schittek, Birgit] Univ Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany; [Schwarz, Michael] Univ Tubingen, Inst Pharmacol & Toxicol, Dept Toxicol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sinnberg, T (corresponding author), Univ Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany.	birgit.schittek@med.uni-tuebingen.de	Sinnberg, Tobias/AFN-8316-2022; Garbe, Claus/ABH-2128-2021	Sinnberg, Tobias/0000-0003-3922-3327; Garbe, Claus/0000-0001-8530-780X; Schittek, Birgit/0000-0003-0081-2001	Deutsche Forschungsgemeinschaft [SFB 773]; Melanoma Research Network of the Deutsche Krebshilfe e. V. (German Cancer Aid)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Melanoma Research Network of the Deutsche Krebshilfe e. V. (German Cancer Aid)(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft SFB 773 and the Melanoma Research Network of the Deutsche Krebshilfe e. V. (German Cancer Aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Curley DP, 2008, PIGM CELL MELANOMA R, V21, P5, DOI 10.1111/j.1755-148X.2007.00434.x; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; HERLYN D, 1990, CANCER RES, V50, P2296; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; *HSU M YEDHM, 1999, HUM CELL CULT, V1, P259; Hsu MY, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P188; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jansen SR, 2010, AM J PHYSIOL-LUNG C, V299, pL204, DOI 10.1152/ajplung.00020.2010; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lapham A, 2009, GENE, V432, P112, DOI 10.1016/j.gene.2008.12.002; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li G, 2004, EXP CELL RES, V297, P142, DOI 10.1016/j.yexcr.2004.03.012; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Meier F, 2003, EXP DERMATOL, V12, P296, DOI 10.1034/j.1600-0625.2003.120310.x; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Minke KS, 2009, EUR J HAEMATOL, V82, P165, DOI 10.1111/j.1600-0609.2008.01188.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schittek B, 2007, INT J CANCER, V120, P2110, DOI 10.1002/ijc.22512; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Takahashi Y, 2008, INT J CANCER, V123, P2315, DOI 10.1002/ijc.23812; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Zhang T, 2001, CANCER RES, V61, P8664	57	95	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23429	10.1371/journal.pone.0023429	http://dx.doi.org/10.1371/journal.pone.0023429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858114	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300046
J	Song, W; He, DN; Brill, I; Malhotra, R; Mulenga, J; Allen, S; Hunter, E; Tang, JM; Kaslow, RA				Song, Wei; He, Dongning; Brill, Ilene; Malhotra, Rakhi; Mulenga, Joseph; Allen, Susan; Hunter, Eric; Tang, Jianming; Kaslow, Richard A.			Disparate Associations of HLA Class I Markers with HIV-1 Acquisition and Control of Viremia in an African Population	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIGEN CLASS-I; T-CELL RESPONSES; DISCORDANT COUPLES; SEX WORKERS; VIRAL LOAD; B ALLELES; HETEROSEXUAL TRANSMISSION; DISEASE PROGRESSION; ZAMBIAN COUPLES	Background: Acquisition of human immunodeficiency virus type 1 (HIV-1) infection is mediated by a combination of characteristics of the infectious and the susceptible member of a transmission pair, including human behavioral and genetic factors, as well as viral fitness and tropism. Here we report on the impact of established and potential new HLA class I determinants of heterosexual HIV-1 acquisition in the HIV-1-exposed seronegative (HESN) partners of serodiscordant Zambian couples. Methodology/Principal Findings: We assessed the relationships of behavioral and clinically documented risk factors, index partner viral load, and host genetic markers to HIV-1 transmission among 568 cohabiting couples followed for at least nine months. We genotyped subjects for three classical HLA class I genes known to influence immune control of HIV-1 infection. From 1995 to December 2006, 240 HESNs seroconverted and 328 remained seronegative. In Cox proportional hazards models, HLA-A*68:02 and the B*42-C*17 haplotype in HESN partners were significantly and independently associated with faster HIV-1 acquisition (relative hazards = 1.57 and 1.55; p = 0.007 and 0.013, respectively) after controlling for other previously established contributing factors in the index partner (viral load and specific class I alleles), in the HESN partner (age, gender), or in the couple (behavioral and clinical risk score). Few if any previously implicated class I markers were associated here with the rate of acquiring infection. Conclusions/Significance: A few HLA class I markers showed modest effects on acquisition of HIV-1 subtype C infection in HESN partners of discordant Zambian couples. However, the striking disparity between those few markers and the more numerous, different markers found to determine HIV-1 disease course makes it highly unlikely that, whatever the influence of class I variation on the rate of infection, the mechanism mediating that phenomenon is identical to that involved in disease control.	[Song, Wei; He, Dongning; Brill, Ilene; Malhotra, Rakhi; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Tang, Jianming; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Mulenga, Joseph; Allen, Susan] Rwanda Zambia HIV 1 Res Grp, Lusaka, Zambia; [Allen, Susan] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Hunter, Eric] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Emory University	Song, W (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	rkaslow@uab.edu	Tang, Jianming "James"/O-4980-2019	Tang, Jianming "James"/0000-0003-0137-7486	National Institute of Allergy and Infectious Diseases (NIAID) [AI040951, AI071906, AI064060, AI076123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071906, R01AI040951, K02AI076123, R01AI064060] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) through grants AI040951 (to S.A.), AI071906 (to R.A.K.), and AI064060 (to E.H.). J.T. is the recipient of an Independent Scientist Award (AI076123) from NIAID. The funding agency had no role in study design, data collection, data analysis, decision to publish, or preparation of this manuscript.	Addo MM, 2011, J INFECT DIS, V203, P258, DOI 10.1093/infdis/jiq028; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Brumme Z, 2009, CLIN INFECT DIS, V49, P956, DOI 10.1086/605503; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2010, AIDS, V24, P1835, DOI 10.1097/QAD.0b013e32833c3219; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Hladik F, 2003, J IMMUNOL, V171, P2671, DOI 10.4049/jimmunol.171.5.2671; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kaul R, 2004, AIDS, V18, P2087, DOI 10.1097/00002030-200410210-00015; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Lazaryan A, 2010, J VIROL, V84, P2610, DOI 10.1128/JVI.01962-09; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Liu CL, 2003, J INFECT DIS, V187, P1404, DOI 10.1086/374394; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Mackelprang RD, 2010, J INFECT DIS, V202, P1273, DOI 10.1086/656318; Teixeira SLM, 2009, INFECT GENET EVOL, V9, P638, DOI 10.1016/j.meegid.2009.03.007; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McKenna SL, 1997, AIDS, V11, pS103; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Merino A, 2011, J INFECT DIS, V203, P487, DOI 10.1093/infdis/jiq075; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang Jianming, 2003, AIDS, V17 Suppl 4, pS51, DOI 10.1097/00002030-200317004-00006; Tang JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009629; Tang JM, 2004, J INFECT DIS, V189, P1696, DOI 10.1086/383280; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Tomiyama H, 2000, EUR J IMMUNOL, V30, P2521, DOI 10.1002/1521-4141(200009)30:9<2521::AID-IMMU2521>3.0.CO;2-Q; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Turnquist HR, 2002, IMMUNOGENETICS, V53, P830, DOI 10.1007/s00251-001-0404-x; WALKER B, 2002, HARNESSING IMMUNE SY; Winchester R, 2004, JAIDS-J ACQ IMM DEF, V36, P659, DOI 10.1097/00126334-200406010-00002; Xu MY, 2004, BIOMED ENVIRON SCI, V17, P203; Yunis Edmond J, 2007, J Stem Cells, V2, P237	60	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23469	10.1371/journal.pone.0023469	http://dx.doi.org/10.1371/journal.pone.0023469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858133	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300050
J	Oshima, K; Ishii, Y; Kakizawa, S; Sugawara, K; Neriya, Y; Himeno, M; Minato, N; Miura, C; Shiraishi, T; Yamaji, Y; Namba, S				Oshima, Kenro; Ishii, Yoshiko; Kakizawa, Shigeyuki; Sugawara, Kyoko; Neriya, Yutaro; Himeno, Misako; Minato, Nami; Miura, Chihiro; Shiraishi, Takuya; Yamaji, Yasuyuki; Namba, Shigetou			Dramatic Transcriptional Changes in an Intracellular Parasite Enable Host Switching between Plant and Insect	PLOS ONE			English	Article							ONION YELLOWS PHYTOPLASMA; GENE-EXPRESSION; MECHANOSENSITIVE CHANNELS; PROTEIN; GENOME; VIRULENCE; ENVIRONMENTS; DIVERSITY; SURVIVAL; PLASMID	Phytoplasmas are bacterial plant pathogens that have devastating effects on the yields of crops and plants worldwide. They are intracellular parasites of both plants and insects, and are spread among plants by insects. How phytoplasmas can adapt to two diverse environments is of considerable interest; however, the mechanisms enabling the "host switching" between plant and insect hosts are poorly understood. Here, we report that phytoplasmas dramatically alter their gene expression in response to "host switching" between plant and insect. We performed a detailed characterization of the dramatic change that occurs in the gene expression profile of Candidatus Phytoplasma asteris OY-M strain (approximately 33% of the genes change) upon host switching between plant and insect. The phytoplasma may use transporters, secreted proteins, and metabolic enzymes in a host-specific manner. As phytoplasmas reside within the host cell, the proteins secreted from phytoplasmas are thought to play crucial roles in the interplay between phytoplasmas and host cells. Our microarray analysis revealed that the expression of the gene encoding the secreted protein PAM486 was highly upregulated in the plant host, which is also observed by immunohistochemical analysis, suggesting that this protein functions mainly when the phytoplasma grows in the plant host. Additionally, phytoplasma growth in planta was partially suppressed by an inhibitor of the MscL osmotic channel that is highly expressed in the plant host, suggesting that the osmotic channel might play an important role in survival in the plant host. These results also suggest that the elucidation of "host switching" mechanism may contribute to the development of novel pest controls.	[Oshima, Kenro; Ishii, Yoshiko; Kakizawa, Shigeyuki; Sugawara, Kyoko; Neriya, Yutaro; Himeno, Misako; Minato, Nami; Miura, Chihiro; Shiraishi, Takuya; Yamaji, Yasuyuki; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan	University of Tokyo	Oshima, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Yamazaki, Kyoko/O-4931-2014; kakizawa, shigeyuki/L-8901-2018	kakizawa, shigeyuki/0000-0003-3885-4434; Neriya, Yutaro/0000-0002-1385-0050; Oshima, Kenro/0000-0001-7327-4481	Japan Society for the Promotion of Science [21248004]; Funding Program for Next Generation World-Leading Researchers [GS005]; Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Grants-in-Aid for Scientific Research [21248004, 11J02951] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (category "A" of Scientific Research Grant 21248004), by the Funding Program for Next Generation World-Leading Researchers (project: GS005), and by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Arashida R, 2008, DNA CELL BIOL, V27, P209, DOI 10.1089/dna.2007.0654; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Christensen NM, 2004, MOL PLANT MICROBE IN, V17, P1175, DOI 10.1094/MPMI.2004.17.11.1175; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Firrao G, 2007, FRONT BIOSCI-LANDMRK, V12, P1353, DOI 10.2741/2153; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hogenhout SA, 2008, CURR OPIN PLANT BIOL, V11, P449, DOI 10.1016/j.pbi.2008.05.007; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Ishii Y, 2009, MICROBIOL-SGM, V155, P2058, DOI 10.1099/mic.0.027409-0; Kakizawa S, 2006, TRENDS MICROBIOL, V14, P254, DOI 10.1016/j.tim.2006.04.008; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim S, 2004, J VET MED SCI, V66, P1059, DOI 10.1292/jvms.66.1059; KUBE M, 2008, BMC GENOMICS, V8, P850; Nicolaisen M, 2008, J PHYTOPATHOL, V156, P403, DOI 10.1111/j.1439-0434.2007.01372.x; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Oshima K, 2001, VIROLOGY, V285, P270, DOI 10.1006/viro.2001.0938; Oshima K, 2001, PHYTOPATHOLOGY, V91, P1024, DOI 10.1094/PHYTO.2001.91.11.1024; Oshima K, 2007, MOL PLANT PATHOL, V8, P481, DOI [10.1111/j.1364-3703.2007.00408.x, 10.1111/J.1364-3703.2007.00408.X]; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sokolov BP, 2003, J NEUROSCI RES, V72, P756, DOI 10.1002/jnr.10631; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Wei W, 2004, PHYTOPATHOLOGY, V94, P244, DOI 10.1094/PHYTO.2004.94.3.244; Wirth DF, 2002, NATURE, V419, P495, DOI 10.1038/419495a	38	53	54	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23242	10.1371/journal.pone.0023242	http://dx.doi.org/10.1371/journal.pone.0023242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858041	gold, Green Published, Green Submitted			2022-12-27	WOS:000294125500022
J	Truppa, V; Mortari, EP; Garofoli, D; Privitera, S; Visalberghi, E				Truppa, Valentina; Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara; Visalberghi, Elisabetta			Same/Different Concept Learning by Capuchin Monkeys in Matching-to-Sample Tasks	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; BABOONS PAPIO-PAPIO; DISCRIMINATION; PIGEONS	The ability to understand similarities and analogies is a fundamental aspect of human advanced cognition. Although subject of considerable research in comparative cognition, the extent to which nonhuman species are capable of analogical reasoning is still debated. This study examined the conditions under which tufted capuchin monkeys (Cebus apella) acquire a same/different concept in a matching-to-sample task on the basis of relational similarity among multi-item stimuli. We evaluated (i) the ability of five capuchin monkeys to learn the same/different concept on the basis of the number of items composing the stimuli and (ii) the ability to match novel stimuli after training with both several small stimulus sets and a large stimulus set. We found the first evidence of same/different relational matching-to-sample abilities in a New World monkey and demonstrated that the ability to match novel stimuli is within the capacity of this species. Therefore, analogical reasoning can emerge in monkeys under specific training conditions.	[Truppa, Valentina; Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara; Visalberghi, Elisabetta] CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy; [Truppa, Valentina; Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara; Visalberghi, Elisabetta] CNR, Inst Cognit Sci & Technol, Ctr Primate, Rome, Italy; [Truppa, Valentina] Univ Padua, Dept Gen Psychol, Padua, Italy; [Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara] Univ Roma La Sapienza, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Padua; Sapienza University Rome	Truppa, V (corresponding author), CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy.	valentina.truppa@istc.cnr.it	Piano Mortari, Eva/Q-9402-2016; Truppa, Valentina/AAK-4510-2021	Piano Mortari, Eva/0000-0002-0054-4732; Truppa, Valentina/0000-0001-7623-7547; Visalberghi, Elisabetta/0000-0001-7407-5468	EC [29088, 231722]	EC(European CommissionEuropean Commission Joint Research Centre)	This research was supported by the EC-ANALOGY grant (#29088) and by the EC-IM-CLeVeR grant (#231722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodily KD, 2008, J EXP PSYCHOL ANIM B, V34, P178, DOI 10.1037/0097-7403.34.1.178; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; Cook RG, 2007, PSYCHON B REV, V14, P1107, DOI 10.3758/BF03193099; COSTELLO F, 2009, NEW FRONTIERS ANALOG, P97; DAMATO MR, 1989, J EXP ANAL BEHAV, V52, P225, DOI 10.1901/jeab.1989.52-225; Elmore LC, 2009, LEARN BEHAV, V37, P204, DOI 10.3758/LB.37.2.204; Fagot J, 2001, J EXP PSYCHOL ANIM B, V27, P316, DOI 10.1037/0097-7403.27.4.316; Fagot J, 2010, J EXP PSYCHOL-ANIM B, V36, P184, DOI 10.1037/a0017169; Flemming TM, 2008, J COMP PSYCHOL, V122, P176, DOI 10.1037/0735-7036.122.2.176; Flemming TM, 2007, J EXP PSYCHOL ANIM B, V33, P55, DOI 10.1037/0097-7403.33.1.55; Flemming TM, 2011, BEHAV PROCESS, V86, P316, DOI 10.1016/j.beproc.2011.01.001; French R.M., 1995, SUBTLETY SAMENESS TH; Gentner D, 1998, COGNITION, V65, P263, DOI 10.1016/S0010-0277(98)00002-X; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; Kennedy EH, 2008, J COMP PSYCHOL, V122, P167, DOI 10.1037/0735-7036.122.2.167; Maddox WT, 2004, PSYCHON B REV, V11, P945, DOI 10.3758/BF03196726; Ortony A., 1989, SIMILARITY ANALOGICA; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Premack D., 1983, MIND APE; Spinozzi G, 2004, J COMP PSYCHOL, V118, P403, DOI 10.1037/0735-7036.118.4.403; Thompson RK., 1995, COMP APPROACHES COGN, V175, P224; Thompson RKR, 2000, COGNITIVE SCI, V24, P363; Thompson RKR, 1997, J EXP PSYCHOL ANIM B, V23, P31, DOI 10.1037/0097-7403.23.1.31; Tomasello M, 1997, PRIMATE COGNITION; Truppa V, 2010, ANIM COGN, V13, P835, DOI 10.1007/s10071-010-0332-y; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; Vonk J, 2003, ANIM COGN, V6, P77, DOI 10.1007/s10071-003-0159-x; Wasserman EA, 2010, J EXP PSYCHOL-ANIM B, V36, P3, DOI 10.1037/a0016327; WRIGHT AA, 1988, ANIM LEARN BEHAV, V16, P436, DOI 10.3758/BF03209384; Young ME, 1997, J EXP PSYCHOL ANIM B, V23, P491, DOI 10.1037/0097-7403.23.4.491; Young ME, 1999, J EXP PSYCHOL ANIM B, V25, P475, DOI 10.1037/0097-7403.25.4.475; Zentall TR, 2008, COMP COGN BEHAV REV, V3, P13, DOI 10.3819/ccbr.2008.30002	35	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23809	10.1371/journal.pone.0023809	http://dx.doi.org/10.1371/journal.pone.0023809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858225	Green Submitted, Green Published, gold			2022-12-27	WOS:000294125500043
J	Tsumori, Y; Ndounga, M; Sunahara, T; Hayashida, N; Inoue, M; Nakazawa, S; Casimiro, P; Isozumi, R; Uemura, H; Tanabe, K; Kaneko, O; Culleton, R				Tsumori, Yoko; Ndounga, Mathieu; Sunahara, Toshihiko; Hayashida, Nozomi; Inoue, Megumi; Nakazawa, Shusuke; Casimiro, Prisca; Isozumi, Rie; Uemura, Haruki; Tanabe, Kazuyuki; Kaneko, Osamu; Culleton, Richard			Plasmodium falciparum: Differential Selection of Drug Resistance Alleles in Contiguous Urban and Peri-Urban Areas of Brazzaville, Republic of Congo	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; CENTRAL-AFRICA; MALARIA TRANSMISSION; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; GENETIC DIVERSITY; VARIABLE LEVELS; BLOOD-SAMPLES; IMMUNE HOSTS; BURKINA-FASO	The African continent is currently experiencing rapid population growth, with rising urbanization increasing the percentage of the population living in large towns and cities. We studied the impact of the degree of urbanization on the population genetics of Plasmodium falciparum in urban and peri-urban areas in and around the city of Brazzaville, Republic of Congo. This field setting, which incorporates local health centers situated in areas of varying urbanization, is of interest as it allows the characterization of malaria parasites from areas where the human, parasite, and mosquito populations are shared, but where differences in the degree of urbanization (leading to dramatic differences in transmission intensity) cause the pattern of malaria transmission to differ greatly. We have investigated how these differences in transmission intensity affect parasite genetic diversity, including the amount of genetic polymorphism in each area, the degree of linkage disequilibrium within the populations, and the prevalence and frequency of drug resistance markers. To determine parasite population structure, heterozygosity and linkage disequilibrium, we typed eight microsatellite markers and performed haplotype analysis of the msp1 gene by PCR. Mutations known to be associated with resistance to the antimalarial drugs chloroquine and pyrimethamine were determined by sequencing the relevant portions of the crt and dhfr genes, respectively. We found that parasite genetic diversity was comparable between the two sites, with high levels of polymorphism being maintained in both areas despite dramatic differences in transmission intensity. Crucially, we found that the frequencies of genetic markers of drug resistance against pyrimethamine and chloroquine differed significantly between the sites, indicative of differing selection pressures in the two areas.	[Tsumori, Yoko; Hayashida, Nozomi; Inoue, Megumi; Nakazawa, Shusuke; Isozumi, Rie; Uemura, Haruki; Kaneko, Osamu; Culleton, Richard] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan; [Tsumori, Yoko; Hayashida, Nozomi; Inoue, Megumi; Nakazawa, Shusuke; Isozumi, Rie; Uemura, Haruki; Kaneko, Osamu; Culleton, Richard] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan; [Ndounga, Mathieu; Casimiro, Prisca] Ctr Etud Resources Veget, Brazzaville, Rep Congo; [Sunahara, Toshihiko] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Int Hlth, Nagasaki 852, Japan; [Tanabe, Kazuyuki; Culleton, Richard] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan; [Culleton, Richard] Nagasaki Univ, Inst Trop Med NEKKEN, Malaria Unit, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Osaka University; Nagasaki University	Tsumori, Y (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan.	richard@nagasaki-u.ac.jp	Culleton, Richard/H-8327-2014	Culleton, Richard/0000-0001-8808-5771	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science [17-05495]; Grants-in-Aid for Scientific Research [22406010] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)'s Special Coordination Funds for Promoting Science and Technology Tenure-Track Research Grant (to R.C.), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science No. 17-05495 (to R.C. and K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Artzy-Randrup Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013588; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Bendixen M, 2001, T ROY SOC TROP MED H, V95, P143, DOI 10.1016/S0035-9203(01)90140-3; COENE J, 1993, MED VET ENTOMOL, V7, P127, DOI 10.1111/j.1365-2915.1993.tb00665.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; Cravo P, 2001, ANTIMICROB AGENTS CH, V45, P2897, DOI 10.1128/AAC.45.10.2897-2901.2001; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; FORSYTH KP, 1989, AM J TROP MED HYG, V41, P259, DOI 10.4269/ajtmh.1989.41.259; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Hastings IM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-130; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; HAY SI, 2005, TEST, V3, P81; HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x; Isozumi R, 2010, J CLIN MICROBIOL, V48, P70, DOI 10.1128/JCM.01449-09; Klein EY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-67; Konate L, 1999, T ROY SOC TROP MED H, V93, pS21, DOI 10.1016/S0035-9203(99)90323-1; Mackinnon MJ, 1998, T ROY SOC TROP MED H, V92, P188, DOI 10.1016/S0035-9203(98)90745-3; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; *NAT U, 2002, POP DIV DOEASA; Ndounga M, 2008, Bull Soc Pathol Exot, V101, P329, DOI 10.3185/pathexo3111; Nei M., 1987, MOL EVOLUTIONARY GEN; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; Omumbo JA, 2005, ACTA TROP, V93, P11, DOI 10.1016/j.actatropica.2004.08.010; Paganotti GM, 2004, AM J TROP MED HYG, V71, P173, DOI 10.4269/ajtmh.2004.71.173; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Plowe CV, 1998, DRUG RESIST UPDATE, V1, P389, DOI 10.1016/S1368-7646(98)80014-9; Sakihama N, 2006, AM J TROP MED HYG, V74, P31, DOI 10.4269/ajtmh.2006.74.31; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Talisuna AO, 2007, AM J TROP MED HYG, V77, P170; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P19, DOI 10.1016/0035-9203(87)90473-1; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P26, DOI 10.1016/0035-9203(87)90474-3; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P1, DOI 10.1016/0035-9203(87)90471-8; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23430	10.1371/journal.pone.0023430	http://dx.doi.org/10.1371/journal.pone.0023430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858115	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953700022
J	Wang, P; Xiao, X; Chou, KC				Wang, Pu; Xiao, Xuan; Chou, Kuo-Chen			NR-2L: A Two-Level Predictor for Identifying Nuclear Receptor Subfamilies Based on Sequence-Derived Features	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; SUBCELLULAR LOCATION; ALGORITHM	Nuclear receptors (NRs) are one of the most abundant classes of transcriptional regulators in animals. They regulate diverse functions, such as homeostasis, reproduction, development and metabolism. Therefore, NRs are a very important target for drug development. Nuclear receptors form a superfamily of phylogenetically related proteins and have been subdivided into different subfamilies due to their domain diversity. In this study, a two-level predictor, called NR-2L, was developed that can be used to identify a query protein as a nuclear receptor or not based on its sequence information alone; if it is, the prediction will be automatically continued to further identify it among the following seven subfamilies: (1) thyroid hormone like (NR1), (2) HNF4-like (NR2), (3) estrogen like, (4) nerve growth factor IB-like (NR4), (5) fushi tarazu-F1 like (NR5), (6) germ cell nuclear factor like (NR6), and (7) knirps like (NR0). The identification was made by the Fuzzy K nearest neighbor (FK-NN) classifier based on the pseudo amino acid composition formed by incorporating various physicochemical and statistical features derived from the protein sequences, such as amino acid composition, dipeptide composition, complexity factor, and low-frequency Fourier spectrum components. As a demonstration, it was shown through some benchmark datasets derived from the NucleaRDB and UniProt with low redundancy that the overall success rates achieved by the jackknife test were about 93% and 89% in the first and second level, respectively. The high success rates indicate that the novel two-level predictor can be a useful vehicle for identifying NRs and their subfamilies. As a user-friendly web server, NR-2L is freely accessible at either http://icpr.jci.edu.cn/bioinfo/NR2Lor http://www.jci-bioinfo.cn/NR2L. Each job submitted to NR-2L can contain up to 500 query protein sequences and be finished in less than 2 minutes. The less the number of query proteins is, the shorter the time will usually be. All the program codes for NR-2L are available for non-commercial purpose upon request.	[Wang, Pu; Xiao, Xuan] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Jingdezhen Ceramic Institute	Wang, P (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xiaoxuan0326@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2009GZS0064, 2010GZS0122]; Department of Education of JiangXi Province [GJJ09271]; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; Department of Education of JiangXi Province; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of JiangXi (2009GZS0064 and 2010GZS0122), the Department of Education of JiangXi Province (No. GJJ09271), and the plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018; Gusev VD, 1999, BIOINFORMATICS, V15, P994; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu T, 2010, PROTEIN PEPTIDE LETT, V17, P1263, DOI 10.2174/092986610792231528; Liu TA, 2010, J THEOR BIOL, V267, P272, DOI 10.1016/j.jtbi.2010.09.007; Liu WM, 1999, PROTEIN ENG, V12, P1041, DOI 10.1093/protein/12.12.1041; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Wang T, 2010, J THEOR BIOL, V262, P208, DOI 10.1016/j.jtbi.2009.09.027; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365	32	98	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23505	10.1371/journal.pone.0023505	http://dx.doi.org/10.1371/journal.pone.0023505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858146	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953700027
J	Marsh, L				Marsh, Lorraine			Prediction of Ligand Binding Using an Approach Designed to Accommodate Diversity in Protein-Ligand Interactions	PLOS ONE			English	Article							MOLECULAR DOCKING; SCORING FUNCTION; AFFINITY PREDICTION; NEURAL-NETWORK; COMPLEXES; ACCURACY; OPTIMIZATION; VALIDATION; INHIBITORS; DISCOVERY	Computational determination of protein-ligand interaction potential is important for many biological applications including virtual screening for therapeutic drugs. The novel internal consensus scoring strategy is an empirical approach with an extended set of 9 binding terms combined with a neural network capable of analysis of diverse complexes. Like conventional consensus methods, internal consensus is capable of maintaining multiple distinct representations of protein-ligand interactions. In a typical use the method was trained using ligand classification data (binding/no binding) for a single receptor. The internal consensus analyses successfully distinguished protein-ligand complexes from decoys (r(2), 0.895 for a series of typical proteins). Results are superior to other tested empirical methods. In virtual screening experiments, internal consensus analyses provide consistent enrichment as determined by ROC-AUC and pROC metrics.	Long Isl Univ, Dept Biol, Brooklyn, NY 11201 USA	Long Island University-Brooklyn Campus	Marsh, L (corresponding author), Long Isl Univ, Dept Biol, Brooklyn, NY 11201 USA.	lmarsh@liu.edu						Baum EB, 1989, NEURAL COMPUT, V1, P151, DOI 10.1162/neco.1989.1.1.151; Brylinski M, 2010, J CHEM INF MODEL, V50, P1839, DOI 10.1021/ci100235n; Chae MH, 2010, PROTEINS, V78, P1026, DOI 10.1002/prot.22626; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; Cheng TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-193; Cross S, 2010, J CHEM INF MODEL, V50, P1442, DOI 10.1021/ci100221g; Durrant JD, 2010, J CHEM INF MODEL, V50, P1865, DOI 10.1021/ci100244v; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fukunishi H, 2008, J CHEM INF MODEL, V48, P988, DOI 10.1021/ci700204v; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Goodarzi M, 2010, EUR J MED CHEM, V45, P3911, DOI 10.1016/j.ejmech.2010.05.045; Guimaraes CRW, 2009, J AM CHEM SOC, V131, P18139, DOI 10.1021/ja9064359; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2008, J COMPUT AID MOL DES, V22, P193, DOI 10.1007/s10822-008-9189-4; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; KIM JH, 2011, J MOL MODEL; Ko GM, 2010, J CHEM INF MODEL, V50, P1759, DOI 10.1021/ci100200u; Lee K, 2010, EUR J MED CHEM, V45, P5420, DOI 10.1016/j.ejmech.2010.09.002; Li HL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-58; Li X, 2010, J COMPUT CHEM, V31, P2109, DOI 10.1002/jcc.21498; Li Y, 2010, J CHEM INF MODEL, V50, P1682, DOI 10.1021/ci100036a; Liang SD, 2009, PROTEINS, V75, P397, DOI 10.1002/prot.22252; Lu SH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-8; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Simon Z, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-32; Thompson DC, 2008, J CHEM INF MODEL, V48, P1081, DOI 10.1021/ci700470c; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai KC, 2008, BIOORG MED CHEM LETT, V18, P3509, DOI 10.1016/j.bmcl.2008.05.026; VON KM, 2009, J CHEM INF MODEL, V49, P209; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wei DG, 2010, J CHEM INF MODEL, V50, P1855, DOI 10.1021/ci900463u; Zhao W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-225	37	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23215	10.1371/journal.pone.0023215	http://dx.doi.org/10.1371/journal.pone.0023215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860668	gold, Green Published			2022-12-27	WOS:000295454200054
J	Pastor, T; Pagani, F				Pastor, Tibor; Pagani, Franco			Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-Derived Intronic Splicing Enhancer Regulates ATM Aberrant Splicing	PLOS ONE			English	Article							BINDING; INSERTION; PROTEINS; HUR	We have previously identified an Alu-derived Intronic Splicing enhancer (ISE) in the Ataxia Teleangectasia Mutated gene (ATM) that facilitates intron pre-mRNA processing and leads to the inclusion of a cryptic exon in the final mRNA transcript. By using an RNA pull-down assay, we show here that hnRNPA1/A2, HuR and DAZAP1 splicing factors and DHX36 RNA helicase bind to the ISE. By functional studies (overexpression and siRNA experiments), we demonstrate that hnRNPA1 and DAZAP1 are indeed involved in ISE-dependent ATM cryptic exon activation, with hnRNPA1 acting negatively and DAZAP1 positively on splicing selection. On the contrary, HuR and DHX36 have no effect on ATM splicing pattern. These data suggest that splicing factors with both negative and positive effect can assemble on the intronic Alu repeats and regulate pre-mRNA splicing.	[Pastor, Tibor; Pagani, Franco] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Pastor, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	pagani@icgeb.org		Pagani, Franco/0000-0002-2678-3459	Associazione Italiana Ricerca sul Cancro [10387]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors thank the Associazione Italiana Ricerca sul Cancro, grant no. 10387. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; Dhir A, 2010, FEBS J, V277, P841, DOI 10.1111/j.1742-4658.2009.07520.x; Dhir A, 2010, EMBO J, V29, P749, DOI 10.1038/emboj.2009.397; Ganguly A, 2003, HUM GENET, V113, P348, DOI 10.1007/s00439-003-0986-5; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Khanna A, 2010, RNA BIOL, V7, P480, DOI 10.4161/rna.7.4.12746; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lewandowska MA, 2005, NUCLEIC ACIDS RES, V33, P4007, DOI 10.1093/nar/gki710; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; PAGANI F, 2003, J BIOL CHEM; Papadopoulou C, 2010, BBA-PROTEINS PROTEOM, V1804, P692, DOI 10.1016/j.bbapap.2009.11.007; Pastor T, 2009, NUCLEIC ACIDS RES, V37, P7258, DOI 10.1093/nar/gkp778; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Skoko N, 2008, FEBS LETT, V582, P2231, DOI 10.1016/j.febslet.2008.05.018; Tighe PJ, 2002, GENES IMMUN, V3, pS66, DOI 10.1038/sj.gene.6363864; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Yang HT, 2009, BIOCHEM BIOPH RES CO, V380, P705, DOI 10.1016/j.bbrc.2009.01.166	23	26	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23349	10.1371/journal.pone.0023349	http://dx.doi.org/10.1371/journal.pone.0023349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858080	Green Published, gold, Green Submitted			2022-12-27	WOS:000293773300024
J	Lesku, JA; Meyer, LCR; Fuller, A; Maloney, SK; Dell'Omo, G; Vyssotski, AL; Rattenborg, NC				Lesku, John A.; Meyer, Leith C. R.; Fuller, Andrea; Maloney, Shane K.; Dell'Omo, Giacomo; Vyssotski, Alexei L.; Rattenborg, Niels C.			Ostriches Sleep like Platypuses	PLOS ONE			English	Article							PIGEON COLUMBA-LIVIA; EYE-MOVEMENT SLEEP; TACHYGLOSSUS-ACULEATUS; PHYLOGENETIC ANALYSIS; PARADOXICAL SLEEP; MAMMALIAN SLEEP; FIELD; BRAIN; BIRDS; EEG	Mammals and birds engage in two distinct states of sleep, slow wave sleep (SWS) and rapid eye movement (REM) sleep. SWS is characterized by slow, high amplitude brain waves, while REM sleep is characterized by fast, low amplitude waves, known as activation, occurring with rapid eye movements and reduced muscle tone. However, monotremes (platypuses and echidnas), the most basal (or 'ancient') group of living mammals, show only a single sleep state that combines elements of SWS and REM sleep, suggesting that these states became temporally segregated in the common ancestor to marsupial and eutherian mammals. Whether sleep in basal birds resembles that of monotremes or other mammals and birds is unknown. Here, we provide the first description of brain activity during sleep in ostriches (Struthio camelus), a member of the most basal group of living birds. We found that the brain activity of sleeping ostriches is unique. Episodes of REM sleep were delineated by rapid eye movements, reduced muscle tone, and head movements, similar to those observed in other birds and mammals engaged in REM sleep; however, during REM sleep in ostriches, forebrain activity would flip between REM sleep-like activation and SWS-like slow waves, the latter reminiscent of sleep in the platypus. Moreover, the amount of REM sleep in ostriches is greater than in any other bird, just as in platypuses, which have more REM sleep than other mammals. These findings reveal a recurring sequence of steps in the evolution of sleep in which SWS and REM sleep arose from a single heterogeneous state that became temporally segregated into two distinct states. This common trajectory suggests that forebrain activation during REM sleep is an evolutionarily new feature, presumably involved in performing new sleep functions not found in more basal animals.	[Lesku, John A.; Rattenborg, Niels C.] Max Planck Inst Ornithol, Seewiesen, Germany; [Meyer, Leith C. R.; Fuller, Andrea; Maloney, Shane K.] Univ Witwatersrand, Johannesburg, South Africa; [Maloney, Shane K.] Univ Western Australia, Crawley, WA, Australia; [Dell'Omo, Giacomo] Ornis Ital, Rome, Italy; [Vyssotski, Alexei L.] Univ Zurich, ETH Zurich, Zurich, Switzerland	Max Planck Society; University of Witwatersrand; University of Western Australia; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Lesku, JA (corresponding author), Max Planck Inst Ornithol, Seewiesen, Germany.	rattenborg@orn.mpg.de	Fuller, Andrea/P-3133-2016; maloney, shane k/AAU-5811-2021; /ABD-1334-2021; Meyer, Leith/AAN-4930-2020	Fuller, Andrea/0000-0001-6370-8151; maloney, shane k/0000-0002-5878-2266; Dell'Omo, Giacomo/0000-0002-9601-9675; Meyer, Leith/0000-0002-5122-2469; Vyssotski, Alexei/0000-0002-9021-1471; Lesku, John/0000-0001-5073-6954	Max Planck Society; Swiss National Science Foundation [31003A-122589]; Forschungskredit Universitat Zurich	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit Universitat Zurich	This study was supported by the Max Planck Society (JAL, NCR) and by grants from the Swiss National Science Foundation (31003A-122589) and Forschungskredit Universitat Zurich (ALV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1972, ARCH ITAL BIOL, V110, P145; Amlaner CJ, 2001, SLEEP, V24, pA202; [Anonymous], 1994, PRINCIPLES PRACTICE; Ayala-Guerrero F, 2003, PHYSIOL BEHAV, V78, P435, DOI 10.1016/S0031-9384(03)00032-5; AYALAGUERRERO F, 1989, PHYSIOL BEHAV, V46, P787, DOI 10.1016/0031-9384(89)90038-3; AYALAGUERRERO F, 1988, BEHAV NEURAL BIOL, V49, P133, DOI 10.1016/S0163-1047(88)90451-7; BERGER RJ, 1972, BEHAV BIOL, V7, P183, DOI 10.1016/S0091-6773(72)80198-6; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; BUCHET C, 1986, PHYSIOL BEHAV, V38, P331, DOI 10.1016/0031-9384(86)90103-4; Calisi RM, 2009, HORM BEHAV, V56, P1, DOI 10.1016/j.yhbeh.2009.02.010; Cooper RG, 2010, TROP ANIM HEALTH PRO, V42, P363, DOI 10.1007/s11250-009-9428-2; Daan S, 2011, SLEEP BIOL RHYTHMS, V9, P1, DOI 10.1111/j.1479-8425.2010.00482.x; Deeming DC, 1999, OSTRICH: BIOLOGY, PRODUCTION AND HEALTH, P83; DEWASMES G, 1985, PHYSIOL BEHAV, V35, P67, DOI 10.1016/0031-9384(85)90173-8; Eiland MM, 2001, ARCH ITAL BIOL, V139, P23; Fuller A, 2004, INT CONGR SER, V1275, P275, DOI 10.1016/j.ics.2004.08.092; Fuller A, 2003, J EXP BIOL, V206, P1171, DOI 10.1242/jeb.00230; Goldstein DL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P237, DOI 10.1086/499995; Gusel'nikova EA, 2007, J EVOL BIOCHEM PHYS+, V43, P442, DOI 10.1134/S0022093007040114; Hartse KM, 1994, PRINCIPLES PRACTICE, P95; IMMELMANN K, 1959, NATURWISSENSCHAFTEN, V46, P564, DOI 10.1007/BF00631301; JOUVET M, 1962, Arch Ital Biol, V100, P125; Komarova T G, 2008, Neurosci Behav Physiol, V38, P245, DOI 10.1007/s11055-008-0036-9; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Lesku JA, 2008, SLEEP MED REV, V12, P229, DOI 10.1016/j.smrv.2007.10.003; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Lesku JA, 2011, P ROY SOC B-BIOL SCI, V278, P2419, DOI 10.1098/rspb.2010.2316; Lesku JA, 2009, NEUROSCI BIOBEHAV R, V33, P1024, DOI 10.1016/j.neubiorev.2009.04.002; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Manger PR, 2002, BRAIN BEHAV EVOLUT, V60, P275, DOI 10.1159/000067195; Martinez-Gonzalez D, 2008, J SLEEP RES, V17, P140, DOI 10.1111/j.1365-2869.2008.00636.x; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Nicol SC, 2000, NEUROSCI LETT, V283, P49, DOI 10.1016/S0304-3940(00)00922-8; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; OOKAWA T, 1982, J TOKYO SOC VET ZOOT, V30, P105; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Pigarev IN, 2011, EXP BRAIN RES, V210, P131, DOI 10.1007/s00221-011-2606-2; Rattenborg N. C., 2011, RAPID EYE MOVEMENT S, P58; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Rattenborg NC, 2001, BRAIN BEHAV EVOLUT, V58, P323, DOI 10.1159/000057573; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; Rattenborg NC, 2007, BRAIN RES BULL, V72, P187, DOI 10.1016/j.brainresbull.2007.02.010; ROJASRAM.JA, 1970, SCIENCE, V167, P1754, DOI 10.1126/science.167.3926.1754; Roth TC, 2006, J SLEEP RES, V15, P395, DOI 10.1111/j.1365-2869.2006.00559.x; RUCKEBUSCH Y, 1972, ANIM BEHAV, V20, P637, DOI 10.1016/S0003-3472(72)80136-2; Sauer E. G. F., 1966, Living Bird, V5, P45; SAUER EGF, 1967, AUK, V84, P571; Siegel JM, 1998, PHILOS T ROY SOC B, V353, P1147, DOI 10.1098/rstb.1998.0272; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Siegel JM, 1999, NEUROSCIENCE, V91, P391, DOI 10.1016/S0306-4522(98)00588-0; Siegel JM, 1996, J NEUROSCI, V16, P3500; Siegel JM, 2011, PRINCIPLES PRACTICE, P92; STAHEL CD, 1984, J COMP PHYSIOL, V154, P487, DOI 10.1007/BF02515153; SUSIC VT, 1973, PHYSIOL BEHAV, V11, P313, DOI 10.1016/0031-9384(73)90005-X; SZYMCZAK JT, 1993, PHYSIOL BEHAV, V53, P1201, DOI 10.1016/0031-9384(93)90380-X; SZYMCZAK JT, 1987, J COMP PHYSIOL A, V161, P321, DOI 10.1007/BF00615252; Szymusiak R, 2010, CURR OPIN PULM MED, V16, P530, DOI 10.1097/MCP.0b013e32833eec92; TOBLER I, 1988, J COMP PHYSIOL A, V163, P729, DOI 10.1007/BF00604050; TOMO AP, 1973, ANTARCT J US, V8, P202; VANTWYVER H, 1972, EXP NEUROL, V35, P138, DOI 10.1016/0014-4886(72)90065-9; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; WILLIAMS JB, 1993, ECOLOGY, V74, P390, DOI 10.2307/1939301	65	53	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23203	10.1371/journal.pone.0023203	http://dx.doi.org/10.1371/journal.pone.0023203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887239	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000295832000010
J	Wyman, MT; Charlton, BD; Locatelli, Y; Reby, D				Wyman, Megan T.; Charlton, Benjamin D.; Locatelli, Yann; Reby, David			Variability of Female Responses to Conspecific vs. Heterospecific Male Mating Calls in Polygynous Deer: An Open Door to Hybridization?	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; SIKA CERVUS-NIPPON; MATE CHOICE; RED DEER; SEXUAL SELECTION; HYBRID ZONE; PREFERENCE; EVOLUTION; BEHAVIOR; DISCRIMINATION	Males of all polygynous deer species (Cervinae) give conspicuous calls during the reproductive season. The extreme interspecific diversity that characterizes these vocalizations suggests that they play a strong role in species discrimination. However, interbreeding between several species of Cervinae indicates permeable interspecific reproductive barriers. This study examines the contribution of vocal behavior to female species discrimination and mating preferences in two closely related polygynous deer species known to hybridize in the wild after introductions. Specifically, we investigate the reaction of estrous female red deer (Cervus elaphus) to playbacks of red deer vs. sika deer (Cervus nippon) male mating calls, with the prediction that females will prefer conspecific calls. While on average female red deer preferred male red deer roars, two out of twenty females spent more time in close proximity to the speaker broadcasting male sika deer moans. We suggest that this absence of strict vocal preference for species-specific mating calls may contribute to the permeability of pre-zygotic reproductive barriers observed between these species. Our results also highlight the importance of examining inter-individual variation when studying the role of female preferences in species discrimination and intraspecific mate selection.	[Wyman, Megan T.; Reby, David] Univ Sussex, Sch Psychol, Falmer, England; [Charlton, Benjamin D.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Locatelli, Yann] Museum Natl Hist Nat, Obterre, France	University of Sussex; University of Vienna; Museum National d'Histoire Naturelle (MNHN)	Wyman, MT (corresponding author), Univ Sussex, Sch Psychol, Falmer, England.	wyman.mt@gmail.com	reby, david/A-4227-2013	Charlton, Benjamin/0000-0002-0218-7177; Locatelli, Yann/0000-0002-2657-9327; Reby, David/0000-0001-9261-1711	National Science Foundation [0908569]; Office Of The Director [0908569] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was funded by a National Science Foundation grant to M. Wyman (International Research Fellowship, grant number 0908569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNATHY K, 1994, MOL ECOL, V3, P551, DOI 10.1111/j.1365-294X.1994.tb00086.x; Andersson Malte, 1994; [Anonymous], 1963, ANIMAL SPECIES EVOLU; [Anonymous], 1968, REPROD BEHAV UNGULAT; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; BAKER MC, 1990, EVOLUTION, V44, P332, DOI 10.1111/j.1558-5646.1990.tb05202.x; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; BARTOS L, 1982, ZOOL ANZ, V208, P30; Bartos Ludek, 2009, P573, DOI 10.1007/978-4-431-09429-6_39; BASOLO AL, 1990, SCIENCE, V250, P808, DOI 10.1126/science.250.4982.808; Basolo AL, 1998, P ROY SOC B-BIOL SCI, V265, P2223, DOI 10.1098/rspb.1998.0563; Bradbury Jack W., 1998, pi; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burley NT, 2006, ANIM BEHAV, V72, P713, DOI 10.1016/j.anbehav.2006.01.017; Buss DM, 1999, J PERS, V67, P209, DOI 10.1111/1467-6494.00053; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Deregnaucourt S, 2003, ETHOLOGY, V109, P107, DOI 10.1046/j.1439-0310.2003.00854.x; Diaz A, 2006, J ZOOL, V270, P227, DOI 10.1111/j.1469-7998.2006.00130.x; Doherty JA, 1996, ANIM BEHAV, V51, P981, DOI 10.1006/anbe.1996.0101; Doi M, 2001, P NATL ACAD SCI USA, V98, P6714, DOI 10.1073/pnas.091421598; Elias DO, 2006, BEHAV ECOL, V17, P765, DOI 10.1093/beheco/arl005; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Farrell ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018533; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Freed-Brown G, 2009, P ROY SOC B-BIOL SCI, V276, P3319, DOI 10.1098/rspb.2009.0580; Gee JM, 2009, BRAIN BEHAV EVOLUT, V74, P258, DOI 10.1159/000264661; Geist V., 1998, DEER WORLD THEIR EVO; GERHARDT HC, 1994, ANIM BEHAV, V47, P959, DOI 10.1006/anbe.1994.1127; Goodman SJ, 1999, GENETICS, V152, P355; HARRINGTON R, 1973, Irish Forestry, V30, P64; HARRINGTON R, 1982, T INT C GAME BIOL, V14, P559; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; HILL GE, 1994, BEHAV ECOL, V5, P64, DOI 10.1093/beheco/5.1.64; Hobel G, 2003, EVOLUTION, V57, P894; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Izzo AS, 2011, ANIM BEHAV, V81, P259, DOI 10.1016/j.anbehav.2010.10.015; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kidjo N, 2008, BIOACOUSTICS, V18, P159, DOI 10.1080/09524622.2008.9753598; LITTLEJOHN MJ, 1976, COPEIA, P76; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; Lynch KS, 2006, HORM BEHAV, V49, P450, DOI 10.1016/j.yhbeh.2005.10.001; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCOMB K, 1987, NATURE, V330, P648, DOI 10.1038/330648a0; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; McDevitt AD, 2009, MAMM BIOL, V74, P263, DOI 10.1016/j.mambio.2009.03.015; Minami Masato, 1992, Journal of the Mammalogical Society of Japan, V17, P71; MIURA S, 1984, Z TIERPSYCHOL, V64, P33; Nuechterlein GL, 1998, BEHAV ECOL, V9, P313, DOI 10.1093/beheco/9.3.313; PALOKANGAS P, 1992, ANIM BEHAV, V43, P659, DOI 10.1016/0003-3472(92)90087-P; Perez-Espona S, 2011, MAMM BIOL, V76, P640, DOI 10.1016/j.mambio.2010.10.001; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; Pfennig KS, 2000, BEHAV ECOL, V11, P220, DOI 10.1093/beheco/11.2.220; Phelps SM, 2006, AM NAT, V167, P28, DOI 10.1086/498538; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Ptacek MB, 1997, EVOLUTION, V51, P1217, DOI 10.1111/j.1558-5646.1997.tb03969.x; Ptacek MB, 2000, BEHAV PROCESS, V51, P111, DOI 10.1016/S0376-6357(00)00123-6; Putman R.J., 1993, Deer, V9, P104; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Ryan MJ, 1993, EVOLUTIONARY PATTERN, V14, P251; SEARCY WA, 1992, AM ZOOL, V32, P71; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senn HV, 2010, J ANIM ECOL, V79, P414, DOI 10.1111/j.1365-2656.2009.01633.x; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Uetz GW, 2007, BEHAV ECOL SOCIOBIOL, V61, P631, DOI 10.1007/s00265-006-0293-y; van der Sluijs I, 2008, PHILOS T R SOC B, V363, P2871, DOI 10.1098/rstb.2008.0045; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; Van Opzeeland I, 2010, MAR ECOL PROG SER, V414, P267, DOI 10.3354/meps08683; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6	82	22	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23296	10.1371/journal.pone.0023296	http://dx.doi.org/10.1371/journal.pone.0023296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887242	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000295832000012
J	Smith, CR; Suarez, AV; Tsutsui, ND; Wittman, SE; Edmonds, B; Freauff, A; Tillberg, CV				Smith, Chris R.; Suarez, Andrew V.; Tsutsui, Neil D.; Wittman, Sarah E.; Edmonds, Benjamin; Freauff, Alex; Tillberg, Chadwick V.			Nutritional Asymmetries Are Related to Division of Labor in a Queenless Ant	PLOS ONE			English	Article							HARVESTER ANT; REPRODUCTION; SIZE; DOMINANCE; COLONIES; SOCIOGENESIS; SOCIOMETRY; WORKERS; HIERARCHY; INSECT	Eusocial species exhibit pronounced division of labor, most notably between reproductive and non-reproductive castes, but also within non-reproductive castes via morphological specialization and temporal polyethism. For species with distinct worker and queen castes, age-related differences in behavior among workers (e. g. within-nest tasks versus foraging) appear to result from physiological changes such as decreased lipid content. However, we know little about how labor is divided among individuals in species that lack a distinct queen caste. In this study, we investigated how fat storage varied among individuals in a species of ant (Dinoponera australis) that lacks a distinct queen caste and in which all individuals are morphologically similar and capable of reproduction (totipotent at birth). We distinguish between two hypotheses, 1) all individuals are physiologically similar, consistent with the possibility that any non-reproductive may eventually become reproductive, and 2) non-reproductive individuals vary in stored fat, similar to highly eusocial species, where depletion is associated with foraging and non-reproductives have lower lipid stores than reproducing individuals. Our data support the latter hypothesis. Location in the nest, the probability of foraging, and foraging effort, were all associated with decreased fat storage.	[Smith, Chris R.] Earlham Coll, Dept Biol, Richmond, IN 47374 USA; [Suarez, Andrew V.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Suarez, Andrew V.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Wittman, Sarah E.] La Trobe Univ, Dept Bot, Melbourne, Vic, Australia; [Edmonds, Benjamin; Freauff, Alex; Tillberg, Chadwick V.] Linfield Coll, Dept Biol, Mcminnville, OR USA	Earlham College; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley; La Trobe University; Linfield University	Smith, CR (corresponding author), Earlham Coll, Dept Biol, Richmond, IN 47374 USA.	crsmith.ant@gmail.com	Edmonds, Benjamin/L-7944-2019	Smith, Chris/0000-0003-4667-9509	Linfield College; MJ Murdock Charitable Trust; NSF [DEB 07-16966]	Linfield College; MJ Murdock Charitable Trust; NSF(National Science Foundation (NSF))	This work was supported by Linfield College and the MJ Murdock Charitable Trust (CVT) and NSF DEB 07-16966 (AVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURKE AFG, 1988, BEHAV ECOL SOCIOBIOL, V23, P323, DOI 10.1007/BF00300579; Cuvillier-Hot V, 2004, ANIM BEHAV, V68, P1209, DOI 10.1016/j.anbehav.2003.11.026; Cuvillier-Hot V, 2002, P ROY SOC B-BIOL SCI, V269, P1295, DOI 10.1098/rspb.2002.1991; Gordon DM, 1999, BEHAV ECOL SOCIOBIOL, V45, P370, DOI 10.1007/s002650050573; Hayashi Y, 2007, SCIENCE, V318, P985, DOI 10.1126/science.1146711; Heinze J, 1999, ANIM BEHAV, V58, P751, DOI 10.1006/anbe.1999.1188; Holldobler B., 1990, pi; HUGHES CR, 1988, BEHAVIOUR, V107, P1, DOI 10.1163/156853988X00151; Julian GE, 2004, ANIM BEHAV, V68, P1, DOI 10.1016/j.anbehav.2003.06.023; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; KERR WE, 1950, GENETICS, V35, P143; Markiewicz DA, 2001, J COMP PHYSIOL A, V187, P327, DOI 10.1007/s003590100204; Monnin T, 2002, NATURE, V419, P61, DOI 10.1038/nature00932; Monnin T, 1999, BEHAV ECOL, V10, P323, DOI 10.1093/beheco/10.3.323; Monnin T, 1999, BEHAV ECOL SOCIOBIOL, V46, P413, DOI 10.1007/s002650050637; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; Monnin T, 2008, NATURWISSENSCHAFTEN, V95, P109, DOI 10.1007/s00114-007-0297-0; Moron D, 2008, ANIM BEHAV, V75, P345, DOI 10.1016/j.anbehav.2007.06.005; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Oster G.F., 1978, Monographs in Population Biology, pi; Paiva RVS, 1995, ETHOL ECOL EVOL, V7, P297, DOI 10.1080/08927014.1995.9522938; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Peeters Christian, 1997, P372; Schwander T, 2005, BEHAV ECOL SOCIOBIOL, V59, P215, DOI 10.1007/s00265-005-0027-6; SIMPSON SJ, 1993, PHYSIOL ENTOMOL, V18, P395, DOI 10.1111/j.1365-3032.1993.tb00613.x; Smith CR, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_32.1; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Smith Chris R, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5243; STUART RJ, 1991, NATURWISSENSCHAFTEN, V78, P375, DOI 10.1007/BF01131615; SULLIVAN JD, 1984, BEHAV ECOL SOCIOBIOL, V15, P249, DOI 10.1007/BF00292986; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; Tilley CA, 1997, ANIM BEHAV, V54, P1483, DOI 10.1006/anbe.1997.0546; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; TSCHINKEL WR, 1987, INSECT SOC, V34, P143, DOI 10.1007/BF02224081; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 1998, INSECT SOC, V45, P385, DOI 10.1007/s000400050097	38	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e24011	10.1371/journal.pone.0024011	http://dx.doi.org/10.1371/journal.pone.0024011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886914	Green Published, gold, Green Submitted			2022-12-27	WOS:000294253500042
J	Nevalainen, EM; Braun, A; Vartiainen, MK; Serlachius, M; Andersson, LC; Moser, M; Lappalainen, P				Nevalainen, Elisa M.; Braun, Attila; Vartiainen, Maria K.; Serlachius, Martina; Andersson, Leif C.; Moser, Markus; Lappalainen, Pekka			Twinfilin-2a Is Dispensable for Mouse Development	PLOS ONE			English	Article								Twinfilins are evolutionarily conserved regulators of cytoskeletal dynamics. They inhibit actin polymerization by binding both actin monomers and filament barbed ends. Inactivation of the single twinfilin gene from budding yeast and fruit fly results in defects in endocytosis, cell migration, and organization of the cortical actin filament structures. Mammals express three twinfilin isoforms, of which twinfilin-1 and twinfilin-2a display largely overlapping expression patterns in non-muscle tissues of developing and adult mice. The expression of twinfilin-2b, which is generated through alternative promoter usage of the twinfilin-2 gene, is restricted to heart and skeletal muscles. However, the physiological functions of mammalian twinfilins have not been reported. As a first step towards understanding the function of twinfilin in vertebrates, we generated twinfilin-2a deficient mice by deleting exon 1 of the twinfilin-2 gene. Twinfilin-2a knockout mice developed normally to adulthood, were fertile, and did not display obvious morphological or behavioural abnormalities. Tissue anatomy and morphology in twinfilin-2a deficient mice was similar to that of wild-type littermates. These data suggest that twinfilin-2a plays a redundant role in cytoskeletal dynamics with the biochemically similar twinfilin-1, which is typically co-expressed in same tissues with twinfilin-2a.	[Nevalainen, Elisa M.; Vartiainen, Maria K.; Serlachius, Martina; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Nevalainen, Elisa M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Braun, Attila; Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Andersson, Leif C.] Univ Helsinki, Dept Pathol, HUSLAB, Helsinki, Finland	University of Helsinki; University of Helsinki; Max Planck Society; University of Helsinki	Nevalainen, EM (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	pekka.lappalainen@helsinki.fi	Vartiainen, Maria/P-7043-2019; Vartiainen, Maria K/F-4767-2013	Vartiainen, Maria/0000-0002-2017-0475; Vartiainen, Maria K/0000-0002-2017-0475; Lappalainen, Pekka/0000-0001-6227-0354	Academy of Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from Academy of Finland and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aszodi A, 1999, MOL CELL BIOL, V19, P7841; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; NEVALAINEN EM, 2009, BIOCHEM J, V2, P593; Nicholson-Dykstra S, 2005, CURR BIOL, V15, pR346, DOI 10.1016/j.cub.2005.04.029; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251	28	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22894	10.1371/journal.pone.0022894	http://dx.doi.org/10.1371/journal.pone.0022894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876732	Green Published, gold, Green Submitted			2022-12-27	WOS:000294126900004
J	Anwar, A; Hosoya, T; Leong, KM; Onogi, H; Okuno, Y; Hiramatsu, T; Koyama, H; Suzuki, M; Hagiwara, M; Garcia-Blanco, MA				Anwar, Azlinda; Hosoya, Takamitsu; Leong, Kok Mun; Onogi, Hiroshi; Okuno, Yukiko; Hiramatsu, Toshiyuki; Koyama, Hiroko; Suzuki, Masaaki; Hagiwara, Masatoshi; Garcia-Blanco, Mariano A.			The Kinase Inhibitor SFV785 Dislocates Dengue Virus Envelope Protein from the Replication Complex and Blocks Virus Assembly	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; NERVE GROWTH-FACTOR; VIRAL REPLICATION; CORE PROTEIN; NONSTRUCTURAL PROTEIN; RNA REPLICATION; GENE-EXPRESSION; LIPID DROPLET; CELL-LINES; INFECTION	Dengue virus (DENV) is the etiologic agent for dengue fever, for which there is no approved vaccine or specific anti-viral drug. As a remedy for this, we explored the use of compounds that interfere with the action of required host factors and describe here the characterization of a kinase inhibitor (SFV785), which has selective effects on NTRK1 and MAPKAPK5 kinase activity, and anti-viral activity on Hepatitis C, DENV and yellow fever viruses. SFV785 inhibited DENV propagation without inhibiting DENV RNA synthesis or translation. The compound did not cause any changes in the cellular distribution of non-structural 3, a protein critical for DENV RNA synthesis, but altered the distribution of the structural envelope protein from a reticulate network to enlarged discrete vesicles, which altered the co-localization with the DENV replication complex. Ultrastructural electron microscopy analyses of DENV-infected SFV785-treated cells showed the presence of viral particles that were distinctly different from viable enveloped virions within enlarged ER cisternae. These viral particles were devoid of the dense nucleocapsid. The secretion of the viral particles was not inhibited by SFV785, however a reduction in the amount of secreted infectious virions, DENV RNA and capsid were observed. Collectively, these observations suggest that SFV785 inhibited the recruitment and assembly of the nucleocapsid in specific ER compartments during the DENV assembly process and hence the production of infectious DENV. SFV785 and derivative compounds could be useful biochemical probes to explore the DENV lifecycle and could also represent a new class of anti-virals.	[Anwar, Azlinda; Leong, Kok Mun; Garcia-Blanco, Mariano A.] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Hosoya, Takamitsu; Hiramatsu, Toshiyuki] Tokyo Med & Dent Univ, Biol Chem Lab, Grad Sch Biomed Sci, Tokyo, Japan; [Hosoya, Takamitsu; Onogi, Hiroshi; Okuno, Yukiko; Hiramatsu, Toshiyuki; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Onogi, Hiroshi; Okuno, Yukiko; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Gene Express Lab, Grad Sch Biomed Sci, Tokyo, Japan; [Onogi, Hiroshi] KinoPharma Inc, Tokyo, Japan; [Koyama, Hiroko] Gifu Univ, Grad Sch Med, Div Regenerat & Adv Med Sci, Gifu, Japan; [Suzuki, Masaaki] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan; [Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto, Japan; [Garcia-Blanco, Mariano A.] Duke Univ, Sch Med, Ctr RNA Biol, Dept Mol Genet & Microbiol, Durham, NC USA; [Garcia-Blanco, Mariano A.] Duke Univ, Sch Med, Ctr RNA Biol, Dept Med, Durham, NC USA	National University of Singapore; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Gifu University; RIKEN; Kyoto University; Duke University; Duke University	Anwar, A (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.	gmsaa@nus.edu.sg; hagiwara.masatoshi.8c@kyoto-u.ac.jp; mariano.garciablanco@duke-nus.edu.sg	Hosoya, Takamitsu/N-7762-2015	Hosoya, Takamitsu/0000-0002-7270-351X	Agency for Science, Technology and Research of Singapore; Singapore Ministry of Health [R-913-200-002-304]; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21249013]; The Uehara Memorial Foundation; The Naito Foundation; Takeda Science Foundation	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health(Ministry of Health-Singapore); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); The Naito Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Agency for Science, Technology and Research of Singapore and the Singapore Ministry of Health Awards R-913-200-002-304 (to M. G. B), and by Grants-in-aid (MH) from Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science, and Technology of Japan (21249013), The Uehara Memorial Foundation, The Naito Foundation Natural Science Scholarship, and Takeda Science Foundation (to M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 2006, ANAL BIOCHEM, V352, P120, DOI 10.1016/j.ab.2006.01.046; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Choi Yook-Wah, 2004, Biochemical and Biophysical Research Communications, V318, P514, DOI 10.1016/j.bbrc.2004.04.052; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gould E., 1985, VIROLOGY PRACTICAL A, P43; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Houlden H, 2001, ANN NEUROL, V49, P521; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jordan R, 1998, J VIROL, V72, P5373, DOI 10.1128/JVI.72.7.5373-5382.1998; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Kriesel JD, 2002, DNA CELL BIOL, V21, P475, DOI 10.1089/10445490260099773; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Murakami K, 2008, J GEN VIROL, V89, P1587, DOI 10.1099/vir.0.83618-0; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; *PED DENG VACC INT, GLOB BURD DENG; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Tanabe Y, 2004, J INFECT DIS, V189, P1129, DOI 10.1086/382595; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Yoon SW, 2006, MOL CELLS, V21, P112	53	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23246	10.1371/journal.pone.0023246	http://dx.doi.org/10.1371/journal.pone.0023246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858043	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300023
J	Dey, B; Jain, R; Gupta, UD; Katoch, VM; Ramanathan, VD; Tyagi, AK				Dey, Bappaditya; Jain, Ruchi; Gupta, Umesh D.; Katoch, V. M.; Ramanathan, V. D.; Tyagi, Anil K.			A Booster Vaccine Expressing a Latency-Associated Antigen Augments BCG Induced Immunity and Confers Enhanced Protection against Tuberculosis	PLOS ONE			English	Article							CD4 T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; DNA VACCINES; GUINEA-PIGS; EFFICACY; IMMUNOGENICITY; COMPONENTS; INFECTION; EFFICIENT; RESPONSES	Background: In spite of a consistent protection against tuberculosis (TB) in children, Mycobacterium bovis Bacille Calmette-Guerin (BCG) fails to provide adequate protection against the disease in adults as well as against reactivation of latent infections or exogenous reinfections. It has been speculated that failure to generate adequate memory T cell response, elicitation of inadequate immune response against latency-associated antigens and inability to impart long-term immunity against M. tuberculosis infections are some of the key factors responsible for the limited efficiency of BCG in controlling TB. Methods/Principal Findings: In this study, we evaluated the ability of a DNA vaccine expressing alpha-crystallin-a key latency antigen of M. tuberculosis to boost the BCG induced immunity. 'BCG prime - DNA boost' regimen (B/D) confers robust protection in guinea pigs along with a reduced pathology in comparison to BCG vaccination (1.37 log(10) and 1.96 log10 fewer bacilli in lungs and spleen, respectively; p<0.01). In addition, B/D regimen also confers enhanced protection in mice. Further, we show that B/D immunization in mice results in a heightened frequency of PPD and antigen specific multifunctional CD4 T cells (3(+)) simultaneously producing interferon (IFN)gamma, tumor necrosis factor (TNF)alpha and interleukin (IL)2. Conclusions/Significance: These results clearly indicate the superiority of alpha-crystallin based B/D regimen over BCG. Our study, also demonstrates that protection against TB is predictable by an increased frequency of 3(+) Th1 cells with superior effector functions. We anticipate that this study would significantly contribute towards the development of superior booster vaccines for BCG vaccinated individuals. In addition, this regimen can also be expected to reduce the risk of developing active TB due to reactivation of latent infection.	[Dey, Bappaditya; Jain, Ruchi; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Umesh D.; Katoch, V. M.] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Ramanathan, V. D.] TB Res Ctr, Dept Clin Pathol, Chennai, Tamil Nadu, India	University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Dey, B (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Dey, Bappaditya/H-1831-2018	Dey, Bappaditya/0000-0003-2728-4683	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brooks JV, 2001, INFECT IMMUN, V69, P2714, DOI 10.1128/IAI.69.4.2714-2717.2001; Chambers MA, 2002, INFECT IMMUN, V70, P2159, DOI 10.1128/IAI.70.4.2159-2165.2002; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018773; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Goncalves Eduardo D C, 2007, Genet Vaccines Ther, V5, P7, DOI 10.1186/1479-0556-5-7; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Khera A, 2005, VACCINE, V23, P5655, DOI 10.1016/j.vaccine.2005.03.056; Lozes E, 1997, VACCINE, V15, P830, DOI 10.1016/S0264-410X(96)00274-5; Ly LH, 2008, EXPERT REV VACCINES, V7, P635, DOI 10.1586/14760584.7.5.635; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; PGAMAR S, EPIDEMIOLOGY TUBERCU; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SHI C, VACCINE, V28, P5237; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Sugawara I, 2003, TUBERCULOSIS, V83, P331, DOI 10.1016/S1472-9792(03)00054-4; Tanghe A, 1999, J IMMUNOL, V162, P1113; Tascon RE, 1996, NAT MED, V2, P888, DOI 10.1038/nm0896-888; Taylor JL, 2003, INFECT IMMUN, V71, P2192, DOI 10.1128/IAI.71.4.2192-2198.2003	35	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23360	10.1371/journal.pone.0023360	http://dx.doi.org/10.1371/journal.pone.0023360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858087	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000294121300038
J	Reinecke, JB; DeVos, SL; McGrath, JP; Shepard, AM; Goncharoff, DK; Tait, DN; Fleming, SR; Vincent, MP; Steinhilb, ML				Reinecke, James B.; DeVos, Sarah L.; McGrath, James P.; Shepard, Amanda M.; Goncharoff, Dustin K.; Tait, Don N.; Fleming, Samantha R.; Vincent, Michael P.; Steinhilb, Michelle L.			Implicating Calpain in Tau-Mediated Toxicity In Vivo	PLOS ONE			English	Article							CONFOCAL IMMUNOFLUORESCENCE; INDUCED NEURODEGENERATION; CLEAVAGE; DROSOPHILA; AGGREGATION; ACTIVATION; TAUOPATHY; PHOSPHORYLATION; NEUROTOXICITY; PROTEOLYSIS	Alzheimer's disease and other related neurodegenerative disorders known as tauopathies are characterized by the accumulation of abnormally phosphorylated and aggregated forms of the microtubule-associated protein tau. Several laboratories have identified a 17 kD proteolytic fragment of tau in degenerating neurons and in numerous cell culture models that is generated by calpain cleavage and speculated to contribute to tau toxicity. In the current study, we employed a Drosophila tauopathy model to investigate the importance of calpain-mediated tau proteolysis in contributing to tau neurotoxicity in an animal model of human neurodegenerative disease. We found that mutations that disrupted endogenous calpainA or calpainB activity in transgenic flies suppressed tau toxicity. Expression of a calpain-resistant form of tau in Drosophila revealed that mutating the putative calpain cleavage sites that produce the 17 kD fragment was sufficient to abrogate tau toxicity in vivo. Furthermore, we found significant toxicity in the fly retina associated with expression of only the 17 kD tau fragment. Collectively, our data implicate calpain-mediated proteolysis of tau as an important pathway mediating tau neurotoxicity in vivo.	[Reinecke, James B.; DeVos, Sarah L.; McGrath, James P.; Shepard, Amanda M.; Goncharoff, Dustin K.; Tait, Don N.; Fleming, Samantha R.; Vincent, Michael P.; Steinhilb, Michelle L.] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA	Central Michigan University	Reinecke, JB (corresponding author), Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA.	stein3ml@cmich.edu	Vincent, Michael/H-4939-2015	Vincent, Michael/0000-0001-9669-4921	National Institutes of Health [1 R15 AG032105-01]; Central Michigan University through the Office of Research; NATIONAL INSTITUTE ON AGING [R15AG032105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Michigan University through the Office of Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health Academic Research Enhancement Award (1 R15 AG032105-01) to MLS (www.nih.gov), and a Research Excellence Fund award - internal grant from Central Michigan University through the Office of Research and Sponsored Programs to MLS (http://www.orsp.cmich.edu/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec E, 2000, NEUROSCIENCE, V100, P663, DOI 10.1016/S0306-4522(00)00281-5; Adamec E, 2002, J NEUROL SCI, V200, P85, DOI 10.1016/S0022-510X(02)00150-8; Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; Amadoro G, 2007, NEUROPHARMACOLOGY, V52, P1366, DOI 10.1016/j.neuropharm.2007.01.020; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Canu N, 1998, J NEUROSCI, V18, P7061; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Delobel P, 2005, FEBS LETT, V579, P1, DOI 10.1016/j.febslet.2004.11.018; Delobel P, 2003, ANN NY ACAD SCI, V1010, P623, DOI 10.1196/annals.1299.115; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Feuillette S, 2010, BRAIN RES, V1345, P182, DOI 10.1016/j.brainres.2010.05.007; Feuillette S, 2010, J NEUROCHEM, V113, P895, DOI 10.1111/j.1471-4159.2010.06663.x; Friedrich P, 2004, BIOESSAYS, V26, P1088, DOI 10.1002/bies.20106; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hung KS, 2005, J NEUROPATH EXP NEUR, V64, P15, DOI 10.1093/jnen/64.1.15; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima-Ando K, 2010, HUM MOL GENET, V19, P1930, DOI 10.1093/hmg/ddq068; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Kraft R, 1998, J NEUROSCI, V18, P8886; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li PA, 1998, NEUROSCI LETT, V247, P17, DOI 10.1016/S0304-3940(98)00266-3; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Loewen CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013084; Mittoo S, 2003, ANAL BIOCHEM, V319, P234, DOI 10.1016/S0003-2697(03)00324-5; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Nicholson AM, 2011, J BIOL CHEM, V286, P976, DOI 10.1074/jbc.M110.154138; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; PETERSON C, 1986, P NATL ACAD SCI USA, V83, P2758, DOI 10.1073/pnas.83.8.2758; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Shulman JM, 2003, GENETICS, V165, P1233; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sinjoanu RC, 2008, NEUROCHEM INT, V53, P79, DOI 10.1016/j.neuint.2008.06.003; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Steinhilb ML, 2007, J NEUROSCI RES, V85, P1271, DOI 10.1002/jnr.21232; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Xie HQ, 1998, J NEUROSCI RES, V53, P153, DOI 10.1002/(SICI)1097-4547(19980715)53:2<153::AID-JNR4>3.3.CO;2-5; Xie HQ, 1997, J NEUROCHEM, V69, P1020; YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x	63	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23865	10.1371/journal.pone.0023865	http://dx.doi.org/10.1371/journal.pone.0023865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858230	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300101
J	Shindo, Y; Fujii, T; Komatsu, H; Citterio, D; Hotta, K; Suzuki, K; Oka, K				Shindo, Yutaka; Fujii, Tomohiko; Komatsu, Hirokazu; Citterio, Daniel; Hotta, Kohji; Suzuki, Koji; Oka, Kotaro			Newly Developed Mg2+-Selective Fluorescent Probe Enables Visualization of Mg2+ Dynamics in Mitochondria	PLOS ONE			English	Article							PC12 CELLS; EMBRYONIC-DEVELOPMENT; MAGNESIUM-DEFICIENCY; CELLULAR MAGNESIUM; CALCIUM; MECHANISM; DISEASE; NEURONS; NEURODEGENERATION; TRANSPORTERS	Mg2+ plays important roles in numerous cellular functions. Mitochondria take part in intracellular Mg2+ regulation and the Mg2+ concentration in mitochondria affects the synthesis of ATP. However, there are few methods to observe Mg2+ in mitochondria in intact cells. Here, we have developed a novel Mg2+-selective fluorescent probe, KMG-301, that is functional in mitochondria. This probe changes its fluorescence properties solely depending on the Mg2+ concentration in mitochondria under physiologically normal conditions. Simultaneous measurements using this probe together with a probe for cytosolic Mg2+, KMG-104, enabled us to compare the dynamics of Mg2+ in the cytosol and in mitochondria. With this method, carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP)-induced Mg2+ mobilization from mitochondria to the cytosol was visualized. Although a FCCP-induced decrease in the Mg2+ concentration in mitochondria and an increase in the cytosol were observed both in differentiated PC12 cells and in hippocampal neurons, the time-courses of concentration changes varied with cell type. Moreover, the relationship between mitochondrial Mg2+ and Parkinson's disease was analyzed in a cellular model of Parkinson's disease by using the 1-methyl-4-phenylpyridinium ion (MPP+). A gradual decrease in the Mg2+ concentration in mitochondria was observed in response to MPP+ in differentiated PC12 cells. These results indicate that KMG-301 is useful for investigating Mg2+ dynamics in mitochondria. All animal procedures to obtain neurons from Wistar rats were approved by the ethical committee of Keio University (permit number is 09106-(1)).	[Shindo, Yutaka; Fujii, Tomohiko; Hotta, Kohji; Oka, Kotaro] Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Grad Sch Sci & Technol, Kanagawa, Japan; [Komatsu, Hirokazu; Citterio, Daniel; Suzuki, Koji] Keio Univ, Ctr Sci & Technol Designing Funct, Sch Integrated Design Engn, Grad Sch Sci & Technol, Kanagawa, Japan	Keio University; Keio University	Shindo, Y (corresponding author), Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Grad Sch Sci & Technol, Kanagawa, Japan.	oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014; Citterio, Daniel/B-7975-2008	Hotta, Kohji/0000-0003-4614-7473; Citterio, Daniel/0000-0001-7420-045X	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S0801008]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2008-2012, (S0801008) (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasi E, 2005, J ALZHEIMERS DIS, V7, P273; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; BOGUCKA K, 1976, BIOCHEM BIOPH RES CO, V71, P161, DOI 10.1016/0006-291X(76)90263-1; Boska MD, 2002, NEUROLOGY, V58, P1227, DOI 10.1212/WNL.58.8.1227; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Chaudhary DP, 2010, BIOL TRACE ELEM RES, V134, P119, DOI 10.1007/s12011-009-8465-z; Cole DEC, 2000, J AM SOC NEPHROL, V11, P1937, DOI 10.1681/ASN.V11101937; Di Francesco A, 1998, ARCH BIOCHEM BIOPHYS, V360, P149, DOI 10.1006/abbi.1998.0937; Drummond RM, 1999, J PHYSIOL-LONDON, V516, P139, DOI 10.1111/j.1469-7793.1999.139aa.x; Gabriel TE, 2007, ARCH BIOCHEM BIOPHYS, V458, P3, DOI 10.1016/j.abb.2006.07.007; Gunzel D, 2001, BIOPHYS J, V80, P1298, DOI 10.1016/S0006-3495(01)76104-8; Hashimoto T, 2008, BRAIN RES, V1197, P143, DOI 10.1016/j.brainres.2007.12.033; Jaiswal MK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-64; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Ko YH, 1999, J BIOL CHEM, V274, P28853, DOI 10.1074/jbc.274.41.28853; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Komatsu H, 2005, J AM CHEM SOC, V127, P10798, DOI 10.1021/ja0528228; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Kubota T, 2005, BBA-MOL CELL RES, V1744, P19, DOI 10.1016/j.bbamcr.2004.10.013; Kubota T, 2003, BIOCHEM BIOPH RES CO, V303, P332, DOI 10.1016/S0006-291X(03)00346-2; Liou AKF, 2005, FASEB J, V19, P1350, DOI 10.1096/fj.04-3258fje; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Oyanagi K, 2006, NEUROPATHOLOGY, V26, P115, DOI 10.1111/j.1440-1789.2006.00672.x; Panov A, 1996, BIOCHEMISTRY-US, V35, P12849, DOI 10.1021/bi960139f; Piskacek M, 2009, J CELL MOL MED, V13, P693, DOI 10.1111/j.1582-4934.2008.00328.x; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shindo Y, 2010, J NEUROSCI RES, V88, P3125, DOI 10.1002/jnr.22467; Shoda T, 2003, ANALYST, V128, P719, DOI 10.1039/b212835g; SONTIA B, 2006, ARCH BIOCH BIOPHYS; Stout AK, 1999, NEUROSCIENCE, V89, P91, DOI 10.1016/S0306-4522(98)00441-2; Suzuki Y, 2002, ANAL CHEM, V74, P1423, DOI 10.1021/ac010914j; Trapani V, 2010, ANALYST, V135, P1855, DOI 10.1039/c0an00087f; Trollinger DR, 2000, BIOPHYS J, V79, P39, DOI 10.1016/S0006-3495(00)76272-2; vandePut FHMM, 1996, J BIOL CHEM, V271, P4999; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Xu Z, 2005, NEUROTOXICOLOGY, V26, P729, DOI 10.1016/j.neuro.2004.12.008; YASUI M, 1992, NEUROTOXICOLOGY, V13, P593; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zsurka G, 2001, GENOMICS, V72, P158, DOI 10.1006/geno.2000.6407	50	47	50	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23684	10.1371/journal.pone.0023684	http://dx.doi.org/10.1371/journal.pone.0023684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858208	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500041
J	Kasukawa, T; Masumoto, K; Nikaido, I; Nagano, M; Uno, KD; Tsujino, K; Hanashima, C; Shigeyoshi, Y; Ueda, HR				Kasukawa, Takeya; Masumoto, Koh-hei; Nikaido, Itoshi; Nagano, Mamoru; Uno, Kenichiro D.; Tsujino, Kaori; Hanashima, Carina; Shigeyoshi, Yasufumi; Ueda, Hiroki R.			Quantitative Expression Profile of Distinct Functional Regions in the Adult Mouse Brain	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; TRANSCRIPTIONAL NETWORK; CIRCADIAN CLOCK; MICROARRAY DATA; HOMEOBOX GENES; RAT-BRAIN; GENOME; ATLAS	The adult mammalian brain is composed of distinct regions with specialized roles including regulation of circadian clocks, feeding, sleep/awake, and seasonal rhythms. To find quantitative differences of expression among such various brain regions, we conducted the BrainStars (B*) project, in which we profiled the genome-wide expression of similar to 50 small brain regions, including sensory centers, and centers for motion, time, memory, fear, and feeding. To avoid confounds from temporal differences in gene expression, we sampled each region every 4 hours for 24 hours, and pooled the samples for DNA-microarray assays. Therefore, we focused on spatial differences in gene expression. We used informatics to identify candidate genes with expression changes showing high or low expression in specific regions. We also identified candidate genes with stable expression across brain regions that can be used as new internal control genes, and ligand-receptor interactions of neurohormones and neurotransmitters. Through these analyses, we found 8,159 multi-state genes, 2,212 regional marker gene candidates for 44 small brain regions, 915 internal control gene candidates, and 23,864 inferred ligand-receptor interactions. We also found that these sets include well-known genes as well as novel candidate genes that might be related to specific functions in brain regions. We used our findings to develop an integrated database (http://brainstars.org/) for exploring genome-wide expression in the adult mouse brain, and have made this database openly accessible. These new resources will help accelerate the functional analysis of the mammalian brain and the elucidation of its regulatory network systems.	[Kasukawa, Takeya; Nikaido, Itoshi; Uno, Kenichiro D.; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Kobe, Hyogo, Japan; [Masumoto, Koh-hei; Nikaido, Itoshi; Tsujino, Kaori; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Kobe, Hyogo, Japan; [Masumoto, Koh-hei; Nagano, Mamoru; Shigeyoshi, Yasufumi] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan; [Tsujino, Kaori; Ueda, Hiroki R.] Osaka Univ, Grad Sch Sci, Osaka, Japan; [Hanashima, Carina] RIKEN Ctr Dev Biol, Lab Neocort Dev, Kobe, Hyogo, Japan; [Ueda, Hiroki R.] Kyoto Univ, Grad Sch Sci, Dept Math, Kyoto, Japan; [Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Kobe, Hyogo, Japan	RIKEN; RIKEN; Kindai University (Kinki University); Osaka University; RIKEN; Kyoto University; RIKEN	Kasukawa, T (corresponding author), RIKEN Ctr Dev Biol, Funct Genom Unit, Kobe, Hyogo, Japan.	shigey@med.kindai.ac.jp; uedah-tky@umin.ac.jp	Kasukawa, Takeya/N-5070-2015; Nikaido, Itoshi/K-2058-2014; Ueda, Hiroki R/C-5037-2014	Kasukawa, Takeya/0000-0001-5085-0802; Nikaido, Itoshi/0000-0002-7261-2570; Ueda, Hiroki R/0000-0001-8342-9176	RIKEN Center for Developmental Biology; Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Center for Developmental Biology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was done as a part of the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (H. R. U.). This research was supported by an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology (H. R. U.), and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; Ahmad Sultan, 2004, Curr Opin Investig Drugs, V5, P67; Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bear M, 2016, NEUROSCIENCE EXPLORI; Bishop C. M, 2006, PATTERN RECOGNITION; Bitton DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-118; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BREDER CD, 1992, J NEUROSCI, V12, P3920; Brodmann K, 1909, VERGLEICHENDE LOKALI; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin MH, 2007, PHYSIOL GENOMICS, V30, P313, DOI 10.1152/physiolgenomics.00287.2006; Dunlap JC, CHRONOBIOLOGY BIOL T; Ertel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-3; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Gormley M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-486; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HalbachOvBu, 2006, NEUROTRANSMITTERS NE; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Horuk R, 1996, J LEUKOCYTE BIOL, V59, P29, DOI 10.1002/jlb.59.1.29; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Ignatov A, 2004, NEUROPHARMACOLOGY, V46, P1114, DOI 10.1016/j.neuropharm.2004.02.004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Isogawa K, 2005, NEUROPSYCHOBIOLOGY, V51, P34, DOI 10.1159/000082853; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; JAMES R, 1991, J BIOL CHEM, V266, P3246; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lau C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-153; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee CK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r23; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Miano JM, 1996, P NATL ACAD SCI USA, V93, P900, DOI 10.1073/pnas.93.2.900; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nadler JJ, 2006, GENETICS, V174, P1229, DOI 10.1534/genetics.106.061481; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; PERRY EK, 1993, HIPPOCAMPUS, V3, P307, DOI 10.1002/hipo.450030306; Reghunandanan Vallath, 2006, J Circadian Rhythms, V4, P2; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Venkataraman S, 2008, NUCLEIC ACIDS RES, V36, pD860, DOI 10.1093/nar/gkm938; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; Wolpert L, 2007, PRINCIPLES DEV; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	69	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23228	10.1371/journal.pone.0023228	http://dx.doi.org/10.1371/journal.pone.0023228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858037	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953500026
J	Ballandras, A; Moreau, K; Robert, X; Confort, MP; Merceron, R; Haser, R; Ronfort, C; Gouet, P				Ballandras, Allison; Moreau, Karen; Robert, Xavier; Confort, Marie-Pierre; Merceron, Romain; Haser, Richard; Ronfort, Corinne; Gouet, Patrice			A Crystal Structure of the Catalytic Core Domain of an Avian Sarcoma and Leukemia Virus Integrase Suggests an Alternate Dimeric Assembly	PLOS ONE			English	Article							RETROVIRAL DNA INTEGRATION; CARBOXYL-TERMINAL DOMAINS; HIV-1 INTEGRASE; ACTIVE-SITE; REVERSE TRANSCRIPTION; TYPE-1 INTEGRASE; PROTEIN; INHIBITORS; MUTATIONS; BINDING	Integrase (IN) is an important therapeutic target in the search for anti-Human Immunodeficiency Virus (HIV) inhibitors. This enzyme is composed of three domains and is hard to crystallize in its full form. First structural results on IN were obtained on the catalytic core domain (CCD) of the avian Rous and Sarcoma Virus strain Schmidt-Ruppin A (RSV-A) and on the CCD of HIV-1 IN. A ribonuclease-H like motif was revealed as well as a dimeric interface stabilized by two pairs of alpha-helices (alpha 1/alpha 5, alpha 5/alpha 1). These structural features have been validated in other structures of IN CCDs. We have determined the crystal structure of the Rous-associated virus type-1 (RAV-1) IN CCD to 1.8 angstrom resolution. RAV-1 IN shows a standard activity for integration and its CCD differs in sequence from that of RSV-A by a single accessible residue in position 182 (substitution A182T). Surprisingly, the CCD of RAV-1 IN associates itself with an unexpected dimeric interface characterized by three pairs of alpha-helices (alpha 3/alpha 5, alpha 1/alpha 1, alpha 5/alpha 3). A182 is not involved in this novel interface, which results from a rigid body rearrangement of the protein at its alpha 1, alpha 3, alpha 5 surface. A new basic groove that is suitable for single-stranded nucleic acid binding is observed at the surface of the dimer. We have subsequently determined the structure of the mutant A182T of RAV-1 IN CCD and obtained a RSV-A IN CCD-like structure with two pairs of buried alpha-helices at the interface. Our results suggest that the CCD of avian INs can dimerize in more than one state. Such flexibility can further explain the multifunctionality of retroviral INs, which beside integration of dsDNA are implicated in different steps of the retroviral cycle in presence of viral ssRNA.	[Ballandras, Allison; Robert, Xavier; Merceron, Romain; Haser, Richard; Gouet, Patrice] Univ Lyon, Inst Biol & Chim Prot, BMSSI Ctr Natl Rech Sci, UMR 5086, Lyon, France; [Moreau, Karen; Confort, Marie-Pierre; Ronfort, Corinne] Univ Lyon, Lab Retrovirus & Pathol Comparee, Inst Natl Rech Agron, Ecole Natl Vet Lyon,UMR 754, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; VetAgro Sup	Ballandras, A (corresponding author), Univ Lyon, Inst Biol & Chim Prot, BMSSI Ctr Natl Rech Sci, UMR 5086, Lyon, France.	ronfort@univ-lyon1.fr; p.gouet@ibcp.fr	Moreau, Karen L/L-9903-2014; ROBERT, Xavier/C-3879-2015	Moreau, Karen L/0000-0001-6297-3543; ROBERT, Xavier/0000-0002-6174-8595; Ballandras-Colas, Allison/0000-0003-4735-4984; gouet, patrice/0000-0001-9485-6157	Cluster 10 Infectiology of the Rhone-Alpes Region	Cluster 10 Infectiology of the Rhone-Alpes Region(Region Auvergne-Rhone-Alpes)	AB is supported by a Ph. D. grant from the Cluster 10 Infectiology of the Rhone-Alpes Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrake MD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-73; ANDRAKE MD, 1995, J BIOL CHEM, V270, P29299, DOI 10.1074/jbc.270.49.29299; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Coleman J, 1999, J BIOL CHEM, V274, P32842, DOI 10.1074/jbc.274.46.32842; *DELANO WL, 2008, PYMOL MOL GRAPH SYST; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kukolj G, 1997, J VIROL, V71, P843, DOI 10.1128/JVI.71.1.843-847.1997; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Lubkowski J, 1998, P NATL ACAD SCI USA, V95, P4831, DOI 10.1073/pnas.95.9.4831; Lubkowski J, 1998, J BIOL CHEM, V273, P32685, DOI 10.1074/jbc.273.49.32685; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Moreau K, 2004, VIROLOGY, V318, P566, DOI 10.1016/j.virol.2003.09.037; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Moreau K, 2002, ARCH VIROL, V147, P1761, DOI 10.1007/s00705-002-0831-5; Moreau K, 2009, VIROLOGY, V392, P94, DOI 10.1016/j.virol.2009.06.031; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishitsuji H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007825; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Pommier Y, 1999, ADV VIRUS RES, V52, P427, DOI 10.1016/S0065-3527(08)60310-3; Reingewertz TH, 2010, PROTEIN PEPTIDE LETT, V17, P988; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Smith JA, 2006, ACS CHEM BIOL, V1, P217, DOI 10.1021/cb600131q; Smith JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-11; SOLTIS DA, 1988, P NATL ACAD SCI USA, V85, P3372, DOI 10.1073/pnas.85.10.3372; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Werner S, 1999, J BIOL CHEM, V274, P26329, DOI 10.1074/jbc.274.37.26329; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yao X, 2010, PROTEIN CELL, V1, P363, DOI 10.1007/s13238-010-0047-5; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	63	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23032	10.1371/journal.pone.0023032	http://dx.doi.org/10.1371/journal.pone.0023032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857987	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300018
J	McCarthy, JS; Sekuloski, S; Griffin, PM; Elliott, S; Douglas, N; Peatey, C; Rockett, R; O'Rourke, P; Marquart, L; Hermsen, C; Duparc, S; Mohrle, J; Trenholme, KR; Humberstone, AJ				McCarthy, James S.; Sekuloski, Silvana; Griffin, Paul M.; Elliott, Suzanne; Douglas, Nanette; Peatey, Chris; Rockett, Rebecca; O'Rourke, Peter; Marquart, Louise; Hermsen, Cornelius; Duparc, Stephan; Moehrle, Joerg; Trenholme, Katharine R.; Humberstone, Andrew J.			A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs	PLOS ONE			English	Article							ACUTE MALARIA; GROWTH-RATES; CGP 56697; IN-VIVO; ATOVAQUONE; PROGUANIL; BENFLUMETOL; ARTEMETHER; CHALLENGE; SAFETY	Background: Critical to the development of new drugs for treatment of malaria is the capacity to safely evaluate their activity in human subjects. The approach that has been most commonly used is testing in subjects with natural malaria infection, a methodology that may expose symptomatic subjects to the risk of ineffective treatment. Here we describe the development and pilot testing of a system to undertake experimental infection using blood stage Plasmodium falciparum parasites (BSP). The objectives of the study were to assess the feasibility and safety of induced BSP infection as a method for assessment of efficacy of new drug candidates for the treatment of P. falciparum infection. Methods and Findings: A prospective, unblinded, Phase IIa trial was undertaken in 19 healthy, malaria-naive, male adult volunteers who were infected with BSP and followed with careful clinical and laboratory observation, including a sensitive, quantitative malaria PCR assay. Volunteers were randomly allocated to treatment with either of two licensed antimalarial drug combinations, artemether-lumefantrine (A/L) or atovaquone-proguanil (A/P). In the first cohort (n = 6) where volunteers received similar to 360 BSP, none reached the target parasitemia of 1,000 before the day designated for antimalarial treatment (day 6). In the second and third cohorts, 13 volunteers received 1,800 BSP, with all reaching the target parasitemia before receiving treatment (A/L, n = 6; A/P, n = 7) The study demonstrated safety in the 19 volunteers tested, and a significant difference in the clearance kinetics of parasitemia between the drugs in the 13 evaluable subjects, with mean parasite reduction ratios of 759 for A/L and 17 for A/P (95% CI 120-4786 and 7-40 respectively; p < 0.01). Conclusions: This system offers a flexible and safe approach to testing the in vivo activity of novel antimalarials.	[McCarthy, James S.; Sekuloski, Silvana; Griffin, Paul M.; Peatey, Chris; O'Rourke, Peter; Marquart, Louise; Trenholme, Katharine R.] Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; [Griffin, Paul M.; Elliott, Suzanne; Douglas, Nanette] Q Pharm Pty Ltd, Brisbane, Qld, Australia; [Rockett, Rebecca] Queensland Pediat Infect Dis Lab, Herston, Qld, Australia; [Hermsen, Cornelius] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Duparc, Stephan; Moehrle, Joerg; Humberstone, Andrew J.] Med Malaria Venture, Geneva, Switzerland	QIMR Berghofer Medical Research Institute; University of Queensland; Radboud University Nijmegen	McCarthy, JS (corresponding author), Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia.	j.mccarthy@uq.edu.au	Duparc, Stephan/AAH-8758-2020; Hermsen, C.C./L-4368-2015; Trenholme, Katharine/C-9244-2013; McCarthy, James S/C-1681-2009; Boyle, Michelle/D-4223-2018; Boyle, Michelle/P-7297-2019; Marquart-Wilson, Louise/CAI-1964-2022; Griffin, Paul/L-4696-2014	Duparc, Stephan/0000-0002-9649-4847; Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; Marquart, Louise/0000-0003-4607-9060; Griffin, Paul/0000-0002-1656-421X; McCarthy, James/0000-0001-6596-9718; Adda, Christopher/0000-0002-0905-8909; Richards, Jack/0000-0001-5786-6989	Medicines for Malaria	Medicines for Malaria	This work was funded by Medicines for Malaria, a non-profit organization whose mission is to advance antimalarial drug development. Three of the authors (SD, JM and AJH) are employees of the funder. The funder therefore had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ARNOLD JD, 1973, ANTIMICROB AGENTS CH, V3, P207, DOI 10.1128/AAC.3.2.207; BEIER JC, 1991, AM J TROP MED HYG, V44, P564, DOI 10.4269/ajtmh.1991.44.564; Bouchaud O, 2000, AM J TROP MED HYG, V63, P274; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; COSGRIFF TM, 1982, AM J TROP MED HYG, V31, P1075, DOI 10.4269/ajtmh.1982.31.1075; COSGRIFF TM, 1984, AM J TROP MED HYG, V33, P767, DOI 10.4269/ajtmh.1984.33.767; deAlencar FEC, 1997, J INFECT DIS, V175, P1544, DOI 10.1086/516497; DEGOWIN RL, 1965, AM J TROP MED HYG, V14, P519, DOI 10.4269/ajtmh.1965.14.519; Dixon MWA, 2009, MOL BIOCHEM PARASIT, V163, P123, DOI 10.1016/j.molbiopara.2008.10.004; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duncan CJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022271; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hatz C, 1998, TROP MED INT HEALTH, V3, P498, DOI 10.1046/j.1365-3156.1998.00250.x; Jiao Xiuquing, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P476; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; Lacy MD, 2002, CLIN INFECT DIS, V35, pE92, DOI 10.1086/343750; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Looareesuwan S, 1999, AM J TROP MED HYG, V60, P238, DOI 10.4269/ajtmh.1999.60.238; Looareesuwan S, 1999, AM J TROP MED HYG, V60, P526, DOI 10.4269/ajtmh.1999.60.526; *MALERA CONS GROUP, 2011, PLOS MED, V0008; MARTIN DC, 1973, ANTIMICROB AGENTS CH, V3, P214, DOI 10.1128/AAC.3.2.214; MARTIN DC, 1967, T ROY SOC TROP MED H, V61, P331, DOI 10.1016/0035-9203(67)90005-3; Mulenga M, 1999, CLIN THER, V21, P841, DOI 10.1016/S0149-2918(99)80006-X; Myint HY, 2004, T ROY SOC TROP MED H, V98, P73, DOI 10.1016/S0035-9203(03)00014-2; Nyunt MM, 2009, AM J TROP MED HYG, V80, P528, DOI 10.4269/ajtmh.2009.80.528; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; RINEHART J, 1976, AM J TROP MED HYG, V25, P769, DOI 10.4269/ajtmh.1976.25.769; ROCKETT RJ, 2011, MALARIA J IN PRESS; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sabchareon A, 1998, T ROY SOC TROP MED H, V92, P201, DOI 10.1016/S0035-9203(98)90749-0; Sanderson F, 2008, AM J TROP MED HYG, V78, P878, DOI 10.4269/ajtmh.2008.78.878; Spring M, 2010, AM J TROP MED HYG, V83, P293; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; van Vugt M, 1998, ANTIMICROB AGENTS CH, V42, P135, DOI 10.1128/AAC.42.1.135; van Vugt M, 1999, AM J TROP MED HYG, V60, P936, DOI 10.4269/ajtmh.1999.60.936; Wells TN, 2010, DISCOV MED, V9, P389; Whiley DM, 2004, DIAGN MICR INFEC DIS, V49, P25, DOI 10.1016/j.diagmicrobio.2003.10.014; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413	47	162	163	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e21914	10.1371/journal.pone.0021914	http://dx.doi.org/10.1371/journal.pone.0021914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887214	Green Published, Green Submitted, gold			2022-12-27	WOS:000294251800002
J	Chang, YJ; Yeh, ML; Li, YC; Hsu, CY; Lin, CC; Hsu, MS; Chiu, WT				Chang, Ying-Jui; Yeh, Min-Li; Li, Yu-Chuan; Hsu, Chien-Yeh; Lin, Chao-Cheng; Hsu, Meng-Shiuan; Chiu, Wen-Ta			Predicting Hospital-Acquired Infections by Scoring System with Simple Parameters	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; ADMINISTRATIVE CODING DATA; TRAUMATIC BRAIN-INJURY; NOSOCOMIAL INFECTIONS; RISK-FACTORS; SURVEILLANCE; PREVENTION; MORTALITY; COSTS	Background: Hospital-acquired infections (HAI) are associated with increased attributable morbidity, mortality, prolonged hospitalization, and economic costs. A simple, reliable prediction model for HAI has great clinical relevance. The objective of this study is to develop a scoring system to predict HAI that was derived from Logistic Regression (LR) and validated by Artificial Neural Networks (ANN) simultaneously. Methodology/Principal Findings: A total of 476 patients from all the 806 HAI inpatients were included for the study between 2004 and 2005. A sample of 1,376 non-HAI inpatients was randomly drawn from all the admitted patients in the same period of time as the control group. External validation of 2,500 patients was abstracted from another academic teaching center. Sixteen variables were extracted from the Electronic Health Records (EHR) and fed into ANN and LR models. With stepwise selection, the following seven variables were identified by LR models as statistically significant: Foley catheterization, central venous catheterization, arterial line, nasogastric tube, hemodialysis, stress ulcer prophylaxes and systemic glucocorticosteroids. Both ANN and LR models displayed excellent discrimination (area under the receiver operating characteristic curve [AUC]: 0.964 versus 0.969, p = 0.507) to identify infection in internal validation. During external validation, high AUC was obtained from both models (AUC: 0.850 versus 0.870, p = 0.447). The scoring system also performed extremely well in the internal (AUC: 0.965) and external (AUC: 0.871) validations. Conclusions: We developed a scoring system to predict HAI with simple parameters validated with ANN and LR models. Armed with this scoring system, infectious disease specialists can more efficiently identify patients at high risk for HAI during hospitalization. Further, using parameters either by observation of medical devices used or data obtained from EHR also provided good prediction outcome that can be utilized in different clinical settings.	[Chang, Ying-Jui; Yeh, Min-Li] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Ying-Jui] Far Eastern Mem Hosp, Dept Dermatol, New Taipei, Taiwan; [Yeh, Min-Li] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan; [Li, Yu-Chuan] Taipei Med Univ, Dept Dermatol, Wan Fang Hosp, Taipei, Taiwan; [Li, Yu-Chuan; Hsu, Chien-Yeh] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Hsu, Chien-Yeh] Taipei Med Univ, CECR, Taipei, Taiwan; [Lin, Chao-Cheng] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu, Meng-Shiuan] Far Eastern Mem Hosp, Infect Dis Sect, Dept Internal Med, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Taipei Medical University; Far Eastern Memorial Hospital; Asia Eastern University of Science & Technology; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	jack@tmu.edu.tw; cyhsu@tmu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657				Archibald LK, 2007, BENNETT BRACHMANS HO, P483; Artigas AT, 2001, CRIT CARE MED, V29, P304, DOI 10.1097/00003246-200102000-00015; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cevik MA, 2005, J HOSP INFECT, V59, P324, DOI 10.1016/j.jhin.2004.10.012; Chong Chee-Fah, 2003, AMIA Annu Symp Proc, P160; D'Agata EMC, 2000, AM J KIDNEY DIS, V35, P1083, DOI 10.1016/S0272-6386(00)70044-8; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Department of Health EY Taiwan, 2010, EL MED REC; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Escolano S, 2000, STAT MED, V19, P3465, DOI 10.1002/1097-0258(20001230)19:24&lt;3465::AID-SIM658&gt;3.0.CO;2-6; Ferrer M, 1999, ANN INTERN MED, V130, P991, DOI 10.7326/0003-4819-130-12-199906150-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Goldstein Melissa M, 2010, Perspect Health Inf Manag, V7; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Kamp-Hopmans TEM, 2003, INFECT CONT HOSP EP, V24, P584, DOI 10.1086/502258; Kostadima E, 2006, EUR RESPIR J, V27, P437, DOI 10.1183/09031936.06.00127405; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Lin CC, 2008, COMPUT METH PROG BIO, V91, P91, DOI 10.1016/j.cmpb.2008.02.004; Mahieu LM, 2001, J HOSP INFECT, V47, P223, DOI 10.1053/jhin.2000.0852; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Shang J S, 2000, Health Care Manag Sci, V3, P287, DOI 10.1023/A:1019018129822; Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Taylor G, 2002, INFECT CONT HOSP EP, V23, P716, DOI 10.1086/501999; Teramoto S, 2006, EUR RESPIR J, V27, P436, DOI 10.1183/09031936.06.00113405; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Wilson JS, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-47; Woeltje KF, 2010, CRIT CARE MED, V38, pS399, DOI 10.1097/CCM.0b013e3181e6d11d	42	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23137	10.1371/journal.pone.0023137	http://dx.doi.org/10.1371/journal.pone.0023137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887234	gold, Green Published, Green Submitted			2022-12-27	WOS:000295832000008
J	Dalmasso, G; Hang, TTN; Yan, YT; Laroui, H; Charania, MA; Ayyadurai, S; Sitaraman, SV; Merlin, D				Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier			Microbiota Modulate Host Gene Expression via MicroRNAs	PLOS ONE			English	Article								Microbiota are known to modulate host gene expression, yet the underlying molecular mechanisms remain elusive. MicroRNAs (miRNAs) are importantly implicated in many cellular functions by post-transcriptionally regulating gene expression via binding to the 3'-untranslated regions (3'-UTRs) of the target mRNAs. However, a role for miRNAs in microbiota-host interactions remains unknown. Here we investigated if miRNAs are involved in microbiota-mediated regulation of host gene expression. Germ-free mice were colonized with the microbiota from pathogen-free mice. Comparative profiling of miRNA expression using miRNA arrays revealed one and eight miRNAs that were differently expressed in the ileum and the colon, respectively, of colonized mice relative to germ-free mice. A computational approach was then employed to predict genes that were potentially targeted by the dysregulated miRNAs during colonization. Overlapping the miRNA potential targets with the microbiota-induced dysregulated genes detected by a DNA microarray performed in parallel revealed several host genes that were regulated by miRNAs in response to colonization. Among them, Abcc3 was identified as a highly potential miRNA target during colonization. Using the murine macrophage RAW 264.7 cell line, we demonstrated that mmu-miR-665, which was dysregulated during colonization, down-regulated Abcc3 expression by directly targeting the Abcc3 3'-UTR. In conclusion, our study demonstrates that microbiota modulate host microRNA expression, which could in turn regulate host gene expression.	[Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Dalmasso, G (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	gdalmas@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK-071594, RO1-DK-55850]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055850, R01DK071594, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399 center grant, RO1-DK-071594 to D.M., RO1-DK-55850 to S.V.S.]; and a research fellowship award from the Crohn's and Colitis Foundation of America [to G.D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; WHITT DD, 1980, INFECT IMMUN, V29, P144, DOI 10.1128/IAI.29.1.144-151.1980; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	17	168	182	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19293	10.1371/journal.pone.0019293	http://dx.doi.org/10.1371/journal.pone.0019293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21886824	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700127
J	Huang, QD; Zhong, GX; Zhang, Y; Ren, J; Fu, Y; Zhang, J; Zhu, W; Yu, XQ				Huang, Qing-Dong; Zhong, Guo-Xing; Zhang, Yang; Ren, Jiang; Fu, Yun; Zhang, Ji; Zhu, Wen; Yu, Xiao-Qi			Cyclen-Based Cationic Lipids for Highly Efficient Gene Delivery towards Tumor Cells	PLOS ONE			English	Article							DNA COMPLEXES; TRANSFECTION; VECTORS; THERAPY; LINKER; GROWTH	Background: Gene therapy has tremendous potential for both inherited and acquired diseases. However, delivery problems limited their clinical application, and new gene delivery vehicles with low cytotoxicity and high transfection efficiency are greatly required. Methods: In this report, we designed and synthesized three amphiphilic molecules (L1-L3) with the structures involving 1, 4, 7, 10-tetraazacyclododecane (cyclen), imidazolium and a hydrophobic dodecyl chain. Their interactions with plasmid DNA were studied via electrophoretic gel retardation assays, fluorescent quenching experiments, dynamic light scattering and transmission electron microscopy. The in vitro gene transfection assay and cytotoxicity assay were conducted in four cell lines. Results: Results indicated that L1 and L3-formed liposomes could effectively bind to DNA to form well-shaped nanoparticles. Combining with neutral lipid DOPE, L3 was found with high efficiency in gene transfer in three tumor cell lines including A549, HepG2 and H460. The optimized gene transfection efficacy of L3 was nearly 5.5 times more efficient than that of the popular commercially available gene delivery agent Lipofectamine 2000 (TM) in human lung carcinoma cells A549. In addition, since L1 and L3 had nearly no gene transfection performance in normal cells HEK293, these cationic lipids showed tumor cell-targeting property to a certain extent. No significant cytotoxicity was found for the lipoplexes formed by L1-L3, and their cytotoxicities were similar to or slightly lower than the lipoplexes prepared from Lipofectamine 2000 (TM). Conclusion: Novel cyclen-based cationic lipids for effective in vitro gene transfection were founded, and these studies here may extend the application areas of macrocyclic polyamines, especially for cyclen.	[Huang, Qing-Dong] Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China; Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Huang, QD (corresponding author), Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China.	jzhang@scu.edu.cn; zhuwen@scu.edu.cn; xqyu@scu.edu.cn	Yu, Xiao-Qi/AAF-2741-2020	YU, WEI/0000-0002-1777-5254	National Science Foundation of China [20972104, 20725206, 20732004, 20902062]; Program for Changjiang Scholars and Innovative Research Team in University; Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	This work was financially supported by the National Science Foundation of China (Nos. 20972104, 20725206, 20732004 and 20902062), the Program for Changjiang Scholars and Innovative Research Team in University, the Key Project of Chinese Ministry of Education in China and the Scientific Fund of Sichuan Province for Outstanding Young Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J GENE MED, V7, P739, DOI 10.1002/jgm.717; Aissaoui A, 2004, J MED CHEM, V47, P5210, DOI 10.1021/jm0408159; Anderson WF, 1998, NATURE, V392, P25; Bajaj A, 2008, J MED CHEM, V51, P2533, DOI 10.1021/jm7010436; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Boktov J, 2007, J GENE MED, V9, P884, DOI 10.1002/jgm.1079; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cheung JL, 1997, J ORG CHEM, V62, P62, DOI 10.1021/jo961254z; Dobbs W, 2009, J AM CHEM SOC, V131, P13338, DOI 10.1021/ja903028f; Ewert K, 2002, J MED CHEM, V45, P5023, DOI 10.1021/jm020233w; Ewert KK, 2006, J AM CHEM SOC, V128, P3998, DOI 10.1021/ja055907h; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fujiwara T, 2000, BBA-BIOMEMBRANES, V1468, P396, DOI 10.1016/S0005-2736(00)00278-9; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Huang QD, 2008, CHEM BIOL DRUG DES, V71, P224, DOI 10.1111/j.1747-0285.2008.00631.x; Kimura E, 1999, CHEM-EUR J, V5, P3113, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3113::AID-CHEM3113>3.0.CO;2-L; Lam AMI, 2000, BBA-BIOMEMBRANES, V1463, P279, DOI 10.1016/S0005-2736(99)00219-9; Li QL, 2006, BIOORGAN MED CHEM, V14, P4151, DOI 10.1016/j.bmc.2006.01.069; Liberska A, 2009, ORG BIOMOL CHEM, V7, P61, DOI 10.1039/b815733b; Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133; Miller AD, 2003, CURR MED CHEM, V10, P1195, DOI 10.2174/0929867033457485; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Petukhov IA, 2010, RUSS CHEM B+, V59, P260, DOI 10.1007/s11172-010-0071-x; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Xia CQ, 2006, BIOORGAN MED CHEM, V14, P5756, DOI 10.1016/j.bmc.2006.04.048; Xiang YZ, 2010, ORG BIOMOL CHEM, V8, P640, DOI 10.1039/b914877a; Yang XB, 2008, BIOORGAN MED CHEM, V16, P3871, DOI 10.1016/j.bmc.2008.01.037; Yi WJ, 2011, ORG BIOMOL CHEM, V9, P2413, DOI 10.1039/c0ob00879f; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Zhang SB, 2007, J CONTROL RELEASE, V123, P1, DOI 10.1016/j.jconrel.2007.07.016; Zhou LH, 2009, CHEM BIOL DRUG DES, V73, P216, DOI 10.1111/j.1747-0285.2008.00765.x	35	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23134					11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21887233				2022-12-27	WOS:000295454200045
J	Cook, S; Conrad, C; Fowlkes, AL; Mohebbi, MH				Cook, Samantha; Conrad, Corrie; Fowlkes, Ashley L.; Mohebbi, Matthew H.			Assessing Google Flu Trends Performance in the United States during the 2009 Influenza Virus A (H1N1) Pandemic	PLOS ONE			English	Article								Background: Google Flu Trends (GFT) uses anonymized, aggregated internet search activity to provide near-real time estimates of influenza activity. GFT estimates have shown a strong correlation with official influenza surveillance data. The 2009 influenza virus A (H1N1) pandemic [pH1N1] provided the first opportunity to evaluate GFT during a non-seasonal influenza outbreak. In September 2009, an updated United States GFT model was developed using data from the beginning of pH1N1. Methodology/Principal Findings: We evaluated the accuracy of each U. S. GFT model by comparing weekly estimates of ILI (influenza-like illness) activity with the U. S. Outpatient Influenza-like Illness Surveillance Network (ILINet). For each GFT model we calculated the correlation and RMSE (root mean square error) between model estimates and ILINet for four time periods: pre-H1N1, Summer H1N1, Winter H1N1, and H1N1 overall (Mar 2009-Dec 2009). We also compared the number of queries, query volume, and types of queries (e. g., influenza symptoms, influenza complications) in each model. Both models' estimates were highly correlated with ILINet pre-H1N1 and over the entire surveillance period, although the original model underestimated the magnitude of ILI activity during pH1N1. The updated model was more correlated with ILINet than the original model during Summer H1N1 (r = 0.95 and 0.29, respectively). The updated model included more search query terms than the original model, with more queries directly related to influenza infection, whereas the original model contained more queries related to influenza complications. Conclusions: Internet search behavior changed during pH1N1, particularly in the categories "influenza complications'' and "term for influenza.'' The complications associated with pH1N1, the fact that pH1N1 began in the summer rather than winter, and changes in health-seeking behavior each may have played a part. Both GFT models performed well prior to and during pH1N1, although the updated model performed better during pH1N1, especially during the summer months.	[Cook, Samantha; Mohebbi, Matthew H.] Google Inc, New York, NY USA; [Conrad, Corrie] Google Inc, London, England; [Fowlkes, Ashley L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Google Incorporated; Google Incorporated; Centers for Disease Control & Prevention - USA	Cook, S (corresponding author), Google Inc, New York, NY USA.	cconrad@google.com		Behmer, Spencer/0000-0002-5038-1046; Cook, Samantha/0000-0002-2173-4471	Google.org; Google Inc.	Google.org; Google Inc.(Google Incorporated)	This research was funded by Google.org, the non-profit arm of Google Inc. This funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Three of the authors (SC, CC, MM) are employees of one of the funders of the study (Google Inc.) and were involved with the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Yes, the authors have the following competing interest. This study was supported by funding from Google Inc., and three of the authors (SC, CC, MM) are employees of Google Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; *CDC, 2007, MMWR-MORBID MORTAL W, V57, P692; *CDC, CDC SEAS INFL FLU FL; *CDCP CDC, INF 2009 H1N1 IMP RA; DEAN J, 2004, OSDI 60 S OP SYST DE; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google.org, 2009, GOOGL FLU TRENDS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed C, 2011, CLIN INFECT DIS, V52, pS90, DOI 10.1093/cid/ciq024; Wilson N, 2009, EUROSURVEILLANCE, V14; [No title captured]	13	225	237	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23610	10.1371/journal.pone.0023610	http://dx.doi.org/10.1371/journal.pone.0023610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886802	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100022
J	Qiu, C; Tian, D; Wan, YM; Zhang, WJ; Qiu, CL; Zhu, ZQ; Ye, RQ; Song, ZG; Zhou, MZ; Yuan, SH; Shi, BS; Wu, M; Liu, Y; Gu, SM; Wei, J; Zhou, ZT; Zhang, XY; Zhang, ZY; Hu, YW; Yuan, ZH; Xu, JQ				Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Wei, Jun; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing			Early Adaptive Humoral Immune Responses and Virus Clearance in Humans Recently Infected with Pandemic 2009 H1N1 Influenza Virus	PLOS ONE			English	Article							ORIGIN; ANTIBODIES	Few studies on the humoral immune responses in human during natural influenza infection have been reported. Here, we used serum samples from pandemic 2009 H1N1 influenza infected patients to characterize the humoral immune responses to influenza during natural infection in humans. We observed for the first time that the pandemic 2009 H1N1 influenza induced influenza A-specific IgM within days after symptoms onset, whereas the unit of IgG did not changed. The magnitude of influenza A-specific IgM antibodies might have a value in predicting the rate of virus clearance to some degree. However, the newly developed IgM was not associated with hemagglutination inhibition (HI) activities in the same samples but correlated with HI activities of subsequently collected sera which were mediated by IgG antibodies, indicating that IgM was critical for influenza infection and influences subsequent IgG antibody responses. These findings provide new important insights on the human immunity to natural influenza infection.	[Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ Hlth, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wei, Jun] Yuncheng CDC, Yuncheng, Peoples R China	Fudan University; Fudan University; Chinese Center for Disease Control & Prevention	Qiu, C (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org; jianqingxu2008@gmail.com	Zhou, Mingzhe/AED-5236-2022; Qiu, Chao/M-6702-2014; , yanmin/GQH-2789-2022	Qiu, Chao/0000-0001-9401-5219; , yanmin/0000-0001-5027-9423; Zhang, Wanju/0000-0001-9913-8584; Zhou, Mingzhe/0000-0002-5518-7330; Zhou, Shi-Rong/0000-0003-2594-3198	National Grand Program on Key Infectious Disease Control [2008ZX10001-002, 2009ZX10602-11]; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program) [2005CB522903]; China Ministry of Science and Technology, China; Key Basic Research Project [10JC1413600]; Science and Technology Commission of Shanghai Municipality, Shanghai	National Grand Program on Key Infectious Disease Control; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); China Ministry of Science and Technology, China(Ministry of Science and Technology, China); Key Basic Research Project; Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by the National Grand Program on Key Infectious Disease Control (Grant #2008ZX10001-002 and 2009ZX10602-11), China Ministry of Health, and by the China National Program on Key Basic Research Projects (973 Program) (No. 2005CB522903), the China Ministry of Science and Technology, China, and by the Key Basic Research Project (10JC1413600), Science and Technology Commission of Shanghai Municipality, Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], MMWR MORB MORTAL WKL; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; McCracken J, 2009, LANCET, V373, P2107, DOI 10.1016/S0140-6736(09)61141-7; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Zhang H, 2009, LANCET INFECT DIS, V9, P456, DOI 10.1016/S1473-3099(09)70181-1	12	66	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22603	10.1371/journal.pone.0022603	http://dx.doi.org/10.1371/journal.pone.0022603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21966459	gold, Green Submitted, Green Published			2022-12-27	WOS:000294253500001
J	Chang, YT; Wu, CC; Shyr, YM; Chen, TC; Hwang, TL; Yeh, TS; Chang, KP; Liu, HP; Liu, YL; Tsai, MH; Chang, YS; Yu, JS				Chang, Ya-Ting; Wu, Chih-Ching; Shyr, Yi-Ming; Chen, Tse-Ching; Hwang, Tsann-Long; Yeh, Ta-Sen; Chang, Kai-Ping; Liu, Hao-Ping; Liu, Yu-Ling; Tsai, Ming-Hung; Chang, Yu-Sun; Yu, Jau-Song			Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CLINICAL-SIGNIFICANCE; PROTEOMIC ANALYSIS; NKG2D LIGANDS; CELL LINES; EXPRESSION; PROTEIN; BIOMARKERS; INDICATOR; DIAGNOSIS	Background: To discover novel markers for improving the efficacy of pancreatic cancer (PC) diagnosis, the secretome of two PC cell lines (BxPC-3 and MIA PaCa-2) was profiled. UL16 binding protein 2 (ULBP2), one of the proteins identified in the PC cell secretome, was selected for evaluation as a biomarker for PC detection because its mRNA level was also found to be significantly elevated in PC tissues. Methods: ULBP2 expression in PC tissues from 67 patients was studied by immunohistochemistry. ULBP2 serum levels in 154 PC patients and 142 healthy controls were measured by bead-based immunoassay, and the efficacy of serum ULBP2 for PC detection was compared with the widely used serological PC marker carbohydrate antigen 19-9 (CA 19-9). Results: Immunohistochemical analyses revealed an elevated expression of ULPB2 in PC tissues compared with adjacent non-cancerous tissues. Meanwhile, the serum levels of ULBP2 among all PC patients (n = 154) and in early-stage cancer patients were significantly higher than those in healthy controls (p < 0.0001). The combination of ULBP2 and CA 19-9 outperformed each marker alone in distinguishing PC patients from healthy individuals. Importantly, an analysis of the area under receiver operating characteristic curves showed that ULBP2 was superior to CA 19-9 in discriminating patients with early-stage PC from healthy controls. Conclusions: Collectively, our results indicate that ULBP2 may represent a novel and useful serum biomarker for pancreatic cancer primary screening.	[Chang, Ya-Ting; Tsai, Ming-Hung; Yu, Jau-Song] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Chih-Ching; Liu, Hao-Ping; Liu, Yu-Ling; Chang, Yu-Sun; Yu, Jau-Song] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Shyr, Yi-Ming] Taipei Vet Gen Hosp, Dept Surg, Div Gen & Transplantat Surg, Taipei, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Anat Pathol, Tao Yuan, Taiwan; [Hwang, Tsann-Long; Yeh, Ta-Sen] Chang Gung Mem Hosp, Dept Surg, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otolaryngol, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Head & Neck Surg, Tao Yuan, Taiwan; [Yu, Jau-Song] Chang Gung Univ, Dept Cell & Mol Biol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, YT (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	luckywu@mail.cgu.edu.tw; yusong@mail.cgu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657	Taiwan National Science Council [NSC 96-2320-B-182-031-MY3]; Department of Health [DOH-99-TD-C-111-006]; Ministry of Education [EMRPD180241, EMRPD180091]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Ministry of Education	This study was supported by the grants from the Taiwan National Science Council (NSC 96-2320-B-182-031-MY3), Department of Health (DOH-99-TD-C-111-006), and Ministry of Education (EMRPD180241 and EMRPD180091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan M, 2001, TUMORI, V87, P337, DOI 10.1177/030089160108700513; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chang ST, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-105; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; *DEP HLTH, 2009, STAND DEATH RAT LEAD; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guo JH, 2009, CANCER SCI, V100, P2292, DOI 10.1111/j.1349-7006.2009.01324.x; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hoimes CJ, 2009, J PANCREAS, V10, P352; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Katz MH, 2005, PANCREATOLOGY, V5, P576, DOI 10.1159/000087500; Lee MX, 2009, J PANCREAS, V10, P104; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Maccalli C, 2007, CLIN CANCER RES, V13, P7459, DOI 10.1158/1078-0432.CCR-07-1166; MAGNANI JL, 1983, CANCER RES, V43, P5489; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Melle C, 2007, CLIN CHEM, V53, P629, DOI 10.1373/clinchem.2006.079194; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Oto A, 2006, CURR PROBL DIAGN RAD, V35, P199, DOI 10.1067/j.cpradiol.2006.06.001; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Pende D, 2002, CANCER RES, V62, P6178; Pliarchopoulou K, 2009, CANCER TREAT REV, V35, P431, DOI 10.1016/j.ctrv.2009.02.005; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; RAVN V, 1993, PATHOL RES PRACT, V189, P1015; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; TEMPERO MA, 1987, CANCER RES, V47, P5501; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Watson NFS, 2006, INT J CANCER, V118, P1445, DOI 10.1002/ijc.21510; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu CC, 2008, PROTEOM CLIN APPL, V2, P1586, DOI 10.1002/prca.200800080; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Yu KH, 2009, J PROTEOME RES, V8, P1565, DOI 10.1021/pr800904z	41	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20029	10.1371/journal.pone.0020029	http://dx.doi.org/10.1371/journal.pone.0020029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21887234	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400031
J	McCarthy, JS; Marjason, J; Elliott, S; Fahey, P; Bang, G; Malkin, E; Tierney, E; Aked-Hurditch, H; Adda, C; Cross, N; Richards, JS; Fowkes, FJI; Boyle, MJ; Long, C; Druilhe, P; Beeson, JG; Anders, RF				McCarthy, James S.; Marjason, Joanne; Elliott, Suzanne; Fahey, Paul; Bang, Gilles; Malkin, Elissa; Tierney, Eveline; Aked-Hurditch, Hayley; Adda, Christopher; Cross, Nadia; Richards, Jack S.; Fowkes, Freya J. I.; Boyle, Michelle J.; Long, Carole; Druilhe, Pierre; Beeson, James G.; Anders, Robin F.			A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide (R) ISA 720	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-2; ANCHORED MEMBRANE-PROTEINS; IN-VITRO GROWTH; PLASMODIUM-FALCIPARUM; CLINICAL-TRIAL; HUMORAL RESPONSE; ENDEMIC AREA; IMMUNOGENICITY; SAFETY; ANTIBODIES	Background: In a previous Phase 1/2b malaria vaccine trial testing the 3D7 isoform of the malaria vaccine candidate Merozoite surface protein 2 (MSP2), parasite densities in children were reduced by 62%. However, breakthrough parasitemias were disproportionately of the alternate dimorphic form of MSP2, the FC27 genotype. We therefore undertook a dose-escalating, double-blinded, placebo-controlled Phase 1 trial in healthy, malaria-naive adults of MSP2-C1, a vaccine containing recombinant forms of the two families of msp2 alleles, 3D7 and FC27 (EcMSP2-3D7 and EcMSP2-FC27), formulated in equal amounts with Montanide (R) ISA 720 as a water-in-oil emulsion. Methodology/Principal Findings: The trial was designed to include three dose cohorts (10, 40, and 80 mu g), each with twelve subjects receiving the vaccine and three control subjects receiving Montanide (R) ISA 720 adjuvant emulsion alone, in a schedule of three doses at 12-week intervals. Due to unexpected local reactogenicity and concern regarding vaccine stability, the trial was terminated after the second immunisation of the cohort receiving the 40 mu g dose; no subjects received the 80 mu g dose. Immunization induced significant IgG responses to both isoforms of MSP2 in the 10 mu g and 40 mu g dose cohorts, with antibody levels by ELISA higher in the 40 mu g cohort. Vaccine-induced antibodies recognised native protein by Western blots of parasite protein extracts and by immunofluorescence microscopy. Although the induced anti-MSP2 antibodies did not directly inhibit parasite growth in vitro, IgG from the majority of individuals tested caused significant antibody-dependent cellular inhibition (ADCI) of parasite growth. Conclusions/Significance: As the majority of subjects vaccinated with MSP2-C1 developed an antibody responses to both forms of MSP2, and that these antibodies mediated ADCI provide further support for MSP2 as a malaria vaccine candidate. However, in view of the reactogenicity of this formulation, further clinical development of MSP2-C1 will require formulation of MSP2 in an alternative adjuvant.	[McCarthy, James S.] Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; [Marjason, Joanne; Elliott, Suzanne; Aked-Hurditch, Hayley] Q Pharm Pty Ltd, Brisbane, Qld, Australia; [Fahey, Paul; Malkin, Elissa; Tierney, Eveline] PATH Malaria Vaccine Initiat, Bethesda, MD USA; [Bang, Gilles; Druilhe, Pierre] Inst Pasteur, Paris, France; [Adda, Christopher; Anders, Robin F.] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia; [Cross, Nadia; Richards, Jack S.; Fowkes, Freya J. I.; Boyle, Michelle J.; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Long, Carole] NIAID, NIH, Bethesda, MD 20892 USA	QIMR Berghofer Medical Research Institute; University of Queensland; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; La Trobe University; Walter & Eliza Hall Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	McCarthy, JS (corresponding author), Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia.	J.McCarthy@uq.edu.au	Duparc, Stephan/AAH-8758-2020; Hermsen, C.C./L-4368-2015; Trenholme, Katharine/C-9244-2013; McCarthy, James S/C-1681-2009; Boyle, Michelle/D-4223-2018; Boyle, Michelle/P-7297-2019; Marquart-Wilson, Louise/CAI-1964-2022; Griffin, Paul/L-4696-2014	Duparc, Stephan/0000-0002-9649-4847; Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; Marquart, Louise/0000-0003-4607-9060; Griffin, Paul/0000-0002-1656-421X; McCarthy, James/0000-0001-6596-9718; Adda, Christopher/0000-0002-0905-8909; Richards, Jack/0000-0001-5786-6989	PATH-MVI; NHMRC; Queensland Health Research Fellowship; Australian Research Council; National Institute of Allergy and Infectious Diseases, NIH	PATH-MVI; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Queensland Health Research Fellowship; Australian Research Council(Australian Research Council); National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The trial was funded by PATH-MVI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JMC is supported by an NHMRC Practitioner Fellowship and a Queensland Health Research Fellowship. JGB was supported by a Career Development Award from the National Health and Medical Research Council, and a Future Fellowship from the Australian Research Council. Carole Long was supported in part by the intramural program of the National Institute of Allergy and Infectious Diseases, NIH. The GIA Reference Center at NIH is supported by the PATH-Malaria Vaccine Initiative.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; ALYAMAN F, 1994, AM J TROP MED HYG, V51, P593, DOI 10.4269/ajtmh.1994.51.593; ALYAMAN F, 1995, PARASITE IMMUNOL, V17, P493, DOI 10.1111/j.1365-3024.1995.tb00920.x; Anders RF, 2010, HUM VACCINES, V6, P39, DOI 10.4161/hv.6.1.10712; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Coler RN, 2009, PARASITE IMMUNOL, V31, P520, DOI 10.1111/j.1365-3024.2009.01142.x; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Collin N, 2010, ADJUVANT TECHNOLOGY; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Cowman AF, 2000, FEBS LETT, V476, P84, DOI 10.1016/S0014-5793(00)01703-8; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Elliott SL, 2008, J VIROL, V82, P1448, DOI 10.1128/JVI.01409-07; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; FENTON B, 1991, MOL CELL BIOL, V11, P963, DOI 10.1128/MCB.11.2.963; Flueck C, 2009, VACCINE, V27, P2653, DOI 10.1016/j.vaccine.2009.02.081; Fourcade J, 2008, J IMMUNOTHER, V31, P781, DOI 10.1097/CJI.0b013e318183af0b; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2000, VACCINE, V18, P2504, DOI 10.1016/S0264-410X(00)00036-0; Genton B, 2003, VACCINE, V22, P30, DOI 10.1016/S0264-410X(03)00536-X; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; HOLM S, 1979, SCAND J STAT, V6, P65; Hu JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001952; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Jouin H, 2004, CYTOM PART A, V57A, P34, DOI 10.1002/cyto.a.10110; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M; Malkin E, 2008, VACCINE, V26, P6864, DOI 10.1016/j.vaccine.2008.09.081; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Miles AP, 2005, VACCINE, V23, P2530, DOI 10.1016/j.vaccine.2004.08.049; MVI, 2009, MVI IDRI COLL AIMS B; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; Oliveira GA, 2005, INFECT IMMUN, V73, P3587, DOI 10.1128/IAI.73.6.3587-3597.2005; Osier FHA, 2010, PARASITE IMMUNOL, V32, P193, DOI 10.1111/j.1365-3024.2009.01178.x; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Pierce MA, 2010, VACCINE, V28, P2236, DOI 10.1016/j.vaccine.2009.12.049; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Pye D, 1997, VACCINE, V15, P1017, DOI 10.1016/S0264-410X(96)00289-7; RAMASAMY R, 1990, IMMUNOL LETT, V23, P305, DOI 10.1016/0165-2478(90)90077-4; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Sanders PR, 2006, INFECT IMMUN, V74, P4330, DOI 10.1128/IAI.00054-06; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; SMYTHE JA, 1988, P NATL ACAD SCI USA, V85, P5195, DOI 10.1073/pnas.85.14.5195; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; STURCHLER D, 1995, AM J TROP MED HYG, V53, P423; TAYLOR RR, 1995, INFECT IMMUN, V63, P4382, DOI 10.1128/IAI.63.11.4382-4388.1995; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Toledo H, 2001, VACCINE, V19, P4328, DOI 10.1016/S0264-410X(01)00111-6; Tongren JE, 2005, INFECT IMMUN, V73, P8119, DOI 10.1128/IAI.73.12.8119-8129.2005; Walther M, 2005, VACCINE, V23, P857, DOI 10.1016/j.vaccine.2004.08.020; World Health Organization, 2021, DEC HLTH AG	64	162	163	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24413	10.1371/journal.pone.0024413	http://dx.doi.org/10.1371/journal.pone.0024413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21887214	Green Published, Green Submitted, gold			2022-12-27	WOS:000295257900013
